*NEWRECORD
RECTYPE = D
MH = Calcimycin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = A-23187|T109|T195|LAB|NRW|NLM (1991)|900308|abbcdef
ENTRY = A23187|T109|T195|LAB|NRW|UNK (19XX)|741111|abbcdef
ENTRY = Antibiotic A23187|T109|T195|NON|NRW|NLM (1991)|900308|abbcdef
ENTRY = A 23187
ENTRY = A23187, Antibiotic
MN = D03.438.221.173
PA = Anti-Bacterial Agents
PA = Calcium Ionophores
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T195
N1 = 4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))-
RN = 37H9VM9WZL
RR = 52665-69-7 (Calcimycin)
PI = Antibiotics (1973-1974)
PI = Carboxylic Acids (1973-1974)
MS = An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.
OL = use CALCIMYCIN to search A 23187 1975-90
PM = 91; was A 23187 1975-90 (see under ANTIBIOTICS 1975-83)
HN = 91(75); was A 23187 1975-90 (see under ANTIBIOTICS 1975-83)
MR = 20130708
DA = 19741119
DC = 1
DX = 19840101
UI = D000001

*NEWRECORD
RECTYPE = D
MH = Temefos
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK RE SD ST TO TU UR
ENTRY = Abate|T115|T131|TRD|NRW|NLM (1996)|941114|abbcdef
ENTRY = Difos|T115|T131|TRD|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Temephos|T115|T131|TRD|EQV|NLM (1996)|941201|abbcdef
MN = D02.705.400.625.800
MN = D02.705.539.345.800
MN = D02.886.300.692.800
PA = Insecticides
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1974)
ST = T115
ST = T131
N1 = Phosphorothioic acid, O,O'-(thiodi-4,1-phenylene) O,O,O',O'-tetramethyl ester
RN = ONP3ME32DL
RR = 3383-96-8 (Temefos)
AN = for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
PI = Insecticides (1966-1971)
MS = An organothiophosphate insecticide.
PM = 96; was ABATE 1972-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90)
HN = 96; was ABATE 1972-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90)
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000002

*NEWRECORD
RECTYPE = D
MH = Abattoirs
AQ = CL EC ES HI IS LJ MA SN ST
PRINT ENTRY = Slaughterhouses|T073|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Abattoir
ENTRY = Slaughterhouse
MN = J01.576.423.200.700.100
MH_TH = NLM (1966)
ST = T073
MS = Places where animals are slaughtered and dressed for market.
MR = 19970620
DA = 19990101
DC = 1
UI = D000003

*NEWRECORD
RECTYPE = D
MH = Abbreviations as Topic
ENTRY = Acronyms as Topic|T170|NON|NRW|NLM (2008)|070629|abcdef
MN = L01.143.506.598.400.556.131
MH_TH = NLM (2008)
ST = T170
AN = includes acronyms; do not confuse with Publication Type ABBREVIATIONS
MS = Shortened forms of written words or phrases used for brevity.
PM = 2008; see ABBREVIATIONS 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D000004

*NEWRECORD
RECTYPE = D
MH = Abdomen
AQ = AB AH BS EM GD IR MI PA PH PP PS RE RI SU US VI
ENTRY = Abdomens
MN = A01.923.047
EC = injuries:Abdominal Injuries
EC = radiography:Radiography, Abdominal
MH_TH = NLM (1966)
ST = T029
AN = GEN: prefer specifics; abdom muscles = ABDOMINAL MUSCLES but RECTUS ABDOMINIS is available; abdominal pain = ABDOMINAL PAIN; abrupt dis requiring emerg surg = ABDOMEN, ACUTE
MS = That portion of the body that lies between the THORAX and the PELVIS.
MR = 20110624
DA = 19990101
DC = 1
UI = D000005

*NEWRECORD
RECTYPE = D
MH = Abdomen, Acute
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Abdomens, Acute
ENTRY = Acute Abdomen
ENTRY = Acute Abdomens
MN = C10.597.617.044.200
MN = C23.888.592.612.054.200
MN = C23.888.821.030.249
MH_TH = NLM (1966)
ST = T184
MS = A clinical syndrome with acute abdominal pain that is severe, localized, and rapid in onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.
CATSH = CAT LIST
MR = 20150708
DA = 19990101
DC = 1
UI = D000006

*NEWRECORD
RECTYPE = D
MH = Abdominal Injuries
DE = ABDOMINAL INJ
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Injuries, Abdominal|T037|NON|EQV|UNK (19XX)|860101|INJ ABDOMINAL|abcdefv
ENTRY = Abdominal Injury
ENTRY = Injury, Abdominal
MN = C26.017
MH_TH = NLM (1966)
ST = T037
AN = general term for inj of organs in the abdom cavity; prefer specific organs /inj
MS = General or unspecified injuries involving organs in the abdominal cavity.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000007

*NEWRECORD
RECTYPE = D
MH = Abdominal Neoplasms
DE = ABDOMINAL NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Abdominal Neoplasm
ENTRY = Neoplasm, Abdominal
ENTRY = Neoplasms, Abdominal
MN = C04.588.033
MH_TH = NLM (1966)
ST = T191
AN = general term for neopl of organs in the abdom cavity; prefer specific organ/neopl terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl if given (IM)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D000008

*NEWRECORD
RECTYPE = D
MH = Abdominal Muscles
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Abdominal Muscle
ENTRY = Muscle, Abdominal
ENTRY = Muscles, Abdominal
MN = A02.633.567.050
FX = Abdominal Wall
MH_TH = NLM (1966)
ST = T024
AN = RECTUS ABDOMINIS is available; hernia = HERNIA, VENTRAL; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
MS = Muscles forming the ABDOMINAL WALL including RECTUS ABDOMINIS, external and internal oblique muscles, transversus abdominis, and quadratus abdominis. (from Stedman, 25th ed)
OL = use ABDOMINAL MUSCLES to search ABDOMINAL WALL 1966-92
PM = 93; was ABDOMINAL WALL 1963-92
HN = 93; was ABDOMINAL WALL 1966-92
MR = 20020702
DA = 19990101
DC = 1
UI = D000009

*NEWRECORD
RECTYPE = D
MH = Abducens Nerve
AQ = AB AH BS CH CY DE EM EN GD IM ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Cranial Nerve VI|T023|NON|EQV|NLM (1998)|960731|abcdef
PRINT ENTRY = Sixth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef
ENTRY = Abducent Nerve|T023|NON|EQV|UNK (19XX)|760526|abcdef
ENTRY = Nerve VI|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Nervus Abducens|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Abducen, Nervus
ENTRY = Abducens, Nervus
ENTRY = Abducent Nerves
ENTRY = Cranial Nerve VIs
ENTRY = Cranial Nerve, Sixth
ENTRY = Nerve VI, Cranial
ENTRY = Nerve VIs
ENTRY = Nerve VIs, Cranial
ENTRY = Nerve, Abducens
ENTRY = Nerve, Abducent
ENTRY = Nerve, Sixth Cranial
ENTRY = Nerves, Sixth Cranial
ENTRY = Nervus Abducen
ENTRY = Sixth Cranial Nerves
MN = A08.800.800.120.030
FX = Abducens Nucleus
EC = injuries:Abducens Nerve Injury
MH_TH = NLM (1966)
ST = T023
AN = neoplasms = ABDUCENS NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)
MS = The 6th cranial nerve which originates in the ABDUCENS NUCLEUS of the PONS and sends motor fibers to the lateral rectus muscles of the EYE. Damage to the nerve or its nucleus disrupts horizontal eye movement control.
OL = use ABDUCENS NERVE to search ABDUCENT NERVE 1966-76
PM = 77; was ABDUCENT NERVE 1963-76
HN = 77; was ABDUCENT NERVE 1963-76
MR = 20140620
DA = 19990101
DC = 1
UI = D000010

*NEWRECORD
RECTYPE = D
MH = Abelson murine leukemia virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Abelson Leukemia Virus|T005|EPO|EQV|NLM (1980)|990101|abcdef
ENTRY = Leukemia Virus, Abelson
ENTRY = Virus, Abelson Leukemia
MN = B04.613.807.375.525.020
MN = B04.820.650.375.525.020
MH_TH = NLM (2002)
ST = T005
AN = infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM)
PI = Mouse Leukemia Viruses (1966-1979)
MS = A replication-defective strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with FRIEND MURINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; or RAUSCHER VIRUS.
PM = 2002; see ABELSON LEUKEMIA VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1980-1990
HN = 2002 (1980)
MR = 20150622
DA = 19790416
DC = 1
DX = 19910101
UI = D000011

*NEWRECORD
RECTYPE = D
MH = Abetalipoproteinemia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bassen-Kornzweig Syndrome|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740329|abcdeeeef
PRINT ENTRY = Microsomal Triglyceride Transfer Protein Deficiency|T047|NON|EQV|NLM (2007)|OMIM (2013)|050720|MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN DEFIC|abcdeefv
ENTRY = Acanthocytosis|T047|NON|EQV|GHR (2014)|OMIM (2013)|111115|abcdeef
ENTRY = Bassen-Kornzweig Disease|T047|EPO|EQV|NLM (2000)|991104|BASSEN KORNZWEIG DIS|abcdefv
ENTRY = Betalipoprotein Deficiency Disease|T047|NON|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090514|abcdeeef
ENTRY = Microsomal Triglyceride Transfer Protein Deficiency Disease|T047|NON|EQV|GHR (2014)|NLM (2000)|ORD (2010)|991104|MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN DEFIC DIS|abcdeeefv
ENTRY = Acanthocytoses
ENTRY = Bassen Kornzweig Disease
ENTRY = Bassen Kornzweig Syndrome
ENTRY = Betalipoprotein Deficiency Diseases
ENTRY = Deficiency Disease, Betalipoprotein
ENTRY = Deficiency Diseases, Betalipoprotein
ENTRY = Disease, Betalipoprotein Deficiency
ENTRY = Diseases, Betalipoprotein Deficiency
MN = C16.320.565.398.500.440.500
MN = C18.452.584.500.875.440.500
MN = C18.452.648.398.500.440.500
MH_TH = GHR (2014)
MH_TH = NLM (1964)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
MS = An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL.
PM = 1966
HN = 1966(1964)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D000012

*NEWRECORD
RECTYPE = D
MH = Congenital Abnormalities
DE = CONGEN ABNORM
AQ = BL CF CL DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Birth Defects|T019|NON|EQV|UNK (19XX)|760508|abcdef
PRINT ENTRY = Congenital Defects|T019|NON|EQV|UNK (19XX)|770322|CONGEN DEFECTS|abcdefv
PRINT ENTRY = Deformities|T019|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Abnormalities, Congenital|T019|NON|EQV|UNK (19XX)|781218|ABNORM CONGEN|abcdefv
ENTRY = Defects, Congenital|T019|NON|EQV|UNK (19XX)|770322|DEFECTS CONGEN|abcdefv
ENTRY = Abnormality, Congenital
ENTRY = Birth Defect
ENTRY = Congenital Abnormality
ENTRY = Congenital Defect
ENTRY = Defect, Birth
ENTRY = Defect, Congenital
ENTRY = Defects, Birth
ENTRY = Deformity
MN = C16.131
EC = chemically induced:Abnormalities, Drug-Induced
MH_TH = NLM (1980)
ST = T019
AN = general only: prefer /abnorm with specific anatomical term or specific animal: Manual 19.7+, 19.8.1; policy: Manual 23.20+
MS = Malformations of organs or body parts during development in utero.
PM = 2008; see ABNORMALITIES 1963-2007
HN = 2008 (1963)
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D000013

*NEWRECORD
RECTYPE = D
MH = Abnormalities, Drug-Induced
DE = ABNORM DRUG IND
AQ = BL CF CL DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Drug-Induced Abnormalities|T019|NON|EQV|UNK (19XX)|771207|DRUG IND ABNORM|abcdefv
ENTRY = Abnormalities, Drug Induced
ENTRY = Abnormality, Drug-Induced
ENTRY = Drug Induced Abnormalities
ENTRY = Drug-Induced Abnormality
MN = C16.131.042
FX = Teratogenesis
FX = Teratogens
MH_TH = NLM (1964)
ST = T019
AN = IM; do not use /chem ind /compl /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific chem /adv eff-pois-tox (IM) + specific organ /abnorm or specific abnorm /chem ind (IM); Manual 23.20.3
MS = Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
PM = 64
HN = 64
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19640101
UI = D000014

*NEWRECORD
RECTYPE = D
MH = Abnormalities, Multiple
DE = ABNORM MULTIPLE
AQ = BL CF CI CL DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Multiple Abnormalities|T019|NON|EQV|UNK (19XX)|860101|MULTIPLE ABNORM|abcdefv
MN = C16.131.077
FX = Intellectual Disability
MH_TH = NLM (1968)
ST = T019
AN = IM; do not use /compl /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific abnorm (IM); Manual 23.20.2
PI = Abnormalities (1966-1967)
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20110705
DA = 19990101
DC = 1
DX = 19680101
UI = D000015

*NEWRECORD
RECTYPE = D
MH = Abnormalities, Radiation-Induced
DE = ABNORM RAD IND
AQ = BL CF CL DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Radiation-Induced Abnormalities|T019|NON|EQV|UNK (19XX)|780320|RAD IND ABNORM|abcdefv
ENTRY = Abnormalities, Radiation Induced
ENTRY = Abnormality, Radiation-Induced
ENTRY = Radiation Induced Abnormalities
ENTRY = Radiation-Induced Abnormality
MN = C16.131.080
MN = C26.733.031
MN = G01.750.748.500.031
MN = N06.850.460.350.850.500.031
MN = N06.850.810.300.360.031
FX = Teratogenesis
MH_TH = NLM (1979)
ST = T019
AN = IM; do not use /compl /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific abnorm (IM)
PI = Abnormalities (1966-1978)
PI = Radiation Injuries (1966-1978)
MS = Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation.
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20150622
DA = 19780320
DC = 1
DX = 19790101
UI = D000016

*NEWRECORD
RECTYPE = D
MH = ABO Blood-Group System
AQ = AD AE AN BI BL CF CH CL CT EC GE HI IM IP ME PD PH PO TO TU UL UR
PRINT ENTRY = ABH Blood Group|T022|NON|EQV|UNK (19XX)|880607|abcdef
PRINT ENTRY = ABO Factors|T129|NON|NRW|UNK (19XX)|750722|abcdef
ENTRY = Blood Group H Type 1 Antigen|T129|NON|NRW|UNK (19XX)|840305|abcdef
ENTRY = H Blood Group|T022|NON|EQV|UNK (19XX)|800804|abcdef
ENTRY = H Blood Group System|T022|NON|EQV|UNK (19XX)|840920|abcdef
ENTRY = ABH Blood Groups
ENTRY = ABO Blood Group System
ENTRY = ABO Blood-Group Systems
ENTRY = ABO Factor
ENTRY = Blood Group, ABH
ENTRY = Blood Group, H
ENTRY = Blood Groups, ABH
ENTRY = Blood Groups, H
ENTRY = Blood-Group System, ABO
ENTRY = Blood-Group Systems, ABO
ENTRY = Factor, ABO
ENTRY = Factors, ABO
ENTRY = H Blood Groups
ENTRY = System, ABO Blood-Group
ENTRY = Systems, ABO Blood-Group
MN = D23.050.301.290.031
MN = D23.050.705.230.031
MH_TH = NLM (1976)
ST = T022
RN = 0
AN = IM; coord with disease /blood (IM), not /immunol nor /genet; TN 230
MS = The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane.
OL = use ABO BLOOD-GROUP SYSTEM to search ABO FACTORS 1966-75
PM = 76; was ABO FACTORS 1963-75
HN = 76; was ABO FACTORS 1963-75
CATSH = CAT LIST
MR = 20050630
DA = 19750725
DC = 1
DX = 19760101
UI = D000017

*NEWRECORD
RECTYPE = D
MH = Abomasum
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Abomasums
MN = A13.869.106
MH_TH = NLM (1968)
ST = T023
AN = a ruminant's 4th stomach; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet (IM) + histol type /vet (IM); ulcer: coord IM with STOMACH ULCER /vet (IM)
PI = Stomach (1966-1967)
MS = The fourth stomach of ruminating animals. It is also called the "true" stomach. It is an elongated pear-shaped sac lying on the floor of the abdomen, on the right-hand side, and roughly between the seventh and twelfth ribs. It leads to the beginning of the small intestine. (From Black's Veterinary Dictionary, 17th ed)
PM = 68
HN = 68
MR = 19950518
DA = 19990101
DC = 1
DX = 19680101
UI = D000018

*NEWRECORD
RECTYPE = D
MH = Abortifacient Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Abortifacient Effect|T039|NON|REL|NLM (2012)|110331|abcdef
ENTRY = Abortifacient Effects|T039|NON|REL|NLM (2012)|110331|abcdef
ENTRY = Abortifacients|T121|NON|EQV|NLM (1993)|911009|abcdef
ENTRY = Contraceptive Agents, Postconception|T121|NON|EQV|POPLINE (1978)|781218|abcdef
ENTRY = Agents, Abortifacient
ENTRY = Agents, Postconception Contraceptive
ENTRY = Effect, Abortifacient
ENTRY = Effects, Abortifacient
ENTRY = Postconception Contraceptive Agents
MN = D27.505.696.875.131
MN = D27.505.954.705.131
FX = Oxytocics
MH_TH = POPLINE (1978)
ST = T121
RN = 0
AN = use no qualifiers for abortifacients when used to interrupt pregnancy; note entry term ABORTIFACIENT EFFECT: use only for the abortifacient effect of a chemical substance
PI = Abortion, Induced (1970-1974)
MS = Chemical substances that interrupt pregnancy after implantation.
PM = 75
HN = 75
MR = 20140625
DA = 19990101
DC = 1
DX = 19750101
UI = D000019

*NEWRECORD
RECTYPE = D
MH = Abortifacient Agents, Nonsteroidal
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Abortifacient Agents, Non-Steroidal|T121|NON|EQV|UNK (19XX)|771207|abcdef
ENTRY = Abortifacient Agents, Non Steroidal
ENTRY = Agents, Non-Steroidal Abortifacient
ENTRY = Agents, Nonsteroidal Abortifacient
ENTRY = Non-Steroidal Abortifacient Agents
ENTRY = Nonsteroidal Abortifacient Agents
MN = D27.505.696.875.131.100
MN = D27.505.954.705.131.100
MH_TH = NLM (1975)
ST = T121
RN = 0
AN = do not use /ther use for use of the abortifacients as abortifacients
PI = Abortion, Induced (1970-1974)
PI = specific chemical (1971-1974)
MS = Non-steroidal chemical compounds with abortifacient activity.
PM = 91; was see under ABORTIFACIENT AGENTS 1975-90
HN = 91(75); was see under ABORTIFACIENT AGENTS 1975-90
MR = 20140625
DA = 19741111
DC = 1
DX = 19910101
UI = D000020

*NEWRECORD
RECTYPE = D
MH = Abortifacient Agents, Steroidal
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Steroid Abortifacients|T110|T121|NON|EQV|POPLINE (1978)|781218|abbcdef
ENTRY = Abortifacients, Steroid
ENTRY = Agents, Steroidal Abortifacient
ENTRY = Steroidal Abortifacient Agents
MN = D27.505.696.875.131.200
MN = D27.505.954.705.131.200
MH_TH = NLM (1975)
ST = T110
ST = T121
RN = 0
AN = do not use /ther use for use of the abortifacients as abortifacients
PI = Abortion, Induced (1970-1974)
PI = specific chemical (1970-1974)
MS = Steroidal compounds with abortifacient activity.
PM = 91; was see under ABORTIFACIENT AGENTS 1975-90
HN = 91(75); was see under ABORTIFACIENT AGENTS 1975-90
MR = 20050630
DA = 19741111
DC = 1
DX = 19910101
UI = D000021

*NEWRECORD
RECTYPE = D
MH = Abortion, Spontaneous
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VI
PRINT ENTRY = Miscarriage|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Abortion, Tubal|T047|NON|NRW|NLM (1980)|781218|abcdef
ENTRY = Spontaneous Abortion|T047|NON|EQV|NLM (2003)|020304|abcdef
ENTRY = Abortions, Spontaneous
ENTRY = Abortions, Tubal
ENTRY = Miscarriages
ENTRY = Spontaneous Abortions
ENTRY = Tubal Abortion
ENTRY = Tubal Abortions
MN = C13.703.039
FX = Aborted Fetus
FX = Abortifacient Agents
EC = veterinary:Abortion, Veterinary
MH_TH = NLM (1999)
ST = T047
AN = /chem ind permitted but do not confuse with ABORTION, INDUCED; check the tags HUMANS & FEMALE & PREGNANCY
MS = Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.
PM = 99; see ABORTION 1966-98; for ABORTION, SPONTANEOUS see ABORTION 1992-98
HN = 99(63)
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D000022

*NEWRECORD
RECTYPE = D
MH = Abortion Applicants
AQ = CL ED HI LJ PX SN
PRINT ENTRY = Abortion Seekers|T101|NON|EQV|POPLINE (1978)|741111|abcdef
ENTRY = Abortion Seekers, Refused|T101|NON|NRW|POPLINE (1978)|781218|abcdef
ENTRY = Abortion Seekers, Repeated|T101|NON|NRW|POPLINE (1978)|781218|abcdef
ENTRY = Abortion Applicant
ENTRY = Abortion Seeker
ENTRY = Abortion Seeker, Refused
ENTRY = Abortion Seeker, Repeated
ENTRY = Applicant, Abortion
ENTRY = Applicants, Abortion
ENTRY = Refused Abortion Seeker
ENTRY = Refused Abortion Seekers
ENTRY = Repeated Abortion Seeker
ENTRY = Repeated Abortion Seekers
ENTRY = Seeker, Abortion
ENTRY = Seeker, Refused Abortion
ENTRY = Seeker, Repeated Abortion
ENTRY = Seekers, Abortion
ENTRY = Seekers, Refused Abortion
ENTRY = Seekers, Repeated Abortion
MN = M01.050
MH_TH = NLM (1975)
ST = T101
AN = don't forget also check tags HUMANS & FEMALE & PREGNANCY
PI = Abortion, Induced (1970-1974)
PI = Abortion, Therapeutic (1966-1974)
MS = Individuals requesting induced abortions.
PM = 76; was see under ABORTION 1975
HN = 76(75); was see under ABORTION 1975
MR = 20150623
DA = 19741119
DC = 1
DX = 19760101
UI = D000023

*NEWRECORD
RECTYPE = D
MH = Abortion, Criminal
AQ = AE CL EC EH ES HI LJ MO PC PX SN TD
PRINT ENTRY = Abortion, Illegal|T033|NON|EQV|POPLINE (1978)|770317|abcdef
ENTRY = Illegal Abortion|T033|NON|EQV|BIOETHICS (1989)|770317|abcdef
ENTRY = Abortions, Criminal
ENTRY = Abortions, Illegal
ENTRY = Criminal Abortion
ENTRY = Criminal Abortions
ENTRY = Illegal Abortions
MN = I01.198.240.089
MH_TH = NLM (1966)
ST = T033
AN = don't forget also check tags HUMANS & FEMALE & PREGNANCY; for abortifacients in crim abort see note on ABORTION, INDUCED
MS = Illegal termination of pregnancy.
MR = 20150623
DA = 19990101
DC = 1
UI = D000024

*NEWRECORD
RECTYPE = D
MH = Abortion, Eugenic
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Eugenic Abortion|T061|NON|EQV|UNK (19XX)|741111|abcdef
ENTRY = Abortion, Selective|T061|NON|NRW|POPLINE (1994)|950322|abcdef
ENTRY = Selective Abortion|T061|NON|NRW|BIOETHICS (1974)|770317|abcdef
ENTRY = Abortions, Eugenic
ENTRY = Abortions, Selective
ENTRY = Eugenic Abortions
ENTRY = Selective Abortions
MN = E04.520.050.050
MH_TH = NLM (1975)
ST = T061
AN = do not use /util except by MeSH definition; don't forget also check tags HUMANS or ANIMALS & FEMALE & PREGNANCY
MS = Abortion performed because of possible fetal defects.
PM = 91; was see under ABORTION, INDUCED 1975-90
HN = 91(75); was see under ABORTION, INDUCED 1975-90
CATSH = CAT LIST
MR = 20150623
DA = 19741119
DC = 1
DX = 19910101
UI = D000025

*NEWRECORD
RECTYPE = D
MH = Abortion, Habitual
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Abortion, Recurrent|T047|NON|EQV|NLM (1998)|960725|abcdef
PRINT ENTRY = Miscarriage, Recurrent|T047|NON|EQV|NLM (1999)|971008|abcdef
ENTRY = Abortions, Habitual
ENTRY = Abortions, Recurrent
ENTRY = Habitual Abortion
ENTRY = Habitual Abortions
ENTRY = Miscarriages, Recurrent
ENTRY = Recurrent Abortion
ENTRY = Recurrent Abortions
ENTRY = Recurrent Miscarriage
ENTRY = Recurrent Miscarriages
MN = C13.703.039.089
FX = Embryo Loss
FX = Fetal Death
MH_TH = NLM (1963)
ST = T047
MS = Three or more consecutive spontaneous abortions.
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D000026

*NEWRECORD
RECTYPE = D
MH = Abortion, Incomplete
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Abortions, Incomplete
ENTRY = Incomplete Abortion
ENTRY = Incomplete Abortions
MN = C13.703.039.093
MH_TH = NLM (1975)
ST = T047
AN = restrict to spontaneous, not induced abortions; check the tags FEMALE & PREGNANCY
PI = Abortion, Spontaneous (1966-1974)
MS = Premature loss of PREGNANCY in which not all the products of CONCEPTION have been expelled.
PM = 75
HN = 75
CATSH = CAT LIST
MR = 20050630
DA = 19741111
DC = 1
DX = 19750901
UI = D000027

*NEWRECORD
RECTYPE = D
MH = Abortion, Induced
DE = ABORTION IND
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Embryotomy|T061|NON|NRW|UNK (19XX)|850606|abcdef
ENTRY = Abortion (Induced)|T061|NON|EQV|NLM (2000)|991109|abcdef
ENTRY = Abortion Failure|T046|T068|NON|REL|POPLINE (1994)|950322|abbcdef
ENTRY = Abortion History|T184|NON|REL|POPLINE (1978)|781218|ABORTION HIST|abcdefv
ENTRY = Abortion Rate|T081|NON|REL|POPLINE (1978)|781218|abcdef
ENTRY = Abortion Technics|T061|NON|REL|NLM (1979)|781218|abcdef
ENTRY = Abortion Techniques|T061|NON|REL|NLM (1991)|900110|abcdef
ENTRY = Abortion, Drug-Induced|T061|NON|NRW|POPLINE (1978)|781218|ABORTION DRUG IND|abcdefv
ENTRY = Abortion, Rivanol|T061|NON|NRW|POPLINE (1978)|790927|abcdef
ENTRY = Abortion, Saline-Solution|T061|NON|NRW|POPLINE (1978)|781218|ABORTION SALINE SOL|abcdefv
ENTRY = Abortion, Soap-Solution|T061|NON|NRW|POPLINE (1978)|781218|ABORTION SOAP SOL|abcdefv
ENTRY = Anti-Abortion Groups|T093|NON|REL|POPLINE (1986)|850808|abcdef
ENTRY = Fertility Control, Postconception|T061|NON|BRD|POPLINE (1978)|781218|abcdef
ENTRY = Induced Abortion|T061|NON|EQV|UNK (19XX)|810826|IND ABORTION|abcdefv
ENTRY = Previous Abortion|T184|NON|REL|POPLINE (1978)|781218|abcdef
ENTRY = Abortion Failures
ENTRY = Abortion Histories
ENTRY = Abortion Rates
ENTRY = Abortion Technic
ENTRY = Abortion Technique
ENTRY = Abortion, Drug Induced
ENTRY = Abortion, Previous
ENTRY = Abortion, Saline Solution
ENTRY = Abortion, Soap Solution
ENTRY = Abortions (Induced)
ENTRY = Abortions, Drug-Induced
ENTRY = Abortions, Induced
ENTRY = Abortions, Previous
ENTRY = Abortions, Rivanol
ENTRY = Abortions, Saline-Solution
ENTRY = Abortions, Soap-Solution
ENTRY = Anti Abortion Groups
ENTRY = Anti-Abortion Group
ENTRY = Drug-Induced Abortion
ENTRY = Drug-Induced Abortions
ENTRY = Embryotomies
ENTRY = Failure, Abortion
ENTRY = Failures, Abortion
ENTRY = Group, Anti-Abortion
ENTRY = Groups, Anti-Abortion
ENTRY = Histories, Abortion
ENTRY = History, Abortion
ENTRY = Induced Abortions
ENTRY = Postconception Fertility Control
ENTRY = Previous Abortions
ENTRY = Rate, Abortion
ENTRY = Rates, Abortion
ENTRY = Rivanol Abortion
ENTRY = Rivanol Abortions
ENTRY = Saline-Solution Abortion
ENTRY = Saline-Solution Abortions
ENTRY = Soap-Solution Abortion
ENTRY = Soap-Solution Abortions
ENTRY = Technic, Abortion
ENTRY = Technics, Abortion
ENTRY = Technique, Abortion
ENTRY = Techniques, Abortion
MN = E04.520.050
FX = Aborted Fetus
MH_TH = BIOETHICS (1999)
MH_TH = POPLINE (1978)
ST = T061
AN = do not use /util except by MeSH definition; for use of an abortifacient here or in ABORTION, CRIMINAL, coord IM with abortifacient agent (IM with no qualif, not /adv eff unless text specifically discusses adverse eff); don't forget also check tags FEMALE & PREGNANCY
PI = Abortion, Criminal (1966-1970)
PI = Abortion, Legal (1966-1970)
PI = Abortion, Therapeutic (1966-1970)
MS = Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978)
OL = use ABORTION, INDUCED to search EMBRYOTOMY 1966-85; search ABORTION, CRIMINAL & ABORTION, LEGAL & ABORTION, THERAPEUTIC 1966-70
PM = 71; was see under ABORTION, CRIMINAL & ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85
HN = 71; was see under ABORTION, CRIMINAL & ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19710101
UI = D000028

*NEWRECORD
RECTYPE = D
MH = Abortion, Legal
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Abortion on Demand|T061|NON|NRW|BIOETHICS (1989)|770317|abcdef
ENTRY = Abortions, Legal
ENTRY = Legal Abortion
ENTRY = Legal Abortions
MN = E04.520.050.055
MH_TH = POPLINE (1978)
ST = T061
AN = /adv eff permitted; do not use /util (except by MeSH definition) /vet; don't forget also HUMANS & FEMALE & PREGNANCY
MS = Termination of pregnancy under conditions allowed under local laws. (POPLINE Thesaurus, 1991)
PM = 64
HN = 64
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19640101
UI = D000029

*NEWRECORD
RECTYPE = D
MH = Abortion, Missed
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Abortions, Missed
ENTRY = Missed Abortion
ENTRY = Missed Abortions
MN = C13.703.039.173
MH_TH = NLM (1966)
ST = T047
AN = check the tags FEMALE & PREGNANCY
MS = The retention in the UTERUS of a dead FETUS two months or more after its DEATH.
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D000030

*NEWRECORD
RECTYPE = D
MH = Abortion, Septic
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Septic Abortion|T047|NON|EQV|NLM (2006)|050420|abcdef
ENTRY = Abortions, Septic
ENTRY = Septic Abortions
MN = C01.539.674.173
MN = C13.703.039.256
MN = C13.703.700.173
MH_TH = NLM (1963)
ST = T047
AN = /vet permitted only if discussed as "septic" abortion: do not use automatically for animal abortion in brucellosis, vibriosis, trichomoniasis, etc; check the tags FEMALE & PREGNANCY
MS = Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D000031

*NEWRECORD
RECTYPE = D
MH = Abortion, Therapeutic
DE = ABORTION THER
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Therapeutic Abortion|T061|NON|EQV|BIOETHICS (1974)|770317|THER ABORTION|abcdefv
ENTRY = Abortions, Therapeutic
ENTRY = Therapeutic Abortions
MN = E04.520.050.060
MH_TH = POPLINE (1978)
ST = T061
AN = do not use /util except by MeSH definition; don't forget also check tags FEMALE & PREGNANCY
MS = Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D000032

*NEWRECORD
RECTYPE = D
MH = Abortion, Threatened
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Abortions, Threatened
ENTRY = Threatened Abortion
ENTRY = Threatened Abortions
MN = C13.703.039.339
MH_TH = NLM (1966)
ST = T047
AN = check the tags FEMALE & PREGNANCY
MS = UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE.
CATSH = CAT LIST
MR = 20050712
DA = 19990101
DC = 1
UI = D000033

*NEWRECORD
RECTYPE = D
MH = Abortion, Veterinary
DE = ABORTION VET
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VI
ENTRY = Veterinary Abortion|T047|NON|EQV|UNK (19XX)|860101|VET ABORTION|abcdefv
ENTRY = Abortions, Veterinary
ENTRY = Veterinary Abortions
MN = C13.703.039.422
MN = C22.021
MH_TH = NLM (1966)
ST = T047
AN = coordinate IM with specific type of abortion /vet (IM); check the tags ANIMALS & FEMALE & PREGNANCY
MS = Premature expulsion of the FETUS in animals.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D000034

*NEWRECORD
RECTYPE = D
MH = Abreaction
ENTRY = Abreactions
MN = F04.754.720.107
MH_TH = NLM (1968)
ST = T041
AN = no qualif
MS = A process in psychotherapy in which the patient is "desensitized" to emotionally painful, often forgotten (repressed) memories by recalling and reacting to them in the "safety" of the treatment setting.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19680101
UI = D000035

*NEWRECORD
RECTYPE = D
MH = Abrin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
ENTRY = Abrin A|T116|T123|NON|NRW|UNK (19XX)|810608|abbcdef
ENTRY = Abrin C|T116|T123|NON|NRW|UNK (19XX)|810608|abbcdef
MN = D08.811.277.450.430.700.750.111
MN = D12.776.503.499.249
MN = D12.776.765.678.906.111
MH_TH = NLM (1975)
ST = T116
ST = T123
N1 = Abrins
RN = 1393-62-0
PI = Disulfides (1973-1974)
PI = Plant Proteins (1971-1975)
MS = A toxic lectin from the seeds of jequirity, Abrus precatorius L. Very active poison. Five different proteins have so far been isolated: Abrus agglutinin, the component responsible for: hemagglutinating activity, & abrins a-d, the toxic principals each consisting of two peptide chains are held together by disulfide bonds.
PM = 91; was see under PLANT PROTEINS 1975-90
HN = 91(75); was see under PLANT PROTEINS 1975-90
MR = 20070709
DA = 19741119
DC = 1
DX = 19910101
UI = D000036

*NEWRECORD
RECTYPE = D
MH = Abruptio Placentae
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Placental Abruption|T047|NON|EQV|NLM (2006)|050303|abcdef
ENTRY = Abruption, Placental
ENTRY = Abruptions, Placental
ENTRY = Placental Abruptions
MN = C13.703.420.078
MN = C13.703.590.132
MH_TH = NLM (1966)
ST = T047
MS = Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D000037

*NEWRECORD
RECTYPE = D
MH = Abscess
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Abscesses
MN = C01.539.830.025
MN = C23.550.470.756.100
FX = Empyema
MH_TH = NLM (1966)
ST = T046
AN = IM; coord IM with site (organ/dis term) (IM) + precoord organism/infect term (IM); if unspecified bacterial abscess do not coord with BACTERIAL INFECTIONS (since most abscesses are bact) but coord with specific bact infect term if given (as ABSCESS + STAPHYLOCOCCAL INFECTIONS)
MS = Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.
CATSH = CAT LIST
MR = 20050801
DA = 19990101
DC = 1
UI = D000038

*NEWRECORD
RECTYPE = D
MH = Peritonsillar Abscess
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Abscess, Peritonsillar|T047|NON|EQV|UNK (19XX)|880523|abcdef
ENTRY = Abscesses, Peritonsillar
ENTRY = Peritonsillar Abscesses
MN = C01.539.830.025.675
MN = C07.550.781.750.500
MN = C08.730.561.750.500
MN = C09.775.649.750.500
MH_TH = NLM (1966)
ST = T047
AN = coordinate IM with infection term (IM) but not BACTERIAL INFECTIONS (since most abscesses are bacterial)
MS = An accumulation of purulent material in the area between the PALATINE TONSIL and its capsule.
OL = use PERITONSILLAR ABSCESS to search ABSCESS, PERITONSILLAR 1966-88
PM = 89; was ABSCESS, PERITONSILLAR 1963-88
HN = 89; was ABSCESS, PERITONSILLAR 1963-88
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000039

*NEWRECORD
RECTYPE = D
MH = Abscisic Acid
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Abscisic Acid Monoammonium Salt, (R)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscisic Acid, (+,-)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscisic Acid, (E,E)-(+-)-Isomer|T109|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscisic Acid, (E,Z)-(+,-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscisic Acid, (R)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscisic Acid, (Z,E)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Abscissic Acid|T109|T123|NON|EQV|NLM (1993)|920325|abbcdef
ENTRY = Abscissins|T109|T123|NON|EQV|NLM (1993)|920415|abbcdef
MN = D02.241.223.268.034
MN = D02.455.326.271.665.202.061
MN = D02.455.426.392.368.367.379.249.024
MN = D02.455.849.131.061
MN = D02.455.849.765.033
PA = Plant Growth Regulators
MH_TH = NLM (1975)
ST = T109
ST = T123
N1 = 2,4-Pentadienoic acid, 5-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-, (S-(Z,E))-
RN = 72S9A8J5GW
RR = 113349-29-4 ((Z,E)-isomer)
RR = 14375-45-2 ((+-)-isomer)
RR = 14398-53-9 ((R)-isomer)
RR = 14674-85-2 ((E,Z)-(+-)-isomer)
RR = 21293-29-8 (Abscisic Acid)
RR = 2228-72-0 ((E,E)-(+-)-isomer)
RR = 41621-76-5 ((R)-isomer, monoammonium salt)
RR = 52392-36-6 ((E,E)-isomer)
RR = 6755-41-5 ((E,E)-isomer)
RR = 7773-56-0 (cpd w/o isomeric designation)
PI = Cyclohexanecarboxylic Acids (1974)
MS = Abscission-accelerating plant growth substance isolated from young cotton fruit, leaves of sycamore, birch, and other plants, and from potatoes, lemons, avocados, and other fruits.
PM = 93; see ABSCISSINS 1991-92, see CYCLOHEXANECARBOXYLIC ACID 1975-90
HN = 93(75)
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000040

*NEWRECORD
RECTYPE = D
MH = Absenteeism
MN = F02.784.692.107
MH_TH = NLM (1966)
ST = T055
AN = IM; no qualif
MS = Chronic absence from work or other duty.
HN = was in Cat F & J 1967-82, was in Cat F & I 1963-66
CATSH = CAT LIST
MR = 19940527
DA = 19990101
DC = 1
UI = D000041

*NEWRECORD
RECTYPE = D
MH = Absorption
AQ = DE GE IM PH RE
MN = G01.595.014
MN = G02.149.767.019
MN = G02.842.750.019
MN = G03.495.023
MN = G03.787.024
MN = G07.690.725.015
FX = Intestinal Absorption
FX = Skin Absorption
MH_TH = NLM (1966)
ST = T070
AN = beginning in 2015: used for searching; INDEXER: Do not use; CATALOGER: Do not use
MS = The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
CATSH = CAT LIST
MR = 20150615
DA = 19990101
DC = 1
UI = D000042

*NEWRECORD
RECTYPE = D
MH = Abstracting and Indexing as Topic
AQ = CL EC ES HI MT SN ST TD UT
PRINT ENTRY = Abstracting as Topic|T057|NON|NRW|NLM (2008)|070621|abcdef
PRINT ENTRY = Indexes as Topic|T170|NON|REL|NLM (2008)|070621|abcdef
PRINT ENTRY = Indexing as Topic|T057|NON|NRW|NLM (2008)|070621|abcdef
ENTRY = Abstracting|T057|NON|NRW|UNK (19XX)|790329|abcdef
ENTRY = Abstracting and Indexing|T057|NON|EQV|NLM (1966)|990101|ABSTRACTING INDEXING|abcdefv
ENTRY = Indexing|T057|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Indexing and Abstracting|T057|NON|EQV|UNK (19XX)|790329|INDEXING ABSTRACTING|abcdefv
ENTRY = Indexing and Abstracting as Topic|T057|NON|EQV|NLM (2008)|071030|abcdef
MN = L01.453.245.100
MH_TH = NLM (2008)
ST = T057
AN = IM; medical abstracting & indexing: do not coordinate with MEDICINE; do not confuse with Publication Types ABSTRACTS or MEETING ABSTRACTS
MS = Activities performed to identify concepts and aspects of published information and research reports.
PM = 2008; see ABSTRACTING AND INDEXING 1963-2007; for INDEXES as topic see REFERENCE BOOKS 1996-98
HN = 2008(1963); for INDEXES as topic use REFERENCE BOOKS 1996-1998
MR = 20071030
DA = 19990101
DC = 1
UI = D000043

*NEWRECORD
RECTYPE = D
MH = Dental Abutments
DE = DENT ABUTMENTS
AQ = AE CL CT EC ES HI MI PS PX SD SN ST TD UT VE VI
PRINT ENTRY = Abutments, Dental|T023|T074|NON|EQV|NLM (1991)|900409|ABUTMENTS DENT|abbcdefv
ENTRY = Abutment, Dental|T023|T074|NON|EQV|NLM (1991)|900125|ABUTMENT DENT|abbcdefv
ENTRY = Dental Abutment|T023|T074|NON|EQV|NLM (1991)|900409|DENT ABUTMENT|abbcdefv
MN = E06.780.346.500
MN = E07.695.190.175
MH_TH = NLM (1970)
ST = T023
ST = T074
AN = tooth or root used as anchor for denture or implant, etc.; DF: DENT ABUTMENTS
PI = Dental Cavity Preparation (1966-1969)
PI = Denture, Partial (1966-1969)
MS = Natural teeth or teeth roots used as anchorage for a fixed or removable denture or other prosthesis (such as an implant) serving the same purpose.
OL = use DENTAL ABUTMENTS to search ABUTMENTS, DENTAL 1970-90
PM = 91; was ABUTMENTS, DENTAL 1970-90
HN = 91; was ABUTMENTS, DENTAL 1970-90
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
DX = 19700101
UI = D000044

*NEWRECORD
RECTYPE = D
MH = Acacia
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Locust Tree|T002|NON|EQV|UNK (19XX)|850514|abcdef
PRINT ENTRY = Wattle Tree|T002|NON|EQV|UNK (19XX)|850514|abcdef
ENTRY = Acacia catechu|T002|NON|NRW|NLM (2003)|010830|abcdef
ENTRY = Acacia catechus
ENTRY = Acacias
ENTRY = Locust Trees
ENTRY = Tree, Locust
ENTRY = Tree, Wattle
ENTRY = Trees, Locust
ENTRY = Trees, Wattle
ENTRY = Wattle Trees
ENTRY = catechu, Acacia
ENTRY = catechus, Acacia
MN = B01.650.940.800.575.100.401.025
MH_TH = NLM (1986)
ST = T002
AN = acacia pharmaceut agents are probably GUM ARABIC
MS = A plant genus of the family FABACEAE. The gums and tanning agents obtained from Acacia are called GUM ARABIC. The common name of catechu is more often used for Areca catechu (ARECA).
PM = 91,63-85; was see under TREES 1986-90; was heading 1963-85
HN = 91(86)63; was see under TREES 1986-90; was heading 1963-85
MR = 20150623
DA = 19990101
DC = 1
DX = 19910101
UI = D000045

*NEWRECORD
RECTYPE = D
MH = Academic Medical Centers
DE = ACAD MED CENTERS
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
PRINT ENTRY = Medical Centers, Academic|T073|T093|NON|EQV|UNK (19XX)|790615|MED CENTERS ACAD|abbcdefv
PRINT ENTRY = Medical Centers, University|T073|T093|NON|EQV|UNK (19XX)|790615|MED CENTERS UNIV|abbcdefv
PRINT ENTRY = University Medical Centers|T073|T093|NON|EQV|UNK (19XX)|790601|UNIV MED CENTERS|abbcdefv
ENTRY = Academic Medical Center|T073|T093|NON|EQV|NLM (1991)|891129|ACAD MED CENTER|abbcdefv
ENTRY = Center, Academic Medical|T073|T093|NON|EQV|NLM (1991)|891129|CENTER ACAD MED|abbcdefv
ENTRY = Center, University Medical|T073|T093|NON|EQV|NLM (1991)|891129|CENTER UNIV MED|abbcdefv
ENTRY = Centers, Academic Medical|T073|T093|NON|EQV|NLM (1991)|891129|CENTERS ACAD MED|abbcdefv
ENTRY = Centers, University Medical|T073|T093|NON|EQV|NLM (1991)|891129|CENTERS UNIV MED|abbcdefv
ENTRY = Medical Center, Academic|T073|T093|NON|EQV|NLM (1991)|891129|MED CENTER ACAD|abbcdefv
ENTRY = Medical Center, University|T073|T093|NON|EQV|NLM (1991)|891129|MED CENTER UNIV|abbcdefv
ENTRY = University Medical Center|T073|T093|NON|EQV|NLM (1991)|891129|UNIV MED CENTER|abbcdefv
MN = N02.278.020
FX = Tertiary Care Centers
MH_TH = NLM (1980)
ST = T073
ST = T093
AN = specify geog; DF: ACAD MED CENTERS
PI = Hospitals, Teaching (1968-1974)
PI = Hospitals, University (1975-1979)
MS = Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.
OL = search HOSPITALS, UNIVERSITY 1979
PM = 80; was see HOSPITALS, UNIVERSITY 1979
HN = 80; was see HOSPITALS, UNIVERSITY 1979
MR = 20120703
DA = 19790601
DC = 1
DX = 19800101
UI = D000046

*NEWRECORD
RECTYPE = D
MH = Academies and Institutes
DE = ACADEMIES INSTITUTES
AQ = CL EC ES HI LJ OG SN ST TD UT
PRINT ENTRY = Institutes|T092|NON|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Research Institutes|T092|NON|NRW|BIOETHICS (1974)|770317|abcdef
ENTRY = Academies|T092|NON|NRW|UNK (19XX)|790329|ACAD|abcdefv
ENTRY = Academy and Institute|T092|NON|EQV|NLM (1991)|891130|ACAD INSTITUTE|abcdefv
ENTRY = Institutes and Academies|T092|NON|EQV|UNK (19XX)|790329|INSTITUTES ACAD|abcdefv
ENTRY = Academy
ENTRY = Institute and Academy
ENTRY = Institute, Research
ENTRY = Institutes, Research
ENTRY = Research Institute
MN = N03.540.052
MH_TH = NLM (1965)
ST = T092
AN = not for educ acad & institutes ( = SCHOOLS or its indentions); Acad of Med: do not index also under MEDICINE; NY Acad of Med: when geog coord needed use NEW YORK CITY; DF: ACADEMIES
MS = Organizations representing specialized fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., National Academy of Sciences, Brookings Institution, etc.
PM = 70
HN = 70(65)
MR = 19991103
DA = 19990101
DC = 1
DX = 19700101
UI = D000047

*NEWRECORD
RECTYPE = D
MH = Acanthamoeba
AQ = CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI
ENTRY = Acanthamoebas
MN = B01.046.500.100.075.080
MH_TH = NLM (1988)
ST = T204
AN = infection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
PI = Amoeba (1966-1987)
MS = A genus of free-living soil amoebae that produces no flagellate stage. Its organisms are pathogens for several infections in humans and have been found in the eye, bone, brain, and respiratory tract.
PM = 88
HN = 88
MR = 20090706
DA = 19870430
DC = 1
DX = 19880101
UI = D000048

*NEWRECORD
RECTYPE = D
MH = Acanthocephala
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Thorny-Headed Worms|T204|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Acanthocephalas
ENTRY = Thorny Headed Worms
ENTRY = Thorny-Headed Worm
ENTRY = Worm, Thorny-Headed
ENTRY = Worms, Thorny-Headed
MN = B01.050.500.500.132
MH_TH = NLM (1974)
ST = T204
AN = infection: coord IM with HELMINTHIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
MS = A phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine.
OL = search HELMINTHS 1966-73
PM = 74; was see under HELMINTHS 1963-73
HN = 74; was see under HELMINTHS 1963-73
MR = 20090706
DA = 19990101
DC = 1
DX = 19740101
UI = D000049

*NEWRECORD
RECTYPE = D
MH = Acanthocytes
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Acanthocyte
MN = A11.118.290.330.100
MN = A11.443.240.330.100
MN = A15.145.229.334.330.100
MH_TH = NLM (1975)
ST = T025
AN = A 11 qualif
MS = Erythrocytes with protoplasmic projections giving the cell a thorny appearance.
PM = 91; was see under ERYTHROCYTES, ABNORMAL 1975-90
HN = 91(75); was see under ERYTHROCYTES, ABNORMAL 1975-90
MR = 20030709
DA = 19741111
DC = 1
DX = 19910101
UI = D000050

*NEWRECORD
RECTYPE = D
MH = Acantholysis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Acantholyses
MN = C17.800.865.070
MN = C23.550.035
MH_TH = NLM (1969)
ST = T046
AN = ACANTHOLYSIS BULLOSA see EPIDERMOLYSIS BULLOSA is also available
PI = Skin/pathology (1966-1968)
PI = specific skin disease/pathology (1966-1968)
MS = Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris (see PEMPHIGUS) and DARIER DISEASE.
PM = 91; was see under SKIN DISEASES 1969-90
HN = 91(69); was see under SKIN DISEASES 1969-90
CATSH = CAT LIST
MR = 20080710
DA = 19990101
DC = 1
DX = 19910101
UI = D000051

*NEWRECORD
RECTYPE = D
MH = Acanthosis Nigricans
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Acanthosis Nigrican
ENTRY = Nigrican, Acanthosis
ENTRY = Nigricans, Acanthosis
MN = C17.800.621.430.530.100
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
AN = a type of melanosis
MS = A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D000052

*NEWRECORD
RECTYPE = D
MH = Acari
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
MN = B01.050.500.131.166.132
MH_TH = NLM (1975)
ST = T204
PI = Arachnida (1966-1974)
MS = A large, subclass of arachnids comprising the MITES and TICKS, including parasites of plants, animals, and humans, as well as several important disease vectors.
PM = 75
HN = 75
MR = 20090706
DA = 19990101
DC = 1
DX = 19750101
UI = D000053

*NEWRECORD
RECTYPE = D
MH = Acceleration
AQ = AE
ENTRY = Accelerations
MN = G01.595.560.107
MH_TH = NLM (1966)
ST = T067
AN = IM
MS = An increase in the rate of speed.
MR = 20090706
DA = 19990101
DC = 1
UI = D000054

*NEWRECORD
RECTYPE = D
MH = Accessory Nerve
AQ = AB AH BS CH CY DE EM EN GD IM ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Cranial Nerve XI|T023|NON|EQV|NLM (1998)|960731|abcdef
PRINT ENTRY = Eleventh Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef
PRINT ENTRY = Spinal Accessory Nerve|T023|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Nerve XI|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Nervus Accessorius|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Accessorius, Nervus
ENTRY = Accessory Nerve, Spinal
ENTRY = Accessory Nerves
ENTRY = Accessory Nerves, Spinal
ENTRY = Cranial Nerve, Eleventh
ENTRY = Cranial Nerves, Eleventh
ENTRY = Eleventh Cranial Nerves
ENTRY = Nerve XIs
ENTRY = Nerve, Accessory
ENTRY = Nerve, Eleventh Cranial
ENTRY = Nerve, Spinal Accessory
ENTRY = Nerves, Accessory
ENTRY = Nerves, Eleventh Cranial
ENTRY = Nerves, Spinal Accessory
ENTRY = Spinal Accessory Nerves
MN = A08.800.800.120.060
EC = injuries:Accessory Nerve Injuries
MH_TH = NLM (1966)
ST = T023
AN = neoplasm = ACCESSORY NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)
MS = The 11th cranial nerve which originates from NEURONS in the MEDULLA and in the CERVICAL SPINAL CORD. It has a cranial root, which joins the VAGUS NERVE (10th cranial) and sends motor fibers to the muscles of the LARYNX, and a spinal root, which sends motor fibers to the TRAPEZIUS and the sternocleidomastoid muscles.
MR = 20140613
DA = 19990101
DC = 1
UI = D000055

*NEWRECORD
RECTYPE = D
MH = Accident Prevention
DE = ACCIDENT PREV
AQ = EC HI IS LJ MT SN ST TD
ENTRY = Prevention, Accident|T061|T078|NON|EQV|UNK (19XX)|860101|PREV ACCIDENT|abbcdefv
ENTRY = Accident Preventions
ENTRY = Preventions, Accident
MN = N06.850.135.060
FX = Protective Devices
MH_TH = NLM (1966)
ST = T061
ST = T078
MS = Efforts and designs to reduce the incidence of unexpected undesirable events in various environments and situations.
MR = 20080708
DA = 19990101
DC = 1
UI = D000056

*NEWRECORD
RECTYPE = D
MH = Accident Proneness
ENTRY = Accident Pronenesses
ENTRY = Proneness, Accident
ENTRY = Pronenesses, Accident
MN = F01.145.015
MH_TH = NLM (1975)
ST = T055
AN = no qualif
PI = Accidents (1966-1974)
MS = Tendency toward involvement in accidents. Implies certain personality characteristics which predispose to accidents.
PM = 75
HN = 75
CATSH = CAT LIST
MR = 20020702
DA = 19741111
DC = 1
DX = 19750901
UI = D000057

*NEWRECORD
RECTYPE = D
MH = Accidental Falls
AQ = EC HI MO PC SN
PRINT ENTRY = Falls, Accidental|T037|NON|EQV|UNK (19XX)|860624|abcdef
ENTRY = Falling|T037|NON|EQV|NLM (2016)|140904|abcdef
ENTRY = Falls|T037|NON|EQV|NLM (2016)|140904|abcdef
ENTRY = Slip and Fall|T037|NON|BRD|NLM (2016)|140904|abcdef
ENTRY = Accidental Fall
ENTRY = Fall and Slip
ENTRY = Fall, Accidental
MN = N06.850.135.122
MH_TH = NLM (1987)
ST = T037
PI = Accidents (1966-1986)
MS = Falls due to slipping or tripping which may result in injury.
PM = 91; was see under ACCIDENTS 1987-90
HN = 91(87); was see under ACCIDENTS 1987-90
MR = 20150616
DA = 19860624
DC = 1
DX = 19910101
UI = D000058

*NEWRECORD
RECTYPE = D
MH = Accidents
AQ = CL EC HI LJ MO PX SN TD
ENTRY = Accident
MN = N06.850.135
EC = prevention & control:Accident Prevention
MH_TH = POPLINE (1986)
ST = T037
AN = GEN or unspecified; prefer specifics
MR = 20090728
DA = 19990101
DC = 1
UI = D000059

*NEWRECORD
RECTYPE = D
MH = Accidents, Aviation
AQ = CL EC HI LJ MO PC PX SN TD
ENTRY = Accident, Aviation
ENTRY = Aviation Accident
ENTRY = Aviation Accidents
MN = N06.850.135.185
MH_TH = NLM (1966)
ST = T037
ST = T068
AN = IM; coord with specific inj (IM)
MR = 20090728
DA = 19990101
DC = 1
UI = D000060

*NEWRECORD
RECTYPE = D
MH = Accidents, Home
AQ = CL EC HI LJ MO PC PX SN TD
PRINT ENTRY = Home Accidents|T067|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Accident, Home
ENTRY = Home Accident
MN = N06.850.135.217
MH_TH = NLM (1969)
ST = T067
AN = IM; coord with specific inj (IM)
PI = Accidents (1966-1968)
PM = 70
HN = 70(69)
MR = 20090728
DA = 19990101
DC = 1
DX = 19700101
UI = D000061

*NEWRECORD
RECTYPE = D
MH = Accidents, Occupational
DE = ACCIDENTS OCCUP
AQ = CL EC HI LJ MO PC PX SN TD
PRINT ENTRY = Accidents, Industrial|T067|NON|NRW|UNK (19XX)|780508|ACCIDENTS INDUST|abcdefv
ENTRY = Industrial Accidents|T067|NON|NRW|NLM (1996)|950315|INDUST ACCIDENTS|abcdefv
ENTRY = Occupational Accidents|T067|NON|EQV|NLM (1996)|950308|OCCUP ACCIDENTS|abcdefv
ENTRY = Accident, Industrial
ENTRY = Accident, Occupational
ENTRY = Industrial Accident
ENTRY = Occupational Accident
MN = N06.850.135.240
FX = Occupational Diseases
FX = Occupational Injuries
MH_TH = NLM (1966)
ST = T067
AN = coordinate IM with specific occupation (IM)
MS = Unforeseen occurrences, especially injuries in the course of work-related activities.
OL = use ACCIDENTS, OCCUPATIONAL to search ACCIDENTS, INDUSTRIAL 1966-78
PM = 79; was ACCIDENTS, INDUSTRIAL 1963-78
HN = 79; was in Cat G & J 1979-82, was ACCIDENTS, INDUSTRIAL in Cat G & J 1967-78 & Cat G & I 1963-66
MR = 20110624
DA = 19990101
DC = 1
UI = D000062

*NEWRECORD
RECTYPE = D
MH = Accidents, Traffic
AQ = CL EC HI LJ MO PC PX SN TD
ENTRY = Traffic Accidents|T067|NON|EQV|BIOETHICS (1982)|930524|abcdef
ENTRY = Accident, Traffic
ENTRY = Traffic Accident
MN = N06.850.135.392
FX = Air Bags
FX = Seat Belts
MH_TH = NLM (1966)
ST = T067
AN = implies automobile accid so do not coord with AUTOMOBILES unless the auto is especially discussed; coord IM with BICYCLING (IM) or MOTORCYCLES (IM) if pertinent; not for railroad accidents ( = RAILROADS + ACCIDENTS) or all-terrain vehicles, motorbikes or snowmobiles ( = OFF-ROAD MOTOR VEHICLES + ACCIDENTS)
MS = Accidents on streets, roads, and highways involving drivers, passengers, pedestrians, or vehicles. Traffic accidents refer to AUTOMOBILES (passenger cars, buses, and trucks), BICYCLING, and MOTORCYCLES but not OFF-ROAD MOTOR VEHICLES; RAILROADS nor snowmobiles.
MR = 20090728
DA = 19990101
DC = 1
UI = D000063

*NEWRECORD
RECTYPE = D
MH = Acclimatization
AQ = DE ES GE IM PH RE
PRINT ENTRY = Acclimation|T040|NON|EQV|NLM (1996)|941031|abcdef
MN = G07.700.062.133
MN = G16.100.057.500.133
MH_TH = NLM (1966)
ST = T040
AN = includes to climate, altitude, weather but not to gravity ( = ADAPTATION, PHYSIOLOGICAL)
MS = Adaptation to a new environment or to a change in the old.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000064

*NEWRECORD
RECTYPE = D
MH = Accommodation, Ocular
AQ = DE ES GE IM PH RE
ENTRY = Accommodation, Lens|T042|NON|NRW|NLM (2006)|040817|abcdef
ENTRY = Ocular Accommodation|T042|NON|EQV|NLM (2006)|041014|abcdef
ENTRY = Ocular Distance Accommodation|T042|NON|EQV|NLM (2006)|041130|abcdef
ENTRY = Accommodation, Ocular Distance
ENTRY = Distance Accommodation, Ocular
ENTRY = Lens Accommodation
ENTRY = Ocular Distance Accommodations
MN = G14.640.079
MH_TH = NLM (1966)
ST = T042
AN = do not confuse with ADAPTATION, OCULAR, adjustment of eye to light
MS = The dioptric adjustment of the EYE (to attain maximal sharpness of retinal imagery for an object of regard) referring to the ability, to the mechanism, or to the process. Ocular accommodation is the effecting of refractive changes by changes in the shape of the CRYSTALLINE LENS. Loosely, it refers to ocular adjustments for VISION, OCULAR at various distances. (Cline et al., Dictionary of Visual Science, 4th ed)
CATSH = CAT LIST
MR = 20080710
DA = 19990101
DC = 1
UI = D000065

*NEWRECORD
RECTYPE = D
MH = Accounting
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Accountings
MN = N03.219.463.030
MH_TH = NLM (1966)
ST = T057
ST = T090
AN = IM; coord with SPEC (IM) or specific financial endeavor (IM)
MS = System of recording financial transactions.
MR = 19960610
DA = 19990101
DC = 1
UI = D000066

*NEWRECORD
RECTYPE = D
MH = Oil and Gas Industry
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Crude Oil Industry|T092|NON|NRW|NLM (2015)|140610|abcdef
ENTRY = Gas and Oil Industry|T057|T092|NON|EQV|NLM (2015)|140612|abbcdef
ENTRY = Industry, Natural Gas|T092|NON|NRW|NLM (2015)|140612|abcdef
ENTRY = Natural Gas Industry|T092|NON|NRW|NLM (2015)|140612|abcdef
ENTRY = Petroleum Industry|T092|NON|NRW|NLM (2015)|140610|abcdef
ENTRY = Crude Oil Industries
ENTRY = Gas Industries, Natural
ENTRY = Gas Industry, Natural
ENTRY = Industries, Crude Oil
ENTRY = Industries, Natural Gas
ENTRY = Industries, Petroleum
ENTRY = Industry, Crude Oil
ENTRY = Industry, Petroleum
ENTRY = Natural Gas Industries
ENTRY = Oil Industries, Crude
ENTRY = Oil Industry, Crude
ENTRY = Petroleum Industries
MN = J01.576.655.875.750
FX = Fossil Fuels
FX = Natural Gas
FX = Petroleum
MH_TH = NLM (2015)
ST = T057
ST = T092
MS = INDUSTRY concerned with the extraction, processing, distribution, marketing and storage of PETROLEUM and NATURAL GAS.
PM = 2015
HN = 2015
MR = 20141023
DA = 20150701
DC = 1
DX = 20160101
UI = D000066388

*NEWRECORD
RECTYPE = D
MH = Coal Industry
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Coal Industries
ENTRY = Industries, Coal
ENTRY = Industry, Coal
MN = J01.576.655.875.200
FX = Fossil Fuels
MH_TH = NLM (2015)
ST = T092
PI = Coal Mining (1965-2014)
MS = Enterprise associated with the mining, processing, marketing and distribution of COAL.
PM = 2015
HN = 2016
MR = 20151005
DA = 20150701
DC = 1
DX = 20160101
UI = D000066428

*NEWRECORD
RECTYPE = D
MH = Driving Under the Influence
AQ = EH LJ PC PX SN TD
ENTRY = Drinking and Driving|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140924|abcdeef
ENTRY = Driving While Intoxicated|T055|NON|EQV|NLM (2016)|OBSSR (2016)|141010|abcdeef
ENTRY = Drunk Driving|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140707|abcdeef
ENTRY = Drunken Driving|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140924|abcdeef
ENTRY = Driving and Drinking
ENTRY = Driving, Drunk
ENTRY = Driving, Drunken
ENTRY = While Intoxicated, Driving
MN = F01.145.250.250
MN = F01.145.263.500
MN = I01.880.735.223.250
MN = I03.125.649
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T055
PI = Automobile Driving (1967-2015)
MS = Operating a motor vehicle while impaired by alcohol or other drugs including those prescribed by physicians.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150702
DC = 1
DX = 20160101
UI = D000066448

*NEWRECORD
RECTYPE = D
MH = Human Embryonic Stem Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Cells, Human Embryonic Stem|T025|NON|EQV|NLM (2016)|140707|abcdef
ENTRY = Human Embryonic Stem Cell|T025|NON|EQV|NLM (2016)|140707|abcdef
ENTRY = Stem Cells, Human Embryonic|T025|NON|EQV|NLM (2016)|140707|abcdef
ENTRY = hESCs|T025|ABB|EQV|NLM (2016)|140707|abcdef
MN = A11.872.700.250.750
MH_TH = NLM (2016)
ST = T025
PI = Embryonic Stem Cells (2006-2015)
MS = A type of PLURIPOTENT STEM CELLS derived from early stage human embryos, up to and including the BLASTOCYST stage.
PM = 2016
HN = 2016
MR = 20141203
DA = 20150701
DC = 1
DX = 20160101
UI = D000066449

*NEWRECORD
RECTYPE = D
MH = Mouse Embryonic Stem Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Cells, Mouse Embryonic Stem|T025|NON|EQV|NLM (2016)|140707|abcdef
ENTRY = Mouse Embryonic Stem Cell|T025|NON|EQV|NLM (2016)|140707|abcdef
ENTRY = Stem Cells, Mouse Embryonic|T025|NON|EQV|NLM (2016)|140707|abcdef
ENTRY = mESCs|T025|ABB|EQV|NLM (2016)|140707|abcdef
MN = A11.872.700.250.875
MH_TH = NLM (2016)
ST = T025
PI = Embryonic Stem Cells (2006-2015)
MS = PLURIPOTENT STEM CELLS derived from the BLASTOCYST INNER CELL MASS of day 3.5 mouse embryos.
PM = 2016
HN = 2016
MR = 20141203
DA = 20150701
DC = 1
DX = 20160101
UI = D000066450

*NEWRECORD
RECTYPE = D
MH = Embryonic Germ Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = EG Cells|T025|NON|EQV|NLM (2016)|140708|abcdef
ENTRY = Germ Cells, Embryonic|T025|NON|EQV|NLM (2016)|140708|abcdef
ENTRY = Cell, EG
ENTRY = Cell, Embryonic Germ
ENTRY = Cells, EG
ENTRY = Cells, Embryonic Germ
ENTRY = EG Cell
ENTRY = Embryonic Germ Cell
ENTRY = Germ Cell, Embryonic
MN = A11.497.124
MN = A11.872.700.250.625
MH_TH = NLM (2016)
ST = T025
PI = Germ Cells (1974-2015)
MS = PLURIPOTENT STEM CELLS that are derived from early GERM CELLS.
PM = 2016
HN = 2016
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000066473

*NEWRECORD
RECTYPE = D
MH = Work Performance
AQ = CL EC ED ES HI LJ MA OG SD SN ST TD UT
ENTRY = Job Performance|T062|T080|NON|REL|NLM (2016)|OBSSR (2016)|150204|abbcdeef
ENTRY = Performance at Work|T062|T080|NON|EQV|NLM (2016)|OBSSR (2016)|140709|abbcdeef
ENTRY = Job Performances
ENTRY = Performance, Job
ENTRY = Performance, Work
ENTRY = Performances, Job
ENTRY = Performances, Work
ENTRY = Work Performances
MN = I03.946.675
FX = Workplace
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T062
ST = T080
PI = Employee Performance Appraisal (1963-2015)
MS = Measure of how well someone performs given tasks at their place of work.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000066477

*NEWRECORD
RECTYPE = D
MH = Criminal Behavior
AQ = CL DE EH ES HI PH
ENTRY = Criminal Conduct|T055|NON|EQV|NLM (2016)|140922|abcdef
ENTRY = Criminal Intent|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140922|abcdeef
ENTRY = Illegal Behavior|T055|NON|EQV|NLM (2016)|OBSSR (2016)|141010|abcdeef
ENTRY = Illicit Behavior|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140922|abcdeef
ENTRY = Unlawful Behavior|T055|NON|EQV|NLM (2016)|OBSSR (2016)|141010|abcdeef
ENTRY = Behavior, Criminal
ENTRY = Behavior, Illegal
ENTRY = Behavior, Illicit
ENTRY = Behavior, Unlawful
ENTRY = Behaviors, Criminal
ENTRY = Behaviors, Illegal
ENTRY = Behaviors, Illicit
ENTRY = Behaviors, Unlawful
ENTRY = Conduct, Criminal
ENTRY = Criminal Behaviors
ENTRY = Criminal Intents
ENTRY = Illegal Behaviors
ENTRY = Illicit Behaviors
ENTRY = Intent, Criminal
ENTRY = Intents, Criminal
ENTRY = Unlawful Behaviors
MN = F01.145.250
FX = Crime
FX = Criminal Psychology
FX = Criminals
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T055
PI = Criminal Psychology (1963-2015)
MS = Conduct leading to commission of unlawful acts.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000066479

*NEWRECORD
RECTYPE = D
MH = Clinical Decision-Making
AQ = ES MT
ENTRY = Medical Decision-Making|T060|NON|EQV|NLM (2016)|OBSSR (2016)|141010|abcdeef
ENTRY = Clinical Decision Making
ENTRY = Decision-Making, Clinical
ENTRY = Decision-Making, Medical
ENTRY = Medical Decision Making
MN = E01.055
FX = Decision Support Systems, Clinical
FX = Decision Support Techniques
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T060
AN = use DECISION MAKING for decision making by the patient
PI = Decision Making (1972-2015)
MS = Process of formulating a diagnosis based on medical history and physical or mental examinations, and/or choosing an appropriate intervention.
PM = 2016
HN = 2016
MR = 20150701
DA = 20150702
DC = 1
DX = 20160101
UI = D000066491

*NEWRECORD
RECTYPE = D
MH = Cognitive Aging
AQ = PH PX
ENTRY = Aging, Cognitive
MN = G07.700.320.124.260
FX = Cognition Disorders
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T041
PI = Aging (1984-2015)
MS = Phenomenon that occurs when learning and memory abilities decrease naturally due to age.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000066492

*NEWRECORD
RECTYPE = D
MH = Cognitive Neuroscience
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Neuroscience, Cognitive
MN = F04.096.628.255.500
MN = H01.158.610.030
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T090
AN = use for the discipline only (education, history, etc)
MS = Field of study concerning MENTAL PROCESSES, LEARNING, and the brain regions associated with them.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000066494

*NEWRECORD
RECTYPE = D
MH = Emotional Adjustment
AQ = CL DE ES PH RE
ENTRY = Emotional Adaptation|T041|NON|EQV|NLM (2016)|OBSSR (2016)|150204|abcdeef
ENTRY = Psychological Adjustment|T041|NON|EQV|NLM (2016)|OBSSR (2016)|150409|abcdeef
ENTRY = Adaptation, Emotional
ENTRY = Adaptations, Emotional
ENTRY = Adjustment, Emotional
ENTRY = Adjustment, Psychological
ENTRY = Adjustments, Emotional
ENTRY = Adjustments, Psychological
ENTRY = Emotional Adaptations
ENTRY = Emotional Adjustments
ENTRY = Psychological Adjustments
MN = F01.058.144
MN = F01.752.543.500.250
FX = Adjustment Disorders
FX = Social Adjustment
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T041
MS = Psychological process that occurs when an individual adapts to a significant emotional event or stimulus.
PM = 2016; for PSYCHOLOGICAL ADJUSTMENT see ADAPTATION, PSYCHOLOGICAL 2000-2015
HN = 2016; for PSYCHOLOGICAL ADJUSTMENT use ADAPTATION, PSYCHOLOGICAL 2000-2015
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000066498

*NEWRECORD
RECTYPE = D
MH = Facial Recognition
AQ = DE ES PH RE
ENTRY = Face Perception|T041|T054|NON|EQV|NLM (2016)|OBSSR (2016)|140711|abbcdeef
ENTRY = Identity Recognition|T054|NON|BRD|NLM (2016)|OBSSR (2016)|150204|abcdeef
ENTRY = Perception, Face
ENTRY = Recognition, Facial
ENTRY = Recognition, Identity
MN = F02.463.593.524.500.500
MN = F02.463.593.932.622.500
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T041
ST = T054
PI = Pattern Recognition, Visual (1977-2015)
MS = Ability to identify an individual and interpret their feelings and emotions based on their facial expressions.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000066499

*NEWRECORD
RECTYPE = D
MH = Grandparents
AQ = ED PX
ENTRY = Grandfather|T099|NON|REL|NLM (2016)|OBSSR (2016)|150204|abcdeef
ENTRY = Grandmother|T099|NON|REL|NLM (2016)|OBSSR (2016)|150204|abcdeef
ENTRY = Grandparent|T099|NON|EQV|NLM (2016)|OBSSR (2016)|140711|abcdeef
ENTRY = Grandfathers
ENTRY = Grandmothers
MN = F01.829.263.403
MN = I01.880.853.150.452
MN = M01.264
FX = Family
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T099
PI = Intergenerational Relations (1963-2015)
MS = Member of a family who has children and grandchildren.
PM = 2016
HN = 2016
MR = 20150409
DA = 20150701
DC = 1
DX = 20160101
UI = D000066502

*NEWRECORD
RECTYPE = D
MH = Help-Seeking Behavior
ENTRY = Behavior, Help-Seeking
ENTRY = Behaviors, Help-Seeking
ENTRY = Help Seeking Behavior
ENTRY = Help-Seeking Behaviors
MN = F01.145.813.217
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T054
MS = Form of social behavior in which assistance is sought from others.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000066505

*NEWRECORD
RECTYPE = D
MH = Heuristics
AQ = CL DE ES PH RE
ENTRY = Rule of Thumb|T041|NON|EQV|NLM (2016)|OBSSR (2016)|141105|abcdeef
ENTRY = Heuristic
MN = F02.463.425.725.500
MN = F02.463.785.810.500
FX = Artificial Intelligence
FX = Computer Heuristics
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T041
MS = Experience-based techniques for problem-solving, learning, and discovery that find a solution which is not guaranteed to be optimal, but sufficient for a given set of goals.
PM = 2016
HN = 2016
MR = 20150615
DA = 20150706
DC = 1
DX = 20160101
UI = D000066506

*NEWRECORD
RECTYPE = D
MH = Intimate Partner Violence
AQ = CL EC EH ES HI LJ PC PX SN TD
ENTRY = Dating Violence|T053|NON|REL|NLM (2016)|OBSSR (2016)|150204|abcdeef
ENTRY = Intimate Partner Abuse|T053|NON|EQV|NLM (2016)|OBSSR (2016)|150408|abcdeef
ENTRY = Abuse, Intimate Partner
ENTRY = Partner Abuse, Intimate
ENTRY = Partner Violence, Intimate
ENTRY = Violence, Dating
ENTRY = Violence, Intimate Partner
MN = I01.198.240.856.575
MN = I01.880.735.900.688
FX = Sex Offenses
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T053
PI = Spouse Abuse (1997-2015)
MS = A pattern of assaultive and coercive behavior by an individual against their partner or spouse that may include physical injury, psychological abuse, sexual assault, progressive isolation, stalking, deprivation, intimidation, and reproductive coercion.
PM = 2016
HN = 2016
MR = 20150409
DA = 20150701
DC = 1
DX = 20160101
UI = D000066511

*NEWRECORD
RECTYPE = D
MH = Neurological Rehabilitation
AQ = CL EC ED ES HI IS LJ MA MT OG PX SN ST TD
ENTRY = Neurologic Rehabilitation|T061|NON|EQV|NLM (2016)|OBSSR (2016)|140714|abcdeef
ENTRY = Neurorehabilitation|T061|NON|EQV|NLM (2016)|OBSSR (2016)|140902|abcdeef
ENTRY = Rehabilitation, Neurologic
ENTRY = Rehabilitation, Neurological
MN = E02.831.477
MN = H02.403.680.600.750
MN = N02.421.784.511
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T061
PI = Rehabilitation (1963-2015)
MS = Physician-supervised programs designed to rehabilitate people with diseases, trauma, or disorders of the NERVOUS SYSTEM.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000066530

*NEWRECORD
RECTYPE = D
MH = Physical Abuse
AQ = CL EC EH ES HI LJ PC PX SN TD
ENTRY = Physical Maltreatment|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140715|abcdeef
ENTRY = Physical Violence|T055|NON|EQV|NLM (2016)|OBSSR (2016)|150408|abcdeef
ENTRY = Abuse, Physical
ENTRY = Maltreatment, Physical
ENTRY = Violence, Physical
MN = I01.198.240.856.688
MN = I01.880.735.900.744
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T055
PI = Child Abuse (1963-2016)
MS = Violence inflicted on an individual through physical contact.
PM = 2016
HN = 2016
MR = 20150409
DA = 20150701
DC = 1
DX = 20160101
UI = D000066550

*NEWRECORD
RECTYPE = D
MH = Problem Behavior
AQ = PX
ENTRY = Behavioral Problem|T048|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140715|abbcdeef
ENTRY = Disruptive Behavior|T080|NON|REL|NLM (2016)|141215|abcdef
ENTRY = Behavior, Disruptive
ENTRY = Behavior, Problem
ENTRY = Behavioral Problems
ENTRY = Behaviors, Disruptive
ENTRY = Behaviors, Problem
ENTRY = Disruptive Behaviors
ENTRY = Problem Behaviors
ENTRY = Problem, Behavioral
ENTRY = Problems, Behavioral
MN = F01.145.126.972
MN = F01.145.179.750
FX = Attention Deficit and Disruptive Behavior Disorders
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T048
ST = T055
PI = Child Behavior Disorders (1963-2016)
MS = Troublesome or disruptive behavioral displays.
PM = 2016
HN = 2016
MR = 20150109
DA = 20150706
DC = 1
DX = 20160101
UI = D000066553

*NEWRECORD
RECTYPE = D
MH = Underage Drinking
AQ = CL EC EH ES HI LJ PC PX SN TD
ENTRY = Adolescent Alcohol Consumption|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Adolescent Alcohol Use|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Adolescent Drinking|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Legal Drinking Age|T055|NON|NRW|NLM (2016)|OBSSR (2016)|141010|abcdeef
ENTRY = Minimum Drinking Age|T055|NON|NRW|NLM (2016)|OBSSR (2016)|141010|abcdeef
ENTRY = Minimum Legal Drinking Age|T055|NON|NRW|NLM (2016)|OBSSR (2016)|141010|abcdeef
ENTRY = Teen Drinking|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Teenage Drinking|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Underage Alcohol Consumption|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Underage Alcohol Use|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Youth Alcohol Consumption|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Youth Drinking|T055|NON|EQV|NLM (2016)|OBSSR (2016)|140718|abcdeef
ENTRY = Alcohol Consumption, Adolescent
ENTRY = Alcohol Consumption, Underage
ENTRY = Alcohol Consumption, Youth
ENTRY = Alcohol Use, Adolescent
ENTRY = Alcohol Use, Underage
ENTRY = Drinking Age, Legal
ENTRY = Drinking Age, Minimum
ENTRY = Drinking Ages, Legal
ENTRY = Drinking Ages, Minimum
ENTRY = Drinking, Adolescent
ENTRY = Drinking, Teen
ENTRY = Drinking, Teenage
ENTRY = Drinking, Underage
ENTRY = Drinking, Youth
ENTRY = Legal Drinking Ages
ENTRY = Minimum Drinking Ages
MN = F01.145.022.750
MN = F01.145.317.269.875
MN = I01.880.735.878
FX = Alcohol Drinking in College
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T055
MS = Consumption of ALCOHOLIC BEVERAGES by persons under the legal drinking age.
PM = 2016
HN = 2016
MR = 20141203
DA = 20150706
DC = 1
DX = 20160101
UI = D000066608

*NEWRECORD
RECTYPE = D
MH = Ectopic Gene Expression
AQ = DE GE IM PH RE
ENTRY = Ectopic Expression|T045|NON|EQV|NLM (2016)|140722|abcdef
ENTRY = Ectopic Expressions
ENTRY = Ectopic Gene Expressions
ENTRY = Expression, Ectopic
ENTRY = Expression, Ectopic Gene
ENTRY = Expressions, Ectopic
ENTRY = Expressions, Ectopic Gene
ENTRY = Gene Expression, Ectopic
ENTRY = Gene Expressions, Ectopic
MN = G05.355.315.202
MH_TH = NLM (2016)
ST = T045
PI = Gene Expression Regulation (1981-2015)
MS = The expression of a gene in an abnormal place,  or at an abnormal  time in an organism. Ectopic Gene  Expression is often induced artificially by genetic techniques.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000066630

*NEWRECORD
RECTYPE = D
MH = Cell Plasticity
AQ = DE GE IM PH RE
ENTRY = Cellular Plasticity|T043|NON|EQV|NLM (2016)|140924|abcdef
ENTRY = Cell Plasticities
ENTRY = Cellular Plasticities
ENTRY = Plasticities, Cell
ENTRY = Plasticities, Cellular
ENTRY = Plasticity, Cell
ENTRY = Plasticity, Cellular
MN = G04.299.335.250
FX = Neuronal Plasticity
MH_TH = NLM (2016)
ST = T043
PI = Cell Differentiation (1966-2015)
MS = The ability of a cell to change its PHENOTYPE in response to changes in the environment.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000066670

*NEWRECORD
RECTYPE = D
MH = Cell Self Renewal
AQ = DE GE IM PH RE
ENTRY = Stem Cell Renewal|T043|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = Stem Cell Self-Renewal|T043|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = Cell Renewal, Stem
ENTRY = Cell Renewals, Stem
ENTRY = Cell Self Renewals
ENTRY = Cell Self-Renewal, Stem
ENTRY = Cell Self-Renewals, Stem
ENTRY = Renewal, Cell Self
ENTRY = Renewal, Stem Cell
ENTRY = Renewals, Cell Self
ENTRY = Renewals, Stem Cell
ENTRY = Self Renewal, Cell
ENTRY = Self Renewals, Cell
ENTRY = Self-Renewal, Stem Cell
ENTRY = Self-Renewals, Stem Cell
ENTRY = Stem Cell Renewals
ENTRY = Stem Cell Self Renewal
ENTRY = Stem Cell Self-Renewals
MN = G04.299.134.220.235
MN = G04.299.233.750.500.375
MN = G05.355.105.415
MN = G07.700.320.249.410.750.500.625
FX = Stem Cells
MH_TH = NLM (2016)
ST = T043
PI = Cell Differentiation (1966-2015)
MS = The ability of certain cell types, such as progenitor cells or tumor cells,  to go through numerous cycles of CELL DIVISION while still maintaining an undifferentiated or partially differentiated state.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000066673

*NEWRECORD
RECTYPE = D
MH = Rehabilitation Research
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Research, Rehabilitation
MN = H01.770.644.145.472
FX = Disabled Persons
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T062
PI = Rehabilitation (2004-2015)
MS = Studies and research concerning the psychological, educational, social, vocational, industrial, and economic aspects of REHABILITATION.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000066768

*NEWRECORD
RECTYPE = D
MH = Orthodontists
AQ = CL EC ES HI LJ OG PX SD SN ST TD UT
ENTRY = Dentofacial Orthopedists|T097|NON|NRW|NLM (2016)|140801|abcdef
ENTRY = Dentofacial Orthopedist
ENTRY = Orthodontist
ENTRY = Orthopedist, Dentofacial
ENTRY = Orthopedists, Dentofacial
MN = M01.526.485.330.655
MN = N02.360.330.655
MH_TH = NLM (2016)
ST = T097
MS = Dentists who specialize in the treatment of misaligned TEETH and MALOCCLUSION.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000066792

*NEWRECORD
RECTYPE = D
MH = Oral and Maxillofacial Surgeons
AQ = CL EC ES HI LJ OG PX SD SN ST TD UT
ENTRY = Exodontists|T097|NON|NRW|NLM (2016)|140807|abcdef
ENTRY = Maxillofacial Surgeons|T097|NON|EQV|NLM (2016)|140801|abcdef
ENTRY = Oral Surgeons|T097|NON|EQV|NLM (2016)|140801|abcdef
ENTRY = Exodontist
ENTRY = Maxillofacial Surgeon
ENTRY = Oral Surgeon
ENTRY = Surgeon, Maxillofacial
ENTRY = Surgeon, Oral
ENTRY = Surgeons, Maxillofacial
ENTRY = Surgeons, Oral
MN = M01.526.485.330.483
MN = N02.360.330.483
MH_TH = NLM (2016)
ST = T097
MS = Dentists who specialize in the surgical treatment of injuries, diseases, and abnormalities of the oral and maxillofacial regions.
PM = 2016
HN = 2016
MR = 20141203
DA = 20150701
DC = 1
DX = 20160101
UI = D000066794

*NEWRECORD
RECTYPE = D
MH = Neuroprotection
AQ = DE GE IM PH RE
ENTRY = Neural Protection|T038|T039|NON|EQV|NLM (2016)|OBSSR (2016)|150408|abbcdeef
ENTRY = Neuron Protection|T038|T039|NON|EQV|NLM (2016)|OBSSR (2016)|150408|abbcdeef
ENTRY = Neuronal Protection|T038|T039|NON|EQV|NLM (2016)|OBSSR (2016)|150408|abbcdeef
ENTRY = Protection, Neural
ENTRY = Protection, Neuron
ENTRY = Protection, Neuronal
MN = G11.561.600.638
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T038
ST = T039
MS = The physiological processes and techniques used by the body to prevent neuronal injury and degeneration in the central nervous system following acute disorders or as a result of chronic neurodegenerative diseases.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000066829

*NEWRECORD
RECTYPE = D
MH = Diet, Food, and Nutrition
MN = G07.203
MH_TH = NLM (2016)
ST = T040
AN = used for searching; INDEXER: Do not use; CATALOGER: Do not use
MS = Concepts involved with nutritional physiology, including categories of substances eaten for sustenance, nutritional phenomena and processes, eating patterns and habits, and measurable nutritional parameters.
PM = 2016
HN = 2016
MR = 20150617
DA = 20150701
DC = 1
DX = 20160101
UI = D000066888

*NEWRECORD
RECTYPE = D
MH = Triticale
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Triticosecale|T168|NON|EQV|NLM (2016)|140812|abcdef
ENTRY = Triticum x Secale|T168|NON|EQV|NLM (2016)|140812|abcdef
MN = B01.650.940.800.575.100.822.906
MH_TH = NLM (1998)
ST = T168
PI = Cereals (1970-2015)
PI = Poaceae (1970-2015)
MS = A CEREAL GRAIN plant resulting from a cross between TRITICUM and SECALE CEREALE.
PM = 2016; see CEREALS 1998-2015
HN = 2016; use EDIBLE GRAIN 1998-2015
MR = 20141014
DA = 20150701
DC = 1
DX = 20160101
UI = D000066889

*NEWRECORD
RECTYPE = D
MH = Critical Care Outcomes
ENTRY = Care Outcome, Critical
ENTRY = Care Outcomes, Critical
ENTRY = Critical Care Outcome
ENTRY = Outcome, Critical Care
ENTRY = Outcomes, Critical Care
MN = N04.761.559.590.399.250
MN = N05.715.360.575.575.200
MH_TH = NLM (2016)
ST = T058
MS = A measure of the mortality and morbidity rates among patients who receive CRITICAL CARE and INTENSIVE CARE as determined from the date of hospital discharge or release.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000066891

*NEWRECORD
RECTYPE = D
MH = Simulation Training
AQ = CL EC ES HI LJ MA MT OG SN ST TD
ENTRY = Interactive Learning|T065|NON|BRD|NLM (2016)|140813|abcdef
ENTRY = Learning, Interactive
ENTRY = Training, Simulation
MN = I02.903.847
MH_TH = NLM (2016)
ST = T065
MS = A highly customized interactive medium or program that allows individuals to learn and practice real world activities in an accurate, realistic, safe and secure environment.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000066908

*NEWRECORD
RECTYPE = D
MH = Millets
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Millet
MN = B01.650.940.800.575.100.822.587
MH_TH = NLM (2016)
ST = T002
ST = T168
AN = general or unspecified; note several specific millet terms are available
PI = Panicum (1981-2015)
MS = An agronomic group especially of small-seeded grasses, mainly grown for human and animal consumption.
PM = 2016
HN = 2016
MR = 20150617
DA = 20150701
DC = 1
DX = 20160101
UI = D000066928

*NEWRECORD
RECTYPE = D
MH = Biobehavioral Sciences
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Biobehavioral Approach|T062|NON|EQV|NLM (2016)|140827|abcdef
ENTRY = Biobehavioral Model|T062|NON|EQV|NLM (2016)|140827|abcdef
ENTRY = Approach, Biobehavioral
ENTRY = Biobehavioral Models
ENTRY = Biobehavioral Science
ENTRY = Model, Biobehavioral
ENTRY = Models, Biobehavioral
ENTRY = Science, Biobehavioral
ENTRY = Sciences, Biobehavioral
MN = H01.770.644.108.687
FX = Interdisciplinary Studies
MH_TH = NLM (2016)
ST = T062
MS = An interdisciplinary scientific approach to the study of complex interactions among biological, social, behavioral, environmental factors, and their effects on health outcomes.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000066949

*NEWRECORD
RECTYPE = D
MH = Protein Corona
AQ = AN CH IM ME MT
ENTRY = Corona, Protein
MN = D12.776.642
MH_TH = NLM (2016)
ST = T116
RN = 0
MS = A layer of protein coating adsorbed by NANOPARTICLES upon entry into PLASMA or other protein-containing biological fluids, which affects how nanoparticles are internalized by cells and cleared from the body.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000066970

*NEWRECORD
RECTYPE = D
MH = Vegetarians
AQ = CL ED HI LJ PX SN
ENTRY = Lacto-Ovo Vegetarians|T098|NON|NRW|NLM (2016)|140909|abcdef
ENTRY = Ovo-Lacto Vegetarians|T098|NON|NRW|NLM (2016)|140909|abcdef
ENTRY = Lacto Ovo Vegetarians
ENTRY = Lacto-Ovo Vegetarian
ENTRY = Ovo Lacto Vegetarians
ENTRY = Ovo-Lacto Vegetarian
ENTRY = Vegetarian
ENTRY = Vegetarian, Lacto-Ovo
ENTRY = Vegetarian, Ovo-Lacto
ENTRY = Vegetarians, Lacto-Ovo
ENTRY = Vegetarians, Ovo-Lacto
MN = M01.928
FX = Diet, Vegetarian
MH_TH = NLM (2016)
ST = T098
PI = Diet, Vegetarian (1963-2015)
MS = Persons who do not eat MEAT.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150706
DC = 1
DX = 20160101
UI = D000066988

*NEWRECORD
RECTYPE = D
MH = Vegans
AQ = CL ED HI LJ PX SN
ENTRY = Vegan
MN = M01.928.500
FX = Diet, Vegan
MH_TH = NLM (2016)
ST = T098
PI = Diet, Vegetarian (1967-2015)
MS = Persons who avoid consuming animal products or animal-derived substances, such as MEAT; EGGS; or HONEY.  Some vegans also refrain from using animals or animal products in any form or for any purpose, such as in CLOTHING or household goods.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150706
DC = 1
DX = 20160101
UI = D000066989

*NEWRECORD
RECTYPE = D
MH = Accounts Payable and Receivable
DE = ACCOUNTS PAYABLE RECEIVABLE
ENTRY = Accounts Payable|T081|NON|NRW|NLM (1991)|900308|abcdef
MN = N03.219.463.030.080
MH_TH = NLM (1978)
ST = T081
AN = no qualif; DF: ACCOUNTS PAYABLE
PI = Accounting (1966-1977)
MS = Short-term debt obligations and assets occurring in the regular course of operational transactions.
PM = 91; was see under ACCOUNTING 1978-90
HN = 91(78); was see under ACCOUNTING 1978-90
MR = 19900530
DA = 19770505
DC = 1
DX = 19910101
UI = D000067

*NEWRECORD
RECTYPE = D
MH = Youth Sports
AQ = CL EC ED ES HI IN LJ PH PX SN ST TD
ENTRY = Adolescent Sports|T056|T100|NON|EQV|NLM (2016)|141014|abbcdef
ENTRY = Children's Sports|T056|T100|NON|EQV|NLM (2016)|140922|abbcdef
ENTRY = Organized Youth Sports|T056|T100|NON|NRW|NLM (2016)|140902|abbcdef
ENTRY = Adolescent Sport
ENTRY = Children Sports
ENTRY = Children's Sport
ENTRY = Childrens Sports
ENTRY = Organized Youth Sport
ENTRY = Sport, Adolescent
ENTRY = Sport, Children's
ENTRY = Sport, Organized Youth
ENTRY = Sport, Youth
ENTRY = Sports, Adolescent
ENTRY = Sports, Children's
ENTRY = Sports, Organized Youth
ENTRY = Sports, Youth
ENTRY = Youth Sport
ENTRY = Youth Sport, Organized
ENTRY = Youth Sports, Organized
MN = I03.450.642.845.987
MH_TH = NLM (2016)
ST = T056
ST = T100
PI = Sports (1970-2014)
MS = SPORTS activities designed and/or organized for CHILDREN or YOUTH.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000067009

*NEWRECORD
RECTYPE = D
MH = Literacy
AQ = EH HI PX SN ST TD
PRINT ENTRY = Illiteracy|T080|NON|REL|NLM (1988)|750101|abcdef
MN = F01.145.209.429
MN = L01.143.563
MN = N01.824.196.500
FX = Handwriting
FX = Health Literacy
FX = Reading
FX = Writing
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T041
MS = Ability to read and write.
PM = 2016; for ILLITERACY see EDUCATIONAL STATUS
HN = 2016; for ILLITERACY use EDUCATIONAL STATUS
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000067010

*NEWRECORD
RECTYPE = D
MH = Severe Acute Malnutrition
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Acute Malnutrition, Severe
ENTRY = Malnutrition, Severe Acute
MN = C18.654.521.719
MH_TH = NLM (2016)
ST = T047
PI = Nutrition Disorders (1980-2014)
MS = Acute form of MALNUTRITION which usually affects children, characterized by a very low weight for height (below -3z scores of the median World Health Organization standards), visible severe wasting, or occurrence of nutritional EDEMA.  It can be a direct or indirect cause of fatality in children suffering from DIARRHEA and PNEUMONIA. Do not confuse with starvation, a condition in which the body is not getting enough food, usually for extended periods of time.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000067011

*NEWRECORD
RECTYPE = D
MH = Banking, Personal
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Bank Accounts|T057|NON|EQV|NLM (2016)|140902|abcdef
ENTRY = Banking, Commercial|T057|NON|EQV|NLM (2016)|140910|abcdef
ENTRY = Banking, Financial|T057|NON|EQV|NLM (2016)|140910|abcdef
ENTRY = Checking Accounts|T057|NON|NRW|NLM (2016)|141014|abcdef
ENTRY = Savings Accounts|T057|NON|NRW|NLM (2016)|140902|abcdef
ENTRY = Account, Bank
ENTRY = Account, Checking
ENTRY = Account, Savings
ENTRY = Accounts, Bank
ENTRY = Accounts, Checking
ENTRY = Accounts, Savings
ENTRY = Bank Account
ENTRY = Checking Account
ENTRY = Commercial Banking
ENTRY = Financial Banking
ENTRY = Personal Banking
ENTRY = Savings Account
MN = N03.219.463.030.100
FX = Medical Savings Accounts
MH_TH = NLM (2016)
ST = T057
PI = Economics (1975-2014)
MS = A financial account set up between a financial institution (such as a commercial bank) and a customer (individual, group, or business), whereby the latter may deposit and withdraw money, and where applicable, be paid interest.
PM = 2016
HN = 2016
MR = 20141023
DA = 20150701
DC = 1
DX = 20160101
UI = D000067012

*NEWRECORD
RECTYPE = D
MH = Evidence-Based Facility Design
AQ = CL EC ES HI IS LJ MA MT SN ST TD
ENTRY = Design, Evidence-Based Facility
ENTRY = Designs, Evidence-Based Facility
ENTRY = Evidence Based Facility Design
ENTRY = Evidence-Based Facility Designs
ENTRY = Facility Design, Evidence-Based
ENTRY = Facility Designs, Evidence-Based
MN = N02.278.200.252
MH_TH = NLM (2016)
ST = T057
MS = An approach, process, or methodology which emphasizes credible evidence and the best available scientific knowledge, judiciously integrated to achieve the best possible outcomes in structural design. For example, the design of a new OUTPATIENT CLINIC might incorporate a review of published research on outpatient clinic design, decisions on similar past projects, along with interviews with staff and consumers.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000067013

*NEWRECORD
RECTYPE = D
MH = Body, Physical Appearance
AQ = DE EH GE IM PH RE
ENTRY = Outward Appearance|T032|NON|EQV|NLM (2016)|140904|abcdef
ENTRY = Physical Appearance|T032|NON|EQV|NLM (2016)|140904|abcdef
ENTRY = Physical Appearance, Body|T032|NON|EQV|NLM (2016)|140904|abcdef
ENTRY = Appearance Body, Physical
ENTRY = Appearance, Body Physical
ENTRY = Appearance, Outward
ENTRY = Appearance, Physical
ENTRY = Body Physical Appearance
ENTRY = Physical Appearance Body
MN = E01.370.600.115.450
MN = G07.100.175
FX = Body Image
MH_TH = NLM (2016)
ST = T032
MS = The superficial physical looks, characteristics, or qualities of an individual as distinguished from the underlying unseen nature or attributes.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000067029

*NEWRECORD
RECTYPE = D
MH = Fruit and Vegetable Juices
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Fruit Juices|T002|T168|NON|NRW|NLM (2016)|140918|abbcdef
ENTRY = Vegetable Juices|T002|T168|NON|NRW|NLM (2016)|140918|abbcdef
ENTRY = Fruit Juice
ENTRY = Juice, Fruit
ENTRY = Juice, Vegetable
ENTRY = Juices, Fruit
ENTRY = Juices, Vegetable
ENTRY = Vegetable Juice
MN = G07.203.100.606
MN = J02.200.606
MH_TH = NLM (2016)
ST = T002
ST = T168
AN = coordinate with specific fruit or vegetable
PI = Beverages (1963-2015)
MS = The liquids extracted from plants.
PM = 2016
HN = 2016
MR = 20141218
DA = 20150701
DC = 1
DX = 20160101
UI = D000067030

*NEWRECORD
RECTYPE = D
MH = Ghee
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Anhydrous Butterfat|T119|T168|NON|EQV|NLM (2016)|141231|abbcdef
ENTRY = Butter Oil|T119|T168|NON|EQV|NLM (2016)|141231|abbcdef
ENTRY = Clarified Butter|T119|T168|NON|EQV|NLM (2016)|140905|abbcdef
ENTRY = Anhydrous Butterfats
ENTRY = Butter Oils
ENTRY = Butter, Clarified
ENTRY = Butterfat, Anhydrous
ENTRY = Butterfats, Anhydrous
ENTRY = Butters, Clarified
ENTRY = Clarified Butters
ENTRY = Ghees
ENTRY = Oil, Butter
ENTRY = Oils, Butter
MN = D10.212.302.199.500
MN = G07.203.300.350.100.500
MN = G07.203.300.375.200.500
MN = J02.500.350.100.500
MN = J02.500.375.200.500
MH_TH = UNK (19XX)
ST = T119
ST = T168
RN = 0
PI = Dietary Fats (1969-2015)
MS = The clarified portion of milk, cream, or butter obtained by the removal of the nonfat constituents. (from Dictionary of Food Ingredients, 4th ed., 2001)
PM = 2016; see DIETARY FATS 1982-2015
HN = 2016; use DIETARY FATS 1982-2015
MR = 20150112
DA = 20150701
DC = 1
DX = 20160101
UI = D000067048

*NEWRECORD
RECTYPE = D
MH = Hydraulic Fracking
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Fraccing|T057|NON|EQV|NLM (2016)|140908|abcdef
ENTRY = Fracking|T057|NON|EQV|NLM (2016)|140908|abcdef
ENTRY = Hydraulic Fracturing|T057|NON|EQV|NLM (2016)|140908|abcdef
ENTRY = Hydrofracking|T057|NON|EQV|NLM (2016)|140922|abcdef
ENTRY = Hydrofracturing|T057|NON|EQV|NLM (2016)|141014|abcdef
ENTRY = Fracking, Hydraulic
ENTRY = Fracturing, Hydraulic
ENTRY = Hydrofracturings
MN = J01.576.655.875.750.500
MH_TH = NLM (2016)
ST = T057
MS = A drilling technology in which NATURAL GAS is extracted from large deposits of impermeable rock formations known as shale, deep within the earths crust. This drilling technique involves injecting large volumes of high-pressure fracturing fluid (a mixture of water, sand, and chemicals) several thousand feet underground, thereby creating cracks or fissures in the shale formation, and releasing trapped gas.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000067071

*NEWRECORD
RECTYPE = D
MH = Psychological Trauma
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Trauma, Psychological
MN = F03.950.750.375
FX = Stress Disorders, Post-Traumatic
MH_TH = NLM (2016)
ST = T048
PI = Depression (1965-2014)
MS = Overwhelming emotional damage caused by a distressful event or series of events.
PM = 2016
HN = 2016
MR = 20150205
DA = 20150706
DC = 1
DX = 20160101
UI = D000067073

*NEWRECORD
RECTYPE = D
MH = Peer Influence
ENTRY = Peer Pressure|T054|NON|NRW|NLM (2016)|140908|abcdef
ENTRY = Influence, Peer
ENTRY = Pressure, Peer
MN = F01.829.316.483.750
MH_TH = NLM (2016)
ST = T054
PI = Peer Group (1968-2015)
MS = The effect or sway that a PEER GROUP exerts on the beliefs, value systems and behavior of each member of a group. The social expectations for individuals to conform to peer group influence is known as peer pressure.
PM = 2016
HN = 2016
MR = 20150701
DA = 20150701
DC = 1
DX = 20160101
UI = D000067074

*NEWRECORD
RECTYPE = D
MH = Vegetable Products
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Product, Vegetable
ENTRY = Products, Vegetable
ENTRY = Vegetable Product
MN = G07.203.300.850.450
MN = J02.500.850.800
MH_TH = NLM (2016)
ST = T168
PI = Vegetables (1966-2015)
MS = Food that is manufactured from various parts of vegetables.
PM = 2016
HN = 2016
MR = 20141014
DA = 20150701
DC = 1
DX = 20160101
UI = D000067075

*NEWRECORD
RECTYPE = D
MH = Direct-to-Consumer Advertising
AQ = CL EC ES HI LJ MT SN ST TD UT
ENTRY = Direct-to-Consumer Marketing|T057|NON|EQV|NLM (2016)|141014|abcdef
ENTRY = Advertising, Direct-to-Consumer
ENTRY = Direct to Consumer Advertising
ENTRY = Direct to Consumer Marketing
ENTRY = Marketing, Direct-to-Consumer
MN = J01.219.687.274.500
MH_TH = NLM (2016)
ST = T057
PI = Advertising as Topic (1983-2014)
MS = Advertising that directly targets consumers of certain products such as pharmaceuticals.
PM = 2016
HN = 2016
MR = 20141015
DA = 20150701
DC = 1
DX = 20160101
UI = D000067088

*NEWRECORD
RECTYPE = D
MH = Direct-To-Consumer Screening and Testing
AQ = CL EC ES HI LJ MA MT OG PX SD SN ST TD UT
ENTRY = Direct-To-Consumer Screening|T060|T062|NON|EQV|NLM (2016)|140910|abbcdef
ENTRY = Direct-To-Consumer Testing|T060|T062|NON|EQV|NLM (2016)|140910|abbcdef
ENTRY = Direct To Consumer Screening
ENTRY = Direct To Consumer Screening and Testing
ENTRY = Direct To Consumer Testing
ENTRY = Direct-To-Consumer Screenings
ENTRY = Direct-To-Consumer Testings
ENTRY = Screening, Direct-To-Consumer
ENTRY = Screenings, Direct-To-Consumer
ENTRY = Testing, Direct-To-Consumer
ENTRY = Testings, Direct-To-Consumer
MN = E01.370.398
MN = N02.421.726.233.166
FX = Diagnostic Self Evaluation
MH_TH = NLM (2016)
ST = T060
ST = T062
MS = Laboratory testing and diagnostic imaging services offered to consumers outside of the patient-physician relationship.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000067108

*NEWRECORD
RECTYPE = D
MH = Extracellular Vesicles
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Apoptotic Bodies|T026|NON|NRW|NLM (2016)|140910|abcdef
ENTRY = Exovesicles|T026|NON|NRW|NLM (2016)|140910|abcdef
ENTRY = Apoptotic Body
ENTRY = Bodies, Apoptotic
ENTRY = Body, Apoptotic
ENTRY = Exovesicle
ENTRY = Extracellular Vesicle
ENTRY = Vesicle, Extracellular
ENTRY = Vesicles, Extracellular
MN = A11.284.295.588
MH_TH = NLM (2016)
ST = T026
MS = Membrane limited structures derived from cell membranes and cytoplasmic material, and released into EXTRACELLULAR SPACE. They circulate through the EXTRACELLULAR FLUID and through the peripheral blood in the MICROVASCULATURE where cells, much larger, cannot, thereby affecting a variety of intercellular communication processes.
PM = 2016
HN = 2016
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000067128

*NEWRECORD
RECTYPE = D
MH = Fungal Viruses
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
ENTRY = Mycoviruses|T005|NON|EQV|NLM (2016)|140911|abcdef
ENTRY = Fungal Virus
ENTRY = Mycovirus
ENTRY = Virus, Fungal
ENTRY = Viruses, Fungal
MN = B04.352
MH_TH = NLM (2016)
ST = T005
AN = coordinate with specific fungus/ virol
PI = Fungi or specific/virology (1994-2015)
MS = Viruses infecting species of FUNGI.
PM = 2016
HN = 2016
MR = 20141218
DA = 20150701
DC = 1
DX = 20160101
UI = D000067148

*NEWRECORD
RECTYPE = D
MH = Telocytes
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Interstitial Cajal-Like Cells|T025|EPO|EQV|NLM (2016)|150107|abcdef
ENTRY = Interstitial Cell of Cajal-Like Cells|T025|EPO|EQV|NLM (2010)|090224|abcdef
ENTRY = Cajal-Like Cells, Interstitial
ENTRY = Cells, Interstitial Cajal-Like
ENTRY = Interstitial Cajal Like Cells
ENTRY = Interstitial Cell of Cajal Like Cells
ENTRY = Telocyte
MN = A11.329.830.750
FX = Interstitial Cells of Cajal
MH_TH = NLM (2016)
ST = T025
MS = A type of interstitial cells that have very long and thin CELL SURFACE EXTENSIONS called TELOPODES.
PM = 2016; for INTERSTITIAL CELL OF CAJAL-LIKE CELLS see INTERSTITIAL CELLS OF CAJAL 2010-2015
HN = 2016; for INTERSTITIAL CELL OF CAJAL-LIKE CELLS use INTERSTITIAL CELLS OF CAJAL 2010-2015
MR = 20150112
DA = 20150706
DC = 1
DX = 20160101
UI = D000067170

*NEWRECORD
RECTYPE = D
MH = Exoskeleton Device
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
ENTRY = Robotic Exoskeleton|T074|NON|NRW|NLM (2016)|140918|abcdef
ENTRY = Device, Exoskeleton
ENTRY = Devices, Exoskeleton
ENTRY = Exoskeleton Devices
ENTRY = Exoskeleton, Robotic
ENTRY = Exoskeletons, Robotic
ENTRY = Robotic Exoskeletons
MN = E07.341
FX = Robotics
MH_TH = NLM (2016)
ST = T074
PI = Orthotic Devices (2006-2015)
PI = Robotics (1999-2015)
MS = Device designed to wear externally to support muscular skeletal system in various movements such as RANGE OF MOTIONS; WEIGHT-BEARING; GAIT; and LOCOMOTION.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000067190

*NEWRECORD
RECTYPE = D
MH = Shellfish Hypersensitivity
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Shellfish Allergy|T047|NON|EQV|NLM (2016)|140922|abcdef
ENTRY = Allergies, Shellfish
ENTRY = Allergy, Shellfish
ENTRY = Hypersensitivities, Shellfish
ENTRY = Hypersensitivity, Shellfish
ENTRY = Shellfish Allergies
ENTRY = Shellfish Hypersensitivities
MN = C20.543.480.370.763
FX = Shellfish Poisoning
MH_TH = NLM (2016)
ST = T047
PI = Food Hypersensitivity (1964-2015)
PI = Shellfish (1964-2015)
MS = Allergic reaction to SHELLFISH or shellfish products.
PM = 2016
HN = 2016
MR = 20141121
DA = 20150706
DC = 1
DX = 20160101
UI = D000067208

*NEWRECORD
RECTYPE = D
MH = Failure to Rescue, Health Care
AQ = CL EC ES HI LJ SN TD
ENTRY = Failure to Rescue (Health Care)|T080|NON|EQV|NLM (2016)|140923|abcdef
ENTRY = Health Care, Failure to Rescue|T080|NON|EQV|NLM (2016)|141121|abcdef
ENTRY = Health Care, Failures to Rescue|T080|NON|EQV|NLM (2016)|141121|abcdef
ENTRY = Failure to Rescues (Health Care)
ENTRY = Rescue, Failure to (Health Care)
ENTRY = Rescues, Failure to (Health Care)
MN = E01.789.800.760.500
MN = H01.770.644.145.431.500
MN = N04.761.559.590.200
MN = N04.761.559.590.800.760.500
MN = N05.715.360.575.575.300
MN = N05.715.360.575.575.800.760.500
MH_TH = NLM (2016)
ST = T080
PI = Resuscitation (1992-2015)
PI = Treatment Failure (2005-2015)
MS = Inability to prevent a clinical deterioration resulting from a complication of an underlying medical condition or a complication of medical care. It implies that common risk factors for such a complication were not recognized in a timely manner or treated appropriately.
PM = 2016
HN = 2016
MR = 20150709
DA = 20150709
DC = 1
DX = 20160101
UI = D000067248

*NEWRECORD
RECTYPE = D
MH = Psychiatric Rehabilitation
AQ = CL EC ED ES HI IS LJ MA MT OG PX SN ST TD
ENTRY = Mental Health Rehabilitation|T058|NON|EQV|NLM (2016)|OBSSR (2016)|150615|abcdeef
ENTRY = Psychosocial Rehabilitation|T058|NON|EQV|NLM (2016)|OBSSR (2016)|140923|abcdeef
ENTRY = Health Rehabilitation, Mental
ENTRY = Rehabilitation, Mental Health
ENTRY = Rehabilitation, Psychiatric
ENTRY = Rehabilitation, Psychosocial
MN = H02.403.680.600.875
MN = N02.421.784.578
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T058
MS = Specialty field that promotes recovery, community functioning, and increased well-being of individuals diagnosed with mental disorders that impair their ability to live meaningful lives.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000067250

*NEWRECORD
RECTYPE = D
MH = Symptom Flare Up
ENTRY = Acute Symptom Flare|T067|NON|EQV|NLM (2016)|141120|abcdef
ENTRY = Symptom Flare-up|T067|NON|EQV|NLM (2016)|141120|abcdef
ENTRY = Symptom Flareup|T067|NON|EQV|NLM (2016)|141120|abcdef
ENTRY = Symptom Flaring Up|T067|NON|EQV|NLM (2016)|141121|abcdef
ENTRY = Acute Symptom Flares
ENTRY = Flare Up, Symptom
ENTRY = Flare Ups, Symptom
ENTRY = Flare, Acute Symptom
ENTRY = Flare-up, Symptom
ENTRY = Flare-ups, Symptom
ENTRY = Flares, Acute Symptom
ENTRY = Flareup, Symptom
ENTRY = Flareups, Symptom
ENTRY = Flaring Up, Symptom
ENTRY = Flaring Ups, Symptom
ENTRY = Symptom Flare Ups
ENTRY = Symptom Flare, Acute
ENTRY = Symptom Flare-ups
ENTRY = Symptom Flares, Acute
ENTRY = Symptom Flareups
ENTRY = Symptom Flaring Ups
MN = C23.550.291.937.500
MH_TH = NLM (2016)
ST = T067
PI = Incidence (1990-2015)
PI = Recurrence (1972-2015)
MS = A transient exacerbation of symptoms of an existing disease or condition.
PM = 2016
HN = 2016
MR = 20150622
DA = 20150701
DC = 1
DX = 20160101
UI = D000067251

*NEWRECORD
RECTYPE = D
MH = Isolated Heart Preparation
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Isolated Heart Preparation Technique|T059|NON|REL|NLM (2016)|140924|abcdef
ENTRY = Isolated Perfused Heart Model|T059|NON|EQV|NLM (2016)|140924|abcdef
ENTRY = Langendorff Perfused Heart|T059|EPO|NRW|NLM (2016)|140924|abcdef
ENTRY = Langendorff Perfused Isolated Heart Preparation|T059|EPO|NRW|NLM (2016)|140924|abcdef
ENTRY = Working Heart Preparation|T059|NON|NRW|NLM (2016)|140924|abcdef
ENTRY = Working Heart Preparation Technique|T059|NON|REL|NLM (2016)|140924|abcdef
ENTRY = Working Heart Technique|T059|NON|NRW|NLM (2016)|140924|abcdef
ENTRY = Heart, Langendorff Perfused
ENTRY = Isolated Heart Preparations
ENTRY = Perfused Heart, Langendorff
ENTRY = Preparation, Isolated Heart
ENTRY = Preparation, Working Heart
ENTRY = Preparations, Isolated Heart
ENTRY = Preparations, Working Heart
ENTRY = Technique, Working Heart
ENTRY = Techniques, Working Heart
ENTRY = Working Heart Preparations
ENTRY = Working Heart Techniques
MN = E05.519
MN = E05.598.750
FX = Myocardial Reperfusion Injury
MH_TH = NLM (2016)
ST = T059
PI = Heart (1963-2015)
PI = Perfusion (1963-2015)
MS = Method of isolation and maintenance ofa working heart forvarious cardiac measurements. The model allows for the separation of cardiac and systemic variables in the denervated heart.
PM = 2016
HN = 2016
MR = 20150622
DA = 20150706
DC = 1
DX = 20160101
UI = D000067268

*NEWRECORD
RECTYPE = D
MH = Diet, Vegan
AQ = AE EC EH HI PX SN
PRINT ENTRY = Vegan Diet|T078|NON|EQV|NLM (2003)|020417|abcdef
ENTRY = Veganism|T078|NON|EQV|NLM (2016)|140828|abcdef
ENTRY = Diets, Vegan
ENTRY = Vegan Diets
MN = E02.642.249.300.750
MN = G07.203.650.240.300.750
FX = Vegans
MH_TH = NLM (2003)
ST = T078
PI = Diet, Vegetarian (1967-2015)
MS = Dietary practice of avoiding animal products in any form.
PM = 2016; see DIET, VEGETARIAN 2003-2015
HN = 2016; use DIET, VEGETARIAN 2003-2015
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000067269

*NEWRECORD
RECTYPE = D
MH = Behavior Observation Techniques
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Behavior Observation|T062|NON|EQV|NLM (2016)|OBSSR (2016)|140925|abcdeef
ENTRY = Behavioral Observation|T062|NON|EQV|NLM (2016)|OBSSR (2016)|140925|abcdeef
ENTRY = Behavioral Observation Techniques|T062|NON|EQV|NLM (2016)|OBSSR (2016)|141021|abcdeef
ENTRY = Behavior Observation Technique
ENTRY = Behavior Observations
ENTRY = Behavioral Observation Technique
ENTRY = Behavioral Observations
ENTRY = Observation Technique, Behavior
ENTRY = Observation Technique, Behavioral
ENTRY = Observation Techniques, Behavior
ENTRY = Observation Techniques, Behavioral
ENTRY = Observation, Behavior
ENTRY = Observation, Behavioral
ENTRY = Observations, Behavior
ENTRY = Observations, Behavioral
MN = E05.796.112
MN = F04.669.112
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T062
MS = A wide range of formal and informal techniques used to document behavior.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000067289

*NEWRECORD
RECTYPE = D
MH = Behavior Rating Scale
AQ = HI SN ST
ENTRY = Behavior Test|T075|NON|REL|NLM (2016)|OBSSR (2016)|140925|abcdeef
ENTRY = Behavioral Rating Scale|T075|NON|EQV|NLM (2016)|OBSSR (2016)|140925|abcdeef
ENTRY = Behavioral Test|T075|NON|REL|NLM (2016)|OBSSR (2016)|140925|abcdeef
ENTRY = Behavior Rating Scales
ENTRY = Behavior Tests
ENTRY = Behavioral Rating Scales
ENTRY = Behavioral Tests
ENTRY = Rating Scale, Behavior
ENTRY = Rating Scale, Behavioral
ENTRY = Rating Scales, Behavior
ENTRY = Rating Scales, Behavioral
ENTRY = Scale, Behavioral Rating
ENTRY = Test, Behavior
ENTRY = Test, Behavioral
ENTRY = Tests, Behavior
ENTRY = Tests, Behavioral
MN = F04.711.271
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T075
MS = Instrument designed to assess human or animal behavior, using a standardized format.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000067290

*NEWRECORD
RECTYPE = D
MH = Alcohol Drinking in College
AQ = EH PX
ENTRY = Alcohol Drinking, College Students|T054|NON|EQV|NLM (2016)|OBSSR (2016)|141119|abcdeef
ENTRY = College Drinking|T054|NON|EQV|NLM (2016)|OBSSR (2016)|140925|abcdeef
ENTRY = College Student Drinking|T054|NON|EQV|NLM (2016)|OBSSR (2016)|141119|abcdeef
ENTRY = University Student Drinking|T054|NON|EQV|NLM (2016)|OBSSR (2016)|141119|abcdeef
ENTRY = Drinking, College
ENTRY = Student Drinking, College
ENTRY = Student Drinking, University
MN = F01.145.317.269.625
FX = Underage Drinking
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T054
PI = Alcohol Drinking (1963-2015)
MS = Alcohol consumption among college students.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000067292

*NEWRECORD
RECTYPE = D
MH = Obesity, Metabolically Benign
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Metabolically Benign Obesity|T184|NON|EQV|NLM (2016)|141001|abcdef
ENTRY = Metabolically Healthy Obesity|T184|NON|EQV|NLM (2016)|141001|abcdef
ENTRY = Benign Obesity, Metabolically
ENTRY = Healthy Obesity, Metabolically
ENTRY = Obesity, Metabolically Healthy
MN = C18.654.726.500.698
MN = C23.888.144.699.500.250
MN = E01.370.600.115.100.160.120.699.500.375
MN = G07.100.100.160.120.699.500.375
MH_TH = NLM (2016)
ST = T184
PI = Obesity (2005-2015)
MS = A sub-PHENOTYPE of obese individuals who have a risk for CARDIOVASCULAR DISEASES between that of healthy individuals with normal weight and unhealthy individuals with obesity.
PM = 2016
HN = 2016
MR = 20150112
DA = 20150701
DC = 1
DX = 20160101
UI = D000067329

*NEWRECORD
RECTYPE = D
MH = Whole Grains
AQ = AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI
ENTRY = Whole Grain Cereals|T002|T168|NON|NRW|NLM (2016)|141215|abbcdef
ENTRY = Cereal, Whole Grain
ENTRY = Cereals, Whole Grain
ENTRY = Grain Cereal, Whole
ENTRY = Grain Cereals, Whole
ENTRY = Grain, Whole
ENTRY = Grains, Whole
ENTRY = Whole Grain
ENTRY = Whole Grain Cereal
MN = G07.203.300.300.550.500
MN = G07.203.300.775.500.500
MN = J02.500.300.550.500
MN = J02.500.775.500.500
MH_TH = NLM (2016)
ST = T002
ST = T168
PI = Cereals (1973-2015)
MS = Edible seeds which contain all components of the seed - germ, bran, and ENDOSPERM.
PM = 2016
HN = 2016
MR = 20150226
DA = 20150701
DC = 1
DX = 20160101
UI = D000067348

*NEWRECORD
RECTYPE = D
MH = Transanal Endoscopic Surgery
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Transanal Endoscopic Surgical Procedures|T061|NON|EQV|NLM (2016)|141017|abcdef
ENTRY = Endoscopic Surgeries, Transanal
ENTRY = Endoscopic Surgery, Transanal
ENTRY = Surgeries, Transanal Endoscopic
ENTRY = Surgery, Transanal Endoscopic
ENTRY = Transanal Endoscopic Surgeries
MN = E01.370.388.250.630.500
MN = E04.210.240.250.680.500
MN = E04.502.250.250.250.680.500
MN = E04.502.250.630.500
MH_TH = NLM (2016)
ST = T061
MS = Surgical procedures performed through the anus using a PROCTOSCOPE.
PM = 2016
HN = 2016
MR = 20150112
DA = 20150701
DC = 1
DX = 20160101
UI = D000067368

*NEWRECORD
RECTYPE = D
MH = Transanal Endoscopic Microsurgery
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Endoscopic Microsurgeries, Transanal
ENTRY = Endoscopic Microsurgery, Transanal
ENTRY = Microsurgeries, Transanal Endoscopic
ENTRY = Microsurgery, Transanal Endoscopic
ENTRY = Transanal Endoscopic Microsurgeries
MN = E01.370.388.250.630.500.500
MN = E04.210.240.250.680.500.500
MN = E04.494.787
MN = E04.502.250.250.250.680.500.500
MN = E04.502.250.630.500.500
MH_TH = NLM (2016)
ST = T061
PI = microsurgery (1985-2015)
MS = A specialized form of transanal endoscopic surgery for microscopically controlled operations in the RECTUM.
PM = 2016
HN = 2016
MR = 20150112
DA = 20150701
DC = 1
DX = 20160101
UI = D000067369

*NEWRECORD
RECTYPE = D
MH = Cold Injury
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Cold Injuries
ENTRY = Injuries, Cold
ENTRY = Injury, Cold
MN = C26.212
MH_TH = NLM (2016)
ST = T037
MS = A physical injury caused by exposure of the body to extremely low ambient temperatures that may lead to loss of body parts, or in extreme cases, death. Examples of cold injury are FROSTBITE and CHILBLAINS.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000067390

*NEWRECORD
RECTYPE = D
MH = Personal Protective Equipment
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
ENTRY = Equipment, Personal Protective
ENTRY = Protective Equipment, Personal
MN = E07.662
MH_TH = NLM (2016)
ST = T073
MS = Specialized clothing or equipment worn for protection against health hazards. Personal Protective Equipment (PPE) may include MASKS, RESPIRATORY PROTECTIVE DEVICES, HEAD PROTECTIVE DEVICES, EYE PROTECTIVE DEVICES, PROTECTIVE CLOTHING and protective footwear.
PM = 2016
HN = 2016
MR = 20141202
DA = 20150701
DC = 1
DX = 20160101
UI = D000067393

*NEWRECORD
RECTYPE = D
MH = Nerve Agents
AQ = AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO
ENTRY = Nerve Gas|T109|NON|EQV|NLM (2016)|141103|abcdef
ENTRY = Agents, Nerve
ENTRY = Gas, Nerve
MN = D27.720.599
MN = D27.720.777.300.500
MH_TH = NLM (2016)
ST = T109
RN = 0
PI = Organophosphorus Compounds (1982-2015)
MS = A class of compounds that adversely affect the transmission of impulses through the NERVOUS SYSTEM.
PM = 2016
HN = 2016
MR = 20141202
DA = 20150701
DC = 1
DX = 20160101
UI = D000067397

*NEWRECORD
RECTYPE = D
MH = War-Related Injuries
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = War-Related Trauma|T037|NON|BRD|NLM (2016)|141104|abcdef
ENTRY = Injuries, War-Related
ENTRY = Injury, War-Related
ENTRY = Trauma, War-Related
ENTRY = War Related Injuries
ENTRY = War Related Trauma
ENTRY = War-Related Injury
MN = C26.946
MN = I01.880.735.950.500.951.500
MN = N06.850.460.350.600.903.500
FX = Stress Disorders, Post-Traumatic
MH_TH = NLM (2016)
ST = T037
MS = WOUNDS and INJURIES and PSYCHOLOGICAL TRAUMA sustained during WAR.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150706
DC = 1
DX = 20160101
UI = D000067398

*NEWRECORD
RECTYPE = D
MH = Abnormal Involuntary Movement Scale
MN = E01.370.600.550.162
MH_TH = NLM (2016)
ST = T081
MS = A rating scale that measures INVOLUNTARY MOVEMENTS known as TARDIVE DYSKINESIA.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000067399

*NEWRECORD
RECTYPE = D
MH = Blood Alcohol Content
ENTRY = Blood Alcohol Concentration|T059|T081|NON|EQV|NLM (2016)|141021|abbcdef
ENTRY = Blood Alcohol Level|T059|T081|NON|EQV|NLM (2016)|141021|abbcdef
ENTRY = Alcohol Concentration, Blood
ENTRY = Alcohol Content, Blood
ENTRY = Alcohol Level, Blood
ENTRY = Concentration, Blood Alcohol
ENTRY = Content, Blood Alcohol
ENTRY = Level, Blood Alcohol
MN = D02.033.375.135
FX = Alcoholism
FX = Driving Under the Influence
MH_TH = NLM (2016)
ST = T059
ST = T081
RN = 0
MS = Mass of alcohol per unit of BLOOD volume.
PM = 2016
HN = 2016
MR = 20141202
DA = 20150702
DC = 1
DX = 20160101
UI = D000067401

*NEWRECORD
RECTYPE = D
MH = Social Communication Disorder
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Pragmatic Communication Disorder|T048|NON|EQV|NLM (2016)|141021|abcdef
ENTRY = Communication Disorder, Pragmatic
ENTRY = Communication Disorder, Social
ENTRY = Communication Disorders, Pragmatic
ENTRY = Communication Disorders, Social
ENTRY = Disorders, Pragmatic Communication
ENTRY = Pragmatic Communication Disorders
ENTRY = Social Communication Disorders
MN = F03.625.374.250
MH_TH = NLM (2016)
ST = T048
MS = Persistent difficulties in the social uses of verbal and nonverbal communications. (DSM-V)
PM = 2016
HN = 2016
MR = 20150210
DA = 20150701
DC = 1
DX = 20160101
UI = D000067404

*NEWRECORD
RECTYPE = D
MH = Legal Services
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Legal Service
ENTRY = Service, Legal
ENTRY = Services, Legal
MN = I01.880.604.583.482
MH_TH = NLM (2016)
ST = T064
MS = Services provided by ATTORNEYS and paralegal staff.
PM = 2016
HN = 2016
MR = 20141202
DA = 20150701
DC = 1
DX = 20160101
UI = D000067408

*NEWRECORD
RECTYPE = D
MH = Defamation
AQ = CL EC EH ES HI LJ PC PX SN TD
ENTRY = Calumny|T080|NON|EQV|NLM (2016)|OBSSR (2016)|150109|abcdeef
ENTRY = Libel|T080|NON|REL|NLM (2016)|OBSSR (2016)|150109|abcdeef
ENTRY = Slander|T080|NON|REL|NLM (2016)|OBSSR (2016)|141203|abcdeef
ENTRY = Vilification|T080|NON|EQV|NLM (2016)|OBSSR (2016)|150109|abcdeef
ENTRY = Calumnies
ENTRY = Defamations
ENTRY = Libels
ENTRY = Vilifications
MN = I01.198.240.240
MN = I01.880.735.191.051
FX = Jurisprudence
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T080
MS = Public false statements that are illegal and damaging to the reputation of a person, group, business, organization, or institution.
PM = 2016
HN = 2016
MR = 20150701
DA = 20150701
DC = 1
DX = 20160101
UI = D000067448

*NEWRECORD
RECTYPE = D
MH = Anger Management Therapy
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Anger Management|T061|NON|EQV|NLM (2016)|OBSSR (2016)|141104|abcdeef
ENTRY = Anger Management Training|T061|NON|EQV|NLM (2016)|OBSSR (2016)|141211|abcdeef
ENTRY = Management Training, Anger
ENTRY = Management, Anger
ENTRY = Therapy, Anger Management
ENTRY = Training, Anger Management
MN = F04.754.137.087
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T061
PI = Anger (1977-2016)
MS = System of psychological and/or therapeutic techniques used to control and or reduce the triggers, degrees, and effects of ANGER.
PM = 2016
HN = 2016
MR = 20150112
DA = 20150701
DC = 1
DX = 20160101
UI = D000067449

*NEWRECORD
RECTYPE = D
MH = Psychology, Sports
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Sport Psychology|T090|NON|EQV|NLM (2016)|OBSSR (2016)|141104|abcdeef
ENTRY = Sports Psychology|T090|NON|EQV|NLM (2016)|OBSSR (2016)|141104|abcdeef
ENTRY = Psychology, Sport
MN = F04.096.628.914
FX = Sports Medicine
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T090
PI = Sports (1970-2015)
MS = Field of research that studies mental factors influencing the attainment of athletic skills and athletic performance.
PM = 2016
HN = 2016
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000067450

*NEWRECORD
RECTYPE = D
MH = War Exposure
AQ = AE CL EC ES HI LJ MA PC SN
ENTRY = Exposure, War
ENTRY = Exposures, War
ENTRY = War Exposures
MN = I01.880.735.950.500.951
MN = N06.850.460.350.600.903
FX = Veterans Health
MH_TH = NLM (2016)
ST = T078
PI = Warfare (1996-2015)
MS = The health and other ramifications of military and civilian exposure to WAR .
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000067453

*NEWRECORD
RECTYPE = D
MH = Childhood-Onset Fluency Disorder
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Childhood Onset Fluency Disorder
ENTRY = Childhood-Onset Fluency Disorders
ENTRY = Disorder, Childhood-Onset Fluency
ENTRY = Disorders, Childhood-Onset Fluency
ENTRY = Fluency Disorder, Childhood-Onset
ENTRY = Fluency Disorders, Childhood-Onset
MN = F03.625.374.125
MH_TH = NLM (2016)
ST = T048
PI = Communication Disorders (1990-2015)
MS = Disturbances in the normal fluency and time patterning of speech that are inappropriate for the individual's age and language skills. (DSM-V)
PM = 2016
HN = 2016
MR = 20150630
DA = 20150701
DC = 1
DX = 20160101
UI = D000067454

*NEWRECORD
RECTYPE = D
MH = No-Show Patients
AQ = EC ES PX SN TD
ENTRY = Patient No-Show|T081|NON|EQV|NLM (2016)|141105|abcdef
ENTRY = Patient Non-Attendance|T081|NON|EQV|NLM (2016)|141105|abcdef
ENTRY = No Show Patients
ENTRY = No-Show Patient
ENTRY = No-Show, Patient
ENTRY = No-Shows, Patient
ENTRY = Non-Attendance, Patient
ENTRY = Patient No Show
ENTRY = Patient Non Attendance
ENTRY = Patient, No-Show
ENTRY = Patients, No-Show
MN = F01.145.488.500.750
MN = N04.452.758.635.500
MN = N05.300.150.600.600.750
FX = Patient Dropouts
MH_TH = NLM (2016)
ST = T081
MS = PATIENTS who do not turn up for scheduled healthcare appointments. Do not confuse with PATIENT DROPOUTS.
PM = 2016
HN = 2016
MR = 20141202
DA = 20150706
DC = 1
DX = 20160101
UI = D000067455

*NEWRECORD
RECTYPE = D
MH = Cellular Reprogramming Techniques
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Cell Programming Techniques|T059|T062|NON|EQV|NLM (2016)|141112|abbcdef
ENTRY = Cell Reprogramming Techniques|T059|T062|NON|EQV|NLM (2016)|141112|abbcdef
ENTRY = Direct Cell Reprogramming Techniques|T059|NON|NRW|NLM (2016)|141112|abcdef
ENTRY = Directed Differentiation Techniques|T059|NON|REL|NLM (2016)|141112|abcdef
ENTRY = Cell Programming Technique
ENTRY = Cell Reprogramming Technique
ENTRY = Cellular Reprogramming Technique
ENTRY = Differentiation Technique, Directed
ENTRY = Differentiation Techniques, Directed
ENTRY = Directed Differentiation Technique
ENTRY = Programming Technique, Cell
ENTRY = Programming Techniques, Cell
ENTRY = Reprogramming Technique, Cell
ENTRY = Reprogramming Technique, Cellular
ENTRY = Reprogramming Techniques, Cell
ENTRY = Reprogramming Techniques, Cellular
ENTRY = Technique, Cell Programming
ENTRY = Technique, Cell Reprogramming
ENTRY = Technique, Cellular Reprogramming
ENTRY = Technique, Directed Differentiation
ENTRY = Techniques, Cell Programming
ENTRY = Techniques, Cell Reprogramming
ENTRY = Techniques, Cellular Reprogramming
ENTRY = Techniques, Directed Differentiation
MN = E05.200.500.380
MN = E05.242.378
MN = E05.393.085
FX = Cellular Reprogramming
MH_TH = NLM (2016)
ST = T059
ST = T062
PI = Cell Dedifferentiation (2008-2015)
PI = Cellular Reprogramming (2015)
MS = Procedures used for the induction of CELLULAR REPROGRAMMING to change the terminal phenotype of a cell, such as the generation of INDUCED PLURIPOTENT STEM CELLS from differentiated adult cells by the forced expression of specific genes.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000067470

*NEWRECORD
RECTYPE = D
MH = Metacognition
AQ = CL DE ES PH RE
ENTRY = Metacognitive Awareness|T041|NON|NRW|NLM (2016)|141118|abcdef
ENTRY = Metacognitive Control|T041|NON|NRW|NLM (2016)|141118|abcdef
ENTRY = Metacognitive Knowledge|T041|NON|NRW|NLM (2016)|141118|abcdef
ENTRY = Metacognitive Monitoring|T041|NON|NRW|NLM (2016)|141118|abcdef
ENTRY = Metamemory|T041|NON|NRW|NLM (2016)|141118|abcdef
ENTRY = Awareness, Metacognitive
ENTRY = Awarenesses, Metacognitive
ENTRY = Control, Metacognitive
ENTRY = Controls, Metacognitive
ENTRY = Knowledge, Metacognitive
ENTRY = Knowledges, Metacognitive
ENTRY = Metacognitions
ENTRY = Metacognitive Awarenesses
ENTRY = Metacognitive Controls
ENTRY = Metacognitive Knowledges
ENTRY = Metacognitive Monitorings
ENTRY = Metamemories
ENTRY = Monitoring, Metacognitive
ENTRY = Monitorings, Metacognitive
MN = F02.463.188.756
FX = Self-Assessment
MH_TH = NLM (2016)
ST = T041
PI = Cognition (1982-2015)
PI = Self-Concept (1985-2015)
MS = Awareness and understanding of one's own thought processes.
PM = 2016
HN = 2016
MR = 20150109
DA = 20150706
DC = 1
DX = 20160101
UI = D000067489

*NEWRECORD
RECTYPE = D
MH = Prescription Drug Overuse
AQ = AE CL EC ES HI LJ MO NU PC PX SN TD
ENTRY = Medication Overuse|T055|NON|EQV|NLM (2016)|141118|abcdef
ENTRY = Medication Overutilization|T055|NON|EQV|NLM (2016)|141118|abcdef
ENTRY = Prescription Drug Overutilization|T055|NON|EQV|NLM (2016)|141118|abcdef
ENTRY = Drug Overuse, Prescription
ENTRY = Drug Overuses, Prescription
ENTRY = Drug Overutilization, Prescription
ENTRY = Drug Overutilizations, Prescription
ENTRY = Medication Overuses
ENTRY = Medication Overutilizations
ENTRY = Overuse, Medication
ENTRY = Overuse, Prescription Drug
ENTRY = Overuses, Medication
ENTRY = Overuses, Prescription Drug
ENTRY = Overutilization, Medication
ENTRY = Overutilization, Prescription Drug
ENTRY = Overutilizations, Medication
ENTRY = Overutilizations, Prescription Drug
ENTRY = Prescription Drug Overuses
ENTRY = Prescription Drug Overutilizations
MN = E02.319.754.750
MH_TH = NLM (2016)
ST = T055
MS = The use of a medication in an amount more than as prescribed.
PM = 2016
HN = 2016
MR = 20150113
DA = 20150701
DC = 1
DX = 20160101
UI = D000067490

*NEWRECORD
RECTYPE = D
MH = Near Miss, Healthcare
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Close Call, Healthcare|T080|NON|EQV|NLM (2016)|141203|abcdef
ENTRY = Close Calls, Healthcare
ENTRY = Healthcare Close Call
ENTRY = Healthcare Close Calls
ENTRY = Healthcare Near Miss
ENTRY = Healthcare Near Misses
ENTRY = Near Misses, Healthcare
MN = E02.319.529.750
MN = N02.421.450.500.750
MN = N02.421.450.550
MN = N04.761.700.594
MN = N05.700.513
MH_TH = NLM (2016)
ST = T080
MS = Event that presented a risk but did not result in a patient harm.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000067491

*NEWRECORD
RECTYPE = D
MH = RNAi Therapeutics
AQ = AE CL CT EC ES HI IS LJ MO MT NU PX SN ST TD UT VE
ENTRY = RNAi Therapy|T061|NON|EQV|NLM (2016)|141118|abcdef
ENTRY = RNAi-Based Therapeutics|T061|ABB|EQV|NLM (2016)|141118|abcdef
ENTRY = RNAi-Based Therapy|T061|NON|EQV|NLM (2016)|141118|abcdef
ENTRY = RNAi Based Therapy
ENTRY = RNAi Therapies
ENTRY = RNAi-Based Therapies
ENTRY = Therapies, RNAi
ENTRY = Therapies, RNAi-Based
ENTRY = Therapy, RNAi
ENTRY = Therapy, RNAi-Based
MN = E02.095.301.250
FX = Gene Expression Regulation
MH_TH = NLM (2016)
ST = T061
PI = RNA Interference (2004-2015)
MS = A form of disease treatment which involves the silencing of genes that are associated with a disease by the process of RNA INTERFERENCE.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150702
DC = 1
DX = 20160101
UI = D000067492

*NEWRECORD
RECTYPE = D
MH = Dynamic Light Scattering
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Quasi-Elastic Light Scattering (QELS)|T059|NON|BRD|NLM (2016)|141118|abcdef
ENTRY = Light Scattering, Dynamic
ENTRY = Light Scattering, Quasi-Elastic (QELS)
ENTRY = Quasi Elastic Light Scattering (QELS)
ENTRY = Quasi-Elastic Light Scatterings (QELS)
ENTRY = Scattering, Dynamic Light
ENTRY = Scattering, Quasi-Elastic Light (QELS)
ENTRY = Scatterings, Quasi-Elastic Light (QELS)
MN = E05.196.822.325
MH_TH = NLM (2016)
ST = T059
PI = Scattering, Radiation (1974-2015)
MS = An analytical technique for measuring particle size of molecules that are less than a micron in diameter dispersed or dissolved in a liquid.
PM = 2016
HN = 2016
MR = 20150121
DA = 20150701
DC = 1
DX = 20160101
UI = D000067493

*NEWRECORD
RECTYPE = D
MH = Time Out, Healthcare
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Surgical Time Out|T058|NON|NRW|NLM (2016)|141212|abcdef
ENTRY = Surgical Timeout|T058|NON|NRW|NLM (2016)|141215|abcdef
ENTRY = Timeout, Healthcare|T058|NON|EQV|NLM (2016)|141215|abcdef
ENTRY = Healthcare Time Out
ENTRY = Healthcare Time Outs
ENTRY = Healthcare Timeout
ENTRY = Healthcare Timeouts
ENTRY = Surgical Time Outs
ENTRY = Surgical Timeouts
ENTRY = Time Out, Surgical
ENTRY = Time Outs, Healthcare
ENTRY = Time Outs, Surgical
ENTRY = Timeout, Surgical
ENTRY = Timeouts, Healthcare
ENTRY = Timeouts, Surgical
MN = N04.761.700.635
MN = N05.700.739
MH_TH = NLM (2016)
ST = T058
MS = A period of time away from normal workflow taken to ensure key procedural details have been reviewed for better PATIENT SAFETY and help prevent MEDICAL ERRORS.
PM = 2016
HN = 2016
MR = 20150109
DA = 20150701
DC = 1
DX = 20160101
UI = D000067494

*NEWRECORD
RECTYPE = D
MH = Healthcare Failure Mode and Effect Analysis
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Failure Mode and Effect Analysis|T080|NON|BRD|NLM (2016)|141119|abcdef
ENTRY = Failure Mode and Effect Analysis, Healthcare|T058|NON|EQV|NLM (2016)|141124|abcdef
ENTRY = HFMEA|T058|ABB|EQV|NLM (2016)|141119|abcdef
MN = E05.318.740.600.800.715.500
MN = N04.452.871.715.400
MN = N05.715.360.750.625.700.690.400
MN = N06.850.505.715.500
MN = N06.850.520.830.600.800.715.500
MH_TH = NLM (2016)
ST = T058
PI = Risk Assessment (2002-2015)
MS = Prospective risk assessment tool aimed at identifying potential risks and their impact in healthcare settings.
PM = 2016
HN = 2016
MR = 20150109
DA = 20150701
DC = 1
DX = 20160101
UI = D000067495

*NEWRECORD
RECTYPE = D
MH = Spirit Possession
AQ = HI
ENTRY = Demon Possession|T053|T078|NON|EQV|NLM (2016)|OBSSR (2016)|141120|abbcdeef
ENTRY = Demonic Possession|T053|T078|NON|EQV|NLM (2016)|OBSSR (2016)|141120|abbcdeef
ENTRY = Demon Possessions
ENTRY = Demonic Possessions
ENTRY = Possession, Demon
ENTRY = Possession, Demonic
ENTRY = Possession, Spirit
ENTRY = Possessions, Demon
ENTRY = Possessions, Demonic
ENTRY = Possessions, Spirit
ENTRY = Spirit Possessions
MN = K01.844.619.500
FX = Parapsychology
FX = Superstitions
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T053
ST = T078
MS = The idea that abnormal behavior or a medical condition is evidence that a person is under the control of a supernatural power or spirit. This belief was most commonly held in religion and medicine of the medieval period and is also held in many tribal cultures today.
PM = 2016
HN = 2016
MR = 20150522
DA = 20150701
DC = 1
DX = 20160101
UI = D000067496

*NEWRECORD
RECTYPE = D
MH = Crew Resource Management, Healthcare
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Crisis Resource Management, Healthcare|T058|NON|EQV|NLM (2016)|141120|abcdef
ENTRY = Healthcare CRM|T058|ABX|EQV|NLM (2016)|141120|abcdef
ENTRY = Healthcare Crew Resource Management|T058|NON|EQV|NLM (2016)|141120|abcdef
ENTRY = Healthcare Crisis Resource Management|T058|NON|EQV|NLM (2016)|141120|abcdef
ENTRY = CRM, Healthcare
ENTRY = CRMs, Healthcare
ENTRY = Healthcare CRMs
MN = N04.590.254
MH_TH = NLM (2016)
ST = T058
PI = Patient Care Team (2000-2015)
MS = A range of healthcare related training designed to reduce MEDICAL ERRORS and improve PATIENT SAFETY by emphasizing TEAMWORK and human factors (see HUMAN ENGINEERING).
PM = 2016
HN = 2016
MR = 20150109
DA = 20150701
DC = 1
DX = 20160101
UI = D000067498

*NEWRECORD
RECTYPE = D
MH = Computer Heuristics
AQ = PX
ENTRY = Computer Heuristic
ENTRY = Heuristic, Computer
ENTRY = Heuristics, Computer
MN = L01.224.050.375.095
FX = Heuristics
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T066
MS = Trial-and-error methods of problem-solving used when an algorithmic approach is impractical
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000067508

*NEWRECORD
RECTYPE = D
MH = Ataxins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Ataxin Proteins|T116|T123|NON|EQV|NLM (2016)|141215|abbcdef
ENTRY = Spinocerebellar Ataxia Proteins|T116|T123|NON|EQV|NLM (2016)|150202|abbcdef
ENTRY = Ataxia Proteins, Spinocerebellar
ENTRY = Proteins, Ataxin
ENTRY = Proteins, Spinocerebellar Ataxia
MN = D12.776.641.069
MN = D12.776.660.075
FX = Spinocerebellar Ataxias
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = Nerve Tissue Proteins (1995-2015)
PI = Nuclear Proteins (1995-2015)
MS = A family of predominantly nuclear proteins that regulate gene transcription and protein degradation. The expansion of CAG trinucleotide repeats in genes that encode Ataxins is associated with SPINOCEREBELLAR ATAXIAS (SCA). In SCA patients, the number of CAG repeats correlates with the severity of disease and inversely correlates with the age of disease onset.
PM = 2016
HN = 2016
MR = 20150219
DA = 20150706
DC = 1
DX = 20160101
UI = D000067528

*NEWRECORD
RECTYPE = D
MH = Alarmins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Alarmin|T116|T123|NON|EQV|NLM (2016)|141203|abbcdef
ENTRY = Alarmin Proteins|T116|T123|NON|EQV|NLM (2016)|141203|abbcdef
ENTRY = Proteins, Alarmin
MN = D12.644.276.087
MN = D12.776.467.087
MN = D23.529.087
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = HMGB1 Protein (2004-2015)
MS = A structurally diverse group of endogenous molecules that includes the HMGB1 PROTEIN; S100 PROTEINS; HSP60, Hsp70, Cathelicidin, IL-33, and DEFENSINS. They are constitutively available, released upon tissue damage, and activate the immune system. Uncontrolled and excessive release of alarmins may contribute to INFLAMMATION; CARCINOGENESIS, and NEOPLASM METASTASIS. Alarmins are also critical for heart and nerve tissue homeostasis.
PM = 2016
HN = 2016
MR = 20150219
DA = 20150701
DC = 1
DX = 20160101
UI = D000067531

*NEWRECORD
RECTYPE = D
MH = Dermal Fillers
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Dermal Filler|T104|T123|NON|EQV|NLM (2016)|150115|abbcdef
ENTRY = Skin Filler|T104|T123|NON|EQV|NLM (2016)|150115|abbcdef
ENTRY = Skin Fillers|T104|T123|NON|EQV|NLM (2016)|150115|abbcdef
ENTRY = Filler, Dermal
ENTRY = Filler, Skin
ENTRY = Fillers, Dermal
ENTRY = Fillers, Skin
MN = D27.720.102.461
FX = Administration, Cutaneous
FX = Cosmetic Techniques
FX = Injections, Subcutaneous
MH_TH = NLM (2016)
ST = T104
ST = T123
RN = 0
MS = Materials such as COLLAGEN or HYALURONIC ACID that are injected or deposited into the DERMIS for the purpose of skin augmentation.
PM = 2016
HN = 2016
MR = 20150121
DA = 20150701
DC = 1
DX = 20160101
UI = D000067548

*NEWRECORD
RECTYPE = D
MH = Action Spectrum
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Spectrum, Action
MN = E05.196.867.826.150
MH_TH = NLM (2016)
ST = T059
MS = A technique used to measure the rate of physiological activity plotted against wavelength of light. An action spectrum depicts the most effective wavelength of light (also known as spectral sensitivity) that is required for each specific process.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000067549

*NEWRECORD
RECTYPE = D
MH = Diplomacy
AQ = CL EC ED ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Diplomat|T097|NON|REL|NLM (2016)|141201|abcdef
ENTRY = Diplomats
MN = F01.829.316.171
MN = F02.463.785.373.520.500
MN = I01.738.305
MH_TH = NLM (2016)
ST = T054
MS = The art and practice of conducting negotiations between people, nations or other parties such as organizations.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000067551

*NEWRECORD
RECTYPE = D
MH = Mutation Accumulation
ENTRY = Spontaneous Mutation Accumulation|T045|NON|NRW|NLM (2016)|141201|abcdef
ENTRY = Accumulation, Mutation
ENTRY = Accumulation, Spontaneous Mutation
ENTRY = Accumulations, Mutation
ENTRY = Accumulations, Spontaneous Mutation
ENTRY = Mutation Accumulation, Spontaneous
ENTRY = Mutation Accumulations
ENTRY = Mutation Accumulations, Spontaneous
ENTRY = Spontaneous Mutation Accumulations
MN = G05.365.590.594
FX = Aging
FX = Mutagenesis
MH_TH = NLM (2016)
ST = T045
PI = Mutation (1977-2015)
MS = Concept which describes the incremental effects of MUTATION in living organisms.
PM = 2016
HN = 2016
MR = 20150121
DA = 20150701
DC = 1
DX = 20160101
UI = D000067552

*NEWRECORD
RECTYPE = D
MH = Internal Ribosome Entry Sites
AQ = DE GE IM PH RE
ENTRY = Internal Ribosome Entry Site|T086|T114|NON|EQV|NLM (2016)|150112|abbcdef
MN = D13.444.735.790.878.942.250
MN = G02.111.570.080.689.687.093
MN = G05.360.080.689.687.093
MH_TH = NLM (2016)
ST = T086
ST = T114
RN = 0
MS = Sequences within MESSENGER RNA that enable PROTEIN TRANSLATION INITIATION independent of 5' CAPPED RNA.
PM = 2016
HN = 2016
MR = 20150112
DA = 20150701
DC = 1
DX = 20160101
UI = D000067556

*NEWRECORD
RECTYPE = D
MH = Biological Mimicry
AQ = DE GE IM PH RE
ENTRY = Aposematism|T070|NON|EQV|NLM (2016)|141214|abcdef
ENTRY = Batesian Mimicry|T070|NON|EQV|NLM (2016)|141214|abcdef
ENTRY = Biological Camouflage|T070|NON|NRW|NLM (2016)|141214|abcdef
ENTRY = Crypses|T070|NON|EQV|NLM (2016)|141214|abcdef
ENTRY = Mullerian Mimicry|T070|NON|EQV|NLM (2016)|141214|abcdef
ENTRY = Aposematisms
ENTRY = Batesian Mimicries
ENTRY = Biological Camouflages
ENTRY = Camouflage, Biological
ENTRY = Camouflages, Biological
ENTRY = Mimicries, Batesian
ENTRY = Mimicries, Mullerian
ENTRY = Mimicry, Batesian
ENTRY = Mimicry, Biological
ENTRY = Mimicry, Mullerian
ENTRY = Mullerian Mimicries
MN = G16.100.057.750
FX = Biomimetics
MH_TH = NLM (2016)
ST = T070
MS = Resemblance in appearance, structure, function, sound, scent or behavior between related or unrelated species, occurring in the same geographic location.
PM = 2016
HN = 2016
MR = 20150121
DA = 20150706
DC = 1
DX = 20160101
UI = D000067558

*NEWRECORD
RECTYPE = D
MH = Specific Learning Disorder
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Disorder, Specific Learning
ENTRY = Learning Disorder, Specific
ENTRY = Learning Disorders, Specific
ENTRY = Specific Learning Disorders
MN = F03.625.562.700
MH_TH = NLM (2016)
ST = T048
MS = Diagnosed when there are specific deficits in an individuals ability to perceive or process information efficiently and accurately. This  disorder first manifests during the years of formal schooling and is characterized by persistent and impairing difficulties with learning foundational academic skills in reading, writing, and/or math. The individuals performance of the affected academic skills is well below average for age, or acceptable performance levels are achieved only with extraordinary effort. Specific learning disorder may occur in individuals identified as intellectually gifted and manifest only when the learning demands or assessment procedures (e.g., timed tests) pose barriers that cannot be overcome by their innate intelligence and compensatory strategies. For all individuals, specific learning disorder can produce lifelong impairments in activities dependent on the skills, including occupational performance. (from DSM-V)
PM = 2016
HN = 2016
MR = 20150210
DA = 20150701
DC = 1
DX = 20160101
UI = D000067559

*NEWRECORD
RECTYPE = D
MH = Potentially Inappropriate Medication List
AQ = CL EC ES HI LJ OG SN ST TD UT
ENTRY = Beers Criteria|T080|EPO|NRW|NLM (2016)|141203|abcdef
ENTRY = Beers Potentially Inappropriate Medications|T080|EPO|NRW|NLM (2016)|141203|abcdef
ENTRY = Medication Appropriateness Index|T080|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = PIM List|T080|ABX|EQV|NLM (2016)|141203|abcdef
ENTRY = Potentially Inappropriate Medications|T080|NON|EQV|NLM (2016)|141203|abcdef
ENTRY = STOPP|T080|ABB|NRW|NLM (2016)|141203|abcdef
ENTRY = STOPP (Screening Tool of Older Person's Potentially Inappropriate Prescriptions)|T080|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = STOPP START Criteria|T080|ABX|NRW|NLM (2016)|150109|abcdef
ENTRY = Screening Tool of Older Person's Potentially Inappropriate Prescriptions|T080|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = de Beers Criteria|T080|EPO|NRW|NLM (2016)|141203|abcdef
ENTRY = Appropriateness Index, Medication
ENTRY = Appropriateness Indices, Medication
ENTRY = Beers Criteria, de
ENTRY = Criteria, STOPP START
ENTRY = Criterias, STOPP START
ENTRY = Inappropriate Medication, Potentially
ENTRY = Inappropriate Medications, Potentially
ENTRY = Index, Medication Appropriateness
ENTRY = Indices, Medication Appropriateness
ENTRY = Medication Appropriateness Indices
ENTRY = Medication, Potentially Inappropriate
ENTRY = Medications, Potentially Inappropriate
ENTRY = PIM Lists
ENTRY = Potentially Inappropriate Medication
ENTRY = START Criteria, STOPP
ENTRY = START Criterias, STOPP
ENTRY = STOPP START Criterias
ENTRY = STOPPs (Screening Tool of Older Person's Potentially Inappropriate Prescriptions)
MN = N04.761.700.615
MN = N05.700.594
FX = Deprescriptions
FX = Inappropriate Prescribing
MH_TH = NLM (2016)
ST = T080
PI = Inappropriate Prescribing (2010-2015)
PI = Medication Errors (2003-2015)
MS = A list, criteria, or screening tool designed to improve PATIENT SAFETY by determining an individual's exposure to potentially inappropriate drugs. They are designed to prevent MEDICATION ERRORS by INAPPROPRIATE PRESCRIBING. Analysis for a list includes factors such as DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; AGE FACTORS; GENDER; and existing medical conditions.
PM = 2016
HN = 2016
MR = 20150709
DA = 20150709
DC = 1
DX = 20160101
UI = D000067561

*NEWRECORD
RECTYPE = D
MH = Late Onset Disorders
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VI
ENTRY = Late Onset Diseases|T047|NON|EQV|NLM (2016)|141203|abcdef
ENTRY = Late-Onset Disorders|T047|NON|EQV|NLM (2016)|150115|abcdef
ENTRY = Later Onset Disorders|T047|NON|EQV|NLM (2016)|150115|abcdef
ENTRY = Disease, Late Onset
ENTRY = Diseases, Late Onset
ENTRY = Disorder, Late Onset
ENTRY = Disorder, Late-Onset
ENTRY = Disorder, Later Onset
ENTRY = Disorders, Late Onset
ENTRY = Disorders, Late-Onset
ENTRY = Disorders, Later Onset
ENTRY = Late Onset Disease
ENTRY = Late Onset Disorder
ENTRY = Late-Onset Disorder
ENTRY = Later Onset Disorder
ENTRY = Onset Disease, Late
ENTRY = Onset Diseases, Late
ENTRY = Onset Disorder, Late
ENTRY = Onset Disorder, Later
ENTRY = Onset Disorders, Late
ENTRY = Onset Disorders, Later
MN = C23.550.291.883
MH_TH = NLM (2016)
ST = T047
PI = Age of Onset (1984-2015)
MS = Pathological conditions (Disorder, SYNDROME, or DISEASE) whose SIGNS AND SYMPTOMS manifest late in the life of an individual.
PM = 2016; see AGE OF ONSET 1997-2015
HN = 2016; use AGE OF ONSET 1997-2015
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000067562

*NEWRECORD
RECTYPE = D
MH = Phakopsora pachyrhizi
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Asian Soybean Rust|T004|NON|EQV|NLM (2016)|150115|abcdef
ENTRY = Phakopsora pachyrhizus
ENTRY = Rust, Asian Soybean
ENTRY = Soybean Rust, Asian
ENTRY = Soybean Rusts, Asian
ENTRY = pachyrhizi, Phakopsora
ENTRY = pachyrhizus, Phakopsora
MN = B01.300.179.110
MH_TH = NLM (2016)
ST = T004
PI = Basidiomycota (1980-2015)
MS = Fungal pathogen which causes Soybean Rust disease in Soybeans (Glycine max).
PM = 2016
HN = 2016
MR = 20150121
DA = 20150701
DC = 1
DX = 20160101
UI = D000067563

*NEWRECORD
RECTYPE = D
MH = Farmers
AQ = CL ED HI LJ PX SN
ENTRY = Agricultural Workers|T097|NON|EQV|NLM (1981)|931129|abcdef
ENTRY = Farm Workers|T097|NON|EQV|NLM (2016)|141204|abcdef
ENTRY = Farmworkers|T097|NON|EQV|NLM (2016)|141204|abcdef
ENTRY = Ranchers|T097|NON|NRW|NLM (2016)|150112|abcdef
ENTRY = Agricultural Worker
ENTRY = Farm Worker
ENTRY = Farmer
ENTRY = Farmworker
ENTRY = Rancher
ENTRY = Worker, Agricultural
ENTRY = Worker, Farm
ENTRY = Workers, Agricultural
ENTRY = Workers, Farm
MN = M01.526.390
MH_TH = NLM (2016)
ST = T097
PI = Agriculture (1963-2015)
MS = Persons who cultivate land or crops, or raise LIVESTOCK.
PM = 2016; for AGRICULTURAL WORKERS see AGRICULTURE 1981-2015
HN = 2016; for AGRICULTURAL WORKERS use AGRICULTURE 1981-2015
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000067565

*NEWRECORD
RECTYPE = D
MH = Culturally Appropriate Technology
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Intermediate Technology|T170|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = Soft Technology|T170|NON|NRW|NLM (2016)|150115|abcdef
ENTRY = Appropriate Technologies, Culturally
ENTRY = Appropriate Technology, Culturally
ENTRY = Culturally Appropriate Technologies
ENTRY = Intermediate Technologies
ENTRY = Soft Technologies
ENTRY = Technologies, Culturally Appropriate
ENTRY = Technologies, Intermediate
ENTRY = Technologies, Soft
ENTRY = Technology, Culturally Appropriate
ENTRY = Technology, Intermediate
ENTRY = Technology, Soft
MN = J01.897.052
FX = Diffusion of Innovation
MH_TH = NLM (2016)
ST = T170
MS = A SCIENCE or TECHNOLOGY that promotes self-sufficiency and is suitable to the cultural, environmental, economic and social conditions of the geographic area in which it is applied.
PM = 2016
HN = 2016
MR = 20150121
DA = 20150701
DC = 1
DX = 20160101
UI = D000067568

*NEWRECORD
RECTYPE = D
MH = Social Learning
AQ = CL DE ES PH RE
ENTRY = Learning, Social
MN = F02.784.629.529.663
FX = Socialization
MH_TH = NLM (2016)
ST = T041
PI = Learning (1963-2015)
MS = The concept of new knowledge acquisition through observation and interaction with others.
PM = 2016
HN = 2016
MR = 20150121
DA = 20150701
DC = 1
DX = 20160101
UI = D000067570

*NEWRECORD
RECTYPE = D
MH = Financial Statements
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Assets, Financial|T081|NON|NRW|NLM (2016)|150115|abcdef
ENTRY = Balance Sheet|T081|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = Cash Flow Statement|T081|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = Equity, Financial|T081|NON|NRW|NLM (2016)|150115|abcdef
ENTRY = Expense Statement|T081|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = Income Statement|T081|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = Liabilities, Financial|T081|NON|NRW|NLM (2016)|150115|abcdef
ENTRY = Net Worth|T081|NON|NRW|NLM (2016)|141203|abcdef
ENTRY = Asset, Financial
ENTRY = Balance Sheets
ENTRY = Cash Flow Statements
ENTRY = Equities, Financial
ENTRY = Expense Statements
ENTRY = Financial Asset
ENTRY = Financial Assets
ENTRY = Financial Equities
ENTRY = Financial Equity
ENTRY = Financial Liabilities
ENTRY = Financial Liability
ENTRY = Financial Statement
ENTRY = Flow Statement, Cash
ENTRY = Flow Statements, Cash
ENTRY = Income Statements
ENTRY = Liability, Financial
ENTRY = Sheet, Balance
ENTRY = Sheets, Balance
ENTRY = Statement, Cash Flow
ENTRY = Statement, Expense
ENTRY = Statement, Financial
ENTRY = Statement, Income
ENTRY = Statements, Cash Flow
ENTRY = Statements, Expense
ENTRY = Statements, Financial
ENTRY = Statements, Income
ENTRY = Worth, Net
MN = N03.219.463.030.140
FX = Financial Management
MH_TH = NLM (2016)
ST = T081
MS = Formal and structured record of financial activities of a business, person, or other entity.
PM = 2016
HN = 2016
MR = 20150702
DA = 20150701
DC = 1
DX = 20160101
UI = D000067571

*NEWRECORD
RECTYPE = D
MH = Miners
AQ = CL ED HI LJ PX SN
ENTRY = Mine Workers|T097|NON|EQV|NLM (2016)|141204|abcdef
ENTRY = Mineworkers|T097|NON|EQV|NLM (2016)|141204|abcdef
ENTRY = Mine Worker
ENTRY = Miner
ENTRY = Mineworker
ENTRY = Worker, Mine
ENTRY = Workers, Mine
MN = M01.526.693
MH_TH = NLM (2016)
ST = T097
PI = Mining (1963-2015)
MS = Persons who work in a mine to extract ore or MINERALS from the earth.
PM = 2016
HN = 2016
MR = 20150112
DA = 20150701
DC = 1
DX = 20160101
UI = D000067572

*NEWRECORD
RECTYPE = D
MH = Chronopharmacokinetics
ENTRY = Chronopharmacokinetic
MN = G07.690.725.249
FX = Drug Chronotherapy
MH_TH = NLM (2016)
ST = T039
MS = Absorption, metabolism and elimination of drugs in relation to time of day at which they are administered, and the mechanisms responsible for time-dependent variations.
PM = 2016
HN = 2016
MR = 20150121
DA = 20150701
DC = 1
DX = 20160101
UI = D000067573

*NEWRECORD
RECTYPE = D
MH = Administrative Claims, Healthcare
AQ = CL EC LJ SN
ENTRY = Administrative Claim, Healthcare
ENTRY = Claim, Healthcare Administrative
ENTRY = Claims, Healthcare Administrative
ENTRY = Healthcare Administrative Claim
ENTRY = Healthcare Administrative Claims
MN = N04.452.859.564.137
MH_TH = NLM (2016)
ST = T058
ST = T170
MS = Information relating to itemized coding of procedures and costs associated with healthcare delivery, used as a means for tracking healthcare utilization, patterns of care, and treatment outcomes.
PM = 2016
HN = 2016
MR = 20150121
DA = 20150701
DC = 1
DX = 20160101
UI = D000067575

*NEWRECORD
RECTYPE = D
MH = Child Health
AQ = CL EC EH ES HI LJ SN ST TD
ENTRY = Children's Health|T078|NON|EQV|NLM (2016)|150120|abcdef
ENTRY = Childrens Health|T078|NON|EQV|NLM (2016)|150121|abcdef
ENTRY = Health, Child
ENTRY = Health, Children's
ENTRY = Health, Childrens
MN = N01.400.225
FX = Child Health Services
FX = Child Welfare
MH_TH = NLM (1978)
ST = T078
PI = Child Health Services (1978-2015)
PI = Child Welfare (1978-2015)
MS = The concept covering the physical and mental conditions of CHILDREN.
PM = 2016; see CHILD WELFARE 1978-2015
HN = 2016; use CHILD WELFARE 1978-2015
MR = 20150707
DA = 20150710
DC = 1
DX = 20160101
UI = D000067576

*NEWRECORD
RECTYPE = D
MH = Interleukin-33
DS = INTERLEUKIN 033
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = IL-33|T116|T123|ABB|EQV|NLM (2016)|141210|abbcdef
ENTRY = IL33|T116|T123|ABB|EQV|NLM (2016)|141210|abbcdef
ENTRY = Interleukin 33
MN = D12.644.276.087.597
MN = D12.644.276.374.465.850
MN = D12.776.467.087.813
MN = D12.776.467.374.465.850
MN = D23.529.087.780
MN = D23.529.374.465.850
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = Interleukins (2005-2015)
MS = A member of the INTERLEUKIN-1 protein  family involved in the maturation of TH2 CELLS and the activation of MAST CELLS; BASOPHILS; EOSINOPHILS and NK CELLS. It is also produced by ENDOTHELIAL CELLS; EPITHELIAL CELLS and FIBROBLASTS; where it can function as an alarmin to modulate immune and inflammatory responses to tissue damage.
PM = 2016; INTERLEUKIN-33 was indexed under INTERLEUKINS 2005-2015
HN = 2016 (2005)
MR = 20150219
DA = 20150701
DC = 1
DX = 20160101
UI = D000067596

*NEWRECORD
RECTYPE = D
MH = S100A12 Protein
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = CAAF1 Protein|T116|T123|ABX|EQV|NLM (2016)|141212|abbcdef
ENTRY = Calgranulin C Protein|T116|T123|NON|EQV|NLM (2016)|141212|abbcdef
ENTRY = EN-RAGE Protein|T116|T123|ABX|EQV|NLM (2016)|141212|abbcdef
ENTRY = ENRAGE Protein|T116|T123|ABX|EQV|NLM (2016)|141212|abbcdef
ENTRY = MRP-6 Protein|T116|T123|ABX|EQV|NLM (2016)|141212|abbcdef
ENTRY = S100 A12 Protein|T116|T123|NON|EQV|NLM (2016)|141212|abbcdef
ENTRY = S100A12|T116|T123|NON|EQV|NLM (2016)|141212|abbcdef
ENTRY = A12 Protein, S100
ENTRY = C Protein, Calgranulin
ENTRY = EN RAGE Protein
ENTRY = MRP 6 Protein
ENTRY = Protein, CAAF1
ENTRY = Protein, Calgranulin C
ENTRY = Protein, EN-RAGE
ENTRY = Protein, ENRAGE
ENTRY = Protein, MRP-6
ENTRY = Protein, S100 A12
ENTRY = Protein, S100A12
MN = D12.644.276.087.901
MN = D12.776.157.125.750.875
MN = D12.776.467.087.937
MN = D23.529.087.943
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = Calcium-Binding Proteins (1994-2002)
PI = S100 Proteins (2003-2015)
MS = A member of the S100 PROTEIN FAMILY that regulates INFLAMMATION and the immune response. It recruits LEUKOCYTES, promotes cytokine and chemokine production, and regulates leukocyte adhesion and migration. S100A12 can also function via binding to ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTORS, to stimulate innate immune cells.
PM = 2016; S100A12 PROTEIN was indexed under S100 PROTEINS 2003-2015, and under CALCIUM-BINDING PROTEINS 1994-2002
HN = 2016 (1994)
MR = 20150219
DA = 20150701
DC = 1
DX = 20160101
UI = D000067616

*NEWRECORD
RECTYPE = D
MH = Telopodes
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Podomers|T026|NON|NRW|NLM (2016)|141212|abcdef
ENTRY = Podoms|T026|NON|NRW|NLM (2016)|141212|abcdef
ENTRY = Podom
ENTRY = Podomer
ENTRY = Telopode
MN = A11.284.180.900
MN = A11.329.830.750.500
MH_TH = NLM (2016)
ST = T026
MS = The very long and thin extensions of telocytes' cell surface, that have alternating thick and thin sections called podoms and podomers.
PM = 2016
HN = 2016
MR = 20150612
DA = 20150701
DC = 1
DX = 20160101
UI = D000067617

*NEWRECORD
RECTYPE = D
MH = Drosophila simulans
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = simulans, Drosophila
MN = B01.050.500.131.617.289.310.250.750
MH_TH = NLM (2016)
ST = T204
PI = Drosophila (1963-2015)
MS = A species of fruit fly.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000067636

*NEWRECORD
RECTYPE = D
MH = Optimism
AQ = PX
MN = F01.100.787
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T055
MS = Mental attitude that interprets life events as generally being positive.
PM = 2016
HN = 2016
MR = 20150225
DA = 20150701
DC = 1
DX = 20160101
UI = D000067656

*NEWRECORD
RECTYPE = D
MH = Pessimism
AQ = PX
MN = F01.100.893
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T055
MS = Mental attitude that interprets life events as generally being negative.
PM = 2016
HN = 2016
MR = 20150225
DA = 20150701
DC = 1
DX = 20160101
UI = D000067657

*NEWRECORD
RECTYPE = D
MH = Ataxin-1
DS = ATAXIN001
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Ataxin-1 Protein|T116|T123|NON|EQV|NLM (2016)|150130|abbcdef
ENTRY = Atxn-1 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Atxn1 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = SCA1 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Spinocerebellar Ataxia Type 1 Protein|T116|T123|ABX|EQV|NLM (2016)|150121|abbcdef
ENTRY = Ataxin 1
ENTRY = Ataxin 1 Protein
ENTRY = Atxn 1 Protein
ENTRY = Protein, Ataxin-1
ENTRY = Protein, Atxn-1
ENTRY = Protein, Atxn1
ENTRY = Protein, SCA1
MN = D12.776.641.069.500
MN = D12.776.660.075.500
FX = Spinocerebellar Ataxias
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = Nerve Tissue Proteins (1995-2015)
PI = Nuclear Proteins (1995-2015)
MS = A chromatin-binding factor that represses Notch signaling and associates with RNA. Expansion of the polyglutamine tract by expanded CAG repeats in the ATXN1 gene coding region is associated with SPINOCEREBELLAR ATAXIA 1.
PM = 2016; ATAXIN-1 was indexed under NERVE TISSUE PROTEINS AND NUCLEAR PROTEINS 1995-2015
HN = 2016 (1995)
MR = 20150219
DA = 20150706
DC = 1
DX = 20160101
UI = D000067696

*NEWRECORD
RECTYPE = D
MH = Adolescent Health
AQ = CL EC EH ES HI LJ SN ST TD
ENTRY = Teen Health|T078|NON|EQV|NLM (2016)|150121|abcdef
ENTRY = Health, Adolescent
ENTRY = Health, Teen
MN = N01.400.075
FX = Adolescent Health Services
FX = Adolescent Medicine
MH_TH = NLM (2016)
ST = T078
MS = The concept covering the physical and mental conditions of ADOLESCENTS.
PM = 2016
HN = 2016
MR = 20150305
DA = 20150706
DC = 1
DX = 20160101
UI = D000067697

*NEWRECORD
RECTYPE = D
MH = Ataxin-2
DS = ATAXIN002
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ATXN2 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Ataxin-2 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Atx-2 Protein|T116|T123|ABX|EQV|NLM (2016)|150121|abbcdef
ENTRY = SCA2 Protein|T116|T123|ABX|EQV|NLM (2016)|150121|abbcdef
ENTRY = Spinocerebellar Ataxia Type 2 Protein|T116|T123|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Ataxin 2
ENTRY = Ataxin 2 Protein
ENTRY = Atx 2 Protein
ENTRY = Protein, ATXN2
ENTRY = Protein, Ataxin-2
ENTRY = Protein, Atx-2
ENTRY = Protein, SCA2
MN = D12.776.157.725.452.125
MN = D12.776.641.069.750
MN = D12.776.660.075.750
MN = D12.776.664.962.452.125
FX = Spinocerebellar Ataxias
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = Nerve Tissue Proteins (2005-2015)
PI = Proteins (1996-2005)
MS = A Poly(A) RNA-binding protein that negatively regulates EGFR ENDOCYTOSIS. An increased risk for developing AMYOTROPHIC LATERAL SCLEROSIS 13 is observed in patients who have more than 23 CAG repeats in the ATXN2 gene coding sequence. Larger CAG expansions in the ATXN2 gene occur in SPINOCEREBELLAR ATAXIA 2 patients.
PM = 2016; ATAXIN-2 was indexed under PROTEINS 1996-2005, and under NERVE TISSUE PROTEINS 2005-2015
HN = 2016; use SCA2 PROTEIN (NM) 1996-2015
MR = 20150219
DA = 20150706
DC = 1
DX = 20160101
UI = D000067698

*NEWRECORD
RECTYPE = D
MH = Ataxin-3
DS = ATAXIN003
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ATXN3 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Ataxin-3 Protein|T116|T123|NON|EQV|NLM (2016)|150130|abbcdef
ENTRY = Machado-Joseph Disease Protein|T116|T123|NON|EQV|NLM (2016)|150130|abbcdef
ENTRY = SCA3 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Spinocerebellar Ataxia 3 Protein|T116|T123|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Ataxin 3
ENTRY = Ataxin 3 Protein
ENTRY = Disease Protein, Machado-Joseph
ENTRY = Machado Joseph Disease Protein
ENTRY = Protein, ATXN3
ENTRY = Protein, Ataxin-3
ENTRY = Protein, Machado-Joseph Disease
ENTRY = Protein, SCA3
MN = D08.811.277.656.300.887.500
MN = D12.776.641.069.875
MN = D12.776.660.075.875
FX = Spinocerebellar Ataxias
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = Nerve Tissue Proteins (1998-2015)
PI = Nuclear Proteins (1998-2015)
PI = Proteins (1995-1997)
MS = A DEUBIQUITINASE involved in protein homeostasis, transcription, cytoskeleton regulation, and myogenesis. It also acts as a histone-binding protein that represses transcription. CAG repeat expansions in the ATXN3 gene coding region are associated with SPINOCEREBELLAR ATAXIA 3 (SCA3).
PM = 2016; ATAXIN-3 was indexed under NERVE TISSUE PROTEINS AND NUCLEAR PROTEINS 1998-2015, and under PROTEINS 1995-1997
HN = 2016 (1995)
MR = 20150219
DA = 20150706
DC = 1
DX = 20160101
UI = D000067699

*NEWRECORD
RECTYPE = D
MH = Point-of-Care Testing
AQ = CL EC ES HI LJ OG SN ST TD UT
PRINT ENTRY = Bedside Testing|T058|NON|NRW|NLM (1996)|950313|abcdef
ENTRY = Point of Care Testing|T060|NON|EQV|NLM (2016)|141219|abcdef
ENTRY = Bedside Testings
ENTRY = Point-of-Care Testings
ENTRY = Testing, Bedside
ENTRY = Testing, Point-of-Care
ENTRY = Testings, Point-of-Care
MN = N04.590.874.500
MH_TH = NLM (2016)
ST = T060
MS = Allows patient diagnoses in the physicians office, in other ambulatory setting or at bedside. The results of care are timely, and allow rapid treatment to the patient. (from NIH Fact Sheet Point-of-Care Diagnostic Testing, 2010.)
PM = 2016; for BEDSIDE TESTING see POINT-OF-CARE SYSTEMS 1995-2015
HN = 2016; for BEDSIDE TESTING use POINT-OF-CARE SYSTEMS 1995-2015
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000067716

*NEWRECORD
RECTYPE = D
MH = Ataxin-7
DS = ATAXIN007
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ATXN7 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Atxn-7 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = SCA7 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Spinocerebellar Ataxia 7 Protein|T116|T123|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Ataxin 7
ENTRY = Atxn 7 Protein
ENTRY = Protein, ATXN7
ENTRY = Protein, Atxn-7
ENTRY = Protein, SCA7
MN = D12.776.641.069.901
MN = D12.776.660.075.900
FX = Spinocerebellar Ataxias
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = Nerve Tissue Proteins (1997-2015)
MS = A component of the STAGA transcription coactivator-HAT complex that functions in Cone Rod Homeobox Protein (CRX)-dependent gene activation. It also stabilizes MICROTUBULES. CAG repeat expansion in the ATXN-7 coding region is associated with the development of SPINOCEREBELLAR ATAXIA 7.
PM = 2016; ATAXIN-7 was indexed under NERVE TISSUE PROTEINS 1997-2015
HN = 2016
MR = 20150706
DA = 20150706
DC = 1
DX = 20160101
UI = D000067719

*NEWRECORD
RECTYPE = D
MH = Ataxin-10
DS = ATAXIN010
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ATXN10 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Atxn-10 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = SCA10 Protein|T116|T123|ABX|EQV|NLM (2016)|150130|abbcdef
ENTRY = Spinocerebellar Ataxia 10 Protein|T116|T123|NON|EQV|NLM (2016)|150130|abbcdef
ENTRY = Ataxin 10
ENTRY = Atxn 10 Protein
ENTRY = Protein, ATXN10
ENTRY = Protein, Atxn-10
ENTRY = Protein, SCA10
MN = D12.776.641.069.950
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = Nerve Tissue Proteins (2006-2015)
MS = An ataxin that is associated with the survival of cerebellar neurons. Expansion of the ATTCT pentanucleotide in the ATXN10 coding region is associated with SPINOCEREBELLAR ATAXIA 10.
PM = 2016; ATAXIN-10 was indexed under NERVE TISSUE PROTEINS 2006-2015
HN = 2016
MR = 20150415
DA = 20150701
DC = 1
DX = 20160101
UI = D000067736

*NEWRECORD
RECTYPE = D
MH = Glucagon-Like Peptide Receptors
AQ = AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL
ENTRY = GLPR Proteins|T116|T192|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = Glucagon-Like Receptors|T116|T192|NON|EQV|NLM (2016)|150202|abbcdef
ENTRY = Glucagon Like Peptide Receptors
ENTRY = Glucagon Like Receptors
ENTRY = Peptide Receptors, Glucagon-Like
ENTRY = Proteins, GLPR
ENTRY = Receptors, Glucagon-Like
ENTRY = Receptors, Glucagon-Like Peptide
MN = D12.776.543.750.100.021
MN = D12.776.543.750.750.360.100
MH_TH = NLM (2016)
ST = T116
ST = T192
RN = 0
PI = Receptors, Cell Surface (1987-1995)
PI = Receptors, Glucagon (1995-2015)
MS = G-PROTEIN COUPLED CELL SURFACE RECEPTORS that bind GLUCAGON-LIKE PEPTIDES and are expressed by cells in pancreatic, intestinal, and neural tissues. These receptors regulate cellular responses to BLOOD GLUCOSE, INSULIN, and INFLAMMATION signals.
PM = 2016
HN = 2016
MR = 20150219
DA = 20150701
DC = 1
DX = 20160101
UI = D000067756

*NEWRECORD
RECTYPE = D
MH = Glucagon-Like Peptide-1 Receptor
AQ = AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL
ENTRY = GLP-1 Receptor|T116|T192|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = GLP-1R Receptor|T116|T192|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = GLP1R Protein|T116|T192|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = GLP1R Receptor|T116|T192|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = GLP 1 Receptor
ENTRY = GLP 1R Receptor
ENTRY = Glucagon Like Peptide 1 Receptor
ENTRY = Peptide-1 Receptor, Glucagon-Like
ENTRY = Protein, GLP1R
ENTRY = Receptor, GLP-1
ENTRY = Receptor, GLP-1R
ENTRY = Receptor, GLP1R
ENTRY = Receptor, Glucagon-Like Peptide-1
MN = D12.776.543.750.100.021.500
MN = D12.776.543.750.750.360.100.500
MH_TH = NLM (2016)
ST = T116
ST = T192
RN = 0
PI = Receptors, Cell Surface (1987-1995)
PI = Receptors, Glucagon (1995-2015)
MS = A receptor for GLUCAGON-LIKE PEPTIDE 1 (GLP-1) expressed primarily on the surface of beta and ductal exocrine cells of the pancreas, as well as cells of other tissues. GLP-1 acts through GLP-1R to potentiate signaling in pancreatic cells in response to glucose-stimulated insulin secretion (GSIS).
PM = 2016; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR was indexed under RECEPTORS, GLUCAGON 1995-2015, and under RECEPTORS, CELL SURFACE 1987-1995
HN = 2016
MR = 20150730
DA = 20150701
DC = 1
DX = 20160101
UI = D000067757

*NEWRECORD
RECTYPE = D
MH = Glucagon-Like Peptide-2 Receptor
AQ = AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL
ENTRY = GLP-2 Receptor|T116|T192|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = GLP-2R Receptor|T116|T192|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = GLP2R Protein|T116|T192|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = Glucagon-Like Peptide 2 Receptor|T116|T192|NON|EQV|NLM (2016)|141222|abbcdef
ENTRY = GLP 2 Receptor
ENTRY = GLP 2R Receptor
ENTRY = Glucagon Like Peptide 2 Receptor
ENTRY = Peptide-2 Receptor, Glucagon-Like
ENTRY = Protein, GLP2R
ENTRY = Receptor, GLP-2
ENTRY = Receptor, GLP-2R
ENTRY = Receptor, Glucagon-Like Peptide-2
MN = D12.776.543.750.100.021.600
MN = D12.776.543.750.750.360.100.600
MH_TH = NLM (2016)
ST = T116
ST = T192
RN = 0
PI = Receptors, Glucagon (2000-2015)
MS = A receptor for GLUCAGON-LIKE PEPTIDE 2 (GLP-2) that is expressed on the surface of intestinal cells as well as neural cells. GLP-2 and other peptides act through GLP-2R to regulate cellular responses to BLOOD GLUCOSE, INFLAMMATION, and FOOD INTAKE.
PM = 2016; GLUCAGON-LIKE PEPTIDE-2 RECEPTOR was indexed under RECEPTORS, GLUCAGON 2000-2015
HN = 2016
MR = 20150219
DA = 20150701
DC = 1
DX = 20160101
UI = D000067758

*NEWRECORD
RECTYPE = D
MH = Advanced Glycosylation End Product-Specific Receptor
AQ = AD AG AI AN BI BL CH CL DE DF GE HI IM IP ME PH RE TU UL
ENTRY = AGE Receptor|T116|T192|ABX|EQV|NLM (2016)|150121|abbcdef
ENTRY = AGER Protein|T116|T192|ABX|EQV|NLM (2016)|150116|abbcdef
ENTRY = Advanced Glycosylation End Product Receptors|T116|T192|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Advanced Glycosylation End-Product Receptor|T116|T192|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Advanced Glycosylation End-Product Receptors|T116|T192|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Amphoterin Receptor|T116|T192|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = RAGE (Receptor for Advanced Glycation End Products)|T116|T192|ABX|EQV|NLM (2016)|150121|abbcdef
ENTRY = Receptor for Advanced Glycation End Products (RAGE)|T116|T192|ABX|EQV|NLM (2016)|150121|abbcdef
ENTRY = Receptor for Advanced Glycation Endproducts|T116|T192|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Receptor, Advanced Glycosylation End-Product|T116|T192|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Receptor, Advanced Glycosylation End-Products|T116|T192|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Advanced Glycosylation End Product Receptor
ENTRY = Advanced Glycosylation End Product Specific Receptor
ENTRY = Protein, AGER
ENTRY = Receptor, AGE
ENTRY = Receptor, Advanced Glycosylation End Product
ENTRY = Receptor, Advanced Glycosylation End Products
ENTRY = Receptor, Amphoterin
MN = D12.776.543.750.006
MH_TH = NLM (2016)
ST = T116
ST = T192
RN = 0
PI = Receptors, Endogenous Substances (1991-1993)
PI = Receptors, Immunologic (1993-2015)
MS = A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCOSYLATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2 . It also binds AMYLOID BETA PEPTIDES and the alarmins S100A12 and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.
PM = 2016; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1993-2015, and under RECEPTORS, ENDOGENOUS SUBSTANCES (1991-1993)
HN = 2016 (1991)
MR = 20150219
DA = 20150701
DC = 1
DX = 20160101
UI = D000067759

*NEWRECORD
RECTYPE = D
MH = RNA Recognition Motif (RRM) Proteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = RNA-Binding Domain (RBD) Proteins|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = RRM Proteins|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = Ribonucleoprotein Domain (RNP) Proteins|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = Proteins, RRM
MN = D12.776.157.725.813
MN = D12.776.664.962.813
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = RNA-Binding Proteins (1993-2015)
MS = A family of RNA-BINDING PROTEINS which contain a motif consisting of two ribonucleoprotein (RNP) domains that bind RNA, and other domains that allow for high affinity binding, sequence specificity, and protein interactions. Examples of RRM proteins include HETEROGENEOUS NUCLEAR RIBONUCLEARPROTEINS (hnRNP) and EMBRYONIC LETHAL ABNORMAL-VISION (ELAV) proteins.
PM = 2016
HN = 2016
MR = 20150226
DA = 20150701
DC = 1
DX = 20160101
UI = D000067776

*NEWRECORD
RECTYPE = D
MH = ELAV-Like Protein 2
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ELAV (Embryonic Lethal, Abnormal Vision, Drosophila)-Like 2 (Hu Antigen B)|T116|T123|T129|ABX|EQV|NLM (2016)|150202|abbbcdef
ENTRY = ELAVL2 protein|T116|T123|T129|ABX|EQV|NLM (2016)|150113|abbbcdef
ENTRY = HuB Antigen|T116|T123|T129|ABX|EQV|NLM (2012)|110125|abbbcdef
ENTRY = HuB Paraneoplastic Encephalomyelitis Antigen|T116|T123|T129|ABX|EQV|NLM (2012)|110125|abbbcdef
ENTRY = HuB Protein|T116|T123|T129|ABX|EQV|NLM (2012)|110125|abbbcdef
ENTRY = 2, ELAV-Like Protein
ENTRY = Antigen, HuB
ENTRY = ELAV Like Protein 2
ENTRY = Protein 2, ELAV-Like
ENTRY = Protein, HuB
ENTRY = protein, ELAVL2
MN = D12.776.157.725.813.500.500
MN = D12.776.641.520.500
MN = D12.776.664.962.813.500.500
MH_TH = NLM (2012)
ST = T116
ST = T123
ST = T129
RN = 0
PI = ELAV Proteins  (2005-2015)
MS = A neural-specific RRM protein that binds to several 3'UTRs, including its own as well as that of PROTO-ONCOGENE PROTEINS C-FOS  and ID DNA BINDING PROTEIN INHIBITOR. It binds through the recognition of a GAAA motif in the RNAs.
PM = 2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015
HN = 2016; use ELAV PROTEINS 2012-2015
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000067777

*NEWRECORD
RECTYPE = D
MH = ELAV-Like Protein 3
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ELAVL3 Protein|T116|T123|T129|ABX|EQV|NLM (2016)|150113|abbbcdef
ENTRY = HuC Antigen|T116|T123|T129|ABX|EQV|NLM (2012)|110125|abbbcdef
ENTRY = HuC Paraneoplastic Encephalomyelitis Antigen|T116|T123|T129|ABX|EQV|NLM (2012)|110125|abbbcdef
ENTRY = HuC Protein|T116|T123|T129|ABX|EQV|NLM (2012)|110125|abbbcdef
ENTRY = 3, ELAV-Like Protein
ENTRY = Antigen, HuC
ENTRY = ELAV Like Protein 3
ENTRY = Protein 3, ELAV-Like
ENTRY = Protein, ELAVL3
ENTRY = Protein, HuC
MN = D12.776.157.725.813.500.750
MN = D12.776.641.520.750
MN = D12.776.664.962.813.500.750
MH_TH = NLM (2012)
ST = T116
ST = T123
ST = T129
RN = 0
PI = ELAV Proteins  (2005-2015)
MS = A neural-specific RRM protein which contains three RNP-type RNA recognition motifs (RRMs). Human ELAVL3 is recognized by the anti-Hu serum antibody from patients with paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/PSN). It also functions in neurogenesis.
PM = 2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015
HN = 2016; use ELAV PROTEINS 2012-2015
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000067778

*NEWRECORD
RECTYPE = D
MH = ELAV-Like Protein 4
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ELAVL4 Protein|T116|T129|ABX|EQV|NLM (2016)|150113|abbcdef
ENTRY = HuD Antigen|T116|T129|ABX|EQV|NLM (2006)|abbcde
ENTRY = HuD Paraneoplastic Encephalomyelitis Antigen|T116|T129|ABX|EQV|NLM (2006)|abbcde
ENTRY = HuD Protein|T116|T129|ABX|EQV|NLM (2012)|110125|abbcdef
ENTRY = Antigen, HuD
ENTRY = ELAV Like Protein 4
ENTRY = Protein, ELAVL4
ENTRY = Protein, HuD
MN = D12.776.157.725.813.500.875
MN = D12.776.641.520.875
MN = D12.776.664.962.813.500.875
MH_TH = NLM (2012)
ST = T116
ST = T129
RN = 0
PI = ELAV Proteins (2005-2015)
MS = An RRM protein which binds AU-rich sequences in the 3' UNTRANSLATED REGIONS of mRNAs for PROTO-ONCOGENE PROTEINS C-FOS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; and GAP-43 PROTEIN. It functions in neuron-specific RNA processing.
PM = 2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015
HN = 2016; use ELAV PROTEINS 2012-2015
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000067779

*NEWRECORD
RECTYPE = D
MH = ELAV-Like Protein 1
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ELAVL1 protein|T116|T123|T129|ABX|EQV|NLM (2016)|150113|abbbcdef
ENTRY = HuR Antigen|T116|T123|T129|ABX|EQV|NLM (2012)|110125|abbbcdef
ENTRY = HuR Paraneoplastic Encephalomyelitis Antigen|T116|T123|T129|ABX|EQV|NLM (2016)|150226|abbbcdef
ENTRY = HuR Protein|T116|T123|T129|ABX|EQV|NLM (2012)|110125|abbbcdef
ENTRY = Antigen, HuR
ENTRY = ELAV Like Protein 1
ENTRY = Protein, HuR
ENTRY = protein, ELAVL1
MN = D12.776.157.725.813.500.250
MN = D12.776.664.962.813.500.250
MH_TH = NLM (2012)
ST = T116
ST = T123
ST = T129
RN = 0
PI = ELAV Proteins (2005-2015)
PI = RNA-Binding Proteins (2000-2015)
MS = An RRM protein that binds to the 3'-UTR region of mRNAs and increases their stability. In EMBRYONIC STEM CELLS, it binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs and preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), to stabilize them and promote differentiation.
PM = 2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015
HN = 2016; use ELAV PROTEINS 2012-2015
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000067780

*NEWRECORD
RECTYPE = D
MH = Whey
AQ = AD AE CH CL CY DE EC EN HI IM ME MI PH PO PS RA RE RI SD SE SN ST TO US UT VI
MN = G07.203.100.700.750
MN = G07.203.300.350.525.760
MN = J02.200.700.750
MN = J02.500.350.525.760
MH_TH = NLM (2016)
ST = T168
PI = Dairy Products (1964-2015)
MS = The liquid components of milk that remain after the CASEIN, fat, and fat soluble components have been removed. It is also a byproduct of cheese production.
PM = 2016
HN = 2016
MR = 20150612
DA = 20150701
DC = 1
DX = 20160101
UI = D000067796

*NEWRECORD
RECTYPE = D
MH = Whey Proteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
ENTRY = Whey Protein|T116|NON|EQV|NLM (2016)|150114|abcdef
ENTRY = Protein, Whey
ENTRY = Proteins, Whey
MN = D12.776.256.626.816
MN = G07.203.300.350.525.520.500
MN = G07.203.300.350.525.760.500
MN = G07.203.300.428.626.500
MN = J02.500.350.525.520.500
MN = J02.500.350.525.760.500
MN = J02.500.428.626.500
MH_TH = NLM (2016)
ST = T116
RN = 0
MS = The protein components of milk obtained from the whey.
PM = 2016; WHEY PROTEIN (NM) was indexed as MILK PROTEINS (1984-2015)
HN = 2016 (1984)
MR = 20150612
DA = 20150701
DC = 1
DX = 20160101
UI = D000067816

*NEWRECORD
RECTYPE = D
MH = Hoarding Disorder
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Disorder, Hoarding
ENTRY = Disorders, Hoarding
ENTRY = Hoarding Disorders
MN = F03.080.600.250
MH_TH = NLM (2016)
ST = T048
MS = Persistent difficulty discarding or parting with possessions due to a perceived need to save the items and distress associated with discarding them. (from DSM-V)
PM = 2016
HN = 2016
MR = 20150630
DA = 20150701
DC = 1
DX = 20160101
UI = D000067836

*NEWRECORD
RECTYPE = D
MH = Poly(ADP-ribose) Polymerase Inhibitors
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Inhibitors of Poly(ADP-ribose) Polymerases|T121|ABX|EQV|NLM (2016)|150102|abcdef
ENTRY = PARP Inhibitors|T121|ABX|EQV|NLM (2016)|150102|abcdef
ENTRY = Poly(ADP-ribosylation) Inhibitors|T121|ABX|EQV|NLM (2016)|150102|abcdef
ENTRY = Inhibitors, PARP
MN = D27.505.519.389.739
MN = D27.505.954.248.692
MH_TH = NLM (2016)
ST = T121
RN = 0
MS = Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000067856

*NEWRECORD
RECTYPE = D
MH = Autism Spectrum Disorder
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Autism Spectrum Disorders|T048|NON|EQV|OMIM (2013)|090428|abcdef
ENTRY = Spectrum Disorders, Autism
MN = F03.625.164.113
MH_TH = NLM (2016)
ST = T048
PI = Child Development Disorders, Pervasive (2010-2015)
MS = Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
PM = 2016; see CHILD DEVELOPMENT DISORDERS, PERVASIVE 2010-2015
HN = 2016; use CHILD DEVELOPMENT DISORDERS, PERVASIVE 2010-2015
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000067877

*NEWRECORD
RECTYPE = D
MH = CELF Proteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = BRUNOL Proteins|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = Bruno-Like Family Member Proteins|T116|T123|NON|EQV|NLM (2016)|150202|abbcdef
ENTRY = CUG Triplet Repeat, RNA-Binding Proteins|T116|T123|NON|EQV|NLM (2016)|150202|abbcdef
ENTRY = CUG-BP Proteins|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = CUGBP Proteins|T116|T123|ABX|EQV|NLM (2016)|150105|abbcdef
ENTRY = CUGBP, Elav-Like Family Member Proteins|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = Bruno Like Family Member Proteins
ENTRY = CUG BP Proteins
ENTRY = CUG Triplet Repeat, RNA Binding Proteins
ENTRY = CUGBP, Elav Like Family Member Proteins
ENTRY = Proteins, BRUNOL
ENTRY = Proteins, CELF
ENTRY = Proteins, CUG-BP
ENTRY = Proteins, CUGBP
MN = D12.776.157.725.813.250
MN = D12.776.664.962.813.250
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = RNA-Binding Proteins (2005-2015)
PI = Ribonucleoproteins (1997-2004)
MS = A family of RRM proteins which contain two N-terminal RNA RECOGNITION MOTIF (RRM) domains, one C-terminal RRM domain, and a divergent segment of 160-230 amino acids between the second and third RRM domains. They regulate pre-mRNA ALTERNATIVE SPLICING and also function in RNA EDITING and PROTEIN BIOSYNTHESIS.
PM = 2016
HN = 2016
MR = 20150226
DA = 20150701
DC = 1
DX = 20160101
UI = D000067878

*NEWRECORD
RECTYPE = D
MH = CELF1 Protein
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = BRUNOL2 Protein|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = Bruno-Like 2 Protein|T116|T123|NON|EQV|NLM (2016)|150202|abbcdef
ENTRY = CUG Triplet Repeat, RNA-Binding Protein 1|T116|T123|NON|EQV|NLM (2016)|150202|abbcdef
ENTRY = CUGBP, Elav-Like Family Member 1 Protein|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = CUGBP1 Protein|T116|T123|ABX|EQV|NLM (2016)|150202|abbcdef
ENTRY = 2 Protein, Bruno-Like
ENTRY = Bruno Like 2 Protein
ENTRY = CUG Triplet Repeat, RNA Binding Protein 1
ENTRY = CUGBP, Elav Like Family Member 1 Protein
ENTRY = Protein, BRUNOL2
ENTRY = Protein, Bruno-Like 2
ENTRY = Protein, CELF1
ENTRY = Protein, CUGBP1
MN = D12.776.157.725.813.250.500
MN = D12.776.664.962.813.250.500
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 0
PI = RNA-Binding Proteins (2005-2015)
PI = Ribonucleoproteins (1997-2004)
MS = A member of the CELF PROTEINS family which binds GU rich elements (GREs) and CUG-triplet repeats in the 3'UTR of mammalian mRNA transcripts that undergo rapid turnover. It also binds AU-rich elements (AREs or EDEN-like) in the 3'UTR of JUN and FOS mRNAs. Mutations in the human CELF1 gene are associated with MYOTONIC DYSTROPHY type 1.
PM = 2016
HN = 2016
MR = 20150226
DA = 20150701
DC = 1
DX = 20160101
UI = D000067879

*NEWRECORD
RECTYPE = D
MH = Industrial Development
AQ = ES HI LJ SN TD
PRINT ENTRY = Industrialization|T057|NON|BRD|NLM (1978)|961202|abcdef
ENTRY = Technology Development|T057|T078|NON|NRW|NLM (2016)|150107|abbcdef
ENTRY = Development, Industrial
ENTRY = Development, Technology
ENTRY = Developments, Industrial
ENTRY = Industrial Developments
ENTRY = Technology Developments
MN = I01.261.262.500
MN = J01.576.519
MH_TH = NLM (2016)
ST = T057
ST = T078
MS = Activity concerned with the planning and building of industries through manufacturing, provision of specialized services, and COMMERCE.
PM = 2016; for INDUSTRIALIZATION see INDUSTRY 2000-2015
HN = 2016; for INDUSTRIALIZATION use INDUSTRY 2000-2015
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000067896

*NEWRECORD
RECTYPE = D
MH = Cloud Computing
AQ = CL EC ES HI LJ SD SN ST TD UT
ENTRY = Cloud Processing|T066|NON|EQV|NLM (2016)|OBSSR (2016)|150312|abcdeef
ENTRY = Cloud Service|T066|NON|EQV|NLM (2016)|OBSSR (2016)|150109|abcdeef
ENTRY = Cloud Storage|T066|NON|EQV|NLM (2016)|OBSSR (2016)|150312|abcdeef
ENTRY = Cloud Storages
ENTRY = Computing, Cloud
ENTRY = Processing, Cloud
ENTRY = Service, Cloud
ENTRY = Storage, Cloud
ENTRY = Storages, Cloud
MN = L01.224.097
FX = Technology
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T066
MS = Storing and processing data on multiple servers that can be accessed through the Internet.
PM = 2016
HN = 2016
MR = 20150622
DA = 20150701
DC = 1
DX = 20160101
UI = D000067917

*NEWRECORD
RECTYPE = D
MH = Natural Resources
AQ = SD
ENTRY = Land Supply|T081|NON|REL|NLM (1982)|861231|abcdef
ENTRY = Land Supplies
ENTRY = Natural Resource
ENTRY = Resource, Natural
ENTRY = Resources, Natural
ENTRY = Supplies, Land
ENTRY = Supply, Land
MN = G16.500.275.553
MN = J01.728
MN = N06.230.350
FX = Conservation of Natural Resources
MH_TH = NLM (1983)
ST = T081
AN = coordinate with  specific natural resource if pertinent
MS = Materials or substances such as land, timber, fresh water, fossil fuels, or mineral deposits that occur in a natural state and have economic value or usefulness to humans.
PM = 2016; see CONSERVATION OF NATURAL RESOURCES 1991-2015; for LAND SUPPLY see AGRICULTURE 1978-2015
HN = 2016;  use CONSERVATION OF NATURAL RESOURCES 1991-2015; for LAND SUPPLY use AGRICULTURE 1978-2015
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000067936

*NEWRECORD
RECTYPE = D
MH = Glycemic Load
AQ = DE EH GE IM PH RE
ENTRY = Load, Glycemic
MN = G07.203.650.660.750
MN = J01.576.423.850.730.750.750
MN = N06.850.601.750.750
MH_TH = NLM (2016)
ST = T081
AN = GLYCEMIC INDEX is also available
PI = Glycemic Index (2003-2015)
MS = A quantitative value of a measured amount of a specific food that is equal to the GLYCEMIC INDEX of that food multiplied by the carbohydrate content of that food.
MR = 20150707
DA = 20150707
DC = 1
DX = 20160101
UI = D000067940

*NEWRECORD
RECTYPE = D
MH = Adenylyl Cyclase Inhibitors
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Adenylate Cyclase Inhibitors|T121|NON|EQV|NLM (2016)|150113|abcdef
ENTRY = Cyclase Inhibitors, Adenylate
ENTRY = Cyclase Inhibitors, Adenylyl
ENTRY = Inhibitors, Adenylate Cyclase
ENTRY = Inhibitors, Adenylyl Cyclase
MN = D27.505.519.389.108
MH_TH = NLM (2016)
ST = T121
RN = 0
PI = Adenylyl Cyclase/antagonists & inhibitors (1968-2015)
MS = Compounds that bind to and inhibit the action of ADENYLYL CYCLASES.
PM = 2016
HN = 2016
MR = 20150402
DA = 20150701
DC = 1
DX = 20160101
UI = D000067956

*NEWRECORD
RECTYPE = D
MH = RAW 264.7 Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = RAW 264.7 Cell Line|T025|ABX|EQV|NLM (2016)|150114|abcdef
ENTRY = 264.7 Cell, RAW
ENTRY = 264.7 Cells, RAW
ENTRY = Cell, RAW 264.7
ENTRY = Cells, RAW 264.7
ENTRY = RAW 264.7 Cell
MN = A11.251.210.172.875
MN = A11.733.397.815
MH_TH = NLM (2016)
ST = T025
AN = almost always NIM with no subheadings; check ANIMALS and MICE
PI = Cell Line (1983-2015)
PI = Macrophages (1983-2015)
MS = A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000067996

*NEWRECORD
RECTYPE = D
MH = Accreditation
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Accreditations
MN = N03.706.110.070
MN = N05.700.200.100
FX = Certification
FX = Licensure
MH_TH = NLM (1964)
ST = T064
AN = by the profession; do not confuse with LICENSURE (by the state)
MS = Certification as complying with a standard set by non-governmental organizations, applied for by institutions, programs, and facilities on a voluntary basis.
PM = 66
HN = 66(64)
MR = 19940603
DA = 19990101
DC = 1
DX = 19660101
UI = D000068

*NEWRECORD
RECTYPE = D
MH = Clostridiales
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.353.625
MH_TH = NLM (2016)
ST = T007
PI = Bacteria (2001-2015)
MS = An order of anaerobic bacteria that are predominantly GRAM POSITIVE within the phylum Firmicutes. It includes the Clostridium and Eubacterium genera.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000068016

*NEWRECORD
RECTYPE = D
MH = Graphic Novels
MN = V02.503
MN = V02.700.375
MH_TH = NLM (2016)
ST = T170
AN = This heading is used as a Publication Type.  INDEXER: Do not use
PI = Cartoons (2014-2015)
MS = Book-length narratives told using a combination of words and sequential art, often presented in comic book style. from (Fletcher-Spear et al., ALA Review, Winter 2005)
HN = 2016; use CARTOONS 2014-2015
MR = 20150629
DA = 20150701
DC = 2
DX = 20160101
UI = D000068036

*NEWRECORD
RECTYPE = D
MH = South Sudan
AQ = EH EP
MN = Z01.058.290.120.745
MH_TH = NLM (2016)
ST = T083
PI = Susan (1988-2015)
MS = A nation located in East-Central Africa; south of Sudan, north of Uganda and Kenya, west of Ethiopia. Independence from SUDAN was attained on 9 July 2011. The capital is Juba. (from CIA. World Factbook, 2014.)
HN = 2016
MR = 20150210
DA = 20150701
DC = 4
DX = 20160101
UI = D000068037

*NEWRECORD
RECTYPE = D
MH = Motor Disorders
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
MN = F03.608
MH_TH = NLM (2016)
ST = T048
PI = Motor Skills Disorders (1998-2015)
MS = Motor skills deficits that significantly and persistently interfere with ACTIVITIES OF DAILY LIVING appropriate to chronological age.  (from DSM-V)
PM = 2016; see MOTOR SKILLS DISORDERS 1998-2015
HN = 2016; use MOTOR SKILLS DISORDERS 1998-2015
MR = 20150210
DA = 20150701
DC = 1
DX = 20160101
UI = D000068079

*NEWRECORD
RECTYPE = D
MH = Maternal Health
AQ = CL EC EH ES HI LJ SN ST TD
ENTRY = Health, Maternal
MN = N01.400.900.500
FX = Maternal Health Services
FX = Maternal Welfare
MH_TH = BIOETHICS (1974)
MH_TH = NLM (1992)
ST = T078
PI = Maternal Welfare (1974-2015)
MS = The health of women during PREGNANCY; childbirth and the POSTPARTUM PERIOD.
PM = 2016; see MATERNAL WELFARE 1974-2015
HN = 2016 (1974); use MATERNAL WELFARE 1974-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000068097

*NEWRECORD
RECTYPE = D
MH = Seed Bank
AQ = CL EC ES HI LJ OG SD SN ST TD UT
ENTRY = Germplasm Bank|T002|NON|BRD|NLM (2016)|150121|abcdef
ENTRY = Seedbank|T002|NON|EQV|NLM (2016)|150121|abcdef
ENTRY = Seeds Bank|T002|NON|EQV|NLM (2016)|150121|abcdef
ENTRY = Bank, Germplasm
ENTRY = Bank, Seed
ENTRY = Bank, Seeds
ENTRY = Banks, Germplasm
ENTRY = Banks, Seed
ENTRY = Germplasm Banks
ENTRY = Seed Banks
ENTRY = Seedbanks
MN = N02.278.065.650
MH_TH = NLM (2016)
ST = T002
PI = Seeds (2000-2015)
MS = A repository of seeds maintained under optimal conditions that ensure long term storage, intended for use as a source of replenishment of seed stock or plant genetic material.
PM = 2016
HN = 2016
MR = 20150302
DA = 20150701
DC = 1
DX = 20160101
UI = D000068098

*NEWRECORD
RECTYPE = D
MH = Trauma and Stressor Related Disorders
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
MN = F03.950
MH_TH = NLM (2016)
ST = T048
MS = Disorders in which exposure to a traumatic or stressful event is explicitly a diagnostic criterion.
PM = 2016
HN = 2016
MR = 20150630
DA = 20150701
DC = 1
DX = 20160101
UI = D000068099

*NEWRECORD
RECTYPE = D
MH = Maternal-Child Health Services
DE = MATERNAL CHILD HEALTH SERV
AQ = CL EC ES HI LJ MA OG SD SN ST TD UT
ENTRY = Health Services, Maternal-Child|T058|NON|EQV|NLM (1996)|950331|HEALTH SERV MATERNAL CHILD|abcdefv
ENTRY = Health Service, Maternal-Child
ENTRY = Health Services, Maternal Child
ENTRY = Maternal Child Health Services
ENTRY = Maternal-Child Health Service
ENTRY = Service, Maternal-Child Health
ENTRY = Services, Maternal-Child Health
MN = N02.421.143.130.660
MN = N02.421.143.620.275
MH_TH = NLM (1978)
ST = T058
PI = Maternal-Child Health Centers (1978-2015)
MS = Programs organized for the purpose of providing medical and social services for mothers and children.
PM = 2016 (1978); see MATERNAL-CHILD HEALTH CENTERS 1978-2015
HN = 2016 (1978); use MATERNAL-CHILD HEALTH CENTERS 1978-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000068101

*NEWRECORD
RECTYPE = D
MH = Serine-Arginine Splicing Factors
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = SR-Rich Splicing Proteins|T116|T123|NON|EQV|NLM (2016)|150319|abbcdef
ENTRY = Serine-Arginine-Rich Splicing Proteins|T116|T123|NON|EQV|NLM (2016)|150121|abbcdef
ENTRY = Factors, Serine-Arginine Splicing
ENTRY = Proteins, SR-Rich Splicing
ENTRY = Proteins, Serine-Arginine-Rich Splicing
ENTRY = SR Rich Splicing Proteins
ENTRY = Serine Arginine Rich Splicing Proteins
ENTRY = Serine Arginine Splicing Factors
ENTRY = Splicing Factors, Serine-Arginine
ENTRY = Splicing Proteins, SR-Rich
ENTRY = Splicing Proteins, Serine-Arginine-Rich
MN = D12.776.157.725.844
MN = D12.776.664.962.844
MH_TH = NLM (2016)
ST = T116
ST = T123
RN = 170974-22-8
MS = A family of splicing regulatory factors essential for constitutive and alternative splicing in RNA metabolism.
PM = 2016; SERINE-ARGININE-RICH SPLICING PROTEINS was indexed under PHOSPHOPROTEINS 1995-2006, under NUCLEAR PROTEINS 2007-2015, and under RNA-BINDING PROTEINS 2007-2015
HN = 2016 (1995)
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000068103

*NEWRECORD
RECTYPE = D
MH = Infant Health
AQ = CL EC EH ES HI LJ SN ST TD
ENTRY = Baby Health|T078|NON|EQV|NLM (2016)|150121|abcdef
ENTRY = Health of Newborn Infants|T078|NON|NRW|NLM (2016)|141204|abcdef
ENTRY = Health of the Newborn Infant|T078|NON|NRW|NLM (2016)|141204|abcdef
ENTRY = Neonatal Health|T078|NON|NRW|NLM (2016)|150223|abcdef
ENTRY = Newborn Health|T078|NON|NRW|NLM (2016)|141204|abcdef
ENTRY = Newborn Infant Health|T078|NON|NRW|NLM (2016)|141204|abcdef
ENTRY = Health, Baby
ENTRY = Health, Infant
ENTRY = Health, Neonatal
ENTRY = Health, Newborn
ENTRY = Health, Newborn Infant
ENTRY = Infant Health, Newborn
MN = N01.400.388
FX = Infant Welfare
MH_TH = NLM (1994)
ST = T078
PI = Infant Welfare (1994-2015)
MS = The concept covering the physical and mental conditions of INFANTS.
PM = 2016; see INFANT WELFARE 1994-2015
HN = 2016; use INFANT WELFARE 1994-2015
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000068104

*NEWRECORD
RECTYPE = D
MH = Bipolar and Related Disorders
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
MN = F03.084
MH_TH = NLM (2016)
ST = T048
MS = These disorders are related to both SCHIZOPHRENIA SPECTRUM AND RELATED DISORDERS and DEPRESSIVE DISORDERS in terms of symptomatology, family history, and genetics. (DSM-V) .
PM = 2016
HN = 2016
MR = 20150630
DA = 20150701
DC = 1
DX = 20160101
UI = D000068105

*NEWRECORD
RECTYPE = D
MH = Gender Dysphoria
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
MN = F03.835.550
MH_TH = NLM (2016)
ST = T048
MS = A marked difference between the individuals expressed/experienced gender and the gender others would assign him or her, and it must continue for at least six months. (from DSM-5)
PM = 2016
HN = 2016
MR = 20150630
DA = 20150701
DC = 1
DX = 20160101
UI = D000068116

*NEWRECORD
RECTYPE = D
MH = Formative Feedback
ENTRY = Constructive Feedback|T057|NON|EQV|NLM (2016)|150130|abcdef
ENTRY = Feedback (Learning)|T057|NON|EQV|NLM (2016)|150130|abcdef
ENTRY = Feedback, Constructive
ENTRY = Feedback, Formative
MN = F02.784.629.529.223
MN = L01.143.283.425.156
MH_TH = NLM (2016)
ST = T057
PI = Learning (2010-2015)
MS = Information communicated to the learner that is intended to modify the learners thinking or behavior for the purpose of improving learning.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000068156

*NEWRECORD
RECTYPE = D
MH = Aripiprazole
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone|T109|T121|EQV|NLM (1995)|abbde
ENTRY = Abilify|T109|T121|TRD|NRW|MX|US|021217|abbcdeef
ENTRY = Aripiprazol|T109|T121|NON|EQV|NLM (2016)|150209|abbcdef
ENTRY = OPC 14597|T109|T121|LAB|NRW|NLM (1995)|abbcde
ENTRY = OPC-14597|T109|T121|NRW|NLM (1995)|abbde
ENTRY = 14597, OPC
MN = D03.383.606.170
MN = D03.438.810.835.122
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 82VFR53I78
MS = An antipsychotic agent that is structurally related to piperazines and quinolones. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A.
PM = 2016; ARIPIPRAZOLE was indexed under QUINOLONES 1995-2015 and under PIPERAZINES 1995-2015
HN = 2016 (1995)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068180

*NEWRECORD
RECTYPE = D
MH = Prunus dulcis
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Almond Tree|T002|NON|EQV|NLM (2002)|010524|abcdef
ENTRY = Almonds|T002|T168|NON|NRW|NLM (2002)|010524|abbcdef
ENTRY = Amygdalus communis|T002|NON|EQV|NLM (2016)|150203|abcdef
ENTRY = Prunis communis|T002|NON|EQV|NLM (2016)|150203|abcdef
ENTRY = Prunus amygdalus|T002|NON|EQV|NLM (2016)|150203|abcdef
ENTRY = Sweet Almond|T002|NON|EQV|NLM (2016)|150203|abcdef
ENTRY = Almond
ENTRY = Almond Trees
ENTRY = Almond, Sweet
ENTRY = Almonds, Sweet
ENTRY = Sweet Almonds
ENTRY = Tree, Almond
ENTRY = Trees, Almond
MN = B01.650.940.800.575.100.842.500.625.500
MH_TH = NLM (2016)
ST = T002
PI = Prunus (2001-2015)
MS = A plant species in the family ROSACEAE, genus Prunus which produces edible seeds called almonds.
PM = 2016; for ALMONDS see PRUNUS 2002-2015
HN = 2016; for ALMONDS use PRUNUS 2002-2015
MR = 20150612
DA = 20150701
DC = 1
DX = 20160101
UI = D000068181

*NEWRECORD
RECTYPE = D
MH = Albumin-Bound Paclitaxel
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = ABI-007|T109|T121|LAB|NRW|NLM (2002)|021015|abbcdef
ENTRY = ABI007|T109|T121|LAB|NRW|NLM (2002)|021015|abbcdef
ENTRY = Abraxane|T109|T121|TRD|NRW|NLM (2005)|050126|abbcdef
ENTRY = Protein-Bound Paclitaxel|T109|T121|NON|EQV|NLM (2016)|150209|abbcdef
ENTRY = ABI 007
ENTRY = Albumin Bound Paclitaxel
ENTRY = Paclitaxel, Albumin-Bound
ENTRY = Paclitaxel, Protein-Bound
ENTRY = Protein Bound Paclitaxel
MN = D02.455.426.392.368.242.888.777.500
MN = D02.455.849.291.850.777.500
MN = D12.776.034.073
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = An injectable formulation of albumin-bound paclitaxel NANOPARTICLES.
PM = 2016; ALBUMIN-BOUND PACLITAXEL was indexed under ALBUMINS and PACLITAXEL 2005-2015, and under TAXOIDS 2002-2005
HN = 2016 (2002)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068196

*NEWRECORD
RECTYPE = D
MH = Child Protective Services
AQ = CL EC ED ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Child Welfare Agencies|T057|NON|EQV|NLM (2016)|OBSSR (2016)|141031|abcdeef
ENTRY = Child Protective Service
ENTRY = Child Welfare Agency
ENTRY = Welfare Agency, Child
MN = I01.409.418.500
MN = N03.540.400.500
FX = Social Work
MH_TH = NLM (2010)
ST = T057
MS = Local governmental offices which investigate reports of abuse and neglect of children, and act to assure a safe environment for minors.
PM = 2016; see CHILD WELFARE 2010-2015
HN = 2016 (2010); use CHILD WELFARE 2010-2015
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000068216

*NEWRECORD
RECTYPE = D
MH = Social Workers
AQ = CL ED HI LJ PX SN
ENTRY = Social Worker
ENTRY = Worker, Social
ENTRY = Workers, Social
MN = M01.526.919
MH_TH = BIOETHICS (1976)
ST = T097
PI = Social Work (2010-2015)
MS = Professionals who work with persons affected by social disadvantages such as POVERTY; mental and physical illness or disability, and social injustice.  Their focus is on both the individual and his or her environment, including violations of their civil liberties and human rights.
PM = 2016; see SOCIAL WORK 1976-2015
HN = 2016 (1976); use SOCIAL WORK 1976-2015
MR = 20150707
DA = 20150707
DC = 1
DX = 20160101
UI = D000068217

*NEWRECORD
RECTYPE = D
MH = Prunus africana
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = African Prune|T002|NON|EQV|NLM (2003)|010924|abcdef
PRINT ENTRY = Prune, African|T002|NON|EQV|NLM (2003)|010924|abcdef
ENTRY = Pygeum africanum|T002|NON|EQV|NLM (2003)|010924|abcdef
ENTRY = African Prunes
ENTRY = Prunes, African
MN = B01.650.940.800.575.100.842.500.625.250
MH_TH = NLM (2003)
ST = T002
MS = A plant species in the family ROSACEAE. The bark extract known as pygeum is an ingredient in FOLK REMEDIES.
PM = 2016 (2002); see PYGEUM 2002-2015; for PYGEUM AFRICANUM see PYGEUM 2002-2015; for AFRICAN PRUNE see PYGEUM 2002-2015
HN = 2016 (2002)
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068218

*NEWRECORD
RECTYPE = D
MH = Prunus armeniaca
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Apricot|T168|NON|NRW|NLM (1983)|970206|abcdef
ENTRY = Apricot Tree|T002|NON|EQV|NLM (2002)|010524|abcdef
ENTRY = Apricots|T168|NON|NRW|NLM (2002)|010524|abcdef
ENTRY = Apricot Trees
ENTRY = Tree, Apricot
ENTRY = Trees, Apricot
MN = B01.650.940.800.575.100.842.500.625.375
MH_TH = NLM (2002)
ST = T002
PI = Prunus (2001-2015)
MS = A plant species in the family ROSACEAE. It is the source of apricot fruit.
PM = 2016; see PRUNUS 2002-2015; for APRICOT see PRUNUS 2002-2015 and ROSALES 1998-2001
HN = 2016; use PRUNUS 2002-2015; for APRICOT use PRUNUS 2002-2015 and ROSALES 1998-2001
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068219

*NEWRECORD
RECTYPE = D
MH = Prunus avium
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Black Cherry|T002|NON|NRW|NLM (2015)|140204|abcdef
ENTRY = Pie Cherry|T002|NON|NRW|NLM (2016)|150205|abcdef
ENTRY = Prunus cerasus|T002|NON|NRW|NLM (2016)|150205|abcdef
ENTRY = Prunus serotina|T002|NON|NRW|NLM (2015)|140204|abcdef
ENTRY = Sour Cherry|T002|NON|NRW|NLM (2016)|150205|abcdef
ENTRY = Sweet Cherries|T001|T168|NON|NRW|NLM (2016)|150206|abbcdef
ENTRY = Sweet Cherry Tree|T002|NON|EQV|NLM (2016)|150205|abcdef
ENTRY = Black Cherries
ENTRY = Cherries, Black
ENTRY = Cherries, Pie
ENTRY = Cherries, Sour
ENTRY = Cherries, Sweet
ENTRY = Cherry Tree, Sweet
ENTRY = Cherry Trees, Sweet
ENTRY = Cherry, Black
ENTRY = Cherry, Pie
ENTRY = Cherry, Sour
ENTRY = Cherry, Sweet
ENTRY = Pie Cherries
ENTRY = Sour Cherries
ENTRY = Sweet Cherry
ENTRY = Sweet Cherry Trees
ENTRY = Tree, Sweet Cherry
ENTRY = Trees, Sweet Cherry
MN = B01.650.940.800.575.100.842.500.625.400
MH_TH = NLM (2016)
ST = T002
PI = Prunus (2001-2015)
MS = A plant species in the family ROSACEAE. It is the source of the sweet cherry fruit.
PM = 2016; for PRUNUS SEROTINA see PRUNUS 2002-2015
HN = 2016; for PRUNUS SEROTINA use PRUNUS 2002-2015
MR = 20150612
DA = 20150701
DC = 1
DX = 20160101
UI = D000068220

*NEWRECORD
RECTYPE = D
MH = Refugium
ENTRY = Refugia|T070|NON|EQV|NLM (2016)|150206|abcdef
MN = G16.500.275.683
MN = G16.500.819
MH_TH = NLM (2016)
ST = T070
MS = Area in an environment in which a population of organisms can survive through a period of unfavorable conditions.
PM = 2016
HN = 2016
MR = 20150624
DA = 20150701
DC = 1
DX = 20160101
UI = D000068236

*NEWRECORD
RECTYPE = D
MH = Distance Counseling
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = E-Counseling|T057|NON|EQV|NLM (2016)|150206|abcdef
ENTRY = E-Therapy|T057|NON|EQV|NLM (2016)|150618|abcdef
ENTRY = Counseling, Distance
ENTRY = E Counseling
ENTRY = E Therapy
ENTRY = E-Therapies
MN = F02.784.176.350
MN = F04.408.413.437
MN = N02.421.143.303.175
MN = N02.421.461.363.437
MN = N04.452.758.849.550.500
MH_TH = NLM (2016)
ST = T057
PI = Counseling (2005-2015)
MS = Counseling conducted via electronic or other non-face-to-face interactions.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000068237

*NEWRECORD
RECTYPE = D
MH = Lubiprostone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amitiza|T119|T121|TRD|BRD|NLM (2006)|060516|abbcdef
ENTRY = Prostan-1-oic acid, 16,16-difluoro-11-hydroxy-9,15-dioxo-, (11alpha)-|T119|T121|EQV|NLM (2007)|070530|abbdef
ENTRY = RU 0211|T119|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = RU-0211|T119|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = RU0211|T119|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = SPI 0211|T119|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = SPI-0211|T119|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = SPI0211|T119|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = 0211, RU
ENTRY = 0211, SPI
MN = D10.251.355.325.050.500
MH_TH = NLM (2016)
ST = T119
ST = T121
N1 = 7-((1R,4R,6R,9R)-4-(1,1-difluoropentyl)-4-hydroxy-8-oxo-5-oxabicyclo(4.3.0)non-9-yl)heptanoic acid
RN = 7662KG2R6K
MS = Member of a bicyclic fatty acid class of compounds derived from PROSTAGLANDIN E1 involved in chloride channel gating.
PM = 2016; LUBIPROSTONE was indexed under ALPROSTADIL 2005-2015
HN = 2016 (2005)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000068238

*NEWRECORD
RECTYPE = D
MH = Prunus persica
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Peach|T002|T168|NON|REL|NLM (2002)|010315|abbcdef
ENTRY = Peach Tree|T002|NON|EQV|NLM (2002)|010524|abcdef
ENTRY = Peaches|T002|T168|NON|REL|NLM (2002)|010524|abbcdef
ENTRY = Peach Trees
ENTRY = Tree, Peach
ENTRY = Trees, Peach
MN = B01.650.940.800.575.100.842.500.625.750
MH_TH = NLM (2002)
ST = T002
PI = Prunus (2001-2015)
MS = A plant species in the family ROSACEAE. It is a tree that produces peach fruit.
PM = 2016; see PRUNUS 2002-2015; for PEACH see PRUNUS 2002-2015
HN = 2016; use PRUNUS 2002-2015; for PEACH use PRUNUS 2002-2015
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068239

*NEWRECORD
RECTYPE = D
MH = Data Anonymization
AQ = ES HI LJ PX ST TR
ENTRY = Data Masking|T066|NON|NRW|NLM (2016)|150206|abcdef
ENTRY = Anonymization, Data
ENTRY = Masking, Data
MN = H01.770.644.205
MN = L01.209.500
MN = N03.706.437.650.124.160
MN = N04.452.910.200.500
FX = Personally Identifiable Information
MH_TH = NLM (2016)
ST = T170
MS = Making information permanently non-identifiable that is associated with the identity of specific entities via encryption or other methods.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150706
DC = 1
DX = 20160101
UI = D000068240

*NEWRECORD
RECTYPE = D
MH = Personally Identifiable Information
AQ = CL EC ED ES HI LJ MA MT OG SD SN ST TD UT
MN = I01.880.604.583.080.660
FX = Data Anonymization
MH_TH = NLM (2016)
ST = T169
MS = Information that can be used to distinguish or trace an individuals identity, either alone or when combined with other personal or identifying information that is linked or linkable to a specific individual.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150706
DC = 1
DX = 20160101
UI = D000068241

*NEWRECORD
RECTYPE = D
MH = Prunus domestica
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Plum|T002|T168|NON|REL|NLM (2002)|010315|abbcdef
ENTRY = Cherry Plum Tree|T002|NON|REL|NLM (2016)|150121|abcdef
ENTRY = Japanese Plum|T002|NON|REL|NLM (2016)|150206|abcdef
ENTRY = Plum Tree|T002|NON|EQV|NLM (2016)|150206|abcdef
ENTRY = Plums|T002|T168|NON|REL|NLM (2002)|010524|abbcdef
ENTRY = Prunus cerasifera|T002|NON|REL|NLM (2016)|150121|abcdef
ENTRY = Prunus salicina|T002|NON|REL|NLM (2016)|150206|abcdef
ENTRY = Cherry Plum Trees
ENTRY = Japanese Plums
ENTRY = Plum Tree, Cherry
ENTRY = Plum Trees
ENTRY = Plum Trees, Cherry
ENTRY = Plum, Japanese
ENTRY = Plums, Japanese
ENTRY = Prunus salicinas
ENTRY = Tree, Cherry Plum
ENTRY = Tree, Plum
ENTRY = Trees, Cherry Plum
ENTRY = Trees, Plum
ENTRY = salicina, Prunus
ENTRY = salicinas, Prunus
MN = B01.650.940.800.575.100.842.500.625.450
MH_TH = NLM (2016)
ST = T002
PI = Prunus (2001-2015)
MS = A plant species in the family ROSACEAE. It is a tree that produces fruits called plums.
PM = 2016; for PRUNUS CERASIFERA see PRUNUS 2002-2015; for PLUM see PRUNUS 2002-2015
HN = 2016; for PRUNUS CERASIFERA use PRUNUS 2002-2015; for PLUM use PRUNUS 2002-2015
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068242

*NEWRECORD
RECTYPE = D
MH = Darbepoetin alfa
AQ = AD AE AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
ENTRY = Aranesp|T116|T121|TRD|NRW|NLM (2016)|020225|abbcdef
ENTRY = Aranest|T116|T121|TRD|NRW|NLM (2016)|041210|abbcdef
ENTRY = Darbepoietin alfa|T116|T121|NON|EQV|NLM (2016)|150209|abbcdef
ENTRY = KRN 321|T116|T123|LAB|NRW|NLM (2006)|060814|abbcdef
ENTRY = KRN-321|T116|T123|LAB|NRW|NLM (2006)|060814|abbcdef
ENTRY = KRN321|T116|T123|LAB|NRW|NLM (2006)|060814|abbcdef
ENTRY = NESP|T116|T121|ACR|EQV|NLM (2016)|150526|abbcdef
ENTRY = Novel Erythropoiesis Stimulating Protein|T116|T121|NON|EQV|NLM (2016)|150209|abbcdef
MN = D12.776.395.240.150.500
MH_TH = NLM (2016)
ST = T116
ST = T121
N1 = 30-l-Asparagine-32-l-threonine-87-l-valine-88-l-asparagine-90-l-threonineerythropoietin (human)
RN = 15UQ94PT4P
RR = 209810-58-2 (darbepoetin alfa)
MS = A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA.
PM = 2016; DARBEPOETIN ALFA was indexed under ERYTHROPOIETIN 2000-2015
HN = 2016 (2000)
MR = 20151006
DA = 20150710
DC = 1
DX = 20160101
UI = D000068256

*NEWRECORD
RECTYPE = D
MH = Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Atripla|T114|TRD|NRW|NLM (2010)|UK|US|100709|abcdeeef
MN = D02.705.429.906.125
MN = D03.383.533.375
MN = D03.383.742.680.245.500.600.125
MN = D03.438.759.138.881.125
MN = D26.310.375
FX = Antiretroviral Therapy, Highly Active
MH_TH = NLM (2016)
ST = T114
RN = 0
MS = Inhibitor or Reverse Transcriptases or of RNA-dIrected DNA polymerase.
PM = 2016; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination was indexed under ADENINE 2007-2015, under DEOXYCYTIDINE 2007-2015, under OXAZINES 2007-2015, under ORGANOPHOSPHATES 2007-2015, and under DRUG COMBINATIONS 2007-2015
HN = 2016 (2007)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000068257

*NEWRECORD
RECTYPE = D
MH = Bevacizumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = Avastin|T121|T129|TRD|NRW|NLM (2003)|030310|abbcdef
MN = D12.776.124.486.485.114.224.060.375
MH_TH = NLM (2016)
ST = T121
ST = T129
RN = 2S9ZZM9Q9V
MS = An anti-VEGF recombinant monoclonal antibody consisting of humanized murine antibody. It inhibits VEGF receptors and prevents the proliferation of blood vessels.
PM = 2016; BEVACIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2015, and under ANTIBODIES, MONOCLONAL 2002-2011
HN = 2016 (2002)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000068258

*NEWRECORD
RECTYPE = D
MH = Giraffes
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Okapis|T015|NON|NRW|NLM (2016)|OBSSR (2016)|150210|abcdeef
ENTRY = Giraffe
ENTRY = Okapi
MN = B01.050.150.900.649.077.380.443
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T015
PI = Artiodactyla (1963-2015)
MS = Four-legged hoofed mammals with extremely long necks and legs belonging to the family Giraffidae.
PM = 2016
HN = 2016
MR = 20150522
DA = 20150701
DC = 1
DX = 20160101
UI = D000068276

*NEWRECORD
RECTYPE = D
MH = Risedronate Sodium
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate|T109|T121|NON|EQV|NLM (2016)|150317|abbcdef
ENTRY = 2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate|T109|T121|EQV|NLM (2005)|050719|abbdef
ENTRY = 2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate|T109|T121|EQV|NLM (1992)|abbde
ENTRY = Actonel|T115|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|UK|US|991228|abbcdeeeeeeeef
ENTRY = Atelvia|T115|T121|TRD|NRW|NLM (2011)|110516|abbcdef
ENTRY = Bisphosphate Risedronate Sodium|T115|T121|NON|NRW|NLM (2016)|150211|abbcdef
ENTRY = Risedronate|T109|T121|NON|EQV|NLM (1992)|150211|abbcdef
ENTRY = Risedronic Acid|T109|T121|NON|BRD|NLM (1992)|150211|abbcdef
ENTRY = Risedronic Acid, Monosodium Salt|T109|T121|NON|EQV|NLM (2016)|150211|abbcdef
ENTRY = Acid, Risedronic
ENTRY = Risedronate Sodium, Bisphosphate
ENTRY = Sodium, Bisphosphate Risedronate
ENTRY = Sodium, Risedronate
MN = D02.705.429.500.830.500
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = NLM (2016)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = OFG5EXG60L
RR = KM2Z91756Z (Risedronic Acid)
MS = An aminobisphosphonate derivative of etidronic acid and CALCIUM CHANNEL BLOCKER that inhibits BONE RESORPTION and is used for the treatment of OSTEOPOROSIS.
PM = 2016; RISEDRONATE SODIUM was indexed under ETIDRONIC ACID 2014-2015
HN = 2016 (2014)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068296

*NEWRECORD
RECTYPE = D
MH = Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Advair|T110|T121|TRD|NRW|NLM (2001)|010330|abbcdef
ENTRY = Advair Diskus|T110|T121|TRD|NRW|NLM (2016)|150211|abbcdef
ENTRY = Advair HFA|T110|T121|TRD|NRW|NLM (2016)|150211|abbcdef
ENTRY = Fluticasone - Salmeterol|T110|T121|NON|EQV|NLM (2016)|150211|abbcdef
ENTRY = Fluticasone Propionate - Salmeterol|T110|T121|NON|EQV|NLM (2016)|150211|abbcdef
ENTRY = Fluticasone Propionate - Salmeterol Combination|T110|T121|NON|EQV|NLM (2016)|150211|abbcdef
ENTRY = Fluticasone Propionate - Salmeterol Xinafoate|T110|T121|NON|EQV|NLM (2016)|150211|abbcdef
ENTRY = Fluticasone Propionate-Salmeterol Drug Combination|T110|T121|NON|EQV|NLM (2016)|150914|abbcdef
ENTRY = Fluticasone Propionate-Salmeterol Xinafoate Combination|T110|T121|NON|EQV|NLM (2016)|150211|abbcdef
ENTRY = Fluticasone Propionate-Salmeterol Xinafoate Drug Combination|T110|T121|NON|EQV|NLM (2016)|150311|abbcdef
ENTRY = Fluticasone-Salmeterol Combination|T110|T121|NON|EQV|NLM (2016)|150211|abbcdef
ENTRY = Fluticasone-Salmeterol Drug Combination|T110|T121|NON|EQV|NLM (2016)|150317|abbcdef
ENTRY = Seretide|T110|T121|TRD|NRW|NLM (2001)|010330|abbcdef
ENTRY = Combination, Fluticasone-Salmeterol
ENTRY = Combination, Fluticasone-Salmeterol Drug
ENTRY = Drug Combination, Fluticasone-Salmeterol
ENTRY = Fluticasone Propionate Salmeterol
ENTRY = Fluticasone Propionate Salmeterol Combination
ENTRY = Fluticasone Propionate Salmeterol Drug Combination
ENTRY = Fluticasone Propionate Salmeterol Xinafoate
ENTRY = Fluticasone Propionate Salmeterol Xinafoate Combination
ENTRY = Fluticasone Propionate Salmeterol Xinafoate Drug Combination
ENTRY = Fluticasone Salmeterol
ENTRY = Fluticasone Salmeterol Combination
ENTRY = Fluticasone Salmeterol Drug Combination
MN = D02.033.100.291.057.750.500
MN = D02.092.063.291.057.750.500
MN = D02.092.471.683.061.750.500
MN = D04.808.054.079.129.114.500
MN = D26.310.438
MH_TH = NLM (2016)
ST = T110
ST = T121
RN = 0
MS = A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
PM = 2016; FLUTICASONE PROPRIONATE-SALMETEROL XINAFOATE DRUG COMBINATION was indexed under ALBUTEROL 2001-2015; and under ANDROSTADIENES 2001-2015.
HN = 2016 (2001)
MR = 20150914
DA = 20150701
DC = 1
DX = 20160101
UI = D000068297

*NEWRECORD
RECTYPE = D
MH = Fluticasone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cutivate|T109|T121|TRD|NRW|NLM (1990)|abbcde
ENTRY = Flixonase|T109|T121|TRD|NRW|NLM (2000)|000714|abbcdef
ENTRY = Flixotide|T109|T121|TRD|NRW|NLM (1990)|abbcde
ENTRY = Flonase|T109|T121|TRD|NRW|NLM (1990)|abbcde
ENTRY = Flovent|T109|T121|TRD|NRW|NLM (2000)|000428|abbcdef
ENTRY = Flovent HFA|T109|T121|TRD|NRW|NLM (2016)|150326|abbcdef
ENTRY = Fluticasone Propionate|T109|T121|NON|NRW|NLM (2016)|150211|abbcdef
ENTRY = HFA, Flovent
ENTRY = Propionate, Fluticasone
MN = D04.808.054.079.129.114
MH_TH = NLM (2016)
ST = T110
ST = T121
RN = CUT2W21N7U
MS = A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.
PM = 2016; FLUTICASONE was indexed under ANDROSTADIENES 1990-2015
HN = 2016 (1990)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068298

*NEWRECORD
RECTYPE = D
MH = Salmeterol Xinafoate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Salmeterol|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2016)|USAN (1985)|150211|abbcdeeeef
ENTRY = Serevent|T109|T121|TRD|NRW|NLM (1989)|abbcde
ENTRY = Xinafoate, Salmeterol
MN = D02.033.100.291.057.750
MN = D02.092.063.291.057.750
MN = D02.092.471.683.061.750
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1989)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 6EW8Q962A5
RR = 2I4BC502BT (Salmeterol)
MS = A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
PM = 2016; SALMETEROL XINAFOATE was indexed under ALBUTEROL 1989-2015
HN = 2016 (1989)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068299

*NEWRECORD
RECTYPE = D
MH = Parks, Recreational
AQ = CL EC HI LJ SN ST
ENTRY = Community Parks|T083|NON|REL|NLM (2016)|150501|abcdef
ENTRY = National Parks|T083|NON|REL|NLM (2016)|150501|abcdef
ENTRY = Urban Parks|T083|NON|REL|NLM (2016)|150501|abcdef
ENTRY = Community Park
ENTRY = National Park
ENTRY = Park, Community
ENTRY = Park, National
ENTRY = Park, Recreational
ENTRY = Park, Urban
ENTRY = Parks, Community
ENTRY = Parks, National
ENTRY = Parks, Urban
ENTRY = Recreational Park
ENTRY = Recreational Parks
ENTRY = Urban Park
MN = N06.850.860.410.375
MH_TH = NLM (2016)
ST = T083
PI = Recreation (1989-2015)
MS = An area of land open to the public for enjoyment.
PM = 2016
HN = 2016
MR = 20150522
DA = 20150701
DC = 1
DX = 20160101
UI = D000068316

*NEWRECORD
RECTYPE = D
MH = Warfare and Armed Conflicts
AQ = CL EC EH ES HI LJ PC PX SN TD
ENTRY = Armed Conflicts and Warfare|T068|NON|EQV|NLM (2016)|150212|abcdef
MN = I01.880.735.950
MH_TH = NLM (2016)
ST = T068
AN = used for searching; INDEXER: Do not use; CATALOGER: Do not use
MS = Engaging in any type of conflict including war or military conflict against another nation or organized group..
PM = 2016
HN = 2016
MR = 20150701
DA = 20150701
DC = 1
DX = 20160101
UI = D000068336

*NEWRECORD
RECTYPE = D
MH = Armed Conflicts
AQ = CL EC EH ES HI LJ PC PX SN TD
ENTRY = Armed Conflict
ENTRY = Conflict, Armed
ENTRY = Conflicts, Armed
MN = I01.880.735.950.250
MH_TH = NLM (2016)
ST = T068
MS = Any differences arising between two nations or groups and leading to the intervention of armed forces.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000068337

*NEWRECORD
RECTYPE = D
MH = Everolimus
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 40-O-(2-hydroxyethyl)-rapamycin|T109|T121|EQV|NLM (1997)|abbde
ENTRY = Afinitor|T109|T121|TRD|NRW|NLM (2016)|150212|abbcdef
ENTRY = Certican|T109|T121|TRD|NRW|NLM (2003)|030310|abbcdef
ENTRY = RAD 001|T109|T121|LAB|NRW|NLM (2001)|010105|abbcdef
ENTRY = RAD001|T109|T121|LAB|NRW|NLM (2009)|090708|abbcdef
ENTRY = SDZ RAD|T109|T121|EQV|NLM (1997)|abbde
ENTRY = SDZ-RAD|T109|T121|EQV|NLM (2003)|030623|abbdef
ENTRY = 001, RAD
ENTRY = RAD, SDZ
MN = D02.540.505.760.500
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 9HW64Q8G6G
MS = A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT.
PM = 2016; EVEROLIMUS was indexed under SIROLIMUS 1998-2015; and under POLYENES 1997-1998
HN = 2016 (1997)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068338

*NEWRECORD
RECTYPE = D
MH = Aspirin, Dipyridamole Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aggrenox|T109|T121|TRD|NRW|NLM (2000)|000323|abbcdef
ENTRY = Asasantin|T109|T121|TRD|NRW|NLM (1986)|abbcde
ENTRY = Asasantin Retard|T109|T121|TRD|NRW|NLM (2000)|000323|abbcdef
ENTRY = Aspirin-Dipyridamole Drug Combination|T109|T121|NON|EQV|NLM (2016)|150311|abbcdef
ENTRY = Extended-Release Dipyridamole-Aspirin|T109|T121|NON|NRW|NLM (2016)|150212|abbcdef
ENTRY = TX 3301|T109|T121|LAB|NRW|NLM (1986)|abbcde
ENTRY = TX-3301|T109|T121|NRW|NLM (1986)|abbde
ENTRY = 3301, TX
ENTRY = Aspirin Dipyridamole Drug Combination
ENTRY = Combination, Aspirin-Dipyridamole Drug
ENTRY = Dipyridamole-Aspirin, Extended-Release
ENTRY = Drug Combination, Aspirin-Dipyridamole
ENTRY = Extended Release Dipyridamole Aspirin
ENTRY = Retard, Asasantin
MN = D02.455.426.559.389.657.410.595.176.500
MN = D03.383.742.175.500
MN = D26.310.125
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.
PM = 2016; ASPIRIN-DIPYRIDAMOLE DRUG COMBINATION was indexed under ASPIRIN and DIPYRIDAMOLE 1986-2015
HN = 2016 (1986)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068342

*NEWRECORD
RECTYPE = D
MH = Self-Control
AQ = PX
ENTRY = Self Control|T054|NON|EQV|NLM (2016)|OBSSR (2016)|150219|abcdeef
ENTRY = Self Regulation|T054|NON|EQV|NLM (2016)|OBSSR (2016)|150219|abcdeef
ENTRY = Self-Regulation|T054|NON|EQV|NLM (2016)|OBSSR (2016)|150219|abcdeef
ENTRY = Control, Self
ENTRY = Regulation, Self
MN = F01.145.813.595
FX = Temperance
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T054
MS = An individual's ability to manage and monitor their emotions, behaviors, and desires in the face of external demands in order to function in society.
PM = 2016; for SELF REGULATION see SOCIAL CONTROL, INFORMAL 1997-2015
HN = 2016; for SELF REGULATION use SOCIAL CONTROL, INFORMAL 1997-2015
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000068356

*NEWRECORD
RECTYPE = D
MH = Saline Waters
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Brackish Water|T167|NON|NRW|NLM (2016)|150615|abcdef
ENTRY = Brackish Waters
ENTRY = Saline Water
ENTRY = Water, Brackish
ENTRY = Water, Saline
ENTRY = Waters, Brackish
ENTRY = Waters, Saline
MN = G16.500.275.725
FX = Hypertonic Solutions
MH_TH = NLM (2016)
ST = T167
MS = Water from natural sources which contain significant concentrations of dissolved salts such as sodium chloride.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000068357

*NEWRECORD
RECTYPE = D
MH = Compassion Fatigue
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Secondary Trauma|T048|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Secondary Traumatic Stress|T048|NON|EQV|NLM (2016)|150220|abcdef
ENTRY = Secondary Traumatization|T048|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Vicarious Trauma|T048|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Vicarious Traumatization|T048|NON|EQV|NLM (2016)|150220|abcdef
ENTRY = Fatigue, Compassion
ENTRY = Secondary Traumas
ENTRY = Secondary Traumatizations
ENTRY = Stress, Secondary Traumatic
ENTRY = Stresses, Secondary Traumatic
ENTRY = Trauma, Secondary
ENTRY = Trauma, Vicarious
ENTRY = Traumas, Secondary
ENTRY = Traumas, Vicarious
ENTRY = Traumatic Stress, Secondary
ENTRY = Traumatization, Secondary
ENTRY = Traumatization, Vicarious
ENTRY = Traumatizations, Secondary
ENTRY = Vicarious Traumas
MN = C23.888.369.500.500
MN = F01.145.126.937.500
MN = F01.145.126.990.469
MN = F02.830.900.333
FX = Burnout, Professional
FX = Stress Disorders, Post-Traumatic
MH_TH = NLM (2016)
ST = T048
MS = Stress response that occurs in individuals working in care giving professions.
PM = 2016
HN = 2016
MR = 20150522
DA = 20150706
DC = 1
DX = 20160101
UI = D000068376

*NEWRECORD
RECTYPE = D
MH = Plantaginaceae
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Globularia|T002|NON|NRW|NLM (2003)|020328|abcdef
PRINT ENTRY = Stemodia|T002|NON|NRW|NLM (2003)|020328|abcdef
ENTRY = Speedwell Family|T002|NON|EQV|NLM (2016)|150220|abcdef
ENTRY = Families, Speedwell
ENTRY = Family, Speedwell
ENTRY = Speedwell Families
MN = B01.650.940.800.575.100.583.700
MH_TH = NLM (1998)
ST = T002
MS = A plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.
PM = 2016; for GLOBULARIA and STEMODIA see SCROPHULARIACEAE 2003-2015
HN = 2016; for GLOBULARIA and STEMODIA use SCROPHULARIACEAE 2003-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000068377

*NEWRECORD
RECTYPE = D
MH = Lamiales
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Proboscidea Plant|T002|NON|NRW|NLM (2003)|010918|abcdef
ENTRY = Plant, Proboscidea
ENTRY = Plants, Proboscidea
ENTRY = Proboscidea Plants
MN = B01.650.940.800.575.100.583
MH_TH = NLM (2016)
ST = T002
PI = Angiosperms (2004-2015)
MS = An order of the Lamiidae clade. Lamiales is one of the largest orders of flowering plants and includes pot-herbs in the mint family (MINT; SAGE; OREGANO; BASIL); SESAME, foxgloves; SNAPDRAGONS; and the olive family.
PM = 2016; for PROBOSCIDEA PLANT see PEDALIACEAE 2003-2015
HN = 2016; for PROBOSCIDEA PLANT use PEDALIACEAE 2003-2015
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068378

*NEWRECORD
RECTYPE = D
MH = Clinical Study
MN = V03.175
MH_TH = NLM (2016)
ST = T062
ST = T170
AN = This heading is used as a Publication Type for original report  of  the conduct or results of a specific clinical study. A different heading CLINICAL STUDIES AS TOPIC is used for general design, methodology, economics, etc. of clinical studies. Prefer the specifics: CLINICAL TRIAL or OBSERVATIONAL STUDY.
MS = A work that reports on the results of a research study to evaluate interventions or exposures on biomedical or health-related outcomes.  The two main types of clinical studies are interventional studies (clinical trials) and observational studies. While most clinical studies concern humans, this publication type may be used for clinical veterinary articles meeting the requisites for humans.
HN = 2016
MR = 20150629
DA = 20150701
DC = 2
DX = 20160101
UI = D000068397

*NEWRECORD
RECTYPE = D
MH = Surgical Clearance
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Medical Clearance|T058|T060|NON|EQV|NLM (2016)|OBSSR (2016)|150225|abbcdeef
ENTRY = Clearance, Medical
ENTRY = Clearance, Surgical
ENTRY = Clearances, Medical
ENTRY = Clearances, Surgical
ENTRY = Medical Clearances
ENTRY = Surgical Clearances
MN = E01.370.505
FX = Physical Examination
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T058
ST = T060
MS = Process of evaluating the health of a patient and determining if they are healthy enough for surgery.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000068436

*NEWRECORD
RECTYPE = D
MH = Pemetrexed
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alimta|T109|T121|TRD|NRW|NLM (2000)|150311|abbcdef
ENTRY = LY 231,514|T109|T121|NRW|NLM (1994)|abbde
ENTRY = LY 231514|T109|T121|LAB|NRW|NLM (1994)|abbcde
ENTRY = LY-231,514|T109|T121|NRW|NLM (1994)|abbde
ENTRY = LY-231514|T109|T121|NRW|NLM (1994)|abbde
ENTRY = LY231514|T109|T121|NRW|NLM (1994)|abbde
ENTRY = MTA|T109|T121|EQV|NLM (1999)|991221|abbdef
ENTRY = N-(4-(2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid|T109|T121|EQV|NLM (1994)|abbde
ENTRY = Pemetrexed Disodium|T109|T121|NON|NRW|NLM (2000)|150225|abbcdef
ENTRY = 231,514, LY
ENTRY = 231514, LY
ENTRY = Disodium, Pemetrexed
MN = D03.438.759.758.399.454.650
MN = D12.125.067.625.525
MN = D12.125.119.409.525
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (2001)
ST = T109
ST = T121
N1 = L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-
RN = 04Q9AIZ7NO
RR = 137281-23-3 (pemetrexed)
RR = 2PKU919BA9
MS = A guanine-derived ANTINEOPLASTIC AGENT that functions as a NUCLEIC ACID SYNTHESIS INHIBITOR through its binding to, and inhibition of, THYMIDYLATE SYNTHASE.
PM = 2016; PEMETREXED was indexed under GLUTAMATES 1994-2015, and under GUANINE 1994-2015
HN = 2016 (1994)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068437

*NEWRECORD
RECTYPE = D
MH = Brimonidine Tartrate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate|T109|T121|NON|EQV|NLM (2016)|150313|abbcdef
ENTRY = 5-bromo-6-(imidazolidinylideneamino)quinoxaline|T109|T121|EQV|NLM (1978)|abbde
ENTRY = 5-bromo-6-(imidazolin-2-ylamino)quinoxaline|T109|T121|EQV|NLM (1978)|abbde
ENTRY = AGN 190342|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = AGN-190342|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = Alphagan|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|MX|NL|UK|011001|abbcdeeeeeeeeef
ENTRY = Alphagan P|T109|T121|TRD|NRW|NLM (2016)|150225|abbcdef
ENTRY = Brimonidine|T109|T121|NON|BRD|FDA SRS (2015)|NLM (1978)|USAN (19XX)|150225|abbcdeeef
ENTRY = Brimonidine Purite|T109|T121|NON|NRW|NLM (2008)|150225|abbcdef
ENTRY = Brimonidine Tartrate (1:1)|T109|T121|NON|NRW|NLM (1978)|150225|abbcdef
ENTRY = Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer|T109|T121|NON|NRW|NLM (1978)|150225|abbcdef
ENTRY = Brimonidine Tartrate, (R-(R*,R*))-Isomer|T109|T121|NON|NRW|NLM (1978)|150225|abbcdef
ENTRY = Bromoxidine|T109|T121|NON|BRD|NLM (1978)|150225|abbcdef
ENTRY = Mirvaso|T121|TRD|NRW|NLM (2014)|150225|abcdef
ENTRY = Ratio-Brimonidine|T121|TRD|NRW|CA|150225|abcdef
ENTRY = Sanrosa|T109|T121|TRD|NRW|NLM (2015)|150317|abbcdef
ENTRY = UK 14,304|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = UK 14,304-18|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = UK 14304|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = UK 14308|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = UK-14,304-18|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = UK-14,308|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = UK-14304|T109|T121|LAB|NRW|NLM (1978)|abbcde
ENTRY = 190342, AGN
ENTRY = AGN190342
ENTRY = Purite, Brimonidine
ENTRY = Ratio Brimonidine
ENTRY = RatioBrimonidine
ENTRY = Tartrate, Brimonidine
ENTRY = UK 14,304 18
ENTRY = UK 14,30418
ENTRY = UK 14,308
ENTRY = UK14,30418
ENTRY = UK14,308
ENTRY = UK14304
MN = D03.438.857.070
MH_TH = NLM (1978)
MH_TH = USAN (19XX)
ST = T109
ST = T121
N1 = 6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-
RN = 4S9CL2DY2H
RR = 59803-98-4
RR = 59803-99-5
RR = 70359-46-5
RR = 79570-19-7
RR = E6GNX3HHTE
MS = A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
PM = 2016; BRIMONIDINE TARTRATE was indexed under QUINOXALINES 1980-2015, and under IMIDAZOLES 1978-1980
HN = 2016 (1978)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068438

*NEWRECORD
RECTYPE = D
MH = Clinical Studies as Topic
AQ = CL EC ES HI IS LJ MT PX SN ST UT VE
MN = E05.318.760.250
MN = N05.715.360.775.088
MN = N06.850.520.450.250
MH_TH = NLM (2016)
ST = T062
ST = T170
AN = for general design, methodology, economics, etc. of clinical studies; a different heading CLINICAL STUDY is used for reports of a specific clinical study
MS = Works about research studies that evaluate interventions or exposures on biomedical or health-related outcomes.  The two main types of clinical studies are interventional studies (clinical trials) and observational studies.
PM = 2016 (1963)
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000068456

*NEWRECORD
RECTYPE = D
MH = Beijing
AQ = EH EP
ENTRY = Peking|T083|NAM|EQV|NLM (2016)|150301|abcdef
MN = Z01.252.474.164.225
MN = Z01.433.114
MH_TH = NLM (2016)
ST = T083
PI = China (1966-2015)
MS = Capital of CHINA.
HN = 2016
MR = 20150527
DA = 20150701
DC = 4
DX = 20160101
UI = D000068476

*NEWRECORD
RECTYPE = D
MH = African Union
AQ = EC HI OG ST
ENTRY = Union, African
MN = I01.615.500.125
MN = N03.540.089
MH_TH = NLM (2016)
ST = T092
AN = Cataloger: Use NAF entry
MS = A geopolitical organization of African nations with a mission to integrate vital interests, promote international relations, political stability, and economic development among member states.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000068516

*NEWRECORD
RECTYPE = D
MH = Firmicutes
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.353
MH_TH = NLM (2016)
ST = T007
PI = Gram-Positive Bacteria (2004-2015)
MS = A phylum of predominantly GRAM-POSITIVE BACTERIA that includes the orders Bacillales and Clostridiales. Firmicutes and BACTEROIDETES are the two bacterial phyla that constitute the majority of the human gut MICROBIOTA.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150707
DC = 1
DX = 20160101
UI = D000068536

*NEWRECORD
RECTYPE = D
MH = Dutasteride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 17beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one|T110|T121|EQV|NLM (1997)|abbde
ENTRY = Avodart|T109|T121|TRD|NRW|DE|US|041214|abbcdeef
ENTRY = GG 745|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = GG-745|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = GG745|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = GI198745|T109|T121|LAB|NRW|NLM (2001)|010919|abbcdef
ENTRY = 745, GG
MN = D04.808.925.100.125
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (1997)
MH_TH = USAN (19XX)
ST = T110
ST = T121
RN = O0J6XJN02I
RR = 164656-23-9
MS = A 5-ALPHA-REDUCTASE INHIBITOR that is reported to inhibit both type-1 and type2 isoforms of the enzyme and is used to treat BENIGN PROSTATIC HYPERPLASIA.
PM = 2016; DUTASTERIDE was indexed under AZASTEROIDS 1998-2015.
HN = 2016 (1998)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068538

*NEWRECORD
RECTYPE = D
MH = Calceolariaceae
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Calceolaria|T002|NON|NRW|NLM (2004)|030506|abcdef
ENTRY = Jovellana|T002|NON|NRW|NLM (2016)|150304|abcdef
ENTRY = Porodittia|T002|NON|NRW|NLM (2016)|150304|abcdef
MN = B01.650.940.800.575.100.583.190
MH_TH = NLM (2016)
ST = T002
MS = A family in the order Lamiales with several species that are used in TRADITIONAL MEDICINE.
PM = 2016; for CALCEOLARIA see SCROPHULARIACEAE 2004-2015
HN = 2016; for CALCEOLARIA use SCROPHULARIACEAE 2004-2015
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068543

*NEWRECORD
RECTYPE = D
MH = Interferon beta-1a
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Avonex|T116|T121|TRD|NRW|NLM (1994)|abbcde
ENTRY = Avonex Pen|T116|T121|TRD|NRW|NLM (2016)|150305|abbcdef
ENTRY = Interferon beta 1a|T116|T121|T129|NON|EQV|NLM (2016)|150429|abbbcdef
ENTRY = Rebif|T116|T121|TRD|NRW|NLM (1994)|US|abbcdee
ENTRY = 1a, Interferon beta
ENTRY = Pen, Avonex
ENTRY = beta 1a, Interferon
ENTRY = beta-1a, Interferon
MN = D12.644.276.374.440.890.275.500
MN = D12.776.467.374.440.890.275.500
MN = D23.529.374.440.890.275.500
MH_TH = NLM (2016)
ST = T116
ST = T121
ST = T129
RN = XRO4566Q4R
RR = 145258-61-3
RR = 74899-71-1
MS = An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.
PM = 2016; INTERFERON BETA 1A was indexed under INTERFERON-BETA 1994-2015
HN = 2016 (1994)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068556

*NEWRECORD
RECTYPE = D
MH = Olmesartan Medoxomil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346|T109|T121|NON|EQV|NLM (2016)|150317|abbcdef
ENTRY = Benicar|T109|T121|TRD|NRW|US|020509|abbcdef
ENTRY = Benicar HCT|T109|T121|TRD|NRW|NLM (2016)|150305|abbcdef
ENTRY = CS 866|T109|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = CS-866|T109|T121|NRW|NLM (1996)|abbde
ENTRY = Olmetec|T109|T121|TRD|NRW|DE|040420|abbcdef
ENTRY = Votum|T109|T121|TRD|NRW|DE|040420|abbcdef
ENTRY = 866, CS
ENTRY = HCT, Benicar
ENTRY = Medoxomil, Olmesartan
MN = D03.383.129.308.674
MN = D03.383.129.617.584
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (2001)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 6M97XTV3HD
RR = 144689-24-7 (olmesartan medoxomil)
MS = An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.
PM = 2016;  OLMESARTAN MEDOXOMIL was  indexed under IMIDAZOLES 1996-2015, and under TETRAZOLES 1996-2015
HN = 2016 (1996)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068557

*NEWRECORD
RECTYPE = D
MH = Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amlodipine Besylate, Olmesartan Medoxomil|T109|T121|NON|EQV|NLM (2016)|150305|abbcdef
ENTRY = Amlodipine Besylate-Olmesartan Medoxomil|T109|T121|NON|EQV|NLM (2016)|150312|abbcdef
ENTRY = Amlodipine Besylate-Olmesartan Medoxomil Drug Combination|T109|T121|NON|EQV|NLM (2016)|150312|abbcdef
ENTRY = Azor|T109|T121|TRD|NRW|NLM (2016)|150305|abbcdef
ENTRY = Amlodipine Besylate Olmesartan Medoxomil
ENTRY = Amlodipine Besylate Olmesartan Medoxomil Drug Combination
ENTRY = Besylate-Olmesartan Medoxomil, Amlodipine
ENTRY = Medoxomil, Amlodipine Besylate-Olmesartan
MN = D03.383.129.308.674.500
MN = D03.383.129.617.584.500
MN = D03.383.725.203.065.500
MN = D26.310.063
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
PI = Amlodipine (2010-2015)
PI = Antihypertensive Agents (2012-2015)
MS = A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil  that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION.
PM = 2016
HN = 2016
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068558

*NEWRECORD
RECTYPE = D
MH = Interferon beta-1b
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Beta-IFN-1b|T116|T121|ABB|EQV|NLM (1985)|150306|abbcdef
ENTRY = Beta-Seron|T116|T121|TRD|NRW|NLM (1985)|abbcde
ENTRY = Betaferon|T116|T121|TRD|NRW|NLM (2001)|010524|abbcdef
ENTRY = Betaseron|T116|T121|TRD|NRW|NLM (1985)|abbcde
ENTRY = Extavia|T116|T121|TRD|NRW|NLM (2011)|101201|abbcdef
ENTRY = IFN-Beta Ser|T116|T121|ABB|EQV|NLM (1985)|150306|abbcdef
ENTRY = Interferon Beta, Ser(17)|T116|T121|ABX|EQV|NLM (1985)|150306|abbcdef
ENTRY = Interferon Beta, Serine(17)|T116|T121|NON|EQV|NLM (1985)|150306|abbcdef
ENTRY = Interferon beta 1b|T116|T121|NON|EQV|NLM (2016)|150429|abbcdef
ENTRY = Ser(17) IFN-beta|T116|T121|EQV|NLM (1985)|abbde
ENTRY = Serine(17) Interferon Beta|T116|T121|NON|EQV|NLM (1985)|150306|abbcdef
ENTRY = 1b, Interferon beta
ENTRY = Beta Seron
ENTRY = beta 1b, Interferon
ENTRY = beta-1b, Interferon
MN = D12.644.276.374.440.890.275.750
MN = D12.776.467.374.440.890.275.750
MN = D23.529.374.440.890.275.750
MH_TH = NLM (2016)
ST = T116
ST = T121
RN = 145155-23-3
MS = A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.
PM = 2016; INTERFERON BETA-1B was previously indexed under INTERFERON BETA, 1991-2015; RECOMBINANT PROTEINS, 1988-1991; and under INTERFERON TYPE I, 1985-1988
HN = 2016 (1985)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068576

*NEWRECORD
RECTYPE = D
MH = Nebivolol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol|T109|T121|NON|EQV|NLM (1987)|150317|abbcdef
ENTRY = Bystolic|T109|T121|TRD|NRW|NLM (2016)|150306|abbcdef
ENTRY = Lobivon|T109|T121|TRD|NRW|ES|040324|abbcdef
ENTRY = Nebilet|T109|T121|TRD|NRW|DE|IE|NL|UK|040324|abbcdeeeef
ENTRY = Nebivolol Hydrochloride|T109|T121|NON|NRW|FDA SRS (2013)|NLM (2004)|NLM (2011)|USAN (19XX)|150306|abbcdeeeef
ENTRY = R 67555|T109|T121|LAB|BRD|NLM (1987)|abbcde
ENTRY = R-67555|T109|T121|LAB|BRD|NLM (1987)|abbcde
ENTRY = Silostar|T109|T121|TRD|NRW|ES|040324|abbcdef
ENTRY = 67555, R
ENTRY = Hydrochloride, Nebivolol
ENTRY = R67555
MN = D02.033.100.291.491
MN = D02.092.063.291.503
MN = D03.383.663.283.755
MN = D03.438.150.755
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = USAN (1987)
ST = T109
ST = T121
RN = 030Y90569U
RR = 118457-14-0
RR = 169293-50-9 (nebivolol hydrochloride)
RR = 99200-09-6 (nebivolol)
RR = JGS34J7L9I
MS = A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
PM = 2016; NEBIVOLOL was indexed under BENZOPYRANS, 1987-2015; and under ETHANOLAMINES 1987-2015
HN = 2016 (1987)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068577

*NEWRECORD
RECTYPE = D
MH = Celecoxib
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide|T109|T121|NON|EQV|NLM (1997)|abbcde
ENTRY = Celebrex|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|MX|UK|US|abbcdeeeeeeeee
ENTRY = SC 58635|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = SC-58635|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = 58635, SC
ENTRY = SC58635
MN = D02.065.884.247
MN = D02.886.590.700.247
MN = D03.383.129.539.160
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (1997)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = JCX84Q7J1L
RR = 169590-42-5
MS = A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.
PM = 2016; CELECOXIB was indexed under PYRAZOLES 1997-2015, and under SULFONAMIDES 1997-2015
HN = 2016 (1997)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068579

*NEWRECORD
RECTYPE = D
MH = Varenicline
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)benzazepine|T109|T121|NON|EQV|NLM (2016)|150317|abbcdef
ENTRY = Champix|T109|TRD|NRW|NLM (2007)|070711|abcdef
ENTRY = Chantix|T109|TRD|NRW|NLM (2006)|060511|abcdef
ENTRY = Varenicline Tartrate|T109|T121|NON|NRW|FDA SRS (2015)|INN (19XX)|USAN (2009)|150306|abbcdeeef
ENTRY = Tartrate, Varenicline
MN = D03.438.079.900
MN = D03.438.857.942
FX = Tobacco Use Cessation Products
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = USAN (2005)
ST = T109
ST = T121
RN = W6HS99O8ZO
RR = 249296-44-4
RR = 375815-87-5
RR = 82269ASB48
MS = A benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
PM = 2016; VARENICLINE was indexed under BENZAZEPINES, 2005-2015 and under QUINOXALINES, 2005-2015
HN = 2016 (2005)
MR = 20150605
DA = 20150706
DC = 1
DX = 20160101
UI = D000068580

*NEWRECORD
RECTYPE = D
MH = Tadalafil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cialis|T109|T121|TRD|NRW|DE|ES|FR|IE|NL|UK|010702|abbcdeeeeeef
ENTRY = IC 351|T109|T121|LAB|NRW|NLM (2001)|010702|abbcdef
ENTRY = IC-351|T109|T121|LAB|NRW|NLM (2003)|030726|abbcdef
ENTRY = IC351|T109|T121|LAB|NRW|NLM (2001)|010702|abbcdef
ENTRY = 351, IC
MN = D03.383.725.150.500
MN = D03.438.473.155.500
MN = D03.494.154.672
FX = Sildenafil Citrate
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2002)
MH_TH = USAN (2001)
ST = T109
ST = T121
N1 = Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-
RN = 742SXX0ICT
RR = 171596-29-5
MS = A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION.
PM = 2016; TADALAFIL was indexed under CARBOLINES 2001-2015; and under PHOSPHODIESTERASE INHIBITORS 2001-2003
HN = 2016 (2001)
MR = 20150605
DA = 20150706
DC = 1
DX = 20160101
UI = D000068581

*NEWRECORD
RECTYPE = D
MH = Certolizumab Pegol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = CDP 870|T116|T121|T129|LAB|NRW|NLM (2002)|021119|abbbcdef
ENTRY = CDP870|T116|T121|T129|LAB|NRW|NLM (2002)|021119|abbbcdef
ENTRY = Cimzia|T116|T121|T129|TRD|NRW|NLM (2012)|110805|abbbcdef
ENTRY = 870, CDP
ENTRY = 870s, CDP
ENTRY = CDP 870s
ENTRY = CDP870s
ENTRY = Certolizumab Pegols
ENTRY = Cimzias
ENTRY = Pegol, Certolizumab
ENTRY = Pegols, Certolizumab
MN = D05.750.741.125
MN = D12.644.541.500.650.250
MN = D12.776.124.486.485.114.224.060.500
MN = D12.776.124.486.485.680.650.250
MN = D12.776.124.790.651.114.224.060.500
MN = D12.776.124.790.651.680.650.250
MN = D12.776.377.715.548.114.224.200.500
MN = D12.776.377.715.548.680.650.250
MN = D25.720.741.125
MN = J01.637.051.720.741.125
MH_TH = FDA SRS (2013)
MH_TH = NLM (2007)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = UMD07X179E
RR = 428863-50-7
MS = A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
PM = 2016; CERTILIZUMAB PEGOL was indexed under IMMUNOGLOBULIN FAB FRAGMENTS 2003-2015, POLYETHYLENE GLYCOLS 2003-2015, and under ANTIBODIES, MONOCLONAL, HUMANIZED 2003-2015
HN = 2016 (2003)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000068582

*NEWRECORD
RECTYPE = D
MH = Censorship, Research
ENTRY = Research Censorship
MN = I01.880.604.238
MN = K01.752.566.479.173.200
MN = N05.350.670.250
FX = Dual Use Research
FX = Ethics
MH_TH = NLM (2016)
ST = T078
MS = The act or practice of scrutinizing the practice of scientific research for the purpose of preventing or suppressing the unethical applications as well knowledge derived from it.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150706
DC = 1
DX = 20160101
UI = D000068597

*NEWRECORD
RECTYPE = D
MH = Data Accuracy
ENTRY = Data Quality|T062|T080|T170|NON|NRW|NLM (2016)|150526|abbbcdef
ENTRY = Accuracies, Data
ENTRY = Accuracy, Data
ENTRY = Data Accuracies
ENTRY = Data Qualities
ENTRY = Qualities, Data
ENTRY = Quality, Data
MN = E05.318.308.028
MN = E05.318.780.725.250
MN = L01.280.202
MN = N05.715.360.300.202
MN = N05.715.360.780.685.250
MH_TH = NLM (2016)
ST = T062
ST = T080
ST = T170
MS = A measure of scientific precision, exactness, or correctness of quantitative or qualitative values, relative to the actual or true measurements.
PM = 2016; for DATA QUALITY see RESEARCH DESIGN 1995-2015
HN = 2016; for DATA QUALITY use RESEARCH DESIGN 1995-2015
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000068598

*NEWRECORD
RECTYPE = D
MH = Brimonidine Tartrate, Timolol Maleate Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Brimonidine Tartrate-Timolol Maleate|T109|T121|NON|EQV|NLM (2016)|150312|abbcdef
ENTRY = Brimonidine Tartrate-Timolol Maleate Drug Combination|T109|T121|NON|EQV|NLM (2016)|150312|abbcdef
ENTRY = Combigan|T121|TRD|NRW|NLM (2011)|150309|abcdef
ENTRY = Brimonidine Tartrate Timolol Maleate
ENTRY = Brimonidine Tartrate Timolol Maleate Drug Combination
ENTRY = Maleate, Brimonidine Tartrate-Timolol
ENTRY = Tartrate-Timolol Maleate, Brimonidine
MN = D02.033.100.624.915.500
MN = D02.033.755.624.915.500
MN = D02.092.063.624.915.500
MN = D02.886.675.867.768.500
MN = D03.383.129.708.867.768.500
MN = D03.438.857.070.500
MN = D26.310.312
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.
PM = 2016; BRIMONIDINE TARTRATE-TIMOLOL MALEATE DRUG COMBINATION was indexed under QUINOXALINES 2011-2015, under TIMOLOL 2011-2015, and under DRUG COMBINATIONS 2011-2015
HN = 2016 (2011)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068599

*NEWRECORD
RECTYPE = D
MH = Albuterol, Ipratropium Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Albuterol-Ipratropium|T109|T121|NON|EQV|NLM (1999)|150310|abbcdef
ENTRY = Albuterol-Ipratropium Drug Combination|T109|T121|NON|EQV|NLM (2016)|150312|abbcdef
ENTRY = Combivent|T109|T121|TRD|NRW|NLM (2008)|080720|abbcdef
ENTRY = Combivent Respimat|T109|T121|TRD|NRW|NLM (2016)|150309|abbcdef
ENTRY = Dey Combination|T109|T121|TRD|NRW|NLM (1999)|150312|abbcdef
ENTRY = Albuterol Ipratropium
ENTRY = Albuterol Ipratropium Drug Combination
ENTRY = Combination, Albuterol-Ipratropium Drug
ENTRY = Combination, Dey
ENTRY = Drug Combination, Albuterol-Ipratropium
ENTRY = Respimat, Combivent
MN = D02.033.100.291.057.125
MN = D02.092.063.291.057.125
MN = D02.092.471.683.061.125
MN = D02.145.074.722.229.400.500
MN = D03.132.760.180.572.400.500
MN = D03.132.889.180.648.400.500
MN = D03.605.869.229.400.500
MN = D04.075.080.875.099.722.229.400.500
MN = D26.310.344
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
PM = 2016; ALBUTEROL-IPRATROPIUM was indexed under ALBUTEROL 1999-2015, and under IPRATROPIUM 1999-2015
HN = 2016 (1999)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068600

*NEWRECORD
RECTYPE = D
MH = Dual Use Research
AQ = ES HI LJ SN
ENTRY = Research, Dual Use
ENTRY = Use Research, Dual
MN = H01.770.644.217
FX = Censorship, Research
MH_TH = NLM (2016)
ST = T062
MS = Concept relating to technologies and/or information emanating from research that holds the potential for both benevolent and malevolent applications to humanity and the environment.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150706
DC = 1
DX = 20160101
UI = D000068601

*NEWRECORD
RECTYPE = D
MH = Professionalism
AQ = EC ED ES HI LJ ST TD
ENTRY = Medical Professionalism|T078|NON|NRW|NLM (2016)|150605|abcdef
ENTRY = Professionalism Education|T057|T078|NON|NRW|NLM (2016)|150310|abbcdef
ENTRY = Surgical Professionalism|T078|NON|NRW|NLM (2016)|150605|abcdef
ENTRY = Education, Professionalism
ENTRY = Professionalism, Medical
ENTRY = Professionalism, Surgical
MN = K01.752.566.479.171.566
MN = N05.350.340.581
FX = Ethics, Medical
FX = Professional Competence
MH_TH = NLM (2016)
ST = T078
MS = The level of skill, good judgment, and polite behavior expected from people trained to do their jobs well.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000068616

*NEWRECORD
RECTYPE = D
MH = Genetic Background
ENTRY = Background, Genetic
ENTRY = Backgrounds, Genetic
ENTRY = Genetic Backgrounds
MN = G05.346
FX = Heredity
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T028
ST = T032
PI = Genetics (1963-2015)
MS = The entire genetic composition of a strain or individual that interacts with a gene of interest.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000068617

*NEWRECORD
RECTYPE = D
MH = Selective Breeding
AQ = GE HI
ENTRY = Breeding, Selective
ENTRY = Breedings, Selective
ENTRY = Selective Breedings
MN = E05.820.150.760
MN = G05.355.090.701
FX = Eugenics
FX = Reproductive Techniques
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T045
ST = T063
MS = A process in which offspring possessing desired genetic traits are produced.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000068618

*NEWRECORD
RECTYPE = D
MH = Legendary Creatures
AQ = HI
ENTRY = Bigfoot|T078|NON|REL|NLM (2016)|150311|abcdef
ENTRY = Mermaids|T078|NON|REL|NLM (2016)|OBSSR (2016)|150311|abcdeef
ENTRY = Mythical Animals|T078|NON|EQV|NLM (2016)|OBSSR (2016)|150408|abcdeef
ENTRY = Mythical Creatures|T078|NON|EQV|NLM (2016)|OBSSR (2016)|150311|abcdeef
ENTRY = Sasquatch|T078|NON|REL|NLM (2016)|OBSSR (2016)|150311|abcdeef
ENTRY = Unicorns|T078|NON|REL|NLM (2016)|OBSSR (2016)|150311|abcdeef
ENTRY = Vampires|T078|NON|REL|NLM (2016)|OBSSR (2016)|141216|abcdeef
ENTRY = Werewolves|T078|NON|REL|NLM (2016)|OBSSR (2016)|141216|abcdeef
ENTRY = Yeti, Himalayan|T078|NON|REL|NLM (2016)|OBSSR (2016)|150311|abcdeef
ENTRY = Animal, Mythical
ENTRY = Animals, Mythical
ENTRY = Bigfoots
ENTRY = Creature, Legendary
ENTRY = Creature, Mythical
ENTRY = Creatures, Legendary
ENTRY = Creatures, Mythical
ENTRY = Himalayan Yeti
ENTRY = Legendary Creature
ENTRY = Mermaid
ENTRY = Mythical Animal
ENTRY = Mythical Creature
ENTRY = Unicorn
ENTRY = Vampire
MN = I01.076.201.450.515.500
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T078
MS = An unverified animal or humanoid, sometimes supernatural, often believed to be real and described in MYTHOLOGY, FOLKLORE, or legends. Some legendary creatures, such as the unicorn, were documented in scholarly antiquarian accounts of natural history.
PM = 2016
HN = 2016
MR = 20150409
DA = 20150701
DC = 1
DX = 20160101
UI = D000068636

*NEWRECORD
RECTYPE = D
MH = Mometasone Furoate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Asmanex|T121|TRD|NRW|NLM (2016)|150316|abcdef
ENTRY = Asmanex Twisthaler|T121|TRD|NRW|NLM (2016)|150316|abcdef
ENTRY = Elocon|T110|T121|TRD|NRW|NLM (1987)|abbcde
ENTRY = Mometasone|T110|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2002)|150316|abbcdeeef
ENTRY = Mometasone Furoate Monohydrate|T110|T121|NON|NRW|NLM (2001)|150316|abbcdef
ENTRY = Nasonex|T110|T121|TRD|NRW|NLM (2001)|010918|abbcdef
ENTRY = Rinelon|T110|T121|TRD|NRW|NLM (2006)|061030|abbcdef
ENTRY = Sch 32088|T110|T121|LAB|NRW|NLM (1987)|abbcde
ENTRY = Sch-32088|T110|T121|LAB|NRW|NLM (1987)|abbcde
ENTRY = Furoate Monohydrate, Mometasone
ENTRY = Furoate, Mometasone
ENTRY = Monohydrate, Mometasone Furoate
ENTRY = Sch32088
ENTRY = Twisthaler, Asmanex
MN = D04.808.745.432.719.526
FX = Formoterol Fumarate
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USAN (1987)
ST = T110
ST = T121
RN = 04201GDN4R
RR = 83919-23-7
RR = 8HR4QJ6DW8
RR = MTW0WEG809
MS = A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders.
PM = 2016; MOMETASONE FUROATE was indexed under PREGNADIENEDIOLS 1987-2015
HN = 2016 (1987)
MR = 20150707
DA = 20150710
DC = 1
DX = 20160101
UI = D000068656

*NEWRECORD
RECTYPE = D
MH = Fallopia multiflora
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Fo-Ti|T002|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Polygonum multiflorum|T002|NON|EQV|NLM (2016)|150317|abcdef
ENTRY = Fo Ti
MN = B01.650.940.800.575.100.825.359.590
MH_TH = NLM (2016)
ST = T002
PI = Polygonaceae (2002-2015)
MS = A species of Fallopia in the buckwheat family (Polygonaceae). Its roots are used in TRADITIONAL CHINESE MEDICINE.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068676

*NEWRECORD
RECTYPE = D
MH = Sildenafil Citrate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate|T109|T121|NON|EQV|NLM (1996)|150318|abbcdef
ENTRY = Acetildenafil|T109|T121|NON|REL|NLM (2006)|150318|abbcdef
ENTRY = Desmethyl Sildenafil|T109|T121|NON|REL|NLM (2005)|150318|abbcdef
ENTRY = Desmethylsildenafil|T109|T121|NON|REL|NLM (2002)|150318|abbcdef
ENTRY = Homosildenafil|T109|T121|NON|NRW|NLM (2006)|150318|abbcdef
ENTRY = Hydroxyhomosildenafil|T109|T121|NON|REL|NLM (2006)|150318|abbcdef
ENTRY = NCX-911|T109|T121|LAB|NRW|NLM (2004)|041220|abbcdef
ENTRY = Revatio|T109|T121|TRD|NRW|US|051103|abbcdef
ENTRY = Sildenafil|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|USAN (1998)|150318|abbcdeeef
ENTRY = Sildenafil Lactate|T109|T121|NON|REL|NLM (2011)|150318|abbcdef
ENTRY = Sildenafil Nitrate|T109|T121|NON|REL|NLM (2016)|150318|abbcdef
ENTRY = UK 92480-10|T109|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = UK-92,480-10|T109|T121|NRW|NLM (1996)|abbde
ENTRY = Viagra|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|MX|NL|UK|US|abbcdeeeeeeeeee
ENTRY = Citrate, Sildenafil
ENTRY = Lactate, Sildenafil
ENTRY = NCX 911
ENTRY = NCX911
ENTRY = Nitrate, Sildenafil
ENTRY = Sildenafil, Desmethyl
ENTRY = UK 92,480 10
ENTRY = UK 92480 10
ENTRY = UK 9248010
MN = D02.065.884.675
MN = D02.886.590.700.675
MN = D03.383.606.854
MN = D03.438.759.824
FX = Tadalafil
MH_TH = FDA SRS (2014)
MH_TH = NLM (1996)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = BW9B0ZE037
RR = 0Z3JH0S0QK
RR = 139755-83-2
RR = 3M7OB98Y7H
RR = 80X7B1F6NW
RR = L6WO34R9YG
RR = TP0E2BW57H
MS = A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT  that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.
PM = 2016; SILDENAFIL CITRATE was indexed under PIPERAZINES; PURINES; and under SULFONAMIDES 1997-2015
HN = 2016 (1997)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000068677

*NEWRECORD
RECTYPE = D
MH = Emtricitabine, Rilpivirine, Tenofovir Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Complera|T114|T121|TRD|NRW|NLM (2012)|120521|abbcdef
ENTRY = Emtricitabine Rilpivirine Tenofovir Drug Combination|T121|NON|EQV|NLM (2016)|150520|abcdef
ENTRY = Emtricitabine-Rilpivirine-Tenofovir Drug Combination|T121|NON|EQV|NLM (2016)|150317|abcdef
ENTRY = Combination, Emtricitabine-Rilpivirine-Tenofovir Drug
ENTRY = Drug Combination, Emtricitabine-Rilpivirine-Tenofovir
MN = D02.626.809.500
MN = D02.705.429.906.500
MN = D03.383.742.680.245.500.600.500
MN = D03.383.742.755.500
MN = D03.438.759.138.881.500
MN = D26.310.407
MH_TH = NLM (2016)
ST = T121
RN = 0
MS = A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS.
PM = 2016; EMTRICITABINE, RILPIVIRINE, TENOFOVIR DRUG COMBINATION was indexed under NITRILES; PYRIMIDINES; ORGANOPHOSPHONATES; ADENINE; and DEOXYCYTIDINE 2012-2015
HN = 2016 (2012)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068678

*NEWRECORD
RECTYPE = D
MH = Emtricitabine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine|T114|T121|NON|EQV|NLM (1999)|150317|abbcdef
ENTRY = Coviracil|T114|T121|TRD|NRW|NLM (2000)|000508|abbcdef
ENTRY = Emtriva|T114|T121|TRD|NRW|NLM (2003)|030717|abbcdef
ENTRY = Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
MN = D03.383.742.680.245.500.600
MN = D13.570.230.329.525
MN = D13.570.685.245.500.600
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1999)
MH_TH = USAN (19XX)
ST = T114
ST = T121
RN = G70B4ETF4S
MS = A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.
PM = 2016; EMTRICITABINE was indexed under DEOXYCYTIDINE 1999-2015
HN = 2016 (1999)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068679

*NEWRECORD
RECTYPE = D
MH = Rilpivirine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = R278474|T109|LAB|NRW|NLM (2005)|050318|abcdef
ENTRY = Rilpivirine HCl|T109|T121|ABX|NRW|NLM (2016)|150318|abbcdef
ENTRY = Rilpivirine Hydrochloride|T109|T121|NON|NRW|BAN (19XX)|INN (19XX)|NLM (2016)|USAN (19XX)|150318|abbcdeeeef
ENTRY = TMC 278|T109|LAB|NRW|NLM (2006)|060101|abcdef
ENTRY = TMC-278|T109|LAB|NRW|NLM (2006)|060101|abcdef
ENTRY = TMC278|T109|LAB|NRW|NLM (2006)|060101|abcdef
ENTRY = 278, TMC
ENTRY = HCl, Rilpivirine
ENTRY = Hydrochloride, Rilpivirine
MN = D02.626.809
MN = D03.383.742.755
MH_TH = FDA SRS (2015)
MH_TH = INN (2005)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = FI96A8X663
RR = 212WAX8KDD
RR = 500287-72-9
MS = A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone.
PM = 2016; RILPIVIRINE was indexed under NITRILES 2005-2015, and under PYRIMIDINES 2005-2015
HN = 2016 (2005)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068696

*NEWRECORD
RECTYPE = D
MH = Tenofovir
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (R)-9-(2-phosphonylmethoxypropyl)adenine|T114|T121|NRW|NLM (1995)|abbde
ENTRY = 9-(2-Phosphonomethoxypropyl)adenine|T114|T121|NON|EQV|NLM (1995)|150318|abbcdef
ENTRY = 9-(2-Phosphonylmethoxypropyl)adenine|T114|T121|NON|EQV|NLM (1995)|150318|abbcdef
ENTRY = 9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer|T114|T121|NON|NRW|NLM (1995)|150318|abbcdef
ENTRY = 9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098|T114|T121|NON|NRW|NLM (1995)|150318|abbcdef
ENTRY = 9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer|T114|T121|NON|NRW|NLM (1995)|150318|abbcdef
ENTRY = 9-PMPA (tenofovir)|T114|T121|EQV|NLM (2014)|140210|abbdef
ENTRY = Tenofovir Disoproxil|T114|T121|NON|EQV|NLM (2001)|150318|abbcdef
ENTRY = Tenofovir Disoproxil Fumarate|T114|T121|NON|NRW|BAN (19XX)|INN (19XX)|NLM (2001)|USAN (19XX)|150318|abbcdeeeef
ENTRY = Viread|T114|T121|TRD|NRW|DE|FR|UK|US|011217|abbcdeeeef
ENTRY = Disoproxil Fumarate, Tenofovir
ENTRY = Disoproxil, Tenofovir
ENTRY = Fumarate, Tenofovir Disoproxil
MN = D02.705.429.906
MN = D03.438.759.138.881
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = NLM (2000)
MH_TH = USAN (19XX)
ST = T114
ST = T121
RN = 99YXE507IL
RR = 121149-89-1 ((+-)-isomer)
RR = 147127-19-3 ((S)-isomer)
RR = 147127-20-6 ((R)-isomer)
RR = OTT9J7900I
MS = An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.
PM = 2016; TENOFOVIR DIDOPROXIL was indexed under ORGANOPHOSPHONATES 2004-2015, ADENINE 2004-2015, and under ORGANOPHOSPHOROUS COMPOUNDS 2001-2004
HN = 2016 (2001)
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000068698

*NEWRECORD
RECTYPE = D
MH = Glatiramer Acetate
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Copaxone|T116|T121|TRD|NRW|AU|CA|DE|FR|UK|US|abbcdeeeeee
ENTRY = Glatiramer|T116|NON|BRD|FDA SRS (2015)|NLM (2016)|150319|abcdeef
ENTRY = TV 5010|T116|T123|LAB|NRW|NLM (2009)|090428|abbcdef
ENTRY = TV-5010|T116|T123|LAB|NRW|NLM (2009)|090428|abbcdef
ENTRY = TV5010|T116|T123|LAB|NRW|NLM (2009)|090428|abbcdef
ENTRY = 5010, TV
ENTRY = Acetate, Glatiramer
MN = D12.644.219
MH_TH = BAN (19XX)
MH_TH = NLM (1994)
MH_TH = USAN (19XX)
ST = T116
ST = T121
RN = 5M691HL4BO
RR = U782C039QP
MS = A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS.
PM = 2016; GLATIRAMER ACETATE was indexed under PEPTIDES 1994-2015
HN = 2016 (1994)
MR = 20150605
DA = 20150701
DC = 1
DX = 20160101
UI = D000068717

*NEWRECORD
RECTYPE = D
MH = Rosuvastatin Calcium
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Crestor|T109|T121|TRD|NRW|NLM (2001)|011019|abbcdef
ENTRY = Rosuvastatin|T109|T121|NON|BRD|FDA SRS (2015)|INN (19XX)|NLM (2001)|USAN (19XX)|150319|abbcdeeeef
ENTRY = ZD 4522|T109|T121|LAB|NRW|NLM (2001)|010330|abbcdef
ENTRY = ZD4522|T109|T121|LAB|NRW|NLM (2001)|010330|abbcdef
ENTRY = Calcium, Rosuvastatin
MN = D02.065.884.650
MN = D02.455.526.510.432.500
MN = D02.886.590.700.650
MN = D03.383.742.775
FX = Simvastatin
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USAN (2001)
ST = T109
ST = T121
RN = 83MVU38M7Q
RR = 287714-41-4 (Rosuvastatin)
RR = 413KH5ZJ73
MS = A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.
PM = 2016; ROSUVASTATIN CALCIUM was indexed under FLUOROBENZENES; PYRIMIDINES; and SULFONAMIDES 2001-2015
HN = 2016 (2001)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000068718

*NEWRECORD
RECTYPE = D
MH = Duloxetine Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cymbalta|T109|T121|TRD|NRW|US|041007|abbcdef
ENTRY = Duloxetine|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (1989)|150320|abbcdeeef
ENTRY = Duloxetine Ethanedioate (1:1), (+-)-isomer - T353987|T109|T121|NON|NRW|NLM (1989)|150320|abbcdef
ENTRY = Duloxetine HCl|T109|T121|NON|EQV|NLM (2016)|150320|abbcdef
ENTRY = Duloxetine, (+)-isomer|T109|T121|NON|NRW|NLM (1989)|150320|abbcdef
ENTRY = LY 227942|T109|T121|LAB|NRW|NLM (1989)|abbcde
ENTRY = LY 248686|T109|T121|LAB|NRW|NLM (1989)|abbcde
ENTRY = LY-227942|T109|T121|LAB|NRW|NLM (1989)|abbcde
ENTRY = LY-248686|T109|T121|LAB|NRW|NLM (1989)|abbcde
ENTRY = LY227942|T109|T121|LAB|NRW|NLM (1989)|abbcde
ENTRY = N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine|T109|T121|BRD|NLM (1989)|abbde
ENTRY = N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide|T109|T121|BRD|NLM (1989)|abbde
ENTRY = HCl, Duloxetine
ENTRY = Hydrochloride, Duloxetine
ENTRY = LY248686
MN = D02.886.778.260
MN = D03.383.903.260
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2004)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 9044SC542W
RR = 116539-58-3
RR = 116539-59-4
RR = 116539-60-7
RR = 118625-29-9
RR = 136434-34-9 (Duloxetine Hydrochloride)
RR = O5TNM5N07U
MS = A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.
PM = 2016; DULOXETINE was indexed under THIOPHENES 1989-2015
HN = 2016 (1989)
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000068736

*NEWRECORD
RECTYPE = D
MH = Tolterodine Tartrate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Detrol|T109|T121|TRD|NRW|CA|US|010307|abbcdeef
ENTRY = Detrol LA|T109|T121|NON|NRW|NLM (2016)|150320|abbcdef
ENTRY = Detrusitol|T109|T121|TRD|NRW|DE|ES|FR|IE|MX|NL|UK|040415|abbcdeeeeeeef
ENTRY = PHA-686464B|T109|T121|LAB|NRW|NLM (2006)|061010|abbcdef
ENTRY = Tolterodine|T109|T121|NON|NRW|FDA SRS (2013)|INN (19XX)|USAN (1996)|150320|abbcdeeef
ENTRY = Unidet|T109|T121|TRD|NRW|CA|050929|abbcdef
ENTRY = Urotrol|T109|T121|TRD|NRW|ES|050929|abbcdef
ENTRY = LA, Detrol
ENTRY = PHA 686464B
ENTRY = PHA686464B
ENTRY = Tartrate, Tolterodine
MN = D02.033.100.624.706.750
MN = D02.033.755.624.706.750
MN = D02.092.063.624.706.800
MN = D02.455.426.559.389.115.900
MN = D02.455.426.559.389.657.239.756
MH_TH = FDA SRS (2014)
MH_TH = NLM (2001)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 5T619TQR3R
RR = 124937-51-5
RR = 124937-52-6 (tolterodine tartrate)
RR = WHE7A56U7K
MS = An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE.
PM = 2016; TOLTERODINE TARTRATE was indexed under BENZHYDRYL COMPOUNDS, CRESOLS, and PHENYLPROPANOLAMINE 1996-2015
HN = 2016 (1996)
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000068737

*NEWRECORD
RECTYPE = D
MH = Valsartan
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = CGP 48933|T109|T121|LAB|NRW|NLM (1993)|abbcde
ENTRY = Diovan|T109|T121|TRD|NRW|CA|DE|ES|IE|MX|NL|UK|US|abbcdeeeeeeee
ENTRY = Kalpress|T109|T121|TRD|NRW|ES|041129|abbcdef
ENTRY = Miten|T109|T121|TRD|NRW|ES|041129|abbcdef
ENTRY = N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine|T109|T121|EQV|NLM (1993)|abbde
ENTRY = Nisis|T109|T121|TRD|NRW|FR|041129|abbcdef
ENTRY = Provas|T109|T121|TRD|NRW|DE|041129|abbcdef
ENTRY = Tareg|T109|T121|TRD|NRW|FR|041129|abbcdef
ENTRY = Vals|T109|T121|TRD|NRW|ES|041129|abbcdef
ENTRY = 48933, CGP
MN = D03.383.129.617.850
MN = D12.125.070.950.550
MN = D12.125.142.930.500
FX = Losartan
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USAN (1993)
ST = T109
ST = T121
N1 = L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
RN = 80M03YXJ7I
RR = 137862-53-4
MS = A tetrazole derivative and ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to treat HYPERTENSION.
PM = 2016; VALSARTAN was indexed under TETRAZOLES and VALINE 1993-2015
HN = 2016 (1993)
MR = 20150615
DA = 20150706
DC = 1
DX = 20160101
UI = D000068756

*NEWRECORD
RECTYPE = D
MH = Ononis
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Rest-Harrow|T002|NON|EQV|NLM (2016)|150320|abcdef
ENTRY = Restharrow|T002|NON|EQV|NLM (2016)|150320|abcdef
ENTRY = Rest Harrow
ENTRY = Rest-Harrows
ENTRY = Restharrows
MN = B01.650.940.800.575.100.401.604
MH_TH = NLM (2016)
ST = T002
MS = A genus of the pea family (Fabaceae), native from Europe to Central Asia and used in TRADITIONAL MEDICINE.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068757

*NEWRECORD
RECTYPE = D
MH = Mometasone Furoate, Formoterol Fumarate Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Dulera|T109|T121|TRD|NRW|NLM (2016)|150320|abbcdef
ENTRY = Mometasone Furoate Formoterol Fumarate Drug Combination|T109|T121|NON|EQV|NLM (2016)|150520|abbcdef
ENTRY = Mometasone Furoate-Formoterol Fumarate Drug Combination|T109|T121|NON|EQV|NLM (2016)|150320|abbcdef
ENTRY = Zenhale|T109|T121|TRD|NRW|NLM (2016)|150320|abbcdef
MN = D02.033.100.291.425.500
MN = D02.092.063.291.425.500
MN = D04.808.745.432.719.526.500
MN = D26.310.469
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = A pharmaceutical preparation of mometasone furoate and formoterol fumarate that is used as an inhaled dosage form for the treatment of ASTHMA.
PM = 2016; MOMETASONE FUROATE, FORMOTEROL FUMARATE DRUG COMBINATION was indexed under ETHANOLAMINES and PREGNADIENEDIOLS 2011-2015
HN = 2016 (2011)
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068758

*NEWRECORD
RECTYPE = D
MH = Formoterol Fumarate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate|T109|T121|NON|EQV|NLM (1976)|150324|abbcdef
ENTRY = Arformoterol|T109|T121|NON|NRW|FDA SRS (2013)|INN (19XX)|NLM (2006)|150324|abbcdeeef
ENTRY = BD 40A|T109|T121|LAB|NRW|NLM (1976)|abbcde
ENTRY = Eformoterol|T109|T121|NON|NRW|NLM (1976)|150324|abbcdef
ENTRY = Foradil|T109|T121|TRD|NRW|NLM (2001)|010913|abbcdef
ENTRY = Formoterol|T109|T121|NON|NRW|FDA SRS (2013)|INN (1976)|INN (19XX)|150324|abbcdeeef
ENTRY = Formoterol Fumarate, ((R*,R*)-(+-))-isomer|T109|T121|NON|EQV|NLM (1976)|150324|abbcdef
ENTRY = Formoterol, ((R*,R*)-(+-))-isomer|T109|T121|NON|NRW|NLM (1976)|150324|abbcdef
ENTRY = Oxis|T109|T121|TRD|NRW|AU|DE|ES|MX|NL|NLM (2003)|UK|030310|abbcdeeeeeeef
MN = D02.033.100.291.425
MN = D02.092.063.291.425
FX = Albuterol
FX = Mometasone Furoate
MH_TH = FDA SRS (2013)
MH_TH = NLM (1976)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
RN = W34SHF8J2K
RR = 43229-80-7 (formoterol fumarate)
RR = 5ZZ84GCW8B
RR = F91H02EBWT
MS = An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
PM = 2016; FORMOTEROL FUMARATE was indexed under ETHANOLAMINES 1976-2015
HN = 2016 (1976)
MR = 20150707
DA = 20150710
DC = 1
DX = 20160101
UI = D000068759

*NEWRECORD
RECTYPE = D
MH = Serotonin and Noradrenaline Reuptake Inhibitors
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = SNRIs|T109|T121|ABB|EQV|NLM (2016)|150501|abbcdef
ENTRY = SSRIs and NRIs|T109|T121|ABX|EQV|NLM (2016)|150506|abbcdef
ENTRY = Serotonin and Noradrenaline Uptake Inhibitors|T109|T121|NON|EQV|NLM (2016)|150320|abbcdef
ENTRY = Serotonin and Norepinephrine Reuptake Inhibitors|T109|T121|NON|EQV|NLM (2016)|150320|abbcdef
ENTRY = Serotonin and Norepinephrine Uptake Inhibitors|T109|T121|NON|EQV|NLM (2016)|150320|abbcdef
ENTRY = NRIs and SSRIs
MN = D27.505.519.562.437.693
MN = D27.505.519.625.600.693
MN = D27.505.696.577.600.693
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
PI = Adrenergic Uptake Inhibitors (1999-2015)
PI = Serotonin Uptake Inhibitors (1999-2015)
MS = Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS.
PM = 2016
HN = 2016
MR = 20150520
DA = 20150701
DC = 1
DX = 20160101
UI = D000068760

*NEWRECORD
RECTYPE = D
MH = Sleep Aids, Pharmaceutical
AQ = AA AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Sleep Inducers|T121|NON|EQV|NLM (2016)|150430|abcdef
ENTRY = Sleep Promoting Agents|T121|NON|EQV|NLM (2016)|150430|abcdef
ENTRY = Agents, Sleep Promoting
ENTRY = Pharmaceutical Sleep Aids
MN = D27.505.954.842
MH_TH = NLM (2016)
ST = T121
RN = 0
PI = Sleep Wake Disorders (1999-2015)
MS = Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS.
PM = 2016
HN = 2016
MR = 20150618
DA = 20150702
DC = 1
DX = 20160101
UI = D000068776

*NEWRECORD
RECTYPE = D
MH = Orexin Receptor Antagonists
AQ = AA AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Dual Orexin Receptor Antagonists|T121|NON|NRW|NLM (2016)|150327|abcdef
ENTRY = Orexin Receptor Blockers|T121|NON|EQV|NLM (2016)|150327|abcdef
ENTRY = Antagonists, Orexin Receptor
ENTRY = Blockers, Orexin Receptor
ENTRY = Receptor Antagonists, Orexin
ENTRY = Receptor Blockers, Orexin
MN = D27.505.519.625.663
MN = D27.505.696.577.663
MN = D27.505.954.842.500
MH_TH = NLM (2016)
ST = T121
RN = 0
PI = Orexin Receptors (2014-2015)
MS = Substances that bind to and inhibit the action of OREXIN RECEPTORS. Drugs in this class have been used as SLEEP AIDS.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150702
DC = 1
DX = 20160101
UI = D000068796

*NEWRECORD
RECTYPE = D
MH = Orexins
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Hypocretin-1|T116|T124|NON|NRW|NLM (2016)|150327|abbcdef
ENTRY = Hypocretin-2|T116|T124|NON|NRW|NLM (2016)|150327|abbcdef
ENTRY = Hypocretins|T123|T124|NON|EQV|NLM (2016)|150430|abbcdef
ENTRY = Orexin-A|T116|T124|NON|NRW|NLM (2016)|150327|abbcdef
ENTRY = Orexin-B|T116|T124|NON|NRW|NLM (2016)|150327|abbcdef
ENTRY = Hypocretin 1
ENTRY = Hypocretin 2
ENTRY = Orexin A
ENTRY = Orexin B
MN = D12.644.400.360
MN = D12.776.641.650.363
FX = Orexin Receptors
MH_TH = NLM (2016)
ST = T123
ST = T124
RN = 0
MS = Neuropeptide hormones that play a role in regulating a variety of behavioral and physiological processes in response to motivational stimuli.
PM = 2016; OREXINS was indexed under NEUROPEPTIDES & INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS 2005-2015, and under CARRIER PROTEINS 1998-2004
HN = 2016
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000068797

*NEWRECORD
RECTYPE = D
MH = Hoodia
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Hoodia gordonii|T002|NON|NRW|NLM (2016)|150324|abcdef
MN = B01.650.940.800.575.100.081.389
MH_TH = NLM (2016)
ST = T002
PI = Apocynaceae  (2007-2015)
MS = A genus in the dogbane family (Apocynaceae) used in TRADITIONAL MEDICINE for appetite-suppressant properties.
PM = 2016
HN = 2016
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068798

*NEWRECORD
RECTYPE = D
MH = Prasugrel Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = CS 747|T109|T121|LAB|NRW|NLM (2000)|000522|abbcdef
ENTRY = CS-747|T109|T121|LAB|NRW|NLM (2000)|000522|abbcdef
ENTRY = Effient|T109|T121|TRD|NRW|NLM (2016)|150324|abbcdef
ENTRY = Efient|T109|T121|TRD|NRW|NLM (2013)|150324|abbcdef
ENTRY = LY 640315|T109|T121|LAB|NRW|NLM (2005)|050914|abbcdef
ENTRY = LY-640315|T109|T121|LAB|NRW|NLM (2005)|050914|abbcdef
ENTRY = LY640315|T109|T121|LAB|NRW|NLM (2005)|050914|abbcdef
ENTRY = Prasugrel|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2005)|150324|abbcdeeef
ENTRY = Prasugrel HCl|T109|T121|NON|EQV|NLM (2016)|150324|abbcdef
ENTRY = 640315, LY
ENTRY = 747, CS
ENTRY = CS747
ENTRY = HCl, Prasugrel
ENTRY = Hydrochloride, Prasugrel
MN = D02.886.778.315
MN = D03.383.606.420
MN = D03.383.903.315
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = G89JQ59I13
RR = 34K66TBT99
RR = 389574-19-0 (prasugrel hydrochloride)
MS = A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.
PM = 2016; PRASUGREL HYDROCHLORIDE was indexed under PIPERAZINES and THIOPHENES 2000-2015
HN = 2016 (2000)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000068799

*NEWRECORD
RECTYPE = D
MH = Etanercept
AQ = AA AD AE BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Enbrel|T116|T121|TRD|NRW|CA|DE|ES|NL|US|abbcdeeeee
ENTRY = Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein|T116|T121|NON|NRW|NLM (1997)|150324|abbcdef
ENTRY = TNF Receptor Type II-IgG Fusion Protein|T116|T121|NON|NRW|NLM (1997)|150324|abbcdef
ENTRY = TNFR-Fc Fusion Protein|T116|T121|ABX|NRW|NLM (1997)|150324|abbcdef
ENTRY = TNR 001|T116|T121|LAB|NRW|NLM (1999)|991228|abbcdef
ENTRY = TNR-001|T116|T121|LAB|NRW|NLM (1999)|991228|abbcdef
ENTRY = TNT Receptor Fusion Protein|T116|T121|ABX|NRW|NLM (1999)|150324|abbcdef
ENTRY = TNTR-Fc|T116|T121|ABB|NRW|NLM (1999)|991228|abbcdef
ENTRY = 001, TNR
ENTRY = Fusion Protein, TNFR-Fc
ENTRY = Protein, TNFR-Fc Fusion
ENTRY = Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein
ENTRY = TNF Receptor Type II IgG Fusion Protein
ENTRY = TNFR Fc Fusion Protein
ENTRY = TNR001
MN = D12.776.124.486.485.114.619.393.261
MN = D12.776.124.790.651.114.619.393.261
MN = D12.776.377.715.548.114.619.393.261
MN = D12.776.543.750.705.852.760.232
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1997)
MH_TH = USAN (19XX)
ST = T116
ST = T121
RN = OP401G7OJC
RR = 185243-69-0
MS = A recombinant version of soluble human TNF receptor that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.
PM = 2016; ETANERCEPT was indexed under IMMUNOGLOBULIN G and RECEPTORS, TUMOR NECROSIS FACTOR 1997-2015
HN = 2016 (1997)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000068800

*NEWRECORD
RECTYPE = D
MH = Adapalene, Benzoyl Peroxide Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Adapalene - Benzoyl Peroxide Drug Combination|T109|T121|NON|EQV|NLM (2016)|150520|abbcdef
ENTRY = Adapalene Benzoyl Peroxide Drug Combination|T109|T121|NON|EQV|NLM (2016)|150616|abbcdef
ENTRY = Adapalene-Benzoyl Peroxide Drug Combination|T109|T121|NON|EQV|NLM (2016)|150324|abbcdef
ENTRY = Epiduo|T109|T121|TRD|NRW|NLM (2016)|150324|abbcdef
MN = D02.241.223.100.133.500
MN = D02.455.426.559.389.127.133.500
MN = D02.455.426.559.847.638.090.500
MN = D04.615.638.090.500
MN = D26.310.032
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
PI = Benzoyl Peroxide (2007-2015)
PI = Naphthalenes (2007-2015)
MS = A pharmaceutical preparation of adapalene and benzoyl peroxide that is used as a DERMATOLOGIC AGENT for the topical treatment of ACNE.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068801

*NEWRECORD
RECTYPE = D
MH = Adapalene
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 6-(3-(1-adamantyl)-4-methoxyphenyl)-2-naphthoic acid|T109|T121|EQV|NLM (1990)|abbde
ENTRY = Adaferin|T109|T121|TRD|NRW|MX|041206|abbcdef
ENTRY = CD 271|T109|T121|LAB|NRW|NLM (1990)|abbcde
ENTRY = CD-271|T109|T121|LAB|NRW|NLM (1990)|abbcde
ENTRY = CD271|T109|T121|LAB|NRW|NLM (1990)|abbcde
ENTRY = Differin|T109|T121|TRD|NRW|AU|CA|DE|IE|UK|US|010917|abbcdeeeeeef
ENTRY = Differine|T109|T121|TRD|NRW|ES|FR|041206|abbcdeef
ENTRY = 271, CD
MN = D02.455.426.559.847.638.090
MN = D04.615.638.090
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (1990)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 1L4806J2QF
RR = 106685-40-9 (adapalene)
MS = A naphthalene derivative that has specificity for RETINOIC ACID RECEPTORS. It is used as a DERMATOLOGIC AGENT for the treatment of ACNE.
PM = 2016; ADAPALENE was indexed under NAPHTHALENES 1990-2015
HN = 2016 (1990)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068816

*NEWRECORD
RECTYPE = D
MH = Epoetin Alfa
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Binocrit|T109|T121|TRD|NRW|NLM (2014)|150325|abbcdef
ENTRY = Epoetin Alfa Hexal|T109|T121|TRD|NRW|NLM (2014)|150325|abbcdef
ENTRY = Epogen|T116|T121|TRD|NRW|NLM (1997)|951218|abbcdef
ENTRY = Eprex|T116|T121|TRD|NRW|NLM (1997)|960117|abbcdef
ENTRY = HX575|T116|T121|LAB|NRW|NLM (2010)|100111|abbcdef
ENTRY = HX575 Compound|T109|T121|NON|NRW|NLM (2014)|150325|abbcdef
ENTRY = Heberitro|T116|T123|TRD|NRW|NLM (2006)|060213|abbcdef
ENTRY = Procrit|T116|T121|TRD|NRW|NLM (2016)|150616|abbcdef
ENTRY = Recombinant 1-165 Erythropoietin, Glycoform Alpha|T116|T121|NON|EQV|NLM (2012)|150325|abbcdef
ENTRY = Alfa Hexal, Epoetin
ENTRY = Alfa, Epoetin
ENTRY = Compound, HX575
ENTRY = Hexal, Epoetin Alfa
ENTRY = Recombinant 1 165 Erythropoietin, Glycoform Alpha
MN = D12.644.276.374.410.240.150.500
MN = D12.776.395.240.150.750
MN = D12.776.467.374.410.240.150.500
MN = D23.529.374.410.240.150.750
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = NLM (1997)
MH_TH = USAN (19XX)
ST = T116
ST = T121
N1 = 1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha
RN = 64FS3BFH5W
RR = 113427-24-0
MS = A recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.
PM = 2016; EPOETIN ALFA was indexed under ERYTHROPOIETIN 2011-2015
HN = 2016 (2011)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068817

*NEWRECORD
RECTYPE = D
MH = Cetuximab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
ENTRY = C225|T109|T121|T129|LAB|NRW|NLM (2000)|abbbcde
ENTRY = Erbitux|T109|T121|T129|TRD|NRW|NLM (2003)|030115|abbbcdef
ENTRY = IMC C225|T109|T121|T129|LAB|NRW|NLM (2000)|000726|abbbcdef
ENTRY = IMC-C225|T109|T121|T129|LAB|NRW|NLM (2003)|030115|abbbcdef
ENTRY = MAb C225|T109|T121|T129|LAB|NRW|NLM (2000)|abbbcde
ENTRY = C225, IMC
ENTRY = C225, MAb
ENTRY = IMCC225
MN = D12.776.124.486.485.114.224.060.750
MN = D12.776.124.790.651.114.224.060.750
MN = D12.776.377.715.548.114.224.200.750
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (2000)
MH_TH = USAN (19XX)
ST = T109
ST = T121
ST = T129
RN = PQX0D8J21J
RR = 205923-56-4
MS = A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.
PM = 2016; CETUXIMAB was indexed under ANTIBODIES, MONOCLONAL 2000-2013; and under ANTIBODIES, MONOCLONAL, HUMANIZED 2013-2015
HN = 2016 (2000)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068818

*NEWRECORD
RECTYPE = D
MH = Hyssopus Plant
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Hyssop|T002|NON|NRW|NLM (2003)|020326|abcdef
ENTRY = Hyssopus officinalis|T002|NON|NRW|NLM (2016)|150325|abcdef
ENTRY = Hyssops
ENTRY = Hyssopus Plants
ENTRY = Plant, Hyssopus
ENTRY = Plants, Hyssopus
MN = B01.650.940.800.575.100.583.520.330
MH_TH = NLM (2016)
ST = T002
PI = Lamiaceae (2002-2015)
MS = A genus in the mint family (Lamiaceae). Members contain thujone and PHENOL. Distinguished from AGASTACHE (giant hyssop) and BACOPA (water hyssop).  Also distinguished from the genus of WASPS with the same genus name Hyssopus.
PM = 2016; for HYSSOP see LAMIACEAE 2003-2015
HN = 2016; for HYSSOP use LAMIACEAE 2003-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000068819

*NEWRECORD
RECTYPE = D
MH = Rivastigmine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate|T109|T121|NON|EQV|NLM (1992)|150326|abbcdef
ENTRY = ENA 713|T109|T121|LAB|NRW|NLM (1992)|abbcde
ENTRY = ENA-713|T109|T121|LAB|NRW|NLM (1992)|abbcde
ENTRY = Exelon|T109|T121|TRD|NRW|NLM (2000)|001102|abbcdef
ENTRY = Rivastigmine Hydrogen Tartrate|T109|T121|NON|NRW|BAN (19XX)|INN (19XX)|150326|abbcdeef
ENTRY = RivastigmineTartrate|T109|T121|NON|NRW|FDA SRS (2015)|NLM (2001)|150326|abbcdeef
ENTRY = SDZ ENA 713|T109|T121|LAB|NRW|NLM (1992)|abbcde
ENTRY = 713, ENA
ENTRY = 713, SDZ ENA
ENTRY = ENA 713, SDZ
ENTRY = ENA713
ENTRY = Hydrogen Tartrate, Rivastigmine
ENTRY = Tartrate, Rivastigmine Hydrogen
MN = D02.241.081.251.583.899
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = NLM (1992)
MH_TH = USAN (19XX)
ST = T109
ST = T121
N1 = Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
RN = PKI06M3IW0
RR = 123441-03-2 (rivastigmine)
RR = 129101-54-8 (rivastigmine hydrogen tartrate)
RR = 9IY2357JPE
MS = A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
PM = 2016; RIVASTIGMINE was indexed under PHENYLCARBAMATES 2004-2015; and under CARBAMATES 1992-2004
HN = 2016 (1992)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000068836

*NEWRECORD
RECTYPE = D
MH = Parmeliaceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Cetraria|T004|NON|NRW|NLM (2016)|150326|abcdef
ENTRY = Cetraria islandica|T002|NON|NRW|NLM (2016)|150326|abcdef
ENTRY = Iceland Moss|T002|NON|NRW|NLM (2016)|150326|abcdef
ENTRY = Iceland Mosses
ENTRY = Moss, Iceland
ENTRY = Mosses, Iceland
MN = B01.300.107.685
MN = B01.300.340.458
MH_TH = NLM (2016)
ST = T004
PI = Ascomycota (2004-2015)
MS = The largest family of lichen-forming fungi.
PM = 2016
HN = 2016
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068837

*NEWRECORD
RECTYPE = D
MH = Amlodipine, Valsartan Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amlodipine - Valsartan|T109|T121|NON|EQV|NLM (2010)|150326|abbcdef
ENTRY = Amlodipine-Valsartan|T109|T121|NON|EQV|NLM (2010)|150326|abbcdef
ENTRY = Amlodipine-Valsartan Drug Combination|T109|T121|NON|EQV|NLM (2010)|150326|abbcdef
ENTRY = Exforge|T109|T121|TRD|NRW|NLM (2008)|UK|US|080630|abbcdeeef
ENTRY = - Valsartan, Amlodipine
ENTRY = Amlodipine Valsartan
ENTRY = Amlodipine Valsartan Drug Combination
ENTRY = Combination, Amlodipine-Valsartan Drug
ENTRY = Drug Combination, Amlodipine-Valsartan
ENTRY = Valsartan, Amlodipine -
MN = D03.383.129.617.850.500
MN = D03.383.725.203.065.750
MN = D12.125.070.950.550.500
MN = D12.125.142.930.500.500
MN = D26.310.094
MH_TH = NLM (2010)
ST = T109
ST = T121
RN = 0
MS = A pharmaceutical preparation of amlodipine and valsartan that is used for the treatment of HYPERTENSION.
PM = 2016; AMLODIPINE, VALSARTAN DRUG COMBINATION was indexed under DRUG COMBINATIONS, TETRAZOLES, and AMLODIPINE 2008-2015
HN = 2016 (2008)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068838

*NEWRECORD
RECTYPE = D
MH = Eugenia
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Brazilian Cherry Tree|T002|NON|NRW|NLM (2016)|150327|abcdef
ENTRY = Euginia uniflora|T002|NON|NRW|NLM (2016)|150327|abcdef
ENTRY = Pitanga|T002|NON|NRW|NLM (2016)|150327|abcdef
ENTRY = Surinam Cherry Tree|T002|NON|NRW|NLM (2016)|150327|abcdef
ENTRY = Brazilian Cherry Trees
ENTRY = Cherry Tree, Brazilian
ENTRY = Cherry Tree, Surinam
ENTRY = Cherry Trees, Brazilian
ENTRY = Cherry Trees, Surinam
ENTRY = Eugenias
ENTRY = Pitangas
ENTRY = Surinam Cherry Trees
ENTRY = Tree, Brazilian Cherry
ENTRY = Tree, Surinam Cherry
ENTRY = Trees, Brazilian Cherry
ENTRY = Trees, Surinam Cherry
MN = B01.650.940.800.575.100.773.374
MH_TH = NLM (2002)
ST = T001
PI = Syzygium (2002-2015)
MS = A genus in the family Myrtaceae sometimes known as "stoppers" in FOLK MEDICINE. Many species of the genus SYZYGIUM have synonymous names that begin with the Eugenia genus name.
PM = 2016; see CLOVE 2002-2004
HN = 2016; see SYZYGIUM 2005-2015; see CLOVE 2002-2004
MR = 20150707
DA = 20150707
DC = 1
DX = 20160101
UI = D000068856

*NEWRECORD
RECTYPE = D
MH = Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
AQ = AA AD AE AG AI BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
ENTRY = Gardasil|T121|T129|TRD|NRW|NLM (2006)|150330|abbcdef
ENTRY = HPV L1 Vaccine, Quadrivalent 6,11,16,18|T121|T129|NON|NRW|NLM (2006)|150327|abbcdef
ENTRY = Human Papillomavirus Vaccine L1, Type 6,11,16,18|T121|T129|NON|NRW|NLM (2006)|150327|abbcdef
MN = D20.215.894.899.498.500
MH_TH = NLM (2016)
ST = T121
ST = T129
RN = 0
MS = A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from HUMAN PAPILLOMAVIRUSES of these subtypes.
PM = 2016; HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE QUADRIVALENT (TYPES 6, 11, 16, 18) was indexed under PAPILLOMAVIRUS VACCINES 2006-2015
HN = 2016 (2006)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068857

*NEWRECORD
RECTYPE = D
MH = Kombucha Tea
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Kombucha Teas
ENTRY = Tea, Kombucha
ENTRY = Teas, Kombucha
MN = D20.215.784.844.500
MN = G07.203.100.831.500
MN = J02.200.831.500
MH_TH = NLM (2016)
ST = T168
RN = 0
PI = Tea (1995-2015)
MS = A beverage made by FERMENTATION of black tea and/or green tea.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068858

*NEWRECORD
RECTYPE = D
MH = Fingolimod Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride|T119|T121|NON|EQV|NLM (1996)|150330|abbcdef
ENTRY = FTY 720|T119|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = FTY-720|T119|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = FTY720|T119|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = Fingolimod|T119|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2006)|150330|abbcdeeef
ENTRY = Gilenia|T119|T121|TRD|NRW|NLM (2016)|150330|abbcdef
ENTRY = Gilenya|T119|T121|TRD|NRW|NLM (2014)|130830|abbcdef
ENTRY = Hydrochloride, Fingolimod
MN = D02.033.100.700.350
MN = D02.033.455.706.431
MN = D02.092.063.700.350
MH_TH = NLM (2008)
MH_TH = USAN (19XX)
ST = T119
ST = T121
RN = G926EC510T
RR = 162359-56-0 (fingolimod hydrochloride)
RR = 3QN8BYN5QF
MS = A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.
PM = 2016; FINGOLIMOD HYDROCHLORIDE was indexed under PROPYLENE GLYCOLS and SPHINGOSINE 1996-2015
HN = 2016 (1996)
MR = 20150702
DA = 20150706
DC = 1
DX = 20160101
UI = D000068876

*NEWRECORD
RECTYPE = D
MH = Imatinib Mesylate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide|T109|T121|NON|BRD|NLM (2013)|150330|abbcdef
ENTRY = CGP 57148|T109|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = CGP-57148|T109|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = CGP57148B|T109|T121|LAB|NRW|NLM (2000)|000531|abbcdef
ENTRY = Gleevec|T109|T121|TRD|NRW|CA|MX|US|010702|abbcdeeef
ENTRY = Glivec|T109|T121|TRD|NRW|DE|FR|UK|010713|abbcdeeef
ENTRY = Imatinib|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2002)|150330|abbcdeeef
ENTRY = Imatinib Methanesulfonate|T109|T121|NON|EQV|NLM (2014)|150330|abbcdef
ENTRY = ST 1571|T109|T121|LAB|NRW|NLM (2001)|011003|abbcdef
ENTRY = ST1571|T109|T121|LAB|NRW|NLM (2001)|011003|abbcdef
ENTRY = STI 571|T109|T121|LAB|NRW|NLM (2000)|000821|abbcdef
ENTRY = STI-571|T109|T121|LAB|NRW|NLM (2000)|000821|abbcdef
ENTRY = STI571|T109|T121|LAB|NRW|NLM (2000)|000825|abbcdef
ENTRY = CGP57148
ENTRY = Mesylate, Imatinib
ENTRY = Methanesulfonate, Imatinib
MN = D02.065.277.456
MN = D02.241.223.100.100.435
MN = D02.455.426.559.389.127.085.465
MN = D03.383.606.405
MN = D03.383.742.349
MH_TH = FDA SRS (2013)
MH_TH = NLM (2001)
MH_TH = NLM (2013)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 8A1O1M485B
RR = 220127-57-1 (imatinib mesilate)
RR = BKJ8M8G5HI
MS = A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.
PM = 2016; IMATINIB MESYLATE was indexed under BENZAMIDES, PIPERAZINES, and PYRIMIDINES 1996-2015
HN = 2016 (1996)
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000068877

*NEWRECORD
RECTYPE = D
MH = Trastuzumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
ENTRY = Herceptin|T116|T121|T129|TRD|NRW|AU|CA|DE|ES|FR|IE|UK|US|abbbcdeeeeeeee
MN = D12.776.124.486.485.114.224.060.875
MN = D12.776.124.790.651.114.224.060.875
MN = D12.776.377.715.548.114.224.200.875
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (1998)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = P188ANX8CK
RR = 180288-69-1
MS = A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
PM = 2016; TRASTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 1998-2015
HN = 2016 (1998)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068878

*NEWRECORD
RECTYPE = D
MH = Adalimumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
ENTRY = D2E7 Antibody|T116|T121|T129|NON|EQV|NLM (2002)|150330|abbbcdef
ENTRY = Humira|T116|T121|T129|TRD|NRW|US|030102|abbbcdef
ENTRY = Antibody, D2E7
MN = D12.776.124.486.485.114.224.060.250
MN = D12.776.124.790.651.114.224.060.250
MN = D12.776.377.715.548.114.224.200.250
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (2002)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = FYS6T7F842
MS = A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
PM = 2016; ADALIMUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2002-2015
HN = 2016 (2002)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068879

*NEWRECORD
RECTYPE = D
MH = Isophane Insulin, Human
AQ = AA AD AE BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Humulin N|T116|T121|TRD|NRW|NLM (2012)|US|110505|abbcdeef
ENTRY = Insulatard|T116|T121|NON|NRW|NLM (2004)|150330|abbcdef
ENTRY = Insulin, NPH, Human|T116|T121|T125|NON|EQV|NLM (2016)|150330|abbbcdef
ENTRY = NPH Insulin, Human|T116|T121|T125|NON|EQV|NLM (2012)|150330|abbbcdef
ENTRY = Novolin N|T116|T121|TRD|NRW|NLM (2012)|110505|abbcdef
ENTRY = Protophan|T116|T121|T125|TRD|EQV|DE|UNK (19XX)|840919|abbbcdeef
ENTRY = Protophane|T116|T121|T125|TRD|EQV|DE|NLM (2012)|110419|abbbcdeef
ENTRY = Human Isophane Insulin
ENTRY = Human NPH Insulin
ENTRY = Insulin, Human Isophane
ENTRY = Insulin, Human NPH
ENTRY = N, Humulin
ENTRY = N, Novolin
MN = D06.472.699.587.200.300.200.500
MN = D06.472.699.587.200.500.625.500.500
MN = D12.644.548.586.200.300.200.500
MN = D12.644.548.586.200.500.625.500.500
MH_TH = NLM (2012)
ST = T116
ST = T121
ST = T125
RN = 0
MS = Human isophane insulin that is used to manage BLOOD GLUCOSE levels in patients with DIABETES.
PM = 2016; ISOPHANE INSULIN, HUMAN was indexed under INSULIN, ISOPHANE and INSULIN, REGULAR, HUMAN 2011-2015
HN = 2016 (2011)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068880

*NEWRECORD
RECTYPE = D
MH = Animals, Exotic
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Exotic Animals|T008|NON|EQV|NLM (2016)|150330|abcdef
ENTRY = Exotic Pets|T008|NON|NRW|NLM (2016)|150330|abcdef
ENTRY = Animal, Exotic
ENTRY = Exotic Animal
ENTRY = Exotic Pet
ENTRY = Pet, Exotic
ENTRY = Pets, Exotic
MN = B01.050.050.126
MH_TH = NLM (2016)
ST = T008
AN = use only when specified by author; coordinate with ANIMALS, WILD or ANIMALS, ZOO as needed
MS = Animals native to a foreign country or of foreign origin or character, that are not native to the United States.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068881

*NEWRECORD
RECTYPE = D
MH = Paliperidone Palmitate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one|T109|T121|NRW|NLM (1993)|abbde
ENTRY = 9-Hydroxy-risperidone|T109|T121|NON|NRW|NLM (1993)|150331|abbcdef
ENTRY = 9-Hydroxyrisperidone|T109|T121|NON|NRW|NLM (1993)|150331|abbcdef
ENTRY = 9-OH-risperidone|T109|T121|NRW|NLM (2009)|090221|abbdef
ENTRY = Invega|T109|T121|TRD|NRW|NLM (2006)|061221|abbcdef
ENTRY = Invega Sustenna|T109|T121|TRD|NRW|NLM (2016)|150330|abbcdef
ENTRY = Paliperidone|T109|T121|NON|NRW|FDA SRS (2015)|INN (19XX)|NLM (2006)|USAN (19XX)|150331|abbcdeeeef
ENTRY = R 76477|T109|T121|LAB|NRW|NLM (1993)|abbcde
ENTRY = R-76477|T109|T121|LAB|NRW|NLM (1993)|abbcde
ENTRY = 9 Hydroxy risperidone
ENTRY = 9 Hydroxyrisperidone
ENTRY = 9 OH risperidone
ENTRY = Palmitate, Paliperidone
ENTRY = R76477
ENTRY = Sustenna, Invega
MN = D03.383.129.385.650
MN = D03.383.742.592
MH_TH = FDA SRS (2013)
MH_TH = NLM (2010)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = R8P8USM8FR
RR = 199739-10-1 (paliperidone palmitate)
RR = 838F01T721
MS = A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.
PM = 2016; PALIPERIDONE was indexed under PYRIMIDINES and ISOXAZOLES, 1993-2015; PALIPERIDONE PALMITATE was indexed under ISOXAZOLES and PALMITATE 2010-2015.
HN = 2016 (1993)
MR = 20150702
DA = 20150706
DC = 1
DX = 20160101
UI = D000068882

*NEWRECORD
RECTYPE = D
MH = Immunosenescence
AQ = DE GE IM PH RE
MN = G07.700.320.124.390
MN = G12.460.500
MH_TH = NLM (2016)
ST = T040
PI = Aging (2015)
MS = The decline in the function of the IMMUNE SYSTEM during aging.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068884

*NEWRECORD
RECTYPE = D
MH = Canagliflozin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973|T118|T121|NON|EQV|NLM (2016)|150401|abbcdef
ENTRY = Canagliflozin Hemihydrate|T118|T121|NON|EQV|NLM (2016)|150401|abbcdef
ENTRY = Invokana|T118|T121|TRD|NRW|NLM (2014)|140813|abbcdef
ENTRY = Hemihydrate, Canagliflozin
MN = D02.886.778.075
MN = D03.383.903.075
MN = D09.408.348.113
MH_TH = FDA SRS (2013)
MH_TH = NLM (2010)
MH_TH = USAN (19XX)
ST = T118
ST = T121
RN = 0SAC974Z85
RR = 928672-86-0
MS = A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.
PM = 2016; CANAGLIFLOZIN was indexed under GLUCOSIDES and THIOPHENES 2014-2015
HN = 2016 (2014)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068896

*NEWRECORD
RECTYPE = D
MH = Iridescence
AQ = DE GE IM PH RE
ENTRY = Goniochromism|T070|NON|EQV|NLM (2016)|150401|abcdef
ENTRY = Iridescent Coloring|T070|NON|EQV|NLM (2016)|150401|abcdef
ENTRY = Opalescence|T070|NON|REL|NLM (2016)|150401|abcdef
ENTRY = Pearlescence|T070|NON|REL|NLM (2016)|150402|abcdef
ENTRY = Coloring, Iridescent
ENTRY = Colorings, Iridescent
ENTRY = Iridescent Colorings
MN = G01.590.310
MH_TH = NLM (2016)
ST = T070
MS = The changing of the color of an object due to variations in the angle of illumination or observation.
PM = 2016; OPALESCENCE was indexed under PEROXIDES 1969-2015
HN = 2016; for OPALESCENCE (NM) use CARBAMIDE PEROXIDE (NM) 1969-2015
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000068897

*NEWRECORD
RECTYPE = D
MH = Raltegravir Potassium
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Isentress|T109|T121|TRD|NRW|NLM (2008)|080801|abbcdef
ENTRY = MK 0518|T109|T121|LAB|NRW|NLM (2006)|060215|abbcdef
ENTRY = MK-0518|T109|T121|LAB|NRW|NLM (2006)|060215|abbcdef
ENTRY = MK0518|T109|T121|LAB|NRW|NLM (2006)|060215|abbcdef
ENTRY = Raltegravir|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2007)|150401|abbcdeeef
ENTRY = 0518, MK
ENTRY = Potassium, Raltegravir
MN = D03.383.773.812.752
MH_TH = FDA SRS (2015)
MH_TH = NLM (2016)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 43Y000U234
RR = 22VKV8053U
RR = 518048-05-0 (raltegravir)
RR = 871038-72-1 (raltegravir potassium)
MS = A pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.
PM = 2016; RALTEGRAVIR POTASSIUM was indexed under PYRROLIDINONES 2008-2015; and under ORGANIC CHEMICALS 2006-2008
HN = 2016 (2006)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000068898

*NEWRECORD
RECTYPE = D
MH = Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
AQ = AA AD AE AG AI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Janumet|T109|NON|NRW|NLM (2008)|150401|abcdef
ENTRY = Sitagliptin Phosphate Metformin Hydrochloride Drug Combination|T121|NON|EQV|NLM (2016)|150520|abcdef
ENTRY = Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination|T121|NON|EQV|NLM (2016)|150401|abcdef
MN = D02.078.370.141.450.500
MN = D03.383.129.799.725.500
MN = D03.383.679.875.500
MN = D26.310.750
MH_TH = NLM (2016)
ST = T121
RN = 0
MS = A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.
PM = 2016; SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE DRUG COMBINATION was indexed under METFORMIN and PYRAZINES 2008-2015
HN = 2016 (2008)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068899

*NEWRECORD
RECTYPE = D
MH = Sitagliptin Phosphate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine|T109|T121|NON|NRW|NLM (2005)|150401|abbcdef
ENTRY = Januvia|T109|T121|TRD|NRW|NLM (2006)|060216|abbcdef
ENTRY = MK 0431|T109|T121|LAB|NRW|NLM (2005)|050216|abbcdef
ENTRY = MK-0431|T109|T121|LAB|NRW|NLM (2005)|050216|abbcdef
ENTRY = MK0431|T109|T121|LAB|NRW|NLM (2005)|050216|abbcdef
ENTRY = Sitagliptin|T109|T121|NON|NRW|FDA SRS (2013)|INN (19XX)|NLM (2016)|150401|abbcdeeef
ENTRY = Sitagliptin Monophosphate Monohydrate|T109|T121|NON|EQV|FDA SRS (2013)|NLM (2013)|150401|abbcdeef
ENTRY = Sitagliptin Phosphate Anhydrous|T109|T121|NON|NRW|FDA SRS (2013)|NLM (2016)|150401|abbcdeef
ENTRY = Sitagliptin Phosphate Monohydrate|T109|T121|NON|EQV|FDA SRS (2013)|NLM (2013)|150401|abbcdeef
ENTRY = 0431, MK
ENTRY = Anhydrous, Sitagliptin Phosphate
ENTRY = Monohydrate, Sitagliptin Monophosphate
ENTRY = Monohydrate, Sitagliptin Phosphate
ENTRY = Monophosphate Monohydrate, Sitagliptin
ENTRY = Phosphate Anhydrous, Sitagliptin
ENTRY = Phosphate Monohydrate, Sitagliptin
ENTRY = Phosphate, Sitagliptin
MN = D03.383.129.799.725
MN = D03.383.679.875
FX = Linagliptin
MH_TH = FDA SRS (2013)
MH_TH = NLM (2006)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = TS63EW8X6F
RR = 486460-32-6 (sitagliptin)
RR = 494P4635I6
RR = 654671-77-9 (sitagliptin phosphate)
RR = QFP0P1DV7Z
MS = A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.
PM = 2016; SITAGLIPTIN PHOSPHATE was indexed under PYRAZINES and TRIAZOLES 2005-2015
HN = 2016 (2005)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000068900

*NEWRECORD
RECTYPE = D
MH = Spatial Regression
ENTRY = Geographically Weighted Regression|T081|NON|NRW|NLM (2016)|150403|abcdef
ENTRY = Geographically Weighted Regressions
ENTRY = Regression, Geographically Weighted
ENTRY = Regression, Spatial
ENTRY = Regressions, Geographically Weighted
ENTRY = Regressions, Spatial
ENTRY = Spatial Regressions
ENTRY = Weighted Regression, Geographically
ENTRY = Weighted Regressions, Geographically
MN = E05.318.740.750.862
MN = E05.318.740.933.375
MN = N05.715.360.750.695.825
MN = N05.715.360.750.746.375
MN = N06.850.520.830.750.862
MN = N06.850.520.830.933.375
MH_TH = NLM (2016)
ST = T081
PI = Regression Analysis (1996-2015)
MS = Methods used to take into account and incorporate spatial autocorrelation and regional variation into regression analysis models of data that has spatial dependency, and also to provide information on the spatial relationships among the variables.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068916

*NEWRECORD
RECTYPE = D
MH = Theranostic Nanomedicine
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Theranostics|T091|NON|BRD|NLM (2016)|150526|abcdef
ENTRY = Nanomedicine, Theranostic
ENTRY = Nanomedicines, Theranostic
ENTRY = Theranostic
ENTRY = Theranostic Nanomedicines
MN = E01.894
MN = E02.921
MN = H01.603.600.500
MN = H02.403.845
MN = J01.897.520.600.600.500
MH_TH = NLM (2016)
ST = T091
PI = Nanomedicine (2013-2015)
MS = An integrated nano-scale approach to MEDICINE which involves concurrent diagnosis, drug delivery, therapy, and monitoring of therapeutic response.
PM = 2016
HN = 2016
MR = 20150707
DA = 20150707
DC = 1
DX = 20160101
UI = D000068936

*NEWRECORD
RECTYPE = D
MH = Cosmeceuticals
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
MN = D26.074
MN = D27.720.269.285
MH_TH = NLM (2016)
ST = T073
RN = 0
PI = Cosmetics (2000-2015)
MS = COSMETICS that are associated with therapeutic effects.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068937

*NEWRECORD
RECTYPE = D
MH = Prisoner Dilemma
PRINT ENTRY = Prisoner's Dilemma|T078|NON|EQV|UNK (19XX)|780310|abcdef
ENTRY = Prisoners Dilemma|T078|NON|EQV|UNK (19XX)|840618|abcdef
ENTRY = Dilemma, Prisoner
ENTRY = Dilemma, Prisoner's
ENTRY = Dilemma, Prisoners
MN = E05.385.500
MH_TH = UNK (19XX)
ST = T078
MS = A scenario in decision analysis in which two individuals motivated entirely by self-preservation at the expense of the other, end up in a worse state than if they had cooperated with each other in the decision-making process.
PM = 2016; see GAME THEORY 1985-2015
HN = 2016; use GAME THEORY 1985-2015
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000068956

*NEWRECORD
RECTYPE = D
MH = Games, Recreational
AQ = IN PX
ENTRY = Game, Recreational
ENTRY = Recreational Game
ENTRY = Recreational Games
MN = I03.450.642.693.465
FX = Video Games
MH_TH = NLM (2016)
ST = T054
ST = T056
MS = Activity typically involving several individuals for the purpose of leisure, amusement, entertainment or pleasure.
PM = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068957

*NEWRECORD
RECTYPE = D
MH = Return to Sport
AQ = CL EC ED ES HI LJ PH PX SN ST TD
ENTRY = Return to Play|T080|NON|EQV|NLM (2016)|150407|abcdef
ENTRY = Return to Sporting Activities|T080|NON|BRD|NLM (2016)|150526|abcdef
ENTRY = Play, Return to
ENTRY = Return to Sports
ENTRY = Sport, Return to
ENTRY = Sports, Return to
ENTRY = to Play, Return
ENTRY = to Sport, Return
ENTRY = to Sports, Return
MN = I03.450.642.845.605
MH_TH = NLM (2016)
ST = T080
MS = Resumption of sporting activity following a hiatus or period of absence due to injury or other reasons.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068958

*NEWRECORD
RECTYPE = D
MH = Body Weight Maintenance
AQ = DE GE IM PH RE
ENTRY = Body Weight Maintenances
ENTRY = Maintenance, Body Weight
ENTRY = Maintenances, Body Weight
ENTRY = Weight Maintenance, Body
ENTRY = Weight Maintenances, Body
MN = G07.700.320.249.314.120.250
MH_TH = NLM (2016)
ST = T052
MS = Sustaining BODY WEIGHT after BODY WEIGHT CHANGES have been achieved.
PM = 2016
HN = 2016
MR = 20150615
DA = 20150701
DC = 1
DX = 20160101
UI = D000068959

*NEWRECORD
RECTYPE = D
MH = Functional Behavior, Psychology
AQ = CL DE ES PH RE
ENTRY = Behavior, Psychology Functional
ENTRY = Behaviors, Psychology Functional
ENTRY = Psychology Functional Behavior
MN = F01.145.437
MH_TH = NLM (2016)
ST = T055
MS = Behaviors driven by distinct MOTIVATION factors that have functionally specific consequences for PERCEPTION; COGNITION, and behavior. Functional behavior often refers to behaviors that appear to be problematic or situationally inappropriate, but have a functional purpose based on the cognitive or motivational state of the individual.
PM = 2016
HN = 2016
MR = 20151202
DA = 20150701
DC = 1
DX = 20160101
UI = D000068960

*NEWRECORD
RECTYPE = D
MH = Concierge Medicine
AQ = CL EC ES HI LJ OG SN ST TD UT
ENTRY = Boutique Medicine|T091|NON|EQV|NLM (2016)|150408|abcdef
ENTRY = Retainer Medicine|T091|NON|EQV|NLM (2016)|150408|abcdef
ENTRY = Medicine, Boutique
ENTRY = Medicine, Concierge
ENTRY = Medicine, Retainer
MN = N04.452.758.708.450.500
MH_TH = NLM (2016)
ST = T091
PI = Health Services Accessibility (2000-2015)
MS = An arrangement in which a patient pays an annual fee to a physician in exchange for services over and beyond normal insurance-reimbursed services.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000068977

*NEWRECORD
RECTYPE = D
MH = Smartphone
AQ = CL EC ES HI IS LJ SD SN ST TD UT
ENTRY = Smart Phone|T073|NON|EQV|NLM (2015)|131213|abcdef
ENTRY = Smart Phones|T073|NON|EQV|NLM (2015)|131213|abcdef
ENTRY = Phone, Smart
ENTRY = Phones, Smart
ENTRY = Smartphones
MN = L01.178.847.698.300.250
MN = L01.224.230.260.550.500.500
FX = Computers, Handheld
MH_TH = NLM (2015)
ST = T073
MS = A cellular phone with advanced computing and connectivity capability built on an operating system.
PM = 2016; see CELL PHONES 2015
HN = 2016; use CELL PHONES 2015
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000068997

*NEWRECORD
RECTYPE = D
MH = Humidifiers
AQ = CL EC ES HI LJ OG SN ST TD UT
ENTRY = Humidifier
MN = E07.451
MN = J01.494.650
FX = Respiration, Artificial
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T074
MS = Machines that add moisture to the air.
PM = 2016
HN = 2016
MR = 20150623
DA = 20150706
DC = 1
DX = 20160101
UI = D000068998

*NEWRECORD
RECTYPE = D
MH = Acculturation
AQ = HI
ENTRY = Assimilation, Cultural|T054|NON|NRW|NLM (2007)|051213|abcdef
ENTRY = Cultural Assimilation
MN = I01.076.201.450.050
MN = I01.880.853.100.079
MH_TH = POPLINE (1986)
ST = T054
MS = Process of cultural change in which one group or members of a group assimilate various cultural patterns from another.
HN = 1963
MR = 20100625
DA = 19990101
DC = 1
UI = D000069

*NEWRECORD
RECTYPE = D
MH = Insulin Glargine
AQ = AA AD AE BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = A21-Gly-B31-Arg-B32-Arg-insulin|T116|T121|EQV|NLM (1997)|abbde
ENTRY = Glargine|T116|T121|NON|EQV|NLM (2000)|150414|abbcdef
ENTRY = HOE 901|T116|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = HOE-901|T116|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = Insulin, Gly(A21)-Arg(B31,B32)|T116|T121|NON|EQV|NLM (1997)|150414|abbcdef
ENTRY = Insulin, Glycyl(A21)-Arginyl(B31,B32)|T116|T121|NON|EQV|NLM (1997)|150414|abbcdef
ENTRY = Lantus|T116|T121|TRD|NRW|NLM (2001)|010822|abbcdef
ENTRY = Lantus Solostar|T116|T121|TRD|NRW|NLM (2016)|150414|abbcdef
ENTRY = 901, HOE
ENTRY = A21 Gly B31 Arg B32 Arg insulin
ENTRY = Glargine, Insulin
ENTRY = HOE901
ENTRY = Solostar, Lantus
MN = D06.472.699.587.200.300.100
MN = D12.644.548.586.200.300.100
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2006)
MH_TH = USAN (19XX)
ST = T116
ST = T121
RN = 2ZM8CX04RZ
RR = 160337-95-1
MS = A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.
PM = 2016; INSULIN GLARGINE was indexed under INSULIN, LONG ACTING 2011-2015; and under INSULIN 1997-2011
HN = 2016 (1997)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000069036

*NEWRECORD
RECTYPE = D
MH = Lurasidone Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Latuda|T109|T121|TRD|NRW|NLM (2014)|150415|abbcdef
ENTRY = Lurasidone|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|USAN (2008)|150415|abbcdeeef
ENTRY = Lurasidone HCl|T109|T121|NON|EQV|NLM (2016)|150415|abbcdef
ENTRY = N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide|T109|T121|BRD|NLM (2008)|080110|abbdef
ENTRY = SM 13496|T109|T121|LAB|NRW|NLM (2008)|080110|abbcdef
ENTRY = SM-13,496|T109|T121|LAB|NRW|NLM (2014)|130822|abbcdef
ENTRY = SM-13496|T109|T121|LAB|NRW|NLM (2008)|080110|abbcdef
ENTRY = SM13496|T109|T121|LAB|NRW|NLM (2008)|080110|abbcdef
ENTRY = 13496, SM
ENTRY = HCl, Lurasidone
ENTRY = Hydrochloride, Lurasidone
ENTRY = SM 13,496
ENTRY = SM13,496
MN = D02.886.675.414
MN = D03.383.129.708.414
MN = D03.438.513.437
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2016)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = O0P4I5851I
RR = 22IC88528T
RR = 367514-87-2 (lurasidone)
RR = 367514-88-3 (lurasidone hydrochloride)
MS = A thiazole derivative and atypical ANTIPSYCHOTIC AGENT that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST; SEROTONIN 5-HT2 RECEPTOR ANTAGONIST, serotonin 5-HT7 receptor antagonist, and antagonist of the adrenergic 2A and 2C receptors, as well as a partial SEROTONIN 5-HT1A RECEPTOR AGONIST. It is used in the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER.
PM = 2016; LURASIDONE HYDROCHLORIDE was indexed under ISOINDOLES and THIAZOLES 2008-2015
HN = 2016 (2008)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069056

*NEWRECORD
RECTYPE = D
MH = Insulin Detemir
AQ = AA AD AE BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 12C-Lys(B29)-DB30I|T116|T121|T125|LAB|EQV|NLM (1997)|abbbcde
ENTRY = B29-tetradecanoyl-Lys-B30-des-Ala-insulin|T116|T121|T125|NON|EQV|NLM (1997)|abbbcde
ENTRY = Basal Insulin Detemir|T116|T121|T125|NON|EQV|NLM (2008)|150415|abbbcdef
ENTRY = Des-(B30)-insulin, Lys(B29)-tetradecanoyl|T116|T121|T125|NON|EQV|NLM (1997)|150415|abbbcdef
ENTRY = Insulin, Tetradecanoyl-Lys(B29)-des-Ala(B30)|T116|T121|T125|NON|EQV|NLM (1997)|150415|abbbcdef
ENTRY = Insulin, Tetradecanoyllysyl(B29)-desalanyl(B30)|T116|T121|T125|NON|EQV|NLM (1997)|150415|abbbcdef
ENTRY = Levemir|T116|T121|T125|TRD|NRW|NLM (2003)|030716|abbbcdef
ENTRY = NN 304|T116|T121|T125|LAB|NRW|NLM (2003)|030716|abbbcdef
ENTRY = NN-304|T116|T121|T125|LAB|NRW|NLM (2003)|030716|abbbcdef
ENTRY = NN304|T116|T121|T125|LAB|NRW|NLM (1997)|abbbcde
ENTRY = 304, NN
ENTRY = B29 tetradecanoyl Lys B30 des Ala insulin
ENTRY = Detemir, Basal Insulin
ENTRY = Detemir, Insulin
ENTRY = Insulin Detemir, Basal
MN = D06.472.699.587.200.300.050
MN = D12.644.548.586.200.300.050
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2003)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T125
RN = 4FT78T86XV
RR = 169148-63-4
MS = A recombinant long-acting insulin and HYPOGLYCEMIC AGENT in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.
PM = 2016; INSULIN DETEMIR was indexed under INSULIN, LONG-ACTING 2011-2015; under INSULIN 1997-2011; and under CARRIER PROTEINS 1997-2004
HN = 2016 (1997)
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000069057

*NEWRECORD
RECTYPE = D
MH = Vardenafil Dihydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine|T109|T121|BRD|NLM (2001)|010521|abbdef
ENTRY = Levitra|T109|T121|TRD|NRW|DE|MX|NL|UK|030313|abbcdeeeef
ENTRY = Vardenafil|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2001)|USAN (19XX)|150415|abbcdeeeef
ENTRY = Vardenafil Hydrochloride|T109|T121|NON|NRW|NLM (2012)|USAN (2001)|150415|abbcdeef
ENTRY = Vardenafil Hydrochloride Anhydrous|T109|T121|NON|NRW|FDA SRS (2015)|NLM (2012)|150415|abbcdeef
ENTRY = Vardenafil Hydrochloride Trihydrate|T109|T121|NON|NRW|FDA SRS (2015)|NLM (2012)|150415|abbcdeef
ENTRY = Anhydrous, Vardenafil Hydrochloride
ENTRY = Dihydrochloride, Vardenafil
ENTRY = Hydrochloride Anhydrous, Vardenafil
ENTRY = Hydrochloride Trihydrate, Vardenafil
ENTRY = Hydrochloride, Vardenafil
ENTRY = Trihydrate, Vardenafil Hydrochloride
MN = D03.383.129.308.980
MN = D03.383.606.960
MH_TH = FDA SRS (2013)
MH_TH = NLM (2011)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 5O8R96XMH7
RR = 224785-90-4
RR = 224789-15-5
RR = 5M8S2CU0TS
RR = IF61NL91H3
RR = UCE6F4125H
MS = A piperazine derivative, PHOSPHODIESTERASE 5 INHIBITOR and VASODILATOR AGENT that is used as a UROLOGICAL AGENT in the treatment of ERECTILE DYSFUNCTION.
PM = 2016; VARDENAFIL DIHYDROCHLORIDE was indexed under IMIDAZOLES and PIPERAZINES 2001-2015
HN = 2016 (2001)
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000069058

*NEWRECORD
RECTYPE = D
MH = Atorvastatin Calcium
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Atorvastatin|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|USAN (1994)|150415|abbcdeeef
ENTRY = Atorvastatin Calcium Anhydrous|T109|T121|NON|NRW|NLM (2014)|150415|abbcdef
ENTRY = Atorvastatin Calcium Hydrate|T109|T121|NON|EQV|NLM (2014)|150415|abbcdef
ENTRY = Atorvastatin Calcium Trihydrate|T109|T121|NON|EQV|NLM (2014)|150415|abbcdef
ENTRY = Atorvastatin, Calcium Salt|T109|T121|NON|EQV|NLM (1990)|150415|abbcdef
ENTRY = CI 981|T109|T121|LAB|NRW|NLM (1990)|abbcde
ENTRY = CI-981|T109|T121|LAB|NRW|NLM (1990)|abbcde
ENTRY = Lipitor|T109|T121|TRD|NRW|NLM (1990)|abbcde
ENTRY = Liptonorm|T109|T121|TRD|NRW|NLM (2016)|150415|abbcdef
ENTRY = Anhydrous, Atorvastatin Calcium
ENTRY = CI981
ENTRY = Calcium Anhydrous, Atorvastatin
ENTRY = Calcium Hydrate, Atorvastatin
ENTRY = Calcium Salt Atorvastatin
ENTRY = Calcium Trihydrate, Atorvastatin
ENTRY = Calcium, Atorvastatin
ENTRY = Hydrate, Atorvastatin Calcium
ENTRY = Trihydrate, Atorvastatin Calcium
MN = D03.383.129.578.075
MN = D10.251.450.200
MH_TH = NLM (1990)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
RN = 48A5M73Z4Q
RR = 110862-48-1
RR = 48A5M73Z4Q
RR = A0JWA85V8F
RR = C0GEJ5QCSO
MS = A pyrrole and heptanoic acid derivative,HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; AND TRIGLYCERIDES and to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS and prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.
PM = 2016; ATORVASTATIN CALCIUM was indexed under HEPTANOIC ACIDS and PYRROLES 1990-2015
HN = 2016 (1990)
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000069059

*NEWRECORD
RECTYPE = D
MH = Fractures, Multiple
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Fracture, Multiple
ENTRY = Multiple Fracture
ENTRY = Multiple Fractures
MN = C26.404.280
MN = C26.640.500
MH_TH = NLM (2016)
ST = T037
MS = Injuries involving the breaking of either several bones or one bone in two or more places.
PM = 2016
HN = 2016
MR = 20150522
DA = 20150701
DC = 1
DX = 20160101
UI = D000069076

*NEWRECORD
RECTYPE = D
MH = Memory Consolidation
AQ = CL DE PH RE
ENTRY = Consolidation, Memory
ENTRY = Consolidations, Memory
ENTRY = Memory Consolidations
MN = F02.463.425.540.305.500
FX = Learning
MH_TH = NLM (2016)
ST = T041
MS = Neurological process involving the conversion of learned information into long-term memory.
PM = 2016
HN = 2016
MR = 20150522
DA = 20150701
DC = 1
DX = 20160101
UI = D000069077

*NEWRECORD
RECTYPE = D
MH = Seroconversion
AQ = DE GE PH RE
ENTRY = Seroconversions
MN = G12.425.900
FX = Immune System Phenomena
MH_TH = NLM (2016)
ST = T070
MS = The appearance of antibodies against causative agents in the blood of individuals during the course of an infection or following immunization.
PM = 2016
HN = 2016
MR = 20150702
DA = 20150706
DC = 1
DX = 20160101
UI = D000069078

*NEWRECORD
RECTYPE = D
MH = Radiation Exposure
AQ = AE AN CL EC ES HI LJ PC SN ST
ENTRY = Exposure, Radiation
MN = G01.750.748
MN = N06.850.460.350.850
FX = Environmental Pollutants
MH_TH = NLM (2016)
ST = T037
MS = Phenomenon in which organisms are subjected to radiation.
PM = 2016
HN = 2016
MR = 20150522
DA = 20150701
DC = 1
DX = 20160101
UI = D000069079

*NEWRECORD
RECTYPE = D
MH = Health Smart Cards
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Patient Identification Cards|T073|T074|NON|EQV|NLM (2016)|150417|abbcdef
ENTRY = Smart Cards|T073|T074|NON|EQV|NLM (2016)|150417|abbcdef
ENTRY = Card, Patient Identification
ENTRY = Card, Smart
ENTRY = Cards, Patient Identification
ENTRY = Cards, Smart
ENTRY = Health Smart Card
ENTRY = Identification Card, Patient
ENTRY = Identification Cards, Patient
ENTRY = Patient Identification Card
ENTRY = Smart Card
ENTRY = Smart Card, Health
ENTRY = Smart Cards, Health
MN = E05.318.308.940.968.625.750
MN = L01.280.900.968.775.500
MN = L01.313.500.750.300.695.300
MN = N04.452.653.250
MN = N04.452.859.564.650.250
MN = N05.715.360.300.715.500.530.500
MN = N06.850.520.308.940.968.625.500
MH_TH = NLM (2016)
ST = T073
ST = T074
MS = Hand-sized cards with built-in computer chips used for accessing, storing, and protecting patients' medical information.
PM = 2016
HN = 2016
MR = 20150522
DA = 20150701
DC = 1
DX = 20160101
UI = D000069098

*NEWRECORD
RECTYPE = D
MH = Type I Secretion Systems
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Bacterial Secretion Systems, Type I|T116|NON|EQV|NLM (2016)|150422|abcdef
ENTRY = T1SS Secretion System|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Type 1 Secretion System|T116|NON|EQV|NLM (2016)|150422|abcdef
ENTRY = Type 1 Secretion Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type I Secretion System|T116|NON|EQV|NLM (2016)|150422|abcdef
ENTRY = Secretion System, T1SS
ENTRY = System, T1SS Secretion
MN = D05.500.890.500.500
MH_TH = NLM (2016)
ST = T116
RN = 0
PI = Bacterial Secretion Systems (2010-2015)
MS = Gram-negative bacterial secretion systems which translocate effectors in a single step across the inner and outer membranes. The one-step secretion is carried out by a channel that passes from the CYTOPLASM, through the inner membrane, PERIPLASMIC SPACE, and outer membrane, to the EXTRACELLULAR SPACE. The specificity of type I secretions systems are determined by the specificity of the three subcomponents forming the channel - an ATP transporter (ATP-BINDING CASSETTE TRANSPORTERS); a membrane fusion protein (MEMBRANE FUSION PROTEINS); and an outer membrane protein (BACTERIAL OUTER MEMBRANE PROTEINS.)
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069177

*NEWRECORD
RECTYPE = D
MH = Type II Secretion Systems
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Bacterial Secretion System, Type II|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = T2SS Secretion System|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Type 2 Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type 2 Secretion Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type II Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Secretion System, T2SS
ENTRY = System, T2SS Secretion
MN = D05.500.890.500.750
MH_TH = NLM (2016)
ST = T116
RN = 0
PI = Bacterial Secretion Systems (2010-2015)
MS = Gram-negative bacterial secretion systems which carry out the secretion of folded proteins.T2SSs secrete folded proteins from the PERIPLASMIC SPACE that have been exported there by SEC TRANSLOCASE or TAT SECRETION SYSTEMS, or they secrete folded proteins directly from the CYTOPLASM. The T2SSs have four substructures, an ATPase, an inner membrane platform, a pseudopilin, and secretin, an outer membrane complex which is a channel for secretion. (This bacterial secretin is not the same as the mammalian hormone also named SECRETIN.)
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069178

*NEWRECORD
RECTYPE = D
MH = Gastrointestinal Microbiome
AQ = DE GE IM PH RE
ENTRY = Gastrointestinal Flora|T001|NON|EQV|NLM (2016)|150423|abcdef
ENTRY = Gastrointestinal Microbiota|T001|NON|EQV|NLM (2016)|150423|abcdef
ENTRY = Gastrointestinal Microflora|T001|NON|EQV|NLM (2016)|150423|abcdef
ENTRY = Gut Flora|T001|NON|EQV|NLM (2016)|150423|abcdef
ENTRY = Gut Microbiome|T001|NON|EQV|NLM (2016)|150423|abcdef
ENTRY = Gut Microbiota|T001|NON|EQV|NLM (2016)|150423|abcdef
ENTRY = Gut Microflora|T001|NON|EQV|NLM (2016)|150423|abcdef
ENTRY = Intestinal Flora|T001|NON|NRW|NLM (2016)|150423|abcdef
ENTRY = Intestinal Microbiome|T001|NON|NRW|NLM (2016)|150423|abcdef
ENTRY = Intestinal Microbiota|T001|NON|NRW|NLM (2016)|150423|abcdef
ENTRY = Intestinal Microflora|T001|NON|NRW|NLM (2016)|150423|abcdef
ENTRY = Flora, Gastrointestinal
ENTRY = Flora, Gut
ENTRY = Flora, Intestinal
ENTRY = Gastrointestinal Microbiomes
ENTRY = Gastrointestinal Microbiotas
ENTRY = Gut Microbiomes
ENTRY = Gut Microbiotas
ENTRY = Intestinal Microbiomes
ENTRY = Intestinal Microbiotas
ENTRY = Microbiome, Gastrointestinal
ENTRY = Microbiome, Gut
ENTRY = Microbiome, Intestinal
ENTRY = Microbiomes, Gastrointestinal
ENTRY = Microbiomes, Gut
ENTRY = Microbiomes, Intestinal
ENTRY = Microbiota, Gastrointestinal
ENTRY = Microbiota, Gut
ENTRY = Microbiota, Intestinal
ENTRY = Microbiotas, Gastrointestinal
ENTRY = Microbiotas, Gut
ENTRY = Microbiotas, Intestinal
ENTRY = Microflora, Gastrointestinal
ENTRY = Microflora, Gut
ENTRY = Microflora, Intestinal
MN = G06.755.375
MN = G16.500.275.157.049.100.500.375
MN = N06.230.124.049.100.500.250
MH_TH = NLM (2016)
ST = T001
MS = All of the microbial organisms that naturally exist within the GASTROINTESTINAL TRACT.
PM = 2016
HN = 2016
MR = 20150616
DA = 20150701
DC = 1
DX = 20160101
UI = D000069196

*NEWRECORD
RECTYPE = D
MH = Contraceptive Prevalence Surveys
AQ = CL EC ES HI LJ SD SN ST TD UT
ENTRY = Contraceptive Prevalence Survey
ENTRY = Survey, Contraceptive Prevalence
ENTRY = Surveys, Contraceptive Prevalence
MN = E05.318.308.980.313
MN = L01.280.960.233
MN = N05.715.360.300.800.313
MN = N06.850.520.308.980.313
MH_TH = POPLINE (1980)
ST = T062
MS = Surveys that measure the usage rate of CONTRACEPTIVE DEVICES or CONTRACEPTIVE AGENTS.
PM = 2016; see DATA COLLECTION 1987-2015
HN = 2016; use DATA COLLECTION 1987-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069216

*NEWRECORD
RECTYPE = D
MH = Pericardial Fluid
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
ENTRY = Pericardium Fluid|T031|NON|EQV|NLM (2016)|150501|abcdef
ENTRY = Fluid, Pericardial
ENTRY = Fluid, Pericardium
ENTRY = Fluids, Pericardial
ENTRY = Fluids, Pericardium
ENTRY = Pericardial Fluids
ENTRY = Pericardium Fluids
MN = A07.541.795.500
MN = A10.615.789.470.500
MN = A12.207.270.651
MH_TH = NLM (2016)
ST = T031
PI = Pericardial Effusion (1967-2015)
PI = Pericardium (1964-2015)
MS = Watery fluid produced in the serous and visceral pericardium surrounding the surface of the HEART.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069236

*NEWRECORD
RECTYPE = D
MH = Arthrocentesis
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Arthrocentesis, TMJ|T058|ABX|NRW|NLM (2016)|150504|abcdef
ENTRY = Arthrocentesis,Temporomandibular Joint|T058|NON|NRW|NLM (2016)|150501|abcdef
ENTRY = Aspiration,Temporomandibular Joint|T058|NON|NRW|NLM (2016)|150501|abcdef
ENTRY = Temporomandibular Joint Arthrocentesis|T058|NON|NRW|NLM (2016)|150501|abcdef
ENTRY = Temporomandibular Joint Aspiration|T058|NON|NRW|NLM (2016)|150501|abcdef
ENTRY = Arthrocenteses
ENTRY = Arthrocenteses, TMJ
ENTRY = Arthrocenteses, Temporomandibular Joint
ENTRY = Arthrocentesis, Temporomandibular Joint
ENTRY = Arthrocentesis,Temporomandibular Joints
ENTRY = Aspiration, Temporomandibular Joint
ENTRY = Aspiration,Temporomandibular Joints
ENTRY = Aspirations, Temporomandibular Joint
ENTRY = Joint Arthrocenteses, Temporomandibular
ENTRY = Joint Arthrocentesis, Temporomandibular
ENTRY = Joint Aspiration, Temporomandibular
ENTRY = Joint Aspirations, Temporomandibular
ENTRY = Joint, Arthrocentesis,Temporomandibular
ENTRY = Joint, Aspiration,Temporomandibular
ENTRY = Joints, Arthrocentesis,Temporomandibular
ENTRY = Joints, Aspiration,Temporomandibular
ENTRY = TMJ Arthrocenteses
ENTRY = TMJ Arthrocentesis
ENTRY = Temporomandibular Joint Arthrocenteses
ENTRY = Temporomandibular Joint Aspirations
MN = E01.370.225.998.329.465
MN = E02.800.550.310
MN = E04.665.600.465
MN = E05.200.998.329.465
MH_TH = NLM (2016)
ST = T058
PI = Paracentesis (1996-2015)
MS = Puncture and aspiration of fluid (e.g., SYNOVIAL FLUID) from a joint cavity. It is used sometimes to irrigate or administer drugs into a joint cavity.
PM = 2016
HN = 2016
MR = 20150709
DA = 20150709
DC = 1
DX = 20160101
UI = D000069237

*NEWRECORD
RECTYPE = D
MH = Thoracentesis
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Chest Aspiration|T060|T061|NON|EQV|NLM (2016)|150514|abbcdef
ENTRY = Pleural Aspiration|T060|T061|NON|EQV|NLM (2016)|150514|abbcdef
ENTRY = Pleurocentesis|T060|T061|NON|EQV|NLM (2016)|150514|abbcdef
ENTRY = Thoracocentesis|T060|T061|NON|EQV|NLM (2016)|150504|abbcdef
ENTRY = Aspiration, Chest
ENTRY = Aspiration, Pleural
ENTRY = Aspirations, Chest
ENTRY = Aspirations, Pleural
ENTRY = Chest Aspirations
ENTRY = Pleural Aspirations
ENTRY = Pleurocenteses
ENTRY = Thoracenteses
ENTRY = Thoracocenteses
MN = E01.370.225.998.329.810
MN = E02.800.550.810
MN = E04.665.600.810
MN = E05.200.998.329.810
FX = Pleural Effusion
FX = Pneumothorax
MH_TH = NLM (2016)
ST = T060
ST = T061
PI = Paracentesis (1966-2015)
MS = Aspiration of fluid or air from the THORACIC CAVITY. It is coupled sometimes  with the administration of drugs into the PLEURAL CAVITY.
PM = 2016
HN = 2016
MR = 20150709
DA = 20150709
DC = 1
DX = 20160101
UI = D000069258

*NEWRECORD
RECTYPE = D
MH = Superficial Musculoaponeurotic System
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Platysma Muscle|T029|NON|REL|NLM (2016)|150519|abcdef
ENTRY = Superficial Musculo-Aponeurotic System|T029|NON|EQV|NLM (2016)|150519|abcdef
ENTRY = Superficial Musculo-aponeurotic System (SMAS)|T029|NON|EQV|NLM (2016)|150519|abcdef
ENTRY = Muscle, Platysma
ENTRY = Muscles, Platysma
ENTRY = Musculo-Aponeurotic System, Superficial
ENTRY = Musculo-Aponeurotic Systems, Superficial
ENTRY = Musculoaponeurotic System, Superficial
ENTRY = Musculoaponeurotic Systems, Superficial
ENTRY = Platysma Muscles
ENTRY = Superficial Musculo Aponeurotic System
ENTRY = Superficial Musculo aponeurotic System (SMAS)
ENTRY = Superficial Musculo-Aponeurotic Systems
ENTRY = Superficial Musculo-aponeurotic Systems (SMAS)
ENTRY = Superficial Musculoaponeurotic Systems
ENTRY = System, Superficial Musculo-Aponeurotic
ENTRY = System, Superficial Musculo-aponeurotic (SMAS)
ENTRY = System, Superficial Musculoaponeurotic
ENTRY = Systems, Superficial Musculo-Aponeurotic
ENTRY = Systems, Superficial Musculoaponeurotic
MN = A01.456.505.875
MN = A01.598.500
FX = Rhytidoplasty
MH_TH = NLM (2016)
ST = T029
PI = Face (1976-2015)
PI = Neck (1976-2015)
MS = Layer between the superficial fat compartment and superficial facial muscles in the head and the neck.
PM = 2016
HN = 2016
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000069259

*NEWRECORD
RECTYPE = D
MH = Podosomes
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Invadopodia|T026|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Invadopodium|T026|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Invadosomes|T026|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Invadopodiums
ENTRY = Invadosome
ENTRY = Podosome
MN = A11.284.180.695
MN = A11.436.275.841
FX = Mechanotransduction, Cellular
MH_TH = NLM (2016)
ST = T026
PI = Cell Surface Extensions (2006-2015)
PI = Extracellular Matrix (1996-2015)
MS = Actin-rich adhesive structures found at the ventral surface of metazoan ENDOTHELIAL CELLS. When found  in cultured cancer cells they are referred to as invadopodia. These are matrix-degrading structures composed of an ACTIN CYTOSKELETON core and an INTEGRINS-containing ring complex.
PM = 2016
HN = 2016
MR = 20150709
DA = 20150709
DC = 1
DX = 20160101
UI = D000069261

*NEWRECORD
RECTYPE = D
MH = Plantar Plate
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Ligamenta Plantaria|T023|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Ligamenta Tarsometatarsea Plantaria|T023|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Plantar Ligament|T023|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Toe Volar Ligament|T023|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Toe Volar Plate|T023|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Volar Ligament, Toe|T023|NON|EQV|NLM (2016)|150505|abcdef
ENTRY = Ligament, Plantar
ENTRY = Ligament, Toe Volar
ENTRY = Ligamenta Plantarias
ENTRY = Ligamenta Tarsometatarsea Plantarias
ENTRY = Ligaments, Plantar
ENTRY = Ligaments, Toe Volar
ENTRY = Plantar Ligaments
ENTRY = Plantar Plates
ENTRY = Plantaria, Ligamenta
ENTRY = Plantarias, Ligamenta
ENTRY = Plate, Plantar
ENTRY = Plate, Toe Volar
ENTRY = Plates, Plantar
ENTRY = Plates, Toe Volar
ENTRY = Tarsometatarsea Plantaria, Ligamenta
ENTRY = Toe Volar Ligaments
ENTRY = Toe Volar Plates
ENTRY = Volar Ligaments, Toe
ENTRY = Volar Plate, Toe
ENTRY = Volar Plates, Toe
MN = A02.165.308.650
MN = A02.513.514.538
MN = A02.835.583.378.531.500
MN = A02.835.583.378.900.500
MN = A02.835.583.512.538
MN = A10.165.382.350.400
MH_TH = NLM (2016)
ST = T023
PI = Metatarsophalangeal Joint (1979-2015)
MS = Fibrocartilaginous ligament at the metatarsophalangeal and the interphalangeal joint of the toe.
PM = 2016
HN = 2016
MR = 20150709
DA = 20150709
DC = 1
DX = 20160101
UI = D000069262

*NEWRECORD
RECTYPE = D
MH = Fallopia
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
MN = B01.650.940.800.575.100.825.359
MH_TH = NLM (2016)
ST = T002
MS = Genus of flowering herbaceous perennial plants and vines in the family Polygonaceae.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069263

*NEWRECORD
RECTYPE = D
MH = Arterial Switch Operation
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Arterial Switch Procedure|T061|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Arterial Switch Technique|T061|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Atrial Switch Operation|T061|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Atrial Switch Procedure|T061|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Atrial Switch Repair|T061|NON|EQV|NLM (2016)|150518|abcdef
ENTRY = Atrial Switch Technique|T061|NON|EQV|NLM (2016)|150518|abcdef
ENTRY = Double-Switch Operation|T061|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Double-Switch Procedure|T061|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Double-Switch Technique|T061|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Jatene Operation|T061|EPO|NRW|NLM (2016)|150518|abcdef
ENTRY = Jatene Procedure|T061|EPO|NRW|NLM (2016)|150518|abcdef
ENTRY = Jatene Technique|T061|EPO|NRW|NLM (2016)|150518|abcdef
ENTRY = Mustard Operation|T061|EPO|NRW|NLM (2016)|150518|abcdef
ENTRY = Mustard Procedure|T061|EPO|NRW|NLM (2016)|150518|abcdef
ENTRY = Mustard Repair|T061|EPO|NRW|NLM (2016)|150518|abcdef
ENTRY = Rastelli Operation|T061|EPO|NRW|NLM (2016)|150506|abcdef
ENTRY = Rastelli Procedure|T061|EPO|NRW|NLM (2016)|150506|abcdef
ENTRY = Rastelli Repair|T061|EPO|NRW|NLM (2016)|150518|abcdef
ENTRY = Rastelli Technique|T061|EPO|NRW|NLM (2016)|150518|abcdef
ENTRY = Senning Operation|T061|EPO|BRD|NLM (2016)|150521|abcdef
ENTRY = Senning Procedure|T061|EPO|BRD|NLM (2016)|150521|abcdef
ENTRY = Arterial Switch Operations
ENTRY = Arterial Switch Procedures
ENTRY = Arterial Switch Techniques
ENTRY = Atrial Switch Operations
ENTRY = Atrial Switch Procedures
ENTRY = Atrial Switch Repairs
ENTRY = Atrial Switch Techniques
ENTRY = Double Switch Operation
ENTRY = Double Switch Procedure
ENTRY = Double Switch Technique
ENTRY = Double-Switch Operations
ENTRY = Double-Switch Procedures
ENTRY = Double-Switch Techniques
ENTRY = Operation, Arterial Switch
ENTRY = Operation, Atrial Switch
ENTRY = Operation, Double-Switch
ENTRY = Operation, Jatene
ENTRY = Operation, Mustard
ENTRY = Operation, Rastelli
ENTRY = Operation, Senning
ENTRY = Operations, Arterial Switch
ENTRY = Operations, Atrial Switch
ENTRY = Operations, Double-Switch
ENTRY = Procedure, Arterial Switch
ENTRY = Procedure, Atrial Switch
ENTRY = Procedure, Double-Switch
ENTRY = Procedure, Jatene
ENTRY = Procedure, Mustard
ENTRY = Procedure, Rastelli
ENTRY = Procedure, Senning
ENTRY = Procedures, Arterial Switch
ENTRY = Procedures, Atrial Switch
ENTRY = Procedures, Double-Switch
ENTRY = Repair, Atrial Switch
ENTRY = Repair, Mustard
ENTRY = Repair, Rastelli
ENTRY = Repairs, Atrial Switch
ENTRY = Technique, Arterial Switch
ENTRY = Technique, Atrial Switch
ENTRY = Technique, Double-Switch
ENTRY = Technique, Jatene
ENTRY = Technique, Rastelli
ENTRY = Techniques, Arterial Switch
ENTRY = Techniques, Atrial Switch
ENTRY = Techniques, Double-Switch
MN = E04.100.376.031
MN = E04.928.220.055
FX = Transposition of Great Vessels
MH_TH = NLM (2016)
ST = T061
PI = Cardiac Surgical Procedures (1990-2015)
PI = Transposition of Great Vessels (1971-2015)
MS = Surgical procedure for anatomical correction of transposed great arteries (e.g., DOUBLE OUTLET RIGHT VENTRICLE).
PM = 2016
HN = 2016
MR = 20150622
DA = 20150706
DC = 1
DX = 20160101
UI = D000069278

*NEWRECORD
RECTYPE = D
MH = Drug Resistant Epilepsy
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Drug Refractory Epilepsy|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Epilepsy, Drug Refractory|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Epilepsy, Drug Resistant|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Epilepsy, Intractable|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Intractable Epilepsy|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Medication Resistant Epilepsy|T047|NON|EQV|NLM (2016)|150626|abcdef
ENTRY = Drug Refractory Epilepsies
ENTRY = Drug Resistant Epilepsies
ENTRY = Epilepsies, Drug Refractory
ENTRY = Epilepsies, Drug Resistant
ENTRY = Epilepsies, Intractable
ENTRY = Epilepsies, Medication Resistant
ENTRY = Epilepsy, Medication Resistant
ENTRY = Intractable Epilepsies
ENTRY = Medication Resistant Epilepsies
ENTRY = Refractory Epilepsies, Drug
ENTRY = Refractory Epilepsy, Drug
ENTRY = Resistant Epilepsies, Drug
ENTRY = Resistant Epilepsies, Medication
ENTRY = Resistant Epilepsy, Drug
ENTRY = Resistant Epilepsy, Medication
MN = C10.228.140.490.125
MH_TH = NLM (2016)
ST = T047
PI = Epilepsy (1968-2015)
MS = Epileptic condition in which adequate trials of two tolerated and appropriately chosen and used ANTIEPILEPTIC DRUGS schedules to achieve sustained seizure freedom failed.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069279

*NEWRECORD
RECTYPE = D
MH = Electrocorticography
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
ENTRY = Electrocorticography (EcoG)|T060|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Extraoperative ECoG|T060|ABX|NRW|NLM (2016)|150506|abcdef
ENTRY = Extraoperative Electrocorticography|T060|NON|NRW|NLM (2016)|150506|abcdef
ENTRY = Intracranial EEG|T060|ABX|EQV|NLM (2016)|150506|abcdef
ENTRY = Intracranial Electroencephalography|T060|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Intraoperative ECoG|T060|ABX|NRW|NLM (2016)|150506|abcdef
ENTRY = Intraoperative Electrocorticography|T060|NON|NRW|NLM (2016)|150506|abcdef
ENTRY = ECoG, Extraoperative
ENTRY = ECoG, Intraoperative
ENTRY = ECoGs, Extraoperative
ENTRY = ECoGs, Intraoperative
ENTRY = EEG, Intracranial
ENTRY = EEGs, Intracranial
ENTRY = Electrocorticographies
ENTRY = Electrocorticographies (EcoG)
ENTRY = Electrocorticographies, Extraoperative
ENTRY = Electrocorticographies, Intraoperative
ENTRY = Electrocorticography, Extraoperative
ENTRY = Electrocorticography, Intraoperative
ENTRY = Electroencephalographies, Intracranial
ENTRY = Electroencephalography, Intracranial
ENTRY = Extraoperative ECoGs
ENTRY = Extraoperative Electrocorticographies
ENTRY = Intracranial EEGs
ENTRY = Intracranial Electroencephalographies
ENTRY = Intraoperative ECoGs
ENTRY = Intraoperative Electrocorticographies
MN = E01.370.376.300.294
MN = E01.370.405.245.431
MH_TH = NLM (2016)
ST = T060
PI = Electroencephalography (1965-2015)
MS = Recording of brain electrical activities in which the electrodes are placed directly on the CEREBRAL CORTEX.
PM = 2016
HN = 2016
MR = 20150622
DA = 20150701
DC = 1
DX = 20160101
UI = D000069280

*NEWRECORD
RECTYPE = D
MH = Autoimmune Hypophysitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anti-PIT-1 Antibody Syndrome|T047|ABX|NRW|NLM (2016)|150522|abcdef
ENTRY = Hypophysitis, Autoimmune|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Hypophysitis, Lymphocytic|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Idiopathic Granulomatous Hypophysitis|T047|NON|NRW|NLM (2016)|150506|abcdef
ENTRY = IgG4-Related Hypophysitis|T047|NON|NRW|NLM (2016)|150506|abcdef
ENTRY = Lymphocytic Adenohypophysitis|T047|NON|NRW|NLM (2016)|150506|abcdef
ENTRY = Lymphocytic Hypophysitis|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Lymphocytic Infundibuloneurohypophysitis|T047|NON|NRW|NLM (2016)|150522|abcdef
ENTRY = Lymphocytic Panhypophysitis|T047|NON|NRW|NLM (2016)|150522|abcdef
ENTRY = Lymphoid Hypophysitis|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Adenohypophysitides, Lymphocytic
ENTRY = Adenohypophysitis, Lymphocytic
ENTRY = Anti PIT 1 Antibody Syndrome
ENTRY = Anti-PIT-1 Antibody Syndromes
ENTRY = Antibody Syndrome, Anti-PIT-1
ENTRY = Antibody Syndromes, Anti-PIT-1
ENTRY = Autoimmune Hypophysitides
ENTRY = Granulomatous Hypophysitides, Idiopathic
ENTRY = Granulomatous Hypophysitis, Idiopathic
ENTRY = Hypophysitides, Autoimmune
ENTRY = Hypophysitides, Idiopathic Granulomatous
ENTRY = Hypophysitides, IgG4-Related
ENTRY = Hypophysitides, Lymphocytic
ENTRY = Hypophysitides, Lymphoid
ENTRY = Hypophysitis, Idiopathic Granulomatous
ENTRY = Hypophysitis, IgG4-Related
ENTRY = Hypophysitis, Lymphoid
ENTRY = Idiopathic Granulomatous Hypophysitides
ENTRY = IgG4 Related Hypophysitis
ENTRY = IgG4-Related Hypophysitides
ENTRY = Infundibuloneurohypophysitides, Lymphocytic
ENTRY = Infundibuloneurohypophysitis, Lymphocytic
ENTRY = Lymphocytic Adenohypophysitides
ENTRY = Lymphocytic Hypophysitides
ENTRY = Lymphocytic Infundibuloneurohypophysitides
ENTRY = Lymphocytic Panhypophysitides
ENTRY = Lymphoid Hypophysitides
ENTRY = Panhypophysitides, Lymphocytic
ENTRY = Panhypophysitis, Lymphocytic
ENTRY = Syndrome, Anti-PIT-1 Antibody
ENTRY = Syndromes, Anti-PIT-1 Antibody
MN = C10.228.140.617.738.100
MN = C19.700.080
MN = C20.111.273
MH_TH = NLM (2016)
ST = T047
PI = Pituitary Diseases (1967-2015)
MS = Immune-mediated inflammation of the PITUITARY GLAND often associated with other autoimmune diseases (e.g., HASHIMOTO DISEASE; GRAVES DISEASE; and ADDISON DISEASE).
PM = 2016
HN = 2016
MR = 20150622
DA = 20150701
DC = 1
DX = 20160101
UI = D000069281

*NEWRECORD
RECTYPE = D
MH = Canaliculitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Lacrimal Canaliculitis|T047|NON|EQV|NLM (2016)|150506|abcdef
ENTRY = Canaliculitides
ENTRY = Canaliculitides, Lacrimal
ENTRY = Canaliculitis, Lacrimal
ENTRY = Lacrimal Canaliculitides
MN = C11.496.221.500
FX = Corneal Ulcer
MH_TH = ORD (2010)
ST = T047
PI = Dacryocystitis (1977-2015)
PI = Lacrimal Apparatus Diseases (1973-2015)
MS = Inflammation and infection of the lacrimal canaliculus area in the LACRIMAL APPARATUS.
PM = 2016; was indexed under CORNEAL ULCER 2010-2015 and DACRYOCYSTITIS 2010-2015
HN = 2016 (2010)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069282

*NEWRECORD
RECTYPE = D
MH = Rituximab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = CD20 Antibody, Rituximab|T116|T121|T129|NON|EQV|NLM (2006)|150506|abbbcdef
ENTRY = GP2013|T116|T129|LAB|NRW|NLM (2015)|150319|abbcdef
ENTRY = IDEC-C2B8|T116|T121|T129|LAB|NRW|NLM (1995)|abbbcde
ENTRY = IDEC-C2B8 Antibody|T116|T121|T129|LAB|NRW|NLM (1995)|150506|abbbcdef
ENTRY = Mabthera|T116|T121|T129|TRD|NRW|AU|DE|FR|MX|UK|030212|abbbcdeeeeef
ENTRY = Rituxan|T116|T121|T129|TRD|NRW|CA|US|abbbcdee
ENTRY = Antibody, Rituximab CD20
ENTRY = IDEC C2B8
ENTRY = IDEC C2B8 Antibody
ENTRY = IDECC2B8
ENTRY = IDECC2B8 Antibody
ENTRY = Rituximab CD20 Antibody
MN = D12.776.124.486.485.114.224.075.785
MN = D12.776.124.790.651.114.224.075.785
MN = D12.776.377.715.548.114.224.284.785
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1995)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = 4F4X42SYQ6
RR = 174722-31-7
MS = A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
PM = 2016; RITUXIMAB was indexed under ANTIBODIES, MONOCLONAL, MURINE-DERIVED 1995-2016
HN = 2016 (1995)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069283

*NEWRECORD
RECTYPE = D
MH = Protein Translocation Systems
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Protein Secretion Systems|T116|NON|NRW|NLM (2016)|150506|abcdef
ENTRY = Secretion Systems, Protein
ENTRY = Systems, Protein Translocation
ENTRY = Translocation Systems, Protein
MN = D05.500.890
FX = Membrane Transport Proteins
MH_TH = NLM (2016)
ST = T116
RN = 0
MS = Multiprotein complexes that carry out PROTEIN TRANSPORT across CELL MEMBRANES.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150706
DC = 1
DX = 20160101
UI = D000069284

*NEWRECORD
RECTYPE = D
MH = Infliximab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = MAb cA2|T116|T121|T129|ABB|EQV|NLM (1997)|abbbcde
ENTRY = Monoclonal Antibody cA2|T116|T121|T129|NON|EQV|NLM (1997)|150506|abbbcdef
ENTRY = Remicade|T116|T121|T129|TRD|NRW|AU|CA|DE|ES|FR|IE|NL|US|991216|abbbcdeeeeeeeef
ENTRY = Antibody cA2, Monoclonal
ENTRY = cA2, Monoclonal Antibody
MN = D12.776.124.486.485.114.224.608
MN = D12.776.124.790.651.114.224.537
MN = D12.776.377.715.548.114.224.642
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1997)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = B72HH48FLU
RR = 170277-31-3
MS = A chimeric monoclonal antibody to TNF ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.
PM = 2016; INFLIXIMAB was indexed under ANTIBODIES, MONOCLONAL 1997-2015
HN = 2016 (1997)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069285

*NEWRECORD
RECTYPE = D
MH = Bortezomib
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = LDP-341|T109|T121|LAB|NRW|NLM (2011)|110909|abbcdef
ENTRY = PS 341|T109|T121|LAB|NRW|NLM (1999)|991117|abbcdef
ENTRY = PS-341|T109|T121|LAB|NRW|NLM (2003)|030614|abbcdef
ENTRY = Velcade|T109|T121|TRD|NRW|NLM (2003)|030310|abbcdef
ENTRY = 341, PS
ENTRY = LDP 341
ENTRY = LDP341
ENTRY = PS341
MN = D01.029.260.110.500
MN = D01.132.285.500
MN = D02.203.200.500
MN = D03.383.679.450
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2002)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 69G8BD63PP
RR = 179324-69-7
MS = A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.
PM = 2016; BORTEZOMIB was indexed under BORONIC ACIDS and PYRAZINES 2000-2015
HN = 2016 (2000)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069286

*NEWRECORD
RECTYPE = D
MH = Capecitabine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine|T114|T121|NON|EQV|NLM (1998)|abbcde
ENTRY = Xeloda|T114|T121|TRD|NRW|NLM (1999)|991126|abbcdef
MN = D03.383.742.680.245.500.425
MN = D03.383.742.698.875.404.425
MN = D13.570.230.329.313
MN = D13.570.685.245.500.425
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = USAN (1997)
ST = T114
ST = T121
RN = 6804DJ8Z9U
RR = 154361-50-9 (capecitabine)
MS = A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.
PM = 2016; CAPECITABINE was indexed under DEOXYCYTIDINE and FLUOROURACIL 1998-2015
HN = 2016 (1998)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069287

*NEWRECORD
RECTYPE = D
MH = Parasite Encystment
AQ = DE GE IM PH RE
ENTRY = Parasite Encystation|T040|NON|EQV|NLM (2016)|150507|abcdef
ENTRY = Protozoan Encystation|T040|NON|EQV|NLM (2016)|150507|abcdef
ENTRY = Protozoan Encystment|T040|NON|EQV|NLM (2016)|150609|abcdef
ENTRY = Protozoan Parasite Encysment|T040|NON|EQV|NLM (2016)|150507|abcdef
ENTRY = Protozoan Parasite Encystation|T040|NON|EQV|NLM (2016)|150507|abcdef
ENTRY = Encysment, Protozoan Parasite
ENTRY = Encysments, Protozoan Parasite
ENTRY = Encystation, Parasite
ENTRY = Encystation, Protozoan
ENTRY = Encystation, Protozoan Parasite
ENTRY = Encystations, Parasite
ENTRY = Encystations, Protozoan
ENTRY = Encystations, Protozoan Parasite
ENTRY = Encystment, Parasite
ENTRY = Encystment, Protozoan
ENTRY = Encystments, Parasite
ENTRY = Encystments, Protozoan
ENTRY = Parasite Encysment, Protozoan
ENTRY = Parasite Encysments, Protozoan
ENTRY = Parasite Encystation, Protozoan
ENTRY = Parasite Encystations
ENTRY = Parasite Encystations, Protozoan
ENTRY = Parasite Encystments
ENTRY = Protozoan Encystations
ENTRY = Protozoan Encystments
ENTRY = Protozoan Parasite Encysments
ENTRY = Protozoan Parasite Encystations
MN = G07.700.320.500.550.875
FX = Trophozoites
MH_TH = NLM (2016)
ST = T040
MS = Process by which certain parasites such as GIARDIA and ENTAMOEBA convert from the TROPHOZOITE to SCHIZONT when exposed to stress.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000069289

*NEWRECORD
RECTYPE = D
MH = Incisional Hernia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Postoperative Hernia|T047|T190|NON|EQV|NLM (2016)|150507|abbcdef
ENTRY = Hernia, Incisional
ENTRY = Hernia, Postoperative
ENTRY = Hernias, Incisional
ENTRY = Hernias, Postoperative
ENTRY = Incisional Hernias
ENTRY = Postoperative Hernias
MN = C23.300.707.945
MN = C23.550.767.500
MH_TH = NLM (2016)
ST = T047
ST = T190
PI = Hernia (1966-2015)
MS = Protrusion of tissue at or near the site of an incision from a previous surgery.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069290

*NEWRECORD
RECTYPE = D
MH = Pyroptosis
AQ = DE GE IM PH RE
ENTRY = Caspase-1 Dependent Cell Death|T043|NON|EQV|NLM (2016)|150626|abcdef
ENTRY = Inflammatory Apoptosis|T043|NON|EQV|NLM (2016)|150507|abcdef
ENTRY = Pyroptotic Cell Death|T043|NON|EQV|NLM (2016)|150520|abcdef
ENTRY = Apoptoses, Inflammatory
ENTRY = Apoptosis, Inflammatory
ENTRY = Caspase 1 Dependent Cell Death
ENTRY = Cell Death, Pyroptotic
ENTRY = Cell Deaths, Pyroptotic
ENTRY = Death, Pyroptotic Cell
ENTRY = Deaths, Pyroptotic Cell
ENTRY = Inflammatory Apoptoses
ENTRY = Pyroptoses
ENTRY = Pyroptotic Cell Deaths
MN = G04.299.139.160.530
FX = Necrosis
MH_TH = NLM (2016)
ST = T043
PI = Apoptosis (2005-2015)
MS = Type of programmed cell death associated with infection by intracellular pathogens. It is characterized by INFLAMMASOME formation; activation of CASPASE 1; and CYTOKINES mediated inflammation.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000069292

*NEWRECORD
RECTYPE = D
MH = Plasmablastic Lymphoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Plasmablastic Diffuse Large B-cell Lymphoma|T191|NON|EQV|NLM (2016)|150507|abcdef
ENTRY = Plasmablasts Diffuse Large B-cell Lymphoma|T191|NON|EQV|NLM (2016)|150507|abcdef
ENTRY = Lymphoma, Plasmablastic
ENTRY = Lymphomas, Plasmablastic
ENTRY = Plasmablastic Diffuse Large B cell Lymphoma
ENTRY = Plasmablastic Lymphomas
ENTRY = Plasmablasts Diffuse Large B cell Lymphoma
MN = C04.557.386.480.150.585.500
MN = C15.604.515.569.480.150.585.500
MN = C20.683.515.761.480.150.585.500
MH_TH = NLM (2016)
ST = T191
PI = Lymphoma, Large B-Cell, Diffuse (1998-2015)
MS = Malignant lymphoma composed of large B lymphoid cells which have the immunophenotype of plasma cells and a predilection for the ORAL CAVITY.
PM = 2016
HN = 2016
MR = 20150709
DA = 20150709
DC = 1
DX = 20160101
UI = D000069293

*NEWRECORD
RECTYPE = D
MH = Twin-Arginine-Translocation System
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = TAT Secretion Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Twin-Arginine-Translocation Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Twin-Arginine-Transport System|T116|NON|EQV|NLM (2016)|150625|abcdef
ENTRY = Secretion Systems, TAT
ENTRY = System, Twin-Arginine-Transport
ENTRY = Systems, TAT Secretion
ENTRY = Systems, Twin-Arginine-Translocation
ENTRY = Twin Arginine Translocation System
ENTRY = Twin Arginine Translocation Systems
ENTRY = Twin Arginine Transport System
MN = D05.500.890.750
MH_TH = NLM (2016)
ST = T116
RN = 0
MS = Protein translocase in BACTERIA or CHLOROPLASTS that exports or secretes folded proteins. In GRAM-NEGATIVE BACTERIA, twin-arginine translocase (TAT) is involved in the export of folded proteins to the PERIPLASM. In chloroplasts, TAT is involved in transporting folded proteins across the membranes of THYLAKOIDS.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069294

*NEWRECORD
RECTYPE = D
MH = Mammary Analogue Secretory Carcinoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
MN = C04.557.470.200.588
MH_TH = NLM (2016)
ST = T191
PI = Carcinoma (2010-2015)
MS = A malignant neoplasm of epithelial cells of the SALIVARY GLANDS, with microcystic architecture, low-grade nuclei, and granular vacuolated cytoplasm.
PM = 2016
HN = 2016
MR = 20150622
DA = 20150701
DC = 1
DX = 20160101
UI = D000069295

*NEWRECORD
RECTYPE = D
MH = Type III Secretion Systems
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Bacterial Secretion System, Type III|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = T3SS Secretion System|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Type 3 Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type 3 Secretion Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type III Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Secretion System, T3SS
ENTRY = System, T3SS Secretion
MN = D05.500.890.500.875
MH_TH = NLM (2016)
ST = T116
RN = 0
PI = Bacterial Secretion Systems (2010-2015)
MS = Multiprotein transmembrane complexes in GRAM-NEGATIVE BACTERIA involved in either the secretion of effector proteins from the bacterial cytoplasm into host cells, or the secretion and assembly of flagellar components. The major component of the T3SSs is called the injectosome or needle complex.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069296

*NEWRECORD
RECTYPE = D
MH = Acne Conglobata
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Acne Conglobatas
ENTRY = Conglobata, Acne
ENTRY = Conglobatas, Acne
MN = C17.800.030.150.500
MN = C17.800.794.111.500
MH_TH = NLM (2016)
ST = T047
PI = Acne Vulgaris (1964-2015)
MS = Severe and chronic form of acne characterized by large, burrowing abscesses associated with disfigurement.
PM = 2016
HN = 2016
MR = 20150622
DA = 20150701
DC = 1
DX = 20160101
UI = D000069316

*NEWRECORD
RECTYPE = D
MH = Type IV Secretion Systems
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Bacterial Secretion System, Type IV|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Bacterial Secretion Systems, Type IV|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = T4SS Secretion System|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Type 4 Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type 4 Secretion Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type IV Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Secretion System, T4SS
ENTRY = System, T4SS Secretion
MN = D05.500.890.500.937
MH_TH = NLM (2016)
ST = T116
RN = 0
PI = Bacterial Secretion Systems (2010-2015)
MS = Multiprotein complexes that transport single proteins, multiprotein complexes, and nucleoprotein complexes from the CYTOPLASM into the EXTRACELLULAR SPACE or into recipient cells. T4SSs are found in GRAM-NEGATIVE BACTERIA, while homologous components to T4SSs are found in GRAM-POSTIVE BACTERIA.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069319

*NEWRECORD
RECTYPE = D
MH = Type V Secretion Systems
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Autotransporters|T116|NON|NRW|NLM (2016)|150508|abcdef
ENTRY = Bacterial Secretion System, Type V|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Two-Partner Secretion Systems|T116|NON|NRW|NLM (2016)|150611|abcdef
ENTRY = Type 5 Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type 5 Secretion Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type V Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Secretion Systems, Two-Partner
ENTRY = Systems, Two-Partner Secretion
ENTRY = Two Partner Secretion Systems
MN = D05.500.890.500.968
MH_TH = NLM (2016)
ST = T116
RN = 0
PI = Bacterial Secretion Systems (2010-2015)
MS = Secretion systems of GRAM-NEGATIVE BACTERIA (single membrane proteins or multiprotein complexes) that carry out secretion of proteins from the PERIPLASMIC SPACE to the EXTRACELLULAR SPACE via a beta-barrel transmembrane pore. There are several T5SS subtypes: T5aSS monomeric autotransporters, T5bSS two-partner secretions systems (TPSS), T5cSS trimeric autotransporters, T5dSS fused two-partner secretion systems, and T5eSS autotransporters with inverted domains.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069320

*NEWRECORD
RECTYPE = D
MH = Mitochondrial Replacement Therapy
AQ = AE CL CT EC ES HI IS LJ MO MT NU PX SN ST TD UT VE
ENTRY = Pronuclear Transfer Technique|T062|NON|EQV|NLM (2016)|150508|abcdef
ENTRY = Spindle Transfer Technique|T062|NON|EQV|NLM (2016)|150508|abcdef
ENTRY = Mitochondrial Replacement Therapies
ENTRY = Pronuclear Transfer Techniques
ENTRY = Replacement Therapies, Mitochondrial
ENTRY = Replacement Therapy, Mitochondrial
ENTRY = Spindle Transfer Techniques
ENTRY = Technique, Pronuclear Transfer
ENTRY = Technique, Spindle Transfer
ENTRY = Techniques, Pronuclear Transfer
ENTRY = Techniques, Spindle Transfer
ENTRY = Therapies, Mitochondrial Replacement
ENTRY = Therapy, Mitochondrial Replacement
ENTRY = Transfer Technique, Pronuclear
ENTRY = Transfer Technique, Spindle
ENTRY = Transfer Techniques, Pronuclear
ENTRY = Transfer Techniques, Spindle
MN = E02.875.800.750.350
MN = E05.200.500.380.250
MN = E05.393.085.250
MN = E05.820.800.750.350
MH_TH = NLM (2016)
ST = T062
PI = Cellular Reprogramming (2014-2015)
MS = In vitro fertilization technique that uses mitochondrial DNA from a healthy donor in order to prevent the transmission of MITOCHONDRIAL DISEASE.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069321

*NEWRECORD
RECTYPE = D
MH = Self Expandable Metallic Stents
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
ENTRY = Self Expandable Metal Stent|T074|NON|EQV|NLM (2016)|150508|abcdef
ENTRY = Self Expandable Metal Stents|T074|NON|EQV|NLM (2016)|150508|abcdef
ENTRY = Self Expandable Metallic Stent|T074|NON|EQV|NLM (2016)|150508|abcdef
MN = E07.695.750.750
MH_TH = NLM (2016)
ST = T074
PI = Stents (2014-2015)
MS = Cylindrical metallic tubes that are inserted to hold open a structure in order to treat vascular, bile duct, esophageal and other tubular organ constrictions.
PM = 2016
HN = 2016
MR = 20150622
DA = 20150701
DC = 1
DX = 20160101
UI = D000069322

*NEWRECORD
RECTYPE = D
MH = Neurovascular Coupling
AQ = DE GE IM PH RE
ENTRY = Cortical Hemodynamic Response|T042|NON|REL|NLM (2016)|150609|abcdef
ENTRY = Cortical Hemodynamic Responses|T042|NON|REL|NLM (2016)|150609|abcdef
ENTRY = Hemodynamic Brain Response|T042|NON|REL|NLM (2016)|150515|abcdef
ENTRY = Hemodynamic Brain Responses|T042|NON|REL|NLM (2016)|150515|abcdef
ENTRY = Brain Response, Hemodynamic
ENTRY = Brain Responses, Hemodynamic
ENTRY = Coupling, Neurovascular
ENTRY = Couplings, Neurovascular
ENTRY = Hemodynamic Response, Cortical
ENTRY = Hemodynamic Responses, Cortical
ENTRY = Neurovascular Couplings
ENTRY = Response, Cortical Hemodynamic
ENTRY = Response, Hemodynamic Brain
ENTRY = Responses, Cortical Hemodynamic
ENTRY = Responses, Hemodynamic Brain
MN = G09.330.190.163.159.500
FX = Hemodynamics
MH_TH = NLM (2016)
ST = T042
PI = Cerebrovascular Circulation (1997-2015)
MS = Mechanism by which changes in neural activity are tightly associated with regional cortical HEMODYNAMICS and metabolism changes. The association is often inferred from NEUROIMAGING signals (e.g., fMRI; or NIR SPECTROSCOPY).
PM = 2016
HN = 2016
MR = 20150709
DA = 20150709
DC = 1
DX = 20160101
UI = D000069336

*NEWRECORD
RECTYPE = D
MH = Fused Kidney
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Cake Kidney|T019|NON|REL|NLM (2016)|150526|abcdef
ENTRY = Congenital Fusion of Kidneys|T019|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Congenital Lobulation of Kidneys|T019|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Crossed Fused Ectopia|T019|NON|REL|NLM (2016)|150526|abcdef
ENTRY = Crossed Fused Ectopia of Kidneys|T019|NON|REL|NLM (2016)|150526|abcdef
ENTRY = Fusion of Kidney|T019|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Horseshoe Kidney|T019|NON|BRD|NLM (2016)|150511|abcdef
ENTRY = Lobulated Kidney|T019|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Lobulation of Kidney|T019|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Pelvic Cake Kidney|T019|NON|REL|NLM (2016)|150526|abcdef
ENTRY = Renal Fusion|T019|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Cake Kidneys
ENTRY = Crossed Fused Ectopias
ENTRY = Fused Kidneys
ENTRY = Fusion, Renal
ENTRY = Fusions, Renal
ENTRY = Horseshoe Kidneys
ENTRY = Kidney Fusion
ENTRY = Kidney Fusions
ENTRY = Kidney Lobulation
ENTRY = Kidney Lobulations
ENTRY = Kidney, Cake
ENTRY = Kidney, Fused
ENTRY = Kidney, Horseshoe
ENTRY = Kidney, Lobulated
ENTRY = Kidneys, Cake
ENTRY = Kidneys, Fused
ENTRY = Kidneys, Horseshoe
ENTRY = Kidneys, Lobulated
ENTRY = Lobulated Kidneys
ENTRY = Pelvic Cake Kidneys
ENTRY = Renal Fusions
MN = C12.706.445
MN = C13.351.875.420
MN = C16.131.939.445
MH_TH = NLM (2016)
ST = T019
PI = Kidney Diseases (1963-2015)
MS = Congenital fusion of two kidneys.
PM = 2016
HN = 2016
MR = 20150622
DA = 20150701
DC = 1
DX = 20160101
UI = D000069337

*NEWRECORD
RECTYPE = D
MH = Neuropathology
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Neuropathologists|T097|NON|REL|NLM (2016)|150511|abcdef
ENTRY = Neuropathologies
ENTRY = Neuropathologist
MN = H01.158.610.184
MN = H02.403.600.250
MN = H02.403.650.375
MH_TH = NLM (2016)
ST = T091
AN = use for the discipline only (education, history, etc.) only
PI = Nervous System Diseases (1965-2015)
MS = The branch of medicine and biomedical science concerned with diseases of the nervous system.
PM = 2016
HN = 2016
MR = 20150701
DA = 20150702
DC = 1
DX = 20160101
UI = D000069338

*NEWRECORD
RECTYPE = D
MH = Trachelectomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Cervicectomy|T061|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Vaginal Cervicectomy|T061|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Vaginal Trachelectomy|T061|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Cervicectomies
ENTRY = Cervicectomies, Vaginal
ENTRY = Cervicectomy, Vaginal
ENTRY = Trachelectomies
ENTRY = Trachelectomies, Vaginal
ENTRY = Trachelectomy, Vaginal
ENTRY = Vaginal Cervicectomies
ENTRY = Vaginal Trachelectomies
MN = E04.950.300.399.690
MH_TH = NLM (2016)
ST = T061
PI = Hysterectomy (1988-2015)
MS = Surgical removal or resection of the CERVIX UTERI.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069339

*NEWRECORD
RECTYPE = D
MH = Deprescriptions
ENTRY = Deprescribing|T058|NON|REL|NLM (2016)|150511|abcdef
ENTRY = Deprescription
MN = E02.319.698.500
FX = Inappropriate Prescribing
FX = Potentially Inappropriate Medication List
MH_TH = NLM (2016)
ST = T170
PI = Drug Prescriptions (2007-2015)
MS = Directions written to discontinue use of PRESCRIPTION DRUGS in order to reduce unnecessary and/or excessive medications (see POLYPHARMACY), DRUG SIDE EFFECTS and ADVERSE DRUG REACTION.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000069340

*NEWRECORD
RECTYPE = D
MH = Transitional Care
AQ = CL EC ES HI LJ OG SN ST TD
ENTRY = Transition Care|T058|NON|EQV|NLM (2016)|150511|abcdef
ENTRY = Care, Transitional
ENTRY = Cares, Transitional
ENTRY = Transition Cares
ENTRY = Transitional Cares
MN = E02.204.812
MN = E02.760.940
MN = N02.421.192.812
MN = N02.421.585.940
MN = N04.590.233.727.210.812
MH_TH = NLM (2016)
ST = T058
PI = Continuity of Patient Care (1987-2015)
MS = Health care provided during a transition to a different mode of care (e.g., TRANSITION TO ADULT CARE).
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069341

*NEWRECORD
RECTYPE = D
MH = Medical Overuse
AQ = EC LJ PC SN TD
PRINT ENTRY = Overutilization of Health Services|T055|T058|NON|EQV|UNK (19XX)|770512|OVERUTIL OF HEALTH SERV|abbcdefv
ENTRY = Health Services Overuse|T055|T058|NON|EQV|NLM (2016)|141119|abbcdef
ENTRY = Health Services Overutilization|T055|T058|NON|EQV|UNK (19XX)|770512|HEALTH SERV OVERUTIL|abbcdefv
ENTRY = Medical Preference Misdiagnosis|T058|T061|NON|NRW|NLM (2016)|150512|abbcdef
ENTRY = Overdiagnosis|T058|NON|NRW|NLM (2016)|150512|abcdef
ENTRY = Overmedication|T055|T058|NON|NRW|NLM (2016)|150512|abbcdef
ENTRY = Overtreatment|T058|T061|NON|NRW|NLM (2016)|150512|abbcdef
ENTRY = Overuse, Health Services|T055|T058|NON|EQV|NLM (2016)|141119|abbcdef
ENTRY = Preference Misdiagnosis|T058|T061|NON|NRW|NLM (2016)|150512|abbcdef
ENTRY = Unwanted Medical Care|T058|T061|NON|NRW|NLM (2016)|150512|abbcdef
ENTRY = Health Services Overuses
ENTRY = Medical Care, Unwanted
ENTRY = Medical Cares, Unwanted
ENTRY = Medical Overuses
ENTRY = Medical Preference Misdiagnoses
ENTRY = Misdiagnoses, Medical Preference
ENTRY = Misdiagnoses, Preference
ENTRY = Misdiagnosis, Medical Preference
ENTRY = Misdiagnosis, Preference
ENTRY = Overdiagnoses
ENTRY = Overmedications
ENTRY = Overtreatments
ENTRY = Overuse, Medical
ENTRY = Overuses, Health Services
ENTRY = Overuses, Medical
ENTRY = Overutilization, Health Services
ENTRY = Preference Misdiagnoses
ENTRY = Preference Misdiagnoses, Medical
ENTRY = Preference Misdiagnosis, Medical
ENTRY = Unwanted Medical Cares
MN = N02.421.380.450
MN = N05.300.150.395.450
FX = Diagnostic Errors
FX = Drug Overdose
FX = Inappropriate Prescribing
FX = Polypharmacy
MH_TH = NLM (2016)
ST = T055
ST = T058
PI = Unnecessary Procedures (2014-2015)
MS = Excessive or unnecessary utilization of health services by patients or physicians.
PM = 2016; for HEALTH SERVICES OVERUTILIZATION see HEALTH SERVICES MISUSE 1978-2015
HN = 2016; for HEALTH SERVICES OVERUTILIZATION use HEALTH SERVICES MISUSE 1978-2015
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069342

*NEWRECORD
RECTYPE = D
MH = Bone-Implant Interface
AQ = AB AH BS EM GD IN IR MI PA PH PP PS RA RE RI SU US VI
ENTRY = Bone-Prosthesis Interface|T030|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Bone Implant Interface
ENTRY = Bone Prosthesis Interface
ENTRY = Bone-Implant Interfaces
ENTRY = Bone-Prosthesis Interfaces
ENTRY = Interface, Bone-Implant
ENTRY = Interface, Bone-Prosthesis
ENTRY = Interfaces, Bone-Implant
ENTRY = Interfaces, Bone-Prosthesis
MN = A02.835.232.022
MN = A10.165.265.183
MN = E07.695.125
FX = Osseointegration
MH_TH = NLM (2016)
ST = T030
PI = Osseointegration (1989-2015)
MS = Region of interaction between the bone and PROSTHESES AND IMPLANTS which becomes bonded through cellular and extracellular interactions similar to OSSEOINTEGRATION.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000069343

*NEWRECORD
RECTYPE = D
MH = Erlotinib Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 11C-erlotinib|T109|T121|NON|NRW|NLM (2014)|140908|abbcdef
ENTRY = CP 358,774|T109|T121|LAB|NRW|NLM (1999)|991122|abbcdef
ENTRY = CP 358774|T109|T121|LAB|NRW|NLM (1999)|991122|abbcdef
ENTRY = CP-358,774|T109|T121|LAB|NRW|NLM (1999)|991122|abbcdef
ENTRY = CP-358774|T109|T121|LAB|NRW|NLM (1999)|991122|abbcdef
ENTRY = Erlotinib|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2003)|150512|abbcdeeef
ENTRY = Erlotinib HCl|T109|T121|NON|EQV|NLM (2006)|150512|abbcdef
ENTRY = N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|T109|T121|BRD|NLM (2010)|100217|abbdef
ENTRY = OSI-774|T109|T121|LAB|NRW|NLM (2001)|011121|abbcdef
ENTRY = Tarceva|T109|T121|TRD|NRW|NLM (2002)|020806|abbcdef
ENTRY = 11C erlotinib
ENTRY = 358,774, CP
ENTRY = 358774, CP
ENTRY = CP358,774
ENTRY = CP358774
ENTRY = HCl, Erlotinib
ENTRY = Hydrochloride, Erlotinib
ENTRY = OSI 774
ENTRY = OSI774
MN = D03.438.786.375
MH_TH = FDA SRS (2013)
MH_TH = NLM (2013)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = DA87705X9K
RR = 183319-69-9
RR = DA87705X9K
RR = J4T82NDH7E
MS = A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.
PM = 2016; ERLOTINIB HYDROCHLORIDE was indexed under QUINAZOLINES 1999-2015
HN = 2016 (1999)
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000069347

*NEWRECORD
RECTYPE = D
MH = Quetiapine Fumarate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol|T109|T121|BRD|NLM (1991)|abbde
ENTRY = Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt)|T109|T121|NON|EQV|NLM (2004)|040401|abbcdef
ENTRY = ICI 204,636|T109|T121|LAB|NRW|NLM (1991)|abbcde
ENTRY = ICI 204636|T109|T121|LAB|NRW|NLM (1991)|abbcde
ENTRY = ICI-204636|T109|T121|LAB|NRW|NLM (1991)|abbcde
ENTRY = Quetiapine|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (1991)|150512|abbcdeeef
ENTRY = Seroquel|T109|T121|TRD|NRW|NLM (1991)|abbcde
ENTRY = 204,636, ICI
ENTRY = 204636, ICI
ENTRY = Fumarate, Quetiapine
ENTRY = ICI204636
MN = D02.886.680.702.500.500
MN = D03.494.276.500
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = NLM (2001)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 2S3PL1B6UJ
RR = 111974-72-2
RR = BGL0JSY5SI
MS = A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.
PM = 2016; QUETIAPINE FUMARATE was indexed under DIBENZOTHIAZEPINES 1991-2015
HN = 2016 (1991)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069348

*NEWRECORD
RECTYPE = D
MH = Linezolid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Linezolide|T109|T121|NON|EQV|NLM (1996)|150512|abbcdef
ENTRY = N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide|T109|T121|EQV|NLM (1996)|abbde
ENTRY = PNU-100766|T109|T121|LAB|NRW|NLM (2001)|011102|abbcdef
ENTRY = U 100766|T109|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = U-100766|T109|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = Zyvox|T109|T121|TRD|NRW|NLM (2001)|000103|abbcdef
ENTRY = 100766, U
ENTRY = PNU 100766
ENTRY = PNU100766
ENTRY = U100766
MN = D02.065.064.463
MN = D02.241.081.018.110.525
MN = D03.383.129.462.600.550
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1996)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = ISQ9I6J12J
RR = 165800-03-3
MS = An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract.
PM = 2016; LINEZOLID was indexed under ACETAMIDES and OXAZOLIDINONES 2000-2015; and under OXAZOLES 1996-2000
HN = 2016 (1996)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069349

*NEWRECORD
RECTYPE = D
MH = Telerehabilitation
AQ = CL EC ES HI IS LJ MA MT OG SN ST TD UT
ENTRY = Remote Rehabilitation|T058|NON|EQV|NLM (2016)|150513|abcdef
ENTRY = Tele-rehabilitation|T058|NON|EQV|NLM (2016)|150513|abcdef
ENTRY = Virtual Rehabilitation|T058|NON|EQV|NLM (2016)|150513|abcdef
ENTRY = Rehabilitation, Remote
ENTRY = Rehabilitation, Virtual
ENTRY = Rehabilitations, Remote
ENTRY = Rehabilitations, Virtual
ENTRY = Remote Rehabilitations
ENTRY = Tele rehabilitation
ENTRY = Tele-rehabilitations
ENTRY = Telerehabilitations
ENTRY = Virtual Rehabilitations
MN = E02.831.891
MN = H02.403.680.600.937
MN = H02.403.840.850
MN = L01.178.847.652.850
MN = N02.421.784.840
MN = N04.590.374.800.850
MH_TH = NLM (2016)
ST = T058
PI = Telemedicine (1996-2015)
MS = Delivery of therapeutic rehabilitation at a distance or offsite using telecommunication technologies.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069350

*NEWRECORD
RECTYPE = D
MH = Tympanocentesis
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Tympanocenteses
MN = E01.370.225.998.329.905
MN = E02.800.550.905
MN = E04.665.600.905
MN = E05.200.998.329.905
FX = Middle Ear Ventilation
FX = Otitis Media
MH_TH = NLM (2016)
ST = T060
ST = T061
PI = Drainage (1973-2015)
PI = Paracentesis (1997-2015)
MS = Needle aspiration of fluid from the MIDDLE EAR through a puncture in the TYMPANIC MEMBRANE.
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069356

*NEWRECORD
RECTYPE = D
MH = Type VI Secretion Systems
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Bacterial Secretion System, Type VI|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = T6SS Secretion Systems|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Type 6 Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type 6 Secretion Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Type VI Secretion System|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Secretion Systems, T6SS
ENTRY = Systems, T6SS Secretion
MN = D05.500.890.500.984
MH_TH = NLM (2016)
ST = T116
RN = 0
PI = Bacterial Secretion Systems (2010-2015)
MS = Multiprotein complexes in GRAM NEGATIVE BACTERIA that deliver effector proteins into eukaryotic or prokaryotic cells by a mechanism similar to the contractile tail of bacteriophages. They are composed of a cell envelope-spanning tube which is surrounded by a contractile sheath and tipped by a cell puncturing complex; a base plate structure that anchors the assembly to the cell envelope; and an ATPase involved in the sheath contraction and disassembly of the complex.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069376

*NEWRECORD
RECTYPE = D
MH = Type VII Secretion Systems
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = ESX Secretion Systems|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Secretion Systems, ESX|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Secretion Systems, Type 7|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Secretion Systems, Type VII|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = T7SS Secretion System|T116|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Type 7 Secretion Systems|T116|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Secretion System, T7SS
ENTRY = System, T7SS Secretion
ENTRY = Systems, ESX Secretion
MN = D05.500.890.500.992
MH_TH = NLM (2016)
ST = T116
RN = 0
PI = Bacterial Secretion Systems (2010-2015)
MS = Bacterial secretion systems found in bacteria that have a MYCOLIC ACID-containing outer membrane such as MYCOBACTERIACEAE; Corynebacteriaceae; and NOCARDIACEAE. These are also known as ESX secretion systems because the first to be discovered is involved in secreting major virulence factors EsxA and EsxB. There are several subtypes of T7SSs including ESX-1, ESX-2, ESX-3, ESX-4, and ESX-5 secretion systems. The subtypes share some core components including an inner membrane channel-forming ATPase complex, a membrane-anchored mycosin, and a second channel that spans the outer mycolic acid-containing membrane.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069377

*NEWRECORD
RECTYPE = D
MH = Mitochondrial Ribosomes
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Mitoribosomes|T026|NON|EQV|NLM (2016)|150518|abcdef
ENTRY = Mitochondrial Ribosome
ENTRY = Mitoribosome
ENTRY = Ribosome, Mitochondrial
ENTRY = Ribosomes, Mitochondrial
MN = A11.284.430.214.190.875.564.755
MN = A11.284.430.214.190.875.811.370
MH_TH = NLM (2016)
ST = T026
PI = Ribosomes (1964-2015)
MS = Multicomponent ribonucleoprotein structures contained in MITOCHONDRIA that specialize in the PROTEIN BIOSYNTHESIS of a small number of proteins involved in energy production for the cell.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069396

*NEWRECORD
RECTYPE = D
MH = Intravital Microscopy
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = In Vivo Microscopy|T060|T062|NON|EQV|NLM (2016)|150625|abbcdef
ENTRY = In Vivo Microscopies
ENTRY = Intravital Microscopies
ENTRY = Microscopies, In Vivo
ENTRY = Microscopies, Intravital
ENTRY = Microscopy, In Vivo
ENTRY = Microscopy, Intravital
ENTRY = Vivo Microscopies, In
ENTRY = Vivo Microscopy, In
MN = E01.370.350.515.277
MN = E05.595.185
MH_TH = NLM (2016)
ST = T060
ST = T062
PI = Microscopy (1963-2015)
MS = Microscopic observation of live tissue in situ to study the behavior of individual cells with respect to their in vivo interactions, adhesion, motility, and location.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069416

*NEWRECORD
RECTYPE = D
MH = Toxicological Phenomena
AQ = DE GE IM PH RE
ENTRY = Toxicologic Phenomena|T038|NON|EQV|NLM (2016)|150122|abcdef
ENTRY = Toxicologic Phenomenon|T038|NON|EQV|NLM (2016)|150122|abcdef
ENTRY = Toxicological Concepts|T038|NON|EQV|NLM (2016)|150122|abcdef
ENTRY = Toxicological Phenomenon|T038|NON|EQV|NLM (2016)|150122|abcdef
ENTRY = Concept, Toxicological
ENTRY = Concepts, Toxicological
ENTRY = Phenomena, Toxicologic
ENTRY = Phenomena, Toxicological
ENTRY = Phenomenon, Toxicologic
ENTRY = Phenomenon, Toxicological
ENTRY = Toxicological Concept
MN = G07.690.936
MH_TH = NLM (2016)
ST = T038
AN = general or unspecified; prefer specifics
PI = Pharmacological Phenomena (1998-2015)
MS = The nature and effects of chemical, physical or biological poisons on living organisms.
PM = 2016
HN = 2016
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069436

*NEWRECORD
RECTYPE = D
MH = Pharmacological Phenomena
AQ = DE GE IM PH RE
PRINT ENTRY = Pharmacologic Processes|T070|NON|NRW|NLM (2009)|080306|abcdef
PRINT ENTRY = Pharmacological Processes|T070|NON|NRW|NLM (2009)|080516|abcdef
ENTRY = Pharmacologic Phenomena|T038|NON|EQV|NLM (2009)|080701|abcdef
ENTRY = Pharmacologic Phenomenon|T038|NON|EQV|NLM (2009)|080701|abcdef
ENTRY = Pharmacologic Process|T070|NON|NRW|NLM (2009)|080306|abcdef
ENTRY = Pharmacological Concepts|T038|NON|EQV|NLM (2009)|080701|abcdef
ENTRY = Pharmacological Phenomenon|T038|NON|EQV|NLM (2009)|080701|abcdef
ENTRY = Concept, Pharmacological
ENTRY = Concepts, Pharmacological
ENTRY = Pharmacological Concept
ENTRY = Phenomena, Pharmacologic
ENTRY = Phenomena, Pharmacological
ENTRY = Phenomenon, Pharmacologic
ENTRY = Phenomenon, Pharmacological
ENTRY = Process, Pharmacologic
ENTRY = Processes, Pharmacologic
ENTRY = Processes, Pharmacological
MN = G07.690.773
MH_TH = NLM (2009)
ST = T038
AN = general or unspecified; prefer specifics
MS = Interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function.
PM = 2016 (2009); for PHARMACOLOGICAL PROCESSES see PHARMACOLOGICAL PROCESSES 2009-2015; for PHARMACOLOGICAL PHENOMENA see PHARMACOLOGICAL PHENOMENA 2009-2015.
HN = 2016 (2009); for PHARMACOLOGICAL PROCESSES use PHARMACOLOGICAL PROCESSES 2009-2015; for PHARMACOLOGICAL PHENOMENA use PHARMACOLOGICAL PHENOMENA 2009-2015.
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069437

*NEWRECORD
RECTYPE = D
MH = Ezetimibe
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone)|T109|T121|EQV|NLM (2000)|000628|abbdef
ENTRY = Ezetimib|T109|T121|NON|EQV|NLM (2002)|150519|abbcdef
ENTRY = Ezetrol|T109|T121|TRD|NRW|DE|030313|abbcdef
ENTRY = SCH 58235|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = SCH-58235|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = SCH58235|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = Zetia|T109|T121|TRD|NRW|US|021106|abbcdef
ENTRY = 58235, SCH
MN = D03.383.082.301.550
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2000)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = EOR26LQQ24
RR = 163222-33-1
MS = An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS.
PM = 2016; EZETIMIBE was indexed under AZETIDINES 1998-2015
HN = 2016 (1998)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069438

*NEWRECORD
RECTYPE = D
MH = Dasatinib
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide|T109|T196|NRW|NLM (2008)|080104|abbdef
ENTRY = BMS 354825|T109|T121|LAB|NRW|NLM (2004)|040807|abbcdef
ENTRY = BMS-354825|T109|T121|LAB|NRW|NLM (2004)|040807|abbcdef
ENTRY = BMS354825|T109|T121|LAB|NRW|NLM (2004)|040807|abbcdef
ENTRY = N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide|T109|T121|EQV|NLM (2004)|040807|abbdef
ENTRY = Sprycel|T109|T121|TRD|NRW|NLM (2006)|060531|abbcdef
ENTRY = 354825, BMS
MN = D02.886.675.184
MN = D03.383.129.708.198
MN = D03.383.742.148
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (2006)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = RBZ1571X5H
RR = 302962-49-8 (dasatinib)
MS = A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.
PM = 2016; DASATINIB was indexed under PYRIMIDINES and THIAZOLES 2004-2015
HN = 2016 (2004)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069439

*NEWRECORD
RECTYPE = D
MH = Natalizumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = Antegren|T116|T121|T129|TRD|NRW|NLM (2002)|021216|abbbcdef
ENTRY = Tysabri|T116|T121|T129|TRD|NRW|NLM (2004)|041206|abbbcdef
MN = D12.776.124.486.485.114.224.060.813
MN = D12.776.124.790.651.114.224.060.813
MN = D12.776.377.715.548.114.224.200.813
FX = Integrin alpha4
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2002)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = 0
MS = A humanized monoclonal immunoglobulin G4 antibody to human INTEGRIN ALPHA4 that binds to the alpha4 subunit of INTEGRIN ALPHA4BETA1 and integrin alpha4beta7. It is used as an IMMUNOLOGIC FACTOR in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS and CROHN'S DISEASE.
PM = 2016; NATALIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015 and under  ANTIBODIES, MONOCLONAL 2002-2011
HN = 2016 (2002)
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000069442

*NEWRECORD
RECTYPE = D
MH = Heptavalent Pneumococcal Conjugate Vaccine
AQ = AA AD AE AG AI BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
ENTRY = 7-valent PncOMPC vaccine|T116|T129|EQV|NLM (1996)|abbde
ENTRY = PCV7 vaccine|T116|T129|NRW|NLM (2014)|140419|abbdef
ENTRY = PNCRM7|T116|T129|EQV|NLM (1999)|991130|abbdef
ENTRY = Prevenar|T116|T129|NRW|NLM (2000)|000615|abbdef
ENTRY = Prevnar|T116|T129|TRD|NRW|NLM (2000)|000615|abbcdef
ENTRY = Seven-Valent Pneumococcal PS-Meningococcal OMPC Conjugate Vaccine|T116|T129|NON|EQV|NLM (1996)|150519|abbcdef
ENTRY = 7 valent PncOMPC vaccine
ENTRY = PncOMPC vaccine, 7-valent
ENTRY = Seven Valent Pneumococcal PS Meningococcal OMPC Conjugate Vaccine
ENTRY = vaccine, 7-valent PncOMPC
ENTRY = vaccine, PCV7
MN = D20.215.894.135.750.600.500
MH_TH = NLM (1996)
ST = T116
ST = T129
RN = 0
MS = A pneumococcal vaccine which  7 pneumococcal serotypes (6B, 14, 19F, 23F, 18C, 4, 9V), each conjugated individually to the outer membrane protein complex of NEISSERIA MENINGITIDIS.
PM = 2016; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE was indexed under MENINGOCOCCAL VACCINES 1996-2009; under BACTERIAL VACCINES 1998-2000; under POLYSACCHARIDES BACTERIAL 1996-1997; and under BACTERIAL OUTER MEMBRANE PROTEINS 1996-1997
HN = 2016 (1996)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069443

*NEWRECORD
RECTYPE = D
MH = Omalizumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = Xolair|T121|T129|TRD|NRW|AU|US|030310|abbcdeef
MN = D12.776.124.486.485.114.071.500
MN = D12.776.124.486.485.114.224.060.844
MN = D12.776.124.790.651.114.071.500
MN = D12.776.124.790.651.114.224.060.844
MN = D12.776.377.715.548.114.071.500
MN = D12.776.377.715.548.114.224.200.844
MH_TH = FDA SRS (2015)
MH_TH = NLM (2001)
MH_TH = USAN (19XX)
ST = T121
ST = T129
N1 = Immunoglobulin G, anti-(human immunoglobulin E Fc region)(human-mouse monoclonal E25 clone pSVIE26 gamma-chain), disulfide with human-mouse monoclonal E25 clone pSVIE26 kappa-chain, dimer
RN = 2P471X1Z11
RR = 242138-07-4
MS = An anti-IgE, recombinant, humanized monoclonal antibody which specifically binds to the C epsilon3 domain of IMMUNOGLOBULIN E, the site of high-affinity IgE receptor binding. It inhibits the binding of IgE to MAST CELLS and BASOPHILS to reduce the severity of the allergic response and is used in the management of persistent allergic ASTHMA.
PM = 2016; OMALIZUMAB was indexed under ANTIBODIES, ANTI-IDIOTYPIC and ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2001-2011
HN = 2016 (2001)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069444

*NEWRECORD
RECTYPE = D
MH = Atomoxetine Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Atomoxetine|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2001)|150519|abbcdeeef
ENTRY = Atomoxetine HCl|T109|T121|NON|EQV|NLM (2016)|150519|abbcdef
ENTRY = LY 139603|T109|T121|LAB|NRW|NLM (1984)|abbcde
ENTRY = N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride|T109|T121|EQV|NLM (1984)|abbde
ENTRY = Strattera|T109|T121|TRD|NRW|US|030623|abbcdef
ENTRY = Tomoxetine|T109|T121|NON|BRD|NLM (1984)|150519|abbcdef
ENTRY = Tomoxetine Hydrochloride, (+)-isomer - T351671|T109|T121|NON|NRW|NLM (1984)|150519|abbcdef
ENTRY = Tomoxetine Hydrochloride, (+-)-isomer|T109|T121|NON|NRW|NLM (1984)|150519|abbcdef
ENTRY = Tomoxetine Hydrochloride, (-)-isomer|T109|T121|NON|NRW|NLM (1984)|150519|abbcdef
ENTRY = 139603, LY
ENTRY = HCl, Atomoxetine
ENTRY = Hydrochloride, Atomoxetine
MN = D02.092.831.085
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2004)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 57WVB6I2W0
RR = 82248-59-7
RR = 82857-39-4
RR = 82857-40-7
RR = 83015-26-3
RR = ASW034S0B8
MS = A propylamine derivative and selective ADRENERGIC UPTAKE INHIBITOR that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
PM = 2016; ATOMOXETINE HYDROCHLORIDE was indexed under PROPYLAMINES 1984-2015
HN = 2016 (1984)
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000069445

*NEWRECORD
RECTYPE = D
MH = Atazanavir Sulfate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester|T109|T121|BRD|NLM (2003)|030623|abbdef
ENTRY = Atazanavir|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2004)|150519|abbcdeeef
ENTRY = BMS 232632|T109|T121|LAB|NRW|NLM (2000)|000922|abbcdef
ENTRY = BMS-232632|T109|T121|LAB|NRW|NLM (2000)|000922|abbcdef
ENTRY = BMS-232632-05|T109|T121|LAB|NRW|NLM (2003)|030210|abbcdef
ENTRY = BMS232632|T109|T121|LAB|NRW|NLM (2000)|000922|abbcdef
ENTRY = CGP 73547|T109|T121|LAB|NRW|NLM (2000)|000922|abbcdef
ENTRY = CGP 75136|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = CGP 75176|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = CGP 75355|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = CGP-73547|T109|T121|LAB|NRW|NLM (2000)|000922|abbcdef
ENTRY = CGP-75136|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = CGP-75176|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = CGP-75355|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = CGP75136|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = CGP75176|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = CGP75355|T109|T121|LAB|NRW|NLM (2001)|011107|abbcdef
ENTRY = Reyataz|T109|T121|TRD|NRW|NLM (2003)|030514|abbcdef
ENTRY = 232632, BMS
ENTRY = 73547, CGP
ENTRY = 75136, CGP
ENTRY = 75176, CGP
ENTRY = 75355, CGP
ENTRY = BMS 232632 05
ENTRY = BMS23263205
ENTRY = CGP73547
ENTRY = Sulfate, Atazanavir
MN = D03.383.725.068
MN = D12.644.456.157
MH_TH = FDA SRS (2015)
MH_TH = INN (1999)
MH_TH = USAN (2002)
ST = T109
ST = T121
RN = 4MT4VIE29P
RR = 198904-31-3 (atazanavir)
RR = 229975-97-7
RR = QZU4H47A3S
MS = An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS.
PM = 2016; ATAZANAVIR SULFATE was indexed under OLIGOPEPTIDES and PYRIDINES 2000-2015
HN = 2016 (2000)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069446

*NEWRECORD
RECTYPE = D
MH = Tiotropium Bromide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide|T109|T121|NON|EQV|NLM (1993)|abbcde
ENTRY = BA 679 BR|T109|T121|LAB|NRW|NLM (1993)|abbcde
ENTRY = BA-679 BR|T109|T121|LAB|NRW|NLM (1993)|abbcde
ENTRY = Spiriva|T109|T121|TRD|NRW|NLM (2000)|000607|abbcdef
ENTRY = Tiotropium|T109|T121|NON|NRW|FDA SRS (2013)|NLM (1993)|150520|abbcdeef
ENTRY = 679 BR, BA
ENTRY = BA679 BR
ENTRY = BR, BA 679
ENTRY = Bromide, Tiotropium
MN = D02.145.074.722.822.887
MN = D03.132.889.601.887
MN = D03.605.869.822.887
MN = D04.075.080.875.099.722.822.887
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1993)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = XX112XZP0J
RR = 0EB439235F
RR = 136310-93-5 (tiotropium bromide)
RR = 186691-13-4 (tiotropium)
MS = A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
PM = 2016; TIOTROPIUM BROMIDE was indexed under SCOPOLAMINE DERIVATIVES 1993-2015
HN = 2016 (1993)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069447

*NEWRECORD
RECTYPE = D
MH = Denosumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = AMG 162|T116|T121|T129|LAB|NRW|NLM (2004)|041223|abbbcdef
ENTRY = Prolia|T116|T121|T129|TRD|NRW|NLM (2012)|110404|abbbcdef
ENTRY = Xgeva|T116|T121|T129|TRD|NRW|NLM (2011)|110223|abbbcdef
ENTRY = 162, AMG
MN = D12.776.124.486.485.114.224.060.782
MN = D12.776.124.790.651.114.224.060.782
MN = D12.776.377.715.548.114.224.200.782
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (2006)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = 4EQZ6YO2HI
RR = 615258-40-7 (denosumab)
MS = A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS.
PM = 2016; DENOSUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2015; and under ANTIBODIES, MONOCLONAL 2004-2012
HN = 2016 (2004)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069448

*NEWRECORD
RECTYPE = D
MH = Cinacalcet Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = AMG 073|T109|T121|LAB|NRW|NLM (2003)|030807|abbcdef
ENTRY = AMG073|T109|T121|LAB|NRW|NLM (2003)|030807|abbcdef
ENTRY = Alpha-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphaR)-hydrochloride|T109|T121|NON|EQV|NLM (2003)|150520|abbcdef
ENTRY = Cinacalcet|T109|T121|NON|BRD|INN (19XX)|NLM (2004)|USAN (19XX)|150520|abbcdeeef
ENTRY = KRN 1493|T109|T121|LAB|NRW|NLM (2004)|040909|abbcdef
ENTRY = Sensipar|T109|T121|TRD|NRW|NLM (2004)|040311|abbcdef
ENTRY = 073, AMG
ENTRY = 1493, KRN
ENTRY = Hydrochloride, Cinacalcet
MN = D02.455.426.559.847.638.183
MN = D04.615.638.183
MH_TH = FDA SRS (2013)
MH_TH = USAN (2002)
ST = T109
ST = T121
RN = 1K860WSG25
RR = 1K860WSG25
RR = 364782-34-3 (cinacalcet)
RR = UAZ6V7728S
MS = A naphthalene derivative and CALCIMIMETIC AGENT that increases the sensitivity of PARATHYROID GLAND calcium-sensing receptors to serum calcium. This action reduces parathyroid hormone secretion and decreases serum calcium in the treatment of PARATHYROID DISEASES.
PM = 2016; CINACALCET HYDROCHLORIDE was indexed under NAPHTHALENES 2003-2015
HN = 2016 (2003)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069449

*NEWRECORD
RECTYPE = D
MH = Liraglutide
AQ = AA AD AE BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = NN 2211|T116|T121|LAB|NRW|NLM (2001)|011127|abbcdef
ENTRY = NN-2211|T116|T121|LAB|NRW|NLM (2001)|011127|abbcdef
ENTRY = NN2211|T116|T121|LAB|NRW|NLM (2001)|011127|abbcdef
ENTRY = Saxenda|T109|T121|TRD|NRW|NLM (2015)|141230|abbcdef
ENTRY = Victoza|T116|T121|TRD|NRW|NLM (2010)|150520|abbcdef
ENTRY = 2211, NN
MN = D06.472.317.469.500.500.500
MH_TH = FDA SRS (2013)
MH_TH = NLM (2004)
MH_TH = USAN (19XX)
ST = T116
ST = T121
RN = 839I73S42A
RR = 204656-20-2
MS = An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.
PM = 2016; LIRAGLUTIDE was indexed under GLUCAGON-LIKE PEPTIDE 1 2005-2015; and under GLUCAGON 2001-2005
HN = 2016 (2001)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069450

*NEWRECORD
RECTYPE = D
MH = Long Term Adverse Effects
AQ = BL CF CI CL CN DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Adverse Effects, Long Term|T046|NON|EQV|NLM (2016)|150611|abcdef
MN = C23.550.543
MH_TH = NLM (2016)
ST = T046
MS = Persistent detrimental effects from treatment for a condition. Included are effects from surgery such as POSTOPERATIVE COMPLICATIONS, and from DRUG THERAPY, such as CHEMICALLY INDUCED DISORDERS, or other THERAPEUTICS. Failure to attain a desired outcome from treatment for the condition is not considered an adverse effect.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069451

*NEWRECORD
RECTYPE = D
MH = Pathogen-Associated Molecular Pattern Molecules
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Molecules, Pathogen-Associated Molecular Pattern|T120|T123|NON|EQV|NLM (2016)|150625|abbcdef
ENTRY = PAMPs|T120|T123|NON|EQV|NLM (2016)|150520|abbcdef
ENTRY = Pathogen-Associated Molecular Patterns|T085|NON|REL|NLM (2016)|150625|abcdef
ENTRY = Molecular Patterns, Pathogen-Associated
ENTRY = Molecules, Pathogen Associated Molecular Pattern
ENTRY = Pathogen Associated Molecular Pattern Molecules
ENTRY = Pathogen Associated Molecular Patterns
ENTRY = Patterns, Pathogen-Associated Molecular
MN = D23.585
MH_TH = NLM (2016)
ST = T120
ST = T123
RN = 0
MS = Pathogens' molecules with specific sequence patterns that are recognized by PATTERN RECOGNITION RECEPTORS. They include microbial DNA, double-stranded RNA, surface glycoproteins, lipopolysaccharides, peptidoglycans, and lipoteichoic acid.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069452

*NEWRECORD
RECTYPE = D
MH = Ultrasonic Waves
AQ = AE
ENTRY = LIPUS|T070|ABB|NRW|NLM (2016)|150521|abcdef
ENTRY = Low Intensity Pulsed Ultrasound|T070|NON|NRW|NLM (2016)|150512|abcdef
ENTRY = Low Intensity Pulsed Ultrasound Radiation|T070|NON|NRW|NLM (2016)|150512|abcdef
ENTRY = Low-Intensity Pulsed Ultrasound (LIPUS)|T070|ABX|NRW|NLM (2016)|150521|abcdef
ENTRY = Pulsed Ultrasound|T070|NON|NRW|NLM (2016)|150512|abcdef
ENTRY = Ultrasonic Vibration|T070|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Ultrasound Radiation|T070|NON|EQV|NLM (2012)|110429|abcdef
ENTRY = Ultrasound Waves|T070|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Low Intensity Pulsed Ultrasound (LIPUS)
ENTRY = Low-Intensity Pulsed Ultrasounds (LIPUS)
ENTRY = Pulsed Ultrasound, Low-Intensity (LIPUS)
ENTRY = Pulsed Ultrasounds
ENTRY = Pulsed Ultrasounds, Low-Intensity (LIPUS)
ENTRY = Radiation, Ultrasound
ENTRY = Ultrasonic Vibrations
ENTRY = Ultrasonic Wave
ENTRY = Ultrasound Wave
ENTRY = Ultrasound, Low-Intensity Pulsed (LIPUS)
ENTRY = Ultrasound, Pulsed
ENTRY = Ultrasounds, Low-Intensity Pulsed (LIPUS)
ENTRY = Ultrasounds, Pulsed
ENTRY = Vibration, Ultrasonic
ENTRY = Vibrations, Ultrasonic
ENTRY = Wave, Ultrasonic
ENTRY = Wave, Ultrasound
ENTRY = Waves, Ultrasonic
ENTRY = Waves, Ultrasound
MN = G01.750.770.776.891
FX = Ultrasonics
EC = therapy:Ultrasonic Therapy
MH_TH = NLM (2016)
ST = T070
PI = Sound (1969-2015)
PI = Ultrasonic Therapy (1969-2015)
PI = Ultrasonics (1966-2015)
PI = Ultrasonography (1963-2015)
MS = Oscillating sound wave with a frequency higher than the upper limit of the human hearing range.
PM = 2016; for ULTRASOUND RADIATION see SOUND 2012-2015
HN = 2016; for ULTRASOUND RADIATION use SOUND 2012-2015
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069453

*NEWRECORD
RECTYPE = D
MH = Darunavir
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Darunavir Ethanolate|T109|T121|NON|NRW|BAN (19XX)|INN (19XX)|NLM (2006)|150521|abbcdeeef
ENTRY = Prezista|T109|T121|TRD|NRW|NLM (2006)|060626|abbcdef
ENTRY = TMC 114|T109|T121|LAB|NRW|NLM (2005)|050209|abbcdef
ENTRY = TMC-114|T109|T121|LAB|NRW|NLM (2005)|050209|abbcdef
ENTRY = TMC114|T109|T121|LAB|NRW|NLM (2005)|050209|abbcdef
ENTRY = UIC-94017|T109|T121|LAB|NRW|NLM (2004)|040304|abbcdef
ENTRY = UIC94017|T109|T121|LAB|NRW|NLM (2004)|040304|abbcdef
ENTRY = 114, TMC
ENTRY = Ethanolate, Darunavir
ENTRY = UIC 94017
MN = D02.065.884.438
MN = D02.241.081.251.222
MN = D02.886.590.700.400
MN = D03.383.312.303
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (2006)
MH_TH = USAN (19XX)
ST = T109
ST = T121
N1 = (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester
RN = YO603Y8113
RR = 206361-99-1 (darunavir)
RR = 33O78XF0BW
MS = An HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.
PM = 2016; DARUNAVIR was indexed under SULFONAMIDES 2004-2015
HN = 2016 (2004)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069454

*NEWRECORD
RECTYPE = D
MH = Palivizumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = MEDI 493|T116|T121|T129|LAB|NRW|NLM (1998)|abbbcde
ENTRY = MEDI-493|T116|T121|T129|LAB|NRW|NLM (1998)|abbbcde
ENTRY = Monoclonal Antibody MEDI-493|T116|T121|T129|NON|NRW|NLM (2016)|150603|abbbcdef
ENTRY = Synagis|T116|T121|T129|TRD|NRW|AU|CA|DE|ES|FR|NL|UK|US|000314|abbbcdeeeeeeeef
ENTRY = 493, MEDI
ENTRY = Antibody MEDI-493, Monoclonal
ENTRY = MEDI-493, Monoclonal Antibody
ENTRY = MEDI493
ENTRY = Monoclonal Antibody MEDI 493
MN = D12.776.124.486.485.114.224.060.860
MN = D12.776.124.790.651.114.224.060.860
MN = D12.776.377.715.548.114.224.200.860
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1998)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = DQ448MW7KS
RR = 188039-54-5
MS = A humanized monoclonal antibody and ANTIVIRAL AGENT  that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.
PM = 2016; PALIVIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 1998-2015
HN = 2016 (1998)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069455

*NEWRECORD
RECTYPE = D
MH = Silent Mutation
AQ = DE GE IM PH RE
ENTRY = Mutations, Silent|T045|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Silent Mutations|T045|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Synonymous Codon Substitutions|T045|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Synonymous Mutations|T045|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Codon Substitution, Synonymous
ENTRY = Codon Substitutions, Synonymous
ENTRY = Mutation, Silent
ENTRY = Mutation, Synonymous
ENTRY = Mutations, Synonymous
ENTRY = Substitution, Synonymous Codon
ENTRY = Substitutions, Synonymous Codon
ENTRY = Synonymous Codon Substitution
ENTRY = Synonymous Mutation
MN = G05.365.590.803
MH_TH = NLM (2016)
ST = T045
PI = Mutation (1982-2015)
MS = A change to a DNA SEQUENCE that doesn't change the AMINO ACID SEQUENCE of the protein made.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069456

*NEWRECORD
RECTYPE = D
MH = Population Forecast
AQ = MT
ENTRY = Population Growth Estimation|T062|NON|NRW|UNK (19XX)|781226|abcdef
ENTRY = Population Projection|T170|NON|EQV|NLM (1981)|861231|abcdef
ENTRY = Estimation, Population Growth
ENTRY = Estimations, Population Growth
ENTRY = Forecasts, Population
ENTRY = Growth Estimation, Population
ENTRY = Growth Estimations, Population
ENTRY = Population Forecasts
ENTRY = Population Growth Estimations
ENTRY = Population Projections
ENTRY = Projection, Population
MN = I01.320.500
MN = N01.224.667
FX = Population Growth
MH_TH = NLM (1981)
ST = T170
PI = Forecasting (1977-2015)
MS = Estimates of projected population.
PM = 2016; see FORECASTING 1981-2015; for POPULATION GROWTH ESTIMATE see POPULATION GROWTH 1980-2015
HN = 2016; use FORECASTING 1981-2015; for POPULATION GROWTH ESTIMATE use POPULATION GROWTH 1980-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069457

*NEWRECORD
RECTYPE = D
MH = Ranolazine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide|T109|T121|EQV|NLM (1988)|abbde
ENTRY = RS 43285|T109|T121|LAB|NRW|NLM (1988)|abbcde
ENTRY = RS 43285-193|T109|T121|LAB|NRW|NLM (1988)|abbcde
ENTRY = RS-43285|T109|T121|LAB|NRW|NLM (1988)|abbcde
ENTRY = Ranexa|T109|T121|TRD|NRW|NLM (2003)|030311|abbcdef
ENTRY = Ranolazine Dihydrochloride|T109|T121|NON|NRW|NLM (2016)|150521|abbcdef
ENTRY = Ranolazine HCl|T109|T121|NON|NRW|NLM (2016)|150521|abbcdef
ENTRY = Ranolazine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2015)|NLM (2016)|USAN (19XX)|150521|abbcdeeef
ENTRY = Renolazine|T109|T121|NON|EQV|NLM (1988)|150521|abbcdef
ENTRY = 43285, RS
ENTRY = Dihydrochloride, Ranolazine
ENTRY = HCl, Ranolazine
ENTRY = Hydrochloride, Ranolazine
ENTRY = RS 43285 193
ENTRY = RS 43285193
ENTRY = RS43285
MN = D02.065.199.092.850
MN = D03.383.606.841
MH_TH = FDA SRS (2015)
MH_TH = NLM (1988)
MH_TH = USAN (1988)
ST = T109
ST = T121
RN = A6IEZ5M406
RR = 110445-25-5
RR = 95635-55-5
RR = F71253DJUN
MS = An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the treatment of ANGINA PECTORIS.
PM = 2016; RANOLAZINE was indexed under ACETANILIDES and PIPERAZINES 1988-2015
HN = 2016 (1988)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069458

*NEWRECORD
RECTYPE = D
MH = Teas, Herbal
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
PRINT ENTRY = Herbal Teas|T168|NON|EQV|UNK (19XX)|850430|abcdef
ENTRY = Tisanes|T168|NON|EQV|NLM (2016)|150625|abcdef
ENTRY = Herbal Tea
ENTRY = Tea, Herbal
ENTRY = Tisane
MN = D20.215.784.937
MN = G07.203.100.950
MN = J02.200.950
MH_TH = NLM (1991)
ST = T168
RN = 0
MS = Beverages prepared from an infusion of plant tissues.
PM = 2016; see BEVERAGES 1986-2015
HN = 2016; use BEVERAGES 1986-2015
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069459

*NEWRECORD
RECTYPE = D
MH = Teas, Medicinal
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Medicinal Teas|T168|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Medicinal Tea
ENTRY = Tea, Medicinal
MN = G07.203.100.975
MN = J02.200.975
MH_TH = UNK (19XX)
ST = T168
MS = Beverages used in TRADITIONAL MEDICINE that are prepared from the infusion of plant tissue (HERBAL TEA), and/or animal tissue or other organisms such as FUNGI.
PM = 2016; see BEVERAGES 1986-2015
HN = 2016; use BEVERAGES 1986-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069460

*NEWRECORD
RECTYPE = D
MH = Bendamustine Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Bendamustin|T109|T121|NON|BRD|NLM (1972)|150521|abbcdef
ENTRY = Bendamustine|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (1972)|150521|abbcdeeef
ENTRY = Cytostasan|T109|T121|TRD|NRW|NLM (1972)|abbcde
ENTRY = IMET 3393|T109|T121|LAB|NRW|NLM (1972)|abbcde
ENTRY = Ribomustin|T109|T121|TRD|NRW|DE|041207|abbcdef
ENTRY = Treanda|T109|T121|TRD|NRW|NLM (2008)|080522|abbcdef
ENTRY = Zimet 3393|T109|T121|LAB|NRW|NLM (1972)|abbcde
ENTRY = Hydrochloride, Bendamustine
MN = D02.241.081.114.625
MN = D02.455.526.728.650.103
MN = D03.438.103.123
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1972)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 981Y8SX18M
RR = 16506-27-7 (bendamustine)
RR = 3543-75-7
RR = 9266D9P3PQ
MS = A nitrogen mustard compound that functions as an ALKYLATING ANTINEOPLASTIC AGENT and is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA and NON-HODGKIN'S LYMPHOMA.
PM = 2016; BENDAMUSTINE HYDROCHLORIDE was indexed under NITROGEN MUSTARD COMPOUNDS 1982-2015 and under BENZIMIDAZOLES 1972-1982
HN = 2016 (1972)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069461

*NEWRECORD
RECTYPE = D
MH = Dimethyl Fumarate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-butenedioic acid, (2E)-, dimethyl ester|T109|EQV|NLM (2013)|130329|abdef
ENTRY = BG 00012|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = BG 12 compound|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = BG-00012|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = BG-12 compound|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = BG00012|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = BG12 compound|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = Dimethylfumarate|T109|NON|EQV|NLM (2004)|150521|abcdef
ENTRY = FAG 201|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = FAG-201|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = FAG201|T109|T121|LAB|NRW|NLM (2005)|051221|abbcdef
ENTRY = Fumaderm|T109|TRD|NRW|NLM (1988)|abcde
ENTRY = Tecfidera|T109|T121|TRD|NRW|NLM (2013)|130329|abbcdef
ENTRY = 00012, BG
ENTRY = 12 compound, BG
ENTRY = 201, FAG
ENTRY = Fumarate, Dimethyl
ENTRY = compound, BG 12
ENTRY = compound, BG12
MN = D02.241.081.337.302.500
MH_TH = NLM (1988)
MH_TH = USAN (19XX)
ST = T109
RN = FO2303MNI2
RR = 624-49-7 (dimethyl fumarate)
MS = A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.
PM = 2016; DIMETHYL FUMARATE was indexed under FUMARATES 1988-2015
HN = 2016 (1988)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069462

*NEWRECORD
RECTYPE = D
MH = Olive Oil
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Olive Oils|T119|T168|NON|EQV|NLM (2016)|150521|abbcdef
ENTRY = Oil, Olive
ENTRY = Oils, Olive
MN = D10.212.302.380.580
MN = D10.212.507.650
MN = D10.627.700.728
MN = G07.203.300.375.400.500
MN = J02.500.375.400.500
MH_TH = NLM (2016)
ST = T119
ST = T168
RN = 0
PI = Plant Oils (1986-2015)
MS = Oil extracted from fruit of the OLIVE TREE (genus Olea).
PM = 2016; OLIVE OIL was indexed under PLANT OILS 1986-2015, and under OILS 1984-1986
HN = 2016
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000069463

*NEWRECORD
RECTYPE = D
MH = Solifenacin Succinate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-|T109|T121|NON|BRD|NLM (2014)|130521|abbcdef
ENTRY = Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate|T109|T121|NON|EQV|NLM (2001)|150521|abbcdef
ENTRY = Solifenacin|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2004)|150521|abbcdeeef
ENTRY = Vesicare|T109|T121|TRD|NRW|NLM (2010)|150521|abbcdef
ENTRY = YM 905|T109|T121|LAB|NRW|NLM (2001)|011213|abbcdef
ENTRY = YM905|T109|T121|LAB|NRW|NLM (2001)|011213|abbcdef
ENTRY = 905, YM
ENTRY = Succinate, Solifenacin
MN = D03.438.531.820.594
MN = D03.605.687.900
MH_TH = FDA SRS (2013)
MH_TH = NLM (2010)
MH_TH = USAN (2001)
ST = T109
ST = T121
RN = KKA5DLD701
RR = 242478-38-2
RR = A8910SQJ1U
MS = A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
PM = 2016; SOLIFENACIN SUCCINATE was indexed under QUINUCLIDINES and TETRAHYDROISOQUINOLINES 2003-2015; and under ISOQUINOLINES 2001-2003
HN = 2016 (2001)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069464

*NEWRECORD
RECTYPE = D
MH = Febuxostat
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid|T109|T121|NRW|NLM (1994)|abbde
ENTRY = TEI 6720|T109|T121|LAB|NRW|NLM (2004)|041006|abbcdef
ENTRY = TEI-6720|T109|T121|LAB|NRW|NLM (2004)|041006|abbcdef
ENTRY = Uloric|T109|T121|TRD|NRW|NLM (2011)|100310|abbcdef
ENTRY = 6720, TEI
ENTRY = TEI6720
MN = D02.886.675.274
MN = D03.383.129.708.274
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USAN (2002)
ST = T109
N1 = 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-
RN = 101V0R1N2E
RR = 144060-53-7
MS = A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.
PM = 2016; FEBUXOSTAT was indexed under THIAZOLES 1994-2015
HN = 2016 (1994)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069465

*NEWRECORD
RECTYPE = D
MH = Red Meat
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Beef|T168|NON|NRW|NLM (2016)|150521|abcdef
ENTRY = Pork|T168|NON|NRW|NLM (2016)|150521|abcdef
ENTRY = Meat, Red
ENTRY = Meats, Red
ENTRY = Red Meats
MN = G07.203.300.600.813
MN = J02.500.600.813
MH_TH = NLM (2016)
ST = T168
PI = Meat (1975-2015)
MS = Meat such as beef, pork, or lamb which contains more MYOGLOBIN than POULTRY or SEAFOOD.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069466

*NEWRECORD
RECTYPE = D
MH = Fecal Microbiota Transplantation
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Donor Feces Infusion|T061|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Fecal Transplant|T061|NON|EQV|NLM (2016)|150625|abcdef
ENTRY = Fecal Transplantation|T061|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Intestinal Microbiota Transfer|T061|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Donor Feces Infusions
ENTRY = Fecal Microbiota Transplantations
ENTRY = Fecal Transplantations
ENTRY = Fecal Transplants
ENTRY = Feces Infusion, Donor
ENTRY = Feces Infusions, Donor
ENTRY = Infusion, Donor Feces
ENTRY = Infusions, Donor Feces
ENTRY = Intestinal Microbiota Transfers
ENTRY = Microbiota Transfer, Intestinal
ENTRY = Microbiota Transfers, Intestinal
ENTRY = Microbiota Transplantation, Fecal
ENTRY = Microbiota Transplantations, Fecal
ENTRY = Transfer, Intestinal Microbiota
ENTRY = Transfers, Intestinal Microbiota
ENTRY = Transplant, Fecal
ENTRY = Transplantation, Fecal
ENTRY = Transplantation, Fecal Microbiota
ENTRY = Transplantations, Fecal
ENTRY = Transplantations, Fecal Microbiota
ENTRY = Transplants, Fecal
MN = E02.095.231
MH_TH = NLM (2016)
ST = T061
MS = Transfer of GASTROINTESTINAL MICROBIOTA from one individual to another by infusion of donor FECES to the upper or lower GASTROINTESTINAL TRACT of the recipient.
PM = 2016
HN = 2016
MR = 20150625
DA = 20150701
DC = 1
DX = 20160101
UI = D000069467

*NEWRECORD
RECTYPE = D
MH = Desvenlafaxine Succinate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate|T109|T121|EQV|NLM (2008)|080801|abbdef
ENTRY = 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol|T109|T121|BRD|NLM (1994)|abbde
ENTRY = Desvenlafaxine|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2013)|150522|abbcdeeef
ENTRY = O-desmethylvenlafaxine|T109|T121|BRD|FDA SRS (2013)|NLM (1994)|abbdee
ENTRY = O-desmethylvenlafaxine Succinate|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = O-desmethylvenlafaxine Succinate Monohydrate|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Pristiq|T109|T121|TRD|NRW|NLM (2007)|070208|abbcdef
ENTRY = WY 45,233|T109|T121|LAB|NRW|NLM (1994)|abbcde
ENTRY = WY 45233|T109|T121|LAB|NRW|NLM (1994)|abbcde
ENTRY = WY-45,233|T109|T121|LAB|NRW|NLM (1994)|abbcde
ENTRY = WY-45233|T109|T121|LAB|NRW|NLM (1994)|abbcde
ENTRY = 45,233, WY
ENTRY = 45233, WY
ENTRY = Monohydrate, O-desmethylvenlafaxine Succinate
ENTRY = O desmethylvenlafaxine
ENTRY = O desmethylvenlafaxine Succinate
ENTRY = O desmethylvenlafaxine Succinate Monohydrate
ENTRY = Succinate Monohydrate, O-desmethylvenlafaxine
ENTRY = Succinate, Desvenlafaxine
ENTRY = Succinate, O-desmethylvenlafaxine
ENTRY = WY45,233
ENTRY = WY45233
MN = D02.033.415.510.500.303
MN = D02.455.426.392.368.367.318.500
MN = D02.455.426.559.389.657.265
MN = D10.289.510.500.303
MH_TH = FDA SRS (2015)
MH_TH = NLM (2006)
MH_TH = USAN (2006)
ST = T109
ST = T121
RN = ZB22ENF0XR
RR = 386750-22-7 (desvenlafaxine succinate)
RR = NG99554ANW
MS = A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.
PM = 2016; DESVENLAFAXINE SUCCINATE was indexed under CYCLOHEXANOLS 1994-2015
HN = 2016 (1994)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069468

*NEWRECORD
RECTYPE = D
MH = Medical-Surgical Nursing
AQ = CL EC ED ES HI LJ MA MT OG SN ST TD
ENTRY = Medical Surgical Nursing|T058|T091|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Nursing, Medical Surgical|T058|T091|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Nursing, Medical-Surgical|T058|T091|NON|EQV|NLM (2016)|150522|abbcdef
MN = H02.478.676.403
MN = N02.421.533.475
FX = Operating Room Nursing
MH_TH = NLM (2016)
ST = T058
ST = T091
MS = The area of nursing concerned with the needs and care of adult medical and surgical patients.
PM = 2016
HN = 2016
MR = 20150630
DA = 20150706
DC = 1
DX = 20160101
UI = D000069469

*NEWRECORD
RECTYPE = D
MH = Venlafaxine Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl|T109|T121|NON|EQV|NLM (1986)|abbcde
ENTRY = Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride|T109|T121|NON|EQV|NLM (2004)|040129|abbcdef
ENTRY = Dobupal|T109|T121|TRD|NRW|ES|041129|abbcdef
ENTRY = Efexor|T109|T121|TRD|NRW|AU|MX|NL|UK|041129|abbcdeeeef
ENTRY = Effexor|T109|T121|TRD|NRW|CA|FR|US|abbcdeee
ENTRY = Sila-Venlafaxine|T109|T121|NON|NRW|NLM (2006)|150522|abbcdef
ENTRY = Trevilor|T109|T121|TRD|NRW|DE|041129|abbcdef
ENTRY = Vandral|T109|T121|TRD|NRW|ES|041129|abbcdef
ENTRY = Venlafaxine|T109|T121|NON|NRW|FDA SRS (2013)|INN (19XX)|USAN (1989)|150522|abbcdeeef
ENTRY = Wy 45030|T109|T121|LAB|NRW|NLM (1986)|abbcde
ENTRY = Wy-45,030|T109|T121|LAB|NRW|NLM (1986)|abbcde
ENTRY = Wy-45030|T109|T121|LAB|NRW|NLM (1986)|abbcde
ENTRY = Hydrochloride, Venlafaxine
ENTRY = Sila Venlafaxine
ENTRY = Wy 45,030
ENTRY = Wy45,030
ENTRY = Wy45030
MN = D02.033.415.510.500.901
MN = D02.092.471.683.948
MN = D02.455.426.392.368.367.318.750
MN = D10.289.510.500.901
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1986)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 7D7RX5A8MO
RR = 99300-78-4 (venlafaxine hydrochloride)
RR = GRZ5RCB1QG
MS = A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.
PM = 2016; VENLAFAXINE HYDROCHLORIDE was indexed under CYCLOHEXANOLS 1986-2015
HN = 2016 (1986)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069470

*NEWRECORD
RECTYPE = D
MH = Neurosurgeons
AQ = CL EC ED ES HI LJ OG PX SD SN ST TD UT
ENTRY = Neurological Surgeons|T097|NON|EQV|NLM (2016)|150630|abcdef
ENTRY = Neurological Surgeon
ENTRY = Neurosurgeon
ENTRY = Surgeon, Neurological
ENTRY = Surgeons, Neurological
MN = M01.526.485.810.910.750
MN = N02.360.810.910.750
MH_TH = NLM (2016)
ST = T097
MS = Qualified medical professionals who specialize in surgical treatment of diseases of the BRAIN and other parts of the NERVOUS SYSTEM.
PM = 2016
HN = 2016
MR = 20150630
DA = 20150701
DC = 1
DX = 20160101
UI = D000069471

*NEWRECORD
RECTYPE = D
MH = Colesevelam Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = CholestaGel|T109|T121|TRD|NRW|NLM (1999)|991228|abbcdef
ENTRY = Colesevelam|T109|T121|NON|BRD|INN (19XX)|NLM (1999)|150522|abbcdeef
ENTRY = Colesevelam HCl|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = GT 31104|T109|T121|LAB|NRW|NLM (1999)|991228|abbcdef
ENTRY = GT-31104|T109|T121|LAB|NRW|NLM (1999)|991228|abbcdef
ENTRY = GT31-104|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = Welchol|T109|T121|TRD|NRW|NLM (2002)|020416|abbcdef
ENTRY = 31104, GT
ENTRY = GT31 104
ENTRY = GT31104
ENTRY = HCl, Colesevelam
ENTRY = Hydrochloride, Colesevelam
MN = D02.092.050.500
MN = D02.455.326.271.122.100.500
MH_TH = FDA SRS (2015)
MH_TH = NLM (1997)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = P4SG24WI5Q
RR = 182815-43-6 (colesevelam)
RR = 182815-44-7 (colesevelam hydrochloride)
RR = 1XU104G55N
MS = An allylamine derivative that binds BILE ACIDS in the intestine and is used as an ANTICHOLESTEREMIC AGENT in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.
PM = 2016; COLESEVELAM HYDROCHLORIDE was indexed under ALLYLAMINE 1997-2015
HN = 2016 (1997)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069472

*NEWRECORD
RECTYPE = D
MH = Dose Hypofractionation
AQ = ST
ENTRY = Hypofractionated Dose|T061|NON|EQV|NLM (2016)|150626|abcdef
ENTRY = Radiotherapy Minibeams|T061|NON|EQV|NLM (2016)|150522|abcdef
ENTRY = Dose, Hypofractionated
ENTRY = Doses, Hypofractionated
ENTRY = Hypofractionated Doses
ENTRY = Hypofractionation, Dose
ENTRY = Minibeam, Radiotherapy
ENTRY = Minibeams, Radiotherapy
ENTRY = Radiotherapy Minibeam
MN = E02.815.639.200.500
MN = E02.815.639.600
FX = Radiation
MH_TH = NLM (2016)
ST = T061
MS = A treatment schedule in which the total dose of radiation is divided into large doses.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000069473

*NEWRECORD
RECTYPE = D
MH = Sofosbuvir
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester|T114|T121|NON|EQV|NLM (2010)|101107|abbcdef
ENTRY = GS-7977|T109|T121|LAB|NRW|NLM (2013)|130117|abbcdef
ENTRY = PSI 7977|T109|T121|LAB|NRW|NLM (2010)|101107|abbcdef
ENTRY = PSI-7977|T109|T121|LAB|NRW|NLM (2010)|101107|abbcdef
ENTRY = PSI7977|T109|T121|LAB|NRW|NLM (2010)|101107|abbcdef
ENTRY = Sovaldi|T114|T121|TRD|NRW|NLM (2014)|141016|abbcdef
ENTRY = 7977, PSI
ENTRY = GS 7977
ENTRY = GS7977
MN = D03.383.742.686.850.877.500
MN = D13.695.740.850.877.500
MN = D13.695.827.919.877.500
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2013)
MH_TH = USAN (19XX)
ST = T114
ST = T121
RN = WJ6CA3ZU8B
MS = A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C.
PM = 2016; SOFOSBUVIR was indexed under URIDINE MONOPHOSPHATE 2010-2015
HN = 2016 (2010)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069474

*NEWRECORD
RECTYPE = D
MH = Re-Irradiation
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Re Irradiation|T061|NON|EQV|NLM (2016)|150626|abcdef
ENTRY = Reirradiation|T061|NON|EQV|NLM (2016)|150522|abcdef
MN = E02.815.791
MN = E02.887.500
MH_TH = NLM (2016)
ST = T061
PI = Radiotherapy (1965-2015)
MS = Treatment in which a repeat course of RADIOTHERAPY is administered.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069475

*NEWRECORD
RECTYPE = D
MH = Linagliptin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|T109|T121|NON|EQV|NLM (2016)|150624|abbcdef
ENTRY = 1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-|T109|T121|NON|EQV|NLM (2016)|150624|abbcdef
ENTRY = BI 1356|T109|T121|LAB|NRW|NLM (2008)|080401|abbcdef
ENTRY = BI-1356|T109|T121|LAB|NRW|NLM (2008)|080401|abbcdef
ENTRY = BI1356|T109|T121|LAB|NRW|NLM (2008)|080401|abbcdef
ENTRY = Tradjenta|T109|T121|TRD|NRW|NLM (2016)|150604|abbcdef
ENTRY = Trajenta|T109|T121|TRD|NRW|NLM (2012)|150522|abbcdef
ENTRY = 1356, BI
MN = D03.438.759.562
MN = D03.438.786.563
FX = Sitagliptin Phosphate
MH_TH = FDA SRS (2013)
MH_TH = NLM (2010)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 3X29ZEJ4R2
RR = 668270-12-0
MS = A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
PM = 2016; LINAGLIPTIN was indexed under PURINES and QUINAZOLINES 2011-2015
HN = 2016 (2011)
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000069476

*NEWRECORD
RECTYPE = D
MH = Lisdexamfetamine Dimesylate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Elvanse|T109|T121|TRD|NRW|NLM (2014)|150522|abbcdef
ENTRY = Lis-dexamfetamine Dimesylate|T109|T121|NON|EQV|NLM (2006)|150522|abbcdef
ENTRY = Lisdexamfetamine|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2013)|150522|abbcdeeef
ENTRY = NRP-104|T109|T121|LAB|NRW|NLM (2006)|061010|abbcdef
ENTRY = NRP104|T109|T121|LAB|NRW|NLM (2006)|061010|abbcdef
ENTRY = Vyvanse|T109|T121|TRD|NRW|NLM (2007)|070220|abbcdef
ENTRY = Dimesylate, Lis-dexamfetamine
ENTRY = Dimesylate, Lisdexamfetamine
ENTRY = Lis dexamfetamine Dimesylate
ENTRY = NRP 104
MN = D02.092.471.683.152.110.200.500
MH_TH = NLM (2006)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = SJT761GEGS
RR = H645GUL8KJ
MS = A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
PM = 2016; LISDEXAMFETAMINE DIMESYLATE was indexed under DEXTROAMPHETAMINE 2006-2015
HN = 2016 (2006)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069478

*NEWRECORD
RECTYPE = D
MH = Buprenorphine, Naloxone Drug Combination
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Buprenorphine Naloxone|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Buprenorphine Naloxone Drug Combination|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Buprenorphine-Naloxone|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Buprenorphine-Naloxone Combination|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Buprenorphine-Naloxone Drug Combination|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Suboxone|T109|T121|TRD|NRW|NLM (2006)|150522|abbcdef
ENTRY = Buprenorphine Naloxone Combination
ENTRY = Combination, Buprenorphine-Naloxone
ENTRY = Combination, Buprenorphine-Naloxone Drug
ENTRY = Drug Combination, Buprenorphine-Naloxone
ENTRY = Naloxone, Buprenorphine
MN = D03.132.577.249.150.500
MN = D03.132.577.249.706.275
MN = D03.549.686.150.500
MN = D03.549.686.750.275
MN = D03.605.497.150.500
MN = D03.605.497.750.275
MN = D04.615.723.795.150.500
MN = D04.615.723.795.706.275
MN = D26.310.352
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with naloxone, a NARCOTIC ANTAGONIST to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIATE SUBSTITUTION THERAPY.
PM = 2016; BUPRENORPHINE, NALOXONE DRUG COMBINATION was indexed under BUPRENORPHINE and NALOXONE 2006-2015
HN = 2016 (2006)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069479

*NEWRECORD
RECTYPE = D
MH = Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination|T109|T121|NON|EQV|NLM (2016)|150522|abbcdef
ENTRY = Truvada|T114|T121|TRD|NRW|NLM (2004)|041103|abbcdef
MN = D02.705.429.906.750
MN = D03.383.742.680.245.500.600.750
MN = D03.438.759.138.881.750
MN = D13.570.230.329.525.500
MN = D13.570.685.245.500.600.500
MN = D26.310.423
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = A pharmaceutical preparation of emtricitabine and tenofovir that is used as an ANTI-HIV AGENT in the treatment and prevention of HIV INFECTIONS.
PM = 2016; EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE DRUG COMBINATION was indexed under DEOXYCYTIDINE and ORGANOPHOSPHORUS COMPOUNDS 2005-2015
HN = 2016 (2005)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069480

*NEWRECORD
RECTYPE = D
MH = Origin of Life
ENTRY = Genesis of Life|T077|NON|EQV|NLM (2016)|150526|abcdef
ENTRY = Life Geneses
ENTRY = Life Genesis
ENTRY = Life Origin
ENTRY = Life Origins
MN = G16.595
MN = I01.076.368.584.542
MH_TH = UNK (19XX)
ST = T077
PI = Organelle Biogenesis (1978-2015)
MS = The process by which life began.
PM = 2016; see BIOGENESIS 1979-2015
HN = 2016; use ORGANELLE BIOGENESIS 1979-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069497

*NEWRECORD
RECTYPE = D
MH = Ezetimibe, Simvastatin Drug Combination
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Ezetimibe Simvastatin Drug Combination|T109|T121|NON|EQV|NLM (2016)|150526|abbcdef
ENTRY = Ezetimibe-Simvastatin Combination|T109|T121|NON|EQV|NLM (2016)|150526|abbcdef
ENTRY = Ezetimibe-Simvastatin Drug Combination|T109|T121|NON|EQV|NLM (2016)|150526|abbcdef
ENTRY = Inegy|T109|T121|TRD|NRW|NLM (2008)|080108|abbcdef
ENTRY = Vytorin|T109|T121|TRD|NRW|NLM (2004)|041016|abbcdef
ENTRY = Combination, Ezetimibe-Simvastatin
ENTRY = Combination, Ezetimibe-Simvastatin Drug
ENTRY = Drug Combination, Ezetimibe-Simvastatin
ENTRY = Ezetimibe Simvastatin Combination
MN = D02.455.426.559.847.638.400.900.500
MN = D03.383.082.301.550.500
MN = D04.615.638.400.900.500
MN = D26.310.431
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = A pharmaceutical preparation of ezetimibe and simvastatin that is used in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.
PM = 2016; ETIMIBE SIMVASTATIN DRUG COMBINATION was indexed under AZETIDINES and SIMVASTATIN 2004-2015
HN = 2016 (2004)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069499

*NEWRECORD
RECTYPE = D
MH = Abiraterone Acetate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 17-(3-pyridyl)-5,16-androstadien-3beta-acetate|T110|T121|NRW|NLM (1994)|abbde
ENTRY = CB 7630|T110|T120|LAB|NRW|NLM (1994)|abbcde
ENTRY = CB-7630|T110|T120|LAB|NRW|NLM (1994)|abbcde
ENTRY = CB7630|T110|T120|LAB|NRW|NLM (1994)|abbcde
ENTRY = Zytiga|T110|T121|TRD|NRW|NLM (2014)|US|121220|abbcdeef
MN = D04.808.054.079.065
MH_TH = FDA SRS (2015)
MH_TH = NLM (2011)
MH_TH = USAN (19XX)
ST = T110
ST = T121
RN = EM5OCB9YJ6
RR = 154229-18-2
MS = An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.
PM = 2016; ABIRATERONE ACETATE was indexed under ANDROSTENES 1994-2015
HN = 2016 (1994)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069501

*NEWRECORD
RECTYPE = D
MH = Budesonide, Formoterol Fumarate Drug Combination
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Budesonide Formoterol Drug Combination|T109|T121|NON|EQV|NLM (2016)|150526|abbcdef
ENTRY = Budesonide Formoterol Fumarate Drug Combination|T109|T121|NON|EQV|NLM (2016)|150526|abbcdef
ENTRY = Budesonide-Formoterol Drug Combination|T109|T121|NON|EQV|NLM (2016)|150526|abbcdef
ENTRY = Budesonide-Formoterol Fumarate Drug Combination|T109|T121|NON|EQV|NLM (2016)|150526|abbcdef
ENTRY = Symbicort|T109|T121|TRD|NRW|NLM (2002)|150526|abbcdef
ENTRY = Combination, Budesonide-Formoterol Drug
ENTRY = Drug Combination, Budesonide-Formoterol
MN = D02.033.100.291.425.250
MN = D02.092.063.291.425.250
MN = D04.808.745.745.654.105.500
MN = D26.310.348
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 0
MS = A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
PM = 2016; BUDESONIDE, FORMOTEROL FUMARATE DRUG COMBINATION was indexed under ETHANOLAMINES and ADRENAL CORTEX HORMONES 2002-2015
HN = 2016 (2002)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069502

*NEWRECORD
RECTYPE = D
MH = Vilazodone Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1)|T109|T121|NON|EQV|NLM (2011)|110823|abbcdef
ENTRY = 5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide|T109|T121|NON|BRD|NLM (1997)|abbcde
ENTRY = EMB-68843|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = EMD 68843|T109|T121|LAB|NRW|NLM (1997)|abbcde
ENTRY = Viibryd|T109|T121|TRD|NRW|NLM (2011)|110823|abbcdef
ENTRY = Vilazodone|T109|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2004)|USAN (19XX)|150526|abbcdeeeef
ENTRY = Vilazodone HCl|T109|T121|NON|EQV|NLM (2016)|150526|abbcdef
ENTRY = 68843, EMD
ENTRY = EMB 68843
ENTRY = EMB68843
ENTRY = HCl, Vilazodone
ENTRY = Hydrochloride, Vilazodone
MN = D03.383.606.980
MN = D03.438.127.818
MN = D03.438.473.957
MH_TH = FDA SRS (2015)
MH_TH = NLM (2011)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = U8HTX2GK8J
RR = 163521-08-2 (vilazodone hydrochloride)
RR = S239O2OOV3
MS = A benzofuran, indole, and piperazine derivative that functions as a SEROTONIN UPTAKE INHIBITOR and partial SEROTONIN 5-HT1 RECEPTOR AGONIST. It is used as an ANTIDEPRESSIVE AGENT.
PM = 2016; VILAZODONE HYDROCHLORIDE was indexed under INDOLES; PIPERAZINES; and BENZOFURANS 2004-2015
HN = 2016 (2004)
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069503

*NEWRECORD
RECTYPE = D
MH = International Law
AQ = ED ES HI
ENTRY = Law of Nations|T089|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Public International Law|T089|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = International Law, Public
ENTRY = International Laws
ENTRY = Law, International
ENTRY = Laws, International
MN = I01.880.604.583.466
MN = N03.706.535.533
FX = Internationality
MH_TH = NLM (2016)
ST = T089
MS = The body of law that governs the legal relations between or among sovereign states or nations.
PM = 2016
HN = 2016
MR = 20150630
DA = 20150701
DC = 1
DX = 20160101
UI = D000069516

*NEWRECORD
RECTYPE = D
MH = Blogs
ENTRY = Web Blogs|T170|NON|EQV|NLM (2016)|150528|abcdef
ENTRY = Weblogs|T170|NON|EQV|NLM (2016)|150528|abcdef
MN = V01.175.125
MN = V02.170.250
MN = V02.530.150.250
MH_TH = NLM (2016)
ST = T170
AN = This heading is used as a Publication Type. INDEXER: Do not use
PI = Blogging  (2010-2015)
MS = A website that contains conversational personal reflections, comments and sometimes links to other sites; typically run by an individual or small group.
HN = 2016
MR = 20150813
DA = 20150701
DC = 2
DX = 20160101
UI = D000069520

*NEWRECORD
RECTYPE = D
MH = Adult Day Care Centers
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Adult Day Care Center|T092|NON|EQV|NLM (2016)|150610|abcdef
ENTRY = Day Care Center, Adult|T092|NON|EQV|NLM (2016)|150610|abcdef
ENTRY = Day Care Centers, Adult|T092|NON|EQV|NLM (2016)|150610|abcdef
MN = N02.421.143.065
FX = Senior Centers
MH_TH = NLM (2016)
ST = T092
PI = Day Care, Medical (1981-2015)
MS = Non-residential facilities that are designed to provide care and companionship for seniors who need assistance or supervision during the day.
PM = 2016
HN = 2016
MR = 20150630
DA = 20150706
DC = 1
DX = 20160101
UI = D000069537

*NEWRECORD
RECTYPE = D
MH = Infectious Encephalitis
DE = INFECT ENCEPH
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Encephalitis Infection|T047|NON|REL|NLM (2016)|150527|abcdef
ENTRY = Encephalitis, Infectious|T047|NON|EQV|NLM (2000)|991105|abcdef
ENTRY = Encephalitis Infections
ENTRY = Infection, Encephalitis
ENTRY = Infections, Encephalitis
MN = C10.228.140.430.520
MN = C10.228.228.399
MH_TH = NLM (2000)
ST = T047
AN = coordinate IM with specific organism /infection term (IM); note ENCEPHALITIS, VIRAL is available
PI = Encephalitis (1964-2015)
MS = Brain inflammation caused by an infectious agent..
PM = 2016; see ENCEPHALITIS 1964-2015
HN = 2016; use ENCEPHALITIS 1964-2015
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069544

*NEWRECORD
RECTYPE = D
MH = Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate|T121|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination|T121|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination|T121|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Quad|T121|NON|NRW|NLM (2013)|150527|abcdef
ENTRY = Quad Pill|T121|NON|NRW|NLM (2016)|150527|abcdef
ENTRY = Stribild|T121|TRD|NRW|NLM (2013)|150527|abcdef
ENTRY = Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination
ENTRY = Pill, Quad
MN = D02.241.081.251.203.500
MN = D02.705.429.906.250
MN = D02.886.675.182.500
MN = D03.383.129.708.189.500
MN = D03.383.742.680.245.500.600.250
MN = D03.438.759.138.881.250
MN = D13.570.230.329.525.250
MN = D13.570.685.245.500.600.250
MN = D26.310.391
MH_TH = NLM (2016)
ST = T121
RN = 0
MS = A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS.
PM = 2016; ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE was indexed under CARBAMATES; DEOXYCITIDINE; THIAZOLES; QUINOLONES and ORGANOPHOSPHONATES 2012-2015
HN = 2016 (2012)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069545

*NEWRECORD
RECTYPE = D
MH = Cobicistat
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = GS 9350|T109|T121|LAB|NRW|NLM (2011)|110626|abbcdef
ENTRY = GS-9350|T109|T121|LAB|NRW|NLM (2011)|110626|abbcdef
ENTRY = GS9350|T109|T121|LAB|NRW|NLM (2011)|110626|abbcdef
ENTRY = Tybost|T109|T121|TRD|NRW|NLM (2016)|150527|abbcdef
ENTRY = 9350, GS
MN = D02.241.081.251.203
MN = D02.886.675.182
MN = D03.383.129.708.189
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2011)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = LW2E03M5PG
MS = A carbamate and thiazole derivative that functions as a CYTOCHROME P450 CYP3A INHIBITOR to enhance the concentration of ANTI-HIV AGENTS, with which it is used in combination, for the treatment of HIV INFECTIONS.
PM = 2016; COBICISTAT was indexed under CARBAMATES and THIAZOLES 2011-2015
HN = 2016 (2011)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069547

*NEWRECORD
RECTYPE = D
MH = Ustekinumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = CNTO 1275|T116|T121|T129|LAB|NRW|NLM (2005)|051005|abbbcdef
ENTRY = CNTO-1275|T116|T121|T129|LAB|NRW|NLM (2005)|051005|abbbcdef
ENTRY = Stelara|T116|T121|T129|TRD|NRW|NLM (2016)|150604|abbbcdef
ENTRY = 1275, CNTO
ENTRY = CNTO1275
MN = D12.776.124.486.485.114.224.060.937
MN = D12.776.124.790.651.114.224.060.937
MN = D12.776.377.715.548.114.224.200.937
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (2008)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = FU77B4U5Z0
MS = A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.
PM = 2016; USTEKINUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011
HN = 2016 (2005)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069549

*NEWRECORD
RECTYPE = D
MH = Machine Learning
AQ = CL EC ES HI LJ SD SN ST TD UT
ENTRY = Learning, Machine
MN = G17.035.250.500
MN = L01.224.050.375.530
MH_TH = NLM (2016)
ST = T066
MS = A type of ARTIFICIAL INTELLIGENCE that enable COMPUTERS to independently initiate and execute LEARNING when exposed to new data.
PM = 2016; see ARTIFICIAL INTELLIGENCE 1997-2015
HN = 2016; use ARTIFICIAL INTELLIGENCE 1997-2015
MR = 20150710
DA = 20150710
DC = 1
DX = 20160101
UI = D000069550

*NEWRECORD
RECTYPE = D
MH = Environmental Psychology
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Psychology, Environmental
MN = F04.096.628.033
FX = Ecology
FX = Environmental Medicine
MH_TH = NLM (2016)
ST = T090
AN = use for the discipline (education, history, etc) only
MS = The field that studies interactions between individuals and the built and natural environment. It includes investigating behaviors that inhibit or foster sustainable, climate-healthy, and nature-enhancing choices.
PM = 2016
HN = 2016
MR = 20150701
DA = 20150701
DC = 1
DX = 20160101
UI = D000069551

*NEWRECORD
RECTYPE = D
MH = Rivaroxaban
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide|T109|T121|NON|EQV|NLM (2005)|050829|abbcdef
ENTRY = BAY 59-7939|T109|T121|LAB|NRW|NLM (2005)|050829|abbcdef
ENTRY = Xarelto|T109|T121|TRD|NRW|NLM (2011)|110705|abbcdef
ENTRY = BAY 59 7939
ENTRY = BAY 597939
MN = D02.886.778.727
MN = D03.383.533.640.713
MN = D03.383.903.727
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2006)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 9NDF7JZ4M3
MS = A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM.  It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.
PM = 2016; RIVAROXABAN was indexed under MORPHOLINES and THIOPHENES 2005-2015
HN = 2016 (2005)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069552

*NEWRECORD
RECTYPE = D
MH = Supervised Machine Learning
AQ = CL EC ES HI LJ SD SN ST TD UT
ENTRY = Active Machine Learning|T066|NON|BRD|NLM (2016)|150527|abcdef
ENTRY = Inductive Machine Learning|T066|NON|BRD|NLM (2016)|150527|abcdef
ENTRY = Learning from Labeled Data|T066|NON|BRD|NLM (2016)|150527|abcdef
ENTRY = Machine Learning with a Teacher|T066|NON|BRD|NLM (2016)|150527|abcdef
ENTRY = Semi-supervised Learning|T066|NON|BRD|NLM (2016)|150527|abcdef
ENTRY = Learning, Active Machine
ENTRY = Learning, Inductive Machine
ENTRY = Learning, Semi-supervised
ENTRY = Learning, Supervised Machine
ENTRY = Machine Learning, Active
ENTRY = Machine Learning, Inductive
ENTRY = Machine Learning, Supervised
ENTRY = Semi supervised Learning
MN = G17.035.250.500.500
MN = L01.224.050.375.530.500
FX = Unsupervised Machine Learning
MH_TH = NLM (2016)
ST = T066
MS = A MACHINE LEARNING paradigm used to make predictions about future instances based on a given set of labeled paired input-output training (sample) data.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150706
DC = 1
DX = 20160101
UI = D000069553

*NEWRECORD
RECTYPE = D
MH = Injection, Intratympanic
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Intratympanic Injection|T061|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Transtympanic Administration|T061|NON|EQV|NLM (2016)|150528|abcdef
ENTRY = Administration, Transtympanic
ENTRY = Administrations, Transtympanic
ENTRY = Injections, Intratympanic
ENTRY = Intratympanic Injections
ENTRY = Transtympanic Administrations
MN = E02.319.267.530.655
MH_TH = NLM (2016)
ST = T061
PI = Injections (1968-2015)
MS = The administration of  liquid substances into the TYMPANIC CAVITY with a hypodermic syringe.
PM = 2016
HN = 2016
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069555

*NEWRECORD
RECTYPE = D
MH = Travoprost
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester|T109|T121|NON|NRW|NLM (2001)|011029|abbcdef
ENTRY = AL-6221|T109|T121|LAB|NRW|NLM (2001)|011029|abbcdef
ENTRY = AL6221|T109|T121|LAB|NRW|NLM (2001)|011029|abbcdef
ENTRY = Travatan|T109|T121|TRD|NRW|CA|DE|FR|MX|UK|US|041203|abbcdeeeeeef
ENTRY = Travatan Z|T109|T121|TRD|NRW|NLM (2007)|070817|abbcdef
ENTRY = AL 6221
ENTRY = Z, Travatan
MN = D10.251.355.255.550.775.500.175.500
MN = D23.469.050.175.725.775.500.175.500
MN = D23.469.700.670.175.500
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2001)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = WJ68R08KX9
RR = 157283-68-6
MS = A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
PM = 2016; TRAVOPROST was indexed under CLOPROSTENOL 2001-2015
HN = 2016 (2001)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069557

*NEWRECORD
RECTYPE = D
MH = Unsupervised Machine Learning
AQ = CL EC ES HI LJ SD SN ST TD UT
ENTRY = Learning, Unsupervised Machine
ENTRY = Machine Learning, Unsupervised
MN = G17.035.250.500.750
MN = L01.224.050.375.530.750
FX = Supervised Machine Learning
MH_TH = NLM (2016)
ST = T066
MS = A MACHINE LEARNING paradigm used to make predictions about future instances based on a given set of unlabeled paired input-output training (sample) data.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150706
DC = 1
DX = 20160101
UI = D000069558

*NEWRECORD
RECTYPE = D
MH = Loteprednol Etabonate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alrex|T110|T121|TRD|NRW|NLM (2001)|010926|abbcdef
ENTRY = CEHOAC|T110|T121|ACR|EQV|NLM (1990)|abbcde
ENTRY = Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate|T110|T121|NON|EQV|NLM (1990)|150527|abbcdef
ENTRY = Lotemax|T110|T121|TRD|NRW|NLM (2001)|010926|abbcdef
ENTRY = Loteprednol|T110|T121|NON|BRD|FDA SRS (2013)|INN (19XX)|NLM (2002)|150527|abbcdeeef
ENTRY = 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl
ENTRY = Chloromethyl 17 ethoxycarbonyloxy 11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate
ENTRY = Etabonate, Loteprednol
MN = D04.808.054.079.129.284
MH_TH = FDA SRS (2015)
MH_TH = NLM (1990)
MH_TH = USAN (19XX)
ST = T110
ST = T121
RN = YEH1EZ96K6
RR = 82034-46-6
MS = An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.
PM = 2016; LOTEPREDNOL ETABONATE was indexed under ANDROSTADIENES 1990-2015
HN = 2016 (1990)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069559

*NEWRECORD
RECTYPE = D
MH = Health Equity
AQ = CL EC ES HI LJ OG SN ST TD UT
ENTRY = Equity, Health
MN = N04.590.374.350.500
MN = N05.300.430.383
MH_TH = NLM (2016)
ST = T080
MS = Opportunity to attain full health potential and no one is disadvantaged from achieving this potential because of their social position or other socially determined circumstance.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069576

*NEWRECORD
RECTYPE = D
MH = Morcellation
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
MN = E04.502.648
MH_TH = NLM (2016)
ST = T061
PI = Minimally Invasive Surgical Procedures (2000-2015)
MS = Use of a non-cauterydependent mechanical device that simultaneously cuts and aspirates polyp and/or myoma tissue.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069577

*NEWRECORD
RECTYPE = D
MH = Waterborne Diseases
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Water-related Diseases|T047|NON|REL|NLM (2016)|150528|abcdef
ENTRY = Disease, Water-related
ENTRY = Disease, Waterborne
ENTRY = Diseases, Water-related
ENTRY = Diseases, Waterborne
ENTRY = Water related Diseases
ENTRY = Water-related Disease
ENTRY = Waterborne Disease
MN = C01.539.221.750
MH_TH = NLM (2016)
ST = T047
MS = Illnesses due to micro-organisms and chemicals in drinking water, those caused by organisms having part of their lifecycle in water or those with water-related vectors, and others spread by aerosols containing pathogens.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069578

*NEWRECORD
RECTYPE = D
MH = Ranibizumab
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
ENTRY = Lucentis|T116|T121|T129|TRD|NRW|NLM (2006)|060703|abbbcdef
ENTRY = RhuFab V2|T116|T121|T129|NON|EQV|NLM (2005)|150528|abbbcdef
ENTRY = V2, RhuFab
MN = D12.776.124.486.485.114.224.060.868
MN = D12.776.124.790.651.114.224.060.868
MN = D12.776.377.715.548.114.224.200.868
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2005)
MH_TH = USAN (19XX)
ST = T116
ST = T121
ST = T129
RN = ZL1R02VT79
RR = 347396-82-1
MS = A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.
PM = 2016; RANIBIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011
HN = 2016 (2005)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069579

*NEWRECORD
RECTYPE = D
MH = Bimatoprost
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = AGN 192024|T119|T121|LAB|NRW|NLM (2001)|010301|abbcdef
ENTRY = Latisse|T119|T121|TRD|NRW|NLM (2012)|150528|abbcdef
ENTRY = Lumigan|T119|T121|TRD|NRW|CA|DE|FR|MX|UK|US|010810|abbcdeeeeeef
ENTRY = 192024, AGN
MN = D02.065.141
MN = D10.251.355.255.550.775.500.175.250
MN = D23.469.050.175.725.775.500.175.250
MN = D23.469.700.670.175.250
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2001)
MH_TH = USAN (19XX)
ST = T119
ST = T121
N1 = 5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-
RN = QXS94885MZ
RR = 155206-00-1
MS = A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
PM = 2016; BIMATOPROST was indexed under AMIDES and CLOPROSTENOL 2001-2015
HN = 2016 (2001)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069580

*NEWRECORD
RECTYPE = D
MH = Exposure to Violence
AQ = CL EC EH ES HI LJ PC PX SN TD
ENTRY = Violence Exposure|T054|NON|EQV|NLM (2016)|150528|abcdef
ENTRY = Violence, Exposure to
MN = I01.880.735.900.869
MH_TH = NLM (2016)
ST = T054
MS = Experience of and exposure to VIOLENCE.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069581

*NEWRECORD
RECTYPE = D
MH = Eszopiclone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Estorra|T109|T121|TRD|NRW|NLM (2006)|061128|abbcdef
ENTRY = Lunesta|T109|T121|TRD|NRW|NLM (2005)|050501|abbcdef
MN = D03.383.606.398
MN = D03.383.679.600
MN = D03.383.725.322
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (2004)
MH_TH = USAN (19XX)
ST = T109
ST = T121
N1 = (+)-(5S)-6(chloropyridine-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)-pyrazin-5-yl-4-methyl-piperazine-1-carboxylate
RN = UZX80K71OE
RR = 138729-47-2
MS = A pyridine, pyrazine, and piperazine derivative that is used as a HYPNOTIC AND SEDATIVE in the treatment of INSOMNIA.
PM = 2016; ESZOPICLONE was indexed under PIPERAZINES and AZABICYCLO COMPOUNDS 2007-2015
HN = 2016 (2007)
MR = 20150626
DA = 20150706
DC = 1
DX = 20160101
UI = D000069582

*NEWRECORD
RECTYPE = D
MH = Pregabalin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (R-)-3-isobutyl GABA|T109|T121|NON|EQV|NLM (1993)|abbcde
ENTRY = (S)-3-(aminomethyl)-5-methylhexanoic acid|T109|T121|NON|EQV|NLM (2014)|130820|abbcdef
ENTRY = (S+)-3-isobutyl GABA|T109|T121|NON|EQV|NLM (1993)|abbcde
ENTRY = 3-(aminomethyl)-5-methylhexanoic acid|T109|T121|NON|EQV|NLM (1996)|abbcde
ENTRY = 3-isobutyl GABA|T109|T121|NON|EQV|NLM (1993)|abbcde
ENTRY = CI 1008|T109|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = CI-1008|T109|T121|LAB|NRW|NLM (1996)|abbcde
ENTRY = Lyrica|T109|T121|TRD|NRW|NLM (2005)|US|050621|abbcdeef
ENTRY = 1008, CI
ENTRY = 3 isobutyl GABA
ENTRY = CI1008
ENTRY = GABA, 3-isobutyl
MN = D02.241.081.114.500.350.500
MN = D12.125.190.350.450
MH_TH = FDA SRS (2013)
MH_TH = INN (19XX)
MH_TH = NLM (1993)
MH_TH = USAN (19XX)
ST = T109
ST = T121
RN = 55JG375S6M
RR = 148553-50-8
MS = A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.
PM = 2016; PREGABALIN was indexed under GAMMA-AMINOBUTYRIC ACID 1993-2015
HN = 2016 (1993)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069583

*NEWRECORD
RECTYPE = D
MH = Unilateral Breast Neoplasms
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Left Sided Breast Cancer|T191|NON|NRW|NLM (2016)|150528|abcdef
ENTRY = Left Sided Breast Neoplasm|T191|NON|NRW|NLM (2016)|150630|abcdef
ENTRY = Left Sided Breast Neoplasms|T191|NON|NRW|NLM (2016)|150528|abcdef
ENTRY = Left-Sided Breast Cancer|T191|NON|NRW|NLM (2016)|150528|abcdef
ENTRY = Left-Sided Breast Neoplasms|T191|NON|NRW|NLM (2016)|150528|abcdef
ENTRY = Right Sided Breast Cancer|T191|NON|NRW|NLM (2016)|150630|abcdef
ENTRY = Right Sided Breast Neoplasm|T191|NON|NRW|NLM (2016)|150630|abcdef
ENTRY = Right-Sided Breast Cancer|T191|NON|NRW|NLM (2016)|150630|abcdef
ENTRY = Right-Sided Breast Neoplasms|T191|NON|NRW|NLM (2016)|150630|abcdef
ENTRY = Unilateral Breast Cancer|T191|NON|EQV|NLM (2016)|150611|abcdef
ENTRY = Breast Cancer, Left-Sided
ENTRY = Breast Cancer, Right-Sided
ENTRY = Breast Cancer, Unilateral
ENTRY = Breast Cancers, Left-Sided
ENTRY = Breast Cancers, Right-Sided
ENTRY = Breast Cancers, Unilateral
ENTRY = Breast Neoplasm, Left-Sided
ENTRY = Breast Neoplasm, Right-Sided
ENTRY = Breast Neoplasm, Unilateral
ENTRY = Breast Neoplasms, Left-Sided
ENTRY = Breast Neoplasms, Right-Sided
ENTRY = Breast Neoplasms, Unilateral
ENTRY = Left-Sided Breast Cancers
ENTRY = Left-Sided Breast Neoplasm
ENTRY = Right Sided Breast Neoplasms
ENTRY = Right-Sided Breast Cancers
ENTRY = Right-Sided Breast Neoplasm
ENTRY = Unilateral Breast Cancers
MN = C04.588.180.682
MN = C17.800.090.500.682
MH_TH = NLM (2016)
ST = T191
AN = human only; coordinate IM with histological type of neoplasm (IM)
PI = Breast Neoplasms (1977-2015)
MS = Tumors or cancer found specifically in one human BREAST, but not in both.
PM = 2016
HN = 2016
MR = 20150708
DA = 20150709
DC = 1
DX = 20160101
UI = D000069584

*NEWRECORD
RECTYPE = D
MH = Filgrastim
AQ = AA AD AE AN BI CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
ENTRY = G-CSF Recombinant, Human Methionyl|T116|T121|T129|EQV|NLM (1997)|960405|abbbdef
ENTRY = Neupogen|T116|T121|T129|TRD|NRW|NLM (1997)|960131|abbbcdef
ENTRY = R-metHuG-CSF|T116|T121|T129|NON|EQV|NLM (2016)|150528|abbbcdef
ENTRY = Recombinant-Methionyl Human Granulocyte Colony-Stimulating Factor|T116|T121|T129|EQV|NLM (1997)|960405|abbbdef
ENTRY = Topneuter|T116|T121|TRD|NRW|NLM (2010)|150528|abbcdef
ENTRY = G CSF Recombinant, Human Methionyl
ENTRY = R metHuG CSF
ENTRY = Recombinant Methionyl Human Granulocyte Colony Stimulating Factor
MN = D12.644.276.374.410.240.350.500
MN = D12.776.395.240.200.500
MN = D12.776.467.374.410.240.350.500
MN = D23.529.374.410.240.350.500
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2012)
MH_TH = INN (19XX)
MH_TH = NLM (1997)
MH_TH = USAN (1990)
ST = T116
ST = T121
ST = T129
RN = PVI5M0M1GW
RR = 121181-53-1
MS = A recombinant granulocyte colony-stimulating factor (G-CSF) that is used in the treatment and prevention of NEUTROPENIA, and to prepare blood progenitor cells for collection and use in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.
PM = 2016; FILGRASTIM was indexed under GRANULOCYTE COLONY-STIMULATING FACTOR 2011-2015
HN = 2016 (2011)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069585

*NEWRECORD
RECTYPE = D
MH = Adult Survivors of Child Adverse Events
AQ = CL HI LJ PX SN
ENTRY = Adult Survivors of Childhood Trauma|T101|NON|EQV|NLM (2016)|150630|abcdef
MN = M01.860.300
MH_TH = NLM (2016)
ST = T101
MS = Persons who experienced traumatic events during childhood.
PM = 2016
HN = 2016
MR = 20150630
DA = 20150701
DC = 1
DX = 20160101
UI = D000069586

*NEWRECORD
RECTYPE = D
MH = Round Ligaments
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Round Ligament|T023|NON|EQV|NLM (1975)|990101|abcdef
ENTRY = Chorda Obliqua|T023|NON|NRW|NLM (2016)|150527|abcdef
ENTRY = Ligamentum Teres|T023|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Oblique Cord|T023|NON|NRW|NLM (2016)|150527|abcdef
ENTRY = Round Ligament of Elbow|T023|NON|NRW|NLM (2016)|150527|abcdef
ENTRY = Chorda Obliquas
ENTRY = Elbow Round Ligament
ENTRY = Elbow Round Ligaments
ENTRY = Ligament, Round
ENTRY = Ligaments, Round
ENTRY = Ligamentum Tere
ENTRY = Oblique Cords
MN = A02.513.901
MH_TH = NLM (2016)
ST = T023
PI = Ligaments (1966-2015)
MS = Cord-like fibrous tissue structure that connects two articular extremities of bones, ligaments and /or cartilages.
PM = 2016; ROUND LIGAMENT now ROUND LIGAMENT OF UTERUS, was a heading 1991-2015
HN = 2016
MR = 20150707
DA = 20150709
DC = 1
DX = 20160101
UI = D000069590

*NEWRECORD
RECTYPE = D
MH = Round Ligament of Liver
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Hepatic Round Ligament|T023|NON|EQV|NLM (2016)|150528|abcdef
ENTRY = Ligamentum Teres Hepatis|T023|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Hepatic Round Ligaments
ENTRY = Ligament, Hepatic Round
ENTRY = Ligaments, Hepatic Round
ENTRY = Ligamentum Teres Hepati
ENTRY = Liver Round Ligament
ENTRY = Liver Round Ligaments
ENTRY = Round Ligament, Hepatic
ENTRY = Round Ligaments, Hepatic
MN = A02.513.901.750
MN = A03.620.575
MH_TH = NLM (2016)
ST = T023
PI = Ligaments (1963-2015)
MS = A cord-like remnant structure formed from the closed left fetal UMBILICAL VEIN. It is located along the lower edge of the falciform ligament.
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069592

*NEWRECORD
RECTYPE = D
MH = Round Ligament of Femur
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Ligamentum Capitis Femoris|T023|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Ligamentum Teres Femoris|T023|NON|EQV|NLM (2016)|150527|abcdef
ENTRY = Femur Round Ligament
ENTRY = Femur Round Ligaments
ENTRY = Ligamentum Capitis Femori
ENTRY = Ligamentum Teres Femori
MN = A02.513.514.800
MN = A02.513.901.500
MN = A02.835.583.411.500
MN = A02.835.583.512.950
MH_TH = NLM (2016)
ST = T023
PI = Femur (1963-2015)
PI = Ligaments (1963-2015)
MS = Ligament that connects the fovea of the FEMUR HEAD and the ACETABULUM notch in the HIP JOINT.
MR = 20150706
DA = 20150707
DC = 1
DX = 20160101
UI = D000069593

*NEWRECORD
RECTYPE = D
MH = Abatacept
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
ENTRY = BMS 188667|T116|T129|LAB|NRW|NLM (2006)|060607|abbcdef
ENTRY = BMS-188667|T116|T129|LAB|NRW|NLM (2006)|060607|abbcdef
ENTRY = BMS-224818|T116|T129|LAB|NRW|NLM (2006)|060607|abbcdef
ENTRY = BMS224818|T116|T129|LAB|NRW|NLM (2006)|060607|abbcdef
ENTRY = Belatacept|T116|T129|NON|NRW|NLM (2006)|150528|abbcdef
ENTRY = CTLA-4-Ig|T116|T129|ABB|NRW|NLM (2006)|060607|abbcdef
ENTRY = CTLA4-Fc|T116|T129|ABB|NRW|NLM (2006)|060607|abbcdef
ENTRY = CTLA4-Ig|T116|T129|ABB|NRW|NLM (2006)|060607|abbcdef
ENTRY = CTLA4-Ig Immunoconjugate|T116|T129|ABX|NRW|NLM (2006)|150528|abbcdef
ENTRY = Cytotoxic T Lymphocyte-associated Antigen 4-immunoglobulin|T116|T129|NON|NRW|NLM (2006)|150528|abbcdef
ENTRY = LEA29Y|T116|T129|LAB|NRW|NLM (2006)|060607|abbcdef
ENTRY = Nulojix|T116|T129|TRD|NRW|NLM (2012)|150528|abbcdef
ENTRY = Orencia|T116|T121|T129|TRD|NRW|NLM (2006)|060330|abbbcdef
ENTRY = 188667, BMS
ENTRY = BMS 224818
ENTRY = BMS188667
ENTRY = CTLA4 Ig Immunoconjugate
ENTRY = Cytotoxic T Lymphocyte associated Antigen 4 immunoglobulin
ENTRY = Immunoconjugate, CTLA4-Ig
MN = D12.776.124.486.485.114.580.225
MN = D12.776.124.790.651.114.580.225
MN = D12.776.377.715.548.114.580.225
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USAN (2004)
ST = T116
ST = T121
ST = T129
RN = 7D0YB67S97
RR = 332348-12-6
MS = A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS.
PM = 2016; ABATACEPT was indexed under IMMUNOCONJUGATES 2002-2015
HN = 2016 (2002)
MR = 20150626
DA = 20150701
DC = 1
DX = 20160101
UI = D000069594

*NEWRECORD
RECTYPE = D
MH = Presenteeism
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Sickness Presence|T091|NON|EQV|NLM (2016)|150629|abcdef
ENTRY = Presence, Sickness
MN = F02.784.692.586
MN = F04.096.628.779.450
MH_TH = NLM (2016)
ST = T091
MS = Reporting for work despite feeling ill.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069597

*NEWRECORD
RECTYPE = D
MH = Crop Production
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Production, Crop
MN = J01.040.227
MH_TH = NLM (2016)
ST = T057
ST = T090
PI = Agriculture (1978-2015)
MS = The science and practice of cultivating PLANTS that have economic value to man. It includes plant breeding, seed production, weeding, use of fertilizers, harvesting, storage, transportation, and marketing.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069599

*NEWRECORD
RECTYPE = D
MH = Plant Breeding
AQ = EC HI LJ MT SN ST
ENTRY = Breeding, Plant
MN = J01.040.227.500
MH_TH = NLM (2016)
ST = T040
MS = The purposeful manipulation of plant species with the goal of creating desired genotypes and phenotypes, using techniques such as controlled pollination and or genetic engineering, followed by artificial selection of progeny.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069600

*NEWRECORD
RECTYPE = D
MH = Crop Protection
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Protection, Crop
MN = J01.040.237
MH_TH = NLM (2016)
ST = T057
ST = T068
MS = The science and practice of preventing, minimizing, or eliminating damage to AGRICULTURAL CROPS by pest organisms, weeds, and disease-causing agents.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069601

*NEWRECORD
RECTYPE = D
MH = Working Poor
AQ = CL EC ED EH ES HI LJ PC PX SN TD
ENTRY = Poor, Working
MN = M01.987
FX = Poverty
FX = Poverty Areas
MH_TH = NLM (2016)
ST = T102
PI = Poverty (1975-2015)
MS = People who are in the labor force either working or looking for work for 27 weeks or more in a year, but whose income fall below a given poverty line.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069602

*NEWRECORD
RECTYPE = D
MH = Sevelamer
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = GT335-012|T109|T121|LAB|NRW|NLM (2006)|060504|abbcdef
ENTRY = RenaGel|T109|T121|TRD|NRW|NLM (2000)|abbcde
ENTRY = Sevelamer Carbonate|T109|T121|NON|NRW|NLM (2016)|150528|abbcdef
ENTRY = Sevelamer Hydrochloride|T109|T121|NON|NRW|NLM (2016)|150609|abbcdef
ENTRY = Carbonate, Sevelamer
ENTRY = GT335 012
ENTRY = GT335012
ENTRY = Hydrochloride, Sevelamer
MN = D02.092.782.634
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = poly(allylamine-co-N,N'-diallyl-1,3-diamino-2-hydroxypropane)
RN = 9YCX42I8IU
RR = 845273-93-0
PI = Epoxy Compounds (2000-2015)
PI = Polyethylene (2000-2015)
MS = A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.
PM = 2016; SEVELAMER was indexed under POLYAMINES 2006-2015, and under EPOXY COMPOUNDS and POLYETHYLENES 2000-2005
HN = 2016 (2000)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000069603

*NEWRECORD
RECTYPE = D
MH = Dabigatran
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = BIBR 1048|T109|T121|LAB|NRW|NLM (2005)|050620|abbcdef
ENTRY = Dabigatran Etexilate|T109|T121|NON|NRW|FDA SRS (2015)|INN (19XX)|NLM (2016)|USAN (19XX)|150609|abbcdeeeef
ENTRY = Dabigatran Etexilate Mesylate|T109|T121|NON|NRW|FDA SRS (2015)|NLM (2016)|USAN (19XX)|150609|abbcdeeef
ENTRY = N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine|T116|T121|EQV|NLM (2011)|110103|abbdef
ENTRY = Pradaxa|T109|T121|TRD|NRW|NLM (2011)|110304|abbcdef
ENTRY = Etexilate Mesylate, Dabigatran
ENTRY = Etexilate, Dabigatran
ENTRY = Mesylate, Dabigatran Etexilate
MN = D03.383.725.192
MN = D03.438.103.280
MH_TH = USAN (19XX)
ST = T116
ST = T121
RN = I0VM4M70GC
RR = 2E18WX195X
RR = SC7NUW5IIT
MS = A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of  thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
PM = 2016; DABIGATRAN was indexed under BENZIMIDOAZOLES and BETA-ALANINE 2010-2015; DABIGATRAN ETEXILATE was indexed under BENZIMIDOAZOLES and PYRIDINES 2002-2015
HN = 2016 (2002)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000069604

*NEWRECORD
RECTYPE = D
MH = Olopatadine Hydrochloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid|T109|T121|NRW|NLM (1992)|abbde
ENTRY = KW 4679|T109|T121|LAB|NRW|NLM (1992)|abbcde
ENTRY = KW-4679|T109|T121|NRW|NLM (1992)|abbde
ENTRY = KW-4943A|T109|T121|LAB|NRW|NLM (1992)|abbcde
ENTRY = Olopatadine|T109|T121|NON|NRW|NLM (2016)|150528|abbcdef
ENTRY = Patanol|T109|T121|TRD|NRW|CA|US|000620|abbcdeef
ENTRY = 4679, KW
ENTRY = Hydrochloride, Olopatadine
ENTRY = KW 4943A
ENTRY = KW4943A
MN = D03.494.382.696
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 2XG66W44KF
RR = 113806-05-6
RR = 2XG66W44KF
RR = D27V6190PM
MS = An antihistamine with mast-cell stabilizing properties used as eye drops in the treatment of ALLERGIC CONJUNCTIVITIS.
PM = 2016; OLOPATADINE HYDROCHLORIDE was indexed under DIBENZOXEPINS1992-2015
HN = 2016 (1992)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000069605

*NEWRECORD
RECTYPE = D
MH = Simeprevir
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = N-(17-(2-(4-isopropylthiazole-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo(13.3.0.04,6)octadec-7-ene-4-carbonyl)(cyclopropyl)sulfonamide|T109|T121|EQV|NLM (2008)|081023|abbdef
ENTRY = Olysio|T109|T121|TRD|NRW|NLM (2014)|131126|abbcdef
ENTRY = TMC 435|T109|LAB|NRW|NLM (2010)|100104|abcdef
ENTRY = TMC 435350|T109|LAB|NRW|NLM (2008)|081023|abcdef
ENTRY = TMC-435|T109|LAB|NRW|NLM (2010)|100104|abcdef
ENTRY = TMC-435350|T109|LAB|NRW|NLM (2008)|081023|abcdef
ENTRY = TMC435|T109|LAB|NRW|NLM (2010)|100104|abcdef
ENTRY = TMC435350|T109|LAB|NRW|NLM (2008)|081023|abcdef
ENTRY = 435, TMC
ENTRY = 435350, TMC
MN = D02.886.590.700.700
MN = D03.494.819
MH_TH = NLM (2016)
ST = T109
ST = T121
RN = 9WS5RD66HZ
MS = Oral HCV-PROTEASE INHIBITOR effective against hepatitis C virus (HCV) serine protease NS3/4A. It is used in the treatment of chronic hepatitis C (Antivirals) genotype 1 infection in adults with compensated liver disease, including CIRRHOSIS.
PM = 2016; SIMEPREVIR was indexed under SULFONAMIDES and HETEROCYCLIC COMPOUNDS, 3-RING 2008-2015
HN = 2016 (2008)
MR = 20150709
DA = 20150710
DC = 1
DX = 20160101
UI = D000069616

*NEWRECORD
RECTYPE = D
MH = Pedestrians
AQ = CL ED HI LJ PX SN
MN = M01.665
MH_TH = NLM (2016)
ST = T098
MS = Persons traveling on foot.
PM = 2016
HN = 2016
MR = 20150629
DA = 20150701
DC = 1
DX = 20160101
UI = D000069636

*NEWRECORD
RECTYPE = D
MH = Undocumented Immigrants
AQ = CL ED HI LJ PX SN
ENTRY = Illegal Aliens|T098|NON|EQV|NLM (2016)|150630|abcdef
ENTRY = Illegal Immigrants|T098|NON|EQV|NLM (2016)|150528|abcdef
ENTRY = Unauthorized Immigrants|T098|NON|EQV|NLM (2016)|150630|abcdef
ENTRY = Undocumented Aliens|T098|NON|EQV|NLM (2016)|150715|abcdef
ENTRY = Undocumented Workers|T098|NON|REL|NLM (2016)|150630|abcdef
ENTRY = Alien, Illegal
ENTRY = Alien, Undocumented
ENTRY = Aliens, Illegal
ENTRY = Aliens, Undocumented
ENTRY = Illegal Alien
ENTRY = Illegal Immigrant
ENTRY = Immigrant, Illegal
ENTRY = Immigrant, Unauthorized
ENTRY = Immigrant, Undocumented
ENTRY = Immigrants, Illegal
ENTRY = Immigrants, Unauthorized
ENTRY = Immigrants, Undocumented
ENTRY = Unauthorized Immigrant
ENTRY = Undocumented Alien
ENTRY = Undocumented Immigrant
ENTRY = Undocumented Worker
ENTRY = Worker, Undocumented
ENTRY = Workers, Undocumented
MN = M01.189.500
MH_TH = NLM (2016)
ST = T098
PI = Emigration and Immigration (1981-2015)
PI = Transients and Migrants (1981-2015)
MS = Foreign nationals residing in a country without legal immigration status, or in violation of the immigration laws of that country.
PM = 2016
HN = 2016
MR = 20150715
DA = 20150707
DC = 1
DX = 20160101
UI = D000069756

*NEWRECORD
RECTYPE = D
MH = Acebutolol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acebutolol Heumann|T109|T121|TRD|NRW|DE|020718|abbcdef
ENTRY = Acebutolol Hydrochloride|T109|T121|NRW|FDA SRS (2014)|NLM (1999)|USP (19XX)|990913|abbdeeef
ENTRY = Acetobutolol|T109|T121|NON|EQV|UNK (19XX)|830629|abbcdef
ENTRY = Acbutolol-ratiopharm|T109|T121|TRD|NRW|FR|020718|abbcdef
ENTRY = Apo-Acebutolol|T109|T121|TRD|NRW|CA|020718|abbcdef
ENTRY = Apotex Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Bayer Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Gepepharm Brand of Acebutolol|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Heumann Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Italfarmaco Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Lafon-Ratiopharm Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = M & B 17803A|T109|T121|LAB|NRW|NLM (1991)|900308|abbcdef
ENTRY = M&B-17803 A|T109|T121|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Monitan|T109|T121|TRD|NRW|CA|020718|abbcdef
ENTRY = Neptal|T109|T121|TRD|NRW|DE|020718|abbcdef
ENTRY = Novo-Acebutolol|T109|T121|TRD|NRW|CA|020718|abbcdef
ENTRY = Novopharm Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Prent|T109|T121|TRD|NRW|DE|NL|020718|abbcdeef
ENTRY = Proctor & Gamble Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Rhodiapharm Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Rhotral|T109|T121|TRD|NRW|CA|020718|abbcdef
ENTRY = Rhne-Poulenc Rorer Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Sectral|T109|T121|TRD|NRW|CA|ES|FR|IE|NL|UK|US|800730|abbcdeeeeeeef
ENTRY = Specia Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Wyeth Brand of Acebutolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Acebutolol Gepepharm Brand
ENTRY = Acbutolol ratiopharm
ENTRY = Acbutololratiopharm
ENTRY = Apo Acebutolol
ENTRY = ApoAcebutolol
ENTRY = Heumann, Acebutolol
ENTRY = Hydrochloride, Acebutolol
ENTRY = Lafon Ratiopharm Brand of Acebutolol Hydrochloride
ENTRY = M&B 17803 A
ENTRY = M&B17803 A
ENTRY = Novo Acebutolol
ENTRY = NovoAcebutolol
ENTRY = Rhne Poulenc Rorer Brand of Acebutolol Hydrochloride
MN = D02.033.100.624.698.025
MN = D02.033.755.624.698.025
MN = D02.092.063.624.698.025
PA = Adrenergic beta-1 Receptor Antagonists
PA = Anti-Arrhythmia Agents
PA = Antihypertensive Agents
PA = Sympathomimetics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1973)
ST = T109
ST = T121
N1 = Butanamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-, (+-)-
RN = 67P356D8GH
RR = 34381-68-5 (Acebutolol Hydrochloride)
RR = 37517-30-9 (Acebutolol)
RR = B025Y34C54
PI = Anilides (1974)
PI = Ethanolamines (1974)
PI = Phenyl Ethers (1974)
PI = Propylamines (1974)
MS = A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
PM = 75
HN = 75
MR = 20130708
DA = 19741119
DC = 1
DX = 19750901
UI = D000070

*NEWRECORD
RECTYPE = D
MH = Zika Virus Infection
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Fever, Zika|T047|EPO|EQV|NLM (2016)|160126|abcdef
ENTRY = Zika Fever|T047|EPO|EQV|NLM (2016)|160126|abcdef
ENTRY = Zika Virus Disease|T047|EPO|EQV|NLM (2016)|160126|abcdef
ENTRY = Infection, Zika Virus
ENTRY = Virus Infection, Zika
MN = C02.081.990
MN = C02.782.350.250.990
MH_TH = NLM (2016)
ST = T047
PI = ArbovirusInfections(1964-2015)
PI = FlavivirusInfections(1972-2015)
MS = A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, however, may be associated with other neurological and autoimmune complications (e.g., GUILLAIN-BARRE SYNDROME; and MICROCEPHALY).
PM = 2016
HN = 2016
MR = 20160126
DA = 20160126
DC = 1
DX = 20160126
UI = D000071243

*NEWRECORD
RECTYPE = D
MH = Zika Virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
ENTRY = Virus, Zika|T005|EPO|EQV|NLM (2016)|160126|abcdef
MN = B04.820.250.350.995
MH_TH = NLM (2016)
ST = T005
AN = infection=ZIKA VIRUS INFECTION
PI = Arboviruses (1964-2015)
PI = Flavivirus(1964-2015)
MS = An arbovirus in the FLAVIVIRUS genus of the family FLAVIVIRIDAE. Originally isolated in the Zika Forest of UGANDA it has been introduced to Asia and the Americas.
PM = 2016
HN = 2016
MR = 20160126
DA = 20160126
DC = 1
DX = 20160126
UI = D000071244

*NEWRECORD
RECTYPE = D
MH = Acedapsone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetyldiphenazonum|T109|T121|NON|EQV|UNK (19XX)|750725|abbcdef
PRINT ENTRY = DADDS|T109|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|750725|abbcdeef
PRINT ENTRY = Diacetyldapsone|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|750725|abbcdeef
ENTRY = 4',4'''-Sulfonylbis(acetanilide)|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = 4,4'-Diacetyldiaminodiphenylsulfone|T109|T121|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Hansolar|T109|T121|TRD|NRW|NLM (1991)|900124|abbcdef
ENTRY = Rodilone|T109|T121|TRD|NRW|NLM (1991)|900124|abbcdef
ENTRY = Sulfadiamine|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1991)|900124|abbcdeef
ENTRY = 4,4' Diacetyldiaminodiphenylsulfone
MN = D02.886.590.263.050
PA = Anti-Infective Agents
PA = Antimalarials
PA = Leprostatic Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1970)
ST = T109
ST = T121
N1 = Acetamide, N,N'-(sulfonyldi-4,1-phenylene)bis-
RN = 0GZ72U84TN
RR = 77-46-3 (Acedapsone)
PI = Acetamides (1975)
PI = Acetanilides (1972-1974)
PI = Dapsone/analogs & derivatives (1975)
PI = Sulfones (1972-1974)
MS = Acetylated sulfone that is slowly metabolized to give long-term, low blood levels of DAPSONE. It has antimicrobial and antimalarial action, but is mainly used as a depot leprostatic agent.
PM = 91; was see under DAPSONE 1976-90
HN = 91(76); was see under DAPSONE 1976-90
MR = 20130708
DA = 19750725
DC = 1
DX = 19910101
UI = D000072

*NEWRECORD
RECTYPE = D
MH = Acenaphthenes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.426.559.847.638.059
MN = D04.615.638.059
MH_TH = NLM (1972)
ST = T109
ST = T130
RN = 0
PI = Naphthalenes (1966-1971)
MS = Tricyclic ethylene-bridged naphthalene derivatives. They are found in petroleum residues and coal tar and used as dye intermediates, in the manufacture of plastics, and in insecticides and fungicides.
PM = 73
HN = 73(72)
MR = 20060705
DA = 19990101
DC = 1
DX = 19730101
UI = D000073

*NEWRECORD
RECTYPE = D
MH = Acenocoumarol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acenocoumarin|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
PRINT ENTRY = Nicoumalone|T109|T121|NON|EQV|BAN (19XX)|761230|abbcdef
ENTRY = Alliance Brand of Acenocoumarol|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Ciba-Geigy Brand of Acenocoumarol|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Mini-Sintrom|T109|T121|TRD|NRW|FR|020718|abbcdef
ENTRY = Novartis Brand of Acenocoumarol|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Sinkumar|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Sinthrome|T109|T121|TRD|NRW|UK|800804|abbcdef
ENTRY = Sintrom|T109|T121|TRD|NRW|CA|ES|FR|MX|NL|830916|abbcdeeeeef
ENTRY = Syncoumar|T109|T121|TRD|NRW|UNK (19XX)|811023|abbcdef
ENTRY = Syncumar|T109|T121|TRD|NRW|UNK (19XX)|810917|abbcdef
ENTRY = Synthrom|T109|T121|TRD|NRW|UNK (19XX)|800804|abbcdef
ENTRY = Acenocoumarol Alliance Brand
ENTRY = Acenocoumarol Ciba-Geigy Brand
ENTRY = Acenocoumarol Novartis Brand
ENTRY = Ciba Geigy Brand of Acenocoumarol
ENTRY = Mini Sintrom
ENTRY = MiniSintrom
MN = D03.383.663.283.446.520.079
MN = D03.438.150.446.520.079
PA = Anticoagulants
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-
RN = I6WP63U32H
RR = 152-72-7 (Acenocoumarol)
MS = A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p233)
MR = 20150622
DA = 19990101
DC = 1
UI = D000074

*NEWRECORD
RECTYPE = D
MH = Acepromazine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetazine|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
PRINT ENTRY = Acetopromazine|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
PRINT ENTRY = Acetylpromazine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef
ENTRY = Acepromazine Maleate|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1973)|USP (19XX)|830909|abbcdeeef
ENTRY = Calmivet|T109|T121|TRD|NRW|FR|020718|abbcdef
ENTRY = Plegicil|T109|T121|TRD|NRW|ES|020718|abbcdef
ENTRY = Sanofi Brand of Acepromazine Maleate|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Seid Brand of Acepromazine Maleate|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Vetranquil|T109|T121|TRD|NRW|FR|020718|abbcdef
ENTRY = Vtoquinol Brand of Acepromazine Maleate|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Maleate, Acepromazine
MN = D02.886.369.029
MN = D03.494.741.029
PA = Antipsychotic Agents
PA = Dopamine Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Ethanone, 1-(10-(3-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-
RN = 54EJ303F0R
RR = 3598-37-6 (maleate)
RR = 37862HP2OM
RR = 61-00-7 (Acepromazine)
MS = A phenothiazine that is used in the treatment of PSYCHOSES.
MR = 20130708
DA = 19990101
DC = 1
UI = D000075

*NEWRECORD
RECTYPE = D
MH = Acetabularia
AQ = CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI
ENTRY = Acetabularias
MN = B01.650.940.150.133
MH_TH = NLM (1972)
ST = T002
PI = Algae, Green (1970-1971)
MS = A genus of green algae found in the Mediterranean and other warm seas.
PM = 91; was see under ALGAE, GREEN 1972-90
HN = 91(72); was see under ALGAE, GREEN 1972-90
MR = 20150622
DA = 19990101
DC = 1
DX = 19910101
UI = D000076

*NEWRECORD
RECTYPE = D
MH = Acetabulum
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
ENTRY = Acetabula|T023|NON|EQV|NLM (2013)|120120|abcdef
ENTRY = Cotyloid Cavity|T023|NON|EQV|NLM (2013)|111213|abcdef
ENTRY = Acetabulas
ENTRY = Acetabulums
ENTRY = Cavities, Cotyloid
ENTRY = Cavity, Cotyloid
ENTRY = Cotyloid Cavities
MN = A02.835.232.043.825.108
MH_TH = NLM (1966)
ST = T023
AN = point of union of the 3 pelvic bones; do not confuse with HIP or HIP JOINT; fractures = ACETABULUM /inj (IM) + FRACTURES, BONE (IM);  /surg: consider also ACETABULOPLASTY
MS = The part of the pelvis that comprises the pelvic socket where the head of FEMUR joins to form HIP JOINT (acetabulofemoral joint).
MR = 20140613
DA = 19990101
DC = 1
UI = D000077

*NEWRECORD
RECTYPE = D
MH = Acetaldehyde
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Ethanal|T109|NON|EQV|FDA SRS (2014)|NLM (1992)|910222|abcdeef
MN = D02.047.064
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
N1 = Acetaldehyde
RN = GO1N1ZPR3B
RR = 75-07-0 (Acetaldehyde)
MS = A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis.
MR = 20130708
DA = 19990101
DC = 1
UI = D000079

*NEWRECORD
RECTYPE = D
MH = Acetals
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.355.071
MH_TH = NLM (1972)
ST = T109
RN = 0
PI = Ethers (1966-1971)
PM = 74
HN = 74(72)
MR = 19920507
DA = 19990101
DC = 1
DX = 19740101
UI = D000080

*NEWRECORD
RECTYPE = D
MH = Acetamides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.065.064
MN = D02.241.081.018.110
MH_TH = NLM (1971)
ST = T109
RN = 0
PI = Acetic Acids (1966-1970)
PI = Amides (1966-1970)
MS = Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
PM = 73
HN = 73(71)
MR = 20120703
DA = 19990101
DC = 1
DX = 19730101
UI = D000081

*NEWRECORD
RECTYPE = D
MH = Acetaminophen
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetamidophenol|T109|T121|NON|EQV|UNK (19XX)|771118|abbcdef
PRINT ENTRY = Hydroxyacetanilide|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Paracetamol|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|740329|abbcdeeef
ENTRY = APAP|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|020515|abbcdeef
ENTRY = Acamol|T109|T121|TRD|NRW|NLM (1995)|930902|abbcdef
ENTRY = Acephen|T109|T121|TRD|NRW|NLM (1991)|900509|abbcdef
ENTRY = Acetaco|T109|T121|TRD|REL|UNK (19XX)|861022|abbcdef
ENTRY = Acetominophen|T109|T121|NON|EQV|UNK (19XX)|810625|abbcdef
ENTRY = Algotropyl|T109|T121|TRD|REL|UNK (19XX)|800825|abbcdef
ENTRY = Anacin-3|T109|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Datril|T109|T121|NON|NRW|UNK (19XX)|861119|abbcdef
ENTRY = N-(4-Hydroxyphenyl)acetanilide|T109|T121|NON|EQV|NLM (1996)|950330|abbcdef
ENTRY = N-Acetyl-p-aminophenol|T109|T121|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Panadol|T109|T121|TRD|NRW|UNK (19XX)|830915|abbcdef
ENTRY = Tylenol|T109|T121|TRD|NRW|UNK (19XX)|830223|abbcdef
ENTRY = p-Acetamidophenol|T109|T121|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = p-Hydroxyacetanilide|T109|T121|NON|EQV|UNK (19XX)|800801|abbcdef
ENTRY = Anacin 3
ENTRY = Anacin3
MN = D02.065.199.092.040
PA = Analgesics, Non-Narcotic
PA = Antipyretics
MH_TH = FDA SRS (2014)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Acetamide, N-(4-hydroxyphenyl)-
RN = 362O9ITL9D
RR = 103-90-2 (Acetaminophen)
MS = Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
PM = 1965; for ACEPHEN see MECLOFENOXATE 1990-2002
HN = 1965; for ACEPHEN use MECLOFENOXATE 1990-2002
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D000082

*NEWRECORD
RECTYPE = D
MH = Acetanilides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acetylanilines|T109|NON|EQV|NLM (2005)|040105|abcdef
ENTRY = N-Phenylacetamides|T109|NON|EQV|NLM (2005)|040105|abcdef
MN = D02.065.199.092
FX = Benzeneacetamides
MH_TH = NLM (1968)
ST = T109
RN = 0
MS = Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA.
OL = use ACETANILIDES to search ACETANILIDE 1968-78 & ACETANILID 1966-67
PM = 79; was ACETANILIDE 1968-78, was ACETANILID 1963-67
HN = 79; was ACETANILIDE 1968-78, was ACETANILID 1963-67
MR = 20060705
DA = 19990101
DC = 1
DX = 19680101
UI = D000083

*NEWRECORD
RECTYPE = D
MH = Acetate Kinase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Acetokinase|T116|T126|NON|EQV|NLM (1994)|921014|abbcdef
ENTRY = Kinase, Acetate
MN = D08.811.913.696.630.025
MH_TH = NLM (1979)
ST = T116
ST = T126
N1 = ATP:acetate phosphotransferase
RN = EC 2.7.2.1
RR = 9027-42-3 (CAS RN)
PI = Acetates (1966-1978)
PI = Acetic Acids (1968-1978)
PI = Phosphotransferases (1966-1973)
PI = Phosphotransferases, ATP (1974-1978)
MS = An enzyme that catalyzes reversibly the phosphorylation of acetate in the presence of a divalent cation and ATP with the formation of acetylphosphate and ADP. It is important in the glycolysis process. EC 2.7.2.1.
PM = 91; was see under PHOSPHOTRANSFERASES, ATP 1979-90
HN = 91(79); was see under PHOSPHOTRANSFERASES, ATP 1979-90
MR = 20030709
DA = 19771208
DC = 1
DX = 19910101
UI = D000084

*NEWRECORD
RECTYPE = D
MH = Acetates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetic Acid Esters|T109|NON|NRW|NLM (1997)|960130|abcdef
ENTRY = Acetic Acids|T109|NON|REL|NLM (1968)|990101|abcdef
ENTRY = Acids, Acetic
ENTRY = Esters, Acetic Acid
MN = D02.241.081.018
MN = D10.251.400.045
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = general or unspecified; prefer specifics
MS = Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.
PM = 1966; see ACETIC ACIDS 1975-1990, see ACETIC ACID ESTERS 1991-1996, for ACETIC ACIDS see ACETIC ACIDS 1968-2012
HN = 1966
MR = 20120703
DA = 19990101
DC = 1
UI = D000085

*NEWRECORD
RECTYPE = D
MH = Acetazolamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acetadiazol|T109|T121|TRD|NRW|MX|020719|abbcdef
ENTRY = Acetazolam|T109|T121|TRD|NRW|CA|020719|abbcdef
ENTRY = Acetazolamide Sodium, (Sterile)|T109|T121|NON|NRW|USP (19XX)|940819|abbcdef
ENTRY = Acetazolamide, Monosodium Salt|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Ak-Zol|T109|T121|TRD|NRW|CA|020719|abbcdef
ENTRY = Apo-Acetazolamide|T109|T121|TRD|NRW|CA|020719|abbcdef
ENTRY = Apotex Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Chiesi Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Ciba Vision Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Cyanamid Brand of Acetazolamide Preparation|T109|T121|NON|NRW|NLM (2003)|020718|abbcdef
ENTRY = Diacarb|T109|T121|TRD|NRW|UNK (19XX)|800801|abbcdef
ENTRY = Diamox|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|NL|UK|US|800731|abbcdeeeeeeeeef
ENTRY = Dioptic Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Diuramide|T109|T121|TRD|NRW|DE|810130|abbcdef
ENTRY = Dfiltran|T109|T121|TRD|NRW|FR|020719|abbcdef
ENTRY = Edemox|T109|T121|TRD|NRW|ES|020719|abbcdef
ENTRY = Glauconox|T109|T121|TRD|NRW|ES|020719|abbcdef
ENTRY = Glaupax|T109|T121|TRD|NRW|DE|IE|NL|020719|abbcdeeef
ENTRY = Grin Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Huma-Zolamide|T109|T121|TRD|NRW|CA|020719|abbcdef
ENTRY = ICN Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Jumer Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Lederle Brand of Acetazolamide Preparation|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Llorens Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Medphano Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Novopharm Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Orion Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Storz Brand of Acetazolamide Preparation|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Thraplix Brand of Acetazolamide Preparation|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Wassermann Brand of Acetazolamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Whelehan Brand of Acetazolamide Preparation|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Wyeth Brand of Acetazolamide Preparation|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Acetazolamide Apotex Brand
ENTRY = Acetazolamide Chiesi Brand
ENTRY = Acetazolamide Dioptic Brand
ENTRY = Acetazolamide Grin Brand
ENTRY = Acetazolamide ICN Brand
ENTRY = Acetazolamide Jumer Brand
ENTRY = Acetazolamide Llorens Brand
ENTRY = Acetazolamide Medphano Brand
ENTRY = Acetazolamide Novopharm Brand
ENTRY = Acetazolamide Orion Brand
ENTRY = Acetazolamide Wassermann Brand
ENTRY = Ak Zol
ENTRY = AkZol
ENTRY = Apo Acetazolamide
ENTRY = ApoAcetazolamide
ENTRY = Huma Zolamide
ENTRY = HumaZolamide
ENTRY = Monosodium Salt Acetazolamide
MN = D02.886.675.867.060
MN = D03.383.129.708.867.060
PA = Anticonvulsants
PA = Carbonic Anhydrase Inhibitors
PA = Diuretics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-
RN = O3FX965V0I
RR = 1424-27-7 (mono-Na salt)
RR = 59-66-5 (Acetazolamide)
MS = One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
MR = 20130708
DA = 19990101
DC = 1
UI = D000086

*NEWRECORD
RECTYPE = D
MH = Acetic Anhydrides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anhydrides, Acetic
MN = D02.113.075
MN = D02.241.081.018.193
MH_TH = NLM (1979)
ST = T109
ST = T130
RN = 0
PI = Acetates (1966-1967)
PI = Acetic Acids (1968-1978)
PI = Anhydrides (1966-1978)
MS = Compounds used extensively as acetylation, oxidation and dehydrating agents and in the modification of proteins and enzymes.
PM = 91; was see under ACETIC ACIDS 1979-90
HN = 91(79); was see under ACETIC ACIDS 1979-90
MR = 20120703
DA = 19771208
DC = 1
DX = 19910101
UI = D000089

*NEWRECORD
RECTYPE = D
MH = Acetoacetates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.241.755.080
MN = D02.522.585.175
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Salts and derivatives of acetoacetic acid.
MR = 20120703
DA = 19990101
DC = 1
UI = D000090

*NEWRECORD
RECTYPE = D
MH = Acetobacter
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.400.425.100.100
MN = B03.660.050.663.050.010
MH_TH = NLM (1966)
ST = T007
AN = do not confuse with ACETOBACTERIUM
MS = A species of gram-negative bacteria of the family ACETOBACTERACEAE found in FLOWERS and FRUIT. Cells are ellipsoidal to rod-shaped and straight or slightly curved.
PM = 1966
HN = 1966
MR = 20090706
DA = 19990101
DC = 1
UI = D000091

*NEWRECORD
RECTYPE = D
MH = Acetohexamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Dimelor|T109|T121|NON|NRW|CA|021011|abbcdef
ENTRY = Dymelor|T109|T121|TRD|NRW|US|861119|abbcdef
ENTRY = Gamadiabet|T109|T121|TRD|NRW|ES|020719|abbcdef
ENTRY = Lilly Brand of Acetohexamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Salvat Brand of Acetohexamide|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Acetohexamide Lilly Brand
ENTRY = Acetohexamide Salvat Brand
MN = D02.886.590.795.071
MN = D02.948.828.071
PA = Hypoglycemic Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzenesulfonamide, 4-acetyl-N-((cyclohexylamino)carbonyl)-
RN = QGC8W08I6I
RR = 968-81-0 (Acetohexamide)
MS = A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide.
PM = 66
HN = 66(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D000092

*NEWRECORD
RECTYPE = D
MH = Acetoin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetylmethylcarbinol|T119|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
ENTRY = 3-hydroxy-2-butanone|T119|T123|NON|EQV|FDA SRS (2014)|NLM (2009)|070204|abbcdeef
ENTRY = 3H-2B butanone|T119|T123|NON|EQV|NLM (2009)|070204|abbcdef
MN = D02.522.296.100
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T119
ST = T123
N1 = 2-Butanone, 3-hydroxy-
RN = BG4D34CO2H
RR = 513-86-0 (Acetoin)
PI = Alcohols, Butyl (1972-1974)
PI = Butanones (1970-1974)
MS = A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide.
PM = 1991; 3-HYDROXY-2-BUTANONE was indexed under ACETOIN 2008, & under BUTANONES 2007
HN = 1991(1975)
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000093

*NEWRECORD
RECTYPE = D
MH = Acetoin Dehydrogenase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Diacetyl Reductase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Diacetyl Reductase ((R)-Acetoin Forming)|T116|T126|NON|NRW|NLM (2014)|130219|abbcdef
ENTRY = Diacetyl Reductase ((S)-Acetoin Forming)|T116|T126|NON|NRW|NLM (2014)|130219|abbcdef
ENTRY = Dehydrogenase, Acetoin
ENTRY = Reductase, Diacetyl
MN = D08.811.682.047.820.200
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Acetoin:NAD+ oxidoreductase
RN = EC 1.1.1.-
RR = EC 1.1.1.303
RR = EC 1.1.1.304
PI = Alcohol Oxidoreductases (1972-1974)
PI = Butanones (1972-1974)
MS = An enzyme that catalyzes the conversion of acetoin to diacetyl in the presence of NAD.
PM = 91; was see under ALCOHOL OXIDOREDUCTASES 1975-90
HN = 91(75); was see under ALCOHOL OXIDOREDUCTASES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000094

*NEWRECORD
RECTYPE = D
MH = Acetolactate Synthase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acetohydroxy Acid Synthase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Acetohydroxy Acid Synthetase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Acetolactate Synthetase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Acetohydroxyacid Synthetase I|T116|T126|NON|NRW|UNK (19XX)|870810|abbcdef
ENTRY = Acetoxyhydroxyacid Synthase III|T116|T126|NON|NRW|UNK (19XX)|831014|abbcdef
ENTRY = Acid Synthase, Acetohydroxy
ENTRY = Acid Synthetase, Acetohydroxy
ENTRY = Synthase III, Acetoxyhydroxyacid
ENTRY = Synthase, Acetohydroxy Acid
ENTRY = Synthase, Acetolactate
ENTRY = Synthetase I, Acetohydroxyacid
ENTRY = Synthetase, Acetohydroxy Acid
ENTRY = Synthetase, Acetolactate
MN = D08.811.913.200.324
MN = D12.776.331.049
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Acetolactate pyruvate-lyase (carboxylating)
RN = EC 2.2.1.6
RR = 9027-45-6 (CAS RN)
PI = Ketoacid-Lyases (1972-1974)
PI = Pyruvates (1972-1974)
MS = A flavoprotein enzyme that catalyzes the formation of acetolactate from 2 moles of PYRUVATE in the biosynthesis of VALINE and the formation of acetohydroxybutyrate from pyruvate and alpha-ketobutyrate in the biosynthesis of ISOLEUCINE. This enzyme was formerly listed as EC 4.1.3.18.
PM = 91; was see under KETOACID-LYASES 1975-90
HN = 91(75); was see under KETOACID-LYASES 1975-90
MR = 20050630
DA = 19741111
DC = 1
DX = 19910101
UI = D000095

*NEWRECORD
RECTYPE = D
MH = Acetone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.522.064
PA = Solvents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
N1 = 2-Propanone
RN = 1364PS73AF
RR = 67-64-1 (Acetone)
AN = ACETONEMIA and ACETONURIA see KETOSIS are also available
MS = A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis.
MR = 20150625
DA = 19990101
DC = 1
UI = D000096

*NEWRECORD
RECTYPE = D
MH = Acetonitriles
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cyanomethanes|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Ethane Nitriles|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Methyl Cyanides|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Cyanides, Methyl
ENTRY = Nitriles, Ethane
MN = D02.626.080
MH_TH = NLM (1975)
ST = T109
ST = T130
RN = 0
PI = Nitriles (1969-1974)
MS = Compounds in which a methyl group is attached to the cyano moiety.
PM = 75
HN = 75
MR = 19920507
DA = 19741111
DC = 1
DX = 19750901
UI = D000097

*NEWRECORD
RECTYPE = D
MH = Acetophenones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.522.120
MH_TH = NLM (1966)
ST = T109
RN = 0
MR = 19920507
DA = 19990101
DC = 1
UI = D000098

*NEWRECORD
RECTYPE = D
MH = Acetoxyacetylaminofluorene
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetoxyacetamidofluorene|T109|T131|NON|EQV|UNK (19XX)|790522|abbcdef
PRINT ENTRY = Acetoxyfluorenylacetamide|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = N-Acetoxy-2-acetylaminofluorene|T109|T131|NON|EQV|UNK (19XX)|870810|abbcdef
ENTRY = N-Acetoxy-N-acetyl-2-aminofluorene|T109|T131|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = N Acetoxy 2 acetylaminofluorene
ENTRY = N Acetoxy N acetyl 2 aminofluorene
MN = D02.065.064.150.100
MN = D02.241.081.018.110.080.070
MN = D02.455.426.559.847.389.050.060
MN = D04.615.389.050.060
PA = Alkylating Agents
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = Acetamide, N-(acetyloxy)-N-9H-fluoren-2-yl-
RN = 6098-44-8
PI = Acetamides (1973-1974)
PI = Acetates (1966-1967)
PI = Acetic Acids (1968-1972)
PI = Amides (1966-1972)
PI = Fluorenes (1966-1974)
MS = An alkylating agent that forms DNA ADDUCTS at the C-8 position in GUANINE, resulting in single strand breaks. It has demonstrated carcinogenic action.
PM = 91; was see under 2-ACETYLAMINOFLUORENE/analogs & derivatives 1980-90; was see under FLUORENES 1975-79
HN = 91(75); was see under 2-ACETYLAMINOFLUORENE/analogs & derivatives 1980-90; was see under FLUORENES 1975-79
MR = 20120703
DA = 19741111
DC = 1
DX = 19910101
UI = D000099

*NEWRECORD
RECTYPE = D
MH = Acetrizoic Acid
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Acetrizoate Sodium|T109|T130|NON|NRW|FDA SRS (2014)|UNK (19XX)|810130|abbcdeef
ENTRY = Jodopax|T109|T130|TRD|NRW|UNK (19XX)|831014|abbcdef
ENTRY = Salpix|T109|T130|TRD|NRW|UNK (19XX)|830330|abbcdef
ENTRY = Triiotrast|T109|T130|TRD|NRW|UNK (19XX)|811023|abbcdef
ENTRY = Visotrast 300|T109|T130|TRD|NRW|UNK (19XX)|810130|abbcdef
ENTRY = Visotrast 400|T109|T130|TRD|NRW|UNK (19XX)|810130|abbcdef
ENTRY = 300, Visotrast
ENTRY = 400, Visotrast
ENTRY = Acid, Acetrizoic
ENTRY = Sodium, Acetrizoate
MN = D02.241.223.100.050.300.100
MN = D02.241.223.100.400.880.020
MN = D02.455.426.559.389.127.020.452.249
MN = D02.455.426.559.389.127.375.880.020
PA = Contrast Media
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T130
N1 = Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-
RN = 24256BQV7M
RR = 5GF4B2I1DD
RR = 85-36-9 (Acetrizoic Acid)
MS = An iodinated radiographic contrast medium used as acetrizoate sodium in HYSTEROSALPINGOGRAPHY.
MR = 20130708
DA = 19990101
DC = 1
UI = D000100

*NEWRECORD
RECTYPE = D
MH = Acetyl-CoA C-Acetyltransferase
DS = ACETYL COA ACETYLTRANSFERASE C
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acetoacetyl CoA Thiolase|T116|T126|EQV|UNK (19XX)|750206|abbdef
PRINT ENTRY = Acetyl Coenzyme A Acetyltransferase|T116|T126|NON|EQV|UNK (19XX)|760317|abbcdef
PRINT ENTRY = Acetyl-CoA Acetyltransferase|T116|T126|EQV|NLM (1998)|961203|abbdef
ENTRY = Acetyl CoA Acetyltransferase
ENTRY = Acetyl CoA C Acetyltransferase
ENTRY = Acetyltransferase, Acetyl-CoA
ENTRY = C-Acetyltransferase, Acetyl-CoA
ENTRY = CoA Thiolase, Acetoacetyl
ENTRY = Thiolase, Acetoacetyl CoA
MN = D08.811.913.050.134.025
FX = Acetyl-CoA C-Acyltransferase
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Acetyl-CoA:acetyl-CoA C-acetyltransferase
RN = EC 2.3.1.9
RR = 9027-46-7 (CAS RN)
AN = do not confuse with ACETYL-COA C-ACYLTRANSFERASE
PI = Acetoacetates (1974)
PI = Acetyl Coenzyme A (1973-1974)
PI = Acetyltransferases (1973-1974)
MS = An enzyme that catalyzes the formation of acetoacetyl-CoA from two molecules of ACETYL COA. Some enzymes called thiolase or thiolase-I have referred to this activity or to the activity of ACETYL-COA C-ACYLTRANSFERASE.
PM = 98(75); see ACETYL-COA ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1975-90
HN = 98(75)
MR = 20060705
DA = 19741119
DC = 1
DX = 19910101
UI = D000101

*NEWRECORD
RECTYPE = D
MH = Acetyl-CoA C-Acyltransferase
DS = ACETYL COA ACYLTRANSFERASE C
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = 3-Ketoacyl CoA Thiolase|T116|T126|EQV|UNK (19XX)|750206|KETOACYL COA THIOLASE 03|abbdefs
PRINT ENTRY = 3-Ketothiolase|T116|T126|NON|EQV|UNK (19XX)|741111|KETOTHIOLASE 3|abbcdefs
PRINT ENTRY = Acetyl CoA Acyltransferase|T116|T126|EQV|NLM (1998)|961203|abbdef
PRINT ENTRY = Acetyl Coenzyme A Acyltransferase|T116|T126|EQV|UNK (19XX)|760317|abbdef
PRINT ENTRY = beta-Ketothiolase|T116|T126|NON|EQV|UNK (19XX)|760517|abbcdef
ENTRY = 2-Methylacetoacetyl CoA Thiolase|T116|T126|EQV|UNK (19XX)|870810|abbdef
ENTRY = 3-Oxoacyl CoA Thiolase|T116|T126|EQV|UNK (19XX)|801120|abbdef
ENTRY = 3-Oxoacyl-Coenzyme A Thiolase|T116|T126|EQV|UNK (19XX)|870812|abbdef
ENTRY = beta-Ketoacyl Thiolase|T116|T126|NON|EQV|NLM (1992)|910225|abbcdef
ENTRY = Acetyl CoA C Acyltransferase
ENTRY = Acyltransferase, Acetyl CoA
ENTRY = C-Acyltransferase, Acetyl-CoA
ENTRY = CoA Acyltransferase, Acetyl
ENTRY = CoA Thiolase, 2-Methylacetoacetyl
ENTRY = CoA Thiolase, 3-Ketoacyl
ENTRY = CoA Thiolase, 3-Oxoacyl
ENTRY = Thiolase, 2-Methylacetoacetyl CoA
ENTRY = Thiolase, 3-Ketoacyl CoA
ENTRY = Thiolase, 3-Oxoacyl CoA
ENTRY = Thiolase, 3-Oxoacyl-Coenzyme A
ENTRY = Thiolase, beta-Ketoacyl
ENTRY = beta Ketoacyl Thiolase
ENTRY = beta Ketothiolase
MN = D08.811.913.050.080
FX = Acetyl-CoA C-Acetyltransferase
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Acyl-CoA:acetyl-CoA C-acyltransferase
RN = EC 2.3.1.16
RR = 9029-97-4 (CAS RN)
AN = do not confuse with ACETYL-COA C-ACETYLTRANSFERASE
PI = Acetyl Coenzyme A (1973-1974)
PI = Acyltransferases (1973-1974)
MS = Enzyme that catalyzes the final step of fatty acid oxidation in which ACETYL COA is released and the CoA ester of a fatty acid two carbons shorter is formed.
PM = 98; use ACETYL COA ACYLTRANSFERASE 1991-97, ACYLTRANSFERASES 1975-90
HN = 98(75)
MR = 20040707
DA = 19741119
DC = 1
DX = 19910101
UI = D000102

*NEWRECORD
RECTYPE = D
MH = Acetyl-CoA Carboxylase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acetyl Coenzyme A Carboxylase|T116|T126|NON|EQV|UNK (19XX)|760317|abbcdef
ENTRY = Acetyl CoA Carboxylase
ENTRY = Carboxylase, Acetyl-CoA
MN = D08.811.464.257.050
MN = D08.811.641.249
MH_TH = NLM (1973)
ST = T116
ST = T126
N1 = Acetyl-CoA:carbon-dioxide ligase (ADP-forming)
RN = EC 6.4.1.2
RR = EC 6.3.4.14
MS = A carboxylating enzyme that catalyzes the conversion of ATP, acetyl-CoA, and HCO3- to ADP, orthophosphate, and malonyl-CoA. It is a biotinyl-protein that also catalyzes transcarboxylation. The plant enzyme also carboxylates propanoyl-CoA and butanoyl-CoA (From Enzyme Nomenclature, 1992) EC 6.4.1.2.
PM = 91; was see under LIGASES 1973-90
HN = 91(73); was see under LIGASES 1973-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000103

*NEWRECORD
RECTYPE = D
MH = Acetyl-CoA Hydrolase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acetyl Coenzyme A Hydrolase|T116|T126|EQV|UNK (19XX)|770517|abbdef
PRINT ENTRY = Acetyl-CoA Acylase|T116|T126|EQV|UNK (19XX)|770517|abbdef
PRINT ENTRY = Acetyl-CoA Deacylase|T116|T126|EQV|UNK (19XX)|770517|abbdef
ENTRY = Acetyl CoA Acylase
ENTRY = Acetyl CoA Deacylase
ENTRY = Acetyl CoA Hydrolase
ENTRY = Acylase, Acetyl-CoA
ENTRY = Deacylase, Acetyl-CoA
ENTRY = Hydrolase, Acetyl-CoA
MN = D08.811.277.352.897.075
MH_TH = NLM (1978)
ST = T116
ST = T126
N1 = Acetyl-CoA hydrolase
RN = EC 3.1.2.1
PI = Thiolester Hydrolases (1973-1977)
MS = An enzyme that catalyzes reversibly the hydrolysis of acetyl-CoA to yield CoA and acetate. The enzyme is involved in the oxidation of fatty acids. EC 3.1.2.1.
PM = 91; was see under THIOLESTER HYDROLASES 1978-90
HN = 91(78); was see under THIOLESTER HYDROLASES 1978-90
MR = 20030709
DA = 19770517
DC = 1
DX = 19910101
UI = D000104

*NEWRECORD
RECTYPE = D
MH = Acetyl Coenzyme A
AQ = AA AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acetyl CoA|T114|T119|T123|NON|EQV|UNK (19XX)|760317|abbbcdef
ENTRY = Acetyl-CoA|T114|T119|T123|NON|EQV|NLM (2006)|050705|abbbcdef
ENTRY = CoA, Acetyl
ENTRY = Coenzyme A, Acetyl
MN = D03.438.759.646.138.382.300.020
MN = D08.211.211.300.075
MN = D13.695.667.138.382.300.020
MN = D13.695.827.068.382.300.020
MH_TH = NLM (1973)
ST = T114
ST = T119
ST = T123
N1 = Coenzyme A, S-acetate
RN = 72-89-9
AN = do not confuse with ACYL COENZYME A
PI = Coenzyme A (1966-1972)
MS = Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent.
PM = 78; was see under COENZYME A 1975-77
HN = 78(73); was see under COENZYME A 1975-77
MR = 20060705
DA = 19990101
DC = 1
DX = 19780101
UI = D000105

*NEWRECORD
RECTYPE = D
MH = Acetate-CoA Ligase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acetate Thiokinase|T116|T126|NON|EQV|UNK (19XX)|750630|abbcdef
PRINT ENTRY = Acetyl Activating Enzyme|T116|T126|NON|EQV|UNK (19XX)|750630|abbcdef
PRINT ENTRY = Acetyl CoA Synthetase|T116|T126|EQV|UNK (19XX)|760517|abbdef
ENTRY = Acetothiokinase|T116|T126|NON|EQV|UNK (19XX)|820903|abbcdef
ENTRY = Acetyl Coenzyme A Synthetase|T116|T126|NON|EQV|NLM (1995)|940305|abbcdef
ENTRY = Acetate CoA Ligase
ENTRY = Activating Enzyme, Acetyl
ENTRY = CoA Synthetase, Acetyl
ENTRY = Enzyme, Acetyl Activating
ENTRY = Ligase, Acetate-CoA
ENTRY = Synthetase, Acetyl CoA
ENTRY = Thiokinase, Acetate
MN = D08.811.464.267.500.200
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = Acetate:CoA ligase (AMP-forming)
RN = EC 6.2.1.1
RR = 9012-31-1 (CAS RN)
PI = Acetyl Coenzyme A (1974-1975)
PI = Coenzyme A Synthetases (1974-1975)
MS = An enzyme that catalyzes the formation of CoA derivatives from ATP, acetate, and CoA to form AMP, pyrophosphate, and acetyl CoA. It acts also on propionates and acrylates. EC 6.2.1.1.
OL = use ACETATE-COA LIGASE to search ACETYL COENZYME A SYNTHETASE 1991-94
PM = 95; was ACETYL COENZYME A SYNTHETASE 1991-94; was see under COENZYME A SYNTHETASES 1976-90
HN = 95; was ACETYL COENZYME A SYNTHETASE 1991-94; was see under COENZYME A SYNTHETASES 1976-90
MR = 20130709
DA = 19750718
DC = 1
DX = 19910101
UI = D000106

*NEWRECORD
RECTYPE = D
MH = Acetylation
AQ = DE RE
ENTRY = Acetylations
MN = G02.111.087.019.052
MN = G02.149.115.019.052
MN = G02.149.465.030.052
MN = G02.607.750.030.052
MN = G03.495.095.052
MH_TH = NLM (1973)
ST = T070
AN = almost never IM; enzymatic acetylation: coord NIM with ACETYLTRANSFERASES (IM) + substrate (NIM) or specific acetyltransferase (IM)
PI = Chemistry, Organic (1966-1972)
MS = Formation of an acetyl derivative. (Stedman, 25th ed)
PM = 91; was see under CHEMISTRY, ORGANIC 1973-90
HN = 91(73); was see under CHEMISTRY, ORGANIC 1973-90
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D000107

*NEWRECORD
RECTYPE = D
MH = Acetylcarnitine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Acetyl Carnitine|T109|T121|T127|NON|EQV|UNK (19XX)|770517|abbbcdef
PRINT ENTRY = Medosan|T109|T121|TRD|NRW|NLM (2004)|abbcde
ENTRY = Acetyl-L-Carnitine|T109|T121|T127|NON|EQV|FDA SRS (2014)|NLM (1999)|970903|abbbcdeef
ENTRY = Acetylcarnitine, (R)-Isomer|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Alcar|T109|T121|TRD|NRW|NLM (1999)|970903|abbcdef
ENTRY = Branigen|T109|T121|TRD|NRW|NLM (2004)|021226|abbcdef
ENTRY = Glaxo Brand of Acetyl L-Carnitine|T109|T121|NON|NRW|NLM (2004)|030226|abbcdef
ENTRY = Levocarnitine Acetyl|T109|T121|T127|NON|EQV|FDA SRS (2014)|NLM (1998)|961120|abbbcdeef
ENTRY = Sigma-Tau brand of Acetyl L-Carnitine|T109|T121|NON|NRW|NLM (2004)|030226|abbcdef
ENTRY = Acetyl L Carnitine
ENTRY = Carnitine, Acetyl
ENTRY = Glaxo Brand of Acetyl L Carnitine
ENTRY = Sigma Tau brand of Acetyl L Carnitine
MN = D02.092.877.883.099.090
PA = Nootropic Agents
PA = Vitamin B Complex
MH_TH = FDA SRS (2014)
MH_TH = NLM (1978)
ST = T109
ST = T121
ST = T127
N1 = 1-Propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, inner salt
RN = 6DH1W9VH8Q
RR = 104220-24-8
RR = 14992-62-2 (Acetylcarnitine)
RR = 3040-38-8 ((R)-isomer)
PI = Carnitine (1966-1977)
MS = An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
PM = 1991; see CARNITINE 1978-1990; MEDOSAN was indexed under ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1988-2003
HN = 1991(1978); use CARNITINE 1978-1990; for MEDOSAN use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL (NM) 1988-2003
MR = 20130708
DA = 19770517
DC = 1
DX = 19910101
UI = D000108

*NEWRECORD
RECTYPE = D
MH = Acetylcholine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = 2-(Acetyloxy)-N,N,N-trimethylethanaminium|T109|T121|T124|NON|EQV|NLM (1995)|931123|abbbcdef
ENTRY = Acetilcolina Cusi|T109|T121|TRD|NRW|ES|020719|abbcdef
ENTRY = Acetylcholine Bromide|T109|T121|T124|NON|NRW|FDA SRS (2014)|NLM (1999)|990913|abbbcdeef
ENTRY = Acetylcholine Chloride|T109|T121|T124|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (1996)|INN (19XX)|USP (1996)|USP (19XX)|940808|abbbcdeeeeeef
ENTRY = Acetylcholine Fluoride|T109|T121|T124|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Acetylcholine Hydroxide|T109|T121|T124|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Acetylcholine Iodide|T109|T121|T124|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Acetylcholine L-Tartrate|T109|T121|T124|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Acetylcholine Perchlorate|T109|T121|T124|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Acetylcholine Picrate|T109|T121|T124|NON|NRW|NLM (1992)|910308|abbbcdef
ENTRY = Acetylcholine Picrate (1:1)|T109|T121|T124|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Acetylcholine Sulfate (1:1)|T109|T121|T124|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Alcon Brand of Acetylcholine Chloride|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Bournonville Brand of Acetylcholine Chloride|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Bromoacetylcholine|T109|T121|T124|NON|NRW|NLM (2001)|abbbcde
ENTRY = Chloroacetylcholine|T109|T121|T124|NON|NRW|NLM (2001)|abbbcde
ENTRY = Ciba Vision Brand of Acetylcholine Chloride|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Iolab Brand of Acetylcholine Chloride|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Miochol|T109|T121|TRD|NRW|AU|CA|DE|NL|UK|US|961206|abbcdeeeeeef
ENTRY = Acetylcholine L Tartrate
ENTRY = Bromide, Acetylcholine
ENTRY = Cusi, Acetilcolina
ENTRY = Fluoride, Acetylcholine
ENTRY = Hydroxide, Acetylcholine
ENTRY = Iodide, Acetylcholine
ENTRY = L-Tartrate, Acetylcholine
ENTRY = Perchlorate, Acetylcholine
MN = D02.092.211.111
PA = Cholinergic Agonists
PA = Vasodilator Agents
FX = Receptors, Cholinergic
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T121
ST = T124
N1 = Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-
RN = N9YNS0M02X
RR = 2260-50-6
RR = 51-84-3 (Acetylcholine)
RR = 52978-03-7
RR = 56-13-3
RR = 60-31-1 (Acetylcholine Chloride)
RR = 66-23-9 (Acetylcholine Bromide)
RR = 7632-27-1
RR = 77822-10-7
RR = 78213-25-9
RR = 927-86-6
RR = AF73293C2R
RR = C12HG588IF
MS = A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.
PM = 1998; MIOCHOL (now ACETYLCHOLINE) was indexed under ACETYLCHOLINE & MANNITOL 1981-97; CHLOROACETYLCHOLINE was indexed under ACETYLCHOLINE 1975-2000 & under CHLORINE 1974-1975; BROMOACETYLCHOLINE was indexed under ACETYLCHOLINE/analogs & derivatives 1974-2000 & ACETYLCHOLINE 1969-1974
HN = 1998; for MIOCHOL use ACETYLCHOLINE (NM) 1981-1997; for CHLOROACETYLCHOLINE use ACETYLCHOLINE (NM) 1969-2000; for BROMOACETYLCHOLINE use ACETYLCHOLINE (NM) 1969-2000
MR = 20130708
DA = 19990101
DC = 1
UI = D000109

*NEWRECORD
RECTYPE = D
MH = Acetylcholinesterase
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Acetylcholine Hydrolase|T116|T126|NON|EQV|UNK (19XX)|810728|abbcdef
ENTRY = Acetylthiocholinesterase|T116|T126|NON|NRW|UNK (19XX)|810427|abbcdef
ENTRY = Hydrolase, Acetylcholine
MN = D08.811.277.352.100.170.176
EC = antagonists & inhibitors:Cholinesterase Inhibitors
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = Acetylcholine acetylhydrolase
RN = EC 3.1.1.7
AN = reactivation or reactivators: coord NIM (with no qualif) with CHOLINESTERASE REACTIVATORS (IM)
MS = An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7.
MR = 20050707
DA = 19990101
DC = 1
UI = D000110

*NEWRECORD
RECTYPE = D
MH = Acetylcysteine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Mercapturic Acid|T116|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef
ENTRY = Acemuc|T116|T121|TRD|NRW|DE|030116|abbcdef
ENTRY = Acetabs|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = Acetylcystein AL|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = Acetylcystein Atid|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = Acetylcystein Heumann|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = Acetylcystein Trom|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = Acetylcysteine Hydrochloride|T116|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Acetylcysteine Sodium|T116|T121|NRW|FDA SRS (2014)|NLM (2014)|990913|abbdeef
ENTRY = Acetylcysteine Zinc|T116|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Acetylcysteine, (D)-Isomer|T116|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Acetylcysteine, (DL)-Isomer|T116|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Acetylcysteine, Monoammonium Salt|T116|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Acetylcysteine, Monosodium Salt|T116|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Acetylin|T116|T121|TRD|NRW|DE|030116|abbcdef
ENTRY = Acetyst|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = Actylcystine GNR|T116|T121|TRD|NRW|FR|030224|abbcdef
ENTRY = Airbron|T116|T121|TRD|NRW|UK|030214|abbcdef
ENTRY = Alcon Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030324|abbcdef
ENTRY = Allen & Hanburys Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = Aluid Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = Alveolex|T116|T121|TRD|NRW|IE|030214|abbcdef
ENTRY = Atid Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = Azubronchin|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = Azupharma Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = Betapharm Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Bioiberica Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Bisolvon NAC|T116|T121|TRD|NRW|DE|030224|abbcdef
ENTRY = Boehringer Ingelheim Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030224|abbcdef
ENTRY = Bouchara Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030319|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Acetylcysteine Sodium Salt|T116|T121|NON|NRW|NLM (2004)|030224|abbcdef
ENTRY = Bromuc|T116|T121|TRD|NRW|DE|030224|abbcdef
ENTRY = Broncho-Fips|T116|T121|TRD|NRW|DE|030224|abbcdef
ENTRY = Broncholysin|T116|T121|TRD|NRW|UNK (19XX)|871021|abbcdef
ENTRY = Broncoclar|T116|T121|TRD|NRW|FR|030224|abbcdef
ENTRY = Centrafarm Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030224|abbcdef
ENTRY = Codotussyl|T116|T121|TRD|NRW|FR|030224|abbcdef
ENTRY = Cystamucil|T116|T121|TRD|NRW|NL|030224|abbcdef
ENTRY = Dampo Mucopect|T116|T121|TRD|NRW|NL|030317|abbcdef
ENTRY = Dey Brand of Acetylcysteine Sodium Salt|T116|T121|NON|NRW|NLM (2004)|030327|abbcdef
ENTRY = Disphar Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030325|abbcdef
ENTRY = Eurespiran|T116|T121|TRD|NRW|DE|030319|abbcdef
ENTRY = Exomuc|T116|T121|TRD|NRW|FR|030319|abbcdef
ENTRY = Fabrol|T116|T121|TRD|NRW|UK|030319|abbcdef
ENTRY = Farmasan Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030326|abbcdef
ENTRY = Fluimucil|T116|T121|TRD|NRW|DE|ES|FR|NL|UNK (19XX)|871021|abbcdeeeeef
ENTRY = Fluprowit|T116|T121|TRD|NRW|DE|030224|abbcdef
ENTRY = Frekatuss|T116|T121|TRD|NRW|DE|030319|abbcdef
ENTRY = Fresenius Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030319|abbcdef
ENTRY = GNR-Pharma Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030224|abbcdef
ENTRY = Genac|T116|T121|TRD|NRW|FR|030319|abbcdef
ENTRY = Guerbet Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030319|abbcdef
ENTRY = Gnvrier Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Hermes Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030327|abbcdef
ENTRY = Heumann Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = Hoestil|T116|TRD|NRW|NL|030319|abcdef
ENTRY = Ilube|T116|T121|TRD|NRW|IE|UK|030324|abbcdeef
ENTRY = Inpharzam Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Intra Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030324|abbcdef
ENTRY = Jenacystein|T116|T121|TRD|NRW|DE|030324|abbcdef
ENTRY = Jenapharm|T116|T121|NON|NRW|NLM (2004)|030324|abbcdef
ENTRY = Klinge Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = Krewel Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = Lantamed|T116|T121|TRD|NRW|DE|030324|abbcdef
ENTRY = Larylin NAC|T116|T121|TRD|NRW|DE|030317|abbcdef
ENTRY = Lichtenstein Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030224|abbcdef
ENTRY = Lindocetyl|T116|T121|TRD|NRW|DE|030324|abbcdef
ENTRY = Lindopharm Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030324|abbcdef
ENTRY = M-Pectil|T116|T121|TRD|NRW|NL|030325|abbcdef
ENTRY = Merck Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030317|abbcdef
ENTRY = Muciteran|T116|T121|TRD|NRW|DE|030326|abbcdef
ENTRY = Muco Sanigen|T116|T121|TRD|NRW|DE|030224|abbcdef
ENTRY = Mucomyst|T116|T121|TRD|NRW|AU|CA|DE|FR|NL|UNK (19XX)|861119|abbcdeeeeeef
ENTRY = Mucosil|T116|T121|TRD|NRW|US|030327|abbcdef
ENTRY = Mucosol|T116|T121|TRD|NRW|US|030327|abbcdef
ENTRY = Mucosolvin|T116|T121|TRD|NRW|UNK (19XX)|830914|abbcdef
ENTRY = N-Acetyl-L-cysteine|T116|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|811218|abbcdeef
ENTRY = N-Acetylcysteine|T116|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|800730|abbcdeef
ENTRY = NAC AL|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = NAC Zambon|T116|T121|TRD|NRW|DE|030116|abbcdef
ENTRY = Oberlin Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030224|abbcdef
ENTRY = Optipect Hustengetrnk|T116|T121|TRD|NRW|DE|030224|abbcdef
ENTRY = Pfleger Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030324|abbcdef
ENTRY = Pharbita Brand of Acetylcysteine|T116|NON|NRW|NLM (2004)|030324|abcdef
ENTRY = Produpharm Lappe Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Roberts Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Roche Nicholas Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030317|abbcdef
ENTRY = Siccoral|T116|T121|TRD|NRW|DE|030116|abbcdef
ENTRY = Siran|T116|T121|TRD|NRW|DE|030116|abbcdef
ENTRY = Solmucol|T116|T121|TRD|NRW|ES|FR|030116|abbcdeef
ENTRY = Temmler Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Teva Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = Thiemann Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030224|abbcdef
ENTRY = Trommsdorff Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = UPSA Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Whitehall Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030224|abbcdef
ENTRY = Zambon Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030116|abbcdef
ENTRY = Zyma Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030319|abbcdef
ENTRY = ac-Pharma Brand of Acetylcysteine|T116|T121|NON|NRW|NLM (2004)|030214|abbcdef
ENTRY = acebraus|T116|T121|TRD|NRW|DE|030214|abbcdef
ENTRY = durabronchal|T116|T121|TRD|NRW|DE|030317|abbcdef
ENTRY = mentopin Acetylcystein|T116|T121|TRD|NRW|DE|030327|abbcdef
ENTRY = Acetylcystein, mentopin
ENTRY = Acetylcysteine Alcon Brand
ENTRY = Acetylcysteine Aluid Brand
ENTRY = Acetylcysteine Atid Brand
ENTRY = Acetylcysteine Azupharma Brand
ENTRY = Acetylcysteine Betapharm Brand
ENTRY = Acetylcysteine Bioiberica Brand
ENTRY = Acetylcysteine Bouchara Brand
ENTRY = Acetylcysteine Centrafarm Brand
ENTRY = Acetylcysteine Disphar Brand
ENTRY = Acetylcysteine Farmasan Brand
ENTRY = Acetylcysteine Fresenius Brand
ENTRY = Acetylcysteine GNR-Pharma Brand
ENTRY = Acetylcysteine Guerbet Brand
ENTRY = Acetylcysteine Gnvrier Brand
ENTRY = Acetylcysteine Hermes Brand
ENTRY = Acetylcysteine Heumann Brand
ENTRY = Acetylcysteine Inpharzam Brand
ENTRY = Acetylcysteine Intra Brand
ENTRY = Acetylcysteine Klinge Brand
ENTRY = Acetylcysteine Krewel Brand
ENTRY = Acetylcysteine Lichtenstein Brand
ENTRY = Acetylcysteine Lindopharm Brand
ENTRY = Acetylcysteine Merck Brand
ENTRY = Acetylcysteine Oberlin Brand
ENTRY = Acetylcysteine Pfleger Brand
ENTRY = Acetylcysteine Pharbita Brand
ENTRY = Acetylcysteine Roberts Brand
ENTRY = Acetylcysteine Temmler Brand
ENTRY = Acetylcysteine Teva Brand
ENTRY = Acetylcysteine Thiemann Brand
ENTRY = Acetylcysteine Trommsdorff Brand
ENTRY = Acetylcysteine UPSA Brand
ENTRY = Acetylcysteine Whitehall Brand
ENTRY = Acetylcysteine Zambon Brand
ENTRY = Acetylcysteine Zyma Brand
ENTRY = Acetylcysteine ac-Pharma Brand
ENTRY = Acid, Mercapturic
ENTRY = Bristol Myers Squibb Brand of Acetylcysteine
ENTRY = Bristol Myers Squibb Brand of Acetylcysteine Sodium Salt
ENTRY = Broncho Fips
ENTRY = BronchoFips
ENTRY = GNR Pharma Brand of Acetylcysteine
ENTRY = Hustengetrnk, Optipect
ENTRY = Hydrochloride, Acetylcysteine
ENTRY = M Pectil
ENTRY = MPectil
ENTRY = Monoammonium Salt Acetylcysteine
ENTRY = Monosodium Salt Acetylcysteine
ENTRY = Mucopect, Dampo
ENTRY = N Acetyl L cysteine
ENTRY = N Acetylcysteine
ENTRY = NAC, Bisolvon
ENTRY = Sanigen, Muco
ENTRY = Sodium, Acetylcysteine
ENTRY = Zambon, NAC
ENTRY = Zinc, Acetylcysteine
ENTRY = ac Pharma Brand of Acetylcysteine
MN = D02.886.030.230.259
MN = D12.125.166.230.259
PA = Antiviral Agents
PA = Expectorants
PA = Free Radical Scavengers
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1963)
MH_TH = USP (19XX)
ST = T116
ST = T121
N1 = L-Cysteine, N-acetyl-
RN = WYQ7N0BPYC
RR = 128645-11-4 (Zn salt)
RR = 18829-79-3 (HCl)
RR = 26117-28-2 ((D)-isomer)
RR = 50807-78-8 (mono-NH3 salt)
RR = 616-91-1 (Acetylcysteine)
RR = 63664-54-0 (Na salt)
RR = 7218-04-4 ((DL)-isomer)
RR = NRD80R06FB
MS = The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.
PM = 66
HN = 66(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D000111

*NEWRECORD
RECTYPE = D
MH = Acetyldigitoxins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Desglucolanatosides A|T110|T118|T121|NON|EQV|UNK (19XX)|790223|abbbcdef
ENTRY = Acedoxin|T110|T118|T121|TRD|NRW|UNK (19XX)|800813|abbbcdef
ENTRY = Acetyldigitoxin|T110|T118|T121|NON|NRW|FDA SRS (2014)|INN (19XX)|UNK (19XX)|790223|abbbcdeeef
ENTRY = Adicin|T110|T118|T121|TRD|NRW|UNK (19XX)|810130|abbbcdef
ENTRY = Digitoxin Monoacetate|T110|T118|T121|NON|NRW|UNK (19XX)|800813|abbbcdef
ENTRY = alpha-Acetyldigitoxin|T110|T118|T121|NON|NRW|UNK (19XX)|810130|abbbcdef
ENTRY = Monoacetate, Digitoxin
ENTRY = alpha Acetyldigitoxin
MN = D04.808.155.580.130.500.336.259
MN = D04.808.155.580.130.625.259
MN = D09.408.180.261.336.259
PA = Anti-Arrhythmia Agents
PA = Cardiotonic Agents
PA = Enzyme Inhibitors
MH_TH = NLM (1975)
ST = T110
ST = T118
ST = T121
RN = 0
RR = 0ZV4Q4L2FU
AN = do not confuse with ACETYLDIGOXINS
MS = Cardioactive derivatives of lanatoside A or of DIGITOXIN. They are used for fast digitalization in congestive heart failure.
OL = use ACETYLDIGITOXINS to search ACETYLDIGITOXIN 1975-79 & DIGITOXIN 1966-74
PM = 91; was see under DIGITOXIN 1980-90; was ACETYLDIGITOXIN see under DIGITOXIN 1966-79
HN = 91(80); was see under DIGITOXIN 1980-90; was ACETYLDIGITOXIN see under DIGITOXIN 1966-79
MR = 20150622
DA = 19990101
DC = 1
DX = 19910101
UI = D000112

*NEWRECORD
RECTYPE = D
MH = Acetyldigoxins
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Desglucolanatosides C|T110|T121|NON|EQV|UNK (19XX)|780316|abbcdef
ENTRY = ASTA Medica Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Digostada|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = Digotab|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = Digoxin Didier|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = Gladixol N|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = Hormosan Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Kardiamed|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = Lilly Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Longdigox|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = Medice Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Novodigal|T110|T121|TRD|NRW|DE|800813|abbcdef
ENTRY = R.A.N. Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Stada Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Stillacor|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = Wolff Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = alpha-Acetyldigoxin|T110|T121|NON|NRW|UNK (19XX)|800813|abbcdef
ENTRY = beta-Acetyldigoxin|T110|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = beta-Acetyldigoxin-ratiopharm|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = corax Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = ct-Arzneimittel Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = digox von ct|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = gepepharm Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = glycotop|T110|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = ratiopharm Brand of beta-Acetyldigoxin|T110|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = ASTA Medica Brand of beta Acetyldigoxin
ENTRY = Didier, Digoxin
ENTRY = Hormosan Brand of beta Acetyldigoxin
ENTRY = Lilly Brand of beta Acetyldigoxin
ENTRY = Medice Brand of beta Acetyldigoxin
ENTRY = N, Gladixol
ENTRY = R.A.N. Brand of beta Acetyldigoxin
ENTRY = Stada Brand of beta Acetyldigoxin
ENTRY = Wolff Brand of beta Acetyldigoxin
ENTRY = alpha Acetyldigoxin
ENTRY = beta Acetyldigoxin
ENTRY = beta Acetyldigoxin ratiopharm
ENTRY = beta-Acetyldigoxin Hormosan Brand
ENTRY = beta-Acetyldigoxin Lilly Brand
ENTRY = beta-Acetyldigoxin Medice Brand
ENTRY = beta-Acetyldigoxin R.A.N. Brand
ENTRY = beta-Acetyldigoxin Stada Brand
ENTRY = beta-Acetyldigoxin Wolff Brand
ENTRY = beta-Acetyldigoxin corax Brand
ENTRY = beta-Acetyldigoxin ct-Arzneimittel Brand
ENTRY = beta-Acetyldigoxin gepepharm Brand
ENTRY = beta-Acetyldigoxin ratiopharm Brand
ENTRY = betaAcetyldigoxinratiopharm
ENTRY = corax Brand of beta Acetyldigoxin
ENTRY = ct Arzneimittel Brand of beta Acetyldigoxin
ENTRY = ct, digox von
ENTRY = gepepharm Brand of beta Acetyldigoxin
ENTRY = ratiopharm Brand of beta Acetyldigoxin
ENTRY = von ct, digox
MN = D04.808.155.580.130.500.436.050
MN = D04.808.155.580.130.688.050
MN = D09.408.180.261.436.050
PA = Anti-Arrhythmia Agents
PA = Cardiotonic Agents
PA = Enzyme Inhibitors
MH_TH = NLM (1979)
ST = T110
ST = T121
RN = 0
RR = P7K44M64CW
AN = Digitalis glycosides; do not confuse with ACETYLDIGITOXINS; alpha isomer & beta isomer go here
PI = Digoxin (1966-1978)
MS = Alpha- or beta-acetyl derivatives of DIGOXIN or lanatoside C from Digitalis lanata. They are better absorbed and longer acting than digoxin and are used in congestive heart failure.
PM = 91; was see under DIGOXIN 1979-90
HN = 91(79); was see under DIGOXIN 1979-90
MR = 20150622
DA = 19780316
DC = 1
DX = 19910101
UI = D000113

*NEWRECORD
RECTYPE = D
MH = Acetylene
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.326.397.259
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
N1 = Ethyne
RN = OC7TV75O83
RR = 74-86-2 (Acetylene)
MR = 20130708
DA = 19990101
DC = 1
UI = D000114

*NEWRECORD
RECTYPE = D
MH = Acetylesterase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acetylase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Acetate Esterase|T116|T126|NON|EQV|UNK (19XX)|840918|abbcdef
ENTRY = Acid Esterase|T116|T126|NON|EQV|UNK (19XX)|830330|abbcdef
ENTRY = Esterase-17|T116|T126|NON|EQV|UNK (19XX)|830916|abbcdef
ENTRY = Esterase 17
ENTRY = Esterase, Acetate
ENTRY = Esterase, Acid
MN = D08.811.277.352.100.050
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = Acetic-ester acetylhydrolase
RN = EC 3.1.1.6
MS = An enzyme that catalyzes the conversion of acetate esters and water to alcohols and acetate. EC 3.1.1.6.
MR = 20030709
DA = 19990101
DC = 1
UI = D000115

*NEWRECORD
RECTYPE = D
MH = Acetylgalactosamine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = 2-Acetamido-2-D-galactopyranose|T118|T123|NON|EQV|UNK (19XX)|811113|abbcdef
ENTRY = 2-Acetamido-2-Deoxy-D-Galactose|T118|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = 2-Acetamido-2-Deoxygalactose|T118|T123|NON|EQV|UNK (19XX)|811113|abbcdef
ENTRY = N-Acetyl-D-Galactosamine|T118|T123|NON|EQV|FDA SRS (2014)|NLM (1989)|890208|abbcdeef
ENTRY = 2 Acetamido 2 D galactopyranose
ENTRY = 2 Acetamido 2 Deoxy D Galactose
ENTRY = 2 Acetamido 2 Deoxygalactose
ENTRY = N Acetyl D Galactosamine
MN = D09.067.342.356.050
MH_TH = NLM (1975)
ST = T118
ST = T123
N1 = Galactose, 2-(acetylamino)-2-deoxy-
RN = KM15WK8O5T
RR = 31022-50-1 (Acetylgalactosamine)
PI = Galactosamine (1973-1974)
MS = The N-acetyl derivative of galactosamine.
PM = 91; was see under GALACTOSAMINE 1975-90
HN = 91(75); was see under GALACTOSAMINE 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000116

*NEWRECORD
RECTYPE = D
MH = Acetylglucosamine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = 2-Acetamido-2-Deoxy-D-Glucose|T118|T123|NON|EQV|UNK (19XX)|850103|abbcdef
ENTRY = 2-Acetamido-2-Deoxyglucose|T118|T123|NON|EQV|UNK (19XX)|821123|abbcdef
ENTRY = N-Acetyl-D-Glucosamine|T118|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = 2 Acetamido 2 Deoxy D Glucose
ENTRY = 2 Acetamido 2 Deoxyglucose
ENTRY = N Acetyl D Glucosamine
MN = D09.067.342.531.050
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T118
ST = T123
N1 = D-Glucose, 2-(acetylamino)-2-deoxy-
RN = V956696549
RR = 7512-17-6 (Acetylglucosamine)
PI = Glucosamine (1973-1974)
MS = The N-acetyl derivative of glucosamine.
PM = 91; was see under GLUCOSAMINE 1975-90
HN = 91(75); was see under GLUCOSAMINE 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D000117

*NEWRECORD
RECTYPE = D
MH = Acetylglucosaminidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = N-Acetyl-beta-D-glucosaminidase|T116|T126|NON|EQV|UNK (19XX)|840411|ACETYL BETA GLUCOSAMINIDASE|abbcdefs
ENTRY = Chitobiase|T116|T126|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = N,N-Diacetylchitobiase|T116|T126|NON|EQV|UNK (19XX)|871208|abbcdef
ENTRY = N-Ac-beta-Glucosaminidase|T116|T126|EQV|UNK (19XX)|811102|abbdef
ENTRY = NAGase|T116|T126|EQV|UNK (19XX)|880912|abbdef
ENTRY = beta-D-Acetamido-2-Deoxyglucosidase|T116|T126|NON|EQV|UNK (19XX)|861007|abbcdef
ENTRY = beta-D-N-acetylglucosaminidase|T116|T126|NON|EQV|UNK (19XX)|811113|abbcdef
ENTRY = beta-N-Acetylglucosaminidase|T116|T126|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = N Ac beta Glucosaminidase
ENTRY = N Acetyl beta D glucosaminidase
ENTRY = N,N Diacetylchitobiase
ENTRY = beta D Acetamido 2 Deoxyglucosidase
ENTRY = beta D N acetylglucosaminidase
ENTRY = beta N Acetylglucosaminidase
MN = D08.811.277.450.483.180.500
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 3.2.1.52
AN = do not confuse with BETA-N-ACETYLHEXOSAMINIDASES
PI = Acetamides (1973-1974)
PI = Glucosaminidase (1972-1974)
MS = A beta-N-Acetylhexosaminidase that catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as MUCOLIPIDOSIS and various inflammatory disorders of muscle and connective tissue.
PM = 91; was see under GLUCOSAMINIDASE 1975-90
HN = 91(75); was see under GLUCOSAMINIDASE 1975-90
MR = 20070709
DA = 19741111
DC = 1
DX = 19910101
UI = D000118

*NEWRECORD
RECTYPE = D
MH = Acetylmuramyl-Alanyl-Isoglutamine
DE = AMAIG
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Mur-NAc-L-Ala-D-isoGln|T116|T121|T129|NRW|UNK (19XX)|780201|abbbdef
PRINT ENTRY = Muramyl Dipeptide|T116|T121|T129|NON|EQV|UNK (19XX)|800514|abbbcdef
ENTRY = Acetylmuramyl Alanyl Isoglutamine|T116|T121|T129|NON|EQV|UNK (19XX)|780201|abbbcdef
ENTRY = N-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-Amide|T116|T121|T129|NON|NRW|UNK (19XX)|820204|abbbcdef
ENTRY = N-Acetylmuramyl-L-Alanyl-D-Isoglutamine|T116|T121|T129|NON|NRW|UNK (19XX)|800813|abbbcdef
ENTRY = Alanyl Isoglutamine, Acetylmuramyl
ENTRY = Dipeptide, Muramyl
ENTRY = Isoglutamine, Acetylmuramyl Alanyl
ENTRY = Mur NAc L Ala D isoGln
ENTRY = N Acetyl Muramyl L Alanyl D Glutamic alpha Amide
ENTRY = N Acetylmuramyl L Alanyl D Isoglutamine
MN = D09.067.550.050
MN = D09.811.522.050
MN = D12.644.233.050
PA = Adjuvants, Immunologic
MH_TH = NLM (1979)
ST = T116
ST = T121
ST = T129
N1 = D-alpha-Glutamine, N2-(N-(N-acetylmuramoyl)-L-alanyl)-
RN = 53678-77-6
AN = /biosyn permitted; DF: AMAIG
PI = Glycopeptides (1971-1978)
PI = Peptides (1966-1970)
PI = Polysaccharides (1966-1970)
MS = Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity.
PM = 83; was see under GLYCOPEPTIDES 1979-82
HN = 83(79); was see under GLYCOPEPTIDES 1979-82
MR = 20040707
DA = 19780201
DC = 1
DX = 19830101
UI = D000119

*NEWRECORD
RECTYPE = D
MH = Acecainide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetylprocainamide|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|940819|abbcdeef
ENTRY = Acecainide Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1977)|940812|abbcdeef
ENTRY = Acecainide Monohydrochloride|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = N-Acetylprocainamide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = Hydrochloride, Acecainide
ENTRY = Monohydrochloride, Acecainide
ENTRY = N Acetylprocainamide
MN = D02.241.223.100.050.500.625
MN = D02.241.223.100.100.033
MN = D02.455.426.559.389.127.020.937.625
MN = D02.455.426.559.389.127.085.033
PA = Anti-Arrhythmia Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Benzamide, 4-(acetylamino)-N-(2-(diethylamino)ethyl)-
RN = 910Q707V6F
RR = 32795-44-1 (Acecainide)
RR = 34118-92-8 (mono-HCl)
RR = B9K738KX14
PI = Procainamide (1966-1974) /analogs & derivatives (1975-1979)
MS = A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
PM = 96; was ACETYLPROCAINAMIDE 1980-95 (see under PROCAINAMIDE 1980-90)
HN = 96; was ACETYLPROCAINAMIDE 1980-95 (see under PROCAINAMIDE 1980-90)
MR = 20130708
DA = 19790227
DC = 1
DX = 19910101
UI = D000120

*NEWRECORD
RECTYPE = D
MH = Acetylserotonin O-Methyltransferase
DS = ACETYLSEROTONIN METHYLTRANSFERASE O
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Hydroxyindole O-Methyltransferase|T116|T126|NON|EQV|UNK (19XX)|741111|HYDROXYINDOLE METHYLTRANSFERASE O|abbcdefs
ENTRY = Acetylserotonin Methyltransferase|T116|T126|NON|EQV|NLM (1998)|970425|abbcdef
ENTRY = HIOMT|T116|T126|ABB|EQV|NLM (2008)|070327|abbcdef
ENTRY = Oxyindol-O-Methyltransferase|T116|T126|NON|EQV|UNK (19XX)|820120|abbcdef
ENTRY = Acetylserotonin O Methyltransferase
ENTRY = Hydroxyindole O Methyltransferase
ENTRY = Methyltransferase, Acetylserotonin
ENTRY = O-Methyltransferase, Acetylserotonin
ENTRY = O-Methyltransferase, Hydroxyindole
ENTRY = Oxyindol O Methyltransferase
MN = D08.811.913.555.500.100
MH_TH = NLM (2008)
ST = T116
ST = T126
N1 = S-Adenosyl-L-methionine:N-acetylserotonin O-methyltransferase
RN = EC 2.1.1.4
RR = 9029-77-0 (CAS RN)
PI = Methyltransferases (1974)
PI = Serotonin (1974)
MS = An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to N-acetylserotonin to form N-acetyl-5-methoxytryptamine (MELATONIN).
PM = 2008; see ACETYLSEROTONIN N-METHYLTRANSFERASE 1998-2007, see ACETYLSEROTONIN METHYLTRANSFERASE 1991-1997, see METHYLTRANSFERASES 1975-1990
HN = 2008(1975)
MR = 20070709
DA = 19741111
DC = 1
DX = 19910101
UI = D000121

*NEWRECORD
RECTYPE = D
MH = Acetylthiocholine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (2-Mercaptoethyl)trimethylammonium Acetate|T109|T121|NON|EQV|UNK (19XX)|800813|abbcdef
MN = D02.092.877.883.333.800.030
MN = D02.675.276.232.800.030
MN = D02.886.489.789.030
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Ethanaminium, 2-(acetylthio)-N,N,N-trimethyl-
RN = 4468-05-7
PI = Acetylcholine (1972-1974)
PI = Sulfhydryl Compounds (1973-1974)
MS = An agent used as a substrate in assays for cholinesterases, especially to discriminate among enzyme types.
PM = 91; was see under CHOLINE 1975-90
HN = 91(75); was see under CHOLINE 1975-90
MR = 20070709
DA = 19741119
DC = 1
DX = 19910101
UI = D000122

*NEWRECORD
RECTYPE = D
MH = Acetyltransferases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D08.811.913.050.134
MH_TH = NLM (1973)
ST = T116
ST = T126
RN = EC 2.3.1.-
RR = 9012-30-0 (CAS RN)
PI = Acyltransferases (1966-1972)
MS = Enzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1.
PM = 73
HN = 73
MR = 20060705
DA = 19990101
DC = 1
DX = 19730101
UI = D000123

*NEWRECORD
RECTYPE = D
MH = Achievement
ENTRY = Achievements
MN = F01.658.059
MN = F02.784.629.054
MH_TH = POPLINE (1978)
ST = T055
AN = no qualif
MS = Success in bringing an effort to the desired end; the degree or level of success attained in some specified area (esp. scholastic) or in general.
PM = 65
HN = 65(64)
CATSH = CAT LIST
MR = 19911102
DA = 19990101
DC = 1
DX = 19650101
UI = D000124

*NEWRECORD
RECTYPE = D
MH = Achilles Tendon
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Tendo Calcaneus|T023|NON|EQV|NLM (2016)|150416|abcdef
ENTRY = Achilles Tendons
ENTRY = Calcaneus, Tendo
ENTRY = Tendon, Achilles
ENTRY = Tendons, Achilles
MN = A02.880.176
MH_TH = NLM (1966)
ST = T023
AN = rupture = ACHILLES TENDON /inj (IM) + RUPTURE (NIM)
MS = A fibrous cord that connects the muscles in the back of the calf to the HEEL BONE.
MR = 20150616
DA = 19990101
DC = 1
UI = D000125

*NEWRECORD
RECTYPE = D
MH = Achlorhydria
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Achylia Gastrica|T046|NON|EQV|UNK (19XX)|780227|abcdef
PRINT ENTRY = Hypochlorhydria|T046|NON|REL|NLM (1991)|900213|abcdef
MN = C06.405.748.045
MN = C18.452.076.087
FX = Gastric Juice
MH_TH = NLM (1966)
ST = T046
MS = A lack of HYDROCHLORIC ACID in GASTRIC JUICE despite stimulation of gastric secretion.
OL = use ACHLORHYDRIA to search ACHYLIA GASTRICA 1966-78
PM = ACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78
HN = ACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D000126

*NEWRECORD
RECTYPE = D
MH = Acholeplasma
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.860.074.150
MH_TH = NLM (1976)
ST = T007
PI = Mycoplasma (1966-1975)
MS = A genus of gram-negative organisms including saprophytic and parasitic or pathogenic species.
PM = 76
HN = 76
MR = 20100625
DA = 19750725
DC = 1
DX = 19760101
UI = D000127

*NEWRECORD
RECTYPE = D
MH = Acholeplasma laidlawii
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Mycoplasma laidlawii|T007|NON|EQV|UNK (19XX)|750711|abcdef
MN = B03.440.860.074.150.500
MH_TH = NLM (1976)
ST = T007
AN = in sewage, dung, soil & animals
PI = Mycoplasma (1966-1971)
MS = An organism originally isolated from sewage, manure, humus, and soil, but recently found as a parasite in mammals and birds.
OL = use ACHOLEPLASMA LAIDLAWII to search MYCOPLASMA LAIDLAWII 1972-75
PM = 76; was MYCOPLASMA LAIDLAWII 1972-75
HN = 76; was MYCOPLASMA LAIDLAWII 1972-75
MR = 20100625
DA = 19750725
DC = 1
DX = 19760101
UI = D000128

*NEWRECORD
RECTYPE = D
MH = Acholeplasmataceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.860.074
MH_TH = NLM (1976)
ST = T007
AN = free-living saphrophytes & mammalian & avian parasites
PI = Bacteria (1966-1974)
PI = Mycoplasmataceae (1975)
MS = Gram-negative organisms including apparently free-living saphrophytes as well as mammalian and avian parasites, and possibly pathogens.
PM = 76
HN = 76
MR = 20100625
DA = 19750725
DC = 1
DX = 19760101
UI = D000129

*NEWRECORD
RECTYPE = D
MH = Achondroplasia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Severe Achondroplasia with Developmental Delay and Acanthosis Nigricans|T047|NON|REL|GHR (2014)|NLM (2012)|100712|abcdeef
ENTRY = Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = SADDAN|T047|NON|REL|GHR (2014)|OMIM (2013)|120618|abcdeef
ENTRY = SADDAN Dysplasia|T047|ACX|REL|GHR (2014)|NLM (2012)|100712|abcdeef
ENTRY = Skeleton-Skin-Brain Syndrome|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = Achondroplasias
ENTRY = Dysplasia, SADDAN
ENTRY = Dysplasias, SADDAN
ENTRY = SADDAN Dysplasias
ENTRY = SADDANs
ENTRY = Skeleton Skin Brain Syndrome
ENTRY = Skeleton-Skin-Brain Syndromes
ENTRY = Syndrome, Skeleton-Skin-Brain
ENTRY = Syndromes, Skeleton-Skin-Brain
MN = C05.116.099.343.110
MN = C05.116.099.708.017
MN = C16.320.240.500
FX = Receptor, Fibroblast Growth Factor, Type 3
MH_TH = GHR (2014)
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T019
MS = An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000130

*NEWRECORD
RECTYPE = D
MH = Acid Etching, Dental
DE = ACID ETCHING DENT
AQ = AE CL CT EC ES HI IS MT PX SN ST TD UT VE
PRINT ENTRY = Dental Acid Etching|T061|NON|EQV|NLM (1991)|900409|DENT ACID ETCHING|abcdefv
ENTRY = Etching, Dental Acid|T061|NON|EQV|NLM (1991)|900209|ETCHING DENT ACID|abcdefv
MN = E06.931.475.111
MH_TH = NLM (1977)
ST = T061
AN = etching of tooth surface to increase adhesion of resins; do not use for etching of metal appliances for better adhesion ( = specific appliance (IM) + METALLURGY (NIM) ); do not use for etching of veneers or resins ( = specific dent restoration); DF: ACID ETCHING DENT
PI = Bonding, Dental (1971-1976)
PI = Dental Enamel (1966-1976)
PI = Phosphoric Acids (1968-1976)
MS = Preparation of TOOTH surfaces and DENTAL MATERIALS with etching agents, usually phosphoric acid, to roughen the surface to increase adhesion or osteointegration.
PM = 91; was see under BONDING, DENTAL 1977-90
HN = 91(77); was see under BONDING, DENTAL 1977-90
CATSH = CAT LIST
MR = 20070709
DA = 19760413
DC = 1
DX = 19910101
UI = D000134

*NEWRECORD
RECTYPE = D
MH = Acid Phosphatase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Acid beta-Glycerophosphatase|T116|T126|NON|NRW|UNK (19XX)|810427|abbcdef
ENTRY = Acid beta Glycerophosphatase
MN = D08.811.277.352.650.025
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = Orthophosphoric-monoester phosphohydrolase (acid optimum)
RN = EC 3.1.3.2
RR = 9001-77-8 (CAS RN)
AN = /defic permitted: TN 222; prostate-specific acid phosphatase (PROSTATE + ACID PHOSPHATASE): do not confuse with PROSTATE-SPECIFIC ANTIGEN, a serine proteinase
MS = An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2.
OL = use ACID PHOSPHATASE to search BLOOD ACID PHOSPHATASE 1966-67
PM = /blood was BLOOD ACID PHOSPHATASE 1963-67
HN = /blood was BLOOD ACID PHOSPHATASE 1963-67
MR = 20030709
DA = 19990101
DC = 1
UI = D000135

*NEWRECORD
RECTYPE = D
MH = Acid-Base Equilibrium
AQ = DE GE IM PH RE
PRINT ENTRY = Anion Gap|T034|T070|NON|REL|UNK (19XX)|800509|abbcdef
ENTRY = Acid-Base Balance|T042|NON|EQV|NLM (1996)|941031|abcdef
ENTRY = Acid Base Balance
ENTRY = Acid Base Equilibrium
ENTRY = Anion Gaps
ENTRY = Balance, Acid-Base
ENTRY = Equilibrium, Acid-Base
ENTRY = Gap, Anion
ENTRY = Gaps, Anion
MN = G02.111.029
MN = G02.300.176
MN = G03.030
MN = G07.700.345.110
MN = G09.188.050
FX = Acidosis
FX = Alkalosis
FX = Buffers
FX = Hydrogen-Ion Concentration
MH_TH = NLM (1966)
ST = T042
AN = consider also ACID-BASE IMBALANCE
MS = The balance between acids and bases in the BODY FLUIDS. The pH (HYDROGEN-ION CONCENTRATION) of the arterial BLOOD provides an index for the total body acid-base balance.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000136

*NEWRECORD
RECTYPE = D
MH = Acid-Base Imbalance
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Acid Base Imbalance
ENTRY = Acid-Base Imbalances
ENTRY = Imbalance, Acid-Base
ENTRY = Imbalances, Acid-Base
MN = C18.452.076
MH_TH = NLM (1976)
ST = T046
PI = Acid-Base Equilibrium (1966-1975)
MS = Disturbances in the ACID-BASE EQUILIBRIUM of the body.
PM = 76
HN = 76; was NON MESH before 1976
CATSH = CAT LIST
MR = 19910617
DA = 19750725
DC = 1
DX = 19760101
UI = D000137

*NEWRECORD
RECTYPE = D
MH = Acidosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Metabolic Acidosis|T046|T047|NON|NRW|NLM (2011)|100303|abbcdef
ENTRY = Acidoses
ENTRY = Acidoses, Metabolic
ENTRY = Acidosis, Metabolic
ENTRY = Metabolic Acidoses
MN = C18.452.076.176
MH_TH = NLM (1966)
ST = T046
ST = T047
AN = general or unspecified; prefer specifics
MS = A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000138

*NEWRECORD
RECTYPE = D
MH = Acidosis, Lactic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Lactic Acidosis|T046|T047|NON|EQV|UNK (19XX)|860418|abbcdef
MN = C18.452.076.176.180
FX = Hyperlactatemia
MH_TH = NLM (1987)
ST = T046
ST = T047
PI = Acidosis (1966-1986)
PI = Lactates (1966-1986)
MS = Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as DIABETES MELLITUS; LEUKEMIA; or LIVER FAILURE.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20140613
DA = 19860418
DC = 1
DX = 19870101
UI = D000140

*NEWRECORD
RECTYPE = D
MH = Acidosis, Renal Tubular
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Renal Tubular Acidosis|T047|NON|EQV|NLM (2007)|051027|abcdef
PRINT ENTRY = Renal Tubular Acidosis, Type I|T047|NON|NRW|NLM (2007)|051101|abcdef
PRINT ENTRY = Renal Tubular Acidosis, Type II|T047|NON|NRW|NLM (2007)|051101|abcdef
PRINT ENTRY = Type I Renal Tubular Acidosis|T047|NON|NRW|NLM (1998)|970519|abcdef
PRINT ENTRY = Type II Renal Tubular Acidosis|T047|NON|NRW|NLM (1998)|970519|abcdef
ENTRY = Acidosis, Renal Tubular, Type I|T047|NON|NRW|NLM (1998)|970519|abcdef
ENTRY = Acidosis, Renal Tubular, Type II|T047|NON|NRW|NLM (1998)|970519|abcdef
ENTRY = Autosomal Dominant Distal Renal Tubular Acidosis|T047|NON|NRW|ORD (2010)|121212|abcdef
ENTRY = Classic Distal Renal Tubular Acidosis|T047|NON|NRW|NLM (1998)|970519|abcdef
ENTRY = Distal Renal Tubular Acidosis|T047|NON|NRW|NLM (1998)|970519|abcdef
ENTRY = Proximal Renal Tubular Acidosis|T047|NON|NRW|NLM (1998)|970519|abcdef
ENTRY = RTA, Classic Type|T047|ABX|NRW|OMIM (2013)|ORD (2010)|121212|abcdeef
ENTRY = RTA, Distal Type, Autosomal Dominant|T047|ABX|NRW|OMIM (2013)|ORD (2010)|121212|abcdeef
ENTRY = RTA, Gradient Type|T047|ABX|NRW|OMIM (2013)|ORD (2010)|121212|abcdeef
ENTRY = RTA, Proximal Type|T047|ABX|NRW|OMIM (2013)|120607|abcdef
ENTRY = Renal Tubular Acidosis 1|T047|NON|NRW|ORD (2010)|121212|abcdef
ENTRY = Renal Tubular Acidosis I|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Renal Tubular Acidosis II|T047|NON|NRW|OMIM (2013)|120607|abcdef
ENTRY = Renal Tubular Acidosis, Distal, Autosomal Dominant|T047|NON|NRW|NLM (2007)|OMIM (2013)|ORD (2010)|051101|abcdeeef
ENTRY = Renal Tubular Acidosis, Proximal|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Renal Tubular Acidosis, Proximal, with Ocular Abnormalities|T047|NON|NRW|NLM (2007)|051101|abcdef
ENTRY = Classic Type RTA
ENTRY = Classic Type RTAs
ENTRY = Gradient Type RTA
ENTRY = Gradient Type RTAs
ENTRY = Proximal Type RTA
ENTRY = Proximal Type RTAs
ENTRY = RTAs, Classic Type
ENTRY = RTAs, Gradient Type
ENTRY = RTAs, Proximal Type
MN = C12.777.419.815.093
MN = C13.351.968.419.815.093
MN = C16.320.565.861.093
MN = C18.452.076.176.210
MN = C18.452.648.861.093
MH_TH = NLM (1965)
ST = T047
MS = A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D000141

*NEWRECORD
RECTYPE = D
MH = Acidosis, Respiratory
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Respiratory Acidosis|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Acidoses, Respiratory
ENTRY = Respiratory Acidoses
MN = C08.618.846.093
MN = C18.452.076.176.310
MH_TH = NLM (1967)
ST = T047
PI = Acidosis (1966)
MS = Respiratory retention of carbon dioxide. It may be chronic or acute.
PM = 67
HN = 67
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
DX = 19670101
UI = D000142

*NEWRECORD
RECTYPE = D
MH = Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.029
MH_TH = NLM (1966)
ST = T103
RN = 0
AN = GEN; avoid; do not use for specific acids, acid-fast bacteria, acid reactions, etc.
MS = Chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water (neutralization). An extension of the term includes substances dissolved in media other than water. (Grant & Hackh's Chemical Dictionary, 5th ed)
MR = 19970620
DA = 19990101
DC = 1
UI = D000143

*NEWRECORD
RECTYPE = D
MH = Acids, Acyclic
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acyclic Acids|T109|NON|EQV|NLM (1998)|961216|abcdef
MN = D02.241.081
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = GEN; prefer specifics; used for mapping supplementary chemicals
MS = Carboxylic acids that have open-chain molecular structures as opposed to ring-shaped structures.
PM = 98
HN = 98; use explode 1967-97
MR = 19970620
DA = 19990101
DC = 1
DX = 19980101
UI = D000144

*NEWRECORD
RECTYPE = D
MH = Acids, Aldehydic
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aldehydic Acids|T109|NON|EQV|NLM (1998)|961216|abcdef
MN = D02.241.152
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = GEN; prefer specifics; used for mapping supplementary chemicals
MS = Dicarboxylic acids in which one of the carboxyl groups (-COOH) has been replaced by an aldehyde group (-CHO).
PM = 98
HN = 98; use explode 1967-97
MR = 19970620
DA = 19990101
DC = 1
DX = 19980101
UI = D000145

*NEWRECORD
RECTYPE = D
MH = Acids, Carbocyclic
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carbocyclic Acids|T109|NON|EQV|NLM (1998)|961216|abcdef
MN = D02.241.223
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = GEN; prefer specifics; used for mapping supplementary chemicals; do not confuse with CARBOXYLIC ACIDS
MS = Carboxylic acids that have a homocyclic ring structure in which all the ring atoms are carbon.
PM = 98
HN = 98; use explode 1967-97
MR = 19980909
DA = 19990101
DC = 1
DX = 19980101
UI = D000146

*NEWRECORD
RECTYPE = D
MH = Acids, Heterocyclic
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Heterocyclic Acids|T109|NON|EQV|NLM (1998)|961216|abcdef
MN = D03.066
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = GEN; prefer specifics; used for mapping supplementary chemicals
MS = A class of acids containing a ring structure in which at least one atom other than CARBON is incorporated.
PM = 98
HN = 98; use explode 1967-97
MR = 20040719
DA = 19990101
DC = 1
DX = 19980101
UI = D000147

*NEWRECORD
RECTYPE = D
MH = Acids, Noncarboxylic
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Noncarboxylic Acids|T197|NON|EQV|NLM (1998)|961216|abcdef
MN = D01.029.260
MH_TH = NLM (1966)
ST = T197
RN = 0
AN = GEN; prefer specifics; used for mapping supplementary chemicals
MS = Inorganic acids with a non metal, other than carbon, attached to hydrogen, or an acid radical containing no carbon.
PM = 98
HN = 98; use explode 1968-97
MR = 19970620
DA = 19990101
DC = 1
DX = 19980101
UI = D000148

*NEWRECORD
RECTYPE = D
MH = Acidulated Phosphate Fluoride
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Phosphate Fluoride, Acidulated|T122|T197|NON|EQV|UNK (19XX)|760414|abbcdef
ENTRY = Acid Phosphate Fluoride|T122|T197|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Fluoride, Acid Phosphate
ENTRY = Fluoride, Acidulated Phosphate
MN = D01.029.260.700.675.374.025
MN = D01.303.350.300.875.050
MN = D01.695.625.675.650.025
MN = D01.857.725.050
MN = D25.223.015
MN = J01.637.051.223.015
MH_TH = NLM (1977)
ST = T122
ST = T197
N1 = Phosphoric acid, mixt. with sodium fluoride (NaF)
RN = 39456-59-2
PI = Fluorides (1966-1976)
PI = Fluorides, Topical (1966-1976)
PI = Phosphates (1966-1976)
MS = A sodium fluoride solution, paste or powder, which has been acidulated to pH 3 to 4 and buffered with a phosphate. It is used in the prevention of dental caries.
PM = 91; was see under SODIUM FLUORIDE 1984-90; was see under FLUORIDES 1977-83
HN = 91(77); was see under SODIUM FLUORIDE 1984-90; was see under FLUORIDES 1977-83
MR = 20130708
DA = 19760416
DC = 1
DX = 19910101
UI = D000149

*NEWRECORD
RECTYPE = D
MH = Acinetobacter
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Herellea|T007|NON|NRW|NLM (1992)|910402|abcdef
PRINT ENTRY = Mima|T007|NON|NRW|NLM (1992)|910402|abcdef
MN = B03.440.400.425.537.050
MN = B03.660.250.530.050
MH_TH = NLM (1975)
ST = T007
AN = infection = ACINETOBACTER INFECTIONS
PI = Alcaligenes (1974)
MS = A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity.
OL = search ALCALIGENES 1974; use ACINETOBACTER to search MIMAE 1966-91, HERELLA 1976-91, & COLLOIDES 1976-91
PM = 76; was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91
HN = 76(75); was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91
MR = 20090706
DA = 19990101
DC = 1
DX = 19760101
UI = D000150

*NEWRECORD
RECTYPE = D
MH = Acinetobacter Infections
DE = ACINETOBACTER INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Mimae Infections|T047|NON|EQV|UNK (19XX)|760414|MIMAE INFECT|abcdefv
ENTRY = Infections, Acinetobacter|T047|NON|EQV|NLM (1992)|910228|INFECT ACINETOBACTER|abcdefv
ENTRY = Infections, Mimae|T047|NON|EQV|NLM (1992)|910228|INFECT MIMAE|abcdefv
ENTRY = Acinetobacter Infection
ENTRY = Infection, Acinetobacter
ENTRY = Infection, Mimae
ENTRY = Mimae Infection
MN = C01.252.400.560.022
MH_TH = NLM (1977)
ST = T047
AN = gram-neg bact infect
PI = Acinetobacter (1966-1967)
MS = Infections with bacteria of the genus ACINETOBACTER.
OL = use ACINETOBACTER INFECTIONS to search MIMAE INFECTIONS 1968-76
PM = 77; was MIMAE INFECTIONS 1968-76
HN = 77; was MIMAE INFECTIONS 1968-76
CATSH = CAT LIST
MR = 20030709
DA = 19760416
DC = 1
DX = 19770101
UI = D000151

*NEWRECORD
RECTYPE = D
MH = Acne Vulgaris
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Acne|T047|NON|EQV|NLM (1993)|920402|abcdef
MN = C17.800.030.150
MN = C17.800.794.111
FX = Hidradenitis Suppurativa
MH_TH = POPLINE (1978)
ST = T047
AN = an acneiform eruption
MS = A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.
OL = use ACNE VULGARIS to search ACNE 1966-92
PM = 93; was ACNE 1963-92
HN = 93; was ACNE 1963-92
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D000152

*NEWRECORD
RECTYPE = D
MH = Acne Keloid
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Keloidal Acne|T047|NON|EQV|NLM (1993)|920406|abcdef
ENTRY = Acne Keloidalis|T047|NON|EQV|NLM (1993)|920406|abcdef
ENTRY = Dermatitis Papillaris Capillitii|T047|NON|EQV|NLM (2016)|150508|abcdef
ENTRY = Folliculitis Keloidalis|T047|NON|EQV|NLM (1993)|920406|abcdef
ENTRY = Folliculitis Keloidalis Nuchae|T047|NON|EQV|NLM (2016)|150508|abcdef
ENTRY = Lichen Keloidalis Nuchae|T047|NON|EQV|NLM (2016)|150508|abcdef
ENTRY = Nuchal Keloid Acne|T047|NON|EQV|NLM (2016)|150508|abcdef
ENTRY = Acne Keloids
ENTRY = Acne, Keloidal
ENTRY = Acne, Nuchal Keloid
ENTRY = Acnes, Nuchal Keloid
ENTRY = Capillitii, Dermatitis Papillaris
ENTRY = Capillitius, Dermatitis Papillaris
ENTRY = Dermatitis Papillaris Capillitius
ENTRY = Keloid Acne, Nuchal
ENTRY = Keloid Acnes, Nuchal
ENTRY = Keloid, Acne
ENTRY = Keloidal Acnes
ENTRY = Keloidalis Nuchae, Folliculitis
ENTRY = Keloidalis Nuchae, Lichen
ENTRY = Keloids, Acne
ENTRY = Nuchae, Folliculitis Keloidalis
ENTRY = Nuchae, Lichen Keloidalis
ENTRY = Nuchal Keloid Acnes
ENTRY = Papillaris Capillitii, Dermatitis
ENTRY = Papillaris Capillitius, Dermatitis
MN = A10.165.450.300.425.125
MN = C17.300.200.425.125
MN = C17.800.030.030
MN = C17.800.329.500.261
MH_TH = NLM (1975)
ST = T047
AN = acneiform eruption with keloid scarring
MS = A type of acneiform disorder in which secondary pyogenic infection in and around pilosebaceous structures ends in keloidal scarring. It manifests as persistent folliculitis of the back of the neck associated with occlusion of the follicular orifices. It is most often encountered in black or Asian men.
OL = search FOLLICULITIS 1966-74
PM = 91; was see under FOLLICULITIS 1975-90
HN = 91(75); was see under FOLLICULITIS 1975-90
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19910101
UI = D000153

*NEWRECORD
RECTYPE = D
MH = Aconitate Hydratase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aconitase|T116|T126|NON|EQV|UNK (19XX)|770401|abbcdef
PRINT ENTRY = Citrate Hydro-Lyase|T116|T126|NON|EQV|UNK (19XX)|770517|abbcdef
PRINT ENTRY = Isocitrate Hydro-Lyase|T116|T126|NON|EQV|UNK (19XX)|770517|abbcdef
ENTRY = Citrate Hydrolyase|T116|T126|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Citrate Hydro Lyase
ENTRY = Hydratase, Aconitate
ENTRY = Hydro-Lyase, Citrate
ENTRY = Hydro-Lyase, Isocitrate
ENTRY = Hydrolyase, Citrate
ENTRY = Isocitrate Hydro Lyase
MN = D08.811.520.241.300.050
MH_TH = NLM (1973)
ST = T116
ST = T126
N1 = Citrate(isocitrate) hydro-lyase
RN = EC 4.2.1.3
RR = 9024-25-3 (CAS RN)
PI = Hydro-Lyases (1966-1972)
MS = An enzyme that catalyzes the reversible hydration of cis-aconitate to yield citrate or isocitrate. It is one of the citric acid cycle enzymes. EC 4.2.1.3.
PM = 78; was see under HYDRO-LYASES 1975-77
HN = 78(73); was see under HYDRO-LYASES 1975-77
MR = 20030709
DA = 19990101
DC = 1
DX = 19780101
UI = D000154

*NEWRECORD
RECTYPE = D
MH = Aconitic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Achilleic Acid|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Aconitate|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Acontic Acid|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Adonic Acid|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Carboxyglutaconic Acid|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Citridic Acid|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Citridinic Acid|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Equisetic Acid|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Pyrocitric Acid|T109|T123|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Acid, Achilleic
ENTRY = Acid, Aconitic
ENTRY = Acid, Acontic
ENTRY = Acid, Adonic
ENTRY = Acid, Carboxyglutaconic
ENTRY = Acid, Citridic
ENTRY = Acid, Citridinic
ENTRY = Acid, Equisetic
ENTRY = Acid, Pyrocitric
MN = D02.241.081.901.177
MH_TH = NLM (1975)
ST = T109
ST = T123
N1 = 1-Propene-1,2,3-tricarboxylic acid
RN = 499-12-7
PM = 91; was see under TRICARBOXYLIC ACIDS 1973-90
HN = 91(73); was see under TRICARBOXYLIC ACIDS 1973-90
MR = 19920507
DA = 19990101
DC = 1
DX = 19910101
UI = D000156

*NEWRECORD
RECTYPE = D
MH = Aconitine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetylbenzoylaconine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Acetylbenzoyl-aconine|T109|T121|NON|EQV|NLM (2005)|031112|abbcdef
ENTRY = Acetylbenzoyl aconine
MN = D02.455.849.291.037
MN = D03.132.030
PA = Adjuvants, Immunologic
PA = Voltage-Gated Sodium Channel Agonists
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Aconitane-3,8,13,14,15-pentol, 20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-, 8-acetate 14-benzoate, (1alpha,3alpha,6alpha,14alpha,15alpha,16beta)-
RN = X8YN71D5WC
RR = 302-27-2 (Aconitine)
AN = ACONITE (see ACONITUM) is also available
PI = Aconite (1972-1974)
MS = A C19 norditerpenoid alkaloid (DITERPENES) from the root of ACONITUM plants. It activates VOLTAGE-GATED SODIUM CHANNELS. It has been used to induce ARRHYTHMIAS in experimental animals and it has antiinflammatory and antineuralgic properties.
PM = 91; was see under ACONITE 1975-90
HN = 91(75); was see under ACONITE 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000157

*NEWRECORD
RECTYPE = D
MH = Acoustic Impedance Tests
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Audiometry, Impedance|T060|NON|BRD|UNK (19XX)|770420|abcdef
PRINT ENTRY = Electroacoustic Impedance Tests|T060|NON|NRW|UNK (19XX)|770420|abcdef
PRINT ENTRY = Impedance Tests, Acoustic|T060|NON|EQV|UNK (19XX)|770420|abcdef
PRINT ENTRY = Tympanometry|T060|NON|BRD|UNK (19XX)|770420|abcdef
ENTRY = Acoustic Impedance Test
ENTRY = Electroacoustic Impedance Test
ENTRY = Impedance Audiometry
ENTRY = Impedance Test, Acoustic
ENTRY = Impedance Test, Electroacoustic
ENTRY = Impedance Tests, Electroacoustic
ENTRY = Test, Acoustic Impedance
ENTRY = Test, Electroacoustic Impedance
ENTRY = Tests, Acoustic Impedance
ENTRY = Tests, Electroacoustic Impedance
MN = E01.370.382.375.050
MH_TH = NLM (1978)
ST = T060
AN = do not use /util except by MeSH definition
PI = Audiometry (1966-1977)
PI = Ear, Middle (1966-1977)
PI = Tympanic Membrane (1966-1977)
MS = Objective tests of middle ear function based on the difficulty (impedance) or ease (admittance) of sound flow through the middle ear. These include static impedance and dynamic impedance (i.e., tympanometry and impedance tests in conjunction with intra-aural muscle reflex elicitation). This term is used also for various components of impedance and admittance (e.g., compliance, conductance, reactance, resistance, susceptance).
PM = 78
HN = 78
CATSH = CAT LIST
MR = 19970620
DA = 19770422
DC = 1
DX = 19780101
UI = D000158

*NEWRECORD
RECTYPE = D
MH = Vestibulocochlear Nerve
AQ = AB AH BS CH CY DE EM EN GD IM ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Cranial Nerve VIII|T023|NON|EQV|NLM (1998)|960731|abcdef
PRINT ENTRY = Eighth Cranial Nerve|T023|NON|EQV|NLM (1998)|960731|abcdef
ENTRY = Cochleovestibular Nerve|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Statoacoustic Nerve|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Cochleovestibular Nerves
ENTRY = Cranial Nerve VIIIs
ENTRY = Cranial Nerve, Eighth
ENTRY = Cranial Nerves, Eighth
ENTRY = Eighth Cranial Nerves
ENTRY = Nerve VIIIs, Cranial
ENTRY = Nerve, Cochleovestibular
ENTRY = Nerve, Eighth Cranial
ENTRY = Nerve, Statoacoustic
ENTRY = Nerve, Vestibulocochlear
ENTRY = Nerves, Cochleovestibular
ENTRY = Nerves, Eighth Cranial
ENTRY = Nerves, Statoacoustic
ENTRY = Nerves, Vestibulocochlear
ENTRY = Statoacoustic Nerves
ENTRY = VIIIs, Cranial Nerve
ENTRY = Vestibulocochlear Nerves
MN = A08.800.800.120.910
EC = injuries:Vestibulocochlear Nerve Injuries
MH_TH = NLM (1994)
ST = T023
AN = neoplasm = VESTIBULOCOCHLEAR NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM) but note that NEUROMA, ACOUSTIC is also available
MS = The 8th cranial nerve. The vestibulocochlear nerve has a cochlear part (COCHLEAR NERVE) which is concerned with hearing and a vestibular part (VESTIBULAR NERVE) which mediates the sense of balance and head position. The fibers of the cochlear nerve originate from neurons of the SPIRAL GANGLION and project to the cochlear nuclei (COCHLEAR NUCLEUS). The fibers of the vestibular nerve arise from neurons of Scarpa's ganglion and project to the VESTIBULAR NUCLEI.
PM = 2000; see ACOUSTIC NERVE 1963-1999; for VESTIBULOCOCHLEAR NERVE see ACOUSTIC NERVE 1963-1999
HN = 2000(1963)
MR = 20140613
DA = 19990101
DC = 1
UI = D000159

*NEWRECORD
RECTYPE = D
MH = Vestibulocochlear Nerve Diseases
DE = VESTIBULOCOCHLEAR NERVE DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Acoustic Nerve Diseases|T047|NON|NRW|NLM (1979)|990101|ACOUSTIC NERVE DIS|abcdefv
PRINT ENTRY = Cochlear Nerve Diseases|T047|NON|NRW|NLM (2000)|991103|COCHLEAR NERVE DIS|abcdefv
PRINT ENTRY = Cranial Nerve VIII Diseases|T047|NON|EQV|NLM (2000)|991103|CRANIAL NERVE VIII DIS|abcdefv
PRINT ENTRY = Vestibular Nerve Diseases|T047|NON|NRW|NLM (2000)|991103|VESTIBULAR NERVE DIS|abcdefv
ENTRY = Acoustic Nerve Disorders|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cochlear Nerve Disorders|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cochlear Neuritis|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cranial Nerve VIII Disorders|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Eighth Cranial Nerve Diseases|T047|NON|EQV|NLM (2000)|991103|EIGHTH CRANIAL NERVE DIS|abcdefv
ENTRY = Vestibular Nerve Disorders|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Acoustic Nerve Disease
ENTRY = Acoustic Nerve Disorder
ENTRY = Cochlear Nerve Disease
ENTRY = Cochlear Nerve Disorder
ENTRY = Cochlear Neuritides
ENTRY = Neuritides, Cochlear
ENTRY = Neuritis, Cochlear
ENTRY = Vestibular Nerve Disease
ENTRY = Vestibular Nerve Disorder
ENTRY = Vestibulocochlear Nerve Disease
MN = C09.218.807.800
MN = C10.292.910
FX = Cranial Nerve Injuries
FX = Hearing Loss, Central
MH_TH = NLM (2000)
ST = T047
AN = coordinate IM with COCHLEAR NERVE (IM) for cochlear nerve disease or with VESTIBULAR NERVE (IM) for vestibular nerve disease: neoplasms: coordinate IM with CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM); DF: ACOUSTIC NERVE DIS
PI = Acoustic Nerve (1966-1978)
PI = Cochlear Nerve (1966-1978)
PI = Peripheral Nerve Diseases (1966-1978)
PI = Vestibular Nerve (1966-1978)
MS = Pathological processes of the VESTIBULOCOCHLEAR NERVE, including the branches of COCHLEAR NERVE and VESTIBULAR NERVE. Common examples are VESTIBULAR NEURITIS, cochlear neuritis, and ACOUSTIC NEUROMA. Clinical signs are varying degree of HEARING LOSS; VERTIGO; and TINNITUS.
PM = 2000; see ACOUSTIC NERVE DISEASES 1980-1999, use PERIPHERAL NERVE DISEASES 1979
HN = 2000(1979)
CATSH = CAT LIST
MR = 20070709
DA = 19780522
DC = 1
DX = 19800101
UI = D000160

*NEWRECORD
RECTYPE = D
MH = Acoustic Stimulation
AQ = AE CL CT EC ED ES HI IS LJ MA MO MT NU OG PX SN ST TD UT VE
PRINT ENTRY = Auditory Stimulation|T060|T061|NON|EQV|NLM (1992)|901002|abbcdef
PRINT ENTRY = Stimulation, Acoustic|T060|T061|NON|EQV|UNK (19XX)|760422|abbcdef
PRINT ENTRY = Stimulation, Auditory|T060|T061|NON|EQV|NLM (1992)|901002|abbcdef
MN = E02.037
MN = E02.190.888.030
MN = E05.723.136
FX = Evoked Potentials, Auditory
FX = Music Therapy
MH_TH = NLM (1973)
ST = T060
ST = T061
PI = Sound (1966-1971)
MS = Use of sound to elicit a response in the nervous system.
PM = 73
HN = 73(72)
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000161

*NEWRECORD
RECTYPE = D
MH = Acoustics
AQ = IS
ENTRY = Acoustic
MN = H01.671.031
FX = Psychoacoustics
FX = Speech Acoustics
MH_TH = NLM (1966)
ST = T070
AN = in speech & hearing research & for the environment (home, hospital, facilities, theater, etc.)
MS = The branch of physics that deals with sound and sound waves. In medicine it is often applied in procedures in speech and hearing studies. With regard to the environment, it refers to the characteristics of a room, auditorium, theatre, building, etc. that determines the audibility or fidelity of sounds in it. (From Random House Unabridged Dictionary, 2d ed)
MR = 19950313
DA = 19990101
DC = 1
UI = D000162

*NEWRECORD
RECTYPE = D
MH = Acquired Immunodeficiency Syndrome
DE = ACQUIRED IMMUNODEFIC SYNDROME
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = AIDS|T047|ABB|EQV|BIOETHICS (1983)|830318|abcdef
PRINT ENTRY = Immunodeficiency Syndrome, Acquired|T047|NON|EQV|UNK (19XX)|830318|IMMUNODEFIC SYNDROME ACQUIRED|abcdefv
PRINT ENTRY = Immunologic Deficiency Syndrome, Acquired|T047|NON|EQV|UNK (19XX)|830318|IMMUNOL DEFIC SYNDROME ACQUIRED|abcdefv
ENTRY = Acquired Immune Deficiency Syndrome|T047|NON|EQV|NLM (1986)|851024|ACQUIRED IMMUNE DEFIC SYNDROME|abcdefv
ENTRY = Acquired Immuno-Deficiency Syndrome|T047|NON|EQV|UNK (19XX)|830318|ACQUIRED IMMUNO DEFIC SYNDROME|abcdefv
ENTRY = Acquired Immuno Deficiency Syndrome
ENTRY = Acquired Immuno-Deficiency Syndromes
ENTRY = Acquired Immunodeficiency Syndromes
ENTRY = Immuno-Deficiency Syndrome, Acquired
ENTRY = Immuno-Deficiency Syndromes, Acquired
ENTRY = Immunodeficiency Syndromes, Acquired
ENTRY = Syndrome, Acquired Immuno-Deficiency
ENTRY = Syndrome, Acquired Immunodeficiency
ENTRY = Syndromes, Acquired Immuno-Deficiency
ENTRY = Syndromes, Acquired Immunodeficiency
MN = C02.782.815.616.400.040
MN = C02.800.801.400.040
MN = C02.839.040
MN = C20.673.480.040
FX = AIDS Arteritis, Central Nervous System
FX = AIDS Dementia Complex
FX = AIDS Serodiagnosis
FX = HIV Seropositivity
FX = HIV Seroprevalence
FX = Lymphoma, AIDS-Related
MH_TH = POPLINE (1986)
ST = T047
AN = caused by HIV; coord IM with HIV-1 or HIV-2 (IM) if pertinent; /epidemiol: consider also HIV SEROPREVALENCE; AIDS-RELATED OPPORTUNISTIC INFECTIONS is available if particularly discussed: see note there; for lymphoma with AIDS, use LYMPHOMA, AIDS-RELATED
PI = Immunologic Deficiency Syndromes (1979-1982)
MS = An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
PM = 83
HN = 83
CATSH = CAT LIST
MR = 20040713
DA = 19830318
DC = 1
DX = 19830101
UI = D000163

*NEWRECORD
RECTYPE = D
MH = Acremonium
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Cephalosporium|T004|NON|EQV|UNK (19XX)|850211|abcdef
ENTRY = Acremoniums
ENTRY = Cephalosporiums
MN = B01.300.381.025
MH_TH = NLM (1966)
ST = T004
AN = infection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)
MS = A mitosporic fungal genus with many reported ascomycetous teleomorphs. Cephalosporin antibiotics are derived from this genus.
PM = 86; see CEPHALOSPORIUM 1963-85
HN = 86(63)
MR = 20110624
DA = 19990101
DC = 1
UI = D000164

*NEWRECORD
RECTYPE = D
MH = Acridine Orange
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Tetramethyl Acridine Diamine|T109|T130|NON|EQV|UNK (19XX)|780201|abbcdef
ENTRY = 3,6-Bis(dimethylamino)acridine|T109|T130|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Acridine Orange Base|T109|T130|EQV|NLM (1999)|990913|abbdef
ENTRY = Basic Orange 3RN|T109|T130|LAB|NRW|NLM (1992)|910220|abbcdef
ENTRY = C.I. 46005|T109|T130|LAB|NRW|NLM (1992)|910220|abbcdef
ENTRY = C.I. Basic Orange 14|T109|T130|LAB|NRW|NLM (1992)|910220|abbcdef
ENTRY = Euchrysine|T109|T130|NON|EQV|FDA SRS (2014)|NLM (2014)|130205|abbcdeef
ENTRY = N,N,N',N'-Tetramethyl-3,6-Acridinediamine Hydrochloride|T109|T130|NON|NRW|NLM (2014)|130205|abbcdef
ENTRY = Rhoduline Orange|T109|T130|NON|EQV|FDA SRS (2014)|NLM (1992)|910220|abbcdeef
ENTRY = Acridine Diamine, Tetramethyl
ENTRY = Base, Acridine Orange
ENTRY = Diamine, Tetramethyl Acridine
ENTRY = Orange 3RN, Basic
ENTRY = Orange Base, Acridine
ENTRY = Orange, Acridine
ENTRY = Orange, Rhoduline
MN = D03.494.046.250.150
PA = Fluorescent Dyes
PA = Mutagens
MH_TH = FDA SRS (2014)
MH_TH = NLM (1979)
ST = T109
ST = T130
RN = F30N4O6XVV
RR = 494-38-2 (Acridine Orange)
RR = 65-61-2 (N,N,N',N'-Tetramethyl-3,6-Acridinediamine Hydrochloride)
PI = Acridines (1966-1978)
PI = Dimethylamines (1974)
MS = A cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms.
PM = 1979; EUCHRYSINE was indexed under AMINOACRIDINES 1979-1980
HN = 1979
MR = 20130708
DA = 19780201
DC = 1
DX = 19790101
UI = D000165

*NEWRECORD
RECTYPE = D
MH = Acridines
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
MN = D03.494.046
MH_TH = POPLINE (1984)
ST = T109
RN = 0
AN = D25-26 qualif; acridinamines & acridinylamines = AMINOACRIDINES
MR = 19911102
DA = 19990101
DC = 1
UI = D000166

*NEWRECORD
RECTYPE = D
MH = Acriflavine
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Xanthacridinum|T109|T121|T130|NON|EQV|UNK (19XX)|761223|abbbcdef
ENTRY = 2,8-Diamino-10-Methylacridinium Chloride Mixture With 2,8-Diaminoacridine|T109|T121|T130|NON|EQV|NLM (2014)|130221|abbbcdef
MN = D03.494.046.250.177
PA = Anti-Infective Agents, Local
PA = Fluorescent Dyes
PA = Intercalating Agents
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T130
N1 = Acridinium, 3,6-diamino-10-methyl-, chloride, mixt. with 3,6-acridinediamine
RN = 1T3A50395T
RR = 65589-70-0 (cpd with unknown MF)
RR = 8048-52-0 (Acriflavine)
AN = D25-26 qualif
MS = 3,6-Diamino-10-methylacridinium chloride mixt. with 3,6-acridinediamine. Fluorescent dye used as a local antiseptic and also as a biological stain. It intercalates into nucleic acids thereby inhibiting bacterial and viral replication.
OL = search ACRIDINES 1966-74
PM = 91; was see under AMINOACRIDINES 1982-90; was see under ACRIDINES 1963-81
HN = 91(75); was see under AMINOACRIDINES 1982-90; was see under ACRIDINES 1963-81
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000167

*NEWRECORD
RECTYPE = D
MH = Acrocephalosyndactylia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Apert Syndrome|T019|EPO|NRW|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|840406|abcdeeeef
PRINT ENTRY = Pfeiffer Syndrome|T019|EPO|NRW|GHR (2014)|NLM (1997)|OMIM (2013)|ORD (2010)|950926|abcdeeeef
PRINT ENTRY = Saethre-Chotzen Syndrome|T019|T047|EPO|NRW|GHR (2014)|NLM (1997)|OMIM (2013)|ORD (2010)|960620|abbcdeeeef
ENTRY = Acrocephalosyndactyly (Apert)|T019|EPO|NRW|NLM (2014)|130418|abcdef
ENTRY = Acrocephalosyndactyly III|T019|T047|NON|NRW|GHR (2014)|130503|abbcdef
ENTRY = Acrocephalosyndactyly, Type 1|T019|NON|NRW|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Acrocephalosyndactyly, Type 3|T019|T047|NON|NRW|NLM (2012)|ORD (2010)|101222|abbcdeef
ENTRY = Acrocephalosyndactyly, Type I|T019|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Acrocephalosyndactyly, Type II|T019|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Acrocephalosyndactyly, Type III|T019|T047|NON|NRW|GHR (2014)|OMIM (2013)|120606|abbcdeef
ENTRY = Acrocephalosyndactyly, Type V|T019|NON|NRW|GHR (2014)|OMIM (2013)|111115|abcdeef
ENTRY = Acrocephaly, Skull Asymmetry, and Mild Syndactyly|T019|T047|NON|NRW|GHR (2014)|NLM (2012)|OMIM (2013)|ORD (2010)|101222|abbcdeeeef
ENTRY = Apert-Crouzon Disease|T019|EPO|NRW|NLM (2011)|OMIM (2013)|ORD (2010)|100415|abcdeeef
ENTRY = Chotzen Syndrome|T019|T047|EPO|NRW|GHR (2014)|NLM (2012)|OMIM (2013)|ORD (2010)|101222|abbcdeeeef
ENTRY = Craniofacial-Skeletal-Dermatologic Dysplasia|T019|NON|NRW|GHR (2014)|OMIM (2013)|111115|abcdeef
ENTRY = Dysostosis Craniofacialis with Hypertelorism|T019|T047|NON|NRW|NLM (2014)|130418|abbcdef
ENTRY = Kurczynski Casperson Syndrome|T019|EPO|EQV|NLM (2011)|ORD (2010)|100414|abcdeef
ENTRY = Noack Syndrome|T019|NON|NRW|GHR (2014)|OMIM (2013)|111115|abcdeef
ENTRY = Syndactylic Oxycephaly|T019|NON|NRW|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Acrocephalosyndactylias
ENTRY = Acrocephalosyndactylies, Type 1
ENTRY = Acrocephalosyndactylies, Type 3
ENTRY = Acrocephalosyndactylies, Type I
ENTRY = Acrocephalosyndactylies, Type II
ENTRY = Acrocephalosyndactylies, Type III
ENTRY = Acrocephalosyndactylies, Type V
ENTRY = Acrocephalosyndactyly IIIs
ENTRY = Apert Crouzon Disease
ENTRY = Disease, Apert-Crouzon
ENTRY = Noack Syndromes
ENTRY = Saethre Chotzen Syndrome
ENTRY = Syndactylic Oxycephalies
ENTRY = Syndrome, Apert
ENTRY = Syndrome, Chotzen
ENTRY = Syndrome, Kurczynski Casperson
ENTRY = Syndrome, Noack
ENTRY = Syndrome, Pfeiffer
ENTRY = Syndrome, Saethre-Chotzen
ENTRY = Syndromes, Noack
ENTRY = Type I Acrocephalosyndactylies
ENTRY = Type I Acrocephalosyndactyly
ENTRY = Type II Acrocephalosyndactylies
ENTRY = Type II Acrocephalosyndactyly
ENTRY = Type III Acrocephalosyndactyly
ENTRY = Type V Acrocephalosyndactylies
ENTRY = Type V Acrocephalosyndactyly
MN = C05.116.099.370.894.232.015
MN = C05.116.099.370.894.819.100
MN = C05.660.207.240.100
MN = C05.660.585.800.100
MN = C05.660.906.364.100
MN = C05.660.906.819.100
MN = C16.131.621.207.240.100
MN = C16.131.621.585.800.100
MN = C16.131.621.906.364.100
MN = C16.131.621.906.819.100
FX = Receptor, Fibroblast Growth Factor, Type 2
FX = Twist Transcription Factor
MH_TH = NLM (1966)
ST = T019
MS = Congenital craniostenosis with syndactyly.
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D000168

*NEWRECORD
RECTYPE = D
MH = Acrodermatitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Gianotti-Crosti Syndrome|T047|EPO|NRW|NLM (1999)|ORD (2010)|980223|abcdeef
PRINT ENTRY = Infantile Papular Acrodermatitis|T047|NON|NRW|NLM (1999)|980223|abcdef
ENTRY = Acrodermatitis Papulosa Infantum|T047|NON|NRW|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Acropapulo-Vesicular Syndrome|T047|NON|NRW|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Erythemato-Vesiculo-Papulous Eruptive Syndrome|T047|NON|NRW|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Papular Acrodermatitis of Childhood|T047|NON|NRW|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Papulovesicular Acrolocated Syndrome|T047|NON|NRW|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Acrodermatitides
ENTRY = Acrodermatitis Papulosa Infantums
ENTRY = Acropapulo Vesicular Syndrome
ENTRY = Acropapulo-Vesicular Syndromes
ENTRY = Childhood Papular Acrodermatitides
ENTRY = Childhood Papular Acrodermatitis
ENTRY = Erythemato Vesiculo Papulous Eruptive Syndrome
ENTRY = Erythemato-Vesiculo-Papulous Eruptive Syndromes
ENTRY = Gianotti Crosti Syndrome
ENTRY = Infantile Papular Acrodermatitides
ENTRY = Papular Acrodermatitides, Infantile
ENTRY = Papular Acrodermatitis, Infantile
ENTRY = Papulovesicular Acrolocated Syndromes
ENTRY = Syndrome, Acropapulo-Vesicular
ENTRY = Syndrome, Erythemato-Vesiculo-Papulous Eruptive
ENTRY = Syndrome, Gianotti-Crosti
ENTRY = Syndromes, Acropapulo-Vesicular
ENTRY = Syndromes, Erythemato-Vesiculo-Papulous Eruptive
ENTRY = Syndromes, Papulovesicular Acrolocated
MN = C16.131.831.066
MN = C17.800.174.100
MN = C17.800.804.066
MH_TH = NLM (1966)
ST = T047
AN = dermatitis of hands or feet so do not bother to coord with HAND DERMATOSES or FOOT DERMATOSES unless particularly discussed
MS = Inflammation involving the skin of the extremities, especially the hands and feet. Several forms are known, some idiopathic and some hereditary. The infantile form is called Gianotti-Crosti syndrome.
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
UI = D000169

*NEWRECORD
RECTYPE = D
MH = Acrodynia
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Feer Disease|T037|EPO|EQV|UNK (19XX)|840615|FEER DIS|abcdefv
PRINT ENTRY = Pink Disease|T037|NON|EQV|UNK (19XX)|740329|PINK DIS|abcdefv
PRINT ENTRY = Swift Disease|T037|EPO|EQV|UNK (19XX)|840615|SWIFT DIS|abcdefv
ENTRY = Acrodynic Erythema|T037|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Chronic Childhood Mercurialism|T037|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Feer's Disease|T037|EPO|EQV|UNK (19XX)|740329|FEERS DIS|abcdefv
ENTRY = Swift's Disease|T037|EPO|EQV|UNK (19XX)|740329|SWIFTS DIS|abcdefv
ENTRY = Childhood Mercurialism, Chronic
ENTRY = Childhood Mercurialisms, Chronic
ENTRY = Chronic Childhood Mercurialisms
ENTRY = Erythema, Acrodynic
ENTRY = Feers Disease
ENTRY = Mercurialism, Chronic Childhood
ENTRY = Swifts Disease
MN = C10.668.829.025
MN = C10.720.475.600.150
MN = C25.723.647.500.100
MH_TH = NLM (1966)
ST = T037
MS = A condition seen primarily in childhood, most often resulting from chronic exposure to MERCURY COMPOUNDS which may result in encephalopathy and POLYNEUROPATHY. Clinical features include pain, swelling and pinkish discoloration of the fingers and toes, weakness in the extremities, extreme irritability, HYPERESTHESIA, and alterations in level of consciousness. (From Menkes, Textbook of Child Neurology, 5th ed, p603)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000170

*NEWRECORD
RECTYPE = D
MH = Acrolein
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-Propenal|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = Acraldehyde|T109|T130|NON|EQV|UNK (19XX)|800813|abbcdef
ENTRY = Acrylaldehyde|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = Acrylic Aldehyde|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = Allyl Aldehyde|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = Aqualin|T109|T130|TRD|NRW|UNK (19XX)|800813|abbcdef
ENTRY = Ethylene Aldehyde|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|800813|abbcdeef
ENTRY = 2 Propenal
ENTRY = Aldehyde, Acrylic
ENTRY = Aldehyde, Allyl
ENTRY = Aldehyde, Ethylene
MN = D02.047.122
MH_TH = FDA SRS (2014)
MH_TH = NLM (1973)
ST = T109
ST = T130
N1 = 2-Propenal
RN = 7864XYD3JJ
RR = 107-02-8 (Acrolein)
OL = search ALDEHYDES 1966-72
PM = 91; was see under ALDEHYDES 1973-90
HN = 91(73); was see under ALDEHYDES 1973-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000171

*NEWRECORD
RECTYPE = D
MH = Acromegaly
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)|T047|NON|EQV|NLM (2000)|991104|INAPPROPRIATE GROWTH HORMONE SECRET SYNDROME ACROMEGALY|abcdefv
PRINT ENTRY = Somatotropin Hypersecretion Syndrome (Acromegaly)|T047|NON|EQV|NLM (2000)|991104|SOMATOTROPIN HYPERSECRET SYNDROME ACROMEGALY|abcdefv
ENTRY = Inappropriate GH Secretion Syndrome (Acromegaly)|T047|NON|EQV|NLM (2000)|991104|INAPPROPRIATE GH SECRET SYNDROME ACROMEGALY|abcdefv
ENTRY = Hypersecretion Syndrome, Somatotropin (Acromegaly)
ENTRY = Hypersecretion Syndromes, Somatotropin (Acromegaly)
ENTRY = Somatotropin Hypersecretion Syndromes (Acromegaly)
ENTRY = Syndrome, Somatotropin Hypersecretion (Acromegaly)
ENTRY = Syndromes, Somatotropin Hypersecretion (Acromegaly)
MN = C05.116.132.082
MN = C10.228.140.617.738.250.100
MN = C19.700.355.179
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = coordinate with GROWTH HORMONE/secret in animals or HUMAN GROWTH HORMONE/secret in humans if pertinent
MS = A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000172

*NEWRECORD
RECTYPE = D
MH = Acromioclavicular Joint
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Acromioclavicular Joints
ENTRY = Joint, Acromioclavicular
ENTRY = Joints, Acromioclavicular
MN = A02.835.583.032
MH_TH = NLM (1975)
ST = T030
AN = dislocation: coord (IM) with DISLOCATIONS (IM)
PI = Shoulder Joint (1966-1974)
MS = The gliding joint formed by the outer extremity of the CLAVICLE and the inner margin of the acromion process of the SCAPULA.
OL = search SHOULDER JOINT 1966-74
PM = 79; was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64
HN = 79(75); was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64
MR = 19991108
DA = 19990101
DC = 1
DX = 19790101
UI = D000173

*NEWRECORD
RECTYPE = D
MH = Acromion
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
ENTRY = Acromions
MN = A02.835.232.087.783.261
MH_TH = NLM (1975)
ST = T023
AN = part of the scapula; fracture = ACROMION /inj (IM) + FRACTURES, BONE (IM), not SHOULDER FRACTURES
MS = The lateral extension of the spine of the SCAPULA and the highest point of the SHOULDER.
OL = search SCAPULA 1966-74
PM = 91; was see under SCAPULA 1975-90
HN = 91(75); was see under SCAPULA 1975-90
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D000174

*NEWRECORD
RECTYPE = D
MH = Acronine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Acronycine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Acronycin|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
MN = D03.132.032.077
MN = D03.494.046.109.077
PA = Antineoplastic Agents, Phytogenic
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1969)
ST = T109
ST = T121
N1 = 7H-Pyrano(2,3-c)acridin-7-one, 3,12-dihydro-6-methoxy-3,3,12-trimethyl-
RN = QE0G097358
RR = 7008-42-6 (Acronine)
AN = /biosyn permitted if by plant
PI = Acridines (1971-1974)
PI = Alkaloids (1971-1974)
MS = A pyrano-acridone alkaloid found in RUTACEAE plants.
PM = 91; was see under ALKALOIDS 1975-90
HN = 91(75); was see under ALKALOIDS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000175

*NEWRECORD
RECTYPE = D
MH = Acrosin
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acrosomal proteinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Akrosin|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = M beta-Acrosin|T116|T123|NON|NRW|UNK (19XX)|840918|abbcdef
ENTRY = M beta Acrosin
ENTRY = beta-Acrosin, M
ENTRY = proteinase, Acrosomal
MN = D08.811.277.656.300.760.030
MN = D08.811.277.656.959.350.030
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 3.4.21.10
PI = Peptide Peptidohydrolases (1973-1974)
MS = A trypsin-like enzyme of spermatozoa which is not inhibited by alpha 1 antitrypsin.
PM = 91; was see under SERINE PROTEINASES 1975-90
HN = 91(75); was see under SERINE ENDOPEPTIDASES 1975-90
MR = 20090706
DA = 19741119
DC = 1
DX = 19910101
UI = D000176

*NEWRECORD
RECTYPE = D
MH = Acrosome
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Acrosomes
MN = A05.360.490.890.820.100
MN = A11.284.430.214.190.875.190.550.040
MN = A11.497.760.400.100
FX = Acrosome Reaction
MH_TH = NLM (1975)
ST = T026
MS = The cap-like structure covering the anterior portion of SPERM HEAD. Acrosome, derived from LYSOSOMES, is a membrane-bound organelle that contains the required hydrolytic and proteolytic enzymes necessary for sperm penetration of the egg in FERTILIZATION.
PM = 91; was see under SPERMATOZOA 1975-90
HN = 91(75); was see under SPERMATOZOA 1975-90
MR = 20030709
DA = 19741111
DC = 1
DX = 19910101
UI = D000177

*NEWRECORD
RECTYPE = D
MH = Acrylamides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.065.122
MN = D02.241.081.069.094
MH_TH = NLM (1971)
ST = T109
RN = 0
AN = ACRYLAMIDE is also available
PI = Acrylates (1966-1970)
MS = Colorless, odorless crystals that are used extensively in research laboratories for the preparation of polyacrylamide gels for electrophoresis and in organic synthesis, and polymerization. Some of its polymers are used in sewage and wastewater treatment, permanent press fabrics, and as soil conditioning agents.
PM = 73
HN = 73(71)
MR = 19980610
DA = 19990101
DC = 1
DX = 19730101
UI = D000178

*NEWRECORD
RECTYPE = D
MH = Acrylates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.241.081.069
MH_TH = NLM (1966)
ST = T109
RN = 0
PM = 66
HN = 66
MR = 19920507
DA = 19990101
DC = 1
DX = 19660101
UI = D000179

*NEWRECORD
RECTYPE = D
MH = Acrylic Resins
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Resins, Acrylic
MN = D05.750.716.822.111
MN = D25.720.716.822.111
MN = J01.637.051.720.716.822.111
FX = Dental Materials
MH_TH = NLM (1966)
ST = T122
RN = 0
AN = D25-26 qualif
MR = 20060705
DA = 19990101
DC = 1
UI = D000180

*NEWRECORD
RECTYPE = D
MH = Acrylonitrile
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Vinyl Cyanide|T109|T131|NON|EQV|UNK (19XX)|760413|abbcdef
ENTRY = Cyanide, Vinyl
MN = D02.626.095
PA = Carcinogens
MH_TH = FDA SRS (2014)
MH_TH = NLM (1977)
ST = T109
ST = T131
N1 = 2-Propenenitrile
RN = MP1U0D42PE
RR = 107-13-1 (Acrylonitrile)
PI = Acrylates (1968-1976)
PI = Nitriles (1968-1976)
PI = Vinyl Compounds (1973-1976)
MS = A highly poisonous compound used widely in the manufacture of plastics, adhesives and synthetic rubber.
PM = 91; see NITRILES 1977-90
HN = 91(77)
MR = 20130708
DA = 19760413
DC = 1
DX = 19910101
UI = D000181

*NEWRECORD
RECTYPE = D
MH = ACTH Syndrome, Ectopic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Ectopic ACTH Syndrome|T047|EQV|UNK (19XX)|790529|abdef
ENTRY = ACTH Syndromes, Ectopic
ENTRY = Ectopic ACTH Syndromes
ENTRY = Syndrome, Ectopic ACTH
ENTRY = Syndromes, Ectopic ACTH
MN = C04.730.713.317
MH_TH = NLM (1980)
ST = T047
AN = caused by "ACTH production by non-pituitary neoplasms"; do not use /blood supply /chem /second /secret /ultrastruct; coord IM with precoord organ/neopl term with /secret (IM) + histol type of neopl /secret (IM)
PI = Adrenocorticotropic Hormone (1966-1979)
MS = Symptom complex due to ACTH production by non-pituitary neoplasms.
PM = 91; was see under NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1980-90
HN = 91(80); was see under NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1980-90
CATSH = CAT LIST
MR = 20040707
DA = 19790529
DC = 1
DX = 19910101
UI = D000182

*NEWRECORD
RECTYPE = D
MH = Actihaemyl
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Solcoseryl|T109|T121|T123|NON|EQV|UNK (19XX)|741111|abbbcdef
ENTRY = S 1021|T109|T121|T123|LAB|NRW|UNK (19XX)|800731|abbbcdef
ENTRY = 1021, S
MN = D20.777.050
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T123
N1 = Actihaemyl
RN = 37239-28-4
PI = Blood (1973-1974)
PI = Tissue Extracts (1973-1974)
MS = An extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics. Its exact composition is unknown. It has been proposed as a radiation-protective agent.
PM = 91; was see under TISSUE EXTRACTS 1975-90
HN = 91(75); was see under TISSUE EXTRACTS 1975-90
MR = 20050630
DA = 19741119
DC = 1
DX = 19910101
UI = D000183

*NEWRECORD
RECTYPE = D
MH = Acting Out
MN = F01.393.047
MH_TH = NLM (1968)
ST = T055
AN = no qualif
PI = Psychoanalytic Therapy (1966-1967)
MS = Expressing unconscious emotional conflicts or feelings, often of hostility or love, through overt behavior.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19680101
UI = D000184

*NEWRECORD
RECTYPE = D
MH = Actinin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = alpha-Actinin|T116|T123|NON|NRW|UNK (19XX)|840416|abbcdef
ENTRY = Eu-Actinin|T116|T123|NON|NRW|UNK (19XX)|810604|abbcdef
ENTRY = beta-Actinin|T116|T123|NON|NRW|UNK (19XX)|830330|abbcdef
ENTRY = Eu Actinin
ENTRY = alpha Actinin
ENTRY = beta Actinin
MN = D05.750.078.730.248
MN = D12.776.210.500.095
MN = D12.776.220.525.250
MH_TH = NLM (1976)
ST = T116
ST = T123
N1 = Actinins, alpha-
RN = 11003-00-2
AN = a muscle & microfilament protein; /biosyn /physiol permitted
PI = Muscle Proteins (1970-1975)
MS = A protein factor that regulates the length of R-actin. It is chemically similar, but immunochemically distinguishable from actin.
PM = 85; was see under MUSCLE PROTEINS 1976-84
HN = 85(76); was see under MUSCLE PROTEINS 1976-84
MR = 20060705
DA = 19750723
DC = 1
DX = 19850101
UI = D000185

*NEWRECORD
RECTYPE = D
MH = Actinium
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.268.271.100.033
MN = D01.268.556.025
MN = D01.552.020.042
MN = D01.552.544.025
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Actinium
RN = NIK1K0956U
RR = 7440-34-8 (Actinium)
AN = naturally radioactive; IM
MS = Actinium. A trivalent radioactive element and the prototypical member of the actinide family. It has the atomic symbol Ac, atomic number 89, and atomic weight 227.0278. Its principal isotope is 227 and decays primarily by beta-emission.
MR = 20150622
DA = 19990101
DC = 1
UI = D000186

*NEWRECORD
RECTYPE = D
MH = Actinobacillosis
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Actinobacilloses
MN = C01.252.400.700.030.178
MN = C22.039
MH_TH = NLM (1968)
ST = T047
AN = a vet dis entity caused by Actinobacillus lignieresii: do not confuse with ACTINOBACILLUS INFECTIONS; check tag ANIMALS
PI = Cattle Diseases (1966-1967)
MS = A disease characterized by suppurative and granulomatous lesions in the respiratory tract, upper alimentary tract, skin, kidneys, joints, and other tissues. Actinobacillus lignieresii infects cattle and sheep while A. equuli infects horses and pigs.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
DX = 19680101
UI = D000187

*NEWRECORD
RECTYPE = D
MH = Actinobacillus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.450.009
MN = B03.660.250.550.050
MH_TH = NLM (1966)
ST = T007
AN = infection = ACTINOBACILLUS INFECTIONS or ACTINOBACILLOSIS: see notes there
MS = A genus of PASTEURELLACEAE described as gram-negative, nonsporeforming, nonmotile, facultative anaerobes. Most members are found both as pathogens and commensal organisms in the respiratory, alimentary, and genital tracts of animals.
MR = 20130709
DA = 19990101
DC = 1
UI = D000188

*NEWRECORD
RECTYPE = D
MH = Actinobacillus Infections
DE = ACTINOBACILLUS INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Infections, Actinobacillus|T047|NON|EQV|NLM (1992)|910228|INFECT ACTINOBACILLUS|abcdefv
ENTRY = Actinobacillus Infection
ENTRY = Infection, Actinobacillus
MN = C01.252.400.700.030
MH_TH = NLM (1972)
ST = T047
AN = do not confuse with ACTINOBACILLOSIS, a specific vet dis entity caused by A. lignieresii
PI = Actinobacillosis (1968-1971)
PI = Actinobacillus (1966-1971)
MS = Infections with bacteria of the genus ACTINOBACILLUS.
PM = 72
HN = 72
CATSH = CAT LIST
MR = 19910617
DA = 19990101
DC = 1
DX = 19720101
UI = D000189

*NEWRECORD
RECTYPE = D
MH = Actinomyces
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.510.024.049.050.050
MN = B03.510.460.400.400.049.049.178
MH_TH = NLM (1966)
ST = T007
AN = a genus of the family ACTINOMYCETACEAE of the order ACTINOMYCETALES; infection = ACTINOMYCOSIS
MS = A genus of gram-positive, rod-shaped bacteria whose organisms are nonmotile. Filaments that may be present in certain species are either straight or wavy and may have swollen or clubbed heads.
MR = 20090706
DA = 19990101
DC = 1
UI = D000190

*NEWRECORD
RECTYPE = D
MH = Actinomycetaceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.510.024.049.050
MN = B03.510.460.400.400.049.049
MH_TH = NLM (1975)
ST = T007
AN = a family of the order ACTINOMYCETALES
PI = Actinomycetales (1966-1974)
MS = A family of bacteria including numerous parasitic and pathogenic forms.
PM = 75
HN = 75
MR = 20090706
DA = 19990101
DC = 1
DX = 19750101
UI = D000191

*NEWRECORD
RECTYPE = D
MH = Actinomycetales
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Corynebacteriaceae|T007|NON|NRW|UNK (1992)|910415|abcdef
PRINT ENTRY = Coryneform Group|T007|NON|REL|UNK (1992)|910415|abcdef
MN = B03.510.024.049
MH_TH = NLM (1967)
ST = T007
AN = infection = ACTINOMYCETALES INFECTIONS
MS = An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments.
OL = use ACTINOMYCETALES to search ACTINOMYCETES 1966; CORYNEBACTERIACEAE 1975-91; CORYNEFORM GROUP 1976-91
PM = 67; was ACTINOMYCETES 1963-66; CORYNEBACTERIACEAE was heading 1975-91 (see under CORYNEFORM GROUP 1976-90); CORYNEFORM GROUP was heading 1976-91
HN = 67; was ACTINOMYCETES 1963-66; CORYNEBACTERIACEAE was heading 1975-91 (see under CORYNEFORM GROUP 1976-90); CORYNEFORM GROUP was heading 1976-91
MR = 20090706
DA = 19990101
DC = 1
DX = 19670101
UI = D000192

*NEWRECORD
RECTYPE = D
MH = Actinomycetales Infections
DE = ACTINOMYCETALES INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Actinomycete Infections|T047|NON|EQV|UNK (19XX)|780322|ACTINOMYCETE INFECT|abcdefv
ENTRY = Infections, Actinomycetales|T047|NON|EQV|NLM (1992)|ORD (2010)|910321|INFECT ACTINOMYCETALES|abcdeefv
ENTRY = Infections, Actinomycete|T047|NON|EQV|NLM (1992)|910321|INFECT ACTINOMYCETE|abcdefv
ENTRY = Actinomycetales Infection
ENTRY = Actinomycete Infection
ENTRY = Infection, Actinomycetales
ENTRY = Infection, Actinomycete
MN = C01.252.410.040
MH_TH = NLM (1972)
MH_TH = ORD (2010)
ST = T047
AN = gram-pos bact infect by organism of the order ACTINOMYCETALES; do not confuse with ACTINOMYCOSIS, infection by genus ACTINOMYCES
PI = Actinomyces (1966-1971)
PI = Actinomycetales (1966-1971)
MS = Infections with bacteria of the order ACTINOMYCETALES.
OL = use ACTINOMYCETALES INFECTIONS to search ACTINOMYCETE INFECTIONS 1972-76
PM = 77; was ACTINOMYCETE INFECTIONS 1972-76
HN = 77; was ACTINOMYCETE INFECTIONS 1972-76
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D000193

*NEWRECORD
RECTYPE = D
MH = Actinomycosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Actinomyces Infections|T047|NON|EQV|NLM (1992)|910412|ACTINOMYCES INFECT|abcdefv
ENTRY = Infections, Actinomyces|T047|NON|EQV|NLM (1992)|910412|INFECT ACTINOMYCES|abcdefv
ENTRY = Actinomyces Infection
ENTRY = Actinomycoses
ENTRY = Infection, Actinomyces
MN = C01.252.410.040.137
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = bact infect, not fungal despite "-mycosis": = infection by genus ACTINOMYCES; do not confuse with ACTINOMYCETALES INFECTIONS, infection by order ACTINOMYCETALES; pulm actinomycosis = ACTINOMYCOSIS (IM) + LUNG DISEASES (IM), not LUNG DISEASES, FUNGAL
MS = Infections with bacteria of the genus ACTINOMYCES.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000196

*NEWRECORD
RECTYPE = D
MH = Actinomycosis, Cervicofacial
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Actinomycoses, Cervicofacial
ENTRY = Cervicofacial Actinomycoses
ENTRY = Cervicofacial Actinomycosis
MN = C01.252.410.040.137.262
MN = C01.252.825.110
MN = C01.539.800.720.110
MN = C17.800.838.765.110
MH_TH = NLM (1966)
ST = T047
AN = bact infect, not fungal despite "-mycosis": = infect by genus ACTINOMYCES
MS = A form of ACTINOMYCOSIS characterized by slow-growing inflammatory lesions of the lymph nodes that drain the mouth (lumpy jaw), reddening of the overlying skin, and intraperitoneal abscesses.
CATSH = CAT LIST
MR = 19940208
DA = 19990101
DC = 1
UI = D000197

*NEWRECORD
RECTYPE = D
MH = Spectinomycin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Actinospectacin|T109|T195|NON|EQV|FDA SRS (2014)|NLM (1993)|920312|abbcdeef
ENTRY = Adspec|T109|T195|TRD|EQV|US|060413|abbcdef
ENTRY = Aspen Brand of Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = CEVA Brand of Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = Chevita Brand of Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = Ferkel Spectam|T109|T195|TRD|NRW|DE|060413|abbcdef
ENTRY = Interpharm Brand of Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = Kempi|T109|T195|TRD|NRW|ES|060413|abbcdef
ENTRY = Osborn Brand of Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = Pharmacia Brand of Spectinomycin|T109|T195|NON|EQV|NLM (2007)|060413|abbcdef
ENTRY = Pharmacia Brand of Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = Pharmacia Spain Brand of Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = Pharmacia Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = Prospec|T109|TRD|NRW|US|060413|abcdef
ENTRY = Salmosan-T|T109|T195|TRD|NRW|DE|060413|abbcdef
ENTRY = Sanofi Brand of Spectinomycin Dihydrochloride|T109|T195|NON|NRW|NLM (2007)|060413|abbcdef
ENTRY = Spectam|T109|T195|TRD|NRW|DE|FR|IE|UK|US|810608|abbcdeeeeef
ENTRY = Spectinomycin Dihydrochloride, Anhydrous|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Spectinomycin Dihydrochloride, Pentahydrate|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Spectinomycin Hydrochloride|T109|T195|NON|NRW|FDA SRS (2014)|NLM (1993)|USAN (1962)|USP (19XX)|920312|abbcdeeeef
ENTRY = Stanilo|T109|T195|TRD|NRW|DE|060413|abbcdef
ENTRY = Trobicin|T109|T195|TRD|NRW|AU|FR|MX|US|861117|abbcdeeeef
ENTRY = Valdar Brand of Spectinomycin|T109|NON|NRW|NLM (2007)|060413|abcdef
ENTRY = Anhydrous Spectinomycin Dihydrochloride
ENTRY = Dihydrochloride, Pharmacia Spectinomycin
ENTRY = Salmosan T
ENTRY = SalmosanT
ENTRY = Spectam, Ferkel
ENTRY = Spectinomycin Dihydrochloride, Pharmacia
ENTRY = Spectinomycin Pharmacia Brand
ENTRY = Spectinomycin Valdar Brand
MN = D03.383.231.388.712
MN = D03.494.835
MN = D09.408.051.836
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = 4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2R-(2alpha,4abeta,5abeta,6beta,7beta,8beta,9alpha,9aalpha,10abeta))-
RN = 93AKI1U6QF
RR = 1695-77-8 (Spectinomycin)
RR = 21736-83-4 (di-HCl, anhydrous)
RR = 22189-32-8 (di-HCl, pentahydrate)
RR = HWT06H303Z
MS = An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.
OL = use SPECTINOMYCIN to search ACTINOSPECTACIN 1966-92 (as Prov 1966-72)
PM = 93; was ACTINOSPECTACIN 1965-92 (Prov 1965-72); SPECTINOMYCIN was see ACTINOSPECTACIN 1978-92
HN = 93; was ACTINOSPECTACIN 1973-92; SPECTINOMYCIN was see ACTINOSPECTACIN 1978-92
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D000198

*NEWRECORD
RECTYPE = D
MH = Actins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = F-Actin|T116|T123|NON|NRW|UNK (19XX)|850605|abbcdef
PRINT ENTRY = G-Actin|T116|T123|NON|NRW|UNK (19XX)|850605|abbcdef
ENTRY = Actin|T116|T123|NON|EQV|NLM (1982)|810512|abbcdef
ENTRY = Isoactin|T116|T123|NON|NRW|UNK (19XX)|831014|abbcdef
ENTRY = N-Actin|T116|T123|NON|NRW|NLM (1992)|910114|abbcdef
ENTRY = alpha-Actin|T116|T123|NON|NRW|UNK (19XX)|800730|abbcdef
ENTRY = alpha-Isoactin|T116|T123|NON|NRW|UNK (19XX)|840919|abbcdef
ENTRY = beta-Actin|T116|T123|NON|NRW|UNK (19XX)|800730|abbcdef
ENTRY = gamma-Actin|T116|T123|NON|NRW|UNK (19XX)|800730|abbcdef
ENTRY = F Actin
ENTRY = G Actin
ENTRY = N Actin
ENTRY = alpha Actin
ENTRY = alpha Isoactin
ENTRY = beta Actin
ENTRY = gamma Actin
MN = D05.750.078.730.250
MN = D12.776.210.500.100
MN = D12.776.220.525.255
MH_TH = NLM (1971)
ST = T116
ST = T123
RN = 0
PI = Muscle Proteins (1966-1970)
MS = Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle.
OL = use ACTINS to search ACTIN 1971-81 (as Prov 1971-72)
PM = 82; was ACTIN 1973-81
HN = 82; was ACTIN 1971-81 (Prov 1971-72)
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000199

*NEWRECORD
RECTYPE = D
MH = Action Potentials
AQ = DE ES GE IM PH RE
PRINT ENTRY = Spike Potentials|T043|NON|REL|NLM (1998)|961010|abcdef
ENTRY = Nerve Impulses|T043|NON|REL|NLM (2007)|051215|abcdef
ENTRY = Action Potential
ENTRY = Impulse, Nerve
ENTRY = Impulses, Nerve
ENTRY = Nerve Impulse
ENTRY = Potential, Action
ENTRY = Potential, Spike
ENTRY = Potentials, Action
ENTRY = Potentials, Spike
ENTRY = Spike Potential
MN = G04.580.100
MN = G07.265.750.100
MN = G11.561.570.100
FX = Neural Conduction
MH_TH = NLM (1967)
ST = T043
AN = do not confuse with SYNAPTIC POTENTIALS see SYNAPTIC TRANSMISSION
PI = Electrophysiology (1966)
MS = Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli.
PM = 68
HN = 68(67)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D000200

*NEWRECORD
RECTYPE = D
MH = Activation Analysis
DE = ACTIVATION ANAL
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Analysis, Activation|T059|NON|EQV|UNK (19XX)|860101|ANAL ACTIVATION|abcdefv
ENTRY = Activation Analyses
ENTRY = Analyses, Activation
MN = E05.196.039
MH_TH = NLM (1963)
ST = T059
AN = an anal chem technique; NIM; DF: ACTIVATION ANAL
MS = A method of chemical analysis based on the detection of characteristic radionuclides following a nuclear bombardment. It is also known as radioactivity analysis. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 67
HN = 67(63)
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19670101
UI = D000201

*NEWRECORD
RECTYPE = D
MH = Activator Appliances
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Andresen Appliance|T074|EPO|NRW|UNK (19XX)|741205|abcdef
PRINT ENTRY = Bionator|T074|TRD|NRW|UNK (19XX)|741205|abcdef
PRINT ENTRY = Orthodontic Appliances, Activator|T074|NON|EQV|UNK (19XX)|741205|abcdef
ENTRY = Function Activator|T074|NON|EQV|NLM (1993)|920127|abcdef
ENTRY = Harvold Activator|T074|EPO|NRW|NLM (1993)|920127|abcdef
ENTRY = Jasper Jumper|T074|EPO|NRW|NLM (1993)|920127|abcdef
ENTRY = Activator Appliance
ENTRY = Activator Orthodontic Appliance
ENTRY = Activator Orthodontic Appliances
ENTRY = Activator, Function
ENTRY = Activator, Harvold
ENTRY = Activators, Function
ENTRY = Appliance, Activator
ENTRY = Appliance, Activator Orthodontic
ENTRY = Appliance, Andresen
ENTRY = Appliances, Activator
ENTRY = Appliances, Activator Orthodontic
ENTRY = Bionators
ENTRY = Function Activators
ENTRY = Jumper, Jasper
ENTRY = Orthodontic Appliance, Activator
MN = E06.658.453.560.100
MN = E06.658.453.578.100
MH_TH = NLM (1975)
ST = T074
MS = Loose-fitting removable orthodontic appliances which redirect the pressures of the facial and masticatory muscles onto the teeth and their supporting structures to produce improvements in tooth arrangements and occlusal relations.
PM = 91; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1975-90
HN = 91(75); was see under ORTHODONTIC APPLIANCES, REMOVABLE 1975-90
CATSH = CAT LIST
MR = 20000621
DA = 19741212
DC = 1
DX = 19910101
UI = D000202

*NEWRECORD
RECTYPE = D
MH = Activities of Daily Living
AQ = CL PX
PRINT ENTRY = ADL|T056|T061|ABB|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Chronic Limitation of Activity|T080|NON|NRW|UNK (19XX)|780112|abcdef
PRINT ENTRY = Limitation of Activity, Chronic|T080|NON|NRW|UNK (19XX)|780112|abcdef
PRINT ENTRY = Self Care (Rehabilitation)|T056|NON|NRW|UNK (19XX)|800519|SELF CARE REHABIL|abcdefv
ENTRY = Activities, Daily Living|T056|T061|NON|EQV|NLM (1990)|890710|abbcdef
ENTRY = Activity, Daily Living
ENTRY = Care, Self (Rehabilitation)
ENTRY = Cares, Self (Rehabilitation)
ENTRY = Daily Living Activities
ENTRY = Daily Living Activity
ENTRY = Living Activities, Daily
ENTRY = Living Activity, Daily
ENTRY = Self Cares (Rehabilitation)
MN = E02.831.067
MN = I03.050
MN = N02.421.784.110
FX = Karnofsky Performance Status
FX = Sickness Impact Profile
MH_TH = NLM (1968)
ST = T056
ST = T061
PI = Rehabilitation (1966-1967)
MS = The performance of the basic activities of self care, such as dressing, ambulation, or eating.
OL = use ACTIVITIES OF DAILY LIVING to search SELF CARE 1979-80
PM = 68; SELF CARE (REHABILITATION) was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80
HN = 68; SELF CARE (REHABILITATION) was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80
CATSH = CAT LIST
MR = 20150629
DA = 19990101
DC = 1
DX = 19680101
UI = D000203

*NEWRECORD
RECTYPE = D
MH = Activity Cycles
AQ = DE ES GE IM PH RE
PRINT ENTRY = Ultradian Cycles|T079|NON|NRW|UNK (19XX)|850618|abcdef
ENTRY = Activity Cycle
ENTRY = Cycle, Activity
ENTRY = Cycle, Ultradian
ENTRY = Cycles, Activity
ENTRY = Cycles, Ultradian
ENTRY = Ultradian Cycle
MN = G07.180.562.190.025
MH_TH = NLM (1975)
ST = T079
AN = less than 24 hours
MS = Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system.
OL = search CIRCADIAN RHYTHM 1968-74
PM = 91; was see under CIRCADIAN RHYTHM 1975-90
HN = 91(75); was see under CIRCADIAN RHYTHM 1975-90
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D000204

*NEWRECORD
RECTYPE = D
MH = Actomyosin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D12.776.210.500.154
MH_TH = NLM (1971)
ST = T116
ST = T123
N1 = Actomyosins
RN = 9013-26-7
AN = a muscle protein; /biosyn /physiol permitted
PI = Muscle Proteins (1966-1970)
MS = A protein complex of actin and MYOSINS occurring in muscle. It is the essential contractile substance of muscle.
OL = search MUSCLE PROTEINS 1966-70
PM = 73; was see under MUSCLE PROTEINS 1963-72
HN = 73(71); was see under MUSCLE PROTEINS 1963-72
MR = 20010803
DA = 19990101
DC = 1
DX = 19730101
UI = D000205

*NEWRECORD
RECTYPE = D
MH = Actuarial Analysis
DE = ACTUARIAL ANAL
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Analysis, Actuarial|T057|NON|EQV|UNK (19XX)|780508|ANAL ACTUARIAL|abcdefv
ENTRY = Actuarial Analyses
ENTRY = Analyses, Actuarial
MN = E05.318.740.100
MN = N05.715.360.750.100
MN = N06.850.520.830.100
MH_TH = NLM (1979)
ST = T057
AN = IM; few qualif apply
MS = The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs.
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20080708
DA = 19780508
DC = 1
DX = 19790101
UI = D000206

*NEWRECORD
RECTYPE = D
MH = Acute Disease
DE = ACUTE DIS
AQ = CL EC EP MO NU PX RH TH
ENTRY = Acute Diseases
ENTRY = Disease, Acute
ENTRY = Diseases, Acute
MN = C23.550.291.125
MH_TH = NLM (1968)
ST = T047
AN = IM GEN only; usually NIM with specific dis IM; no qualif when NIM; Manual 23.16+
MS = Disease having a short and relatively severe course.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
DX = 19680101
UI = D000208

*NEWRECORD
RECTYPE = D
MH = Acute-Phase Proteins
AQ = AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acute-Phase Reactants|T116|T123|NON|EQV|UNK (19XX)|860414|abbcdef
PRINT ENTRY = Proteins, Acute-Phase|T116|T123|NON|EQV|UNK (19XX)|860414|abbcdef
PRINT ENTRY = Reactants, Acute-Phase|T116|T123|NON|EQV|UNK (19XX)|860414|abbcdef
ENTRY = Acute-Phase Glycoproteins|T116|T123|NON|NRW|UNK (19XX)|860414|abbcdef
ENTRY = Acute-Phase Protein|T116|T123|NON|EQV|NLM (1989)|891012|abbcdef
ENTRY = Acute Phase Glycoproteins
ENTRY = Acute Phase Protein
ENTRY = Acute Phase Proteins
ENTRY = Acute Phase Reactants
ENTRY = Glycoproteins, Acute-Phase
ENTRY = Protein, Acute-Phase
ENTRY = Proteins, Acute Phase
ENTRY = Reactants, Acute Phase
MN = D12.776.124.050
MH_TH = NLM (1987)
ST = T116
ST = T123
RN = 0
AN = blood proteins; /biosyn /drug eff /physiol permitted
PI = Blood Proteins (1966-1986)
PI = C-Reactive Protein (1966-1986)
PI = Glycoproteins (1966-1986)
MS = Proteins that are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumor markers.
PM = 87
HN = 87
MR = 19950602
DA = 19860414
DC = 1
DX = 19870101
UI = D000209

*NEWRECORD
RECTYPE = D
MH = Acute-Phase Reaction
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Acute-Phase State|T033|T046|NON|EQV|UNK (19XX)|860325|abbcdef
PRINT ENTRY = Reaction, Acute-Phase|T033|T046|NON|EQV|UNK (19XX)|860325|abbcdef
PRINT ENTRY = Response, Acute-Phase|T033|T046|NON|EQV|UNK (19XX)|860325|abbcdef
ENTRY = Acute Phase Reaction
ENTRY = Acute Phase State
ENTRY = Acute-Phase Response
ENTRY = Reaction, Acute Phase
ENTRY = Response, Acute Phase
ENTRY = State, Acute-Phase
MN = C23.550.470.099
MH_TH = NLM (1987)
ST = T033
ST = T046
AN = note category: in presence of a dis, use /etiol, not /compl
PI = Acute Disease (1968-1986)
PI = Inflammation (1966-1986)
MS = An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.
OL = use ACUTE-PHASE REACTION to search ACUTE PHASE REACTION 1987-91
PM = 92; was ACUTE PHASE REACTION 1987-91 (see under INFLAMMATION 1987-90)
HN = 92; was ACUTE PHASE REACTION 1987-91 (see under INFLAMMATION 1987-90)
CATSH = CAT LIST
MR = 19991103
DA = 19860325
DC = 1
DX = 19910101
UI = D000210

*NEWRECORD
RECTYPE = D
MH = Acyclovir
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acycloguanosine|T114|T121|NON|EQV|UNK (19XX)|820505|abbcdef
ENTRY = 9-((2-Hydroxyethoxy)methyl)guanine|T114|T121|NON|EQV|FDA SRS (2014)|NLM (1998)|961122|abbcdeef
ENTRY = Abello Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = Aci-Sanorania|T114|T121|TRD|NRW|DE|030418|abbcdef
ENTRY = Acic|T114|T121|TRD|NRW|DE|030418|abbcdef
ENTRY = Aciclobeta|T114|T121|TRD|NRW|DE|030418|abbcdef
ENTRY = Aciclostad|T114|T121|TRD|NRW|DE|030418|abbcdef
ENTRY = Aciclovir|T114|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|820505|abbcdeeef
ENTRY = Aciclovir Alonga|T114|T121|TRD|NRW|ES|030418|abbcdef
ENTRY = Aciclovir-Sanorania|T114|T121|TRD|NRW|DE|030418|abbcdef
ENTRY = Acifur|T114|T121|TRD|NRW|MX|030423|abbcdef
ENTRY = Acipen Solutab|T114|TRD|NRW|NL|030423|abcdef
ENTRY = Acivir|T114|T121|TRD|NRW|DE|030715|abbcdef
ENTRY = Activir|T114|T121|TRD|NRW|FR|030423|abbcdef
ENTRY = Acyclo-V|T114|T121|TRD|NRW|AU|030514|abbcdef
ENTRY = Acyclovir Sodium|T114|T121|NON|NRW|FDA SRS (2014)|USAN (1984)|940805|abbcdeef
ENTRY = Alcon Brand of Aciclovir|T114|NON|NRW|NLM (2004)|030605|abcdef
ENTRY = Alonga Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Alonga Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Alphapharm Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030514|abbcdef
ENTRY = Amrad Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = Antiherpes Creme|T114|T121|TRD|NRW|DE|030423|abbcdef
ENTRY = Avirax|T114|T121|TRD|NRW|CA|030514|abbcdef
ENTRY = Azupharma Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = Betapharm Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Britisfarma Brand of Aciclovir|T114|NON|NRW|NLM (2004)|030605|abcdef
ENTRY = Britisfarma Brand of Aciclovir Sodium Salt|T114|NON|NRW|NLM (2004)|030605|abcdef
ENTRY = Bull Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Cicloferon|T114|T121|TRD|NRW|MX|030605|abbcdef
ENTRY = Clonmel Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030605|abbcdef
ENTRY = Clonorax|T114|T121|TRD|NRW|IE|030605|abbcdef
ENTRY = Cusiviral|T114|TRD|NRW|ES|030605|abcdef
ENTRY = Dermapharm Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Fabrigen Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030514|abbcdef
ENTRY = Fustery Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030423|abbcdef
ENTRY = Genvir|T114|T121|TRD|NRW|NLM (2003)|020425|abbcdef
ENTRY = Glaxo Wellcome Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Glaxo Wellcome Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Grin Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = Grnenthal Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030605|abbcdef
ENTRY = Grnenthal Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030605|abbcdef
ENTRY = Herpetad|T114|T121|TRD|NRW|DE|030611|abbcdef
ENTRY = Herpofug|T114|T121|TRD|NRW|DE|030611|abbcdef
ENTRY = Herpotern|T114|T121|TRD|NRW|DE|030611|abbcdef
ENTRY = Herpoviric|T114|T121|TRD|NRW|DE|030616|abbcdef
ENTRY = Hexal Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Hexal Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Isavir|T114|T121|TRD|NRW|MX|030715|abbcdef
ENTRY = Isis Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030626|abbcdef
ENTRY = Kendrick Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = Laciken|T114|T121|TRD|NRW|MX|030616|abbcdef
ENTRY = Lichtenstein Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Liomont Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030605|abbcdef
ENTRY = Mann Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Mapox|T114|T121|TRD|NRW|DE|030616|abbcdef
ENTRY = Maynar|T114|T121|TRD|NRW|ES|030616|abbcdef
ENTRY = Menarini Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Menarini Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Milavir|T114|T121|TRD|NRW|ES|030616|abbcdef
ENTRY = Niddapharm Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = Novag Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = Novartis Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = Opthavir|T114|T121|TRD|NRW|MX|030616|abbcdef
ENTRY = Parke Davis Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Pensa Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Pensa Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Pharma Investi Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030626|abbcdef
ENTRY = Pisa Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Rentschler Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030611|abbcdef
ENTRY = Rentschler Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Sanorania Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Sanorania Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Stada Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Supraviran|T114|T121|TRD|NRW|DE|030605|abbcdef
ENTRY = TAD Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030611|abbcdef
ENTRY = Ursapharm Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030626|abbcdef
ENTRY = Viclovir|T114|T121|TRD|NRW|ES|030616|abbcdef
ENTRY = Vipral|T114|T121|TRD|NRW|ES|030626|abbcdef
ENTRY = Virax-Puren|T114|T121|TRD|NRW|DE|030626|abbcdef
ENTRY = Virherpes|T114|T121|TRD|NRW|ES|030715|abbcdef
ENTRY = Virmen|T114|T121|TRD|NRW|ES|030715|abbcdef
ENTRY = Virolex|T114|T121|TRD|NRW|NLM (1998)|961122|abbcdef
ENTRY = Virupos|T114|T121|TRD|NRW|DE|030626|abbcdef
ENTRY = Virzin|T114|T121|TRD|NRW|DE|030715|abbcdef
ENTRY = Warner Wellcome Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Warner-Lambert Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030423|abbcdef
ENTRY = Wellcome Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Wellcome Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030418|abbcdef
ENTRY = Wellcome-248U|T114|T121|LAB|NRW|UNK (19XX)|820505|abbcdef
ENTRY = Wolff Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030611|abbcdef
ENTRY = Yamanouchi Brand of Aciclovir|T114|NON|NRW|NLM (2004)|030423|abcdef
ENTRY = Zoliparin|T114|T121|TRD|NRW|DE|030715|abbcdef
ENTRY = Zovirax|T114|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|MX|NL|UK|UNK (19XX)|US|820505|abbcdeeeeeeeeeeef
ENTRY = Zovirax for Injection|T114|T121|TRD|NRW|CA|030605|abbcdef
ENTRY = Zyclir|T114|T121|TRD|NRW|AU|030616|abbcdef
ENTRY = Zyma Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030616|abbcdef
ENTRY = aciclovir von ct|T114|T121|TRD|NRW|DE|030423|abbcdef
ENTRY = ct-Arzneimittel Brand of Aciclovir|T114|T121|NON|NRW|NLM (2004)|030423|abbcdef
ENTRY = curasan Brand of Aciclovir Sodium Salt|T114|T121|NON|NRW|NLM (2004)|030715|abbcdef
ENTRY = Aci Sanorania
ENTRY = Aciclovir Abello Brand
ENTRY = Aciclovir Alcon Brand
ENTRY = Aciclovir Alphapharm Brand
ENTRY = Aciclovir Amrad Brand
ENTRY = Aciclovir Azupharma Brand
ENTRY = Aciclovir Betapharm Brand
ENTRY = Aciclovir Britisfarma Brand
ENTRY = Aciclovir Clonmel Brand
ENTRY = Aciclovir Dermapharm Brand
ENTRY = Aciclovir Fabrigen Brand
ENTRY = Aciclovir Fustery Brand
ENTRY = Aciclovir Grin Brand
ENTRY = Aciclovir Grnenthal Brand
ENTRY = Aciclovir Hexal Brand
ENTRY = Aciclovir Isis Brand
ENTRY = Aciclovir Kendrick Brand
ENTRY = Aciclovir Lichtenstein Brand
ENTRY = Aciclovir Liomont Brand
ENTRY = Aciclovir Mann Brand
ENTRY = Aciclovir Menarini Brand
ENTRY = Aciclovir Niddapharm Brand
ENTRY = Aciclovir Novag Brand
ENTRY = Aciclovir Novartis Brand
ENTRY = Aciclovir Pensa Brand
ENTRY = Aciclovir Pisa Brand
ENTRY = Aciclovir Rentschler Brand
ENTRY = Aciclovir Sanorania
ENTRY = Aciclovir Sanorania Brand
ENTRY = Aciclovir Stada Brand
ENTRY = Aciclovir TAD Brand
ENTRY = Aciclovir Ursapharm Brand
ENTRY = Aciclovir Warner-Lambert Brand
ENTRY = Aciclovir Wellcome Brand
ENTRY = Aciclovir Wolff Brand
ENTRY = Aciclovir Yamanouchi Brand
ENTRY = Aciclovir Zyma Brand
ENTRY = Aciclovir ct-Arzneimittel Brand
ENTRY = Acyclo V
ENTRY = Sodium, Acyclovir
ENTRY = Solutab, Acipen
ENTRY = Virax Puren
ENTRY = ViraxPuren
ENTRY = Warner Lambert Brand of Aciclovir
ENTRY = Wellcome 248U
ENTRY = Wellcome248U
ENTRY = ct Arzneimittel Brand of Aciclovir
MN = D03.438.759.758.399.454.250
PA = Antiviral Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = USAN (1979)
MH_TH = USP (19XX)
ST = T114
ST = T121
N1 = 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-
RN = X4HES1O11F
RR = 59277-89-3 (Acyclovir)
RR = 69657-51-8 (Acyclovir Sodium)
RR = 927L42J563
PI = Guanine (1966-1982)
MS = A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.
PM = 83
HN = 83
MR = 20130708
DA = 19820505
DC = 1
DX = 19830101
UI = D000212

*NEWRECORD
RECTYPE = D
MH = Acyl Carrier Protein
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Myristoyl-ACP|T116|T123|NRW|UNK (19XX)|841002|abbdef
ENTRY = Carrier Protein, Acyl
ENTRY = Myristoyl ACP
ENTRY = Protein, Acyl Carrier
MN = D12.776.157.050
MH_TH = NLM (1978)
ST = T116
ST = T123
RN = 0
AN = /biosyn /physiol permitted
PI = Carrier Proteins (1971-1977)
MS = Consists of a polypeptide chain and 4'-phosphopantetheine linked to a serine residue by a phosphodiester bond. Acyl groups are bound as thiol esters to the pantothenyl group. Acyl carrier protein is involved in every step of fatty acid synthesis by the cytoplasmic system.
PM = 78
HN = 78
MR = 19920522
DA = 19770520
DC = 1
DX = 19780101
UI = D000213

*NEWRECORD
RECTYPE = D
MH = Acyl Coenzyme A
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acyl CoA|T114|T119|EQV|UNK (19XX)|770520|abbdef
PRINT ENTRY = Fatty Acyl CoA|T114|T119|EQV|UNK (19XX)|770520|abbdef
PRINT ENTRY = Long-Chain Acyl CoA|T114|T119|EQV|UNK (19XX)|770520|abbdef
ENTRY = Acyl CoA, Fatty
ENTRY = Acyl CoA, Long-Chain
ENTRY = CoA, Acyl
ENTRY = CoA, Fatty Acyl
ENTRY = CoA, Long-Chain Acyl
ENTRY = Coenzyme A, Acyl
ENTRY = Long Chain Acyl CoA
MN = D03.438.759.646.138.382.300
MN = D08.211.211.300
MN = D13.695.667.138.382.300
MN = D13.695.827.068.382.300
MH_TH = NLM (1978)
ST = T114
ST = T119
RN = 0
AN = do not confuse with ACETYL COENZYME A
PI = Coenzyme A (1966-1977)
MS = S-Acyl coenzyme A. Fatty acid coenzyme A derivatives that are involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation.
PM = 78
HN = 78
MR = 20060705
DA = 19770520
DC = 1
DX = 19780101
UI = D000214

*NEWRECORD
RECTYPE = D
MH = Acylation
AQ = DE GE IM PH RE
MN = G02.111.087.019
MN = G02.149.115.019
MN = G02.149.465.030
MN = G02.607.750.030
MN = G03.495.095
MH_TH = NLM (1971)
ST = T070
AN = almost never IM; enzymatic acylation: coord NIM with ACYLTRANSFERASES (IM) + substrate (NIM) or specific acyltransferase (IM); ACETYLATION & ACETYLTRANSFERASES are also available
PI = Chemistry, Organic (1966-1970)
MS = The addition of an organic acid radical into a molecule.
PM = 74
HN = 74(71)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19740101
UI = D000215

*NEWRECORD
RECTYPE = D
MH = N-Acylneuraminate Cytidylyltransferase
DS = ACYLNEURAMINATE Z
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acylneuraminate Cytidylyltransferase|T116|T126|NON|EQV|NLM (1998)|961204|abbcdef
PRINT ENTRY = CMP Sialate Pyrophosphorylase|T116|T126|EQV|UNK (19XX)|750206|abbdef
PRINT ENTRY = CMP Sialate Synthase|T116|T126|EQV|UNK (19XX)|750206|abbdef
PRINT ENTRY = CMP-N-Acetylneuraminic Acid Synthetase|T116|T126|EQV|UNK (19XX)|741111|CMP ACETYLNEURAMINIC ACID SYNTHETASE N|abbdefs
ENTRY = CMP-Sialic Acid Synthetase|T116|T126|EQV|NLM (1992)|910114|abbdef
ENTRY = Cytidine 5'-Monophosphosialic Acid Synthetase|T116|T126|NON|EQV|UNK (19XX)|810427|abbcdef
ENTRY = Cytidine 5-Monophosphosialate Synthase|T116|T126|NON|EQV|UNK (19XX)|880808|abbcdef
ENTRY = CMP N Acetylneuraminic Acid Synthetase
ENTRY = CMP Sialic Acid Synthetase
ENTRY = Cytidine 5 Monophosphosialate Synthase
ENTRY = Cytidine 5' Monophosphosialic Acid Synthetase
ENTRY = Cytidylyltransferase, Acylneuraminate
ENTRY = Cytidylyltransferase, N-Acylneuraminate
ENTRY = N Acylneuraminate Cytidylyltransferase
ENTRY = Pyrophosphorylase, CMP Sialate
ENTRY = Sialate Pyrophosphorylase, CMP
ENTRY = Sialate Synthase, CMP
ENTRY = Synthase, CMP Sialate
ENTRY = Synthase, Cytidine 5-Monophosphosialate
ENTRY = Synthetase, CMP-N-Acetylneuraminic Acid
ENTRY = Synthetase, CMP-Sialic Acid
MN = D08.811.913.696.445.035
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = CTP:N-acylneuraminate cytidylyltransferase
RN = EC 2.7.7.43
RR = 9067-82-7 (CAS RN)
PI = Cytosine Nucleotides (1973-1974)
PI = Neuraminic Acids (1973-1974)
PI = Nucleotidyltransferases (1973-1974)
MS = An enzyme that forms CMP-acylneuraminic acids, which donate the N-acylneuraminic acid residues to the terminal sugar residue of a ganglioside or glycoprotein. EC 2.7.7.43.
PM = 98; see ACYLNEURAMINATE CYTIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90
HN = 98(75); see NUCLEOTIDYLTRANSFERASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D000216

*NEWRECORD
RECTYPE = D
MH = Acyltransferases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D08.811.913.050
MH_TH = NLM (1964)
ST = T116
ST = T126
RN = EC 2.3.-
MS = Enzymes from the transferase class that catalyze the transfer of acyl groups from donor to acceptor, forming either esters or amides. (From Enzyme Nomenclature 1992) EC 2.3.
PM = 64
HN = 64
MR = 20060705
DA = 19990101
DC = 1
DX = 19640101
UI = D000217

*NEWRECORD
RECTYPE = D
MH = Adamantane
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Diamantane|T109|NON|EQV|NLM (1996)|940906|abcdef
MN = D02.455.426.100.050
MN = D02.455.426.392.368.075
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
N1 = Tricyclo(3.3.1.1(3,7))decane
RN = PJY633525U
RR = 281-23-2 (Adamantane)
AN = a cycloparaffin
PI = Bridged Compounds (1966-1974)
PI = Cycloparaffins (1966-1974)
MS = A tricyclo bridged hydrocarbon.
OL = use ADAMANTANE to search DIAMANTANE 1975-95
PM = 80; was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95
HN = 80(75); was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95
MR = 20130708
DA = 19741119
DC = 1
DX = 19800101
UI = D000218

*NEWRECORD
RECTYPE = D
MH = Adams-Stokes Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Stokes-Adams Attacks|T047|EPO|EQV|UNK (19XX)|860418|abcdef
ENTRY = Adam-Stokes Attacks|T047|EPO|EQV|NLM (1992)|900905|abcdef
ENTRY = Stokes-Adams Syndrome|T047|EPO|EQV|UNK (19XX)|860418|abcdef
ENTRY = Adam Stokes Attacks
ENTRY = Adams Stokes Syndrome
ENTRY = Attacks, Adam-Stokes
ENTRY = Attacks, Stokes-Adams
ENTRY = Stokes Adams Attacks
ENTRY = Stokes Adams Syndrome
ENTRY = Syndrome, Adams-Stokes
ENTRY = Syndrome, Stokes-Adams
MN = C14.280.067.558.137
MN = C23.550.073.425.025
MH_TH = NLM (1963)
ST = T047
MS = A condition of fainting spells caused by heart block, often an atrioventricular block, that leads to BRADYCARDIA and drop in CARDIAC OUTPUT. When the cardiac output becomes too low, the patient faints (SYNCOPE). In some cases, the syncope attacks are transient and in others cases repetitive and persistent.
PM = 65; was see under HEART BLOCK 1963-64
HN = 65(63); was see under HEART BLOCK 1963-64
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19650101
UI = D000219

*NEWRECORD
RECTYPE = D
MH = Adaptation, Biological
DE = ADAPTATION BIOL
AQ = DE ES GE IM PH RE
ENTRY = Adaptation, Biologic|T070|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Biological Adaptation|T070|NON|EQV|NLM (1990)|890831|BIOL ADAPTATION|abcdefv
ENTRY = Biologic Adaptation
MN = G16.100.057
FX = Adaptation, Physiological
MH_TH = NLM (1966)
ST = T070
AN = much of biol adapt will be ADAPTATION, PHYSIOLOGICAL as more specific; mimicry except for MOLECULAR MIMICRY goes here; DF: ADAPTATION BIOL
MS = Changes in biological features that help an organism cope with its ENVIRONMENT. These changes include physiological (ADAPTATION, PHYSIOLOGICAL), phenotypic and genetic changes.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000220

*NEWRECORD
RECTYPE = D
MH = Adaptation, Ocular
AQ = DE ES GE IM PH RE
PRINT ENTRY = Light Adaptation|T042|NON|NRW|NLM (1996)|950216|abcdef
ENTRY = Adaptation, Light
ENTRY = Adaptations, Light
ENTRY = Adaptations, Ocular
ENTRY = Light Adaptations
ENTRY = Ocular Adaptation
ENTRY = Ocular Adaptations
MN = G14.640.154
MH_TH = NLM (1966)
ST = T042
AN = adjustment of eye to variations in intensity of light; do not confuse with ACCOMMODATION, OCULAR, adjustment of lens to distance
MS = The adjustment of the eye to variations in the intensity of light. Light adaptation is the adjustment of the eye when the light threshold is increased; DARK ADAPTATION when the light is greatly reduced. (From Cline et al., Dictionary of Visual Science, 4th ed)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000221

*NEWRECORD
RECTYPE = D
MH = Adaptation, Physiological
DE = ADAPTATION PHYSIOL
AQ = DE ES GE IM PH RE
ENTRY = Adaptation, Physiologic|T040|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Adaptations, Physiologic|T040|NON|EQV|NLM (1994)|930129|abcdef
ENTRY = Adaptations, Physiological|T040|NON|EQV|NLM (1994)|930129|ADAPTATIONS PHYSIOL|abcdefv
ENTRY = Physiological Adaptation|T040|NON|EQV|UNK (19XX)|780626|PHYSIOL ADAPTATION|abcdefv
ENTRY = Physiologic Adaptation
ENTRY = Physiologic Adaptations
ENTRY = Physiological Adaptations
MN = G07.700.062
MN = G16.100.057.500
MH_TH = NLM (1966)
ST = T040
AN = PSYCHOLOGICAL ADAPTATION is also available; DF: ADAPTATION PHYSIOL
MS = The non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000222

*NEWRECORD
RECTYPE = D
MH = Adaptation, Psychological
DE = ADAPTATION PSYCHOL
AQ = CL DE ES PH RE
PRINT ENTRY = Behavior, Adaptive|T055|NON|NRW|NLM (1992)|910429|abcdef
PRINT ENTRY = Coping Behavior|T055|NON|NRW|UNK (19XX)|830606|abcdef
ENTRY = Adaptation, Psychologic|T055|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Coping Skills|T055|NON|NRW|NLM (1992)|910429|abcdef
ENTRY = Psychological Adaptation|T055|NON|EQV|UNK (19XX)|780626|PSYCHOL ADAPTATION|abcdefv
ENTRY = Adaptive Behavior
ENTRY = Adaptive Behaviors
ENTRY = Behavior, Coping
ENTRY = Behaviors, Adaptive
ENTRY = Behaviors, Coping
ENTRY = Coping Behaviors
ENTRY = Coping Skill
ENTRY = Psychologic Adaptation
ENTRY = Skill, Coping
ENTRY = Skills, Coping
MN = F01.058
FX = Social Adjustment
MH_TH = NLM (1966)
ST = T055
AN = human & animal; DF: ADAPTATION PSYCHOL
MS = A state of harmony between internal needs and external demands and the processes used in achieving this condition. (From APA Thesaurus of Psychological Index Terms, 8th ed)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D000223

*NEWRECORD
RECTYPE = D
MH = Addison Disease
DE = ADDISON DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Addison's Disease|T047|EPO|EQV|NLM (1963)|ORD (2010)|990101|ADDISONS DIS|abcdeefv
ENTRY = Primary Adrenal Insufficiency|T047|NON|EQV|NLM (2005)|040218|abcdef
ENTRY = Primary Adrenocortical Insufficiency|T047|NON|EQV|NLM (2005)|040218|abcdef
ENTRY = Primary Hypoadrenalism|T047|NON|EQV|NLM (2005)|040218|abcdef
ENTRY = Addisons Disease
ENTRY = Adrenal Insufficiency, Primary
ENTRY = Adrenocortical Insufficiencies, Primary
ENTRY = Adrenocortical Insufficiency, Primary
ENTRY = Disease, Addison
ENTRY = Hypoadrenalism, Primary
ENTRY = Hypoadrenalisms, Primary
ENTRY = Insufficiencies, Primary Adrenocortical
ENTRY = Insufficiency, Primary Adrenocortical
ENTRY = Primary Adrenocortical Insufficiencies
MN = C19.053.500.263
MN = C20.111.163
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
MH_TH = UNK (19XX)
ST = T047
MS = An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.
PM = 2005; see ADDISON'S DISEASE 1966-2004
HN = 2005 (1963)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D000224

*NEWRECORD
RECTYPE = D
MH = Adenine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
PRINT ENTRY = Vitamin B 4|T114|T123|NON|EQV|NLM (1998)|970311|VITAMIN B A 04|abbcdefs
ENTRY = 4, Vitamin B
ENTRY = B 4, Vitamin
MN = D03.438.759.138
MH_TH = FDA SRS (2014)
MH_TH = JAN (19XX)
MH_TH = NLM (1966)
MH_TH = USP (19XX)
ST = T114
ST = T123
N1 = 1H-Purin-6-amine
RN = JAC85A2161
RR = 73-24-5 (Adenine)
AN = /biosyn/physiol permitted
MS = A purine base and a fundamental unit of ADENINE NUCLEOTIDES.
MR = 20130708
DA = 19990101
DC = 1
UI = D000225

*NEWRECORD
RECTYPE = D
MH = Mitochondrial ADP, ATP Translocases
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = ADP,ATP Carrier|T116|T123|BRD|UNK (19XX)|830617|abbdef
PRINT ENTRY = ADP,ATP Translocator Protein|T116|T123|BRD|UNK (19XX)|830617|abbdef
PRINT ENTRY = Adenine Nucleotide Translocase|T116|T123|NON|BRD|NLM (1976)|990101|abbcdef
ENTRY = ADP Translocase|T116|T123|BRD|UNK (19XX)|821123|abbdef
ENTRY = ATP Translocase|T116|T123|BRD|UNK (19XX)|821123|abbdef
ENTRY = ATP,ADP-Carrier|T116|T123|BRD|UNK (19XX)|830617|abbdef
ENTRY = ATP-ADP Translocase|T116|T123|BRD|UNK (19XX)|810427|abbdef
ENTRY = Adenine Nucleotide Carrier (Mitochondrial)|T116|T123|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = Mitochondrial ADP-ATP Carriers|T116|T123|ACX|EQV|NLM (2003)|011108|abbcdef
ENTRY = ADP-ATP Carriers, Mitochondrial
ENTRY = Mitochondrial ADP ATP Carriers
MN = D12.776.157.530.625.875.500
MN = D12.776.543.585.450.162.225
MN = D12.776.543.585.475.500
MN = D12.776.543.585.625.875.500
MN = D12.776.575.750.500
MH_TH = NLM (2003)
ST = T116
ST = T123
RN = 9068-80-8
PI = Adenine Nucleotides (1972-1975)
PI = Nucleotidyltransferases (1972-1975)
MS = A class of nucleotide translocases found abundantly in mitochondria that function as integral components of the inner mitochondrial membrane. They facilitate the exchange of ADP and ATP between the cytosol and the mitochondria, thereby linking the subcellular compartments of ATP production to those of ATP utilization.
PM = 2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1991-2002 & NUCLEOTIDYLTRANSFERASES 1976-1990
HN = 2003(1976)
MR = 20110624
DA = 19750718
DC = 1
DX = 19910101
UI = D000226

*NEWRECORD
RECTYPE = D
MH = Adenine Nucleotides
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Adenosine Phosphates|T114|NON|EQV|UNK (19XX)|770401|abcdef
ENTRY = Nucleotides, Adenine
ENTRY = Phosphates, Adenosine
MN = D03.438.759.646.138
MN = D13.695.667.138
MN = D13.695.827.068
MH_TH = NLM (1966)
ST = T114
RN = 0
AN = /biosyn /physiol permitted
MR = 20060705
DA = 19990101
DC = 1
UI = D000227

*NEWRECORD
RECTYPE = D
MH = Adenine Phosphoribosyltransferase
DE = APRT
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = AMP Pyrophosphorylase|T116|T126|EQV|UNK (19XX)|741111|abbdef
PRINT ENTRY = Transphosphoribosidase|T116|T126|NON|EQV|UNK (19XX)|750822|abbcdef
ENTRY = APRTase|T116|T126|EQV|UNK (19XX)|881102|abbdef
ENTRY = Phosphoribosyltransferase, Adenine
ENTRY = Pyrophosphorylase, AMP
MN = D08.811.913.400.725.100
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = AMP:pyrophosphate phospho-D-ribosyltransferase
RN = EC 2.4.2.7
RR = 9027-80-9 (CAS RN)
AN = DF: APRT
PI = Adenine (1972-1974)
PI = Pentosephosphates (1972-1974)
PI = Pentosyltransferases (1972-1974)
PI = Pyrophosphoric Acids (1972-1974)
MS = An enzyme catalyzing the formation of AMP from adenine and phosphoribosylpyrophosphate. It can act as a salvage enzyme for recycling of adenine into nucleic acids. EC 2.4.2.7.
PM = 91; was see under PENTOSYLTRANSFERASES 1975-90
HN = 91(75); was see under PENTOSYLTRANSFERASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D000228

*NEWRECORD
RECTYPE = D
MH = Dependovirus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Adeno-Associated Viruses|T005|NON|NRW|NLM (1994)|921210|ADENO ASSOC VIRUSES|abcdefv
ENTRY = Adeno-Associated Virus|T005|NON|NRW|NLM (1995)|931130|ADENO ASSOC VIRUS|abcdefv
ENTRY = Virus, Adeno-Associated|T005|NON|NRW|NLM (1995)|931130|VIRUS ADENO ASSOC|abcdefv
ENTRY = Viruses, Adeno-Associated|T005|NON|NRW|NLM (1995)|931130|VIRUSES ADENO ASSOC|abcdefv
ENTRY = Dependoviruses
MN = B04.280.580.650.170
MH_TH = NLM (1979)
ST = T005
AN = infection: coord IM with PARVOVIRIDAE INFECTIONS (IM)
PI = Adenoviridae (1966)
PI = Satellite Viruses (1967-1978)
PI = Viruses (1966)
MS = A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, which are dependent on a coinfection with helper adenoviruses or herpesviruses for their efficient replication. The type species is Adeno-associated virus 2.
OL = use DEPENDOVIRUS to search ADENO-ASSOCIATED VIRUSES 1979-93; use SATELLITE VIRUSES 1975-78; use PARVOVIRIDAE to search DEPENDOVIRUS 1992-93
PM = 94; was ADENO-ASSOCIATED VIRUSES 1979-93; was ADENO-ASSOCIATED VIRUSES see SATELLITE VIRUSES 1975-78; DEPENDOVIRUS was see PARVOVIRIDAE 1992-93
HN = 94; was ADENO-ASSOCIATED VIRUSES 1979-93; was ADENO-ASSOCIATED VIRUSES see SATELLITE VIRUSES 1975-78; DEPENDOVIRUS was see PARVOVIRIDAE 1992-93
MR = 20150622
DA = 19771205
DC = 1
DX = 19790101
UI = D000229

*NEWRECORD
RECTYPE = D
MH = Adenocarcinoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Adenocarcinoma, Basal Cell|T191|NON|REL|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenocarcinoma, Granular Cell|T191|NON|NRW|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenocarcinoma, Oxyphilic|T191|NON|NRW|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenocarcinoma, Tubular|T191|NON|NRW|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenoma, Malignant|T191|NON|EQV|NLM (1998)|961216|abcdef
PRINT ENTRY = Carcinoma, Cribriform|T191|NON|REL|NLM (1994)|ORD (2010)|930326|abcdeef
PRINT ENTRY = Carcinoma, Granular Cell|T191|NON|NRW|NLM (1994)|930326|abcdef
PRINT ENTRY = Carcinoma, Tubular|T191|NON|NRW|NLM (1994)|930326|abcdef
ENTRY = Adenocarcinomas
ENTRY = Adenocarcinomas, Basal Cell
ENTRY = Adenocarcinomas, Granular Cell
ENTRY = Adenocarcinomas, Oxyphilic
ENTRY = Adenocarcinomas, Tubular
ENTRY = Adenomas, Malignant
ENTRY = Basal Cell Adenocarcinoma
ENTRY = Basal Cell Adenocarcinomas
ENTRY = Carcinomas, Cribriform
ENTRY = Carcinomas, Granular Cell
ENTRY = Carcinomas, Tubular
ENTRY = Cribriform Carcinoma
ENTRY = Cribriform Carcinomas
ENTRY = Granular Cell Adenocarcinoma
ENTRY = Granular Cell Adenocarcinomas
ENTRY = Granular Cell Carcinoma
ENTRY = Granular Cell Carcinomas
ENTRY = Malignant Adenoma
ENTRY = Malignant Adenomas
ENTRY = Oxyphilic Adenocarcinoma
ENTRY = Oxyphilic Adenocarcinomas
ENTRY = Tubular Adenocarcinoma
ENTRY = Tubular Adenocarcinomas
ENTRY = Tubular Carcinoma
ENTRY = Tubular Carcinomas
MN = C04.557.470.200.025
MH_TH = NLM (1966)
ST = T191
AN = coord IM with precoord organ/neopl term (IM)
MS = A malignant epithelial tumor with a glandular organization.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000230

*NEWRECORD
RECTYPE = D
MH = Adenocarcinoma, Papillary
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Adenocarcinomas, Papillary
ENTRY = Papillary Adenocarcinoma
ENTRY = Papillary Adenocarcinomas
MN = C04.557.470.200.025.085
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D000231

*NEWRECORD
RECTYPE = D
MH = Adenofibroma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
ENTRY = Fibroadenosis|T191|NON|REL|POPLINE (1978)|781218|abcdef
ENTRY = Adenofibromas
MN = C04.557.450.565.590.595.050
MN = C04.557.470.625.050
MH_TH = NLM (1966)
ST = T191
AN = do not confuse with FIBROADENOMA; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D000232

*NEWRECORD
RECTYPE = D
MH = Adenoidectomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Adenoidectomies
MN = E04.580.068
MH_TH = NLM (1966)
ST = T061
AN = do not use /util except by MeSH definition
MS = Excision of the adenoids. (Dorland, 28th ed)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D000233

*NEWRECORD
RECTYPE = D
MH = Adenoids
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
PRINT ENTRY = Pharyngeal Tonsils|T023|NON|EQV|NLM (2009)|071024|abcdef
PRINT ENTRY = Tonsil, Pharyngeal|T023|NON|EQV|NLM (1998)|960711|abcdef
ENTRY = Pharyngeal Tonsil|T023|NON|EQV|NLM (1998)|960711|abcdef
ENTRY = Adenoid
ENTRY = Tonsils, Pharyngeal
MN = A04.623.557.500
MN = A10.549.100
MN = A14.724.557.500
MN = A15.382.520.604.100
FX = Adenoidectomy
MH_TH = NLM (1966)
ST = T023
MS = A collection of lymphoid nodules on the posterior wall and roof of the NASOPHARYNX.
MR = 20080708
DA = 19990101
DC = 1
UI = D000234

*NEWRECORD
RECTYPE = D
MH = Adenolymphoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
PRINT ENTRY = Cystadenoma Lymphomatosum, Papillary|T191|NON|EQV|UNK (19XX)|800509|abcdef
PRINT ENTRY = Warthin Tumor|T191|EPO|EQV|UNK (19XX)|800509|abcdef
ENTRY = Adenolymphomas
ENTRY = Papillary Cystadenoma Lymphomatosum
ENTRY = Tumor, Warthin
MN = C04.557.435.075
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = A benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma. It is usually found in the salivary glands, especially the parotid.
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D000235

*NEWRECORD
RECTYPE = D
MH = Adenoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
PRINT ENTRY = Adenoma, Basal Cell|T191|NON|REL|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenoma, Follicular|T191|NON|NRW|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenoma, Microcystic|T191|NON|REL|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenoma, Monomorphic|T191|NON|REL|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenoma, Papillary|T191|NON|REL|NLM (1994)|930326|abcdef
PRINT ENTRY = Adenoma, Trabecular|T191|NON|REL|NLM (1994)|930326|abcdef
ENTRY = Adenomas
ENTRY = Adenomas, Basal Cell
ENTRY = Adenomas, Follicular
ENTRY = Adenomas, Microcystic
ENTRY = Adenomas, Monomorphic
ENTRY = Adenomas, Papillary
ENTRY = Adenomas, Trabecular
ENTRY = Basal Cell Adenoma
ENTRY = Basal Cell Adenomas
ENTRY = Follicular Adenoma
ENTRY = Follicular Adenomas
ENTRY = Microcystic Adenoma
ENTRY = Microcystic Adenomas
ENTRY = Monomorphic Adenoma
ENTRY = Monomorphic Adenomas
ENTRY = Papillary Adenoma
ENTRY = Papillary Adenomas
ENTRY = Trabecular Adenoma
ENTRY = Trabecular Adenomas
MN = C04.557.470.035
MH_TH = NLM (1966)
ST = T191
AN = GEN or unspecified; prefer specifics; coord IM with precoord organ/neopl term (IM)
MS = A benign epithelial tumor with a glandular organization.
CATSH = CAT LIST
MR = 19991109
DA = 19990101
DC = 1
UI = D000236

*NEWRECORD
RECTYPE = D
MH = Adenoma, Basophil
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
ENTRY = Adenoma, Basophilic|T191|NON|EQV|NLM (1994)|930513|abcdef
ENTRY = Adenomas, Basophil
ENTRY = Adenomas, Basophilic
ENTRY = Basophil Adenoma
ENTRY = Basophil Adenomas
ENTRY = Basophilic Adenoma
ENTRY = Basophilic Adenomas
MN = C04.557.465.625.650.075
MN = C04.557.470.035.075
MN = C04.557.580.625.650.075
FX = Cushing Syndrome
FX = Pituitary Neoplasms
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /secret /ultrastruct permitted; coord IM with PITUITARY NEOPLASMS (IM)
MS = A small tumor of the anterior lobe of the pituitary gland whose cells stain with basic dyes. It may give rise to excessive secretion of ACTH, resulting in CUSHING SYNDROME. (Dorland, 27th ed)
OL = use ADENOMA, BASOPHIL to search ADENOMA, BASOPHILIC 1966-93
PM = 94; was ADENOMA, BASOPHILIC 1963-93
HN = 94; was ADENOMA, BASOPHILIC 1963-93
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
UI = D000237

*NEWRECORD
RECTYPE = D
MH = Adenoma, Chromophobe
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
ENTRY = Adenomas, Chromophobe
ENTRY = Chromophobe Adenoma
ENTRY = Chromophobe Adenomas
MN = C04.557.465.625.650.095
MN = C04.557.470.035.095
MN = C04.557.580.625.650.095
FX = Pituitary Neoplasms
MH_TH = NLM (1966)
ST = T191
AN = coord IM with PITUITARY NEOPLASMS (IM)
MS = A benign tumor of the anterior pituitary in which the cells do not stain with acidic or basic dyes.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D000238

*NEWRECORD
RECTYPE = D
MH = Adenoma, Acidophil
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
PRINT ENTRY = Adenoma, Eosinophilic|T191|NON|EQV|NLM (1994)|930329|abcdef
ENTRY = Adenoma, Acidophilic|T191|NON|EQV|NLM (1994)|930329|abcdef
ENTRY = Adenoma, Eosinophil|T191|NON|EQV|NLM (1994)|930329|abcdef
ENTRY = Acidophil Adenoma
ENTRY = Acidophil Adenomas
ENTRY = Acidophilic Adenoma
ENTRY = Acidophilic Adenomas
ENTRY = Adenomas, Acidophil
ENTRY = Adenomas, Acidophilic
ENTRY = Adenomas, Eosinophil
ENTRY = Adenomas, Eosinophilic
ENTRY = Eosinophil Adenoma
ENTRY = Eosinophil Adenomas
ENTRY = Eosinophilic Adenoma
ENTRY = Eosinophilic Adenomas
MN = C04.557.465.625.650.025
MN = C04.557.470.035.025
MN = C04.557.580.625.650.025
FX = Acromegaly
FX = Gigantism
FX = Pituitary Neoplasms
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /secret /ultrastruct permitted; coord IM with PITUITARY NEOPLASMS (IM)
MS = A benign tumor, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumors may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhea. (Dorland, 27th ed)
OL = use ADENOMA, ACIDOPHIL to search ADENOMA, EOSINOPHILIC 1966-93
PM = 94; was ADENOMA, EOSINOPHILIC 1963-93
HN = 94; was ADENOMA, EOSINOPHILIC 1963-93
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
UI = D000239

*NEWRECORD
RECTYPE = D
MH = Adenosine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Adenocard|T114|T123|TRD|NRW|NLM (1998)|961121|abbcdef
ENTRY = Adenoscan|T114|T121|TRD|NRW|NLM (2015)|131203|abbcdef
MN = D03.438.759.590.138
MN = D13.570.583.138
MN = D13.570.800.096
PA = Analgesics
PA = Anti-Arrhythmia Agents
PA = Purinergic P1 Receptor Agonists
PA = Vasodilator Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
MH_TH = USAN (1988)
MH_TH = USP (19XX)
ST = T114
ST = T123
N1 = Adenosine
RN = K72T3FS567
RR = 58-61-7 (Adenosine)
PI = Nucleosides (1966-1971)
MS = A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
OL = search NUCLEOSIDES 1966-71
PM = 72; was see under NUCLEOSIDES 1963-71
HN = 72; was see under NUCLEOSIDES 1963-71
MR = 20140617
DA = 19990101
DC = 1
DX = 19720101
UI = D000241

*NEWRECORD
RECTYPE = D
MH = Cyclic AMP
DE = CYCL AMP
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Adenosine Cyclic 3',5'-Monophosphate|T114|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|790522|ADENOSINE CYCLIC MONOPHOSPHATE 03 05|abbcdeefs
ENTRY = Adenosine Cyclic 3,5 Monophosphate|T114|T123|NON|EQV|UNK (19XX)|840727|abbcdef
ENTRY = Adenosine Cyclic Monophosphate|T114|T123|NON|EQV|NLM (1994)|921218|abbcdef
ENTRY = Adenosine Cyclic-3',5'-Monophosphate|T114|T123|NON|EQV|UNK (19XX)|850612|abbcdef
ENTRY = Cyclic AMP, (R)-Isomer|T114|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Cyclic AMP, Disodium Salt|T114|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Cyclic AMP, Monoammonium Salt|T114|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Cyclic AMP, Monopotassium Salt|T114|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Cyclic AMP, Monosodium Salt|T114|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Cyclic AMP, Sodium Salt|T114|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = 3',5'-Monophosphate, Adenosine Cyclic
ENTRY = AMP, Cyclic
ENTRY = Adenosine Cyclic 3',5' Monophosphate
ENTRY = Cyclic 3',5'-Monophosphate, Adenosine
ENTRY = Cyclic Monophosphate, Adenosine
ENTRY = Cyclic-3',5'-Monophosphate, Adenosine
ENTRY = Monophosphate, Adenosine Cyclic
MN = D03.438.759.646.138.395
MN = D13.695.462.200
MN = D13.695.667.138.395
MN = D13.695.827.068.395
FX = Receptors, Cyclic AMP
MH_TH = FDA SRS (2014)
MH_TH = POPLINE (1984)
ST = T114
ST = T123
N1 = Adenosine, cyclic 3',5'-(hydrogen phosphate)
RN = E0399OZS9N
RR = 33116-15-3 (Na salt)
RR = 37839-81-9 (mono-Na salt)
RR = 55576-98-2 (mono-K salt)
RR = 60-92-4 (Cyclic AMP)
RR = 66067-13-8 (di-Na salt)
RR = 68407-13-6 (mono-NH4 salt)
RR = 86594-34-5 ((R)-isomer)
AN = /biosyn /physiol permitted; cAMP receptor protein, cyclic AMP receptor protein: index under RECEPTORS, CYCLIC AMP; DF: CYCL AMP
PI = Adenine Nucleotides (1966-1968)
MS = An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.
OL = use CYCLIC AMP to search ADENOSINE CYCLIC MONOPHOSPHATE & ADENOSINE CYCLIC 2',3'-MONOPHOSPHATE 1980-93 & ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE 1968-79 (as Prov 1968-71)
PM = 94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3',5' MONOPHOSPHATE 1972-77; CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2',3'-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93
HN = 94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3',5' MONOPHOSPHATE 1968-77 (Prov 1968-71); CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2',3'-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93
MR = 20130708
DA = 19990101
DC = 1
DX = 19720101
UI = D000242

*NEWRECORD
RECTYPE = D
MH = Adenosine Deaminase
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Adenosine Aminohydrolase|T116|T126|NON|EQV|UNK (19XX)|741125|abbcdef
ENTRY = Aminohydrolase, Adenosine
ENTRY = Deaminase, Adenosine
MN = D08.811.277.151.486.075
EC = antagonists & inhibitors:Adenosine Deaminase Inhibitors
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Adenosine aminohydrolase
RN = EC 3.5.4.4
AN = /defic: consider also SEVERE COMBINED IMMUNODEFICIENCY or SCID
PI = Adenosine (1972-1974)
PI = Aminohydrolases (1972-1974)
MS = An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA.
PM = 91; was see under NUCLEOSIDE DEAMINASES 1975-90
HN = 91(75); was see under NUCLEOSIDE DEAMINASES 1975-90
MR = 20100625
DA = 19741127
DC = 1
DX = 19910101
UI = D000243

*NEWRECORD
RECTYPE = D
MH = Adenosine Diphosphate
AQ = AA AD AE AG AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = ADP|T114|T123|ABB|EQV|UNK (19XX)|750101|abbcdef
PRINT ENTRY = Adenosine Pyrophosphate|T114|T123|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Magnesium ADP|T114|T123|ABX|NRW|NLM (1990)|890512|abbcdef
PRINT ENTRY = MgADP|T114|T123|ABB|NRW|NLM (1990)|890512|abbcdef
ENTRY = Adenosine 5'-Pyrophosphate|T114|T123|NON|EQV|NLM (1990)|890517|abbcdef
ENTRY = 5'-Pyrophosphate, Adenosine
ENTRY = ADP, Magnesium
ENTRY = Adenosine 5' Pyrophosphate
ENTRY = Diphosphate, Adenosine
ENTRY = Pyrophosphate, Adenosine
MN = D03.438.759.646.138.124
MN = D13.695.667.138.124
MN = D13.695.827.068.124
MH_TH = FDA SRS (2014)
MH_TH = NLM (1971)
ST = T114
ST = T123
N1 = Adenosine 5'-(trihydrogen diphosphate)
RN = 61D2G4IYVH
RR = 58-64-0 (Adenosine Diphosphate)
PI = Adenine Nucleotides (1966-1970)
MS = Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position.
PM = 73
HN = 73(71)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D000244

*NEWRECORD
RECTYPE = D
MH = Adenosine Diphosphate Glucose
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = ADP Glucose|T114|T118|T123|EQV|UNK (19XX)|760513|abbbdef
PRINT ENTRY = ADPG|T114|T118|T123|ABB|EQV|UNK (19XX)|741111|abbbcdef
PRINT ENTRY = Adenosine Diphosphoglucose|T114|T118|T123|NON|EQV|UNK (19XX)|741111|abbbcdef
PRINT ENTRY = Adenosine Pyrophosphateglucose|T114|T118|T123|NON|EQV|UNK (19XX)|741111|abbbcdef
ENTRY = Diphosphate Glucose, Adenosine
ENTRY = Diphosphoglucose, Adenosine
ENTRY = Glucose, ADP
ENTRY = Glucose, Adenosine Diphosphate
ENTRY = Pyrophosphateglucose, Adenosine
MN = D03.438.759.646.138.124.070.075
MN = D09.408.620.569.070.075
MN = D13.695.667.138.124.070.075
MN = D13.695.827.068.124.070.075
MN = D13.695.827.708.070.075
MH_TH = NLM (1975)
ST = T114
ST = T118
ST = T123
N1 = Adenosine 5'-(trihydrogen diphosphate), P'-alpha-D-glucopyranosyl ester
RN = 2140-58-1
PI = Adenosine (1973-1974)
PI = Glucose (1973-1974)
PI = Nucleoside Diphosphate Sugars (1973-1974)
MS = Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants.
PM = 90; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90
HN = 91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90
MR = 20060705
DA = 19741119
DC = 1
DX = 19910101
UI = D000245

*NEWRECORD
RECTYPE = D
MH = Adenosine Diphosphate Ribose
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = ADP Ribose|T114|T118|T123|EQV|UNK (19XX)|790522|abbbdef
PRINT ENTRY = Adenosine Diphosphoribose|T114|T118|T123|NON|EQV|UNK (19XX)|790522|abbbcdef
ENTRY = ADP-Ribose|T114|T118|T123|ACX|EQV|NLM (2003)|011231|abbbcdef
ENTRY = ADPribose|T114|T118|T123|ACX|EQV|NLM (2003)|011231|abbbcdef
ENTRY = Adenosine 5'-Diphosphoribose|T114|T118|T123|NON|EQV|UNK (19XX)|800922|abbbcdef
ENTRY = 5'-Diphosphoribose, Adenosine
ENTRY = Adenosine 5' Diphosphoribose
ENTRY = Diphosphate Ribose, Adenosine
ENTRY = Diphosphoribose, Adenosine
ENTRY = Ribose, ADP
ENTRY = Ribose, Adenosine Diphosphate
MN = D03.438.759.646.138.124.070.125
MN = D09.408.620.569.070.125
MN = D13.695.667.138.124.070.125
MN = D13.695.827.068.124.070.125
MN = D13.695.827.708.070.125
MH_TH = NLM (1980)
ST = T114
ST = T118
ST = T123
N1 = Adenosine 5'-(trihydrogen diphosphate), P'-5-ester with D-ribose
RN = 20762-30-5
PI = Adenine Nucleotides (1966-1970)
PI = Adenosine Diphosphate Sugars (1975-1979)
PI = Nucleoside Diphosphate Sugars (1971-1974)
PI = Ribose (1966-1974) /AA (1975-1979)
MS = An ester formed between the aldehydic carbon of RIBOSE and the terminal phosphate of ADENOSINE DIPHOSPHATE. It is produced by the hydrolysis of nicotinamide-adenine dinucleotide (NAD) by a variety of enzymes, some of which transfer an ADP-ribosyl group to target proteins.
PM = 87; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86
HN = 87(80); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86
MR = 20060705
DA = 19790522
DC = 1
DX = 19870101
UI = D000246

*NEWRECORD
RECTYPE = D
MH = Adenosine Diphosphate Sugars
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = ADP Sugars|T114|T118|EQV|UNK (19XX)|760507|abbdef
ENTRY = Diphosphate Sugars, Adenosine
ENTRY = Sugars, ADP
ENTRY = Sugars, Adenosine Diphosphate
MN = D03.438.759.646.138.124.070
MN = D09.408.620.569.070
MN = D13.695.667.138.124.070
MN = D13.695.827.068.124.070
MN = D13.695.827.708.070
MH_TH = NLM (1975)
ST = T114
ST = T118
RN = 0
PI = Adenosine (1973-1974)
PI = Nucleoside Diphosphate Sugars (1973-1974)
MS = Esters formed between the aldehydic carbon of sugars and the terminal phosphate of adenosine diphosphate.
PM = 91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90
HN = 91(75); was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90
MR = 20060705
DA = 19741119
DC = 1
DX = 19910101
UI = D000247

*NEWRECORD
RECTYPE = D
MH = Adenosine Kinase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Kinase, Adenosine
MN = D08.811.913.696.620.010
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = ATP:adenosine 5'-phosphotransferase
RN = EC 2.7.1.20
RR = 9027-72-9 (CAS RN)
PI = Adenosine (1974)
PI = Phosphotransferases, ATP (1974)
MS = An enzyme that catalyzes the formation of ADP plus AMP from adenosine plus ATP. It can serve as a salvage mechanism for returning adenosine to nucleic acids. EC 2.7.1.20.
PM = 91; was see under PHOSPHOTRANSFERASES, ATP 1975-90
HN = 91(75); was see under PHOSPHOTRANSFERASES, ATP 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D000248

*NEWRECORD
RECTYPE = D
MH = Adenosine Monophosphate
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = AMP|T114|T123|ABB|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Adenylic Acid|T114|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = 2'-AMP|T114|ABB|NRW|NLM (1992)|abcde
ENTRY = 2'-Adenosine Monophosphate|T114|NON|NRW|NLM (2014)|130424|abcdef
ENTRY = 2'-Adenylic Acid|T114|NON|NRW|NLM (2014)|130424|abcdef
ENTRY = 5'-Adenylic Acid|T114|NON|NRW|NLM (2014)|130531|abcdef
ENTRY = Adenosine 2'-Phosphate|T114|NON|NRW|UNK (19XX)|840920|abcdef
ENTRY = Adenosine 3'-Phosphate|T114|NON|NRW|UNK (19XX)|840920|abcdef
ENTRY = Adenosine 5'-Phosphate|T114|T123|NON|NRW|UNK (19XX)|840920|abbcdef
ENTRY = Adenosine Phosphate Dipotassium|T114|T123|NON|NRW|NLM (2014)|130515|abbcdef
ENTRY = Adenosine Phosphate Disodium|T114|T123|NON|NRW|FDA SRS (2014)|130426|abbcdef
ENTRY = Phosphaden|T114|T121|TRD|NRW|UNK (19XX)|800319|abbcdef
ENTRY = 2' Adenosine Monophosphate
ENTRY = 2' Adenylic Acid
ENTRY = 5' Adenylic Acid
ENTRY = 5'-Phosphate, Adenosine
ENTRY = Acid, 2'-Adenylic
ENTRY = Acid, 5'-Adenylic
ENTRY = Adenosine 2' Phosphate
ENTRY = Adenosine 3' Phosphate
ENTRY = Adenosine 5' Phosphate
ENTRY = Dipotassium, Adenosine Phosphate
ENTRY = Disodium, Adenosine Phosphate
ENTRY = Monophosphate, 2'-Adenosine
ENTRY = Phosphate Dipotassium, Adenosine
ENTRY = Phosphate Disodium, Adenosine
MN = D03.438.759.646.138.180
MN = D13.695.667.138.180
MN = D13.695.827.068.180
MH_TH = FDA SRS (2014)
MH_TH = NLM (1971)
ST = T114
ST = T123
N1 = 5'-Adenylic acid
RN = 415SHH325A
RR = 130-49-4
RR = 225M14T7DD
RR = 61-19-8 (Adenosine Monophosphate)
RR = T1WZ11DSRN
PI = Adenine Nucleotides (1966-1970)
MS = Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.
OL = to search ADENYLIC ACIDS use ADENOSINE MONOPHOSPHATE 1971-73, ADENOSINE MONOPHOSPHATE & ADENINE NUCLEOTIDES 1971-72, & ADENINE NUCLEOTIDES 1966-70
PM = 73; ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72
HN = 73(71); ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72
MR = 20130709
DA = 19990101
DC = 1
DX = 19730101
UI = D000249

*NEWRECORD
RECTYPE = D
MH = Adenosine Phosphosulfate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Adenylyl Sulfate|T114|T123|NON|EQV|UNK (19XX)|780310|abbcdef
ENTRY = Adenosine 5'-Phosphosulfate|T114|T123|NON|EQV|UNK (19XX)|881011|abbcdef
ENTRY = Phospho-Adenylsulfate|T114|T123|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = 5'-Phosphosulfate, Adenosine
ENTRY = Adenosine 5' Phosphosulfate
ENTRY = Phospho Adenylsulfate
ENTRY = Phosphosulfate, Adenosine
ENTRY = Sulfate, Adenylyl
MN = D03.438.759.646.138.180.080
MN = D13.695.667.138.180.080
MN = D13.695.827.068.180.080
MH_TH = NLM (1979)
ST = T114
ST = T123
N1 = 5'-Adenylic acid, monoanhydride with sulfuric acid
RN = 485-84-7
PI = Adenine Nucleotides (1966-1970)
PI = Adenosine Monophosphate (1971-1978)
PI = Sulfuric Acids (1966-1975)
MS = 5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS.
PM = 91; was see under ADENOSINE MONOPHOSPHATE 1979-90
HN = 91(79); was see under ADENOSINE MONOPHOSPHATE 1979-90
MR = 20060705
DA = 19780306
DC = 1
DX = 19910101
UI = D000250

*NEWRECORD
RECTYPE = D
MH = Adenosine Triphosphatases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = ATPases|T116|T126|ABX|EQV|NLM (2007)|060106|abbcdef
PRINT ENTRY = Adenosinetriphosphatase|T116|T126|NON|NRW|NLM (1966)|990101|abbcdef
ENTRY = ATPase|T116|T126|ABX|NRW|NLM (1977)|760513|abbcdef
ENTRY = ATPase, DNA-Dependent|T116|T126|ABX|NRW|NLM (2007)|abbcde
ENTRY = Adenosine Triphosphatase|T116|T126|NON|NRW|NLM (1993)|920413|abbcdef
ENTRY = DNA-Dependent ATPase|T116|T126|ABX|NRW|NLM (2007)|abbcde
ENTRY = DNA-Dependent Adenosinetriphosphatases|T116|T126|ABX|NRW|NLM (2007)|040901|abbcdef
ENTRY = ATPase, DNA Dependent
ENTRY = Adenosinetriphosphatases, DNA-Dependent
ENTRY = DNA Dependent ATPase
ENTRY = DNA Dependent Adenosinetriphosphatases
ENTRY = Triphosphatase, Adenosine
MN = D08.811.277.040.025
MH_TH = NLM (2007)
ST = T116
ST = T126
N1 = ATP phosphohydrolase
RN = EC 3.6.1.-
RR = 9000-83-3 (CAS RN)
RR = EC 3.6.1.-
RR = EC 3.6.1.3
MS = A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.
PM = 2007; see ADENOSINE TRIPHOSPHATASES 1993-2006, see ADENOSINE TRIPHOSPHATASE 1963-1992, DNA-DEPENDENT ADENOSINETRIPHOSPHATASES was indexed under ADENOSINETRIPHOSPHATASE & DNA HELICASES 1980-2006
HN = 2007(1963)
MR = 20150707
DA = 19990101
DC = 1
UI = D000251

*NEWRECORD
RECTYPE = D
MH = Calcium-Transporting ATPases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = ATPase, Calcium|T116|T126|EQV|UNK (19XX)|780310|ATPASE CA|abbdefv
PRINT ENTRY = Adenosinetriphosphatase, Calcium|T116|T126|NON|EQV|NLM (1993)|920402|abbcdef
PRINT ENTRY = Ca(2+)-Transporting ATPase|T116|T126|ACX|EQV|NLM (1979)|990101|CA 02 TRANSPORTING ATPASE|CA ATPASE|abbcdefsv
PRINT ENTRY = Calcium ATPase|T116|T126|EQV|UNK (19XX)|780310|abbdef
PRINT ENTRY = Calcium Adenosinetriphosphatase|T116|T126|NON|EQV|UNK (19XX)|880603|abbcdef
ENTRY = Adenosine Triphosphatase, Calcium|T116|T126|NON|EQV|NLM (1993)|920410|abbcdef
ENTRY = Ca2+ ATPase|T116|T126|EQV|NLM (1993)|920421|abbdef
ENTRY = Calcium-ATPase|T116|T126|EQV|NLM (1993)|920421|abbdef
ENTRY = ATPase, Ca2+
ENTRY = ATPases, Calcium-Transporting
ENTRY = Calcium Adenosine Triphosphatase
ENTRY = Calcium Transporting ATPases
ENTRY = Triphosphatase, Calcium Adenosine
MN = D08.811.277.040.025.125
MN = D12.776.157.530.450.250.500
MN = D12.776.543.585.450.250.500
FX = Ca(2+) Mg(2+)-ATPase
FX = Calcium Channels
MH_TH = NLM (2007)
ST = T116
ST = T126
N1 = ATP phosphohydrolase (Ca(2+)-transporting)
RN = EC 3.6.3.8
AN = general; prefer specifics
PI = Adenosine Triphosphatase (1966-1978)
PI = Calcium (1966-1978)
MS = Cation-transporting proteins that utilize the energy of ATP hydrolysis for the transport of CALCIUM. They differ from CALCIUM CHANNELS which allow calcium to pass through a membrane without the use of energy.
PM = 2007; see CA(2+)-TRANSPORTING ATPASE 1994-2006, see ADENOSINE TRIPHOSPHATASE, CALCIUM 1979-1992, see CALCIUM PUMP 1992-1993,
HN = 2007(1993)
MR = 20100625
DA = 19780306
DC = 1
DX = 19790101
UI = D000252

*NEWRECORD
RECTYPE = D
MH = Sodium-Potassium-Exchanging ATPase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = ATPase, Sodium, Potassium|T116|T126|EQV|UNK (19XX)|780310|ATPASE NA K|abbdefv
PRINT ENTRY = Adenosinetriphosphatase, Sodium, Potassium|T116|T126|NON|EQV|NLM (1993)|920402|abbcdef
PRINT ENTRY = Na(+)-K(+)-Exchanging ATPase|T116|T126|ABX|EQV|NLM (1979)|990101|NA K EXCHANGING ATPASE|NA K ATPASE|abbcdefsv
PRINT ENTRY = Na(+)-K(+)-Transporting ATPase|T116|T126|EQV|NLM (1994)|921120|NA K TRANSPORTING ATPASE|abbdefs
PRINT ENTRY = Potassium Pump|T116|T126|NON|EQV|NLM (1994)|930211|K PUMP|abbcdefv
PRINT ENTRY = Sodium Pump|T116|T126|NON|EQV|NLM (1994)|930211|NA PUMP|abbcdefv
PRINT ENTRY = Sodium, Potassium ATPase|T116|T126|EQV|UNK (19XX)|780310|abbdef
PRINT ENTRY = Sodium, Potassium Adenosinetriphosphatase|T116|T126|NON|EQV|UNK (19XX)|880603|abbcdef
PRINT ENTRY = Sodium-Potassium Pump|T116|T126|NON|EQV|NLM (1994)|930211|NA K PUMP|abbcdefv
ENTRY = Adenosine Triphosphatase, Sodium, Potassium|T116|T126|NON|EQV|NLM (1993)|920414|abbcdef
ENTRY = Na(+) K(+)-Transporting ATPase|T116|T126|EQV|NLM (1994)|930702|abbdef
ENTRY = Sodium, Potassium Adenosine Triphosphatase|T116|T126|NON|EQV|NLM (1993)|920414|abbcdef
ENTRY = ATPase Sodium, Potassium
ENTRY = ATPase, Sodium-Potassium-Exchanging
ENTRY = Adenosinetriphosphatase Sodium, Potassium
ENTRY = Pump, Potassium
ENTRY = Pump, Sodium
ENTRY = Pump, Sodium-Potassium
ENTRY = Sodium Potassium Exchanging ATPase
ENTRY = Sodium Potassium Pump
MN = D08.811.277.040.025.810
MN = D12.776.157.530.450.162.780
MN = D12.776.157.530.450.250.880
MN = D12.776.543.585.450.162.800
MN = D12.776.543.585.450.250.890
MH_TH = NLM (2008)
ST = T116
ST = T126
N1 = ATP phosphohydrolase (Na(+)-K(+)-transporting)
RN = EC 3.6.3.9
AN = DF: NA K ATPASE
PI = Adenosine Triphosphatase (1966-1978)
PI = Potassium (1966-1978)
PI = Sodium (1966-1978)
MS = An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients.
PM = 2008; see NA(+)-K(+)-EXCHANGING ATPASE 1994-2007, see NA(+) K(+)-TRANSPORTING ATPASE 1993; see SODIUM-POTASSIUM PUMP 1992-93; see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1979-1992
HN = 2008(1978)
MR = 20070709
DA = 19780306
DC = 1
DX = 19790101
UI = D000254

*NEWRECORD
RECTYPE = D
MH = Adenosine Triphosphate
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = ATP|T114|T121|T123|ABB|EQV|UNK (19XX)|740329|abbbcdef
PRINT ENTRY = Adenosine Triphosphate, Calcium Salt|T114|T123|NRW|NLM (1998)|970226|abbdef
PRINT ENTRY = Adenosine Triphosphate, Chromium Salt|T114|T123|NRW|NLM (1998)|970226|abbdef
PRINT ENTRY = Adenosine Triphosphate, Magnesium Salt|T114|T123|NRW|NLM (1990)|890424|abbdef
PRINT ENTRY = Adenosine Triphosphate, Manganese Salt|T114|T123|NON|NRW|NLM (2002)|abbcde
PRINT ENTRY = Adenylpyrophosphate|T114|T121|T123|NON|EQV|UNK (19XX)|740329|abbbcdef
PRINT ENTRY = CaATP|T114|T123|NRW|UNK (19XX)|850528|abbdef
PRINT ENTRY = CrATP|T114|T123|ABB|NRW|NLM (1998)|970226|abbcdef
PRINT ENTRY = Manganese Adenosine Triphosphate|T114|T123|NON|NRW|NLM (2002)|abbcde
PRINT ENTRY = MgATP|T114|T123|NRW|NLM (1990)|890424|abbdef
PRINT ENTRY = MnATP|T114|T123|NON|NRW|NLM (2002)|abbcde
ENTRY = ATP-MgCl2|T114|T121|T123|NRW|NLM (1990)|890424|abbbdef
ENTRY = Adenosine Triphosphate, Chromium Ammonium Salt|T114|T123|NRW|NLM (1998)|970226|abbdef
ENTRY = Adenosine Triphosphate, Magnesium Chloride|T114|T121|T123|NON|NRW|NLM (2002)|010413|abbbcdef
ENTRY = Atriphos|T114|T121|T123|TRD|NRW|NLM (1990)|890607|abbbcdef
ENTRY = Chromium Adenosine Triphosphate|T114|T123|NON|NRW|NLM (1998)|970226|abbcdef
ENTRY = Cr(H2O)4 ATP|T114|T123|ABB|NRW|NLM (1998)|970226|abbcdef
ENTRY = Magnesium Adenosine Triphosphate|T114|T123|NON|NRW|NLM (2002)|010413|abbcdef
ENTRY = Striadyne|T114|T121|T123|TRD|NRW|NLM (1996)|950403|abbbcdef
ENTRY = ATP MgCl2
MN = D03.438.759.646.138.236
MN = D13.695.667.138.236
MN = D13.695.827.068.236
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T114
ST = T121
ST = T123
N1 = Adenosine 5'-(tetrahydrogen triphosphate)
RN = 8L70Q75FXE
RR = 1476-84-2
RR = 56-65-5 (Adenosine Triphosphate)
RR = 56842-80-9
MS = An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.
PM = 1998; CHROMIUM ADENOSINE TRIPHOSPHATE was indexed under ADENOSINE TRIPHSOPHATE 1974-1997 and CHROMIUM 1974-1982; MANGANESE ATP was indexed under ADENOSINE TRIPHOSPHATE 1981-2001
HN = 1998; for CHROMIUM ADENOSINE TRIPHOSPHATE use ADENOSINE TRIPHOSPHATE (NM) 1974-1997; for MANGANESE ATP use ADENOSINE TRIPHOSPHATE (NM) 1981-2001
MR = 20130708
DA = 19990101
DC = 1
UI = D000255

*NEWRECORD
RECTYPE = D
MH = Adenoviridae
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
ENTRY = Adenoviruses|T005|NON|EQV|UNK (19XX)|800514|abcdef
ENTRY = Adenovirus
MN = B04.280.030
MH_TH = NLM (1966)
ST = T005
AN = a family of DNA viruses; adeno- refers to early isol from adenoids; infection = ADENOVIRIDAE INFECTIONS
MS = A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases.
OL = use ADENOVIRIDAE to search ADENOVIRUSES 1975-80 & ADENOVIRUS 1966-74
PM = 81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74
HN = 81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74
MR = 20150622
DA = 19990101
DC = 1
UI = D000256

*NEWRECORD
RECTYPE = D
MH = Adenoviridae Infections
DE = ADENOVIRIDAE INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Adenovirus Infections|T047|NON|EQV|NLM (1994)|930525|ADENOVIRUS INFECT|abcdefv
ENTRY = Infections, Adenoviridae|T047|NON|EQV|NLM (1994)|930505|INFECT ADENOVIRIDAE|abcdefv
ENTRY = Infections, Adenovirus|T047|NON|EQV|NLM (1994)|930505|INFECT ADENOVIRUS|abcdefv
ENTRY = Adenoviridae Infection
ENTRY = Adenovirus Infection
ENTRY = Infection, Adenoviridae
ENTRY = Infection, Adenovirus
MN = C02.256.076
MH_TH = NLM (1966)
ST = T047
AN = GEN or unspecified; prefer specifics; ADENOVIRUS INFECTIONS, HUMAN is available
MS = Virus diseases caused by the ADENOVIRIDAE.
OL = use ADENOVIRIDAE INFECTIONS to search ADENOVIRUS INFECTIONS 1966-93
PM = 94; was ADENOVIRUS INFECTIONS 1963-93
HN = 94; was ADENOVIRUS INFECTIONS 1963-93
CATSH = CAT LIST
MR = 20040713
DA = 19990101
DC = 1
UI = D000257

*NEWRECORD
RECTYPE = D
MH = Adenovirus Infections, Human
DE = ADENOVIRUS INFECT HUMAN
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VI
PRINT ENTRY = Pharyngo-Conjunctival Fever|T047|NON|NRW|UNK (19XX)|760517|abcdef
ENTRY = Human Adenovirus Infections|T047|NON|EQV|NLM (1991)|900425|HUMAN ADENOVIRUS INFECT|abcdefv
ENTRY = Infections, Human Adenovirus|T047|NON|EQV|NLM (1991)|900425|INFECT HUMAN ADENOVIRUS|abcdefv
ENTRY = Adenovirus Infection, Human
ENTRY = Fever, Pharyngo-Conjunctival
ENTRY = Human Adenovirus Infection
ENTRY = Infection, Human Adenovirus
ENTRY = Pharyngo Conjunctival Fever
MN = C02.256.076.045
MH_TH = NLM (1975)
ST = T047
MS = Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses.
OL = use ADENOVIRUS INFECTIONS, HUMAN to search PHARYNGO-CONJUNCTIVAL FEVER 1977-present; use ADENOVIRUS INFECTIONS 1966-76
PM = 91; was see under ADENOVIRUS INFECTIONS 1977-90; PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76
HN = 91(77); was see under ADENOVIRUS INFECTIONS 1977-90; PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76
CATSH = CAT LIST
MR = 20040713
DA = 19990101
DC = 1
DX = 19910101
UI = D000258

*NEWRECORD
RECTYPE = D
MH = Aviadenovirus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Adenoviruses, Avian|T005|NON|EQV|NLM (1994)|921105|abcdef
PRINT ENTRY = Avian Adenoviruses|T005|NON|EQV|NLM (1994)|921106|abcdef
ENTRY = Adenovirus, Avian
ENTRY = Aviadenoviruses
ENTRY = Avian Adenovirus
MN = B04.280.030.100
MH_TH = NLM (1977)
ST = T005
AN = infection: coord IM with ADENOVIRIDAE INFECTIONS (IM); DUCK ADENOVIRUS A see ATADENOVIRUS and TURKEY ADENOVIRUS 3 and TURKEY ADENOVIRUS A see SIADENOVIRUS are also available
PI = Adenoviruses (1966-1974)
MS = A genus of ADENOVIRIDAE that infects birds. The type species is FOWL ADENOVIRUS A.
PM = 1994; see ADENOVIRUSES, AVIAN 1990-93, see ADENOVIRIDAE 1981-1990, see ADENOVIRUSES 1977-1980
HN = 1994(1977)
MR = 20150622
DA = 19760416
DC = 1
DX = 19910101
UI = D000259

*NEWRECORD
RECTYPE = D
MH = Adenoviruses, Human
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = APC Viruses|T005|NON|EQV|UNK (19XX)|760416|abcdef
ENTRY = APC Virus
ENTRY = Adenovirus, Human
ENTRY = Human Adenovirus
ENTRY = Human Adenoviruses
MN = B04.280.030.500.350
MH_TH = NLM (1977)
ST = T005
AN = infection = ADENOVIRUS INFECTIONS, HUMAN
PI = Adenoviridae (1966-1974)
MS = Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes (named with Arabic numbers) have been grouped into species designated Human adenovirus A-F.
PM = 1977; for APC VIRUS (Adenoidal-Pharyngeal-Conjunctival virus) see ADENOVIRUSES 1975-1976, see ADENOVIRUS 1963-1974
HN = 1977
MR = 20150720
DA = 19760416
DC = 1
DX = 19770101
UI = D000260

*NEWRECORD
RECTYPE = D
MH = Adenoviruses, Simian
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Simian Adenoviruses|T005|NON|EQV|UNK (19XX)|741205|abcdef
ENTRY = Adenovirus, Simian
ENTRY = Simian Adenovirus
MN = B04.280.030.500.700
MH_TH = NLM (1975)
ST = T005
AN = species of the genus Mastadenovirus; infection: coord IM with ADENOVIRIDAE INFECTIONS (IM)
MS = Species of the genus MASTADENOVIRUS associated with respiratory and enteric infections in primate hosts.
PM = 91; was see under ADENOVIRIDAE 1981-90; was see under ADENOVIRUSES 1975-80
HN = 91(75); was see under ADENOVIRIDAE 1981-90; was see under ADENOVIRUSES 1975-80
MR = 20150622
DA = 19741212
DC = 1
DX = 19910101
UI = D000261

*NEWRECORD
RECTYPE = D
MH = Adenylyl Cyclases
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Adenyl Cyclase|T116|T126|NON|EQV|NLM (1998)|961115|abbcdef
PRINT ENTRY = Adenylate Cyclase|T116|T126|NON|EQV|NLM (1968)|990101|abbcdef
ENTRY = 3',5'-cyclic AMP Synthetase|T116|T126|ABX|EQV|NLM (2016)|150113|abbcdef
ENTRY = Adenylyl Cyclase|T116|T126|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = 3',5' cyclic AMP Synthetase
ENTRY = AMP Synthetase, 3',5'-cyclic
ENTRY = Cyclase, Adenyl
ENTRY = Cyclase, Adenylate
ENTRY = Cyclase, Adenylyl
ENTRY = Cyclases, Adenylyl
ENTRY = Synthetase, 3',5'-cyclic AMP
MN = D08.811.520.650.200
MN = D12.644.360.050
MN = D12.776.476.050
EC = antagonists & inhibitors:Adenylyl Cyclase Inhibitors
MH_TH = NLM (2016)
ST = T116
ST = T126
N1 = ATP pyrophosphate-lyase (cyclizing)
RN = EC 4.6.1.1
PI = Adenine Nucleotides (1966-1967)
PI = Enzymes (1966-1967)
MS = Enzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP.
PM = 2016; see ADENYLATE CYCLASE 1998-2015, see ADENYL CYCLASE 1972-97
HN = 2016(68)
MR = 20150402
DA = 19990101
DC = 1
DX = 19720101
UI = D000262

*NEWRECORD
RECTYPE = D
MH = Adenylate Kinase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Myokinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = AMP Kinase|T116|T126|EQV|UNK (19XX)|800818|abbdef
ENTRY = ATP-AMP Phosphotransferase|T116|T126|EQV|UNK (19XX)|821206|abbdef
ENTRY = ATP-AMP Transphosphorylase|T116|T126|EQV|UNK (19XX)|830330|abbdef
ENTRY = Adenylokinase|T116|T126|NON|EQV|NLM (1992)|910114|abbcdef
ENTRY = ATP AMP Phosphotransferase
ENTRY = ATP AMP Transphosphorylase
ENTRY = Kinase, AMP
ENTRY = Kinase, Adenylate
ENTRY = Phosphotransferase, ATP-AMP
ENTRY = Transphosphorylase, ATP-AMP
MN = D08.811.913.696.650.025
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = ATP:AMP phosphotransferase
RN = EC 2.7.4.3
RR = 9013-02-9 (CAS RN)
PI = Adenosine Monophosphate (1974)
PI = Phosphotransferases, ATP (1974)
MS = An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3.
PM = 91; was see under PHOSPHOTRANSFERASES, ATP 1975-90
HN = 91(75); was see under PHOSPHOTRANSFERASES, ATP 1975-90
MR = 20030709
DA = 19741111
DC = 1
DX = 19910101
UI = D000263

*NEWRECORD
RECTYPE = D
MH = Adenylosuccinate Lyase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Adenylosuccinase|T116|T126|NON|EQV|UNK (19XX)|780516|abbcdef
ENTRY = Lyase, Adenylosuccinate
MN = D08.811.520.232.300.200
MH_TH = NLM (1979)
ST = T116
ST = T126
N1 = N(6)-(1,2-Dicarboxyethyl)AMP AMP-lyase
RN = EC 4.3.2.2
RR = 9027-81-0 (CAS RN)
PI = Adenosine Monophosphate (1971-1978)
PI = Lyases (1966-1978)
PI = Succinates (1966-1978)
MS = An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyzes the conversion of 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole to 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. EC 4.3.2.2.
PM = 91; was see under LYASES 1979-90
HN = 91(79); was see under LYASES 1979-90
MR = 20030709
DA = 19780516
DC = 1
DX = 19910101
UI = D000264

*NEWRECORD
RECTYPE = D
MH = Adenylosuccinate Synthase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Adenylosuccinate Synthetase|T116|T126|NON|EQV|NLM (1998)|961105|abbcdef
ENTRY = Succino-AMP Synthetase|T116|T126|EQV|UNK (19XX)|840918|abbdef
ENTRY = Succino AMP Synthetase
ENTRY = Synthase, Adenylosuccinate
ENTRY = Synthetase, Adenylosuccinate
ENTRY = Synthetase, Succino-AMP
MN = D08.811.464.259.100
MH_TH = NLM (1979)
ST = T116
ST = T126
N1 = IMP:L-aspartate ligase (GDP-forming)
RN = EC 6.3.4.4
RR = 9023-57-8 (CAS RN)
PI = Aspartic Acid (1966-1978)
PI = Inosine Monophosphate (1975-1978)
PI = Inosine Nucleotides (1971-1978)
PI = Ligases (1966-1978)
MS = A carbon-nitrogen ligase. During purine ribonucleotide biosynthesis, this enzyme catalyzes the synthesis of adenylosuccinate from GTP; IMP; and aspartate with the formation of orthophosphate and GDP. EC 6.3.4.4.
PM = 98; see ADENYLOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1979-90
HN = 98(79)
MR = 20030709
DA = 19780516
DC = 1
DX = 19910101
UI = D000265

*NEWRECORD
RECTYPE = D
MH = Adenylyl Imidodiphosphate
DE = APPNHP
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Adenyl Imidodiphosphate|T114|T121|NON|EQV|UNK (19XX)|750630|abbcdef
PRINT ENTRY = gamma-Imino-ATP|T114|T121|EQV|UNK (19XX)|750630|abbdef
ENTRY = AMP-PNP|T114|T121|ABB|EQV|UNK (19XX)|800801|abbcdef
ENTRY = AMPPNP|T114|T121|ABB|EQV|UNK (19XX)|800818|abbcdef
ENTRY = ATP(beta,gamma-NH)|T114|T121|EQV|UNK (19XX)|821123|abbdef
ENTRY = Adenosine 5'-(beta,gamma-Imino)triphosphate|T114|T121|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = Adenylimidodiphosphate|T114|T121|NON|EQV|UNK (19XX)|800818|abbcdef
ENTRY = Adenylylimidodiphosphate|T114|T121|NON|EQV|UNK (19XX)|800818|abbcdef
ENTRY = Mg AMP-PNP|T114|T121|NRW|UNK (19XX)|861203|abbdef
ENTRY = Mg-5'-Adenylylimidodiphosphate|T114|T121|NRW|UNK (19XX)|821123|abbdef
ENTRY = beta,gamma-imido-ATP|T114|T121|EQV|UNK (19XX)|821123|abbdef
ENTRY = gamma-Imido-ATP|T114|T121|EQV|UNK (19XX)|800821|abbdef
ENTRY = AMP-PNP, Mg
ENTRY = Imidodiphosphate, Adenyl
ENTRY = Imidodiphosphate, Adenylyl
ENTRY = Mg 5' Adenylylimidodiphosphate
ENTRY = Mg AMP PNP
ENTRY = beta,gamma imido ATP
ENTRY = gamma Imido ATP
ENTRY = gamma Imino ATP
MN = D03.438.759.646.138.236.050
MN = D13.695.667.138.236.050
MN = D13.695.827.068.236.050
MH_TH = NLM (1976)
ST = T114
ST = T121
N1 = 5'-Adenylic acid, monoanhydride with imidodiphosphoric acid
RN = 25612-73-1
AN = /biosyn /physiol permitted; DF: APPNHP
PI = Adenosine Diphosphate (1973-1974)
PI = Adenosine Triphosphate/analogs & derivatives (1975)
PI = Imides (1973-1975)
PI = Phosphoric Acids (1973-1974)
MS = 5'-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation.
PM = 91; was see under ADENOSINE TRIPHOSPHATE 1976-90
HN = 91(76); was see under ADENOSINE TRIPHOSPHATE 1976-90
MR = 20060705
DA = 19750723
DC = 1
DX = 19910101
UI = D000266

*NEWRECORD
RECTYPE = D
MH = Tissue Adhesions
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Adhesions, Tissue|T020|T047|NON|EQV|NLM (2009)|071015|abbcdef
ENTRY = Surgery-Induced Tissue Adhesions|T020|T047|NON|NRW|NLM (2009)|071116|abbcdef
ENTRY = Surgical Adhesions|T020|T047|NON|NRW|NLM (2009)|071015|abbcdef
ENTRY = Adhesion, Surgery-Induced Tissue
ENTRY = Adhesion, Surgical
ENTRY = Adhesion, Tissue
ENTRY = Adhesions, Surgery-Induced Tissue
ENTRY = Adhesions, Surgical
ENTRY = Surgery Induced Tissue Adhesions
ENTRY = Surgery-Induced Tissue Adhesion
ENTRY = Surgical Adhesion
ENTRY = Tissue Adhesion
ENTRY = Tissue Adhesion, Surgery-Induced
ENTRY = Tissue Adhesions, Surgery-Induced
MN = C23.550.355.274.840
MH_TH = NLM (2009)
ST = T020
ST = T047
AN = IM GEN only; coordinate NIM with organ/disease term
MS = Pathological processes consisting of the union of the opposing surfaces of a wound.
PM = 2009; was ADHESIONS 1978-2008
HN = 2009 (1978)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000267

*NEWRECORD
RECTYPE = D
MH = Adhesiveness
AQ = DE RE
ENTRY = Adhesivenesses
MN = G02.842.850.139
FX = Platelet Adhesiveness
MH_TH = NLM (1969)
ST = T070
AN = NIM
PI = Surface Properties (1966-1968)
MS = A property of the surface of an object that makes it stick to another surface.
PM = 74
HN = 74(69)
MR = 20090706
DA = 19990101
DC = 1
DX = 19740101
UI = D000268

*NEWRECORD
RECTYPE = D
MH = Adhesives
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Glues|T073|NON|REL|UNK (19XX)|770418|abcdef
ENTRY = Mucilage Adhesive|T073|NON|NRW|NLM (2013)|111004|abcdef
ENTRY = Mucilage Adhesives|T073|NON|NRW|NLM (2013)|111004|abcdef
ENTRY = Mucilages, Adhesive|T073|NON|NRW|NLM (2013)|111004|abcdef
ENTRY = Adhesive
ENTRY = Adhesive Mucilage
ENTRY = Adhesive Mucilages
ENTRY = Adhesive, Mucilage
ENTRY = Adhesives, Mucilage
ENTRY = Glue
ENTRY = Mucilage, Adhesive
MN = D27.720.013
MN = J01.637.016
FX = Plant Mucilage
FX = Tissue Adhesives
MH_TH = NLM (1978)
ST = T073
ST = T122
RN = 0
AN = coordinate IM with DENTURE RETENTION (IM) for denture adhesives; spray adhesives: coordinate IM with AEROSOLS (NIM) if pertinent; BONE CEMENTS & DENTAL CEMENTS are also available; do not confuse entry term MUCILAGES, ADHESIVE with PLANT MUCILAGE
MS = Substances that cause the adherence of two surfaces. They include glues (properly collagen-derived adhesives), mucilages, sticky pastes, gums, resins, or latex.
PM = 78
HN = 78
MR = 20120703
DA = 19770422
DC = 1
DX = 19780101
UI = D000269

*NEWRECORD
RECTYPE = D
MH = Adie Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Holmes-Adie Syndrome|T047|EPO|EQV|NLM (1990)|OMIM (2013)|ORD (2010)|890322|abcdeeef
ENTRY = Adie's Syndrome|T047|EPO|EQV|NLM (1966)|990101|abcdef
ENTRY = Poorly Reacting Pupils|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Holmes Adie Syndrome
ENTRY = Poorly Reacting Pupil
ENTRY = Pupil, Poorly Reacting
ENTRY = Pupils, Poorly Reacting
ENTRY = Syndrome, Adie
ENTRY = Syndrome, Adie's
ENTRY = Syndrome, Holmes-Adie
MN = C10.177.045
MN = C10.292.562.700.250
MN = C11.590.436.200
MN = C11.710.800.180
MH_TH = NLM (2000)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
MS = A syndrome characterized by a TONIC PUPIL that occurs in combination with decreased lower extremity reflexes. The affected pupil will respond more briskly to accommodation than to light (light-near dissociation) and is supersensitive to dilute pilocarpine eye drops, which induce pupillary constriction. Pathologic features include degeneration of the ciliary ganglion and postganglionic parasympathetic fibers that innervate the pupillary constrictor muscle. (From Adams et al., Principles of Neurology, 6th ed, p279)
PM = 2000; see ADIE'S SYNDROME 1963-1999
HN = 2000 (1963)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D000270

*NEWRECORD
RECTYPE = D
MH = Adipates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Adipic Acids|T109|NON|REL|NLM (1966)|990101|abcdef
ENTRY = Hexanedioic Acids|T109|NON|REL|NLM (2013)|120125|abcdef
ENTRY = Acids, Adipic
ENTRY = Acids, Hexanedioic
MN = D02.241.081.337.052
MH_TH = NLM (2013)
ST = T109
RN = 0
MS = Derivatives of adipic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,6-carboxy terminated aliphatic structure.
PM = 2013; see ADIPIC ACIDS 1975-2013; see ADIPIC ACID 1963-1974
HN = 2013(1975)
MR = 20120703
DA = 19990101
DC = 1
UI = D000272

*NEWRECORD
RECTYPE = D
MH = Adipose Tissue
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Fatty Tissue|T024|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Body Fat|T024|NON|NRW|NLM (2007)|051104|abcdef
ENTRY = Fat Pad|T024|NON|NRW|NLM (2007)|050714|abcdef
ENTRY = Fat Pads
ENTRY = Pad, Fat
ENTRY = Pads, Fat
ENTRY = Tissue, Adipose
ENTRY = Tissue, Fatty
MN = A10.165.114
FX = Lipectomy
FX = Skinfold Thickness
MH_TH = NLM (1966)
ST = T024
AN = inflammation = PANNICULITIS; /surg: consider also LIPECTOMY; do not confuse with FAT BODY
MS = Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white.
MR = 20060705
DA = 19990101
DC = 1
UI = D000273

*NEWRECORD
RECTYPE = D
MH = Adiposis Dolorosa
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Dercum's Disease|T047|EPO|EQV|GHR (2014)|UNK (19XX)|740329|DERCUMS DIS|abcdeefv
ENTRY = Adiposalgia|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Adipose Tissue Rheumatism|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Ander's Syndrome|T047|EPO|EQV|GHR (2014)|ORD (2010)|150113|abcdeef
ENTRY = Anders Syndrome|T047|NON|EQV|GHR (2014)|NLM (2014)|130502|abcdeef
ENTRY = Decum-Vitaut Syndrome|T047|EPO|EQV|NLM (2016)|150113|abcdef
ENTRY = Dercum Disease|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|840615|DERCUM DIS|abcdeeeefv
ENTRY = Lipomatosis Dolorosa|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Morbus Dercum|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Adiposalgias
ENTRY = Adipose Tissue Rheumatisms
ENTRY = Ander Syndrome
ENTRY = Anders Syndromes
ENTRY = Decum Vitaut Syndrome
ENTRY = Dercum, Morbus
ENTRY = Dercums Disease
ENTRY = Dercums, Morbus
ENTRY = Disease, Dercum
ENTRY = Disease, Dercum's
ENTRY = Dolorosa, Lipomatosis
ENTRY = Dolorosas, Lipomatosis
ENTRY = Lipomatosis Dolorosas
ENTRY = Morbus Dercums
ENTRY = Rheumatism, Adipose Tissue
ENTRY = Rheumatisms, Adipose Tissue
ENTRY = Syndrome, Ander's
ENTRY = Syndrome, Anders
ENTRY = Syndrome, Decum-Vitaut
ENTRY = Syndromes, Anders
ENTRY = Tissue Rheumatism, Adipose
ENTRY = Tissue Rheumatisms, Adipose
MN = C17.800.463.249
MN = C18.452.584.718.500
MH_TH = GHR (2014)
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
MS = A rare disease characterized by multiple tumor-like fatty deposits that press on nerves in various sites causing pain and weakness. Often these lipoma-like structures are located on the trunk and limbs but not on the face and hands.
CATSH = CAT LIST
MR = 20150708
DA = 19990101
DC = 1
UI = D000274

*NEWRECORD
RECTYPE = D
MH = Adjustment Disorders
DE = ADJUSTMENT DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Anniversary Reaction|T048|NON|NRW|UNK (19XX)|860325|abcdef
PRINT ENTRY = Depression, Reactive|T048|NON|NRW|UNK (19XX)|800521|abcdef
PRINT ENTRY = Reactive Disorders|T048|NON|EQV|UNK (19XX)|800521|REACTIVE DIS|abcdefv
PRINT ENTRY = Transient Situational Disturbance|T048|NON|NRW|UNK (19XX)|830606|abcdef
ENTRY = Adjustment Disorder|T048|NON|EQV|UNK (19XX)|800521|abcdef
ENTRY = Anniversary Reactions
ENTRY = Depressions, Reactive
ENTRY = Disorder, Adjustment
ENTRY = Disorder, Reactive
ENTRY = Disorders, Adjustment
ENTRY = Disorders, Reactive
ENTRY = Disturbance, Transient Situational
ENTRY = Disturbances, Transient Situational
ENTRY = Reaction, Anniversary
ENTRY = Reactions, Anniversary
ENTRY = Reactive Depression
ENTRY = Reactive Depressions
ENTRY = Reactive Disorder
ENTRY = Situational Disturbance, Transient
ENTRY = Situational Disturbances, Transient
ENTRY = Transient Situational Disturbances
MN = F03.950.500
FX = Emotional Adjustment
MH_TH = NLM (1966)
ST = T048
MS = Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor.
OL = use ADJUSTMENT DISORDERS to search DEPRESSION, REACTIVE 1966-80 (as Prov 1966-68)
PM = 81; was DEPRESSION, REACTIVE 1969-80
HN = 81; was DEPRESSION, REACTIVE 1966-80 (Prov 1966-68)
CATSH = CAT LIST
MR = 20150409
DA = 19990101
DC = 1
DX = 19690101
UI = D000275

*NEWRECORD
RECTYPE = D
MH = Adjuvants, Immunologic
DE = ADJUVANTS IMMUNOL
AQ = AD AE AN BI BL CF CH CL CS CT DF EC GE HI IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Immunoactivators|T121|T129|NON|EQV|UNK (19XX)|781215|abbcdef
PRINT ENTRY = Immunoadjuvants|T121|T129|NON|EQV|UNK (19XX)|781215|abbcdef
PRINT ENTRY = Immunopotentiators|T121|T129|NON|EQV|UNK (19XX)|781215|abbcdef
PRINT ENTRY = Immunostimulants|T121|T129|NON|EQV|UNK (19XX)|781215|abbcdef
ENTRY = Adjuvant, Immunologic|T121|T129|NON|EQV|NLM (1992)|901002|ADJUVANT IMMUNOL|abbcdefv
ENTRY = Adjuvants, Immunological|T121|T129|NON|EQV|UNK (19XX)|780626|abbcdef
ENTRY = Immunologic Adjuvants|T121|T129|NON|EQV|UNK (19XX)|880729|IMMUNOL ADJUVANTS|abbcdefv
ENTRY = Immunological Adjuvant|T121|T129|NON|EQV|NLM (1994)|930127|IMMUNOL ADJUVANT|abbcdefv
ENTRY = Adjuvant, Immunological
ENTRY = Immunologic Adjuvant
ENTRY = Immunological Adjuvants
MN = D27.505.696.477.067
FX = Adjuvants, Pharmaceutic
MH_TH = NLM (1965)
ST = T121
ST = T129
RN = 0
AN = DF: ADJUVANTS IMMUNOL
MS = Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
PM = 65
HN = 65
MR = 20140625
DA = 19990101
DC = 1
DX = 19650101
UI = D000276

*NEWRECORD
RECTYPE = D
MH = Adjuvants, Pharmaceutic
DE = ADJUVANTS PHARM
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Adjuvant, Pharmaceutic|T120|NON|EQV|NLM (1994)|930122|ADJUVANT PHARM|abcdefv
ENTRY = Adjuvant, Pharmaceutical|T120|NON|EQV|NLM (1994)|930122|abcdef
ENTRY = Adjuvants, Pharmaceutical|T120|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Pharmaceutic Adjuvant|T120|NON|EQV|NLM (1994)|930122|PHARM ADJUVANT|abcdefv
ENTRY = Pharmaceutic Adjuvants|T120|NON|EQV|NLM (1994)|930111|PHARM ADJUVANTS|abcdefv
ENTRY = Pharmaceutical Adjuvant|T120|NON|EQV|NLM (1994)|930122|abcdef
ENTRY = Pharmaceutical Adjuvants|T120|NON|EQV|NLM (1994)|930122|abcdef
MN = D26.650.064
MN = D27.720.744.064
FX = Adjuvants, Immunologic
MH_TH = NLM (1975)
ST = T120
RN = 0
AN = DF: ADJUVANTS PHARM
PI = Pharmaceutic Aids (1968-1974)
MS = Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects.
OL = search PHARMACEUTIC AIDS 1969-74
PM = 75; was see under PHARMACEUTIC AIDS 1969-74
HN = 75; was see under PHARMACEUTIC AIDS 1969-74
MR = 20050630
DA = 19990101
DC = 1
DX = 19750101
UI = D000277

*NEWRECORD
RECTYPE = D
MH = Administration, Buccal
DE = ADMIN BUCCAL
PRINT ENTRY = Buccal Drug Administration|T061|NON|EQV|UNK (19XX)|870507|BUCCAL DRUG ADMIN|abcdefv
PRINT ENTRY = Drug Administration, Buccal|T061|NON|EQV|UNK (19XX)|870507|DRUG ADMIN BUCCAL|abcdefv
ENTRY = Buccal Administration|T061|NON|EQV|UNK (19XX)|870507|BUCCAL ADMIN|abcdefv
ENTRY = Administration, Buccal Drug
ENTRY = Administrations, Buccal
ENTRY = Administrations, Buccal Drug
ENTRY = Buccal Administrations
ENTRY = Buccal Drug Administrations
ENTRY = Drug Administrations, Buccal
MN = E02.319.267.100.028
MN = E02.319.267.120.040
MH_TH = NLM (1988)
ST = T061
AN = NIM but only if discussed: do not index here routinely for every buccally administered drug; no qualif
PI = Administration, Oral (1971-1987)
PI = Administration, Topical (1975-1987)
PI = Cheek (1966-1987)
MS = Administration of a soluble dosage form between the cheek and gingiva. It may involve direct application of a drug onto the buccal mucosa, as by painting or spraying.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20080708
DA = 19870507
DC = 1
DX = 19880101
UI = D000278

*NEWRECORD
RECTYPE = D
MH = Administration, Cutaneous
DE = ADMIN CUTANEOUS
PRINT ENTRY = Cutaneous Drug Administration|T061|NON|EQV|UNK (19XX)|860625|CUTANEOUS DRUG ADMIN|abcdefv
PRINT ENTRY = Dermal Drug Administration|T061|NON|EQV|UNK (19XX)|860625|DERMAL DRUG ADMIN|abcdefv
PRINT ENTRY = Drug Administration, Dermal|T061|NON|EQV|UNK (19XX)|860625|DRUG ADMIN DERMAL|abcdefv
PRINT ENTRY = Percutaneous Administration|T061|NON|NRW|UNK (19XX)|860625|PERCUTANEOUS ADMIN|abcdefv
PRINT ENTRY = Skin Drug Administration|T061|NON|EQV|UNK (19XX)|860625|SKIN DRUG ADMIN|abcdefv
PRINT ENTRY = Transcutaneous Administration|T061|NON|NRW|UNK (19XX)|860625|TRANSCUTANEOUS ADMIN|abcdefv
PRINT ENTRY = Transdermal Administration|T061|NON|NRW|UNK (19XX)|860625|TRANSDERMAL ADMIN|abcdefv
ENTRY = Administration, Dermal|T061|NON|EQV|NLM (1992)|910512|ADMIN DERMAL|abcdefv
ENTRY = Administration, Transcutaneous|T061|NON|NRW|UNK (19XX)|880625|ADMIN TRANSCUTANEOUS|abcdefv
ENTRY = Administration, Transdermal|T061|NON|NRW|UNK (19XX)|860625|ADMIN TRANSDERMAL|abcdefv
ENTRY = Cutaneous Administration|T061|NON|EQV|NLM (1992)|910512|CUTANEOUS ADMIN|abcdefv
ENTRY = Cutaneous Administration, Drug|T061|NON|EQV|NLM (1987)|910512|CUTANEOUS ADMIN DRUG|abcdefv
ENTRY = Dermal Administration|T061|NON|EQV|NLM (1992)|910512|DERMAL ADMIN|abcdefv
ENTRY = Drug Administration, Cutaneous|T061|NON|EQV|NLM (1992)|910512|DRUG ADMIN CUTANEOUS|abcdefv
ENTRY = Skin Administration, Drug|T061|NON|EQV|NLM (1987)|910512|SKIN ADMIN DRUG|abcdefv
ENTRY = Administration, Cutaneous Drug
ENTRY = Administration, Dermal Drug
ENTRY = Administration, Percutaneous
ENTRY = Administrations, Cutaneous
ENTRY = Administrations, Cutaneous Drug
ENTRY = Administrations, Dermal
ENTRY = Administrations, Dermal Drug
ENTRY = Administrations, Percutaneous
ENTRY = Administrations, Transcutaneous
ENTRY = Administrations, Transdermal
ENTRY = Cutaneous Administrations
ENTRY = Cutaneous Administrations, Drug
ENTRY = Cutaneous Drug Administrations
ENTRY = Dermal Administrations
ENTRY = Dermal Drug Administrations
ENTRY = Drug Administrations, Cutaneous
ENTRY = Drug Administrations, Dermal
ENTRY = Drug Skin Administrations
ENTRY = Percutaneous Administrations
ENTRY = Skin Administrations, Drug
ENTRY = Skin Drug Administrations
ENTRY = Transcutaneous Administrations
ENTRY = Transdermal Administrations
MN = E02.319.267.120.060
FX = Skin Absorption
MH_TH = NLM (1987)
ST = T061
AN = NIM but only if discussed: do not index here routinely for every cutaneously administered drug; no qualif
PI = Administration, Topical (1966-1986)
MS = The application of suitable drug dosage forms to the skin for either local or systemic effects.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20080708
DA = 19860625
DC = 1
DX = 19870101
UI = D000279

*NEWRECORD
RECTYPE = D
MH = Administration, Inhalation
DE = ADMIN INHALATION
PRINT ENTRY = Drug Administration, Inhalation|T061|NON|EQV|UNK (19XX)|860604|DRUG ADMIN INHALATION|abcdefv
PRINT ENTRY = Drug Administration, Respiratory|T061|NON|EQV|UNK (19XX)|860604|DRUG ADMIN RESPIRATORY|abcdefv
PRINT ENTRY = Drug Aerosol Therapy|T061|NON|REL|UNK (19XX)|860604|DRUG AEROSOL THER|abcdefv
PRINT ENTRY = Inhalation Drug Administration|T061|NON|EQV|UNK (19XX)|860604|INHALATION DRUG ADMIN|abcdefv
PRINT ENTRY = Inhalation of Drugs|T061|NON|REL|UNK (19XX)|860604|abcdef
PRINT ENTRY = Respiratory Drug Administration|T061|NON|EQV|UNK (19XX)|860604|RESPIRATORY DRUG ADMIN|abcdefv
ENTRY = Aerosol Drug Therapy|T061|NON|REL|NLM (1992)|911122|AEROSOL DRUG THER|abcdefv
ENTRY = Aerosol Therapy, Drug|T061|NON|REL|UNK (19XX)|860604|AEROSOL THER DRUG|abcdefv
ENTRY = Drug Therapy, Aerosol|T061|NON|REL|NLM (1992)|911122|DRUG THER AEROSOL|abcdefv
ENTRY = Inhalation Administration|T061|NON|EQV|UNK (19XX)|860604|INHALATION ADMIN|abcdefv
ENTRY = Administration, Inhalation Drug
ENTRY = Administration, Respiratory Drug
ENTRY = Therapy, Aerosol Drug
ENTRY = Therapy, Drug Aerosol
MN = E02.319.267.050
FX = Administration, Intranasal
FX = Aerosols
FX = Anesthesia, Inhalation
FX = Nebulizers and Vaporizers
FX = Respiratory Therapy
FX = Respiratory Tract Absorption
MH_TH = NLM (1987)
ST = T061
AN = NIM but only if discussed: do not index here routinely for every drug admin by inhalation; no qualif
PI = Aerosols (1966-1986)
PI = Lung (1966-1986)
PI = Respiration (1966-1986)
PI = Respiratory Therapy (1978-1986)
MS = The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20140606
DA = 19860604
DC = 1
DX = 19870101
UI = D000280

*NEWRECORD
RECTYPE = D
MH = Administration, Intranasal
DE = ADMIN INTRANASAL
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Drug Administration, Intranasal|T061|NON|EQV|UNK (19XX)|740329|DRUG ADMIN INTRANASAL|abcdefv
ENTRY = Administration, Intranasal Drug|T061|NON|EQV|UNK (19XX)|740329|ADMIN INTRANASAL DRUG|abcdefv
ENTRY = Administration, Nasal|T061|NON|EQV|NLM (2012)|101020|abcdef
ENTRY = Intranasal Administration|T061|NON|EQV|UNK (19XX)|740329|INTRANASAL ADMIN|abcdefv
ENTRY = Intranasal Drug Administration|T061|NON|EQV|UNK (19XX)|740329|INTRANASAL DRUG ADMIN|abcdefv
ENTRY = Administrations, Intranasal
ENTRY = Administrations, Intranasal Drug
ENTRY = Administrations, Nasal
ENTRY = Drug Administrations, Intranasal
ENTRY = Intranasal Administrations
ENTRY = Intranasal Drug Administrations
ENTRY = Nasal Administration
ENTRY = Nasal Administrations
MN = E02.319.267.120.655.500
FX = Administration, Inhalation
FX = Nasal Sprays
FX = Nebulizers and Vaporizers
MH_TH = NLM (1973)
ST = T061
PI = specific drug/administration & dosage (1966-1972)
MS = Delivery of medications through the nasal mucosa.
PM = 73
HN = 73
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19730101
UI = D000281

*NEWRECORD
RECTYPE = D
MH = Administration, Intravaginal
DE = ADMIN INTRAVAGINAL
PRINT ENTRY = Administration, Vaginal|T061|NON|EQV|UNK (19XX)|860604|ADMIN VAGINAL|abcdefv
PRINT ENTRY = Drug Administration, Vaginal|T061|NON|NRW|UNK (19XX)|860604|DRUG ADMIN VAGINAL|abcdefv
PRINT ENTRY = Instillation, Vaginal|T061|NON|NRW|UNK (19XX)|860604|abcdef
PRINT ENTRY = Intravaginal Administration|T061|NON|EQV|UNK (19XX)|860604|INTRAVAGINAL ADMIN|abcdefv
PRINT ENTRY = Vaginal Drug Administration|T061|NON|NRW|UNK (19XX)|860604|VAGINAL DRUG ADMIN|abcdefv
ENTRY = Vaginal Administration|T061|NON|EQV|UNK (19XX)|860604|VAGINAL ADMIN|abcdefv
ENTRY = Administration, Vaginal Drug
ENTRY = Administrations, Intravaginal
ENTRY = Administrations, Vaginal
ENTRY = Administrations, Vaginal Drug
ENTRY = Drug Administrations, Vaginal
ENTRY = Instillations, Vaginal
ENTRY = Intravaginal Administrations
ENTRY = Vaginal Administrations
ENTRY = Vaginal Drug Administrations
ENTRY = Vaginal Instillation
ENTRY = Vaginal Instillations
MN = E02.319.267.120.500
FX = Vaginal Absorption
FX = Vaginal Creams, Foams, and Jellies
MH_TH = NLM (1987)
ST = T061
AN = NIM but only if discussed: do not index here routinely for every intravaginally administered drug; no qualif
PI = Administration, Topical (1974-1986)
PI = Vagina (1966-1986)
PI = Vaginal Creams, Foams and Jellies (1975-1986)
MS = The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.
PM = 90; was see under ADMINISTRATION, TOPICAL 1987-89
HN = 90(87); was see under ADMINISTRATION, TOPICAL 1987-89
CATSH = CAT LIST
MR = 20140606
DA = 19860604
DC = 1
DX = 19900101
UI = D000282

*NEWRECORD
RECTYPE = D
MH = Administration, Intravesical
DE = ADMIN INTRAVESICAL
PRINT ENTRY = Bladder Drug Administration|T061|NON|EQV|NLM (1990)|890215|BLADDER DRUG ADMIN|abcdefv
PRINT ENTRY = Drug Administration, Bladder|T061|NON|EQV|UNK (19XX)|860604|DRUG ADMIN BLADDER|abcdefv
PRINT ENTRY = Instillation, Bladder|T061|NON|NRW|UNK (19XX)|860604|abcdef
PRINT ENTRY = Intravesical Drug Administration|T061|NON|EQV|UNK (19XX)|860604|INTRAVESICAL DRUG ADMIN|abcdefv
ENTRY = Administration, Intravesical Drug|T061|NON|EQV|UNK (19XX)|860604|ADMIN INTRAVESICAL DRUG|abcdefv
ENTRY = Injections, Intravesical|T061|NON|NRW|NLM (1991)|900103|INJECT INTRAVESICAL|abcdefv
ENTRY = Intravesical Administration|T061|NON|EQV|UNK (19XX)|860604|INTRAVESICAL ADMIN|abcdefv
ENTRY = Intravesical Injection|T061|NON|NRW|UNK (19XX)|860604|INTRAVESICAL INJECT|abcdefv
ENTRY = Intravesical Instillation|T061|NON|NRW|UNK (19XX)|860604|abcdef
ENTRY = Administration, Bladder Drug
ENTRY = Administrations, Bladder Drug
ENTRY = Administrations, Intravesical
ENTRY = Administrations, Intravesical Drug
ENTRY = Bladder Drug Administrations
ENTRY = Bladder Instillation
ENTRY = Bladder Instillations
ENTRY = Drug Administration, Intravesical
ENTRY = Drug Administrations, Bladder
ENTRY = Drug Administrations, Intravesical
ENTRY = Injection, Intravesical
ENTRY = Instillation, Intravesical
ENTRY = Instillations, Bladder
ENTRY = Instillations, Intravesical
ENTRY = Intravesical Administrations
ENTRY = Intravesical Drug Administrations
ENTRY = Intravesical Injections
ENTRY = Intravesical Instillations
MN = E02.319.267.120.505
MH_TH = NLM (1987)
ST = T061
AN = NIM but only if discussed: do not index here routinely for every intravesically administered drug; no qualif
PI = Administration, Topical (1974-1986)
PI = Bladder (1966-1986)
MS = The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20080708
DA = 19860604
DC = 1
DX = 19870101
UI = D000283

*NEWRECORD
RECTYPE = D
MH = Administration, Oral
DE = ADMIN ORAL
PRINT ENTRY = Drug Administration, Oral|T061|NON|EQV|UNK (19XX)|740329|DRUG ADMIN ORAL|abcdefv
ENTRY = Administration, Oral Drug|T061|NON|EQV|UNK (19XX)|740329|ADMIN ORAL DRUG|abcdefv
ENTRY = Oral Administration|T061|NON|EQV|UNK (19XX)|740329|ORAL ADMIN|abcdefv
ENTRY = Oral Drug Administration|T061|NON|EQV|UNK (19XX)|740329|ORAL DRUG ADMIN|abcdefv
ENTRY = Administrations, Oral
ENTRY = Administrations, Oral Drug
ENTRY = Drug Administrations, Oral
ENTRY = Oral Administrations
ENTRY = Oral Drug Administrations
MN = E02.319.267.100
MH_TH = NLM (1970)
ST = T061
AN = NIM but only if discussed: do not index here routinely for every orally administered drug; no qualif
PI = specific drug/administration & dosage (1966-1969)
MS = The giving of drugs, chemicals, or other substances by mouth.
PM = 73
HN = 73(70)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19730101
UI = D000284

*NEWRECORD
RECTYPE = D
MH = Administration, Rectal
DE = ADMIN RECTAL
PRINT ENTRY = Anal Drug Administration|T061|NON|EQV|UNK (19XX)|860604|ANAL DRUG ADMIN|abcdefv
PRINT ENTRY = Drug Administration, Rectal|T061|NON|EQV|UNK (19XX)|860604|DRUG ADMIN RECTAL|abcdefv
PRINT ENTRY = Instillation, Rectal|T061|NON|EQV|UNK (19XX)|860604|abcdef
PRINT ENTRY = Rectal Drug Administration|T061|NON|EQV|UNK (19XX)|860604|RECTAL DRUG ADMIN|abcdefv
ENTRY = Drug Administration, Anal|T061|NON|EQV|UNK (19XX)|860604|DRUG ADMIN ANAL|abcdefv
ENTRY = Rectal Administration|T061|NON|EQV|UNK (19XX)|860604|RECTAL ADMIN|abcdefv
ENTRY = Administration, Anal Drug
ENTRY = Administration, Rectal Drug
ENTRY = Administrations, Anal Drug
ENTRY = Administrations, Rectal
ENTRY = Administrations, Rectal Drug
ENTRY = Anal Drug Administrations
ENTRY = Drug Administrations, Anal
ENTRY = Drug Administrations, Rectal
ENTRY = Instillations, Rectal
ENTRY = Rectal Administrations
ENTRY = Rectal Drug Administrations
ENTRY = Rectal Instillation
ENTRY = Rectal Instillations
MN = E02.319.267.120.655.750
FX = Anesthesia, Rectal
FX = Rectal Absorption
FX = Suppositories
MH_TH = NLM (1987)
ST = T061
AN = NIM but only if discussed: do not index here routinely for every rectally administered drug
PI = Intestinal Absorption (1966-1986)
PI = Rectum (1966-1986)
PI = Suppositories (1966-1986)
MS = The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20150630
DA = 19860604
DC = 1
DX = 19870101
UI = D000285

*NEWRECORD
RECTYPE = D
MH = Administration, Sublingual
DE = ADMIN SUBLINGUAL
PRINT ENTRY = Drug Administration, Sublingual|T061|NON|EQV|UNK (19XX)|870507|DRUG ADMIN SUBLINGUAL|abcdefv
PRINT ENTRY = Sublingual Drug Administration|T061|NON|EQV|UNK (19XX)|870507|SUBLINGUAL DRUG ADMIN|abcdefv
ENTRY = Sublingual Administration|T061|NON|EQV|UNK (19XX)|870507|SUBLINGUAL ADMIN|abcdefv
ENTRY = Administration, Sublingual Drug
ENTRY = Administrations, Sublingual
ENTRY = Administrations, Sublingual Drug
ENTRY = Drug Administrations, Sublingual
ENTRY = Sublingual Administrations
ENTRY = Sublingual Drug Administrations
MN = E02.319.267.100.878
MH_TH = NLM (1988)
ST = T061
AN = NIM but only if discussed: do not index here routinely for every sublingually administered drug; no qualif
PI = Administration, Oral (1971-1987)
MS = Administration of a soluble dosage form by placement under the tongue.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20080708
DA = 19870507
DC = 1
DX = 19880101
UI = D000286

*NEWRECORD
RECTYPE = D
MH = Administration, Topical
DE = ADMIN TOPICAL
PRINT ENTRY = Drug Administration, Topical|T061|NON|EQV|UNK (19XX)|740329|DRUG ADMIN TOPICAL|abcdefv
ENTRY = Administration, Topical Drug|T061|NON|EQV|UNK (19XX)|740329|ADMIN TOPICAL DRUG|abcdefv
ENTRY = Topical Administration|T061|NON|EQV|UNK (19XX)|740329|TOPICAL ADMIN|abcdefv
ENTRY = Topical Drug Administration|T061|NON|EQV|UNK (19XX)|740329|TOPICAL DRUG ADMIN|abcdefv
ENTRY = Administrations, Topical
ENTRY = Administrations, Topical Drug
ENTRY = Drug Administrations, Topical
ENTRY = Topical Administrations
ENTRY = Topical Drug Administrations
MN = E02.319.267.120
MH_TH = NLM (1974)
ST = T061
AN = general; prefer specifics; "topical" in titles frequently means ADMINISTRATION, CUTANEOUS
MS = The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
PM = 74
HN = 74
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19740101
UI = D000287

*NEWRECORD
RECTYPE = D
MH = Administrative Personnel
AQ = CL EC ED ES HI LJ OG PX SD SN ST TD UT
PRINT ENTRY = Administrators|T097|NON|NRW|BIOETHICS (1978)|781204|abcdef
ENTRY = Policy Makers|T097|NON|NRW|POPLINE (1993)|940315|abcdef
ENTRY = Administrator
ENTRY = Personnel, Administrative
ENTRY = Policy Maker
MN = M01.526.070
MH_TH = POPLINE (1978)
ST = T097
PI = Organization and Administration (1966-1967)
MS = Individuals responsible for the development of policy and supervision of the execution of plans and functional operations.
PM = 68
HN = 68
MR = 19940317
DA = 19990101
DC = 1
DX = 19680101
UI = D000288

*NEWRECORD
RECTYPE = D
MH = Admitting Department, Hospital
DE = ADMITTING DEP HOSP
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
PRINT ENTRY = Hospital Admissions Office|T093|NON|EQV|UNK (19XX)|770519|HOSP ADMISSIONS OFFICE|abcdefv
PRINT ENTRY = Hospital Admitting Department|T093|NON|EQV|UNK (19XX)|770519|HOSP ADMITTING DEP|abcdefv
ENTRY = Admitting Department|T093|NON|BRD|NLM (1991)|900308|ADMIT DEP|abcdefv
ENTRY = Admissions Office, Hospital
ENTRY = Admissions Offices, Hospital
ENTRY = Admitting Departments
ENTRY = Admitting Departments, Hospital
ENTRY = Department, Admitting
ENTRY = Department, Hospital Admitting
ENTRY = Departments, Admitting
ENTRY = Departments, Hospital Admitting
ENTRY = Hospital Admissions Offices
ENTRY = Hospital Admitting Departments
ENTRY = Office, Hospital Admissions
ENTRY = Offices, Hospital Admissions
MN = N02.278.216.500.968.040
MN = N04.452.442.422.040
MH_TH = NLM (1977)
ST = T093
AN = DF: ADMIT DEP
MS = Hospital department responsible for the flow of patients and the processing of admissions, discharges, transfers, and also most procedures to be carried out in the event of a patient's death.
PM = 91; was see under HOSPITAL DEPARTMENTS 1977-90
HN = 91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90
MR = 20150622
DA = 19770519
DC = 1
DX = 19910101
UI = D000289

*NEWRECORD
RECTYPE = D
MH = Adnexa Uteri
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
PRINT ENTRY = Uterine Appendages|T023|NON|EQV|NLM (2003)|011119|abcdef
ENTRY = Appendage, Uterine
ENTRY = Appendages, Uterine
ENTRY = Uterine Appendage
MN = A05.360.319.114
FX = Adnexal Diseases
MH_TH = NLM (1966)
ST = T023
AN = seen in titles more frequently in adjective form "adnexal"; inflammation = ADNEXITIS
MS = Appendages of the UTERUS which include the FALLOPIAN TUBES, the OVARY, and the supporting ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).
MR = 20130709
DA = 19990101
DC = 1
UI = D000290

*NEWRECORD
RECTYPE = D
MH = Adnexal Diseases
DE = ADNEXAL DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Adnexal Disease
ENTRY = Disease, Adnexal
ENTRY = Diseases, Adnexal
MN = C13.351.500.056
MH_TH = NLM (1966)
ST = T047
AN = inflamm dis = PELVIC INFLAMMATORY DISEASE
MS = Diseases of the uterine appendages (ADNEXA UTERI) including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19660101
UI = D000291

*NEWRECORD
RECTYPE = D
MH = Pelvic Inflammatory Disease
DE = PELVIC INFLAMM DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Adnexitis|T047|NON|NRW|NLM (1963)|990101|abcdef
ENTRY = Inflammatory Disease, Pelvic|T047|NON|EQV|NLM (1996)|950309|INFLAMM DIS PELVIC|abcdefv
ENTRY = Inflammatory Pelvic Disease|T047|NON|EQV|NLM (1996)|950309|INFLAMM PELVIC DIS|abcdefv
ENTRY = Pelvic Disease, Inflammatory|T047|NON|EQV|NLM (1996)|950309|PELVIC DIS INFLAMM|abcdefv
ENTRY = Disease, Inflammatory Pelvic
ENTRY = Disease, Pelvic Inflammatory
ENTRY = Diseases, Inflammatory Pelvic
ENTRY = Diseases, Pelvic Inflammatory
ENTRY = Inflammatory Diseases, Pelvic
ENTRY = Inflammatory Pelvic Diseases
ENTRY = Pelvic Diseases, Inflammatory
ENTRY = Pelvic Inflammatory Diseases
MN = C01.539.635.500
MN = C13.351.500.056.750
MH_TH = NLM (1966)
ST = T047
AN = female only: note category; "male adnexitis": index under GENITAL DISEASES, MALE or PELVIC INFECTION
MS = A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.
PM = 2003; see ADNEXITIS 1963-2002
HN = 2003 (1963)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D000292

*NEWRECORD
RECTYPE = D
MH = Adolescent
AQ = LJ PH
PRINT ENTRY = Adolescence|T100|NON|REL|NLM (1966)|990101|abcdef
PRINT ENTRY = Youth|T100|NON|BRD|NLM (1987)|740329|abcdef
ENTRY = Adolescents|T100|NON|EQV|BIOETHICS (1974)|NLM (1978)|770317|abcdeef
ENTRY = Adolescents, Female|T100|NON|REL|NLM (1979)|781218|abcdef
ENTRY = Adolescents, Male|T100|NON|REL|NLM (1978)|781218|abcdef
ENTRY = Teenagers|T100|NON|REL|NLM (2003)|020227|abcdef
ENTRY = Teens|T100|NON|REL|NLM (1994)|930201|abcdef
ENTRY = Adolescent, Female
ENTRY = Adolescent, Male
ENTRY = Female Adolescent
ENTRY = Female Adolescents
ENTRY = Male Adolescent
ENTRY = Male Adolescents
ENTRY = Teen
ENTRY = Teenager
ENTRY = Youths
MN = M01.060.057
FX = Minors
EC = psychology:Psychology, Adolescent
MH_TH = NLM (2003)
ST = T100
AN = almost always check tag: NIM no qualifiers; see Manual Chapter 9
MS = A person 13 to 18 years of age.
MR = 20150623
DA = 19990101
DC = 1
UI = D000293

*NEWRECORD
RECTYPE = D
MH = Adolescent Behavior
AQ = CL DE EH ES HI PH PX RE
PRINT ENTRY = Behavior, Adolescent|T055|NON|EQV|UNK (19XX)|800507|abcdef
ENTRY = Adolescent Behaviors
ENTRY = Behaviors, Adolescent
MN = F01.145.022
FX = Adolescent Development
MH_TH = NLM (1981)
ST = T055
AN = check also tag ADOLESCENCE
PI = Adolescent Psychology (1967-1980)
MS = Any observable response or action of an adolescent.
PM = 81
HN = 81
CATSH = CAT LIST
MR = 20100625
DA = 19800507
DC = 1
DX = 19810101
UI = D000294

*NEWRECORD
RECTYPE = D
MH = Adolescent Medicine
DE = ADOLESCENT MED
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Ephebiatrics|T091|NON|EQV|NLM (2016)|141217|abcdef
ENTRY = Hebiatrics|T091|NON|EQV|NLM (2016)|141217|abcdef
ENTRY = Medicine, Adolescent|T091|NON|EQV|NLM (1991)|891129|MED ADOLESCENT|abcdefv
MN = H02.403.014
FX = Adolescent Health
FX = Adolescent Health Services
MH_TH = NLM (1980)
ST = T091
AN = a specialty but may  also be used for very general articles on adolescent diseases
PI = Adolescence (1966-1979)
MS = A branch of medicine pertaining to the diagnosis and treatment of diseases occurring during the period of ADOLESCENCE.
PM = 80
HN = 80
MR = 20150629
DA = 19790529
DC = 1
DX = 19800101
UI = D000295

*NEWRECORD
RECTYPE = D
MH = Adolescent Psychiatry
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Psychiatry, Adolescent
MN = F04.096.544.065
MN = H02.403.690.080
MH_TH = POPLINE (1994)
ST = T091
AN = SPEC: SPEC qualif; not for mental disorders in adolescents ( = MENTAL DISORDERS (IM) + ADOLESCENT (NIM) ): Manual 27.9
PI = Child Psychiatry (1966)
PI = Psychiatry (1966)
PI = Psychoanalysis (1966)
MS = The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in individuals 13-18 years.
PM = 67
HN = 67
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19670101
UI = D000296

*NEWRECORD
RECTYPE = D
MH = Psychology, Adolescent
DE = PSYCHOL ADOLESCENT
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Adolescent Psychology|T091|NON|EQV|NLM (1966)|990101|ADOLESCENT PSYCHOL|abcdefv
MN = F04.096.628.065
FX = Psychology, Developmental
MH_TH = UNK (19XX)
ST = T091
AN = use for the specialty and also for articles on the way a normal adolescent thinks & acts
MS = Field of psychology involving the study of normal and abnormal behavior of adolescents. It includes mental processes as well as observable responses.
PM = 1967; see ADOLESCENT PSYCHOLOGY 1967-2014
HN = 1967; use ADOLESCENT PSYCHOLOGY 1967-2014
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
UI = D000297

*NEWRECORD
RECTYPE = D
MH = Adolescent, Hospitalized
AQ = ED PX SN
ENTRY = Adolescents, Hospitalized
ENTRY = Hospitalized Adolescent
ENTRY = Hospitalized Adolescents
MN = M01.643.050
FX = Adolescent, Institutionalized
MH_TH = NLM (1983)
ST = T101
AN = not for dis in adolescent in hosp for diag or ther: use only for hospitalized adolescents as a psychol, sociol or social entity; check also tag ADOLESCENT
PI = Adolescence (1966-1982)
PI = Hospitalization (1966-1982)
MS = Adolescent hospitalized for short term care.
PM = 83
HN = 83
MR = 20020702
DA = 19820428
DC = 1
DX = 19830101
UI = D000298

*NEWRECORD
RECTYPE = D
MH = Adolescent, Institutionalized
AQ = ED PX SN
PRINT ENTRY = Institutionalized Adolescent|T101|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Adolescents, Institutionalized
ENTRY = Institutionalized Adolescents
MN = M01.643.154
MH_TH = NLM (1983)
ST = T101
AN = check also tag ADOLESCENT
PI = Adolescence (1966-1982)
PI = Institutionalization (1979-1982)
PI = Residential Facilities (1968-1982)
MS = An adolescent who is receiving long-term in-patient services or who resides in an institutional setting.
PM = 83
HN = 83
MR = 20020702
DA = 19820428
DC = 1
DX = 19830101
UI = D000299

*NEWRECORD
RECTYPE = D
MH = Adoption
AQ = EH LJ PX
ENTRY = Adoptions
MN = I01.880.853.150.140
MH_TH = BIOETHICS (1989)
MH_TH = POPLINE (1981)
ST = T054
MS = Voluntary acceptance of a child of other parents to be as one's own child, usually with legal confirmation.
MR = 19970620
DA = 19990101
DC = 1
UI = D000300

*NEWRECORD
RECTYPE = D
MH = Adosterol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 6-Iodomethylnorcholesterol|T110|T130|NON|EQV|UNK (19XX)|780516|IODOMETHYLNORCHOLESTEROL 06|abbcdefs
ENTRY = NCL-6|T110|T130|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = NP-59|T110|T130|LAB|NRW|UNK (19XX)|780516|abbcdef
ENTRY = 6 Iodomethylnorcholesterol
ENTRY = NCL 6
ENTRY = NCL6
ENTRY = NP59
MN = D04.808.247.808.050
MN = D10.570.938.073
MH_TH = NLM (1979)
ST = T110
ST = T130
N1 = 19-Norcholest-5(10)-en-3-ol, 6-(iodomethyl)-, (3beta,6beta)-
RN = 55623-03-5
PI = Cholestenes (1973-1978)
PI = Iodine Radioisotopes (1966-1978)
PI = Sterols (1966-1978)
MS = A sterol usually substituted with radioactive iodine. It is an adrenal cortex scanning agent with demonstrated high adrenal concentration and superior adrenal imaging.
PM = 91; was see under CHOLESTEROL 1989-90; was see under STEROLS 1979-88
HN = 91(79); was see under CHOLESTEROL 1989-90; was see under STEROLS 1979-88
MR = 20150622
DA = 19780516
DC = 1
DX = 19910101
UI = D000301

*NEWRECORD
RECTYPE = D
MH = Adrenal Cortex
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Cortex, Adrenal
MN = A06.407.071.140
MH_TH = NLM (1975)
ST = T023
AN = PITUITARY-ADRENAL SYSTEM is available
PI = Adrenal Glands (1966-1974)
MS = The outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones (outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS) with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN.
OL = search ADRENAL GLANDS 1966-74
PM = 78,63-67; was see under ADRENAL GLANDS 1968-77
HN = 78(75)63-67; was see under ADRENAL GLANDS 1968-77
MR = 20040707
DA = 19990101
DC = 1
DX = 19780101
UI = D000302

*NEWRECORD
RECTYPE = D
MH = Adrenal Cortex Diseases
DE = ADRENAL CORTEX DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Adrenal Cortex Disease
ENTRY = Cortex Disease, Adrenal
ENTRY = Cortex Diseases, Adrenal
ENTRY = Disease, Adrenal Cortex
ENTRY = Diseases, Adrenal Cortex
MN = C19.053.098
MH_TH = NLM (1975)
ST = T047
PI = Adrenal Gland Diseases (1966-1974)
MS = Pathological processes of the ADRENAL CORTEX.
OL = search ADRENAL GLAND DISEASES 1966-74
PM = 79,63-67; was see under ADRENAL GLAND DISEASES 1975-78
HN = 79(75)63-67; was see under ADRENAL GLAND DISEASES 1975-78
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
DX = 19790101
UI = D000303

*NEWRECORD
RECTYPE = D
MH = Adrenal Cortex Function Tests
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
MN = E01.370.374.050
MH_TH = NLM (1975)
ST = T060
MS = Examinations that evaluate and monitor hormone production in the adrenal cortex.
OL = search PITUITARY-ADRENAL FUNCTION TESTS 1966-74
PM = 91,63-67; was see under PITUITARY-ADRENAL FUNCTION TESTS 1975-90; was heading 1963-67
HN = 91(75)63-67; was see under PITUITARY-ADRENAL FUNCTION TESTS 1975-90; was heading 1963-67
CATSH = CAT LIST
MR = 20150522
DA = 19990101
DC = 1
DX = 19910101
UI = D000304

*NEWRECORD
RECTYPE = D
MH = Adrenal Cortex Hormones
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Corticoids|T110|T125|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Corticosteroids|T110|T125|NON|EQV|UNK (19XX)|750101|abbcdef
ENTRY = Hormones, Adrenal Cortex
MN = D06.472.040
FX = Adrenal Insufficiency
FX = Adrenocortical Hyperfunction
FX = Receptors, Glucocorticoid
MH_TH = POPLINE (1978)
ST = T110
ST = T125
RN = 0
AN = GEN only; avoid: prefer specifics; /defic: consider also ADRENAL GLAND HYPOFUNCTION
MR = 20040720
DA = 19990101
DC = 1
UI = D000305

*NEWRECORD
RECTYPE = D
MH = Adrenal Cortex Neoplasms
DE = ADRENAL CORTEX NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Adrenocortical Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Cancer of Adrenal Cortex|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Adrenal Cortex Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer of the Adrenal Cortex|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Neoplasms, Adrenal Cortex|T191|NON|EQV|NLM (1995)|930901|NEOPL ADRENAL CORTEX|abcdefv
ENTRY = Adrenal Cortex Cancers
ENTRY = Adrenal Cortex Neoplasm
ENTRY = Adrenocortical Cancers
ENTRY = Cancer, Adrenal Cortex
ENTRY = Cancer, Adrenocortical
ENTRY = Cancers, Adrenal Cortex
ENTRY = Cancers, Adrenocortical
ENTRY = Neoplasm, Adrenal Cortex
MN = C04.588.322.078.265
MN = C19.053.098.265
MN = C19.053.347.500
MN = C19.344.078.265
MH_TH = NLM (1975)
ST = T191
AN = coord IM with histol type of neopl (IM)
PI = Adrenal Gland Neoplasms (1966-1974)
MS = Tumors or cancers of the ADRENAL CORTEX.
OL = search ADRENAL GLAND NEOPLASMS 1966-74
PM = 79,63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78
HN = 79(75)63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
DX = 19790101
UI = D000306

*NEWRECORD
RECTYPE = D
MH = Adrenal Gland Diseases
DE = ADRENAL GLAND DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Adrenal Gland Disease
ENTRY = Disease, Adrenal Gland
ENTRY = Diseases, Adrenal Gland
ENTRY = Gland Disease, Adrenal
ENTRY = Gland Diseases, Adrenal
MN = C19.053
MH_TH = NLM (1966)
ST = T047
AN = general; prefer specifics; coordinate IM with ADRENAL MEDULLA (IM) for diseases of adrenal medulla; for adrenal hyperplasia see note at ADRENAL GLANDS
MS = Pathological processes of the ADRENAL GLANDS.
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
UI = D000307

*NEWRECORD
RECTYPE = D
MH = Adrenocortical Hyperfunction
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Hyperadrenocorticism|T047|NON|EQV|NLM (2005)|040122|abcdef
PRINT ENTRY = Hypercorticism|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Adrenal Gland Hyperfunction|T047|NON|EQV|NLM (1968)|990101|abcdef
ENTRY = Hyperadrenalism|T047|NON|EQV|NLM (2005)|040122|abcdef
ENTRY = Hyperfunction, Adrenal Gland
ENTRY = Hyperfunction, Adrenocortical
MN = C19.053.800
FX = Hyperandrogenism
EC = congenital:Adrenal Hyperplasia, Congenital
MH_TH = NLM (2005)
ST = T047
AN = do not confuse with ADRENAL GLAND HYPOFUNCTION; non-congenital adrenal hyperplasia: index under ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM)
MS = Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM.
PM = 2005; see ADRENAL GLAND HYPERFUNCTION 1968-2004
HN = 2005 (1968)
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
DX = 19680101
UI = D000308

*NEWRECORD
RECTYPE = D
MH = Adrenal Insufficiency
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Adrenal Gland Hypofunction|T047|NON|EQV|NLM (1968)|990101|abcdef
ENTRY = Hypoadrenalism|T047|NON|EQV|NLM (2005)|040218|abcdef
ENTRY = Adrenal Insufficiencies
ENTRY = Hypofunction, Adrenal Gland
MN = C19.053.500
FX = Adrenal Cortex Hormones
MH_TH = NLM (2005)
ST = T047
AN = do not confuse with ADRENAL GLAND HYPERFUNCTION
MS = Conditions in which the production of adrenal CORTICOSTEROIDS falls below the requirement of the body. Adrenal insufficiency can be caused by defects in the ADRENAL GLANDS, the PITUITARY GLAND, or the HYPOTHALAMUS.
PM = 2005; see ADRENAL GLAND HYPOFUNCTION 1968-2004
HN = 2005 (1968)
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
DX = 19680101
UI = D000309

*NEWRECORD
RECTYPE = D
MH = Adrenal Gland Neoplasms
DE = ADRENAL GLAND NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Adrenal Cancer|T191|NON|NRW|NLM (2000)|ORD (2010)|991108|abcdeef
ENTRY = Adrenal Gland Cancer|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Adrenal Neoplasm|T191|NON|EQV|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Cancer of the Adrenal Gland|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Neoplasms, Adrenal Gland|T191|NON|EQV|NLM (2000)|991108|NEOPL ADRENAL GLAND|abcdefv
ENTRY = Adrenal Cancers
ENTRY = Adrenal Gland Cancers
ENTRY = Adrenal Gland Neoplasm
ENTRY = Adrenal Neoplasms
ENTRY = Cancer, Adrenal
ENTRY = Cancer, Adrenal Gland
ENTRY = Cancers, Adrenal
ENTRY = Cancers, Adrenal Gland
ENTRY = Neoplasm, Adrenal
ENTRY = Neoplasm, Adrenal Gland
ENTRY = Neoplasms, Adrenal
MN = C04.588.322.078
MN = C19.053.347
MN = C19.344.078
MH_TH = NLM (1966)
ST = T191
AN = coord IM with histol type of neopl (IM)
MS = Tumors or cancer of the ADRENAL GLANDS.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000310

*NEWRECORD
RECTYPE = D
MH = Adrenal Glands
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Adrenal Gland
ENTRY = Gland, Adrenal
ENTRY = Glands, Adrenal
MN = A06.407.071
FX = Adrenalectomy
MH_TH = NLM (1966)
ST = T023
AN = /surg = probably ADRENALECTOMY; hypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM; hyperplasia = ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM); congenital adrenal hyperplasia (CAH) = ADRENAL HYPERPLASIA, CONGENITAL
MS = A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS.
MR = 20040707
DA = 19990101
DC = 1
UI = D000311

*NEWRECORD
RECTYPE = D
MH = Adrenal Hyperplasia, Congenital
DE = ADRENAL HYPERPLASIA CONGEN
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Congenital Adrenal Hyperplasia|T047|NON|EQV|UNK (19XX)|790613|CONGEN ADRENAL HYPERPLASIA|abcdefv
ENTRY = Hyperplasia, Congenital Adrenal|T047|NON|EQV|UNK (19XX)|790613|HYPERPLASIA CONGEN ADRENAL|abcdefv
ENTRY = Adrenal Hyperplasias, Congenital
ENTRY = Congenital Adrenal Hyperplasias
ENTRY = Hyperplasias, Congenital Adrenal
MN = C12.706.316.129.500
MN = C13.351.875.253.129.500
MN = C16.131.939.316.129.500
MN = C16.320.033
MN = C16.320.565.925.249
MN = C18.452.648.925.249
MN = C19.053.440
MN = C19.391.119.129.500
FX = 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
FX = Puberty, Precocious
FX = Steroid 11-beta-Hydroxylase
FX = Steroid 17-alpha-Hydroxylase
FX = Steroid 21-Hydroxylase
FX = Virilism
MH_TH = NLM (1966)
ST = T047
MS = A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders.
OL = use ADRENAL HYPERPLASIA, CONGENITAL to search ADRENOGENITAL SYNDROME 1966-79
PM = 80; was ADRENOGENITAL SYNDROME 1963-79
HN = 80; was ADRENOGENITAL SYNDROME 1963-79
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000312

*NEWRECORD
RECTYPE = D
MH = Adrenal Medulla
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Adrenal Medullas
ENTRY = Medulla, Adrenal
ENTRY = Medullas, Adrenal
MN = A06.407.071.265
MH_TH = NLM (1966)
ST = T023
AN = dis = ADRENAL MEDULLA (IM) + ADRENAL GLAND DISEASES (IM); medulla enucleation: for physiol studies, ADRENAL MEDULLA /physiol, for surg ther, ADRENAL MEDULLA /surg
MS = The inner portion of the adrenal gland. Derived from ECTODERM, adrenal medulla consists mainly of CHROMAFFIN CELLS that produces and stores a number of NEUROTRANSMITTERS, mainly adrenaline (EPINEPHRINE) and NOREPINEPHRINE. The activity of the adrenal medulla is regulated by the SYMPATHETIC NERVOUS SYSTEM.
MR = 20040707
DA = 19990101
DC = 1
UI = D000313

*NEWRECORD
RECTYPE = D
MH = Adrenal Rest Tumor
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
PRINT ENTRY = Adrenal Cortical Rest Tumor|T191|NON|EQV|UNK (19XX)|810519|abcdef
ENTRY = Adrenal Rest Tumors
ENTRY = Rest Tumor, Adrenal
ENTRY = Rest Tumors, Adrenal
ENTRY = Tumor, Adrenal Rest
ENTRY = Tumors, Adrenal Rest
MN = C04.557.470.035.232
MH_TH = NLM (1966)
ST = T191
AN = coordinate IM with tissue-specific neoplasms such as TESTICULAR NEOPLASMS (IM)
MS = Neoplasm derived from displaced cells (rest cells) of the primordial ADRENAL GLANDS, generally in patients with CONGENITAL ADRENAL HYPERPLASIA. Adrenal rest tumors have been identified in TESTES; LIVER; and other tissues. They are dependent on ADRENOCORTICOTROPIN for growth and adrenal steroid secretion.
OL = use ADRENAL REST TUMOR to search ADRENAL CORTICAL REST TUMOR 1966-81
PM = 82; was ADRENAL CORTICAL REST TUMOR 1963-81
HN = 82; was ADRENAL CORTICAL REST TUMOR 1963-81
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
UI = D000314

*NEWRECORD
RECTYPE = D
MH = Adrenalectomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Adrenalectomies
MN = E04.270.115
MH_TH = NLM (1966)
ST = T061
AN = excision of entire adrenal; enucleation: see note under ADRENAL MEDULLA
MS = Excision of one or both adrenal glands. (From Dorland, 28th ed)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D000315

*NEWRECORD
RECTYPE = D
MH = Adrenergic alpha-Agonists
DE = ADREN ALPHA AG
DS = ADRENERGIC AGONISTS ALPHA
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Adrenergic alpha-Receptor Agonists|T121|NON|EQV|NLM (1995)|940128|ADRENERGIC RECEPTOR AGONISTS ALPHA|ADREN ALPHA RECEPT AGON|abcdefsv
PRINT ENTRY = alpha-Adrenergic Receptor Agonists|T121|NON|EQV|UNK (19XX)|740329|ALPHA ADREN RECEPT AGON|abcdefv
ENTRY = Adrenergic alpha-Agonist|T121|NON|EQV|NLM (1995)|940419|ADREN ALPHA AGON|abcdefv
ENTRY = Adrenergic alpha-Receptor Agonist|T121|NON|EQV|NLM (1995)|940526|ADREN ALPHA RECEPT AG|abcdefv
ENTRY = Receptor Agonists, Adrenergic alpha|T121|NON|EQV|NLM (1995)|940425|RECEPT AGON ADREN ALPHA|abcdefv
ENTRY = Receptor Agonists, alpha-Adrenergic|T121|NON|EQV|NLM (1995)|940425|RECEPT AGON ALPHA ADREN|abcdefv
ENTRY = alpha-Adrenergic Agonist|T121|NON|EQV|NLM (1995)|940513|ALPHA ADREN AG|abcdefv
ENTRY = alpha-Adrenergic Agonists|T121|NON|EQV|NLM (1995)|940128|ALPHA ADREN AGON|abcdefv
ENTRY = alpha-Adrenergic Receptor Agonist|T121|NON|EQV|NLM (1995)|940513|ALPHA ADREN RECEPT AG|abcdefv
ENTRY = Adrenergic alpha Agonist
ENTRY = Adrenergic alpha Agonists
ENTRY = Adrenergic alpha Receptor Agonist
ENTRY = Adrenergic alpha Receptor Agonists
ENTRY = Agonist, Adrenergic alpha-Receptor
ENTRY = Agonist, alpha-Adrenergic
ENTRY = Agonist, alpha-Adrenergic Receptor
ENTRY = Agonists, Adrenergic alpha-Receptor
ENTRY = Agonists, alpha-Adrenergic
ENTRY = Agonists, alpha-Adrenergic Receptor
ENTRY = Receptor Agonist, alpha-Adrenergic
ENTRY = Receptor Agonists, alpha Adrenergic
ENTRY = alpha Adrenergic Agonist
ENTRY = alpha Adrenergic Agonists
ENTRY = alpha Adrenergic Receptor Agonist
ENTRY = alpha Adrenergic Receptor Agonists
ENTRY = alpha-Agonist, Adrenergic
ENTRY = alpha-Agonists, Adrenergic
ENTRY = alpha-Receptor Agonist, Adrenergic
ENTRY = alpha-Receptor Agonists, Adrenergic
MN = D27.505.519.625.050.100.100
MN = D27.505.696.577.050.100.100
MH_TH = NLM (1969)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-ANTAGONISTS; DF: ADREN ALPHA AGON or ADREN ALPHA AG
PI = Sympathomimetics (1966-1968)
MS = Drugs that selectively bind to and activate alpha adrenergic receptors.
OL = use ADRENERGIC ALPHA-AGONISTS to search ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (as Prov 1969-72)
PM = 95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1973-94
HN = 95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (Prov 1969-72)
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000316

*NEWRECORD
RECTYPE = D
MH = Adrenergic alpha-Antagonists
DE = ADREN ALPHA ANTAG
DS = ADRENERGIC ANTAGONISTS ALPHA
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Adrenergic alpha-Receptor Blockaders|T121|NON|EQV|NLM (1995)|940202|ADRENERGIC RECEPTOR BLOCKADERS ALPHA|ADREN ALPHA RECEPT BLOCK|abcdefsv
PRINT ENTRY = alpha-Adrenergic Blocking Agents|T121|NON|EQV|IOM (1990)|890417|ALPHA ADREN BLOCK AGENTS|abcdefv
PRINT ENTRY = alpha-Adrenergic Receptor Blockaders|T121|NON|EQV|UNK (19XX)|740329|ALPHA ADREN RECEPT BLOCK|abcdefv
PRINT ENTRY = alpha-Blockers, Adrenergic|T121|NON|EQV|IOM (1990)|890417|ALPHA BLOCK ADREN|abcdefv
ENTRY = Adrenergic alpha-Blockers|T121|NON|EQV|NLM (1995)|940202|ADREN ALPHA BLOCKERS|abcdefv
ENTRY = alpha-Adrenergic Blockers|T121|NON|EQV|NLM (1995)|940314|ALPHA ADREN BLOCK|abcdefv
ENTRY = Adrenergic alpha Antagonists
ENTRY = Adrenergic alpha Blockers
ENTRY = Adrenergic alpha Receptor Blockaders
ENTRY = Agents, alpha-Adrenergic Blocking
ENTRY = Blockaders, Adrenergic alpha-Receptor
ENTRY = Blockaders, alpha-Adrenergic Receptor
ENTRY = Blockers, alpha-Adrenergic
ENTRY = Blocking Agents, alpha-Adrenergic
ENTRY = Receptor Blockaders, alpha-Adrenergic
ENTRY = alpha Adrenergic Blockers
ENTRY = alpha Adrenergic Blocking Agents
ENTRY = alpha Adrenergic Receptor Blockaders
ENTRY = alpha Blockers, Adrenergic
ENTRY = alpha-Antagonists, Adrenergic
ENTRY = alpha-Receptor Blockaders, Adrenergic
MN = D27.505.519.625.050.200.100
MN = D27.505.696.577.050.200.100
MH_TH = NLM (1969)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-AGONISTS; DF: ADREN ALPHA ANTAG
PI = Sympatholytics (1966-1968)
MS = Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
OL = use ADRENERGIC ALPHA-ANTAGONISTS to search ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 (as Prov 1969-72)
PM = 95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1973-94
HN = 95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 (Prov 1969-72)
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000317

*NEWRECORD
RECTYPE = D
MH = Adrenergic beta-Agonists
DE = ADREN BETA AG
DS = ADRENERGIC AGONISTS BETA
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Adrenergic beta-Receptor Agonists|T121|NON|EQV|NLM (1995)|940128|ADRENERGIC RECEPTOR AGONISTS BETA|ADREN BETA RECEPT AGON|abcdefsv
PRINT ENTRY = beta-Adrenergic Agonists|T121|NON|EQV|NLM (1995)|940128|BETA ADREN AGON|abcdefv
PRINT ENTRY = beta-Adrenergic Receptor Agonists|T121|NON|EQV|UNK (19XX)|740329|BETA ADREN RECEPT AGON|abcdefv
ENTRY = Adrenergic beta-Agonist|T121|NON|EQV|NLM (1995)|940419|ADREN BETA AGON|abcdefv
ENTRY = Adrenergic beta-Receptor Agonist|T121|NON|EQV|NLM (1995)|940526|ADREN BETA RECEPT AG|abcdefv
ENTRY = Betamimetics|T121|NON|EQV|NLM (2008)|060724|abcdef
ENTRY = Receptor Agonists, beta-Adrenergic|T121|NON|EQV|NLM (1995)|940425|RECEPT AGON BETA ADREN|abcdefv
ENTRY = Receptors Agonists, Adrenergic beta|T121|NON|EQV|NLM (1995)|940425|RECEPT AGON ADREN BETA|abcdefv
ENTRY = beta-Adrenergic Agonist|T121|NON|EQV|NLM (1995)|940513|BETA ADREN AG|abcdefv
ENTRY = beta-Adrenergic Receptor Agonist|T121|NON|EQV|NLM (1995)|940513|BETA ADREN RECEPT AG|abcdefv
ENTRY = Adrenergic beta Agonist
ENTRY = Adrenergic beta Agonists
ENTRY = Adrenergic beta Receptor Agonist
ENTRY = Adrenergic beta Receptor Agonists
ENTRY = Agonist, Adrenergic beta-Receptor
ENTRY = Agonist, beta-Adrenergic
ENTRY = Agonist, beta-Adrenergic Receptor
ENTRY = Agonists, Adrenergic beta-Receptor
ENTRY = Agonists, beta-Adrenergic
ENTRY = Agonists, beta-Adrenergic Receptor
ENTRY = Receptor Agonist, beta-Adrenergic
ENTRY = Receptor Agonists, beta Adrenergic
ENTRY = beta Adrenergic Agonist
ENTRY = beta Adrenergic Agonists
ENTRY = beta Adrenergic Receptor Agonist
ENTRY = beta Adrenergic Receptor Agonists
ENTRY = beta-Agonist, Adrenergic
ENTRY = beta-Agonists, Adrenergic
ENTRY = beta-Receptor Agonist, Adrenergic
ENTRY = beta-Receptor Agonists, Adrenergic
MN = D27.505.519.625.050.100.200
MN = D27.505.696.577.050.100.200
MH_TH = NLM (1969)
ST = T121
RN = 0
AN = general or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-ANTAGONISTS; DF: ADREN BETA AGON or ADREN BETA AG
PI = Sympathomimetics (1966-1968)
MS = Drugs that selectively bind to and activate beta-adrenergic receptors.
OL = use ADRENERGIC BETA-AGONISTS to search ADRENERGIC BETA RECEPTOR AGONISTS 1969-94 (as Prov 1969-72)
PM = 95; was ADRENERGIC BETA RECEPTOR AGONISTS 1973-94
HN = 95; was ADRENERGIC BETA RECEPTOR AGONISTS 1969-94 (Prov 1969-72)
MR = 20070709
DA = 19990101
DC = 1
DX = 19730101
UI = D000318

*NEWRECORD
RECTYPE = D
MH = Adrenergic beta-Antagonists
DE = ADREN BETA ANTAG
DS = ADRENERGIC ANTAGONISTS BETA
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Adrenergic beta-Receptor Blockaders|T121|NON|EQV|NLM (1995)|940202|ADRENERGIC RECEPTOR BLOCKADERS BETA|ADREN BETA RECEPT BLOCK|abcdefsv
PRINT ENTRY = beta-Adrenergic Blocking Agents|T121|NON|EQV|IOM (1990)|890417|BETA ADREN BLOCK AGENTS|abcdefv
PRINT ENTRY = beta-Adrenergic Receptor Blockaders|T121|NON|EQV|UNK (19XX)|740329|BETA ADREN RECEPT BLOCK|abcdefv
PRINT ENTRY = beta-Blockers, Adrenergic|T121|NON|EQV|IOM (1990)|890417|BETA BLOCKERS ADREN|abcdefv
ENTRY = beta-Adrenergic Blockers|T121|NON|EQV|NLM (1995)|940314|BETA ADREN BLOCK|abcdefv
ENTRY = Adrenergic beta Antagonists
ENTRY = Adrenergic beta Receptor Blockaders
ENTRY = Adrenergic beta-Blockers
ENTRY = Agents, beta-Adrenergic Blocking
ENTRY = Blockaders, Adrenergic beta-Receptor
ENTRY = Blockaders, beta-Adrenergic Receptor
ENTRY = Blockers, beta-Adrenergic
ENTRY = Blocking Agents, beta-Adrenergic
ENTRY = Receptor Blockaders, beta-Adrenergic
ENTRY = beta Adrenergic Blockers
ENTRY = beta Adrenergic Blocking Agents
ENTRY = beta Adrenergic Receptor Blockaders
ENTRY = beta Blockers, Adrenergic
ENTRY = beta-Antagonists, Adrenergic
ENTRY = beta-Receptor Blockaders, Adrenergic
MN = D27.505.519.625.050.200.200
MN = D27.505.696.577.050.200.200
MH_TH = NLM (1969)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-AGONISTS; DF: ADREN BETA ANTAG
PI = Sympatholytics (1966-1968)
MS = Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
OL = use ADRENERGIC BETA-ANTAGONISTS to search ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94 (as Prov 1969-72)
PM = 95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94
HN = 95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1969-94 (Prov 1969-72)
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000319

*NEWRECORD
RECTYPE = D
MH = Adrenergic Fibers
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Sympathetic Fibers|T024|NON|EQV|UNK (19XX)|760427|abcdef
ENTRY = Adrenergic Fiber
ENTRY = Fiber, Adrenergic
ENTRY = Fiber, Sympathetic
ENTRY = Fibers, Adrenergic
ENTRY = Fibers, Sympathetic
ENTRY = Sympathetic Fiber
MN = A08.675.100.500
MN = A08.675.542.075
MN = A11.671.501.075
FX = Adrenergic Neurons
MH_TH = NLM (1977)
ST = T024
AN = ADRENERGIC NEURONS is also available
PI = Sympathetic Nervous System (1966-1976)
MS = Nerve fibers liberating catecholamines at a synapse after an impulse.
PM = 77
HN = 77
MR = 20110624
DA = 19760427
DC = 1
DX = 19770101
UI = D000320

*NEWRECORD
RECTYPE = D
MH = Adrenergic Agonists
DE = ADREN AG
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Adrenomimetics|T121|NON|EQV|NLM (1995)|940406|abcdef
ENTRY = Adrenergic Agonist|T121|NON|EQV|NLM (1995)|940419|ADREN AGON|abcdefv
ENTRY = Adrenergic Receptor Agonist|T121|NON|EQV|NLM (1995)|940513|ADREN RECEPT AG|abcdefv
ENTRY = Adrenergic Receptor Agonists|T121|NON|EQV|NLM (1995)|940127|ADREN RECEPT AGON|abcdefv
ENTRY = Receptor Agonists, Adrenergic|T121|NON|EQV|NLM (1994)|930212|RECEPT AGON ADREN|abcdefv
ENTRY = Agonist, Adrenergic
ENTRY = Agonist, Adrenergic Receptor
ENTRY = Agonists, Adrenergic
ENTRY = Agonists, Adrenergic Receptor
ENTRY = Receptor Agonist, Adrenergic
MN = D27.505.519.625.050.100
MN = D27.505.696.577.050.100
MH_TH = NLM (1975)
ST = T121
RN = 0
AN = do not confuse with ADRENERGIC ANTAGONISTS; DF: ADREN AGON or ADREN AG
PI = Sympathomimetics (1966-1974)
MS = Drugs that bind to and activate adrenergic receptors.
OL = use ADRENERGIC AGONISTS to search ADRENERGIC RECEPTOR AGONISTS 1975-94
PM = 95; was ADRENERGIC RECEPTOR AGONISTS 1975-94
HN = 95; was ADRENERGIC RECEPTOR AGONISTS 1975-94
MR = 20050630
DA = 19990101
DC = 1
DX = 19750101
UI = D000322

*NEWRECORD
RECTYPE = D
MH = Adrenochrome
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
MN = D03.438.473.025
MN = D23.767.061
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T123
N1 = 1H-Indole-5,6-dione, 2,3-dihydro-3-hydroxy-1-methyl-
RN = 70G54NQL71
RR = 54-06-8 (Adrenochrome)
AN = /physiol permitted
MS = Pigment obtained by the oxidation of epinephrine.
MR = 20130708
DA = 19990101
DC = 1
UI = D000323

*NEWRECORD
RECTYPE = D
MH = Adrenocorticotropic Hormone
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = ACTH|T116|T124|T125|ABB|EQV|UNK (19XX)|740329|abbbcdef
PRINT ENTRY = Adrenocorticotropin|T116|T124|T125|NON|EQV|UNK (19XX)|870504|abbbcdef
PRINT ENTRY = Corticotropin|T116|T124|T125|NON|EQV|NLM (1966)|990101|abbbcdef
ENTRY = 1-39 ACTH|T116|T124|T125|ABB|EQV|UNK (19XX)|810625|abbbcdef
ENTRY = ACTH (1-39)|T116|T124|T125|ABB|EQV|UNK (19XX)|830909|abbbcdef
ENTRY = Adrenocorticotrophic Hormone|T116|T124|T125|NON|EQV|NLM (1991)|900319|abbbcdef
ENTRY = Corticotrophin|T116|T124|T125|NON|EQV|NLM (1991)|900319|abbbcdef
ENTRY = Corticotrophin (1-39)|T116|T124|T125|NON|EQV|NLM (1991)|900319|abbbcdef
ENTRY = Corticotropin (1-39)|T116|T124|T125|NON|EQV|UNK (19XX)|810427|abbbcdef
ENTRY = Hormone, Adrenocorticotrophic
ENTRY = Hormone, Adrenocorticotropic
MN = D06.472.699.327.935.531.500
MN = D06.472.699.631.525.600.531.500
MN = D12.644.400.400.935.531.500
MN = D12.644.548.365.935.531.500
MN = D12.644.548.691.525.690.531.500
MN = D12.776.641.650.405.935.531.500
PA = Hormones
FX = Petrosal Sinus Sampling
FX = Receptors, Corticotropin
MH_TH = NLM (1994)
ST = T116
ST = T124
ST = T125
RN = 9002-60-2
MS = An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP).
PM = 2007; see CORTICOTROPIN 1994-2006, see ADRENOCORTICOTROPIC HORMONE 1987-1993, see CORTICOTROPIN 1963-1986
HN = 2007, 1987-1993 (1963)
MR = 20150622
DA = 19990101
DC = 1
UI = D000324

*NEWRECORD
RECTYPE = D
MH = Adrenodoxin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D12.776.157.427.374.375.025
MN = D12.776.556.579.374.375.025
MH_TH = NLM (1975)
ST = T116
ST = T123
N1 = Adrenodoxins
RN = 12687-22-8
AN = an iron-sulfur protein
PI = Carrier Proteins (1974)
PI = Ferredoxins (1966-1974)
PI = Metalloproteins (1974)
MS = An iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin, and cytochrome P-450.
PM = 75
HN = 75
MR = 20020702
DA = 19741119
DC = 1
DX = 19750901
UI = D000325

*NEWRECORD
RECTYPE = D
MH = Adrenoleukodystrophy
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Adrenomyeloneuropathy|T047|NON|REL|GHR (2014)|NLM (1993)|OMIM (2013)|ORD (2010)|910926|abcdeeeef
PRINT ENTRY = Schilder-Addison Complex|T047|EPO|EQV|GHR (2014)|NLM (2000)|ORD (2010)|991103|abcdeeef
PRINT ENTRY = X-Linked Adrenoleukodystrophy|T047|NON|EQV|GHR (2014)|NLM (2000)|ORD (2010)|991103|abcdeeef
ENTRY = ALD (Adrenoleukodystrophy)|T047|ABX|EQV|GHR (2014)|NLM (2000)|991103|abcdeef
ENTRY = Addison Disease and Cerebral Sclerosis|T047|NON|EQV|OMIM (2013)|ORD (2010)|150601|abcdeef
ENTRY = Bronze Schilder Disease|T047|NON|EQV|OMIM (2013)|ORD (2010)|150601|abcdeef
ENTRY = Melanodermic Leukodystrophy|T047|NON|EQV|OMIM (2013)|ORD (2010)|150601|abcdeef
ENTRY = Siemerling-Creutzfeldt Disease|T047|NON|EQV|OMIM (2013)|ORD (2010)|150601|abcdeef
ENTRY = X-ALD|T047|NON|EQV|NLM (2014)|130613|abcdef
ENTRY = X-ALD (X-Linked Adrenoleukodystrophy)|T047|NON|EQV|GHR (2014)|NLM (2014)|130502|abcdeef
ENTRY = Adrenoleukodystrophy, X-Linked
ENTRY = Leukodystrophies, Melanodermic
ENTRY = Leukodystrophy, Melanodermic
ENTRY = Schilder Addison Complex
ENTRY = Siemerling Creutzfeldt Disease
ENTRY = X ALD
ENTRY = X ALD (X Linked Adrenoleukodystrophy)
ENTRY = X Linked Adrenoleukodystrophy
MN = C10.228.140.163.100.084
MN = C10.228.140.163.100.362.250
MN = C10.228.140.695.625.250
MN = C10.314.400.250
MN = C10.597.606.643.455.124
MN = C16.320.322.500.124
MN = C16.320.400.525.124
MN = C16.320.565.189.084
MN = C16.320.565.189.362.250
MN = C16.320.565.663.100
MN = C18.452.132.100.084
MN = C18.452.132.100.362.250
MN = C18.452.648.189.084
MN = C18.452.648.189.362.250
MN = C18.452.648.663.100
MN = C19.053.500.270
FX = ATP-Binding Cassette Transporters
MH_TH = GHR (2014)
MH_TH = NLM (1983)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
AN = do not confuse with ADRENOLEUKODYSTROPHY, NEONATAL see PEROXISOMAL DISORDERS
PI = Adrenal Gland Hypofunction (1968-1982)
PI = Cerebral Sclerosis, Diffuse (1966-1982)
PI = Demyelinating Diseases (1966-1982)
MS = An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein (ATP-BINDING CASSETTE TRANSPORTERS).
PM = 1991; see CEREBRAL SCLEROSIS, DIFFUSE 1983-1990
HN = 1991(1983)
CATSH = CAT LIST
MR = 20150605
DA = 19820427
DC = 1
DX = 19910101
UI = D000326

*NEWRECORD
RECTYPE = D
MH = Adsorption
AQ = DE GE IM PH RE
ENTRY = Adsorptions
MN = G01.595.037
MN = G02.149.767.029
MN = G02.842.750.029
MH_TH = NLM (1966)
ST = T059
AN = almost never IM
MS = The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily.
MR = 20140606
DA = 19990101
DC = 1
UI = D000327

*NEWRECORD
RECTYPE = D
MH = Adult
AQ = PX
ENTRY = Adults|T100|NON|EQV|BIOETHICS (1989)|770317|abcdef
MN = M01.060.116
MH_TH = POPLINE (1978)
ST = T100
AN = almost always check tag: NIM no qualifiers; see Manual Chapter 9
MS = A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
PM = 66
HN = 66
MR = 20150623
DA = 19990101
DC = 1
DX = 19660101
UI = D000328

*NEWRECORD
RECTYPE = D
MH = Advertising as Topic
AQ = CL EC ES HI LJ MT SN ST TD UT
ENTRY = Advertisement as Topic|T057|NON|EQV|NLM (2008)|070621|abcdef
ENTRY = Advertisement as Topics
ENTRY = Advertising as Topics
MN = J01.219.687.274
MN = L01.143.050
MH_TH = NLM (2008)
ST = T057
AN = IM; medical advertising: do not coordinate with MEDICINE; coordinate with subject of advertising & medium if relevant (IM); do not confuse with Publication Type ADVERTISEMENTS for newspaper, magazine, billboard, etc. advertising
MS = The act or practice of calling public attention to a product, service, need, etc., especially by paid announcements in newspapers, magazines, on radio, or on television. (Random House Unabridged Dictionary, 2d ed)
PM = 2008; see ADVERTISING 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D000329

*NEWRECORD
RECTYPE = D
MH = Aedes
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Aede
MN = B01.050.500.131.617.289.275.100
MH_TH = NLM (1966)
ST = T204
AN = mosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
MS = A genus of mosquitoes (CULICIDAE) frequently found in tropical and subtropical regions. YELLOW FEVER and DENGUE are two of the diseases that can be transmitted by species of this genus.
MR = 20090706
DA = 19990101
DC = 1
UI = D000330

*NEWRECORD
RECTYPE = D
MH = Aequorin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Aequorine|T116|T126|T130|NON|EQV|UNK (19XX)|841002|abbbcdef
MN = D12.776.532.020
PA = Luminescent Agents
MH_TH = NLM (1975)
ST = T116
ST = T126
ST = T130
N1 = Aequorins
RN = 50934-79-7
PI = Coelenterata (1972-1974)
PI = Proteins (1972-1974)
MS = A photoprotein isolated from the bioluminescent jellyfish Aequorea. It emits visible light by an intramolecular reaction when a trace amount of calcium ion is added. The light-emitting moiety in the bioluminescence reaction is believed to be 2-amino-3-benzyl-5-(p-hydroxyphenyl)pyrazine (AF-350).
PM = 91; was see under LUMINESCENT PROTEINS 1979-90; was see under PROTEINS 1975-78
HN = 91(75); was see under LUMINESCENT PROTEINS 1979-90; was see under PROTEINS 1975-78
MR = 20040707
DA = 19741119
DC = 1
DX = 19910101
UI = D000331

*NEWRECORD
RECTYPE = D
MH = Aerobiosis
AQ = DE GE IM PH RE
ENTRY = Aerobioses
MN = G02.111.087.024
MN = G02.149.115.024
MN = G03.495.112
MH_TH = NLM (1971)
ST = T040
AN = almost never IM
MS = Life or metabolic reactions occurring in an environment containing oxygen.
PM = 91; was see under METABOLISM 1971-90
HN = 91(71); was see under METABOLISM 1971-90
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D000332

*NEWRECORD
RECTYPE = D
MH = Aeromonas
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.450.019.025
MN = B03.660.250.017.025
MH_TH = NLM (1966)
ST = T007
AN = in fish; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
MS = A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish.
MR = 20090706
DA = 19990101
DC = 1
UI = D000333

*NEWRECORD
RECTYPE = D
MH = Aerophagy
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Air Swallowing|T046|T184|NON|EQV|UNK (19XX)|800507|abbcdef
ENTRY = Swallowing, Air
MN = C23.888.821.061
MH_TH = NLM (1966)
ST = T046
ST = T184
MS = Spasmodic swallowing of air.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D000334

*NEWRECORD
RECTYPE = D
MH = Aerosol Propellants
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Propellants, Aerosol
MN = D26.255.165.055.055
MH_TH = NLM (1973)
ST = T120
RN = 0
AN = IM; coord with propellant if relevant (IM); D25-26 qualif with discretion
PI = Aerosols (1966-1972)
PI = specific chemical (1966-1972)
MS = Compressed gases or vapors in a container which, upon release of pressure and expansion through a valve, carry another substance from the container. They are used for cosmetics, household cleaners, and so on. Examples are BUTANES; CARBON DIOXIDE; FLUOROCARBONS; NITROGEN; and PROPANE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 91; was see under AEROSOLS 1973-90; was in Cat D & J 1973-82
HN = 91(73); was see under AEROSOLS 1973-90; was in Cat D & J 1973-82
MR = 20060705
DA = 19990101
DC = 1
DX = 19910101
UI = D000335

*NEWRECORD
RECTYPE = D
MH = Aerosols
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
MN = D20.280.055
MN = D26.255.165.055
MH_TH = NLM (1966)
ST = T104
RN = 0
AN = IM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in aerosol form, not the aerosol
MS = Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.
HN = was in Cat D & J 1973-82, was in Cat D only 1963-72
MR = 20060705
DA = 19990101
DC = 1
UI = D000336

*NEWRECORD
RECTYPE = D
MH = Aerospace Medicine
DE = AEROSPACE MED
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Aviation Medicine|T091|NON|NRW|UNK (19XX)|790529|AVIATION MED|abcdefv
PRINT ENTRY = Space Medicine|T091|NON|NRW|UNK (19XX)|790529|SPACE MED|abcdefv
ENTRY = Medicine, Aerospace|T091|NON|EQV|NLM (1991)|891128|MED AEROSPACE|abcdefv
ENTRY = Medicine, Aviation|T091|NON|NRW|NLM (1991)|891128|MED AVIATION|abcdefv
ENTRY = Medicine, Space|T091|NON|NRW|NLM (1991)|891128|MED SPACE|abcdefv
MN = H02.403.029
FX = Accidents, Aviation
FX = Air Travel
FX = Altitude
FX = Decompression Sickness
FX = Space Flight
MH_TH = NLM (1980)
ST = T091
AN = specialty; med, physiol or psychol aspects of AVIATION go here but med, physiol or psychol aspects of space flight go under SPACE FLIGHT or other space related terms: Manual 28.8; DF: AEROSPACE MED
PI = Space Flight (1975-1979)
MS = That branch of medicine dealing with the studies and effects of flight through the atmosphere or in space upon the human body and with the prevention or cure of physiological or psychological malfunctions arising from these effects. (from NASA Thesaurus)
OL = search SPACE FLIGHT 1975-79; use AEROSPACE MEDICINE to search AVIATION MEDICINE 1966-74; use AEROSPACE MEDICINE + DENTISTRY to search AVIATION DENTISTRY 1966-79
PM = 80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79
HN = 80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79
MR = 20130708
DA = 19790529
DC = 1
DX = 19800101
UI = D000337

*NEWRECORD
RECTYPE = D
MH = beta-Aminoethyl Isothiourea
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = 2-Aminoethylisothiuronium Bromide|T109|T121|NON|NRW|NLM (1993)|920213|AMINOETHYLISOTHIURONIUM BROMIDE 02|abbcdefs
PRINT ENTRY = beta-Aminoethylisothiuronium Diacetate|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
PRINT ENTRY = beta-Aminoethylisothiuronium Dihydrobromide|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = 2-Aminoethylisothiuronium Diacetate|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = 2-Aminoethylisothiuronium Dihydrochloride|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = 2-Aminoethylisothiuronium Dihydroiodide|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = 2-Aminoethylisothiuronium Diperchlorate|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = 2-Aminoethylisothiuronium Monohydrobromide|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = 2-Aminoethylisothiuronium Phosphate (1:1)|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = 2-Aminoethylisothiuronium Sulfate (1:1)|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = AET|T109|T121|ACR|NRW|NLM (1966)|990101|abbcdef
ENTRY = Aminoethylisothiuronium Bromide Hydrobromide|T109|T121|NON|NRW|NLM (1993)|920116|abbcdef
ENTRY = Carbamimidothioic acid, 2-aminoethyl ester, dihydrobromide|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = Isothiourea, (2-Aminoethyl)|T109|T121|NON|EQV|NLM (1999)|990913|abbcdef
ENTRY = Ixecur|T109|T121|TRD|NRW|UNK (19XX)|811218|abbcdef
ENTRY = S-(2-Aminoethyl)isothiourea|T109|T121|NON|EQV|NLM (2001)|abbcde
ENTRY = beta-Aminoethylisothiuronium Bromide|T109|T121|NON|NRW|NLM (2001)|000511|abbcdef
ENTRY = beta-Aminoethylisothiuronium Dihydrochloride|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = beta-Aminoethylisothiuronium Dihydroiodide|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = beta-Aminoethylisothiuronium Diperchlorate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = beta-Aminoethylisothiuronium Monohydrobromide|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = beta-Aminoethylisothiuronium Phosphate (1:1)|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = beta-Aminoethylisothiuronium Sulfate (1:1)|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 2 Aminoethylisothiuronium Bromide
ENTRY = 2 Aminoethylisothiuronium Diacetate
ENTRY = 2 Aminoethylisothiuronium Dihydrochloride
ENTRY = 2 Aminoethylisothiuronium Dihydroiodide
ENTRY = 2 Aminoethylisothiuronium Diperchlorate
ENTRY = 2 Aminoethylisothiuronium Monohydrobromide
ENTRY = Bromide, 2-Aminoethylisothiuronium
ENTRY = Bromide, beta-Aminoethylisothiuronium
ENTRY = Diacetate, 2-Aminoethylisothiuronium
ENTRY = Diacetate, beta-Aminoethylisothiuronium
ENTRY = Dihydrobromide, beta-Aminoethylisothiuronium
ENTRY = Dihydrochloride, 2-Aminoethylisothiuronium
ENTRY = Dihydrochloride, beta-Aminoethylisothiuronium
ENTRY = Dihydroiodide, 2-Aminoethylisothiuronium
ENTRY = Dihydroiodide, beta-Aminoethylisothiuronium
ENTRY = Diperchlorate, 2-Aminoethylisothiuronium
ENTRY = Diperchlorate, beta-Aminoethylisothiuronium
ENTRY = Hydrobromide, Aminoethylisothiuronium Bromide
ENTRY = Isothiourea, beta-Aminoethyl
ENTRY = Monohydrobromide, 2-Aminoethylisothiuronium
ENTRY = Monohydrobromide, beta-Aminoethylisothiuronium
ENTRY = beta Aminoethyl Isothiourea
ENTRY = beta Aminoethylisothiuronium Bromide
ENTRY = beta Aminoethylisothiuronium Diacetate
ENTRY = beta Aminoethylisothiuronium Dihydrobromide
ENTRY = beta Aminoethylisothiuronium Dihydrochloride
ENTRY = beta Aminoethylisothiuronium Dihydroiodide
ENTRY = beta Aminoethylisothiuronium Diperchlorate
ENTRY = beta Aminoethylisothiuronium Monohydrobromide
MN = D02.886.904.100
MN = D02.948.898.100
PA = Radiation-Protective Agents
MH_TH = NLM (2001)
ST = T109
ST = T121
RN = 151-16-6
RR = 18144-22-4
RR = 2141-04-0
RR = 56-10-0
RR = 63680-10-4
RR = 63680-11-5
RR = 63680-12-6
RR = 63680-13-7
RR = 871-25-0
MS = A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.
PM = 2001; see AET 1967-2000; for S-(2-AMINOETHYL)ISOTHIOTHIOUREA see ISOTHIUREA, (BETA-AMINOETHYL) 1997-2000
HN = 2001(1967); for S-(2-AMINOETHYL)ISOTHIOTHIOUREA use ISOTHIUREA, (BETA-AMINOETHYL) (NM) 1997-2000
MR = 20000621
DA = 19990101
DC = 1
UI = D000338

*NEWRECORD
RECTYPE = D
MH = Affect
AQ = CL DE ES PH RE
PRINT ENTRY = Mood|T041|NON|REL|UNK (19XX)|870430|abcdef
ENTRY = Affects
ENTRY = Moods
MN = F01.470.047
MH_TH = NLM (1964)
ST = T041
MS = The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves.
PM = 65; was see under EMOTIONS 1963-64
HN = 65(64); was see under EMOTIONS 1963-64
CATSH = CAT LIST
MR = 19920325
DA = 19990101
DC = 1
DX = 19650101
UI = D000339

*NEWRECORD
RECTYPE = D
MH = Affective Disorders, Psychotic
DE = AFFECTIVE DIS PSYCHOTIC
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Depression, Reactive, Psychotic|T048|NON|NRW|UNK (19XX)|800606|abcdef
PRINT ENTRY = Mood Disorders, Psychotic|T048|NON|NRW|UNK (19XX)|840529|MOOD DIS PSYCHOTIC|abcdefv
PRINT ENTRY = Psychoses, Affective|T048|NON|EQV|UNK (19XX)|800521|abcdef
ENTRY = Psychotic Affective Disorders|T048|NON|EQV|NLM (1992)|910611|PSYCHOTIC AFFECTIVE DIS|abcdefv
ENTRY = Psychotic Mood Disorders|T048|NON|NRW|NLM (1992)|910611|PSYCHOTIC MOOD DIS|abcdefv
ENTRY = Affective Disorder, Psychotic
ENTRY = Affective Psychoses
ENTRY = Disorder, Psychotic Affective
ENTRY = Disorders, Psychotic Affective
ENTRY = Mood Disorder, Psychotic
ENTRY = Psychotic Affective Disorder
ENTRY = Psychotic Mood Disorder
MN = F03.700.150
MH_TH = NLM (1981)
ST = T048
MS = Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.
OL = use AFFECTIVE DISORDERS, PSYCHOTIC to search DEPRESSION, REACTIVE, PSYCHOTIC 1977-80; search AFFECTIVE DISTURBANCES under AFFECTIVE SYMPTOMS 1969-80
PM = 81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80
HN = 81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80
CATSH = CAT LIST
MR = 20150630
DA = 19800521
DC = 1
DX = 19810101
UI = D000341

*NEWRECORD
RECTYPE = D
MH = Affective Symptoms
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Alexithymia|T184|NON|NRW|UNK (19XX)|830705|abcdef
PRINT ENTRY = Emotional Disturbances|T048|T184|NON|BRD|UNK (19XX)|740329|abbcdef
ENTRY = Affective Symptom
ENTRY = Alexithymias
ENTRY = Disturbance, Emotional
ENTRY = Disturbances, Emotional
ENTRY = Emotional Disturbance
ENTRY = Symptom, Affective
ENTRY = Symptoms, Affective
MN = F01.145.126.100
MH_TH = NLM (1969)
ST = T184
AN = human only; do not confuse with AFFECTIVE DISORDERS: read MeSH definitions & follow text
PI = Affect (1966-1968)
PI = Anxiety (1966-1968)
PI = Emotions (1966-1968)
MS = Mood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus.
OL = use AFFECTIVE SYMPTOMS to search AFFECTIVE DISTURBANCES 1969-80
PM = 81; was AFFECTIVE DISTURBANCES 1969-80
HN = 81; was AFFECTIVE DISTURBANCES 1969-80
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19690101
UI = D000342

*NEWRECORD
RECTYPE = D
MH = Afferent Loop Syndrome
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Afferent Loop Syndromes
ENTRY = Loop Syndrome, Afferent
ENTRY = Loop Syndromes, Afferent
ENTRY = Syndrome, Afferent Loop
ENTRY = Syndromes, Afferent Loop
MN = C06.405.469.531.099
MN = C23.550.767.050
MH_TH = NLM (1969)
ST = T047
PI = Dumping Syndrome (1966-1968)
MS = A complication of gastrojejunostomy (BILLROTH II PROCEDURE), a reconstructive GASTROENTEROSTOMY. It is caused by acute (complete) or chronic (intermittent) obstruction of the afferent jejunal loop due to HERNIA, intussusception, kinking, VOLVULUS, etc. It is characterized by PAIN and VOMITING of BILE-stained fluid.
OL = search DUMPING SYNDROME 1966-68
PM = 70; was see under DUMPING SYNDROME 1963-69
HN = 70(69); was see under DUMPING SYNDROME 1963-69
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
DX = 19700101
UI = D000343

*NEWRECORD
RECTYPE = D
MH = Afferent Pathways
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Afferent Pathway
ENTRY = Pathway, Afferent
ENTRY = Pathways, Afferent
MN = A08.612.220
MH_TH = NLM (1976)
ST = T023
AN = coord NIM with origin (IM) + termination (IM)
PI = Neural Transmission (1968-1975)
PI = Neurons, Afferent (1969-1975)
PI = Receptors, Sensory (1966-1975)
PI = specific central nervous system heading
PI = specific sensory receptor
MS = Nerve structures through which impulses are conducted from a peripheral part toward a nerve center.
PM = 76
HN = 76; was NON MESH before 1976
MR = 19920325
DA = 19750725
DC = 1
DX = 19760101
UI = D000344

*NEWRECORD
RECTYPE = D
MH = Affinity Labels
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Affinity Labeling Reagents|T130|NON|EQV|UNK (19XX)|741111|abcdef
ENTRY = Labeling Reagents, Affinity
ENTRY = Labels, Affinity
ENTRY = Reagents, Affinity Labeling
MN = D27.720.470.410.080
MH_TH = NLM (1975)
ST = T130
RN = 0
AN = D25-26 qualif; use with caution: few apply
PI = Binding Sites (1968-1974)
PI = Indicators and Reagents (1968-1974)
MS = Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.
PM = 75
HN = 75
MR = 20030709
DA = 19741119
DC = 1
DX = 19750901
UI = D000345

*NEWRECORD
RECTYPE = D
MH = Afghanistan
AQ = EH EP
MN = Z01.252.245.500.125
MH_TH = POPLINE (1978)
ST = T083
MR = 20150527
DA = 19990101
DC = 4
UI = D000346

*NEWRECORD
RECTYPE = D
MH = Afibrinogenemia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Fibrinogen Deficiency|T047|NON|EQV|UNK (19XX)|740329|FIBRINOGEN DEFIC|abcdefv
ENTRY = Afibrinogenemia, Congenital|T047|REL|OMIM (2013)|ORD (2010)|111115|abdeef
ENTRY = Congenital Afibrinogenaemia|T047|NON|REL|NLM (2010)|150529|abcdef
ENTRY = Congenital Afibrinogenemia|T047|NON|REL|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Deficiency, Fibrinogen|T047|NON|EQV|UNK (19XX)|740329|DEFIC FIBRINOGEN|abcdefv
ENTRY = Familial Afibrinogenemia|T047|NON|REL|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Hypofibrinogenemia, Congenital|T047|REL|OMIM (2013)|111115|abdef
ENTRY = Afibrinogenaemia, Congenital
ENTRY = Afibrinogenaemias, Congenital
ENTRY = Afibrinogenemia, Familial
ENTRY = Afibrinogenemias
ENTRY = Afibrinogenemias, Congenital
ENTRY = Afibrinogenemias, Familial
ENTRY = Congenital Afibrinogenaemias
ENTRY = Congenital Afibrinogenemias
ENTRY = Congenital Hypofibrinogenemia
ENTRY = Congenital Hypofibrinogenemias
ENTRY = Familial Afibrinogenemias
ENTRY = Fibrinogen Deficiencies
ENTRY = Hypofibrinogenemias, Congenital
MN = C15.378.100.100.056
MN = C15.378.100.141.072
MN = C15.378.463.067
MN = C16.320.099.056
MH_TH = GHR (2014)
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
MS = A deficiency or absence of FIBRINOGEN in the blood.
CATSH = CAT LIST
MR = 20150701
DA = 19990101
DC = 1
UI = D000347

*NEWRECORD
RECTYPE = D
MH = Aflatoxins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aflatoxin|T109|T131|NON|EQV|UNK (19XX)|760905|abbcdef
MN = D03.383.663.283.119
MN = D03.438.150.119
MN = D23.946.587.142
PA = Poisons
MH_TH = NLM (1965)
ST = T109
ST = T131
RN = 0
AN = /antag permitted but consider also ANTITOXINS
MS = Furano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2.
OL = use AFLATOXINS to search AFLATOXIN 1966-74
PM = 75; was AFLATOXIN 1967-74
HN = 75; was AFLATOXIN 1965-74 (Prov 1965-66)
MR = 20150622
DA = 19990101
DC = 1
DX = 19670101
UI = D000348

*NEWRECORD
RECTYPE = D
MH = Africa
AQ = EH EP
MN = Z01.058
MH_TH = NLM (1978)
ST = T083
AN = for the continent or unspecified only: prefer smaller geographic subdivisions, as AFRICA, NORTHERN; AFRICA, CENTRAL; etc.
MR = 20080708
DA = 19990101
DC = 4
UI = D000349

*NEWRECORD
RECTYPE = D
MH = Africa, Central
AQ = EH EP
ENTRY = Central Africa|T083|NAM|EQV|NLM (2009)|080325|abcdef
MN = Z01.058.290.100
MH_TH = NLM (1966)
ST = T083
AN = a geographic area; prefer specific countries
MS = The geographical area of Africa comprising CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; EQUATORIAL GUINEA; GABON; and DEMOCRATIC REPUBLIC OF THE CONGO.
MR = 20080708
DA = 19990101
DC = 4
UI = D000350

*NEWRECORD
RECTYPE = D
MH = Africa, Eastern
AQ = EH EP
ENTRY = British Indian Ocean Territory|T083|NAM|NRW|NLM (1983)|861231|abcdef
ENTRY = East Africa|T083|NAM|EQV|NLM (2013)|111017|abcdef
ENTRY = Eastern Africa|T083|NAM|EQV|NLM (1983)|861231|abcdef
MN = Z01.058.290.120
MH_TH = NLM (1966)
ST = T083
AN = a geographic area; prefer specific countries
MS = The geographical area of Africa comprising BURUNDI; DJIBOUTI; ETHIOPIA; KENYA; RWANDA; SOMALIA; SUDAN; TANZANIA; and UGANDA.
MR = 20120703
DA = 19990101
DC = 4
UI = D000351

*NEWRECORD
RECTYPE = D
MH = Africa, Northern
AQ = EH EP
PRINT ENTRY = French-Speaking Africa|T083|NAM|EQV|NLM (1994)|921123|abcdef
PRINT ENTRY = Maghreb|T083|NAM|EQV|NLM (1996)|950217|abcdef
PRINT ENTRY = Sahara|T083|NAM|NRW|NLM (1994)|930119|abcdef
ENTRY = Africa, French-Speaking|T083|NAM|EQV|NLM (1994)|921123|abcdef
ENTRY = French Speaking Africa|T083|NAM|EQV|NLM (1983)|940311|abcdef
ENTRY = Maghrib|T083|NAM|EQV|NLM (1996)|950217|abcdef
ENTRY = North Africa|T083|NAM|EQV|NLM (1996)|941116|abcdef
ENTRY = Northern Africa|T083|NAM|EQV|NLM (1994)|861231|abcdef
MN = Z01.058.266
MH_TH = NLM (1966)
ST = T083
AN = a geographic area; prefer specific countries; titles often refer to the Maghreb or Maghrib, the Arabic name for Algeria, Morocco, Tunisia & sometimes Libya collectively: check text for possible specificity, otherwise index under AFRICA, NORTHERN
MS = The geographical area of Africa comprising ALGERIA; EGYPT; LIBYA; MOROCCO; and TUNISIA. It includes also the vast deserts and oases of the Sahara. It is often referred to as North Africa, French-speaking Africa, or the Maghreb. (From Webster's New Geographical Dictionary, 1988, p856)
MR = 20080708
DA = 19990101
DC = 4
UI = D000352

*NEWRECORD
RECTYPE = D
MH = Africa, Southern
AQ = EH EP
ENTRY = Southern Africa|T083|NAM|EQV|NLM (1983)|861231|abcdef
MN = Z01.058.290.175
MH_TH = NLM (1966)
ST = T083
AN = a geographic area: prefer specific countries; do not confuse with SOUTH AFRICA ( = Union of South Africa 1910-60)
MS = The geographical area of Africa comprising ANGOLA; BOTSWANA; LESOTHO; MALAWI; MOZAMBIQUE; NAMIBIA; SOUTH AFRICA; SWAZILAND; ZAMBIA; and ZIMBABWE.
MR = 20080708
DA = 19990101
DC = 4
UI = D000353

*NEWRECORD
RECTYPE = D
MH = Africa, Western
AQ = EH EP
ENTRY = Africa, West|T083|NON|EQV|NLM (2013)|111027|abcdef
ENTRY = West Africa|T083|NON|EQV|NLM (2013)|111027|abcdef
ENTRY = Western Africa|T083|NAM|EQV|NLM (1983)|861231|abcdef
MN = Z01.058.290.190
MH_TH = NLM (1966)
ST = T083
AN = a geographic area: prefer specific countries
MS = The geographical area of Africa comprising BENIN; BURKINA FASO; COTE D'IVOIRE; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; LIBERIA; MALI; MAURITANIA; NIGER; NIGERIA; SENEGAL; SIERRA LEONE; and TOGO.
MR = 20120703
DA = 19990101
DC = 4
UI = D000354

*NEWRECORD
RECTYPE = D
MH = African Horse Sickness
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
PRINT ENTRY = Equine Plague|T047|NON|EQV|NLM (1998)|960807|abcdef
ENTRY = African Horsesickness|T047|NON|EQV|NLM (1998)|970114|abcdef
ENTRY = African Horse Sicknesses
ENTRY = African Horsesicknesses
ENTRY = Equine Plagues
ENTRY = Horse Sickness, African
ENTRY = Horse Sicknesses, African
ENTRY = Horsesickness, African
ENTRY = Horsesicknesses, African
ENTRY = Plague, Equine
ENTRY = Plagues, Equine
ENTRY = Sickness, African Horse
ENTRY = Sicknesses, African Horse
MN = C02.081.030
MN = C02.782.791.142
MN = C22.488.088
MH_TH = NLM (1970)
ST = T047
AN = caused by an Orbivirus; in horses, mules & donkeys; if in horses don't forget also HORSES (NIM) & check tag ANIMALS; if in mules or donkeys, coord IM with EQUIDAE (IM) & check tag ANIMALS
PI = Horse Diseases (1966-1969)
PI = Reovirus Infections (1968-1979)
MS = An insect-borne reovirus infection of horses, mules and donkeys in Africa and the Middle East; characterized by pulmonary edema, cardiac involvement, and edema of the head and neck.
PM = 98; see AFRICAN HORSESICKNESS 1970-97
HN = 98
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
DX = 19700101
UI = D000355

*NEWRECORD
RECTYPE = D
MH = African Horse Sickness Virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
MN = B04.820.630.550.050
MH_TH = NLM (1975)
ST = T005
AN = infection = AFRICAN HORSE SICKNESS
MS = A species of ORBIVIRUS that causes disease in horses, mules, and donkeys. Via its principal vector CULICOIDES, it can also infect dogs, elephants, camels, cattle, sheep, goats, and, in special circumstances, humans.
PM = 98; see AFRICAN HORSESICKNESS VIRUS 1991-97, see REOVIRIDAE 1981-90, see REOVIRUSES 1975-80
HN = 98(75)
MR = 20150709
DA = 19741119
DC = 1
DX = 19910101
UI = D000356

*NEWRECORD
RECTYPE = D
MH = African Swine Fever
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
PRINT ENTRY = Swine Fever, African|T047|EPO|EQV|NLM (2002)|010420|abcdef
ENTRY = Wart-Hog Disease|T047|NON|EQV|NLM (1993)|920127|WART HOG DIS|abcdefv
ENTRY = Wart Hog Disease
ENTRY = Wart-Hog Diseases
MN = C02.081.885.125
MN = C02.256.142
MN = C22.905.072
MH_TH = NLM (1970)
ST = T047
AN = do not confuse with SWINE FEVER see CLASSICAL SWINE FEVER
PI = Swine Diseases (1966-1969)
PI = Virus Diseases (1966-1969)
MS = A sometimes fatal ASFIVIRUS infection of pigs, characterized by fever, cough, diarrhea, hemorrhagic lymph nodes, and edema of the gallbladder. It is transmitted between domestic swine by direct contact, ingestion of infected meat, or fomites, or mechanically by biting flies or soft ticks (genus Ornithodoros).
PM = 70
HN = 70
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
DX = 19700101
UI = D000357

*NEWRECORD
RECTYPE = D
MH = African Swine Fever Virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Wart-Hog Disease Virus|T005|NON|EQV|UNK (19XX)|741205|WART HOG DIS VIRUS|abcdefv
ENTRY = Virus, Wart-Hog Disease
ENTRY = Wart Hog Disease Virus
MN = B04.280.049.035
MH_TH = NLM (1975)
ST = T005
AN = infection = AFRICAN SWINE FEVER: see note there
PI = DNA Viruses (1966-1974)
MS = The lone species of the genus Asfivirus. It infects domestic and wild pigs, warthogs, and bushpigs. Disease is endemic in domestic swine in many African countries and Sardinia. Soft ticks of the genus Ornithodoros are also infected and act as vectors.
PM = 91; was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77
HN = 91(75); was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77
MR = 20150622
DA = 19741212
DC = 1
DX = 19910101
UI = D000358

*NEWRECORD
RECTYPE = D
MH = Aftercare
AQ = CL EC ES HI LJ MA MT OG PX SN ST TD UT
ENTRY = After Care|T058|NON|EQV|NLM (1994)|920723|abcdef
ENTRY = After-Treatment|T058|EQV|NLM (1992)|900906|abdef
ENTRY = Postabortal Programs|T058|NON|REL|POPLINE (1978)|781218|abcdef
ENTRY = Postabortion|T058|NON|REL|POPLINE (1978)|781218|abcdef
ENTRY = After Treatment
ENTRY = After-Treatments
ENTRY = Postabortal Program
ENTRY = Program, Postabortal
ENTRY = Programs, Postabortal
MN = E02.760.058
MN = N02.421.585.058
FX = Halfway Houses
MH_TH = NLM (1968)
ST = T058
AN = med, nurs, psychiat care after discharge from a hosp or other health facil; differentiate from REHABILITATION which is for getting a person back to pre-illness work or other activity
PI = Progressive Patient Care (1966-1967)
MS = The care and treatment of a convalescent patient, especially that of a patient after surgery.
OL = use AFTERCARE to search AFTER CARE 1968-93
PM = 94; was AFTER CARE 1968-93
HN = 94; was AFTER CARE 1968-93
CATSH = CAT LIST
MR = 20150629
DA = 19990101
DC = 1
DX = 19680101
UI = D000359

*NEWRECORD
RECTYPE = D
MH = Afterimage
AQ = CL DE ES PH RE
ENTRY = Afterimages
MN = F02.463.593.932.073
MN = G14.040
MH_TH = NLM (1966)
ST = T041
ST = T042
AN = differentiate from FIGURAL AFTEREFFECT which is displacement of (usually) geometric pattern in shape & space; while both are in the field of perception, AFTERIMAGE is likely to be in ophthalmol jrnls, FIGURAL AFTEREFFECT, in psychol jrnls
MS = Continuation of visual impression after cessation of stimuli causing the original image.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000360

*NEWRECORD
RECTYPE = D
MH = Agammaglobulinemia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Hypogammaglobulinemia|T047|NON|REL|GHR (2014)|UNK (19XX)|770616|abcdeef
ENTRY = Agammaglobulinemias
ENTRY = Hypogammaglobulinemias
MN = C15.378.147.142
MN = C15.604.515.032
MN = C20.673.088
FX = Protein-Losing Enteropathies
MH_TH = GHR (2014)
MH_TH = NLM (1966)
ST = T047
AN = DYSGAMMAGLOBULINEMIA is also available
MS = An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000361

*NEWRECORD
RECTYPE = D
MH = Agar
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU UL
MN = D09.698.360.041
PA = Culture Media
MH_TH = NLM (1966)
ST = T118
ST = T121
ST = T130
N1 = Agar
RN = 9002-18-0
AN = D25-26 qualif
MS = A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.
MR = 20040707
DA = 19990101
DC = 1
UI = D000362

*NEWRECORD
RECTYPE = D
MH = Agaricales
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Agaricaceae|T004|NON|NRW|UNK (19XX)|850208|abcdef
PRINT ENTRY = Mushrooms|T004|NON|EQV|NLM (1999)|971210|abcdef
ENTRY = Agaricale
ENTRY = Mushroom
MN = B01.300.179.100
MH_TH = NLM (1975)
ST = T004
AN = note entry term MUSHROOMS; poisoning = MUSHROOM POISONING
PI = Basidiomycetes (1966-1974)
MS = An extensive order of basidiomycetous fungi whose fruiting bodies are commonly called mushrooms.
PM = 1986; for MUSHROOMS see BASIDOMYCETES 1986-1998, see MUSHROOMS 1963-1985; for AGARICACEAE see AGARICACEAE 1975-1985, see MUSHROOMS 1963-1974
HN = 1986(1975); for MUSHROOMS use BASIDIOMYCOTA 1963-1998; for AGARICACEAE use BASIDIOMYCOTA 1966-1974
MR = 20090706
DA = 19741119
DC = 1
DX = 19750101
UI = D000363

*NEWRECORD
RECTYPE = D
MH = Agaricus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B01.300.179.100.105
MH_TH = NLM (1986)
ST = T004
AN = a basidiomycete
PI = Agaricales (1966-1985)
PI = Basidiomycetes (1966-1985)
MS = A basidiomycetous fungal genus of the family Agaricaceae, order Agaricales, which includes the field mushroom (A. campestris) and the commercial mushroom (A. bisporus).
PM = 91; was see under AGARICALES 1986-90
HN = 91(86); was see under AGARICALES 1986-90
MR = 20090706
DA = 19850208
DC = 1
DX = 19910101
UI = D000364

*NEWRECORD
RECTYPE = D
MH = Age Determination by Skeleton
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Bone Age Measurement|T060|NON|REL|UNK (19XX)|740329|abcdef
PRINT ENTRY = Skeletal Age Measurement|T060|NON|REL|UNK (19XX)|740329|abcdef
ENTRY = Skeletal Maturation Index|T034|NON|REL|NLM (2014)|121127|abcdef
ENTRY = Age Measurement, Bone
ENTRY = Age Measurement, Skeletal
ENTRY = Age Measurements, Bone
ENTRY = Age Measurements, Skeletal
ENTRY = Bone Age Measurements
ENTRY = Index, Skeletal Maturation
ENTRY = Indices, Skeletal Maturation
ENTRY = Maturation Index, Skeletal
ENTRY = Maturation Indices, Skeletal
ENTRY = Measurement, Bone Age
ENTRY = Measurement, Skeletal Age
ENTRY = Measurements, Bone Age
ENTRY = Measurements, Skeletal Age
ENTRY = Skeletal Age Measurements
ENTRY = Skeletal Maturation Indices
MN = E01.370.049
MN = E01.370.350.700.050
MH_TH = NLM (1967)
ST = T060
MS = Establishment of the age of an individual by examination of their skeletal structure.
OL = use AGE DETERMINATION BY SKELETON to search SKELETAL AGE MEASUREMENT 1966
PM = 67; was SKELETAL AGE MEASUREMENT 1965-66
HN = 67; was SKELETAL AGE MEASUREMENT 1965-66
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19670101
UI = D000365

*NEWRECORD
RECTYPE = D
MH = Age Determination by Teeth
AQ = MT VE
MN = E01.370.350.700.720.050
MN = E01.370.600.024.650.500
MN = E05.041.650.500
MN = E06.342.764.142
MN = E06.623.500
MH_TH = NLM (1964)
ST = T060
MS = A means of identifying the age of an animal or human through tooth examination.
PM = 67
HN = 67(64)
CATSH = CAT LIST
MR = 20150522
DA = 19990101
DC = 1
DX = 19670101
UI = D000366

*NEWRECORD
RECTYPE = D
MH = Age Factors
ENTRY = Age Reporting|T079|NON|REL|POPLINE (1978)|781218|abcdef
ENTRY = Age Factor
ENTRY = Factor, Age
ENTRY = Factors, Age
MN = N05.715.350.075
MN = N06.850.490.250
MH_TH = BIOETHICS (1997)
MH_TH = POPLINE (1978)
ST = T079
AN = NIM; no qualif; human & animal; related to cause & effect: do not confuse with AGE DISTRIBUTION which is largely statistical; differentiate from AGING, a physiol concept; policy: Manual 35.7
PI = Aging (1966-1967)
MS = Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
OL = use AGE DISTRIBUTION and SEX DISTRIBUTION to search AGE-SEX DISTRIBUTION 1994 forward; use AGE FACTORS to search AGE-SEX DISTRIBUTION 1990-92
PM = 68; AGE-SEX DISTRIBUTION was see AGE FACTORS 1990-92
HN = 68; AGE-SEX DISTRIBUTION was see AGE FACTORS 1990-92
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D000367

*NEWRECORD
RECTYPE = D
MH = Aged
AQ = PH PX SN
PRINT ENTRY = Elderly|T100|NON|EQV|NLM (1989)|900405|abcdef
MN = M01.060.116.100
FX = Health Services for the Aged
FX = Homes for the Aged
FX = Housing for the Elderly
FX = Pensions
FX = Retirement
MH_TH = BIOETHICS (1989)
MH_TH = POPLINE (1978)
ST = T100
AN = almost always check tag: NIM no qualifiers; see Manual Chapter 9; differentiate from AGING, a physiological process, & AGE FACTORS & AGE DISTRIBUTION, statistical concepts
MS = A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
OL = pre-explosion = AGED (PX)
PM = 66; was see under GERIATRICS 1963-65
HN = 66; was see under GERIATRICS 1963-65
MR = 20140613
DA = 19990101
DC = 1
DX = 19660101
UI = D000368

*NEWRECORD
RECTYPE = D
MH = Aged, 80 and over
DE = AGED 80
AQ = PH PX SN
PRINT ENTRY = Centenarians|T100|NON|NRW|UNK (19XX)|860325|abcdef
PRINT ENTRY = Nonagenarians|T100|NON|NRW|UNK (19XX)|860325|abcdef
PRINT ENTRY = Octogenarians|T100|NON|NRW|UNK (19XX)|860325|abcdef
PRINT ENTRY = Oldest Old|T100|NON|EQV|UNK (19XX)|860325|abcdef
ENTRY = Centenarian
ENTRY = Nonagenarian
ENTRY = Octogenarian
MN = M01.060.116.100.080
MH_TH = POPLINE (1987)
ST = T100
AN = almost always check tag: NIM no qualifiers; see Manual Chapter 9
PI = Aged (1966-1986)
MS = A person 80 years of age and older.
PM = 87; CENTENARIANS, NONAGENARIANS, & OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, & OCTOGENARIAN 1987-95
HN = 87; CENTENERIANS, NONAGENARIANS, & OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, & OCTOGENARIAN 1987-95
MR = 20150623
DA = 19860325
DC = 1
DX = 19870101
UI = D000369

*NEWRECORD
RECTYPE = D
MH = Ageusia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Ageusia, Hysterical|T048|T184|NON|NRW|NLM (2000)|991104|abbcdef
PRINT ENTRY = Hypogeusia|T184|NON|BRD|NLM (2000)|991104|abcdef
PRINT ENTRY = Taste-Blindness|T184|NON|REL|NLM (2000)|991104|abcdef
ENTRY = Ageusias, Hysterical
ENTRY = Hypogeusias
ENTRY = Hysterical Ageusia
ENTRY = Hysterical Ageusias
ENTRY = Taste Blindness
MN = C10.597.751.861.184
MN = C23.888.592.763.861.184
MH_TH = NLM (1975)
ST = T184
AN = do not confuse with DYSGEUSIA, distortion of sense of taste
MS = Complete or severe loss of the subjective sense of taste, frequently accompanied by OLFACTION DISORDERS.
PM = 1991; see TASTE DISORDERS 1975-1990
HN = 1991(1975)
CATSH = CAT LIST
MR = 19991104
DA = 19990101
DC = 1
DX = 19910101
UI = D000370

*NEWRECORD
RECTYPE = D
MH = Agglutination
AQ = DE GE IM PH RE
MN = G02.111.087.026
MN = G02.149.115.026
MN = G12.425.143.100
FX = Agglutination Tests
MH_TH = NLM (1966)
ST = T044
AN = NIM
MS = The clumping together of suspended material resulting from the action of AGGLUTININS.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000371

*NEWRECORD
RECTYPE = D
MH = Agglutination Tests
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Agglutination Test
ENTRY = Test, Agglutination
ENTRY = Tests, Agglutination
MN = E01.370.225.812.735.050
MN = E05.200.812.735.050
MN = E05.478.594.760.050
FX = Agglutination
MH_TH = NLM (1966)
ST = T059
MS = Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed)
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
DX = 19660101
UI = D000372

*NEWRECORD
RECTYPE = D
MH = Agglutinins
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
MN = D27.505.696.477.136
MH_TH = NLM (1973)
ST = T129
RN = 0
PI = Antibodies (1966-1972)
MS = Substances, usually of biological origin, that cause cells or other organic particles to aggregate and stick to each other. They include those ANTIBODIES which cause aggregation or agglutination of particulate or insoluble ANTIGENS.
PM = 73
HN = 73
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000373

*NEWRECORD
RECTYPE = D
MH = Aggression
AQ = CL DE ES PH PX RE
ENTRY = Aggressions
MN = F01.145.126.125
MN = F01.145.813.045
MH_TH = BIOETHICS (1989)
MH_TH = NLM (1986)
ST = T048
ST = T054
ST = T055
AN = human & animal; "agression" in French is translated "stress" & indexed under STRESS, PHYSIOLOGICAL or specific; "agressologie" = STRESS, PHYSIOLOGICAL
MS = Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000374

*NEWRECORD
RECTYPE = D
MH = Aging
AQ = BL CF DE EH ES GE IM ME PA PH PX RE UR
PRINT ENTRY = Senescence|T040|T079|NON|NRW|UNK (19XX)|740329|abbcdef
ENTRY = Aging, Biological|T040|T079|NON|NRW|NLM (1990)|890831|AGING BIOL|abbcdefv
ENTRY = Biological Aging|T040|T079|NON|NRW|POPLINE (1981)|861231|BIOL AGING|abbcdefv
MN = G07.700.320.124
FX = Cell Aging
FX = Skin Aging
MH_TH = NLM (1966)
ST = T040
ST = T079
AN = human & animal; IM; aging process anywhere between birth & old age; differentiation from other age-related terms: Manual 28.16, 34.10; "aging" of lower organisms, cultures, drugs, etc. is probably TIME FACTORS; AGING, PREMATURE is also available
MS = The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000375

*NEWRECORD
RECTYPE = D
MH = Agmatine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-Amino-4-guanidinobutane|T109|T123|NON|EQV|UNK (19XX)|800821|abbcdef
ENTRY = 4-(Aminobutyl)guanidine|T109|T123|NON|EQV|NLM (1996)|950517|abbcdef
ENTRY = 1 Amino 4 guanidinobutane
MN = D02.078.370.060
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T123
N1 = Guanidine, (4-aminobutyl)-
RN = 70J407ZL5Q
RR = 306-60-5 (Agmatine)
PI = Butylamines (1973-1974)
PI = Guanidines (1968-1974)
MS = Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.
PM = 91; was see under GUANIDINES 1975-90
HN = 91(75); was see under GUANIDINES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000376

*NEWRECORD
RECTYPE = D
MH = Agnosia
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Auditory Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Finger Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Sensory Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Tactile Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Visual Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Agnosia for Pain|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Agnosia for Smell|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Agnosia for Taste|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Agnosia for Temperature|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Anosognosia|T048|NON|NRW|NLM (2014)|121113|abcdef
ENTRY = Auditory Agnosia, Congenital|T048|NON|NRW|NLM (2000)|991108|AUDITORY AGNOSIA CONGEN|abcdefv
ENTRY = Body-Image Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Congenital Auditory Agnosia|T048|NON|NRW|NLM (2000)|991108|CONGEN AUDITORY AGNOSIA|abcdefv
ENTRY = Developmental Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Gustatory Agnosia|T048|NON|NRW|NLM (2014)|121219|abcdef
ENTRY = Ideational Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Olfactory Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Position Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Somatosensory Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Time Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Topographical Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Visual Agnosia for Objects|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Visual Disorientation Syndrome|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Visuospatial Agnosia|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Agnosia for Tastes
ENTRY = Agnosia, Auditory
ENTRY = Agnosia, Body-Image
ENTRY = Agnosia, Congenital Auditory
ENTRY = Agnosia, Developmental
ENTRY = Agnosia, Finger
ENTRY = Agnosia, Gustatory
ENTRY = Agnosia, Ideational
ENTRY = Agnosia, Olfactory
ENTRY = Agnosia, Position
ENTRY = Agnosia, Sensory
ENTRY = Agnosia, Somatosensory
ENTRY = Agnosia, Tactile
ENTRY = Agnosia, Time
ENTRY = Agnosia, Topographical
ENTRY = Agnosia, Visual
ENTRY = Agnosia, Visuospatial
ENTRY = Agnosias
ENTRY = Agnosias, Auditory
ENTRY = Agnosias, Body-Image
ENTRY = Agnosias, Congenital Auditory
ENTRY = Agnosias, Developmental
ENTRY = Agnosias, Finger
ENTRY = Agnosias, Ideational
ENTRY = Agnosias, Olfactory
ENTRY = Agnosias, Position
ENTRY = Agnosias, Sensory
ENTRY = Agnosias, Somatosensory
ENTRY = Agnosias, Tactile
ENTRY = Agnosias, Time
ENTRY = Agnosias, Topographical
ENTRY = Agnosias, Visual
ENTRY = Agnosias, Visuospatial
ENTRY = Anosognosias
ENTRY = Auditory Agnosias
ENTRY = Auditory Agnosias, Congenital
ENTRY = Body Image Agnosia
ENTRY = Body-Image Agnosias
ENTRY = Congenital Auditory Agnosias
ENTRY = Developmental Agnosias
ENTRY = Finger Agnosias
ENTRY = Ideational Agnosias
ENTRY = Olfactory Agnosias
ENTRY = Position Agnosias
ENTRY = Sensory Agnosias
ENTRY = Somatosensory Agnosias
ENTRY = Syndrome, Visual Disorientation
ENTRY = Syndromes, Visual Disorientation
ENTRY = Tactile Agnosias
ENTRY = Time Agnosias
ENTRY = Topographical Agnosias
ENTRY = Visual Agnosias
ENTRY = Visual Disorientation Syndromes
ENTRY = Visuospatial Agnosias
MN = C10.597.606.762.100
MN = C23.888.592.604.764.100
MN = F01.700.750.100
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T048
AN = coordinate IM with type of stimulus that is not recognized (IM)
MS = Loss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000377

*NEWRECORD
RECTYPE = D
MH = Agonistic Behavior
AQ = CL DE ES PH RE
ENTRY = Agonistic Behaviors
ENTRY = Behavior, Agonistic
ENTRY = Behaviors, Agonistic
MN = F01.145.126.125.100
MH_TH = NLM (1975)
ST = T054
MS = Any behavior associated with conflict between two individuals.
OL = search AGGRESSION 1968-74
PM = 91; was see under AGGRESSION 1975-90
HN = 91(75); was see under AGGRESSION 1975-90
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19910101
UI = D000378

*NEWRECORD
RECTYPE = D
MH = Agoraphobia
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Agoraphobias
MN = F03.080.100
MH_TH = NLM (1975)
ST = T048
MS = Obsessive, persistent, intense fear of open places.
PM = 90; was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80
HN = 90(75); was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19900101
UI = D000379

*NEWRECORD
RECTYPE = D
MH = Agranulocytosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Granulocytopenia|T033|T047|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Agranulocytoses
ENTRY = Granulocytopenias
MN = C15.378.553.546.184
MH_TH = NLM (1966)
ST = T033
ST = T047
MS = A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
CATSH = CAT LIST
MR = 20050715
DA = 19990101
DC = 1
UI = D000380

*NEWRECORD
RECTYPE = D
MH = Agraphia
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Dysgraphia|T048|NON|REL|NLM (2000)|991104|abcdef
PRINT ENTRY = Pure Agraphia|T048|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Acquired Agraphia|T048|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Acquired Dysgraphia|T048|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Constructional Agraphia|T048|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Developmental Agraphia|T048|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Developmental Dysgraphia|T048|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Acquired Agraphias
ENTRY = Acquired Dysgraphias
ENTRY = Agraphia, Acquired
ENTRY = Agraphia, Constructional
ENTRY = Agraphia, Developmental
ENTRY = Agraphia, Pure
ENTRY = Agraphias
ENTRY = Agraphias, Acquired
ENTRY = Agraphias, Constructional
ENTRY = Agraphias, Developmental
ENTRY = Agraphias, Pure
ENTRY = Constructional Agraphias
ENTRY = Developmental Agraphias
ENTRY = Developmental Dysgraphias
ENTRY = Dysgraphia, Acquired
ENTRY = Dysgraphia, Developmental
ENTRY = Dysgraphias
ENTRY = Dysgraphias, Acquired
ENTRY = Dysgraphias, Developmental
ENTRY = Pure Agraphias
MN = C10.597.606.150.500.050
MN = C23.888.592.604.150.500.050
MH_TH = NLM (1966)
ST = T048
MS = Loss or impairment of the ability to write (letters, syllables, words, or phrases) due to an injury to a specific cerebral area or occasionally due to emotional factors. This condition rarely occurs in isolation, and often accompanies APHASIA. (From Adams et al., Principles of Neurology, 6th ed, p485; APA, Thesaurus of Psychological Index Terms, 1994)
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
UI = D000381

*NEWRECORD
RECTYPE = D
MH = Agricultural Workers' Diseases
DE = AGRICULTURAL WORKERS DIS
AQ = BL CF CI CL DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Agricultural Worker Disease|T047|NON|EQV|UNK (19XX)|810316|AGRICULTURAL WORKER DIS|abcdefv
ENTRY = Agricultural Worker's Disease|T047|NON|EQV|UNK (19XX)|810316|abcdef
ENTRY = Agricultural Worker Diseases
ENTRY = Agricultural Worker's Diseases
ENTRY = Agricultural Workers Disease
ENTRY = Agricultural Workers Diseases
ENTRY = Agricultural Workers' Disease
ENTRY = Disease, Agricultural Worker
ENTRY = Disease, Agricultural Worker's
ENTRY = Disease, Agricultural Workers'
ENTRY = Diseases, Agricultural Worker
ENTRY = Diseases, Agricultural Worker's
ENTRY = Diseases, Agricultural Workers'
ENTRY = Worker Disease, Agricultural
ENTRY = Worker Diseases, Agricultural
ENTRY = Worker's Disease, Agricultural
ENTRY = Worker's Diseases, Agricultural
ENTRY = Workers' Disease, Agricultural
ENTRY = Workers' Diseases, Agricultural
MN = C24.080
MH_TH = NLM (1966)
ST = T047
AN = coord IM with specific dis (IM); specify geog if pertinent
MS = Diseases in persons engaged in cultivating and tilling soil, growing plants, harvesting crops, raising livestock, or otherwise engaged in husbandry and farming. The diseases are not restricted to farmers in the sense of those who perform conventional farm chores: the heading applies also to those engaged in the individual activities named above, as in those only gathering harvest or in those only dusting crops.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000382

*NEWRECORD
RECTYPE = D
MH = Agriculture
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Agricultural Development|T090|NON|NRW|NLM (1981)|861231|abcdef
ENTRY = Farming|T090|NON|EQV|NLM (2016)|141203|abcdef
ENTRY = Farms|T080|NON|REL|NLM (2016)|141204|abcdef
ENTRY = Gardens|T080|NON|REL|NLM (2016)|141204|abcdef
ENTRY = Development, Agricultural
ENTRY = Farm
ENTRY = Garden
MN = J01.040
FX = Agricultural Inoculants
MH_TH = NLM (1978)
ST = T090
MS = The science, art or practice of cultivating soil, producing crops, and raising livestock .
MR = 20150305
DA = 19990101
DC = 1
UI = D000383

*NEWRECORD
RECTYPE = D
MH = Aid to Families with Dependent Children
DE = AFDC
AQ = CL EC ES HI LJ OG SN ST TD UT
ENTRY = Family Allowances|T064|NON|BRD|POPLINE (1978)|781218|abcdef
ENTRY = Allowance, Family
ENTRY = Allowances, Family
ENTRY = Family Allowance
MN = N03.219.521.346.506.849.095
MH_TH = NLM (1975)
ST = T064
AN = treed under SOCIAL SECURITY; specify geog; DF: AFDC
MS = Financial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the Social Security Act, Title IV, in the U.S.
OL = search PUBLIC ASSISTANCE 1968-74
PM = 78; was see under PUBLIC ASSISTANCE 1968-77
HN = 78(75); was see under PUBLIC ASSISTANCE 1968-77
MR = 19991103
DA = 19990101
DC = 1
DX = 19780101
UI = D000385

*NEWRECORD
RECTYPE = D
MH = AIDS-Related Complex
DE = AIDS RELAT COMPLEX
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = ARC|T047|ABB|EQV|NLM (1994)|930524|abcdef
PRINT ENTRY = Lymphadenopathy Syndrome|T047|NON|EQV|UNK (19XX)|860618|abcdef
ENTRY = AIDS Related Complex
ENTRY = Complex, AIDS-Related
ENTRY = Lymphadenopathy Syndromes
ENTRY = Syndrome, Lymphadenopathy
ENTRY = Syndromes, Lymphadenopathy
MN = C02.782.815.616.400.080
MN = C02.800.801.400.080
MN = C02.839.080
MN = C20.673.480.080
MH_TH = POPLINE (1988)
ST = T047
AN = coord IM with HIV-1 or HIV-2 (IM) if pertinent; DF: note short X ref
PI = Acquired Immunodeficiency Syndrome (1983-1986)
MS = A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20040713
DA = 19860618
DC = 1
DX = 19870101
UI = D000386

*NEWRECORD
RECTYPE = D
MH = Ainhum
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Dactylolysis Spontanea|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Spontaneous Dactylolysis|T047|NON|EQV|NLM (2011)|ORD (2010)|100112|abcdeef
ENTRY = Dactylolyses, Spontaneous
ENTRY = Dactylolysis, Spontaneous
ENTRY = Spontaneous Dactylolyses
MN = C05.116.264.143
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
MS = Spontaneous autoamputation of the fourth or fifth toe.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D000387

*NEWRECORD
RECTYPE = D
MH = Air
AQ = AN LJ PS ST
MN = G16.500.275.063.150
MN = N06.230.300.100.150
EC = microbiology:Air Microbiology
EC = virology:Air Microbiology
MH_TH = NLM (1966)
ST = T167
AN = do not confuse with ATMOSPHERE or OXYGEN
MS = The mixture of gases present in the earth's atmosphere consisting of oxygen, nitrogen, carbon dioxide, and small amounts of other gases.
MR = 20080708
DA = 19990101
DC = 1
UI = D000388

*NEWRECORD
RECTYPE = D
MH = Air Conditioning
AQ = AE EC ES HI IS LJ MT SN ST TD
PRINT ENTRY = Air Revitalization|T068|NON|NRW|NLM (1995)|931126|abcdef
PRINT ENTRY = Climate Control|T068|NON|BRD|NLM (1995)|931126|abcdef
ENTRY = Air Conditionings
ENTRY = Air Revitalizations
ENTRY = Climate Controls
ENTRY = Conditioning, Air
ENTRY = Conditionings, Air
ENTRY = Control, Climate
ENTRY = Controls, Climate
ENTRY = Revitalization, Air
ENTRY = Revitalizations, Air
MN = N06.230.150.050
MH_TH = NLM (1966)
ST = T068
MS = The maintenance of certain aspects of the environment within a defined space to facilitate the function of that space; aspects controlled include air temperature and motion, radiant heat level, moisture, and concentration of pollutants such as dust, microorganisms, and gases. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
MR = 20080708
DA = 19990101
DC = 1
UI = D000389

*NEWRECORD
RECTYPE = D
MH = Air Ionization
AQ = DE RE
ENTRY = Air Ionizations
ENTRY = Ionization, Air
ENTRY = Ionizations, Air
MN = G02.149.767.040
MN = G02.842.750.040
MN = G16.500.240.070
MN = N06.230.300.100.150.100
MH_TH = NLM (1965)
ST = T070
MS = The dissociation of molecules in the air into positive and negative ions under the influence of an electric field.
PM = 70
HN = 70(65)
MR = 20150622
DA = 19990101
DC = 1
DX = 19700101
UI = D000390

*NEWRECORD
RECTYPE = D
MH = Air Microbiology
DE = AIR MICROBIOL
AQ = ST
ENTRY = Microbiology, Air|T067|NON|EQV|UNK (19XX)|860101|MICROBIOL AIR|abcdefv
MN = H01.158.273.540.274.110
MN = N06.850.425.110
MH_TH = NLM (1966)
ST = T067
AN = IM; coord IM with specific bact, virus or fungus (IM); DF: AIR MICROBIOL
MS = The presence of bacteria, viruses, and fungi in the air. This term is not restricted to pathogenic organisms.
MR = 20080708
DA = 19990101
DC = 1
UI = D000391

*NEWRECORD
RECTYPE = D
MH = Air Movements
ENTRY = Air Movement
ENTRY = Movement, Air
ENTRY = Movements, Air
MN = G16.500.240.135.249
MN = G16.500.275.063.725.154
MN = N06.230.300.100.150.185
MH_TH = NLM (1972)
ST = T070
AN = WIND is also available but see note there
PI = Air (1966-1971)
PI = Weather (1966-1971)
MS = The motion of air currents.
PM = 74
HN = 74(72)
MR = 20090706
DA = 19990101
DC = 1
DX = 19740101
UI = D000392

*NEWRECORD
RECTYPE = D
MH = Air Pollutants
AQ = AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR
ENTRY = Air Pollutants, Environmental|T131|NON|NRW|NLM (1975)|990101|AIR POLLUTANTS ENVIR|abcdefv
ENTRY = Environmental Air Pollutants|T131|NON|NRW|UNK (19XX)|770425|ENVIR AIR POLLUTANTS|abcdefv
ENTRY = Environmental Pollutants, Air|T131|NON|NRW|NLM (1996)|950308|ENVIR POLLUTANTS AIR|abcdefv
ENTRY = Air Environmental Pollutants
ENTRY = Pollutants, Air
ENTRY = Pollutants, Air Environmental
ENTRY = Pollutants, Environmental Air
MN = D27.888.284.101
MH_TH = NLM (1975)
ST = T131
RN = 0
AN = specify pollutant if pertinent
PI = Air Pollution (1966-1974)
MS = Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or material. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS.
PM = 1975; for AIR POLLUTANTS, ENVIRONMENTAL see AIR POLLUTANTS, ENVIRONMENTAL 1984-2006
HN = 1975
MR = 20140625
DA = 19990101
DC = 1
DX = 19750901
UI = D000393

*NEWRECORD
RECTYPE = D
MH = Air Pollutants, Occupational
DE = AIR POLLUTANTS OCCUP
AQ = AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR
PRINT ENTRY = Occupational Air Pollutants|T131|NON|EQV|UNK (19XX)|770425|OCCUP AIR POLLUTANTS|abcdefv
ENTRY = Pollutants, Occupational Air
MN = D27.888.284.101.268
FX = Confined Spaces
FX = Gas Scavengers
MH_TH = NLM (1975)
ST = T131
RN = 0
AN = specify pollutant or occup if pertinent (IM or NIM); DF: AIR POLLUTANTS OCCUP
MS = Air pollutants found in the work area. They are usually produced by the specific nature of the occupation.
PM = 84; was see under AIR POLLUTANTS 1975-83
HN = 84(75); was see under AIR POLLUTANTS 1975-83
MR = 20140625
DA = 19990101
DC = 1
DX = 19840101
UI = D000395

*NEWRECORD
RECTYPE = D
MH = Air Pollutants, Radioactive
AQ = AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO UR
PRINT ENTRY = Radioactive Air Pollutants|T131|NON|EQV|UNK (19XX)|770425|abcdef
ENTRY = Pollutants, Radioactive Air
MN = D20.693.101
MN = D27.888.284.101.393
MH_TH = NLM (1975)
ST = T131
RN = 0
AN = specify radiopollutant if pertinent (IM or NIM)
MS = Pollutants, present in air, which exhibit radioactivity.
PM = 91; was see under AIR POLLUTANTS 1975-90
HN = 91(75); was see under AIR POLLUTANTS 1975-90
MR = 20140625
DA = 19990101
DC = 1
DX = 19910101
UI = D000396

*NEWRECORD
RECTYPE = D
MH = Air Pollution
AQ = AE AN EC ES HI LJ PC SN
ENTRY = Air Pollutions
ENTRY = Pollution, Air
ENTRY = Pollutions, Air
MN = N06.850.460.100
MH_TH = NLM (1966)
ST = T069
AN = includes pollen in the air (coordinate with POLLEN)
MS = The presence of contaminants or pollutant substances in the air (AIR POLLUTANTS) that interfere with human health or welfare, or produce other harmful environmental effects. The substances may include GASES; PARTICULATE MATTER; or volatile ORGANIC CHEMICALS.
MR = 20080708
DA = 19990101
DC = 1
UI = D000397

*NEWRECORD
RECTYPE = D
MH = Air Pollution, Radioactive
AQ = AE AN EC ES HI LJ PC SN
ENTRY = Air Pollutions, Radioactive
ENTRY = Pollution, Radioactive Air
ENTRY = Pollutions, Radioactive Air
ENTRY = Radioactive Air Pollution
ENTRY = Radioactive Air Pollutions
MN = N06.850.460.100.110
MN = N06.850.810.080
MH_TH = NLM (1966)
ST = T069
AN = IM; coord with specific source of radiation (IM); specify geog if pertinent
MR = 20080708
DA = 19990101
DC = 1
UI = D000398

*NEWRECORD
RECTYPE = D
MH = Air Pressure
ENTRY = Air Pressures
ENTRY = Pressure, Air
ENTRY = Pressures, Air
MN = G16.500.750.274.100
MN = N06.230.300.100.185.100
MH_TH = NLM (1975)
ST = T070
AN = no qualif
MS = The force per unit area that the air exerts on any surface in contact with it. Primarily used for articles pertaining to air pressure within a closed environment.
OL = search ATMOSPHERIC PRESSURE 1966-74
PM = 91; was see under ATMOSPHERIC PRESSURE 1975-90
HN = 91(75); was see under ATMOSPHERIC PRESSURE 1975-90
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D000399

*NEWRECORD
RECTYPE = D
MH = Air Sacs
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Air Bladder|T023|NON|EQV|UNK (19XX)|800522|abcdef
PRINT ENTRY = Swimbladder|T023|NON|EQV|UNK (19XX)|800512|abcdef
ENTRY = Air Bladders
ENTRY = Air Sac
ENTRY = Bladder, Air
ENTRY = Bladders, Air
ENTRY = Sac, Air
ENTRY = Sacs, Air
ENTRY = Swimbladders
MN = A13.048
MH_TH = NLM (1968)
ST = T023
AN = in birds, fish, insects & mammals; sacculitis in veterinary animals: coord IM with RESPIRATORY TRACT DISEASES/vet (IM) or RESPIRATORY TRACT INFECTIONS/vet (IM)
PI = Birds (1966-1967)
PI = Bronchi (1966-1967)
MS = Thin-walled sacs or spaces which function as a part of the respiratory system in birds, fishes, insects, and mammals.
OL = use AIR SACS to search AIR BLADDER 1968-80
PM = 68; AIR BLADDER was heading 1968-80
HN = 68; AIR BLADDER was heading 1968-80
MR = 19980610
DA = 19990101
DC = 1
DX = 19680101
UI = D000400

*NEWRECORD
RECTYPE = D
MH = Aircraft
AQ = CL EC ES HI IS LJ SN ST
PRINT ENTRY = Ejection Seats|T073|NON|NRW|UNK (19XX)|820610|abcdef
PRINT ENTRY = Helicopters|T073|NON|NRW|UNK (19XX)|860325|abcdef
ENTRY = Airplanes|T073|NON|NRW|NLM (2008)|070124|abcdef
ENTRY = Airplane
ENTRY = Ejection Seat
ENTRY = Helicopter
ENTRY = Seat, Ejection
ENTRY = Seats, Ejection
MN = J01.937.285.100
MH_TH = NLM (1966)
ST = T073
MS = A weight-carrying structure for navigation of the air that is supported either by its own buoyancy or by the dynamic action of the air against its surfaces. (Webster, 1973)
OL = use AIRCRAFT to search EJECTION SEATS 1966-82
PM = EJECTION SEATS was heading 1963-82
HN = EJECTION SEATS was heading 1963-82
MR = 20070709
DA = 19990101
DC = 1
UI = D000401

*NEWRECORD
RECTYPE = D
MH = Airway Obstruction
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Choking|T046|T184|NON|NRW|UNK (19XX)|810519|abbcdef
ENTRY = Airway Obstructions
ENTRY = Obstruction, Airway
ENTRY = Obstructions, Airway
MN = C08.618.846.185
MH_TH = NLM (1971)
ST = T047
AN = acute; chronic airway obstruction = PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; NASAL OBSTRUCTION is also available
PI = Respiratory Tract Diseases (1966-1970)
MS = Any hindrance to the passage of air into and out of the lungs.
PM = 72
HN = 72(71)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19720101
UI = D000402

*NEWRECORD
RECTYPE = D
MH = Airway Resistance
AQ = DE ES GE IM PH RE
ENTRY = Airway Resistances
ENTRY = Resistance, Airway
ENTRY = Resistances, Airway
MN = E01.370.386.700.050
MN = G09.772.060
FX = Respiratory Mechanics
MH_TH = NLM (1970)
ST = T034
ST = T042
PI = Respiration (1966-1970)
PI = Respiratory System/physiology (1966-1970)
MS = Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow.
PM = 70
HN = 70
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19700101
UI = D000403

*NEWRECORD
RECTYPE = D
MH = Ajmaline
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
ENTRY = ASTA Medica Brand of Ajmaline|T109|T121|NON|NRW|NLM (2004)|030409|abbcdef
ENTRY = Ajmaline Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2014)|130425|abbcdeef
ENTRY = Aritmina|T109|T121|TRD|NRW|DE|020719|abbcdef
ENTRY = Cardiorythmine|T109|T121|TRD|NRW|FR|020719|abbcdef
ENTRY = Forest Brand of Ajmaline|T109|T121|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Gilurtymal|T109|T121|TRD|NRW|DE|ES|800731|abbcdeef
ENTRY = Giulini Brand of Ajmaline|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Lacer Brand of Ajmaline|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Protea Brand of Ajmaline|T109|T121|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Rauverid|T109|T121|TRD|NRW|US|020722|abbcdef
ENTRY = Serenol|T109|T121|TRD|NRW|AU|020722|abbcdef
ENTRY = Servier Brand of Ajmaline|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Solvay Brand of Ajmaline|T109|T121|NON|NRW|NLM (2003)|020719|abbcdef
ENTRY = Tachmalin|T109|T121|TRD|NRW|DE|UNK (19XX)|841010|abbcdeef
ENTRY = Wolfina|T109|T121|TRD|NRW|US|020722|abbcdef
ENTRY = Ajmaline Forest Brand
ENTRY = Ajmaline Giulini Brand
ENTRY = Ajmaline Lacer Brand
ENTRY = Ajmaline Protea Brand
ENTRY = Ajmaline Servier Brand
ENTRY = Ajmaline Solvay Brand
ENTRY = Hydrochloride, Ajmaline
MN = D03.132.436.681.077
MN = D03.438.473.402.681.077
PA = Anti-Arrhythmia Agents
PA = Voltage-Gated Sodium Channel Blockers
MH_TH = FDA SRS (2014)
MH_TH = NLM (1971)
ST = T109
ST = T121
N1 = Ajmalan-17,21-diol, (17R,21alpha)-
RN = 1PON08459R
RR = 140MW6WGAF
RR = 4360-12-7 (Ajmaline)
PI = Rauwolfia (1966-1970)
MS = An alkaloid found in the root of RAUWOLFIA SERPENTINA, among other plant sources. It is a class Ia antiarrhythmic agent that apparently acts by changing the shape and threshold of cardiac action potentials.
PM = 73
HN = 73(71)
MR = 20140606
DA = 19990101
DC = 1
DX = 19730101
UI = D000404

*NEWRECORD
RECTYPE = D
MH = Akinetic Mutism
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Mutism, Akinetic|T048|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Akinetic Autism|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Coma Vigil|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Coma Vigilans|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Akinetic Mutisms
ENTRY = Autism, Akinetic
ENTRY = Vigil, Coma
ENTRY = Vigils, Coma
MN = C10.228.140.042
FX = Persistent Vegetative State
MH_TH = NLM (1971)
ST = T048
PI = Mutism (1966-1970)
MS = A syndrome characterized by a silent and inert state without voluntary motor activity despite preserved sensorimotor pathways and vigilance. Bilateral FRONTAL LOBE dysfunction involving the anterior cingulate gyrus and related brain injuries are associated with this condition. This may result in impaired abilities to communicate and initiate motor activities. (From Adams et al., Principles of Neurology, 6th ed, p348; Fortschr Neurol Psychiatr 1995 Feb;63(2):59-67)
PM = 1971
HN = 1971
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
DX = 19710101
UI = D000405

*NEWRECORD
RECTYPE = D
MH = AKR murine leukemia virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = AKR Virus|T005|ACX|EQV|NLM (1975)|990101|abcdef
ENTRY = Gross Virus|T005|NON|REL|NLM (1966)|990101|abcdef
ENTRY = AKR Viruses
ENTRY = Virus, AKR
ENTRY = Virus, Gross
ENTRY = Viruses, AKR
MN = B04.613.807.375.525.050
MN = B04.820.650.375.525.050
MH_TH = NLM (2002)
ST = T005
AN = infection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM) (for spontaneous leukemia)
MS = A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) isolated from spontaneous leukemia in AKR strain mice.
PM = 2002; see AKR VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1975-1990; for GROSS VIRUS use GROSS VIRUS 1966-2006
HN = 2002 (1975)
MR = 20150622
DA = 19741212
DC = 1
DX = 19910101
UI = D000406

*NEWRECORD
RECTYPE = D
MH = Alabama
AQ = EH EP
MN = Z01.107.567.875.075.100
MN = Z01.107.567.875.750.100
MH_TH = POPLINE (1978)
ST = T083
MR = 19970620
DA = 19990101
DC = 4
UI = D000407

*NEWRECORD
RECTYPE = D
MH = Alamethicin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.345.566.040
MN = D12.644.504.111
MN = D12.644.641.040
PA = Anti-Bacterial Agents
PA = Ionophores
PA = Uncoupling Agents
MH_TH = NLM (1975)
ST = T116
ST = T195
N1 = Alamethicin
RN = 27061-78-5
PI = Antibiotics (1971-1975)
PI = Peptides, Cyclic (1973-1974)
MS = A cyclic nonadecapeptide antibiotic that can act as an ionophore and is produced by strains of Trichoderma viride. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
PM = 91; was see under ANTIBIOTICS 1975-90
HN = 91(75); was see under ANTIBIOTICS 1975-90
MR = 20070709
DA = 19741119
DC = 1
DX = 19910101
UI = D000408

*NEWRECORD
RECTYPE = D
MH = Alanine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Abufne|T116|T121|T123|TRD|NRW|FR|020722|abbbcdef
ENTRY = Alanine, L-Isomer|T116|T123|EQV|NLM (1999)|990913|abbdef
ENTRY = Doms-Adrian Brand of Alanine|T116|T121|T123|NON|NRW|NLM (2003)|020722|abbbcdef
ENTRY = L-Alanine|T116|T123|NON|EQV|FDA SRS (2014)|NLM (2000)|991109|abbcdeef
ENTRY = Alanine Doms-Adrian Brand
ENTRY = Alanine, L Isomer
ENTRY = Doms Adrian Brand of Alanine
ENTRY = L Alanine
ENTRY = L-Isomer Alanine
MN = D12.125.042
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1966)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T116
ST = T123
N1 = (L)-Alanine
RN = OF5P57N2ZX
RR = 56-41-7 (Alanine)
RR = 6898-94-8
AN = BETA-ALANINE is also available
MS = A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
MR = 20130708
DA = 19990101
DC = 1
UI = D000409

*NEWRECORD
RECTYPE = D
MH = Alanine Transaminase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Alanine Aminotransferase|T116|T126|NON|EQV|NLM (1998)|960906|abbcdef
PRINT ENTRY = Glutamic-Pyruvic Transaminase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = SGPT|T116|T126|ABB|NRW|UNK (19XX)|740329|abbcdef
ENTRY = Alanine-2-Oxoglutarate Aminotransferase|T116|T126|NON|EQV|NLM (1991)|900112|abbcdef
ENTRY = Glutamic-Alanine Transaminase|T116|T126|NON|EQV|UNK (19XX)|871208|abbcdef
ENTRY = Alanine 2 Oxoglutarate Aminotransferase
ENTRY = Aminotransferase, Alanine
ENTRY = Aminotransferase, Alanine-2-Oxoglutarate
ENTRY = Glutamic Alanine Transaminase
ENTRY = Glutamic Pyruvic Transaminase
ENTRY = Transaminase, Alanine
ENTRY = Transaminase, Glutamic-Alanine
ENTRY = Transaminase, Glutamic-Pyruvic
MN = D08.811.913.477.700.100
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = L-Alanine:2-oxoglutarate aminotransferase
RN = EC 2.6.1.2
AN = /blood = SGPT /blood (not just SGPT)
MS = An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2.
PM = 98; see ALANINE AMINOTRANSFERASE 1966-97; for GLUTAMIC-PYRUVIC TRANSMINASE see ALANINE 1963
HN = 98(66)
MR = 20030709
DA = 19990101
DC = 1
UI = D000410

*NEWRECORD
RECTYPE = D
MH = Alanine Racemase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Racemase, Alanine
MN = D08.811.399.894.200.200
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = Alanine racemase
RN = EC 5.1.1.1
RR = 9024-06-0 (CAS RN)
PI = Alanine (1974-1975)
PI = Amino Acid Isomerases (1970-1975)
MS = A pyridoxal-phosphate protein that reversibly catalyzes the conversion of L-alanine to D-alanine. EC 5.1.1.1.
PM = 91; was see under AMINO ACID ISOMERASES 1976-90
HN = 91(76); was see under AMINO ACID ISOMERASES 1976-90
MR = 20030709
DA = 19750718
DC = 1
DX = 19910101
UI = D000411

*NEWRECORD
RECTYPE = D
MH = Alanine-tRNA Ligase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Alanyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef
ENTRY = Ala-tRNA Ligase|T116|T126|NON|EQV|NLM (2001)|000316|abbcdef
ENTRY = Alanyl-tRNA Synthetase|T116|T126|NON|EQV|NLM (2001)|000316|abbcdef
ENTRY = Ala tRNA Ligase
ENTRY = Alanine tRNA Ligase
ENTRY = Alanyl tRNA Synthetase
ENTRY = Ligase, Ala-tRNA
ENTRY = Ligase, Alanine-tRNA
ENTRY = Synthetase, Alanyl-tRNA
MN = D08.811.464.263.200.050
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = L-Alanine:tRNA(Ala) ligase (AMP-forming)
RN = EC 6.1.1.7
PI = Alanine (1973-1974)
PI = Amino Acyl T RNA Synthetases (1973-1974)
MS = An enzyme that activates alanine with its specific transfer RNA. EC 6.1.1.7.
PM = 98; see ALANYL T RNA SYNTHETASE 1991-97; see AMINOACYL T RNA SYNTHETASES 1975-90
HN = 98(75)
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D000412

*NEWRECORD
RECTYPE = D
MH = Alaska
AQ = EH EP
PRINT ENTRY = Aleutian Islands|T083|NAM|NRW|NLM (1994)|920820|abcdef
MN = Z01.107.567.875.580.100
MH_TH = POPLINE (1978)
ST = T083
MR = 19970620
DA = 19990101
DC = 4
UI = D000413

*NEWRECORD
RECTYPE = D
MH = Albania
AQ = EH EP
MN = Z01.542.248.020
MH_TH = POPLINE (1978)
ST = T083
AN = in translations of historical articles use spelling People's Republic, not Peoples' nor Peoples
MR = 20011203
DA = 19990101
DC = 4
UI = D000415

*NEWRECORD
RECTYPE = D
MH = Alberta
AQ = EH EP
MN = Z01.107.567.176.064
MH_TH = NLM (1966)
ST = T083
AN = a province of Canada
MS = A province of western Canada, lying between the provinces of British Columbia and Saskatchewan. Its capital is Edmonton. It was named in honor of Princess Louise Caroline Alberta, the fourth daughter of Queen Victoria. (From Webster's New Geographical Dictionary, 1988, p26 & Room, Brewer's Dictionary of Names, 1992, p12)
MR = 19950217
DA = 19990101
DC = 4
UI = D000416

*NEWRECORD
RECTYPE = D
MH = Albinism
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
MN = C11.270.040
MN = C16.320.290.040
MN = C16.320.565.100.102
MN = C16.320.850.080
MN = C17.800.621.440.102
MN = C17.800.827.080
MN = C18.452.648.100.102
FX = Chediak-Higashi Syndrome
MH_TH = NLM (1966)
ST = T019
AN = hypopigmentation of skin, hair, eye; GEN or unspecified; prefer specifics; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
MS = General term for a number of inherited defects of amino acid metabolism in which there is a deficiency or absence of pigment in the eyes, skin, or hair.
CATSH = CAT LIST
MR = 20150618
DA = 19990101
DC = 1
UI = D000417

*NEWRECORD
RECTYPE = D
MH = Albumins
AQ = AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL
MN = D12.776.034
FX = Prealbumin
FX = Receptors, Albumin
EC = blood:Serum Albumin
EC = urine:Albuminuria
MH_TH = NLM (1966)
ST = T116
ST = T123
RN = 0
MS = Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.
MR = 20050630
DA = 19990101
DC = 1
UI = D000418

*NEWRECORD
RECTYPE = D
MH = Albuminuria
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Albuminurias
MN = C12.777.934.734.269
MN = C13.351.968.934.734.269
MN = C23.888.942.750.269
MH_TH = NLM (1966)
ST = T034
ST = T047
MS = The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D000419

*NEWRECORD
RECTYPE = D
MH = Albuterol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Salbutamol|T109|T121|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|UNK (19XX)|740329|abbdeeeef
ENTRY = 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol|T109|T121|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = Albuterol Sulfate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1996)|USAN (1974)|USP (19XX)|940808|abbcdeeeef
ENTRY = Proventil|T109|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Sultanol|T109|T121|TRD|NRW|NLM (1998)|961114|abbcdef
ENTRY = Ventolin|T109|T121|TRD|NRW|UNK (19XX)|820519|abbcdef
MN = D02.033.100.291.057
MN = D02.092.063.291.057
MN = D02.092.471.683.061
PA = Adrenergic beta-2 Receptor Agonists
PA = Bronchodilator Agents
PA = Tocolytic Agents
FX = Formoterol Fumarate
MH_TH = FDA SRS (2014)
MH_TH = USAN (1971)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-
RN = QF8SVZ843E
RR = 021SEF3731
RR = 18559-94-9 (Albuterol)
RR = 51022-70-9 (Albuterol Sulfate)
MS = A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
PM = 74
HN = 74
MR = 20150526
DA = 19990101
DC = 1
DX = 19740101
UI = D000420

*NEWRECORD
RECTYPE = D
MH = Alcaligenes
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.400.425.117.050
MN = B03.660.075.027.050
MH_TH = NLM (1966)
ST = T007
AN = ALCALIGENES EUTROPHA see CUPRIAVIDUS NECATOR is available; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
MS = A genus of gram-negative, aerobic, motile bacteria that occur in water and soil. Some are common inhabitants of the intestinal tract of vertebrates. These bacteria occasionally cause opportunistic infections in humans.
PM = 1976; see ACHROMOBACTER 1963-1975
HN = 1976 (1963)
MR = 20090706
DA = 19990101
DC = 1
UI = D000421

*NEWRECORD
RECTYPE = D
MH = Alchemy
ENTRY = Alchemies
MN = K01.400.075
MH_TH = NLM (1966)
ST = T090
AN = no qualif
MR = 20060705
DA = 19990101
DC = 1
UI = D000422

*NEWRECORD
RECTYPE = D
MH = Alcian Blue
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Alcian Blue 8GS|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|860929|abbcdeef
ENTRY = Alcian Blue 8GX|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|800825|abbcdeef
ENTRY = 8GS, Alcian Blue
ENTRY = 8GX, Alcian Blue
ENTRY = Blue 8GS, Alcian
ENTRY = Blue 8GX, Alcian
ENTRY = Blue, Alcian
MN = D03.438.473.050
PA = Coloring Agents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = Alcian Blue
RN = P4448TJR7J
RR = 12040-44-7 (Alcian Blue)
AN = D25-26 qualif
PI = Indoles (1973-1974)
PI = Onium Compounds (1974)
MS = A copper-containing dye used as a gelling agent for lubricants, for staining of bacteria and for the dyeing of histiocytes and fibroblasts in vivo.
PM = 91; was see under INDOLES 1975-90
HN = 91(75); was see under INDOLES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000423

*NEWRECORD
RECTYPE = D
MH = Alcohol Amnestic Disorder
DE = ALCOHOL AMNESTIC DIS
AQ = BL CF CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Alcohol-Induced Amnestic Syndrome|T048|NON|EQV|NLM (2000)|991103|ALCOHOL IND AMNESTIC SYNDROME|abcdefv
PRINT ENTRY = Alcoholic Korsakoff Syndrome|T048|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Amnestic Psychosis, Alcohol-Induced|T048|NON|EQV|NLM (2000)|991103|AMNESTIC PSYCHOSIS ALCOHOL IND|abcdefv
ENTRY = Alcohol Amnestic Syndrome|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Alcohol-Induced Amnestic Psychosis|T048|NON|EQV|NLM (2000)|991103|ALCOHOL IND AMNESTIC PSYCHOSIS|abcdefv
ENTRY = Alcohol-Induced Dysmnesic Psychosis|T048|NON|EQV|NLM (2000)|991103|ALCOHOL IND DYSMNESIC PSYCHOSIS|abcdefv
ENTRY = Alcohol-Induced Dysmnesic Syndrome|T048|NON|EQV|NLM (2000)|991103|ALCOHOL IND DYSMNESIC SYNDROME|abcdefv
ENTRY = Alcohol-Induced Korsakoff Syndrome|T048|NON|EQV|NLM (2000)|991103|ALCOHOL IND KORSAKOFF SYNDROME|abcdefv
ENTRY = Alcohol-Induced Persisting Amnestic Disorder|T048|NON|EQV|NLM (2000)|991103|ALCOHOL IND PERSISTING AMNESTIC DIS|abcdefv
ENTRY = Alcohol Amnestic Disorders
ENTRY = Alcohol Amnestic Syndromes
ENTRY = Alcohol Induced Amnestic Psychosis
ENTRY = Alcohol Induced Amnestic Syndrome
ENTRY = Alcohol Induced Dysmnesic Psychosis
ENTRY = Alcohol Induced Dysmnesic Syndrome
ENTRY = Alcohol Induced Korsakoff Syndrome
ENTRY = Alcohol Induced Persisting Amnestic Disorder
ENTRY = Alcohol-Induced Amnestic Psychoses
ENTRY = Alcohol-Induced Amnestic Syndromes
ENTRY = Alcohol-Induced Dysmnesic Psychoses
ENTRY = Alcohol-Induced Dysmnesic Syndromes
ENTRY = Alcohol-Induced Korsakoff Syndromes
ENTRY = Alcoholic Korsakoff Syndromes
ENTRY = Amnestic Disorder, Alcohol
ENTRY = Amnestic Disorders, Alcohol
ENTRY = Amnestic Psychoses, Alcohol-Induced
ENTRY = Amnestic Psychosis, Alcohol Induced
ENTRY = Amnestic Syndrome, Alcohol
ENTRY = Amnestic Syndrome, Alcohol-Induced
ENTRY = Amnestic Syndromes, Alcohol
ENTRY = Amnestic Syndromes, Alcohol-Induced
ENTRY = Dysmnesic Psychoses, Alcohol-Induced
ENTRY = Dysmnesic Psychosis, Alcohol-Induced
ENTRY = Dysmnesic Syndrome, Alcohol-Induced
ENTRY = Dysmnesic Syndromes, Alcohol-Induced
ENTRY = Korsakoff Syndrome, Alcohol-Induced
ENTRY = Korsakoff Syndrome, Alcoholic
ENTRY = Korsakoff Syndromes, Alcohol-Induced
ENTRY = Korsakoff Syndromes, Alcoholic
ENTRY = Psychoses, Alcohol-Induced Amnestic
ENTRY = Psychoses, Alcohol-Induced Dysmnesic
ENTRY = Psychosis, Alcohol-Induced Amnestic
ENTRY = Psychosis, Alcohol-Induced Dysmnesic
ENTRY = Syndrome, Alcohol Amnestic
ENTRY = Syndrome, Alcohol-Induced Amnestic
ENTRY = Syndrome, Alcohol-Induced Dysmnesic
ENTRY = Syndrome, Alcohol-Induced Korsakoff
ENTRY = Syndrome, Alcoholic Korsakoff
ENTRY = Syndromes, Alcohol Amnestic
ENTRY = Syndromes, Alcohol-Induced Amnestic
ENTRY = Syndromes, Alcohol-Induced Dysmnesic
ENTRY = Syndromes, Alcohol-Induced Korsakoff
ENTRY = Syndromes, Alcoholic Korsakoff
MN = C10.720.112.100
MN = C25.723.705.150.100
MN = C25.775.100.087.193.100
MN = F03.615.200.125
MN = F03.900.100.050
MH_TH = NLM (1966)
ST = T048
MS = A mental disorder associated with chronic ethanol abuse (ALCOHOLISM) and nutritional deficiencies characterized by short term memory loss, confabulations, and disturbances of attention. (Adams et al., Principles of Neurology, 6th ed, p1139)
OL = use ALCOHOL AMNESTIC DISORDER to search KORSAKOFF'S SYNDROME 1966-80
PM = 81; was KORSAKOFF'S SYNDROME 1963-80
HN = 81; was KORSAKOFF'S SYNDROME 1963-80
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
UI = D000425

*NEWRECORD
RECTYPE = D
MH = Alcohol Dehydrogenase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Alcohol Dehydrogenase (NAD+)|T116|T126|EQV|UNK (19XX)|860409|abbdef
ENTRY = Alcohol Dehydrogenase I|T116|T126|NON|NRW|UNK (19XX)|860409|abbcdef
ENTRY = Alcohol Dehydrogenase II|T116|T126|NON|NRW|UNK (19XX)|860409|abbcdef
ENTRY = Alcohol-NAD+ Oxidoreductase|T116|T126|EQV|UNK (19XX)|860409|abbdef
ENTRY = Yeast Alcohol Dehydrogenase|T116|T126|NON|NRW|UNK (19XX)|860409|abbcdef
ENTRY = Alcohol Dehydrogenase, Yeast
ENTRY = Alcohol NAD+ Oxidoreductase
ENTRY = Dehydrogenase, Alcohol
ENTRY = Dehydrogenase, Yeast Alcohol
ENTRY = Oxidoreductase, Alcohol-NAD+
MN = D08.811.682.047.820.250
MH_TH = NLM (1987)
ST = T116
ST = T126
N1 = Alcohol:NAD+ oxidoreductase
RN = EC 1.1.1.1
AN = a specific enzyme; do not confuse with ALCOHOL OXIDOREDUCTASES
PI = Alcohol Oxidoreductases (1966-1986)
MS = A zinc-containing enzyme which oxidizes primary and secondary alcohols or hemiacetals in the presence of NAD. In alcoholic fermentation, it catalyzes the final step of reducing an aldehyde to an alcohol in the presence of NADH and hydrogen.
PM = 87
HN = 87
MR = 20130708
DA = 19860409
DC = 1
DX = 19870101
UI = D000426

*NEWRECORD
RECTYPE = D
MH = Alcohol Deterrents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Deterrents, Alcohol
MN = D27.505.954.427.020
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = consider also ALCOHOLISM /drug ther
MS = Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism.
MR = 20140625
DA = 19990101
DC = 1
UI = D000427

*NEWRECORD
RECTYPE = D
MH = Alcohol Drinking
AQ = AE BL CF DT EC EH EP GE HI IM LJ ME MO PA PC PP PX TD TH UR
PRINT ENTRY = Alcohol Consumption|T055|NON|EQV|NLM (1992)|901002|abcdef
PRINT ENTRY = Drinking, Alcohol|T055|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Consumption, Alcohol
MN = F01.145.317.269
FX = Alcoholism
FX = Temperance
MH_TH = POPLINE (1981)
ST = T055
AN = available also are BINGE DRINKING and DRUNKENNESS see ALCOHOLIC INTOXICATION; acute alcohol intoxication = ETHANOL / pois; chronic alcohol consumption = ALCOHOLISM; TEMPERANCE is available for "abstinence from alcohol" but do not confuse with alcohol withdrawal (see note under ALCOHOL WITHDRAWAL DELIRIUM & SUBSTANCE WITHDRAWAL SYNDROME)
PI = Alcoholic Beverages (1966-1968)
MS = Behaviors associated with the ingesting of alcoholic beverages, including social drinking.
PM = 69
HN = 69
CATSH = CAT LIST
MR = 20120927
DA = 19990101
DC = 1
DX = 19690101
UI = D000428

*NEWRECORD
RECTYPE = D
MH = Alcohol Oxidoreductases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Carbonyl Reductases|T116|T126|NON|EQV|UNK (19XX)|810130|abbcdef
ENTRY = Ketone Reductases|T116|T126|NON|EQV|UNK (19XX)|810130|abbcdef
ENTRY = Oxidoreductases, Alcohol
ENTRY = Reductases, Carbonyl
ENTRY = Reductases, Ketone
MN = D08.811.682.047
MH_TH = NLM (1964)
ST = T116
ST = T126
RN = EC 1.1.-
MS = A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ (subclass 1.1.1), cytochrome (1.1.2), oxygen (1.1.3), quinone (1.1.5), or another acceptor (1.1.99).
PM = 64
HN = 64
MR = 20060705
DA = 19990101
DC = 1
DX = 19640101
UI = D000429

*NEWRECORD
RECTYPE = D
MH = Alcohol Withdrawal Delirium
AQ = BL CF CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Alcohol Withdrawal Hallucinosis|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Autonomic Hyperactivity, Alcohol Withdrawal Associated|T047|NON|NRW|NLM (2000)|991103|AUTONOMIC HYPERACTIVITY ALCOHOL WITHDRAWAL ASSOC|abcdefv
PRINT ENTRY = Delirium Tremens|T047|NON|EQV|UNK (19XX)|800521|abcdef
ENTRY = Alcohol Withdrawal Associated Autonomic Hyperactivity|T047|NON|NRW|NLM (2000)|991103|ALCOHOL WITHDRAWAL ASSOC AUTONOMIC HYPERACTIVITY|abcdefv
ENTRY = Alcohol Withdrawal-Induced Delirium Tremens|T047|NON|EQV|NLM (2000)|991103|ALCOHOL WITHDRAWAL IND DELIRIUM TREMENS|abcdefv
ENTRY = Delirium Tremens, Alcohol Withdrawal Induced|T047|NON|EQV|NLM (2000)|991103|DELIRIUM TREMENS ALCOHOL WITHDRAWAL IND|abcdefv
ENTRY = Alcohol Withdrawal Induced Delirium Tremens
ENTRY = Delirium, Alcohol Withdrawal
ENTRY = Hallucinosis, Alcohol Withdrawal
MN = C10.720.112.200
MN = C25.723.705.150.200
MN = C25.775.100.087.193.200
MN = C25.775.835.250
MN = F03.900.100.100
MN = F03.900.825.500
MH_TH = NLM (1975)
ST = T047
AN = note X ref; do not confuse with "alcohol withdrawal syndrome" ( = SUBSTANCE WITHDRAWAL SYNDROME (IM) + ETHANOL /adv eff (IM)); ALCOHOL WITHDRAWAL SEIZURES is available
MS = An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175)
OL = use ALCOHOL WITHDRAWAL DELIRIUM to search DELIRIUM TREMENS 1975-80 & use PSYCHOSES, ALCOHOLIC 1966-74
PM = 91; was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80
HN = 91(81); was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000430

*NEWRECORD
RECTYPE = D
MH = Ethanol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alcohol, Ethyl|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1998)|970115|abbcdeef
ENTRY = Absolute Alcohol|T109|NON|NRW|UNK (19XX)|840920|abcdef
ENTRY = Grain Alcohol|T109|T121|NON|EQV|NLM (1998)|970115|abbcdef
ENTRY = Alcohol, Absolute
ENTRY = Alcohol, Grain
ENTRY = Ethyl Alcohol
MN = D02.033.375
PA = Anti-Infective Agents, Local
PA = Central Nervous System Depressants
PA = Solvents
FX = Alcoholic Beverages
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T121
N1 = Ethanol
RN = 3K9958V90M
RR = 64-17-5 (Ethanol)
AN = for "alcohol" unspecified; / antag: consider also ALCOHOL DETERRENTS; ethanol production by organisms = / metab; use/ pois for acute alcohol poisoning & acute alcoholic intoxication; available also are BINGE DRINKING, DRUNKENNESS see ALCOHOLIC INTOXICATION, ALCOHOLISM and ALCOHOLIC BEVERAGES; hypophysectomy by alcohol injection = HYPOPHYSECTOMY, CHEMICAL & do not index under ETHANOL unless particularly discussed; "abstinence from alcohol" = TEMPERANCE
MS = A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.
PM = 98; see ALCOHOL, ETHYL 1963-97
HN = 98(63)
MR = 20130708
DA = 19990101
DC = 1
UI = D000431

*NEWRECORD
RECTYPE = D
MH = Methanol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alcohol, Methyl|T109|T131|NON|EQV|FDA SRS (2014)|NLM (1998)|970115|abbcdeef
ENTRY = Carbinol|T109|T131|NON|EQV|UNK (19XX)|831020|abbcdef
ENTRY = Sodium Methoxide|T109|T130|NON|NRW|FDA SRS (2014)|NLM (1998)|970115|abbcdeef
ENTRY = Wood Alcohol|T109|T131|NON|EQV|NLM (1998)|970115|abbcdef
ENTRY = Alcohol, Wood
ENTRY = Methoxide, Sodium
ENTRY = Methyl Alcohol
MN = D02.033.623
PA = Solvents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T131
N1 = Methanol
RN = Y4S76JWI15
RR = 67-56-1 (Methanol)
RR = IG663U5EMC
AN = for wood alcohol
MS = A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.
PM = 98; see ALCOHOL, METHYL 1966-97
HN = 98;
MR = 20130708
DA = 19990101
DC = 1
UI = D000432

*NEWRECORD
RECTYPE = D
MH = 1-Propanol
DS = PROPANOL 01
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alcohol, Propyl|T109|NON|EQV|NLM (1998)|970221|abcdef
PRINT ENTRY = Propanol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970429|abcdeef
PRINT ENTRY = n-Propanol|T109|NON|EQV|FDA SRS (2014)|NLM (1998)|970429|PROPANOL N|abcdeefs
ENTRY = 1 Propanol
ENTRY = Propyl Alcohol
ENTRY = n Propanol
MN = D02.033.755.600
EC = analogs & derivatives:Propanols
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
N1 = 1-Propanol
RN = 96F264O9SV
RR = 71-23-8 (1-Propanol)
MS = A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.
PM = 98; see ALCOHOL, PROPYL 1963-97
HN = 98(63)
MR = 20130708
DA = 19990101
DC = 1
UI = D000433

*NEWRECORD
RECTYPE = D
MH = Alcoholic Beverages
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Alcoholic Beverage
ENTRY = Beverage, Alcoholic
ENTRY = Beverages, Alcoholic
MN = G07.203.100.100
MN = J02.200.100
MH_TH = NLM (1966)
ST = T168
AN = GEN; BEER & WINE are available; chronic consumption of alcoholic bev = ALCOHOLISM
MS = Drinkable liquids containing ETHANOL.
MR = 20141014
DA = 19990101
DC = 1
UI = D000434

*NEWRECORD
RECTYPE = D
MH = Alcoholic Intoxication
DE = ALCOHOLIC INTOX
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Drunkenness|T037|T048|NON|EQV|NLM (2000)|991108|abbcdef
PRINT ENTRY = Intoxication, Alcoholic|T037|T048|NON|EQV|UNK (19XX)|810514|INTOX ALCOHOLIC|abbcdefv
ENTRY = Drunkennesses
MN = C25.775.100.175
MN = F03.900.100.300
MH_TH = NLM (1966)
ST = T037
ST = T048
AN = human & animal
MS = An acute brain syndrome which results from the excessive ingestion of ETHANOL or ALCOHOLIC BEVERAGES.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000435

*NEWRECORD
RECTYPE = D
MH = Alcoholics Anonymous
AQ = EC HI OG
ENTRY = Anonymous, Alcoholics
MN = N03.540.782.270
MH_TH = NLM (1974)
ST = T095
AN = CATALOGER: use NAF entry
MS = An organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence.
PM = 74
HN = 74
MR = 20150605
DA = 19990101
DC = 1
DX = 19740101
UI = D000436

*NEWRECORD
RECTYPE = D
MH = Alcoholism
AQ = BL CF CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Alcohol Abuse|T048|NON|REL|BIOETHICS (1976)|770317|abcdef
PRINT ENTRY = Alcoholic Intoxication, Chronic|T048|NON|EQV|NLM (1998)|960710|ALCOHOLIC INTOX CHRONIC|abcdefv
ENTRY = Alcohol Addiction|T048|NON|EQV|NLM (2014)|121106|abcdef
ENTRY = Alcohol Dependence|T048|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Abuse, Alcohol
ENTRY = Addiction, Alcohol
ENTRY = Chronic Alcoholic Intoxication
ENTRY = Dependence, Alcohol
ENTRY = Intoxication, Chronic Alcoholic
MN = C25.775.100.250
MN = F03.900.100.350
FX = Alcohol Deterrents
FX = Alcoholics Anonymous
FX = Psychoses, Alcoholic
FX = Temperance
EC = congenital:Fetal Alcohol Spectrum Disorders
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
ST = T048
AN = human & animal; note entry term ALCOHOLIC INTOXICATION, CHRONIC: do not coordinate with CHRONIC DISEASE; available also are BINGE DRINKING, DRUNKENNESS see ALCOHOLIC INTOXICATION and ALCOHOLICS; acute alcoholic intoxication = ETHANOL /pois; consider also ALCOHOL-INDUCED DISORDERS and specifics; index other complications of alcoholism under ALCOHOLISM /compl (IM) + disease /etiol not /chem ind (IM); abstinence from alcohol in alcoholism: coordinate with TEMPERANCE (NIM)
MS = A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000437

*NEWRECORD
RECTYPE = D
MH = Alcohols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.033
MH_TH = POPLINE (1984)
ST = T109
RN = 0
AN = do not use for "alcohol" ( = ETHANOL); diols = GLYCOLS; hypophysectomy by alcohol (ethanol) injection = HYPOPHYSECTOMY, CHEMICAL & do not index under ETHANOL unless particularly discussed
MS = Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)
MR = 19970620
DA = 19990101
DC = 1
UI = D000438

*NEWRECORD
RECTYPE = D
MH = Pentanols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alcohols, Amyl|T119|NON|EQV|NLM (1998)|970428|abcdef
PRINT ENTRY = Pentyl Alcohols|T119|NON|EQV|NLM (1998)|970428|abcdef
ENTRY = Hydroxypentanes|T119|NON|EQV|UNK (19XX)|800821|abcdef
ENTRY = Methylbutanols|T119|NON|EQV|UNK (19XX)|800821|abcdef
ENTRY = Alcohols, Pentyl
ENTRY = Amyl Alcohols
MN = D02.033.415.640
MN = D10.289.640
MH_TH = NLM (1972)
ST = T119
RN = 0
PI = Alcohols (1966-1971)
MS = Isomeric forms and derivatives of pentanol (C5H11OH).
PM = 98; see ALCOHOLS, AMYL 1974-97
HN = 98(72)
MR = 20030709
DA = 19990101
DC = 1
DX = 19740101
UI = D000439

*NEWRECORD
RECTYPE = D
MH = Butanols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alcohols, Butyl|T119|NON|EQV|NLM (1998)|970424|abcdef
ENTRY = Butylhydroxides|T119|NON|EQV|UNK (19XX)|800821|abcdef
ENTRY = Hydroxybutanes|T119|NON|EQV|UNK (19XX)|800821|abcdef
ENTRY = Butyl Alcohols
MN = D02.033.415.110
MN = D10.289.110
MH_TH = NLM (1972)
ST = T119
RN = 0
AN = 1-BUTANOL and TERT-BUTYL ALCOHOL also available
PI = Alcohols (1966-1971)
MS = Isomeric forms and derivatives of butanol (C4H9OH).
PM = 98; see ALCOHOLS, BUTYL 1972-97
HN = 98(72)
MR = 20030709
DA = 19990101
DC = 1
DX = 19740101
UI = D000440

*NEWRECORD
RECTYPE = D
MH = Hexanols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alcohols, Hexyl|T119|NON|EQV|NLM (1998)|970425|abcdef
ENTRY = Amylcarbinols|T119|NON|NRW|UNK (19XX)|800821|abcdef
ENTRY = Hydroxyhexanes|T119|NON|EQV|UNK (19XX)|800821|abcdef
ENTRY = Hexyl Alcohols
MN = D02.033.415.510
MN = D10.289.510
MH_TH = NLM (1972)
ST = T119
RN = 0
MS = Isomeric forms and derivatives of hexanol (C6H11OH).
PM = 98; see ALCOHOLS, HEXYL 1974-97
HN = 98(72)
MR = 20150622
DA = 19990101
DC = 1
DX = 19740101
UI = D000441

*NEWRECORD
RECTYPE = D
MH = Octanols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alcohols, Octyl|T119|NON|EQV|NLM (1998)|970610|abcdef
ENTRY = Heptylcarbinols|T119|NON|EQV|UNK (19XX)|800821|abcdef
ENTRY = Hydroxyoctanes|T119|NON|EQV|UNK (19XX)|800821|abcdef
ENTRY = Octylic Alcohols|T119|NON|EQV|UNK (19XX)|800821|abcdef
ENTRY = Alcohols, Octylic
ENTRY = Octyl Alcohols
MN = D02.033.415.600
MN = D10.289.600
MH_TH = NLM (1972)
ST = T119
RN = 0
AN = 1-OCTANOL is also available
MS = Isomeric forms and derivatives of octanol (C8H17OH).
PM = 98; see ALCOHOLS, OCTYL 1974-97
HN = 98(72)
MR = 20030709
DA = 19990101
DC = 1
DX = 19740101
UI = D000442

*NEWRECORD
RECTYPE = D
MH = Alcuronium
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alcuronium Chloride|T109|T121|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|USAN (1967)|930301|abbcdeeeef
PRINT ENTRY = Allnortoxiferine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Diallylnortoxiferine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
ENTRY = Alcuronium Dichloride|T109|T121|NRW|FDA SRS (2014)|NLM (1999)|990913|abbdeef
ENTRY = Alloferin|T109|T121|TRD|NRW|NLM (1994)|930301|abbcdef
ENTRY = Dialferine|T109|T121|NON|NRW|UNK (19XX)|800917|abbcdef
ENTRY = N,N'-Diallylnortoxiferinium Dichloride|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|800917|abbcdeef
ENTRY = Dichloride, Alcuronium
ENTRY = Dichloride, N,N'-Diallylnortoxiferinium
MN = D02.092.877.844.050
MN = D02.675.276.844.050
MN = D03.132.098.833.050
MN = D03.438.531.085.777.050
MN = D03.438.531.820.687.050
PA = Adjuvants, Anesthesia
PA = Neuromuscular Nondepolarizing Agents
PA = Nicotinic Antagonists
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Toxiferine I, 4,4'-didemethyl-4,4'-di-2-propenyl-
RN = S8U3J5W06N
RR = 15180-03-7 (dichloride)
RR = 23214-96-2 (Alcuronium)
RR = 490DW6501Y
PI = Allyl Compounds (1972-1974)
PI = Toxiferine (1972-1974)
MS = A non-depolarizing skeletal muscle relaxant similar to TUBOCURARINE. It is used as an anesthesia adjuvant.
OL = use ALCURONIUM to search ALLOFERIN 1978-93
PM = 91; was see under TOXIFERINE 1975-90; ALLOFERIN was see ALCURONIUM 1978-93
HN = 91(75); was see under TOXIFERINE 1975-90; ALLOFERIN was see ALCURONIUM 1978-93
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000443

*NEWRECORD
RECTYPE = D
MH = Aldehyde Dehydrogenase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = D-Glucuronolactone Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|840411|GLUCURONOLACTONE DEHYDROGENASE D|abbcdefs
ENTRY = Aldehyde Dehydrogenase (NAD(+))|T116|T126|ABX|EQV|NLM (2008)|070327|abbcdef
ENTRY = Aldehyde Dehydrogenase E1|T116|T126|NON|NRW|UNK (19XX)|840411|abbcdef
ENTRY = Aldehyde Dehydrogenase E2|T116|T126|NON|NRW|UNK (19XX)|840411|abbcdef
ENTRY = Aldehyde-NAD Oxidoreductase|T116|T126|EQV|UNK (19XX)|840411|abbdef
ENTRY = Aldehyde NAD Oxidoreductase
ENTRY = D Glucuronolactone Dehydrogenase
ENTRY = Dehydrogenase, Aldehyde
ENTRY = Dehydrogenase, D-Glucuronolactone
MN = D08.811.682.657.163.249
MH_TH = NLM (1985)
ST = T116
ST = T126
N1 = Aldehyde:NAD+ oxidoreductase
RN = EC 1.2.1.3
PI = Alcohol Oxidoreductases (1974-1979)
PI = Aldehyde Oxidoreductases (1980-1984)
MS = An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. This enzyme was formerly classified as EC 1.1.1.70.
PM = 85
HN = 85
MR = 20070709
DA = 19840411
DC = 1
DX = 19850101
UI = D000444

*NEWRECORD
RECTYPE = D
MH = Aldehyde Oxidoreductases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Oxidoreductases, Aldehyde
MN = D08.811.682.657.163
MH_TH = NLM (1973)
ST = T116
ST = T126
RN = EC 1.2.-
PI = Oxidoreductases (1966-1972)
MS = Oxidoreductases that are specific for ALDEHYDES.
PM = 73
HN = 73
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000445

*NEWRECORD
RECTYPE = D
MH = Aldehyde-Lyases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Aldolases|T116|T126|NON|EQV|NLM (2001)|000516|abbcdef
ENTRY = Aldehyde Lyases
MN = D08.811.520.224.062
MH_TH = NLM (1966)
ST = T116
ST = T126
RN = EC 4.1.2.-
MS = Enzymes that catalyze a reverse aldol condensation. A molecule containing a hydroxyl group and a carbonyl group is cleaved at a C-C bond to produce two smaller molecules (ALDEHYDES or KETONES). EC 4.1.2.
MR = 20060705
DA = 19990101
DC = 1
UI = D000446

*NEWRECORD
RECTYPE = D
MH = Aldehydes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.047
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Organic compounds containing a carbonyl group in the form -CHO.
MR = 20000621
DA = 19990101
DC = 1
UI = D000447

*NEWRECORD
RECTYPE = D
MH = Aldicarb
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = ENT-27,093|T109|T131|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Temik|T109|T131|TRD|NRW|UNK (19XX)|800730|abbcdef
ENTRY = UC-21,149|T109|T131|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = UC-21149|T109|T131|LAB|NRW|NLM (1991)|900319|abbcdef
ENTRY = ENT 27,093
ENTRY = ENT27,093
ENTRY = UC 21,149
ENTRY = UC 21149
ENTRY = UC21,149
ENTRY = UC21149
MN = D02.241.081.251.046
PA = Cholinesterase Inhibitors
PA = Insecticides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T131
N1 = Propanal, 2-methyl-2-(methylthio)-, O-((methylamino)carbonyl)oxime
RN = 8V071SH05P
RR = 116-06-3 (Aldicarb)
PI = Carbamates (1966-1971)
PI = Insecticides (1966-1971)
MS = Carbamate derivative used as an insecticide, acaricide, and nematocide.
PM = 91; was see under INSECTICIDES, CARBAMATE 1972-90
HN = 91(72); was see under INSECTICIDES, CARBAMATE 1972-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000448

*NEWRECORD
RECTYPE = D
MH = Aldehyde Reductase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aldose Reductase|T116|T126|NON|EQV|NLM (1992)|910114|abbcdef
ENTRY = Aldose Reductase Ia|T116|T123|NON|NRW|UNK (19XX)|850103|abbcdef
ENTRY = Aldose Reductase Ib|T116|T126|NON|NRW|UNK (19XX)|850103|abbcdef
ENTRY = Erythrose Reductase|T116|T126|NON|NRW|NLM (1992)|900928|abbcdef
ENTRY = Xylose Reductase|T116|T126|NON|NRW|NLM (1992)|910114|abbcdef
ENTRY = Reductase Ia, Aldose
ENTRY = Reductase Ib, Aldose
ENTRY = Reductase, Aldehyde
ENTRY = Reductase, Aldose
ENTRY = Reductase, Erythrose
ENTRY = Reductase, Xylose
MN = D08.811.682.047.150.700.075
MN = D08.811.682.047.820.275
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = Alditol:NAD(P)+ 1-oxidoreductase
RN = EC 1.1.1.21
PI = Alcohol Oxidoreductases (1972-1975)
PI = Sugar Alcohols (1972-1975)
MS = An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21.
OL = use ALDEHYDE REDUCTASE to search ALDOSE REDUCTASE 1976-91
PM = 92; was ALDOSE REDUCTASE 1976-91 (see under SUGAR ALCOHOL DEHYDROGENASES 1978-90, see under ALCOHOL OXIDOREDUCTASES 1976-77)
HN = 92; was ALDOSE REDUCTASE 1976-91 (see under SUGAR ALCOHOL DEHYDROGENASES 1978-90, see under ALCOHOL OXIDOREDUCTASES 1976-77)
MR = 20130708
DA = 19750723
DC = 1
DX = 19910101
UI = D000449

*NEWRECORD
RECTYPE = D
MH = Aldosterone
AQ = AA AD AE AG AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Aldosterone, (+-)-Isomer|T110|T121|T125|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Aldosterone, (11 beta,17 alpha)-Isomer|T110|T121|T125|NON|NRW|NLM (1999)|990913|abbbcdef
MN = D04.808.745.745.654.062
MN = D06.472.040.585.353.118
FX = Hyperaldosteronism
FX = Hypoaldosteronism
FX = Pseudohypoaldosteronism
FX = Receptors, Mineralocorticoid
FX = Renin-Angiotensin System
EC = antagonists & inhibitors:Mineralocorticoid Receptor Antagonists
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1966)
ST = T110
ST = T121
ST = T125
N1 = Pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)-
RN = 4964P6T9RB
RR = 125-77-9 ((+-)-isomer)
RR = 13479-36-2 ((11 beta,17 alpha)-isomer)
RR = 52-39-1 (Aldosterone)
AN = /defic: consider also HYPOALDOSTERONISM; consider also RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM see RENIN-ANGIOTENSIN SYSTEM & do not index under ALDOSTERONE unless particularly discussed
MS = A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.
MR = 20130708
DA = 19990101
DC = 1
UI = D000450

*NEWRECORD
RECTYPE = D
MH = Mineralocorticoid Receptor Antagonists
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aldosterone Antagonists|T121|NON|NRW|NLM (1978)|990101|ALDOSTERONE ANTAG|abcdefv
ENTRY = Aldosterone Receptor Antagonists|T121|NON|EQV|NLM (2013)|120118|abcdef
ENTRY = Mineralocorticoid Antagonists|T121|NON|EQV|NLM (2013)|120118|abcdef
ENTRY = Antagonists, Aldosterone
ENTRY = Antagonists, Aldosterone Receptor
ENTRY = Antagonists, Mineralocorticoid
ENTRY = Antagonists, Mineralocorticoid Receptor
ENTRY = Receptor Antagonists, Aldosterone
ENTRY = Receptor Antagonists, Mineralocorticoid
MN = D06.347.700
MN = D27.505.696.399.450.600
MN = D27.505.696.560.500.726.249
MH_TH = NLM (2013)
ST = T121
RN = 0
PI = Aldosterone (1966-1977)
MS = Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE.
PM = 2013; see ALDOSTERONE ANTAGONISTS 1966-2012
HN = 2013(1963)
MR = 20120703
DA = 19770517
DC = 1
DX = 19780101
UI = D000451

*NEWRECORD
RECTYPE = D
MH = Aldrin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Isodrin|T109|T131|NON|REL|UNK (19XX)|841002|abbcdef
MN = D02.455.526.439.042
PA = Insecticides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1971)
ST = T109
ST = T131
N1 = 1,4:5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-, (1alpha,4alpha,4abeta,5alpha,8alpha,8abeta)-
RN = OZE3CLY605
RR = 309-00-2 (Aldrin)
AN = TN 111 for eff on insects
PI = Hydrocarbons, Halogenated (1966-1970)
PI = Insecticides (1966-1970)
MS = A highly poisonous substance that was formerly used as an insecticide. The manufacture and use has been discontinued in the U.S. (From Merck Index, 11th ed)
PM = 73
HN = 73(71)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D000452

*NEWRECORD
RECTYPE = D
MH = Aleutian Mink Disease
DE = ALEUTIAN MINK DIS
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Aleutian Disease of Mink|T047|EPO|EQV|NLM (1991)|900413|ALEUTIAN DIS MINK|abcdefv
ENTRY = Disease, Aleutian Mink
ENTRY = Mink Disease, Aleutian
MN = C02.256.700.091
MN = C02.839.091
MN = C20.673.774.257.270
MN = C22.062
FX = Chediak-Higashi Syndrome
MH_TH = NLM (1971)
ST = T047
AN = caused by a parvovirus; don't forget also MINK (NIM) & check tag ANIMALS
PI = Carnivora (1966-1967)
PI = Mink (1968-1970)
PI = Virus Diseases (1966-1970)
MS = A slow progressive disease of mink caused by the ALEUTIAN MINK DISEASE VIRUS. It is characterized by poor reproduction, weight loss, autoimmunity, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible.
PM = 71
HN = 71
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
DX = 19710101
UI = D000453

*NEWRECORD
RECTYPE = D
MH = Aleutian Mink Disease Virus
DE = ALEUTIAN MINK DIS VIRUS
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Aleutian Disease Virus|T005|EPO|EQV|NLM (1991)|900413|ALEUTIAN DIS VIRUS|abcdefv
ENTRY = Aleutian Mink Disease Parvovirus|T005|NON|EQV|NLM (1997)|950927|abcdef
MN = B04.280.580.650.040.050
MH_TH = NLM (1975)
ST = T005
AN = a species of Parvovirus; infection = ALEUTIAN MINK DISEASE: see note there; DF: ALEUTIAN MINK DIS PARVOVIRUS
MS = A species of PARVOVIRUS that causes a disease in mink, mainly those homozygous for the recessive Aleutian gene which determines a desirable coat color.
PM = 97,75-93; was ALEUTIAN MINK DISEASE PARVOVIRUS 1994-96; was see under PARVOVIRIDAE 1986-90, see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85
HN = 97,75-93; was ALEUTIAN MINK DISEASE PARVOVIRUS 1994-96; was see under PARVOVIRIDAE 1986-90, see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D000454

*NEWRECORD
RECTYPE = D
MH = Medicago sativa
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Alfalfa|T002|NON|EQV|NLM (1966)|990101|abcdef
PRINT ENTRY = Lucerne|T002|NON|EQV|UNK (19XX)|740329|abcdef
MN = B01.650.940.800.575.100.401.590.500
MH_TH = NLM (2002)
ST = T002
PI = Alfalfa (1963-2001)
MS = A plant species of the family FABACEAE widely cultivated for ANIMAL FEED.
PM = 2002; see ALFALFA 1963-2001
HN = 2002(1963)
MR = 20150623
DA = 19990101
DC = 1
UI = D000455

*NEWRECORD
RECTYPE = D
MH = Cyanobacteria
DE = CYANOBACT
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Algae, Blue-Green|T007|NON|EQV|NLM (1992)|910404|abcdef
PRINT ENTRY = Blue-Green Bacteria|T007|NON|EQV|NLM (1992)|910404|BLUE GREEN BACT|abcdefv
PRINT ENTRY = Cyanophyceae|T007|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Algae, Blue Green|T007|NON|EQV|NLM (1992)|910415|abcdef
ENTRY = Bacteria, Blue Green|T007|NON|EQV|NLM (1992)|910415|abcdef
ENTRY = Bacteria, Blue-Green|T007|NON|EQV|NLM (1992)|910410|BACT BLUE GREEN|abcdefv
ENTRY = Blue Green Algae|T007|NON|EQV|NLM (1992)|910415|abcdef
ENTRY = Blue Green Bacteria|T007|NON|EQV|NLM (1992)|910415|abcdef
ENTRY = Blue-Green Algae|T007|NON|EQV|UNK (19XX)|880708|abcdef
MN = B03.280
MN = B03.440.475.100
FX = Phytoplankton
MH_TH = NLM (1970)
ST = T007
AN = general or unspecified; prefer specifics; do not confuse X ref CYANOPHYCEAE with CYANOPHORA
PI = Algae (1966-1969)
MS = A phylum of oxygenic photosynthetic bacteria comprised of unicellular to multicellular bacteria possessing CHLOROPHYLL a and carrying out oxygenic PHOTOSYNTHESIS. Cyanobacteria are the only known organisms capable of fixing both CARBON DIOXIDE (in the presence of light) and NITROGEN. Cell morphology can include nitrogen-fixing heterocysts and/or resting cells called akinetes. Formerly called blue-green algae, cyanobacteria were traditionally treated as ALGAE.
OL = use CYANOBACTERIA to search ALGAE, BLUE-GREEN & CYANOPHYTA 1970-91
PM = 92; was ALGAE, BLUE-GREEN 1970-91; CYANOBACTERIA was see ALGAE, BLUE-GREEN 1978-91; CYANOPHYTA was see ALGAE, BLUE-GREEN 1970-91
HN = 92; was ALGAE, BLUE-GREEN 1970-91; CYANOBACTERIA was see ALGAE, BLUE-GREEN 1978-91; CYANOPHYTA was see ALGAE, BLUE-GREEN 1970-91
MR = 20090706
DA = 19990101
DC = 1
DX = 19700101
UI = D000458

*NEWRECORD
RECTYPE = D
MH = Phaeophyta
AQ = CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Algae, Brown|T204|NON|EQV|NLM (1971)|990101|abcdef
PRINT ENTRY = Phaeophyceae|T204|NON|EQV|NLM (2004)|030603|abcdef
ENTRY = Brown Algae|T204|NON|EQV|NLM (2004)|030228|abcdef
MN = B01.750.600
MH_TH = NLM (2004)
ST = T204
AN = general or unspecified; prefer specifics
PI = Algae (1966-1970)
MS = A division of predominantly marine EUKARYOTA, commonly known as brown algae, having CHROMATOPHORES containing carotenoid PIGMENTS, BIOLOGICAL. ALGINATES and phlorotannins occur widely in all major orders. They are considered the most highly evolved algae because of their well-developed multicellular organization and structural complexity.
PM = 2011; see ALGAE, BROWN 1991-2010, see ALGAE 1971-1990
HN = 2011 (1971)
MR = 20100625
DA = 19990101
DC = 1
DX = 19910101
UI = D000459

*NEWRECORD
RECTYPE = D
MH = Chlorophyta
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Algae, Green|T002|NON|EQV|NLM (1970)|990101|abcdef
ENTRY = Green Algae|T002|NON|EQV|NLM (1992)|900911|abcdef
MN = B01.650.940.150
FX = Phytoplankton
MH_TH = UNK (19XX)
ST = T002
AN = general or unspecified; prefer specifics
PI = Algae (1966-1969)
MS = A phylum of photosynthetic EUKARYOTA bearing double membrane-bound plastids containing chlorophyll a and b. They comprise the classical green algae, and represent over 7000 species that live in a variety of primarily aquatic habitats. Only about ten percent are marine species, most live in freshwater.
PM = 70
HN = 70
MR = 20150622
DA = 19990101
DC = 1
DX = 19700101
UI = D000460

*NEWRECORD
RECTYPE = D
MH = Rhodophyta
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Algae, Red|T002|NON|EQV|NLM (1971)|990101|abcdef
PRINT ENTRY = Red Algae|T002|NON|EQV|NLM (2011)|091124|abcdef
MN = B01.650.700
FX = Seaweed
MH_TH = NLM (2004)
ST = T002
AN = general or unspecified; prefer specifics
PI = Algae (1966-1970)
MS = Plants of the division Rhodophyta, commonly known as red algae, in which the red pigment (PHYCOERYTHRIN) predominates. However, if this pigment is destroyed, the algae can appear purple, brown, green, or yellow. Two important substances found in the cell walls of red algae are AGAR and CARRAGEENAN. Some rhodophyta are notable SEAWEED (macroalgae).
PM = 2011; see ALGAE, RED 1974-2010
HN = 2011 (1971)
MR = 20150624
DA = 19990101
DC = 1
DX = 19740101
UI = D000461

*NEWRECORD
RECTYPE = D
MH = Algeria
AQ = EH EP
MN = Z01.058.266.104
MH_TH = NLM (1978)
ST = T083
MS = A country in northern Africa bordering the Mediterranean Sea, between MOROCCO and TUNISIA. Its capital is Algiers.
MR = 20080708
DA = 19990101
DC = 4
UI = D000462

*NEWRECORD
RECTYPE = D
MH = Algestone Acetophenide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alphasone Acetophenide|T110|T121|NON|EQV|UNK (19XX)|760324|abbcdef
PRINT ENTRY = Dihydroxyprogesterone Acetophenide|T110|T121|NON|EQV|UNK (19XX)|760324|abbcdef
ENTRY = Acetophenide, Algestone
ENTRY = Acetophenide, Alphasone
ENTRY = Acetophenide, Dihydroxyprogesterone
MN = D04.808.745.745.654.829.025.025
PA = Anti-Inflammatory Agents
PA = Contraceptives, Oral, Synthetic
PA = Progestins
MH_TH = FDA SRS (2014)
MH_TH = POPLINE (1984)
MH_TH = USAN (1969)
ST = T110
ST = T121
N1 = Pregn-4-ene-3,20-dione, 16,17-((1-phenylethylidene)bis(oxy))-, (16alpha(R))-
RN = OL7KC2O3OT
RR = 24356-94-3 (Algestone Acetophenide)
MS = A progesterone that has been used in ESTRUS SYNCHRONIZATION and has been evaluated as an injectable contraceptive in combination with estradiol enanthate. It is also used therapeutically as a topical anti-inflammatory and is applied topically in the treatment of ACNE.
PM = 74
HN = 74
MR = 20130708
DA = 19990101
DC = 1
UI = D000463

*NEWRECORD
RECTYPE = D
MH = Alginates
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU UL
MN = D09.698.068
FX = Dental Impression Materials
MH_TH = NLM (1966)
ST = T118
ST = T121
ST = T122
RN = 0
AN = D25-26 qualif
MS = Salts of alginic acid that are extracted from marine kelp and used to make dental impressions and as absorbent material for surgical dressings.
MR = 20040707
DA = 19990101
DC = 1
UI = D000464

*NEWRECORD
RECTYPE = D
MH = Algorithms
ENTRY = Algorithm
MN = G17.035
MN = L01.224.050
MH_TH = NLM (1987)
ST = T170
MS = A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task.
PM = 87
HN = 87
MR = 20080708
DA = 19860618
DC = 1
DX = 19870101
UI = D000465

*NEWRECORD
RECTYPE = D
MH = Alkadienes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Diolefins|T109|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Pentadienes|T109|NON|NRW|NLM (1998)|961219|abcdef
MN = D02.455.326.271.665.146
MH_TH = NLM (1974)
ST = T109
RN = 0
MS = Acyclic branched or unbranched hydrocarbons having two carbon-carbon double bonds.
PM = 74
HN = 74
MR = 19970620
DA = 19990101
DC = 1
DX = 19740101
UI = D000466

*NEWRECORD
RECTYPE = D
MH = Alkalies
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alkali|T197|NON|EQV|NLM (1994)|920730|abcdef
ENTRY = Alkalis|T197|NON|EQV|NLM (1994)|920730|abcdef
MN = D01.045
FX = Hypercalcemia
MH_TH = NLM (1966)
ST = T197
RN = 0
AN = singular form is "alkali"; /adv eff: consider also MILK-ALKALI SYNDROME see HYPERCALCEMIA
MS = Usually a hydroxide of lithium, sodium, potassium, rubidium or cesium, but also the carbonates of these metals, ammonia, and the amines. (Grant & Hackh's Chemical Dictionary, 5th ed)
MR = 19930604
DA = 19990101
DC = 1
UI = D000468

*NEWRECORD
RECTYPE = D
MH = Alkaline Phosphatase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D08.811.277.352.650.035
FX = Hypophosphatasia
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = Orthophosphoric-monoester phosphohydrolase (alkaline optimum)
RN = EC 3.1.3.1
RR = 9001-78-9 (CAS RN)
AN = /defic: consider also HYPOPHOSPHATASIA
MS = An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
OL = use ALKALINE PHOSPHATASE to search BLOOD ALKALINE PHOSPHATASE 1966-67
PM = /blood was BLOOD ALKALINE PHOSPHATASE 1963-67
HN = /blood was BLOOD ALKALINE PHOSPHATASE 1963-67
MR = 20030709
DA = 19990101
DC = 1
UI = D000469

*NEWRECORD
RECTYPE = D
MH = Alkaloids
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Plant Alkaloids|T109|NON|NRW|NLM (2014)|130111|abcdef
ENTRY = Alkaloids, Plant
MN = D03.132
MH_TH = POPLINE (1984)
ST = T109
RN = 0
AN = general or unspecified; prefer specific groups or specific alkaloid; note entry term Plant Alkaloids: coordinate with specific plant if pertinent
MS = Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed)
MR = 20130708
DA = 19990101
DC = 1
UI = D000470

*NEWRECORD
RECTYPE = D
MH = Alkalosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Alkaloses
MN = C18.452.076.354
MH_TH = NLM (1966)
ST = T046
ST = T047
MS = A pathological condition that removes acid or adds base to the body fluids.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000471

*NEWRECORD
RECTYPE = D
MH = Alkalosis, Respiratory
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Respiratory Alkalosis|T046|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Alkaloses, Respiratory
ENTRY = Respiratory Alkaloses
MN = C08.618.501.271
MN = C18.452.076.354.271
MH_TH = NLM (1971)
ST = T046
AN = excess loss of CO2 from body
PI = Alkalosis (1966-1970)
PI = Hyperventilation (1966-1970)
MS = A state due to excess loss of carbon dioxide from the body. (Dorland, 27th ed)
PM = 74
HN = 74(71)
CATSH = CAT LIST
MR = 19980610
DA = 19990101
DC = 1
DX = 19740101
UI = D000472

*NEWRECORD
RECTYPE = D
MH = Alkanes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.326.146
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = cycloalkanes = CYCLOPARAFFINS
MS = The generic name for the group of aliphatic hydrocarbons Cn-H2n+2. They are denoted by the suffix -ane. (Grant & Hackh's Chemical Dictionary, 5th ed)
PM = 66
HN = 66
MR = 19950316
DA = 19990101
DC = 1
DX = 19660101
UI = D000473

*NEWRECORD
RECTYPE = D
MH = Alkaptonuria
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Alcaptonuria|T047|NON|EQV|GHR (2014)|NLM (2012)|ORD (2010)|080925|abcdeeef
ENTRY = Homogentisic Acid Oxidase Deficiency|T047|NON|EQV|GHR (2014)|OMIM (2013)|111115|abcdeef
ENTRY = Homogentisic Acidura|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Alcaptonurias
MN = C16.320.565.100.187
MN = C18.452.648.100.187
FX = Homogentisate 1,2-Dioxygenase
MH_TH = GHR (2014)
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
MS = An inborn error of amino acid metabolism resulting from a defect in the enzyme HOMOGENTISATE 1,2-DIOXYGENASE, an enzyme involved in the breakdown of PHENYLALANINE and TYROSINE. It is characterized by accumulation of HOMOGENTISIC ACID in the urine, OCHRONOSIS in various tissues, and ARTHRITIS.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000474

*NEWRECORD
RECTYPE = D
MH = Alkenes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Olefins|T109|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Pentenes|T109|NON|NRW|NLM (1998)|961219|abcdef
MN = D02.455.326.271
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Unsaturated hydrocarbons of the type Cn-H2n, indicated by the suffix -ene. (Grant & Hackh's Chemical Dictionary, 5th ed, p408)
PM = 66
HN = 66
MR = 19970620
DA = 19990101
DC = 1
DX = 19660101
UI = D000475

*NEWRECORD
RECTYPE = D
MH = Alkanesulfonates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alkyl Sulfonates|T109|NON|EQV|NLM (1994)|930510|abcdef
ENTRY = Sulfonates, Alkyl
MN = D02.455.326.146.100.050
MN = D02.886.645.600.055.050
MH_TH = NLM (1973)
ST = T109
RN = 0
PI = Alkylating Agents (1966-1972)
PI = Sulfonic Acids (1966-1972)
MS = Organic esters or salts of sulfonic acid derivatives containing an aliphatic hydrocarbon radical.
OL = use ALKANESULFONATES to search ALKYL SULFONATES 1973-93
PM = 94; was ALKYL SULFONATES 1973-93
HN = 94; was ALKYL SULFONATES 1973-93
MR = 19930604
DA = 19990101
DC = 1
DX = 19730101
UI = D000476

*NEWRECORD
RECTYPE = D
MH = Alkylating Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alkylators|T121|T130|T131|NON|EQV|NLM (1996)|941020|abbbcdef
ENTRY = Agents, Alkylating
MN = D27.505.519.124
MN = D27.888.569.035
MH_TH = NLM (1964)
ST = T121
ST = T130
ST = T131
RN = 0
MS = Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases.
PM = 66
HN = 66(64)
MR = 20140625
DA = 19990101
DC = 1
DX = 19660101
UI = D000477

*NEWRECORD
RECTYPE = D
MH = Alkylation
AQ = DE GE IM PH RE
ENTRY = Alkylations
MN = G02.111.087.029
MN = G02.149.115.029
MN = G02.149.465.040
MN = G02.607.750.040
MN = G03.495.130
MH_TH = NLM (1966)
ST = T070
AN = almost never IM; enzymatic alkylation: coord NIM with TRANSFERASES (IM) + substrate (NIM); METHYLATION & METHYLTRANSFERASES are also available
MS = The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group.
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19660101
UI = D000478

*NEWRECORD
RECTYPE = D
MH = Alkylmercury Compounds
DE = ALKYLMERCURY CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alkyl Mercury Compounds|T109|T131|NON|EQV|UNK (19XX)|790523|ALKYL MERCURY CPDS|abbcdefv
PRINT ENTRY = Alkylmercurials|T109|T131|NON|EQV|UNK (19XX)|760414|abbcdef
ENTRY = Compounds, Alkyl Mercury
ENTRY = Compounds, Alkylmercury
ENTRY = Mercury Compounds, Alkyl
MN = D02.691.750.100
MH_TH = NLM (1977)
ST = T109
ST = T131
RN = 0
AN = DF: ALKYLMERCURY CPDS
PI = Mercury (1966-1976)
PI = Organometallic Compounds (1968-1976)
MS = Organic mercury compounds in which the mercury is attached to an alkyl group.
OL = use ALKYLMERCURY COMPOUNDS to search ALKYL MERCURY COMPOUNDS 1977-79
PM = 80; was ALKYL MERCURY COMPOUNDS 1977-79
HN = 80; was ALKYL MERCURY COMPOUNDS 1977-79
MR = 20110624
DA = 19760416
DC = 1
DX = 19770101
UI = D000479

*NEWRECORD
RECTYPE = D
MH = Alkynes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetylenic Compounds|T109|NON|EQV|NLM (2007)|051201|abcdef
ENTRY = Acetylenes|T109|NON|EQV|NLM (2007)|051201|abcdef
MN = D02.455.326.397
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2.
PM = 66
HN = 66
MR = 20060705
DA = 19990101
DC = 1
DX = 19660101
UI = D000480

*NEWRECORD
RECTYPE = D
MH = Allantoin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Campbell Brand of Allantoin|T109|T121|T123|NON|NRW|NLM (2003)|020723|abbbcdef
ENTRY = Herpecin-L|T109|T121|T123|TRD|NRW|US|020723|abbbcdef
ENTRY = Reed & Carnrick Brand of Allantoin|T109|T121|T123|NON|NRW|NLM (2003)|020723|abbbcdef
ENTRY = Sebical|T109|T121|T123|TRD|NRW|US|020723|abbbcdef
ENTRY = Sween Brand of Allantoin|T109|T121|T123|NON|NRW|NLM (2003)|020723|abbbcdef
ENTRY = Woun'dres|T109|T121|T123|TRD|NRW|US|020723|abbbcdef
ENTRY = Allantoin Campbell Brand
ENTRY = Allantoin Sween Brand
ENTRY = Herpecin L
ENTRY = HerpecinL
MN = D02.948.058
MN = D03.383.129.308.432.555.105
PA = Dermatologic Agents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1964)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
ST = T123
N1 = Urea, (2,5-dioxo-4-imidazolidinyl)-
RN = 344S277G0Z
RR = 97-59-6 (Allantoin)
MS = A urea hydantoin that is found in URINE and PLANTS and is used in dermatological preparations.
PM = 72
HN = 72(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19720101
UI = D000481

*NEWRECORD
RECTYPE = D
MH = Allantois
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Allantoic Membrane|T018|NON|EQV|NLM (2006)|041021|abcdef
ENTRY = Membrane, Allantoic
MN = A10.615.284.147
MN = A16.254.750.147
FX = Chorioallantoic Membrane
MH_TH = NLM (1975)
ST = T018
MS = An extra-embryonic membranous sac derived from the YOLK SAC of REPTILES; BIRDS; and MAMMALS. It lies between two other extra-embryonic membranes, the AMNION and the CHORION. The allantois serves to store urinary wastes and mediate exchange of gas and nutrients for the developing embryo.
OL = search FETAL MEMBRANES 1966-74
PM = 91; was see under FETAL MEMBRANES 1975-90
HN = 91(75); was see under FETAL MEMBRANES 1975-90
MR = 20070711
DA = 19990101
DC = 1
DX = 19910101
UI = D000482

*NEWRECORD
RECTYPE = D
MH = Alleles
PRINT ENTRY = Allelomorphs|T028|NON|EQV|NLM (1998)|960725|abcdef
ENTRY = Allele
ENTRY = Allelomorph
MN = G05.360.340.024.340.030
MH_TH = NLM (1968)
ST = T028
PI = Genes (1966-1967)
MS = Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D000483

*NEWRECORD
RECTYPE = D
MH = Allergens
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
MN = D23.050.063
FX = Bites and Stings
FX = Dust
FX = Feathers
FX = Fungi
MH_TH = NLM (1965)
ST = T129
RN = 0
AN = coord IM with specific allergen (IM), e.g., pollen as an allergen = ALLERGENS + POLLEN
MS = Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
PM = 65
HN = 65
MR = 20060705
DA = 19990101
DC = 1
DX = 19650101
UI = D000485

*NEWRECORD
RECTYPE = D
MH = Allergy and Immunology
DE = ALLERGY IMMUNOLOGY
AQ = CL EC ED ES HI IS LJ MA OG SN ST TD
PRINT ENTRY = Immunology|T091|NON|NRW|UNK (19XX)|790529|IMMUNOL|abcdefv
ENTRY = Allergy Specialty|T091|NON|NRW|NLM (2012)|110218|abcdef
ENTRY = Allergy, Immunology|T091|NON|EQV|UNK (19XX)|790529|ALLERGY IMMUNOL|abcdefv
ENTRY = Immunology and Allergy|T091|NON|EQV|UNK (19XX)|790529|IMMUNOLOGY ALLERGY|abcdefv
ENTRY = Immunology, Allergy|T091|NON|EQV|UNK (19XX)|790529|IMMUNOL ALLERGY|abcdefv
ENTRY = Specialty, Allergy
MN = H02.403.044
EC = methods:Immunologic Techniques
MH_TH = NLM (1966)
ST = T091
AN = the discipline (education, history, etc) only; use IMMUNE SYSTEM PHENOMENA or specifics treed under it for immunologic processes and properties; use HYPERSENSITIVITY or specifics treed under it for allergic conditions; the qualifier / immunol is available for use with specific anatomical terms, organisms, diseases, etc
MS = A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder.
OL = use ALLERGY AND IMMUNOLOGY to search IMMUNOLOGY 1966-79; search RADIATION IMMUNOLOGY under RADIATION EFFECTS 1966
PM = 80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66
HN = 80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66
MR = 20110624
DA = 19990101
DC = 1
UI = D000486

*NEWRECORD
RECTYPE = D
MH = Allethrin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Allethrins|T109|T131|NON|EQV|NLM (1996)|950118|abbcdef
MN = D02.455.849.575.812.272
PA = Insecticides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T131
N1 = Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, 2-methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl ester
RN = 0X03II877M
RR = 584-79-2 (Allethrin)
AN = TN 111 for eff on insects
PI = Cycloparaffins (1966-1971)
PI = Pyrethrum (1966-1971)
MS = Synthetic analogs of the naturally occurring insecticides cinerin, jasmolin, and pyrethrin. (From Merck Index, 11th ed)
PM = 74
HN = 74(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D000487

*NEWRECORD
RECTYPE = D
MH = Allied Health Personnel
AQ = CL EC ED ES HI LJ OG PX SD SN ST TD UT
PRINT ENTRY = Paramedical Personnel|T097|NON|REL|POPLINE (1978)|780503|PARAMED PERSONNEL|abcdefv
PRINT ENTRY = Paramedics|T097|NON|REL|UNK (19XX)|830622|abcdef
ENTRY = Population Program Specialists|T097|NON|NRW|POPLINE (1978)|781218|abcdef
ENTRY = Health Personnel, Allied
ENTRY = Paramedic
ENTRY = Personnel, Allied Health
ENTRY = Personnel, Paramedical
ENTRY = Population Program Specialist
ENTRY = Program Specialist, Population
ENTRY = Program Specialists, Population
ENTRY = Specialist, Population Program
ENTRY = Specialists, Population Program
MN = M01.526.485.067
MN = N02.360.067
MH_TH = BIOETHICS (1995)
ST = T097
PI = Health Manpower (1968-1970)
PI = Health Occupations (1966-1970)
MS = Health care workers specially trained and licensed to assist and support the work of health professionals. Often used synonymously with paramedical personnel, the term generally refers to all health care workers who perform tasks which must otherwise be performed by a physician or other health professional.
PM = 71
HN = 71
MR = 19941019
DA = 19990101
DC = 1
DX = 19710101
UI = D000488

*NEWRECORD
RECTYPE = D
MH = Alligators and Crocodiles
DE = ALLIGATORS CROCODILES
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Caimans|T014|NON|NRW|NLM (1991)|900319|abcdef
PRINT ENTRY = Crocodiles|T014|NON|NRW|UNK (19XX)|741211|abcdef
ENTRY = Alligators|T014|NON|NRW|UNK (19XX)|790329|abcdef
ENTRY = Caymans|T014|NON|NRW|NLM (1991)|900319|abcdef
ENTRY = Alligator
ENTRY = Caiman
ENTRY = Cayman
ENTRY = Crocodile
ENTRY = Crocodiles and Alligators
MN = B01.050.150.900.833.100
MH_TH = NLM (1975)
ST = T014
AN = IM; qualif permitted; DF: ALLIGATORS
MS = Large, long-tailed reptiles, including caimans, of the order Loricata.
PM = 91; was see under REPTILES 1975-90
HN = 91(75); was see under REPTILES 1975-90
MR = 20090706
DA = 19741212
DC = 1
DX = 19910101
UI = D000489

*NEWRECORD
RECTYPE = D
MH = Allium
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Alliaceae|T002|NON|BRD|NLM (1998)|961021|abcdef
MN = B01.650.940.800.575.100.610.100
MH_TH = NLM (1986)
ST = T002
PI = Garlic (1966-1985)
PI = Plants (1966-1985)
PI = Vegetables (1966-1985)
MS = A genus of the plant family Liliaceae (sometimes classified as Alliaceae) in the order Liliales. Many produce pungent, often bacteriostatic and physiologically active compounds and are used as VEGETABLES; CONDIMENTS; and medicament, the latter in traditional medicine.
PM = 86
HN = 86
MR = 20141218
DA = 19850503
DC = 1
DX = 19860101
UI = D000490

*NEWRECORD
RECTYPE = D
MH = Allophanate Hydrolase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Hydrolase, Allophanate
MN = D08.811.277.087.060
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Urea-1-carboxylate amidohydrolase
RN = EC 3.5.1.54
PI = Amidohydrolases (1974)
PI = Carboxylic Acids (1974)
PI = Urea (1974)
MS = An enzyme that catalyzes the hydrolysis of allophanic acid to two molecules of ammonia plus two molecules of "active carbon dioxide". EC 3.5.1.54.
PM = 91; was see under AMIDOHYDROLASES 1975-90
HN = 91(75); was see under AMIDOHYDROLASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D000492

*NEWRECORD
RECTYPE = D
MH = Allopurinol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = APS Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Allohexal|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Allohexan|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Alloprin|T109|T121|TRD|NRW|CA|030717|abbcdef
ENTRY = Allopurin|T109|T121|TRD|NRW|ES|030717|abbcdef
ENTRY = Allorin|T109|T121|TRD|NRW|AU|030717|abbcdef
ENTRY = Allpargin|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Allural|T109|T121|TRD|NRW|ES|030718|abbcdef
ENTRY = Alphapharm Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Amrad Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Apulonga|T109|T121|TRD|NRW|DE|030718|abbcdef
ENTRY = Apurin|T109|T121|TRD|NRW|NL|030718|abbcdef
ENTRY = Ashbourne Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Atisuril|T109|T121|TRD|NRW|MX|030721|abbcdef
ENTRY = Azupharma Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = BASF Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Bicther Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Bleminol|T109|T121|TRD|NRW|DE|030721|abbcdef
ENTRY = Boehringer Mannheim Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Boots Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Byk Gulden Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Caplenal|T109|T121|TRD|NRW|IE|UK|030721|abbcdeef
ENTRY = Capurate|T109|T121|TRD|NRW|AU|030721|abbcdef
ENTRY = Cellidrin|T109|T121|TRD|NRW|DE|UNK (19XX)|810108|abbcdeef
ENTRY = Clonmel Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Dorsch Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030718|abbcdef
ENTRY = Douglas Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Embarin|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Fawns & McAllan Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Foligan|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Glaxo Wellcome Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Hamarin|T109|T121|TRD|NRW|UK|030717|abbcdef
ENTRY = Hennig Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Henning Berlin Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Hexal Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Horner Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = ICN Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Jenapharm Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Jenapurinol|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Lopurin|T109|T121|TRD|NRW|UNK (19XX)|US|861119|abbcdeef
ENTRY = Lysuron|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Merckle Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Merz Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Milurit|T109|T121|TRD|NRW|DE|UNK (19XX)|831209|abbcdeef
ENTRY = Milurite|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Multipharma Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Nicholas Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Novopharm Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Novopurol|T109|T121|TRD|NRW|CA|030716|abbcdef
ENTRY = Pan Quimica|T109|T121|NON|NRW|NLM (2004)|030718|abbcdef
ENTRY = Pharmafarm Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Pinewood Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Progout|T109|T121|TRD|NRW|AU|030716|abbcdef
ENTRY = Protea Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Pureduct|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Purinol|T109|T121|TRD|NRW|CA|IE|030716|abbcdeef
ENTRY = R.A.N. Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Reig Jofre Brand of Allopurinol|T109|NON|NRW|NLM (2004)|030716|abcdef
ENTRY = Remid|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Rhne-Poulenc Rorer Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Rima Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Rimapurinol|T109|T121|TRD|NRW|UK|030716|abbcdef
ENTRY = Roche Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Rosen Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Roucol|T109|T121|TRD|NRW|CA|030716|abbcdef
ENTRY = Rougier Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Suspendol|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = TAD Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Thiemann Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Tipuric|T109|T121|TRD|NRW|IE|030716|abbcdef
ENTRY = Uribenz|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Uridocid|T109|TRD|NRW|ES|030716|abcdef
ENTRY = Uripurinol|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Urosin|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Urtias|T109|T121|TRD|NRW|DE|030716|abbcdef
ENTRY = Wellcome Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030716|abbcdef
ENTRY = Xanthomax|T109|T121|TRD|NRW|UK|030716|abbcdef
ENTRY = Xanturic|T109|T121|TRD|NRW|FR|030716|abbcdef
ENTRY = Zygout|T109|T121|TRD|NRW|AU|030716|abbcdef
ENTRY = Zyloprim|T109|T121|TRD|NRW|AU|CA|MX|UNK (19XX)|US|861121|abbcdeeeeef
ENTRY = Zyloric|T109|T121|TRD|NRW|DE|ES|FR|IE|NL|UK|030716|abbcdeeeeeef
ENTRY = gepepharm Brand of Allopurinol|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Allopurinol APS Brand
ENTRY = Allopurinol Alphapharm Brand
ENTRY = Allopurinol Amrad Brand
ENTRY = Allopurinol Ashbourne Brand
ENTRY = Allopurinol Azupharma Brand
ENTRY = Allopurinol BASF Brand
ENTRY = Allopurinol Bicther Brand
ENTRY = Allopurinol Boots Brand
ENTRY = Allopurinol Clonmel Brand
ENTRY = Allopurinol Dorsch Brand
ENTRY = Allopurinol Douglas Brand
ENTRY = Allopurinol Hennig Brand
ENTRY = Allopurinol Hexal Brand
ENTRY = Allopurinol Horner Brand
ENTRY = Allopurinol ICN Brand
ENTRY = Allopurinol Jenapharm Brand
ENTRY = Allopurinol Merckle Brand
ENTRY = Allopurinol Merz Brand
ENTRY = Allopurinol Multipharma Brand
ENTRY = Allopurinol Nicholas Brand
ENTRY = Allopurinol Novopharm Brand
ENTRY = Allopurinol Pharmafarm Brand
ENTRY = Allopurinol Pinewood Brand
ENTRY = Allopurinol Protea Brand
ENTRY = Allopurinol R.A.N. Brand
ENTRY = Allopurinol Rima Brand
ENTRY = Allopurinol Roche Brand
ENTRY = Allopurinol Rosen Brand
ENTRY = Allopurinol Rougier Brand
ENTRY = Allopurinol TAD Brand
ENTRY = Allopurinol Thiemann Brand
ENTRY = Allopurinol Wellcome Brand
ENTRY = Allopurinol gepepharm Brand
ENTRY = Quimica, Pan
ENTRY = Rhne Poulenc Rorer Brand of Allopurinol
MN = D03.438.759.160
PA = Antimetabolites
PA = Enzyme Inhibitors
PA = Free Radical Scavengers
PA = Gout Suppressants
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = JAN (19XX)
MH_TH = USAN (1964)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-
RN = 63CZ7GJN5I
RR = 315-30-0 (Allopurinol)
PI = Enzymes (1966)
PI = Xanthine Oxidase (1966)
MS = A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.
PM = 68
HN = 68(67)
MR = 20130708
DA = 19990101
DC = 1
DX = 19680101
UI = D000493

*NEWRECORD
RECTYPE = D
MH = Allosteric Regulation
DE = ALLOSTERIC REG
AQ = DE GE IM PH RE
ENTRY = Regulation, Allosteric|T044|NON|EQV|NLM (1992)|901015|REG ALLOSTERIC|abcdefv
ENTRY = Allosteric Regulations
ENTRY = Regulations, Allosteric
MN = G02.111.087.040
MN = G02.149.115.040
FX = Allosteric Site
MH_TH = NLM (1971)
ST = T044
AN = almost never IM; DF: ALLOSTERIC REG
PI = Binding Sites (1968-1970)
PI = Chemistry (1966-1970)
PI = Enzyme Activation (1969-1970)
PI = Enzyme Induction (1966-1970)
PI = Kinetics (1966-1970)
MS = The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES.
PM = 78; was see under BIOCHEMISTRY 1975-77
HN = 78(71); was see under BIOCHEMISTRY 1975-77
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19780101
UI = D000494

*NEWRECORD
RECTYPE = D
MH = Allosteric Site
AQ = DE GE IM PH RE
ENTRY = Allosteric Sites|T082|T169|NON|EQV|NLM (2009)|080129|abbcdef
ENTRY = Site, Allosteric
ENTRY = Sites, Allosteric
MN = G02.111.570.120.147
FX = Allosteric Regulation
MH_TH = NLM (1975)
ST = T082
ST = T169
MS = A site on an enzyme which upon binding of a modulator, causes the enzyme to undergo a conformational change that may alter its catalytic or binding properties.
OL = search BINDING SITES 1968-74
PM = 91; was see under BINDING SITES 1975-90
HN = 91(75); was see under BINDING SITES 1975-90
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D000495

*NEWRECORD
RECTYPE = D
MH = Alloxan
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.383.742.698.122
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T123
ST = T195
N1 = 2,4,5,6(1H,3H)-Pyrimidinetetrone
RN = 6SW5YHA5NG
RR = 50-71-5 (Alloxan)
AN = ALLOXAN DIABETES indexed as DIABETES MELLITUS, EXPERIMENTAL (IM) + ALLOXAN (NIM) only if chem is particularly discussed
MR = 20130708
DA = 19990101
DC = 1
UI = D000496

*NEWRECORD
RECTYPE = D
MH = Alloys
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Alloy
MN = D01.552.033
MN = D25.058
MN = J01.637.051.058
MH_TH = NLM (1965)
ST = T122
ST = T197
RN = 0
AN = D25-26 qualif
MS = A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions.
PM = 65
HN = 65
MR = 20060705
DA = 19990101
DC = 1
DX = 19650101
UI = D000497

*NEWRECORD
RECTYPE = D
MH = Allyl Compounds
DE = ALLYL CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compounds, Allyl
MN = D02.455.326.271.122
MH_TH = NLM (1971)
ST = T109
RN = 0
AN = DF: ALLYL CPDS
PI = Alkenes (1966-1970)
PM = 73
HN = 73(71)
MR = 19920507
DA = 19990101
DC = 1
DX = 19730101
UI = D000498

*NEWRECORD
RECTYPE = D
MH = Allylamine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 3-Aminopropylene|T109|T121|T131|NON|EQV|UNK (19XX)|750701|AMINOPROPYLENE 03|abbbcdefs
ENTRY = 3 Aminopropylene
MN = D02.092.050
MN = D02.455.326.271.122.100
MH_TH = FDA SRS (2014)
MH_TH = NLM (1976)
ST = T109
ST = T121
ST = T131
N1 = 2-Propen-1-amine
RN = 48G762T011
RR = 107-11-9 (Allylamine)
PI = Allyl Compounds (1974-1975)
PI = Amines (1974-1975)
MS = Possesses an unusual and selective cytotoxicity for VASCULAR SMOOTH MUSCLE cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation.
PM = 91; was see under AMINES 1976-90
HN = 91(76); was see under AMINES 1976-90
MR = 20130708
DA = 19750723
DC = 1
DX = 19910101
UI = D000499

*NEWRECORD
RECTYPE = D
MH = Allylestrenol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Allyloestrenol|T110|T121|NON|EQV|BAN (1989)|FDA SRS (2014)|890208|abbcdeef
ENTRY = Gestanin|T110|T121|TRD|NRW|UK|020723|abbcdef
ENTRY = Gestanon|T110|T121|TRD|NRW|ES|811102|abbcdef
ENTRY = Organon Brand of Allylestrenol|T110|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Turinal|T110|T121|TRD|NRW|UNK (19XX)|811209|abbcdef
ENTRY = Allylestrenol Organon Brand
MN = D04.808.365.415.050
PA = Progestins
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T110
ST = T121
N1 = Estr-4-en-17-ol, 17-(2-propenyl)-, (17beta)-
RN = I47VB5DZ8O
RR = 432-60-0 (Allylestrenol)
PI = Allyl Compounds (1973-1974)
PI = Estranes (1970-1974)
PI = Hydroxysteroids (1973-1974)
MS = A synthetic steroid with progestational activity.
PM = 91; was see under ESTRENES 1975-90
HN = 91(75); was see under ESTRENES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D000500

*NEWRECORD
RECTYPE = D
MH = Allylglycine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-Amino-4-Pentenoic Acid|T116|T121|NON|EQV|UNK (19XX)|800917|abbcdef
MN = D02.455.326.271.122.260
MN = D12.125.481.100
PA = Convulsants
PA = GABA Antagonists
MH_TH = NLM (1980)
ST = T116
ST = T121
N1 = 4-Pentenoic acid, 2-amino-
RN = 1069-48-3
PI = Allyl Compounds (1971-1975)
PI = Analeptics (1966-1974)
PI = Convulsants (1974-1979)
PI = Glycine (1966-1974) /antagonists & inhibitors (1975-1979)
MS = An inhibitor of glutamate decarboxylase and an antagonist of GAMMA-AMINOBUTYRIC ACID. It is used to induce convulsions in experimental animals.
PM = 91; was see under GLYCINE 1980-90
HN = 91(80); was see under GLYCINE 1980-90
MR = 20010803
DA = 19790523
DC = 1
DX = 19910101
UI = D000501

*NEWRECORD
RECTYPE = D
MH = Allylisopropylacetamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-Isopropyl-4-Pentenamide|T109|NON|EQV|UNK (19XX)|800917|abcdef
ENTRY = 2 Isopropyl 4 Pentenamide
MN = D02.065.064.189
MN = D02.241.081.018.110.189
MN = D02.455.326.271.122.272
MH_TH = NLM (1973)
ST = T109
N1 = 4-Pentenamide, 2-(1-methylethyl)-
RN = 299-78-5
MS = An allylic compound that acts as a suicide inactivator of CYTOCHROME P450 by covalently binding to its heme moiety or surrounding protein.
PM = 91; was see under ACETAMIDES 1973-90
HN = 91(73); was see under ACETAMIDES 1973-90
MR = 20120703
DA = 19990101
DC = 1
DX = 19910101
UI = D000502

*NEWRECORD
RECTYPE = D
MH = Almanacs as Topic
AQ = HI
ENTRY = Almanacs as Topics
MN = L01.178.682.192.836.072
MH_TH = NLM (2008)
ST = T170
AN = for medical almanacs, do not coordinate with MEDICINE; do not confuse with Publication Type ALMANACS
MS = Publications, usually annual, containing a calendar for the coming year, the times of such events and phenomena as anniversaries, sunrises, sunsets, phases of the moon, tides, meteorological, and other statistical information and related topics. Almanacs are also annual reference books of useful and interesting facts relating to countries of the world, sports, entertainment, population groups, etc. (Random House Unabridged Dictionary, 2d ed)
PM = 1963
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D000503

*NEWRECORD
RECTYPE = D
MH = Aloe
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Aloe vera|T002|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aloe veras
ENTRY = Aloes
ENTRY = vera, Aloe
ENTRY = veras, Aloe
MN = B01.650.940.800.575.100.027
MH_TH = NLM (1964)
ST = T002
AN = for HESPERALOE see AGAVACEAE is also available
MS = A plant genus of the family Aloeaceae, order Liliales (or Asphodelaceae, Asparagales in APG system) which is used medicinally. It contains anthraquinone glycosides such as aloin-emodin or aloe-emodin (EMODIN).
PM = 91,63-77; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77
HN = 91(78)63; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77; was in Cat B & D 1963-77
MR = 20150622
DA = 19990101
DC = 1
DX = 19640101
UI = D000504

*NEWRECORD
RECTYPE = D
MH = Alopecia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Alopecia, Androgenetic|T047|NON|REL|NLM (1993)|920504|ALOPECIA ANDROGENET|abcdefv
PRINT ENTRY = Baldness|T047|T184|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Male Pattern Baldness|T047|NON|REL|GHR (2014)|NLM (1993)|920504|abcdeef
PRINT ENTRY = Pseudopelade|T047|NON|NRW|NLM (1992)|900905|abcdef
ENTRY = Alopecia Cicatrisata|T047|NON|NRW|NLM (2012)|ORD (2010)|090313|abcdeef
ENTRY = Alopecia, Androgenetic, 1|T047|T184|NON|NRW|OMIM (2013)|111115|abbcdef
ENTRY = Alopecia, Male Pattern|T047|NON|REL|GHR (2014)|NLM (1993)|920504|abcdeef
ENTRY = Androgenetic Alopecia|T047|NON|REL|GHR (2014)|NLM (1993)|OMIM (2013)|920504|ANDROGENET ALOPECIA|abcdeeefv
ENTRY = Androgenic Alopecia|T047|NON|REL|GHR (2014)|130507|abcdef
ENTRY = Baldness, Male Pattern|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Female Pattern Baldness|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = Pattern Baldness|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = Alopecia Cicatrisatas
ENTRY = Cicatrisata, Alopecia
ENTRY = Cicatrisatas, Alopecia
ENTRY = Male Pattern Alopecia
MN = C17.800.329.937.122
MN = C23.300.035
MH_TH = POPLINE (1978)
ST = T047
ST = T184
MS = Absence of hair from areas where it is normally present.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000505

*NEWRECORD
RECTYPE = D
MH = Alopecia Areata
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Alopecia Circumscripta|T047|NON|EQV|NLM (2012)|ORD (2010)|090313|abcdeef
MN = C17.800.329.937.122.147
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
MS = Loss of scalp and body hair involving microscopically inflammatory patchy areas.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D000506

*NEWRECORD
RECTYPE = D
MH = Mucinosis, Follicular
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Alopecia Mucinosa|T047|NON|EQV|NLM (1993)|920406|abcdef
ENTRY = Follicular Mucinoses
ENTRY = Follicular Mucinosis
ENTRY = Mucinoses, Follicular
MN = C17.300.550.550
MN = C17.800.329.937.122.550
MN = C17.800.794.550
MH_TH = NLM (1965)
ST = T047
AN = a sebaceous gland dis
MS = A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary (idiopathic) or secondary to mycosis fungoides or reticulosis.
OL = use MUCINOSIS, FOLLICULAR to search ALOPECIA MUCINOSA 1966-92
PM = 93; was ALOPECIA MUCINOSA 1965-92 (see under ALOPECIA 1965-90)
HN = 93; was ALOPECIA MUCINOSA 1965-92 (see under ALOPECIA 1965-90)
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
DX = 19910101
UI = D000507

*NEWRECORD
RECTYPE = D
MH = Alouatta
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Monkey, Howler|T015|NON|EQV|UNK (19XX)|800512|abcdef
ENTRY = Howler Monkeys|T015|NON|EQV|UNK (19XX)|800512|abcdef
ENTRY = Alouattas
ENTRY = Howler Monkey
ENTRY = Monkeys, Howler
MN = B01.050.150.900.649.801.400.600.075.050.075
MH_TH = NLM (1975)
ST = T015
AN = index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
MS = A genus of the subfamily ALOUATTINAE, family ATELIDAE, inhabiting the forests of Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches.
OL = use ALOUATTA to search HOWLER MONKEYS 1975-80
PM = 91; was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80
HN = 91(81); was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80
MR = 20090706
DA = 19741111
DC = 1
DX = 19910101
UI = D000508

*NEWRECORD
RECTYPE = D
MH = alpha-Fetoproteins
AQ = AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = alpha-Fetoprotein|T116|T123|NON|EQV|UNK (19XX)|870511|abbcdef
ENTRY = alpha Fetoprotein
ENTRY = alpha Fetoproteins
MN = D12.776.124.790.106.092
MN = D12.776.320.525.500
MN = D12.776.377.228.500
MN = D12.776.377.715.085.092
MN = D23.101.140.050
FX = Anencephaly
MH_TH = POPLINE (1979)
ST = T116
ST = T123
RN = 0
PI = Fetal Proteins (1970-1974)
MS = The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.
OL = use ALPHA-FETOPROTEINS to search ALPHA FETOPROTEINS 1975-95
PM = 96; was ALPHA FETOPROTEINS 1975-95 (see under FETAL GLOBULINS 1975-76)
HN = 96; was ALPHA FETOPROTEINS 1975-95 (see under FETAL GLOBULINS 1975-76)
MR = 20150626
DA = 19741111
DC = 1
DX = 19770101
UI = D000509

*NEWRECORD
RECTYPE = D
MH = Alpha-Globulins
AQ = AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Alpha-Globulin|T116|T123|NON|EQV|UNK (19XX)|760905|abbcdef
ENTRY = Alpha Globulin
ENTRY = Alpha Globulins
MN = D12.776.124.790.106
MN = D12.776.377.715.085
MH_TH = NLM (1964)
ST = T116
ST = T123
RN = 0
AN = GEN or unspecified; prefer specifics
MS = Serum proteins that have the most rapid migration during ELECTROPHORESIS. This subgroup of globulins is divided into faster and slower alpha(1)- and alpha(2)-globulins.
OL = use ALPHA-GLOBULINS to search ALPHA GLOBULIN 1966-74
PM = 75; was ALPHA GLOBULIN 1965-74
HN = 75; was ALPHA GLOBULIN 1964-74 (Prov 1964)
MR = 20000621
DA = 19990101
DC = 1
DX = 19650101
UI = D000510

*NEWRECORD
RECTYPE = D
MH = alpha-Macroglobulins
AQ = AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Slow alpha 2-Macroglobulins|T116|T123|NON|NRW|UNK (19XX)|750701|SLOW ALPHA MACROGLOBULINS 02|abbcdefs
PRINT ENTRY = alpha 2-Acute Phase Globulins|T116|T123|NON|NRW|UNK (19XX)|750701|ALPHA ACUTE PHASE GLOBULINS 02|abbcdefs
PRINT ENTRY = alpha 2-Glucoproteins|T116|T123|NON|NRW|UNK (19XX)|750701|ALPHA GLUCOPROTEINS 02|abbcdefs
PRINT ENTRY = alpha-Macrofetoproteins|T116|T123|NON|EQV|UNK (19XX)|750701|abbcdef
ENTRY = 45S RNP|T116|T123|EQV|UNK (19XX)|871208|abbdef
ENTRY = Acute-Phase alpha 1-Protein|T116|T123|NON|NRW|UNK (19XX)|820903|abbcdef
ENTRY = Slow alpha 2-Globulin|T116|T123|NON|NRW|UNK (19XX)|800917|abbcdef
ENTRY = alpha 1-Acute Phase Globulin|T116|T123|NON|NRW|UNK (19XX)|831209|abbcdef
ENTRY = alpha 1-Acute Phase Protein|T116|T123|NON|NRW|UNK (19XX)|800917|abbcdef
ENTRY = alpha 1-Macroglobulin|T116|T123|NON|NRW|UNK (19XX)|810918|abbcdef
ENTRY = alpha 2-Acute Phase Globulin|T116|T123|NON|NRW|UNK (19XX)|800917|abbcdef
ENTRY = alpha 2-Glucoprotein|T116|T123|NON|NRW|UNK (19XX)|800917|abbcdef
ENTRY = alpha 2-Macroglobulin|T116|T123|NON|NRW|UNK (19XX)|800917|abbcdef
ENTRY = alpha-Macrofetoprotein|T116|T123|NON|NRW|UNK (19XX)|800917|abbcdef
ENTRY = alpha2-Macroglobulin|T116|T123|NON|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Acute Phase alpha 1 Protein
ENTRY = RNP, 45S
ENTRY = Slow alpha 2 Globulin
ENTRY = Slow alpha 2 Macroglobulins
ENTRY = alpha 1 Acute Phase Globulin
ENTRY = alpha 1 Acute Phase Protein
ENTRY = alpha 1 Macroglobulin
ENTRY = alpha 1-Protein, Acute-Phase
ENTRY = alpha 2 Acute Phase Globulin
ENTRY = alpha 2 Acute Phase Globulins
ENTRY = alpha 2 Glucoprotein
ENTRY = alpha 2 Glucoproteins
ENTRY = alpha 2 Macroglobulin
ENTRY = alpha 2-Globulin, Slow
ENTRY = alpha 2-Macroglobulins, Slow
ENTRY = alpha Macrofetoprotein
ENTRY = alpha Macrofetoproteins
ENTRY = alpha Macroglobulins
ENTRY = alpha2 Macroglobulin
MN = D12.776.124.050.080
MN = D12.776.124.790.106.100
MN = D12.776.124.790.720.100
MN = D12.776.377.715.085.100
MN = D12.776.377.715.647.100
MH_TH = NLM (1976)
ST = T116
ST = T123
RN = 0
PI = Macroglobulins (1973-1975)
PI = alpha Globulins (1974-1975)
MS = Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters.
OL = use ALPHA-MACROGLOBULINS to search ALPHA MACROGLOBULINS 1976-95
PM = 96; was ALPHA MACROGLOBULINS 1976-95
HN = 96; was ALPHA MACROGLOBULINS 1976-95
MR = 19950316
DA = 19750718
DC = 1
DX = 19760101
UI = D000511

*NEWRECORD
RECTYPE = D
MH = Alpha Particles
AQ = AE CL HI TU
PRINT ENTRY = Alpha Rays|T070|T072|NON|REL|UNK (19XX)|840302|abbcdef
ENTRY = Alpha Radiation|T070|T072|NON|REL|NLM (1995)|940630|ALPHA RAD|abbcdefv
ENTRY = Radiation, Alpha|T070|T072|NON|REL|NLM (1995)|940630|RAD ALPHA|abbcdefv
ENTRY = Alpha Particle
ENTRY = Alpha Ray
ENTRY = Particle, Alpha
ENTRY = Particles, Alpha
ENTRY = Ray, Alpha
ENTRY = Rays, Alpha
MN = G01.750.750.055
MH_TH = NLM (1966)
ST = T070
ST = T072
MS = Positively charged particles composed of two protons and two NEUTRONS, i.e. equivalent to HELIUM nuclei, which are emitted during disintegration of heavy ISOTOPES. Alpha rays have very strong ionizing power, but weak penetrability.
PM = 66
HN = 66
MR = 20110624
DA = 19990101
DC = 1
DX = 19660101
UI = D000512

*NEWRECORD
RECTYPE = D
MH = Alpha Rhythm
AQ = DE GE IM PH RE
ENTRY = Alpha Rhythms
ENTRY = Rhythm, Alpha
ENTRY = Rhythms, Alpha
MN = E01.370.376.300.150.374
MN = E01.370.405.245.287.374
MN = G07.265.087.500
MN = G11.561.127.500
MH_TH = NLM (1972)
ST = T042
PI = Electroencephalography (1966-1971)
MS = Brain waves characterized by a relatively high voltage or amplitude and a frequency of 8-13 Hz. They constitute the majority of waves recorded by EEG registering the activity of the parietal and occipital lobes when the individual is awake, but relaxed with the eyes closed.
PM = 74
HN = 74(72)
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
DX = 19740101
UI = D000513

*NEWRECORD
RECTYPE = D
MH = alpha 1-Antichymotrypsin
DS = ALPHA ANTICHYMOTRYPSIN 01
AQ = AD AE AG AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Serpin A3|T116|T123|NON|EQV|NLM (2010)|090209|abbcdef
ENTRY = alpha(1)-Antichymotrypsin|T116|T123|NON|EQV|UNK (19XX)|860414|abbcdef
ENTRY = alpha 1 Antichymotrypsin
MN = D12.644.861.030
MN = D12.776.124.050.050
MN = D12.776.124.790.106.050
MN = D12.776.377.715.085.050
MN = D12.776.395.045
MN = D12.776.872.030
PA = Serine Proteinase Inhibitors
MH_TH = NLM (1987)
ST = T116
ST = T123
RN = 0
PI = Chymotrypsin/antagonists & inhibitors (1968-1986)
PI = Glycoproteins (1966-1986)
PI = Protease Inhibitors (1979-1986)
MS = Glycoprotein found in alpha(1)-globulin region in human serum. It inhibits chymotrypsin-like proteinases in vivo and has cytotoxic killer-cell activity in vitro. The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumor marker. It is a member of the serpin superfamily.
PM = 87
HN = 87
MR = 20150623
DA = 19860414
DC = 1
DX = 19870101
UI = D000514

*NEWRECORD
RECTYPE = D
MH = alpha 1-Antitrypsin
DS = ALPHA ANTITRYPSIN A 01
AQ = AD AE AG AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Trypsin Inhibitor, alpha 1-Antitrypsin|T116|T121|T123|NON|EQV|UNK (19XX)|770401|TRYPSIN INHIBITOR ALPHA ANTITRYPSIN 01|TRYPSIN INHIB ALPHA 1 ANTITRYPSIN|abbbcdefsv
PRINT ENTRY = alpha 1-Protease Inhibitor|T116|T121|T123|NON|EQV|NLM (1990)|890426|ALPHA PROTEASE INHIBITOR 01|ALPHA 1 PROTEASE INHIB|abbbcdefsv
PRINT ENTRY = alpha 1-Proteinase Inhibitor|T116|T121|T123|NON|EQV|NLM (1990)|890426|ALPHA PROTEINASE INHIBITOR 01|ALPHA 1 PROTEINASE INHIB|abbbcdefsv
ENTRY = A1PI|T116|T121|T123|ABB|EQV|NLM (1998)|970311|abbbcdef
ENTRY = Prolastin|T116|T121|TRD|NRW|NLM (1998)|961209|abbcdef
ENTRY = Serpin A1|T116|T121|T123|NON|EQV|NLM (2010)|090209|abbbcdef
ENTRY = Zemaira|T116|T121|TRD|NRW|NLM (2005)|040324|abbcdef
ENTRY = alpha 1 Antiprotease|T116|T121|T123|NON|EQV|UNK (19XX)|810918|abbbcdef
ENTRY = alpha 1-Antiproteinase|T116|T121|T123|NON|EQV|UNK (19XX)|881102|abbbcdef
ENTRY = 1-Antiproteinase, alpha
ENTRY = Antiprotease, alpha 1
ENTRY = Inhibitor, alpha 1-Protease
ENTRY = Inhibitor, alpha 1-Proteinase
ENTRY = Trypsin Inhibitor, alpha 1 Antitrypsin
ENTRY = alpha 1 Antiproteinase
ENTRY = alpha 1 Antitrypsin
ENTRY = alpha 1 Protease Inhibitor
ENTRY = alpha 1 Proteinase Inhibitor
MN = D12.644.861.035
MN = D12.776.124.050.070
MN = D12.776.124.790.106.085
MN = D12.776.377.715.085.085
MN = D12.776.395.068
MN = D12.776.872.035
PA = Serine Proteinase Inhibitors
PA = Trypsin Inhibitors
FX = alpha 1-Antitrypsin Deficiency
EC = deficiency:alpha 1-Antitrypsin Deficiency
MH_TH = NLM (1974)
ST = T116
ST = T121
ST = T123
RN = 0
MS = Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES.
PM = 74
HN = 74
MR = 20150623
DA = 19990101
DC = 1
DX = 19740101
UI = D000515

*NEWRECORD
RECTYPE = D
MH = alpha-Amylases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Taka-Amylase A|T116|T126|TRD|NRW|UNK (19XX)|850605|abbcdef
PRINT ENTRY = alpha-Amylase|T116|T126|NON|EQV|USAN (1962)|990101|abbcdef
ENTRY = Alpha-Amylase Bayer|T116|T121|T126|TRD|NRW|FR|041207|abbbcdef
ENTRY = Bayer Brand of alpha-Amylase|T116|T121|T126|NON|NRW|NLM (2006)|041207|abbbcdef
ENTRY = Leurquin Brand of alpha-Amylase|T116|T121|T126|NON|NRW|NLM (2006)|041207|abbbcdef
ENTRY = Maxilase|T116|T121|T126|TRD|NRW|FR|041207|abbbcdef
ENTRY = Mgamylase|T116|T121|T126|TRD|NRW|FR|041207|abbbcdef
ENTRY = Sanofi Synthelabo Brand of alpha-Amylase|T116|T121|T126|NON|NRW|NLM (2006)|041207|abbbcdef
ENTRY = alpha-1,4-D-Glucanglucanohydrolase|T116|T126|NON|EQV|NLM (1990)|890609|abbcdef
ENTRY = Alpha Amylase Bayer
ENTRY = AlphaAmylase Bayer
ENTRY = Taka Amylase A
ENTRY = TakaAmylase A
ENTRY = alpha 1,4 D Glucanglucanohydrolase
ENTRY = alpha Amylase
ENTRY = alpha Amylases
MN = D08.811.277.450.066.050
MH_TH = NLM (2009)
ST = T116
ST = T126
N1 = 1,4-alpha-D-Glucan glucanohydrolase
RN = EC 3.2.1.1
RR = 9000-90-2 (CAS RN)
PI = Amylases (1966-1977)
MS = Enzymes that catalyze the endohydrolysis of 1,4-alpha-glycosidic linkages in STARCH; GLYCOGEN; and related POLYSACCHARIDES and OLIGOSACCHARIDES containing 3 or more 1,4-alpha-linked D-glucose units.
PM = 2009; see ALPHA-AMYLASE 1984-2008, see AMYLASES 1978-1983
HN = 2009(1978)
MR = 20080708
DA = 19770415
DC = 1
DX = 19840101
UI = D000516

*NEWRECORD
RECTYPE = D
MH = alpha-Chlorohydrin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = alpha-Chlorhydrin|T109|T121|NON|EQV|UNK (19XX)|760517|abbcdef
ENTRY = 3-Chloro-1,2-propanediol|T109|T121|NON|EQV|UNK (19XX)|820330|abbcdef
ENTRY = 3-Chloropropanediol|T109|T121|NON|EQV|UNK (19XX)|870810|abbcdef
ENTRY = 3-MCPD|T109|T121|ABB|EQV|NLM (2004)|040505|abbcdef
ENTRY = 3-Monochloropropane-1,2-diol|T109|T121|NON|EQV|NLM (2015)|140501|abbcdef
ENTRY = Glycerol alpha-Monochlorohydrin|T109|T121|NON|EQV|UNK (19XX)|810918|abbcdef
ENTRY = U-5897|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = 3 Chloro 1,2 propanediol
ENTRY = 3 Chloropropanediol
ENTRY = 3 Monochloropropane 1,2 diol
ENTRY = Glycerol alpha Monochlorohydrin
ENTRY = U 5897
ENTRY = U5897
ENTRY = alpha Chlorhydrin
ENTRY = alpha Chlorohydrin
ENTRY = alpha-Monochlorohydrin, Glycerol
MN = D02.033.260.100
MN = D02.033.455.706.100
PA = Chemosterilants
MH_TH = POPLINE (1978)
ST = T109
ST = T121
N1 = 1,2-Propanediol, 3-chloro-
RN = 96-24-2
RR = 52340-46-2 ((+-)-isomer)
RR = 57090-45-6 ((R)-isomer)
RR = 60827-45-4 ((S)-isomer)
PI = Chlorine (1972-1974)
PI = Propanediols (1969-1974)
MS = A chlorinated PROPANEDIOL with antifertility activity in males used as a chemosterilant in rodents.
PM = 91; was see under CHLOROHYDRINS 1975-90
HN = 91(75); was see under CHLOROHYDRINS 1975-90
MR = 20140625
DA = 19741114
DC = 1
DX = 19910101
UI = D000517

*NEWRECORD
RECTYPE = D
MH = Eflornithine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Difluoromethylornithine|T116|T121|NON|REL|FDA SRS (2014)|UNK (19XX)|860603|DFMO|abbcdeefv
PRINT ENTRY = alpha-Difluoromethylornithine|T116|T121|NON|EQV|NLM (1991)|900319|abbcdef
ENTRY = DL-alpha-Difluoromethylornithine|T116|T121|NON|REL|NLM (2002)|001128|abbcdef
ENTRY = Eflornithine Hydrochloride|T116|T121|NON|NRW|FDA SRS (2014)|NLM (1996)|USAN (1986)|940722|abbcdeeef
ENTRY = Eflornithine Monohydrochloride, Monohydrate|T116|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = MDL-71,782 A|T116|T121|LAB|NRW|UNK (19XX)|860603|abbcdef
ENTRY = Ornidyl|T109|T121|TRD|NRW|UNK (19XX)|880423|abbcdef
ENTRY = RMI 71782|T116|T121|LAB|NRW|UNK (19XX)|860603|abbcdef
ENTRY = Vaniqa|T116|T121|TRD|NRW|US|041104|abbcdef
ENTRY = Women First Brand of Eflornithine Hydrochloride|T116|T121|NON|NRW|NLM (2006)|050527|abbcdef
ENTRY = alpha-Difluoromethyl Ornithine|T116|T121|NON|EQV|UNK (19XX)|860603|abbcdef
ENTRY = 71782, RMI
ENTRY = DL alpha Difluoromethylornithine
ENTRY = Hydrochloride, Eflornithine
ENTRY = MDL 71,782 A
ENTRY = MDL71,782 A
ENTRY = Monohydrochloride, Monohydrate Eflornithine
ENTRY = Ornithine, alpha-Difluoromethyl
ENTRY = alpha Difluoromethyl Ornithine
ENTRY = alpha Difluoromethylornithine
MN = D12.125.068.665.340
MN = D12.125.095.765.340
PA = Antineoplastic Agents
PA = Ornithine Decarboxylase Inhibitors
PA = Trypanocidal Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T116
ST = T121
N1 = Ornithine, 2-(difluoromethyl)-
RN = ZQN1G5V6SR
RR = 4NH22NDW9H
RR = 67037-37-0 (Difluoromethylornithine)
RR = 70052-12-9 (Eflornithine)
RR = 96020-91-6 (mono-HCl, monohydrate)
PI = Ornithine (1966-1974)
PI = Ornithine/analogs & derivatives (1975-1986)
MS = An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
OL = use EFLORNITHINE to search ALPHA-DIFLUOROMETHYLORNITHINE 1987-90
PM = 91; was ALPHA-DIFLUOROMETHYLORNITHINE 1987-90
HN = 91; was ALPHA-DIFLUOROMETHYLORNITHINE 1987-90
MR = 20140612
DA = 19860603
DC = 1
DX = 19870101
UI = D000518

*NEWRECORD
RECTYPE = D
MH = alpha-Galactosidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Beano|T116|TRD|NRW|NLM (1997)|950713|abcdef
ENTRY = Melibiase|T116|T126|NON|EQV|NLM (1994)|930210|abbcdef
ENTRY = alpha-Galactosidase A|T116|T126|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = alpha-Galactosidases|T116|T126|NON|EQV|NLM (1994)|930210|abbcdef
ENTRY = alpha Galactosidase
ENTRY = alpha Galactosidase A
ENTRY = alpha Galactosidases
MN = D08.811.277.450.410.050
FX = Fabry Disease
EC = deficiency:Fabry Disease
MH_TH = NLM (1978)
ST = T116
ST = T126
N1 = alpha-D-galactoside galactohydrolase
RN = EC 3.2.1.22
PI = Galactosidases (1966-1978)
MS = An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids.
OL = use ALPHA-GALACTOSIDASE to search ALPHA-GALACTOSIDASES & MELIBIASES 1978-93; use GALACTOSIDASES to search MELIBIASE 1966-78
PM = 94; was ALPHA-GALACTOSIDASES 1978-93 (see under GALACTOSIDASES 1978-90); MELIBIASES was see ALPHA-GALACTOSIDASE 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74
HN = 94; was ALPHA-GALACTOSIDASES 1978-93 (see under GALACTOSIDASES 1978-90); MELIBIASES was see ALPHA-GALACTOSIDASES 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74
MR = 20130709
DA = 19770415
DC = 1
DX = 19910101
UI = D000519

*NEWRECORD
RECTYPE = D
MH = alpha-Glucosidases
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acid Maltase|T116|T126|NON|NRW|UNK (19XX)|770331|abbcdef
PRINT ENTRY = Lysosomal alpha-Glucosidase|T116|T126|NON|NRW|UNK (19XX)|770331|abbcdef
PRINT ENTRY = Maltases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef
ENTRY = Maltase-Glucoamylase|T116|T126|NON|EQV|NLM (1991)|900329|abbcdef
ENTRY = Neutral Maltase|T116|T126|NON|NRW|UNK (19XX)|830914|abbcdef
ENTRY = Neutral alpha-Glucosidase|T116|T126|NON|NRW|UNK (19XX)|820603|abbcdef
ENTRY = alpha-Glucosidase|T116|T126|NON|EQV|NLM (2008)|070327|abbcdef
ENTRY = Lysosomal alpha Glucosidase
ENTRY = Maltase Glucoamylase
ENTRY = Neutral alpha Glucosidase
ENTRY = alpha Glucosidase
ENTRY = alpha Glucosidases
ENTRY = alpha-Glucosidase, Lysosomal
ENTRY = alpha-Glucosidase, Neutral
MN = D08.811.277.450.420.050
FX = Glycogen Storage Disease Type II
EC = antagonists & inhibitors:Glycoside Hydrolase Inhibitors
MH_TH = NLM (1978)
ST = T116
ST = T126
N1 = alpha-D-Glucoside glucohydrolases
RN = EC 3.2.1.20
AN = defic/: consider also GLYCOGEN STORAGE DISEASE TYPE II
PI = Glucosidases (1966-1977)
MS = Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II.
PM = 1987; see GLUCOSIDASES 1978-1986, for LYSOSOMAL ALPHA-GLUCOSIDASE & ACID MALTASE see GLUCAN 1,4-ALPHA-GLUCOSIDASE 1978-2006
HN = 1987(1978)
MR = 20150708
DA = 19770415
DC = 1
DX = 19870101
UI = D000520

*NEWRECORD
RECTYPE = D
MH = alpha-MSH
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = MSH, alpha|T116|T124|T125|ACX|EQV|UNK (19XX)|870505|abbbcdef
PRINT ENTRY = alpha-Melanocyte-Stimulating Hormone|T116|T124|T125|NON|EQV|UNK (19XX)|870505|abbbcdef
ENTRY = (Des-Acetyl)-alpha-MSH|T116|T125|ACX|NRW|NLM (2007)|abbcde
ENTRY = (Desacetyl)alpha-MSH|T116|T125|ACX|NRW|NLM (2007)|abbcde
ENTRY = ACTH (1-13)|T116|ACR|NRW|NLM (2007)|abcde
ENTRY = ACTH (1-13)NH2|T116|T125|ACR|NRW|NLM (2007)|060112|abbcdef
ENTRY = ACTH(1-13)|T116|ACR|NRW|NLM (2007)|abcde
ENTRY = Acetylated ACTH (1-13)NH2|T116|T124|T125|ACX|EQV|NLM (2007)|060112|abbbcdef
ENTRY = Adrenocorticotropin (1-13)NH2|T116|T125|NON|NRW|NLM (2007)|abbcde
ENTRY = DE-alpha-MSH|T116|T125|ACX|NRW|NLM (2007)|abbcde
ENTRY = Des-Acetyl MSH|T116|T125|ACX|NRW|NLM (2007)|abbcde
ENTRY = Desacetyl alpha-MSH|T116|T125|ACX|NRW|NLM (2007)|abbcde
ENTRY = Desacetyl alpha-Melanocyte-Stimulating Hormone|T116|T125|NON|NRW|NLM (2007)|abbcde
ENTRY = MSH, (Desacetyl)alpha-|T116|T125|ACX|NRW|NLM (2007)|abbcde
ENTRY = alpha-Melanotropin|T116|T124|T125|NON|EQV|UNK (19XX)|870505|abbbcdef
ENTRY = Desacetyl alpha MSH
ENTRY = Desacetyl alpha Melanocyte Stimulating Hormone
ENTRY = Hormone, Desacetyl alpha-Melanocyte-Stimulating
ENTRY = Hormone, alpha-Melanocyte-Stimulating
ENTRY = MSH, Des-Acetyl
ENTRY = alpha MSH
ENTRY = alpha Melanocyte Stimulating Hormone
ENTRY = alpha Melanotropin
ENTRY = alpha-MSH, Desacetyl
ENTRY = alpha-Melanocyte-Stimulating Hormone, Desacetyl
MN = D06.472.699.327.935.179
MN = D06.472.699.327.935.531.750.050
MN = D06.472.699.631.525.600.179
MN = D06.472.699.631.525.600.531.750.050
MN = D12.644.400.400.935.179
MN = D12.644.400.400.935.531.750.050
MN = D12.644.400.460.050
MN = D12.644.548.365.935.179
MN = D12.644.548.365.935.531.750.050
MN = D12.644.548.691.525.690.179
MN = D12.644.548.691.525.690.531.750.050
MN = D12.776.641.650.405.935.179
MN = D12.776.641.650.405.935.531.750.050
MN = D12.776.641.650.460.050
PA = Hormones
MH_TH = NLM (1988)
ST = T116
ST = T124
ST = T125
N1 = alpha-Melanotropin
RN = 581-05-5
PI = MSH (1966-1987)
MS = A 13-amino acid peptide derived from proteolytic cleavage of ADRENOCORTICOTROPIC HORMONE, the N-terminal segment of ACTH. ACTH (1-13) is amidated at the C-terminal to form ACTH (1-13)NH2 which in turn is acetylated to form alpha-MSH in the secretory granules. Alpha-MSH stimulates the synthesis and distribution of MELANIN in MELANOCYTES in mammals and MELANOPHORES in lower vertebrates.
PM = 1988; ACTH (1-13) was indexed under PEPTIDE FRAGMENTS & ALPHA-MSH 1981-2006
HN = 1988 (1981)
MR = 20070709
DA = 19870505
DC = 1
DX = 19880101
UI = D000521

*NEWRECORD
RECTYPE = D
MH = Alphaprodine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Prodine|T109|T121|NON|BRD|UNK (19XX)|760317|abbcdef
ENTRY = Alphaprodine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1996)|USP (19XX)|940810|abbcdeeef
ENTRY = Nisentil|T109|T121|TRD|NRW|UNK (19XX)|991012|abbcdef
ENTRY = Hydrochloride, Alphaprodine
MN = D03.383.621.040
PA = Analgesics, Opioid
PA = Narcotics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 4-Piperidinol, 1,3-dimethyl-4-phenyl-, propanoate (ester), cis-
RN = 001O2254AC
RR = 561-78-4 (HCl)
RR = 77-20-3 (Alphaprodine)
RR = CO51Q2EI5Z
MS = An opioid analgesic chemically related to and with an action resembling that of MEPERIDINE, but more rapid in onset and of shorter duration. It has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1067)
PM = 65
HN = 65(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D000522

*NEWRECORD
RECTYPE = D
MH = Algestone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alphasone|T110|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760317|abbcdeef
PRINT ENTRY = Dihydroxyprogesterone|T110|T121|NON|EQV|UNK (19XX)|750101|abbcdef
ENTRY = 16 alpha,17-Dihydroxypregn-4-ene-3,20-dione|T110|T121|NON|EQV|NLM (2007)|060314|abbcdef
MN = D04.808.745.745.654.829.025
PA = Contraceptives, Oral, Synthetic
PA = Progestins
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T110
ST = T121
N1 = Pregn-4-ene-3,20-dione, 16,17-dihydroxy-, (16alpha)-
RN = 3JEB53B3WT
RR = 595-77-7 (Algestone)
MS = A synthetic progestational dihydroxy derivative of PROGESTERONE. Its acetonide possesses anti-inflammatory properties.
OL = use ALGESTONE to search ALPHASONE 1974-90; use ALGESTONE to search DIHYDROXYPROGESTERONE 1977-present & use ALGESTONE ACETOPHENIDE 1966-76 (as Prov 1966-73)
PM = 91; was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs & derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974
HN = 91(75); was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs & derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974, was heading 1964-73 (Prov)
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000523

*NEWRECORD
RECTYPE = D
MH = Alphavirus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Arboviruses, Group A|T005|NON|EQV|UNK (19XX)|800514|abcdef
PRINT ENTRY = Barmah forest virus|T005|EPO|NRW|NLM (1994)|930223|abcdef
PRINT ENTRY = Getah virus|T005|EPO|NRW|NLM (1994)|930223|abcdef
ENTRY = Alpha Virus|T005|NON|EQV|NLM (1994)|930223|abcdef
ENTRY = Alphaviruses|T005|NON|EQV|NLM (1994)|930223|abcdef
ENTRY = Alpha Viruses
ENTRY = Arbovirus, Group A
ENTRY = Group A Arbovirus
ENTRY = Group A Arboviruses
MN = B04.820.850.054
MH_TH = NLM (1981)
ST = T005
AN = infection = ALPHAVIRUS INFECTIONS
PI = Arboviruses (1966-1980)
MS = A genus of TOGAVIRIDAE, also known as Group A arboviruses, serologically related to each other but not to other Togaviridae. The viruses are transmitted by mosquitoes. The type species is the SINDBIS VIRUS.
OL = use ALPHAVIRUS to search ALPHAVIRUSES 1981-93; use ARBOVIRUSES 1978-80
PM = 94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80
HN = 94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80
MR = 20150622
DA = 19800514
DC = 1
DX = 19810101
UI = D000524

*NEWRECORD
RECTYPE = D
MH = Alprazolam
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alprazolan|T109|T121|NON|EQV|NLM (1990)|890609|abbcdef
ENTRY = Alphapharm Brand of Alprazolam|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Alprox|T109|T121|TRD|NRW|IE|020723|abbcdef
ENTRY = Apo-Alpraz|T109|T121|TRD|NRW|CA|020723|abbcdef
ENTRY = Apotex Brand of Alprazolam|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Arzneimittelwerk Dresden Brand of Alprazolam|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Cassadan|T109|T121|TRD|NRW|DE|020723|abbcdef
ENTRY = D-65MT|T109|T121|LAB|NRW|UNK (19XX)|860616|abbcdef
ENTRY = Esparon|T109|T121|TRD|NRW|DE|020723|abbcdef
ENTRY = Kalma|T109|T121|TRD|NRW|AU|020723|abbcdef
ENTRY = Kenral Brand of Alprazolam|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Novo-Alprazol|T109|T121|TRD|NRW|CA|020723|abbcdef
ENTRY = Novopharm Brand of Alprazolam|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Nu-Alpraz|T109|T121|TRD|NRW|CA|020723|abbcdef
ENTRY = Nu-Pharm Brand of Alprazolam|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Orion Brand of Alprazolam|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Pfizer Brand of Alprazolam|T109|T121|NON|NRW|NLM (2011)|100511|abbcdef
ENTRY = Ralozam|T109|T121|TRD|NRW|AU|020723|abbcdef
ENTRY = Tafil|T109|T121|TRD|NRW|DE|MX|020723|abbcdeef
ENTRY = Temmler Brand of Alprazolam|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Trankimazin|T109|T121|TRD|NRW|ES|020723|abbcdef
ENTRY = U-31,889|T109|T121|LAB|NRW|UNK (19XX)|860616|abbcdef
ENTRY = Xanax|T109|T121|TRD|NRW|AU|CA|DE|FR|IE|NL|UK|US|860616|abbcdeeeeeeeef
ENTRY = Alprazolam Alphapharm Brand
ENTRY = Alprazolam Apotex Brand
ENTRY = Alprazolam Kenral Brand
ENTRY = Alprazolam Novopharm Brand
ENTRY = Alprazolam Nu-Pharm Brand
ENTRY = Alprazolam Orion Brand
ENTRY = Alprazolam Pfizer Brand
ENTRY = Alprazolam Temmler Brand
ENTRY = Apo Alpraz
ENTRY = ApoAlpraz
ENTRY = D65MT
ENTRY = Novo Alprazol
ENTRY = NovoAlprazol
ENTRY = Nu Alpraz
ENTRY = Nu Pharm Brand of Alprazolam
ENTRY = NuAlpraz
ENTRY = U31,889
MN = D03.438.079.080.030
PA = Anti-Anxiety Agents
PA = GABA Modulators
PA = Hypnotics and Sedatives
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1973)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-
RN = YU55MQ3IZY
RR = 28981-97-7 (Alprazolam)
PI = Azepines (1966-1967)
PI = Benzazepines (1968-1973)
PI = Benzodiazepines (1975-1986)
MS = A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
PM = 87
HN = 87
MR = 20130708
DA = 19860616
DC = 1
DX = 19870101
UI = D000525

*NEWRECORD
RECTYPE = D
MH = Alprenolol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|800917|abbcdeef
ENTRY = Alfeprol|T109|T121|TRD|NRW|UNK (19XX)|800825|abbcdef
ENTRY = Alpheprol|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Alprenolol Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1996)|USAN (1968)|940810|abbcdeeef
ENTRY = Aptin|T109|T121|TRD|NRW|AU|020723|abbcdef
ENTRY = Aptin-Duriles|T109|T121|TRD|NRW|DE|020723|abbcdef
ENTRY = Aptina|T109|T121|TRD|NRW|ES|020723|abbcdef
ENTRY = Aptine|T109|T121|TRD|NRW|NL|020723|abbcdef
ENTRY = Astra Brand of Alprenolol Benzoate|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Astra Brand of Alprenolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = H-56-28|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Made Brand of Alprenolol Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020723|abbcdef
ENTRY = Aptin Duriles
ENTRY = AptinDuriles
ENTRY = H 56 28
ENTRY = H5628
MN = D02.033.100.624.698.055
MN = D02.033.755.624.698.055
MN = D02.092.063.624.698.055
PA = Adrenergic beta-Antagonists
PA = Anti-Arrhythmia Agents
PA = Antihypertensive Agents
PA = Sympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyl)phenoxy)-
RN = 877K5MQ27W
RR = 13655-52-2 (Alprenolol)
RR = 13707-88-5 (Alprenolol Hydrochloride)
RR = 2502C2OIRK
PI = Amino Alcohols (1966-1971)
PI = Sympatholytics (1966-1971)
MS = One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
PM = 73
HN = 73(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D000526

*NEWRECORD
RECTYPE = D
MH = Alprostadil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = PGE1|T111|T121|ABB|EQV|UNK (19XX)|880602|PGE 01|abbcdefs
PRINT ENTRY = Prostaglandin E1|T111|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|880602|PROSTAGLANDIN E 01|abbcdeefs
ENTRY = Abbott Brand of Alprostadil|T111|T121|NON|NRW|NLM (2006)|041027|abbcdef
ENTRY = Allphar Brand of Alprostadil|T111|T121|NON|NRW|NLM (2006)|041027|abbcdef
ENTRY = Astra Brand of Alprostadil|T111|T121|NON|NRW|NLM (2005)|040112|abbcdef
ENTRY = AstraZeneca Brand of Alprostadil|T111|T121|NON|NRW|NLM (2006)|041027|abbcdef
ENTRY = Caverject|T111|T121|TRD|NRW|AU|CA|DE|ES|FR|IE|MX|NL|UK|US|040112|abbcdeeeeeeeeeef
ENTRY = Edex|T111|T121|TRD|NRW|FR|US|040112|abbcdeef
ENTRY = Hoyer Brand of Alprostadil|T111|T121|NON|NRW|NLM (2005)|040112|abbcdef
ENTRY = Janssen Brand of Alprostadil|T111|T121|NON|NRW|NLM (2005)|040112|abbcdef
ENTRY = Lipo-PGE1|T111|T121|EQV|UNK (19XX)|880423|abbdef
ENTRY = Minprog|T111|T121|TRD|NRW|DE|040112|abbcdef
ENTRY = Muse|T121|TRD|NRW|AU|CA|DE|FR|IE|MX|NL|UK|US|040112|abcdeeeeeeeeef
ENTRY = PGE1alpha|T111|T121|EQV|UNK (19XX)|850308|abbdef
ENTRY = Paladin Brand of Alprostadil|T111|T121|NON|NRW|NLM (2006)|041027|abbcdef
ENTRY = Pharmacia Brand 1 of Alprostadil|T111|T121|NON|NRW|NLM (2005)|040112|abbcdef
ENTRY = Pharmacia Brand 2 of Alprostadil|T111|T121|NON|NRW|NLM (2006)|041027|abbcdef
ENTRY = Prostaglandin E1alpha|T111|T121|NON|EQV|UNK (19XX)|850308|abbcdef
ENTRY = Prostavasin|T111|T121|TRD|NRW|DE|041027|abbcdef
ENTRY = Prostin VR|T111|T121|TRD|NRW|AU|CA|UK|US|040112|abbcdeeeef
ENTRY = Prostine VR|T111|T121|TRD|NRW|AU|FR|040112|abbcdeef
ENTRY = Schwarz Brand of Alprostadil|T111|T121|NON|NRW|NLM (2005)|040112|abbcdef
ENTRY = Schwarz Pharma Brand of Alprostadil|T111|T121|NON|NRW|NLM (2011)|091118|abbcdef
ENTRY = Sugiran|T111|T121|TRD|NRW|ES|041027|abbcdef
ENTRY = Vasaprostan|T111|T121|TRD|NRW|NLM (2011)|091118|abbcdef
ENTRY = Viridal|T111|T121|TRD|NRW|DE|IE|UK|040112|abbcdeeef
ENTRY = Vivus Brand of Alprostadil|T111|T121|NON|NRW|NLM (2006)|041027|abbcdef
ENTRY = Lipo PGE1
MN = D10.251.355.255.550.250.100
MN = D10.251.355.325.050
MN = D23.469.050.175.725.250.100
PA = Platelet Aggregation Inhibitors
PA = Urological Agents
PA = Vasodilator Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1977)
MH_TH = USP (19XX)
ST = T111
ST = T121
N1 = Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-
RN = F5TD010360
RR = 745-65-3 (Alprostadil)
PI = Prostaglandins (1966-1974)
PI = Prostaglandins E (1975-1985)
MS = A potent vasodilator agent that increases peripheral blood flow.
PM = 86; VASOPROSTAN (now ALPROSTADIL) was indexed under VASODILATOR AGENTS 1995-97
HN = 86; see VASOPROSTAN (NM) 1995-97
MR = 20150608
DA = 19850308
DC = 1
DX = 19860101
UI = D000527

*NEWRECORD
RECTYPE = D
MH = Alternaria
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Alternarias
MN = B01.300.381.075
MH_TH = NLM (1975)
ST = T004
AN = infection = ALTERNARIOSIS
MS = A mitosporic Loculoascomycetes fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. Its teleomorph is Lewia.
PM = 91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85
HN = 91(75)
MR = 20110624
DA = 19741212
DC = 1
DX = 19910101
UI = D000528

*NEWRECORD
RECTYPE = D
MH = Complementary Therapies
DE = COMPLEMENTARY THER
AQ = AE CL CT EC ED ES HI IS LJ MA MO MT NU OG PX SN ST TD UT VE
PRINT ENTRY = Alternative Medicine|T091|NON|NRW|NLM (1986)|990101|ALTERNATIVE MED|abcdefv
PRINT ENTRY = Complementary Medicine|T091|NON|NRW|NLM (1996)|950301|COMPLEMENTARY MED|abcdefv
PRINT ENTRY = Medicine, Alternative|T091|NON|NRW|UNK (19XX)|850225|MED ALTERNATIVE|abcdefv
PRINT ENTRY = Medicine, Complementary|T091|NON|NRW|NLM (1996)|950301|MED COMPLEMENTARY|abcdefv
ENTRY = Alternative Therapies|T061|NON|NRW|BIOETHICS (1989)|860624|ALTERNATIVE THER|abcdefv
ENTRY = Therapy, Alternative|T061|NON|NRW|NLM (1991)|891129|THER ALTERNATIVE|abcdefv
ENTRY = Therapy, Complementary|T061|NON|EQV|NLM (1996)|950301|THER COMPLEMENTARY|abcdefv
ENTRY = Therapies, Alternative
ENTRY = Therapies, Complementary
MN = E02.190
MH_TH = NLM (1996)
ST = T061
AN = General or unspecified; prefer specifics; not for "alternative health care delivery system" (= DELIVERY OF HEALTH CARE) or specific health service.
MS = Therapeutic practices which are not currently considered an integral part of conventional allopathic medical practice. They may lack biomedical explanations but as they become better researched some (PHYSICAL THERAPY MODALITIES; DIET; ACUPUNCTURE) become widely accepted whereas others (humors, radium therapy) quietly fade away, yet are important historical footnotes. Therapies are termed as Complementary when used in addition to conventional treatments and as Alternative when used instead of conventional treatment.
PM = 2002; see ALTERNATIVE MEDICINE (1986-2001)
HN = 2002(1986)
CATSH = CAT LIST
MR = 20130709
DA = 19850225
DC = 1
DX = 19860101
UI = D000529

*NEWRECORD
RECTYPE = D
MH = Alfaxalone Alfadolone Mixture
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alfatesine|T110|T121|TRD|NRW|UNK (19XX)|800825|abbcdef
ENTRY = Alfathesin|T110|T121|TRD|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Alphadione|T110|T121|TRD|NRW|UNK (19XX)|741111|abbcdef
ENTRY = Alphathesin|T110|T121|TRD|NRW|UNK (19XX)|810424|abbcdef
ENTRY = Althesin|T110|T121|TRD|NRW|NLM (1975)|990101|abbcdef
ENTRY = CT-1341|T110|T121|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Glaxovet|T110|T121|TRD|NRW|UNK (19XX)|870617|abbcdef
ENTRY = Saffan|T110|T121|TRD|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Alfadolone Mixture, Alfaxalone
ENTRY = CT 1341
ENTRY = CT1341
MN = D04.808.745.558.050
MH_TH = NLM (2001)
ST = T110
ST = T121
N1 = Pregnane-11,20-dione, 21-(acetyloxy)-3-hydroxy-, (3alpha,5alpha)-, mixt. with (3alpha,5alpha)-3-hydroxypregnane-11,20-dione
RN = 8067-82-1
PI = Drug Combinations (1974)
PI = Hydroxysteroids (1974)
PI = Pregnanediones (1974)
MS = A 3:1 mixture of alfaxalone with alfadolone acetate that previously had been used as a general anesthetic. It is no longer actively marketed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1445)
PM = 2000; see ALTHESIN 1980-2000 & PREGNANEDIONES 1975-79
HN = 2001(1975)
MR = 20020724
DA = 19741111
DC = 1
DX = 19800101
UI = D000530

*NEWRECORD
RECTYPE = D
MH = Altitude
ENTRY = Altitudes
MN = G16.500.275.058
MN = N06.230.058
FX = Mountaineering
MH_TH = NLM (1986)
ST = T081
AN = consider also ATMOSPHERIC PRESSURE; /adv eff = probably ALTITUDE SICKNESS
MS = A vertical distance measured from a known level on the surface of a planet or other celestial body.
MR = 20090706
DA = 19990101
DC = 1
UI = D000531

*NEWRECORD
RECTYPE = D
MH = Altitude Sickness
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Mountain Sickness|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Altitude Hypoxia|T047|NON|BRD|NLM (2016)|141020|abcdef
ENTRY = Altitude Hypoxias
ENTRY = Hypoxia, Altitude
ENTRY = Sickness, Altitude
ENTRY = Sickness, Mountain
MN = C08.618.020
FX = Anoxia
MH_TH = NLM (1975)
ST = T047
MS = Multiple symptoms associated with reduced oxygen at high ALTITUDE.
OL = search ANOXIA 1966-74
PM = 91; was see under ANOXIA 1975-90
HN = 91(75); was see under ANOXIA 1975-90
CATSH = CAT LIST
MR = 20150707
DA = 19990101
DC = 1
DX = 19910101
UI = D000532

*NEWRECORD
RECTYPE = D
MH = Altruism
PRINT ENTRY = Humanitarianism|T054|NON|NRW|NLM (1995)|931123|abcdef
MN = F01.145.813.090
FX = Beneficence
FX = Gift Giving
MH_TH = BIOETHICS (1974)
ST = T054
AN = no qualif
PI = Social Behavior (1969-1977)
MS = Consideration and concern for others, as opposed to self-love or egoism, which can be a motivating influence.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 20020702
DA = 19770422
DC = 1
DX = 19780101
UI = D000533

*NEWRECORD
RECTYPE = D
MH = Alum Compounds
DE = ALUM CPDS
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Compounds, Alum
MN = D01.056.025
MN = D01.875.800.800.850.025
MH_TH = NLM (1975)
ST = T121
ST = T197
RN = 0
AN = astringents; also many indust uses; used also in vet med; D25-26 qualif; DF: ALUM CPDS
PI = Aluminum (1973-1974)
PI = Sulfates (1973-1974)
MS = Aluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhea, conjunctivitis, pharyngitis, metritis, and minor wounds.
OL = use ALUM COMPOUNDS to search ALUMINUM AMMONIUM SULFATE & ALUMINUM POTASSIUM SULFATE 1975-93
PM = 91; was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE & ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93
HN = 91(75); was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE & ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93
MR = 19930604
DA = 19741119
DC = 1
DX = 19910101
UI = D000534

*NEWRECORD
RECTYPE = D
MH = Aluminum
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.557.050
MN = D01.552.547.050
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Aluminum
RN = CPD4NFA903
RR = 7429-90-5 (Aluminum)
AN = Al-27; Al-23-26, 28-30 = ALUMINUM (IM) + RADIOISOTOPES (IM)
MS = A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.
MR = 20130708
DA = 19990101
DC = 1
UI = D000535

*NEWRECORD
RECTYPE = D
MH = Aluminum Hydroxide
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hydrated Alumina|T121|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|770516|abbcdeef
ENTRY = Aldrox|T121|T197|TRD|NRW|DE|020722|abbcdef
ENTRY = Algeldrate|T121|T197|NON|NRW|UNK (19XX)|870810|abbcdef
ENTRY = Alhydrogel|T121|T197|TRD|NRW|UNK (19XX)|820830|abbcdef
ENTRY = Alugel|T121|T197|TRD|NRW|CA|ES|020722|abbcdeef
ENTRY = Amphojel|T121|T197|TRD|NRW|AU|CA|US|800918|abbcdeeef
ENTRY = Atlas Brand of Algeldrate|T121|T197|NON|NRW|CA|NLM (2011)|100511|abbcdeef
ENTRY = Axcan Brand of Algeldrate|T121|T197|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Basalgel|T121|T197|TRD|NRW|CA|020722|abbcdef
ENTRY = Brasivil|T121|T197|TRD|NRW|DE|020722|abbcdef
ENTRY = Chefaro Brand of Algeldrate|T121|T197|NON|NRW|ES|NLM (2011)|100511|abbcdeef
ENTRY = Dialume|T121|T197|TRD|NRW|US|830915|abbcdef
ENTRY = Nephrox|T121|T197|TRD|NRW|US|020722|abbcdef
ENTRY = Pepsamer|T121|T197|TRD|NRW|ES|020722|abbcdef
ENTRY = Rhne-Poulenc Rorer Brand of Algeldrate|T121|T197|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Rocgel|T121|T197|TRD|NRW|FR|020722|abbcdef
ENTRY = Roques Brand of Algeldrate|T121|T197|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Sanofi Winthrop Brand of Algeldrate|T121|T197|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = SmithKline Beecham Brand of Algeldrate|T121|T197|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Stiefel Brand of Algeldrate|T121|T197|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Whitehall Brand of Algeldrate|T121|T197|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Wyeth Brand of Algeldrate|T121|T197|NON|NRW|NLM (2003)|020722|abbcdef
ENTRY = Algeldrate Atlas Brand
ENTRY = Algeldrate Axcan Brand
ENTRY = Algeldrate Chefaro Brand
ENTRY = Algeldrate Roques Brand
ENTRY = Algeldrate Stiefel Brand
ENTRY = Algeldrate Whitehall Brand
ENTRY = Algeldrate Wyeth Brand
ENTRY = Alumina, Hydrated
ENTRY = Hydroxide, Aluminum
ENTRY = Rhne Poulenc Rorer Brand of Algeldrate
MN = D01.045.250.050
MN = D01.056.037
MN = D01.248.497.158.459.075
PA = Adjuvants, Immunologic
PA = Antacids
MH_TH = FDA SRS (2014)
MH_TH = NLM (1978)
ST = T121
ST = T197
N1 = Aluminum hydroxide (Al(OH)3)
RN = 5QB0T2IUN0
RR = 21645-51-2 (Aluminum Hydroxide)
PI = Aluminum (1966-1977)
PI = Antacids (1966-1971)
PI = Hydroxides (1966-1977)
MS = A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.
OL = use ALUMINUM HYDROXIDE to search ALUMINUM HYDROXIDE GEL 1972-77 (as Prov 1972); use ANTACIDS 1966-71
PM = 78; ALUMINUM HYDROXIDE GEL was heading 1973-77; ALUMINUM GELS was see under ANTACIDS 1963-72
HN = 78; ALUMINUM HYDROXIDE GEL was heading 1972-77 (Prov 1972); ALUMINUM GELS was see under ANTACIDS 1963-72
MR = 20150622
DA = 19770516
DC = 1
DX = 19780101
UI = D000536

*NEWRECORD
RECTYPE = D
MH = Aluminum Oxide
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Alumina|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|770331|abcdeef
ENTRY = Alumina Ceramic|T197|NON|REL|NLM (1992)|901022|abcdef
ENTRY = Aluminum Oxide (Al130O40)|T197|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Aluminum Oxide (Al2O)|T197|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Aluminum Oxide (AlO2)|T197|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Bauxite|T197|NON|NRW|UNK (19XX)|870326|abcdef
ENTRY = Corundum|T197|NON|NRW|UNK (19XX)|820302|abcdef
ENTRY = Sapphire|T197|NON|NRW|UNK (19XX)|840919|abcdef
ENTRY = Ceramic, Alumina
ENTRY = Oxide, Aluminum
MN = D01.056.050
MN = D01.650.550.050
MH_TH = FDA SRS (2014)
MH_TH = NLM (1978)
ST = T197
N1 = Aluminum oxide (Al2O3)
RN = LMI26O6933
RR = 11092-32-3 (AlO2)
RR = 116066-61-6 (Al130O40)
RR = 12004-36-3 (Al2O)
RR = 1344-28-1 (Aluminum Oxide)
PI = Aluminum (1966-1977)
PI = Oxides (1966-1977)
MS = An oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories.
PM = 91; was see under ALUMINUM 1978-90
HN = 91(78); was see under ALUMINUM 1978-90
MR = 20130708
DA = 19770415
DC = 1
DX = 19910101
UI = D000537

*NEWRECORD
RECTYPE = D
MH = Aluminum Silicates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Silicates, Aluminum
MN = D01.056.050.075
MN = D01.578.725.025
MN = D01.650.550.050.075
MN = D01.837.725.700.760.050
MH_TH = NLM (1966)
ST = T197
RN = 0
AN = "numerous types of clay"
MS = Any of the numerous types of clay which contain varying proportions of Al2O3 and SiO2. They are made synthetically by heating aluminum fluoride at 1000-2000 degrees C with silica and water vapor. (From Hawley's Condensed Chemical Dictionary, 11th ed)
MR = 19930604
DA = 19990101
DC = 1
UI = D000538

*NEWRECORD
RECTYPE = D
MH = Alveolar Process
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
PRINT ENTRY = Alveolar Ridge|T023|NON|NRW|NLM (1998)|960710|abcdef
ENTRY = Alveolar Processes
ENTRY = Process, Alveolar
ENTRY = Processes, Alveolar
ENTRY = Ridge, Alveolar
MN = A02.835.232.781.324.502.125
MN = A14.521.125
MN = A14.549.167.646.094
FX = Alveolectomy
FX = Alveoloplasty
FX = Dental Arch
MH_TH = NLM (1965)
ST = T023
AN = dis: coord with JAW DISEASES or specific precoord jaw dis (IM); for /surg, prefer ALVEOLECTOMY or ALVEOLOPLASTY
MS = The thickest and spongiest part of the maxilla and mandible hollowed out into deep cavities for the teeth.
PM = 65
HN = 65
MR = 20080708
DA = 19990101
DC = 1
DX = 19650101
UI = D000539

*NEWRECORD
RECTYPE = D
MH = Alveolar Ridge Augmentation
AQ = AE CL CT EC ES HI IS MA MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Mandibular Ridge Augmentation|T061|NON|NRW|UNK (19XX)|790427|abcdef
PRINT ENTRY = Maxillary Ridge Augmentation|T061|NON|NRW|UNK (19XX)|790427|abcdef
ENTRY = Alveolar Ridge Augmentations
ENTRY = Augmentation, Alveolar Ridge
ENTRY = Augmentation, Mandibular Ridge
ENTRY = Augmentation, Maxillary Ridge
ENTRY = Augmentations, Alveolar Ridge
ENTRY = Augmentations, Mandibular Ridge
ENTRY = Augmentations, Maxillary Ridge
ENTRY = Mandibular Ridge Augmentations
ENTRY = Maxillary Ridge Augmentations
ENTRY = Ridge Augmentation, Alveolar
ENTRY = Ridge Augmentation, Mandibular
ENTRY = Ridge Augmentation, Maxillary
ENTRY = Ridge Augmentations, Alveolar
ENTRY = Ridge Augmentations, Mandibular
ENTRY = Ridge Augmentations, Maxillary
MN = E04.545.550.100
MN = E06.645.550.100
MH_TH = NLM (1980)
ST = T061
AN = do not use /util except by MeSH definition
PI = Alveoloplasty (1966-1979)
PI = Mandible/surgery (1966-1979)
PI = Mandibular Diseases/surgery (1966-1979)
MS = Preprosthetic surgery involving rib, cartilage, or iliac crest bone grafts, usually autologous, or synthetic implants for rebuilding the alveolar ridge.
PM = 91; was see under SURGERY, ORAL, PREPROSTHETIC 1980-90
HN = 91(80); was see under SURGERY, ORAL, PREPROSTHETIC 1980-90
CATSH = CAT LIST
MR = 19970620
DA = 19790427
DC = 1
DX = 19910101
UI = D000540

*NEWRECORD
RECTYPE = D
MH = Alveolectomy
AQ = AE CL CT EC ES HI IS MA MO MT NU PX SN ST TD UT VE
ENTRY = Alveolectomies
MN = E04.545.550.110
MN = E06.645.550.110
MH_TH = NLM (1965)
ST = T061
AN = excision of part of the ALVEOLAR PROCESS (see note there); do not confuse with ALVEOLOPLASTY; do not use /util except by MeSH definition
MS = Subtotal or complete excision of the alveolar process of the maxilla or mandible. (Dorland, 28th ed)
PM = 65
HN = 65
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19650101
UI = D000541

*NEWRECORD
RECTYPE = D
MH = Alveolitis, Extrinsic Allergic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Allergic Alveolitis, Extrinsic|T047|NON|EQV|UNK (19XX)|760427|abcdef
PRINT ENTRY = Hypersensitivity Pneumonitis|T047|NON|EQV|UNK (19XX)|760427|abcdef
PRINT ENTRY = Pneumonitis, Hypersensitivity|T047|NON|EQV|NLM (1993)|920122|abcdef
ENTRY = Allergic Alveolitides, Extrinsic
ENTRY = Alveolitides, Extrinsic Allergic
ENTRY = Extrinsic Allergic Alveolitides
ENTRY = Extrinsic Allergic Alveolitis
ENTRY = Hypersensitivity Pneumonitides
ENTRY = Pneumonitides, Hypersensitivity
MN = C08.381.483.125
MN = C08.674.055
MN = C20.543.480.680.075
MH_TH = NLM (1977)
ST = T047
PI = Respiratory Hypersensitivity (1966-1976)
MS = A common interstitial lung disease caused by hypersensitivity reactions of PULMONARY ALVEOLI after inhalation of and sensitization to environmental antigens of microbial, animal, or chemical sources. The disease is characterized by lymphocytic alveolitis and granulomatous pneumonitis.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 20080708
DA = 19760427
DC = 1
DX = 19770101
UI = D000542

*NEWRECORD
RECTYPE = D
MH = Alveoloplasty
AQ = AE CL CT EC ES HI IS MA MO MT NU PX SN ST TD UT VE
ENTRY = Alveoloplasties
MN = E04.545.550.120
MN = E06.645.550.120
FX = Denture, Complete, Immediate
MH_TH = NLM (1965)
ST = T061
AN = refers to ALVEOLAR PROCESS (see note there); do not confuse with ALVEOLECTOMY; do not use /util except by MeSH definition
MS = Conservative contouring of the alveolar process, in preparation for immediate or future denture construction. (Dorland, 28th ed)
PM = 65
HN = 65
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19650101
UI = D000543

*NEWRECORD
RECTYPE = D
MH = Alzheimer Disease
DE = ALZHEIMER DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Acute Confusional Senile Dementia|T048|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Dementia, Alzheimer Type|T047|EPO|EQV|NLM (2000)|991108|abcdef
PRINT ENTRY = Dementia, Senile|T047|NON|EQV|NLM (1966)|970523|abcdef
PRINT ENTRY = Presenile Alzheimer Dementia|T047|EPO|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Senile Dementia, Alzheimer Type|T047|EPO|EQV|NLM (2000)|991108|abcdef
ENTRY = Alzheimer Dementia (AD)|T047|NON|EQV|GHR (2014)|130507|abcdef
ENTRY = Alzheimer Disease, Early Onset|T047|EPO|NRW|NLM (2000)|991108|ALZHEIMER DIS EARLY ONSET|abcdefv
ENTRY = Alzheimer Disease, Late Onset|T048|EPO|NRW|NLM (2000)|991108|ALZHEIMER DIS LATE ONSET|abcdefv
ENTRY = Alzheimer Sclerosis|T047|NON|EQV|GHR (2014)|130418|abcdef
ENTRY = Alzheimer Syndrome|T047|NON|EQV|GHR (2014)|130418|abcdef
ENTRY = Alzheimer Type Senile Dementia|T047|EPO|EQV|NLM (2000)|991108|abcdef
ENTRY = Alzheimer's Disease|T047|EPO|EQV|GHR (2014)|NLM (1998)|960916|ALZHEIMERS DIS|abcdeefv
ENTRY = Alzheimer's Disease, Focal Onset|T048|EPO|NRW|NLM (2000)|991108|ALZHEIMERS DIS FOCAL ONSET|abcdefv
ENTRY = Alzheimer-Type Dementia (ATD)|T047|NON|EQV|GHR (2014)|130507|abcdef
ENTRY = Dementia, Presenile|T048|NON|NRW|NLM (1967)|970523|abcdef
ENTRY = Dementia, Primary Senile Degenerative|T047|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Early Onset Alzheimer Disease|T047|NON|NRW|NLM (2000)|991108|EARLY ONSET ALZHEIMER DIS|abcdefv
ENTRY = Familial Alzheimer Disease (FAD)|T047|NON|NRW|GHR (2014)|130507|abcdef
ENTRY = Focal Onset Alzheimer's Disease|T048|EPO|NRW|NLM (2000)|991108|FOCAL ONSET ALZHEIMERS DIS|abcdefv
ENTRY = Late Onset Alzheimer Disease|T048|NON|NRW|NLM (2000)|ORD (2010)|991108|LATE ONSET ALZHEIMER DIS|abcdeefv
ENTRY = Primary Senile Degenerative Dementia|T047|NON|EQV|GHR (2014)|NLM (2000)|991108|abcdeef
ENTRY = Senile Dementia, Acute Confusional|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Alzheimer Type Dementia
ENTRY = Alzheimer Type Dementia (ATD)
ENTRY = Dementia, Alzheimer (AD)
ENTRY = Dementia, Alzheimer-Type (ATD)
ENTRY = Disease, Alzheimer
ENTRY = Disease, Alzheimer's
ENTRY = Presenile Dementia
ENTRY = Sclerosis, Alzheimer
ENTRY = Senile Dementia
ENTRY = Syndrome, Alzheimer
MN = C10.228.140.380.100
MN = C10.574.945.249
MN = F03.615.400.100
FX = Amyloid beta-Peptides
FX = Amyloid beta-Protein Precursor
FX = Aphasia, Primary Progressive
FX = Cerebral Amyloid Angiopathy
FX = Kluver-Bucy Syndrome
FX = Neurofilament Proteins
FX = tau Proteins
MH_TH = GHR (2014)
MH_TH = NLM (1975)
MH_TH = OMIM (2013)
ST = T047
MS = A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
PM = 1998; see ALZHEIMER'S DISEASE 1984-1997, see DEMENTIA, PRESENILE 1967-1983, see PSYCHOSES, PRESENILE 1963-1966; for DEMENTIA PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE, SENILE see DEMENTIA 1981-1999; for DEMENTIA, SENILE see DEMENTIA 1966-1999
HN = 1998(1963); for DEMENTIA, PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE SENILE use DEMENTIA 1981-1999; for DEMENTIA SENILE use DEMENTIA 1966-1999
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
DX = 19840101
UI = D000544

*NEWRECORD
RECTYPE = D
MH = Amanita
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Amanitas
MN = B01.300.179.100.110
MH_TH = NLM (1975)
ST = T004
AN = a poisonous basidiomycete; coord NIM for MUSHROOM POISONING (IM) by Amanita
MS = A genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous.
PM = 91; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85
HN = 91(75); was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85
MR = 20090706
DA = 19741212
DC = 1
DX = 19910101
UI = D000545

*NEWRECORD
RECTYPE = D
MH = Amanitins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
MN = D04.345.566.050
MN = D12.644.456.050
MN = D12.644.641.050
MN = D23.946.587.175
PA = Enzyme Inhibitors
PA = Nucleic Acid Synthesis Inhibitors
PA = Poisons
MH_TH = NLM (1975)
ST = T116
ST = T131
RN = 0
AN = /antag permitted but consider also ANTITOXINS
PI = Mycotoxins (1974)
PI = Oligopeptides (1974)
PI = Peptides, Cyclic (1974)
MS = Cyclic peptides extracted from carpophores of various mushroom species. They are potent inhibitors of RNA polymerases in most eukaryotic species, blocking the production of mRNA and protein synthesis. These peptides are important in the study of transcription. Alpha-amanitin is the main toxin from the species Amanitia phalloides, poisonous if ingested by humans or animals.
PM = 75
HN = 75
MR = 20070709
DA = 19741111
DC = 1
DX = 19750901
UI = D000546

*NEWRECORD
RECTYPE = D
MH = Amantadine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-Aminoadamantane|T109|T121|NON|EQV|UNK (19XX)|811023|abbcdef
ENTRY = AbZ Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Adamantylamine|T109|T121|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = Adekin|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Aliud Brand of Amantadine Sulfate|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Alliance Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Aman|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amanta|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amanta-HCI-AZU|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amanta-Sulfate-AZU|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amantadin AL|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amantadin AZU|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amantadin Stada|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amantadin-neuraxpharm|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amantadin-ratiopharm|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Amantadina Juventus|T109|T121|TRD|NRW|ES|020724|abbcdef
ENTRY = Amantadina Llorente|T109|T121|TRD|NRW|ES|020724|abbcdef
ENTRY = Amantadine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1964)|USP (19XX)|940725|abbcdeeef
ENTRY = Amantadine Sulfate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|821129|abbcdeef
ENTRY = Amixx|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Azupharma Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Azupharma Brand of Amantadine Sulfate|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Cerebramed|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Ciba-Geigy Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Desitin Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Du Pont Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Endantadine|T109|T121|TRD|NRW|CA|020724|abbcdef
ENTRY = Endo Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Gen-Amantadine|T109|T121|TRD|NRW|CA|020724|abbcdef
ENTRY = Genpharm Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Hexal Brand of Amantadine Sulfate|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Hormosan Brand of Amantadine Sulfate|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Infecto-Flu|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Infectopharm Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Infex|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = Juventus Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Krewel Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Llorente Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Mantadix|T109|T121|TRD|NRW|FR|020724|abbcdef
ENTRY = Merz Brand of Amantadine Sulfate|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Midantan|T109|T121|TRD|NRW|UNK (19XX)|861009|abbcdef
ENTRY = Neuro Hexal Brand of Amantadine Sulfate|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Novartis Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Orion Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = PMS-Amantadine|T109|T121|TRD|NRW|CA|020724|abbcdef
ENTRY = Pharmascience Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Solvay Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Stada Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Stada Brand of Amantadine Sulfate|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Symadine|T109|T121|TRD|NRW|US|020724|abbcdef
ENTRY = Symmetrel|T109|T121|TRD|NRW|AU|CA|IE|NL|UK|US|861119|abbcdeeeeeef
ENTRY = Thiemann Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Viregyt|T109|T121|TRD|NRW|DE|831209|abbcdef
ENTRY = Wiregyt|T109|T121|TRD|NRW|UNK (19XX)|831209|abbcdef
ENTRY = neuraxpharm Brand of Amantadine Sulfate|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = ratiopharm Brand of Amantadine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = tregor|T109|T121|TRD|NRW|DE|020724|abbcdef
ENTRY = 1 Aminoadamantane
ENTRY = AL, Amantadin
ENTRY = AZU, Amantadin
ENTRY = Amanta HCI AZU
ENTRY = Amanta Sulfate AZU
ENTRY = AmantaHCIAZU
ENTRY = AmantaSulfateAZU
ENTRY = Amantadin neuraxpharm
ENTRY = Amantadin ratiopharm
ENTRY = Amantadinneuraxpharm
ENTRY = Amantadinratiopharm
ENTRY = Ciba Geigy Brand of Amantadine Hydrochloride
ENTRY = Gen Amantadine
ENTRY = GenAmantadine
ENTRY = Hydrochloride, Amantadine
ENTRY = Infecto Flu
ENTRY = InfectoFlu
ENTRY = Juventus, Amantadina
ENTRY = Llorente, Amantadina
ENTRY = PMS Amantadine
ENTRY = PMSAmantadine
ENTRY = Stada, Amantadin
ENTRY = Sulfate, Amantadine
MN = D02.455.426.100.050.035
PA = Analgesics, Non-Narcotic
PA = Antiparkinson Agents
PA = Antiviral Agents
PA = Dopamine Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Tricyclo(3.3.1.13,7)decan-1-amine
RN = BF4C9Z1J53
RR = 665-66-7 (HCl)
RR = 768-94-5 (Amantadine)
RR = 9921T5P019
RR = M6Q1EO9TD0
MS = An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.
PM = 68
HN = 68(65)
MR = 20130708
DA = 19990101
DC = 1
DX = 19680101
UI = D000547

*NEWRECORD
RECTYPE = D
MH = Amaranth Dye
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Red Dye No. 2|T109|T130|T131|NON|NRW|UNK (19XX)|760317|RED DYE NO 02|RED DYE NO 2|abbbcdefsv
ENTRY = FD & C Red No. 2|T109|T130|T131|LAB|NRW|NLM (1991)|900306|abbbcdef
ENTRY = Dye, Amaranth
MN = D02.172.025
MN = D02.455.426.559.847.638.555.200
MN = D02.886.645.600.080.050.650.012
MN = D04.615.638.555.200
PA = Coloring Agents
PA = Indicators and Reagents
MH_TH = NLM (2002)
ST = T109
ST = T130
ST = T131
N1 = 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-((4-sulfo-1-naphthalenyl)azo)-, trisodium salt
RN = 915-67-3
AN = AMARANTH PLANT see AMARANTHUS is also available; D25-26 qualif
PI = Azo Compounds (1969-1975)
PI = Naphthalenesulfonates (1974)
MS = A sulfonic acid-based naphthylazo dye used as a coloring agent for foodstuffs and medicines and as a dye and chemical indicator. It was banned by the FDA in 1976 for use in foods, drugs, and cosmetics. (From Merck Index, 11th ed)
PM = 2002; see AMARANTH 1991-2001, see AZO COMPOUNDS 1975-1990; for C.I. ACID RED 27, C.I. 16185, & FD&C RED NO. 2 see AMARANTH 1975-1993
HN = 1991(1975)
MR = 20060705
DA = 19741119
DC = 1
DX = 19910101
UI = D000548

*NEWRECORD
RECTYPE = D
MH = Ambenonium Chloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Mytelase|T109|T121|TRD|NRW|FR|US|020724|abbcdeef
ENTRY = Sanofi Winthrop Brand of Ambenonium Chloride|T109|T121|NON|NRW|NLM (2003)|020724|abbcdef
ENTRY = Chloride, Ambenonium
MN = D02.092.877.096.019
MN = D02.675.276.046
PA = Cholinesterase Inhibitors
PA = Parasympathomimetics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzenemethanaminium, N,N'-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-N,N-diethyl)-, dichloride
RN = 51FOB87G3I
RR = 115-79-7 (Ambenonium Chloride)
MS = A quaternary ammonium compound that is an inhibitor of cholinesterase activity with actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given by mouth in the treatment of myasthenia gravis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1112)
OL = use AMBENONIUM CHLORIDE to search AMBESTIGMINUM 1977-94
PM = 65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94
HN = 65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D000549

*NEWRECORD
RECTYPE = D
MH = Amblyopia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anisometropic Amblyopia|T047|NON|NRW|NLM (2000)|991104|abcdef
PRINT ENTRY = Lazy Eye|T047|NON|REL|NLM (2000)|991104|abcdef
ENTRY = Amblyopia, Developmental|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Amblyopia, Stimulus Deprivation-Induced|T047|NON|NRW|NLM (2000)|991104|AMBLYOPIA STIMULUS DEPRIVATION IND|abcdefv
ENTRY = Amblyopia, Suppression|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Stimulus Deprivation-Induced Amblyopia|T047|NON|NRW|NLM (2000)|991104|STIMULUS DEPRIVATION IND AMBLYOPIA|abcdefv
ENTRY = Amblyopia, Anisometropic
ENTRY = Amblyopia, Stimulus Deprivation Induced
ENTRY = Amblyopias
ENTRY = Amblyopias, Anisometropic
ENTRY = Amblyopias, Developmental
ENTRY = Amblyopias, Stimulus Deprivation-Induced
ENTRY = Amblyopias, Suppression
ENTRY = Anisometropic Amblyopias
ENTRY = Deprivation-Induced Amblyopia, Stimulus
ENTRY = Deprivation-Induced Amblyopias, Stimulus
ENTRY = Developmental Amblyopia
ENTRY = Developmental Amblyopias
ENTRY = Eye, Lazy
ENTRY = Eyes, Lazy
ENTRY = Lazy Eyes
ENTRY = Stimulus Deprivation Induced Amblyopia
ENTRY = Stimulus Deprivation-Induced Amblyopias
ENTRY = Suppression Amblyopia
ENTRY = Suppression Amblyopias
MN = C10.228.140.055
MN = C10.597.751.941.073
MN = C11.966.073
MN = C23.888.592.763.941.073
MH_TH = NLM (1966)
ST = T047
MS = A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.
CATSH = CAT LIST
MR = 20040719
DA = 19990101
DC = 1
UI = D000550

*NEWRECORD
RECTYPE = D
MH = Ambroxol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Bromhexine Metabolite VIII|T109|T121|NON|EQV|UNK (19XX)|760414|BROMHEXINE METABOLITE 08|abbcdefs
ENTRY = 4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexanol|T109|T121|NON|EQV|NLM (1995)|940405|abbcdef
ENTRY = AMBROPP|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Abrohexal|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Ambril|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Ambro-Puren|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Ambrobeta|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Ambrofur|T109|T121|TRD|NRW|MX|030724|abbcdef
ENTRY = Ambrohexal|T109|T121|TRD|NRW|DE|030721|abbcdef
ENTRY = Ambrolitic|T109|T121|TRD|NRW|ES|030724|abbcdef
ENTRY = Ambrols|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Ambroten|T109|T121|TRD|NRW|US|030717|abbcdef
ENTRY = Ambroxin|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Ambroxocompren|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Berlin-Chemie Brand of Abmbroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030730|abbcdef
ENTRY = Betapharm Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Bisolvon AM|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Boehringer Ingelheim Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Bronchopront|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Bronchowern|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Broxol|T109|T121|TRD|NRW|MX|030724|abbcdef
ENTRY = Carnot Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Cascan Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Chiesi Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Contac Husten-Trunk|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Degort's Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Diba Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030729|abbcdef
ENTRY = Dinobroxol|T109|T121|TRD|NRW|ES|030724|abbcdef
ENTRY = Duramucal|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Ebromin|T109|T121|TRD|NRW|MX|030724|abbcdef
ENTRY = Esparma Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Europharma Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|030812|abbcdef
ENTRY = Expeflen|T109|T121|TRD|NRW|MX|030729|abbcdef
ENTRY = Expit|T109|T121|TRD|NRW|DE|030729|abbcdef
ENTRY = Farmabroxol|T109|T121|TRD|NRW|DE|030729|abbcdef
ENTRY = Farmasan Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030729|abbcdef
ENTRY = Flavamed|T109|T121|TRD|NRW|DE|030730|abbcdef
ENTRY = Frenopect|T109|T121|TRD|NRW|DE|030730|abbcdef
ENTRY = Fustery Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Gelopol|T109|T121|TRD|NRW|DE|030730|abbcdef
ENTRY = Glaxo Wellcome Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Hefa Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030730|abbcdef
ENTRY = Hexal Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Isis Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Larylin Husten-Lser|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Lasolvan|T109|T121|TRD|NRW|DE|UNK (19XX)|821123|abbcdeef
ENTRY = Lichtenstein Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Mack Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Marjan Brand of Ambroxol|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Merck Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Mibrox|T109|T121|TRD|NRW|DE|030812|abbcdef
ENTRY = Motosol|T109|T121|TRD|NRW|ES|030812|abbcdef
ENTRY = Muco-Fips|T109|T121|TRD|NRW|DE|030721|abbcdef
ENTRY = Mucosolvan|T109|T121|TRD|NRW|DE|030717|abbcdef
ENTRY = Mucotablin|T109|T121|TRD|NRW|DE|030721|abbcdef
ENTRY = NA-872|T109|T121|LAB|NRW|UNK (19XX)|760414|abbcdef
ENTRY = Nattermann Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Orion Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|030812|abbcdef
ENTRY = Pect Hustenlser|T109|T121|TRD|NRW|DE|030721|abbcdef
ENTRY = Promeco Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030717|abbcdef
ENTRY = Pulmonal S|T109|T121|TRD|NRW|DE|030721|abbcdef
ENTRY = Pulmopharm Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Pdia Brand of Ambroxol|T109|T121|NON|NRW|NLM (2004)|030722|abbcdef
ENTRY = Pdiamuc|T109|T121|TRD|NRW|DE|030722|abbcdef
ENTRY = Rentschler Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Ringelheimer Pulmonal|T109|T121|TRD|NRW|DE|030721|abbcdef
ENTRY = Sankyo Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Schaper & Brmmer Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Sekretovit|T109|T121|TRD|NRW|DE|MX|030717|abbcdeef
ENTRY = SmithKline Beecham Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Stada Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030721|abbcdef
ENTRY = Surbronc|T109|T121|TRD|NRW|DE|FR|030717|abbcdeef
ENTRY = Teva Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030729|abbcdef
ENTRY = Therapin Hustenlser|T109|T121|TRD|NRW|DE|030724|abbcdef
ENTRY = Thomae Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = Wernigerode Brand of Ambroxol Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030724|abbcdef
ENTRY = stas-Hustenlser|T109|T121|TRD|NRW|DE|030721|abbcdef
ENTRY = AM, Bisolvon
ENTRY = Ambro Puren
ENTRY = AmbroPuren
ENTRY = Ambroxol Marjan Brand
ENTRY = Ambroxol Pdia Brand
ENTRY = Berlin Chemie Brand of Abmbroxol Hydrochloride
ENTRY = Contac Husten Trunk
ENTRY = Contac HustenTrunk
ENTRY = Hustenlser, Pect
ENTRY = Hustenlser, Therapin
ENTRY = Larylin Husten Lser
ENTRY = Larylin HustenLser
ENTRY = Metabolite VIII, Bromhexine
ENTRY = Muco Fips
ENTRY = MucoFips
ENTRY = NA 872
ENTRY = NA872
ENTRY = Pulmonal, Ringelheimer
ENTRY = stas Hustenlser
ENTRY = stasHustenlser
MN = D02.092.146.271.100
MN = D02.092.384.175.100
PA = Expectorants
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, trans-
RN = 200168S0CL
RR = 18683-91-5 (Ambroxol)
PI = Aniline Compounds (1974)
PI = Bromhexine/analogs & derivatives (1975-1976)
PI = Cyclohexylamines (1974)
MS = A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
PM = 91; was see under BROMHEXINE 1977-90
HN = 91(77); was see under BROMHEXINE 1977-90
MR = 20130708
DA = 19760416
DC = 1
DX = 19910101
UI = D000551

*NEWRECORD
RECTYPE = D
MH = Ambulances
AQ = CL EC ES HI LJ MA OG SD SN ST UT
PRINT ENTRY = Emergency Mobile Units|T073|NON|BRD|UNK (19XX)|820426|abcdef
PRINT ENTRY = Mobile Emergency Units|T073|NON|BRD|UNK (19XX)|820426|abcdef
ENTRY = Ambulance
ENTRY = Emergency Mobile Unit
ENTRY = Emergency Unit, Mobile
ENTRY = Emergency Units, Mobile
ENTRY = Mobile Emergency Unit
ENTRY = Mobile Unit, Emergency
ENTRY = Mobile Units, Emergency
ENTRY = Unit, Emergency Mobile
ENTRY = Unit, Mobile Emergency
ENTRY = Units, Emergency Mobile
ENTRY = Units, Mobile Emergency
MN = J01.937.500.050
MN = N02.421.297.879.100
MH_TH = NLM (1966)
ST = T073
MS = A vehicle equipped for transporting patients in need of emergency care.
MR = 20150629
DA = 19990101
DC = 1
UI = D000552

*NEWRECORD
RECTYPE = D
MH = Ambulatory Care
AQ = CL EC ES HI LJ MA MT OG PX SN ST TD UT
PRINT ENTRY = Outpatient Care|T058|NON|EQV|NLM (1992)|910521|abcdef
PRINT ENTRY = Outpatient Health Services|T058|NON|BRD|NLM (1992)|910429|OUTPATIENT HEALTH SERV|abcdefv
ENTRY = Clinic Visits|T058|NON|REL|POPLINE (1978)|781218|abcdef
ENTRY = Health Services, Outpatient|T058|NON|BRD|NLM (1996)|950213|HEALTH SERV OUTPATIENT|abcdefv
ENTRY = Services, Outpatient Health|T058|NON|BRD|NLM (1996)|950213|SERV OUTPATIENT HEALTH|abcdefv
ENTRY = Urgent Care|T058|NON|NRW|NLM (2010)|090616|abcdef
ENTRY = Care, Ambulatory
ENTRY = Care, Outpatient
ENTRY = Care, Urgent
ENTRY = Cares, Urgent
ENTRY = Clinic Visit
ENTRY = Health Service, Outpatient
ENTRY = Outpatient Health Service
ENTRY = Service, Outpatient Health
ENTRY = Urgent Cares
ENTRY = Visit, Clinic
ENTRY = Visits, Clinic
MN = E02.760.106
MN = N02.421.585.106
MH_TH = NLM (1966)
ST = T058
MS = Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility.
PM = 68
HN = 68(66)
CATSH = CAT LIST
MR = 20150629
DA = 19990101
DC = 1
DX = 19680101
UI = D000553

*NEWRECORD
RECTYPE = D
MH = Ambulatory Care Facilities
AQ = CL EC ES HI LJ MA OG SD SN ST TD UT
PRINT ENTRY = Clinics, Free-Standing|T093|NON|NRW|UNK (19XX)|790529|abcdef
PRINT ENTRY = Health Centers, Ambulatory|T093|NON|BRD|UNK (19XX)|820430|abcdef
PRINT ENTRY = Outpatient Clinics|T073|T093|NON|EQV|UNK (19XX)|820430|abbcdef
ENTRY = Abortion Centers|T093|NON|NRW|POPLINE (1978)|781226|abcdef
ENTRY = Abortion Clinics|T093|NON|NRW|NLM (2010)|090513|abcdef
ENTRY = Ambulatory Care Facilities, Non Hospital|T093|NON|NRW|UNK (19XX)|790529|abcdef
ENTRY = Ambulatory Care Facilities, Non-Hospital|T093|NON|NRW|UNK (19XX)|820430|AMBULATORY CARE FACILITIES NON HOSP|abcdefv
ENTRY = Ambulatory Care Facilities, Nonhospital|T093|NON|NRW|UNK (19XX)|790529|AMBULATORY CARE FACILITIES NONHOSP|abcdefv
ENTRY = Clinic Activities|T058|NON|REL|POPLINE (1978)|781226|abcdef
ENTRY = Family Planning Centers|T093|NON|NRW|POPLINE (1978)|781226|abcdef
ENTRY = Outpatient Clinic|T073|T093|NON|EQV|POPLINE (1978)|911102|abbcdef
ENTRY = Urgent Care Centers|T093|NON|NRW|NLM (2010)|081125|abcdef
ENTRY = Urgent Care Clinics|T093|NON|NRW|NLM (2010)|090513|abcdef
ENTRY = Abortion Center
ENTRY = Abortion Clinic
ENTRY = Activities, Clinic
ENTRY = Activity, Clinic
ENTRY = Ambulatory Care Facility
ENTRY = Ambulatory Health Center
ENTRY = Ambulatory Health Centers
ENTRY = Care Center, Urgent
ENTRY = Care Centers, Urgent
ENTRY = Care Clinic, Urgent
ENTRY = Care Clinics, Urgent
ENTRY = Center, Abortion
ENTRY = Center, Ambulatory Health
ENTRY = Center, Family Planning
ENTRY = Center, Urgent Care
ENTRY = Centers, Abortion
ENTRY = Centers, Ambulatory Health
ENTRY = Centers, Family Planning
ENTRY = Centers, Urgent Care
ENTRY = Clinic Activity
ENTRY = Clinic, Abortion
ENTRY = Clinic, Free-Standing
ENTRY = Clinic, Outpatient
ENTRY = Clinic, Urgent Care
ENTRY = Clinics, Abortion
ENTRY = Clinics, Free Standing
ENTRY = Clinics, Outpatient
ENTRY = Clinics, Urgent Care
ENTRY = Facilities, Ambulatory Care
ENTRY = Facility, Ambulatory Care
ENTRY = Family Planning Center
ENTRY = Free-Standing Clinic
ENTRY = Free-Standing Clinics
ENTRY = Health Center, Ambulatory
ENTRY = Urgent Care Center
ENTRY = Urgent Care Clinic
MN = N02.278.035
MH_TH = NLM (1979)
ST = T073
ST = T093
PI = Health Facilities (1968-1978)
MS = Those facilities which administer health services to individuals who do not require hospitalization or institutionalization.
OL = use AMBULATORY CARE FACILITIES to search AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82 & HEALTH CENTERS 1979
PM = 83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979
HN = 83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979
MR = 20090706
DA = 19780426
DC = 1
DX = 19790101
UI = D000554

*NEWRECORD
RECTYPE = D
MH = Ambulatory Care Information Systems
AQ = CL EC ES HI LJ OG SN ST TD UT
ENTRY = Information Systems, Ambulatory Care|T170|NON|EQV|NLM (1991)|900409|abcdef
MN = L01.313.500.750.300.680.360.113
MN = N04.452.442.452.050
MN = N04.452.515.360.050
MH_TH = NLM (1987)
ST = T170
AN = IM
MS = Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of ambulatory care services and facilities.
PM = 91; was see under INFORMATION SYSTEMS 1987-90
HN = 91(87); was see under INFORMATION SYSTEMS 1987-90
MR = 20150626
DA = 19860617
DC = 1
DX = 19910101
UI = D000555

*NEWRECORD
RECTYPE = D
MH = Ambulatory Surgical Procedures
DE = AMBULATORY SURG PROCEDURES
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Ambulatory Surgery|T061|NON|EQV|NLM (1998)|970613|AMBULATORY SURG|abcdefv
PRINT ENTRY = Day Surgery|T061|NON|REL|NLM (1996)|950530|DAY SURG|abcdefv
PRINT ENTRY = Office Surgery|T061|NON|NRW|UNK (19XX)|790425|OFFICE SURG|abcdefv
PRINT ENTRY = Outpatient Surgery|T061|NON|EQV|UNK (19XX)|790425|OUTPATIENT SURG|abcdefv
PRINT ENTRY = Surgery, Office|T061|NON|NRW|UNK (19XX)|790425|SURG OFFICE|abcdefv
PRINT ENTRY = Surgery, Outpatient|T061|NON|EQV|UNK (19XX)|790425|SURG OUTPATIENT|abcdefv
ENTRY = Ambulatory Surgical Procedure|T061|NON|EQV|NLM (1998)|970530|AMBULATORY SURG PROCEDURE|abcdefv
ENTRY = Procedure, Ambulatory Surgical|T061|NON|EQV|NLM (1998)|970530|PROCEDURE AMBULATORY SURG|abcdefv
ENTRY = Procedures, Ambulatory Surgical|T061|NON|EQV|NLM (1998)|970530|PROCEDURES AMBULATORY SURG|abcdefv
ENTRY = Surgery, Ambulatory|T061|NON|EQV|NLM (1998)|970613|SURG AMBULATORY|abcdefv
ENTRY = Surgery, Day|T061|NON|REL|NLM (1996)|950530|SURG DAY|abcdefv
ENTRY = Surgical Procedure, Ambulatory|T061|NON|EQV|NLM (1998)|970530|SURG PROCEDURE AMBULATORY|abcdefv
ENTRY = Surgical Procedures, Ambulatory|T061|NON|EQV|NLM (1998)|970530|SURG PROCEDURES AMBULATORY|abcdefv
ENTRY = Ambulatory Surgeries
ENTRY = Day Surgeries
ENTRY = Office Surgeries
ENTRY = Outpatient Surgeries
ENTRY = Surgeries, Ambulatory
ENTRY = Surgeries, Day
ENTRY = Surgeries, Office
ENTRY = Surgeries, Outpatient
MN = E04.030
FX = Surgicenters
MH_TH = NLM (1980)
ST = T061
AN = outpatient surg performed in MD's office, surgicenter or hosp
PI = Ambulatory Care (1966-1979)
PI = Outpatient Clinics, Hospital (1966-1979)
MS = Surgery performed on an outpatient basis. It may be hospital-based or performed in an office or surgicenter.
PM = 98; see AMBULATORY SURGERY 1980-97
HN = 98(80)
CATSH = CAT LIST
MR = 19970620
DA = 19790425
DC = 1
DX = 19800101
UI = D000556

*NEWRECORD
RECTYPE = D
MH = Ambystoma
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Amblystoma|T011|NON|EQV|UNK (19XX)|750101|abcdef
PRINT ENTRY = Ambystoma tigrinum|T011|NON|NRW|NLM (2010)|081222|abcdef
ENTRY = Tiger Salamander|T011|NON|NRW|NLM (2010)|081222|abcdef
ENTRY = Amblystomas
ENTRY = Ambystomas
ENTRY = Salamander, Tiger
ENTRY = Salamanders, Tiger
ENTRY = Tiger Salamanders
ENTRY = tigrinum, Ambystoma
MN = B01.050.150.900.090.608.080.068
MH_TH = NLM (1972)
ST = T011
AN = NIM with no qualifiers when an experimental animal
PI = Urodela (1966-1971)
MS = A genus of the Ambystomatidae family. The best known species are the axolotl AMBYSTOMA MEXICANUM and the closely related tiger salamander Ambystoma tigrinum. They may retain gills and remain aquatic without developing all of the adult characteristics. However, under proper changes in the environment they metamorphose.
PM = 72
HN = 72
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D000557

*NEWRECORD
RECTYPE = D
MH = Ambystoma mexicanum
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Axolotl|T011|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Mexican Salamander|T011|EPO|EQV|NLM (2010)|081222|abcdef
ENTRY = Ambystoma mexicanums
ENTRY = Axolotls
ENTRY = Salamander, Mexican
ENTRY = mexicanum, Ambystoma
ENTRY = mexicanums, Ambystoma
MN = B01.050.150.900.090.608.080.068.525
MH_TH = NLM (1981)
ST = T011
AN = NIM with no qualifiers when an experimental animal
PI = Ambystoma (1972-1980)
MS = A salamander found in Mexican mountain lakes and accounting for about 30 percent of the urodeles used in research. The axolotl remains in larval form throughout its life, a phenomenon known as neoteny.
PM = 1991; see AMBYSTOMA 1981-1990; for AXOLOTL see AMBYSTOMA 1972-2009
HN = 1991(1981); for AXOLOTL use AMBYSTOMA 1972-2009
MR = 20090706
DA = 19800402
DC = 1
DX = 19910101
UI = D000558

*NEWRECORD
RECTYPE = D
MH = Ambystomatidae
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Salamander, Mole|T011|NON|NRW|UNK (19XX)|800402|abcdef
ENTRY = Mole Salamander
ENTRY = Mole Salamanders
ENTRY = Salamanders, Mole
MN = B01.050.150.900.090.608.080
MH_TH = NLM (1981)
ST = T011
AN = a family of salamanders; NIM when exper animal: no qualif; when IM, qualif permitted
MS = A family of the class Urodela which includes 4 living genera, about 33 species, and occurs only in North America. Adults are usually terrestrial, but the larval forms are aquatic.
PM = 81
HN = 81
MR = 20090706
DA = 19800402
DC = 1
DX = 19810101
UI = D000559

*NEWRECORD
RECTYPE = D
MH = Amdinocillin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Mecillinam|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2015)|INN (19XX)|840302|abbcdeeef
ENTRY = FL-1060|T109|T195|LAB|NRW|UNK (19XX)|770420|abbcdef
ENTRY = Penicillin Hx|T109|T195|NON|EQV|UNK (19XX)|820203|abbcdef
ENTRY = FL 1060
ENTRY = FL1060
MN = D02.065.589.099.750.124
MN = D02.886.108.750.124
MN = D03.438.260.825.124
MN = D03.605.084.737.124
MN = D04.075.080.875.099.221.750.124
PA = Anti-Bacterial Agents
PA = Anti-Infective Agents, Urinary
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USAN (1981)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-
RN = V10579P3QZ
RR = 32887-01-7
PI = Antibiotics (1966-1972)
PI = Penicillanic Acids (1973-1977)
PI = Thiazoles (1966-1972)
MS = An amidinopenicillanic acid derivative with broad spectrum antibacterial action.
OL = use AMDINOCILLIN to search MECILLINAM 1978-84
PM = 85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84; AMDINOCILLIN PIVOXIL was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84
HN = 85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84
MR = 20141014
DA = 19770422
DC = 1
DX = 19850101
UI = D000560

*NEWRECORD
RECTYPE = D
MH = Amdinocillin Pivoxil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Pivmecillinam|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|840302|abbcdeeef
ENTRY = FL-1039|T109|T195|LAB|NRW|UNK (19XX)|770418|abbcdef
ENTRY = Leo Brand of Pivmecillinam Hydrochloride|T109|T195|NON|NRW|NLM (2006)|041102|abbcdef
ENTRY = Mecillinam Pivaloyl Ester|T109|T195|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = Pivamdinocillin|T109|T195|NON|EQV|UNK (19XX)|831014|abbcdef
ENTRY = Pivmecillinam Hydrochloride|T109|T195|NON|NRW|FDA SRS (2014)|NLM (2006)|041102|abbcdeef
ENTRY = Selexid|T109|T195|TRD|NRW|CA|FR|UK|820519|abbcdeeef
ENTRY = FL 1039
ENTRY = FL1039
ENTRY = Hydrochloride, Pivmecillinam
ENTRY = Pivaloyl Ester, Mecillinam
ENTRY = Pivoxil, Amdinocillin
MN = D02.065.589.099.750.124.036
MN = D02.886.108.750.124.036
MN = D03.438.260.825.124.036
MN = D03.605.084.737.124.036
MN = D04.075.080.875.099.221.750.124.036
PA = Anti-Bacterial Agents
PA = Anti-Infective Agents, Urinary
MH_TH = FDA SRS (2014)
MH_TH = USAN (1981)
ST = T109
ST = T195
N1 = 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2S-(2alpha,5alpha,6beta))-
RN = 1WAM1OQ30B
RR = 32886-97-8 (Amdinocillin Pivoxil)
RR = 48FX7N21H2
PI = Antibiotics (1966-1972)
PI = Penicillanic Acids (1973-1977)
PI = Thiazoles (1966-1977)
MS = Pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin.
OL = use AMDINOCILLIN PIVOXIL to search PIVMECILLINAM 1978-84
PM = 91; was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84
HN = 91(85); was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84
MR = 20130708
DA = 19770422
DC = 1
DX = 19910101
UI = D000561

*NEWRECORD
RECTYPE = D
MH = Amebiasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Abscess, Amebic|T047|NON|NRW|NLM (1998)|960725|abcdef
PRINT ENTRY = Ameboma|T047|NON|REL|UNK (19XX)|800407|abcdef
PRINT ENTRY = Amoebiasis|T047|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Iodamoebiasis|T047|NON|NRW|UNK (19XX)|850322|abcdef
ENTRY = Abscesses, Amebic
ENTRY = Amebiases
ENTRY = Amebic Abscess
ENTRY = Amebic Abscesses
ENTRY = Amebomas
ENTRY = Amoebiases
ENTRY = Iodamoebiases
MN = C03.752.049
FX = Amebicides
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = caused by "any of various amebae"; /drug ther: consider also AMEBICIDES; note X ref ABSCESS, AMEBIC: LIVER ABSCESS, AMEBIC is also available
MS = Infection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000562

*NEWRECORD
RECTYPE = D
MH = Amebicides
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amoebicides|T121|NON|EQV|NLM (1990)|891115|abcdef
MN = D27.505.954.122.250.100.055
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specific amebicide; consider also AMOEBA /drug eff & AMEBIASIS /drug ther
MS = Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal.
MR = 20140625
DA = 19990101
DC = 1
UI = D000563

*NEWRECORD
RECTYPE = D
MH = Ameloblastoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Ameloblastomas
MN = C04.557.695.065
FX = Ameloblasts
MH_TH = NLM (1965)
MH_TH = ORD (2010)
ST = T191
AN = benign or malignant; coordinate IM with probably JAW NEOPLASMS (IM) or precoordinated jaw/neoplasm term (IM)
MS = An immature epithelial tumor of the JAW originating from the epithelial rests of Malassez or from other epithelial remnants of the ENAMEL from the developmental period. It is a slowly growing tumor, usually benign, but displays a marked propensity for invasive growth.
PM = 1965; see ADAMANTINOMA 1963-1964
HN = 1965 (1963)
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19650101
UI = D000564

*NEWRECORD
RECTYPE = D
MH = Ameloblasts
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Ameloblast
MN = A11.436.107
FX = Ameloblastoma
MH_TH = NLM (1965)
ST = T025
MS = Cylindrical epithelial cells in the innermost layer of the ENAMEL ORGAN. Their functions include contribution to the development of the dentinoenamel junction by the deposition of a layer of the matrix, thus producing the foundation for the prisms (the structural units of the DENTAL ENAMEL), and production of the matrix for the enamel prisms and interprismatic substance. (From Jablonski's Dictionary of Dentistry, 1992)
PM = 65
HN = 65
MR = 20050630
DA = 19990101
DC = 1
DX = 19650101
UI = D000565

*NEWRECORD
RECTYPE = D
MH = Amelogenesis
AQ = DE GE IM PH RE
ENTRY = Amelogeneses
MN = G07.700.320.500.325.377.750.190
MH_TH = NLM (1965)
ST = T042
AN = formation of dent enamel; DENTINOGENESIS, formation of dentin, is also available
MS = The elaboration of dental enamel by ameloblasts, beginning with its participation in the formation of the dentino-enamel junction to the production of the matrix for the enamel prisms and interprismatic substance. (Jablonski, Dictionary of Dentistry, 1992).
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D000566

*NEWRECORD
RECTYPE = D
MH = Amelogenesis Imperfecta
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Congenital Enamel Hypoplasia|T019|T047|NON|EQV|GHR (2014)|NLM (2014)|130501|abbcdeef
MN = C07.650.800.255.500
MN = C07.793.700.255.500
MN = C16.131.850.800.255.500
MH_TH = GHR (2014)
MH_TH = NLM (1965)
ST = T019
ST = T047
MS = A clinically and genetically heterogeneous group of hereditary conditions characterized by malformed DENTAL ENAMEL, usually involving DENTAL ENAMEL HYPOPLASIA and/or TOOTH HYPOMINERALIZATION.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D000567

*NEWRECORD
RECTYPE = D
MH = Amenorrhea
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Postpartum Amenorrhea|T033|T046|NON|NRW|UNK (19XX)|781218|abbcdef
ENTRY = Amenorrhea, Postpartum
ENTRY = Postpartum Amenorrheas
MN = C23.550.568.500
FX = Oligomenorrhea
MH_TH = POPLINE (1978)
ST = T047
ST = T184
AN = "postpartum amenorrhea" is indexed under AMENORRHEA (IM) + PUERPERIUM (IM) & not LACTATION unless lactation is particularly discussed
MS = Absence of menstruation.
CATSH = CAT LIST
MR = 19991109
DA = 19990101
DC = 1
UI = D000568

*NEWRECORD
RECTYPE = D
MH = Americas
AQ = EH EP
ENTRY = America|T083|NAM|EQV|NLM (1996)|950324|abcdef
MN = Z01.107
MH_TH = POPLINE (1983)
ST = T083
AN = too general; avoid; prefer specific continents or countries; titles saying "American" are likely to be indexed to UNITED STATES, not here
MS = The general name for NORTH AMERICA; CENTRAL AMERICA; and SOUTH AMERICA unspecified or combined.
HN = 96; was AMERICA 1975-95
MR = 20010725
DA = 19990101
DC = 4
UI = D000569

*NEWRECORD
RECTYPE = D
MH = American Cancer Society
AQ = EC HI OG
ENTRY = American Cancer Societies
ENTRY = Cancer Societies, American
ENTRY = Cancer Society, American
ENTRY = Societies, American Cancer
ENTRY = Society, American Cancer
MN = N03.540.630.780.080
MH_TH = NLM (1975)
ST = T093
AN = add UNITED STATES or specific state;  CATALOGER: Use NAF entry
PI = Neoplasms (1966-1974)
PI = Societies, Medical (1966-1974)
PI = Societies, Scientific (1966-1974)
PI = Voluntary Health Agencies (1966-1974)
PI = specific neoplasm
MS = A voluntary organization concerned with the prevention and treatment of cancer through education and research.
OL = search VOLUNTARY HEALTH AGENCIES 1967-74
PM = 91; was see under VOLUNTARY HEALTH AGENCIES 1975-90
HN = 91(75); was see under VOLUNTARY HEALTH AGENCIES 1975-90
MR = 20150605
DA = 19990101
DC = 1
DX = 19910101
UI = D000570

*NEWRECORD
RECTYPE = D
MH = American Dental Association
DE = ADA
AQ = EC HI OG
ENTRY = Association, American Dental
ENTRY = Dental Association, American
MN = N03.540.828.506.274
MH_TH = NLM (1966)
ST = T094
AN = add UNITED STATES; CATALOGER: Use NAF entry
MS = Professional society representing the field of dentistry.
PM = 66
HN = 66
MR = 20150605
DA = 19990101
DC = 1
DX = 19660101
UI = D000571

*NEWRECORD
RECTYPE = D
MH = American Heart Association
DE = AMERICAN HEART ASSOC
AQ = EC HI OG
ENTRY = American Heart Associations
ENTRY = Association, American Heart
ENTRY = Associations, American Heart
ENTRY = Heart Association, American
ENTRY = Heart Associations, American
MN = N03.540.630.780.110
MH_TH = NLM (1975)
ST = T093
AN = add UNITED STATES or specific state; CATALOGER: Use NAF entry
PI = Cardiovascular Diseases (1966-1974)
PI = Heart Diseases (1966-1974)
PI = Societies, Medical (1966-1974)
PI = Voluntary Health Agencies (1966-1974)
MS = A voluntary organization concerned with the prevention and treatment of heart and vascular diseases.
OL = search VOLUNTARY HEALTH AGENCIES 1967-74
PM = 91; was see under VOLUNTARY HEALTH AGENCIES 1975-90
HN = 91(75); was see under VOLUNTARY HEALTH AGENCIES 1975-90
MR = 20150605
DA = 19990101
DC = 1
DX = 19910101
UI = D000572

*NEWRECORD
RECTYPE = D
MH = American Hospital Association
DE = AHA
AQ = EC HI OG
ENTRY = Association, American Hospital|T094|NON|EQV|NLM (1997)|951003|ASSOC AMERICAN HOSP|abcdefv
MN = N03.540.828.540.080
MH_TH = NLM (1978)
ST = T094
AN = add UNITED STATES; CATALOGER: Use NAF entry
MS = A professional society in the United States whose membership is composed of hospitals.
PM = 78
HN = 78
MR = 20150605
DA = 19770505
DC = 1
DX = 19780101
UI = D000573

*NEWRECORD
RECTYPE = D
MH = American Medical Association
DE = AMA
AQ = EC HI OG
ENTRY = Association, American Medical
ENTRY = Medical Association, American
MN = N03.540.828.589.274
MH_TH = NLM (1966)
ST = T094
AN = add UNITED STATES; CATALOGER: Use NAF entry
MS = Professional society representing the field of medicine.
PM = 66
HN = 66
MR = 20150605
DA = 19990101
DC = 1
DX = 19660101
UI = D000574

*NEWRECORD
RECTYPE = D
MH = American Nurses' Association
DE = ANA
AQ = EC HI OG
ENTRY = American Nurses Association
ENTRY = American Nurses' Associations
ENTRY = Association, American Nurses'
ENTRY = Associations, American Nurses'
ENTRY = Nurses' Association, American
ENTRY = Nurses' Associations, American
MN = N03.540.828.672.274
MH_TH = NLM (1965)
ST = T094
AN = add UNITED STATES; CATALOGER: Use NAF entry
MS = Professional society representing the field of nursing.
PM = 67
HN = 67(65)
MR = 20150605
DA = 19990101
DC = 1
DX = 19670101
UI = D000575

*NEWRECORD
RECTYPE = D
MH = Americium
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.268.271.100.050
MN = D01.268.556.037
MN = D01.552.020.086
MN = D01.552.544.037
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T121
ST = T196
N1 = Americium
RN = VW92PHU2UY
RR = 7440-35-9 (Americium)
AN = naturally radioactive; IM
MS = Americium. A completely man-made radioactive actinide with atomic symbol Am, atomic number 95, and atomic weight 243. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.
MR = 20150622
DA = 19990101
DC = 1
UI = D000576

*NEWRECORD
RECTYPE = D
MH = Amides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.065
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed)
MR = 19950316
DA = 19990101
DC = 1
UI = D000577

*NEWRECORD
RECTYPE = D
MH = Amidines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.078
MH_TH = NLM (1966)
ST = T109
RN = 0
MR = 19920507
DA = 19990101
DC = 1
UI = D000578

*NEWRECORD
RECTYPE = D
MH = Amidinotransferases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Transamidinases|T116|T126|NON|EQV|UNK (19XX)|750822|abbcdef
MN = D08.811.913.555.150
MH_TH = NLM (1974)
ST = T116
ST = T126
RN = EC 2.1.4.-
MS = Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4.
PM = 74
HN = 74(73)
MR = 20060705
DA = 19990101
DC = 1
DX = 19740101
UI = D000579

*NEWRECORD
RECTYPE = D
MH = Amido Black
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Amido Black, Dilithium salt|T109|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Amido Black, Sodium salt|T109|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = C.I. Acid Black 1|T109|T130|LAB|NRW|NLM (1996)|950524|abbcdef
ENTRY = C.I.-20470|T109|T130|LAB|NRW|NLM (1996)|950524|abbcdef
ENTRY = Black, Amido
ENTRY = C.I. 20470
ENTRY = C.I.20470
MN = D02.172.029
MN = D02.455.426.559.847.638.555.220
MN = D02.886.645.600.080.050.650.025
MN = D04.615.638.555.220
PA = Coloring Agents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1976)
ST = T109
ST = T130
N1 = 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-((4-nitrophenyl)azo)-6-(phenylazo)-, disodium salt
RN = SZT789770M
RR = 1064-48-8 (Amido Black)
RR = 83006-55-7 (Na salt)
RR = 85294-31-1 (di-Li salt)
AN = D25-26 qualif
PI = Azo Compounds (1969-1975)
PI = Naphthalenesulfonates (1974-1975)
PI = Nitrobenzenes (1974-1975)
MS = A dye used to stain proteins in electrophoretic techniques. It is used interchangeably with its acid form.
OL = use AMIDO BLACK to search ACID BLACK 1, NAPHTHOL BLUE BLACK, & C.I. ACID BLACK 1 1976-93
PM = 91; was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, & C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93
HN = 91(76); was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, & C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93
MR = 20130708
DA = 19750723
DC = 1
DX = 19910101
UI = D000580

*NEWRECORD
RECTYPE = D
MH = Amidohydrolases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Amidases|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef
MN = D08.811.277.087
MH_TH = NLM (1966)
ST = T116
ST = T126
RN = EC 3.5.-
MR = 20060705
DA = 19990101
DC = 1
UI = D000581

*NEWRECORD
RECTYPE = D
MH = Amidophosphoribosyltransferase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Glutamine Phosphoribosyl Pyrophosphate Amidotransferase|T116|T126|NON|EQV|UNK (19XX)|750211|abbcdef
PRINT ENTRY = Phosphoribosyl Pyrophosphate Amidotransferase|T116|T126|NON|EQV|UNK (19XX)|750211|abbcdef
ENTRY = Glutamine-Amidophosphoribosyltransferase|T116|T126|NON|EQV|UNK (19XX)|820203|abbcdef
ENTRY = Phosphoribosyldiphosphate 5-Amidotransferase|T116|T126|NON|EQV|NLM (1992)|910212|abbcdef
ENTRY = 5-Amidotransferase, Phosphoribosyldiphosphate
ENTRY = Amidotransferase, Phosphoribosyl Pyrophosphate
ENTRY = Glutamine Amidophosphoribosyltransferase
ENTRY = Phosphoribosyldiphosphate 5 Amidotransferase
ENTRY = Pyrophosphate Amidotransferase, Phosphoribosyl
MN = D08.811.913.400.725.130
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = 5-Phosphoribosylamine:pyrophosphate phospho-alpha-D-ribosyltransferase (glutamate-amidating)
RN = EC 2.4.2.14
RR = 9031-82-7 (CAS RN)
PI = Glutamine (1974)
PI = Pentosephosphates (1974)
PI = Pentosyltransferases (1974)
PI = Pyrophosphoric Acids (1974)
MS = An enzyme, involved in the early steps of purine nucleotide biosynthesis, that catalyzes the formation of 5-phosphoribosylamine from glutamine and phosphoribosylpyrophosphate. EC 2.4.2.14.
PM = 91; was see under PENTOSYLTRANSFERASES 1975-90
HN = 91(75); was see under PENTOSYLTRANSFERASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D000582

*NEWRECORD
RECTYPE = D
MH = Amikacin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = A.M.K|T118|T195|TRD|NRW|MX|020725|abbcdef
ENTRY = Amikacin Sulfate|T118|T195|NRW|FDA SRS (2014)|USAN (1973)|USP (19XX)|821123|abbdeeef
ENTRY = Amikacina Medical|T118|T195|TRD|NRW|ES|020725|abbcdef
ENTRY = Amikacina Normon|T118|T195|TRD|NRW|ES|020725|abbcdef
ENTRY = Amikafur|T118|T195|TRD|NRW|MX|020725|abbcdef
ENTRY = Amikalem|T118|T195|TRD|NRW|MX|020725|abbcdef
ENTRY = Amikason's|T118|T195|TRD|NRW|MX|020725|abbcdef
ENTRY = Amikayect|T118|T195|TRD|NRW|MX|020725|abbcdef
ENTRY = Amikin|T118|T195|TRD|NRW|AU|CA|IE|MX|UK|US|020725|abbcdeeeeeef
ENTRY = Amiklin|T118|T195|TRD|NRW|FR|020725|abbcdef
ENTRY = Amukin|T118|T195|TRD|NRW|NL|020725|abbcdef
ENTRY = Apothecon Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = BB-K 8|T118|T195|LAB|NRW|UNK (19XX)|741111|abbcdef
ENTRY = BB-K8|T118|T195|LAB|NRW|UNK (19XX)|741111|abbcdef
ENTRY = Biclin|T118|T195|TRD|NRW|ES|MX|020725|abbcdeef
ENTRY = Biklin|T118|T195|TRD|NRW|DE|020725|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Collins Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Cryopharma Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Fustery Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Galen Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Gamikal|T118|T195|TRD|NRW|MX|020725|abbcdef
ENTRY = Grossmann Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Kanbine|T118|T195|TRD|NRW|ES|020725|abbcdef
ENTRY = Lemery Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Mead Johnson Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Medical Brand of Amikacin Sulfate|T118|T195|TRD|NRW|NLM (2003)|020725|abbcdef
ENTRY = Norman Brand of Amikacin Sulfate|T118|T195|TRD|NRW|NLM (2003)|020725|abbcdef
ENTRY = Oprad|T118|T195|TRD|NRW|MX|020725|abbcdef
ENTRY = Pisa Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Rovi Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Son's Brand of Amikacin Sulfate|T118|T195|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Yectamid|T118|T195|TRD|NRW|MX|020725|abbcdef
ENTRY = BB K 8
ENTRY = BB K8
ENTRY = BBK 8
ENTRY = BBK8
ENTRY = Bristol Myers Squibb Brand of Amikacin Sulfate
ENTRY = Medical, Amikacina
ENTRY = Normon, Amikacina
ENTRY = Sulfate, Amikacin
MN = D09.408.051.476.060
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T118
ST = T195
N1 = D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
RN = 84319SGC3C
RR = 37517-28-5 (Amikacin)
RR = 39831-55-5 (Amikacin Sulfate)
RR = N6M33094FD
PI = Aminobutyric Acids (1973-1974)
PI = Kanamycin (1973-1974)
MS = A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
PM = 87; was see under KANAMYCIN 1975-86
HN = 87(75); was see under KANAMYCIN 1975-86
MR = 20130708
DA = 19741119
DC = 1
DX = 19870101
UI = D000583

*NEWRECORD
RECTYPE = D
MH = Amiloride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alphapharm Brand of Amiloride Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Amidal|T109|T121|TRD|NRW|AU|020725|abbcdef
ENTRY = Amiduret Trom|T109|T121|TRD|NRW|DE|020725|abbcdef
ENTRY = Amiloberag|T109|T121|TRD|NRW|DE|020725|abbcdef
ENTRY = Amiloride Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1967)|USP (19XX)|940805|abbcdeeef
ENTRY = Amiloride Hydrochloride, Anhydrous|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Amrad Brand of Amiloride Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Berolina Brand of Amiloride Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Cahill May Roberts Brand of Amiloride Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Douglas Brand of Amiloride Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Kaluril|T109|T121|TRD|NRW|AU|020725|abbcdef
ENTRY = Merck Brand of Amiloride Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Merck Sharp & Dohme Brand of Amiloride Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Midamor|T109|T121|TRD|NRW|AU|CA|IE|NL|UK|US|861119|abbcdeeeeeef
ENTRY = Midoride|T109|T121|TRD|NRW|AU|020725|abbcdef
ENTRY = Modamide|T109|T121|TRD|NRW|FR|020725|abbcdef
ENTRY = Trommsdorff Brand of Amiloride Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Anhydrous Amiloride Hydrochloride
ENTRY = Hydrochloride, Amiloride
ENTRY = Hydrochloride, Anhydrous Amiloride
ENTRY = Trom, Amiduret
MN = D03.383.679.149
PA = Acid Sensing Ion Channel Blockers
PA = Diuretics
PA = Epithelial Sodium Channel Blockers
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-
RN = 7DZO8EB0Z3
RR = 17440-83-4 (Amiloride Hydrochloride)
RR = 2016-88-8
RR = 2609-46-3 (Amiloride)
RR = FZJ37245UC
PI = Diuretics (1966-1971)
PI = Pyrazines (1966-1971)
MS = A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705)
PM = 86; was see under PYRAZINES 1975-85
HN = 86(72); was see under PYRAZINES 1975-85, was Prov 1972-74
MR = 20130708
DA = 19990101
DC = 1
DX = 19860101
UI = D000584

*NEWRECORD
RECTYPE = D
MH = Aminacrine
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = 9-Aminoacridine|T109|T121|T130|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|790228|AMINOACRIDINE 09|abbbbcdeefs
PRINT ENTRY = Acridinamine|T109|T121|T130|T131|NON|EQV|UNK (19XX)|790228|abbbbcdef
ENTRY = Aminacrine Hydrochloride|T109|T121|T130|T131|NON|NRW|FDA SRS (2014)|USAN (1964)|001031|abbbbcdeef
ENTRY = Aminoacridine|T109|T121|T130|T131|NON|EQV|FDA SRS (2014)|INN (19XX)|940727|abbbbcdeef
ENTRY = Aminoacridine Hydrochloride|T109|T121|T130|T131|NON|NRW|FDA SRS (2014)|INN (19XX)|940727|abbbbcdeef
ENTRY = Aminopt|T109|T121|T130|T131|TRD|NRW|AU|020725|abbbbcdef
ENTRY = Beutlich Brand of Aminacrine Hydrochloride|T109|T121|T130|T131|NON|NRW|NLM (2003)|020725|abbbbcdef
ENTRY = Mykocert|T109|T121|T130|T131|TRD|NRW|US|020725|abbbbcdef
ENTRY = Sigma Brand of Aminacrine Hydrochloride|T109|T121|T130|T131|NON|NRW|NLM (2003)|020725|abbbbcdef
ENTRY = 9 Aminoacridine
ENTRY = Hydrochloride, Aminacrine
ENTRY = Hydrochloride, Aminoacridine
MN = D03.494.046.250.200
PA = Anti-Infective Agents, Local
PA = Fluorescent Dyes
PA = Indicators and Reagents
PA = Mutagens
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T121
ST = T130
ST = T131
N1 = 9-Acridinamine
RN = 78OY3Z0P7Z
RR = 134-50-9 (Aminacrine Hydrochloride)
RR = 90-45-9 (Aminacrine)
RR = OR5RM3Q5QL
AN = D25-26 qualif
PI = Acridines (1966-1979)
MS = A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.
PM = 91; was see under AMINOACRIDINES 1980-90
HN = 91(80); was see under AMINOACRIDINES 1980-90
MR = 20130708
DA = 19790228
DC = 1
DX = 19910101
UI = D000585

*NEWRECORD
RECTYPE = D
MH = Amination
AQ = DE GE IM PH RE
ENTRY = Aminations
MN = G02.111.087.045
MN = G02.149.115.045
MN = G02.149.465.050
MN = G02.607.750.050
MN = G03.495.140
FX = Deamination
MH_TH = NLM (1971)
ST = T070
AN = almost never IM; enzymatic amination: coord NIM with TRANSAMINASES (IM) + substrate (NIM) or specific transaminase (IM)
PI = Chemistry, Organic (1966-1970)
MS = The creation of an amine. It can be produced by the addition of an amino group to an organic compound or reduction of a nitro group.
PM = 74
HN = 74(71)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19740101
UI = D000586

*NEWRECORD
RECTYPE = D
MH = Oxidoreductases Acting on CH-NH Group Donors
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Secondary Amine Oxidoreductases|T116|T126|NON|EQV|NLM (2006)|050311|abbcdef
ENTRY = Amine Oxidoreductases, Secondary Amine|T116|T126|NON|EQV|NLM (2006)|050311|abbcdef
ENTRY = Amine Oxidoreductases, Secondary
ENTRY = Oxidoreductases Acting on CH NH Group Donors
ENTRY = Oxidoreductases, Secondary Amine
MN = D08.811.682.662
MH_TH = NLM (2006)
ST = T116
ST = T126
RN = EC 1.5.-
AN = do not confuse with OXIDOREDUCTASES ACTING ON CH-NH2 GROUP DONORS
PI = Oxidoreductases (1966-1974)
MS = Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed.
PM = 2006; see AMINE OXIDOREDUCTASES 1975-2005
HN = 2006(1975)
MR = 20050630
DA = 19990101
DC = 1
DX = 19750101
UI = D000587

*NEWRECORD
RECTYPE = D
MH = Amines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.092
MH_TH = POPLINE (1984)
ST = T109
RN = 0
MS = A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed)
MR = 19950316
DA = 19990101
DC = 1
UI = D000588

*NEWRECORD
RECTYPE = D
MH = Amino Acid Chloromethyl Ketones
DE = AACK
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Peptide Chloromethyl Ketones|T116|T121|NON|EQV|UNK (19XX)|760516|abbcdef
ENTRY = Chloromethyl Ketones, Peptide
ENTRY = Ketones, Peptide Chloromethyl
MN = D12.125.065
PA = Alkylating Agents
PA = Protein Synthesis Inhibitors
PA = Serine Proteinase Inhibitors
MH_TH = NLM (1977)
ST = T116
ST = T121
RN = 0
AN = serine proteinase inhib; DF: AACK
PI = Peptides (1966-1976)
PI = specific amino acid (1966-1976)
MS = Inhibitors of SERINE ENDOPEPTIDASES and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process.
PM = 77; TOSYLLYSINE CHLOROMETHYL KETONE was see under LYSINE 1975-76; TOSYLPHENYLALANYL CHLOROMETHYL KETONE was see under PHENYLALANINE 1975-76
HN = 77
MR = 19991109
DA = 19760519
DC = 1
DX = 19770101
UI = D000590

*NEWRECORD
RECTYPE = D
MH = Amino Acid Isomerases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Amino Acid Racemases|T116|T126|NON|NRW|UNK (19XX)|840918|abbcdef
ENTRY = Acid Isomerases, Amino
ENTRY = Acid Racemases, Amino
ENTRY = Isomerases, Amino Acid
ENTRY = Racemases, Amino Acid
MN = D08.811.399.894.200
MH_TH = NLM (1972)
ST = T116
ST = T126
RN = EC 5.1.1.-
PI = Isomerases (1966-1971)
PI = specific amino acid (1966-1971)
MS = Enzymes that catalyze either the racemization or epimerization of chiral centers within amino acids or derivatives. EC 5.1.1.
PM = 74
HN = 74(72)
MR = 20030709
DA = 19990101
DC = 1
DX = 19740101
UI = D000591

*NEWRECORD
RECTYPE = D
MH = Amino Acid Metabolism, Inborn Errors
DE = AA METAB INBORN ERR
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Amino Acidopathies, Congenital|T047|NON|EQV|NLM (2000)|991108|AMINO ACIDOPATHIES CONGEN|abcdefv
ENTRY = Amino Acid Metabolism Disorders, Inborn|T047|NON|EQV|NLM (2000)|991108|AA METAB DIS INBORN|abcdefv
ENTRY = Amino Acid Metabolism, Inborn Error|T047|NON|EQV|NLM (1991)|900320|abcdef
ENTRY = Amino Acid Metabolism, Inherited Disorders|T047|NON|NRW|NLM (2000)|991108|AA METAB INHERITED DIS|abcdefv
ENTRY = Amino Acidopathies, Inborn|T047|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Congenital Amino Acidopathies|T047|NON|EQV|NLM (2000)|991108|CONGEN AMINO ACIDOPATHIES|abcdefv
ENTRY = Inborn Errors, Amino Acid Metabolism|T047|NON|EQV|NLM (2000)|991108|INBORN ERR AA METAB|abcdefv
ENTRY = Inherited Errors of Amino Acid Metabolism|T047|NON|NRW|NLM (2000)|991108|INHERITED ERR AA METAB|abcdefv
ENTRY = Amino Acidopathy, Congenital
ENTRY = Amino Acidopathy, Inborn
ENTRY = Congenital Amino Acidopathy
ENTRY = Inborn Amino Acidopathies
ENTRY = Inborn Amino Acidopathy
MN = C16.320.565.100
MN = C18.452.648.100
MH_TH = NLM (1966)
ST = T047
AN = coord IM with specific amino acid /metab (IM); DF: AA METAB INBORN ERR
MS = Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., ACIDOSIS) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.
PM = 1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964
HN = 1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D000592

*NEWRECORD
RECTYPE = D
MH = Amino Acid Oxidoreductases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Acid Oxidoreductases, Amino
ENTRY = Oxidoreductases, Amino Acid
MN = D08.811.682.664.500
MH_TH = NLM (1964)
ST = T116
ST = T126
RN = EC 1.4.-
MS = A class of enzymes that catalyze oxidation-reduction reactions of amino acids.
OL = use AMINO ACID OXIDOREDUCTASES to search AMINOACID OXIDOREDUCTASES 1966-73
PM = 74; was AMINOACID OXIDOREDUCTASES 1964-73
HN = 74; was AMINOACID OXIDOREDUCTASES 1964-73
MR = 20060705
DA = 19990101
DC = 1
DX = 19640101
UI = D000594

*NEWRECORD
RECTYPE = D
MH = Amino Acid Sequence
DE = AMINO ACID SEQ
AQ = DE GE PH RE
PRINT ENTRY = Protein Structure, Primary|T087|NON|EQV|NLM (1993)|920327|abcdef
ENTRY = Amino Acid Sequences|T087|NON|EQV|NLM (1993)|911231|AA SEQ|abcdefv
ENTRY = Sequence, Amino Acid|T087|NON|EQV|NLM (1993)|911121|SEQ AMINO ACID|abcdefv
ENTRY = Sequences, Amino Acid|T087|NON|EQV|NLM (1993)|911231|SEQ AA|abcdefv
ENTRY = Primary Protein Structure
ENTRY = Primary Protein Structures
ENTRY = Protein Structures, Primary
ENTRY = Structure, Primary Protein
ENTRY = Structures, Primary Protein
MN = G02.111.570.060
MN = L01.453.245.667.060
MH_TH = NLM (1966)
ST = T087
AN = IM general; coordinate NIM with specific protein or peptide; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: AMINO ACID SEQ or AA SEQ
MS = The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19660101
UI = D000595

*NEWRECORD
RECTYPE = D
MH = Amino Acids
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Acids, Amino
MN = D12.125
FX = Receptors, Amino Acid
MH_TH = NLM (1966)
ST = T116
ST = T123
RN = 0
AN = /urine permitted but consider also RENAL AMINOACIDURIAS
MS = Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.
OL = pre-explosion = AMINO ACIDS (PX)
PM = /metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64
HN = /metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64
MR = 20060707
DA = 19990101
DC = 1
UI = D000596

*NEWRECORD
RECTYPE = D
MH = Amino Acids, Branched-Chain
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Amino Acids, Branched Chain|T116|T123|NON|EQV|UNK (19XX)|780516|abbcdef
ENTRY = Acids, Branched-Chain Amino
ENTRY = Branched-Chain Amino Acids
MN = D12.125.070
MH_TH = NLM (1979)
ST = T116
ST = T123
RN = 0
PI = Amino Acids (1966-1978)
MS = Amino acids which have a branched carbon chain.
PM = 79
HN = 79
MR = 19920507
DA = 19780516
DC = 1
DX = 19790101
UI = D000597

*NEWRECORD
RECTYPE = D
MH = Amino Acids, Cyclic
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Cyclic Amino Acids|T116|NON|EQV|NLM (1998)|961216|abcdef
ENTRY = Acids, Cyclic Amino
MN = D12.125.072
MH_TH = NLM (1966)
ST = T116
RN = 0
AN = GEN; prefer specifics; used for mapping supplementary chemicals
MS = A class of amino acids characterized by a closed ring structure.
PM = 98
HN = 98; use explode 1967-97
MR = 19970626
DA = 19990101
DC = 1
DX = 19980101
UI = D000598

*NEWRECORD
RECTYPE = D
MH = Amino Acids, Diamino
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Amino Acids, Dibasic|T116|NON|EQV|UNK (19XX)|860414|abcdef
PRINT ENTRY = Diamino Amino Acids|T116|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Dibasic Amino Acids|T116|NON|EQV|UNK (19XX)|831209|abcdef
ENTRY = Acids, Diamino Amino
ENTRY = Acids, Dibasic Amino
MN = D12.125.095
MH_TH = NLM (1974)
ST = T116
RN = 0
PM = 74; DIAMINOPIMELIC ACID was see under PIMELIC ACIDS 1975-79
HN = 74
MR = 19920507
DA = 19990101
DC = 1
DX = 19740101
UI = D000599

*NEWRECORD
RECTYPE = D
MH = Amino Acids, Dicarboxylic
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Dicarboxylic Amino Acids|T116|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Acids, Dicarboxylic Amino
MN = D12.125.119
MH_TH = NLM (1974)
ST = T116
RN = 0
PM = 74
HN = 74
MR = 19920507
DA = 19990101
DC = 1
DX = 19740101
UI = D000600

*NEWRECORD
RECTYPE = D
MH = Amino Acids, Essential
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Essential Amino Acids|T116|T123|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Acids, Essential Amino
MN = D12.125.142
MH_TH = NLM (1974)
ST = T116
ST = T123
RN = 0
MS = Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs.
PM = 74
HN = 74
MR = 20040713
DA = 19990101
DC = 1
DX = 19740101
UI = D000601

*NEWRECORD
RECTYPE = D
MH = Amino Acids, Peptides, and Proteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
MN = D12
RH = D12 - AMINO ACIDS, PEPTIDES, AND PROTEINS
MH_TH = NLM (1974)
ST = T116
RN = 0
AN = used for searching; INDEXER: Do not use; CATALOGER: Do not use
MS = Amino acids and chains of amino acids connected by peptide linkages.
PM = 98
HN = 98; use explode
MR = 20150605
DA = 19990101
DC = 1
DX = 19980101
UI = D000602

*NEWRECORD
RECTYPE = D
MH = Amino Acids, Sulfur
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Sulfur Amino Acids|T116|T123|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Acids, Sulfur Amino
MN = D02.886.030
MN = D12.125.166
MH_TH = NLM (1974)
ST = T116
ST = T123
RN = 0
PM = 74
HN = 74
MR = 20050630
DA = 19990101
DC = 1
DX = 19740101
UI = D000603

*NEWRECORD
RECTYPE = D
MH = Amino Acyl-tRNA Synthetases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Amino Acyl T RNA Synthetases|T116|T126|EQV|NLM (1998)|961105|abbdef
PRINT ENTRY = Amino Acyl-tRNA Ligases|T116|T126|ACX|EQV|NLM (1972)|990101|abbcdef
ENTRY = Aminoacyl Transfer RNA Synthetase|T116|T126|NON|EQV|NLM (2005)|040518|abbcdef
ENTRY = Aminoacyl-tRNA Synthetase|T116|T126|EQV|NLM (1989)|880720|abbdef
ENTRY = Transfer RNA Synthetase|T116|T126|NON|EQV|NLM (2005)|031015|abbcdef
ENTRY = tRNA Synthetase|T116|T126|EQV|UNK (19XX)|870504|abbdef
ENTRY = Acyl-tRNA Ligases, Amino
ENTRY = Acyl-tRNA Synthetases, Amino
ENTRY = Amino Acyl tRNA Ligases
ENTRY = Amino Acyl tRNA Synthetases
ENTRY = Aminoacyl tRNA Synthetase
ENTRY = Ligases, Amino Acyl-tRNA
ENTRY = RNA Synthetase, Transfer
ENTRY = Synthetase, Aminoacyl-tRNA
ENTRY = Synthetase, Transfer RNA
ENTRY = Synthetase, tRNA
ENTRY = Synthetases, Amino Acyl-tRNA
MN = D08.811.464.263.200
FX = Transfer RNA Aminoacylation
MH_TH = NLM (2001)
ST = T116
ST = T126
RN = EC 6.1.1.-
PI = Ligases (1966-1971)
MS = A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS.
PM = 2005; see AMINO ACYL-TRNA LIGASES 1998-2004, see AMINO ACYL T RNA SYNTHETASES 1972-1997
HN = 2005(1972); use LIGASES 1966-1971
MR = 20040707
DA = 19990101
DC = 1
DX = 19720101
UI = D000604

*NEWRECORD
RECTYPE = D
MH = Amino Alcohols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alcohols, Amino
MN = D02.033.100
MN = D02.092.063
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2).
MR = 19970620
DA = 19990101
DC = 1
UI = D000605

*NEWRECORD
RECTYPE = D
MH = Amino Sugars
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Sugars, Amino
MN = D09.067
FX = Aminoglycosides
MH_TH = NLM (1966)
ST = T118
RN = 0
MS = SUGARS containing an amino group. GLYCOSYLATION of other compounds with these amino sugars results in AMINOGLYCOSIDES.
MR = 20040707
DA = 19990101
DC = 1
UI = D000606

*NEWRECORD
RECTYPE = D
MH = Aminoacetonitrile
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cyanomethylamine|T109|T121|NON|EQV|UNK (19XX)|750708|abbcdef
PRINT ENTRY = Glycinonitrile|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
MN = D02.626.080.085
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Acetonitrile, amino-
RN = 3739OQ10IJ
RR = 540-61-4 (Aminoacetonitrile)
PI = Methylamines (1972-1974)
PI = Nitriles (1968-1974)
MS = Cyanomethylamine.
PM = 91; was see under ACETONITRILES 1975-90
HN = 91(75); was see under ACETONITRILES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000607

*NEWRECORD
RECTYPE = D
MH = Renal Aminoacidurias
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aminoaciduria, Renal|T047|NON|EQV|NLM (1965)|990101|abcdef
ENTRY = Aminoacidurias, Renal
ENTRY = Renal Aminoaciduria
MN = C12.777.419.815.885
MN = C13.351.968.419.815.885
MN = C16.320.565.861.885
MN = C18.452.648.861.885
FX = Urine
MH_TH = NLM (2007)
ST = T047
AN = coordinate IM with specific amino acid /urine (IM)
MS = A group of inherited kidney disorders characterized by the abnormally elevated levels of AMINO ACIDS in URINE. Genetic mutations of transport proteins result in the defective reabsorption of free amino acids at the PROXIMAL RENAL TUBULES. Renal aminoaciduria are classified by the specific amino acid or acids involved.
PM = 2007; see AMINOACIDURIA, RENAL 1965-2006, see AMINOACIDURIA 1963-1964
HN = 2007 (1963)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19650101
UI = D000608

*NEWRECORD
RECTYPE = D
MH = Aminoacridines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.494.046.250
MH_TH = NLM (1980)
ST = T109
ST = T121
RN = 0
PI = Acridines (1966-1979)
MS = Acridines which are substituted in any position by one or more amino groups or substituted amino groups.
PM = 80; ACRIFLAVINE was see under ACRIDINES 1963-81; NITRACRINE was see under ACRIDINES 1975-80; TACRINE was see under ACRIDINES 1975-83
HN = 80
MR = 19920507
DA = 19790221
DC = 1
DX = 19800101
UI = D000609

*NEWRECORD
RECTYPE = D
MH = Aminobiphenyl Compounds
DE = AMINOBIPHENYL CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Biphenylamines|T109|NON|EQV|UNK (19XX)|741111|abcdef
ENTRY = Compounds, Aminobiphenyl
MN = D02.455.426.559.389.185.060
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = DF: AMINOBIPHENYL CPDS
PI = Biphenyl Compounds (1972-1974)
MS = Biphenyl compounds substituted in any position by one or more amino groups. Permitted are any substituents except fused rings.
PM = 75
HN = 75
MR = 19920507
DA = 19741111
DC = 1
DX = 19750901
UI = D000611

*NEWRECORD
RECTYPE = D
MH = 4-Aminobutyrate Transaminase
DS = AMINOBUTYRATE TRANSAMINASE 04
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aminobutyrate Aminotransferase|T116|T126|NON|EQV|NLM (1998)|961204|abbcdef
PRINT ENTRY = GABA Transaminase|T116|T126|EQV|UNK (19XX)|790523|abbdef
PRINT ENTRY = beta-Alanine Ketoglutarate Aminotransferase|T116|T126|NON|EQV|UNK (19XX)|760517|abbcdef
ENTRY = GABA Aminotransferase|T116|T126|EQV|UNK (19XX)|830330|abbdef
ENTRY = GABA-alpha-Ketoglutarate Aminotransferase|T116|T126|EQV|UNK (19XX)|821206|abbdef
ENTRY = 4 Aminobutyrate Transaminase
ENTRY = Aminotransferase, Aminobutyrate
ENTRY = Aminotransferase, GABA
ENTRY = Aminotransferase, GABA-alpha-Ketoglutarate
ENTRY = Aminotransferase, beta-Alanine Ketoglutarate
ENTRY = GABA alpha Ketoglutarate Aminotransferase
ENTRY = Ketoglutarate Aminotransferase, beta-Alanine
ENTRY = Transaminase, 4-Aminobutyrate
ENTRY = Transaminase, GABA
ENTRY = beta Alanine Ketoglutarate Aminotransferase
MN = D08.811.913.477.700.200
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = 4-Aminobutanoate:2-oxoglutarate aminotransferase
RN = EC 2.6.1.19
RR = 9037-67-6 (CAS RN)
PI = Aminobutyric Acid (1974)
PI = Aminotransferases (1974)
MS = An enzyme that converts brain gamma-aminobutyric acid (GAMMA-AMINOBUTYRIC ACID) into succinate semialdehyde, which can be converted to succinic acid and enter the citric acid cycle. It also acts on beta-alanine. EC 2.6.1.19.
PM = 98; see AMINOBUTYRATE AMINOTRANSFERASE 1984-97, see AMINOTRANSFERASES 1975-83
HN = 98(75)
MR = 20030709
DA = 19741119
DC = 1
DX = 19840101
UI = D000612

*NEWRECORD
RECTYPE = D
MH = Aminobutyrates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aminobutyric Acids|T116|T123|NON|REL|NLM (1966)|990101|abbcdef
ENTRY = Aminobutyric Acid|T116|T121|NON|NRW|UNK (19XX)|760905|abbcdef
ENTRY = Acid, Aminobutyric
ENTRY = Acids, Aminobutyric
MN = D02.241.081.114.500
MN = D12.125.190
FX = Receptors, GABA-A
MH_TH = NLM (2013)
ST = T109
RN = 0
AN = general or unspecified; prefer specifics
MS = Derivatives of BUTYRIC ACID that contain one or more amino groups attached to the aliphatic structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobutryrate structure.
PM = 1975;see AMINOBUTYRIC ACIDS 1975-2013, see AMINOBUTYRIC ACID 1963-1974
HN = 1975(2013)
MR = 20120703
DA = 19990101
DC = 1
UI = D000613

*NEWRECORD
RECTYPE = D
MH = Aminocaproates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aminocaproic Acids|T116|T121|NON|REL|NLM (1963)|990101|abbcdef
ENTRY = Aminocaproic Acid Derivatives|T116|T121|NON|REL|NLM (2014)|130610|abbcdef
ENTRY = Aminohexanoates|T109|NON|EQV|NLM (2014)|130610|abcdef
ENTRY = Aminohexanoic Acid Derivatives|T116|T121|NON|REL|NLM (2014)|130610|abbcdef
ENTRY = Aminohexanoic Acids|T116|T121|NON|REL|NLM (2014)|130610|abbcdef
ENTRY = Acid Derivatives, Aminocaproic
ENTRY = Acid Derivatives, Aminohexanoic
ENTRY = Acids, Aminocaproic
ENTRY = Acids, Aminohexanoic
ENTRY = Derivatives, Aminocaproic Acid
ENTRY = Derivatives, Aminohexanoic Acid
MN = D02.241.081.193.150
MN = D12.125.213
MH_TH = NLM (2014)
ST = T109
RN = 0
MS = Amino derivatives of caproic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the amino caproic acid structure.
PM = 1975; see AMINOCAPROIC ACIDS 1975-2013. see AMINOCAPROIC ACID 1964-1974
HN = 2014(1975)
MR = 20130708
DA = 19990101
DC = 1
DX = 19640101
UI = D000614

*NEWRECORD
RECTYPE = D
MH = Aminoethylphosphonic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 2-Aminoethylphosphonic Acid|T115|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|AMINOETHYLPHOSPHONIC ACID 02|abbcdeefs
PRINT ENTRY = Ciliatine|T115|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|760317|abbcdeef
ENTRY = 2 Aminoethylphosphonic Acid
ENTRY = Acid, 2-Aminoethylphosphonic
ENTRY = Acid, Aminoethylphosphonic
MN = D02.705.429.249
MH_TH = NLM (1975)
ST = T115
ST = T123
N1 = Phosphonic acid, (2-aminoethyl)-
RN = AH00YJQ334
RR = 2041-14-7 (Aminoethylphosphonic Acid)
PI = Ethylamines (1973-1974)
PI = Organophosphorus Compounds (1973-1974)
PI = Phosphonic Acids (1973-1974)
MS = An organophosphorus compound isolated from human and animal tissues.
PM = 91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90
HN = 91(75); was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000615

*NEWRECORD
RECTYPE = D
MH = Aminoglutethimide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Ciba Vision Brand of Aminoglutethimide|T109|T121|NON|NRW|NLM (2006)|050308|abbcdef
ENTRY = Cytadren|T109|T121|TRD|NRW|AU|US|020725|abbcdeef
ENTRY = Novartis Brand of Aminoglutethimide|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Orimeten|T109|T121|TRD|NRW|DE|ES|FR|NL|UK|890607|abbcdeeeeef
MN = D03.383.621.808.425.100
PA = Antineoplastic Agents, Hormonal
PA = Aromatase Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-
RN = 0O54ZQ14I9
RR = 125-84-8 (Aminoglutethimide)
MS = An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
PM = 73
HN = 73(66)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D000616

*NEWRECORD
RECTYPE = D
MH = Aminoglycosides
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
MN = D09.408.051
FX = Amino Sugars
MH_TH = NLM (1974)
ST = T118
RN = 0
MS = Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
PM = 74
HN = 74
MR = 20040719
DA = 19990101
DC = 1
DX = 19740101
UI = D000617

*NEWRECORD
RECTYPE = D
MH = Aminohippuric Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acids, Aminohippuric
MN = D02.065.277.431.192
MN = D02.241.223.100.100.100
MN = D02.241.755.360.192
MN = D02.455.426.559.389.127.085.067
MH_TH = NLM (1965)
ST = T109
ST = T130
RN = 0
MS = A group of glycine amides of aminobenzoic acids.
OL = use AMINOHIPPURIC ACIDS to search AMINOHIPPURIC ACID 1966-76
PM = 77; was AMINOHIPPURIC ACID 1965-76
HN = 77; was AMINOHIPPURIC ACID 1965-76
MR = 20120703
DA = 19990101
DC = 1
DX = 19650101
UI = D000618

*NEWRECORD
RECTYPE = D
MH = Aminohydrolases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D08.811.277.151
MH_TH = NLM (1966)
ST = T116
ST = T126
RN = EC 3.5.4.-
MR = 20060705
DA = 19990101
DC = 1
UI = D000619

*NEWRECORD
RECTYPE = D
MH = Aminoimidazole Carboxamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Ba 2756|T109|T121|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Carboxamide, Aminoimidazole
MN = D03.383.129.308.030
MH_TH = NLM (1978)
ST = T109
ST = T121
ST = T130
N1 = 1H-Imidazole-4-carboxamide, 5-amino-
RN = 360-97-4
PI = Imidazoles (1966-1977)
MS = An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.
PM = 91; was see under IMIDAZOLES 1978-90
HN = 91(78); was see under IMIDAZOLES 1978-90
MR = 20050630
DA = 19770415
DC = 1
DX = 19910101
UI = D000620

*NEWRECORD
RECTYPE = D
MH = Aminoisobutyric Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acids, Aminoisobutyric
MN = D02.241.081.114.968.249
MN = D12.125.070.075
MN = D12.125.190.055
MH_TH = NLM (1966)
ST = T116
RN = 0
MS = A group of compounds that are derivatives of the amino acid 2-amino-2-methylpropanoic acid.
OL = use AMINOISOBUTYRIC ACIDS to search AMINOISOBUTYRIC ACID 1966-82
PM = 83; was AMINOISOBUTYRIC ACID 1963-82
HN = 83; was AMINOISOBUTYRIC ACID 1963-82
MR = 20120703
DA = 19990101
DC = 1
UI = D000621

*NEWRECORD
RECTYPE = D
MH = Aminolevulinic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5-Aminolaevulinate|T116|T123|NON|NRW|UNK (19XX)|820302|abbcdef
ENTRY = 5-Aminolevulinate|T116|T123|NON|NRW|UNK (19XX)|820204|abbcdef
ENTRY = Aminolevulinic Acid Hydrochloride|T116|T121|NON|NRW|NLM (2006)|041206|abbcdef
ENTRY = Bertek Brand of Aminolevulinic Acid Hydrochloride|T116|T121|NON|NRW|NLM (2006)|041206|abbcdef
ENTRY = Delta-Aminolevulinic Acid|T116|T121|T123|NON|EQV|UNK (19XX)|810625|abbbcdef
ENTRY = Levulan|T116|T121|TRD|NRW|NLM (2005)|US|031112|abbcdeef
ENTRY = 5 Aminolaevulinate
ENTRY = 5 Aminolevulinate
ENTRY = Acid Hydrochloride, Aminolevulinic
ENTRY = Acid, Aminolevulinic
ENTRY = Acid, Delta-Aminolevulinic
ENTRY = Delta Aminolevulinic Acid
ENTRY = Hydrochloride, Aminolevulinic Acid
MN = D02.241.755.547.276
MN = D12.125.262
PA = Photosensitizing Agents
MH_TH = NLM (1975)
ST = T116
ST = T121
ST = T123
N1 = Pentanoic acid, 5-amino-4-oxo-
RN = 88755TAZ87
RR = 106-60-5 (Aminolevulinic Acid)
RR = V35KBM8JGR
MS = A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
PM = 91; see LEVULINIC ACIDS 1975-90; see LEVULINIC ACID 1973-74
HN = 91(73)
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000622

*NEWRECORD
RECTYPE = D
MH = Porphobilinogen Synthase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aminolevulinate Hydro-Lyase|T116|T126|NON|EQV|UNK (19XX)|770523|abbcdef
PRINT ENTRY = Aminolevulinic Acid Dehydratase|T116|T126|NON|EQV|NLM (1998)|961115|abbcdef
ENTRY = ALA-Dehydrase|T116|T126|EQV|UNK (19XX)|820302|abbdef
ENTRY = delta-Aminolevulinate Dehydratase|T116|T126|NON|EQV|UNK (19XX)|811218|abbcdef
ENTRY = delta-Aminolevulinic Acid Dehydratase|T116|T126|NON|EQV|UNK (19XX)|810807|abbcdef
ENTRY = ALA Dehydrase
ENTRY = Acid Dehydratase, Aminolevulinic
ENTRY = Acid Dehydratase, delta-Aminolevulinic
ENTRY = Aminolevulinate Hydro Lyase
ENTRY = Dehydratase, Aminolevulinic Acid
ENTRY = Dehydratase, delta-Aminolevulinate
ENTRY = Dehydratase, delta-Aminolevulinic Acid
ENTRY = Hydro-Lyase, Aminolevulinate
ENTRY = Synthase, Porphobilinogen
ENTRY = delta Aminolevulinate Dehydratase
ENTRY = delta Aminolevulinic Acid Dehydratase
MN = D08.811.520.241.300.550
MH_TH = NLM (1973)
ST = T116
ST = T126
N1 = 5-Aminolevulinate hydro-lyase (adding 5-aminolevulinate and cyclizing)
RN = EC 4.2.1.24
RR = 9036-37-7 (CAS RN)
AN = DF: ALA DEHYDRASE
PI = Hydro-Lyases (1966-1972)
MS = An enzyme that catalyzes the formation of porphobilinogen from two molecules of 5-aminolevulinic acid. EC 4.2.1.24.
PM = 98; see AMINOLEVULINIC ACID DEHYDRATASE 1978-97, see HYDRO-LYASES 1973-77
HN = 98(73)
MR = 20030709
DA = 19990101
DC = 1
DX = 19780101
UI = D000623

*NEWRECORD
RECTYPE = D
MH = 5-Aminolevulinate Synthetase
DS = AMINOLEVULINATE SYNTHETASE 05
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aminolevulinic Acid Synthetase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef
PRINT ENTRY = delta-Aminolevulinate Synthase|T116|T126|NON|EQV|NLM (1998)|970501|abbcdef
ENTRY = 5-Aminolevulinate Synthase|T116|T126|NON|EQV|NLM (2008)|070327|abbcdef
ENTRY = delta-Aminolevulinic Acid Synthetase|T116|T126|NON|EQV|UNK (19XX)|810625|abbcdef
ENTRY = 5 Aminolevulinate Synthase
ENTRY = 5 Aminolevulinate Synthetase
ENTRY = Acid Synthetase, Aminolevulinic
ENTRY = Acid Synthetase, delta-Aminolevulinic
ENTRY = Synthase, 5-Aminolevulinate
ENTRY = Synthase, delta-Aminolevulinate
ENTRY = Synthetase, 5-Aminolevulinate
ENTRY = Synthetase, Aminolevulinic Acid
ENTRY = Synthetase, delta-Aminolevulinic Acid
ENTRY = delta Aminolevulinate Synthase
ENTRY = delta Aminolevulinic Acid Synthetase
MN = D08.811.913.050.276
MH_TH = NLM (1972)
ST = T116
ST = T126
N1 = Succinyl-CoA:glycine C-Succinyltransferase (decarboxylating)
RN = EC 2.3.1.37
RR = 9037-14-3 (CAS RN)
PI = Acyltransferases (1966-1971)
MS = An enzyme of the transferase class that catalyzes condensation of the succinyl group from succinyl coenzyme A with glycine to form delta-aminolevulinate. It is a pyridoxyal phosphate protein and the reaction occurs in mitochondria as the first step of the heme biosynthetic pathway. The enzyme is a key regulatory enzyme in heme biosynthesis. In liver feedback is inhibited by heme. EC 2.3.1.37.
PM = 98; see AMINOLEVULINIC ACID SYNTHETASE 1972-97
HN = 98(72)
MR = 20070709
DA = 19990101
DC = 1
DX = 19730101
UI = D000624

*NEWRECORD
RECTYPE = D
MH = Aminooxyacetic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aminooxyacetate|T109|T121|NON|NRW|UNK (19XX)|741111|abbcdef
ENTRY = Carboxymethoxyamine|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1992)|910225|abbcdeef
ENTRY = Acid, Aminooxyacetic
MN = D02.092.570.050
MN = D02.241.081.018.207
PA = Enzyme Inhibitors
PA = GABA Agents
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Acetic acid, (aminooxy)-
RN = 14I68GI3OQ
RR = 645-88-5 (Aminooxyacetic Acid)
PI = Acetic Acids (1972-1974)
PI = Hydroxylamines (1972-1974)
MS = A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues.
PM = 91; was see under ACETIC ACIDS 1975-90
HN = 91(75); was see under ACETIC ACIDS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000625

*NEWRECORD
RECTYPE = D
MH = Aminopeptidases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D08.811.277.656.350.100
MH_TH = NLM (1966)
ST = T116
ST = T126
RN = EC 3.4.11.-
MS = A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11.
MR = 20060705
DA = 19990101
DC = 1
UI = D000626

*NEWRECORD
RECTYPE = D
MH = Aminophenols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hydroxyanilines|T109|NON|EQV|UNK (19XX)|771208|abcdef
MN = D02.092.146.100
MN = D02.455.426.559.389.657.050
MH_TH = NLM (1979)
ST = T109
RN = 0
PI = Amines (1966-1978)
PI = Aniline Compounds (1966-1978)
PI = Phenols (1966-1978)
MS = Phenols substituted in any position by an amino group.
PM = 79; PHENETIDINE was see under ANILINE COMPOUNDS 1975-78
HN = 79
MR = 20120703
DA = 19771208
DC = 1
DX = 19790101
UI = D000627

*NEWRECORD
RECTYPE = D
MH = Aminophylline
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Afonilum|T109|T121|TRD|NRW|DE|020725|abbcdef
ENTRY = Aminodur|T109|T121|TRD|NRW|US|020725|abbcdef
ENTRY = Aminophyllin|T109|T121|TRD|NRW|DE|US|020725|abbcdeef
ENTRY = Aminophylline DF|T109|T121|TRD|NRW|US|020725|abbcdef
ENTRY = Cardophyllin|T109|T121|TRD|NRW|AU|020725|abbcdef
ENTRY = Carine|T109|T121|TRD|NRW|AU|020725|abbcdef
ENTRY = Clonofilin|T109|T121|TRD|NRW|IE|020725|abbcdef
ENTRY = Corophyllin|T109|T121|TRD|NRW|CA|020725|abbcdef
ENTRY = Diaphyllin|T109|T121|TRD|NRW|UNK (19XX)|820830|abbcdef
ENTRY = Drafilyn|T109|T121|TRD|NRW|MX|020725|abbcdef
ENTRY = Duraphyllin|T109|T121|TRD|NRW|DE|020725|abbcdef
ENTRY = Eufilina|T109|T121|TRD|NRW|ES|020725|abbcdef
ENTRY = Eufilina Venosa|T109|T121|TRD|NRW|ES|020725|abbcdef
ENTRY = Euphyllin|T109|T121|TRD|NRW|NL|020725|abbcdef
ENTRY = Euphyllin Retard|T109|T121|TRD|NRW|UNK (19XX)|840305|abbcdef
ENTRY = Euphylline|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Godafilin|T109|T121|TRD|NRW|ES|020725|abbcdef
ENTRY = Mini-Lix|T109|T121|TRD|NRW|US|020725|abbcdef
ENTRY = Mundiphyllin|T109|T121|TRD|NRW|DE|020725|abbcdef
ENTRY = Mundiphyllin Retard|T109|T121|TRD|NRW|UNK (19XX)|840305|abbcdef
ENTRY = Novophyllin|T109|T121|TRD|NRW|UNK (19XX)|830330|abbcdef
ENTRY = Phyllocontin|T109|T121|TRD|NRW|CA|IE|UK|US|020725|abbcdeeeef
ENTRY = Phyllotemp|T109|T121|TRD|NRW|DE|830915|abbcdef
ENTRY = Somophyllin|T109|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Tari-Dog|T109|T121|TRD|NRW|FR|020726|abbcdef
ENTRY = Theophyllamin Jenapharm|T109|T121|TRD|NRW|DE|020726|abbcdef
ENTRY = Theophyllamine|T109|T121|NON|EQV|UNK (19XX)|811102|abbcdef
ENTRY = Theophyllin EDA-ratiopharm|T109|T121|TRD|NRW|DE|020726|abbcdef
ENTRY = Theophylline Ethylenediamine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|830909|abbcdeef
ENTRY = Truphylline|T109|T121|TRD|NRW|US|020726|abbcdef
ENTRY = Ethylenediamine, Theophylline
ENTRY = Theophyllin EDA ratiopharm
ENTRY = Theophyllin EDAratiopharm
MN = D02.092.782.258.368.050
MN = D03.438.759.758.824.751.075
MN = D26.310.048
PA = Bronchodilator Agents
PA = Cardiotonic Agents
PA = Phosphodiesterase Inhibitors
PA = Purinergic P1 Receptor Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compd. with 1,2-ethanediamine (2:1)
RN = 27Y3KJK423
RR = 317-34-0 (Aminophylline)
MS = A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications.
MR = 20150626
DA = 19990101
DC = 1
UI = D000628

*NEWRECORD
RECTYPE = D
MH = Aminopropionitrile
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = beta-Aminopropionitrile|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|820330|abbcdeef
ENTRY = BAPN|T109|T130|ABB|EQV|FDA SRS (2014)|UNK (19XX)|820226|abbcdeef
ENTRY = beta Aminopropionitrile
MN = D02.626.151
FX = Lathyrism
MH_TH = NLM (1964)
ST = T109
ST = T130
N1 = Propanenitrile, 3-amino-
RN = 151-18-8
MS = Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.
PM = 72
HN = 72(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19720101
UI = D000629

*NEWRECORD
RECTYPE = D
MH = Aminopterin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aminopterin Sodium|T109|T131|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|941206|abbcdeeef
ENTRY = Aminopterin, Disodium Salt|T109|T131|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Disodium Salt Aminopterin
ENTRY = Sodium, Aminopterin
MN = D03.438.733.631.192
PA = Folic Acid Antagonists
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T121
ST = T131
N1 = L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)amino)benzoyl)-
RN = JYB41CTM2Q
RR = 31823-54-8 (Na salt)
RR = 54-62-6 (Aminopterin)
RR = 58602-66-7 (di-Na salt)
RR = FZU1QI13O9
MS = A folic acid derivative used as a rodenticide that has been shown to be teratogenic.
MR = 20130708
DA = 19990101
DC = 1
UI = D000630

*NEWRECORD
RECTYPE = D
MH = Aminopyridines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.092.080
MN = D03.383.725.050
MH_TH = NLM (1979)
ST = T109
RN = 0
AN = = pyridinamines & pyridylamines
PI = Amines (1966-1978)
PI = Pyridines (1966-1978)
MS = Pyridines substituted in any position with an amino group. May be hydrogenated, but must retain at least one double bond.
PM = 79; METHAPYRILENE was see under PYRIDINES 1975-78, was see under ANTIHISTAMINICS 1963-74; PHENAZOPYRIDINE & PYRILAMINE were see under PYRIDINES 1975-78
HN = 79
MR = 19920507
DA = 19771208
DC = 1
DX = 19790101
UI = D000631

*NEWRECORD
RECTYPE = D
MH = Aminopyrine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Amidophenazon|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
PRINT ENTRY = Aminophenazone|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|750708|abbcdeef
PRINT ENTRY = Dimethylaminophenazone|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
PRINT ENTRY = Dipyrine|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
ENTRY = Amidazophen|T109|T121|NON|EQV|UNK (19XX)|811023|abbcdef
ENTRY = Amidophen|T109|T121|NON|EQV|UNK (19XX)|830223|abbcdef
ENTRY = Amidopyrine|T109|T121|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = Aminofenazone|T109|T121|NON|EQV|UNK (19XX)|810318|abbcdef
ENTRY = Berlin-Chemie Brand of Aminophenazone|T109|T121|NON|NRW|NLM (2004)|030131|abbcdef
ENTRY = Dimethyl-N-aminoantipyrine|T109|T121|NON|EQV|UNK (19XX)|810423|abbcdef
ENTRY = Dimethylaminoantipyrine|T109|T121|NON|EQV|UNK (19XX)|810423|abbcdef
ENTRY = Eufibron|T109|T121|NON|NRW|NLM (2004)|030131|abbcdef
ENTRY = Aminophenazone Berlin-Chemie Brand
ENTRY = Berlin Chemie Brand of Aminophenazone
ENTRY = Dimethyl N aminoantipyrine
MN = D03.383.129.539.850.077
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T121
N1 = 3H-Pyrazol-3-one, 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-
RN = 01704YP3MO
RR = 58-15-1 (Aminopyrine)
AN = do not confuse DIPYRINE (X ref) with DIPYRONE
MS = A pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of AGRANULOCYTOSIS. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of CYTOCHROME P-450 metabolic activity in LIVER FUNCTION TESTS.
MR = 20130708
DA = 19990101
DC = 1
UI = D000632

*NEWRECORD
RECTYPE = D
MH = Aminopyrine N-Demethylase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Aminopyrine N Demethylase|T116|T126|NON|EQV|UNK (19XX)|780126|abbcdef
ENTRY = Demethylase, Aminopyrine N
ENTRY = N Demethylase, Aminopyrine
ENTRY = N-Demethylase, Aminopyrine
MN = D08.811.682.662.582.276
MH_TH = NLM (1972)
ST = T116
ST = T126
RN = EC 1.5.3.-
PI = Oxidoreductases, N-Demethylating
PM = 74
HN = 74(72)
MR = 20050630
DA = 19990101
DC = 1
DX = 19740101
UI = D000633

*NEWRECORD
RECTYPE = D
MH = Aminoquinolines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.438.810.050
MH_TH = NLM (1975)
ST = T109
RN = 0
PI = Quinolines (1968-1974)
MS = Quinolines substituted in any position by one or more amino groups.
PM = 75
HN = 75
MR = 19920507
DA = 19741111
DC = 1
DX = 19750901
UI = D000634

*NEWRECORD
RECTYPE = D
MH = Aminorex
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aminoxafen|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Aminoxaphen|T109|T121|NON|EQV|UNK (19XX)|771005|abbcdef
ENTRY = Menocil|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
MN = D03.383.129.462.050
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1963)
ST = T109
ST = T121
N1 = 2-Oxazolamine, 4,5-dihydro-5-phenyl-
RN = 2SH16612I9
RR = 2207-50-3 (Aminorex)
PI = Amines (1972-1974)
PI = Oxazoles (1968-1974)
MS = An amphetamine-like anorectic agent. It may cause pulmonary hypertension.
PM = 91; was see under OXAZOLES 1975-90
HN = 91(75); was see under OXAZOLES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D000635

*NEWRECORD
RECTYPE = D
MH = Aminosalicylic Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acids, Aminosalicylic
MN = D02.241.223.100.300.595.100
MN = D02.241.511.390.595.100
MN = D02.455.426.559.389.127.281.595.100
MN = D02.455.426.559.389.657.410.595.100
MH_TH = NLM (1966)
ST = T109
ST = T121
RN = 0
AN = AMINOSALICYLIC ACID is also available
MS = A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.
OL = use AMINOSALICYLIC ACIDS to search AMINOSALICYLIC ACID 1966-76
PM = 77; was AMINOSALICYLIC ACID 1963-76
HN = 77; was AMINOSALICYLIC ACID 1963-76
MR = 20120703
DA = 19990101
DC = 1
UI = D000636

*NEWRECORD
RECTYPE = D
MH = Transaminases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aminotransferases|T116|T126|NON|EQV|NLM (1998)|961216|abbcdef
MN = D08.811.913.477.700
MH_TH = NLM (1966)
ST = T116
ST = T126
RN = EC 2.6.1.-
RR = 9031-66-7 (CAS RN)
MS = A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.
PM = 98; see AMINOTRANSFERASES 1963-97; for TRANSAMINASES see AMINOTRANSFERASES 1974-97
HN = 98(63)
MR = 20060705
DA = 19990101
DC = 1
UI = D000637

*NEWRECORD
RECTYPE = D
MH = Amiodarone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = ASTA Medica Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Alphapharm Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Amiobeta|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Amiodarex|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Amiodarona|T109|T121|TRD|NRW|ES|020730|abbcdef
ENTRY = Amiodarone Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2014)|130403|abbcdeef
ENTRY = Amiohexal|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Aratac|T109|T121|TRD|NRW|AU|020730|abbcdef
ENTRY = Armstrong Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Berenguer Infale Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Betapharm Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Braxan|T109|T121|TRD|NRW|MX|020730|abbcdef
ENTRY = Corbionax|T109|T121|TRD|NRW|FR|020730|abbcdef
ENTRY = Cordarex|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Cordarone|T109|T121|TRD|NRW|AU|CA|FR|IE|MX|NL|UK|US|020730|abbcdeeeeeeeef
ENTRY = G Gam Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Hexal Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Kordaron|T109|T121|TRD|NRW|UNK (19XX)|841002|abbcdef
ENTRY = L-3428|T109|T121|LAB|NRW|NLM (1991)|900320|abbcdef
ENTRY = Leurquin Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Ortacrone|T109|T121|TRD|NRW|ES|020730|abbcdef
ENTRY = Pharma Investi Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Rytmarone|T109|T121|TRD|NRW|FR|020730|abbcdef
ENTRY = SKF 33134-A|T109|T121|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Sanofi Winthrop Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Tachydaron|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Trangorex|T109|T121|TRD|NRW|ES|020730|abbcdef
ENTRY = Wyeth Brand of Amiodarone Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Hydrochloride, Amiodarone
ENTRY = L 3428
ENTRY = L3428
ENTRY = SKF 33134 A
ENTRY = SKF 33134A
MN = D03.438.127.075
PA = Anti-Arrhythmia Agents
PA = Cytochrome P-450 CYP1A2 Inhibitors
PA = Cytochrome P-450 CYP2C9 Inhibitors
PA = Cytochrome P-450 CYP2D6 Inhibitors
PA = Cytochrome P-450 CYP3A Inhibitors
PA = Potassium Channel Blockers
PA = Sodium Channel Blockers
PA = Vasodilator Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1987)
ST = T109
ST = T121
N1 = Methanone, (2-butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)-
RN = N3RQ532IUT
RR = 1951-25-3 (Amiodarone)
RR = 976728SY6Z
PI = Benzofurans (1968-1974)
PI = Diethylamines (1974)
PI = Iodobenzoates (1973-1974)
MS = An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
PM = 87; was see under BENZOFURANS 1975-86
HN = 87(75); was see under BENZOFURANS 1975-86
MR = 20140617
DA = 19741119
DC = 1
DX = 19870101
UI = D000638

*NEWRECORD
RECTYPE = D
MH = Amitriptyline
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = APS Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Alphapharm Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020731|abbcdef
ENTRY = Amineurin|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Amitrip|T109|T121|TRD|NRW|AU|020730|abbcdef
ENTRY = Amitriptylin Desitin|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Amitriptylin RPh|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Amitriptylin beta|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Amitriptylin-neuraxpharm|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Amitriptyline Hydrochloride|T109|T123|NON|NRW|FDA SRS (2014)|NLM (1996)|USP (1996)|940811|abbcdeeef
ENTRY = Amitrol|T109|T121|TRD|NRW|AU|020730|abbcdef
ENTRY = Amrad Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Anapsique|T109|T121|TRD|NRW|MX|020730|abbcdef
ENTRY = Apo-Amitriptyline|T109|T121|TRD|NRW|CA|020730|abbcdef
ENTRY = Apotex Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Bayer Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Betapharm Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Cahill May Roberts Brand of Amitriptyline Embonate|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Cahill May Roberts Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = DDSA Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030409|abbcdef
ENTRY = Damilen|T109|T121|TRD|NRW|NLM (1992)|910311|abbcdef
ENTRY = Desitin Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Domical|T109|T121|TRD|NRW|IE|UK|020730|abbcdeef
ENTRY = Douglas Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Elavil|T109|T121|TRD|NRW|CA|FR|UK|US|030409|abbcdeeeef
ENTRY = Endep|T109|T121|TRD|NRW|AU|US|020731|abbcdeef
ENTRY = Goldshield Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020731|abbcdef
ENTRY = Hexal Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Krewel Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Laroxyl|T109|T121|TRD|NRW|FR|901022|abbcdef
ENTRY = Lentizol|T109|T121|TRD|NRW|IE|UK|810625|abbcdeef
ENTRY = Lundbeck Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Merck Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Merck Sharp & Dohme Brand of Amitriptyline Embonate|T109|T121|NON|NRW|NLM (2004)|030409|abbcdef
ENTRY = Merck Sharp & Dohme Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Neuro Hexal Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Novoprotect|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Parke Davis Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Protea Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Psicofarma Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Rhne-Poulenc Rorer Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Roche Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020731|abbcdef
ENTRY = Rodleben Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Saroten|T109|T121|TRD|NRW|DE|NL|901022|abbcdeef
ENTRY = Sarotex|T109|T121|TRD|NRW|NL|020730|abbcdef
ENTRY = Syneudon|T109|T121|TRD|NRW|DE|020730|abbcdef
ENTRY = Triptafen|T109|T121|TRD|NRW|IE|UK|020730|abbcdeef
ENTRY = Tryptanol|T109|T121|TRD|NRW|AU|MX|020730|abbcdeef
ENTRY = Tryptine|T109|T121|TRD|NRW|AU|020730|abbcdef
ENTRY = Tryptizol|T109|T121|TRD|NRW|ES|IE|NL|UK|901022|abbcdeeeef
ENTRY = Zeneca Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2004)|030409|abbcdef
ENTRY = neuraxpharm Brand of Amitriptyline Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Amitriptylin neuraxpharm
ENTRY = Amitriptylinneuraxpharm
ENTRY = Apo Amitriptyline
ENTRY = ApoAmitriptyline
ENTRY = Desitin, Amitriptylin
ENTRY = RPh, Amitriptylin
ENTRY = Rhne Poulenc Rorer Brand of Amitriptyline Hydrochloride
ENTRY = beta, Amitriptylin
MN = D02.455.426.559.847.181.384.100
MN = D04.615.181.384.100
PA = Adrenergic Uptake Inhibitors
PA = Analgesics, Non-Narcotic
PA = Antidepressive Agents, Tricyclic
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-
RN = 1806D8D52K
RR = 17086-03-2 (pamoate (2:1))
RR = 26LUD4JO9K
RR = 30227-34-0 (maleate (1:1))
RR = 50-48-6 (Amitriptyline)
RR = 51052-95-0 (maleate (2:1))
RR = 51390-24-0 (maleate)
RR = 549-18-8 (HCl)
RR = 87987-25-5 (phosphate (1:1))
MS = Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
PM = 64
HN = 64(63)
MR = 20130708
DA = 19991108
DC = 1
DX = 19640101
UI = D000639

*NEWRECORD
RECTYPE = D
MH = Amitrole
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aminotriazole|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|810512|abbcdeef
ENTRY = 3-Amino-1,2,4-triazole|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|800730|abbcdeef
MN = D03.383.129.799.100
PA = Enzyme Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T131
N1 = 1H-1,2,4-Triazol-3-amine
RN = ZF80H5GXUF
RR = 61-82-5 (Amitrole)
PI = Herbicides (1966-1971)
PI = Triazoles (1966-1971)
MS = A non-selective post-emergence, translocated herbicide. According to the Seventh Annual Report on Carcinogens (PB95-109781, 1994) this substance may reasonably be anticipated to be a carcinogen. (From Merck Index, 12th ed) It is an irreversible inhibitor of CATALASE, and thus impairs activity of peroxisomes.
PM = 91; was see under TRIAZOLES 1972-90
HN = 91(72); was see under TRIAZOLES 1972-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000640

*NEWRECORD
RECTYPE = D
MH = Ammonia
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.362.075
MN = D01.625.050
FX = Ammonium Hydroxide
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T123
ST = T197
N1 = Ammonia
RN = 7664-41-7
MS = A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. Note that the aqueous form of ammonia is referred to as AMMONIUM HYDROXIDE.
MR = 20130708
DA = 19990101
DC = 1
UI = D000641

*NEWRECORD
RECTYPE = D
MH = Ammonia-Lyases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Ammonia Lyases
MN = D08.811.520.232.400
MH_TH = NLM (1973)
ST = T116
ST = T126
RN = EC 4.3.1.-
PI = Lyases (1966-1972)
MS = Enzymes that catalyze the formation of a carbon-carbon double bond by the elimination of AMMONIA. EC 4.3.1.
PM = 73
HN = 73
MR = 20130709
DA = 19990101
DC = 1
DX = 19730101
UI = D000642

*NEWRECORD
RECTYPE = D
MH = Ammonium Chloride
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Sal Ammoniac|T121|T197|NON|EQV|NLM (2007)|060323|abbcdef
ENTRY = Ammoniac, Sal
ENTRY = Chloride, Ammonium
MN = D01.210.450.150.050
MN = D01.625.062.249
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
MH_TH = USP (19XX)
ST = T121
ST = T197
N1 = Ammonium chloride ((NH4)Cl)
RN = 01Q9PC255D
RR = 12125-02-9 (Ammonium Chloride)
RR = 54450-56-5 ((NH4)HCl2)
AN = /analogs = probably AMMONIUM COMPOUNDS
MS = An acidifying agent that has expectorant and diuretic effects. Also used in etching and batteries and as a flux in electroplating.
MR = 20130708
DA = 19990101
DC = 1
UI = D000643

*NEWRECORD
RECTYPE = D
MH = Quaternary Ammonium Compounds
DE = QUATERNARY AMMONIUM CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Ammonium Compounds, Quaternary
MN = D01.625.062.500
MN = D02.092.877
MN = D02.675.276
FX = Pyridinium Compounds
FX = Quinolinium Compounds
MH_TH = NLM (2006)
ST = T109
RN = 0
AN = general or unspecified; prefer specifics
MS = Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN=CR2.
PM = 2006; see AMMONIUM COMPOUNDS 1963-2005
HN = 2006(1963)
MR = 20130708
DA = 19990101
DC = 1
UI = D000644

*NEWRECORD
RECTYPE = D
MH = Ammonium Sulfate
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Sulfate, Ammonium
MN = D01.625.062.374
MN = D01.875.800.800.850.050
MH_TH = FDA SRS (2014)
MH_TH = NLM (1971)
ST = T130
ST = T197
N1 = Sulfuric acid diammonium salt
RN = SU46BAM238
RR = 7783-20-2 (Ammonium Sulfate)
PI = Ammonium Compounds (1966-1970)
MS = Sulfuric acid diammonium salt. It is used in CHEMICAL FRACTIONATION of proteins.
PM = 74
HN = 74(71)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D000645

*NEWRECORD
RECTYPE = D
MH = Ammotherapy
DE = AMMOTHER
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Baths, Sand|T061|NON|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Sand Baths|T061|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Sandbaths|T061|NON|NRW|UNK (19XX)|880711|abcdef
ENTRY = Bath, Sand
ENTRY = Sand Bath
ENTRY = Sandbath
MN = E02.056.020
MN = E02.565.020
MH_TH = NLM (1986)
ST = T061
AN = do not use /util except by MeSH definition
MS = Treatment by application of hot sand.
PM = 91,63-85; was see under HYPERTHERMIA, INDUCED 1986-90; was heading 1963-85
HN = 91(86)63; was see under HYPERTHERMIA, INDUCED 1986-90; was heading 1963-85
CATSH = CAT LIST
MR = 20150626
DA = 19990101
DC = 1
DX = 19910101
UI = D000646

*NEWRECORD
RECTYPE = D
MH = Amnesia
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Amnesia, Dissociative|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Amnesia, Global|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Amnesia, Hysterical|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Amnesia, Tactile|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Amnesia, Temporary|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Amnesia-Memory Loss|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Amnestic State|T033|NON|REL|NLM (2000)|991103|abcdef
ENTRY = Amnesia Memory Loss
ENTRY = Amnesia-Memory Losses
ENTRY = Amnesias
ENTRY = Amnesias, Dissociative
ENTRY = Amnesias, Global
ENTRY = Amnesias, Hysterical
ENTRY = Amnesias, Tactile
ENTRY = Amnesias, Temporary
ENTRY = Amnestic States
ENTRY = Dissociative Amnesia
ENTRY = Dissociative Amnesias
ENTRY = Global Amnesia
ENTRY = Global Amnesias
ENTRY = Hysterical Amnesia
ENTRY = Hysterical Amnesias
ENTRY = State, Amnestic
ENTRY = States, Amnestic
ENTRY = Tactile Amnesia
ENTRY = Tactile Amnesias
ENTRY = Temporary Amnesia
ENTRY = Temporary Amnesias
MN = C10.597.606.525.100
MN = C23.888.592.604.529.100
MN = F01.700.625.100
MN = F03.615.200
MH_TH = NLM (1966)
ST = T048
MS = Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7)
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
UI = D000647

*NEWRECORD
RECTYPE = D
MH = Amnesia, Retrograde
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Pre-Ictal Memory Loss|T048|NON|NRW|NLM (2000)|991108|PREICTAL MEMORY LOSS|abcdefs
PRINT ENTRY = Retrograde Amnesia|T041|T048|NON|EQV|NLM (2000)|991108|abbcdef
ENTRY = Amnesia, Pre-Ictal|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Memory Loss, Retrograde|T048|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Amnesia, Pre Ictal
ENTRY = Amnesias, Pre-Ictal
ENTRY = Amnesias, Retrograde
ENTRY = Memory Loss, Pre-Ictal
ENTRY = Memory Losses, Pre-Ictal
ENTRY = Memory Losses, Retrograde
ENTRY = Pre Ictal Memory Loss
ENTRY = Pre-Ictal Amnesia
ENTRY = Pre-Ictal Amnesias
ENTRY = Pre-Ictal Memory Losses
ENTRY = Retrograde Amnesias
ENTRY = Retrograde Memory Loss
ENTRY = Retrograde Memory Losses
MN = C10.597.606.525.100.150
MN = C23.888.592.604.529.100.150
MN = F01.700.625.100.150
MN = F03.615.200.150
MH_TH = NLM (1976)
ST = T041
ST = T048
PI = Amnesia (1966-1975)
MS = Loss of the ability to recall information that had been previously encoded in memory prior to a specified or approximate point in time. This process may be organic or psychogenic in origin. Organic forms may be associated with CRANIOCEREBRAL TRAUMA; CEREBROVASCULAR ACCIDENTS; SEIZURES; DEMENTIA; and a wide variety of other conditions that impair cerebral function. (From Adams et al., Principles of Neurology, 6th ed, pp426-9)
PM = 1991; was see under AMNESIA 1976-1990
HN = 1991(1976); was see under AMNESIA 1976-1990
CATSH = CAT LIST
MR = 20150630
DA = 19750721
DC = 1
DX = 19910101
UI = D000648

*NEWRECORD
RECTYPE = D
MH = Amniocentesis
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Amniocenteses
MN = E01.370.225.500.384.050
MN = E01.370.225.998.329.309
MN = E01.370.378.630.050
MN = E04.665.600.309
MN = E05.200.500.384.050
MN = E05.200.998.329.309
MN = E05.242.384.050
FX = Chorionic Villi Sampling
MH_TH = BIOETHICS (1974)
MH_TH = POPLINE (1978)
ST = T060
PI = Amnion (1966-1970)
PI = Punctures (1966-1970)
MS = Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions.
PM = 73
HN = 73(71)
CATSH = CAT LIST
MR = 20150707
DA = 19990101
DC = 1
DX = 19730101
UI = D000649

*NEWRECORD
RECTYPE = D
MH = Amnion
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Amniotic Membrane|T018|NON|EQV|NLM (2006)|041021|abcdef
ENTRY = Amnions
ENTRY = Amniotic Membranes
ENTRY = Membrane, Amniotic
ENTRY = Membranes, Amniotic
MN = A10.615.284.277
MN = A16.254.750.277
FX = Fetoscopy
MH_TH = NLM (1966)
ST = T018
AN = not restricted to mammals; intra-amniotic injections = AMNION + INJECTIONS; amniotomy = AMNION /surg + probably LABOR, INDUCED
MS = The innermost membranous sac that surrounds and protects the developing embryo which is bathed in the AMNIOTIC FLUID. Amnion cells are secretory EPITHELIAL CELLS and contribute to the amniotic fluid.
MR = 20070711
DA = 19990101
DC = 1
UI = D000650

*NEWRECORD
RECTYPE = D
MH = Amniotic Band Syndrome
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Amniotic Bands|T019|NON|BRD|UNK (19XX)|820419|abcdef
PRINT ENTRY = Amputation, Intrauterine|T047|NON|BRD|UNK (19XX)|820419|abcdef
PRINT ENTRY = Annular Grooves|T047|NON|NRW|UNK (19XX)|820419|abcdef
PRINT ENTRY = Ring Constrictions, Intrauterine|T047|NON|NRW|UNK (19XX)|820419|abcdef
PRINT ENTRY = Streeter Syndrome|T047|EPO|EQV|UNK (19XX)|820419|abcdef
ENTRY = Amniotic Band
ENTRY = Amputations, Intrauterine
ENTRY = Annular Groove
ENTRY = Band, Amniotic
ENTRY = Bands, Amniotic
ENTRY = Constriction, Intrauterine Ring
ENTRY = Constrictions, Intrauterine Ring
ENTRY = Groove, Annular
ENTRY = Grooves, Annular
ENTRY = Intrauterine Amputation
ENTRY = Intrauterine Amputations
ENTRY = Intrauterine Ring Constriction
ENTRY = Intrauterine Ring Constrictions
ENTRY = Ring Constriction, Intrauterine
ENTRY = Syndrome, Amniotic Band
ENTRY = Syndrome, Streeter
MN = C16.614.042
MH_TH = NLM (1983)
MH_TH = ORD (2010)
ST = T047
AN = constriction bands in newborn inf; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
PI = Amnion (1966-1982)
PI = specific anatomic heading/abnormalities (1966-1982)
MS = A disorder present in the newborn infant in which constriction rings or bands, causing soft tissue depressions, encircle digits, extremities, or limbs and sometimes the neck, thorax, or abdomen. They may be associated with intrauterine amputations.
PM = 83
HN = 83
CATSH = CAT LIST
MR = 20090706
DA = 19820419
DC = 1
DX = 19830101
UI = D000652

*NEWRECORD
RECTYPE = D
MH = Amniotic Fluid
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
PRINT ENTRY = Amniotic Fluid Index|T081|NON|REL|NLM (2000)|991105|abcdef
ENTRY = Amniotic Fluid Indices
ENTRY = Amniotic Fluids
ENTRY = Fluid Index, Amniotic
ENTRY = Fluid Indices, Amniotic
ENTRY = Fluid, Amniotic
ENTRY = Fluids, Amniotic
ENTRY = Index, Amniotic Fluid
ENTRY = Indices, Amniotic Fluid
MN = A12.098
MN = A16.378.149
FX = Embolism, Amniotic Fluid
FX = Fetoscopy
FX = Oligohydramnios
FX = Polyhydramnios
MH_TH = NLM (1966)
ST = T031
AN = intra-amniotic injections do not go here: use AMNION + INJECTIONS; excess fluid and hydramnios = POLYHYDRAMNIOS; fluid deficiency = OLIGOHYDRAMNIOS
MS = A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS).
MR = 20070709
DA = 19990101
DC = 1
UI = D000653

*NEWRECORD
RECTYPE = D
MH = Amobarbital
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Amylobarbitone|T109|T121|NON|EQV|BAN (19XX)|761230|abbcdef
PRINT ENTRY = Pentymal|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
ENTRY = Adams Brand of Amobarbital Sodium|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Adams Brand of Amorbarbital|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Amobarbital Sodium|T109|T121|NRW|FDA SRS (2014)|UNK (19XX)|990913|abbdeef
ENTRY = Amsal|T109|T121|TRD|NRW|AU|020730|abbcdef
ENTRY = Amylbarb sodium|T109|T121|TRD|NRW|AU|020730|abbcdef
ENTRY = Amylobeta|T109|T121|TRD|NRW|AU|020730|abbcdef
ENTRY = Amytal|T109|T121|TRD|NRW|CA|UK|US|800918|abbcdeeef
ENTRY = Amytal Sodium|T109|T121|TRD|NRW|AU|US|811113|abbcdeef
ENTRY = Barbamyl|T109|T121|TRD|NRW|UNK (19XX)|761230|abbcdef
ENTRY = Bramble Brand of Amobarbital Sodium|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Eunoctal|T109|T121|TRD|NRW|FR|020730|abbcdef
ENTRY = Fawns & McAllan Brand of Amorbarbital|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Flynn Brand of Amobarbital|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Flynn Brand of Amobarbital Sodium|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Hosbon Brand of Amorbarbital|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Houd Brand of Amobarbital Sodium|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = ICN Brand of Amorbarbital|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Isoamitil Sedante|T109|T121|TRD|NRW|ES|020730|abbcdef
ENTRY = Isonal|T109|T121|TRD|NRW|CA|020730|abbcdef
ENTRY = Lilly Brand of Amobarbital|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Lilly Brand of Amobarbital Sodium|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Miquel Brand of Amorbarbital|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Neur-Amyl|T109|T121|TRD|NRW|AU|020730|abbcdef
ENTRY = Novamobarb|T109|T121|TRD|NRW|CA|020730|abbcdef
ENTRY = Novopharm Brand of Amobarbital Sodium|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Placidel|T109|T121|TRD|NRW|ES|020730|abbcdef
ENTRY = Protea Brand of Amobarbital Sodium|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Sodium Amobarbital|T109|T121|NON|NRW|USP (19XX)|810130|abbcdef
ENTRY = Sodium Amytal|T109|T121|TRD|NRW|IE|UK|811113|abbcdeef
ENTRY = Transital|T109|T121|TRD|NRW|ES|020730|abbcdef
ENTRY = Amobarbital, Sodium
ENTRY = Amorbarbital Miquel Brand
ENTRY = NeurAmyl
ENTRY = Sodium, Amobarbital
MN = D03.383.742.698.253.077
PA = GABA Modulators
PA = Hypnotics and Sedatives
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-
RN = GWH6IJ239E
RR = 57-43-2 (Amobarbital)
RR = 64-43-7 (Na)
RR = G0313KNC7D
MS = A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
MR = 20130708
DA = 19990101
DC = 1
UI = D000654

*NEWRECORD
RECTYPE = D
MH = Amodiaquine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amodiachin|T109|T121|NON|EQV|NLM (1996)|950120|abbcdef
ENTRY = Amodiaquin|T109|T121|NON|EQV|NLM (1998)|961113|abbcdef
ENTRY = Amodiaquine Hydrochloride|T109|NON|NRW|FDA SRS (2014)|NLM (2007)|060323|abcdeef
ENTRY = Camoquin|T109|T121|TRD|NRW|UNK (19XX)|811202|abbcdef
ENTRY = Camoquine|T109|T121|TRD|NRW|NLM (1990)|890607|abbcdef
ENTRY = Flavoquine|T109|T121|TRD|NRW|FR|020730|abbcdef
ENTRY = Roussel Brand of Amodiaquine Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Hydrochloride, Amodiaquine
MN = D03.438.810.050.060
PA = Antimalarials
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Phenol, 4-((7-chloro-4-quinolinyl)amino)-2-((diethylamino)methyl)-
RN = 220236ED28
RR = 86-42-0 (Amodiaquine)
RR = K6PW2S574L
MS = A 4-aminoquinoline compound with anti-inflammatory properties.
PM = AMODIACHIN was see AMODIAQUINE 1978-95
HN = AMODIACHIN was see AMODIAQUINE 1978-95
MR = 20130708
DA = 19990101
DC = 1
UI = D000655

*NEWRECORD
RECTYPE = D
MH = Amoeba
AQ = CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Ameba|T204|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Amebas
ENTRY = Amoebas
MN = B01.046.500.100.700.089
FX = Amebicides
MH_TH = NLM (1966)
ST = T204
AN = the genus name: entry term AMEBA sometimes used loosely for the common nouns ameba & amoeba; infection = AMEBIASIS; for antigens, coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
MS = A genus of ameboid protozoa. Characteristics include a vesicular nucleus and the formation of several lodopodia, one of which is dominant at a given time. Reproduction occurs asexually by binary fission.
MR = 20090706
DA = 19990101
DC = 1
UI = D000656

*NEWRECORD
RECTYPE = D
MH = Amoxapine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|950405|abbcdeef
ENTRY = Asendin|T109|T121|TRD|NRW|CA|US|861119|abbcdeef
ENTRY = Asendis|T109|T121|TRD|NRW|IE|UK|020730|abbcdeef
ENTRY = CL-67,772|T109|T121|LAB|NRW|UNK (19XX)|800731|CL 67772|abbcdefv
ENTRY = Cyanamid Brand of Amoxapine|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Demolox|T109|T121|TRD|NRW|ES|020730|abbcdef
ENTRY = Desmethylloxapine|T109|T121|NON|EQV|UNK (19XX)|810918|abbcdef
ENTRY = Dfanyl|T109|T121|TRD|NRW|FR|020730|abbcdef
ENTRY = Lederle Brand of Amoxapine|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Wyeth Brand of Amoxapine|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Amoxapine Cyanamid Brand
ENTRY = Amoxapine Lederle Brand
ENTRY = Amoxapine Wyeth Brand
ENTRY = CL 67,772
ENTRY = CL67,772
MN = D03.494.347.500.040
PA = Adrenergic Uptake Inhibitors
PA = Antidepressive Agents, Second-Generation
PA = Dopamine Antagonists
PA = Neurotransmitter Uptake Inhibitors
PA = Serotonin Uptake Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(1-piperazinyl)-
RN = R63VQ857OT
RR = 14028-44-5 (Amoxapine)
PI = Dibenzoxazepines (1971-1974)
PI = Piperazines (1971-1974)
MS = The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both. It also blocks dopamine receptors.
PM = 91; was see under DIBENZOXAZEPINES 1975-90
HN = 91(75); was see under DIBENZOXAZEPINES 1975-90
MR = 20130708
DA = 19741127
DC = 1
DX = 19910101
UI = D000657

*NEWRECORD
RECTYPE = D
MH = Amoxicillin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hydroxyampicillin|T109|T195|NON|EQV|UNK (19XX)|790223|abbcdef
ENTRY = Actimoxi|T109|T195|TRD|NRW|ES|031006|abbcdef
ENTRY = Amoxicillin Anhydrous|T109|T195|NON|NRW|FDA SRS (2014)|NLM (2014)|130617|abbcdeef
ENTRY = Amoxicillin Monopotassium Salt|T109|T195|NON|NRW|NLM (2014)|130222|abbcdef
ENTRY = Amoxicillin Monosodium Salt|T109|T195|NON|NRW|NLM (2014)|130222|abbcdef
ENTRY = Amoxicillin Sodium|T109|T195|NON|NRW|FDA SRS (2014)|NLM (2014)|USAN (19XX)|130617|abbcdeeef
ENTRY = Amoxicillin Trihydrate|T109|T195|NON|EQV|FDA SRS (2014)|NLM (2014)|130226|abbcdeef
ENTRY = Amoxicillin, (R*)-Isomer|T109|T195|NON|NRW|NLM (2014)|130222|abbcdef
ENTRY = Amoxicilline|T109|T195|NON|NRW|FDA SRS (2014)|INN (19XX)|941027|abbcdeef
ENTRY = Amoxil|T109|T195|TRD|NRW|UNK (19XX)|800918|abbcdef
ENTRY = Amoxycillin|T109|T195|NON|EQV|BAN (19XX)|741111|abbcdef
ENTRY = BRL-2333|T109|T195|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Clamoxyl|T109|T195|TRD|NRW|ES|FR|NL|910311|abbcdeeef
ENTRY = Clamoxyl G.A.|T109|T195|TRD|NRW|FR|031006|abbcdef
ENTRY = Clamoxyl parenteral|T109|T195|TRD|NRW|DE|031006|abbcdef
ENTRY = Clariana Brand of Amoxicillin|T109|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Penamox|T109|T195|TRD|NRW|MX|031006|abbcdef
ENTRY = Pfizer Brand of Amoxicillin Sodium Salt|T109|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Polymox|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = SmithKline Beecham Brand of Amoxicillin Sodium Salt|T109|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Trimox|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Wymox|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Amoxicillin Clariana Brand
ENTRY = Anhydrous, Amoxicillin
ENTRY = BRL 2333
ENTRY = BRL2333
ENTRY = G.A., Clamoxyl
ENTRY = Sodium, Amoxicillin
ENTRY = Trihydrate, Amoxicillin
ENTRY = parenteral, Clamoxyl
MN = D02.065.589.099.750.750.050.050
MN = D02.886.108.750.750.050.050
MN = D03.438.260.825.750.050.050
MN = D03.605.084.737.750.050.050
MN = D04.075.080.875.099.221.750.750.050.050
PA = Anti-Bacterial Agents
MH_TH = FDA SRS (2014)
MH_TH = USAN (1972)
MH_TH = USP (19XX)
ST = T109
ST = T195
RN = 804826J2HU
RR = 26787-78-0 (Amoxicillin)
RR = 26889-93-0 ((R*)-isomer)
RR = 34642-78-9 (mono-K salt)
RR = 544Y3D6MYH
RR = 61336-70-7 (Amoxicillin trihydrate)
RR = 9EM05410Q9
PI = Ampicillin (1975-1974)
PI = Penicillins (1972-1974)
MS = A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.
PM = 80; was see under AMPICILLIN 1975-79
HN = 80(75); was see under AMPICILLIN 1975-79
MR = 20130708
DA = 19741111
DC = 1
DX = 19800101
UI = D000658

*NEWRECORD
RECTYPE = D
MH = AMP Deaminase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = AMP Aminase|T116|T126|EQV|UNK (19XX)|741114|abbdef
PRINT ENTRY = Adenylate Deaminase|T116|T126|NON|EQV|UNK (19XX)|741114|abbcdef
ENTRY = 5'-AMP Deaminase|T116|T126|EQV|UNK (19XX)|810828|abbdef
ENTRY = AMP Aminohydrolase|T116|T126|EQV|UNK (19XX)|820302|abbdef
ENTRY = Myoadenylate Deaminase|T116|T126|NON|EQV|UNK (19XX)|810714|abbcdef
ENTRY = 5' AMP Deaminase
ENTRY = Aminase, AMP
ENTRY = Aminohydrolase, AMP
ENTRY = Deaminase, 5'-AMP
ENTRY = Deaminase, AMP
ENTRY = Deaminase, Adenylate
ENTRY = Deaminase, Myoadenylate
MN = D08.811.277.151.653.060
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = AMP aminohydrolase
RN = EC 3.5.4.6
PI = Adenosine Monophosphate (1974)
PI = Aminohydrolases (1974)
MS = An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6.
PM = 91; was see under NUCLEOTIDE DEAMINASES 1975-90
HN = 91(75); was see under NUCLEOTIDE DEAMINASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D000659

*NEWRECORD
RECTYPE = D
MH = Amphetamine
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Desoxynorephedrin|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
PRINT ENTRY = Levoamphetamine|T109|T121|NON|REL|UNK (19XX)|770311|abbcdef
PRINT ENTRY = Phenopromin|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
PRINT ENTRY = l-Amphetamine|T109|T121|NON|REL|UNK (19XX)|770311|AMPHETAMINE A L|abbcdefs
ENTRY = Amfetamine|T109|T121|NON|EQV|INN (19XX)|940811|abbcdef
ENTRY = Amphetamine Sulfate|T109|T121|NON|NRW|FDA SRS (2014)|USP (19XX)|940811|abbcdeef
ENTRY = Amphetamine Sulfate (2:1)|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Centramina|T109|T121|TRD|NRW|ES|020725|abbcdef
ENTRY = Fenamine|T109|T121|TRD|NRW|UNK (19XX)|830914|abbcdef
ENTRY = Miquel Brand of Amfetamine Sulfate|T109|T121|NON|NRW|NLM (2003)|020725|abbcdef
ENTRY = Mydrial|T109|T121|TRD|NRW|UNK (19XX)|810625|abbcdef
ENTRY = Phenamine|T109|T121|NON|EQV|UNK (19XX)|800804|abbcdef
ENTRY = Thyramine|T109|T121|TRD|NRW|UNK (19XX)|810625|abbcdef
ENTRY = levo-Amphetamine|T109|T121|NON|REL|NLM (1995)|940426|abbcdef
ENTRY = Sulfate, Amphetamine
ENTRY = l Amphetamine
ENTRY = levo Amphetamine
MN = D02.092.471.683.152.110
PA = Adrenergic Agents
PA = Adrenergic Uptake Inhibitors
PA = Central Nervous System Stimulants
PA = Dopamine Agents
PA = Dopamine Uptake Inhibitors
PA = Sympathomimetics
EC = analogs & derivatives:Amphetamines
MH_TH = BAN (19XX)
ST = T109
ST = T121
N1 = Benzeneethanamine, alpha-methyl-, (+-)-
RN = CK833KGX7E
RR = 300-62-9 (Amphetamine)
RR = 60-13-9 (Amphetamine Sulfate)
RR = 60-15-1 (Amphetamine)
RR = 6DPV8NK46S
AN = a specific chem: do not confuse with AMPHETAMINES; d-amphetamine = DEXTROAMPHETAMINE; N-methylamphetamine = METHAMPHETAMINE
MS = A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
MR = 20130708
DA = 19990101
DC = 1
UI = D000661

*NEWRECORD
RECTYPE = D
MH = Amphetamines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.092.471.683.152
FX = Appetite Depressants
FX = Central Nervous System Stimulants
MH_TH = NLM (1976)
ST = T109
RN = 0
AN = GEN or unspecified; prefer specifics; do not confuse with AMPHETAMINE, a specific chem; N-methylamphetamine = METHAMPHETAMINE
PI = Amphetamine (1966-1975)
MS = Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
PM = 76
HN = 76; was NON MESH before 1976
MR = 20040719
DA = 19750725
DC = 1
DX = 19760101
UI = D000662

*NEWRECORD
RECTYPE = D
MH = Amphibians
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Amphibia|T011|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Amphibian
MN = B01.050.150.900.090
FX = Amphibian Proteins
MH_TH = NLM (2002)
ST = T011
AN = general or unspecified; prefer specific available genera; NIM when experimental animal
MS = VERTEBRATES belonging to the class amphibia such as frogs, toads, newts and salamanders that live in a semiaquatic environment.
PM = 2009; see AMPHIBIA 1963-2008
HN = 2009 (1963)
MR = 20090706
DA = 19990101
DC = 1
UI = D000663

*NEWRECORD
RECTYPE = D
MH = Amphibian Venoms
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC EN GE HI IM IP ME PD PK PO RE SE TO TU UR
PRINT ENTRY = Frog Venoms|T123|T131|NON|NRW|UNK (19XX)|770418|abbcdef
PRINT ENTRY = Toad Venoms|T123|T131|NON|NRW|UNK (19XX)|770418|abbcdef
ENTRY = Amphibian Venom|T123|T131|NON|EQV|NLM (1999)|980217|abbcdef
ENTRY = Frog Venom|T123|T131|NON|NRW|NLM (1999)|980217|abbcdef
ENTRY = Toad Venom|T123|T131|NON|NRW|NLM (1999)|980217|abbcdef
ENTRY = Venom, Amphibian
ENTRY = Venom, Frog
ENTRY = Venom, Toad
ENTRY = Venoms, Amphibian
ENTRY = Venoms, Frog
ENTRY = Venoms, Toad
MN = D20.888.033
MN = D23.946.833.033
MH_TH = NLM (1978)
ST = T123
ST = T131
RN = 0
AN = /antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific amphibian (IM or NIM)
PI = Amphibia (1966-1977)
PI = Venoms (1966-1977)
MS = Venoms produced by frogs, toads, salamanders, etc. The venom glands are usually on the skin of the back and contain cardiotoxic glycosides, cholinolytics, and a number of other bioactive materials, many of which have been characterized. The venoms have been used as arrow poisons and include bufogenin, bufotoxin, bufagin, bufotalin, histrionicotoxins, and pumiliotoxin.
PM = 78
HN = 78
MR = 20050630
DA = 19770422
DC = 1
DX = 19780101
UI = D000664

*NEWRECORD
RECTYPE = D
MH = Ampholyte Mixtures
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Ampholines|T130|NON|EQV|UNK (19XX)|790227|abcdef
PRINT ENTRY = Carrier Ampholytes|T130|NON|EQV|UNK (19XX)|790227|abcdef
PRINT ENTRY = Isoelectric Focusing Agents|T130|NON|EQV|UNK (19XX)|790227|abcdef
ENTRY = Agents, Isoelectric Focusing
ENTRY = Ampholytes, Carrier
ENTRY = Focusing Agents, Isoelectric
ENTRY = Mixtures, Ampholyte
MN = D27.720.470.280.060
MH_TH = NLM (1980)
ST = T130
RN = 0
AN = buffers; D25-26 qualif
PI = Buffers (1966-1979)
PI = Isoelectric Focusing (1970-1979)
MS = Such mixtures of amphoteric electrolytes or buffers that provide a continuous range of pH in an electric field; used for separating proteins by their isoelectric points, i.e., by isoelectric focusing.
PM = 91; was see under BUFFERS 1980-90
HN = 91(80); was see under BUFFERS 1980-90
MR = 20030709
DA = 19790227
DC = 1
DX = 19910101
UI = D000665

*NEWRECORD
RECTYPE = D
MH = Amphotericin B
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amphocil|T109|T195|TRD|NRW|NLM (1998)|961206|abbcdef
ENTRY = Amphotericin|T109|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|820603|abbcdeef
ENTRY = Amphotericin B Cholesterol Dispersion|T109|T195|NON|NRW|NLM (1998)|961206|abbcdef
ENTRY = Amphotericin B Colloidal Dispersion|T109|T195|NON|NRW|NLM (1998)|961206|abbcdef
ENTRY = Fungizone|T109|T195|TRD|NRW|UNK (19XX)|801120|abbcdef
MN = D02.540.576.500.500
PA = Amebicides
PA = Anti-Bacterial Agents
PA = Antifungal Agents
PA = Antiprotozoal Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = Amphotericin B
RN = 7XU7A7DROE
RR = 1397-89-3 (Amphotericin B)
MS = Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
PM = 98; AMPHOCIL (now AMPHOTERICIN B) was indexed under AMPHOTERICIN B/*analogs & derivatives & CHOLESTEROL ESTERS 1992-97
HN = 98; for AMPHOCIL use AMPHOTERICIN B (NM) 1992-97
MR = 20150622
DA = 19990101
DC = 1
UI = D000666

*NEWRECORD
RECTYPE = D
MH = Ampicillin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Penicillin, Aminobenzyl|T109|T195|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Amcill|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Aminobenzylpenicillin|T109|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|831014|abbcdeef
ENTRY = Ampicillin Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1966)|USP (19XX)|941027|abbcdeeef
ENTRY = Ampicillin Trihydrate|T109|T195|NON|NRW|FDA SRS (2014)|UNK (19XX)|820519|abbcdeef
ENTRY = Antibiotic KS-R1|T109|T195|NON|NRW|NLM (2013)|120424|abbcdef
ENTRY = Omnipen|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Pentrexyl|T109|T195|TRD|NRW|UNK (19XX)|821123|abbcdef
ENTRY = Polycillin|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Ukapen|T109|T195|TRD|NRW|UNK (19XX)|840918|abbcdef
ENTRY = Aminobenzyl Penicillin
ENTRY = Antibiotic KS R1
ENTRY = KS-R1, Antibiotic
ENTRY = Sodium, Ampicillin
ENTRY = Trihydrate, Ampicillin
MN = D02.065.589.099.750.750.050
MN = D02.886.108.750.750.050
MN = D03.438.260.825.750.050
MN = D03.605.084.737.750.050
MN = D04.075.080.875.099.221.750.750.050
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = JAN (19XX)
MH_TH = USAN (1962)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-
RN = 7C782967RD
RR = 69-52-3 (mono-Na salt)
RR = 69-53-4 (Ampicillin)
RR = 7177-48-2 (trihydrate)
RR = HXQ6A1N7R6
RR = JFN36L5S8K
MS = Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
PM = 65
HN = 65(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D000667

*NEWRECORD
RECTYPE = D
MH = Ampicillin Resistance
AQ = DE EH GE IM PH RE
ENTRY = Ampicillin Resistances
ENTRY = Resistance, Ampicillin
ENTRY = Resistances, Ampicillin
MN = G06.099.225.500.600.050
MN = G06.225.347.500.600.050
MN = G07.690.773.984.269.347.500.600.050
MH_TH = NLM (1988)
ST = T032
PI = Ampicillin (1966-1987)
PI = Drug Resistance, Microbial (1966-1987)
MS = Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20150630
DA = 19870509
DC = 1
DX = 19880101
UI = D000668

*NEWRECORD
RECTYPE = D
MH = Amplifiers, Electronic
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
ENTRY = Amplifier, Electronic
ENTRY = Electronic Amplifier
ENTRY = Electronic Amplifiers
MN = E07.305.061
MH_TH = NLM (2009)
ST = T073
MS = Electronic devices that increase the magnitude of a signal's power level or current.
PM = 2009; see AMPLIFIERS 1967-2008
HN = 2009 (1967)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19730101
UI = D000669

*NEWRECORD
RECTYPE = D
MH = Amprolium
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amprol|T109|T121|TRD|NRW|UNK (19XX)|800515|abbcdef
ENTRY = Amprolium Chloride|T109|T121|NON|REL|FDA SRS (2015)|NLM (2016)|140805|abbcdeef
ENTRY = Amprolium Hydrochloride|T109|T121|NON|NRW|FDA SRS (2015)|NLM (2014)|130617|abbcdeef
ENTRY = Anticoccid|T109|T121|TRD|NRW|UNK (19XX)|800918|abbcdef
ENTRY = No-Socopharm Hydrochloride|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Nmaprol|T109|T121|TRD|NRW|FR|020730|abbcdef
ENTRY = Pyridinium, 1-((4-Amino-2-propyl-5-pyrimidinyl)methyl)-2-methyl-, Chloride (1:1)|T109|T121|NON|REL|FDA SRS (2015)|NLM (2014)|130617|abbcdeef
ENTRY = Chloride, Amprolium
ENTRY = Hydrochloride, Amprolium
ENTRY = Hydrochloride, No-Socopharm
ENTRY = No Socopharm Hydrochloride
MN = D03.383.725.676.152
PA = Coccidiostats
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
RN = H2T307KMZR
RR = 137-88-2
RR = 71M75T660B
RR = 95CO6N199Q
PI = Antiprotozoal Agents (1966-1971)
PI = Picolines (1966-1971)
MS = A veterinary coccidiostat that interferes with THIAMINE metabolism.
OL = use AMPROLIUM to search AMPROL 1975-81
PM = 91; was see under PICOLINES 1981-90; was AMPROL see under PICOLINES 1979-80 & see under PICOLINE/analogs & derivatives 1975-78
HN = 91(81); was see under PICOLINES 1981-90; was AMPROL see under PICOLINES 1979-80 & see under PICOLINE/analogs & derivatives 1975-78
MR = 20141014
DA = 19990101
DC = 1
DX = 19910101
UI = D000670

*NEWRECORD
RECTYPE = D
MH = Amputation
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Amputations
MN = E04.555.080
MH_TH = NLM (1966)
ST = T061
AN = a surg procedure: do not confuse with AMPUTATION, TRAUMATIC; do not use /util except by MeSH definition
MS = The removal of a limb or other appendage or outgrowth of the body. (Dorland, 28th ed)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D000671

*NEWRECORD
RECTYPE = D
MH = Amputation Stumps
AQ = AH BS IN IR MI PA PP PS RA RE RI SU US VE VI
ENTRY = Amputation Stump
ENTRY = Stump, Amputation
ENTRY = Stumps, Amputation
MN = A01.378.100
FX = Phantom Limb
MH_TH = NLM (1966)
ST = T020
AN = restrict to extremities: do not use for gastric stump ( = GASTRIC STUMP), appendiceal stump, ureteral stump, cervical stump & the like (indexed probably under relevant -ECTOMY or other surg term)
MS = The part of a limb or tail following amputation that is proximal to the amputated section.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D000672

*NEWRECORD
RECTYPE = D
MH = Amputation, Traumatic
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Amputations, Traumatic
ENTRY = Traumatic Amputation
ENTRY = Traumatic Amputations
MN = C26.062
FX = Replantation
MH_TH = NLM (1972)
ST = T037
AN = by accident or inj: do not confuse with AMPUTATION, a surg procedure; /surg: consider also REPLANTATION
PI = Amputation (1966-1971)
MS = Loss of a limb or other bodily appendage by accidental injury.
PM = 72
HN = 72
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19720101
UI = D000673

*NEWRECORD
RECTYPE = D
MH = Amputees
AQ = CL ED HI LJ PX RH SN
ENTRY = Amputee
MN = M01.150.100
MH_TH = NLM (1966)
ST = T101
AN = do not coord ARM (NIM) or LEG (NIM) unless specifically relevant
MR = 19920507
DA = 19990101
DC = 1
UI = D000674

*NEWRECORD
RECTYPE = D
MH = Ampyrone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aminoantipyrine|T109|T121|T130|NON|EQV|UNK (19XX)|790430|abbbcdef
ENTRY = 4-Amino-1,5-Dimethyl-2-Phenyl-3H-Pyrazolone|T109|T121|T130|NON|EQV|NLM (2004)|030131|abbbcdef
ENTRY = 4-Aminoantipyrine|T109|T121|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|800826|abbbcdeef
ENTRY = 4-Aminophenazone|T109|T121|T130|NON|EQV|NLM (1995)|930902|abbbcdef
ENTRY = 4 Amino 1,5 Dimethyl 2 Phenyl 3H Pyrazolone
ENTRY = 4 Aminoantipyrine
ENTRY = 4 Aminophenazone
MN = D03.383.129.539.850.077.025
PA = Anti-Inflammatory Agents, Non-Steroidal
PA = Indicators and Reagents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1980)
ST = T109
ST = T121
ST = T130
N1 = 3H-Pyrazol-3-one, 4-amino-1,2-dihydro-1,5-dimethyl-2-phenyl-
RN = 0M0B7474RA
RR = 83-07-8 (Ampyrone)
AN = an analgesic & non-steroidal anti-inflamm agent
PI = Antipyrine (1966-1974) /analogs & derivatives (1975-1979)
MS = A metabolite of AMINOPYRINE with analgesic and anti-inflammatory properties. It is used as a reagent for biochemical reactions producing peroxides or phenols. Ampyrone stimulates LIVER MICROSOMES and is also used to measure extracellular water.
PM = 91; was see under ANTIPYRINE 1980-90
HN = 91(80); was see under ANTIPYRINE 1980-90
MR = 20130708
DA = 19790430
DC = 1
DX = 19910101
UI = D000675

*NEWRECORD
RECTYPE = D
MH = Amrinone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5-Amino-(3,4'-bipyridine)-6(1H)-one|T109|T121|NON|EQV|NLM (1997)|950713|abbcdef
ENTRY = Amrinon|T109|T121|NON|EQV|NLM (1997)|950713|abbcdef
ENTRY = Cordemcura|T109|T121|TRD|NRW|DE|020731|abbcdef
ENTRY = Inocor|T109|T121|TRD|NRW|CA|FR|860616|abbcdeef
ENTRY = LAW Brand of Amrinone|T109|T121|NON|NRW|NLM (2003)|020731|abbcdef
ENTRY = Sanofi Brand of Amrinone Lactate|T109|T121|NON|NRW|NLM (2003)|020731|abbcdef
ENTRY = Sanofi Winthrop Brand of Amrinone|T109|T121|NON|NRW|NLM (2003)|020730|abbcdef
ENTRY = Sanofi Winthrop Brand of Amrinone Lactate|T109|T121|NON|NRW|NLM (2003)|020731|abbcdef
ENTRY = Win-40680|T109|T121|LAB|NRW|UNK (19XX)|860616|abbcdef
ENTRY = Wincoram|T109|T121|TRD|NRW|DE|ES|950713|abbcdeef
ENTRY = Amrinone LAW Brand
ENTRY = Win 40680
ENTRY = Win40680
MN = D02.092.080.085
MN = D03.383.725.050.085
PA = Calcium Channel Blockers
PA = Cardiotonic Agents
PA = Phosphodiesterase 3 Inhibitors
PA = Vasodilator Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1977)
ST = T109
ST = T121
N1 = (3,4'-Bipyridin)-6(1H)-one, 5-amino-
RN = JUT23379TN
RR = 60719-84-8 (Amrinone)
PI = Aminopyridines (1979-1986)
PI = Pyridines (1966-1978)
MS = A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
PM = 87
HN = 87
MR = 20130708
DA = 19860616
DC = 1
DX = 19870101
UI = D000676

*NEWRECORD
RECTYPE = D
MH = Amsacrine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = m-AMSA|T109|T121|ABB|EQV|UNK (19XX)|860603|AMSA M|abbcdefs
ENTRY = AMSA|T109|T121|ABB|EQV|UNK (19XX)|860603|abbcdef
ENTRY = AMSA P-D|T109|T121|TRD|NRW|CA|020731|abbcdef
ENTRY = Amsacrina|T109|T121|TRD|NRW|ES|020731|abbcdef
ENTRY = Amsidine|T109|T121|TRD|NRW|FR|NL|UK|860603|abbcdeeef
ENTRY = Amsidyl|T109|T121|TRD|NRW|AU|DE|860603|abbcdeef
ENTRY = Cain's Acridine|T109|T121|EPO|EQV|UNK (19XX)|860603|abbcdef
ENTRY = NSC-141549|T109|T121|LAB|NRW|UNK (19XX)|860603|abbcdef
ENTRY = NSC-156303|T109|T121|LAB|NRW|UNK (19XX)|860603|abbcdef
ENTRY = NSC-249992|T109|T121|LAB|NRW|UNK (19XX)|860603|abbcdef
ENTRY = SN-11841|T109|T121|LAB|NRW|NLM (1991)|900320|abbcdef
ENTRY = SN11841|T109|T121|LAB|NRW|UNK (19XX)|860603|abbcdef
ENTRY = meta-AMSA|T109|T121|EQV|UNK (19XX)|860603|abbdef
ENTRY = AMSA P D
ENTRY = AMSA PD
ENTRY = Cain Acridine
ENTRY = Cains Acridine
ENTRY = NSC 141549
ENTRY = NSC 156303
ENTRY = NSC 249992
ENTRY = NSC141549
ENTRY = NSC156303
ENTRY = NSC249992
ENTRY = SN 11841
ENTRY = meta AMSA
MN = D03.494.046.250.225
PA = Antineoplastic Agents
PA = Intercalating Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USAN (1980)
ST = T109
ST = T121
N1 = Methanesulfonamide, N-(4-(9-acridinylamino)-3-methoxyphenyl)-
RN = 00DPD30SOY
RR = 51264-14-3
PI = Acridines (1966-1979)
PI = Aminoacridines (1980-1986)
MS = An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
PM = 87
HN = 87
MR = 20141014
DA = 19860603
DC = 1
DX = 19870101
UI = D000677

*NEWRECORD
RECTYPE = D
MH = Amygdalin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Amygdaloside|T118|T121|NON|EQV|UNK (19XX)|750630|abbcdef
PRINT ENTRY = Mandelonitrile-beta-Gentiobioside|T118|T121|NON|EQV|UNK (19XX)|750630|MANDELONITRILE GENTIOBIOSIDE BETA|abbcdefs
ENTRY = Laetrile|T118|T121|TRD|NRW|NLM (1996)|940901|abbcdef
ENTRY = Neoamygdalin|T118|T121|NON|EQV|UNK (19XX)|830901|abbcdef
ENTRY = Mandelonitrile beta Gentiobioside
MN = D02.626.175
MN = D09.408.348.050
PA = Antineoplastic Agents, Phytogenic
MH_TH = FDA SRS (2014)
MH_TH = NLM (1976)
ST = T118
ST = T121
N1 = Benzeneacetonitrile, alpha-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-, (R)-
RN = 214UUQ9N0H
RR = 29883-15-6 (Amygdalin)
AN = /biosyn permitted if by plant
PI = Cyanides (1966-1967)
PI = Glycosides (1966-1975)
PI = Mandelic Acids (1966-1975)
PI = Nitriles (1968-1975)
MS = A cyanogenic glycoside found in the seeds of Rosaceae.
OL = use AMYGDALIN to search LAETRILE 1975-78
PM = 79; was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78;
HN = 79(76); was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78
MR = 20130708
DA = 19750723
DC = 1
DX = 19790101
UI = D000678

*NEWRECORD
RECTYPE = D
MH = Amygdala
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Amygdaloid Body|T023|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Amygdaloid Nuclear Complex|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Amygdaloid Nucleus|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Archistriatum|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Corpus Amygdaloideum|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Intercalated Amygdaloid Nuclei|T023|NON|NRW|NLM (2015)|140418|abcdef
ENTRY = Massa Intercalata|T023|NON|NRW|NLM (2015)|140418|abcdef
ENTRY = Nucleus Amygdalae|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Amygdalae, Nucleus
ENTRY = Amygdaloid Bodies
ENTRY = Amygdaloid Nuclear Complices
ENTRY = Amygdaloid Nuclei, Intercalated
ENTRY = Amygdaloid Nucleus, Intercalated
ENTRY = Amygdaloideum, Corpus
ENTRY = Amygdaloideums, Corpus
ENTRY = Archistriatums
ENTRY = Complex, Amygdaloid Nuclear
ENTRY = Complices, Amygdaloid Nuclear
ENTRY = Corpus Amygdaloideums
ENTRY = Intercalata, Massa
ENTRY = Intercalatas, Massa
ENTRY = Intercalated Amygdaloid Nucleus
ENTRY = Massa Intercalatas
ENTRY = Nuclear Complex, Amygdaloid
ENTRY = Nuclear Complices, Amygdaloid
ENTRY = Nuclei, Intercalated Amygdaloid
ENTRY = Nucleus, Amygdaloid
ENTRY = Nucleus, Intercalated Amygdaloid
MN = A08.186.211.464.090
MN = A08.186.211.730.885.287.249.152
MH_TH = UNK (19XX)
ST = T023
MS = Almond-shaped group of basal nuclei anterior to the INFERIOR HORN OF THE LATERAL VENTRICLE of the TEMPORAL LOBE. The amygdala is part of the limbic system.
PM = 2000(1966); see AMYGDALOID BODY 1966-1996; for AMYGDALA see AMYGDALOID BODY 1979-1999
HN = 2000(1966)
MR = 20140609
DA = 19990101
DC = 1
UI = D000679

*NEWRECORD
RECTYPE = D
MH = Amyl Nitrite
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Nitrite, Amyl
MN = D02.633.025
PA = Vasodilator Agents
MH_TH = USP (19XX)
ST = T109
ST = T121
RN = 8017-89-8
MS = A vasodilator that is administered by inhalation. It is also used recreationally due to its supposed ability to induce euphoria and act as an aphrodisiac.
MR = 20000621
DA = 19990101
DC = 1
UI = D000680

*NEWRECORD
RECTYPE = D
MH = Amylases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Diastase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Amylase|T116|T126|NON|EQV|UNK (19XX)|770127|abbcdef
MN = D08.811.277.450.066
MH_TH = NLM (1966)
ST = T116
ST = T126
RN = EC 3.2.1.-
AN = amylase isoenzymes: index under AMYLASES (IM) + ISOENZYMES (IM), not ISOAMYLASE; amylases/blood: consider HYPERAMYLASEMIA
MS = A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-.
OL = use AMYLASES to search AMYLASE 1966-77
PM = 78; was AMYLASE 1963-77
HN = 78; was AMYLASE 1963-77
MR = 20030709
DA = 19990101
DC = 1
UI = D000681

*NEWRECORD
RECTYPE = D
MH = Amyloid
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Amyloid Fibrils|T116|T123|NON|NRW|NLM (2005)|031104|abbcdef
ENTRY = Amyloid Substance|T116|T123|NON|EQV|NLM (2005)|031110|abbcdef
ENTRY = Fibrils, Amyloid
ENTRY = Substance, Amyloid
MN = D05.500.049
MN = D12.776.049
FX = Amyloidosis
MH_TH = NLM (1968)
ST = T116
ST = T123
RN = 0
AN = PLAQUE, AMYLOID is also available
MS = A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease.
OL = use AMYLOID to search AMYLOID SUBSTANCE 1966-67 (as Cat C heading)
PM = 68; was AMYLOID SUBSTANCE 1963-67
HN = 68; was AMYLOID SUBSTANCE 1963-67 (Cat C heading only 1966-67, Cat A heading only 1963-64)
MR = 20100625
DA = 19990101
DC = 1
DX = 19680101
UI = D000682

*NEWRECORD
RECTYPE = D
MH = Serum Amyloid P-Component
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Amyloid P Component|T116|T123|NON|EQV|NLM (1987)|990101|abbcdef
ENTRY = Amyloid P-Component, Serum
ENTRY = P Component, Amyloid
ENTRY = P-Component, Serum Amyloid
ENTRY = Serum Amyloid P Component
MN = D12.776.049.407.875
MN = D12.776.124.050.730
MN = D12.776.395.690
MH_TH = UNK (19XX)
ST = T116
ST = T123
RN = 0
AN = /biosyn /physiol permitted
PI = Amyloid (1966-1986)
MS = Amyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It is an acute phase protein, modulates immunologic responses, inhibits ELASTASE, and has been suggested as an indicator of LIVER DISEASE.
PM = 87
HN = 87
MR = 20100625
DA = 19860414
DC = 1
DX = 19870101
UI = D000683

*NEWRECORD
RECTYPE = D
MH = Serum Amyloid A Protein
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Amyloid Protein SAA|T116|T129|ACX|EQV|NLM (1979)|990101|abbcdef
PRINT ENTRY = Amyloid Serum Protein SAA|T116|T129|EQV|UNK (19XX)|780516|abbdef
PRINT ENTRY = Serum A Related Protein|T116|T129|NON|EQV|UNK (19XX)|780516|SERUM A RELAT PROTEIN|abbcdefv
ENTRY = Amyloid A Precursor|T116|T129|NON|EQV|NLM (2005)|abbcde
ENTRY = Amyloid A Protein|T116|T123|NON|REL|UNK (19XX)|780516|abbcdef
ENTRY = Amyloid A Protein-Related Serum Component|T116|T129|NON|EQV|UNK (19XX)|800917|AMYLOID A PROTEIN RELAT SERUM COMPONENT|abbcdefv
ENTRY = Amyloid Fibril Protein AA|T116|T123|ABX|REL|UNK (19XX)|780516|abbcdef
ENTRY = Amyloid Protein AA|T116|T123|ABX|REL|NLM (1979)|990101|abbcdef
ENTRY = Amyloid Protein AA Precursor|T116|T129|NON|EQV|NLM (2005)|abbcde
ENTRY = Amyloid-Related Serum Protein (SAA)|T116|T129|EQV|UNK (19XX)|800917|AMYLOID RELAT SERUM PROTEIN SAA|abbdefv
ENTRY = Serum Amyloid A|T116|T129|NON|EQV|NLM (2005)|abbcde
ENTRY = Serum Amyloid Protein A|T116|T129|NON|EQV|UNK (19XX)|780516|abbcdef
ENTRY = Amyloid A Protein Related Serum Component
MN = D12.776.049.407.750
MN = D12.776.124.050.725
MH_TH = NLM (2005)
ST = T116
ST = T129
RN = 0
PI = Amyloid (1966-1978)
PI = Blood Proteins (1966-1978)
MS = An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.
PM = 2005; see AMYLOID PROTEIN SAA 1987-2004; see AMYLOID 1979-1986; for AMYLOID PROTEIN AA see AMYLOID PROTEIN AA 1988-2004; AMYLOID PROTEIN AA PRECURSOR was indexed under AMYLOID PROTEIN AA & APOLIPOPROTEINS 1996-2004
HN = 2005(1979)
MR = 20130709
DA = 19780516
DC = 1
DX = 19870101
UI = D000685

*NEWRECORD
RECTYPE = D
MH = Amyloidosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Amyloidoses
MN = C18.452.845.500
FX = Amyloid
FX = Lymphoproliferative Disorders
FX = Paraproteinemias
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = coord IM with organ/dis precoord (IM); /genet: consider also AMYLOIDOSIS, HEREDITARY
MS = A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000686

*NEWRECORD
RECTYPE = D
MH = Amylopectin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D09.698.365.855.194
MH_TH = NLM (1974)
ST = T118
ST = T123
N1 = Amylopectin
RN = 9037-22-3
MS = A highly branched glucan in starch.
PM = 74
HN = 74
MR = 20040707
DA = 19990101
DC = 1
DX = 19740101
UI = D000687

*NEWRECORD
RECTYPE = D
MH = Amylose
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D09.698.365.855.361
MH_TH = NLM (1974)
ST = T118
N1 = Amylose
RN = 9005-82-7
MS = An unbranched glucan in starch.
PM = 74
HN = 74
MR = 20040707
DA = 19990101
DC = 1
DX = 19740101
UI = D000688

*NEWRECORD
RECTYPE = D
MH = Amyotrophic Lateral Sclerosis
DE = ALS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Lou Gehrig Disease|T047|EPO|EQV|GHR (2014)|NLM (2000)|991108|LOU GEHRIG DIS|abcdeefv
PRINT ENTRY = Motor Neuron Disease, Amyotrophic Lateral Sclerosis|T047|NON|EQV|GHR (2014)|NLM (2000)|991108|MOTOR NEURON DIS AMYOTROPHIC LATERAL SCLEROSIS|abcdeefv
ENTRY = ALS (Amyotrophic Lateral Sclerosis)|T047|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Amyotrophic Lateral Sclerosis With Dementia|T047|NON|REL|GHR (2014)|NLM (2000)|991108|abcdeef
ENTRY = Amyotrophic Lateral Sclerosis, Guam Form|T047|EPO|NRW|NLM (2000)|991108|abcdef
ENTRY = Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam|T047|EPO|NRW|NLM (2013)|130613|abcdef
ENTRY = Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1|T047|NON|NRW|NLM (2012)|111213|abcdef
ENTRY = Charcot Disease|T047|EPO|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Dementia With Amyotrophic Lateral Sclerosis|T047|NON|REL|GHR (2014)|NLM (2000)|991108|abcdeef
ENTRY = Gehrig's Disease|T047|EPO|EQV|NLM (1990)|890414|GEHRIGS DIS|abcdefv
ENTRY = Guam Disease|T047|EPO|NRW|NLM (2012)|ORD (2010)|101228|abcdeef
ENTRY = Guam Form of Amyotrophic Lateral Sclerosis|T047|EPO|NRW|NLM (2000)|991108|abcdef
ENTRY = Lou Gehrig's Disease|T047|EPO|EQV|NLM (1990)|890414|LOU GEHRIGS DIS|abcdefv
ENTRY = Lou-Gehrigs Disease|T047|EPO|EQV|NLM (2010)|ORD (2010)|090630|abcdeef
ENTRY = Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1
ENTRY = Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam
ENTRY = Disease, Guam
ENTRY = Disease, Lou-Gehrigs
ENTRY = Gehrig Disease
ENTRY = Gehrigs Disease
ENTRY = Sclerosis, Amyotrophic Lateral
MN = C10.228.854.139
MN = C10.574.562.250
MN = C10.574.950.050
MN = C10.668.467.250
MN = C18.452.845.800.050
MH_TH = BIOETHICS (1998)
MH_TH = GHR (2014)
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
MS = A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000690

*NEWRECORD
RECTYPE = D
MH = Anabasine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Neonicotine|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
MN = D03.132.066
MN = D03.383.621.050
PA = Insecticides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = Pyridine, 3-(2-piperidinyl)-, (S)-
RN = LMS11II2LO
RR = 494-52-0 (Anabasine)
PI = Alkaloids (1974)
PI = Piperidines (1969-1974)
PI = Pyridines (1973-1974)
MS = A piperidine botanical insecticide.
PM = 91; was see under PIPERIDINES 1975-90
HN = 91(75); was see under PIPERIDINES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000691

*NEWRECORD
RECTYPE = D
MH = Anaerobiosis
AQ = DE GE IM PH RE
ENTRY = Anaerobioses
MN = G02.111.087.050
MN = G02.149.115.050
MN = G03.495.146
MH_TH = NLM (1971)
ST = T040
AN = almost never IM
PI = Oxygen (1966-1970)
MS = The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
PM = 91; was see under METABOLISM 1971-90
HN = 91(71); was see under METABOLISM 1971-90
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D000693

*NEWRECORD
RECTYPE = D
MH = Anal Gland Neoplasms
DE = ANAL GLAND NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SC SE SU TH UL UR US VI
PRINT ENTRY = Circumanal Gland Neoplasms|T191|NON|EQV|UNK (19XX)|740329|CIRCUMANAL GLAND NEOPL|abcdefv
PRINT ENTRY = Perianal Gland Neoplasms|T191|NON|EQV|UNK (19XX)|740329|PERIANAL GLAND NEOPL|abcdefv
ENTRY = Neoplasms, Anal Gland|T191|NON|EQV|NLM (1992)|910617|NEOPL ANAL GLAND|abcdefv
ENTRY = Neoplasms, Circumanal Gland|T191|NON|EQV|NLM (1992)|910617|NEOPL CIRCUMANAL GLAND|abcdefv
ENTRY = Neoplasms, Perianal Gland|T191|NON|EQV|NLM (1992)|910617|NEOPL PERIANAL GLAND|abcdefv
ENTRY = Anal Gland Neoplasm
ENTRY = Circumanal Gland Neoplasm
ENTRY = Neoplasm, Anal Gland
ENTRY = Neoplasm, Circumanal Gland
ENTRY = Neoplasm, Perianal Gland
ENTRY = Perianal Gland Neoplasm
MN = C04.588.083
MN = C04.588.274.476.411.307.790.040.040
MN = C06.301.371.411.307.790.040.040
MN = C06.405.249.411.307.790.040.040
MN = C06.405.469.491.307.790.040.040
MN = C06.405.469.860.101.163.083
MN = C06.405.469.860.180.500.040.040
MN = C22.073
MH_TH = NLM (1968)
ST = T191
AN = coord IM with histol type of neopl (IM); do not confuse with ANUS NEOPLASMS; coord with ANAL SACS for anal sac neoplasms; don't forget check tag ANIMALS
PI = Anus Neoplasms (1966-1967)
MS = Tumors or cancer of the anal gland.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
DX = 19680101
UI = D000694

*NEWRECORD
RECTYPE = D
MH = Anal Sacs
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Anal Glands, Animal|T023|NON|EQV|NLM (2004)|030106|abcdef
ENTRY = Anal Gland, Animal
ENTRY = Anal Sac
MN = A13.073
MH_TH = NLM (1968)
ST = T023
AN = for neopl, coord with ANAL GLAND NEOPLASMS
PI = Anus (1966-1967)
PI = Carnivora (1966-1967)
MS = A pair of anal glands or sacs, located on either side of the ANUS, that produce and store a dark, foul-smelling fluid in carnivorous animals such as MEPHITIDAE and DOGS. The expelled fluid is used as a defensive repellent (in skunks) or a material to mark territory (in dogs).
PM = 68
HN = 68
MR = 20150623
DA = 19990101
DC = 1
DX = 19680101
UI = D000695

*NEWRECORD
RECTYPE = D
MH = Central Nervous System Stimulants
DE = CNS STIMULANTS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Analeptics|T121|NON|NRW|NLM (1995)|940505|abcdef
ENTRY = Analeptic Agents|T121|NON|NRW|NLM (1996)|950518|abcdef
ENTRY = Analeptic Drugs|T121|NON|NRW|NLM (1996)|950518|abcdef
ENTRY = Central Stimulants|T121|NON|EQV|UNK (19XX)|840501|abcdef
ENTRY = Agents, Analeptic
ENTRY = Drugs, Analeptic
ENTRY = Stimulants, Central
MN = D27.505.696.282
MN = D27.505.954.427.220
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specifics; consider also CENTRAL NERVOUS SYSTEM /drug eff & BRAIN /drug eff; DF: CNS STIMULANTS
MS = A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
OL = use CENTRAL NERVOUS SYSTEM STIMULANTS to search ANALEPTICS 1966-94
PM = 95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94
HN = 95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94
MR = 20050630
DA = 19990101
DC = 1
UI = D000697

*NEWRECORD
RECTYPE = D
MH = Analgesia
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Analgesias
MN = E03.091
FX = Pain
MH_TH = POPLINE (1978)
ST = T061
AN = do not use /util except by MeSH definition
MS = Methods of PAIN relief that may be used with or in place of ANALGESICS.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000698

*NEWRECORD
RECTYPE = D
MH = Pain Insensitivity, Congenital
DE = PAIN INSENSITIVITY CONGEN
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Analgesia, Congenital|T047|NON|EQV|NLM (1996)|940919|ANALGESIA CONGEN|abcdefv
PRINT ENTRY = Pain Indifference, Congenital|T047|NON|EQV|NLM (2000)|991108|PAIN INDIFFERENCE CONGEN|abcdefv
ENTRY = Channelopathy-Associated Insensitivity To Pain|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Congenital Analgesia|T047|NON|EQV|GHR (2014)|UNK (19XX)|740329|CONGEN ANALGESIA|abcdeefv
ENTRY = Congenital Indifference to Pain|T047|NON|EQV|GHR (2014)|NLM (2000)|991108|abcdeef
ENTRY = Congenital Insensitivity To Pain|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Congenital Pain Indifference|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Congenital Pain Insensitivity|T047|NON|EQV|UNK (19XX)|740329|CONGEN PAIN INSENSITIVITY|abcdefv
ENTRY = Insensitivity To Pain, Congenital|T047|NON|EQV|OMIM (2013)|121130|abcdef
ENTRY = Insensitivity, Congenital Pain|T047|NON|EQV|UNK (19XX)|740329|INSENSITIVITY CONGEN PAIN|abcdefv
ENTRY = Congenital Pain Indifferences
MN = C10.668.829.700
MN = C16.320.775
FX = Hereditary Sensory and Autonomic Neuropathies
FX = Pain
MH_TH = GHR (2014)
MH_TH = NLM (1964)
ST = T047
AN = congenital insensitivity to pain with anhidrosis = HSAN TYPE IV see NEUROPATHIES, HEREDITARY SENSORY AND AUTONOMIC; DF: PAIN INSENSITIVITY CONGEN
MS = A syndrome characterized by indifference to PAIN despite the ability to distinguish noxious from non-noxious stimuli. Absent corneal reflexes and INTELLECTUAL DISABILITY may be associated. Familial forms with autosomal recessive and autosomal dominant patterns of inheritance have been described. (Adams et al., Principles of Neurology, 6th ed, p1343)
OL = use PAIN INSENSITIVITY, CONGENITAL to search ANALGESIA, CONGENITAL 1966-95 (as Prov 1966-72)
PM = 96; was ANALGESIA, CONGENITAL 1973-95; PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95
HN = 96; was ANALGESIA, CONGENITAL 1964-95 (Prov 1964-72); PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D000699

*NEWRECORD
RECTYPE = D
MH = Analgesics
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Anodynes|T121|NON|EQV|UNK (19XX)|781215|abcdef
PRINT ENTRY = Antinociceptive Agents|T123|NON|REL|UNK (19XX)|770421|abcdef
ENTRY = Analgesic Agents|T121|NON|EQV|NLM (1996)|941130|abcdef
ENTRY = Analgesic Drugs|T121|NON|EQV|NLM (1996)|941130|abcdef
ENTRY = Agents, Analgesic
ENTRY = Drugs, Analgesic
MN = D27.505.696.663.850.014
MN = D27.505.954.427.040
FX = Anesthetics
FX = Pain
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = general or unspecified; prefer specific groups
MS = Compounds capable of relieving pain without the loss of CONSCIOUSNESS.
OL = use ANALGESICS to search ANALGESICS AND ANTIPYRETICS 1966-77
PM = 78; ANALGESICS AND ANTIPYRETICS was heading 1963-77
HN = 78; ANALGESICS AND ANTIPYRETICS was heading 1963-77
MR = 20140625
DA = 19990101
DC = 1
UI = D000700

*NEWRECORD
RECTYPE = D
MH = Analgesics, Opioid
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Opioid Analgesics|T121|NON|EQV|NLM (1995)|940131|abcdef
PRINT ENTRY = Opioids|T121|T131|NON|NRW|NLM (1993)|920502|abbcdef
ENTRY = Full Opioid Agonists|T121|NON|NRW|NLM (2015)|130909|abcdef
ENTRY = Opioid Full Agonists|T121|NON|NRW|NLM (2015)|130909|abcdef
ENTRY = Opioid Mixed Agonist-Antagonists|T121|NON|NRW|NLM (2015)|140623|abcdef
ENTRY = Opioid Partial Agonists|T121|NON|NRW|NLM (2015)|130909|abcdef
ENTRY = Partial Opioid Agonists|T121|NON|NRW|NLM (2015)|130909|abcdef
ENTRY = Agonist-Antagonists, Opioid Mixed
ENTRY = Agonists, Full Opioid
ENTRY = Agonists, Opioid Full
ENTRY = Agonists, Opioid Partial
ENTRY = Agonists, Partial Opioid
ENTRY = Full Agonists, Opioid
ENTRY = Mixed Agonist-Antagonists, Opioid
ENTRY = Opioid Agonists, Full
ENTRY = Opioid Agonists, Partial
ENTRY = Opioid Mixed Agonist Antagonists
ENTRY = Partial Agonists, Opioid
MN = D27.505.696.277.600.500
MN = D27.505.696.663.850.014.760.500
MN = D27.505.954.427.040.550.500
MN = D27.505.954.427.210.600.500
FX = Opioid-Related Disorders
MH_TH = NLM (1975)
ST = T121
RN = 0
PI = Analgesics (1966-1974)
MS = Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.
OL = use ANALGESICS, OPIOID to search ANALGESICS, ADDICTIVE 1975-94
PM = 95; was ANALGESICS, ADDICTIVE 1975-94
HN = 95; was ANALGESICS, ADDICTIVE 1975-94
MR = 20140623
DA = 19990101
DC = 1
DX = 19750101
UI = D000701

*NEWRECORD
RECTYPE = D
MH = Analog-Digital Conversion
ENTRY = Analogue-Digital Conversion|T066|NON|EQV|NLM (1994)|931007|abcdef
ENTRY = Analog Digital Conversion
ENTRY = Analog-Digital Conversions
ENTRY = Analogue Digital Conversion
ENTRY = Analogue-Digital Conversions
ENTRY = Conversion, Analog-Digital
ENTRY = Conversion, Analogue-Digital
ENTRY = Conversions, Analog-Digital
ENTRY = Conversions, Analogue-Digital
MN = L01.224.230.260.280.080
MH_TH = NLM (1964)
ST = T066
AN = no qualif
MS = The process of converting analog data such as continually measured voltage to discrete, digital form.
PM = 73
HN = 73(64)
MR = 20040707
DA = 19990101
DC = 1
DX = 19730101
UI = D000703

*NEWRECORD
RECTYPE = D
MH = Analysis of Variance
DE = ANAL VARIANCE
PRINT ENTRY = ANOVA|T081|ABB|EQV|NLM (1990)|890509|abcdef
ENTRY = Analysis, Variance|T081|NON|EQV|UNK (19XX)|860101|abcdef
ENTRY = Variance Analysis|T081|NON|EQV|UNK (19XX)|860101|VARIANCE ANAL|abcdefv
ENTRY = Analyses, Variance
ENTRY = Variance Analyses
MN = E05.318.740.150
MN = N05.715.360.750.125
MN = N06.850.520.830.150
MH_TH = NLM (1968)
ST = T081
AN = IM GEN only; coord NIM with specific disease or other concept (IM); no qualif
PI = Statistics (1966-1967)
MS = A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
PM = 74
HN = 74(68)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19740101
UI = D000704

*NEWRECORD
RECTYPE = D
MH = Anaphase
AQ = DE GE IM PH RE
ENTRY = Anaphases
MN = G04.299.134.220.220.687.222
MN = G04.299.134.220.220.781.050
MN = G05.355.105.220.687.250
MN = G05.355.105.220.781.050
MH_TH = NLM (1978)
ST = T079
AN = coordinate with specific cell /cytol; permitted with microorganisms
PI = Cell Division (1966-1977)
PI = Meiosis (1968-1977)
PI = Mitosis (1968-1977)
MS = The phase of cell nucleus division following METAPHASE, in which the CHROMATIDS separate and migrate to opposite poles of the spindle.
PM = 81; was see under CELL CYCLE 1978-80
HN = 81(78); was see under CELL CYCLE 1978-80
CATSH = CAT LIST
MR = 20150701
DA = 19770510
DC = 1
DX = 19810101
UI = D000705

*NEWRECORD
RECTYPE = D
MH = Anaphylatoxins
AQ = AD AG AI AN BI CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK RE SE TU UR
ENTRY = Anaphylatoxin|T116|T123|T131|NON|NRW|NLM (1990)|890418|abbbcdef
MN = D12.776.124.486.274.024
PA = Immunologic Factors
MH_TH = NLM (1977)
ST = T116
ST = T123
ST = T131
RN = 0
PI = Complement (1968-1976)
PI = Peptide Fragments (1974-1976)
PI = Peptides (1966-1976)
PI = specific complement (1975-1976)
MS = Serum peptides derived from certain cleaved COMPLEMENT PROTEINS during COMPLEMENT ACTIVATION. They induce smooth MUSCLE CONTRACTION; mast cell HISTAMINE RELEASE; PLATELET AGGREGATION; and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from the strongest to the weakest is C5a, C3a, C4a, and C5a des-arginine.
PM = 90; was see under PEPTIDES 1977-89
HN = 90(77); was see under PEPTIDES 1977-89
MR = 20150331
DA = 19760519
DC = 1
DX = 19900101
UI = D000706

*NEWRECORD
RECTYPE = D
MH = Anaphylaxis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anaphylactic Reaction|T047|NON|EQV|NLM (1998)|960725|abcdef
PRINT ENTRY = Shock, Anaphylactic|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Anaphylactic Reactions
ENTRY = Anaphylactic Shock
ENTRY = Reaction, Anaphylactic
ENTRY = Reactions, Anaphylactic
MN = C20.543.480.099
FX = SRS-A
MH_TH = NLM (1966)
ST = T047
MS = An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D000707

*NEWRECORD
RECTYPE = D
MH = Anaplasia
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Anaplasias
MN = C04.697.045
MN = C23.550.727.045
MH_TH = NLM (1977)
ST = T191
AN = IM GEN only; coord NIM with organ /pathol (IM); note CARCINOMA, ANAPLASTIC see CARCINOMA: do not coord with ANAPLASIA unless anaplasia is particularly discussed
MS = Loss of structural differentiation and useful function of neoplastic cells.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 20030709
DA = 19760519
DC = 1
DX = 19770101
UI = D000708

*NEWRECORD
RECTYPE = D
MH = Anaplasma
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.040.050
MN = B03.660.050.020.050
MH_TH = NLM (1966)
ST = T007
AN = infection = ANAPLASMOSIS
MS = A genus of gram-negative bacteria whose organisms are obligate parasites of vertebrates. Species are transmitted by arthropod vectors with the host range limited to ruminants. Anaplasma marginale is the most pathogenic species and is the causative agent of severe bovine anaplasmosis.
MR = 20090706
DA = 19990101
DC = 1
UI = D000709

*NEWRECORD
RECTYPE = D
MH = Anaplasmataceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Ehrlichieae|T007|NON|EQV|NLM (1992)|990101|abcdef
MN = B03.440.040
MN = B03.660.050.020
MH_TH = NLM (1975)
ST = T007
AN = infection = ANAPLASMATACEAE INFECTIONS
PI = Bacteria (1966-1974)
MS = A family of bacteria which inhabit RED BLOOD CELLS and cause several animal diseases.
PM = 1975
HN = 1975
MR = 20090706
DA = 19990101
DC = 1
DX = 19750101
UI = D000710

*NEWRECORD
RECTYPE = D
MH = Anaplasmataceae Infections
DE = ANAPLASMATACEAE INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Haemobartonellosis|T047|NON|NRW|UNK (19XX)|790104|abcdef
ENTRY = Infections, Anaplasmataceae|T047|NON|EQV|NLM (1992)|910228|INFECT ANAPLASMATACEAE|abcdefv
ENTRY = Anaplasmataceae Infection
ENTRY = Haemobartonelloses
ENTRY = Infection, Anaplasmataceae
MN = C01.252.400.054
MH_TH = NLM (1977)
ST = T047
AN = rickettsial infect
PI = Anaplasmosis (1966-1976)
PI = Rickettsial Infections (1975-1976)
MS = Infections with bacteria of the family ANAPLASMATACEAE.
OL = use ANAPLASMATACEAE INFECTIONS to search HAEMOBARTONELLOSIS 1977-79
PM = 77; HAEMOBARTONELLOSIS was heading 1977-79
HN = 77; HAEMOBARTONELLOSIS was heading 1977-79
CATSH = CAT LIST
MR = 20030709
DA = 19760427
DC = 1
DX = 19770101
UI = D000711

*NEWRECORD
RECTYPE = D
MH = Anaplasmosis
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Anaplasmoses
MN = C01.252.400.054.050
MN = C01.252.400.825.050
MN = C22.085
MH_TH = NLM (1966)
ST = T047
AN = tick-borne dis; usually animal; check tag ANIMALS
MS = A disease of cattle caused by parasitization of the red blood cells by bacteria of the genus ANAPLASMA.
PM = 68
HN = 68(66)
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
DX = 19680101
UI = D000712

*NEWRECORD
RECTYPE = D
MH = Anastomosis, Roux-en-Y
DE = ROUX EN Y
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Roux-en-Y Anastomosis|T061|NON|EQV|UNK (19XX)|870318|abcdef
PRINT ENTRY = Roux-en-Y Diversion|T061|NON|EQV|UNK (19XX)|870318|abcdef
PRINT ENTRY = Roux-en-Y Loop|T061|NON|EQV|UNK (19XX)|870318|abcdef
ENTRY = Anastomoses, Roux-en-Y
ENTRY = Anastomosis, Roux en Y
ENTRY = Diversion, Roux-en-Y
ENTRY = Diversions, Roux-en-Y
ENTRY = Loop, Roux-en-Y
ENTRY = Loops, Roux-en-Y
ENTRY = Roux en Y Anastomosis
ENTRY = Roux en Y Diversion
ENTRY = Roux en Y Loop
ENTRY = Roux-en-Y Anastomoses
ENTRY = Roux-en-Y Diversions
ENTRY = Roux-en-Y Loops
MN = E04.035.070
MN = E04.210.070
MH_TH = NLM (1988)
ST = T061
AN = coordinate with specific organ /surg; do not routinely add as a coordinate with GASTRIC BYPASS; DF: ROUX EN Y
PI = specific digestive system organ or disease/surgery (1966-1987)
MS = A Y-shaped surgical anastomosis of any part of the digestive system which includes the small intestine as the eventual drainage site.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20060705
DA = 19870318
DC = 1
DX = 19880101
UI = D000713

*NEWRECORD
RECTYPE = D
MH = Anastomosis, Surgical
DE = ANASTOMOSIS SURG
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Surgical Anastomosis|T061|NON|EQV|UNK (19XX)|870316|SURG ANASTOMOSIS|abcdefv
ENTRY = Anastomoses, Surgical
ENTRY = Surgical Anastomoses
MN = E04.035
FX = Anastomotic Leak
MH_TH = NLM (1988)
ST = T061
AN = NIM with specific organ /surg (IM); do not use /util except by MeSH definition; DF: ANASTOMOSIS SURG
PI = organ/disease/surgery (1966-1987)
PI = specific surgical technique (1966-1987)
MS = Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20100625
DA = 19870316
DC = 1
DX = 19880101
UI = D000714

*NEWRECORD
RECTYPE = D
MH = Anatomy
DE = ANAT
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Anatomies
MN = H01.158.100
FX = Dissection
MH_TH = NLM (1984)
ST = T091
AN = the discipline only (education, history, etc); for anatomical structures, use the qualifier / anat with specific anatomical terms or organisms
MS = A branch of biology dealing with the structure of organisms.
MR = 20130709
DA = 19990101
DC = 1
UI = D000715

*NEWRECORD
RECTYPE = D
MH = Anatomy, Artistic
DE = ANAT ARTISTIC
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Artistic Anatomy|T091|T170|NON|EQV|UNK (19XX)|860101|ARTISTIC ANAT|abbcdefv
ENTRY = Anatomies, Artistic
ENTRY = Artistic Anatomies
MN = H01.158.100.091
MN = K01.093.410.100
MH_TH = NLM (1966)
ST = T091
ST = T170
AN = use for the discipline (education, history, etc) only; anatomical atlases go under ATLASES AS TOPIC (IM) + ANATOMY, ARTISTIC (IM)
MS = The study of the structures of organisms for applications in art: drawing, painting, sculpture, illustration, etc.
MR = 20090706
DA = 19990101
DC = 1
UI = D000716

*NEWRECORD
RECTYPE = D
MH = Anatomy, Comparative
DE = ANAT COMPARATIVE
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Comparative Anatomy|T091|NON|EQV|UNK (19XX)|860101|COMPARATIVE ANAT|abcdefv
ENTRY = Anatomies, Comparative
ENTRY = Comparative Anatomies
MN = H01.158.100.154
MH_TH = NLM (1966)
ST = T091
AN = SPEC: IM, SPEC qualif; do not check COMPARATIVE STUDY for, as a field, it is not a substitute for a comparison of two or more anatomical concepts ( = COMPARATIVE STUDY tag); Manual 18.13.4: relation to COMPARATIVE STUDY
MS = The comparative study of animal structure with regard to homologous organs or parts. (Stedman, 25th ed)
MR = 20080708
DA = 19990101
DC = 1
UI = D000717

*NEWRECORD
RECTYPE = D
MH = Anatomy, Regional
DE = ANAT REGIONAL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Regional Anatomy|T090|NON|EQV|UNK (19XX)|860101|REGIONAL ANAT|abcdefv
ENTRY = Anatomies, Regional
ENTRY = Regional Anatomies
MN = H01.158.100.216
MH_TH = NLM (1966)
ST = T090
AN = the discipline only (education, history, etc); for anatomical structures, use the qualifier / anat with specific organ or organism
MS = The anatomical study of specific regions or parts of organisms, emphasizing the relationship between the various structures (e.g. muscles, nerves, skeletal, cardiovascular, etc.).
MR = 20090706
DA = 19990101
DC = 1
UI = D000718

*NEWRECORD
RECTYPE = D
MH = Anatomy, Veterinary
DE = ANAT VET
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Veterinary Anatomy|T091|NON|EQV|NLM (1990)|890501|VET ANAT|abcdefv
ENTRY = Anatomies, Veterinary
ENTRY = Veterinary Anatomies
MN = H01.158.100.279
MH_TH = NLM (1966)
ST = T091
AN = use for the discipline (education, history, etc) only
MS = The study of the anatomical structures of animals.
MR = 20090706
DA = 19990101
DC = 1
UI = D000719

*NEWRECORD
RECTYPE = D
MH = Ancillary Services, Hospital
DE = ANCILLARY SERV HOSP
AQ = CL EC ES HI LJ MA OG SD SN ST TD UT
PRINT ENTRY = Hospital Ancillary Services|T058|NON|EQV|UNK (19XX)|830610|HOSP ANCILLARY SERV|abcdefv
PRINT ENTRY = Services, Hospital Ancillary|T058|NON|EQV|NLM (1996)|940811|SERV HOSP ANCILLARY|abcdefv
ENTRY = Ancillary Service, Hospital
ENTRY = Hospital Ancillary Service
ENTRY = Service, Hospital Ancillary
MN = N02.278.216.500.500
MN = N04.452.442.060
MH_TH = NLM (1984)
ST = T058
AN = DF: ANCILLARY SERV HOSP
MS = Those support services other than room, board, and medical and nursing services that are provided to hospital patients in the course of care. They include such services as laboratory, radiology, pharmacy, and physical therapy services.
PM = 91; was see under HOSPITAL ADMINISTRATION 1984-90
HN = 91(84); was see under HOSPITAL ADMINISTRATION 1984-90
MR = 20150622
DA = 19830610
DC = 1
DX = 19910101
UI = D000720

*NEWRECORD
RECTYPE = D
MH = Ancrod
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Agkistrodon Serine Proteinase|T116|T121|T126|NON|EQV|NLM (1991)|900320|abbbcdef
PRINT ENTRY = Agkistrodon rhodostoma Venom Protease|T116|T121|T126|NON|EQV|NLM (1991)|900320|abbbcdef
ENTRY = Arvin|T116|T121|T126|TRD|NRW|CA|ES|UK|950122|abbbcdeeef
ENTRY = Arvin IRC-50|T116|T121|T126|TRD|NRW|NLM (1975)|900320|abbbcdef
ENTRY = Arwin|T116|T121|T126|TRD|NRW|DE|861003|abbbcdef
ENTRY = Berk Brand of Ancrod|T116|T121|T126|NON|NRW|NLM (2003)|020731|abbbcdef
ENTRY = Knoll Brand of Ancrod|T116|T121|T126|NON|NRW|NLM (2003)|020731|abbbcdef
ENTRY = Venacil|T116|T121|T126|TRD|NRW|NLM (1991)|900320|abbbcdef
ENTRY = Ancrod Berk Brand
ENTRY = Ancrod Knoll Brand
ENTRY = Arvin IRC 50
ENTRY = Arvin IRC50
MN = D08.811.277.656.300.760.955.060
MN = D08.811.277.656.959.350.955.060
MN = D20.888.850.960.200.050
MN = D23.946.833.850.960.200.050
PA = Anticoagulants
PA = Fibrinolytic Agents
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = USAN (1975)
ST = T116
ST = T121
ST = T126
RN = EC 3.4.21.-
RR = 9046-56-4 (CAS RN)
PI = Peptide Hydrolases (1972-1974)
PI = Peptide Peptidohydrolases (1966-1974)
PI = Venoms (1972-1974)
MS = An enzyme fraction from the venom of the Malayan pit viper, Agkistrodon rhodostoma. It catalyzes the hydrolysis of a number of amino acid esters and a limited proteolysis of fibrinogen. It is used clinically to produce controlled defibrination in patients requiring anticoagulant therapy. EC 3.4.21.-.
OL = use ANCROD to search ARVIN 1975-77
PM = 78; was ARVIN see under PEPTIDE PEPTIDOHYDROLASES 1975-77; ARVIN was see ANCROD 1978-95
HN = 78; was ARVIN see under ENDOPEPTIDASES 1975-77; ARVIN was see ANCROD 1978-95
MR = 20090706
DA = 19741111
DC = 1
DX = 19780101
UI = D000721

*NEWRECORD
RECTYPE = D
MH = Ancylostoma
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Ancylostoma caninum|T204|NON|NRW|NLM (1993)|911108|abcdef
PRINT ENTRY = Ancylostoma duodenale|T204|NON|NRW|UNK (19XX)|780127|abcdef
PRINT ENTRY = Hookworm, Old World|T204|NON|NRW|UNK (19XX)|780127|abcdef
ENTRY = Ancylostoma caninums
ENTRY = Ancylostoma duodenales
ENTRY = Ancylostomas
ENTRY = Hookworms, Old World
ENTRY = Old World Hookworm
ENTRY = Old World Hookworms
ENTRY = World Hookworm, Old
ENTRY = World Hookworms, Old
ENTRY = caninum, Ancylostoma
ENTRY = caninums, Ancylostoma
ENTRY = duodenale, Ancylostoma
ENTRY = duodenales, Ancylostoma
MN = B01.050.500.500.294.700.775.100.100
MH_TH = NLM (1966)
ST = T204
AN = a genus of nematodes; infection = ANCYLOSTOMIASIS; coord with specific pre-coordinated helminth terms (e.g., ANTIGENS, HELMINTH) if pertinent
MS = A genus of nematode intestinal parasites that consists of several species. A. duodenale is the common hookworm in humans. A. braziliense, A. ceylonicum, and A. caninum occur primarily in cats and dogs, but all have been known to occur in humans.
OL = use ANCYLOSTOMA to search UNCINARIA DUODENALE 1979-92
PM = ANCYLOSTOMA DUODENALE was UNCINARIA DUODENALE 1979-92
HN = ANCYLOSTOMA DUODENALE was UNCINARIA DUODENALE 1979-92
MR = 20090706
DA = 19990101
DC = 1
UI = D000722

*NEWRECORD
RECTYPE = D
MH = Ancylostomatoidea
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Bunostomum|T204|NON|NRW|UNK (19XX)|850321|abcdef
PRINT ENTRY = Hookworms|T204|NON|EQV|UNK (19XX)|850321|abcdef
PRINT ENTRY = Uncinaria stenocephala|T204|NON|NRW|UNK (19XX)|780127|abcdef
ENTRY = Ancylostomatoideas
ENTRY = Bunostomums
ENTRY = Hookworm
ENTRY = Uncinaria stenocephalas
ENTRY = stenocephala, Uncinaria
ENTRY = stenocephalas, Uncinaria
MN = B01.050.500.500.294.700.775.100
MH_TH = NLM (1966)
ST = T204
AN = a superfamily of nematodes (hookworms): HOOKWORM, NEW WORLD see NECATOR & HOOKWORM, OLD WORLD see ANCYLOSTOMA are available; infection = HOOKWORM INFECTIONS but see note under ANCYLOSTOMA; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
MS = A superfamily of nematode parasitic hookworms consisting of four genera: ANCYLOSTOMA; NECATOR; Bunostomum; and Uncinaria. ANCYLOSTOMA and NECATOR occur in humans and other mammals. Bunostomum is common in ruminants and Uncinaria in wolves, foxes, and dogs.
OL = use ANCYLOSTOMATOIDEA to search HOOKWORMS 1966-85
PM = 86; was HOOKWORMS 1963-85
HN = 86; was HOOKWORMS 1963-85
MR = 20090730
DA = 19990101
DC = 1
UI = D000723

*NEWRECORD
RECTYPE = D
MH = Ancylostomiasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Ancylostomiases
MN = C03.335.508.700.775.455.154
MH_TH = NLM (1968)
ST = T047
AN = hookworm infect; Ancylostoma americanum infection = NECATORIASIS, not ANCYLOSTOMIASIS
PI = Hookworm Infections (1966-1967)
MS = Infection of humans or animals with hookworms of the genus ANCYLOSTOMA. Characteristics include anemia, dyspepsia, eosinophilia, and abdominal swelling.
OL = search HOOKWORM INFECTIONS 1966-67
PM = 68; was see under HOOKWORM INFECTION 1963-67
HN = 68; was see under HOOKWORM INFECTION 1963-67
CATSH = CAT LIST
MR = 19930604
DA = 19990101
DC = 1
DX = 19680101
UI = D000724

*NEWRECORD
RECTYPE = D
MH = Andorra
AQ = EH EP
MN = Z01.542.049
MH_TH = POPLINE (1983)
ST = T083
AN = a country lying between France & Spain
MS = A principality in the Pyrenees between France and Spain. Its capital is also called Andorra. (From Webster's New Geographical Dictionary, 1988, p50)
MR = 19950217
DA = 19990101
DC = 4
UI = D000725

*NEWRECORD
RECTYPE = D
MH = Androgen Antagonists
DE = ANDROGEN ANTAG
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antiandrogens|T121|NON|EQV|UNK (19XX)|770517|abcdef
ENTRY = Anti-Androgen Effect|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Anti-Androgen Effects|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Antiandrogen Effect|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Antiandrogen Effects|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Antagonists, Androgen
ENTRY = Anti Androgen Effect
ENTRY = Anti Androgen Effects
ENTRY = Effect, Anti-Androgen
ENTRY = Effect, Antiandrogen
ENTRY = Effects, Anti-Androgen
ENTRY = Effects, Antiandrogen
MN = D06.347.065
MN = D27.505.696.399.450.065
MH_TH = NLM (1978)
ST = T121
RN = 0
AN = note entry term ANTI-ANDROGEN EFFECT: use only for the antiandrogen effect of a chemical substance
PI = Androgens (1966-1977)
PI = specific androgen (1966-1977)
MS = Compounds which inhibit or antagonize the biosynthesis or actions of androgens.
PM = 78
HN = 78
MR = 20140625
DA = 19770517
DC = 1
DX = 19780101
UI = D000726

*NEWRECORD
RECTYPE = D
MH = Androgen-Binding Protein
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Androgen Binding Protein|T116|T123|NON|EQV|UNK (19XX)|790625|abbcdef
ENTRY = Binding Protein, Androgen
ENTRY = Protein, Androgen Binding
ENTRY = Protein, Androgen-Binding
MN = D12.776.157.065
FX = Sex Hormone-Binding Globulin
MH_TH = NLM (1980)
ST = T116
ST = T123
RN = 0
PI = Carrier Proteins (1971-1979)
PI = Proteins (1966-1970)
PI = Receptors, Androgen (1977-1979)
PI = Receptors, Endogenous Substances (1973-1976)
MS = Carrier proteins produced in the Sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. They participate in the transport of androgens. Androgen-binding protein has the same amino acid sequence as SEX HORMONE-BINDING GLOBULIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.
PM = 2000; see ANDROGEN-BINDING PROTEINS 1986-1999, see CARRIER PROTEINS 1980-85
HN = 2000(1980)
MR = 20050729
DA = 19790523
DC = 1
DX = 19860101
UI = D000727

*NEWRECORD
RECTYPE = D
MH = Androgens
AQ = AD AE AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Androgen Effect|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Androgen Effects|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Androgen Receptor Agonists|T121|T125|NON|EQV|NLM (2011)|100421|abbcdef
ENTRY = Androgenic Agents|T121|T125|NON|EQV|NLM (2004)|030512|abbcdef
ENTRY = Androgenic Compounds|T121|T125|NON|EQV|NLM (2004)|030512|abbcdef
ENTRY = Agents, Androgenic
ENTRY = Agonists, Androgen Receptor
ENTRY = Compounds, Androgenic
ENTRY = Effect, Androgen
ENTRY = Effects, Androgen
ENTRY = Receptor Agonists, Androgen
MN = D27.505.696.399.472.161
FX = Androgen Antagonists
FX = Receptors, Androgen
EC = antagonists & inhibitors:Androgen Antagonists
MH_TH = NLM (1963)
ST = T121
ST = T125
RN = 0
AN = deficiency: consider also HYPOGONADISM & other gonadal disorders; note entry term ANDROGEN EFFECT: use only for the androgen effect of a chemical substance
MS = Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
PM = 1963
HN = 1963
MR = 20140625
DA = 19990101
DC = 1
UI = D000728

*NEWRECORD
RECTYPE = D
MH = Androstadienes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.054.079.129
MH_TH = NLM (1975)
ST = T110
RN = 0
MS = Derivatives of the steroid androstane having two double bonds at any site in any of the rings.
OL = search ANDROSTENES 1973-74
PM = 75; was see under ANDROSTENES 1973-74
HN = 75; was see under ANDROSTENES 1973-74
MR = 19930603
DA = 19990101
DC = 1
DX = 19750101
UI = D000730

*NEWRECORD
RECTYPE = D
MH = Androstanes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.054
MH_TH = NLM (1968)
ST = T110
RN = 0
AN = do not confuse with ANDROSTENES
MS = The family of steroids from which the androgens are derived.
PM = 68
HN = 68
MR = 19930603
DA = 19990101
DC = 1
DX = 19680101
UI = D000731

*NEWRECORD
RECTYPE = D
MH = Androstanols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hydroxyandrostanes|T110|NON|EQV|UNK (19XX)|790523|abcdef
MN = D04.808.054.040
MH_TH = NLM (1980)
ST = T110
RN = 0
AN = do not confuse with ANDROSTENOLS
PI = Androstanes (1968-1979)
PI = Hydroxysteroids (1972-1979)
PI = Steroids (1966-1967)
MS = Androstanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups.
PM = 80
HN = 80
MR = 19930603
DA = 19790523
DC = 1
DX = 19800101
UI = D000732

*NEWRECORD
RECTYPE = D
MH = Androstatrienes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.054.079.229
MH_TH = NLM (1975)
ST = T110
RN = 0
MS = Derivatives of the steroid androstane having three double bonds at any site in any of the rings.
OL = search ANDROSTENES 1973-74
PM = 75; was see under ANDROSTENES 1973-74
HN = 75; was see under ANDROSTENES 1973-74
MR = 19930603
DA = 19990101
DC = 1
DX = 19750101
UI = D000733

*NEWRECORD
RECTYPE = D
MH = Androstenediols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.054.079.429.154
MH_TH = NLM (1975)
ST = T110
RN = 0
AN = do not confuse with ANDROSTANE-3,17-DIOL
PI = Androstenes (1973)
PI = Androstenols (1974)
MS = Unsaturated androstane derivatives which are substituted with two hydroxy groups in any position in the ring system.
OL = search ANDROSTENOLS 1974 & ANDROSTENES 1973
PM = 75; was see under ANDROSTENOLS 1974; was see under ANDROSTENES 1973
HN = 75; was see under ANDROSTENOLS 1974; was see under ANDROSTENES 1973
MR = 20060705
DA = 19990101
DC = 1
DX = 19750901
UI = D000734

*NEWRECORD
RECTYPE = D
MH = Androstenedione
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = 4-Androstene-3,17-dione|T110|T125|NON|EQV|FDA SRS (2014)|UNK (19XX)|800825|abbcdeef
ENTRY = delta-4-Androstenedione|T110|T125|NON|EQV|UNK (19XX)|830916|abbcdef
ENTRY = 4 Androstene 3,17 dione
ENTRY = delta 4 Androstenedione
MN = D04.808.054.079.329
MN = D04.808.578.502.112
MN = D06.472.040.502.112
MN = D06.472.334.851.968.875
MH_TH = FDA SRS (2014)
MH_TH = NLM (1974)
ST = T110
ST = T125
N1 = Androst-4-ene-3,17-dione
RN = 409J2J96VR
RR = 63-05-8 (Androstenedione)
MS = A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.
PM = 74
HN = 74(73)
MR = 20140606
DA = 19990101
DC = 1
DX = 19740101
UI = D000735

*NEWRECORD
RECTYPE = D
MH = Androstenes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.054.079
MH_TH = NLM (1973)
ST = T110
RN = 0
AN = do not confuse with ANDROSTANES
PI = Androstanes (1968-1972)
MS = Unsaturated derivatives of the steroid androstane containing at least one double bond at any site in any of the rings.
PM = 73
HN = 73
MR = 19930603
DA = 19990101
DC = 1
DX = 19730101
UI = D000736

*NEWRECORD
RECTYPE = D
MH = Androstenols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hydroxyandrostenes|T110|NON|EQV|UNK (19XX)|740329|abcdef
MN = D04.808.054.079.429
MH_TH = NLM (1967)
ST = T110
RN = 0
AN = do not confuse with ANDROSTANOLS
MS = Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system.
OL = use ANDROSTENOLS to search ANDROSTENOL 1966-73 (as Prov)
PM = 74
HN = 74; was ANDROSTENOL 1963-73 (Prov)
MR = 19920507
DA = 19990101
DC = 1
DX = 19740101
UI = D000737

*NEWRECORD
RECTYPE = D
MH = Androsterone
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = 3-alpha-Hydroxy-5-alpha-Androstan-17-One|T110|T125|NON|EQV|NLM (2004)|021126|abbcdef
ENTRY = 5 alpha-Androstan-3 alpha-ol-17-one|T110|T125|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = Epiandrosterone|T110|T125|NON|REL|FDA SRS (2014)|UNK (19XX)|830901|abbcdeef
ENTRY = 3 alpha Hydroxy 5 alpha Androstan 17 One
ENTRY = 5 alpha Androstan 3 alpha ol 17 one
MN = D04.808.054.040.129
MN = D04.808.578.502.195
MN = D06.472.040.502.195
MN = D06.472.334.851.968.937
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T110
ST = T125
N1 = Androstan-17-one, 3-hydroxy-, (3alpha,5alpha)-
RN = C24W7J5D5R
RR = 53-41-8 (Androsterone)
RR = 8TR252Z538
MS = A metabolite of TESTOSTERONE or ANDROSTENEDIONE with a 3-alpha-hydroxyl group and without the double bond. The 3-beta hydroxyl isomer is epiandrosterone.
MR = 20130708
DA = 19990101
DC = 1
UI = D000738

*NEWRECORD
RECTYPE = D
MH = Anecdotes as Topic
ENTRY = Anecdotes as Topics
MN = K01.517.067
FX = Narration
MH_TH = NLM (2008)
ST = T170
AN = do not confuse with Publication Type ANECDOTES
MS = Brief accounts or narratives of an incident or event.
PM = 19662008; see ANECDOTES 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D000739

*NEWRECORD
RECTYPE = D
MH = Anemia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anemias
MN = C15.378.071
FX = Hepcidins
MH_TH = NLM (1994)
ST = T047
AN = GEN or unspecified; prefer specifics
MS = A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000740

*NEWRECORD
RECTYPE = D
MH = Anemia, Aplastic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anemia, Hypoplastic|T047|NON|REL|NLM (1992)|910109|abcdef
ENTRY = Aplastic Anemia|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Anemias, Aplastic
ENTRY = Anemias, Hypoplastic
ENTRY = Aplastic Anemias
ENTRY = Hypoplastic Anemia
ENTRY = Hypoplastic Anemias
MN = C15.378.071.085
MN = C15.378.190.196
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = a bone marrow dis
MS = A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D000741

*NEWRECORD
RECTYPE = D
MH = Anemia, Dyserythropoietic, Congenital
DE = ANEMIA DYSERYTHROPOIETIC CONGEN
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Dyserythropoietic Anemia, Congenital|T047|NON|EQV|UNK (19XX)|790423|DYSERYTHROPOIETIC ANEMIA CONGEN|abcdefv
PRINT ENTRY = HEMPAS|T047|ABB|NRW|OMIM (2013)|UNK (19XX)|810515|abcdeef
ENTRY = Anemia With Multinucleated Erythroblasts|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Anemia, Congenital Dyserythropoietic|T047|NON|EQV|UNK (19XX)|790423|ANEMIA CONGEN DYSERYTHROPOIETIC|abcdefv
ENTRY = Anemia, Congenital Dyserythropoietic, Type II|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Anemia, Dyserythropoietic Congenital, Type I|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Anemia, Dyserythropoietic Congenital, Type II|T047|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Anemia, Dyserythropoietic Congenital, Type III|T047|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Anemia, Dyserythropoietic, Congenital Type 1|T047|NON|NRW|NLM (2010)|ORD (2010)|090527|abcdeef
ENTRY = Anemia, Dyserythropoietic, Congenital Type 2|T047|NON|NRW|NLM (2010)|ORD (2010)|090527|abcdeef
ENTRY = Anemia, Dyserythropoietic, Congenital, Type I|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Anemia, Dyserythropoietic, Congenital, Type II|T047|NON|NRW|NLM (1991)|900124|abcdef
ENTRY = Anemia, Dyserythropoietic, Congenital, Type III|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Congenital Dyserythropoietic Anemia|T047|NON|EQV|GHR (2014)|UNK (19XX)|790423|CONGEN DYSERYTHROPOIETIC ANEMIA|abcdeefv
ENTRY = Congenital Dyserythropoietic Anemia Type 1|T047|NON|NRW|NLM (2010)|ORD (2010)|090527|abcdeef
ENTRY = Congenital Dyserythropoietic Anemia Type II|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Congenital Dyserythropoietic Anemia, Type I|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Congenital Dyserythropoietic Anemia, Type III|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Dyserythropoietic Anemia, Congenital Type 1|T047|NON|NRW|NLM (2010)|ORD (2010)|090527|abcdeef
ENTRY = Dyserythropoietic Anemia, Congenital Type 2|T047|NON|NRW|NLM (2010)|ORD (2010)|090527|abcdeef
ENTRY = Dyserythropoietic Anemia, Congenital, Type I|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Dyserythropoietic Anemia, Congenital, Type II|T047|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Dyserythropoietic Anemia, Congenital, Type III|T047|NON|NRW|OMIM (2013)|120606|abcdef
ENTRY = Dyserythropoietic Anemia, HEMPAS Type|T047|ABX|NRW|NLM (2010)|OMIM (2013)|ORD (2010)|090527|abcdeeef
ENTRY = HEMPAS Anemia|T047|ABX|NRW|NLM (2010)|090527|abcdef
ENTRY = Hereditary Erythroblast Multinuclearity with Positive Acidified Serum|T047|NON|NRW|NLM (2006)|050425|abcdef
ENTRY = Hereditary Erythroblastic Multinuclearity with Positive Acidified-Serum Test|T047|NON|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101206|abcdeeef
ENTRY = Type I Congenital Dyserythropoietic Anemia|T047|NON|NRW|NLM (2010)|ORD (2010)|090527|abcdeef
ENTRY = Anemias, Congenital Dyserythropoietic
ENTRY = Congenital Dyserythropoietic Anemias
ENTRY = Dyserythropoietic Anemias, Congenital
ENTRY = HEMPAS Anemias
MN = C15.378.071.141.150.095
MN = C16.320.070.095
MH_TH = GHR (2014)
MH_TH = NLM (1980)
ST = T047
PI = Anemia (1966-1979)
PI = Erythropoiesis (1966-1979)
MS = A familial disorder characterized by ANEMIA with multinuclear ERYTHROBLASTS, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors (ERYTHROID PRECURSOR CELLS). Type II is the most common of the 3 types; it is often referred to as HEMPAS, based on the Hereditary Erythroblast Multinuclearity with Positive Acidified Serum test.
PM = 1991; see ANEMIA, HEMOLYTIC, CONGENITAL 1980-1990
HN = 1991(1980); use ANEMIA, HEMOLYTIC, CONGENITAL 1980-1990
CATSH = CAT LIST
MR = 20130708
DA = 19790423
DC = 1
DX = 19910101
UI = D000742

*NEWRECORD
RECTYPE = D
MH = Anemia, Hemolytic
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anemia, Hemolytic, Acquired|T047|NON|NRW|UNK (19XX)|810519|abcdef
PRINT ENTRY = Anemia, Microangiopathic|T047|NON|NRW|UNK (19XX)|810519|abcdef
PRINT ENTRY = Hemolytic Anemia|T047|NON|EQV|NLM (2008)|060809|abcdef
ENTRY = Hemolytic Anemia, Acquired|T047|NON|NRW|NLM (1992)|910617|abcdef
ENTRY = Microangiopathic Hemolytic Anemia|T047|NON|NRW|GHR (2014)|NLM (2012)|OMIM (2013)|ORD (2010)|101202|abcdeeeef
ENTRY = Acquired Hemolytic Anemia
ENTRY = Anemia, Acquired Hemolytic
ENTRY = Microangiopathic Anemia
MN = C15.378.071.141
EC = congenital:Anemia, Hemolytic, Congenital
MH_TH = NLM (1966)
ST = T047
AN = general or unspecified: prefer specifics
MS = A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
PM = ANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67; ; for MICROANGIOPATHIC HEMOLYTIC ANEMIA see PURPURA, THROMBOTIC THROMBOCYTOPENIC 2012
HN = ANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67; for MICROANGIOPATHIC HEMOLYTIC ANEMIA use PURPURA, THROMBOTIC THROMBOCYTOPENIC 2012
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000743

*NEWRECORD
RECTYPE = D
MH = Anemia, Hemolytic, Autoimmune
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anemia, Hemolytic, Idiopathic Acquired|T047|NON|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Autoimmune Hemolytic Anemia|T047|NON|EQV|NLM (2006)|ORD (2010)|050426|abcdeef
PRINT ENTRY = Cold Agglutinin Disease|T047|NON|NRW|ORD (2010)|UNK (19XX)|810515|COLD AGGLUTININ DIS|abcdeefv
PRINT ENTRY = Hemolytic Anemia, Autoimmune|T047|NON|EQV|NLM (2006)|050511|abcdef
ENTRY = Acquired Autoimmune Hemolytic Anemia|T047|NON|NRW|NLM (2010)|ORD (2010)|090512|abcdeef
ENTRY = Anemia, Hemolytic, Cold Antibody|T047|NON|NRW|NLM (2012)|ORD (2010)|101202|abcdeef
ENTRY = Cold Antibody Disease|T047|NON|NRW|NLM (2012)|ORD (2010)|101202|abcdeef
ENTRY = Cold Antibody Hemolytic Anemia|T047|NON|NRW|NLM (2012)|ORD (2010)|101202|abcdeef
ENTRY = Idiopathic Autoimmune Hemolytic Anemia|T047|NON|NRW|NLM (2010)|ORD (2010)|090512|abcdeef
ENTRY = Agglutinin Disease, Cold
ENTRY = Agglutinin Diseases, Cold
ENTRY = Anemia, Autoimmune Hemolytic
ENTRY = Anemias, Autoimmune Hemolytic
ENTRY = Autoimmune Hemolytic Anemias
ENTRY = Cold Agglutinin Diseases
ENTRY = Cold Antibody Diseases
ENTRY = Disease, Cold Agglutinin
ENTRY = Disease, Cold Antibody
ENTRY = Diseases, Cold Agglutinin
ENTRY = Diseases, Cold Antibody
ENTRY = Hemolytic Anemias, Autoimmune
MN = C15.378.071.141.125
MN = C20.111.175
MH_TH = NLM (1968)
MH_TH = ORD (2010)
ST = T047
MS = Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.
PM = 1968; see ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-1967
HN = 1968; use ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-1967
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
DX = 19680101
UI = D000744

*NEWRECORD
RECTYPE = D
MH = Anemia, Hemolytic, Congenital
DE = ANEMIA HEMOLYTIC CONGEN
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anemia, Hemolytic, Hereditary|T047|NON|EQV|NLM (1998)|960716|abcdef
ENTRY = Congenital Hemolytic Anemia|T047|NON|EQV|NLM (1991)|ORD (2010)|900524|CONGEN HEMOLYTIC ANEMIA|abcdeefv
ENTRY = Hemolytic Anemia, Congenital|T047|NON|EQV|NLM (1991)|900524|HEMOLYTIC ANEMIA CONGEN|abcdefv
ENTRY = Hemolytic Anemia, Hereditary|T047|NON|EQV|NLM (1998)|960716|abcdef
ENTRY = Hereditary Hemolytic Anemia|T047|NON|EQV|NLM (1998)|960716|abcdef
ENTRY = Anemia, Congenital Hemolytic
ENTRY = Anemia, Hereditary Hemolytic
ENTRY = Anemias, Congenital Hemolytic
ENTRY = Anemias, Hereditary Hemolytic
ENTRY = Congenital Hemolytic Anemias
ENTRY = Hemolytic Anemias, Congenital
ENTRY = Hemolytic Anemias, Hereditary
ENTRY = Hereditary Hemolytic Anemias
MN = C15.378.071.141.150
MN = C16.320.070
MH_TH = NLM (1968)
ST = T047
MS = Hemolytic anemia due to various intrinsic defects of the erythrocyte.
OL = use ANEMIA, HEMOLYTIC, CONGENITAL to search ANEMIA, CONGENITAL HEMOLYTIC 1966-67
PM = 68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64; ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC was heading 1968-81, was ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1965-67
HN = 68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D000745

*NEWRECORD
RECTYPE = D
MH = Anemia, Hemolytic, Congenital Nonspherocytic
DE = ANEMIA HEMOL CONGEN NONSPHER
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anemia, Congenital Nonspherocytic Hemolytic|T047|NON|EQV|NLM (1991)|900427|ANEMIA CONGEN NONSPHEROCYTIC HEMOLYTIC|abcdefv
ENTRY = Anemia, Hemolytic Congenital, Nonspherocytic|T047|NON|EQV|UNK (19XX)|790323|ANEMIA HEMOLYTIC CONGEN NONSPHEROCYTIC|abcdefv
ENTRY = Congenital Nonspherocytic Hemolytic Anemia|T047|NON|EQV|NLM (1991)|900427|CONGEN NONSPHEROCYTIC HEMOLYTIC ANEMIA|abcdefv
ENTRY = Hemolytic Anemia, Congenital Nonspherocytic|T047|NON|EQV|NLM (1991)|900427|HEMOLYTIC ANEMIA CONGEN NONSPHEROCYTIC|abcdefv
MN = C15.378.071.141.150.100
MN = C16.320.070.100
MH_TH = NLM (1968)
ST = T047
AN = do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; DF: ANEMIA HEMOL CONGEN NONSPHER
MS = Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. Common causes include deficiencies in GLUCOSE-6-PHOSPHATE ISOMERASE; PYRUVATE KINASE; and GLUCOSE-6-PHOSPHATE DEHYDROGENASE.
OL = use ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC to search ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1966-67
PM = 91,68; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1982-90; was heading 1968-81; was ANEMIA, CONGENITAL NONSPHEROCYTIC HEMOLYTIC 1965-67
HN = 91(82)68; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1982-90; was heading 1968-81; was ANEMIA, CONGENITAL NONSPHEROCYTIC HEMOLYTIC 1965-67
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
DX = 19680101
UI = D000746

*NEWRECORD
RECTYPE = D
MH = Anemia, Hypochromic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Chlorosis|T047|NON|NRW|UNK (19XX)|880518|abcdef
ENTRY = Anemias, Hypochromic
ENTRY = Chloroses
ENTRY = Hypochromic Anemia
ENTRY = Hypochromic Anemias
MN = C15.378.071.196
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
AN = note X ref; ANEMIA, IRON-DEFICIENCY is also available
MS = Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D000747

*NEWRECORD
RECTYPE = D
MH = Anemia, Macrocytic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anemias, Macrocytic
ENTRY = Macrocytic Anemia
ENTRY = Macrocytic Anemias
MN = C15.378.071.252
FX = FIGLU Test
MH_TH = NLM (1966)
ST = T047
MS = Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).
CATSH = CAT LIST
MR = 19900529
DA = 19990101
DC = 1
UI = D000748

*NEWRECORD
RECTYPE = D
MH = Anemia, Megaloblastic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anemias, Megaloblastic
ENTRY = Megaloblastic Anemia
ENTRY = Megaloblastic Anemias
MN = C15.378.071.252.196
FX = Megaloblasts
MH_TH = NLM (1975)
MH_TH = ORD (2010)
ST = T047
MS = A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.
OL = search ANEMIA, MACROCYTIC 1966-74
PM = 91; was see under ANEMIA, MACROCYTIC 1975-90
HN = 91(75); was see under ANEMIA, MACROCYTIC 1975-90
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19910101
UI = D000749

*NEWRECORD
RECTYPE = D
MH = Anemia, Myelophthisic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anemia, Leukoerythroblastic|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Anemias, Leukoerythroblastic
ENTRY = Anemias, Myelophthisic
ENTRY = Leukoerythroblastic Anemia
ENTRY = Leukoerythroblastic Anemias
ENTRY = Myelophthisic Anemia
ENTRY = Myelophthisic Anemias
MN = C15.378.071.307
MN = C15.378.190.636.085
MH_TH = NLM (1966)
ST = T047
MS = Anemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue.
CATSH = CAT LIST
MR = 19910613
DA = 19990101
DC = 1
UI = D000750

*NEWRECORD
RECTYPE = D
MH = Anemia, Neonatal
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anemia Neonatorum|T047|NON|EQV|NLM (1994)|930524|abcdef
ENTRY = Anemias, Neonatal
ENTRY = Neonatal Anemia
ENTRY = Neonatal Anemias
MN = C15.378.071.363
MN = C16.614.053
MH_TH = NLM (1968)
ST = T047
AN = do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; check the tag INFANT, NEWBORN
PI = Anemia (1966-1967)
PI = Infant, Newborn, Diseases (1966-1967)
MS = The mildest form of erythroblastosis fetalis in which anemia is the chief manifestation.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
DX = 19680101
UI = D000751

*NEWRECORD
RECTYPE = D
MH = Anemia, Pernicious
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Addison's Anemia|T047|EPO|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Anemia, Addison's|T047|EPO|EQV|UNK (19XX)|740329|abcdef
ENTRY = Pernicious Anemia|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Addison Anemia
ENTRY = Addisons Anemia
ENTRY = Anemia, Addison
ENTRY = Anemia, Addisons
MN = C15.378.071.252.196.500
MN = C18.654.521.500.133.699.923.280
FX = Schilling Test
MH_TH = NLM (1966)
ST = T047
AN = a type of megaloblastic anemia
MS = A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D000752

*NEWRECORD
RECTYPE = D
MH = Anemia, Refractory
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Refractory Anemia|T047|NON|EQV|UNK (19XX)|850606|abcdef
ENTRY = Anemias, Refractory
ENTRY = Refractory Anemias
MN = C15.378.071.400
MN = C15.378.190.625.062
MH_TH = NLM (1986)
ST = T047
PI = Anemia, Aplastic (1966-1985)
MS = A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy.
OL = search ANEMIA, APLASTIC 1975-85
PM = 86; was see ANEMIA, APLASTIC 1975-85
HN = 86; was see ANEMIA, APLASTIC 1975-85
CATSH = CAT LIST
MR = 19910624
DA = 19850606
DC = 1
DX = 19860101
UI = D000753

*NEWRECORD
RECTYPE = D
MH = Anemia, Refractory, with Excess of Blasts
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Leukemia, Smoldering|T047|NON|EQV|NLM (2006)|050729|abcdef
PRINT ENTRY = RAEB|T047|ABB|EQV|UNK (19XX)|850606|abcdef
PRINT ENTRY = RAEM|T047|ABB|EQV|UNK (19XX)|850606|abcdef
PRINT ENTRY = Refractory Anemia with Excess of Blasts|T047|NON|EQV|UNK (19XX)|850606|abcdef
ENTRY = Leukemia, Smouldering|T047|NON|EQV|UNK (19XX)|850606|abcdef
ENTRY = Leukemias, Smoldering
ENTRY = Smoldering Leukemia
ENTRY = Smoldering Leukemias
ENTRY = Smouldering Leukemia
MN = C15.378.071.400.080
MN = C15.378.190.625.062.080
MH_TH = NLM (1986)
ST = T047
PI = Anemia, Aplastic (1966-1985)
MS = Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.
PM = 86
HN = 86
CATSH = CAT LIST
MR = 20050729
DA = 19850606
DC = 1
DX = 19860101
UI = D000754

*NEWRECORD
RECTYPE = D
MH = Anemia, Sickle Cell
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Hemoglobin S Disease|T047|NON|EQV|GHR (2014)|NLM (1998)|ORD (2010)|960730|HEMOGLOBIN S DIS|abcdeeefv
ENTRY = HbS Disease|T047|NON|EQV|GHR (2014)|NLM (2014)|130501|abcdeef
ENTRY = Sickle Cell Anemia|T047|NON|EQV|BIOETHICS (1974)|NLM (1992)|OMIM (2013)|ORD (2010)|900905|abcdeeeef
ENTRY = Sickle Cell Disease|T047|NON|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090514|abcdeeef
ENTRY = Sickle Cell Disorders|T047|NON|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090514|abcdeeef
ENTRY = Sickling Disorder Due to Hemoglobin S|T047|NON|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090514|abcdeeef
ENTRY = Anemias, Sickle Cell
ENTRY = Cell Disease, Sickle
ENTRY = Cell Diseases, Sickle
ENTRY = Cell Disorder, Sickle
ENTRY = Cell Disorders, Sickle
ENTRY = Disease, Hemoglobin S
ENTRY = Hemoglobin S Diseases
ENTRY = Sickle Cell Anemias
ENTRY = Sickle Cell Diseases
ENTRY = Sickle Cell Disorder
MN = C15.378.071.141.150.150
MN = C15.378.420.155
MN = C16.320.070.150
MN = C16.320.365.155
FX = Antisickling Agents
MH_TH = NLM (1966)
ST = T047
AN = PL 92-294: Natl Sickle Cell Anemia Control Act; sickle cell dis goes here unless specifically HEMOGLOBIN SC DISEASE or HEMOGLOBIN C DISEASE or SICKLE CELL TRAIT or THALASSEMIA; /drug ther: consider also ANTISICKLING AGENTS
MS = A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D000755

*NEWRECORD
RECTYPE = D
MH = Anemia, Sideroblastic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anemias, Sideroblastic
ENTRY = Sideroblastic Anemia
ENTRY = Sideroblastic Anemias
MN = C15.378.071.419
MN = C15.378.190.625.070
MH_TH = NLM (1963)
ST = T047
MS = Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.
OL = use ANEMIA, SIDEROBLASTIC to search ANEMIA, SIDEROBLASTIC REFRACTORY 1966 (as Prov 1966)
PM = 67
HN = 67; was ANEMIA, SIDEROBLASTIC REFRACTORY 1963-66 (Prov 1966)
CATSH = CAT LIST
MR = 19900329
DA = 19990101
DC = 1
DX = 19670101
UI = D000756

*NEWRECORD
RECTYPE = D
MH = Anencephaly
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aprosencephaly|T019|NON|NRW|GHR (2014)|NLM (2000)|991103|abcdeef
ENTRY = Absence of Brain, Congenital|T019|NON|EQV|NLM (2000)|991103|ABSENCE OF BRAIN CONGEN|abcdefv
ENTRY = Anencephalia|T019|NON|EQV|GHR (2014)|NLM (2000)|991103|abcdeef
ENTRY = Anencephalus|T019|NON|EQV|GHR (2014)|ORD (2010)|UNK (19XX)|771202|abcdeeef
ENTRY = Congenital Absence of Brain|T019|NON|EQV|GHR (2014)|NLM (2000)|991103|CONGEN ABSENCE OF BRAIN|abcdeefv
ENTRY = Hemicranial Anencephaly|T019|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Incomplete Anencephaly|T019|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Partial Anencephaly|T019|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Anencephalias
ENTRY = Anencephalies, Partial
ENTRY = Anencephaly, Hemicranial
ENTRY = Anencephaly, Incomplete
ENTRY = Anencephaly, Partial
ENTRY = Aprosencephalies
ENTRY = Brain Congenital Absence
ENTRY = Partial Anencephalies
MN = C10.500.680.196
MN = C16.131.085.197
MN = C16.131.666.680.196
FX = alpha-Fetoproteins
MH_TH = BIOETHICS (1988)
MH_TH = GHR (2014)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T019
MS = A malformation of the nervous system caused by failure of the anterior neuropore to close. Infants are born with intact spinal cords, cerebellums, and brainstems, but lack formation of neural structures above this level. The skull is only partially formed but the eyes are usually normal. This condition may be associated with folate deficiency. Affected infants are only capable of primitive (brain stem) reflexes and usually do not survive for more than two weeks. (From Menkes, Textbook of Child Neurology, 5th ed, p247)
OL = use ANENCEPHALY to search ANENCEPHALUS 1966-78
PM = 79; was ANENCEPHALUS 1966-78
HN = 79; was ANENCEPHALUS 1964-78 (Prov 1964-65)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D000757

*NEWRECORD
RECTYPE = D
MH = Anesthesia
AQ = AE CL CT EC ES HI MO MT NU PX SN ST TD UT VE
MN = E03.155
EC = education:Anesthesiology:education
EC = instrumentation:Anesthesiology:instrumentation
MH_TH = BIOETHICS (1985)
MH_TH = POPLINE (1978)
ST = T061
AN = Manual 26.21+
MS = A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
OL = pre-explosion = ANESTHESIA (PX)
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D000758

*NEWRECORD
RECTYPE = D
MH = Adjuvants, Anesthesia
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Anesthesia Adjuvants|T121|NON|EQV|NLM (1999)|980515|abcdef
ENTRY = Anesthetic Adjuvants|T121|NON|EQV|NLM (1995)|940216|abcdef
ENTRY = Adjuvants, Anesthetic
MN = D27.505.954.427.010
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = IM; coord with specific adjuvant (IM) & specific type of anesthesia (IM)
MS = Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.
PM = 99; see ANESTHESIA ADJUVANTS 1963-98
HN = 99(63)
MR = 20140625
DA = 19990101
DC = 1
UI = D000759

*NEWRECORD
RECTYPE = D
MH = Anesthesia and Analgesia
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Analgesia and Anesthesia
MN = E03
RH = E3 - PROCEDURES AND TECHNIQUES-ANESTHETIC AND ANALGESIC
MH_TH = NLM (1966)
ST = T061
AN = used for searching; INDEXER: Do not use; CATALOGER: Do not use
MS = Medical methods of either relieving pain caused by a particular condition or removing the sensation of pain during a surgery or other medical procedure.
HN = 98; use explode 1971-97
CATSH = CAT LIST
MR = 20150601
DA = 19990101
DC = 1
DX = 19980101
UI = D000760

*NEWRECORD
RECTYPE = D
MH = Anesthesia Department, Hospital
DE = ANESTH DEP HOSP
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
PRINT ENTRY = Hospital Anesthesia Department|T093|NON|EQV|UNK (19XX)|770519|HOSP ANESTH DEP|abcdefv
PRINT ENTRY = Hospital Anesthesia-Resuscitation Department|T093|NON|BRD|UNK (19XX)|770519|HOSP ANESTH RESUSCITATION DEP|abcdefv
ENTRY = Anesthesia Department|T093|NON|EQV|NLM (1991)|900320|ANESTH DEP|abcdefv
ENTRY = Anesthesia-Resuscitation Department, Hospital|T093|NON|BRD|NLM (1997)|950804|ANESTH RESUSCITATION DEP HOSP|abcdefv
ENTRY = Anesthesia Departments
ENTRY = Anesthesia Departments, Hospital
ENTRY = Anesthesia Resuscitation Department, Hospital
ENTRY = Anesthesia-Resuscitation Departments, Hospital
ENTRY = Department, Anesthesia
ENTRY = Department, Hospital Anesthesia
ENTRY = Department, Hospital Anesthesia-Resuscitation
ENTRY = Departments, Anesthesia
ENTRY = Departments, Hospital Anesthesia
ENTRY = Departments, Hospital Anesthesia-Resuscitation
ENTRY = Hospital Anesthesia Departments
ENTRY = Hospital Anesthesia Resuscitation Department
ENTRY = Hospital Anesthesia-Resuscitation Departments
MN = N02.278.216.500.968.070
MN = N04.452.442.422.070
MH_TH = NLM (1977)
ST = T093
AN = DF: ANESTH DEP
PI = Anesthesiology (1966-Jul 1977)
PI = Hospital Departments (1968-Jul 1977)
MS = Hospital department responsible for the administration of functions and activities pertaining to the delivery of anesthetics.
PM = 91; was see under HOSPITAL DEPARTMENTS 1977-90
HN = 91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90
MR = 20150622
DA = 19770519
DC = 1
DX = 19910101
UI = D000761

*NEWRECORD
RECTYPE = D
MH = Anesthesia Recovery Period
PRINT ENTRY = Recovery Period, Anesthesia|T079|NON|EQV|UNK (19XX)|850228|abcdef
ENTRY = Anesthesia Recovery Periods
ENTRY = Period, Anesthesia Recovery
ENTRY = Periods, Anesthesia Recovery
ENTRY = Recovery Periods, Anesthesia
MN = E03.160
MN = E04.614.750.055
MN = N02.421.585.753.750.055
FX = Delayed Emergence from Anesthesia
FX = Postanesthesia Nursing
MH_TH = NLM (1986)
ST = T079
AN = no qualif
PI = Anesthesia or specific (1966-1985)
PI = Postoperative Care (1966-1985)
MS = The period of emergence from general anesthesia, where different elements of consciousness return at different rates.
PM = 91; was see under POSTOPERATIVE PERIOD 1986-90
HN = 91(86); was see under POSTOPERATIVE PERIOD 1986-90
CATSH = CAT LIST
MR = 20150629
DA = 19850228
DC = 1
DX = 19910101
UI = D000762

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Caudal
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Anesthesia, Sacral Epidural|T061|NON|EQV|UNK (19XX)|741211|abcdef
ENTRY = Caudal Anesthesia
ENTRY = Epidural Anesthesia, Sacral
ENTRY = Sacral Epidural Anesthesia
MN = E03.155.086.131.100
MH_TH = NLM (1975)
ST = T061
AN = /educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
MS = Epidural anesthesia administered via the sacral canal.
PM = 91; was see under ANESTHESIA, EPIDURAL 1975-90
HN = 91(75); was see under ANESTHESIA, EPIDURAL 1975-90
CATSH = CAT LIST
MR = 19930220
DA = 19741212
DC = 1
DX = 19910101
UI = D000763

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Closed-Circuit
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Anesthesia, Rebreathing|T061|NON|EQV|UNK (19XX)|860620|abcdef
PRINT ENTRY = Closed-Circuit Anesthesia|T061|NON|EQV|UNK (19XX)|860620|abcdef
ENTRY = Anesthesia, Closed Circuit
ENTRY = Anesthesias, Closed-Circuit
ENTRY = Anesthesias, Rebreathing
ENTRY = Closed Circuit Anesthesia
ENTRY = Closed-Circuit Anesthesias
ENTRY = Rebreathing Anesthesia
ENTRY = Rebreathing Anesthesias
MN = E03.155.197.197.280
MH_TH = NLM (1987)
ST = T061
AN = /educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
PI = Anesthesia, Inhalation (1966-1986)
MS = Inhalation anesthesia where the gases exhaled by the patient are rebreathed as some carbon dioxide is simultaneously removed and anesthetic gas and oxygen are added so that no anesthetic escapes into the room. Closed-circuit anesthesia is used especially with explosive anesthetics to prevent fires where electrical sparking from instruments is possible.
PM = 91; was see under ANESTHESIA, INHALATION 1987-90
HN = 91(87); was see under ANESTHESIA, INHALATION 1987-90
CATSH = CAT LIST
MR = 19920325
DA = 19860620
DC = 1
DX = 19910101
UI = D000764

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Conduction
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Anesthesia, Regional|T061|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Conduction Anesthesia
ENTRY = Regional Anesthesia
MN = E03.155.086
MH_TH = NLM (1966)
ST = T061
MS = Injection of an anesthetic into the nerves to inhibit nerve transmission in a specific part of the body.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D000765

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Dental
DE = ANESTHESIA DENT
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Dental Anesthesia|T061|NON|EQV|IOM (1990)|890414|DENT ANESTHESIA|abcdefv
MN = E03.155.141
MN = E06.045
MH_TH = NLM (1966)
ST = T061
MS = A range of methods used to reduce pain and anxiety during dental procedures.
OL = use ANESTHESIA, DENTAL to search ANESTHESIA, INTRALIGAMENTAL, DENTAL 1984-92
PM = ANESTHESIA, INTRALIGAMENTAL, DENTAL was see ANESTHESIA, DENTAL 1984-92
HN = ANESTHESIA, INTRALIGAMENTAL, DENTAL was see ANESTHESIA, DENTAL 1984-92
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D000766

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Epidural
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Anesthesia, Extradural|T061|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Anesthesia, Peridural|T061|NON|EQV|UNK (19XX)|750101|abcdef
PRINT ENTRY = Epidural Anesthesia|T061|NON|EQV|UNK (19XX)|880602|abcdef
ENTRY = Anesthesias, Epidural
ENTRY = Anesthesias, Extradural
ENTRY = Anesthesias, Peridural
ENTRY = Epidural Anesthesias
ENTRY = Extradural Anesthesia
ENTRY = Extradural Anesthesias
ENTRY = Peridural Anesthesia
ENTRY = Peridural Anesthesias
MN = E03.155.086.131
MH_TH = NLM (1971)
ST = T061
PI = Anesthesia, Conduction (1966-1970)
PI = Anesthesia, Obstetrical (1966-1970)
MS = Procedure in which an anesthetic is injected into the epidural space.
PM = 72
HN = 72(71)
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
DX = 19720101
UI = D000767

*NEWRECORD
RECTYPE = D
MH = Anesthesia, General
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Anesthesias, General
ENTRY = General Anesthesia
ENTRY = General Anesthesias
MN = E03.155.197
MH_TH = NLM (1966)
ST = T061
MS = Procedure in which patients are induced into an unconscious state through use of various medications so that they do not feel pain during surgery.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D000768

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Inhalation
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Insufflation Anesthesia|T061|NON|NRW|UNK (19XX)|860604|abcdef
ENTRY = Anesthesia, Insufflation
ENTRY = Inhalation Anesthesia
MN = E03.155.197.197
MH_TH = NLM (1966)
ST = T061
AN = /educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
MS = Anesthesia caused by the breathing of anesthetic gases or vapors or by insufflating anesthetic gases or vapors into the respiratory tract.
CATSH = CAT LIST
MR = 19930220
DA = 19990101
DC = 1
UI = D000769

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Endotracheal
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Anesthesia, Intratracheal|T061|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Endotracheal Anesthesia|T061|NON|EQV|NLM (2016)|OBSSR (2016)|150223|abcdeef
ENTRY = Intratracheal Anesthesia|T061|NON|EQV|NLM (2016)|OBSSR (2016)|150223|abcdeef
ENTRY = Anesthesias, Endotracheal
ENTRY = Anesthesias, Intratracheal
ENTRY = Endotracheal Anesthesias
ENTRY = Intratracheal Anesthesias
MN = E03.155.253
MH_TH = NLM (2016)
MH_TH = OBSSR (2016)
ST = T061
MS = Procedure in which an anesthetic such as a gas or mixture of gases is inhaled through a tube into the lungs.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D000770

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Intravenous
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Anesthesias, Intravenous
ENTRY = Intravenous Anesthesia
ENTRY = Intravenous Anesthesias
MN = E03.155.308
MH_TH = NLM (1966)
ST = T061
MS = Process of administering an anesthetic through injection directly into the bloodstream.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D000771

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Local
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Anesthesia, Infiltration|T061|NON|NRW|NLM (1996)|940711|abcdef
ENTRY = Local Anesthesia|T061|NON|EQV|NLM (2006)|041227|abcdef
ENTRY = Neural Therapy of Huneke|T061|EPO|NRW|NLM (2006)|040921|abcdef
ENTRY = Huneke Neural Therapy
ENTRY = Infiltration Anesthesia
MN = E03.155.086.231
FX = Anesthetics, Local
MH_TH = NLM (1966)
ST = T061
MS = A blocking of nerve conduction to a specific area by an injection of an anesthetic agent.
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D000772

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Obstetrical
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Anesthesia, Gynecological|T061|NON|REL|UNK (19XX)|781218|ANESTHESIA GYNECOL|abcdefv
ENTRY = Anesthesia, Obstetric|T061|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Gynecologic Anesthesia|T061|NON|REL|NLM (1992)|900927|GYNECOL ANESTHESIA|abcdefv
ENTRY = Paracervical Block|T061|NON|NRW|UNK (19XX)|781218|abcdef
ENTRY = Anesthesia, Gynecologic
ENTRY = Block, Paracervical
ENTRY = Blocks, Paracervical
ENTRY = Gynecological Anesthesia
ENTRY = Obstetric Anesthesia
ENTRY = Obstetrical Anesthesia
ENTRY = Paracervical Blocks
MN = E03.155.364
MH_TH = NLM (1966)
ST = T061
MS = A variety of anesthetic methods such as EPIDURAL ANESTHESIA used to control the pain of childbirth.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D000773

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Rectal
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Anesthesias, Rectal
ENTRY = Rectal Anesthesia
ENTRY = Rectal Anesthesias
MN = E03.155.197.364
MH_TH = NLM (1966)
ST = T061
MS = Procedure involving the instillation of an anesthetic into the rectum.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D000774

*NEWRECORD
RECTYPE = D
MH = Anesthesia, Spinal
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Anesthesias, Spinal
ENTRY = Spinal Anesthesia
ENTRY = Spinal Anesthesias
MN = E03.155.086.331
MH_TH = NLM (1966)
ST = T061
MS = Procedure in which an anesthetic is injected directly into the spinal cord.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D000775

*NEWRECORD
RECTYPE = D
MH = Anesthesiology
DE = ANESTHESIOL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = H02.403.066
MH_TH = NLM (1966)
ST = T091
AN = SPEC: SPEC qualif; DF: ANESTHESIOL
MS = A specialty concerned with the study of anesthetics and anesthesia.
MR = 20090706
DA = 19990101
DC = 1
UI = D000776

*NEWRECORD
RECTYPE = D
MH = Anesthetics
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anesthetic Agents|T121|NON|EQV|NLM (1996)|950518|abcdef
ENTRY = Anesthetic Drugs|T121|NON|EQV|NLM (1996)|950518|abcdef
ENTRY = Anesthetic Effect|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Anesthetic Effects|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Agents, Anesthetic
ENTRY = Drugs, Anesthetic
ENTRY = Effect, Anesthetic
ENTRY = Effects, Anesthetic
MN = D27.505.696.277.100
MN = D27.505.954.427.210.100
FX = Adjuvants, Anesthesia
FX = Analgesics
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = general or unspecified; prefer specific groups; use no qualifiers for anesthetics when used to produce anesthesia; coordinate with type of anesthesia: Manual 26.21+; policy: Manual 25.20+
MS = Agents that are capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.
MR = 20140625
DA = 19990101
DC = 1
UI = D000777

*NEWRECORD
RECTYPE = D
MH = Anesthetics, Dissociative
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Dissociative Anesthetics|T121|NON|EQV|NLM (1995)|940526|abcdef
MN = D27.505.696.277.100.035.075.035
MN = D27.505.954.427.210.100.035.075.035
MH_TH = NLM (1971)
ST = T121
RN = 0
AN = intravenous anesthetics inducing selective loss of some sensations, leaving others intact
PI = Anesthetics (1966-1970)
MS = Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed)
PM = 91; was see under ANESTHETICS 1971-90
HN = 91(71); was see under ANESTHETICS 1971-90
MR = 20140625
DA = 19990101
DC = 1
DX = 19910101
UI = D000778

*NEWRECORD
RECTYPE = D
MH = Anesthetics, Local
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Anesthetics, Conduction-Blocking|T121|NON|EQV|UNK (19XX)|860619|ANESTHETICS CONDUCTION BLOCK|abcdefv
PRINT ENTRY = Conduction-Blocking Anesthetics|T121|NON|EQV|UNK (19XX)|860619|CONDUCTION BLOCK ANESTHETICS|abcdefv
ENTRY = Anesthetics, Topical|T121|NON|NRW|NLM (2012)|101006|abcdef
ENTRY = Anesthetics, Conduction Blocking
ENTRY = Conduction Blocking Anesthetics
ENTRY = Local Anesthetics
MN = D27.505.696.277.100.200
MN = D27.505.696.663.850.025
MN = D27.505.954.427.210.100.200
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = see note at ANESTHETICS
MS = Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.
MR = 20140625
DA = 19990101
DC = 1
UI = D000779

*NEWRECORD
RECTYPE = D
MH = Anestrus
AQ = BL CF DE GE IM ME PH RE UR
MN = G08.686.195.249
MH_TH = NLM (1975)
ST = T079
AN = non-primate mammals only
MS = A state of sexual inactivity in female animals exhibiting no ESTROUS CYCLE. Causes of anestrus include pregnancy, presence of offspring, season, stress, and pathology.
PM = 91; was see under ESTRUS 1975-90
HN = 91(75); was see under ESTRUS 1975-90
CATSH = CAT LIST
MR = 20080708
DA = 19741111
DC = 1
DX = 19910101
UI = D000780

*NEWRECORD
RECTYPE = D
MH = Anethole Trithione
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Anetholtrithion|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760416|abbcdeef
PRINT ENTRY = Trithioanethol|T109|T121|NON|EQV|UNK (19XX)|760416|abbcdef
PRINT ENTRY = Trithioparamethoxyphenylpropene|T109|T121|NON|EQV|UNK (19XX)|760416|abbcdef
ENTRY = Anethol Dithiolthione|T109|T121|NON|EQV|UNK (19XX)|840213|abbcdef
ENTRY = Anetholetrithione|T109|T121|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = Anetholtrithione|T109|T121|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = Anisyldithiolthionine|T109|T121|NON|EQV|UNK (19XX)|861125|abbcdef
ENTRY = Felviten|T109|T121|TRD|NRW|NLM (1991)|900320|abbcdef
ENTRY = Heporal|T109|T121|TRD|NRW|NLM (1991)|900320|abbcdef
ENTRY = Kali Brand of Anethole Trithione|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Mucinol|T109|T121|TRD|NRW|DE|020802|abbcdef
ENTRY = SL-25|T109|T121|NON|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Sanofi Winthrop Brand of Anethole Trithione|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Sialor|T109|T121|TRD|REL|CA|820830|abbcdef
ENTRY = Solvay Brand of Anethole Trithione|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Sonicur|T109|T121|TRD|NRW|ES|020802|abbcdef
ENTRY = Sulfarlem|T109|T121|TRD|NRW|CA|DE|FR|800825|abbcdeeef
ENTRY = Sulfralem|T109|T121|TRD|NRW|NLM (1991)|900320|abbcdef
ENTRY = Tiotrifar|T109|T121|TRD|NRW|NLM (1991)|900320|abbcdef
ENTRY = Trithio|T109|T121|TRD|NRW|NLM (1991)|900320|abbcdef
ENTRY = Dithiolthione, Anethol
ENTRY = SL 25
ENTRY = Trithione, Anethole
MN = D02.355.601.200.100
MN = D02.355.726.158.100
MN = D02.455.426.559.389.657.654.158.100
MN = D02.886.753.077
MH_TH = FDA SRS (2014)
MH_TH = NLM (1977)
ST = T109
ST = T121
N1 = 3H-1,2-Dithiole-3-thione, 5-(4-methoxyphenyl)-
RN = QUY32964DJ
RR = 532-11-6 (Anethole Trithione)
PI = Anisoles (1974-1976)
PI = Heterocyclic Compounds (1974-1976)
PI = Thiones (1974-1975)
MS = Choleretic used to allay dry mouth and constipation due to tranquilizers.
PM = 91; was see under ANISOLES 1977-90
HN = 91(77); was see under ANISOLES 1977-90
MR = 20130708
DA = 19760416
DC = 1
DX = 19910101
UI = D000781

*NEWRECORD
RECTYPE = D
MH = Aneuploidy
ENTRY = Aneuploid|T049|NON|EQV|NLM (2004)|030129|abcdef
ENTRY = Aneuploid Cell|T025|NON|REL|NLM (2004)|030129|abcdef
ENTRY = Aneuploid Cells
ENTRY = Aneuploidies
ENTRY = Aneuploids
ENTRY = Cell, Aneuploid
ENTRY = Cells, Aneuploid
MN = C23.550.210.050
MN = G05.365.590.175.050
MN = G05.700.131
MH_TH = NLM (1968)
ST = T049
PI = Chromosome Abnormalities (1966-1967)
MS = The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell (DIPLOIDY) the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is MONOSOMY (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is TRISOMY (symbol: 2N+1).
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D000782

*NEWRECORD
RECTYPE = D
MH = Aneurysm
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Saccular Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Fusiform Aneurysm|T047|T190|NON|NRW|NLM (2008)|061005|abbcdef
ENTRY = Aneurysm, Fusiform
ENTRY = Aneurysms
ENTRY = Aneurysms, Fusiform
ENTRY = Fusiform Aneurysms
MN = C14.907.055
MH_TH = NLM (1966)
ST = T047
ST = T190
AN = general; prefer specifics; coordinate IM with specific vessel (IM) or precoordinated vascular disease if available (IM); rupture = ANEURYSM, RUPTURED (see note there)
MS = Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000783

*NEWRECORD
RECTYPE = D
MH = Aneurysm, Dissecting
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Dissecting Aneurysm|T020|T047|NON|EQV|UNK (19XX)|760426|abbcdef
ENTRY = Aneurysms, Dissecting
ENTRY = Dissecting Aneurysms
MN = C14.907.055.050
MH_TH = NLM (1977)
ST = T020
ST = T047
AN = coordinate with specific aneurysm term, often AORTIC ANEURYSM or its specifics; otherwise coordinate with specific vessel (IM) or precoordinated vascular disease (IM)
PI = Aneurysm (1966-1976)
PI = Aortic Aneurysm (1966-1976)
MS = Aneurysm caused by a tear in the TUNICA INTIMA of a blood vessel leading to interstitial HEMORRHAGE, and splitting (dissecting) of the vessel wall, often involving the AORTA. Dissection between the intima and media causes luminal occlusion. Dissection at the media, or between the media and the outer adventitia causes aneurismal dilation.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 20070709
DA = 19760427
DC = 1
DX = 19770101
UI = D000784

*NEWRECORD
RECTYPE = D
MH = Aneurysm, Infected
DE = ANEURYSM INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Aneurysm, Bacterial|T047|NON|NRW|UNK (19XX)|860418|ANEURYSM BACT|abcdefv
PRINT ENTRY = Aneurysm, Mycotic|T047|NON|NRW|UNK (19XX)|860418|abcdef
PRINT ENTRY = Mycotic Aneurysm|T047|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Bacterial Aneurysm|T047|NON|NRW|UNK (19XX)|860418|BACT ANEURYSM|abcdefv
ENTRY = Bacterial Aneurysms|T047|NON|NRW|NLM (1992)|901102|BACT ANEURYSMS|abcdefv
ENTRY = Fungal Aneurysm|T047|NON|NRW|NLM (2008)|061005|abcdef
ENTRY = Infected Aneurysm|T047|NON|EQV|UNK (19XX)|860418|INFECT ANEURYSM|abcdefv
ENTRY = Aneurysm, Fungal
ENTRY = Aneurysms, Bacterial
ENTRY = Aneurysms, Fungal
ENTRY = Aneurysms, Infected
ENTRY = Aneurysms, Mycotic
ENTRY = Fungal Aneurysms
ENTRY = Infected Aneurysms
ENTRY = Mycotic Aneurysms
MN = C01.539.069
MN = C14.907.055.131
MH_TH = NLM (1964)
ST = T047
AN = coordinate IM with specific bacteria or fungal infection (IM); note X refs ANEURYSM, BACTERIAL & ANEURYSM, MYCOTIC: do not coordinate with BACTERIAL INFECTIONS or MYCOSES if the specific bacterium or fungus is not specified
MS = Aneurysm due to growth of microorganisms in the arterial wall, or infection arising within preexisting arteriosclerotic aneurysms.
OL = use ANEURYSM, INFECTED to search ANEURYSM, MYCOTIC 1966-86 (as Prov 1966-69)
PM = 87; was ANEURYSM, MYCOTIC 1970-86
HN = 87; was ANEURYSM, MYCOTIC 1964-86 (Prov 1964-69)
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19700101
UI = D000785

*NEWRECORD
RECTYPE = D
MH = Anger
AQ = CL DE ES PH RE
ENTRY = Angers
MN = F01.470.093
MH_TH = NLM (1969)
ST = T041
AN = human & animal
PI = Hostility (1968)
MS = A strong emotional feeling of displeasure aroused by being interfered with, injured or threatened.
PM = 72
HN = 72(69)
CATSH = CAT LIST
MR = 19920325
DA = 19990101
DC = 1
DX = 19720101
UI = D000786

*NEWRECORD
RECTYPE = D
MH = Angina Pectoris
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Angor Pectoris|T047|T184|NON|EQV|UNK (19XX)|860418|abbcdef
PRINT ENTRY = Stenocardia|T047|T184|NON|EQV|UNK (19XX)|860418|abbcdef
ENTRY = Stenocardias
MN = C10.597.617.192.500
MN = C14.280.647.187
MN = C14.907.585.187
MN = C23.888.592.612.233.500
MH_TH = NLM (1966)
ST = T047
ST = T184
MS = The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
CATSH = CAT LIST
MR = 20150626
DA = 19990101
DC = 1
UI = D000787

*NEWRECORD
RECTYPE = D
MH = Angina Pectoris, Variant
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Prinzmetal Angina|T047|T184|EPO|EQV|NLM (2002)|ORD (2010)|001121|abbcdeef
ENTRY = Prinzmetal's Angina|T047|T184|EPO|EQV|UNK (19XX)|760426|abbcdef
ENTRY = Angina, Prinzmetal
ENTRY = Angina, Prinzmetal's
ENTRY = Prinzmetals Angina
ENTRY = Variant Angina Pectoris
MN = C10.597.617.192.500.150.150
MN = C14.280.647.187.150.150
MN = C14.907.585.187.150.500
MN = C23.888.592.612.233.500.150.150
MH_TH = NLM (1977)
ST = T047
ST = T184
PI = Angina Pectoris (1966-1976)
MS = A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.
PM = 84; was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81
HN = 84(77); was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81
CATSH = CAT LIST
MR = 20150626
DA = 19760427
DC = 1
DX = 19840101
UI = D000788

*NEWRECORD
RECTYPE = D
MH = Angina, Unstable
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Angina at Rest|T184|NON|EQV|NLM (1996)|940711|abcdef
PRINT ENTRY = Angina, Preinfarction|T184|NON|EQV|UNK (19XX)|830503|abcdef
PRINT ENTRY = Myocardial Preinfarction Syndrome|T047|NON|REL|UNK (19XX)|830503|abcdef
ENTRY = Angina Pectoris, Unstable|T184|NON|EQV|NLM (2012)|101221|abcdef
ENTRY = Unstable Angina|T184|NON|EQV|UNK (19XX)|860418|abcdef
ENTRY = Angina Pectori, Unstable
ENTRY = Anginas, Preinfarction
ENTRY = Anginas, Unstable
ENTRY = Myocardial Preinfarction Syndromes
ENTRY = Preinfarction Angina
ENTRY = Preinfarction Anginas
ENTRY = Preinfarction Syndrome, Myocardial
ENTRY = Preinfarction Syndromes, Myocardial
ENTRY = Syndrome, Myocardial Preinfarction
ENTRY = Syndromes, Myocardial Preinfarction
ENTRY = Unstable Angina Pectori
ENTRY = Unstable Angina Pectoris
ENTRY = Unstable Anginas
MN = C10.597.617.192.500.150
MN = C14.280.647.187.150
MN = C14.907.585.187.150
MN = C23.888.592.612.233.500.150
MH_TH = NLM (1984)
ST = T184
PI = Angina Pectoris (1966-1983)
PI = Angina Pectoris, Variant (1977-1983)
PI = Coronary Disease (1966-1983)
MS = Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.
PM = 91; was see under ANGINA PECTORIS 1984-90
HN = 91(84); was see under ANGINA PECTORIS 1984-90
CATSH = CAT LIST
MR = 20150626
DA = 19830503
DC = 1
DX = 19910101
UI = D000789

*NEWRECORD
RECTYPE = D
MH = Angiocardiography
DE = ANGIOCARDIOGR
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
ENTRY = Angiocardiographies
MN = E01.370.350.130.249
MN = E01.370.350.700.060.050
MN = E01.370.370.050.050
MN = E01.370.370.380.050
MH_TH = NLM (1966)
ST = T060
AN = NIM; a specific x-ray (not radionuclide) technique: do not confuse with HEART /radiogr or CORONARY ANGIOGRAPHY; coord with disease /radiogr; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ANGIOCARDIOGR
MS = Radiography of the heart and great vessels after injection of a contrast medium.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000790

*NEWRECORD
RECTYPE = D
MH = Angiography
DE = ANGIOGR
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
PRINT ENTRY = Arteriography|T060|NON|REL|UNK (19XX)|750116|ARTERIOGR|abcdefv
ENTRY = Angiographies
ENTRY = Arteriographies
MN = E01.370.350.700.060
MN = E01.370.370.050
MH_TH = NLM (1966)
ST = T060
AN = NIM; GEN or unspecified; prefer /radiogr with specific blood vessels but CORONARY ANGIOGRAPHY is available; /drug eff /rad eff permitted; DF: ANGIOGR
MS = Radiography of blood vessels after injection of a contrast medium.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D000792

*NEWRECORD
RECTYPE = D
MH = Angioid Streaks
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Angioid Streak
ENTRY = Streak, Angioid
ENTRY = Streaks, Angioid
MN = C11.768.094
FX = Retina
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
ST = T047
MS = Small breaks in the elastin-filled tissue of the retina.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D000793

*NEWRECORD
RECTYPE = D
MH = Angiokeratoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
ENTRY = Angiokeratomas
MN = C04.557.645.115
MH_TH = NLM (1966)
ST = T191
AN = coord IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant
MS = A vascular, horny neoplasm of the skin characterized by TELANGIECTASIS and secondary epithelial changes including acanthosis and hyperkeratosis.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D000794

*NEWRECORD
RECTYPE = D
MH = Fabry Disease
DE = FABRY DIS
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anderson-Fabry Disease|T047|EPO|EQV|GHR (2014)|NLM (1992)|OMIM (2013)|ORD (2010)|900912|abcdeeeef
PRINT ENTRY = Angiokeratoma Corporis Diffusum|T047|NON|EQV|GHR (2014)|NLM (1992)|OMIM (2013)|ORD (2010)|900912|abcdeeeef
ENTRY = Angiokeratoma Diffuse|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Angiokeratoma, Diffuse|T047|NON|EQV|NLM (2012)|ORD (2010)|101201|abcdeef
ENTRY = Ceramide Trihexosidase Deficiency|T047|NON|EQV|GHR (2014)|NLM (2012)|OMIM (2013)|ORD (2010)|101201|abcdeeeef
ENTRY = Fabry's Disease|T047|EPO|EQV|GHR (2014)|NLM (1999)|980312|abcdeef
ENTRY = GLA Deficiency|T047|ABX|EQV|GHR (2014)|NLM (2014)|130501|abcdeef
ENTRY = Hereditary Dystopic Lipidosis|T047|NON|EQV|GHR (2014)|NLM (2012)|OMIM (2013)|ORD (2010)|101201|abcdeeeef
ENTRY = alpha-Galactosidase A Deficiency|T047|NON|EQV|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090615|abcdeeeef
ENTRY = alpha-Galactosidase A Deficiency Disease|T047|NON|EQV|NLM (2007)|050801|ALPHA GALACTOSIDASE A DEFIC DIS|abcdefv
ENTRY = Anderson Fabry Disease
ENTRY = Deficiency, Ceramide Trihexosidase
ENTRY = Deficiency, GLA
ENTRY = Deficiency, alpha-Galactosidase A
ENTRY = Diffuse Angiokeratoma
ENTRY = Lipidosis, Hereditary Dystopic
ENTRY = alpha Galactosidase A Deficiency
ENTRY = alpha Galactosidase A Deficiency Disease
MN = C10.228.140.163.100.435.825.200
MN = C10.228.140.300.275.374
MN = C14.907.253.329.374
MN = C16.320.322.124
MN = C16.320.565.189.435.825.200
MN = C16.320.565.398.641.803.300
MN = C16.320.565.595.554.825.200
MN = C18.452.132.100.435.825.200
MN = C18.452.584.687.803.300
MN = C18.452.648.189.435.825.200
MN = C18.452.648.398.641.803.300
MN = C18.452.648.595.554.825.200
FX = Ceramides
FX = alpha-Galactosidase
MH_TH = GHR (2014)
MH_TH = NLM (1973)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
AN = do not confuse entry term ANDERSON-FABRY DISEASE with ANDERSEN'S DISEASE
PI = Angiokeratoma (1966-1972)
MS = An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.
PM = 1999; see FABRY'S DISEASE 1992-1998; see ANGIOKERATOMA CORPORIS DIFFUSUM 1973-1991; for FABRY'S DISEASE see ANGIOKERATOMA CORPORIS DIFFUSUM 1974-1991
HN = 1999(1973)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D000795

*NEWRECORD
RECTYPE = D
MH = Angiolymphoid Hyperplasia with Eosinophilia
DE = ALHE
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Granuloma, Pseudopyogenic|T047|NON|NRW|UNK (19XX)|840529|abcdef
PRINT ENTRY = Kimura Disease|T047|EPO|REL|ORD (2010)|UNK (19XX)|840529|KIMURA DIS|abcdeefv
ENTRY = Eosinophilic Granuloma of Soft Tissue|T047|NON|REL|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Eosinophilic Hyperplastic Lymphogranuloma|T047|NON|REL|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Eosinophilic Lymphofollicular Granuloma|T047|NON|REL|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Eosinophilic Lymphofolliculosis|T047|NON|REL|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Pseudopyogenic Granuloma|T047|NON|NRW|UNK (19XX)|840529|abcdef
ENTRY = Disease, Kimura
ENTRY = Eosinophilic Hyperplastic Lymphogranulomas
ENTRY = Eosinophilic Lymphofollicular Granulomas
ENTRY = Eosinophilic Lymphofolliculoses
ENTRY = Granuloma, Eosinophilic Lymphofollicular
ENTRY = Granulomas, Eosinophilic Lymphofollicular
ENTRY = Granulomas, Pseudopyogenic
ENTRY = Hyperplastic Lymphogranuloma, Eosinophilic
ENTRY = Hyperplastic Lymphogranulomas, Eosinophilic
ENTRY = Lymphofollicular Granuloma, Eosinophilic
ENTRY = Lymphofollicular Granulomas, Eosinophilic
ENTRY = Lymphofolliculoses, Eosinophilic
ENTRY = Lymphofolliculosis, Eosinophilic
ENTRY = Lymphogranuloma, Eosinophilic Hyperplastic
ENTRY = Lymphogranulomas, Eosinophilic Hyperplastic
ENTRY = Pseudopyogenic Granulomas
MN = C15.378.553.231.085
MN = C15.604.515.292.007
MN = C17.800.060
MH_TH = NLM (1985)
MH_TH = ORD (2010)
ST = T047
AN = DF: ALHE
PI = Eosinophilia (1966-1984)
MS = Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.
PM = 85
HN = 85
CATSH = CAT LIST
MR = 20100625
DA = 19840529
DC = 1
DX = 19850101
UI = D000796

*NEWRECORD
RECTYPE = D
MH = Angiomatosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Angiomatoses
MN = C14.907.077
FX = Telangiectasia, Hereditary Hemorrhagic
MH_TH = NLM (1966)
ST = T047
AN = coordinate IM with precoordinated organ disease term (IM)
MS = A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D000798

*NEWRECORD
RECTYPE = D
MH = Angioedema
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Quincke's Edema|T046|EPO|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Urticaria, Giant|T046|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Angioneurotic Edema|T046|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Angioedemas
ENTRY = Angioneurotic Edemas
ENTRY = Edema, Angioneurotic
ENTRY = Edema, Quincke's
ENTRY = Edemas, Angioneurotic
ENTRY = Giant Urticaria
ENTRY = Giant Urticarias
ENTRY = Quincke Edema
ENTRY = Quinckes Edema
ENTRY = Urticarias, Giant
MN = C14.907.079
MN = C17.800.862.945.066
MN = C20.543.480.904.066
MH_TH = UNK (19XX)
ST = T046
AN = /genet: consider also ANGIOEDEMAS, HEREDITARY
MS = Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.
PM = 2008; see ANGIONEUROTIC EDEMA 1963-2007
HN = 2008 (1963)
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000799

*NEWRECORD
RECTYPE = D
MH = Angioplasty, Balloon
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Balloon Angioplasty|T061|NON|EQV|UNK (19XX)|810223|abcdef
ENTRY = Dilation, Transluminal Arterial|T061|NON|EQV|NLM (2011)|100301|abcdef
ENTRY = Arterial Dilation, Transluminal
ENTRY = Arterial Dilations, Transluminal
ENTRY = Dilations, Transluminal Arterial
ENTRY = Transluminal Arterial Dilation
ENTRY = Transluminal Arterial Dilations
MN = E02.148.050.060
MN = E04.100.814.529.124.060
MN = E04.502.382.124.060
MN = E05.157.016.060
MH_TH = NLM (1982)
ST = T061
AN = coordinate IM with disease / ther (IM)
PI = Arterial Occlusive Diseases (1973-1981)
PI = Catheterization (1966-1981)
PI = Dilatation (1968-1981)
PI = Heart Catheterization (1976-1981)
PI = specific arterial occlusive disease (1966-1981)
MS = Use of a balloon catheter for dilation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of BALLOON DILATION in coronary arteries, ANGIOPLASTY, BALLOON, CORONARY is available.
OL = use ANGIOPLASTY, BALLOON to search ANGIOPLASTY, TRANSLUMINAL 1982-92
PM = 93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92
HN = 93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92
CATSH = CAT LIST
MR = 20150622
DA = 19810223
DC = 1
DX = 19820101
UI = D000800

*NEWRECORD
RECTYPE = D
MH = Angiostrongylus
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
MN = B01.050.500.500.294.700.775.588.080
MH_TH = NLM (1981)
ST = T204
AN = a genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
PI = Metastrongyloidea (1966-1980)
MS = A genus of parasitic nematodes of the superfamily METASTRONGYLOIDEA. Two species, ANGIOSTRONGYLUS CANTONENSIS and A. vasorum, infest the lungs of rats and dogs, respectively. A. cantonensis is transmissible to man where it causes frequently fatal infection of the central nervous system.
PM = 91; was see under METASTRONGYLOIDEA 1981-90
HN = 91(81); was see under METASTRONGYLOIDEA 1981-90
MR = 20090706
DA = 19800328
DC = 1
DX = 19910101
UI = D000801

*NEWRECORD
RECTYPE = D
MH = Angiotensin Amide
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Angiotensinamide|T116|T121|T125|NON|EQV|INN (19XX)|900427|abbbcdef
ENTRY = 1-Asparagine-5-valine Angiotensin II|T116|T121|T125|NON|EQV|UNK (19XX)|810917|abbbcdef
ENTRY = 5-Valine-Angiotensin II Amide|T116|T121|T125|NON|EQV|UNK (19XX)|801205|abbbcdef
ENTRY = Hypertensin|T116|T121|T125|TRD|NRW|UNK (19XX)|830330|abbbcdef
ENTRY = 1 Asparagine 5 valine Angiotensin II
ENTRY = 5 Valine Angiotensin II Amide
ENTRY = Amide, 5-Valine-Angiotensin II
ENTRY = Amide, Angiotensin
ENTRY = Angiotensin II, 1-Asparagine-5-valine
MN = D12.644.456.073.041.050
MN = D23.469.050.050.050.050
PA = Vasoconstrictor Agents
MH_TH = BAN (19XX)
MH_TH = USAN (1962)
ST = T116
ST = T121
ST = T125
N1 = Angiotensin II, 1-L-asparagine-5-L-valine-
RN = 53-73-6
PI = Angiotensin II (1966-1974)
MS = The octapeptide amide of bovine angiotensin II used to increase blood pressure by vasoconstriction.
OL = search ANGIOTENSIN II 1966-74
PM = 91,66-73; was see under ANGIOTENSIN II/analogs & derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73
HN = 91(75)66-73; was see under ANGIOTENSIN II/analogs & derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73
MR = 20050630
DA = 19990101
DC = 1
DX = 19660101
UI = D000802

*NEWRECORD
RECTYPE = D
MH = Angiotensin I
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = I, Angiotensin
MN = D06.472.699.094.075
MN = D12.644.400.070.075
MN = D12.644.456.073.021
MN = D12.644.548.058.075
MN = D12.776.641.650.070.075
MN = D23.469.050.050.025
MH_TH = NLM (1978)
ST = T116
ST = T124
N1 = Angiotensin I
RN = 9041-90-1
PI = Angiotensin II (1966-1977)
MS = A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
PM = 87; was see under ANGIOTENSINS 1978-86
HN = 87(78); was see under ANGIOTENSINS 1978-86
MR = 20070709
DA = 19770609
DC = 1
DX = 19870101
UI = D000803

*NEWRECORD
RECTYPE = D
MH = Angiotensin II
AQ = AA AD AE AG AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Angiotensin II, Ile(5)-|T116|T121|T123|NON|NRW|NLM (2000)|991108|abbbcdef
PRINT ENTRY = Angiotensin II, Val(5)-|T116|T121|T123|NON|NRW|NLM (2000)|991108|abbbcdef
ENTRY = 5-L-Isoleucine Angiotensin II|T116|T121|T123|NON|NRW|JAN (19XX)|NLM (2000)|991108|abbbcdeef
ENTRY = ANG-(1-8)Octapeptide|T116|T121|T123|NON|EQV|UNK (19XX)|880808|abbbcdef
ENTRY = Angiotensin II, Isoleucine(5)-|T116|T121|T123|NON|NRW|NLM (2000)|991108|abbbcdef
ENTRY = Angiotensin II, Valine(5)-|T116|T121|T123|NON|NRW|NLM (2000)|991108|abbbcdef
ENTRY = Angiotensin-(1-8) Octapeptide|T116|T121|T123|NON|EQV|UNK (19XX)|880912|abbbcdef
ENTRY = Isoleucine(5)-Angiotensin|T116|T121|T123|NON|NRW|NLM (2000)|991108|abbbcdef
ENTRY = Isoleucyl(5)-Angiotensin II|T116|T121|T123|NON|NRW|UNK (19XX)|820331|abbbcdef
ENTRY = Valyl(5)-Angiotensin II|T116|T121|T123|NON|NRW|UNK (19XX)|820331|abbbcdef
ENTRY = 5 L Isoleucine Angiotensin II
ENTRY = Angiotensin II, 5-L-Isoleucine
ENTRY = II, 5-L-Isoleucine Angiotensin
MN = D06.472.699.094.078
MN = D12.644.400.070.078
MN = D12.644.456.073.041
MN = D12.644.548.058.078
MN = D12.776.641.650.070.078
MN = D23.469.050.050.050
PA = Vasoconstrictor Agents
FX = Renin-Angiotensin System
MH_TH = INN (19XX)
ST = T116
ST = T121
ST = T123
N1 = Angiotensin II
RN = 11128-99-7
RR = 4474-91-3 (human)
MS = An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.
PM = 1974; see ANGIOTENSIN 1971-1973, see ANGIOTENSIN 1967-1970; ANGIOTENSIN was heading 1964-1978, was HYPERTENSIN 1963 (HYPERTENSIN see ANGIOTENSIN 1964-1965, see ANGIOTENSIN AMIDE 1966-1973); ANGIOTENSIN II, ILE(5)- was indexed under ANGIOTENSIN II 1981-1999, and ISOLEUCINE 1975-1981
HN = 1974(1963); for ANGIOTENSIN II, ILE(5)- use ANGIOTENSIN II (NM) 1974-1999
MR = 20120703
DA = 19990101
DC = 1
UI = D000804

*NEWRECORD
RECTYPE = D
MH = Angiotensin III
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Des-Asp Angiotensin II|T116|T123|EQV|UNK (19XX)|800801|abbdef
ENTRY = Des-Aspartyl-Angiotensin II|T116|T123|NON|EQV|UNK (19XX)|800821|abbcdef
ENTRY = Angiotensin II, Des-Asp
ENTRY = Des Asp Angiotensin II
ENTRY = Des Aspartyl Angiotensin II
MN = D06.472.699.094.080
MN = D12.644.400.070.080
MN = D12.644.456.073.055
MN = D12.644.548.058.080
MN = D12.776.641.650.070.080
MN = D23.469.050.050.075
MH_TH = NLM (1977)
ST = T116
ST = T123
N1 = Angiotensin II, 1-de-L-aspartic acid-
RN = 12687-51-3
PI = Angiotensin II (1966-1976)
MS = A heptapeptide formed from ANGIOTENSIN II after the removal of an amino acid at the N-terminal by AMINOPEPTIDASE A. Angiotensin III has the same efficacy as ANGIOTENSIN II in promoting ALDOSTERONE secretion and modifying renal blood flow, but less vasopressor activity (about 40%).
PM = 91; was see under ANGIOTENSIN II 1977-90
HN = 91(77); was see under ANGIOTENSIN II 1977-90
MR = 20070709
DA = 19760519
DC = 1
DX = 19910101
UI = D000805

*NEWRECORD
RECTYPE = D
MH = Angiotensin-Converting Enzyme Inhibitors
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = ACE Inhibitors|T121|EQV|NLM (1992)|910419|ACE INHIB|abdefv
PRINT ENTRY = Kininase II Inhibitors|T121|NON|EQV|UNK (19XX)|870504|KININASE II INHIB|abcdefv
ENTRY = Angiotensin I-Converting Enzyme Inhibitors|T121|NON|EQV|NLM (1994)|930208|ANGIOTENSIN I CONVERTING ENZYME INHIB|abcdefv
ENTRY = Angiotensin-Converting Enzyme Antagonists|T121|NON|EQV|UNK (19XX)|870504|ANGIOTENSIN CONVERTING ENZYME ANTAG|abcdefv
ENTRY = Antagonists, Angiotensin-Converting Enzyme|T121|NON|EQV|NLM (1992)|910419|ANTAG ANGIOTENSIN CONVERTING ENZYME|abcdefv
ENTRY = Antagonists, Kininase II|T121|NON|EQV|NLM (1992)|910419|ANTAG KININASE II|abcdefv
ENTRY = Inhibitors, ACE|T121|EQV|NLM (1992)|910419|INHIB ACE|abdefv
ENTRY = Inhibitors, Angiotensin-Converting Enzyme|T121|NON|EQV|NLM (1992)|910419|INHIB ANGIOTENSIN CONVERTING ENZYME|abcdefv
ENTRY = Inhibitors, Kininase II|T121|NON|EQV|UNK (19XX)|870504|INHIB KININASE II|abcdefv
ENTRY = Kininase II Antagonists|T121|NON|EQV|UNK (19XX)|870504|KININASE II ANTAG|abcdefv
ENTRY = Angiotensin Converting Enzyme Antagonists
ENTRY = Angiotensin Converting Enzyme Inhibitors
ENTRY = Angiotensin I Converting Enzyme Inhibitors
ENTRY = Antagonists, Angiotensin Converting Enzyme
ENTRY = Enzyme Antagonists, Angiotensin-Converting
ENTRY = Enzyme Inhibitors, Angiotensin-Converting
ENTRY = Inhibitors, Angiotensin Converting Enzyme
MN = D27.505.519.389.745.085
MH_TH = NLM (1988)
ST = T121
RN = 0
AN = protease inhib & antihypertensives; DF: ACE INHIB
PI = Enzyme Inhibitors (1975-1987)
PI = Enzymes/antagonists & inhibitors (1968-1974)
PI = Kininase II/antagonists & inhibitors (1973-1987)
MS = A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
OL = use TEPROTIDE to search ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR 1991-93
PM = 88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93
HN = 88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93
MR = 20140625
DA = 19870504
DC = 1
DX = 19880101
UI = D000806

*NEWRECORD
RECTYPE = D
MH = Angiotensinogen
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Hypertensinogen|T116|T123|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Renin-Substrate|T116|T123|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Proangiotensin|T116|T123|NON|EQV|UNK (19XX)|810210|abbcdef
ENTRY = Renin Substrate Tetradecapeptide|T116|T123|NON|NRW|UNK (19XX)|811023|abbcdef
ENTRY = Serpin A8|T116|T123|NON|EQV|NLM (2010)|090209|abbcdef
ENTRY = Renin Substrate
ENTRY = Tetradecapeptide, Renin Substrate
MN = D12.644.456.073.070
MN = D12.644.861.020
MN = D12.776.811.070
MN = D12.776.872.020
PA = Serine Proteinase Inhibitors
MH_TH = NLM (1975)
ST = T116
ST = T123
N1 = Angiotensinogen (protein renin substrate)
RN = 11002-13-4
PI = Alpha Globulins (1968-1974)
PI = Angiotensin II (1968-1974)
PI = Protein Precursors (1971-1974)
MS = An alpha-globulin of about 453 amino acids, depending on the species. It is produced by the liver and secreted into blood circulation. Angiotensinogen is the inactive precursor of natural angiotensins. Upon successive enzyme cleavages, angiotensinogen yields angiotensin I, II, and III with amino acids numbered at 10, 8, and 7, respectively.
PM = 87; was see under ANGIOTENSINS 1975-86
HN = 87(75); was see under ANGIOTENSINS 1975-86
MR = 20150622
DA = 19741119
DC = 1
DX = 19870101
UI = D000808

*NEWRECORD
RECTYPE = D
MH = Angiotensins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Angiotensin|T116|T121|T123|NON|EQV|UNK (19XX)|770428|abbbcdef
MN = D06.472.699.094
MN = D12.644.400.070
MN = D12.644.456.073
MN = D12.644.548.058
MN = D12.776.641.650.070
MN = D23.469.050.050
FX = Receptors, Angiotensin
FX = Renin-Angiotensin System
MH_TH = NLM (1964)
ST = T116
ST = T121
ST = T123
RN = 0
PI = Angiotensin II (1966-1977)
PI = Angiotensin III (1977)
MS = Oligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized.
PM = 1978; for ANGIOTENSIN see ANGIOTENSIN II 1978-1999
HN = 1978; for ANGIOTENSIN use ANGIOTENSIN II 1978-1999
MR = 20070709
DA = 19990101
DC = 1
DX = 19640101
UI = D000809

*NEWRECORD
RECTYPE = D
MH = Angola
AQ = EH EP
MN = Z01.058.290.175.095
MH_TH = NLM (1978)
ST = T083
MS = A republic in southern Africa, southwest of DEMOCRATIC REPUBLIC OF THE CONGO and west of ZAMBIA. Its capital is Luanda.
MR = 20080708
DA = 19990101
DC = 4
UI = D000810

*NEWRECORD
RECTYPE = D
MH = Anguilla
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
ENTRY = Anguillas
MN = B01.050.150.900.493.338.282
MH_TH = NLM (1972)
ST = T013
AN = eel; NIM when exper animal: no qualif; when IM, qualif permitted
PI = Eels (1966-1971)
PM = 72
HN = 72
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D000811

*NEWRECORD
RECTYPE = D
MH = Anhydrides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.113
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Chemical compounds derived from acids by the elimination of a molecule of water.
PM = 66
HN = 66
MR = 20000621
DA = 19990101
DC = 1
DX = 19660101
UI = D000812

*NEWRECORD
RECTYPE = D
MH = Anilides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.065.199
MH_TH = NLM (1966)
ST = T109
RN = 0
MR = 19920507
DA = 19990101
DC = 1
UI = D000813

*NEWRECORD
RECTYPE = D
MH = Aniline Compounds
DE = ANILINE CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Phenylamines|T109|NON|EQV|UNK (19XX)|750708|abcdef
ENTRY = Compounds, Aniline
MN = D02.092.146
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = DF: ANILINE CPDS
MR = 19920507
DA = 19990101
DC = 1
UI = D000814

*NEWRECORD
RECTYPE = D
MH = Aniline Hydroxylase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Hydroxylase, Aniline
MN = D08.244.453.040.050
MN = D08.811.682.690.708.170.040.050
MN = D12.776.422.220.453.040.050
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 1.14.14.-
AN = a cytochrome P-450 enzyme
PI = Aniline Compounds (1973-1974)
PI = Hydroxylases (1973-1974)
MS = A drug-metabolizing, cytochrome P-450 enzyme which catalyzes the hydroxylation of aniline to hydroxyaniline in the presence of reduced flavoprotein and molecular oxygen. EC 1.14.14.-.
PM = 91; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76
HN = 91(75); was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76
MR = 20040707
DA = 19741111
DC = 1
DX = 19910101
UI = D000815

*NEWRECORD
RECTYPE = D
MH = Aniline Mustard
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Lymphochin|T109|T121|TRD|NRW|NLM (1996)|950122|abbcdef
ENTRY = Lymphocin|T109|T121|TRD|NRW|UNK (19XX)|750630|abbcdef
ENTRY = Lymphoquin|T109|T121|TRD|NRW|NLM (1996)|950122|abbcdef
ENTRY = N,N-Di(2-Chloroethyl)aniline|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|810305|abbcdeef
ENTRY = N,N-bis(2-chloroethyl)aniline|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|800825|abbcdeef
ENTRY = N,N-bis-(2-chloroethyl)aniline|T109|T121|NON|EQV|NLM (2009)|050202|abbcdef
ENTRY = Mustard, Aniline
MN = D02.455.526.728.650.050
PA = Antineoplastic Agents, Alkylating
MH_TH = FDA SRS (2014)
MH_TH = NLM (1976)
ST = T109
ST = T121
N1 = Benzenamine, N,N-bis(2-chloroethyl)-
RN = CUJ6745Z9J
RR = 553-27-5 (Aniline Mustard)
PI = Aniline Compounds (1970-1975)
PI = Nitrogen Mustard Compounds (1970-1975)
MS = Alkylating anti-neoplastic agent.
PM = 1991; N,N-BIS-(2-CHOLOROETHYL)ANILINE was indexed under ANILINE MUSTARD 2005-2008, & under ANILINE COMPOUNDS (2005)
HN = 1991(1976)
MR = 20130708
DA = 19750721
DC = 1
DX = 19910101
UI = D000816

*NEWRECORD
RECTYPE = D
MH = Anilino Naphthalenesulfonates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Naphthalenesulfonates, Anilino
MN = D02.092.146.125
MN = D02.455.426.559.847.638.555.282
MN = D02.886.645.600.080.050.650.050
MN = D04.615.638.555.282
MH_TH = NLM (1974)
ST = T109
RN = 0
MS = A class of organic compounds which contain an anilino (phenylamino) group linked to a salt or ester of naphthalenesulfonic acid. They are frequently used as fluorescent dyes and sulfhydryl reagents.
PM = 74
HN = 74
MR = 20060705
DA = 19990101
DC = 1
DX = 19740101
UI = D000817

*NEWRECORD
RECTYPE = D
MH = Animals
PRINT ENTRY = Animal|T008|NON|EQV|NLM (1976)|990101|abcdef
PRINT ENTRY = Metazoa|T008|NON|REL|NLM (2009)|080317|abcdef
ENTRY = Animalia|T008|NON|EQV|NLM (2004)|020925|abcdef
MN = B01.050
MH_TH = NLM (2004)
ST = T008
AN = NIM as check tag; Manual 18.7+; relation to /vet: Manual 19.8.81
MS = Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.
PM = 2004
HN = 2004 (1974); was check tag only (not a descriptor) 1974-2003
MR = 20100625
DA = 19750725
DC = 1
DX = 19760101
UI = D000818

*NEWRECORD
RECTYPE = D
MH = Animal Communication
ENTRY = Animal Communications
ENTRY = Communication, Animal
ENTRY = Communications, Animal
MN = F01.145.113.055
FX = Pheromones
FX = Vocalization, Animal
MH_TH = NLM (1968)
ST = T054
AN = no qualif; do not forget also to check tag ANIMALS
PI = Communication (1966-1967)
MS = Communication between animals involving the giving off by one individual of some chemical or physical signal, that, on being received by another, influences its behavior.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
DX = 19680101
UI = D000819

*NEWRECORD
RECTYPE = D
MH = Animal Diseases
DE = ANIMAL DIS
AQ = BL CF CI CL CN DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Diseases, Animal|T047|NON|EQV|NLM (1991)|891129|DIS ANIMAL|abcdefv
MN = C22
RH = C22 - DISEASES-ANIMAL
MH_TH = NLM (1966)
ST = T047
AN = avoid: too general; IM general only for unspecified animal & unspecified disease; NIM with specific animal (IM) for which no precoord animal/diseases term exists; do not use at all when a specific dis /vet is used; do not forget also to check tag ANIMALS; policy: Manual 23.33+; animal neopl: Manual 24.6+; TN 136; TN 193
PM = 66; was see under VETERINARY MEDICINE & ZOONOSES 1963-65
HN = 66; was see under VETERINARY MEDICINE & ZOONOSES 1963-65
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
DX = 19660101
UI = D000820

*NEWRECORD
RECTYPE = D
MH = Animal Feed
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Fodder|T168|NON|NRW|NLM (2016)|140821|abcdef
ENTRY = Animal Feeds
ENTRY = Feed, Animal
ENTRY = Feeds, Animal
ENTRY = Fodders
MN = G07.203.300.300.100
MN = J02.500.300.100
MH_TH = NLM (1966)
ST = T168
AN = differentiate from ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA & DIET
MS = Foodstuff used especially for domestic and laboratory animals, or livestock.
PM = 68
HN = 68(66)
MR = 20141218
DA = 19990101
DC = 1
DX = 19680101
UI = D000821

*NEWRECORD
RECTYPE = D
MH = Animal Husbandry
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Animal Husbandries
ENTRY = Husbandries, Animal
ENTRY = Husbandry, Animal
MN = J01.040.090
FX = Veterinary Medicine
MH_TH = NLM (1976)
ST = T090
AN = includes animal "breeding, feeding & care ... housing & nutrition"; do not confuse with VETERINARY MEDICINE; SPEC: SPEC qualif
PI = Agriculture (1966-1975)
MS = The science of breeding, feeding and care of domestic animals; includes housing and nutrition.
PM = 76
HN = 76
MR = 19890613
DA = 19750723
DC = 1
DX = 19760101
UI = D000822

*NEWRECORD
RECTYPE = D
MH = Animal Identification Systems
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Animal Identification System
ENTRY = Identification System, Animal
ENTRY = Identification Systems, Animal
ENTRY = System, Animal Identification
ENTRY = Systems, Animal Identification
MN = E05.035
MH_TH = NLM (1978)
ST = T170
AN = does not include classif or taxonomy: for individual animals only
MS = Procedures for recognizing individual animals and certain identifiable characteristics pertaining to them; includes computerized methods, ear tags, etc.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 19920526
DA = 19770512
DC = 1
DX = 19780101
UI = D000823

*NEWRECORD
RECTYPE = D
MH = Animal Nutritional Physiological Phenomena
AQ = DE EH GE IM PH RE
PRINT ENTRY = Animal Nutrition Physiology|T040|NON|EQV|NLM (2007)|051122|abcdef
PRINT ENTRY = Animal Nutritional Physiology Phenomena|T040|NON|EQV|NLM (2009)|080701|abcdef
ENTRY = Animal Nutritional Physiological Phenomenon|T040|NON|EQV|NLM (2009)|080703|abcdef
ENTRY = Animal Nutritional Physiology|T040|NON|EQV|NLM (2007)|051122|abcdef
ENTRY = Animal Nutritional Physiology Phenomenon|T040|NON|EQV|NLM (2009)|080701|abcdef
ENTRY = Veterinary Nutritional Physiology|T040|NON|NRW|NLM (2007)|051123|abcdef
ENTRY = Nutrition Physiologies, Animal
ENTRY = Nutrition Physiology, Animal
ENTRY = Nutritional Physiology, Animal
ENTRY = Nutritional Physiology, Veterinary
ENTRY = Physiology, Animal Nutrition
ENTRY = Physiology, Animal Nutritional
ENTRY = Physiology, Veterinary Nutritional
MN = G07.203.650.161
FX = Animal Nutrition Sciences
MH_TH = NLM (2009)
ST = T040
AN = differentiate from ANIMAL FEED & DIET; ANIMAL NUTRITION SCIENCES is available for the discipline
PI = Nutrition (1966-1967)
MS = Nutritional physiology of animals.
PM = 2009; see ANIMAL NUTRITION PHYSIOLOGY 2007-2008, see ANIMAL NUTRITION 1968-2006
HN = 2009(1968)
CATSH = CAT LIST
MR = 20150629
DA = 19990101
DC = 1
DX = 19680101
UI = D000824

*NEWRECORD
RECTYPE = D
MH = Animal Structures
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Animal Organs|T023|NON|NRW|BIOETHICS (1984)|850626|abcdef
ENTRY = Animal Organ
ENTRY = Animal Structure
ENTRY = Organ, Animal
ENTRY = Organs, Animal
ENTRY = Structure, Animal
ENTRY = Structures, Animal
MN = A13
RH = A13 - ANATOMY-ANIMAL STRUCTURES
MH_TH = NLM (1966)
ST = T017
AN = avoid: too general; prefer specifics
PI = Animals/anatomy & histology (1966-1997)
PI = specific animal/anatomy & histology (1966-1997)
MS = Organs and other anatomical structures of non-human vertebrate and invertebrate animals.
PM = 1998; for ANIMAL ORGANS see ANIMAL 1986-2003
HN = 1998 (1967); for ANIMAL ORGANS use ANIMALS 1986-2003
MR = 20030709
DA = 19990101
DC = 1
DX = 19980101
UI = D000825

*NEWRECORD
RECTYPE = D
MH = Animal Testing Alternatives
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Alternatives to Animal Testing|T062|NON|EQV|UNK (19XX)|840611|abcdef
ENTRY = Alternative, Animal Testing
ENTRY = Alternatives, Animal Testing
ENTRY = Animal Testing Alternative
ENTRY = Testing Alternative, Animal
ENTRY = Testing Alternatives, Animal
MN = E05.017.080.100
MH_TH = BIOETHICS (1989)
ST = T062
AN = SPEC qualif
MS = Procedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories.
PM = 85
HN = 85
MR = 20080708
DA = 19840611
DC = 1
DX = 19850101
UI = D000826

*NEWRECORD
RECTYPE = D
MH = Animal Welfare
AQ = EC ES HI LJ OG SN ST TD
ENTRY = Animal Cruelty|T053|NON|REL|NLM (2003)|020501|abcdef
ENTRY = Cruelty, Animal
ENTRY = Welfare, Animal
MN = I01.880.604.100
FX = Animal Use Alternatives
FX = Euthanasia, Animal
MH_TH = NLM (1986)
ST = T052
MS = The protection of animals in laboratories or other specific environments by promoting their health through better nutrition, housing, and care.
PM = 1986
HN = 1986
MR = 20030724
DA = 19850225
DC = 1
DX = 19860101
UI = D000827

*NEWRECORD
RECTYPE = D
MH = Animal Population Groups
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Animal Population Group
ENTRY = Population Group, Animal
ENTRY = Population Groups, Animal
MN = B01.050.050
MH_TH = NLM (2001)
ST = T096
AN = GEN; prefer specifics; /surg: consider also SURGERY, VETERINARY
MS = Animals grouped according to ecological, morphological or genetic populations.
PM = 2004; see ANIMALS 1963-2003
HN = 2004 (1963)
MR = 20090706
DA = 19990101
DC = 1
UI = D000828

*NEWRECORD
RECTYPE = D
MH = Animals, Domestic
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Farm Animals|T008|NON|NRW|NLM (1993)|910924|abcdef
ENTRY = Domestic Animals|T008|NON|EQV|NLM (2011)|090917|abcdef
ENTRY = Domesticated Animals|T008|NON|EQV|NLM (2011)|091001|abcdef
ENTRY = Animal, Domestic
ENTRY = Animal, Domesticated
ENTRY = Animal, Farm
ENTRY = Animals, Domesticated
ENTRY = Animals, Farm
ENTRY = Domestic Animal
ENTRY = Domesticated Animal
ENTRY = Farm Animal
MN = B01.050.050.116
MH_TH = NLM (1966)
ST = T008
AN = general or unspecified; domestication goes here
MS = Animals which have become adapted through breeding in captivity to a life intimately associated with humans. They include animals domesticated by humans to live and breed in a tame condition on farms or ranches for economic reasons, including LIVESTOCK (specifically CATTLE; SHEEP; HORSES; etc.), POULTRY; and those raised or kept for pleasure and companionship, e.g., PETS; or specifically DOGS; CATS; etc.
MR = 20100625
DA = 19990101
DC = 1
UI = D000829

*NEWRECORD
RECTYPE = D
MH = Animals, Laboratory
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Laboratory Animals|T008|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Animal, Laboratory
ENTRY = Laboratory Animal
MN = B01.050.050.199
FX = Animal Testing Alternatives
FX = Disease Models, Animal
FX = Laboratory Animal Science
MH_TH = NLM (1963)
ST = T008
AN = GEN or unspecified; prefer specifics; IM; qualif permitted; do not forget also to check tag ANIMALS
MR = 20090706
DA = 19990101
DC = 1
UI = D000830

*NEWRECORD
RECTYPE = D
MH = Animals, Newborn
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Animals, Neonatal|T008|NON|EQV|NLM (2007)|060308|abcdef
ENTRY = Animal, Neonatal
ENTRY = Animal, Newborn
ENTRY = Neonatal Animal
ENTRY = Neonatal Animals
ENTRY = Newborn Animal
ENTRY = Newborn Animals
MN = B01.050.050.282
MH_TH = NLM (1966)
ST = T008
AN = not for humans; NIM when experimental animal: no qualifiers; when IM, qualifiers permitted; do not forget also to check tag ANIMALS
MS = Refers to animals in the period of time just after birth.
MR = 20090706
DA = 19990101
DC = 1
UI = D000831

*NEWRECORD
RECTYPE = D
MH = Animals, Poisonous
DE = ANIMALS POIS
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
ENTRY = Poisonous Animals|T008|NON|EQV|UNK (19XX)|860101|POIS ANIMALS|abcdefv
ENTRY = Animal, Poisonous
ENTRY = Poisonous Animal
MN = B01.050.050.286
MH_TH = NLM (1968)
ST = T008
AN = IM; qualif permitted; coord IM with specific poisonous animal (IM); do not forget also to check tag ANIMALS
PI = Animals (1966-1967)
PM = 68
HN = 68
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D000832

*NEWRECORD
RECTYPE = D
MH = Animals, Suckling
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Animal, Suckling
ENTRY = Suckling Animal
ENTRY = Suckling Animals
MN = B01.050.050.293
MH_TH = NLM (1979)
ST = T015
AN = suckled by mother or by bottle; coord with specific suckling; NIM when exper animal: no qualif; when IM, qualif permitted; suckling of animals (the act, as in the eff of suckling on animal physiol) goes under LACTATION; do not forget also to check tag ANIMALS
MS = Young, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed.
PM = 87; was see under ANIMALS 1979-86
HN = 87(79); was see under ANIMALS 1979-86
MR = 20090706
DA = 19780504
DC = 1
DX = 19870101
UI = D000833

*NEWRECORD
RECTYPE = D
MH = Animals, Wild
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Animals, Nondomestic|T008|NON|NRW|UNK (19XX)|770512|abcdef
ENTRY = Animal, Nondomestic
ENTRY = Animal, Wild
ENTRY = Nondomestic Animal
ENTRY = Nondomestic Animals
ENTRY = Wild Animal
ENTRY = Wild Animals
MN = B01.050.050.300
MH_TH = NLM (1978)
ST = T008
AN = general or unspecified; do not  routinely add as a coordinate  with animals ordinarily considered wild such as LIONS; BEARS; etc.
PI = Animals (1966-1977)
MS = Animals considered to be wild or feral or not adapted for domestic use. It does not include wild animals in zoos for which ANIMALS, ZOO is available.
PM = 87; was see under ANIMALS 1978-86
HN = 87(78); was see under ANIMALS 1978-86
MR = 20150622
DA = 19770512
DC = 1
DX = 19870101
UI = D000835

*NEWRECORD
RECTYPE = D
MH = Animals, Zoo
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Animal, Zoo
ENTRY = Zoo Animal
ENTRY = Zoo Animals
MN = B01.050.050.448
MH_TH = NLM (1968)
ST = T008
AN = IM; qualif permitted; coord IM with specific zoo animal (IM); do not forget also to check tag ANIMALS
PI = Animals (1966-1967)
PM = 68
HN = 68
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D000836

*NEWRECORD
RECTYPE = D
MH = Anion Exchange Resins
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Anion Exchangers (Resins)|T121|T122|T130|NON|EQV|NLM (2002)|010319|abbbcdef
ENTRY = Exchange Resins, Anion
ENTRY = Resins, Anion Exchange
MN = D27.720.470.420.050
MH_TH = NLM (1975)
ST = T121
ST = T122
ST = T130
RN = 0
MS = High-molecular-weight insoluble polymers that contain functional cationic groups capable of undergoing exchange reactions with anions.
OL = search ION EXCHANGE RESINS 1966-74
PM = 91; was see under ION EXCHANGE RESINS 1975-90
HN = 91(75); was see under ION EXCHANGE RESINS 1975-90
MR = 20030709
DA = 19990101
DC = 1
DX = 19910101
UI = D000837

*NEWRECORD
RECTYPE = D
MH = Anions
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.248.497.158
MH_TH = NLM (1974)
ST = T196
RN = 0
AN = GEN or unspecified; prefer specifics
MS = Negatively charged atoms, radicals or groups of atoms which travel to the anode or positive pole during electrolysis.
PM = 74
HN = 74
MR = 19980610
DA = 19990101
DC = 1
DX = 19740101
UI = D000838

*NEWRECORD
RECTYPE = D
MH = Aniseikonia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
MN = C11.744.116
MH_TH = NLM (1964)
ST = T184
AN = refractive error in which each eye sees a different size & shape of an object
MS = A condition in which the ocular image of an object as seen by one eye differs in size and shape from that seen by the other.
PM = 66
HN = 66(64)
CATSH = CAT LIST
MR = 19930806
DA = 19990101
DC = 1
DX = 19660101
UI = D000839

*NEWRECORD
RECTYPE = D
MH = Anisoles
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Methylphenyl Ethers|T109|NON|EQV|UNK (19XX)|750208|abcdef
ENTRY = Ethers, Methylphenyl
MN = D02.355.601.200
MN = D02.355.726.158
MN = D02.455.426.559.389.657.654.158
MH_TH = NLM (1971)
ST = T109
RN = 0
PI = Ethers (1966-1970)
PI = Phenols (1966-1970)
MS = A group of compounds that are derivatives of methoxybenzene and contain the general formula R-C7H7O.
OL = use ANISOLES to search ANISOLE 1971-72 (as Prov)
PM = 73
HN = 73; was ANISOLE 1971-72 (Prov)
MR = 20120703
DA = 19990101
DC = 1
DX = 19730101
UI = D000840

*NEWRECORD
RECTYPE = D
MH = Anisomycin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Flagecidin|T109|T195|TRD|NRW|NLM (1996)|940720|abbcdef
MN = D03.383.773.050
PA = Anti-Bacterial Agents
PA = Antiprotozoal Agents
PA = Nucleic Acid Synthesis Inhibitors
PA = Protein Synthesis Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T195
N1 = 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2alpha,3alpha,4beta))-
RN = 6C74YM2NGI
RR = 22862-76-6 (Anisomycin)
PI = Antibiotics (1968-1974)
PI = Benzyl Compounds (1972-1974)
PI = Pyrrolidines (1968-1974)
MS = An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.
PM = 91; was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95
HN = 91(75); was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000841

*NEWRECORD
RECTYPE = D
MH = Ankle
AQ = AB AH BS EM GD IR MI PA PH PP PS RA RE RI SU US VI
PRINT ENTRY = Tarsus|T029|NON|EQV|NLM (1988)|990101|abcdef
ENTRY = Regio tarsalis|T029|NON|EQV|NLM (2002)|010313|abcdef
ENTRY = Ankles
MN = A01.378.610.250.149
FX = Ankle Joint
FX = Tarsal Bones
EC = injuries:Ankle Injuries
MH_TH = NLM (1966)
ST = T029
AN = primates only; use TARSUS, ANIMAL for non-primate vertebrates; differentiate from ANKLE JOINT; ANKLE BONES see TARSAL BONES is also available; do not confuse X ref TARSUS with tarsus or tarsal referring to the eyelid
MS = The region of the lower limb between the FOOT and the LEG.
PM = 1963; see ANKLE INJURIES to search ANKLE/injuries 1966-91; for TARSUS see TARSUS 1988-2001
HN = 1963; use ANKLE INJURIES to search ANKLE/injuries 1966-91
MR = 20130709
DA = 19990101
DC = 1
UI = D000842

*NEWRECORD
RECTYPE = D
MH = Ankle Joint
AQ = AB AH BS CH CY DE EM EN GD IM IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Ankle Syndesmosis|T030|NON|REL|NLM (2014)|121219|abcdef
ENTRY = Articulatio talocruralis|T030|NON|EQV|NLM (2002)|010313|abcdef
ENTRY = Inferior Tibiofibular Joint|T030|NON|EQV|NLM (2014)|121219|abcdef
ENTRY = Tibiofibular Ankle Syndesmosis|T030|NON|REL|NLM (2014)|121219|abcdef
ENTRY = Tibiofibular Syndesmosis|T030|NON|REL|NLM (2014)|121219|abcdef
ENTRY = Ankle Joints
ENTRY = Ankle Syndesmoses
ENTRY = Ankle Syndesmoses, Tibiofibular
ENTRY = Ankle Syndesmosis, Tibiofibular
ENTRY = Inferior Tibiofibular Joints
ENTRY = Joint, Ankle
ENTRY = Joint, Inferior Tibiofibular
ENTRY = Joints, Ankle
ENTRY = Joints, Inferior Tibiofibular
ENTRY = Syndesmoses, Ankle
ENTRY = Syndesmoses, Tibiofibular
ENTRY = Syndesmoses, Tibiofibular Ankle
ENTRY = Syndesmosis, Ankle
ENTRY = Syndesmosis, Tibiofibular
ENTRY = Syndesmosis, Tibiofibular Ankle
ENTRY = Tibiofibular Ankle Syndesmoses
ENTRY = Tibiofibular Joint, Inferior
ENTRY = Tibiofibular Joints, Inferior
ENTRY = Tibiofibular Syndesmoses
MN = A02.835.583.378.062
FX = Ankle
EC = injuries:Ankle Injuries
MH_TH = NLM (1965)
ST = T030
AN = primates only; differentiation from ANKLE
MS = The joint that is formed by the inferior articular and malleolar articular surfaces of the TIBIA; the malleolar articular surface of the FIBULA; and the medial malleolar, lateral malleolar, and superior surfaces of the TALUS.
OL = use ANKLE INJURIES to search ANKLE JOINT/injuries 1966-91
PM = 65; /injuries was ANKLE JOINT/injuries 1965-91
HN = 65; /injuries was ANKLE JOINT/injuries 1965-91
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D000843

*NEWRECORD
RECTYPE = D
MH = Ankylosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Ankyloses
MN = C05.550.069
MH_TH = NLM (1966)
ST = T020
ST = T047
MS = Fixation and immobility of a joint.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D000844

*NEWRECORD
RECTYPE = D
MH = Annelida
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Segmented Worms|T204|NON|EQV|NLM (1998)|970203|abcdef
PRINT ENTRY = Worms, Segmented|T204|NON|EQV|NLM (1998)|970203|abcdef
ENTRY = Annelidas
ENTRY = Segmented Worm
ENTRY = Worm, Segmented
MN = B01.050.500.091
MH_TH = NLM (1966)
ST = T204
AN = a phylum of segmented worms; GEN or unspecified; prefer specifics; /microbiol /parasitol /virol permitted
MS = A phylum of metazoan invertebrates comprising the segmented worms, and including marine annelids (POLYCHAETA), freshwater annelids, earthworms (OLIGOCHAETA), and LEECHES. Only the leeches are of medical interest. (Dorland, 27th ed)
MR = 20090706
DA = 19990101
DC = 1
UI = D000845

*NEWRECORD
RECTYPE = D
MH = Anniversaries and Special Events
DE = ANNIVERSARIES SPECIAL EVENTS
PRINT ENTRY = Dedications|T052|NON|NRW|UNK (19XX)|770505|abcdef
ENTRY = Anniversaries|T051|NON|NRW|NLM (1991)|900427|abcdef
ENTRY = Special Events|T051|NON|NRW|NLM (1991)|900427|abcdef
ENTRY = Anniversary
ENTRY = Event, Special
ENTRY = Events, Special
ENTRY = Special Event
MN = K01.400.095
MN = N04.452.822.070
MH_TH = NLM (1977)
ST = T051
AN = NIM; no qualif; note X ref below: do not index here for anniversaries, centennials, etc. in historical articles; do not coord here for ANNIVERSARY REACTION; DF: ANNIVERSARIES
MS = Occasions to commemorate an event or occasions designated for a specific purpose.
PM = 91; was see under PUBLIC RELATIONS 1977-90
HN = 91(Aug 77); was see under PUBLIC RELATIONS 1977-90
MR = 20060705
DA = 19770505
DC = 1
DX = 19910101
UI = D000846

*NEWRECORD
RECTYPE = D
MH = Annual Reports as Topic
MN = N04.452.070
MH_TH = NLM (2008)
ST = T073
ST = T170
AN = coordinate with specific organization or society (IM) + geographic term; do not confuse with Publication Type ANNUAL REPORTS
MS = Annual statements reviewing the status of the administrative and operational functions and accomplishments of an institution or organization.
PM = 2008; see ANNUAL REPORTS 1991-2007; see ORGANIZATION AND ADMINISTRATION 1977-1990
HN = 2008(1977)
MR = 20130709
DA = 19770505
DC = 1
DX = 19910101
UI = D000847

*NEWRECORD
RECTYPE = D
MH = Anodontia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Hypodontia|T019|NON|REL|UNK (19XX)|740329|abcdef
ENTRY = Hypodontia Oligodontia 1|T019|NON|NRW|NLM (2016)|151020|abcdef
ENTRY = Tooth Agenesis, Familial|T019|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Tooth Agenesis, Selective, 1|T019|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Ageneses, Familial Tooth
ENTRY = Agenesis, Familial Tooth
ENTRY = Familial Tooth Ageneses
ENTRY = Familial Tooth Agenesis
ENTRY = Hypodontia Oligodontia 1s
ENTRY = Oligodontia 1, Hypodontia
ENTRY = Oligodontia 1s, Hypodontia
ENTRY = Tooth Ageneses, Familial
MN = C07.650.800.100
MN = C07.793.700.100
MN = C16.131.850.800.100
MH_TH = NLM (1965)
ST = T019
AN = congen absence of teeth; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; congen absence of one or more teeth: do not confuse with JAW, EDENTULOUS (total lack of teeth in either jaw through disease or extraction), JAW, EDENTULOUS, PARTIALLY (partial lack in either jaw) or MOUTH, EDENTULOUS (total lack of teeth in both jaws through disease or extraction)
MS = Congenital absence of the teeth; it may involve all (total anodontia) or only some of the teeth (partial anodontia, hypodontia), and both the deciduous and the permanent dentition, or only teeth of the permanent dentition. (Dorland, 27th ed)
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20151020
DA = 19990101
DC = 1
DX = 19650101
UI = D000848

*NEWRECORD
RECTYPE = D
MH = Anomia
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Aphasia, Amnesic|T048|NON|EQV|UNK (19XX)|781214|abcdef
PRINT ENTRY = Aphasia, Anomic|T048|NON|EQV|UNK (19XX)|781214|abcdef
PRINT ENTRY = Aphasia, Nominal|T048|NON|EQV|NLM (1991)|900321|abcdef
PRINT ENTRY = Color Anomia|T048|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Dysnomia|T048|NON|EQV|NLM (1998)|970312|abcdef
ENTRY = Anomic Dysphasia|T048|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Nominal Dysphasia|T048|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Amnesic Aphasia
ENTRY = Anomia, Color
ENTRY = Anomias, Color
ENTRY = Anomic Aphasia
ENTRY = Anomic Dysphasias
ENTRY = Color Anomias
ENTRY = Dysnomias
ENTRY = Dysphasia, Anomic
ENTRY = Dysphasia, Nominal
ENTRY = Dysphasias, Anomic
ENTRY = Dysphasias, Nominal
ENTRY = Nominal Aphasia
ENTRY = Nominal Dysphasias
MN = C10.597.606.150.500.090
MN = C23.888.592.604.150.500.090
MH_TH = NLM (1980)
ST = T048
AN = inability to name objects: do not confuse with ANOMIE ("state of social disorganization & demoralization in society...", often called "anomia")
PI = Aphasia (1966-1979)
MS = A language dysfunction characterized by the inability to name people and objects that are correctly perceived. The individual is able to describe the object in question, but cannot provide the name. This condition is associated with lesions of the dominant hemisphere involving the language areas, in particular the TEMPORAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, p484)
PM = 1991; see under APHASIA 1980-1990, see APHASIA 1975-1979
HN = 1991(1980); use APHASIA 1975-1979
CATSH = CAT LIST
MR = 19991108
DA = 19781214
DC = 1
DX = 19910101
UI = D000849

*NEWRECORD
RECTYPE = D
MH = Anomie
PRINT ENTRY = Social Disorganization|T054|NON|BRD|UNK (19XX)|740329|abcdef
ENTRY = Anomies
ENTRY = Disorganization, Social
ENTRY = Disorganizations, Social
ENTRY = Social Disorganizations
MN = F01.145.813.093
MN = I01.880.853.450.283
FX = Personality Disorders
FX = Social Behavior Disorders
MH_TH = NLM (1971)
ST = T048
ST = T054
AN = no qualif; "state of social disorganization & demoralization in society..."; sometimes called "anomia" but do not confuse with ANOMIA ("inability to name objects")
PI = Social Behavior Disorders (1969-1970)
PI = Social Problems (1968-1970)
MS = A state of social disorganization and demoralization in society which is largely the result of disharmony between cultural goals and the means for attaining them. This may be reflected in the behavior of the individual in many ways - non-conformity, social withdrawal, deviant behavior, etc.
PM = 71
HN = 71
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19710101
UI = D000850

*NEWRECORD
RECTYPE = D
MH = Anonyms and Pseudonyms
DE = ANONYMS PSEUDONYMS
PRINT ENTRY = Pseudonyms|T170|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Anonyms|T170|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Pseudonyms and Anonyms|T170|NON|EQV|UNK (19XX)|740329|PSEUDONYMS ANONYMS|abcdefv
ENTRY = Anonym
ENTRY = Pseudonym
MN = L01.143.506.598.400.556.283
MH_TH = NLM (1966)
ST = T170
AN = no qualif; DF: ANONYMS
MS = Designations for persons whose names are not known or who wish to remain anonymous (anonyms) and for persons who wish to conceal or obscure their identity by assuming a fictitious name (pseudonyms).
MR = 19950313
DA = 19990101
DC = 1
UI = D000851

*NEWRECORD
RECTYPE = D
MH = Anopheles
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Anophele
MN = B01.050.500.131.617.289.275.120
MH_TH = NLM (1966)
ST = T204
AN = mosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
MS = A genus of mosquitoes (CULICIDAE) that are known vectors of MALARIA.
MR = 20090706
DA = 19990101
DC = 1
UI = D000852

*NEWRECORD
RECTYPE = D
MH = Anophthalmos
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anophthalmia|T019|NON|EQV|NLM (1990)|890417|abcdef
ENTRY = Anophthalmias
MN = C11.250.080
MN = C16.131.384.159
MH_TH = NLM (1966)
ST = T019
AN = absence of one or both eyes; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
MS = Congenital absence of the eye or eyes.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D000853

*NEWRECORD
RECTYPE = D
MH = Anoplura
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Haematopinus|T204|NON|NRW|NLM (1999)|971030|abcdef
PRINT ENTRY = Hoplopleura|T204|NON|NRW|NLM (1999)|971030|abcdef
PRINT ENTRY = Linognathus|T204|NON|NRW|NLM (1999)|971030|abcdef
PRINT ENTRY = Polyplax|T204|NON|NRW|NLM (1999)|971030|abcdef
PRINT ENTRY = Solenopotes|T204|NON|NRW|NLM (1999)|971030|abcdef
PRINT ENTRY = Sucking Lice|T204|NON|EQV|NLM (1998)|960710|abcdef
ENTRY = Sucking Louse|T204|NON|EQV|NLM (1998)|960710|abcdef
ENTRY = Anopluras
ENTRY = Hoplopleuras
ENTRY = Lice, Sucking
ENTRY = Lices, Sucking
ENTRY = Louse, Sucking
ENTRY = Louses, Sucking
ENTRY = Polyplaxs
ENTRY = Solenopote
ENTRY = Sucking Lices
ENTRY = Sucking Louses
MN = B01.050.500.131.617.690.060
MH_TH = NLM (1972)
ST = T204
AN = do not use /drug eff for insecticides: TN 111
PI = Lice (1966-1971)
MS = An order of insects comprising the sucking lice, which are blood-sucking ectoparasites of mammals. Recognized families include: Echinphthiriidae, Haematopinidae, and Pediculidae. The latter contains the medically important genera affecting humans: PEDICULUS and PHTHIRUS.
PM = 72
HN = 72
MR = 20100625
DA = 19990101
DC = 1
DX = 19720101
UI = D000854

*NEWRECORD
RECTYPE = D
MH = Anorexia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anorexias
MN = C23.888.821.108
FX = Anorexia Nervosa
MH_TH = NLM (1975)
ST = T184
AN = ANOREXIA NERVOSA is also available
MS = The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
PM = 91; was see under EATING DISORDERS 1975-90
HN = 91(75); was see under EATING DISORDERS 1975-90
CATSH = CAT LIST
MR = 20050630
DA = 19741111
DC = 1
DX = 19910101
UI = D000855

*NEWRECORD
RECTYPE = D
MH = Anorexia Nervosa
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Anorexia Nervosas
ENTRY = Nervosa, Anorexia
ENTRY = Nervosas, Anorexia
MN = F03.400.125
FX = Anorexia
FX = Body Dysmorphic Disorders
MH_TH = NLM (1966)
ST = T048
AN = ANOREXIA is also available
MS = An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)
CATSH = CAT LIST
MR = 20150701
DA = 19990101
DC = 1
UI = D000856

*NEWRECORD
RECTYPE = D
MH = Olfaction Disorders
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anosmia|T184|NON|NRW|NLM (1963)|990101|abcdef
PRINT ENTRY = Paraosmia|T184|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Smell Disorders|T047|NON|EQV|NLM (2000)|991103|SMELL DIS|abcdefv
ENTRY = Cacosmia|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Dysosmia|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cacosmias
ENTRY = Dysosmias
ENTRY = Olfaction Disorder
ENTRY = Paraosmias
ENTRY = Smell Disorder
MN = C10.597.751.600
MN = C23.888.592.763.550
FX = Olfactory Nerve Diseases
MH_TH = NLM (2000)
ST = T047
MS = Loss of or impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.
PM = 2000; see ANOSMIA 1963-1999
HN = 2000(1963)
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
DX = 19660101
UI = D000857

*NEWRECORD
RECTYPE = D
MH = Anovulation
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anovulations
MN = C13.351.500.056.630.050
MN = C19.391.630.050
MN = G08.686.785.760.690.080
MH_TH = NLM (1975)
ST = T047
PI = Ovulation (1966-1974)
MS = Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.
PM = 75
HN = 75
CATSH = CAT LIST
MR = 20080708
DA = 19741111
DC = 1
DX = 19750901
UI = D000858

*NEWRECORD
RECTYPE = D
MH = Anoxia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Hypoxia|T046|NON|REL|UNK (19XX)|740329|abcdef
PRINT ENTRY = Oxygen Deficiency|T046|NON|REL|UNK (19XX)|740329|OXYGEN DEFIC|abcdefv
ENTRY = Anoxemia|T034|T184|NON|NRW|NLM (1966)|990101|abbcdef
ENTRY = Deficiency, Oxygen|T046|NON|REL|UNK (19XX)|740329|DEFIC OXYGEN|abcdefv
ENTRY = Hypoxemia|T034|T184|NON|NRW|UNK (19XX)|740329|abbcdef
ENTRY = Anoxemias
ENTRY = Anoxias
ENTRY = Deficiencies, Oxygen
ENTRY = Hypoxemias
ENTRY = Hypoxias
ENTRY = Oxygen Deficiencies
MN = C23.888.852.079
FX = Hypoxia, Brain
FX = Hypoxia-Ischemia, Brain
MH_TH = NLM (1966)
ST = T046
AN = do not confuse entry term HYPOXIA with HYPEROXIA; FETAL HYPOXIA and CEREBRAL ANOXIA are also available; restrict to disease or clinical state in human and vertebrates: do not use for anoxic or hypoxic state in invertebrates or micro-organisms ( = OXYGEN or ANAEROBIOSIS); decrease of oxygen in tissues and cells = CELL HYPOXIA
MS = Relatively complete absence of oxygen in one or more tissues.
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
UI = D000860

*NEWRECORD
RECTYPE = D
MH = Anserine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
ENTRY = Balanine|T116|T123|NON|EQV|UNK (19XX)|811009|abbcdef
ENTRY = Beta-Alanyl-3-Methylhistidine|T116|T123|NON|EQV|UNK (19XX)|811009|abbcdef
ENTRY = Ophidine|T116|T123|NON|EQV|UNK (19XX)|811009|abbcdef
ENTRY = Beta Alanyl 3 Methylhistidine
MN = D12.644.456.345.159
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T116
ST = T123
N1 = L-Histidine, N-beta-alanyl-3-methyl-
RN = HDQ4N37UGV
RR = 584-85-0 (Anserine)
AN = a dipeptide
OL = search DIPEPTIDES 1967-74 & PEPTIDES 1966
PM = 91; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66
HN = 91(75); was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D000861

*NEWRECORD
RECTYPE = D
MH = Ant Venoms
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC EN GE HI IM IP ME PD PK PO RE SE TO TU UR
PRINT ENTRY = Formicoidea Venoms|T123|T131|NON|EQV|UNK (19XX)|770426|abbcdef
ENTRY = Ant Venom|T123|T131|NON|EQV|NLM (1999)|980217|abbcdef
ENTRY = Fire Ant Venoms|T123|T131|NON|NRW|UNK (19XX)|840919|abbcdef
ENTRY = Venom, Ant
ENTRY = Venoms, Ant
ENTRY = Venoms, Fire Ant
ENTRY = Venoms, Formicoidea
MN = D20.888.065.055
MN = D23.946.833.065.055
MH_TH = NLM (1978)
ST = T123
ST = T131
RN = 0
AN = /antag permitted but consider also ANTIVENINS; /enzymol permitted
PI = Ants (1966-1977)
PI = Venoms (1966-1977)
MS = Venoms from the superfamily Formicoidea, Ants. They may contain protein factors and toxins, histamine, enzymes, and alkaloids and are often allergenic or immunogenic.
PM = 91; was see under ARTHROPOD VENOMS 1978-90
HN = 91(78); was see under ARTHROPOD VENOMS 1978-90
MR = 20050630
DA = 19770427
DC = 1
DX = 19910101
UI = D000862

*NEWRECORD
RECTYPE = D
MH = Antacids
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alkalinizing Agents|T121|NON|EQV|NLM (2015)|130826|abcdef
ENTRY = Agents, Alkalinizing
MN = D27.505.519.170
MN = D27.505.954.483.080
FX = Anti-Ulcer Agents
MH_TH = NLM (1966)
ST = T121
RN = 0
MS = Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.
MR = 20140610
DA = 19990101
DC = 1
UI = D000863

*NEWRECORD
RECTYPE = D
MH = Antarctic Regions
AQ = EH EP
MN = Z01.158
MH_TH = NLM (1966)
ST = T083
MS = The continent lying around the South Pole and the southern waters of the Atlantic, Pacific, and Indian Oceans. It includes the Falkland Islands Dependencies. (From Webster's New Geographical Dictionary, 1988, p55)
MR = 20150623
DA = 19990101
DC = 4
UI = D000864

*NEWRECORD
RECTYPE = D
MH = Antazoline
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Imidamine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Phenazoline|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Analergine|T109|T121|TRD|REL|UNK (19XX)|800825|abbcdef
ENTRY = Antasten|T109|T121|TRD|NRW|UNK (19XX)|800825|abbcdef
ENTRY = Antazoline Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USP (1996)|940811|abbcdeef
ENTRY = Antazoline Phosphate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|USP (19XX)|830217|abbcdeeef
ENTRY = Antazoline Phosphate (1:1)|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Antistine|T109|T121|TRD|NRW|UNK (19XX)|800825|abbcdef
ENTRY = Arithmin|T109|T121|TRD|NRW|US|020802|abbcdef
ENTRY = Lannett Brand of Antazoline Phosphate|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Hydrochloride, Antazoline
ENTRY = Phosphate, Antazoline
MN = D03.383.129.308.040
PA = Anti-Allergic Agents
PA = Histamine H1 Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 1H-Imidazole-2-methanamine, 4,5-dihydro-N-phenyl-N-(phenylmethyl)-
RN = DHA8014SS1
RR = 154-68-7 (phosphate (1:1))
RR = 2508-72-7 (HCl)
RR = 91-75-8 (Antazoline)
RR = FP8Q8F72JH
RR = VPR5FPH326
PI = Aniline Compounds (1968-1974)
PI = Benzyl Compounds (1973-1974)
PI = Imidazoles (1968-1975)
MS = An antagonist of histamine H1 receptors.
PM = 91; was see under IMIDAZOLES 1975-90
HN = 91(75); was see under IMIDAZOLES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D000865

*NEWRECORD
RECTYPE = D
MH = Antelopes
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Antelopines|T015|NON|EQV|UNK (19XX)|860418|abcdef
PRINT ENTRY = Hippotragines|T015|NON|BRD|UNK (19XX)|860418|abcdef
ENTRY = Antelope
ENTRY = Antelopine
ENTRY = Hippotragine
MN = B01.050.150.900.649.077.380.100
MH_TH = NLM (1975)
ST = T015
AN = includes dik-dik, eland, gazelle, gnu, hartebeest, impala, springbok, wildebeest; IM; qualif permitted
MS = Any of various ruminant mammals of the order Bovidae. They include numerous species in Africa and the American pronghorn.
PM = 91; was see under ARTIODACTYLA 1975-90
HN = 91(75); was see under ARTIODACTYLA 1975-90
MR = 20090706
DA = 19741119
DC = 1
DX = 19910101
UI = D000866

*NEWRECORD
RECTYPE = D
MH = Anterior Chamber
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Anterior Chambers
ENTRY = Chamber, Anterior
ENTRY = Chambers, Anterior
MN = A09.371.060.067
MH_TH = NLM (1964)
ST = T023
AN = the space between the cornea & lens which contains the aqueous humor; do not confuse with ANTERIOR EYE SEGMENT; hemorrhage within anterior chamber = HYPHEMA; anterior chamber endothelium = ENDOTHELIUM, ANTERIOR CHAMBER see ENDOTHELIUM, CORNEAL
MS = The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109)
PM = 66; was see under AQUEOUS HUMOR 1963-65
HN = 66(64); was see under AQUEOUS HUMOR 1963-65
MR = 19950518
DA = 19990101
DC = 1
DX = 19660101
UI = D000867

*NEWRECORD
RECTYPE = D
MH = Anterior Compartment Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anterior Tibial Syndrome|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Anterior Compartment Syndromes
ENTRY = Anterior Tibial Syndromes
ENTRY = Compartment Syndrome, Anterior
ENTRY = Compartment Syndromes, Anterior
ENTRY = Syndrome, Anterior Compartment
ENTRY = Syndrome, Anterior Tibial
ENTRY = Syndromes, Anterior Compartment
ENTRY = Syndromes, Anterior Tibial
ENTRY = Tibial Syndrome, Anterior
ENTRY = Tibial Syndromes, Anterior
MN = C05.651.180.063
MN = C14.907.303.063
MH_TH = NLM (1972)
ST = T047
AN = in tibia; note X ref: restricted to anterior muscle
PI = Muscular Diseases (1966-1971)
PI = Tibia (1966-1971)
PI = Vascular Diseases (1966-1971)
MS = Rapid swelling, increased tension, pain, and ischemic necrosis of the muscles of the anterior tibial compartment of the leg, often following excessive PHYSICAL EXERTION.
PM = 91,72-80; was see under COMPARTMENT SYNDROMES 1981-90; was heading 1972-80
HN = 91(81)72; was see under COMPARTMENT SYNDROMES 1981-90; was heading 1972-80
CATSH = CAT LIST
MR = 20080709
DA = 19990101
DC = 1
DX = 19720101
UI = D000868

*NEWRECORD
RECTYPE = D
MH = Anterior Eye Segment
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Anterior Eye Segments
ENTRY = Eye Segment, Anterior
ENTRY = Eye Segments, Anterior
ENTRY = Segment, Anterior Eye
ENTRY = Segments, Anterior Eye
MN = A09.371.060
MH_TH = NLM (1985)
ST = T023
AN = do not confuse with ANTERIOR CHAMBER
PI = Anterior Chamber (1966-1984)
PI = Cornea (1966-1984)
PI = Eye (1966-1984)
MS = The front third of the eyeball that includes the structures between the front surface of the cornea and the front of the VITREOUS BODY.
PM = 85
HN = 85
MR = 20070709
DA = 19840430
DC = 1
DX = 19850101
UI = D000869

*NEWRECORD
RECTYPE = D
MH = Anterior Horn Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Anterior Horn Neurons|T025|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Neurons, Anterior Horn|T025|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Neurons, Ventral Horn|T025|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Ventral Horn Cells|T025|NON|EQV|NLM (1994)|920903|abcdef
PRINT ENTRY = Ventral Horn Neurons|T025|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Anterior Horn Cell
ENTRY = Anterior Horn Neuron
ENTRY = Cell, Anterior Horn
ENTRY = Cell, Ventral Horn
ENTRY = Cells, Anterior Horn
ENTRY = Cells, Ventral Horn
ENTRY = Neuron, Anterior Horn
ENTRY = Neuron, Ventral Horn
ENTRY = Ventral Horn Cell
ENTRY = Ventral Horn Neuron
MN = A08.186.854.729.500
MN = A08.675.655.500.050
MN = A11.671.655.500.050
MH_TH = NLM (1964)
ST = T025
MS = MOTOR NEURONS in the anterior (ventral) horn of the SPINAL CORD which project to SKELETAL MUSCLES.
OL = search MOTOR NEURONS 1966-74
PM = 91; was see under MOTOR NEURONS 1973-90
HN = 91(64); was see under MOTOR NEURONS 1964-90 (Prov 1964-72)
MR = 19991103
DA = 19990101
DC = 1
DX = 19910101
UI = D000870

*NEWRECORD
RECTYPE = D
MH = Anthelmintics
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Vermifuges|T121|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Antihelmintics|T121|NON|EQV|NLM (2009)|071023|abcdef
MN = D27.505.954.122.250.075
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = general or unspecified; prefer specific groups
MS = Agents destructive to parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.
MR = 20140625
DA = 19990101
DC = 1
UI = D000871

*NEWRECORD
RECTYPE = D
MH = Anthocyanins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Anthocyanidin|T109|NON|NRW|NLM (2003)|011019|abcdef
ENTRY = Anthocyanidins|T109|NON|NRW|NLM (2003)|020628|abcdef
ENTRY = Anthocyanin|T109|NON|EQV|NLM (2003)|abcde
ENTRY = Leucoanthocyanidins|T109|NON|NRW|NLM (2003)|020628|abcdef
MN = D03.383.663.283.266.450.087
MN = D03.438.150.266.450.087
MN = D09.408.084
MN = D23.767.124
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = A group of FLAVONOIDS derived from FLAVONOLS, which lack the ketone oxygen at the 4-position. They are glycosylated versions of cyanidin, pelargonidin or delphinidin. The conjugated bonds result in blue, red, and purple colors in flowers of plants.
PM = 1963; ANTHOCYANIN was indexed under ANTHOCYANINS
HN = 1963; for ANTHOCYANIN use ANTHOCYANINS (NM)
MR = 20150622
DA = 19990101
DC = 1
UI = D000872

*NEWRECORD
RECTYPE = D
MH = Anthracenes
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Anthrones|T109|NON|NRW|NLM (2004)|021216|abcdef
MN = D02.455.426.559.847.117
MN = D04.615.117
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = X ref ANTHRONES: for two ketone groups use ANTHRAQUINONES
MS = A group of compounds with three aromatic rings joined in linear arrangement.
MR = 20060705
DA = 19990101
DC = 1
UI = D000873

*NEWRECORD
RECTYPE = D
MH = Anthracosilicosis
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anthracosilicoses
MN = C08.381.483.581.062.500
MN = C08.381.483.581.760.125
MN = C08.381.520.702.062.500
MN = C08.381.520.702.760.125
MN = C24.800.834.201
MH_TH = NLM (1966)
ST = T037
ST = T047
AN = do not coordinate with OCCUPATIONAL DISEASES
MS = A form of pneumoconiosis caused by inhalation of dust that contains both CARBON and crystalline SILICON DIOXIDE. These foreign matters induce fibrous nodule formation in the lung.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D000874

*NEWRECORD
RECTYPE = D
MH = Anthralin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 1,8-Dihydroxy-9-anthrone|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1991)|900223|DIHYDROXYANTHRONE 010809|abbcdeefs
PRINT ENTRY = Dithranol|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741111|abbcdeeef
ENTRY = 1,8,9-Anthracenetriol|T109|T121|NON|EQV|UNK (19XX)|800917|abbcdef
ENTRY = 1,8-Dihydroxy-9(10H)-anthracenone|T109|T121|NON|EQV|NLM (1995)|930901|abbcdef
ENTRY = Anthraforte|T109|T121|TRD|NRW|US|041015|abbcdef
ENTRY = Anthranol|T109|T121|TRD|NRW|MX|041015|abbcdef
ENTRY = Bioglan Brand of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = Cahill May Roberts Brand of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = Cignolin|T109|T121|TRD|NRW|UNK (19XX)|800917|abbcdef
ENTRY = Cygnoline|T109|T121|TRD|NRW|UNK (19XX)|840920|abbcdef
ENTRY = Dermal Brand of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = Dihydroxyanthranol|T109|T121|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = Dithrocream|T109|T121|TRD|NRW|AU|IE|UK|041015|abbcdeeef
ENTRY = Ditranol FNA|T109|T121|TRD|NRW|NL|041015|abbcdef
ENTRY = FNA Brand of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = Hamilton Brand of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = Lasan|T109|T121|TRD|NRW|US|041015|abbcdef
ENTRY = Micanol|T109|T121|TRD|NRW|ES|IE|UK|041015|abbcdeeef
ENTRY = Psoradrate|T109|T121|TRD|NRW|UNK (19XX)|830914|abbcdef
ENTRY = Psoricrme|T109|T121|TRD|NRW|NL|041015|abbcdef
ENTRY = Schering-Plough Brand of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = Stiefel Brand 1 of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = Stiefel Brand 2 of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = Vinas Brand of Anthralin|T109|T121|NON|NRW|NLM (2006)|050523|abbcdef
ENTRY = 1,8 Dihydroxy 9 anthrone
ENTRY = Schering Plough Brand of Anthralin
MN = D02.455.426.559.847.117.050
MN = D04.615.117.050
PA = Dermatologic Agents
MH_TH = FDA SRS (2014)
MH_TH = USP (19XX)
ST = T109
ST = T121
RN = U8CJK0JH5M
RR = 480-22-8 (Anthralin)
PI = Anthracenes (1968-1974)
MS = An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
PM = 87; was see under ANTHRACENES 1975-86
HN = 87(75); was see under ANTHRACENES 1975-86
MR = 20130708
DA = 19741119
DC = 1
DX = 19870101
UI = D000875

*NEWRECORD
RECTYPE = D
MH = Anthramycin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anthramycin, (11a alpha)-Isomer|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Antramycin|T109|T195|NON|EQV|FDA SRS (2014)|INN (19XX)|940825|abbcdeef
MN = D03.438.079.080.070.050
MN = D03.494.060
PA = Antibiotics, Antineoplastic
MH_TH = FDA SRS (2014)
MH_TH = USAN (1966)
ST = T109
ST = T195
N1 = 2-Propenamide, 3-(5,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1H-pyrrolo(2,1-c)(1,4)benzodiazepin-2-yl)-, (11R-(2(E),11alpha,11abeta))-
RN = 0WZD9Y66WN
RR = 35599-87-2 ((11a alpha)-isomer)
RR = 4803-27-4 (Anthramycin)
PI = Acrylamides (1973-1974)
PI = Benzodiazepinones (1974)
PI = Pyrroles (1972-1974)
MS = A broad-spectrum spectrum antineoplastic antibiotic isolated from Streptomyces refuineus var. thermotolerans. It has low toxicity, some activity against Trichomonas and Endamoeba, and inhibits RNA and DNA synthesis. It binds irreversibly to DNA.
PM = 91; was see under BENZODIAZEPINONES 1975-90
HN = 91(75); was see under BENZODIAZEPINONES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D000876

*NEWRECORD
RECTYPE = D
MH = Anthranilate Phosphoribosyltransferase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Phosphoribosylanthranilate Pyrophosphorylase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Anthranilate PR Transferase|T116|T126|ACX|EQV|NLM (2002)|000913|abbcdef
ENTRY = PR Transferase, Anthranilate
ENTRY = Phosphoribosyltransferase, Anthranilate
ENTRY = Pyrophosphorylase, Phosphoribosylanthranilate
MN = D08.811.600.075
MN = D08.811.913.400.725.160
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = N-(5-Phospho-D-ribosyl)-anthranilate:pyrophosphate phospho-alpha-D-ribosyltransferase
RN = EC 2.4.2.18
RR = 9059-35-2 (CAS RN)
PI = Anthranilic Acids (1972-1974)
PI = Pentosephosphates (1972-1974)
PI = Pentosyltransferases (1972-1974)
PI = Pyrophosphoric Acids (1972-1974)
MS = An enzyme that catalyzes the formation of N-5'-phosphoribosylanthranilic acid from anthranilate and phosphoribosylpyrophosphate, the first step in tryptophan synthesis in E. coli. It exists in a complex with ANTHRANILATE SYNTHASE in bacteria. EC 2.4.2.18.
PM = 91; was see under PENTOSYLTRANSFERASES 1975-90
HN = 91(75); was see under PENTOSYLTRANSFERASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D000877

*NEWRECORD
RECTYPE = D
MH = Anthranilate Synthase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Anthranilate Synthetase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Anthranilate Synthase Component I|T116|T126|NON|NRW|UNK (19XX)|811202|abbcdef
ENTRY = Synthase, Anthranilate
ENTRY = Synthetase, Anthranilate
MN = D08.811.520.224.600.200
MN = D08.811.600.085
MH_TH = NLM (1974)
ST = T116
ST = T126
N1 = Chorismate pyruvate-lyase (amino-accepting)
RN = EC 4.1.3.27
RR = 9031-59-8 (CAS RN)
MS = An enzyme that catalyzes the formation of anthranilate (o-aminobenzoate) and pyruvic acid from chorismate and glutamine. Anthranilate is the biosynthetic precursor of tryptophan and numerous secondary metabolites, including inducible plant defense compounds. EC 4.1.3.27.
PM = 74
HN = 74
MR = 20040719
DA = 19990101
DC = 1
DX = 19740101
UI = D000878

*NEWRECORD
RECTYPE = D
MH = Anthraquinones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Anthracenediones|T109|NON|EQV|NLM (1991)|900303|abcdef
ENTRY = Anthranoids|T109|NON|EQV|NLM (2004)|030109|abcdef
ENTRY = Anthraquinone Compounds|T109|NON|EQV|NLM (2015)|140205|abcdef
ENTRY = Anthraquinone Derivatives|T109|NON|EQV|NLM (2015)|140219|abcdef
ENTRY = Compounds, Anthraquinone
ENTRY = Derivatives, Anthraquinone
MN = D02.455.426.559.847.117.159
MN = D02.806.100
MN = D04.615.117.159
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Compounds based on ANTHRACENES which contain two KETONES in any position. Substitutions can be in any position except on the ketone groups.
PM = EMODIN was see under CATHARTICS 1963-74
MR = 20140606
DA = 19990101
DC = 1
UI = D000880

*NEWRECORD
RECTYPE = D
MH = Anthrax
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
MN = C01.252.410.090.072
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = Bacillus infect; human & animal; /vet permitted
MS = An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin (cutaneous anthrax), the lungs (inhalation anthrax), or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000881

*NEWRECORD
RECTYPE = D
MH = Haplorhini
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Anthropoidea|T015|NON|REL|NLM (1992)|901101|abcdef
PRINT ENTRY = Monkeys|T015|NON|NRW|UNK (19XX)|800522|abcdef
ENTRY = Anthropoids|T015|NON|REL|UNK (19XX)|800509|abcdef
ENTRY = Monkey
MN = B01.050.150.900.649.801.400
MH_TH = NLM (1975)
ST = T015
AN = note X refs; many Old World & New World monkey families & genera are available: diseases of monkey families & genera: coordinate IM with MONKEY DISEASES (IM); Manual 22.28+
MS = A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes).
OL = use HAPLORHINI to search ANTHROPOIDEA 1975-91 & MONKEYS 1966-80; use PRIMATES to search ANTHROPOIDS 1966-74
PM = 92; was ANTHROPOIDEA 1981-91; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80
HN = 92; was ANTHROPOIDEA 1981-91; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80
MR = 20090706
DA = 19990101
DC = 1
DX = 19810101
UI = D000882

*NEWRECORD
RECTYPE = D
MH = Anthropology
DE = ANTHROPOL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = F04.096.879.201
MN = I01.076
FX = Hominidae
MH_TH = BIOETHICS (1999)
MH_TH = POPLINE (1984)
ST = T090
AN = IM as SPEC: SPEC qualif; HOMINIDAE is available as taxonomic Man; NIM as coord with no qualif; med anthropology: do not coord with MEDICINE; DF: ANTHROPOL
MS = The science devoted to the comparative study of man.
CATSH = CAT LIST
MR = 19991228
DA = 19990101
DC = 1
UI = D000883

*NEWRECORD
RECTYPE = D
MH = Anthropology, Cultural
DE = ANTHROPOL CULTURAL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Ethnography|T090|NON|NRW|NLM (1993)|911106|abcdef
ENTRY = Cultural Anthropology|T090|NON|EQV|NLM (1994)|920821|CULTURAL ANTHROPOL|abcdefv
ENTRY = Ethnographies
MN = I01.076.201
FX = Ethnopsychology
FX = Qualitative Research
MH_TH = NLM (1978)
ST = T090
AN = IM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate
PI = Anthropology (1966-1967)
PI = Australoid Race (1966-1967)
PI = Blacks (1966-1967)
PI = Caucasoid Race (1966-1967)
PI = Ethnology (1966-1967)
PI = Ethnopsychology (1966-1967)
PI = Mongoloid Race (1966-1967)
MS = It is the study of social phenomena which characterize the learned, shared, and transmitted social activities of particular ethnic groups with focus on the causes, consequences, and complexities of human social and cultural variability.
PM = 68
HN = 68
MR = 20140606
DA = 19990101
DC = 1
DX = 19680101
UI = D000884

*NEWRECORD
RECTYPE = D
MH = Anthropology, Physical
DE = ANTHROPOL PHYSICAL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Physical Anthropology|T090|NON|EQV|NLM (1994)|920821|PHYSICAL ANTHROPOL|abcdefv
MN = I01.076.368
FX = Anthropometry
FX = Biometry
FX = Genetics, Medical
MH_TH = NLM (1968)
ST = T090
AN = IM as SPEC: SPEC qualif; NIM as coord, no qualif; DF: ANTHROPOL PHYSICAL
PI = Anthropology (1966-1967)
PI = Anthropometry (1966-1967)
PI = Ethnology (1966-1967)
PI = Genetics, Medical (1966-1967)
MS = The comparative science dealing with the physical characteristics of humans as related to their origin, evolution, and development in the total environment.
PM = 68
HN = 68
MR = 19991103
DA = 19990101
DC = 1
DX = 19680101
UI = D000885

*NEWRECORD
RECTYPE = D
MH = Anthropometry
AQ = HI IS MT
MN = E01.370.600.024
MN = E05.041
MN = N06.850.505.200.100
FX = Body Composition
FX = Body Weights and Measures
MH_TH = POPLINE (1978)
ST = T062
AN = primate only; consider also specific terms under BODY WEIGHTS AND MEASURES
MS = The technique that deals with the measurement of the size, weight, and proportions of the human or other primate body.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D000886

*NEWRECORD
RECTYPE = D
MH = Anthroposophy
AQ = HI PX
MN = E02.190.088
MN = K01.844.058
MH_TH = NLM (1966)
ST = T090
MS = Knowledge of the nature of man. A spiritual and mystical doctrine that grew out of theosophy and derives mainly from the philosophy of Rudolph Steiner, Austrian social philosopher (1861-1925). (Webster, 3d ed)
PM = 67,63-65
HN = 67,63-65
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
UI = D000887

*NEWRECORD
RECTYPE = D
MH = Antibodies, Anti-Idiotypic
DE = ANTIBODIES ANTI ID
DS = ANTIBODIES ANTIIDIOTYPIC
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Anti-Antibodies|T129|NON|BRD|NLM (1990)|881214|ANTIANTIBODIES|abcdefs
PRINT ENTRY = Anti-Idiotype Antibodies|T116|T129|NON|EQV|NLM (1990)|890227|ANTIIDIOTYPE ANTIBODIES|ANTI ID ANTIBODIES|abbcdefsv
PRINT ENTRY = Antibodies, Internal Image|T129|NON|REL|NLM (1995)|940329|abcdef
PRINT ENTRY = Antigamma Globulin Antibodies|T129|NON|BRD|UNK (19XX)|740329|abcdef
PRINT ENTRY = Antiglobulins|T129|NON|BRD|UNK (19XX)|740329|abcdef
ENTRY = Anti Antibodies|T129|NON|BRD|UNK (19XX)|780126|abcdef
ENTRY = Anti-gamma Globulin Antibodies|T129|NON|BRD|NLM (2006)|050419|abcdef
ENTRY = Anti Idiotype Antibodies
ENTRY = Anti gamma Globulin Antibodies
ENTRY = Anti-Idiotypic Antibodies
ENTRY = Antibodies, Anti
ENTRY = Antibodies, Anti Idiotypic
ENTRY = Antibodies, Anti-Idiotype
ENTRY = Antibodies, Anti-gamma Globulin
ENTRY = Antibodies, Antigamma Globulin
ENTRY = Globulin Antibodies, Anti-gamma
ENTRY = Globulin Antibodies, Antigamma
ENTRY = Image Antibodies, Internal
ENTRY = Internal Image Antibodies
MN = D12.776.124.486.485.114.071
MN = D12.776.124.790.651.114.071
MN = D12.776.377.715.548.114.071
PA = Immunologic Factors
FX = Immunoglobulin Idiotypes
FX = Molecular Mimicry
MH_TH = NLM (1990)
ST = T116
ST = T129
RN = 0
AN = use only for anti-immunoglobulin antibodies such as anti-IGA antibodies, anti-IGG antibodies, etc.: coordinate IM with IMMUNOGLOBULIN A (IM), IMMUNOGLOBULIN G (IM), etc.; caution: anti-liver antibodies for example = ANTIBODIES + LIVER /immunol, not ANTI-ANTIBODIES
MS = Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
OL = use ANTIBODIES, ANTI-IDIOTYPIC to search ANTI-ANTIBODIES 1966-89
PM = 90; was ANTI-ANTIBODIES 1967-89
HN = 90; was ANTI-ANTIBODIES 1966-89 (Prov 1966)
MR = 20130709
DA = 19990101
DC = 1
DX = 19670101
UI = D000888

*NEWRECORD
RECTYPE = D
MH = Anti-Arrhythmia Agents
DS = ANTIARRHYTHMIA AGENTS
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antifibrillatory Agents|T121|NON|NRW|UNK (19XX)|750711|abcdef
PRINT ENTRY = Cardiac Depressants|T121|NON|REL|UNK (19XX)|750711|abcdef
PRINT ENTRY = Myocardial Depressants|T121|NON|REL|UNK (19XX)|750711|abcdef
ENTRY = Anti-Arrhythmia Drugs|T121|NON|EQV|NLM (1996)|941024|abcdef
ENTRY = Anti-Arrhythmics|T121|NON|EQV|NLM (1996)|940719|ANTIARRHYTHMICS|abcdefv
ENTRY = Antiarrhythmia Agents|T121|NON|EQV|NLM (1996)|950122|abcdef
ENTRY = Antiarrhythmia Drugs|T121|NON|EQV|NLM (1996)|950122|abcdef
ENTRY = Antiarrhythmic Drugs|T121|NON|EQV|NLM (1996)|941024|abcdef
ENTRY = Agents, Anti-Arrhythmia
ENTRY = Agents, Antiarrhythmia
ENTRY = Agents, Antifibrillatory
ENTRY = Anti Arrhythmia Agents
ENTRY = Anti Arrhythmia Drugs
ENTRY = Anti Arrhythmics
ENTRY = Depressants, Cardiac
ENTRY = Depressants, Myocardial
ENTRY = Drugs, Anti-Arrhythmia
ENTRY = Drugs, Antiarrhythmia
ENTRY = Drugs, Antiarrhythmic
MN = D27.505.954.411.097
FX = Adrenergic beta-Antagonists
FX = Calcium Channel Blockers
MH_TH = NLM (1976)
ST = T121
RN = 0
AN = consider also ARRHYTHMIAS, CARDIAC /drug ther
MS = Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
OL = use ANTI-ARRHYTHMIA AGENTS to search MYOCARDIAL DEPRESSANTS 1966-75
PM = 76; was MYOCARDIAL DEPRESSANTS 1963-75
HN = 76; was NON MESH before 1976; MYOCARDIAL DEPRESSANTS was heading 1963-75
MR = 20140625
DA = 19750725
DC = 1
DX = 19760101
UI = D000889

*NEWRECORD
RECTYPE = D
MH = Anti-Infective Agents
DE = ANTI INFECT AGENTS
DS = ANTIINFECTIVE AGENTS
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Microbicides|T121|NON|NRW|NLM (2003)|010912|abcdef
ENTRY = Anti-Microbial Agents|T121|NON|NRW|NLM (2006)|050111|abcdef
ENTRY = Antiinfective Agents|T121|NON|EQV|UNK (19XX)|810521|ANTIINFECT AGENTS|abcdefv
ENTRY = Antimicrobial Agents|T121|NON|NRW|NLM (2006)|050111|abcdef
ENTRY = Agents, Anti-Infective
ENTRY = Agents, Anti-Microbial
ENTRY = Agents, Antiinfective
ENTRY = Agents, Antimicrobial
ENTRY = Anti Infective Agents
ENTRY = Anti Microbial Agents
MN = D27.505.954.122
FX = Anthelmintics
FX = Antiprotozoal Agents
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = general or unspecified; prefer specific groups
MS = Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
MR = 20140625
DA = 19990101
DC = 1
UI = D000890

*NEWRECORD
RECTYPE = D
MH = Anti-Infective Agents, Local
DE = ANTI INFECT AGENTS LOCAL
DS = ANTIINFECTIVE AGENTS LOCAL
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Anti-Infective Agents, Topical|T121|NON|EQV|NLM (1996)|940727|ANTIINFECTIVE AGENTS TOPICAL|ANTI INFECT AGENTS TOPICAL|abcdefsv
PRINT ENTRY = Antiseptics|T121|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Microbicides, Local|T121|NON|NRW|NLM (2003)|010912|abcdef
PRINT ENTRY = Microbicides, Topical|T121|NON|NRW|NLM (2003)|010912|abcdef
ENTRY = Antiinfective Agents, Local|T121|NON|EQV|UNK (19XX)|810521|ANTIINFECT AGENTS LOCAL|abcdefv
ENTRY = Antiinfective Agents, Topical|T121|NON|EQV|NLM (1996)|940727|ANTIINFECT AGENTS TOPICAL|abcdefv
ENTRY = Local Anti-Infective Agents|T121|NON|EQV|UNK (19XX)|810521|LOCAL ANTI INFECT AGENTS|abcdefv
ENTRY = Local Antiinfective Agents|T121|NON|EQV|UNK (19XX)|810521|LOCAL ANTIINFECT AGENTS|abcdefv
ENTRY = Topical Anti-Infective Agents|T121|NON|EQV|NLM (1996)|940727|TOPICAL ANTI INFECT AGENTS|abcdefv
ENTRY = Topical Antiinfective Agents|T121|NON|EQV|NLM (1996)|940727|TOPICAL ANTIINFECT AGENTS|abcdefv
ENTRY = Agents, Local Anti-Infective
ENTRY = Agents, Local Antiinfective
ENTRY = Agents, Topical Anti-Infective
ENTRY = Agents, Topical Antiinfective
ENTRY = Anti Infective Agents, Local
ENTRY = Anti Infective Agents, Topical
ENTRY = Local Anti Infective Agents
ENTRY = Topical Anti Infective Agents
MN = D27.505.954.122.187
FX = Disinfectants
MH_TH = NLM (1967)
ST = T121
RN = 0
MS = Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects.
OL = use ANTI-INFECTIVE AGENTS, LOCAL to search ANTISEPTICS 1966; search ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM under ANTI-INFECTIVE AGENTS 1966
PM = 67; ANTISEPTICS & ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66
HN = 67; ANTISEPTICS & ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66
MR = 20140625
DA = 19990101
DC = 1
DX = 19670101
UI = D000891

*NEWRECORD
RECTYPE = D
MH = Anti-Infective Agents, Urinary
DE = ANTI INFECT AGENTS URINARY
DS = ANTIINFECTIVE AGENTS URINARY
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antiseptics, Urinary|T121|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Antiinfective Agents, Urinary|T121|NON|EQV|UNK (19XX)|810521|ANTIINFECT AGENTS URINARY|abcdefv
ENTRY = Urinary Anti-Infective Agents|T121|NON|EQV|UNK (19XX)|810521|URINARY ANTI INFECT AGENTS|abcdefv
ENTRY = Urinary Antiinfective Agents|T121|NON|EQV|UNK (19XX)|810521|URINARY ANTIINFECT AGENTS|abcdefv
ENTRY = Agents, Urinary Anti-Infective
ENTRY = Agents, Urinary Antiinfective
ENTRY = Anti Infective Agents, Urinary
ENTRY = Urinary Anti Infective Agents
ENTRY = Urinary Antiseptics
MN = D27.505.954.122.237
MN = D27.505.954.613.056
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = consider also URINARY TRACT INFECTIONS /drug ther
MS = Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.
PM = 66
HN = 66
MR = 20140625
DA = 19990101
DC = 1
DX = 19660101
UI = D000892

*NEWRECORD
RECTYPE = D
MH = Anti-Inflammatory Agents
DE = ANTI INFLAMM AGENTS
DS = ANTIINFLAMMATORY AGENTS
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Agents, Anti-Inflammatory|T121|NON|EQV|NLM (1996)|950315|AGENTS ANTI INFLAMM|abcdefv
ENTRY = Agents, Antiinflammatory|T121|NON|EQV|NLM (1996)|950309|AGENTS ANTIINFLAMM|abcdefv
ENTRY = Anti-Inflammatories|T121|NON|EQV|NLM (1996)|950316|ANTI INFLAMM|abcdefv
ENTRY = Antiinflammatories|T121|NON|EQV|NLM (1996)|950217|ANTIINFLAMM|abcdefv
ENTRY = Antiinflammatory Agents|T121|NON|EQV|UNK (19XX)|860625|ANTIINFLAMM AGENTS|abcdefv
ENTRY = Agents, Anti Inflammatory
ENTRY = Anti Inflammatories
ENTRY = Anti Inflammatory Agents
MN = D27.505.954.158
MH_TH = NLM (1964)
ST = T121
RN = 0
AN = do not confuse with INFLAMMATION MEDIATORS; DF: ANTI INFLAMM AGENTS or ANTIINFLAMM AGENTS
MS = Substances that reduce or suppress INFLAMMATION.
PM = 66
HN = 66(64)
MR = 20140625
DA = 19990101
DC = 1
DX = 19660101
UI = D000893

*NEWRECORD
RECTYPE = D
MH = Anti-Inflammatory Agents, Non-Steroidal
DE = NSAID
DS = ANTIINFLAMMATORY AGENTS NONSTEROIDAL
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Analgesics, Anti-Inflammatory|T121|NON|NRW|UNK (1990)|890511|ANALGESICS ANTIINFLAMMATORY|ANALGESICS ANTI INFLAMM|abcdefsv
PRINT ENTRY = Anti-Rheumatic Agents, Non-Steroidal|T121|NON|REL|NLM (1990)|890511|ANTIRHEUMATIC AGENTS NONSTEROIDAL|abcdefs
PRINT ENTRY = Aspirin-Like Agents|T121|NON|NRW|UNK (19XX)|860623|abcdef
PRINT ENTRY = Non-Steroidal Anti-Inflammatory Agents|T121|NON|EQV|UNK (19XX)|860623|NONSTEROIDAL ANTIINFLAMMATORY AGENTS|NON STEROIDAL ANTI INFLAMM AGENTS|abcdefsv
ENTRY = Anti Inflammatory Agents, Nonsteroidal|T121|NON|EQV|UNK (19XX)|860711|ANTI INFLAMM AGENTS NONSTEROIDAL|abcdefv
ENTRY = Antiinflammatory Agents, Non Steroidal|T121|NON|EQV|UNK (19XX)|860625|ANTIINFLAMM AGENTS NON STEROIDAL|abcdefv
ENTRY = Antiinflammatory Agents, Nonsteroidal|T121|NON|EQV|NLM (1991)|900329|AIANS|abcdefv
ENTRY = Antirheumatic Agents, Non-Steroidal|T121|NON|REL|NLM (1993)|920427|abcdef
ENTRY = NSAIDs|T121|ABB|EQV|NLM (1995)|940131|abcdef
ENTRY = Nonsteroidal Anti-Inflammatory Agents|T121|NON|EQV|NLM (1991)|900329|NSAIA|abcdefv
ENTRY = Agents, Aspirin-Like
ENTRY = Agents, Non-Steroidal Anti-Inflammatory
ENTRY = Agents, Non-Steroidal Anti-Rheumatic
ENTRY = Agents, Non-Steroidal Antirheumatic
ENTRY = Agents, Nonsteroidal Anti-Inflammatory
ENTRY = Agents, Nonsteroidal Antiinflammatory
ENTRY = Analgesics, Anti Inflammatory
ENTRY = Anti Inflammatory Agents, Non Steroidal
ENTRY = Anti Rheumatic Agents, Non Steroidal
ENTRY = Anti-Inflammatory Agents, Nonsteroidal
ENTRY = Anti-Inflammatory Analgesics
ENTRY = Antirheumatic Agents, Non Steroidal
ENTRY = Aspirin Like Agents
ENTRY = Non Steroidal Anti Inflammatory Agents
ENTRY = Non-Steroidal Anti-Rheumatic Agents
ENTRY = Non-Steroidal Antirheumatic Agents
ENTRY = Nonsteroidal Anti Inflammatory Agents
ENTRY = Nonsteroidal Antiinflammatory Agents
MN = D27.505.696.663.850.014.040.500
MN = D27.505.954.158.030
MN = D27.505.954.329.030
MH_TH = NLM (1987)
ST = T121
RN = 0
PI = Analgesics, Anti-Inflammatory (1966-1986)
PI = Anti-Inflammatory Agents (1966-1986)
MS = Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
OL = use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL to search ANALGESICS, ANTI-INFLAMMATORY 1975-89
PM = 87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89
HN = 87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89
MR = 20130708
DA = 19860623
DC = 1
DX = 19870101
UI = D000894

*NEWRECORD
RECTYPE = D
MH = Anti-Ulcer Agents
DS = ANTIULCER AGENTS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anti-Ulcer Drugs|T121|NON|EQV|NLM (1995)|940407|abcdef
ENTRY = Agents, Anti-Ulcer
ENTRY = Anti Ulcer Agents
ENTRY = Anti Ulcer Drugs
ENTRY = Drugs, Anti-Ulcer
MN = D27.505.954.483.203
FX = Antacids
FX = Histamine H2 Antagonists
MH_TH = NLM (1977)
ST = T121
RN = 0
AN = restrict to gastrointestinal ulcers
PI = Antacids (1966-1976)
PI = Gastrointestinal Agents (1966-1976)
MS = Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
PM = 77
HN = 77
MR = 20050630
DA = 19760416
DC = 1
DX = 19770101
UI = D000897

*NEWRECORD
RECTYPE = D
MH = Antibiosis
AQ = DE GE IM PH RE
PRINT ENTRY = Bacterial Interference|T070|NON|NRW|NLM (1997)|960326|BACT INTERFERENCE|abcdefv
PRINT ENTRY = Microbial Antagonism|T070|NON|EQV|UNK (19XX)|860619|abcdef
ENTRY = Interference, Bacterial|T070|NON|NRW|NLM (1997)|960326|INTERFERENCE BACT|abcdefv
ENTRY = Antagonism, Microbial
ENTRY = Antagonisms, Microbial
ENTRY = Antibioses
ENTRY = Bacterial Interferences
ENTRY = Interferences, Bacterial
ENTRY = Microbial Antagonisms
MN = G06.590.580.050
MN = G16.100.065
MH_TH = NLM (1965)
ST = T070
MS = A natural association between organisms that is detrimental to at least one of them. This often refers to the production of chemicals by one microorganism that is harmful to another.
PM = 72
HN = 72(65)
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D000898

*NEWRECORD
RECTYPE = D
MH = Aurodox
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Goldinodox|T118|T121|NON|EQV|UNK (19XX)|800331|abbcdef
ENTRY = Antibiotic X 5108|T118|T121|LAB|NRW|NLM (1991)|900228|abbcdef
ENTRY = Goldinomycin|T118|T121|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = N-Methylkirromycin|T118|T121|NON|EQV|NLM (1992)|910225|abbcdef
ENTRY = X-5108|T118|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = X5108|T118|T121|LAB|NRW|UNK (19XX)|820903|abbcdef
ENTRY = N Methylkirromycin
ENTRY = X 5108
MN = D02.455.326.271.665.155
PA = Anti-Bacterial Agents
MH_TH = NLM (1976)
ST = T118
ST = T121
N1 = Mocimycin, 1-methyl-
RN = 12704-90-4
PI = Furans (1974-1975)
PI = Pyridones (1974-1975)
MS = Antibiotic obtained from a Streptomyces variant considered as possibly effective against Streptococcus pyogenes infections. It may promote growth in poultry.
OL = use AURODOX to search ANTIBIOTIC X 5108 1976-90
PM = 91; was ANTIBIOTIC X 5108 see under ANTIBIOTICS 1976-90
HN = 91(76); was ANTIBIOTIC X 5108 see under ANTIBIOTICS 1976-90
MR = 20040707
DA = 19750721
DC = 1
DX = 19910101
UI = D000899

*NEWRECORD
RECTYPE = D
MH = Anti-Bacterial Agents
DS = ANTIBACTERIAL AGENTS
AQ = AD AE AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antibiotics|T195|NON|REL|NLM (1963)|990101|abcdef
ENTRY = Anti-Mycobacterial Agents|T195|NON|NRW|NLM (2004)|030418|abcdef
ENTRY = Antibacterial Agents|T195|NON|EQV|NLM (2004)|030418|abcdef
ENTRY = Antimycobacterial Agents|T195|NON|NRW|NLM (2004)|030418|abcdef
ENTRY = Bacteriocidal Agents|T195|NON|NRW|NLM (2004)|030418|abcdef
ENTRY = Bacteriocides|T195|NON|NRW|NLM (2004)|030418|abcdef
ENTRY = Agents, Anti-Bacterial
ENTRY = Agents, Anti-Mycobacterial
ENTRY = Agents, Antibacterial
ENTRY = Agents, Antimycobacterial
ENTRY = Agents, Bacteriocidal
ENTRY = Anti Bacterial Agents
ENTRY = Anti Mycobacterial Agents
MN = D27.505.954.122.085
MH_TH = NLM (2004)
ST = T195
RN = 0
AN = GEN or unspecified; resistance to antibiotics = DRUG RESISTANCE, BACTERIAL or specifics; preop use of antibiotics for prev of infect: index under ANTIBIOTIC PROPHYLAXIS (IM) + specific antibiotic /ther use (IM)
MS = Substances that reduce the growth or reproduction of BACTERIA.
PM = 2004; see ANTIBIOTICS 1963-2003
HN = 2004(1963)
MR = 20140625
DA = 19990101
DC = 1
UI = D000900

*NEWRECORD
RECTYPE = D
MH = Antibiotics, Antineoplastic
DE = ANTIBIOTICS ANTINEOPL
AQ = AD AE AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antineoplastic Antibiotics|T121|NON|EQV|NLM (1996)|950316|ANTINEOPL ANTIBIOTICS|abcdefv
PRINT ENTRY = Cytotoxic Antibiotics|T121|NON|NRW|UNK (19XX)|740320|CYTOTOX ANTIBIOTICS|abcdefv
ENTRY = Antibiotics, Cytotoxic|T121|NON|NRW|NLM (1996)|950316|ANTIBIOTICS CYTOTOX|abcdefv
MN = D27.505.954.248.106
MH_TH = NLM (1967)
ST = T121
RN = 0
AN = GEN: prefer specifics
PI = Antibiotics (1966)
PI = Antineoplastic Agents (1966)
MS = Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.
PM = 67
HN = 67
MR = 20140625
DA = 19990101
DC = 1
DX = 19670101
UI = D000903

*NEWRECORD
RECTYPE = D
MH = Antibiotics, Antitubercular
AQ = AD AE AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Antitubercular Antibiotics
MN = D27.505.954.122.085.255.135
MH_TH = NLM (1975)
ST = T195
RN = 0
PI = Antibiotics (1966-1974)
PI = Antitubercular Agents (1966-1974)
MS = Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.
PM = 75
HN = 75
MR = 20150622
DA = 19990101
DC = 1
DX = 19750901
UI = D000904

*NEWRECORD
RECTYPE = D
MH = Antibodies
AQ = AD AE AN BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
MN = D12.776.124.486.485.114
MN = D12.776.124.790.651.114
MN = D12.776.377.715.548.114
PA = Immunologic Factors
FX = Antigen-Antibody Reactions
EC = biosynthesis:Antibody Formation
EC = deficiency:Immunologic Deficiency Syndromes
MH_TH = POPLINE (1978)
ST = T129
RN = 0
AN = antibodies to IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; etc. = ANTIBODIES, ANTI-IDIOTYPIC (IM) + IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; etc. (IM); ANTIBODY-TOXIN CONJUGATES is available as toxin carrier: see note there
MS = Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
OL = pre-explosion = ANTIBODIES (PX)
MR = 20130709
DA = 19990101
DC = 1
UI = D000906

*NEWRECORD
RECTYPE = D
MH = Antibodies, Bacterial
DE = ANTIBODIES BACT
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Bacterial Antibodies|T116|T129|NON|EQV|UNK (19XX)|740329|BACT ANTIBODIES|abbcdefv
MN = D12.776.124.486.485.114.107
MN = D12.776.124.790.651.114.125
MN = D12.776.377.715.548.114.125
PA = Immunologic Factors
MH_TH = NLM (1973)
ST = T116
ST = T129
RN = 0
AN = coordinate IM with specific bacterium /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn; DF: ANTIBODIES BACT
PI = Antibodies (1966-1972)
MS = Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
PM = 73
HN = 73
MR = 20100625
DA = 19990101
DC = 1
DX = 19730101
UI = D000907

*NEWRECORD
RECTYPE = D
MH = Antibodies, Fungal
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Fungal Antibodies|T116|T129|NON|EQV|UNK (19XX)|740329|abbcdef
MN = D12.776.124.486.485.114.179
MN = D12.776.124.790.651.114.179
MN = D12.776.377.715.548.114.179
PA = Immunologic Factors
MH_TH = NLM (1973)
ST = T116
ST = T129
RN = 0
AN = coordinate IM with specific fungus /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn
PI = Antibodies (1966-1972)
MS = Immunoglobulins produced in a response to FUNGAL ANTIGENS.
PM = 73
HN = 73
MR = 20100625
DA = 19990101
DC = 1
DX = 19730101
UI = D000908

*NEWRECORD
RECTYPE = D
MH = Antibodies, Helminth
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Helminth Antibodies|T129|NON|EQV|UNK (19XX)|870320|abcdef
MN = D12.776.124.486.485.114.185
MN = D12.776.124.790.651.114.185
MN = D12.776.377.715.548.114.185
PA = Immunologic Factors
MH_TH = NLM (1988)
ST = T129
RN = 0
AN = coordinate IM with specific helminth /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn
PI = Antibodies (1966-1987)
PI = Antigens, Helminth/immunology (1985-1987)
PI = IgE (1971-1987)
MS = Immunoglobulins produced in a response to HELMINTH ANTIGENS.
PM = 88
HN = 88
MR = 20100625
DA = 19870320
DC = 1
DX = 19880101
UI = D000909

*NEWRECORD
RECTYPE = D
MH = Antibodies, Heterophile
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Antibodies, Heterogenetic|T116|T129|NON|EQV|NLM (1990)|890110|ANTIBODIES HETEROGENET|abbcdefv
PRINT ENTRY = Antibodies, Heterotypic|T116|T129|NON|EQV|UNK (19XX)|860619|abbcdef
PRINT ENTRY = Antibodies, Xenogeneic|T116|T129|NON|EQV|NLM (1990)|890110|abbcdef
PRINT ENTRY = H-D Antibodies|T116|T129|ABX|NRW|NLM (1991)|900420|abbcdef
PRINT ENTRY = Hanganutziu-Deicher Antibodies|T116|T129|EPO|NRW|NLM (1991)|900420|abbcdef
PRINT ENTRY = Heteroantibodies|T116|T129|NON|EQV|NLM (1990)|890110|abbcdef
PRINT ENTRY = Heterologous Antibodies|T116|T129|NON|EQV|UNK (19XX)|860619|HETEROL ANTIBODIES|abbcdefv
PRINT ENTRY = Heterophile Antibodies|T116|T129|NON|EQV|UNK (19XX)|820505|abbcdef
PRINT ENTRY = P-B Antibodies|T116|T129|ABX|NRW|NLM (1991)|900420|abbcdef
PRINT ENTRY = Paul-Bunnell Antibodies|T116|T129|EPO|NRW|NLM (1991)|900420|abbcdef
PRINT ENTRY = Xenoantibodies|T116|T129|NON|EQV|NLM (1990)|890110|abbcdef
ENTRY = Antibodies, Heterologous|T116|T129|NON|EQV|UNK (19XX)|880609|ANTIBODIES HETEROL|abbcdefv
ENTRY = Antibodies, Heterophil|T116|T129|NON|EQV|NLM (1990)|890110|abbcdef
ENTRY = Antibodies, Xenogenic|T116|T129|NON|EQV|NLM (1990)|890222|abbcdef
ENTRY = Forssman Antibody|T116|T129|NON|NRW|NLM (2005)|abbcde
ENTRY = Heterogenetic Antibodies|T116|T129|NON|EQV|NLM (1990)|890222|HETEROGENET ANTIBODIES|abbcdefv
ENTRY = Antibody, Forssman
ENTRY = Heterophil Antibodies
ENTRY = Heterotypic Antibodies
ENTRY = Xenogeneic Antibodies
ENTRY = Xenogenic Antibodies
MN = D12.776.124.486.485.114.191
MN = D12.776.124.790.651.114.191
MN = D12.776.377.715.548.114.191
PA = Immunologic Factors
MH_TH = NLM (1964)
ST = T116
ST = T129
RN = 0
AN = do not coordinate with ANTIBODY FORMATION for /biosyn
MS = Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.
PM = 1987; see ANTIBODIES, HETEROTYPIC 1964-1986; FORSSMAN ANTIBODY was indexed under ANTIBODIES, HETEROPHILE 1985-2004
HN = 1987 (1964)
MR = 20050630
DA = 19990101
DC = 1
DX = 19720101
UI = D000910

*NEWRECORD
RECTYPE = D
MH = Antibodies, Monoclonal
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
PRINT ENTRY = Monoclonal Antibodies|T129|NON|EQV|UNK (19XX)|810520|abcdef
MN = D12.776.124.486.485.114.224
MN = D12.776.124.790.651.114.224
MN = D12.776.377.715.548.114.224
PA = Immunologic Factors
FX = Hybridomas
MH_TH = NLM (1982)
ST = T129
RN = 0
AN = do not coordinate with ANTIBODY FORMATION for biosyn; ANTIBODY-TOXIN CONJUGATES is available as a toxin carrier: see note there
PI = Antibodies (1975-1981)
PI = B Lymphocytes (1975-1981)
MS = Antibodies produced by a single clone of cells.
PM = 82
HN = 82
MR = 20100625
DA = 19810520
DC = 1
DX = 19820101
UI = D000911

*NEWRECORD
RECTYPE = D
MH = Antibodies, Neoplasm
DE = ANTIBODIES NEOPL
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Neoplasm Antibodies|T129|NON|EQV|UNK (19XX)|740329|NEOPL ANTIBODIES|abcdefv
PRINT ENTRY = Tumor Antibodies|T129|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Antibodies, Tumor
MN = D12.776.124.486.485.114.240
MN = D12.776.124.790.651.114.240
MN = D12.776.377.715.548.114.240
PA = Immunologic Factors
MH_TH = NLM (1973)
ST = T129
RN = 0
AN = coordinate IM with required neoplasm terms with /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn; DF: ANTIBODIES NEOPL
PI = Antibodies (1966-1972)
MS = Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS.
PM = 73
HN = 73
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000912

*NEWRECORD
RECTYPE = D
MH = Antibodies, Protozoan
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Protozoan Antibodies|T129|NON|EQV|UNK (19XX)|870316|abcdef
MN = D12.776.124.486.485.114.252
MN = D12.776.124.790.651.114.252
MN = D12.776.377.715.548.114.252
PA = Immunologic Factors
MH_TH = NLM (1988)
ST = T129
RN = 0
AN = coordinate IM with specific protozoan /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn
PI = Antibodies (1966-1987)
PI = Antigens, Protozoan/immunology (1985-1987)
MS = Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.
PM = 88
HN = 88
MR = 20100625
DA = 19870316
DC = 1
DX = 19880101
UI = D000913

*NEWRECORD
RECTYPE = D
MH = Antibodies, Viral
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Viral Antibodies|T116|T129|NON|EQV|UNK (19XX)|740329|abbcdef
MN = D12.776.124.486.485.114.254
MN = D12.776.124.790.651.114.254
MN = D12.776.377.715.548.114.254
PA = Immunologic Factors
MH_TH = NLM (1973)
ST = T116
ST = T129
RN = 0
AN = coordinate IM with specific virus /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn
PI = Antibodies (1966-1972)
MS = Immunoglobulins produced in response to VIRAL ANTIGENS.
PM = 73
HN = 73
MR = 20100625
DA = 19990101
DC = 1
DX = 19730101
UI = D000914

*NEWRECORD
RECTYPE = D
MH = Antibody Affinity
AQ = DE ES GE IM PH RE
PRINT ENTRY = Affinity, Antibody|T044|T081|NON|EQV|UNK (19XX)|771202|abbcdef
PRINT ENTRY = Antibody Avidity|T081|NON|NRW|UNK (19XX)|771202|abcdef
PRINT ENTRY = Avidity, Antibody|T081|NON|NRW|UNK (19XX)|771202|abcdef
ENTRY = Affinities, Antibody
ENTRY = Antibody Affinities
ENTRY = Antibody Avidities
ENTRY = Avidities, Antibody
MN = G12.040
MN = G12.425.143.125
MH_TH = NLM (1979)
ST = T044
ST = T081
AN = do not confuse with BINDING SITES, ANTIBODY or ANTIGENIC DETERMINANTS
PI = Antibodies (1966-1978)
PI = Antigen-Antibody Reactions (1966-1978)
PI = Antigenic Determinants (1970-1978)
PI = Binding Sites, Antibody (1973-1978)
MS = A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes.
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20080708
DA = 19771202
DC = 1
DX = 19790101
UI = D000915

*NEWRECORD
RECTYPE = D
MH = Antibody Diversity
AQ = DE GE IM PH RE
PRINT ENTRY = Germ Line Theory|T078|NON|NRW|UNK (19XX)|790223|abcdef
ENTRY = Antibody Diversities
ENTRY = Diversities, Antibody
ENTRY = Diversity, Antibody
ENTRY = Germ Line Theories
ENTRY = Theories, Germ Line
ENTRY = Theory, Germ Line
MN = G05.365.036
MN = G12.500.199
MH_TH = NLM (1980)
ST = T044
PI = Antibodies (1966-1969)
PI = Antibody Specificity (1970-1979)
MS = The phenomenon of immense variability characteristic of ANTIBODIES. It enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: (1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; (2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and (3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of IMMUNOGLOBULIN VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20150622
DA = 19790223
DC = 1
DX = 19800101
UI = D000916

*NEWRECORD
RECTYPE = D
MH = Antibody Formation
AQ = DE GE IM PH RE
PRINT ENTRY = Antibody Production|T043|NON|EQV|NLM (1998)|960725|abcdef
PRINT ENTRY = Antibody Response|T043|NON|EQV|NLM (1998)|960725|abcdef
ENTRY = Antibody Responses
ENTRY = Formation, Antibody
ENTRY = Production, Antibody
ENTRY = Response, Antibody
ENTRY = Responses, Antibody
MN = G12.425.071
FX = Clonal Selection, Antigen-Mediated
MH_TH = NLM (1966)
ST = T043
AN = general only: do not use as coordinate for formation of specific antibodies
MS = The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D000917

*NEWRECORD
RECTYPE = D
MH = Antibody Specificity
AQ = DE GE IM PH RE
ENTRY = Antibody Specificities
ENTRY = Specificities, Antibody
ENTRY = Specificity, Antibody
MN = G12.100
FX = Antibodies, Bispecific
FX = T-Cell Antigen Receptor Specificity
MH_TH = NLM (1970)
ST = T044
AN = coord IM with specific antibody (IM)
PI = Antibodies (1966-1969)
MS = The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
PM = 72
HN = 72(70)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19720101
UI = D000918

*NEWRECORD
RECTYPE = D
MH = Antibody-Coated Bacteria Test, Urinary
DE = ACBU
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Antibody Coated Bacteria Test, Urinary|T059|NON|EQV|UNK (19XX)|790307|ANTIBODY COATED BACT TEST URINARY|abcdefv
ENTRY = Urinary Antibody-Coated Bacteria Test|T059|NON|EQV|NLM (1991)|900110|URINARY ANTIBODY COATED BACT TEST|abcdefv
ENTRY = Urinary Antibody Coated Bacteria Test
MN = E01.370.225.500.607.512.240.149
MN = E01.370.225.750.551.512.240.149
MN = E01.370.225.812.049
MN = E01.370.390.050
MN = E05.200.500.607.512.240.149
MN = E05.200.750.551.512.240.149
MN = E05.200.812.049
MN = E05.478.583.375.050
MN = E05.478.594.049
MH_TH = NLM (1980)
ST = T059
AN = DF: ACBU
PI = Antibodies, Bacterial (1974-1979)
PI = Bacteriuria (1974-1979)
PI = Pyelonephritis (1974-1979)
PI = Urinary Tract Infections (1974-1979)
MS = Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively.
PM = 91; was see under FLUORESCENT ANTIBODY TECHNIQUE 1980-90
HN = 91(80); was see under FLUORESCENT ANTIBODY TECHNIQUE 1980-90
CATSH = CAT LIST
MR = 20150622
DA = 19790307
DC = 1
DX = 19910101
UI = D000919

*NEWRECORD
RECTYPE = D
MH = Antibody-Dependent Cell Cytotoxicity
DE = ANTIBODY DEPENDENT CELL CYTOTOX
AQ = DE ES GE IM PH RE
PRINT ENTRY = ADCC|T043|ABB|EQV|NLM (1995)|930929|abcdef
PRINT ENTRY = Cytotoxicity, Antibody-Dependent Cell|T043|NON|EQV|UNK (19XX)|770513|CYTOTOX ANTIBODY DEPENDENT CELL|abcdefv
ENTRY = Cell Cytoxicity, Antibody-Dependent|T043|NON|EQV|NLM (1992)|910521|CELL CYTOTOX ANTIBODY DEPENDENT|abcdefv
ENTRY = Antibody Dependent Cell Cytotoxicity
ENTRY = Antibody-Dependent Cell Cytotoxicities
ENTRY = Antibody-Dependent Cell Cytoxicities
ENTRY = Antibody-Dependent Cell Cytoxicity
ENTRY = Cell Cytotoxicities, Antibody-Dependent
ENTRY = Cell Cytotoxicity, Antibody-Dependent
ENTRY = Cell Cytoxicities, Antibody-Dependent
ENTRY = Cell Cytoxicity, Antibody Dependent
ENTRY = Cytotoxicities, Antibody-Dependent Cell
ENTRY = Cytotoxicity, Antibody Dependent Cell
ENTRY = Cytoxicities, Antibody-Dependent Cell
ENTRY = Cytoxicity, Antibody-Dependent Cell
MN = G12.425.270.070
MH_TH = NLM (1978)
ST = T043
AN = DF: note short X ref
PI = Cytotoxicity Tests, Immunologic (1971-1977)
PI = Immunity, Cellular (1970-1977)
PI = Lymphocytes (1966-1977)
MS = The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 20080708
DA = 19770513
DC = 1
DX = 19780101
UI = D000920

*NEWRECORD
RECTYPE = D
MH = Antibody-Producing Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Antibody-Secreting Cells|T025|NON|NRW|UNK (19XX)|860618|ANTIBODY SECRET CELLS|abcdefv
PRINT ENTRY = Immunoglobulin-Producing Cells|T025|NON|EQV|UNK (19XX)|860618|IG PRODUCING CELLS|abcdefv
PRINT ENTRY = Immunoglobulin-Secreting Cells|T025|NON|NRW|UNK (19XX)|860618|IG SECRET CELLS|abcdefv
ENTRY = Antibody Producing Cells
ENTRY = Antibody Secreting Cells
ENTRY = Antibody-Producing Cell
ENTRY = Antibody-Secreting Cell
ENTRY = Cell, Antibody-Producing
ENTRY = Cell, Antibody-Secreting
ENTRY = Cell, Immunoglobulin-Producing
ENTRY = Cell, Immunoglobulin-Secreting
ENTRY = Cells, Antibody-Producing
ENTRY = Cells, Antibody-Secreting
ENTRY = Cells, Immunoglobulin-Producing
ENTRY = Cells, Immunoglobulin-Secreting
ENTRY = Immunoglobulin Producing Cells
ENTRY = Immunoglobulin Secreting Cells
ENTRY = Immunoglobulin-Producing Cell
ENTRY = Immunoglobulin-Secreting Cell
MN = A11.063
MN = A15.382.032
FX = Hemolytic Plaque Technique
MH_TH = NLM (1970)
ST = T025
AN = A 11 qualif
PI = Antibody Formation (1966-1969)
MS = Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize.
PM = 72
HN = 72(70)
MR = 20030709
DA = 19990101
DC = 1
DX = 19720101
UI = D000921

*NEWRECORD
RECTYPE = D
MH = Immunotoxins
AQ = AD AE AN BL CF CH CL CT DE EC GE HI IM IP ME PD PK PO RE TO TU UL UR
PRINT ENTRY = Antibody-Toxin Conjugates|T121|T129|NON|EQV|UNK (19XX)|860325|abbcdef
PRINT ENTRY = Antibody-Toxin Hybrids|T121|T129|NON|EQV|UNK (19XX)|860325|abbcdef
PRINT ENTRY = Chimeric Toxins|T121|NON|BRD|NLM (1991)|900420|abcdef
PRINT ENTRY = Cytotoxin-Antibody Conjugates|T121|T129|NON|EQV|NLM (1988)|881125|abbcdef
PRINT ENTRY = Targeted Toxins|T121|NON|BRD|NLM (1990)|890105|abcdef
PRINT ENTRY = Toxin Carriers|T121|NON|BRD|NLM (1990)|890105|abcdef
PRINT ENTRY = Toxin Conjugates|T121|NON|BRD|NLM (1990)|890105|abcdef
PRINT ENTRY = Toxin-Antibody Conjugates|T121|T129|NON|EQV|UNK (19XX)|860325|abbcdef
PRINT ENTRY = Toxin-Antibody Hybrids|T121|T129|NON|EQV|UNK (19XX)|860325|abbcdef
PRINT ENTRY = Toxins, Chimeric|T121|NON|BRD|NLM (1991)|900511|abcdef
PRINT ENTRY = Toxins, Targeted|T121|NON|BRD|UNK (19XX)|860325|abcdef
ENTRY = Affinotoxins|T121|T129|NON|EQV|UNK (19XX)|860325|abbcdef
ENTRY = Chimeric Toxin|T121|NON|BRD|NLM (1991)|900420|abcdef
ENTRY = Immunotoxin|T121|T129|NON|EQV|NLM (1990)|890105|abbcdef
ENTRY = Monoclonal Antibody-Toxin Conjugates|T121|T129|NON|EQV|UNK (19XX)|860325|abbcdef
ENTRY = Toxin Carrier|T121|NON|BRD|NLM (1990)|890105|abcdef
ENTRY = Toxin Conjugate|T121|NON|BRD|NLM (1990)|890105|abcdef
ENTRY = Antibody Toxin Conjugates
ENTRY = Antibody Toxin Hybrids
ENTRY = Antibody-Toxin Conjugates, Monoclonal
ENTRY = Carrier, Toxin
ENTRY = Carriers, Toxin
ENTRY = Conjugate, Toxin
ENTRY = Conjugates, Antibody-Toxin
ENTRY = Conjugates, Cytotoxin-Antibody
ENTRY = Conjugates, Monoclonal Antibody-Toxin
ENTRY = Conjugates, Toxin
ENTRY = Conjugates, Toxin-Antibody
ENTRY = Cytotoxin Antibody Conjugates
ENTRY = Hybrids, Antibody-Toxin
ENTRY = Hybrids, Toxin-Antibody
ENTRY = Monoclonal Antibody Toxin Conjugates
ENTRY = Toxin Antibody Conjugates
ENTRY = Toxin Antibody Hybrids
ENTRY = Toxin, Chimeric
MN = D12.776.124.486.485.114.580.450
MN = D12.776.124.790.651.114.580.450
MN = D12.776.377.715.548.114.580.450
MN = D27.888.569.271
PA = Immunologic Factors
MH_TH = NLM (1987)
ST = T121
ST = T129
RN = 0
AN = coordinate IM with specific toxin (IM) + specific immune substance (NIM)
PI = Antibodies, Monoclonal (1982-1986)
PI = Antigens, Surface (1979-1986)
PI = Antitoxins (1966-1986)
PI = Cytotoxicity, Immunologic (1978-1986)
PI = Ricin (1978-1985)
MS = Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect.
OL = use IMMUNOTOXINS to search ANTIBODY-TOXIN CONJUGATES 1987-89
PM = 90; was ANTIBODY-TOXIN CONJUGATES 1987-89
HN = 90; was ANTIBODY-TOXIN CONJUGATES 1987-89
MR = 20090710
DA = 19860325
DC = 1
DX = 19870101
UI = D000922

*NEWRECORD
RECTYPE = D
MH = Anticestodal Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Taeniacides|T121|NON|NRW|UNK (19XX)|741018|abcdef
ENTRY = Agents, Anticestodal
MN = D27.505.954.122.250.075.100.040
MH_TH = NLM (1975)
ST = T121
RN = 0
AN = consider also CESTODA /drug eff & CESTODE INFECTIONS /drug ther or pertinent specifics
PI = Anthelmintics (1966-1974)
MS = Agents used to treat tapeworm infestations in man or animals.
PM = 75
HN = 75
MR = 20140625
DA = 19990101
DC = 1
DX = 19750901
UI = D000923

*NEWRECORD
RECTYPE = D
MH = Anticholesteremic Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cholesterol Inhibitors|T121|NON|EQV|UNK (19XX)|770401|CHOLESTEROL INHIB|abcdefv
PRINT ENTRY = Hypocholesteremic Agents|T121|NON|REL|UNK (19XX)|740329|abcdef
ENTRY = Anticholesteremic Drugs|T121|NON|EQV|NLM (1996)|941114|abcdef
ENTRY = Anticholesteremics|T121|NON|EQV|NLM (1996)|941114|abcdef
ENTRY = Inhibitors, Cholesterol|T121|NON|EQV|UNK (19XX)|770401|INHIB CHOLESTEROL|abcdefv
ENTRY = Agents, Anticholesteremic
ENTRY = Agents, Hypocholesteremic
ENTRY = Drugs, Anticholesteremic
MN = D27.505.519.186.071.202
MN = D27.505.954.557.500.202
MH_TH = NLM (1964)
ST = T121
RN = 0
MS = Substances used to lower plasma CHOLESTEROL levels.
PM = 66
HN = 66(64)
MR = 20140625
DA = 19990101
DC = 1
DX = 19660101
UI = D000924

*NEWRECORD
RECTYPE = D
MH = Anticoagulants
DE = ANTICOAG
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
ENTRY = Anticoagulant Agents|T121|NON|EQV|NLM (1996)|941130|abcdef
ENTRY = Anticoagulant Drugs|T121|NON|EQV|NLM (1996)|941130|abcdef
ENTRY = Indirect Thrombin Inhibitors|T121|NON|NRW|NLM (2011)|100324|abcdef
ENTRY = Agents, Anticoagulant
ENTRY = Drugs, Anticoagulant
ENTRY = Inhibitors, Indirect Thrombin
ENTRY = Thrombin Inhibitors, Indirect
MN = D27.505.954.502.119
MH_TH = NLM (1966)
ST = T121
RN = 0
MS = Agents that prevent clotting.
MR = 20140625
DA = 19990101
DC = 1
UI = D000925

*NEWRECORD
RECTYPE = D
MH = Anticodon
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Anticodons
MN = D13.444.735.757.286
MN = G05.360.335.060
MH_TH = NLM (1975)
ST = T114
ST = T123
RN = 0
MS = The sequential set of three nucleotides in TRANSFER RNA that interacts with its complement in MESSENGER RNA, the CODON, during translation in the ribosome.
OL = search RNA, TRANSFER 1974
PM = 91; was see under RNA, TRANSFER 1975-90
HN = 91(75); was see under RNA, TRANSFER 1975-90
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D000926

*NEWRECORD
RECTYPE = D
MH = Anticonvulsants
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antiepileptic Agents|T121|NON|REL|UNK (19XX)|771005|abcdef
ENTRY = Anticonvulsant Drugs|T121|NON|EQV|NLM (1995)|940404|abcdef
ENTRY = Anticonvulsive Agents|T121|NON|EQV|NLM (1995)|940126|abcdef
ENTRY = Anticonvulsive Drugs|T121|NON|EQV|NLM (1996)|941130|abcdef
ENTRY = Antiepileptic Drugs|T121|NON|REL|NLM (1996)|941024|abcdef
ENTRY = Antiepileptics|T121|NON|REL|NLM (1995)|940126|abcdef
ENTRY = Agents, Anticonvulsive
ENTRY = Agents, Antiepileptic
ENTRY = Drugs, Anticonvulsant
ENTRY = Drugs, Anticonvulsive
ENTRY = Drugs, Antiepileptic
MN = D27.505.954.427.080
FX = Seizures
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specifics; consider also CONVULSIONS /drug ther
MS = Drugs used to prevent SEIZURES or reduce their severity.
MR = 20140625
DA = 19990101
DC = 1
UI = D000927

*NEWRECORD
RECTYPE = D
MH = Antidepressive Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antidepressants|T121|NON|EQV|UNK (19XX)|870504|abcdef
PRINT ENTRY = Thymoanaleptics|T121|NON|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Thymoleptics|T121|NON|NRW|UNK (19XX)|771118|abcdef
ENTRY = Antidepressant Drugs|T121|NON|EQV|NLM (1995)|940404|abcdef
ENTRY = Agents, Antidepressive
ENTRY = Drugs, Antidepressant
MN = D27.505.954.427.700.122
FX = Monoamine Oxidase Inhibitors
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specific groups or specific antidepressive agents; consider also DEPRESSION /drug ther
MS = Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
OL = use ANTIDEPRESSIVE AGENTS to search PSYCHIC ENERGIZERS 1966-94; use ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS to search THYMOLEPTICS 1969-78
PM = 66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78
HN = 66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78
MR = 20140625
DA = 19990101
DC = 1
UI = D000928

*NEWRECORD
RECTYPE = D
MH = Antidepressive Agents, Tricyclic
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antidepressants, Tricyclic|T109|T121|NON|EQV|UNK (19XX)|870504|abbcdef
PRINT ENTRY = Tricyclic Antidepressive Agents|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Antidepressant Drugs, Tricyclic|T109|T121|NON|EQV|NLM (1995)|940404|abbcdef
ENTRY = Agents, Tricyclic Antidepressive
ENTRY = Drugs, Tricyclic Antidepressant
ENTRY = Tricyclic Antidepressant Drugs
ENTRY = Tricyclic Antidepressants
MN = D27.505.954.427.700.122.055
MH_TH = NLM (1975)
ST = T109
ST = T121
RN = 0
PI = Antidepressive Agents (1968-1974)
MS = Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.
PM = 75
HN = 75
MR = 20140625
DA = 19741111
DC = 1
DX = 19750901
UI = D000929

*NEWRECORD
RECTYPE = D
MH = Antidiarrheals
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antiperistaltics|T121|NON|REL|NLM (1996)|941116|abcdef
ENTRY = Antidiarrheal Agents|T121|NON|EQV|NLM (1996)|941116|abcdef
ENTRY = Antidiarrheal Drugs|T121|NON|EQV|NLM (1996)|941116|abcdef
ENTRY = Antiperistaltic Agents|T121|NON|REL|NLM (1996)|941116|abcdef
ENTRY = Antiperistaltic Drugs|T121|NON|REL|NLM (1996)|941116|abcdef
ENTRY = Agents, Antidiarrheal
ENTRY = Agents, Antiperistaltic
ENTRY = Drugs, Antidiarrheal
ENTRY = Drugs, Antiperistaltic
MN = D27.505.954.483.161
MH_TH = NLM (1975)
ST = T121
RN = 0
AN = consider also DIARRHEA /drug ther
PI = Gastrointestinal Agents (1967-1974)
MS = Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.
OL = search GASTROINTESTINAL AGENTS 1969-74
PM = 75; was see under GASTROINTESTINAL AGENTS 1969-74
HN = 75; was see under GASTROINTESTINAL AGENTS 1969-74
MR = 20140625
DA = 19990101
DC = 1
DX = 19750901
UI = D000930

*NEWRECORD
RECTYPE = D
MH = Antidotes
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Theriacs|T121|NON|EQV|NLM (2004)|030128|abcdef
MN = D27.505.696.706.037
MN = D27.720.799.037
FX = Antivenins
FX = Chelating Agents
FX = Cholinesterase Reactivators
MH_TH = NLM (1964)
ST = T121
RN = 0
MS = Agents counteracting or neutralizing the action of POISONS.
PM = 66
HN = 66(64)
MR = 20050630
DA = 19990101
DC = 1
DX = 19660101
UI = D000931

*NEWRECORD
RECTYPE = D
MH = Antiemetics
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anti-Emetic Effect|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Anti-Emetic Effects|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Anti-emetics|T121|NON|EQV|NLM (2005)|031112|abcdef
ENTRY = Antiemetic Agents|T121|NON|EQV|NLM (1995)|940408|abcdef
ENTRY = Antiemetic Drugs|T121|NON|EQV|NLM (1995)|940404|abcdef
ENTRY = Antiemetic Effect|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Antiemetic Effects|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Agents, Antiemetic
ENTRY = Anti Emetic Effect
ENTRY = Anti Emetic Effects
ENTRY = Anti emetics
ENTRY = Drugs, Antiemetic
ENTRY = Effect, Anti-Emetic
ENTRY = Effect, Antiemetic
ENTRY = Effects, Anti-Emetic
ENTRY = Effects, Antiemetic
MN = D27.505.696.663.050.030
MN = D27.505.954.427.095
MN = D27.505.954.483.200
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = note entry term ANTIEMETIC EFFECT: use only for the antiemetic effect of a chemical substance
MS = Drugs used to prevent NAUSEA or VOMITING.
MR = 20140625
DA = 19990101
DC = 1
UI = D000932

*NEWRECORD
RECTYPE = D
MH = Antifibrinolytic Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antifibrinolysins|T121|NON|EQV|UNK (19XX)|781215|abcdef
PRINT ENTRY = Antiplasmins|T121|NON|NRW|UNK (19XX)|781215|abcdef
ENTRY = Antifibrinolytics|T121|NON|EQV|NLM (1996)|941013|abcdef
ENTRY = Plasmin Inhibitor|T121|NON|NRW|UNK (19XX)|820204|PLASMIN INHIB|abcdefv
ENTRY = Plasmin Inhibitors|T121|NON|NRW|NLM (2010)|090209|abcdef
ENTRY = Agents, Antifibrinolytic
ENTRY = Inhibitor, Plasmin
ENTRY = Inhibitors, Plasmin
MN = D27.505.519.421.500
MN = D27.505.954.502.270.463.091
MH_TH = NLM (1966)
ST = T121
RN = 0
MS = Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
PM = 66
HN = 66
MR = 20140625
DA = 19990101
DC = 1
DX = 19660101
UI = D000933

*NEWRECORD
RECTYPE = D
MH = Antifoaming Agents
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Antiflatulents|T121|NON|NRW|UNK (19XX)|760413|abcdef
PRINT ENTRY = Defoaming Agents|T120|NON|NRW|UNK (19XX)|760413|abcdef
PRINT ENTRY = Foam Retardants|T120|NON|NRW|UNK (19XX)|760413|abcdef
ENTRY = Agents, Antifoaming
ENTRY = Agents, Defoaming
ENTRY = Retardants, Foam
MN = D27.505.519.178
MN = D27.720.877.048
MH_TH = NLM (1977)
ST = T120
RN = 0
AN = D25-26 qualif; consider also FLATULENCE /drug ther
PI = Silicones (1966-1976)
PI = Surface-Active Agents (1966-1976)
MS = Agents used to prevent the formation of foam or to treat flatulence or bloat.
PM = 91; was see under SURFACE-ACTIVE AGENTS 1977-90
HN = 91(77); was see under SURFACE-ACTIVE AGENTS 1977-90
MR = 20130708
DA = 19760413
DC = 1
DX = 19910101
UI = D000934

*NEWRECORD
RECTYPE = D
MH = Antifungal Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Fungicides, Therapeutic|T121|NON|EQV|UNK (19XX)|740329|FUNGICIDES THER|abcdefv
ENTRY = Antibiotics, Antifungal|T195|NON|NRW|NLM (1967)|990101|abcdef
ENTRY = Therapeutic Fungicides|T121|NON|EQV|UNK (19XX)|740329|THER FUNGICIDES|abcdefv
ENTRY = Agents, Antifungal
ENTRY = Antifungal Antibiotics
MN = D27.505.954.122.136
FX = Fungicides, Industrial
MH_TH = NLM (1967)
ST = T121
RN = 0
AN = used in therapy: differentiate from FUNGICIDES, INDUSTRIAL; for resistance to antifungal agents, DRUG RESISTANCE, FUNGAL and DRUG RESISTANCE, MULTIPLE, FUNGAL are available
MS = Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
PM = 1967; for ANTIBIOTICS, ANTIFUNGAL see ANTIBIOTICS, ANTIFUNGAL 1967-2009
HN = 1967
MR = 20140625
DA = 19990101
DC = 1
DX = 19670101
UI = D000935

*NEWRECORD
RECTYPE = D
MH = Antigen-Antibody Complex
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Immune Complex|T116|T129|NON|EQV|NLM (1993)|911218|abbcdef
ENTRY = Antigen-Antibody Complexes|T116|T129|NON|EQV|NLM (1993)|911218|abbcdef
ENTRY = Immune Complexes|T116|T129|NON|EQV|NLM (1993)|911218|abbcdef
ENTRY = Antigen Antibody Complex
ENTRY = Antigen Antibody Complexes
ENTRY = Complex, Antigen-Antibody
ENTRY = Complex, Immune
ENTRY = Complexes, Antigen-Antibody
ENTRY = Complexes, Immune
MN = D12.776.124.486.485.114.257
MN = D12.776.124.790.651.114.257
MN = D12.776.377.715.548.114.257
MN = D23.050.101
PA = Immunologic Factors
FX = Immune Complex Diseases
MH_TH = NLM (1970)
ST = T116
ST = T129
RN = 0
PI = Antibodies (1966-1969)
PI = Antigens (1966-1969)
MS = The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES.
PM = 72
HN = 72(70)
MR = 20050630
DA = 19990101
DC = 1
DX = 19720101
UI = D000936

*NEWRECORD
RECTYPE = D
MH = Antigen-Antibody Reactions
AQ = DE GE IM PH RE
ENTRY = Antigen Antibody Reactions
ENTRY = Antigen-Antibody Reaction
ENTRY = Reaction, Antigen-Antibody
ENTRY = Reactions, Antigen-Antibody
MN = G12.425.143
FX = Binding Sites, Antibody
FX = Hypersensitivity, Immediate
MH_TH = NLM (1984)
ST = T044
MS = The processes triggered by interactions of ANTIBODIES with their ANTIGENS.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D000937

*NEWRECORD
RECTYPE = D
MH = Antigen-Presenting Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Accessory Cells, Immunologic|T025|NON|EQV|UNK (19XX)|840530|ACCESSORY CELLS IMMUNOL|abcdefv
PRINT ENTRY = Immunologic Accessory Cells|T025|NON|EQV|NLM (1991)|891213|IMMUNOL ACCESSORY CELLS|abcdefv
ENTRY = Accessory Cell, Immunologic|T025|NON|EQV|NLM (1994)|920825|ACCESSORY CELL IMMUNOL|abcdefv
ENTRY = Cell, Immunologic Accessory|T025|NON|EQV|NLM (1994)|920825|CELL IMMUNOL ACCESSORY|abcdefv
ENTRY = Cells, Immunologic Accessory|T025|NON|EQV|UNK (19XX)|840530|CELLS IMMUNOL ACCESSORY|abcdefv
ENTRY = Immunologic Accessory Cell|T025|NON|EQV|NLM (1999)|971009|IMMUNOL ACCESSORY CELL|abcdefv
ENTRY = Antigen Presenting Cells
ENTRY = Antigen-Presenting Cell
ENTRY = Cell, Antigen-Presenting
ENTRY = Cells, Antigen-Presenting
MN = A11.066
MN = A15.382.066
FX = Antigen Presentation
FX = Histocompatibility Antigens Class II
FX = Lymphocyte Activation
MH_TH = NLM (1985)
ST = T025
PI = Antigenic Determinants (1970-1984)
PI = Antigens, Immune Response (1981-1984)
PI = Lymphocyte Transformation (1969-1984)
PI = T Lymphocytes (1973-1984)
MS = A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.
PM = 85
HN = 85
MR = 20070709
DA = 19840530
DC = 1
DX = 19850101
UI = D000938

*NEWRECORD
RECTYPE = D
MH = Epitopes
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Antigenic Determinants|T129|NON|EQV|NLM (1996)|950210|abcdef
PRINT ENTRY = Antigenic Specificity|T070|NON|REL|UNK (19XX)|750116|abcdef
ENTRY = Determinants, Antigenic
ENTRY = Specificity, Antigenic
MN = D23.050.550
FX = Antibodies, Anti-Idiotypic
FX = Antibody Affinity
FX = Epitope Mapping
FX = Molecular Mimicry
MH_TH = NLM (1970)
ST = T129
RN = 0
AN = X ref ANTIGENIC DETERMINANTS: do not confuse with genetic determinants ( = GENES or specific)
PI = Antigens (1966-1969)
MS = Sites on an antigen that interact with specific antibodies.
PM = 96; was ANTIGENIC DETERMINANTS 1972-95
HN = 96; was ANTIGENIC DETERMINANTS 1970-95 (as Prov 1970-71)
MR = 20050630
DA = 19990101
DC = 1
DX = 19720101
UI = D000939

*NEWRECORD
RECTYPE = D
MH = Antigenic Variation
AQ = DE GE IM PH RE
PRINT ENTRY = Antigen Switching|T044|NON|NRW|UNK (19XX)|870511|abcdef
PRINT ENTRY = Antigenic Diversity|T044|NON|REL|NLM (2003)|020207|abcdef
PRINT ENTRY = Variation, Antigenic|T044|NON|EQV|UNK (19XX)|870511|abcdef
ENTRY = Antigen Variation|T044|NON|EQV|UNK (19XX)|870511|abcdef
ENTRY = Antigenic Switching|T044|NON|NRW|UNK (19XX)|870519|abcdef
ENTRY = Antigenic Variability|T044|NON|EQV|NLM (1999)|980403|abcdef
ENTRY = Switching, Antigenic|T044|NON|NRW|NLM (1990)|890420|abcdef
ENTRY = Diversity, Antigenic
ENTRY = Switching, Antigen
ENTRY = Variability, Antigenic
ENTRY = Variation, Antigen
MN = G05.365.073
MN = G12.500.249
MH_TH = NLM (1988)
ST = T044
AN = microbes only; ANTIBODY DIVERSITY is also available
PI = Antigenic Determinants (1975-1987)
PI = Genetics, Microbial (1973-1987)
PI = Variation (Genetics) (1966-1987)
MS = Change in the surface ANTIGEN of a microorganism. There are two different types. One is a phenomenon, especially associated with INFLUENZA VIRUSES, where they undergo spontaneous variation both as slow antigenic drift and sudden emergence of new strains (antigenic shift). The second type is when certain PARASITES, especially trypanosomes, PLASMODIUM, and BORRELIA, survive the immune response of the host by changing the surface coat (antigen switching). (From Herbert et al., The Dictionary of Immunology, 4th ed)
PM = 1988
HN = 1988
CATSH = CAT LIST
MR = 20080708
DA = 19870511
DC = 1
DX = 19880101
UI = D000940

*NEWRECORD
RECTYPE = D
MH = Antigens
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
ENTRY = Antigen|T129|NON|EQV|NLM (1988)|870509|abcdef
MN = D23.050
FX = Antigen-Antibody Reactions
FX = Receptors, Antigen
MH_TH = POPLINE (1994)
ST = T129
RN = 0
AN = GEN or unspecified: prefer specifics
MS = Substances that are recognized by the immune system and induce an immune reaction.
MR = 20050630
DA = 19990101
DC = 1
UI = D000941

*NEWRECORD
RECTYPE = D
MH = Antigens, Bacterial
DE = ANTIGENS BACT
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Bacterial Antigens|T129|NON|EQV|UNK (19XX)|740329|BACT ANTIGENS|abcdefv
MN = D23.050.161
MH_TH = NLM (1973)
ST = T129
RN = 0
AN = coord IM with specific bacterium /immunol (IM); DF: ANTIGENS BACT
PI = Antigens (1966-1970)
PI = Polysaccharides, Bacterial (1966-1970)
MS = Substances elaborated by bacteria that have antigenic activity.
OL = use ANTIGENS, BACTERIAL to search BACTERIAL ANTIGENS 1971-72 (as Prov)
PM = 73
HN = 73; was BACTERIAL ANTIGENS 1971-72 (Prov)
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000942

*NEWRECORD
RECTYPE = D
MH = Antigens, Differentiation
DE = ANTIGENS DIFFER
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Differentiation Antigens|T129|NON|EQV|UNK (19XX)|870313|DIFFER ANTIGENS|abcdefv
PRINT ENTRY = Differentiation Antigens, Hairy Cell Leukemia|T129|NON|NRW|NLM (1992)|910404|DIFFER ANTIGENS HAIRY CELL LEUKEMIA|abcdefv
PRINT ENTRY = Differentiation Markers|T129|NON|EQV|UNK (19XX)|870313|DIFFER MARKERS|abcdefv
PRINT ENTRY = Leu Antigens|T129|NRW|UNK (19XX)|880516|abdef
PRINT ENTRY = Marker Antigens|T129|NON|EQV|UNK (19XX)|870313|abcdef
ENTRY = Markers, Differentiation|T129|NON|EQV|NLM (1992)|900904|MARKERS DIFFER|abcdefv
ENTRY = Antigens, Leu
ENTRY = Antigens, Marker
MN = D23.050.301.264
MN = D23.101.100
MH_TH = NLM (1988)
ST = T129
RN = 0
AN = GEN: prefer specific groups & specific differentiation antigens; note X ref LEU ANTIGENS but several specific Leu antigens are also available; DF: ANTIGENS DIFFER
PI = Antigens (1966-1977)
PI = Antigens, Neoplasm (1973-1987)
PI = Antigens, Surface (1979-1987)
PI = Cell Differentiation (1966-1987)
PI = Cell Transformation, Neoplastic (1970-1987)
PI = specific cell or tissue (1966-1987)
MS = Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.
OL = use ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE to search DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA 1988-91; use ANTIGENS, DIFFERENTIATION to search LEU ANTIGENS 1989 to present; use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988
PM = 88; DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA was see ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-91; LEU ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988
HN = 88; DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA was see ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-91; LEU ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988
MR = 20050729
DA = 19870313
DC = 1
DX = 19880101
UI = D000943

*NEWRECORD
RECTYPE = D
MH = Antigens, Differentiation, B-Lymphocyte
DE = B CELL DIFFER ANTIGENS
DS = ANTIGENS DIFFERENTIATION LYMPHO B
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Antigens, Differentiation, B-Cell|T129|EQV|NLM (1990)|890714|ANTIGENS DIFFERENTIATION B CELL|ANTIGENS DIFFER B CELL|abdefsv
PRINT ENTRY = B-Cell Differentiation Antigens|T129|EQV|UNK (19XX)|870413|abdef
PRINT ENTRY = B-Lymphocyte Differentiation Antigens|T129|EQV|UNK (19XX)|870413|LYMPHOCYTE DIFFERENTIATION ANTIGENS B|B LYMPHOCYTE DIFFER ANTIGENS|abdefsv
PRINT ENTRY = Blast-2 Antigen, B-Cell|T129|NRW|UNK (19XX)|870413|BLAST ANTIGEN B CELL 002|BLAST 2 ANTIGEN B CELL|abdefsv
PRINT ENTRY = Differentiation Antigens, B-Cell|T129|EQV|UNK (19XX)|870413|DIFFER ANTIGENS B CELL|abdefv
PRINT ENTRY = Differentiation Antigens, B-Lymphocyte|T129|EQV|UNK (19XX)|870413|DIFFERENTIATION ANTIGENS LYMPHOCYTE B|DIFFER ANTIGENS B LYMPHOCYTE|abdefsv
PRINT ENTRY = Leu Antigens, B-Lymphocyte|T129|EQV|UNK (19XX)|880506|LEU ANTIGENS LYMPHOCYTE B|LEU ANTIGENS B LYMPHOCYTE|abdefsv
PRINT ENTRY = Plasma Cell Antigens PC-1|T129|NRW|UNK (19XX)|870413|PLASMA CELL ANTIGENS PC 001|abdefs
ENTRY = Antigens, Differentiation, B Lymphocyte|T129|EQV|NLM (1990)|890224|ANTIGENS DIFFER B LYMPHOCYTE|abdefv
ENTRY = Antigens, Plasma Cell, PC-1|T129|NRW|UNK (19XX)|870515|abdef
ENTRY = B-Cell Blast-2 Antigen|T129|NRW|UNK (19XX)|870515|abdef
ENTRY = Antigen, B-Cell Blast-2
ENTRY = Antigens, B-Cell Differentiation
ENTRY = Antigens, B-Lymphocyte Differentiation
ENTRY = Antigens, B-Lymphocyte Leu
ENTRY = B Cell Blast 2 Antigen
ENTRY = B Cell Differentiation Antigens
ENTRY = B Lymphocyte Differentiation Antigens
ENTRY = B-Lymphocyte Leu Antigens
ENTRY = Blast 2 Antigen, B Cell
ENTRY = Differentiation Antigens, B Cell
ENTRY = Differentiation Antigens, B Lymphocyte
ENTRY = Leu Antigens, B Lymphocyte
ENTRY = Plasma Cell Antigens PC 1
MN = D23.050.301.264.051
MN = D23.101.100.150
MH_TH = NLM (1988)
ST = T129
RN = 0
AN = DF: B CELL DIFFER ANTIGENS
PI = Antigens, Surface (1979-1987)
PI = B-Lymphocytes (1973-1987)
PI = Cell Differentiation (1966-1987)
MS = Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin.
OL = use ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE to search ANTIGENS, DIFFERENTIATION B LYMPHOCYTE 1988-89
PM = 90; was ANTIGENS, DIFFERENTIATION, B LYMPHOCYTE 1988-89
HN = 90; was ANTIGENS, DIFFERENTIATION, B LYMPHOCYTE 1988-89
MR = 20050630
DA = 19870413
DC = 1
DX = 19880101
UI = D000944

*NEWRECORD
RECTYPE = D
MH = Antigens, Differentiation, T-Lymphocyte
DS = ANTIGENS DIFFERENTIATION LYMPHO T
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Antigens, Differentiation, T-Cell|T116|T129|EQV|NLM (1990)|890224|ANTIGENS DIFFERENTIATION T CELL|ANTIGENS DIFFER T CELL|abbdefsv
PRINT ENTRY = Differentiation Antigens, T-Cell|T116|T129|EQV|UNK (19XX)|870313|DIFFER ANTIGENS T CELL|abbdefv
PRINT ENTRY = L3T4 Antigens|T116|T129|NRW|UNK (19XX)|870313|L A T ANTIGENS 03 04|abbdefs
PRINT ENTRY = Leu Antigens, T-Lymphocyte|T116|T129|EQV|UNK (19XX)|880506|LEU ANTIGENS LYMPHOCYTE T|abbdefs
PRINT ENTRY = T-Cell Differentiation Antigens|T116|T129|EQV|UNK (19XX)|870313|T CELL DIFFER ANTIGENS|abbdefv
PRINT ENTRY = T-Lymphocyte Differentiation Antigens|T116|T129|EQV|UNK (19XX)|880506|LYMPHOCYTE DIFFERENTIATION ANTIGENS T|T LYMPHOCYTE DIFFER ANTIGENS|abbdefsv
PRINT ENTRY = T6 Antigens|T116|T129|NRW|UNK (19XX)|870313|T AAC ANTIGENS 06|abbdefs
ENTRY = Antigens, Differentiation, T Lymphocyte|T116|T129|EQV|NLM (1990)|890224|ANTIGENS DIFFER T LYMPHOCYTE|abbdefv
ENTRY = Differentiation Antigens, T Lymphocyte|T116|T129|EQV|UNK (19XX)|870515|DIFFER ANTIGENS T LYMPHOCYTE|abbdefv
ENTRY = Antigens, L3T4
ENTRY = Antigens, T-Cell Differentiation
ENTRY = Antigens, T-Lymphocyte Differentiation
ENTRY = Antigens, T-Lymphocyte Leu
ENTRY = Antigens, T6
ENTRY = Differentiation Antigens, T Cell
ENTRY = Differentiation Antigens, T-Lymphocyte
ENTRY = Leu Antigens, T Lymphocyte
ENTRY = T Cell Differentiation Antigens
ENTRY = T Lymphocyte Differentiation Antigens
ENTRY = T-Lymphocyte Leu Antigens
MN = D23.050.301.264.894
MN = D23.101.100.894
MH_TH = NLM (1988)
ST = T116
ST = T129
RN = 0
AN = DF: T CELL DIFFER ANTIGENS
PI = Antigens (1971-1978)
PI = Antigens, Surface (1979-1987)
PI = Cell Differentiation (1966-1987)
PI = T-Lymphocytes (1973-1987)
MS = Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function.
OL = use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE to search T8 ANTIGENS 1988-92 & ANTIGENS, DIFFERENTIATION T LYMPHOCYTE 1988-89
PM = 90; was ANTIGENS, DIFFERENTIATION, T LYMPHOCYTE 1988-89; T8 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92
HN = 90; was ANTIGENS, DIFFERENTIATION, T LYMPHOCYTE 1988-89; T8 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92
MR = 20050630
DA = 19870313
DC = 1
DX = 19880101
UI = D000945

*NEWRECORD
RECTYPE = D
MH = Antigens, Fungal
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Fungal Antigens|T129|NON|EQV|UNK (19XX)|740329|abcdef
MN = D23.050.202
MH_TH = NLM (1973)
ST = T129
RN = 0
AN = coord IM with specific fungus /immunol (IM)
PI = Antigens (1966-1972)
MS = Substances of fungal origin that have antigenic activity.
PM = 73
HN = 73
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000946

*NEWRECORD
RECTYPE = D
MH = Antigens, Helminth
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Helminth Antigens|T129|NON|EQV|UNK (19XX)|840502|abcdef
MN = D23.050.223
MH_TH = NLM (1985)
ST = T129
RN = 0
AN = coord IM with specific helminth /immunol (IM)
PI = Antigens (1966-1984)
PI = Antigens, Surface (1979-1984)
MS = Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes.
PM = 85
HN = 85
MR = 20050630
DA = 19840502
DC = 1
DX = 19850101
UI = D000947

*NEWRECORD
RECTYPE = D
MH = Histocompatibility Antigens Class II
DS = HISTOCOMPATIBILITY ANTIGENS CLASS 02
AQ = AD AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Antigens, Immune Response|T116|T129|NON|EQV|UNK (19XX)|880607|ANTIGENS IR|abbcdefv
PRINT ENTRY = Class II Antigens|T116|T129|NON|EQV|UNK (19XX)|860625|abbcdef
PRINT ENTRY = Ia Antigens|T116|T129|EQV|UNK (19XX)|800513|abbdef
PRINT ENTRY = Ia-Like Antigens|T116|T129|EQV|UNK (19XX)|860625|abbdef
PRINT ENTRY = Immune Response Antigens|T116|T129|NON|EQV|UNK (19XX)|800513|IR ANTIGENS|abbcdefv
PRINT ENTRY = Immune-Associated Antigens|T129|NON|BRD|UNK (19XX)|860625|abcdef
PRINT ENTRY = Immune-Response-Associated Antigens|T116|T129|NON|EQV|UNK (19XX)|860625|abbcdef
ENTRY = Class II Antigen|T116|T129|NON|EQV|UNK (19XX)|870509|abbcdef
ENTRY = Class II Histocompatibility Antigens|T116|T129|NON|EQV|UNK (19XX)|861008|abbcdef
ENTRY = Class II Major Histocompatibility Antigens|T116|T129|NON|EQV|NLM (1992)|910308|abbcdef
ENTRY = I-A Antigen|T116|T129|EQV|NLM (1994)|930220|abbdef
ENTRY = I-A-Antigen|T116|T129|EQV|NLM (1994)|930221|abbdef
ENTRY = IA Antigen|T116|T129|EQV|NLM (1994)|930221|abbdef
ENTRY = Antigen, Class II
ENTRY = Antigen, I-A
ENTRY = Antigen, IA
ENTRY = Antigens, Class II
ENTRY = Antigens, Ia
ENTRY = Antigens, Ia-Like
ENTRY = Antigens, Immune-Associated
ENTRY = Antigens, Immune-Response-Associated
ENTRY = I A Antigen
ENTRY = Ia Like Antigens
ENTRY = Immune Associated Antigens
ENTRY = Immune Response Associated Antigens
MN = D12.776.395.550.509
MN = D12.776.543.550.423
MN = D23.050.301.500.400
MN = D23.050.705.552.410
MH_TH = NLM (1981)
ST = T116
ST = T129
RN = 0
AN = human & animal; GEN: prefer specifics; see also HLA ANTIGENS & specifics for human; X ref IA ANTIGENS refers to any class II histocompatibility antigen
PI = HLA Antigens (1975-1980)
PI = Histocompatibility Antigens (1973-1980)
PI = Isoantigens (1973-1980)
MS = Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen.
OL = use HISTOCOMPATIBILITY ANTIGENS CLASS II to search ANTIGENS, IMMUNE RESPONSE 1981-88 & I-A-ANTIGEN 1987-93
PM = 89; was ANTIGENS, IMMUNE RESPONSE 1981-88; I-A-ANTIGEN was indexed under HISTOCOMPATIBILITY ANTIGENS CLASS II 1987-93
HN = 89; was ANTIGENS, IMMUNE RESPONSE 1981-88; I-A-ANTIGEN was NM 1987-93
MR = 20110624
DA = 19800513
DC = 1
DX = 19810101
UI = D000949

*NEWRECORD
RECTYPE = D
MH = Antigens, Ly
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Ly Antigens|T129|EQV|UNK (19XX)|810520|abdef
MN = D23.050.301.264.920
MN = D23.101.100.920
MH_TH = NLM (1982)
ST = T129
RN = 0
PI = Lymphocytes (1966-1981)
PI = T Lymphocytes (1975-1981)
MS = A group of lymphocyte surface antigens located on mouse LYMPHOCYTES. Specific Ly antigens are useful markers for distinguishing subpopulations of lymphocytes.
PM = 82
HN = 82
MR = 20080708
DA = 19810520
DC = 1
DX = 19820101
UI = D000950

*NEWRECORD
RECTYPE = D
MH = Antigens, Neoplasm
DE = ANTIGENS NEOPL
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Neoplasm Antigens|T129|NON|EQV|UNK (19XX)|740329|NEOPL ANTIGENS|abcdefv
PRINT ENTRY = Tumor Antigens|T129|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Antigens, Tumor
MN = D23.050.285
MH_TH = NLM (1973)
ST = T129
RN = 0
AN = coord IM with required neopl coords with /immunol (IM); Manual 24.4.4.1+
PI = Antigens (1966-1972)
PI = Neoplasms/immunology (1966-1972)
PI = specific neoplasm/immunology (1966-1972)
MS = Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
PM = 73
HN = 73
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000951

*NEWRECORD
RECTYPE = D
MH = Antigens, Polyomavirus Transforming
DE = PVTA
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Polyomavirus Large T Antigens|T129|NON|NRW|UNK (19XX)|870507|abcdef
PRINT ENTRY = Polyomavirus Middle T Antigens|T129|NON|NRW|UNK (19XX)|870507|abcdef
PRINT ENTRY = Polyomavirus Small T Antigens|T129|NON|NRW|UNK (19XX)|870507|abcdef
PRINT ENTRY = Polyomavirus T Proteins|T116|T129|NON|NRW|UNK (19XX)|870507|abbcdef
PRINT ENTRY = Polyomavirus Transforming Antigens|T129|NON|EQV|UNK (19XX)|870507|abcdef
PRINT ENTRY = Polyomavirus Tumor Antigens|T129|NON|EQV|UNK (19XX)|870507|abcdef
PRINT ENTRY = SV40 T Antigens|T129|NRW|UNK (19XX)|870507|SV T ANTIGENS 40|abdefs
PRINT ENTRY = SV40 T Proteins|T129|NON|NRW|UNK (19XX)|870507|SV T PROTEINS 40|abcdefs
PRINT ENTRY = Simian Sarcoma Virus Proteins|T116|T129|NON|NRW|UNK (19XX)|870507|abbcdef
ENTRY = Polyomaviruses Large T Proteins|T129|NON|NRW|UNK (19XX)|870507|abcdef
ENTRY = Polyomaviruses Middle T Proteins|T129|NON|NRW|UNK (19XX)|870507|abcdef
ENTRY = Polyomaviruses Small T Proteins|T129|NON|NRW|UNK (19XX)|870507|abcdef
ENTRY = Antigens, Polyomavirus Tumor
ENTRY = Antigens, SV40 T
ENTRY = Proteins, Polyomavirus T
ENTRY = Proteins, SV40 T
ENTRY = T Antigens, SV40
ENTRY = T Proteins, Polyomavirus
ENTRY = T Proteins, SV40
ENTRY = Transforming Antigens, Polyomavirus
ENTRY = Tumor Antigens, Polyomavirus
MN = D12.776.624.664.520.090
MN = D12.776.964.700.090
MN = D23.050.285.062.090
MN = D23.050.327.062.090
MH_TH = NLM (1988)
ST = T129
RN = 0
AN = coord IM with specific polyoma virus /immunol (IM); DF: PVTA
PI = Antigens, Viral (1973-1983)
PI = Antigens, Viral, Tumor (1984-1987)
PI = Oncogene Proteins, Viral (1986-1987)
PI = Viral Proteins (1966-1985)
MS = Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle.
PM = 88
HN = 88
MR = 20050630
DA = 19870507
DC = 1
DX = 19880101
UI = D000952

*NEWRECORD
RECTYPE = D
MH = Antigens, Protozoan
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Protozoan Antigens|T129|NON|EQV|UNK (19XX)|840620|abcdef
MN = D23.050.293
MH_TH = NLM (1985)
ST = T129
RN = 0
AN = coord IM with specific protozoan /immunol (IM)
PI = Antigens (1966-1984)
PI = Antigens, Surface (1979-1984)
MS = Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.
PM = 85
HN = 85
MR = 20050630
DA = 19840502
DC = 1
DX = 19850101
UI = D000953

*NEWRECORD
RECTYPE = D
MH = Antigens, Surface
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Cell Surface Antigens|T129|NON|EQV|UNK (19XX)|870509|abcdef
PRINT ENTRY = Surface Antigens|T129|NON|EQV|UNK (19XX)|780501|abcdef
PRINT ENTRY = Surface Markers, Immunological|T129|NON|EQV|UNK (19XX)|840502|SURFACE MARKERS IMMUNOL|abcdefv
ENTRY = Cell Surface Antigen|T129|NON|EQV|UNK (19XX)|870509|abcdef
ENTRY = Immunologic Surface Markers|T129|NON|EQV|NLM (1990)|891020|IMMUNOL SURFACE MARKERS|abcdefv
ENTRY = Markers, Immunological Surface|T129|NON|EQV|UNK (19XX)|840502|MARKERS IMMUNOL SURFACE|abcdefv
ENTRY = Surface Antigen|T129|NON|EQV|NLM (1988)|870509|abcdef
ENTRY = Surface Markers, Immunologic|T129|NON|EQV|UNK (19XX)|840502|abcdef
ENTRY = Antigen, Cell Surface
ENTRY = Antigen, Surface
ENTRY = Antigens, Cell Surface
ENTRY = Immunological Surface Markers
ENTRY = Markers, Immunologic Surface
ENTRY = Surface Antigen, Cell
ENTRY = Surface Antigens, Cell
MN = D23.050.301
MH_TH = NLM (1979)
ST = T129
RN = 0
AN = coord NIM with specific antigen/organism heading (IM)
PI = Antigens (1966-1978)
MS = Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.
PM = 79
HN = 79
MR = 20050630
DA = 19780501
DC = 1
DX = 19790101
UI = D000954

*NEWRECORD
RECTYPE = D
MH = Antigens, T-Independent
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = T-Independent Antigens|T129|EQV|UNK (19XX)|810520|abdef
PRINT ENTRY = Thymus-Independent Antigens|T129|NON|EQV|UNK (19XX)|810520|abcdef
ENTRY = Antigens, T Independent|T129|EQV|UNK (19XX)|810520|abdef
ENTRY = TI-2 Antigens|T129|NRW|UNK (19XX)|830223|abdef
ENTRY = Antigens, TI-2
ENTRY = Antigens, Thymus-Independent
ENTRY = Independent Antigens, T
ENTRY = T Independent Antigens
ENTRY = TI 2 Antigens
ENTRY = Thymus Independent Antigens
MN = D23.050.324
MH_TH = NLM (1982)
ST = T129
RN = 0
PI = Antibody Formation (1969-1971)
PI = B Lymphocytes (1973-1981)
PI = Lymphocytes (1969-1972)
PI = T Lymphocytes (1973-1981)
MS = Antigens which may directly stimulate B lymphocytes without the cooperation of T lymphocytes.
PM = 82
HN = 82
MR = 20050630
DA = 19810520
DC = 1
DX = 19820101
UI = D000955

*NEWRECORD
RECTYPE = D
MH = Antigens, Viral
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Viral Antigens|T129|NON|EQV|UNK (19XX)|740329|abcdef
MN = D23.050.327
MH_TH = NLM (1973)
ST = T129
RN = 0
AN = coord IM with specific virus /immunol (IM)
PI = Antigens (1966-1972)
PI = Viruses/immunology (1966-1972)
MS = Substances elaborated by viruses that have antigenic activity.
PM = 73
HN = 73
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000956

*NEWRECORD
RECTYPE = D
MH = Antigens, Viral, Tumor
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Antigens, Neoplasm, Viral|T129|NON|BRD|UNK (19XX)|830610|ANTIGENS NEOPL VIRAL|abcdefv
PRINT ENTRY = Neoplasm Antigens, Viral|T129|NON|BRD|UNK (19XX)|830610|NEOPL ANTIGENS VIRAL|abcdefv
PRINT ENTRY = T Antigens|T129|NON|EQV|UNK (19XX)|830610|abcdef
PRINT ENTRY = Tumor Antigens, Viral|T129|NON|EQV|UNK (19XX)|830610|abcdef
PRINT ENTRY = Viral Tumor Antigens|T129|NON|EQV|UNK (19XX)|830610|abcdef
PRINT ENTRY = Virus Transforming Antigens|T129|NON|EQV|UNK (19XX)|870508|abcdef
ENTRY = Large T Antigen|T129|NON|NRW|UNK (19XX)|870518|abcdef
ENTRY = Large T-Antigen|T129|NON|NRW|UNK (19XX)|870511|abcdef
ENTRY = Small T Antigen|T129|NON|NRW|UNK (19XX)|870518|abcdef
ENTRY = Small T-Antigen|T129|NON|NRW|UNK (19XX)|870511|abcdef
ENTRY = T Antigen|T129|NON|EQV|UNK (19XX)|870518|abcdef
ENTRY = T-Antigen|T129|NON|EQV|UNK (19XX)|870511|abcdef
ENTRY = Viral T Antigens|T129|NON|EQV|UNK (19XX)|830919|abcdef
ENTRY = Antigen, Large T
ENTRY = Antigen, Small T
ENTRY = Antigen, T
ENTRY = Antigens, T
ENTRY = Antigens, Viral Neoplasm
ENTRY = Antigens, Viral T
ENTRY = Antigens, Viral Tumor
ENTRY = Antigens, Virus Transforming
ENTRY = T Antigen, Large
ENTRY = T Antigen, Small
ENTRY = T Antigens, Viral
ENTRY = T-Antigen, Large
ENTRY = T-Antigen, Small
ENTRY = Transforming Antigens, Virus
ENTRY = Viral Neoplasm Antigens
MN = D23.050.285.062
MN = D23.050.327.062
MH_TH = NLM (1984)
ST = T129
RN = 0
AN = coord IM with specific virus /immunol (IM)
PI = Antigens (1966-1972)
PI = Antigens, Neoplasm (1973-1983)
PI = Antigens, Viral (1973-1983)
MS = Those proteins recognized by antibodies from serum of animals bearing tumors induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation.
PM = 84
HN = 84
MR = 20050630
DA = 19830610
DC = 1
DX = 19840101
UI = D000957

*NEWRECORD
RECTYPE = D
MH = Antigua and Barbuda
AQ = EH EP
PRINT ENTRY = Antigua|T083|NAM|NRW|NLM (1975)|990101|abcdef
PRINT ENTRY = Barbuda|T083|NAM|NRW|NLM (1994)|920908|abcdef
PRINT ENTRY = Barbuda and Antigua|T083|NAM|EQV|NLM (1992)|911102|abcdef
MN = Z01.107.084.900.050
MN = Z01.639.880.050
MH_TH = NLM (1983)
ST = T083
MS = Islands in the Lesser Antilles, within the Leeward Islands. ANTIGUA, BARBUDA, and Redonda, an uninhabited island, constitute the independent state of ANTIGUA AND BARBUDA. The capital is St. Johns.
MR = 20120703
DA = 19741111
DC = 4
DX = 19750101
UI = D000958

*NEWRECORD
RECTYPE = D
MH = Antihypertensive Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anti-Hypertensive Agents|T121|NON|EQV|NLM (1996)|940818|abcdef
ENTRY = Anti-Hypertensive Drugs|T121|NON|EQV|NLM (1996)|940818|abcdef
ENTRY = Anti-Hypertensives|T121|NON|EQV|NLM (1996)|940818|abcdef
ENTRY = Antihypertensive Drugs|T121|NON|EQV|NLM (1996)|940818|abcdef
ENTRY = Antihypertensives|T121|NON|EQV|NLM (1996)|940818|abcdef
ENTRY = Agents, Anti-Hypertensive
ENTRY = Agents, Antihypertensive
ENTRY = Anti Hypertensive Agents
ENTRY = Anti Hypertensive Drugs
ENTRY = Anti Hypertensives
ENTRY = Drugs, Anti-Hypertensive
ENTRY = Drugs, Antihypertensive
MN = D27.505.954.411.162
FX = Adrenergic alpha-Antagonists
FX = Adrenergic beta-Antagonists
FX = Angiotensin-Converting Enzyme Inhibitors
FX = Diuretics
FX = Ganglionic Blockers
FX = Vasodilator Agents
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = not for ocular hypertension
MS = Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
MR = 20050713
DA = 19990101
DC = 1
UI = D000959

*NEWRECORD
RECTYPE = D
MH = Hypolipidemic Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antilipemic Agents|T121|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Antihyperlipemics|T121|NON|EQV|IOM (1990)|890512|abcdef
ENTRY = Antihyperlipidemics|T121|NON|EQV|IOM (1990)|890512|abcdef
ENTRY = Antilipemic Drugs|T121|NON|EQV|NLM (1996)|941114|abcdef
ENTRY = Antilipemics|T121|NON|EQV|NLM (1996)|950217|abcdef
ENTRY = Hypolipidemic Drugs|T121|NON|EQV|NLM (2011)|090923|abcdef
ENTRY = Agents, Antilipemic
ENTRY = Agents, Hypolipidemic
ENTRY = Drugs, Antilipemic
ENTRY = Drugs, Hypolipidemic
MN = D27.505.519.186.071
MN = D27.505.954.557.500
MH_TH = NLM (1990)
ST = T121
RN = 0
MS = Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.
PM = 2010
HN = 2010(1966)
MR = 20140625
DA = 19990101
DC = 1
DX = 19720101
UI = D000960

*NEWRECORD
RECTYPE = D
MH = Antilymphocyte Serum
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = ATGAM|T087|T116|T129|TRD|NRW|UNK (19XX)|830915|abbbcdef
PRINT ENTRY = Antilymphoblast Globulins|T116|T121|T129|NON|NRW|UNK (19XX)|810513|abbbcdef
PRINT ENTRY = Antilymphocyte Antibodies|T116|T129|NON|NRW|UNK (19XX)|780501|abbcdef
PRINT ENTRY = Antilymphocyte Globulin|T116|T121|T129|NON|NRW|UNK (19XX)|780501|abbbcdef
PRINT ENTRY = Lymphocytotoxic Antibodies|T116|T129|NON|NRW|UNK (19XX)|780501|abbcdef
ENTRY = Anti-Thymocyte Globulin|T116|T121|T129|NON|NRW|NLM (2005)|031015|abbbcdef
ENTRY = Antilymphocyte Immunoglobulin|T116|T121|T129|NON|NRW|UNK (19XX)|870811|abbbcdef
ENTRY = Antithymocyte Globulin|T116|T121|T129|NON|NRW|UNK (19XX)|800918|abbbcdef
ENTRY = Antithymoglobulin|T116|T121|T129|NON|NRW|UNK (19XX)|880912|abbbcdef
ENTRY = Lymphocyte Immune Globulin, Anti-Thymocyte Globulin|T116|T121|T129|NON|NRW|NLM (2005)|031015|abbbcdef
ENTRY = Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine)|T116|T121|T129|NON|NRW|NLM (2005)|031015|abbbcdef
ENTRY = Pressimmune|T116|T121|T129|TRD|NRW|UNK (19XX)|821206|abbbcdef
ENTRY = Anti Thymocyte Globulin
ENTRY = Anti-Thymocyte Globulins
ENTRY = Antibodies, Antilymphocyte
ENTRY = Antibodies, Lymphocytotoxic
ENTRY = Antibody, Antilymphocyte
ENTRY = Antibody, Lymphocytotoxic
ENTRY = Antilymphoblast Globulin
ENTRY = Antilymphocyte Antibody
ENTRY = Antilymphocyte Globulins
ENTRY = Antilymphocyte Immunoglobulins
ENTRY = Antilymphocyte Serums
ENTRY = Antithymocyte Globulins
ENTRY = Antithymoglobulins
ENTRY = Globulin, Anti-Thymocyte
ENTRY = Globulin, Antilymphoblast
ENTRY = Globulin, Antilymphocyte
ENTRY = Globulin, Antithymocyte
ENTRY = Globulins, Anti-Thymocyte
ENTRY = Globulins, Antilymphoblast
ENTRY = Globulins, Antilymphocyte
ENTRY = Globulins, Antithymocyte
ENTRY = Immunoglobulin, Antilymphocyte
ENTRY = Immunoglobulins, Antilymphocyte
ENTRY = Lymphocyte Immune Globulin, Anti Thymocyte Globulin
ENTRY = Lymphocytotoxic Antibody
ENTRY = Serum, Antilymphocyte
ENTRY = Serums, Antilymphocyte
MN = A12.207.152.846.500.203
MN = D12.776.124.486.485.114.573.203
MN = D12.776.124.790.651.114.573.203
MN = D12.776.377.715.548.114.573.203
MN = D20.215.401.203
PA = Immunologic Factors
PA = Immunosuppressive Agents
MH_TH = NLM (1968)
ST = T116
ST = T121
ST = T129
RN = 0
AN = antithymocyte & anti-theta serum: index ANTILYMPHOCYTE SERUM + T LYMPHOCYTES /immunol; "lymphocytotoxin": index CYTOTOXINS + LYMPHOCYTES but note entry term LYMPHOCYTOTOXIC ANTIBODIES for antibodies to lymphocytes
PI = Immune Sera (1966-1967)
PI = Lymphocytes (1966-1967)
MS = Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.
OL = search LYMPHOCYTOTOXINS under LYMPHOTOXINS 1978
PM = 70; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978
HN = 70(68); LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978
MR = 20110624
DA = 19990101
DC = 1
DX = 19700101
UI = D000961

*NEWRECORD
RECTYPE = D
MH = Antimalarials
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anti-Malarials|T121|NON|EQV|NLM (2004)|030321|abcdef
ENTRY = Antimalarial Agents|T121|NON|EQV|NLM (1996)|940728|abcdef
ENTRY = Antimalarial Drugs|T121|NON|EQV|NLM (1996)|940728|abcdef
ENTRY = Agents, Antimalarial
ENTRY = Anti Malarials
ENTRY = Drugs, Antimalarial
MN = D27.505.954.122.250.100.085
FX = Antirheumatic Agents
MH_TH = NLM (1966)
ST = T121
RN = 0
MS = Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
MR = 20140625
DA = 19990101
DC = 1
UI = D000962

*NEWRECORD
RECTYPE = D
MH = Antimetabolites
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D27.505.519.186
MN = D27.888.569.042
MH_TH = POPLINE (1978)
ST = T121
RN = 0
MS = Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033)
MR = 20140625
DA = 19990101
DC = 1
UI = D000963

*NEWRECORD
RECTYPE = D
MH = Antimetabolites, Antineoplastic
DE = ANTIMETAB ANTINEOPL
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antineoplastic Antimetabolites|T121|NON|EQV|NLM (1996)|950122|ANTINEOPL ANTIMETAB|abcdefv
MN = D27.505.519.186.144
MN = D27.505.954.248.144
MN = D27.888.569.042.030
MH_TH = NLM (1975)
ST = T121
RN = 0
AN = TN 4: relation to ANTINEOPLASTIC AGENTS
PI = Antineoplastic Agents (1966-1974)
MS = Antimetabolites that are useful in cancer chemotherapy.
PM = 75
HN = 75
MR = 20140625
DA = 19990101
DC = 1
DX = 19750901
UI = D000964

*NEWRECORD
RECTYPE = D
MH = Antimony
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.513.124
MN = D01.268.556.050
MN = D01.552.544.050
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Antimony
RN = 9IT35J3UV3
RR = 7440-36-0 (Antimony)
AN = Sb-121; Sb-123 = ANTIMONY (IM) + ISOTOPES (NIM); Sb-112-120, 122, 124-133 = ANTIMONY (IM) + RADIOISOTOPES (IM)
MS = A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.
MR = 20130708
DA = 19990101
DC = 1
UI = D000965

*NEWRECORD
RECTYPE = D
MH = Antimony Potassium Tartrate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Potassium Antimonyltartrate|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef
PRINT ENTRY = Tartar Emetic|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef
ENTRY = Tartrated Antimony|T109|T121|NON|EQV|NLM (1994)|920805|abbcdef
ENTRY = Antimony, Tartrated
ENTRY = Antimonyltartrate, Potassium
ENTRY = Emetic, Tartar
ENTRY = Potassium Tartrate, Antimony
ENTRY = Tartrate, Antimony Potassium
MN = D02.691.075
PA = Schistosomicides
MH_TH = FDA SRS (2014)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4))di-, dipotassium, trihydrate, stereoisomer
RN = DL6OZ476V3
RR = 28300-74-5 (Antimony Potassium Tartrate)
PI = Antimony (1969-1975)
PI = Tartrates (1969-1975)
MS = A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.
PM = 91; was see under ANTIMONY 1976-90
HN = 91(76); was see under ANTIMONY 1976-90
MR = 20130708
DA = 19750723
DC = 1
DX = 19910101
UI = D000966

*NEWRECORD
RECTYPE = D
MH = Antimony Sodium Gluconate
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antimony Gluconate Sodium|T109|T121|NON|EQV|UNK (19XX)|760414|abbcdef
PRINT ENTRY = Sodium Stibogluconate|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1994)|921013|abbcdeeef
ENTRY = Antimony Gluconic Acid|T109|T121|NON|BRD|UNK (19XX)|800917|abbcdef
ENTRY = Antimony Sodium Gluconates|T109|T121|NON|BRD|NLM (1994)|921013|abbcdef
ENTRY = GlaxoSmithKline Brand of Sodium Stibogluconate|T109|T121|NON|NRW|NLM (2006)|041113|abbcdef
ENTRY = Myostibin|T109|T121|TRD|NRW|NLM (1992)|901001|abbcdef
ENTRY = Pentostam|T109|T121|TRD|NRW|UK|UNK (19XX)|800917|abbcdeef
ENTRY = Solustibosan|T109|T121|TRD|NRW|NLM (1992)|901001|abbcdef
ENTRY = Stibatin|T109|T121|TRD|NRW|NLM (1992)|901001|abbcdef
ENTRY = Stibogluconate Sodium|T109|T121|NON|EQV|NLM (1994)|921013|abbcdef
ENTRY = Triostam|T109|T121|TRD|NRW|UNK (19XX)|850528|abbcdef
ENTRY = Sodium Gluconates, Antimony
ENTRY = Sodium, Stibogluconate
ENTRY = Stibogluconate, Sodium
MN = D02.241.081.844.322.060
MN = D02.241.511.902.322.060
MN = D02.691.080
MN = D09.811.308.060
PA = Antiprotozoal Agents
PA = Schistosomicides
MH_TH = NLM (1977)
ST = T109
ST = T121
RN = V083S0159D
PI = Antimony (1970-1975)
PI = Gluconates (1970-1976)
MS = Antimony complex where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate is used in leishmaniasis. The trivalent gluconate is most frequently used in schistosomiasis.
OL = use ANTIMONY SODIUM GLUCONATE to search ANTIMONY SODIUM GLUCONATES 1977-93
PM = 94; was ANTIMONY SODIUM GLUCONATES 1991-93 (see under GLUCONATES 1977-90); SODIUM STIBOGLUCONATE was STIBOGLUCONATE SODIUM 1977-93
HN = 94; was ANTIMONY SODIUM GLUCONATES 1991-93 (see under GLUCONATES 1977-90); SODIUM STIBOGLUCONATE was STIBOGLUCONATE SODIUM 1977-93
MR = 20130708
DA = 19760416
DC = 1
DX = 19910101
UI = D000967

*NEWRECORD
RECTYPE = D
MH = Antimycin A
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Antimycin A1|T109|T195|NON|NRW|UNK (19XX)|840918|abbcdef
MN = D02.540.576.500.750
PA = Anti-Bacterial Agents
PA = Antifungal Agents
MH_TH = NLM (1964)
ST = T109
ST = T195
N1 = Butanoic acid, 2(or 3)-methyl-, 3-((3-(formylamino)-2-hydroxybenzoyl)amino)-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl ester
RN = 642-15-9
MS = An antibiotic substance produced by Streptomyces species. It inhibits mitochondrial respiration and may deplete cellular levels of ATP. Antimycin A1 has been used as a fungicide, insecticide, and miticide. (From Merck Index, 12th ed)
PM = 66
HN = 66(64)
MR = 20150622
DA = 19990101
DC = 1
DX = 19660101
UI = D000968

*NEWRECORD
RECTYPE = D
MH = Antinematodal Agents
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Nematocides|T121|NON|EQV|UNK (19XX)|750716|abcdef
ENTRY = Antinematodal Drugs|T121|NON|EQV|NLM (1996)|940825|abcdef
ENTRY = Antinematodals|T121|NON|EQV|NLM (1996)|940825|abcdef
ENTRY = Agents, Antinematodal
ENTRY = Drugs, Antinematodal
MN = D27.505.954.122.250.075.080
MH_TH = NLM (1976)
ST = T121
RN = 0
AN = consider also NEMATODA /drug eff & NEMATODE INFECTIONS /drug ther or pertinent specifics
PI = Anthelmintics (1966-1973)
MS = Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice.
OL = use ANTINEMATODAL AGENTS to search NEMATOCIDES 1974-75
PM = 76; was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75
HN = 76(75); was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75
MR = 20140625
DA = 19990101
DC = 1
DX = 19760101
UI = D000969

*NEWRECORD
RECTYPE = D
MH = Antineoplastic Agents
DE = ANTINEOPL AGENTS
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anticancer Agents|T121|NON|EQV|NLM (2013)|110720|abcdef
ENTRY = Antineoplastic Drugs|T121|NON|EQV|NLM (1996)|941115|abcdef
ENTRY = Antineoplastics|T121|NON|EQV|NLM (1996)|941031|abcdef
ENTRY = Antitumor Agents|T121|NON|EQV|NLM (2008)|070605|abcdef
ENTRY = Antitumor Drugs|T121|NON|EQV|NLM (2008)|070605|abcdef
ENTRY = Cancer Chemotherapy Agents|T121|NON|EQV|NLM (2013)|110914|abcdef
ENTRY = Cancer Chemotherapy Drugs|T121|NON|EQV|NLM (2013)|110720|abcdef
ENTRY = Chemotherapeutic Anticancer Agents|T121|NON|EQV|NLM (2013)|110720|abcdef
ENTRY = Chemotherapeutic Anticancer Drug|T121|NON|EQV|NLM (2013)|110914|abcdef
ENTRY = Agents, Anticancer
ENTRY = Agents, Antineoplastic
ENTRY = Agents, Antitumor
ENTRY = Agents, Cancer Chemotherapy
ENTRY = Agents, Chemotherapeutic Anticancer
ENTRY = Chemotherapy Agents, Cancer
ENTRY = Chemotherapy Drugs, Cancer
ENTRY = Drug, Chemotherapeutic Anticancer
ENTRY = Drugs, Antineoplastic
ENTRY = Drugs, Antitumor
ENTRY = Drugs, Cancer Chemotherapy
MN = D27.505.954.248
FX = Anticarcinogenic Agents
FX = Chemoembolization, Therapeutic
FX = Chemotherapy, Cancer, Regional Perfusion
FX = Cytotoxins
FX = Infusions, Intra-Arterial
FX = Tumor Lysis Syndrome
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = /admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+
MS = Substances that inhibit or prevent the proliferation of NEOPLASMS.
MR = 20140625
DA = 19990101
DC = 1
UI = D000970

*NEWRECORD
RECTYPE = D
MH = Antineoplastic Combined Chemotherapy Protocols
AQ = AD AE AI AN BL CF CH CL CS CT EC HI IM ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Anticancer Drug Combinations|T061|NON|EQV|NLM (1990)|890216|abcdef
PRINT ENTRY = Antineoplastic Agents, Combined|T061|NON|EQV|NLM (1984)|990101|ANTINEOPL AGENTS COMBINED|abcdefv
PRINT ENTRY = Antineoplastic Chemotherapy Protocols|T061|NON|BRD|NLM (2002)|000922|abcdef
PRINT ENTRY = Antineoplastic Drug Combinations|T061|NON|EQV|NLM (1990)|890216|ANTINEOPL DRUG COMB|abcdefv
PRINT ENTRY = Cancer Chemotherapy Protocols|T061|NON|BRD|NLM (2002)|000803|abcdef
PRINT ENTRY = Chemotherapy Protocols, Antineoplastic|T061|NON|BRD|NLM (2002)|000918|abcdef
PRINT ENTRY = Drug Combinations, Antineoplastic|T061|NON|EQV|NLM (1990)|890405|DRUG COMBINATIONS ANTINEOPL|abcdefv
ENTRY = Antineoplastic Combined Chemotherapy Regimens|T061|NON|EQV|NLM (2002)|001005|abcdef
ENTRY = Combined Antineoplastic Agents|T061|NON|EQV|UNK (19XX)|830617|COMBINED ANTINEOPL AGENTS|abcdefv
ENTRY = Agent, Combined Antineoplastic
ENTRY = Agents, Combined Antineoplastic
ENTRY = Anticancer Drug Combination
ENTRY = Antineoplastic Agent, Combined
ENTRY = Antineoplastic Chemotherapy Protocol
ENTRY = Antineoplastic Drug Combination
ENTRY = Cancer Chemotherapy Protocol
ENTRY = Chemotherapy Protocol, Antineoplastic
ENTRY = Chemotherapy Protocol, Cancer
ENTRY = Chemotherapy Protocols, Cancer
ENTRY = Combinations, Antineoplastic Drug
ENTRY = Combined Antineoplastic Agent
ENTRY = Drug Combination, Anticancer
ENTRY = Drug Combination, Antineoplastic
ENTRY = Drug Combinations, Anticancer
ENTRY = Protocol, Antineoplastic Chemotherapy
ENTRY = Protocol, Cancer Chemotherapy
ENTRY = Protocols, Antineoplastic Chemotherapy
ENTRY = Protocols, Cancer Chemotherapy
MN = E02.183.750.500
MN = E02.319.077.500
MN = E02.319.310.037
MH_TH = NLM (2002)
ST = T061
AN = coordinate IM with specific antineoplastic agents (IM or NIM)
PI = Drug Therapy, Combination (1974-1983)
MS = The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
PM = 2002; see ANTINEOPLASTIC AGENTS, COMBINED (1984-2001)
HN = 2002(1984)
MR = 20150623
DA = 19830617
DC = 1
DX = 19840101
UI = D000971

*NEWRECORD
RECTYPE = D
MH = Antineoplastic Agents, Phytogenic
DE = ANTINEOPL AGENTS PHYTOGENIC
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antineoplastics, Botanical|T121|NON|EQV|UNK (19XX)|741226|ANTINEOPL BOTANIC|abcdefv
ENTRY = Antineoplastics, Phytogenic|T121|NON|EQV|UNK (19XX)|750731|abcdef
ENTRY = Agents, Phytogenic Antineoplastic
ENTRY = Botanical Antineoplastics
ENTRY = Phytogenic Antineoplastic Agents
ENTRY = Phytogenic Antineoplastics
MN = D27.505.954.248.179
MH_TH = NLM (1975)
ST = T121
RN = 0
PI = Antineoplastic Agents (1966-1974)
MS = Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.
OL = use ANTINEOPLASTIC AGENTS, PHYTOGENIC to search ANTINEOPLASTICS, PHYTOGENIC 1975
PM = 76; was ANTINEOPLASTICS, PHYTOGENIC 1975
HN = 76; was ANTINEOPLASTICS, PHYTOGENIC 1975
MR = 20090706
DA = 19990101
DC = 1
DX = 19750901
UI = D000972

*NEWRECORD
RECTYPE = D
MH = Antibodies, Antinuclear
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Anti-DNA Antibodies|T116|T129|NRW|IOM (1990)|890413|ANTIDNA ANTIBODIES|abbdefs
PRINT ENTRY = Antibodies, Anti-DNA|T116|T129|NRW|NLM (1990)|890413|ANTIBODIES ANTIDNA|abbdefs
PRINT ENTRY = Antinuclear Antibodies|T059|T116|T129|NON|EQV|NLM (1990)|890413|abbbcdef
PRINT ENTRY = Antinuclear Factors|T059|T116|T129|NON|EQV|NLM (1990)|890413|abbbcdef
PRINT ENTRY = Fluorescent Antinuclear Antibodies|T116|T129|NON|NRW|NLM (1990)|890413|abbcdef
ENTRY = Antinuclear Antibody|T059|T116|T129|NON|EQV|NLM (1990)|890413|abbbcdef
ENTRY = Antinuclear Factor|T059|T116|T129|NON|EQV|UNK (19XX)|811113|abbbcdef
ENTRY = Anti DNA Antibodies
ENTRY = Antibodies, Anti DNA
ENTRY = Antibodies, Fluorescent Antinuclear
ENTRY = Antibody, Antinuclear
ENTRY = Antinuclear Antibodies, Fluorescent
ENTRY = Factor, Antinuclear
ENTRY = Factors, Antinuclear
MN = D12.776.124.486.485.114.323.204
MN = D12.776.124.790.651.114.323.204
MN = D12.776.377.715.548.114.323.204
PA = Immunologic Factors
FX = Collagen Diseases
MH_TH = NLM (1966)
ST = T059
ST = T116
ST = T129
RN = 0
AN = coordinate with specific nuclear antigen; do not coordinate with ANTIBODY FORMATION for /biosyn
MS = Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease.
OL = use ANTIBODIES, ANTINUCLEAR to search ANTINUCLEAR FACTORS 1966-89 (Prov 1966-69)
PM = 90; was ANTINUCLEAR FACTORS 1970-89
HN = 90; was ANTINUCLEAR FACTORS 1966-89 (Prov 1966-69)
MR = 20050630
DA = 19990101
DC = 1
DX = 19700101
UI = D000974

*NEWRECORD
RECTYPE = D
MH = Antioxidants
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PH PK PO RE SD ST TO TU
ENTRY = Anti-Oxidant Effect|T039|NON|REL|NLM (2012)|110404|abcdef
ENTRY = Anti-Oxidant Effects|T039|NON|REL|NLM (2012)|110404|abcdef
ENTRY = Antioxidant Effect|T039|NON|REL|NLM (2012)|110404|abcdef
ENTRY = Antioxidant Effects|T039|NON|REL|NLM (2012)|110404|abcdef
ENTRY = Anti Oxidant Effect
ENTRY = Anti Oxidant Effects
ENTRY = Effect, Anti-Oxidant
ENTRY = Effect, Antioxidant
ENTRY = Effects, Anti-Oxidant
ENTRY = Effects, Antioxidant
MN = D27.505.519.217
MN = D27.505.696.706.125
MN = D27.720.799.047
FX = Oxidative Stress
FX = Pharmaceutic Aids
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = note entry term ANTIOXIDANT EFFECT: use only for the antioxidant effect of a chemical substance
MS = Naturally occurring or synthetic substances that inhibit or retard the oxidation of a substance to which it is added. They counteract the harmful and damaging effects of oxidation in animal tissues.
MR = 20110624
DA = 19990101
DC = 1
UI = D000975

*NEWRECORD
RECTYPE = D
MH = Antipain
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
MN = D12.644.456.120
PA = Protease Inhibitors
MH_TH = NLM (1980)
ST = T116
ST = T121
N1 = L-Valinamide, N2-(((1-carboxy-2-phenylethyl)amino)carbonyl)-L-arginyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-
RN = 37691-11-5
AN = nothing to do with pain: a bacterial protease inhibitor
PI = Oligopeptides (1973-1979)
PI = Peptide Hydrolases/AI (1968-1978)
PI = Peptide Peptidohydrolases/AI (1968-1978)
PI = Peptides (1966-1972)
PI = Protease Inhibitors (1979)
MS = An oligopeptide produced by various bacteria which acts as a protease inhibitor.
PM = 91; was see under OLIGOPEPTIDES 1980-90
HN = 91(80); was see under OLIGOPEPTIDES 1980-90
MR = 19950608
DA = 19790523
DC = 1
DX = 19910101
UI = D000976

*NEWRECORD
RECTYPE = D
MH = Antiparasitic Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Parasiticides|T121|NON|EQV|NLM (1996)|950301|abcdef
ENTRY = Antiparasitic Drugs|T121|NON|EQV|NLM (1996)|941115|abcdef
ENTRY = Antiparasitics|T121|NON|EQV|NLM (1996)|941115|abcdef
ENTRY = Agents, Antiparasitic
ENTRY = Drugs, Antiparasitic
MN = D27.505.954.122.250
MH_TH = NLM (1974)
ST = T121
RN = 0
MS = Drugs used to treat or prevent parasitic infections.
OL = use ANTIPROTOZOAL AGENTS to search PARASITICIDES 1966
PM = 96; PARASITICIDES was heading 1963-66
HN = 96; was NON MESH 1967-95; PARASITICIDES was heading 1963-66
MR = 20030709
DA = 19990101
DC = 1
DX = 19960101
UI = D000977

*NEWRECORD
RECTYPE = D
MH = Antiparkinson Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Antiparkinson Drugs|T121|NON|EQV|UNK (19XX)|750731|abcdef
ENTRY = Antiparkinsonian Agents|T121|NON|EQV|NLM (1995)|940314|abcdef
ENTRY = Antiparkinsonians|T121|NON|EQV|NLM (1995)|940314|abcdef
ENTRY = Agents, Antiparkinson
ENTRY = Agents, Antiparkinsonian
ENTRY = Drugs, Antiparkinson
MN = D27.505.954.427.090.050
MH_TH = NLM (1972)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specifics; consider also PARKINSON DISEASE /drug ther
PI = Parasympatholytics (1966-1972)
PI = Parkinsonism/drug therapy (1966-1972)
MS = Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
OL = use ANTIPARKINSON AGENTS to search ANTIPARKINSON DRUGS 1972-75 (as Prov 1972) & PARASYMPATHOLYTICS 1966-71
PM = 76; was ANTIPARKINSON DRUGS 1973-75; was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72
HN = 76; was ANTIPARKINSON DRUGS 1972-75 (Prov 1972); was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D000978

*NEWRECORD
RECTYPE = D
MH = alpha-2-Antiplasmin
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = alpha 2-Plasmin Inhibitor|T116|T129|NON|EQV|UNK (19XX)|790523|ALPHA PLASMIN INHIBITOR 02|ALPHA 2 PLASMIN INHIB|abbcdefsv
ENTRY = Serpin F2|T116|T129|NON|EQV|NLM (2010)|090209|abbcdef
ENTRY = alpha(2)-Plasmin Inhibitor|T116|T129|NON|EQV|UNK (19XX)|800918|abbcdef
ENTRY = alpha-2 Antiplasmin|T116|T129|NON|EQV|UNK (19XX)|810604|abbcdef
ENTRY = alpha 2 Antiplasmin
ENTRY = alpha 2 Plasmin Inhibitor
MN = D12.644.861.050
MN = D12.776.124.790.106.090
MN = D12.776.377.715.085.090
MN = D12.776.395.080
MN = D12.776.872.050
PA = Antifibrinolytic Agents
PA = Serine Proteinase Inhibitors
MH_TH = NLM (2000)
ST = T116
ST = T129
RN = 0
PI = Fibrinolysin/antagonists & inhibitors (1968-1979)
MS = A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.
PM = 2010; see ANTIPLASMIN 1980-2009
HN = 2010(1980)
MR = 20150623
DA = 19790523
DC = 1
DX = 19800101
UI = D000979

*NEWRECORD
RECTYPE = D
MH = Antiplatyhelmintic Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Antiplatyhelmintic Drugs|T121|NON|EQV|NLM (1996)|941114|abcdef
ENTRY = Antiplatyhelmintics|T121|NON|EQV|NLM (1996)|941015|abcdef
ENTRY = Agents, Antiplatyhelmintic
ENTRY = Drugs, Antiplatyhelmintic
MN = D27.505.954.122.250.075.100
MH_TH = NLM (1975)
ST = T121
RN = 0
AN = consider also PLATYHELMINTHS /drug eff or pertinent specifics
PI = Anthelmintics (1966-1974)
MS = Agents used to treat cestode, trematode, or other flatworm infestations in man or animals.
PM = 75
HN = 75
MR = 20030709
DA = 19990101
DC = 1
DX = 19750901
UI = D000980

*NEWRECORD
RECTYPE = D
MH = Antiprotozoal Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Schizonticides|T121|NON|NRW|NLM (2007)|051101|abcdef
ENTRY = Agents, Antiprotozoal
MN = D27.505.954.122.250.100
MH_TH = NLM (1967)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specific groups or specific antiprotozoal agent
MS = Substances that are destructive to protozoans.
PM = 67
HN = 67
MR = 20090710
DA = 19990101
DC = 1
DX = 19670101
UI = D000981

*NEWRECORD
RECTYPE = D
MH = Antipruritics
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Antipruritic Agents|T121|NON|EQV|NLM (1995)|940314|abcdef
ENTRY = Antipruritic Drugs|T121|NON|EQV|NLM (1995)|940409|abcdef
ENTRY = Agents, Antipruritic
ENTRY = Drugs, Antipruritic
MN = D27.505.954.444.075
MH_TH = NLM (1975)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specifics; D25-26 qualif; consider also PRURITUS /drug ther
MS = Agents, usually topical, that relieve itching (pruritus).
OL = search DERMATOLOGIC AGENTS 1967-74
PM = 91; was see under DERMATOLOGIC AGENTS 1975-90
HN = 91(75); was see under DERMATOLOGIC AGENTS 1975-90
MR = 20050630
DA = 19990101
DC = 1
DX = 19910101
UI = D000982

*NEWRECORD
RECTYPE = D
MH = Antipyrine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Phenazone|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|741114|abbcdeeef
ENTRY = Anodynin|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Pyramidone|T109|T121|TRD|NRW|UNK (19XX)|811209|abbcdef
MN = D03.383.129.539.850.088
PA = Anti-Inflammatory Agents, Non-Steroidal
MH_TH = FDA SRS (2014)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 3H-Pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-2-phenyl-
RN = T3CHA1B51H
RR = 60-80-0 (Antipyrine)
MS = An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
MR = 20130708
DA = 19990101
DC = 1
UI = D000983

*NEWRECORD
RECTYPE = D
MH = Antisepsis
AQ = HI IS MT ST
MN = N06.850.780.200.450.150
MH_TH = NLM (1966)
ST = T061
AN = differentiate from ASEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion
MS = The destruction of germs causing disease.
MR = 20080708
DA = 19990101
DC = 1
UI = D000985

*NEWRECORD
RECTYPE = D
MH = Antisickling Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Desickling Agents|T121|NON|NRW|UNK (19XX)|760412|abcdef
ENTRY = Agents, Antisickling
ENTRY = Agents, Desickling
MN = D27.505.954.502.135
MH_TH = NLM (1977)
ST = T121
RN = 0
AN = consider also ANEMIA, SICKLE CELL /drug ther
PI = Anemia, Sickle Cell (1966-1976)
PI = Hemoglobin, Sickle (1975-1976)
PI = Hemoglobins, Abnormal (1966-1974)
MS = Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.
PM = 77
HN = 77
MR = 20050630
DA = 19760413
DC = 1
DX = 19770101
UI = D000986

*NEWRECORD
RECTYPE = D
MH = Antisocial Personality Disorder
DE = ANTISOCIAL PERSONALITY DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Dyssocial Behavior|T055|NON|BRD|UNK (19XX)|750716|abcdef
PRINT ENTRY = Personality Disorder, Antisocial|T048|NON|EQV|UNK (19XX)|800521|PERSONALITY DIS ANTISOCIAL|abcdefv
PRINT ENTRY = Psychopathic Personality|T048|NON|EQV|UNK (19XX)|750716|abcdef
PRINT ENTRY = Sociopathic Personality|T048|NON|EQV|UNK (19XX)|750716|abcdef
ENTRY = Antisocial Personality|T048|NON|EQV|UNK (19XX)|800521|abcdef
ENTRY = Antisocial Personalities
ENTRY = Antisocial Personality Disorders
ENTRY = Behavior, Dyssocial
ENTRY = Behaviors, Dyssocial
ENTRY = Disorder, Antisocial Personality
ENTRY = Disorders, Antisocial Personality
ENTRY = Dyssocial Behaviors
ENTRY = Personalities, Antisocial
ENTRY = Personalities, Psychopathic
ENTRY = Personalities, Sociopathic
ENTRY = Personality Disorders, Antisocial
ENTRY = Personality, Antisocial
ENTRY = Personality, Psychopathic
ENTRY = Personality, Sociopathic
ENTRY = Psychopathic Personalities
ENTRY = Sociopathic Personalities
MN = F03.675.050
FX = Conduct Disorder
MH_TH = NLM (1963)
ST = T048
MS = A personality disorder whose essential feature is a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood. The individual must be at least age 18 and must have a history of some symptoms of CONDUCT DISORDER before age 15. (From DSM-IV, 1994)
OL = use ANTISOCIAL PERSONALITY DISORDER to search ANTISOCIAL PERSONALITY 1976-80 & SOCIOPATHIC PERSONALITY 1966-75
PM = 81; was ANTISOCIAL PERSONALITY 1976-80, was SOCIOPATHIC PERSONALITY 1963-75
HN = 81; was ANTISOCIAL PERSONALITY 1976-80, was ANTISOCIAL PERSONALITY see under SOCIOPATHIC PERSONALITY 1969-75; SOCIOPATHIC PERSONALITY was heading 1963-75
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19760101
UI = D000987

*NEWRECORD
RECTYPE = D
MH = Antispermatogenic Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Sperm Maturation Blocking Agents|T121|NON|NRW|POPLINE (1981)|910328|SPERM MATURATION BLOCK AGENTS|abcdefv
ENTRY = Antispermatogenic Effect|T039|NON|REL|NLM (2012)|110331|abcdef
ENTRY = Antispermatogenic Effects|T039|NON|REL|NLM (2012)|110331|abcdef
ENTRY = Blocking Agents, Sperm Maturation|T121|NON|NRW|NLM (1996)|950525|BLOCK AGENTS SPERM MATURATION|abcdefv
ENTRY = Agents, Antispermatogenic
ENTRY = Effect, Antispermatogenic
ENTRY = Effects, Antispermatogenic
MN = D27.505.696.138
MN = D27.505.696.875.360.443.068
MN = D27.505.954.705.360.443.068
MN = D27.888.569.071
MH_TH = NLM (1975)
ST = T121
RN = 0
PI = Contraceptive Agents (1967-1974)
PI = Spermatogenesis/drug effects (1971-1974)
MS = Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis.
OL = use ANTISPERMATOGENIC AGENTS to search SPERM MATURATION BLOCKING AGENTS 1975-91
PM = 75; SPERM MATURATION BLOCKING AGENTS was heading 1975-91
HN = 75; SPERM MATURATION BLOCKING AGENTS was heading 1975-91
MR = 20110624
DA = 19990101
DC = 1
DX = 19750101
UI = D000988

*NEWRECORD
RECTYPE = D
MH = Antistreptolysin
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
ENTRY = Antistreptolysin O|T129|NON|NRW|UNK (19XX)|810728|abcdef
ENTRY = O, Antistreptolysin
MN = D12.776.124.486.485.114.107.288
MN = D12.776.124.790.651.114.125.288
MN = D12.776.377.715.548.114.125.288
PA = Immunologic Factors
MH_TH = NLM (1966)
ST = T129
N1 = Antistreptolysin
RN = 9006-92-2
MS = Antibodies specific to STREPTOLYSINS which indicate STREPTOCOCCAL INFECTIONS.
MR = 20050630
DA = 19990101
DC = 1
UI = D000989

*NEWRECORD
RECTYPE = D
MH = Antithrombin III
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Heparin Cofactor I|T116|T129|NON|EQV|UNK (19XX)|780207|abbcdef
ENTRY = Antithrombin III-Alpha|T116|T121|TRD|NRW|DE|020802|abbcdef
ENTRY = Atenativ|T116|T121|TRD|NRW|US|020802|abbcdef
ENTRY = Aventis Behring Brand of Antithrombin III|T116|T121|NON|NRW|NLM (2011)|100324|abbcdef
ENTRY = Bayer Brand of Antithrombin|T116|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Grifols Brand of Antithrombin|T116|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Heparin Co-Factor I|T116|T129|NON|EQV|UNK (19XX)|780606|abbcdef
ENTRY = Kybernin|T116|T121|TRD|NRW|DE|NLM (2011)|abbcdee
ENTRY = Pharmacia Brand of Antithrombin|T116|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Serpin C1|T116|T129|NON|EQV|NLM (2010)|090209|abbcdef
ENTRY = Thrombate III|T116|T121|TRD|NRW|CA|020802|abbcdef
ENTRY = Antithrombin Bayer Brand
ENTRY = Antithrombin Grifols Brand
ENTRY = Antithrombin III Alpha
ENTRY = Antithrombin IIIAlpha
ENTRY = Antithrombin Pharmacia Brand
ENTRY = Cofactor I, Heparin
ENTRY = Heparin Co Factor I
MN = D12.644.861.060.500
MN = D12.776.124.790.106.125
MN = D12.776.377.715.085.125
MN = D12.776.872.060.500
MN = D23.113.025
PA = Antithrombins
EC = deficiency:Antithrombin III Deficiency
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
ST = T116
ST = T129
RN = 9000-94-6
MS = A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
PM = 1979; see HEPARIN CO-FACTOR 1975-1978; KYBERNIN was indexed under ANTITHROMBIN III 1992-2010
HN = 1979
MR = 20150622
DA = 19990101
DC = 1
DX = 19790101
UI = D000990

*NEWRECORD
RECTYPE = D
MH = Antithrombins
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
PRINT ENTRY = Direct Antithrombins|T121|NON|EQV|NLM (2011)|100330|abcdef
ENTRY = Direct Thrombin Inhibitors|T121|NON|EQV|NLM (2011)|100324|abcdef
ENTRY = Antithrombins, Direct
ENTRY = Thrombin Inhibitors, Direct
MN = D27.505.519.389.745.800.449
MN = D27.505.954.502.119.500
MH_TH = NLM (2011)
ST = T121
RN = 0
AN = ANTITHROMBIN PROTEINS is also available
MS = Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins.
PM = see ANTITHROMBIN 1964-1966
HN = 2011(1964)
MR = 20140610
DA = 19990101
DC = 1
DX = 19670101
UI = D000991

*NEWRECORD
RECTYPE = D
MH = Antitoxins
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
MN = D12.776.124.486.485.114.573.601
MN = D12.776.124.790.651.114.573.601
MN = D12.776.377.715.548.114.573.601
MN = D20.215.401.601
PA = Immunologic Factors
MH_TH = NLM (1966)
ST = T121
ST = T129
RN = 0
AN = coordinate IM with specific toxin (IM or NIM)
MS = Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS.
PM = 66; TOXINS AND ANTITOXINS was heading 1963-65
HN = 66; TOXINS AND ANTITOXINS was heading 1963-65
MR = 20150622
DA = 19990101
DC = 1
DX = 19660101
UI = D000992

*NEWRECORD
RECTYPE = D
MH = Antitreponemal Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antisyphilitic Agents|T121|NON|NRW|NLM (1996)|940801|abcdef
ENTRY = Antisyphilitic Drugs|T121|NON|NRW|NLM (1996)|950301|abcdef
ENTRY = Antisyphilitics|T121|NON|NRW|NLM (1996)|940801|abcdef
ENTRY = Antitreponemal Drugs|T121|NON|EQV|NLM (1996)|950301|abcdef
ENTRY = Agents, Antisyphilitic
ENTRY = Agents, Antitreponemal
ENTRY = Drugs, Antisyphilitic
ENTRY = Drugs, Antitreponemal
MN = D27.505.954.122.085.222
MH_TH = NLM (1974)
ST = T121
RN = 0
MS = Agents used to treat infections with bacteria of the genus TREPONEMA. This includes SYPHILIS & YAWS.
PM = 96
HN = 96; was NON MESH 1975-95
MR = 20050720
DA = 19990101
DC = 1
DX = 19960101
UI = D000993

*NEWRECORD
RECTYPE = D
MH = Antitrichomonal Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Antitrichomonal Drugs|T121|NON|EQV|NLM (1996)|941114|abcdef
ENTRY = Antitrichomonals|T121|NON|EQV|NLM (1996)|941017|abcdef
ENTRY = Trichomonicides|T121|NON|EQV|NLM (1996)|950301|abcdef
ENTRY = Agents, Antitrichomonal
ENTRY = Drugs, Antitrichomonal
MN = D27.505.954.122.250.100.115
MH_TH = NLM (1965)
ST = T121
RN = 0
AN = consider also TRICHOMONAS /drug eff & TRICHOMONAS INFECTIONS /drug ther or pertinent specifics
MS = Agents used to treat trichomonas infections.
PM = 72
HN = 72(66)
MR = 20030709
DA = 19990101
DC = 1
DX = 19720101
UI = D000994

*NEWRECORD
RECTYPE = D
MH = Antitubercular Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Tuberculostatic Agents|T121|NON|EQV|UNK (19XX)|741230|abcdef
ENTRY = Antitubercular Drugs|T121|NON|EQV|NLM (1996)|941130|abcdef
ENTRY = Agents, Antitubercular
ENTRY = Agents, Tuberculostatic
ENTRY = Drugs, Antitubercular
MN = D27.505.954.122.085.255
FX = Tuberculosis
FX = Tuberculosis, Multidrug-Resistant
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = consider also MYCOBACTERIUM TUBERCULOSIS /drug eff & TUBERCULOSIS /drug ther
MS = Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
MR = 20100625
DA = 19990101
DC = 1
UI = D000995

*NEWRECORD
RECTYPE = D
MH = Antitussive Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Antitussive Drugs|T121|NON|EQV|NLM (1995)|940404|abcdef
ENTRY = Antitussives|T121|NON|EQV|NLM (1995)|940314|abcdef
ENTRY = Cough Suppressants|T121|NON|EQV|NLM (2011)|090916|abcdef
ENTRY = Agents, Antitussive
ENTRY = Drugs, Antitussive
ENTRY = Suppressants, Cough
MN = D27.505.954.427.153
MN = D27.505.954.796.090
FX = Expectorants
MH_TH = NLM (1966)
ST = T121
RN = 0
MS = Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.
MR = 20100625
DA = 19990101
DC = 1
UI = D000996

*NEWRECORD
RECTYPE = D
MH = Antivenins
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
ENTRY = Anti-Venins|T121|T129|NON|EQV|NLM (2006)|041203|abbcdef
ENTRY = Anti-Venoms|T121|T129|NON|EQV|NLM (2006)|041203|abbcdef
ENTRY = Antivenoms|T121|T129|NON|EQV|NLM (2006)|041203|abbcdef
ENTRY = Anti Venins
ENTRY = Anti Venoms
MN = D12.776.124.486.485.114.573.601.138
MN = D12.776.124.790.651.114.573.601.138
MN = D12.776.377.715.548.114.573.601.138
MN = D20.215.401.601.163
PA = Immunologic Factors
FX = Antidotes
MH_TH = NLM (1963)
ST = T121
ST = T129
RN = 0
AN = coordinate IM with specific venom
MS = Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS.
PM = 65
HN = 65(63)
MR = 20150622
DA = 19990101
DC = 1
DX = 19650101
UI = D000997

*NEWRECORD
RECTYPE = D
MH = Antiviral Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antivirals|T121|NON|EQV|NLM (1996)|940819|abcdef
ENTRY = Antiviral Drugs|T121|NON|EQV|NLM (1996)|940819|abcdef
ENTRY = Agents, Antiviral
ENTRY = Drugs, Antiviral
MN = D27.505.954.122.388
FX = Reverse Transcriptase Inhibitors
FX = Virus Inactivation
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = for resistance to antiviral agents, DRUG RESISTANCE, VIRAL and DRUG RESISTANCE, MULTIPLE, VIRAL are available
MS = Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
MR = 20130709
DA = 19990101
DC = 1
UI = D000998

*NEWRECORD
RECTYPE = D
MH = Antlers
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Antler
MN = A13.507.288
MH_TH = NLM (1975)
ST = T023
AN = a type of horn, on males of the deer family
MS = The horn of an animal of the deer family, typically present only in the male. It differs from the HORNS of other animals in being a solid, generally branched bony outgrowth that is shed and renewed annually. The word antler comes from the Latin anteocularis, ante (before) + oculus (eye). (From Webster, 3d ed)
OL = search HORNS 1968-74
PM = 91; was see under HORNS 1975-90
HN = 91(75); was see under HORNS 1975-90
MR = 19950313
DA = 19990101
DC = 1
DX = 19910101
UI = D000999

*NEWRECORD
RECTYPE = D
MH = Ants
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Ant
MN = B01.050.500.131.617.479.205
MH_TH = NLM (1966)
ST = T204
AN = /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
MS = Insects of the family Formicidae, very common and widespread, probably the most successful of all the insect groups. All ants are social insects, and most colonies contain three castes, queens, males, and workers. Their habits are often very elaborate and a great many studies have been made of ant behavior. Ants produce a number of secretions that function in offense, defense, and communication. (From Borror, et al., An Introduction to the Study of Insects, 4th ed, p676)
MR = 20090706
DA = 19990101
DC = 1
UI = D001000

*NEWRECORD
RECTYPE = D
MH = Anura
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Bombina|T011|NON|NRW|UNK (19XX)|800402|abcdef
PRINT ENTRY = Frogs and Toads|T011|NON|EQV|UNK (19XX)|800402|FROGS TOADS|abcdefv
PRINT ENTRY = Salientia|T011|NON|REL|UNK (19XX)|800402|abcdef
PRINT ENTRY = Toad, Fire-Bellied|T011|NON|NRW|UNK (19XX)|800402|abcdef
PRINT ENTRY = Toads and Frogs|T011|NON|EQV|UNK (19XX)|800402|TOADS FROGS|abcdefv
ENTRY = Anuras
ENTRY = Fire-Bellied Toad
ENTRY = Fire-Bellied Toads
ENTRY = Salientias
ENTRY = Toad, Fire Bellied
ENTRY = Toads, Fire-Bellied
MN = B01.050.150.900.090.180
MH_TH = NLM (1981)
ST = T011
AN = GEN or unspecified; prefer specific available families & genera; frogs & toads; NIM when exper animal: no qualif; when IM, qualif permitted
PI = Amphibia (1966-1980)
MS = An order of the class Amphibia, which includes several families of frogs and toads. They are characterized by well developed hind limbs adapted for jumping, fused head and trunk and webbed toes. The term "toad" is ambiguous and is properly applied only to the family Bufonidae.
OL = use ANURA to search FROGS & TOADS 1966-80
PM = 81; FROGS & TOADS were headings 1964-80
HN = 81; FROGS & TOADS were headings 1964-80
MR = 20090706
DA = 19800402
DC = 1
DX = 19810101
UI = D001001

*NEWRECORD
RECTYPE = D
MH = Anuria
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anurias
MN = C12.777.419.078
MN = C12.777.934.141
MN = C13.351.968.419.078
MN = C13.351.968.934.070
MH_TH = NLM (1966)
ST = T047
AN = do not confuse with OLIGURIA, diminished amount
MS = Absence of urine formation. It is usually associated with complete bilateral ureteral (URETER) obstruction, complete lower urinary tract obstruction, or unilateral ureteral obstruction when a solitary kidney is present.
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D001002

*NEWRECORD
RECTYPE = D
MH = Anal Canal
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Anal Gland, Human|T023|NON|NRW|NLM (2004)|030325|abcdef
PRINT ENTRY = Anal Sphincter|T023|NON|NRW|UNK (19XX)|800407|abcdef
PRINT ENTRY = Anus|T023|NON|NRW|NLM (1966)|990101|abcdef
ENTRY = Anal Gland|T023|NON|NRW|NLM (1993)|911106|abcdef
ENTRY = Anal Glands, Human|T023|NON|NRW|NLM (2004)|030325|abcdef
ENTRY = Anal Sphincters
ENTRY = Gland, Human Anal
ENTRY = Glands, Human Anal
ENTRY = Human Anal Gland
ENTRY = Human Anal Glands
ENTRY = Sphincter, Anal
ENTRY = Sphincters, Anal
MN = A03.556.124.526.070
MN = A03.556.249.249.070
FX = Proctoscopy
MH_TH = NLM (2004)
ST = T023
AN = inflammation = PROCTITIS; do not confuse X ref ANAL GLAND with ANAL GLAND, ANIMAL see ANAL SACS
CX = consider also terms at PROCT-
MS = The terminal segment of the LARGE INTESTINE, beginning from the ampulla of the RECTUM and ending at the anus.
MR = 20110624
DA = 19990101
DC = 1
UI = D001003

*NEWRECORD
RECTYPE = D
MH = Anus Diseases
DE = ANUS DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Anus Disease
ENTRY = Disease, Anus
ENTRY = Diseases, Anus
MN = C06.405.469.860.101
MH_TH = NLM (1966)
ST = T047
AN = inflamm dis = PROCTITIS
PM = 66
HN = 66
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19660101
UI = D001004

*NEWRECORD
RECTYPE = D
MH = Anus Neoplasms
DE = ANUS NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Anal Cancer|T191|NON|NRW|NLM (2000)|ORD (2010)|991103|abcdeef
PRINT ENTRY = Cancer of Anus|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Anal Neoplasms|T191|NON|EQV|NLM (2000)|991103|ANAL NEOPL|abcdefv
ENTRY = Cancer of the Anus|T191|NON|NRW|NLM (2000)|ORD (2010)|991103|abcdeef
ENTRY = Neoplasms, Anal|T191|NON|EQV|NLM (2000)|991103|NEOPL ANAL|abcdefv
ENTRY = Neoplasms, Anus|T191|NON|EQV|NLM (1995)|940204|NEOPL ANUS|abcdefv
ENTRY = Anal Cancers
ENTRY = Anal Neoplasm
ENTRY = Anus Cancer
ENTRY = Anus Cancers
ENTRY = Anus Neoplasm
ENTRY = Cancer, Anal
ENTRY = Cancers, Anal
ENTRY = Neoplasm, Anal
ENTRY = Neoplasm, Anus
MN = C04.588.274.476.411.307.790.040
MN = C06.301.371.411.307.790.040
MN = C06.405.249.411.307.790.040
MN = C06.405.469.491.307.790.040
MN = C06.405.469.860.101.163
MN = C06.405.469.860.180.500.040
MH_TH = NLM (1966)
ST = T191
AN = do not confuse with ANAL GLAND NEOPLASMS (in animals only); coord IM with histol type of neopl (IM)
MS = Tumors or cancer of the ANAL CANAL.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001005

*NEWRECORD
RECTYPE = D
MH = Anus, Imperforate
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anal Atresia|T019|T047|NON|EQV|NLM (1998)|ORD (2010)|960725|abbcdeef
PRINT ENTRY = Atresia, Anal|T019|T047|NON|EQV|NLM (1998)|960725|abbcdef
ENTRY = Anal Atresias
ENTRY = Atresias, Anal
ENTRY = Imperforate Anus
MN = C06.198.050
MN = C16.131.314.094
MH_TH = NLM (1964)
MH_TH = OMIM (2013)
ST = T019
ST = T047
MS = A congenital abnormality characterized by the persistence of the anal membrane, resulting in a thin membrane covering the normal ANAL CANAL. Imperforation is not always complete and is treated by surgery in infancy. This defect is often associated with NEURAL TUBE DEFECTS; MENTAL RETARDATION; and DOWN SYNDROME.
PM = 66
HN = 66(64)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19660101
UI = D001006

*NEWRECORD
RECTYPE = D
MH = Anxiety
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Hypervigilance|T184|NON|REL|NLM (2012)|110321|abcdef
ENTRY = Nervousness|T041|T184|NON|REL|NLM (1978)|781218|abbcdef
ENTRY = Anxieties
MN = F01.470.132
FX = Anti-Anxiety Agents
FX = Anxiety Disorders
MH_TH = NLM (1966)
ST = T041
ST = T184
AN = human & animal; differentiate from ANXIETY DISORDERS, a psychiatric diagnosis
MS = Feeling or emotion of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001007

*NEWRECORD
RECTYPE = D
MH = Anxiety Disorders
DE = ANXIETY DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Anxiety Neuroses|T048|NON|NRW|UNK (19XX)|800609|abcdef
PRINT ENTRY = Anxiety States, Neurotic|T048|NON|NRW|UNK (19XX)|800521|abcdef
PRINT ENTRY = Neuroses, Anxiety|T048|NON|NRW|UNK (19XX)|800521|abcdef
ENTRY = Anxiety Disorder
ENTRY = Anxiety State, Neurotic
ENTRY = Disorder, Anxiety
ENTRY = Disorders, Anxiety
ENTRY = Neurotic Anxiety State
ENTRY = Neurotic Anxiety States
ENTRY = State, Neurotic Anxiety
ENTRY = States, Neurotic Anxiety
MN = F03.080
FX = Anti-Anxiety Agents
FX = Anxiety
MH_TH = NLM (1966)
ST = T048
AN = differentiate from ANXIETY
MS = Persistent and disabling ANXIETY.
OL = use ANXIETY DISORDERS to search NEUROSES, ANXIETY 1966-80
PM = 81; was NEUROSES, ANXIETY 1963-80
HN = 81; was NEUROSES, ANXIETY 1963-80
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D001008

*NEWRECORD
RECTYPE = D
MH = Anxiety, Castration
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Castration Complex|T048|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Castration Anxiety
ENTRY = Castration Complices
ENTRY = Complex, Castration
ENTRY = Complices, Castration
MN = F01.470.132.150
MH_TH = NLM (1965)
ST = T048
MS = Anxiety due to fantasized injuries to or loss of the genitals.
PM = 70
HN = 70(65)
CATSH = CAT LIST
MR = 20040719
DA = 19990101
DC = 1
DX = 19700101
UI = D001009

*NEWRECORD
RECTYPE = D
MH = Anxiety, Separation
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Separation Anxiety Disorder|T048|NON|EQV|NLM (1998)|970317|SEPARATION ANXIETY DIS|abcdefv
ENTRY = Anxiety Disorder, Separation
ENTRY = Separation Anxiety
MN = F03.080.300
MN = F03.625.047
MH_TH = NLM (1968)
ST = T048
PI = Anxiety (1966-1967)
PI = Child Behavior Disorders (1966-1967)
PI = Child Psychology (1966-1967)
MS = Anxiety experienced by an individual upon separation from a person or object of particular significance to the individual.
OL = use ANXIETY, SEPARATION to search HOMESICKNESS 1975-78; use EMOTIONS 1966-74
PM = 68; HOMESICKNESS was see under EMOTIONS 1963-74
HN = 68; HOMESICKNESS was see under ANXIETY, SEPARATION 1975-78, was see under EMOTIONS 1963-74
CATSH = CAT LIST
MR = 20150707
DA = 19990101
DC = 1
DX = 19680101
UI = D001010

*NEWRECORD
RECTYPE = D
MH = Aorta
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RE RI SE SU TR UL US VI
PRINT ENTRY = Aorta, Ascending|T023|NON|NRW|UNK (19XX)|840210|abcdef
ENTRY = Ascending Aorta|T023|NON|NRW|UNK (19XX)|840210|abcdef
ENTRY = Aortas
ENTRY = Aortas, Ascending
ENTRY = Ascending Aortas
MN = A07.231.114.056
FX = Aortography
FX = Coronary Artery Bypass
EC = radiography:Aortography
MH_TH = NLM (1966)
ST = T023
AN = /surg: consider also CORONARY ARTERY BYPASS; inflammation = AORTITIS but note also AORTITIS, SYPHILITIC see SYPHILIS, CARDIOVASCULAR
MS = The main trunk of the systemic arteries.
MR = 19920325
DA = 19990101
DC = 1
UI = D001011

*NEWRECORD
RECTYPE = D
MH = Aorta, Abdominal
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Abdominal Aorta|T023|NON|EQV|NLM (2005)|040512|abcdef
ENTRY = Abdominal Aortas
ENTRY = Aortas, Abdominal
MN = A07.231.114.056.205
MH_TH = NLM (1966)
ST = T023
AN = coord NIM with aortic dis terms (IM)
MS = The aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries.
MR = 20040707
DA = 19990101
DC = 1
UI = D001012

*NEWRECORD
RECTYPE = D
MH = Aorta, Thoracic
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Aorta, Descending|T023|NON|BRD|UNK (19XX)|840210|abcdef
PRINT ENTRY = Aortic Arch|T023|T032|NON|REL|UNK (19XX)|770428|abbcdef
PRINT ENTRY = Arch of the Aorta|T023|T032|NON|REL|NLM (2005)|040421|abbcdef
ENTRY = Thoracic Aorta|T023|NON|EQV|NLM (2008)|061005|abcdef
ENTRY = Arch, Aortic
ENTRY = Descending Aorta
MN = A07.231.114.056.372
MH_TH = NLM (1963)
ST = T023
AN = diseases: coordinate IM with AORTIC DISEASES (IM) or specifics (IM)
MS = The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA.
MR = 20070709
DA = 19990101
DC = 1
UI = D001013

*NEWRECORD
RECTYPE = D
MH = Aortic Aneurysm
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aneurysm, Aortic|T190|NON|EQV|NLM (2008)|061005|abcdef
ENTRY = Aneurysms, Aortic
ENTRY = Aortic Aneurysms
MN = C14.907.055.239
MN = C14.907.109.139
MH_TH = NLM (1966)
ST = T190
AN = general or unspecified; prefer specifics; ruptured aortic aneurysm = AORTIC RUPTURE; for dissecting aneurysm of aorta, coordinate IM with ANEURYSM, DISSECTING (IM)
MS = An abnormal balloon- or sac-like dilatation in the wall of AORTA.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D001014

*NEWRECORD
RECTYPE = D
MH = Aortic Arch Syndromes
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aortic Arch Syndrome|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Syndrome, Aortic Arch
ENTRY = Syndromes, Aortic Arch
MN = C14.907.109.239
MH_TH = NLM (1965)
MH_TH = ORD (2010)
ST = T047
MS = Conditions resulting from abnormalities in the arteries branching from the ASCENDING AORTA, the curved portion of the aorta. These syndromes are results of occlusion or abnormal blood flow to the head-neck or arm region leading to neurological defects and weakness in an arm. These syndromes are associated with vascular malformations; ATHEROSCLEROSIS; TRAUMA; and blood clots.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19650101
UI = D001015

*NEWRECORD
RECTYPE = D
MH = Aortic Bodies
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Aortic Glomus|T023|NON|EQV|NLM (1994)|921006|abcdef
PRINT ENTRY = Glomus Aorticum|T023|NON|EQV|NLM (1994)|921006|abcdef
PRINT ENTRY = Glomus Vagale|T023|NON|EQV|NLM (1994)|930112|abcdef
PRINT ENTRY = Vagal Body|T023|NON|EQV|NLM (1994)|921006|abcdef
ENTRY = Aortic Body
ENTRY = Aorticum, Glomus
ENTRY = Bodies, Aortic
ENTRY = Bodies, Vagal
ENTRY = Body, Aortic
ENTRY = Body, Vagal
ENTRY = Glomus, Aortic
ENTRY = Vagal Bodies
ENTRY = Vagale, Glomus
MN = A08.675.650.915.500.600.050
MN = A08.800.950.500.600.050
MN = A11.671.650.915.500.600.050
MH_TH = NLM (1975)
ST = T023
AN = do not confuse with PARA-AORTIC BODIES
MS = Small clusters of chemoreceptive and supporting cells located near the ARCH OF THE AORTA; the PULMONARY ARTERIES; and the CORONARY ARTERIES. The aortic bodies sense PH; CARBON DIOXIDE; and OXYGEN concentrations in the BLOOD and participate in the control of RESPIRATION. The aortic bodies should not be confused with the PARA-AORTIC BODIES in the abdomen (which are sometimes also called aortic bodies).
OL = search PARAGANGLIA, NONCHROMAFFIN 1966-74
PM = 91; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90
HN = 91(75); was see under PARAGANGLIA, NONCHROMAFFIN 1975-90
MR = 20140613
DA = 19990101
DC = 1
DX = 19910101
UI = D001016

*NEWRECORD
RECTYPE = D
MH = Aortic Coarctation
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Coarctation of Aorta|T019|NON|EQV|OMIM (2013)|120209|abcdef
ENTRY = Coarctation of Aorta Dominant|T019|NON|NRW|ORD (2010)|120209|abcdef
ENTRY = Coarctation of the Aorta|T019|NON|EQV|ORD (2010)|120209|abcdef
ENTRY = Aorta Coarctation
ENTRY = Aorta Coarctations
ENTRY = Aorta Dominant Coarctation
ENTRY = Aorta Dominant Coarctations
ENTRY = Aortic Coarctations
ENTRY = Coarctation, Aortic
ENTRY = Coarctations, Aortic
MN = C14.240.400.090
MN = C14.280.400.090
MN = C16.131.240.400.090
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T019
MS = A birth defect characterized by the narrowing of the AORTA that can be of varying degree and at any point from the transverse arch to the iliac bifurcation. Aortic coarctation causes arterial HYPERTENSION before the point of narrowing and arterial HYPOTENSION beyond the narrowed portion.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D001017

*NEWRECORD
RECTYPE = D
MH = Aortic Diseases
DE = AORTIC DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aortic Disease
ENTRY = Disease, Aortic
ENTRY = Diseases, Aortic
MN = C14.907.109
MH_TH = NLM (1966)
ST = T047
AN = inflammatory disease = AORTITIS but note AORTITIS, SYPHILITIC; GIANT CELL AORTITIS; and AORTITIS SYNDROME are also available
MS = Pathological processes involving any part of the AORTA.
CATSH = CAT LIST
MR = 20090710
DA = 19990101
DC = 1
UI = D001018

*NEWRECORD
RECTYPE = D
MH = Aortic Rupture
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aortic Aneurysm, Ruptured|T037|T047|NON|NRW|NLM (1993)|920514|abbcdef
ENTRY = Ruptured Aortic Aneurysm|T037|T047|NON|NRW|NLM (2008)|061005|abbcdef
ENTRY = Aneurysm, Ruptured Aortic
ENTRY = Aneurysms, Ruptured Aortic
ENTRY = Aortic Aneurysms, Ruptured
ENTRY = Aortic Ruptures
ENTRY = Rupture, Aortic
ENTRY = Ruptured Aortic Aneurysms
ENTRY = Ruptures, Aortic
MN = C14.907.055.185.125
MN = C14.907.055.239.175
MN = C14.907.109.139.175
MN = C26.761.125
MH_TH = NLM (1966)
ST = T037
ST = T047
AN = do not coordinate with RUPTURE, SPONTANEOUS unless particularly discussed & then only NIM
MS = The tearing or bursting of the wall along any portion of the AORTA, such as thoracic or abdominal. It may result from the rupture of an aneurysm or it may be due to TRAUMA.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001019

*NEWRECORD
RECTYPE = D
MH = Aortic Stenosis, Subvalvular
DE = AORTIC STENOSIS SUBVALV
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aortic Subvalvular Stenosis|T047|NON|EQV|NLM (1975)|990101|AORTIC SUBVALV STENOSIS|abcdefv
PRINT ENTRY = Subvalvular Aortic Stenosis|T047|NON|EQV|NLM (2001)|ORD (2010)|000228|SUBVALV AORTIC STENOSIS|abcdeefv
ENTRY = Aortic Stenoses, Subvalvular
ENTRY = Aortic Subvalvular Stenoses
ENTRY = Stenoses, Aortic Subvalvular
ENTRY = Stenoses, Subvalvular Aortic
ENTRY = Stenosis, Aortic Subvalvular
ENTRY = Stenosis, Subvalvular Aortic
ENTRY = Subvalvular Aortic Stenoses
ENTRY = Subvalvular Stenoses, Aortic
ENTRY = Subvalvular Stenosis, Aortic
MN = C14.280.484.150.070
MN = C14.280.955.249.070
MH_TH = NLM (2001)
ST = T047
MS = A pathological constriction occurring in the region below the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
OL = search CARDIOMYOPATHY, HYPERTROPHIC 1967-74
PM = 91; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85
HN = 91(75); was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19910101
UI = D001020

*NEWRECORD
RECTYPE = D
MH = Aortic Valve
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Aortic Valves
ENTRY = Valve, Aortic
ENTRY = Valves, Aortic
MN = A07.541.510.110
MH_TH = NLM (1966)
ST = T023
AN = dis: coord IM with HEART VALVE DISEASES (IM) but note specific aortic valve dis; atresia: index AORTIC VALVE /abnorm
MS = The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.
OL = search AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966
PM = AORTIC VALVE DISEASES was heading 1963-66
HN = AORTIC VALVE DISEASES was heading 1963-66
MR = 19980610
DA = 19990101
DC = 1
UI = D001021

*NEWRECORD
RECTYPE = D
MH = Aortic Valve Insufficiency
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aortic Incompetence|T047|NON|EQV|UNK (19XX)|850326|abcdef
PRINT ENTRY = Aortic Regurgitation|T047|NON|EQV|NLM (1993)|910924|abcdef
PRINT ENTRY = Aortic Valve Incompetence|T047|NON|EQV|UNK (19XX)|860418|abcdef
ENTRY = Regurgitation, Aortic Valve|T047|NON|EQV|NLM (1993)|920109|abcdef
ENTRY = Incompetence, Aortic
ENTRY = Incompetence, Aortic Valve
ENTRY = Insufficiency, Aortic Valve
ENTRY = Regurgitation, Aortic
MN = C14.280.484.095
MH_TH = NLM (1967)
ST = T047
PI = Heart Valve Diseases (1966)
MS = Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).
PM = 67; AORTIC REGURGITATION was REGURGITATION, AORTIC VALVE 1963-92
HN = 67; AORTIC REGURGITATION was REGURGITATION, AORTIC VALVE 1963-92
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19670101
UI = D001022

*NEWRECORD
RECTYPE = D
MH = Aortic Valve Prolapse
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aortic Valve Prolapses
ENTRY = Prolapse, Aortic Valve
ENTRY = Prolapses, Aortic Valve
ENTRY = Valve Prolapse, Aortic
ENTRY = Valve Prolapses, Aortic
MN = C14.280.484.400.100
MH_TH = NLM (1988)
ST = T047
PI = Aortic Valve (1966-1987)
PI = Aortic Valve Insufficiency (1967-1987)
MS = The downward displacement of the cuspal or pointed end of the trileaflet AORTIC VALVE causing misalignment of the cusps. Severe valve distortion can cause leakage and allow the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to aortic regurgitation.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20070709
DA = 19870430
DC = 1
DX = 19880101
UI = D001023

*NEWRECORD
RECTYPE = D
MH = Aortic Valve Stenosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aortic Stenosis|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Aortic Valve Stenoses
ENTRY = Stenoses, Aortic
ENTRY = Stenoses, Aortic Valve
ENTRY = Stenosis, Aortic
ENTRY = Stenosis, Aortic Valve
ENTRY = Valve Stenoses, Aortic
ENTRY = Valve Stenosis, Aortic
MN = C14.280.484.150
MN = C14.280.955.249
FX = Cardiomyopathy, Hypertrophic
MH_TH = NLM (1967)
ST = T047
AN = aortic valve atresia = AORTIC VALVE /abnorm
MS = A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
OL = use AORTIC VALVE STENOSIS to search AORTIC STENOSIS 1966; search AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966
PM = 67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66
HN = 67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19670101
UI = D001024

*NEWRECORD
RECTYPE = D
MH = Aortitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aortitides
MN = C14.907.109.320
MN = C14.907.940.080
MH_TH = NLM (1980)
ST = T047
PI = Aortic Diseases (1966-1979)
PI = Arteritis (1966-1979)
MS = Inflammation of the wall of the AORTA.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20070709
DA = 19790424
DC = 1
DX = 19800101
UI = D001025

*NEWRECORD
RECTYPE = D
MH = Coronary Artery Bypass
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Aortocoronary Bypass|T061|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Bypass, Coronary Artery|T061|NON|EQV|NLM (1990)|890413|abcdef
ENTRY = Bypass Surgery, Coronary Artery|T061|NON|EQV|IOM (1990)|890413|BYPASS SURG CORONARY ARTERY|abcdefv
ENTRY = Coronary Artery Bypass Grafting|T061|NON|EQV|IOM (1990)|890413|CABG|abcdefv
ENTRY = Coronary Artery Bypass Surgery|T061|NON|EQV|IOM (1990)|890413|CORONARY ARTERY BYPASS SURG|abcdefv
ENTRY = Aortocoronary Bypasses
ENTRY = Artery Bypass, Coronary
ENTRY = Artery Bypasses, Coronary
ENTRY = Bypass, Aortocoronary
ENTRY = Bypasses, Aortocoronary
ENTRY = Bypasses, Coronary Artery
ENTRY = Coronary Artery Bypasses
MN = E04.100.376.719.332
MN = E04.100.814.868.750
MN = E04.928.220.520.220
MH_TH = IOM (1990)
ST = T061
AN = do not use /util except by MeSH definition
PI = Coronary Disease/surgery (1966-1971)
PI = Coronary Vessels/surgery (1966-1971)
PI = Myocardial Infarct/surgery (1966-1971)
MS = Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.
OL = use CORONARY ARTERY BYPASS to search AORTOCORONARY BYPASS 1972-89 (Prov 1972)
PM = 90; was AORTOCORONARY BYPASS 1973-89
HN = 90; was AORTOCORONARY BYPASS 1973-89 (Prov 1972)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19730101
UI = D001026

*NEWRECORD
RECTYPE = D
MH = Aortography
DE = AORTOGR
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
ENTRY = Aortographies
MN = E01.370.350.700.060.070
MN = E01.370.370.050.070
MH_TH = NLM (1966)
ST = T060
AN = NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: AORTOGR
MS = Radiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures.
PM = 66; was see under ANGIOGRAPHY 1963-65
HN = 66; was see under ANGIOGRAPHY 1963-65
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19660101
UI = D001027

*NEWRECORD
RECTYPE = D
MH = Aortopulmonary Septal Defect
DE = AORTOPULM SEPTAL DEFECT
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aorticopulmonary Septal Defect|T019|NON|EQV|UNK (19XX)|830531|AORTICOPULM SEPTAL DEFECT|abcdefv
ENTRY = Aorticopulmonary Septal Defects|T019|NON|EQV|NLM (1992)|900925|AORTICOPULM SEPTAL DEFECTS|abcdefv
ENTRY = Aortopulmonary Septal Defects|T019|NON|EQV|NLM (1992)|900925|AORTOPULM SEPTAL DEFECTS|abcdefv
ENTRY = Septal Defect, Aorticopulmonary|T019|NON|EQV|NLM (1992)|900925|SEPTAL DEFECT AORTICOPULM|abcdefv
ENTRY = Septal Defect, Aortopulmonary|T019|NON|EQV|NLM (1992)|900925|SEPTAL DEFECT AORTOPULM|abcdefv
ENTRY = Septal Defects, Aorticopulmonary|T019|NON|EQV|NLM (1992)|900925|SEPTAL DEFECTS AORTICOPULM|abcdefv
ENTRY = Septal Defects, Aortopulmonary|T019|NON|EQV|NLM (1992)|900925|SEPTAL DEFECTS AORTOPULM|abcdefv
MN = C14.240.400.560.098
MN = C14.280.400.560.098
MN = C16.131.240.400.560.098
MH_TH = NLM (1984)
ST = T019
AN = DF: AORTOPULM SEPTAL DEFECT
PI = Aorta, Thoracic/abnormalities (1966-1983)
PI = Aorta/abnormalities (1966-1983)
PI = Heart Defects, Congenital (1966-1983)
PI = Pulmonary Artery/abnormalities (1966-1983)
MS = A developmental abnormality in which the spiral (aortopulmonary) septum failed to completely divide the TRUNCUS ARTERIOSUS into ASCENDING AORTA and PULMONARY ARTERY. This abnormal communication between the two major vessels usually lies above their respective valves (AORTIC VALVE; PULMONARY VALVE).
PM = 91; was see under HEART DEFECTS, CONGENITAL 1984-90
HN = 91(84); was see under HEART DEFECTS, CONGENITAL 1984-90
CATSH = CAT LIST
MR = 20070709
DA = 19830531
DC = 1
DX = 19910101
UI = D001028

*NEWRECORD
RECTYPE = D
MH = Aotus trivirgatus
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Monkey, Northern Night|T015|NON|EQV|NLM (1992)|901128|abcdef
PRINT ENTRY = Night Monkey, Northern|T015|NON|EQV|NLM (1992)|901102|abcdef
ENTRY = Monkeys, Northern Night
ENTRY = Night Monkeys, Northern
ENTRY = Northern Night Monkey
ENTRY = Northern Night Monkeys
ENTRY = trivirgatus, Aotus
MN = B01.050.150.900.649.801.400.600.037.092
MH_TH = NLM (1975)
ST = T015
AN = index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
MS = A species in the family AOTIDAE, inhabiting the forested regions of Central and South America (from Panama to the Amazon). Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys.
OL = use AOTUS TRIVIRGATUS to search NIGHT MONKEYS 1975-80
PM = 91; was see under CEBIDAE 1981-90; was NIGHT MONKEYS see under MONKEYS 1975-80
HN = 91(81); was see under CEBIDAE 1981-90; was NIGHT MONKEYS see under MONKEYS 1975-80
MR = 20090706
DA = 19741111
DC = 1
DX = 19910101
UI = D001029

*NEWRECORD
RECTYPE = D
MH = Apamin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
MN = D20.888.065.115.060
MN = D23.946.833.065.115.060
MH_TH = NLM (1978)
ST = T116
ST = T123
ST = T131
N1 = Apamin
RN = 24345-16-2
AN = /antag permitted but consider also ANTIVENINS
PI = Bees (1966-1977)
PI = Venoms (1966-1977)
MS = A highly neurotoxic polypeptide from the venom of the honey bee (Apis mellifera). It consists of 18 amino acids with two disulfide bridges and causes hyperexcitability resulting in convulsions and respiratory paralysis.
PM = 91; was see under BEE VENOMS 1978-90
HN = 91(78); was see under BEE VENOMS 1978-90
MR = 20150331
DA = 19770427
DC = 1
DX = 19910101
UI = D001030

*NEWRECORD
RECTYPE = D
MH = Apatites
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.029.260.700.675.374.075.025
MN = D01.146.360.050
MN = D01.578.122
MN = D01.695.625.675.650.075.025
MH_TH = NLM (1964)
ST = T197
RN = 0
AN = a group of phosphate minerals
MS = A group of phosphate minerals that includes ten mineral species and has the general formula X5(YO4)3Z, where X is usually calcium or lead, Y is phosphorus or arsenic, and Z is chlorine, fluorine, or OH-. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 66
HN = 66(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D001031

*NEWRECORD
RECTYPE = D
MH = Apazone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Azapropazone|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|UNK (19XX)|741111|abbcdeeeef
ENTRY = 5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione|T109|T121|NON|EQV|NLM (1995)|930901|abbcdef
ENTRY = ASTA Medica Brand of Azapropazone|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Apazone Dihydrate|T109|T121|NRW|FDA SRS (2014)|NLM (1999)|990913|abbdeef
ENTRY = Dagra Brand of Azapropazone Dihydrate|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Du Pont Brand of Azapropazone Dihydrate|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Prolixan|T109|T121|TRD|NRW|NL|UNK (19XX)|800731|abbcdeef
ENTRY = Rheumox|T109|T121|TRD|NRW|IE|UK|US|021028|abbcdeeef
ENTRY = Robins Brand of Azapropazone Dihydrate|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Tolyprin|T109|T121|TRD|NRW|DE|US|021028|abbcdeef
ENTRY = Wyeth Brand of Azapropazone Dihydrate|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Dihydrate, Apazone
MN = D03.383.931.190
PA = Anti-Inflammatory Agents, Non-Steroidal
PA = Uricosuric Agents
MH_TH = FDA SRS (2014)
MH_TH = USAN (1969)
ST = T109
ST = T121
N1 = 1H-Pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione, 5-(dimethylamino)-9-methyl-2-propyl-
RN = K2VOT966ZI
RR = 13539-59-8 (Apazone)
RR = 22304-30-9 (di-hydrate)
RR = BF18764H96
PI = Dimethylamines (1973-1974)
PI = Malonates (1973-1974)
PI = Triazines (1971-1974)
MS = An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout.
PM = 91; was see under TRIAZINES 1975-90
HN = 91(75); was see under TRIAZINES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001032

*NEWRECORD
RECTYPE = D
MH = Apgar Score
ENTRY = Score, Apgar
MN = E01.370.600.050
MH_TH = NLM (1971)
ST = T032
AN = check the tags HUMANS & INFANT, NEWBORN
PI = Infant, Newborn (1966-1970)
PI = Physical Examination (1966-1970)
MS = A method, developed by Dr. Virginia Apgar, to evaluate a newborn's adjustment to extrauterine life. Five items - heart rate, respiratory effort, muscle tone, reflex irritability, and color - are evaluated 60 seconds after birth and again five minutes later on a scale from 0-2, 0 being the lowest, 2 being normal. The five numbers are added for the Apgar score. A score of 0-3 represents severe distress, 4-7 indicates moderate distress, and a score of 7-10 predicts an absence of difficulty in adjusting to extrauterine life.
PM = 73
HN = 73(71)
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19730101
UI = D001034

*NEWRECORD
RECTYPE = D
MH = Aphakia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aphakias
MN = C11.510.103
MH_TH = NLM (1978)
ST = T190
AN = absence of lens from any cause (congen, inj, dis); /congen permitted; after cataract extract = APHAKIA, POSTCATARACT; "aphakic eye" is probably APHAKIA, POSTCATARACT but PSEUDOPHAKIA is available for the postcataract eye fitted with an intraocular lens
PI = Lens, Crystalline (1966-1977)
MS = Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 19970620
DA = 19770411
DC = 1
DX = 19780101
UI = D001035

*NEWRECORD
RECTYPE = D
MH = Aphakia, Postcataract
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aphakias, Postcataract
ENTRY = Postcataract Aphakia
ENTRY = Postcataract Aphakias
MN = C11.510.103.110
FX = Pseudophakia
MH_TH = NLM (1978)
ST = T020
AN = "aphakic eye" probably goes here unless truly congen ( = APHAKIA /congen); do not coord with CATARACT EXTRACTION unless particularly discussed; PSEUDOPHAKIA is available for the postcataract eye with an intraocular lens
PI = Cataract Extraction (1966-1977)
PI = Lens, Crystalline (1966-1977)
MS = Absence of the crystalline lens resulting from cataract extraction.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 19970620
DA = 19770411
DC = 1
DX = 19780101
UI = D001036

*NEWRECORD
RECTYPE = D
MH = Aphasia
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Aphasia, Acquired|T048|NON|NRW|NLM (1996)|991103|abcdef
PRINT ENTRY = Dysphasia|T048|NON|NRW|UNK (19XX)|780522|abcdef
ENTRY = Alogia|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Anepia|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Ageusic|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Auditory Discriminatory|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Commisural|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Functional|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Global|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Graphomotor|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Intellectual|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Mixed|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Post-Ictal|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Post-Traumatic|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Progressive|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Semantic|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Syntactical|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Dejerine-Lichtheim Phenomenon|T048|EPO|REL|NLM (2000)|991103|abcdef
ENTRY = Dysphasia, Global|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Lichtheim's Sign|T048|EPO|REL|NLM (2000)|991103|abcdef
ENTRY = Logagnosia|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Logamnesia|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Logasthenia|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Acquired Aphasia
ENTRY = Ageusic Aphasia
ENTRY = Ageusic Aphasias
ENTRY = Alogias
ENTRY = Anepias
ENTRY = Aphasia, Post Ictal
ENTRY = Aphasia, Post Traumatic
ENTRY = Aphasias, Ageusic
ENTRY = Aphasias, Auditory Discriminatory
ENTRY = Aphasias, Commisural
ENTRY = Aphasias, Functional
ENTRY = Aphasias, Global
ENTRY = Aphasias, Graphomotor
ENTRY = Aphasias, Intellectual
ENTRY = Aphasias, Mixed
ENTRY = Aphasias, Post-Ictal
ENTRY = Aphasias, Post-Traumatic
ENTRY = Aphasias, Progressive
ENTRY = Aphasias, Semantic
ENTRY = Aphasias, Syntactical
ENTRY = Auditory Discriminatory Aphasia
ENTRY = Auditory Discriminatory Aphasias
ENTRY = Commisural Aphasia
ENTRY = Commisural Aphasias
ENTRY = Dejerine Lichtheim Phenomenon
ENTRY = Discriminatory Aphasia, Auditory
ENTRY = Discriminatory Aphasias, Auditory
ENTRY = Dysphasias, Global
ENTRY = Functional Aphasia
ENTRY = Functional Aphasias
ENTRY = Global Aphasia
ENTRY = Global Aphasias
ENTRY = Global Dysphasia
ENTRY = Global Dysphasias
ENTRY = Graphomotor Aphasia
ENTRY = Graphomotor Aphasias
ENTRY = Intellectual Aphasia
ENTRY = Intellectual Aphasias
ENTRY = Lichtheim Sign
ENTRY = Lichtheims Sign
ENTRY = Logagnosias
ENTRY = Logamnesias
ENTRY = Logasthenias
ENTRY = Mixed Aphasia
ENTRY = Mixed Aphasias
ENTRY = Phenomenon, Dejerine-Lichtheim
ENTRY = Post-Ictal Aphasia
ENTRY = Post-Ictal Aphasias
ENTRY = Post-Traumatic Aphasia
ENTRY = Post-Traumatic Aphasias
ENTRY = Progressive Aphasia
ENTRY = Progressive Aphasias
ENTRY = Semantic Aphasia
ENTRY = Semantic Aphasias
ENTRY = Sign, Lichtheim's
ENTRY = Syntactical Aphasia
ENTRY = Syntactical Aphasias
MN = C10.597.606.150.500.800.100
MN = C23.888.592.604.150.500.800.100
FX = Landau-Kleffner Syndrome
MH_TH = NLM (1966)
ST = T048
AN = GEN or unspecified; prefer specifics
MS = A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.
PM = 1963; for APHASIA, ACQUIRED see APHASIA, ACQUIRED 1991-1995, see APHASIA 1980-1990
HN = 1963
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D001037

*NEWRECORD
RECTYPE = D
MH = Aphasia, Broca
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Agrammatism|T048|NON|EQV|UNK (19XX)|860618|abcdef
PRINT ENTRY = Aphasia, Motor|T048|NON|EQV|UNK (19XX)|781214|abcdef
PRINT ENTRY = Aphasia, Nonfluent|T048|NON|EQV|UNK (19XX)|781214|abcdef
PRINT ENTRY = Broca Aphasia|T048|NON|EQV|NLM (2000)|991108|abcdef
PRINT ENTRY = Dysphasia, Broca|T048|EPO|EQV|NLM (2000)|991108|abcdef
ENTRY = Agrammatic Broca Aphasia|T048|NON|EQV|NLM (2015)|140116|abcdef
ENTRY = Agrammatic Broca's Aphasia|T048|NON|EQV|NLM (2015)|140116|abcdef
ENTRY = Aphasia, Anterior|T048|NON|REL|NLM (2000)|991108|abcdef
ENTRY = Aphasia, Ataxic|T048|NON|REL|NLM (2000)|991108|abcdef
ENTRY = Aphasia, Expressive|T048|NON|BRD|UNK (19XX)|781214|abcdef
ENTRY = Aphasia, Frontocortical|T048|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Dysphasia, Broca's|T048|EPO|EQV|NLM (2000)|991108|abcdef
ENTRY = Verbal Aphasia Syndrome|T048|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Agrammatic Broca Aphasias
ENTRY = Agrammatic Broca's Aphasias
ENTRY = Agrammatic Brocas Aphasia
ENTRY = Anterior Aphasia
ENTRY = Anterior Aphasias
ENTRY = Aphasia Syndrome, Verbal
ENTRY = Aphasia Syndromes, Verbal
ENTRY = Aphasia, Agrammatic Broca
ENTRY = Aphasia, Agrammatic Broca's
ENTRY = Aphasias, Agrammatic Broca
ENTRY = Aphasias, Agrammatic Broca's
ENTRY = Aphasias, Anterior
ENTRY = Aphasias, Ataxic
ENTRY = Aphasias, Broca
ENTRY = Aphasias, Frontocortical
ENTRY = Ataxic Aphasia
ENTRY = Ataxic Aphasias
ENTRY = Broca Aphasia, Agrammatic
ENTRY = Broca Aphasias
ENTRY = Broca Aphasias, Agrammatic
ENTRY = Broca Dysphasia
ENTRY = Broca's Aphasia, Agrammatic
ENTRY = Broca's Aphasias, Agrammatic
ENTRY = Broca's Dysphasia
ENTRY = Dysphasia, Brocas
ENTRY = Expressive Aphasia
ENTRY = Frontocortical Aphasia
ENTRY = Frontocortical Aphasias
ENTRY = Motor Aphasia
ENTRY = Nonfluent Aphasia
ENTRY = Syndrome, Verbal Aphasia
ENTRY = Syndromes, Verbal Aphasia
ENTRY = Verbal Aphasia Syndromes
MN = C10.597.606.150.500.800.100.100
MN = C23.888.592.604.150.500.800.100.100
MH_TH = NLM (1980)
ST = T048
AN = do not confuse with APHASIA, WERNICKE
PI = Aphasia (1966-1979)
MS = An aphasia characterized by impairment of expressive LANGUAGE (speech, writing, signs) and relative preservation of receptive language abilities (i.e., comprehension). This condition is caused by lesions of the motor association cortex in the FRONTAL LOBE (BROCA AREA and adjacent cortical and white matter regions).
PM = 1991; see APHASIA 1980-1990
HN = 1991(1980)
CATSH = CAT LIST
MR = 20140613
DA = 19781214
DC = 1
DX = 19910101
UI = D001039

*NEWRECORD
RECTYPE = D
MH = Aphasia, Wernicke
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Dysphasia, Wernicke|T048|EPO|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Receptive Aphasia|T048|NON|BRD|UNK (19XX)|781214|abcdef
PRINT ENTRY = Sensory Aphasia|T048|NON|BRD|NLM (2000)|991103|abcdef
PRINT ENTRY = Wernicke Aphasia|T048|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Fluent|T048|NON|BRD|UNK (19XX)|781214|abcdef
ENTRY = Aphasia, Jargon|T048|NON|REL|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Posterior|T048|NON|BRD|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Psychosensory|T048|NON|BRD|NLM (2000)|991103|abcdef
ENTRY = Dysphasia, Fluent|T048|NON|BRD|NLM (2000)|991103|abcdef
ENTRY = Dysphasia, Receptive|T048|NON|BRD|NLM (2000)|991103|abcdef
ENTRY = Dysphasia, Sensory|T048|NON|BRD|NLM (2000)|991103|abcdef
ENTRY = Dysphasia, Wernicke's|T048|EPO|EQV|NLM (2000)|991103|abcdef
ENTRY = Fluent Aphasia, Wernicke's|T048|EPO|EQV|NLM (2000)|991103|abcdef
ENTRY = Aphasia, Receptive
ENTRY = Aphasia, Sensory
ENTRY = Aphasia, Wernicke's Fluent
ENTRY = Aphasias, Jargon
ENTRY = Aphasias, Posterior
ENTRY = Aphasias, Psychosensory
ENTRY = Aphasias, Wernicke
ENTRY = Dysphasia, Wernickes
ENTRY = Dysphasias, Fluent
ENTRY = Dysphasias, Receptive
ENTRY = Dysphasias, Sensory
ENTRY = Fluent Aphasia
ENTRY = Fluent Aphasia, Wernicke
ENTRY = Fluent Aphasia, Wernickes
ENTRY = Fluent Dysphasia
ENTRY = Fluent Dysphasias
ENTRY = Jargon Aphasia
ENTRY = Jargon Aphasias
ENTRY = Posterior Aphasia
ENTRY = Posterior Aphasias
ENTRY = Psychosensory Aphasia
ENTRY = Psychosensory Aphasias
ENTRY = Receptive Dysphasia
ENTRY = Receptive Dysphasias
ENTRY = Sensory Dysphasia
ENTRY = Sensory Dysphasias
ENTRY = Wernicke Aphasias
ENTRY = Wernicke Dysphasia
ENTRY = Wernicke's Dysphasia
ENTRY = Wernicke's Fluent Aphasia
MN = C10.597.606.150.500.800.100.166
MN = C23.888.592.604.150.500.800.100.166
MH_TH = NLM (1980)
ST = T048
AN = do not confuse with APHASIA, BROCA where subject understands language but cannot express it
PI = Aphasia (1966-1979)
MS = Impairment in the comprehension of speech and meaning of words, both spoken and written, and of the meanings conveyed by their grammatical relationships in sentences. It is caused by lesions that primarily affect Wernicke's area, which lies in the posterior perisylvian region of the temporal lobe of the dominant hemisphere. (From Brain & Bannister, Clinical Neurology, 7th ed, p141; Kandel et al., Principles of Neural Science, 3d ed, p846)
PM = 1991; see APHASIA 1980-1990
HN = 1991(1980)
CATSH = CAT LIST
MR = 19991103
DA = 19781214
DC = 1
DX = 19910101
UI = D001041

*NEWRECORD
RECTYPE = D
MH = Aphids
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Aphididae|T204|NON|EQV|NLM (1999)|970822|abcdef
PRINT ENTRY = Lice, Plant|T204|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Myzus|T204|NON|NRW|NLM (1999)|980408|abcdef
PRINT ENTRY = Plant Lice|T204|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Schizaphis|T204|NON|NRW|NLM (1999)|980408|abcdef
ENTRY = Louse, Plant|T204|NON|EQV|UNK (19XX)|880711|abcdef
ENTRY = Plant Louse|T204|NON|EQV|UNK (19XX)|880711|abcdef
ENTRY = Aphid
ENTRY = Lices, Plant
ENTRY = Louses, Plant
ENTRY = Plant Lices
ENTRY = Plant Louses
ENTRY = Schizaphi
MN = B01.050.500.131.617.412.165
MH_TH = NLM (1972)
ST = T204
AN = do not use /drug eff for insecticides: TN 111
PI = Insects (1966-1971)
MS = A family (Aphididae) of small insects, in the suborder Sternorrhyncha, that suck the juices of plants. Important genera include Schizaphis and Myzus. The latter is known to carry more than 100 virus diseases between plants.
PM = 72
HN = 72
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D001042

*NEWRECORD
RECTYPE = D
MH = Aphonia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Spastic Aphonia|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Absence of Voice|T184|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Aphonia Paralytica|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Functional Aphonia|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Nonorganic Aphonia|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aphonia, Functional
ENTRY = Aphonia, Nonorganic
ENTRY = Aphonia, Spastic
ENTRY = Aphonias, Functional
ENTRY = Aphonias, Nonorganic
ENTRY = Aphonias, Spastic
ENTRY = Functional Aphonias
ENTRY = Nonorganic Aphonias
ENTRY = Paralytica, Aphonia
ENTRY = Spastic Aphonias
ENTRY = Voice Absence
ENTRY = Voice Absences
MN = C08.360.940.160
MN = C09.400.940.160
MN = C10.597.975.100
MN = C23.888.592.979.100
MH_TH = NLM (1969)
ST = T184
PI = Voice (1966-1968)
MS = Complete loss of phonation due to organic disease of the larynx or to nonorganic (i.e., psychogenic) causes.
PM = 1972; see VOICE 1963-1971
HN = 1972(1963)
CATSH = CAT LIST
MR = 19991123
DA = 19990101
DC = 1
DX = 19720101
UI = D001044

*NEWRECORD
RECTYPE = D
MH = Aphorisms and Proverbs as Topic
ENTRY = Fables as Topic|T170|NON|NRW|NLM (2008)|070629|abcdef
ENTRY = Proverbs and Aphorisms as Topic|T170|NON|EQV|NLM (2008)|070626|abcdef
ENTRY = Proverbs as Topic|T170|NON|NRW|NLM (2008)|070626|abcdef
ENTRY = Fables as Topics
ENTRY = Proverbs as Topics
MN = K01.517.116
MH_TH = NLM (2008)
ST = T170
AN = includes fables & maxims; do not confuse with Publication Type APHORISMS AND PROVERBS
MS = Short popular sayings effectively expressing or astutely professing general truths or useful thoughts. (From Random House Unabridged Dictionary, 2d ed, p97, p1556)
PM = 2008; see APHORISMS AND PROVERBS 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D001045

*NEWRECORD
RECTYPE = D
MH = Aphrodisiacs
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aphrodisiac Effect|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Aphrodisiac Effects|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Effect, Aphrodisiac
ENTRY = Effects, Aphrodisiac
MN = D27.505.696.282.045
MN = D27.505.954.427.220.045
MH_TH = NLM (1966)
ST = T120
RN = 0
MS = Chemical agents or odors that stimulate sexual desires. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
MR = 20110624
DA = 19990101
DC = 1
UI = D001046

*NEWRECORD
RECTYPE = D
MH = Apicoectomy
AQ = AE CL CT EC ES HI IS MA MO MT NU PX SN ST TD UT VE
ENTRY = Apicoectomies
MN = E04.545.100
MN = E06.397.102
MN = E06.645.100
MH_TH = NLM (1965)
ST = T061
AN = do not use /util except by MeSH definition
MS = Excision of the apical portion of a tooth through an opening made in the overlying labial, buccal, or palatal alveolar bone. (Dorland, 28th ed)
PM = 65
HN = 65
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19650101
UI = D001047

*NEWRECORD
RECTYPE = D
MH = Aplysia
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Aplysias
MN = B01.050.500.644.400.060
MH_TH = NLM (1978)
ST = T204
AN = mollusk; /microbiol /parasitol /virol permitted
PI = Mollusca (1966-1977)
MS = An opisthobranch mollusk of the order Anaspidea. It is used frequently in studies of nervous system development because of its large identifiable neurons. Aplysiatoxin and its derivatives are not biosynthesized by Aplysia, but acquired by ingestion of Lyngbya (seaweed) species.
PM = 78
HN = 78
MR = 20090706
DA = 19770513
DC = 1
DX = 19780101
UI = D001048

*NEWRECORD
RECTYPE = D
MH = Apnea
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Apneas
MN = C08.618.085
MN = C23.888.852.130
MH_TH = NLM (1966)
ST = T046
ST = T184
AN = do not confuse APNEA with other resp disord: use only when text uses APNEA; apnea neonatorum = APNEA + check tags INFANT, NEWBORN + HUMAN
MS = A transient absence of spontaneous respiration.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D001049

*NEWRECORD
RECTYPE = D
MH = Apocrine Glands
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Apocrine Gland
ENTRY = Gland, Apocrine
ENTRY = Glands, Apocrine
MN = A10.336.899.206
MN = A17.815.830.206
FX = Sweating
MH_TH = NLM (1975)
ST = T023
AN = /secret: consider also SWEAT or SWEATING
MS = Large, branched, specialized sweat glands that empty into the upper portion of a HAIR FOLLICLE instead of directly onto the SKIN.
OL = search SWEAT GLANDS 1971-74
PM = 91; was see under SWEAT GLANDS 1975-90
HN = 91(75); was see under SWEAT GLANDS 1975-90
MR = 20020702
DA = 19990101
DC = 1
DX = 19910101
UI = D001050

*NEWRECORD
RECTYPE = D
MH = Apoenzymes
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
ENTRY = Apoenzyme|T116|T126|NON|EQV|NLM (2007)|051129|abbcdef
MN = D08.811.255.500
MN = D12.776.070.290
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = 0
AN = IM general only; coordinate NIM with specific enzyme (IM)
MS = The protein components of enzyme complexes (HOLOENZYMES). An apoenzyme is the holoenzyme minus any cofactors (ENZYME COFACTORS) or prosthetic groups required for the enzymatic function.
OL = search APOPROTEINS 1974
PM = 91; was see under APOPROTEINS 1975-90
HN = 91(75); was see under APOPROTEINS 1975-90
MR = 20060705
DA = 19990101
DC = 1
DX = 19910101
UI = D001051

*NEWRECORD
RECTYPE = D
MH = Apoferritins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Apoferritin|T116|T123|NON|EQV|NLM (1975)|990101|abbcdef
ENTRY = Ferritin H Subunit|T116|T126|NON|NRW|NLM (2007)|060316|abbcdef
ENTRY = Ferritin Heavy Chain|T116|T126|NON|NRW|NLM (2007)|060316|abbcdef
ENTRY = Ferritin L Subunit|T116|T126|NON|NRW|NLM (2007)|060316|abbcdef
ENTRY = Ferritin Light Chain|T116|T126|NON|NRW|NLM (2007)|060316|abbcdef
ENTRY = H Ferritin|T116|T126|NON|NRW|NLM (2007)|010903|abbcdef
ENTRY = H-Ferritin|T116|T126|NON|NRW|NLM (2007)|abbcde
ENTRY = L-Ferritin|T116|T126|NON|NRW|NLM (2007)|abbcde
ENTRY = Ferritin, H
ENTRY = H Subunit, Ferritin
ENTRY = Heavy Chain, Ferritin
ENTRY = L Ferritin
ENTRY = L Subunit, Ferritin
ENTRY = Light Chain, Ferritin
MN = D12.776.070.345
MN = D12.776.157.427.249.290
MN = D12.776.556.579.249.290
MH_TH = NLM (2007)
ST = T116
ST = T123
N1 = Ferritins, apo-
RN = 9013-31-4
RR = EC 1.16.3.1
MS = The protein components of ferritins. Apoferritins are shell-like structures containing nanocavities and ferroxidase activities. Apoferritin shells are composed of 24 subunits, heteropolymers in vertebrates and homopolymers in bacteria. In vertebrates, there are two types of subunits, light chain and heavy chain. The heavy chain contains the ferroxidase activity.
PM = 2007; see APOFERRITIN 1991-2006, see FERRITIN 1975-1990; H-FERRITIN was indexed under FERRITIN 1972-2006; L-FERRITIN was indexed under FERRITIN 1996-2006
HN = 2007 (1975); for H-FERRITIN use FERRITIN (NM) 1972-2006; for L-FERRITIN use FERRITIN (NM) 1996-2006
MR = 20060705
DA = 19990101
DC = 1
DX = 19910101
UI = D001052

*NEWRECORD
RECTYPE = D
MH = Apolipoproteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Apolipoprotein|T116|T123|NON|EQV|UNK (19XX)|870504|abbcdef
MN = D10.532.091
MN = D12.776.070.400
MN = D12.776.521.120
MH_TH = NLM (1977)
ST = T116
ST = T123
RN = 0
AN = general; prefer specifics
PI = Apoproteins (1972-1976)
PI = Lipoproteins (1966-1976)
PI = specific lipoprotein (1972-1976)
MS = Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.
PM = 77
HN = 77
MR = 20060705
DA = 19760416
DC = 1
DX = 19770101
UI = D001053

*NEWRECORD
RECTYPE = D
MH = Apolipoproteins A
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Apo-A|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef
ENTRY = ApoA|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef
MN = D10.532.091.200
MN = D12.776.070.400.200
MN = D12.776.521.120.200
MH_TH = NLM (1985)
ST = T116
ST = T123
RN = 0
AN = do not confuse with APOLIPOPROTEIN (A)
PI = Apolipoproteins (1977-1984)
MS = Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE.
PM = 85
HN = 85
MR = 20060705
DA = 19840525
DC = 1
DX = 19850101
UI = D001054

*NEWRECORD
RECTYPE = D
MH = Apolipoproteins B
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Apo-B|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef
ENTRY = Apo B|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef
ENTRY = ApoB|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef
ENTRY = Apoprotein (B)|T116|T123|NON|BRD|NLM (1994)|930510|abbcdef
ENTRY = Apoproteins B|T116|T123|NON|BRD|UNK (19XX)|840525|abbcdef
MN = D10.532.091.300
MN = D12.776.070.400.300
MN = D12.776.521.120.300
FX = Abetalipoproteinemia
MH_TH = NLM (1985)
ST = T116
ST = T123
RN = 0
PI = Apolipoproteins (1977-1984)
MS = Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA.
OL = use APOLIPOPROTEINS B to search APOLIPOPROTEIN B 1985-93
PM = 85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93
HN = 85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93
MR = 20060705
DA = 19840525
DC = 1
DX = 19850101
UI = D001055

*NEWRECORD
RECTYPE = D
MH = Apolipoproteins C
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Apo-C|T116|T123|ABB|EQV|UNK (19XX)|840530|abbcdef
ENTRY = Apo C|T116|T123|ABB|EQV|UNK (19XX)|840530|abbcdef
ENTRY = ApoC|T116|T123|ABB|EQV|UNK (19XX)|840530|abbcdef
ENTRY = Apoprotein (C)|T116|T123|NON|BRD|NLM (1994)|930510|abbcdef
ENTRY = Apoproteins C|T116|T123|NON|BRD|UNK (19XX)|840530|abbcdef
MN = D10.532.091.400
MN = D12.776.070.400.400
MN = D12.776.521.120.400
MH_TH = NLM (1985)
ST = T116
ST = T123
RN = 0
PI = Apolipoproteins (1977-1984)
MS = A group of apolipoproteins that can readily exchange among the various classes of lipoproteins (HDL; VLDL; CHYLOMICRONS). After lipolysis of TRIGLYCERIDES on VLDL and chylomicrons, Apo-C proteins are normally transferred to HDL. The subtypes can modulate remnant binding to receptors, LECITHIN CHOLESTEROL ACYLTRANSFERASE, or LIPOPROTEIN LIPASE.
OL = use APOLIPOPROTEINS C to search APOLIPOPROTEIN C 1985-93
PM = 85; APOLIPOPROTEIN C was see APOLIPOPROTEINS C 1985-93
HN = 85; APOLIPOPROTEIN C was see APOLIPOPROTEINS C 1985-93
MR = 20060705
DA = 19840530
DC = 1
DX = 19850101
UI = D001056

*NEWRECORD
RECTYPE = D
MH = Apolipoproteins E
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Apo-E|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef
ENTRY = Apo E|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef
ENTRY = Apo E Isoproteins|T116|T123|NON|NRW|NLM (2007)|abbcde
ENTRY = ApoE|T116|T123|ABB|EQV|UNK (19XX)|840525|abbcdef
ENTRY = Apolipoprotein E Isoproteins|T116|T123|NON|NRW|NLM (2007)|abbcde
ENTRY = Apoprotein (E)|T116|T123|NON|BRD|NLM (1994)|930510|abbcdef
ENTRY = Apoproteins E|T116|T123|NON|BRD|UNK (19XX)|840525|abbcdef
ENTRY = Isoproteins, Apo E
ENTRY = Isoproteins, Apolipoprotein E
MN = D10.532.091.500
MN = D12.776.070.400.500
MN = D12.776.521.120.500
MH_TH = NLM (1985)
ST = T116
ST = T123
RN = 0
PI = Apolipoproteins (1977-1984)
MS = A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.
PM = 1985; APOLIPOPROTEIN E ISOPROTEINS was indexed under APOLIPOPROTEINS E 1985-2006 & under APOLIPOPROTEINS 1983-1984
HN = 1985; for APOLIPOPROTEIN E ISOPROTEINS use APOLIPOPROTEINS E 1985-2006 & use APOLIPOPROTEINS 1983-1984
MR = 20060705
DA = 19840525
DC = 1
DX = 19850101
UI = D001057

*NEWRECORD
RECTYPE = D
MH = Apomorphine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aguettant Brand of Apomorphine Hydrochloride|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Apokinon|T109|T121|TRD|NRW|FR|020802|abbcdef
ENTRY = Apomorphin-Teclapharm|T109|T121|TRD|NRW|DE|020802|abbcdef
ENTRY = Apomorphine Chloride|T109|T121|NON|NRW|NLM (19XX)|940811|abbcdef
ENTRY = Apomorphine Hydrochloride|T109|T121|NON|NRW|NLM (2014)|USP (19XX)|130521|abbcdeef
ENTRY = Apomorphine Hydrochloride Anhydrous|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2014)|130521|abbcdeef
ENTRY = Apomorphine Hydrochloride, Anhydrous|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Apomorphine Hydrochloride, Hemihydrate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1999)|990913|abbcdeef
ENTRY = Britaject|T109|T121|TRD|NRW|UK|020802|abbcdef
ENTRY = Britannia Brand of Apomorphine Hydrochloride|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Teclapharm Brand of Apomorphine Hydrochloride|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Anhydrous Apomorphine Hydrochloride
ENTRY = Anhydrous, Apomorphine Hydrochloride
ENTRY = Apomorphin Teclapharm
ENTRY = ApomorphinTeclapharm
ENTRY = Chloride, Apomorphine
ENTRY = Hemihydrate Apomorphine Hydrochloride
ENTRY = Hydrochloride Anhydrous, Apomorphine
ENTRY = Hydrochloride, Anhydrous Apomorphine
ENTRY = Hydrochloride, Apomorphine
ENTRY = Hydrochloride, Hemihydrate Apomorphine
MN = D03.132.098.038.290
MN = D03.438.531.085.030.290
MN = D03.549.095.290
PA = Dopamine Agonists
PA = Emetics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T121
N1 = 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)-
RN = N21FAR7B4S
RR = 58-00-4 (Apomorphine)
RR = 9K13MD7A0D
RR = F39049Y068
AN = apomorphine derivatives = APOMORPHINE/analogs
MS = A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.
OL = use APOMORPHINE/analogs & derivatives to search APOMORPHINE DERIVATIVES 1975-77; use APOMORPHINE 1969-74
PM = APOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77
HN = APOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77
MR = 20130708
DA = 19990101
DC = 1
UI = D001058

*NEWRECORD
RECTYPE = D
MH = Apoproteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Apoprotein|T116|T123|NON|EQV|NLM (2007)|051129|abbcdef
MN = D12.776.070
MH_TH = NLM (1972)
ST = T116
ST = T123
RN = 0
PI = Enzymes (1966-1971)
PI = Proteins (1966-1971)
PI = specific enzyme or protein (1966-1971)
MS = The protein components of a number of complexes, such as enzymes (APOENZYMES), ferritin (APOFERRITINS), or lipoproteins (APOLIPOPROTEINS).
PM = 74
HN = 74(72)
MR = 20060707
DA = 19990101
DC = 1
DX = 19740101
UI = D001059

*NEWRECORD
RECTYPE = D
MH = Aporphines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.132.098.038
MN = D03.438.531.085.030
MN = D03.549.095
MH_TH = NLM (1969)
ST = T109
RN = 0
PI = Apomorphine (1966-1968)
MS = Dibenzoquinolines derived in plants from (S)-reticuline (BENZYLISOQUINOLINES).
PM = 69
HN = 69
MR = 20060705
DA = 19990101
DC = 1
DX = 19690101
UI = D001060

*NEWRECORD
RECTYPE = D
MH = Appalachian Region
AQ = EH EP
ENTRY = Appalachia|T083|NAM|EQV|NLM (1990)|890520|abcdef
MN = Z01.107.567.875.075
MH_TH = NLM (1975)
ST = T083
AN = index specific states as needed but use APPALACHIAN REGION when text uses the term & when the region is the intent of the author; CATALOGER: Use for 4 or more states
MS = A geographical area of the United States with no definite boundaries but comprising northeastern Alabama, northwestern Georgia, northwestern South Carolina, western North Carolina, eastern Kentucky, eastern Tennessee, western Virginia, West Virginia, western Maryland, southwestern Pennsylvania, southern Ohio, and southern New York.
HN = 75
MR = 20150605
DA = 19990101
DC = 4
DX = 19750101
UI = D001061

*NEWRECORD
RECTYPE = D
MH = Appendectomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Appendectomies
MN = E04.210.078
MH_TH = NLM (1966)
ST = T061
AN = do not use /util except by MeSH definition
MS = Surgical removal of the vermiform appendix. (Dorland, 28th ed)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001062

*NEWRECORD
RECTYPE = D
MH = Appendiceal Neoplasms
DE = APPENDICEAL NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Appendiceal Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Cancer of Appendix|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Appendix Cancer|T191|NON|NRW|NLM (2004)|030228|abcdef
ENTRY = Cancer of the Appendix|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer, Appendiceal|T191|NON|NRW|NLM (2004)|030228|abcdef
ENTRY = Neoplasms, Appendiceal|T191|NON|EQV|NLM (2000)|991103|NEOPL APPENDICEAL|abcdefv
ENTRY = Appendiceal Neoplasm
ENTRY = Cancer, Appendix
ENTRY = Neoplasm, Appendiceal
MN = C04.588.274.476.411.184.290
MN = C06.301.371.411.184.290
MN = C06.405.249.411.184.290
MN = C06.405.469.110.417.290
MN = C06.405.469.491.184.290
FX = Pseudomyxoma Peritonei
MH_TH = NLM (1966)
ST = T191
AN = coord IM with histol type of neopl (IM)
MS = Tumors or cancer of the APPENDIX.
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D001063

*NEWRECORD
RECTYPE = D
MH = Appendicitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Perforated Appendicitis|T047|NON|NRW|NLM (2004)|021220|abcdef
ENTRY = Ruptured Appendicitis|T047|NON|NRW|NLM (2004)|030428|abcdef
ENTRY = Appendicitis, Perforated
ENTRY = Appendicitis, Ruptured
MN = C01.539.463.099
MN = C06.405.205.099
MN = C06.405.469.110.207
MH_TH = NLM (1966)
ST = T047
MS = Acute inflammation of the APPENDIX. Acute appendicitis is classified as simple, gangrenous, or perforated.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001064

*NEWRECORD
RECTYPE = D
MH = Appendix
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Vermiform Appendix|T023|NON|EQV|NLM (2004)|021219|abcdef
ENTRY = Appendix, Vermiform
MN = A03.556.124.526.209.290
MN = A03.556.249.249.209.290
FX = Appendectomy
MH_TH = NLM (1966)
ST = T023
AN = /surg: probably APPENDECTOMY; diseases: coord IM with CECAL DISEASES (IM); inflammation = APPENDICITIS; "ruptured" or "perforated" appendix: see note under APPENDICITIS
MS = A worm-like blind tube extension from the CECUM.
MR = 20030709
DA = 19990101
DC = 1
UI = D001065

*NEWRECORD
RECTYPE = D
MH = Appetite
AQ = DE EH GE IM PH RE
ENTRY = Appetite Alterations|T040|NON|REL|POPLINE (1978)|950324|abcdef
ENTRY = Alteration, Appetite
ENTRY = Alterations, Appetite
ENTRY = Appetite Alteration
ENTRY = Appetites
MN = F02.830.071
MN = G07.203.650.390.070
MN = G10.261.390.070
FX = Appetite Depressants
FX = Appetite Stimulants
FX = Craving
MH_TH = NLM (1966)
ST = T040
MS = Natural recurring desire for food. Alterations may be induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS.
CATSH = CAT LIST
MR = 20150629
DA = 19990101
DC = 1
UI = D001066

*NEWRECORD
RECTYPE = D
MH = Appetite Depressants
DE = APPETITE DEPRESS
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Anorectics|T121|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Appetite Suppressants|T121|NON|EQV|IOM (1990)|890417|abcdef
ENTRY = Anorectic Agents|T121|NON|EQV|NLM (2011)|091203|abcdef
ENTRY = Anorexic Drugs|T121|NON|EQV|NLM (1999)|970825|abcdef
ENTRY = Anorexigenic Drugs|T121|NON|EQV|NLM (1996)|950518|abcdef
ENTRY = Appetite-Depressing Drugs|T121|NON|EQV|NLM (1996)|941130|abcdef
ENTRY = Appetite-Suppressant Drugs|T121|NON|EQV|NLM (1999)|970825|abcdef
ENTRY = Agents, Anorectic
ENTRY = Appetite Depressing Drugs
ENTRY = Appetite Suppressant Drugs
ENTRY = Depressants, Appetite
ENTRY = Drugs, Anorexic
ENTRY = Drugs, Anorexigenic
ENTRY = Drugs, Appetite-Depressing
ENTRY = Drugs, Appetite-Suppressant
ENTRY = Suppressants, Appetite
MN = D27.505.954.427.140.155
MH_TH = NLM (1966)
ST = T121
RN = 0
MS = Agents that are used to suppress appetite.
MR = 20100625
DA = 19990101
DC = 1
UI = D001067

*NEWRECORD
RECTYPE = D
MH = Feeding and Eating Disorders
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Appetite Disorders|T048|NON|NRW|UNK (19XX)|880608|APPETITE DIS|abcdefv
ENTRY = Eating and Feeding Disorders|T048|NON|EQV|NLM (2016)|150701|abcdef
ENTRY = Appetite Disorder
MN = F03.400
MH_TH = NLM (2016)
ST = T048
AN = in children, use FEEDING AND EATING DISORDERS OF CHILDHOOD if related to mental disorder
MS = A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.
PM = 2016; see EATING AND FEEDING DISORDERS 1989-2015,  see APPETITE DISORDERS 1963-1988
HN = 2016 (1983)
CATSH = CAT LIST
MR = 20150708
DA = 19990101
DC = 1
UI = D001068

*NEWRECORD
RECTYPE = D
MH = Appetite Regulation
DE = APPETITE REG
AQ = DE EH GE IM PH RE
PRINT ENTRY = Food Intake Regulation|T040|NON|NRW|UNK (19XX)|880608|FOOD INTAKE REG|abcdefv
ENTRY = Intake Regulation, Food|T040|NON|NRW|NLM (1992)|901015|INTAKE REG FOOD|abcdefv
ENTRY = Regulation, Appetite|T040|NON|EQV|NLM (1992)|901015|REG APPETITE|abcdefv
ENTRY = Regulation, Food Intake|T040|NON|NRW|NLM (1992)|901015|REG FOOD INTAKE|abcdefv
ENTRY = Appetite Regulations
ENTRY = Food Intake Regulations
ENTRY = Intake Regulations, Food
ENTRY = Regulations, Appetite
ENTRY = Regulations, Food Intake
MN = G07.203.650.390.070.290
MN = G07.203.650.593.080
MN = G07.700.620.080
MN = G10.261.390.070.290
MH_TH = NLM (1966)
ST = T040
AN = DF: APPETITE REG
MS = Physiologic mechanisms which regulate or control the appetite and food intake.
PM = 72
HN = 72(66)
CATSH = CAT LIST
MR = 20150629
DA = 19990101
DC = 1
DX = 19720101
UI = D001069

*NEWRECORD
RECTYPE = D
MH = Appetitive Behavior
AQ = CL DE ES PH RE
PRINT ENTRY = Searching Behavior|T055|NON|EQV|NLM (1998)|970320|abcdef
ENTRY = Appetitive Behaviors
ENTRY = Behavior, Appetitive
ENTRY = Behavior, Searching
ENTRY = Behaviors, Appetitive
ENTRY = Behaviors, Searching
ENTRY = Searching Behaviors
MN = F01.145.113.111
FX = Ceremonial Behavior
MH_TH = NLM (1968)
ST = T055
AN = usually animal; introduct phase of instinctive behav; nothing to do with APPETITE, the desire for food
PI = Behavior (1966-1967)
MS = Animal searching behavior. The variable introductory phase of an instinctive behavior pattern or sequence, e.g., looking for food, or sequential courtship patterns prior to mating.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19680101
UI = D001070

*NEWRECORD
RECTYPE = D
MH = Appointments and Schedules
DE = APPOINTMENTS SCHEDULES
PRINT ENTRY = Patient Appointments|T058|T079|NON|NRW|UNK (19XX)|780508|abbcdef
PRINT ENTRY = Patient Schedules|T058|T079|NON|NRW|UNK (19XX)|780508|abbcdef
PRINT ENTRY = Schedules, Patient|T058|T079|NON|NRW|UNK (19XX)|780508|abbcdef
ENTRY = Appointments|T079|NON|NRW|NLM (1992)|910610|abcdef
ENTRY = Schedules|T170|NON|NRW|NLM (1992)|910610|abcdef
ENTRY = Appointment
ENTRY = Appointment, Patient
ENTRY = Appointments, Patient
ENTRY = Patient Appointment
ENTRY = Patient Schedule
ENTRY = Schedule
ENTRY = Schedule, Patient
ENTRY = Schedules and Appointments
MN = N04.452.095
MH_TH = NLM (1968)
ST = T079
AN = no qualif; DF: APPOINTMENTS
PI = Outpatient Clinics, Hospital (1966-1967)
MS = The different methods of scheduling patient visits, appointment systems, individual or group appointments, waiting times, waiting lists for hospitals, walk-in clinics, etc.
PM = 68
HN = 68
MR = 19910610
DA = 19990101
DC = 1
DX = 19680101
UI = D001071

*NEWRECORD
RECTYPE = D
MH = Apraxias
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Dressing Apraxia|T048|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Dyspraxia|T048|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Ideational Apraxia|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Apraxia|T048|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Apraxia of Phonation|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Apraxia, Articulatory|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Apraxia, Developmental Verbal|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Apraxia, Facial-Oral|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Apraxia, Gestural|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Apraxia, Motor|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Apraxia, Oral|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Apraxia, Verbal|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Developmental Verbal Dyspraxia|T048|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Dyspraxia, Articulatory|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Dyspraxia, Oral|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Dyspraxia, Verbal|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Speech And Language Disorder With Orofacial Dyspraxia|T048|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Speech-Language Disorder 1|T048|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = 1, Speech-Language Disorder
ENTRY = 1s, Speech-Language Disorder
ENTRY = Apraxia, Dressing
ENTRY = Apraxia, Facial Oral
ENTRY = Apraxia, Ideational
ENTRY = Apraxias, Articulatory
ENTRY = Apraxias, Developmental Verbal
ENTRY = Apraxias, Dressing
ENTRY = Apraxias, Facial-Oral
ENTRY = Apraxias, Gestural
ENTRY = Apraxias, Ideational
ENTRY = Apraxias, Motor
ENTRY = Apraxias, Oral
ENTRY = Apraxias, Verbal
ENTRY = Articulatory Apraxia
ENTRY = Articulatory Apraxias
ENTRY = Articulatory Dyspraxia
ENTRY = Articulatory Dyspraxias
ENTRY = Developmental Verbal Apraxia
ENTRY = Developmental Verbal Apraxias
ENTRY = Developmental Verbal Dyspraxias
ENTRY = Disorder 1, Speech-Language
ENTRY = Disorder 1s, Speech-Language
ENTRY = Dressing Apraxias
ENTRY = Dyspraxia, Developmental Verbal
ENTRY = Dyspraxias
ENTRY = Dyspraxias, Articulatory
ENTRY = Dyspraxias, Developmental Verbal
ENTRY = Dyspraxias, Oral
ENTRY = Dyspraxias, Verbal
ENTRY = Facial-Oral Apraxia
ENTRY = Facial-Oral Apraxias
ENTRY = Gestural Apraxia
ENTRY = Gestural Apraxias
ENTRY = Ideational Apraxias
ENTRY = Motor Apraxia
ENTRY = Motor Apraxias
ENTRY = Oral Apraxia
ENTRY = Oral Apraxias
ENTRY = Oral Dyspraxia
ENTRY = Oral Dyspraxias
ENTRY = Phonation Apraxia
ENTRY = Phonation Apraxias
ENTRY = Speech Language Disorder 1
ENTRY = Speech-Language Disorder 1s
ENTRY = Verbal Apraxia
ENTRY = Verbal Apraxia, Developmental
ENTRY = Verbal Apraxias
ENTRY = Verbal Apraxias, Developmental
ENTRY = Verbal Dyspraxia
ENTRY = Verbal Dyspraxia, Developmental
ENTRY = Verbal Dyspraxias
ENTRY = Verbal Dyspraxias, Developmental
MN = C10.597.606.881.350
MN = C23.888.592.604.882.350
MN = F01.700.875.350
MH_TH = NLM (2000)
ST = T048
MS = A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)
PM = 2000; see APRAXIA 1966-1999
HN = 2000(1966)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001072

*NEWRECORD
RECTYPE = D
MH = Aprindine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amidonal|T109|T121|TRD|NRW|DE|020802|abbcdef
ENTRY = Christiaens Brand of Aprindine Hydrochloride|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = Fiboran|T109|T121|TRD|NRW|ES|FR|NL|020802|abbcdeeef
ENTRY = Nycomed Brand of Aprindine Hydrochloride|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
ENTRY = PCR Brand of Aprindine Hydrochloride|T109|T121|NON|NRW|NLM (2004)|020802|abbcdef
MN = D02.455.426.559.847.486.487.060
MN = D04.615.486.487.060
PA = Anti-Arrhythmia Agents
PA = Voltage-Gated Sodium Channel Blockers
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1973)
ST = T109
ST = T121
N1 = 1,3-Propanediamine, N-(2,3-dihydro-1H-inden-2-yl)-N',N'-diethyl-N-phenyl-
RN = 5Y48085P9Q
RR = 37640-71-4 (Aprindine)
PI = Aniline Compounds (1974)
PI = Diethylamines (1974)
PI = Indenes (1973-1975)
MS = A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
PM = 91; was see under INDENES 1975-90
HN = 91(75); was see under INDENES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001073

*NEWRECORD
RECTYPE = D
MH = Propoxur
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aprocarb|T109|T131|TRD|NRW|NLM (1972)|990101|abbcdef
ENTRY = Baygon|T109|T131|TRD|NRW|UNK (19XX)|800917|abbcdef
ENTRY = O-Isopropoxyphenylmethylcarbamate|T109|T131|NON|EQV|UNK (19XX)|800917|abbcdef
ENTRY = Sendran|T109|T131|TRD|NRW|UNK (19XX)|800917|abbcdef
ENTRY = Unden|T109|T131|TRD|NRW|UNK (19XX)|800917|abbcdef
ENTRY = O Isopropoxyphenylmethylcarbamate
MN = D02.241.081.251.583.788
PA = Cholinesterase Inhibitors
PA = Insecticides
MH_TH = FDA SRS (2014)
MH_TH = UNK (19XX)
ST = T109
ST = T131
N1 = Phenol, 2-(1-methylethoxy)-, methylcarbamate
RN = BFH029TL73
RR = 114-26-1 (Propoxur)
PI = Carbamates (1966-1971)
PI = Insecticides (1966-1971)
MS = A carbamate insecticide.
PM = 2001; see APROCARB 1972-2000
HN = 2001(1972)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D001074

*NEWRECORD
RECTYPE = D
MH = Aptitude
AQ = CL DE ES PH RE
PRINT ENTRY = Ability|T032|NON|BRD|UNK (19XX)|740329|abcdef
PRINT ENTRY = Talent|T041|NON|REL|UNK (19XX)|780503|abcdef
ENTRY = Abilities
ENTRY = Aptitudes
ENTRY = Talents
MN = F02.784.629.131
MH_TH = NLM (1966)
ST = T041
MS = The ability to acquire general or special types of knowledge or skill.
OL = use APTITUDE to search TALENT 1966-78
HN = TALENT was see under APTITUDE 1963-78
CATSH = CAT LIST
MR = 19920325
DA = 19990101
DC = 1
UI = D001076

*NEWRECORD
RECTYPE = D
MH = Aptitude Tests
AQ = HI SN ST
ENTRY = Aptitude Test
ENTRY = Test, Aptitude
ENTRY = Tests, Aptitude
MN = F04.711.141
MH_TH = NLM (1966)
ST = T060
MS = Primarily non-verbal tests designed to predict an individual's future learning ability or performance.
CATSH = CAT LIST
MR = 19920325
DA = 19990101
DC = 1
UI = D001077

*NEWRECORD
RECTYPE = D
MH = APUD Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Amine Precursor Uptake and Decarboxylation Cells|T025|NON|EQV|NLM (2007)|051220|abcdef
ENTRY = APUD Cell
ENTRY = Cell, APUD
ENTRY = Cells, APUD
MN = A11.382.249
FX = Enteroendocrine Cells
MH_TH = NLM (1978)
ST = T025
AN = named APUD from Amine Precursor Uptake & Decarboxylation; use term only when used by author
MS = Cells with the capacity to take up and decarboxylate the amine precursors DIHYDROXYPHENYLALANINE or 5-HYDROXYTRYPTOPHAN. This is a property of endocrine cells of neural and non-neural origin. APUDOMA is a general term collectively applied to tumors associated with APUD cells.
PM = 78
HN = 78
MR = 20150622
DA = 19770427
DC = 1
DX = 19780101
UI = D001078

*NEWRECORD
RECTYPE = D
MH = Apudoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Apudomas
MN = C04.557.465.625.650.135
MN = C04.557.470.035.250
MN = C04.557.580.625.650.135
FX = Multiple Endocrine Neoplasia
MH_TH = NLM (1978)
MH_TH = ORD (2010)
ST = T191
AN = for derivation of word see note on APUD; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ /neopl term (IM)
MS = A general term collectively applied to tumors associated with the APUD CELLS series, irrespective of their specific identification.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 20090706
DA = 19770427
DC = 1
DX = 19780101
UI = D001079

*NEWRECORD
RECTYPE = D
MH = Apurinic Acid
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Acid, Apurinic
MN = D03.383.742.686.050
MN = D13.695.578.500.050
MN = D13.695.578.550.050
MN = D13.695.740.050
MH_TH = NLM (1975)
ST = T114
N1 = Apurinic acid
RN = 11002-22-5
PI = Polynucleotides (1972-1975)
PI = Pyrimidine Nucleotides (1974)
MS = Hydrolysate of DNA in which purine bases have been removed.
PM = 91; was see under POLYNUCLEOTIDES 1975-90
HN = 91(75); was see under POLYNUCLEOTIDES 1975-90
MR = 20060705
DA = 19741119
DC = 1
DX = 19910101
UI = D001080

*NEWRECORD
RECTYPE = D
MH = Apyrase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = ADPase|T116|T126|EQV|UNK (19XX)|750630|abbdef
PRINT ENTRY = ATP-Diphosphatase|T116|T126|EQV|UNK (19XX)|750630|abbdef
PRINT ENTRY = Adenosine Diphosphatase|T116|T126|NON|EQV|UNK (19XX)|750630|abbcdef
ENTRY = ADP Phosphohydrolase|T116|T126|EQV|UNK (19XX)|830914|abbdef
ENTRY = ATP Diphosphohydrolase|T116|T126|NON|EQV|UNK (19XX)|830916|abbcdef
ENTRY = ATP-ADPase|T116|T126|EQV|UNK (19XX)|810625|abbdef
ENTRY = ATP ADPase
ENTRY = ATP Diphosphatase
ENTRY = Diphosphatase, Adenosine
ENTRY = Diphosphohydrolase, ATP
ENTRY = Phosphohydrolase, ADP
MN = D08.811.277.040.050
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = ATP diphosphohydrolase
RN = EC 3.6.1.5
RR = 9000-95-7 (CAS RN)
PI = Adenosine Triphosphate (1974-1975)
PI = Phosphatases (1974-1975)
MS = A calcium-activated enzyme that catalyzes the hydrolysis of ATP to yield AMP and orthophosphate. It can also act on ADP and other nucleoside triphosphates and diphosphates. EC 3.6.1.5.
PM = 91; was see under PHOSPHATASES 1976-90; ATP-DIPHOSPHATASE was ATP DIPHOSPHATASE 1976-93
HN = 91(76); was see under PHOSPHATASES 1976-90; ATP-DIPHOSPHATASE was ATP DIPHOSPHATASE 1976-93
MR = 20030709
DA = 19750721
DC = 1
DX = 19910101
UI = D001081

*NEWRECORD
RECTYPE = D
MH = Aqueous Humor
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
PRINT ENTRY = Aqueous Flare|T039|NON|REL|NLM (1998)|960916|abcdef
PRINT ENTRY = Intraocular Fluid|T031|NON|EQV|NLM (1998)|961106|abcdef
ENTRY = Aqueous Flares
ENTRY = Aqueous Humors
ENTRY = Flare, Aqueous
ENTRY = Fluid, Intraocular
ENTRY = Fluids, Intraocular
ENTRY = Humor, Aqueous
ENTRY = Humors, Aqueous
ENTRY = Intraocular Fluids
MN = A09.371.060.067.070
MN = A12.207.270.040
MH_TH = NLM (1966)
ST = T031
AN = in the eye
MS = The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319)
MR = 20030709
DA = 19990101
DC = 1
UI = D001082

*NEWRECORD
RECTYPE = D
MH = Arabia
AQ = EH EP
MN = Z01.586.035.100
MH_TH = NLM (1966)
ST = T083
AN = a hist name; do not confuse with SAUDI ARABIA nor with ARAB WORLD, the culture & civilization; Manual 36.13
MS = The great peninsula of southwest Asia comprising most of the present countries of the Middle East. It has been known since the first millennium B.C. In early times it was divided into Arabia Petraea, the northwest part, the only part ever conquered, becoming a Roman province; Arabia Deserta, the northern part between Syria and Mesopotamia; and Arabia Felix, the main part of the peninsula but by some geographers restricted to modern Yemen. (From Webster's New Geographical Dictionary, 1988, p63)
MR = 20040719
DA = 19990101
DC = 4
UI = D001083

*NEWRECORD
RECTYPE = D
MH = Vidarabine Phosphate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Adenine Arabinoside Monophosphate|T114|T121|NON|EQV|UNK (19XX)|780516|abbcdef
PRINT ENTRY = Ara-AMP|T114|T121|EQV|UNK (19XX)|780516|abbdef
PRINT ENTRY = Arabinofuranosyladenine Monophosphate|T114|T121|NON|EQV|NLM (1996)|940805|abbcdef
PRINT ENTRY = Vidarabine Monophosphate|T114|T121|NON|EQV|UNK (19XX)|780516|abbcdef
ENTRY = 9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine|T114|T121|NON|EQV|NLM (1996)|950522|abbcdef
ENTRY = Ara AMP
ENTRY = Monophosphate, Adenine Arabinoside
ENTRY = Monophosphate, Arabinofuranosyladenine
ENTRY = Monophosphate, Vidarabine
ENTRY = Phosphate, Vidarabine
MN = D03.438.759.646.138.925
MN = D13.695.065.900
MN = D13.695.667.138.925
PA = Antimetabolites
PA = Antiviral Agents
MH_TH = FDA SRS (2014)
MH_TH = USAN (1979)
ST = T114
ST = T121
N1 = 9H-Purin-6-amine, 9-(5-O-phosphono-beta-D-arabinofuranosyl)-
RN = 106XV160TZ
RR = 29984-33-6 (Vidarabine Phosphate)
AN = a vidarabine ester antimetabolite; DF: note short X ref
PI = Adenine Nucleotides (1966-1970)
PI = Adenosine Monophosphate (1971-1978)
PI = Vidarabine (1975-1978)
MS = An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of VIDARABINE with antiviral and possibly antineoplastic properties.
PM = 96; was ARABINOFURANOSYLADENINE MONOPHOSPHATE 1979-95 (see under ARABINONUCLEOTIDES 1979-90)
HN = 96; was ARABINOFURANOSYLADENINE MONOPHOSPHATE 1979-95 (see under ARABINONUCLEOTIDES 1979-90)
MR = 20130708
DA = 19780516
DC = 1
DX = 19910101
UI = D001084

*NEWRECORD
RECTYPE = D
MH = Arabinofuranosylcytosine Triphosphate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Ara-CTP|T114|T121|EQV|UNK (19XX)|780516|abbdef
PRINT ENTRY = Arabinosylcytosine Triphosphate|T114|T121|NON|EQV|UNK (19XX)|780516|abbcdef
PRINT ENTRY = Cytarabine Triphosphate|T114|T121|NON|EQV|UNK (19XX)|780516|abbcdef
PRINT ENTRY = Cytosine Arabinoside Triphosphate|T114|T121|NON|EQV|UNK (19XX)|780516|abbcdef
ENTRY = Ara CTP
ENTRY = Triphosphate, Arabinofuranosylcytosine
ENTRY = Triphosphate, Arabinosylcytosine
ENTRY = Triphosphate, Cytarabine
ENTRY = Triphosphate, Cytosine Arabinoside
MN = D03.383.742.686.246.050
MN = D13.695.065.200
MN = D13.695.740.246.050
PA = Nucleic Acid Synthesis Inhibitors
MH_TH = NLM (1979)
ST = T114
ST = T121
N1 = 2(1H)-Pyrimidinone, 4-amino-1-(5-O-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-D-arabinofuranosyl)-
RN = 13191-15-6
AN = a cytarabine analog; DF: note short X ref
PI = Cytarabine (1966-1978)
MS = A triphosphate nucleotide analog which is the biologically active form of CYTARABINE. It inhibits nuclear DNA synthesis.
PM = 91; was see under ARABINONUCLEOTIDES 1979-90
HN = 91(79); was see under ARABINONUCLEOTIDES 1979-90
MR = 20060705
DA = 19780516
DC = 1
DX = 19910101
UI = D001085

*NEWRECORD
RECTYPE = D
MH = Arabinofuranosyluracil
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Ara-U|T114|T123|EQV|UNK (19XX)|760526|abbdef
PRINT ENTRY = Arabinosyluracil|T114|T123|NON|EQV|UNK (19XX)|760305|abbcdef
PRINT ENTRY = Arauridine|T114|T123|NON|EQV|UNK (19XX)|750701|abbcdef
PRINT ENTRY = Sponguridine|T114|T123|NON|EQV|UNK (19XX)|750701|abbcdef
PRINT ENTRY = Uracil Arabinofuranoside|T114|T123|NON|EQV|UNK (19XX)|750701|abbcdef
PRINT ENTRY = Uracil Arabinoside|T114|T123|NON|EQV|UNK (19XX)|750701|abbcdef
ENTRY = 1-beta-D-Arabinofuranosyl Uracil|T114|T123|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = NSC 68928|T114|T123|LAB|NRW|NLM (1991)|900427|abbcdef
ENTRY = 1 beta D Arabinofuranosyl Uracil
ENTRY = Ara U
ENTRY = Arabinofuranoside, Uracil
ENTRY = Arabinoside, Uracil
ENTRY = Uracil, 1-beta-D-Arabinofuranosyl
MN = D03.383.742.680.852.150
MN = D13.570.065.090
MN = D13.570.685.852.150
MH_TH = NLM (1976)
ST = T114
ST = T123
N1 = 2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-
RN = 3083-77-0
AN = /biosyn /physiol permitted
PI = Arabinose (1972-1974)/analogs & derivatives (1975)
PI = Nucleosides (1972-1974)
PI = Uracil (1972-1974)
PI = Uridine/analogs & derivatives (1975)
MS = A pyrimidine nucleoside formed in the body by the deamination of CYTARABINE.
PM = 91; was see under URIDINE/analogs & derivatives 1978-90; was see under PYRIMIDINE NUCLEOSIDES 1976-77
HN = 91(76); was see under URIDINE/analogs & derivatives 1978-90; was see under PYRIMIDINE NUCLEOSIDES 1976-77
MR = 20060705
DA = 19750723
DC = 1
DX = 19910101
UI = D001086

*NEWRECORD
RECTYPE = D
MH = Arabinonucleosides
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Arabinofuranosylnucleosides|T114|NON|EQV|UNK (19XX)|780517|abcdef
MN = D13.570.065
MH_TH = NLM (1979)
ST = T114
RN = 0
PI = Nucleosides (1966-1978)
PI = specific nucleoside (1966-1978)
MS = Nucleosides containing arabinose as their sugar moiety.
PM = 79
HN = 79
MR = 19920507
DA = 19780517
DC = 1
DX = 19790101
UI = D001087

*NEWRECORD
RECTYPE = D
MH = Arabinonucleotides
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Arabinofuranosylnucleotides|T114|NON|EQV|UNK (19XX)|780516|abcdef
MN = D13.695.065
MH_TH = NLM (1979)
ST = T114
RN = 0
PI = Nucleotides (1966-1978)
PI = specific nucleotide (1966-1978)
MS = Nucleotides containing arabinose as their sugar moiety.
PM = 79
HN = 79
MR = 19920507
DA = 19780516
DC = 1
DX = 19790101
UI = D001088

*NEWRECORD
RECTYPE = D
MH = Arabinose
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = L-Arabinose|T118|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|850103|abbcdeef
ENTRY = L Arabinose
MN = D09.546.627.166
MH_TH = NLM (1966)
ST = T118
ST = T123
N1 = Arabinose
RN = B40ROO395Z
RR = 147-81-9 (Arabinose)
MR = 20130708
DA = 19990101
DC = 1
UI = D001089

*NEWRECORD
RECTYPE = D
MH = Arachidonate Lipoxygenases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Arachidonic Acid Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|abbcdef
ENTRY = Lipoxygenase, Arachidonic Acid
ENTRY = Lipoxygenases, Arachidonate
MN = D08.811.682.690.416.583.500
MN = D12.776.556.579.374.568.500
MH_TH = NLM (1987)
ST = T116
ST = T126
RN = EC 1.13.11.-
PI = Lipoxygenases (1974-1986)
PI = Oxygenases (1966-1973)
MS = Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- .
PM = 87
HN = 87
MR = 20100625
DA = 19860616
DC = 1
DX = 19870101
UI = D001091

*NEWRECORD
RECTYPE = D
MH = Arachidonate 12-Lipoxygenase
DS = ARACHIDONATE LIPOXYGENASE 12
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = 12-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|LIPOXYGENASE A 12|abbcdefs
ENTRY = Arachidonic Acid 12-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|abbcdef
ENTRY = 12 Lipoxygenase
ENTRY = 12-Lipoxygenase, Arachidonate
ENTRY = 12-Lipoxygenase, Arachidonic Acid
ENTRY = Arachidonate 12 Lipoxygenase
ENTRY = Arachidonic Acid 12 Lipoxygenase
MN = D08.811.682.690.416.583.500.060
MN = D12.776.556.579.374.568.500.025
EC = antagonists & inhibitors:Lipoxygenase Inhibitors
MH_TH = NLM (1987)
ST = T116
ST = T126
N1 = Arachidonate:oxygen 12-oxidoreductase
RN = EC 1.13.11.31
PI = Lipoxygenases (1974-1986)
PI = Oxygenases (1966-1973)
MS = An enzyme that catalyzes the oxidation of arachidonic acid to yield 12-hydroperoxyarachidonate (12-HPETE) which is itself rapidly converted by a peroxidase to 12-hydroxy-5,8,10,14-eicosatetraenoate (12-HETE). The 12-hydroperoxides are preferentially formed in PLATELETS.
PM = 91; was see under ARACHIDONATE LIPOXYGENASES 1987-90
HN = 91(87); was see under ARACHIDONATE LIPOXYGENASES 1987-90
MR = 20100625
DA = 19860616
DC = 1
DX = 19910101
UI = D001092

*NEWRECORD
RECTYPE = D
MH = Arachidonate 15-Lipoxygenase
DS = ARACHIDONATE LIPOXYGENASE 15
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = 15-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|LIPOXYGENASE A 15|abbcdefs
ENTRY = Arachidonic Acid 15-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|abbcdef
ENTRY = 15 Lipoxygenase
ENTRY = 15-Lipoxygenase, Arachidonate
ENTRY = 15-Lipoxygenase, Arachidonic Acid
ENTRY = Arachidonate 15 Lipoxygenase
ENTRY = Arachidonic Acid 15 Lipoxygenase
MN = D08.811.682.690.416.583.500.065
MN = D12.776.556.579.374.568.500.030
EC = antagonists & inhibitors:Lipoxygenase Inhibitors
MH_TH = NLM (1987)
ST = T116
ST = T126
N1 = Arachidonate:oxygen 15-oxidoreductase
RN = EC 1.13.11.33
PI = Lipoxygenases (1974-1986)
PI = Oxygenases (1966-1973)
MS = An enzyme that catalyzes the oxidation of arachidonic acid to yield 15-hydroperoxyarachidonate (15-HPETE) which is rapidly converted to 15-hydroxy-5,8,11,13-eicosatetraenoate (15-HETE). The 15-hydroperoxides are preferentially formed in NEUTROPHILS and LYMPHOCYTES.
PM = 91; was see under ARACHIDONATE LIPOXYGENASES 1987-90
HN = 91(87); was see under ARACHIDONATE LIPOXYGENASES 1987-90
MR = 20100625
DA = 19860616
DC = 1
DX = 19910101
UI = D001093

*NEWRECORD
RECTYPE = D
MH = Arachidonate 5-Lipoxygenase
DS = ARACHIDONATE LIPOXYGENASE 05
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = 5-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|LIPOXYGENASE A 05|abbcdefs
ENTRY = Arachidonic Acid 5-Lipoxygenase|T116|T126|NON|EQV|UNK (19XX)|860616|abbcdef
ENTRY = LTA4 Synthase|T116|T126|EQV|UNK (19XX)|870403|abbdef
ENTRY = Leukotriene A Synthase|T116|T126|NON|EQV|UNK (19XX)|871201|abbcdef
ENTRY = Leukotriene A4 Synthase|T116|T126|NON|EQV|UNK (19XX)|870403|abbcdef
ENTRY = Leukotriene A4 Synthetase|T116|T126|NON|EQV|UNK (19XX)|870403|abbcdef
ENTRY = 5 Lipoxygenase
ENTRY = 5-Lipoxygenase, Arachidonate
ENTRY = 5-Lipoxygenase, Arachidonic Acid
ENTRY = Arachidonate 5 Lipoxygenase
ENTRY = Arachidonic Acid 5 Lipoxygenase
ENTRY = Synthase, LTA4
ENTRY = Synthase, Leukotriene A
ENTRY = Synthase, Leukotriene A4
ENTRY = Synthetase, Leukotriene A4
MN = D08.811.682.690.416.583.500.055
MN = D12.776.556.579.374.568.500.020
EC = antagonists & inhibitors:Lipoxygenase Inhibitors
MH_TH = NLM (1987)
ST = T116
ST = T126
N1 = Arachidonate:oxygen 5-oxidoreductase
RN = EC 1.13.11.34
PI = Lipoxygenases (1974-1986)
PI = Oxygenases (1966-1973)
MS = An enzyme that catalyzes the oxidation of arachidonic acid to yield 5-hydroperoxyarachidonate (5-HPETE) which is rapidly converted by a peroxidase to 5-hydroxy-6,8,11,14-eicosatetraenoate (5-HETE). The 5-hydroperoxides are preferentially formed in leukocytes.
PM = 91; was see under ARACHIDONATE LIPOXYGENASES 1987-90
HN = 91(87); was see under ARACHIDONATE LIPOXYGENASES 1987-90
MR = 20100625
DA = 19860616
DC = 1
DX = 19910101
UI = D001094

*NEWRECORD
RECTYPE = D
MH = Arachidonic Acids
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Eicosatetraenoic Acids|T111|NON|BRD|UNK (19XX)|760520|abcdef
ENTRY = Acids, Arachidonic
ENTRY = Acids, Eicosatetraenoic
MN = D10.251.355.255.100
MN = D10.251.355.310.166
MH_TH = NLM (1967)
ST = T111
RN = 0
AN = do not confuse with ARACHIDONIC ACID
PI = Fatty Acids, Essential (1966)
OL = use ARACHIDONIC ACIDS to search ARACHIDONIC ACID 1967-74; use FATTY ACIDS, ESSENTIAL to search ARACHIDONIC ACID 1966
PM = 75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66
HN = 75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66
MR = 20150625
DA = 19990101
DC = 1
DX = 19670101
UI = D001095

*NEWRECORD
RECTYPE = D
MH = Arachnid Vectors
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Arachnid Vector
ENTRY = Vector, Arachnid
ENTRY = Vectors, Arachnid
MN = N06.850.310.350.100.100
MH_TH = NLM (1971)
ST = T204
AN = coord IM with specific arachnid (IM); specify both infecting organism & vector if pertinent; in the rickettsial-tick-dog relationship, the tick is the arachnid vector, not the dog
PI = Arthropod Vectors (1966-1970)
MS = Members of the class Arachnida, especially SPIDERS; SCORPIONS; MITES; and TICKS; which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
PM = 74
HN = 74(71)
MR = 20080708
DA = 19990101
DC = 1
DX = 19740101
UI = D001096

*NEWRECORD
RECTYPE = D
MH = Arachnida
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Arachnids|T204|NON|EQV|NLM (1992)|900911|abcdef
ENTRY = Arachnid
ENTRY = Arachnidas
MN = B01.050.500.131.166
MH_TH = NLM (1966)
ST = T204
MS = A class of Arthropoda that includes SPIDERS; TICKS; MITES; and SCORPIONS.
MR = 20090706
DA = 19990101
DC = 1
UI = D001097

*NEWRECORD
RECTYPE = D
MH = Spider Bites
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Arachnidism|T037|NON|NRW|NLM (1966)|990101|abcdef
ENTRY = Necrotic Arachnidism|T037|NON|NRW|NLM (2004)|030311|abcdef
ENTRY = Arachnidism, Necrotic
ENTRY = Bite, Spider
ENTRY = Bites, Spider
ENTRY = Spider Bite
MN = C25.723.127.723
MN = C26.176.790
FX = Spider Venoms
MH_TH = NLM (2014)
ST = T037
MS = The effects, both local and systemic, caused by the bites of SPIDERS.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001098

*NEWRECORD
RECTYPE = D
MH = Arachnoid
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arachnoid Mater|T023|NON|EQV|NLM (2015)|140401|abcdef
ENTRY = Arachnoid Maters
ENTRY = Arachnoids
ENTRY = Mater, Arachnoid
ENTRY = Maters, Arachnoid
MN = A08.186.566.166
MH_TH = NLM (1966)
ST = T023
AN = inflammation = ARACHNOIDITIS
MS = A delicate membrane enveloping the brain and spinal cord. It lies between the PIA MATER and the DURA MATER. It is separated from the pia mater by the subarachnoid cavity which is filled with CEREBROSPINAL FLUID.
MR = 20140613
DA = 19990101
DC = 1
UI = D001099

*NEWRECORD
RECTYPE = D
MH = Arachnoiditis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Arachnoid Membrane Inflammation|T047|NON|EQV|NLM (2000)|991104|ARACHNOID MEMBRANE INFLAMM|abcdefv
ENTRY = Inflammation, Arachnoid Membrane|T047|NON|EQV|NLM (2000)|991104|INFLAMM ARACHNOID MEMBRANE|abcdefv
ENTRY = Arachnoid Membrane Inflammations
ENTRY = Arachnoiditides
ENTRY = Inflammations, Arachnoid Membrane
MN = C10.228.614.097
MH_TH = NLM (1967)
MH_TH = ORD (2010)
ST = T047
PI = Brain Diseases (1966)
PI = Meningitis (1966)
MS = Acute or chronic inflammation of the arachnoid membrane of the meninges most often involving the spinal cord or base of the brain. This term generally refers to a persistent inflammatory process characterized by thickening of the ARACHNOID membrane and dural adhesions. Associated conditions include prior surgery, infections, trauma, SUBARACHNOID HEMORRHAGE, and chemical irritation. Clinical features vary with the site of inflammation, but include cranial neuropathies, radiculopathies, and myelopathies. (From Joynt, Clinical Neurology, 1997, Ch48, p25)
PM = 1967
HN = 1967
CATSH = CAT LIST
MR = 20150701
DA = 19990101
DC = 1
DX = 19670101
UI = D001100

*NEWRECORD
RECTYPE = D
MH = Arbaprostil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 15-Methylprostaglandin E2|T111|T121|NON|EQV|UNK (19XX)|790523|METHYLPROSTAGLANDIN E2 A 15|abbcdefs
ENTRY = Arbacet|T111|T121|TRD|NRW|UNK (19XX)|861007|abbcdef
ENTRY = U-42842|T111|T121|LAB|NRW|NLM (1994)|921214|abbcdef
ENTRY = 15 Methylprostaglandin E2
ENTRY = U 42842
ENTRY = U42842
MN = D10.251.355.255.550.775.450.050
MN = D23.469.050.175.725.775.450.050
MN = D23.469.700.660.050
PA = Anti-Ulcer Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1976)
ST = T111
ST = T121
N1 = Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-15-methyl-9-oxo-, (5Z,11alpha,13E,15R)-
RN = M6B59S6MEF
RR = 55028-70-1 (Arbaprostil)
PI = Prostaglandins (1966-1974)
PI = Prostaglandins E (1975-1977)
PI = Prostaglandins E, Synthetic (1978-1979)
PI = Prostaglandins, Synthetic (1977)
MS = A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and can inhibit the growth of experimental tumors.
OL = use ARBAPROSTIL to search 15-METHYLPROSTAGLANDIN E2 METHYL ESTER & METHYLDINOPROSTONE 1980-93
PM = 91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER & METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93
HN = 91(80); was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER & METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93
MR = 20150608
DA = 19790523
DC = 1
DX = 19910101
UI = D001101

*NEWRECORD
RECTYPE = D
MH = Arbovirus Infections
DE = ARBOVIRUS INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Arbovirus Infection
ENTRY = Infection, Arbovirus
ENTRY = Infections, Arbovirus
MN = C02.081
MH_TH = NLM (1965)
ST = T047
AN = GEN; consider also 2 major groups, BUNYAVIRUS INFECTIONS & TOGAVIRUS INFECTIONS or specifics
MS = Infections caused by arthropod-borne viruses, general or unspecified.
PM = 65; was ARBORVIRUS INFECTIONS 1963-64
HN = 65; was ARBORVIRUS INFECTIONS 1963-64
CATSH = CAT LIST
MR = 20040713
DA = 19990101
DC = 1
DX = 19650101
UI = D001102

*NEWRECORD
RECTYPE = D
MH = Arboviruses
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Arthropod-Borne Viruses|T005|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Arbovirus
ENTRY = Arthropod Borne Viruses
ENTRY = Arthropod-Borne Virus
ENTRY = Virus, Arthropod-Borne
ENTRY = Viruses, Arthropod-Borne
MN = B04.080
FX = Arenaviridae
FX = Bunyaviridae
FX = Flaviviridae
FX = Reoviridae
FX = Togaviridae
MH_TH = NLM (1965)
ST = T005
AN = GEN; from ARthropod-BOrne; infection = ARBOVIRUS INFECTIONS
MS = Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. (From Dictionary of Microbiology and Molecular Biology, 2nd ed)
OL = use ARBOVIRUSES to search ARBOVIRUS 1966-74
PM = 75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80
HN = 75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80
MR = 20010725
DA = 19990101
DC = 1
DX = 19650101
UI = D001103

*NEWRECORD
RECTYPE = D
MH = Arbutin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
MN = D09.408.348.075
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T118
ST = T121
N1 = beta-D-Glucopyranoside, 4-hydroxyphenyl
RN = C5INA23HXF
RR = 497-76-7 (Arbutin)
OL = search PLANTS, MEDICINAL 1966-74
PM = 91; was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75
HN = 91(75); was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001104

*NEWRECORD
RECTYPE = D
MH = Archaea
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Archaebacteria|T194|NON|EQV|NLM (1992)|910330|ARCHAEBACT|abcdefv
PRINT ENTRY = Archaeobacteria|T194|NON|EQV|NLM (1998)|960930|ARCHAEOBACT|abcdefv
ENTRY = Archaeon|T194|NON|EQV|NLM (1998)|970304|abcdef
ENTRY = Archebacteria|T194|NON|EQV|NLM (1992)|910418|ARCHEBACT|abcdefv
MN = B02
RH = B2 - ORGANISMS-ARCHAEA
MH_TH = NLM (1981)
ST = T194
AN = in taxonomy, one of the 3 domains of life along with BACTERIA & Eucarya
PI = Bacteria (1966-1980)
MS = One of the three domains of life (the others being BACTERIA and Eukarya), formerly called Archaebacteria under the taxon Bacteria, but now considered separate and distinct. They are characterized by: (1) the presence of characteristic tRNAs and ribosomal RNAs; (2) the absence of peptidoglycan cell walls; (3) the presence of ether-linked lipids built from branched-chain subunits; and (4) their occurrence in unusual habitats. While archaea resemble bacteria in morphology and genomic organization, they resemble eukarya in their method of genomic replication. The domain contains at least four kingdoms: CRENARCHAEOTA; EURYARCHAEOTA; NANOARCHAEOTA; and KORARCHAEOTA.
PM = 98; see ARCHAEOBACTERIA 1992-97, see ARCHAEBACTERIA 1991, see BACTERIA 1981-90; ARCHAEA was see ARCHAEOBACTERIA 1995-97
HN = 98(81); ARCHAEA was see ARCHAEOBACTERIA 1995-97
MR = 20090706
DA = 19800402
DC = 1
DX = 19910101
UI = D001105

*NEWRECORD
RECTYPE = D
MH = Archaeology
DE = ARCHAEOL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Archeology|T090|NON|EQV|UNK (19XX)|881119|ARCHEOL|abcdefv
MN = I01.076.201.208
FX = Paleography
MH_TH = NLM (1966)
ST = T090
AN = IM; SPEC; SPEC qualif; pre-Columbian: nothing later; DF: ARCHAEOL
MS = The scientific study of past societies through artifacts, fossils, etc.
MR = 19930604
DA = 19990101
DC = 1
UI = D001106

*NEWRECORD
RECTYPE = D
MH = Architectural Accessibility
DE = ARCHITECTURAL ACCESS
AQ = CL EC ES HI IS LJ MT SN ST
PRINT ENTRY = Barriers, Architectural|T073|NON|NRW|UNK (19XX)|770505|abcdef
PRINT ENTRY = Facility Access|T078|NON|NRW|UNK (19XX)|770505|abcdef
PRINT ENTRY = Ramps|T073|NON|NRW|UNK (19XX)|770505|abcdef
ENTRY = Accessibility, Architectural|T080|NON|EQV|NLM (1997)|950725|ACCESS ARCHITECTURAL|abcdefv
ENTRY = Physical Barriers|T080|NON|NRW|NLM (2016)|141014|abcdef
ENTRY = Access, Facility
ENTRY = Accesses, Facility
ENTRY = Architectural Barrier
ENTRY = Architectural Barriers
ENTRY = Barrier, Architectural
ENTRY = Barrier, Physical
ENTRY = Barriers, Physical
ENTRY = Facility Accesses
ENTRY = Physical Barrier
ENTRY = Ramp
MN = J01.086.339.070
MH_TH = NLM (1977)
ST = T080
AN = for approaching inside or outside areas; DF: note short X ref
PI = Architecture (1966-Jul 1977)
MS = Designs for approaching areas inside or outside facilities.
PM = 91; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90
HN = 91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90
MR = 20141015
DA = 19770505
DC = 1
DX = 19910101
UI = D001107

*NEWRECORD
RECTYPE = D
MH = Architecture as Topic
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Architecture|T090|T170|NON|EQV|NLM (1966)|990101|abbcdef
ENTRY = Architecture as Topics
ENTRY = Architectures
MN = J01.086
MH_TH = NLM (2008)
ST = T090
ST = T170
MS = The art and science of designing buildings and structures. More generally, it is the design of the total built environment, including town planning, urban design, and landscape architecture.
PM = 2008; see ARCHITECTURE 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D001108

*NEWRECORD
RECTYPE = D
MH = Archives
AQ = HI
ENTRY = Archive
MN = K01.400.152
MN = L01.346.208
MH_TH = NLM (1966)
ST = T073
AN = restricted use; note category; archives of clinical or other biological specimens = BIOLOGICAL SPECIMEN BANKS or specifics; for "medical archives" do not coordinate with MEDICINE; note PICTURE ARCHIVING, RADIOLOGIC see RADIOLOGY INFORMATION SYSTEMS is available
MR = 20130709
DA = 19990101
DC = 1
UI = D001109

*NEWRECORD
RECTYPE = D
MH = Arctic Regions
AQ = EH EP
MN = Z01.208
MH_TH = NLM (1966)
ST = T083
AN = note spelling: arctic: neither spelled nor pronounced "artic"
MS = The Arctic Ocean and the lands in it and adjacent to it. It includes Point Barrow, Alaska, most of the Franklin District in Canada, two thirds of Greenland, Svalbard, Franz Josef Land, Lapland, Novaya Zemlya, and Northern Siberia. (Webster's New Geographical Dictionary, 1988, p66)
MR = 20090730
DA = 19990101
DC = 4
UI = D001110

*NEWRECORD
RECTYPE = D
MH = Arcuate Nucleus of Hypothalamus
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Arcuate Nucleus|T023|NON|EQV|NLM (1983)|990101|abcdef
PRINT ENTRY = Infundibular Nucleus|T023|NON|EQV|UNK (19XX)|820423|abcdef
ENTRY = Hypothalamus Arcuate Nucleus
ENTRY = Nucleus, Arcuate
ENTRY = Nucleus, Infundibular
MN = A08.186.211.464.497.352.081
MN = A08.186.211.730.317.357.352.081
MH_TH = NLM (2015)
ST = T023
PI = Hypothalamus (1966-1982)
MS = A nucleus located in the middle hypothalamus in the most ventral part of the THIRD VENTRICLE near the entrance of the infundibular recess. Its small cells are in close contact with the EPENDYMA.
PM = 2015; see ARCUATE NUCLEUS 1983-2014
HN = 2015; use ARCUATE NUCLEUS 1983-2014
MR = 20140625
DA = 19820423
DC = 1
DX = 19830101
UI = D001111

*NEWRECORD
RECTYPE = D
MH = Arcus Senilis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Corneal Arcus|T020|NON|EQV|NLM (1990)|OMIM (2013)|890217|abcdeef
ENTRY = Arcus Corneae|T020|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Arcus, Corneal
MN = C11.204.299.070
MH_TH = NLM (1964)
MH_TH = OMIM (2013)
ST = T020
AN = cholesterol or hyalin deposits in cornea causing opacity; frequent in those over 50
MS = A corneal disease in which there is a deposition of phospholipid and cholesterol in the corneal stroma and anterior sclera.
PM = 91; was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89
HN = 91(64); was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19910101
UI = D001112

*NEWRECORD
RECTYPE = D
MH = Area Health Education Centers
DE = AREA HEALTH EDUC CENTERS
AQ = CL EC ES HI LJ MA OG SN ST TD
ENTRY = Area Health Education Center|T093|NON|EQV|UNK (19XX)|790323|AHEC|abcdefv
MN = I02.783.495.125
MH_TH = NLM (1975)
ST = T093
AN = specify geog if pertinent; DF: AHEC
MS = Education centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act.
PM = 91; was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90
HN = 91(75); was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90
MR = 20150622
DA = 19741111
DC = 1
DX = 19910101
UI = D001113

*NEWRECORD
RECTYPE = D
MH = Areca
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Betel Nut|T121|NON|REL|NLM (2003)|010824|abcdef
ENTRY = Areca catechu|T002|NON|NRW|NLM (2003)|010824|abcdef
ENTRY = Areca catechus
ENTRY = Arecas
ENTRY = Betel Nuts
ENTRY = Nut, Betel
ENTRY = Nuts, Betel
ENTRY = catechu, Areca
ENTRY = catechus, Areca
MN = B01.650.940.800.575.100.093.088
MH_TH = NLM (1986)
ST = T002
AN = Betel may go here or under PIPER BETLE; 'catechu' may go here or under ACACIA CATECHU see ACACIA; check text
MS = A plant genus of the family ARECACEAE. Members contain ARECOLINE and CATECHIN. The leaves and nuts have been used as masticatories, stimulants, and astringents in traditional medicine. The common name of betel is also used for PIPER BETLE. The common name of catechu is sometimes used for ACACIA CATECHU.
PM = 91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85
HN = 91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85
MR = 20150623
DA = 19990101
DC = 1
DX = 19910101
UI = D001114

*NEWRECORD
RECTYPE = D
MH = Arecoline
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Methylarecaidin|T109|T121|NON|EQV|UNK (19XX)|800523|abbcdef
ENTRY = Arecaline|T109|T121|NON|EQV|UNK (19XX)|800523|abbcdef
ENTRY = Arecholin|T109|T121|NON|EQV|NLM (1996)|950301|abbcdef
ENTRY = Arecholine|T109|T121|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = Arecolin|T109|T121|NON|EQV|UNK (19XX)|800523|abbcdef
MN = D03.066.515.292
MN = D03.132.080
MN = D03.383.725.547.292
PA = Cholinergic Agonists
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T121
N1 = 3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester
RN = 4ALN5933BH
RR = 63-75-2 (Arecoline)
PI = Nicotinic Acids (1969-1972)
PI = Parasympatholytics (1966-1968)
MS = An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.
OL = search NICOTINIC ACID 1969-71 & PARASYMPATHOMIMETICS 1966-68
PM = 73; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95
HN = 73(72); was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D001115

*NEWRECORD
RECTYPE = D
MH = Arenaviridae
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
MN = B04.820.057
MH_TH = NLM (1978)
ST = T005
AN = infection = ARENAVIRIDAE INFECTIONS
PI = RNA Viruses (1966-1977)
MS = A family of RNA viruses naturally infecting rodents and consisting of one genus (ARENAVIRUS) with two groups: Old World Arenaviruses (ARENAVIRUSES, OLD WORLD) and New World Arenaviruses (ARENAVIRUSES, NEW WORLD). Infection in rodents is persistent and silent. Vertical transmission is through milk-, saliva-, or urine-borne routes. Horizontal transmission to humans, monkeys, and other animals is important.
OL = use ARENAVIRIDAE to search ARENAVIRUSES 1978-80
PM = 81; was ARENAVIRUSES 1978-80
HN = 81; was ARENAVIRUSES 1978-80
MR = 20150622
DA = 19770504
DC = 1
DX = 19780101
UI = D001116

*NEWRECORD
RECTYPE = D
MH = Arenaviridae Infections
DE = ARENAVIRIDAE INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Arenavirus Infections|T047|NON|NRW|NLM (1994)|930511|ARENAVIRUS INFECT|abcdefv
ENTRY = Infections, Arenaviridae|T047|NON|EQV|NLM (1994)|930505|INFECT ARENAVIRIDAE|abcdefv
ENTRY = Infections, Arenavirus|T047|NON|NRW|NLM (1994)|930511|INFECT ARENAVIRUS|abcdefv
ENTRY = Arenaviridae Infection
ENTRY = Arenavirus Infection
ENTRY = Infection, Arenaviridae
ENTRY = Infection, Arenavirus
MN = C02.782.082
MH_TH = NLM (1981)
ST = T047
AN = GEN or unspecified; prefer specifics
PI = Arenaviridae (1978-1980)
PI = Virus Diseases (1966-1980)
MS = Virus diseases caused by the ARENAVIRIDAE.
OL = use ARENAVIRIDAE INFECTIONS to search ARENAVIRUS INFECTIONS 1981-93
PM = 94; was ARENAVIRUS INFECTIONS 1981-93
HN = 94; was ARENAVIRUS INFECTIONS 1981-93
CATSH = CAT LIST
MR = 19930604
DA = 19800513
DC = 1
DX = 19810101
UI = D001117

*NEWRECORD
RECTYPE = D
MH = Argentina
AQ = EH EP
MN = Z01.107.757.077
MH_TH = POPLINE (1978)
ST = T083
MR = 19911102
DA = 19990101
DC = 4
UI = D001118

*NEWRECORD
RECTYPE = D
MH = Arginase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Arginase A1|T116|T126|NON|NRW|UNK (19XX)|830914|abbcdef
ENTRY = Arginase A4|T116|T126|NON|NRW|UNK (19XX)|830914|abbcdef
ENTRY = Hepatic Proliferation Inhibitor|T116|T126|NON|EQV|NLM (1992)|901102|HEPATIC PROLIFERATION INHIB|abbcdefv
ENTRY = Liver Immunoregulatory Protein|T116|T126|NON|EQV|NLM (1992)|901102|abbcdef
ENTRY = Liver-Derived Inhibitory Protein|T116|T126|NON|EQV|NLM (1992)|901102|abbcdef
ENTRY = Liver-Derived Lymphocyte Proliferation Inhibiting Protein|T116|T126|NON|NRW|NLM (1992)|901102|LIVER DERIVED LYMPHOCYTE PROLIFERATION INHIB PROTEIN|abbcdefv
ENTRY = Immunoregulatory Protein, Liver
ENTRY = Inhibitor, Hepatic Proliferation
ENTRY = Inhibitory Protein, Liver-Derived
ENTRY = Liver Derived Inhibitory Protein
ENTRY = Liver Derived Lymphocyte Proliferation Inhibiting Protein
ENTRY = Proliferation Inhibitor, Hepatic
ENTRY = Protein, Liver Immunoregulatory
ENTRY = Protein, Liver-Derived Inhibitory
MN = D08.811.277.913.292
FX = Hyperargininemia
EC = deficiency:Hyperargininemia
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = L-Arginine amidinohydrolase
RN = EC 3.5.3.1
MS = A ureahydrolase that catalyzes the hydrolysis of arginine or canavanine to yield L-ornithine (ORNITHINE) and urea. Deficiency of this enzyme causes HYPERARGININEMIA. EC 3.5.3.1.
MR = 20090706
DA = 19990101
DC = 1
UI = D001119

*NEWRECORD
RECTYPE = D
MH = Arginine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Arginine Hydrochloride|T116|NON|NRW|NLM (2014)|USAN (19XX)|USP (19XX)|130403|abcdeeef
ENTRY = Arginine, L-Isomer|T116|T123|EQV|NLM (1999)|990913|abbdef
ENTRY = DL-Arginine Acetate, Monohydrate|T116|T123|NON|BRD|NLM (1992)|910114|abbcdef
ENTRY = L-Arginine|T116|T123|NON|EQV|FDA SRS (2014)|NLM (2000)|991103|abbcdeef
ENTRY = Arginine, L Isomer
ENTRY = DL Arginine Acetate, Monohydrate
ENTRY = Hydrochloride, Arginine
ENTRY = L Arginine
ENTRY = L-Isomer Arginine
ENTRY = Monohydrate DL-Arginine Acetate
MN = D12.125.068.050
MN = D12.125.095.104
MN = D12.125.142.087
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1966)
MH_TH = USP (19XX)
ST = T116
ST = T123
N1 = L-Arginine
RN = 94ZLA3W45F
RR = 7004-12-8
RR = 74-79-3 (Arginine)
RR = F7LTH1E20Y
AN = /biosyn /defic /physiol permitted
MS = An essential amino acid that is physiologically active in the L-form.
MR = 20130708
DA = 19990101
DC = 1
UI = D001120

*NEWRECORD
RECTYPE = D
MH = Lysine Carboxypeptidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carboxypeptidase N|T116|T126|NON|EQV|UNK (19XX)|810512|abbcdef
PRINT ENTRY = Kininase I|T116|T126|NON|EQV|UNK (19XX)|810512|abbcdef
ENTRY = Anaphylatoxin Inactivator|T116|T126|NON|EQV|UNK (19XX)|870812|abbcdef
ENTRY = Bradykininase|T116|T126|NON|EQV|UNK (19XX)|830217|abbcdef
ENTRY = Carboxypeptidase, Lysine
ENTRY = Inactivator, Anaphylatoxin
MN = D08.811.277.656.350.245.450
MN = D08.811.277.656.350.555.750
MN = D08.811.277.656.675.555.750
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 3.4.17.3
PI = Arginine (1972-1974)
PI = Carboxypeptidases (1972-1974)
PI = Peptides (1972-1974)
MS = A metallocarboxypeptidase that removes C-terminal basic amino acid from peptides and proteins, with preference shown for lysine over arginine. It is a plasma zinc enzyme that inactivates bradykinin and anaphylatoxins.
PM = 1997; see ARGININE CARBOXYPEPTIDASE 1991-1996, see CARBOXYPEPTIDASES 1975-1990; for KININASE I see CARBOXYPEPTIDASES 1975-1981
HN = 1997 (1975)
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001121

*NEWRECORD
RECTYPE = D
MH = Arginine Kinase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Kinase, Arginine
MN = D08.811.913.696.640.025
MH_TH = NLM (1979)
ST = T116
ST = T126
N1 = ATP:L-arginine N-phosphotransferase
RN = EC 2.7.3.3
RR = 9026-70-4 (CAS RN)
PI = Arginine (1966-1978)
PI = Phosphotransferases (1966-1973)
PI = Phosphotransferases, ATP (1974-1978)
MS = An enzyme that catalyzes the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. EC 2.7.3.3.
PM = 91; was see under PHOSPHOTRANSFERASES, ATP 1979-90
HN = 91(79); was see under PHOSPHOTRANSFERASES, ATP 1979-90
MR = 20030709
DA = 19771208
DC = 1
DX = 19910101
UI = D001122

*NEWRECORD
RECTYPE = D
MH = Argininosuccinate Lyase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Argininosuccinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Lyase, Argininosuccinate
MN = D08.811.520.232.300.400
FX = Argininosuccinic Aciduria
EC = deficiency:Argininosuccinic Aciduria
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = N-(L-Argininosuccinate) arginine-lyase
RN = EC 4.3.2.1
RR = 9027-34-3 (CAS RN)
PI = Arginine (1973-1974)
PI = Lyases (1973-1974)
PI = Succinates (1973-1974)
MS = An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease ARGININOSUCCINIC ACIDURIA in man. EC 4.3.2.1.
PM = 1991; see LYASES 1975-1990
HN = 1991(1975); use LYASES 1975-1990
MR = 20090706
DA = 19741119
DC = 1
DX = 19910101
UI = D001123

*NEWRECORD
RECTYPE = D
MH = Argininosuccinate Synthase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Argininosuccinate Synthetase|T116|T126|NON|EQV|NLM (1998)|961105|abbcdef
ENTRY = Synthase, Argininosuccinate
ENTRY = Synthetase, Argininosuccinate
MN = D08.811.464.259.300
FX = Citrullinemia
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = L-Citrulline:L-aspartate ligase (AMP-forming)
RN = EC 6.3.4.5
RR = 9023-58-9 (CAS RN)
AN = /defic: consider also CITRULLINEMIA
PI = Arginine (1973-1974)
PI = Ligases (1973-1974)
PI = Succinates (1973-1974)
MS = An enzyme of the urea cycle that catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. Absence or deficiency of this enzyme causes the metabolic disease CITRULLINEMIA in humans. EC 6.3.4.5.
PM = 98; see ARGININOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1975-90
HN = 98(75)
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001124

*NEWRECORD
RECTYPE = D
MH = Argininosuccinic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = N-(4-Amino-4-carboxybutyl)amidino-L-aspartic Acid|T116|T123|NON|EQV|NLM (1998)|970310|abbcdef
ENTRY = Acid, Argininosuccinic
MN = D02.241.081.337.759.124
MN = D12.125.068.050.075
MN = D12.125.095.104.075
MH_TH = NLM (1976)
ST = T116
ST = T123
N1 = L-Aspartic acid, N-(((4-amino-4-carboxybutyl)amino)iminomethyl)-, (S)-
RN = 2387-71-5
PI = Arginine (1971-1974) /analogs & derivatives (1975)
PI = Succinates (1971-1975)
MS = This amino acid is formed during the urea cycle from citrulline, aspartate and ATP. This reaction is catalyzed by argininosuccinic acid synthetase.
PM = 91; was see under ARGININE 1976-90
HN = 91(76); was see under ARGININE 1976-90
MR = 20120703
DA = 19750721
DC = 1
DX = 19910101
UI = D001125

*NEWRECORD
RECTYPE = D
MH = Arginine-tRNA Ligase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Arginyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef
ENTRY = Arg-tRNA Ligase|T116|T126|NON|EQV|NLM (2001)|000316|abbcdef
ENTRY = Arginyl-tRNA Synthetase|T116|T126|NON|EQV|NLM (2001)|000316|abbcdef
ENTRY = Arg tRNA Ligase
ENTRY = Arginine tRNA Ligase
ENTRY = Arginyl tRNA Synthetase
ENTRY = Ligase, Arg-tRNA
ENTRY = Ligase, Arginine-tRNA
ENTRY = Synthetase, Arginyl-tRNA
MN = D08.811.464.263.200.100
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = L-Arginine:tRNA(Arg)ligase (AMP-forming)
RN = EC 6.1.1.19
PI = Amino Acyl T RNA Synthetases (1973-1974)
PI = Arginine (1973-1974)
MS = An enzyme that activates arginine with its specific transfer RNA. EC 6.1.1.19.
PM = 98; see ARGINYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90
HN = 98(75)
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001126

*NEWRECORD
RECTYPE = D
MH = Arginine Vasopressin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Argipressin|T116|T121|T125|NON|EQV|BAN (19XX)|INN (19XX)|990101|abbbcdeef
PRINT ENTRY = Vasopressin, Arginine|T116|T121|T125|NON|EQV|UNK (19XX)|741111|abbbcdef
ENTRY = Arg-Vasopressin|T116|T121|T125|ABX|EQV|NLM (2007)|060124|abbbcdef
ENTRY = Argipressin Tannate|T116|T121|T125|NON|NRW|FDA SRS (2014)|USAN (1977)|940811|abbbcdeef
ENTRY = Arg Vasopressin
MN = D06.472.699.631.692.781.100
MN = D12.644.400.900.100
MN = D12.644.456.925.100
MN = D12.644.548.691.692.781.100
MN = D12.776.641.650.937.100
PA = Antidiuretic Agents
PA = Hemostatics
PA = Vasoconstrictor Agents
MH_TH = UNK (19XX)
ST = T116
ST = T121
ST = T125
N1 = Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2, cyclic 1-6 disulfide
RN = 113-79-1
RR = 4R069M4O1P
PI = Arginine (1966-1974)
PI = Vasopressins (1966-1974)
MS = The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
PM = 2007; see ARGIPRESSIN 1979-2006
HN = 2007 (1979)
MR = 20130708
DA = 19741111
DC = 1
DX = 19790101
UI = D001127

*NEWRECORD
RECTYPE = D
MH = Argon
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.613.050
MN = D01.362.641.113
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Argon
RN = 67XQY1V3KH
RR = 7440-37-1 (Argon)
AN = a rare gas; Ar-40; Ar-36, 38 = ARGON (IM) + ISOTOPES (NIM); Ar-35, 37, 39, 41, 42 = ARGON (IM) + RADIOISOTOPES (IM)
MS = Argon. A noble gas with the atomic symbol Ar, atomic number 18, and atomic weight 39.948. It is used in fluorescent tubes and wherever an inert atmosphere is desired and nitrogen cannot be used.
MR = 20130708
DA = 19990101
DC = 1
UI = D001128

*NEWRECORD
RECTYPE = D
MH = Argyria
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Argyrias
MN = C17.800.621.166
MN = C25.723.068
MH_TH = NLM (1966)
ST = T037
AN = caused by prolonged use of silver salts
MS = A permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001129

*NEWRECORD
RECTYPE = D
MH = Arizona
AQ = EH EP
MN = Z01.107.567.875.760.100
MH_TH = POPLINE (1978)
ST = T083
MR = 19970620
DA = 19990101
DC = 4
UI = D001130

*NEWRECORD
RECTYPE = D
MH = Arkansas
AQ = EH EP
MN = Z01.107.567.875.750.110
MH_TH = POPLINE (1978)
ST = T083
MR = 19970620
DA = 19990101
DC = 4
UI = D001131

*NEWRECORD
RECTYPE = D
MH = Arm
AQ = AB AH BS EM GD IR MI PA PH PP PS RA RE RI SU TR US VI
ENTRY = Arms
MN = A01.378.800.075
FX = Forelimb
EC = injuries:Arm Injuries
MH_TH = NLM (1966)
ST = T029
AN = primates only; for whole arm or upper arm; FOREARM is also available; Manual 21.58: extremities of humans & animals; NIM when merely locational as in skin dis (IM)
MS = The superior part of the upper extremity between the SHOULDER and the ELBOW.
MR = 20020702
DA = 19990101
DC = 1
UI = D001132

*NEWRECORD
RECTYPE = D
MH = Bones of Upper Extremity
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
ENTRY = Upper Extremity Bone
ENTRY = Upper Extremity Bones
MN = A02.835.232.087
MH_TH = NLM (1974)
ST = T023
AN = avoid: too general; prefer specifics; permitted with all vertebrates; Manual 21.58
PI = Arm (1966-1997)
PI = Forearm (1969-1997)
PI = specific bones of arm (1966-1997)
MS = The bones of the upper and lower ARM. They include the CLAVICLE and SCAPULA.
PM = 98
HN = 98; use explode 1975-97
MR = 20080708
DA = 19990101
DC = 1
DX = 19980101
UI = D001133

*NEWRECORD
RECTYPE = D
MH = Arm Injuries
DE = ARM INJ
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Injuries, Arm|T037|NON|EQV|UNK (19XX)|860101|INJ ARM|abcdefv
ENTRY = Arm Injury
ENTRY = Injury, Arm
MN = C26.088
MH_TH = NLM (1966)
ST = T037
AN = GEN or unspecified; consider also /inj with specific bones of arm; also available are FOREARM INJURIES; HAND INJURIES; FINGER INJURIES; WRIST INJURIES & many specific organ/fract precoords
MS = General or unspecified injuries involving the arm.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001134

*NEWRECORD
RECTYPE = D
MH = Armadillos
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Armadillo
MN = B01.050.150.900.649.900.200
MH_TH = NLM (1975)
ST = T015
AN = IM; qualif permitted
MS = Burrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas.
PM = 91; was see under EDENTATA 1975-90
HN = 91(75); was see under EDENTATA 1975-90
MR = 20090706
DA = 19741119
DC = 1
DX = 19910101
UI = D001135

*NEWRECORD
RECTYPE = D
MH = Armenia
AQ = EH EP
PRINT ENTRY = Armenian S.S.R.|T083|NAM|EQV|NLM (1993)|991012|abcdef
ENTRY = Armenian SSR|T083|NAM|EQV|NLM (1993)|920422|abcdef
MN = Z01.542.900.099
MN = Z01.586.035.150
MN = Z01.586.200.099
MN = Z01.586.950.099
MH_TH = POPLINE (1993)
ST = T083
AN = includes present and historical contexts
MS = An ancient country in western Asia, by the twentieth century divided among the former USSR, Turkey, and Iran. It was attacked at various times from before the 7th century B.C. to 69 B.C. by Assyrians, Medes, Persians, the Greeks under Alexander, and the Romans. It changed hands frequently in wars between Neo-Persian and Roman Empires from the 3d to 7th centuries and later under Arabs, Seljuks, Byzantines, and Mongols. In the 19th century Armenian nationalism arose but suffered during Russo-Turkish hostilities. It became part of the Soviet Republic in 1921, with part remaining under Turkey. (Webster's New Geographical Dictionary, 1988)
OL = use ARMENIA to search ARMENIAN S.S.R 1982-92 & ARMENIAN SSR 1975-81
HN = ARMENIAN S.S.R. was heading 1982-92; was ARMENIAN SSR 1975-81
MR = 19940419
DA = 19990101
DC = 4
UI = D001136

*NEWRECORD
RECTYPE = D
MH = Armin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Armine|T115|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|780517|abbcdeef
ENTRY = Ethyl-p-Nitrophenyl Ethylphosphonate|T115|T121|NON|EQV|NLM (2001)|000508|abbcdef
MN = D02.705.429.374
PA = Cholinesterase Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = NLM (1979)
ST = T115
ST = T121
RN = H39MRI1X2O
RR = 546-71-4 (Armin)
RR = 8053-54-1 (other CAS number)
PI = Cholinesterase Inhibitors (1966-1978)
PI = Nitrobenzenes (1966-1978)
PI = Organophosphorus Compounds (1971-1978)
MS = A reversible organophosphorus cholinesterase inhibitor. It also affects the presynaptic membrane and inhibits membrane postsynaptic cholinergic receptors. The compound had former use as a miotic.
PM = 91; was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90
HN = 91(79); was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90
MR = 20130708
DA = 19780517
DC = 1
DX = 19910101
UI = D001138

*NEWRECORD
RECTYPE = D
MH = Arnold-Chiari Malformation
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Arnold-Chiari Deformity|T019|EPO|EQV|NLM (1966)|990101|abcdef
ENTRY = Arnold-Chiari Malformation, Type 1|T019|EPO|NRW|NLM (2010)|ORD (2010)|090518|abcdeef
ENTRY = Arnold-Chiari Malformation, Type 2|T019|EPO|NRW|NLM (2010)|ORD (2010)|090518|abcdeef
ENTRY = Arnold-Chiari Malformation, Type 3|T019|EPO|NRW|NLM (2010)|ORD (2010)|090518|abcdeef
ENTRY = Arnold-Chiari Malformation, Type 4|T019|EPO|NRW|NLM (2010)|ORD (2010)|090518|abcdeef
ENTRY = Arnold-Chiari Malformation, Type I|T019|EPO|NRW|NLM (2000)|991104|abcdef
ENTRY = Arnold-Chiari Malformation, Type II|T019|EPO|NRW|NLM (2000)|991104|abcdef
ENTRY = Arnold-Chiari Malformation, Type III|T019|EPO|NRW|NLM (2000)|991104|abcdef
ENTRY = Arnold-Chiari Malformation, Type IV|T019|EPO|NRW|NLM (2000)|991104|abcdef
ENTRY = Arnold-Chiari Syndrome|T019|EPO|EQV|NLM (1991)|891228|abcdef
ENTRY = Chiari Malformation Type 2|T019|NON|NRW|ORD (2010)|131126|abcdef
ENTRY = Chiari Malformation Type I|T019|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Chiari Malformation Type II|T019|NON|NRW|OMIM (2013)|120808|abcdef
ENTRY = Malformation, Arnold-Chiari|T019|EPO|EQV|NLM (2000)|991104|abcdef
ENTRY = Type I Arnold-Chiari Malformation|T019|EPO|NRW|NLM (2000)|991104|abcdef
ENTRY = Type II Arnold-Chiari Malformation|T019|EPO|NRW|NLM (2000)|991104|abcdef
ENTRY = Type III Arnold-Chiari Malformation|T019|EPO|NRW|NLM (2000)|991104|abcdef
ENTRY = Type IV Arnold-Chiari Malformation|T019|EPO|NRW|NLM (2000)|991104|abcdef
ENTRY = Arnold Chiari Deformity
ENTRY = Arnold Chiari Malformation
ENTRY = Arnold Chiari Malformation, Type 1
ENTRY = Arnold Chiari Malformation, Type 2
ENTRY = Arnold Chiari Malformation, Type 3
ENTRY = Arnold Chiari Malformation, Type 4
ENTRY = Arnold Chiari Malformation, Type I
ENTRY = Arnold Chiari Malformation, Type II
ENTRY = Arnold Chiari Malformation, Type III
ENTRY = Arnold Chiari Malformation, Type IV
ENTRY = Arnold Chiari Syndrome
ENTRY = Deformity, Arnold-Chiari
ENTRY = Malformation, Arnold Chiari
ENTRY = Syndrome, Arnold-Chiari
ENTRY = Type I Arnold Chiari Malformation
ENTRY = Type II Arnold Chiari Malformation
ENTRY = Type III Arnold Chiari Malformation
ENTRY = Type IV Arnold Chiari Malformation
MN = C10.500.680.291
MN = C16.131.666.680.291
MH_TH = NLM (2000)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T019
AN = do not confuse with CHIARI'S SYNDROME see BUDD-CHIARI SYNDROME
MS = A group of congenital malformations involving the brainstem, cerebellum, upper spinal cord, and surrounding bony structures. Type II is the most common, and features compression of the medulla and cerebellar tonsils into the upper cervical spinal canal and an associated MENINGOMYELOCELE. Type I features similar, but less severe malformations and is without an associated meningomyelocele. Type III has the features of type II with an additional herniation of the entire cerebellum through the bony defect involving the foramen magnum, forming an ENCEPHALOCELE. Type IV is a form a cerebellar hypoplasia. Clinical manifestations of types I-III include TORTICOLLIS; opisthotonus; HEADACHE; VERTIGO; VOCAL CORD PARALYSIS; APNEA; NYSTAGMUS, CONGENITAL; swallowing difficulties; and ATAXIA. (From Menkes, Textbook of Child Neurology, 5th ed, p261; Davis, Textbook of Neuropathology, 2nd ed, pp236-46)
PM = 2000; see ARNOLD-CHIARI DEFORMITY 1963-1999; for ARNOLD-CHIARI MALFORMATION see ARNOLD-CHIARI DEFORMITY 1963-1999
HN = 2000(1963)
CATSH = CAT LIST
MR = 20140613
DA = 19990101
DC = 1
UI = D001139

*NEWRECORD
RECTYPE = D
MH = Aroclors
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aroclor|T109|T131|TRD|NRW|UNK (19XX)|760905|abbcdef
MN = D02.455.526.439.773.292
MN = D02.455.526.439.785.292
PA = Environmental Pollutants
MH_TH = NLM (1975)
ST = T109
ST = T131
RN = 0
AN = indust chem, a widespread environ pollutant; TN 111: eff on insects; CHLORODIPHENYL (54% CHLORINE); is also available
MS = Industrial chemicals which have become widespread environmental pollutants. Each aroclor is a mixture of chlorinated biphenyls (1200 series) or chlorinated terphenyls (5400 series) or a combination of both (4400 series).
OL = search POLYCHLOROBIPHENYL COMPOUNDS 1973-74
PM = 91; was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90
HN = 91(75); was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90
MR = 20090730
DA = 19990101
DC = 1
DX = 19910101
UI = D001140

*NEWRECORD
RECTYPE = D
MH = Aromatase
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = CYP19|T116|T126|ABB|EQV|NLM (1997)|960221|CYP 019|abbcdefs
PRINT ENTRY = Cytochrome P-450 CYP19|T116|T126|EQV|NLM (1997)|960221|CYTOCHROME P 450 CYP 019|abbdefs
PRINT ENTRY = Cytochrome P-450(AROM)|T116|T126|EQV|UNK (19XX)|870507|CYTOCHROME P 450 AROM|abbdefs
ENTRY = Androstenedione Aromatase|T116|T126|NON|EQV|UNK (19XX)|861007|abbcdef
ENTRY = CYP 19|T116|T126|ABB|EQV|NLM (1997)|960221|abbcdef
ENTRY = CYP19 Protein|T116|T126|NON|EQV|NLM (2003)|020313|abbcdef
ENTRY = Cytochrome P450 19|T116|T126|NON|EQV|NLM (1997)|960223|abbcdef
ENTRY = Estrogen Synthase|T116|T126|NON|EQV|NLM (1997)|960208|abbcdef
ENTRY = Estrogen Synthetase|T116|T126|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = P450AROM|T116|T126|ABB|EQV|NLM (1997)|960424|abbcdef
ENTRY = Aromatase, Androstenedione
ENTRY = Cytochrome P 450 CYP19
ENTRY = Protein, CYP19
MN = D08.244.453.915.099
MN = D08.811.682.690.708.170.915.099
MN = D12.776.422.220.453.915.099
EC = antagonists & inhibitors:Aromatase Inhibitors
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 1.14.14.1
PI = Androstanes (1972-1974)
PI = Estrogens (1972-1974)
PI = Oxidoreductases (1972-1974)
MS = An enzyme that catalyzes the desaturation (aromatization) of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system.
PM = 86; was see under OXIDOREDUCTASES 1975-85
HN = 86(75); was see under OXIDOREDUCTASES 1975-85
MR = 20150622
DA = 19741119
DC = 1
DX = 19860101
UI = D001141

*NEWRECORD
RECTYPE = D
MH = Aromatic-L-Amino-Acid Decarboxylases
DE = AAAD
DS = AROMATIC AMINO ACID DECARBOXYLASES L
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Amino Acid Decarboxylases, Aromatic|T116|T126|NON|EQV|UNK (19XX)|790221|abbcdef
PRINT ENTRY = Aromatic Amino Acid Decarboxylases|T116|T126|NON|EQV|NLM (1998)|961115|abbcdef
ENTRY = 5-HTPase|T116|T126|EQV|UNK (19XX)|840920|abbdef
ENTRY = 5-Hydroxytryptophan Decarboxylase|T116|T126|NON|EQV|UNK (19XX)|800815|abbcdef
ENTRY = Aromatic-L-Amino-Acid Decarboxylase|T116|T126|NON|EQV|NLM (2008)|070327|abbcdef
ENTRY = Hydroxytryptophan Decarboxylase|T116|T126|NON|EQV|UNK (19XX)|800815|abbcdef
ENTRY = Tryptophan Decarboxylase|T116|T126|NON|EQV|UNK (19XX)|870810|abbcdef
ENTRY = 5 HTPase
ENTRY = 5 Hydroxytryptophan Decarboxylase
ENTRY = Aromatic L Amino Acid Decarboxylase
ENTRY = Aromatic L Amino Acid Decarboxylases
ENTRY = Decarboxylase, 5-Hydroxytryptophan
ENTRY = Decarboxylase, Aromatic-L-Amino-Acid
ENTRY = Decarboxylase, Hydroxytryptophan
ENTRY = Decarboxylase, Tryptophan
ENTRY = Decarboxylases, Aromatic-L-Amino-Acid
MN = D08.811.520.224.125.100
EC = antagonists & inhibitors:Aromatic Amino Acid Decarboxylase Inhibitors
MH_TH = NLM (1980)
ST = T116
ST = T126
N1 = Aromatic-L-amino-acid carboxy-lyase
RN = EC 4.1.1.28
RR = 9042-64-2 (CAS RN)
PI = Dopa Decarboxylase (1966-1979)
MS = An enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dihydroxyphenylalanine (DOPA DECARBOXYLASE); TRYPTOPHAN; and HYDROXYTRYPTOPHAN.
PM = 98; see AROMATIC AMINO ACID DECARBOXYLASES 1980-97
HN = 98(80)
MR = 20140610
DA = 19790221
DC = 1
DX = 19800101
UI = D001142

*NEWRECORD
RECTYPE = D
MH = Arousal
AQ = CL DE ES GE PH RE
PRINT ENTRY = Vigilance, Cortical|T041|NON|NRW|UNK (19XX)|780426|abcdef
ENTRY = Arousals
ENTRY = Cortical Vigilance
MN = F02.830.104
MN = G11.561.600.042
MH_TH = NLM (1964)
ST = T041
AN = human & animal
MS = Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system.
PM = 66
HN = 66(64)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19660101
UI = D001143

*NEWRECORD
RECTYPE = D
MH = Arrhythmias, Cardiac
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Arrhythmia|T033|T046|NON|EQV|NLM (1966)|990101|abbcdef
ENTRY = Arrythmia|T033|T046|NON|EQV|NLM (1991)|900119|abbcdef
ENTRY = Cardiac Arrhythmia|T033|T046|NON|EQV|NLM (2008)|OMIM (2013)|060919|abbcdeef
ENTRY = Cardiac Arrhythmias|T033|T046|NON|EQV|NLM (2008)|060919|abbcdef
ENTRY = Cardiac Dysrhythmia|T033|T046|NON|EQV|NLM (2008)|070112|abbcdef
ENTRY = Arrhythmia, Cardiac
ENTRY = Dysrhythmia, Cardiac
MN = C14.280.067
MN = C23.550.073
FX = Anti-Arrhythmia Agents
FX = Electric Countershock
MH_TH = NLM (2008)
ST = T033
ST = T046
AN = general: prefer specifics
MS = Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
PM = 2008; see ARRHYTHMIA 1963-2007
HN = 2008 (1963)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D001145

*NEWRECORD
RECTYPE = D
MH = Arrhythmia, Sinus
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Sinus Arrhythmia|T033|T046|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Arrhythmia, Sinoatrial|T033|T046|NON|EQV|NLM (2008)|060919|abbcdef
ENTRY = Sinoatrial Arrhythmia|T033|T046|NON|EQV|NLM (2008)|060919|abbcdef
ENTRY = Arrhythmias, Sinoatrial
ENTRY = Arrhythmias, Sinus
ENTRY = Sinoatrial Arrhythmias
ENTRY = Sinus Arrhythmias
MN = C14.280.067.093
MN = C23.550.073.093
MH_TH = NLM (1966)
ST = T033
ST = T046
AN = sinus parasystole: coordinate IM with PARASYSTOLE (IM)
MS = Irregular HEART RATE caused by abnormal function of the SINOATRIAL NODE. It is characterized by a greater than 10% change between the maximum and the minimum sinus cycle length or 120 milliseconds.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D001146

*NEWRECORD
RECTYPE = D
MH = Arsanilic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 4-Aminobenzenearsonic Acid|T109|T121|NON|EQV|UNK (19XX)|800917|abbcdef
ENTRY = Atoxyl|T109|T121|TRD|NRW|UNK (19XX)|780517|abbcdef
ENTRY = Sodium Arsanilate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|800917|abbcdeef
ENTRY = Sodium Arsenilate|T109|T121|NON|NRW|UNK (19XX)|800917|abbcdef
ENTRY = p-Aminophenylarsonic Acid|T109|T121|NON|EQV|UNK (19XX)|800917|abbcdef
ENTRY = 4 Aminobenzenearsonic Acid
ENTRY = Acid, 4-Aminobenzenearsonic
ENTRY = Acid, Arsanilic
ENTRY = Acid, p-Aminophenylarsonic
ENTRY = Arsanilate, Sodium
ENTRY = Arsenilate, Sodium
ENTRY = p Aminophenylarsonic Acid
MN = D02.691.088.030
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1979)
MH_TH = USP (19XX)
ST = T109
ST = T121
RN = UDX9AKS7GM
RR = UC2409302Q
PI = Arsenicals (1966-1978)
MS = An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals.
PM = 91; was see under ARSENICALS 1979-90
HN = 91(79); was see under ARSENICALS 1979-90
MR = 20130708
DA = 19780517
DC = 1
DX = 19910101
UI = D001147

*NEWRECORD
RECTYPE = D
MH = Arsenamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Thiacetarsamide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
PRINT ENTRY = Thioarsenite|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|771005|abbcdeef
ENTRY = Caparsolate|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
MN = D02.691.088.040
PA = Filaricides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Acetic acid, 2,2'-(((4-(aminocarbonyl)phenyl)arsinidene)bis(thio))bis-
RN = VMF4ELY9TZ
RR = 531-72-6 (Arsenamide)
PI = Arsenicals (1969-1974)
PI = Benzamides (1973-1974)
PI = Sulfides (1973-1974)
MS = Proposed chemotherapeutic agent against filaria and trichomonas.
PM = 91; was see under ARSENICALS 1975-90
HN = 91(75); was see under ARSENICALS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001148

*NEWRECORD
RECTYPE = D
MH = Arsenates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.075.025
MN = D01.248.497.158.050
MN = D02.691.088.042
MH_TH = NLM (1975)
ST = T104
RN = 0
AN = do not confuse with ARSENITES
MS = Inorganic or organic salts and esters of arsenic acid.
OL = search ARSENATES 1968-74
PM = 91; was see under ARSENIC 1975-90
HN = 91(75); was see under ARSENIC 1975-90
MR = 20110624
DA = 19990101
DC = 1
DX = 19910101
UI = D001149

*NEWRECORD
RECTYPE = D
MH = Arsenazo III
DS = ARSENAZO 03
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = III, Arsenazo
MN = D02.172.040
MN = D02.691.088.044
PA = Coloring Agents
PA = Indicators and Reagents
MH_TH = NLM (1980)
ST = T109
ST = T130
N1 = 2,7-Naphthalenedisulfonic acid, 3,6-bis((2-arsonophenyl)azo)-4,5-dihydroxy-
RN = 1668-00-4
AN = D25-26 qualif
PI = Arsenicals (1966-1979)
PI = Azo Compounds (1966-1979)
PI = Dyes (1966-1979)
PI = Indicators and Reagents (1966-1979)
MS = Metallochrome indicator that changes color when complexed to the calcium ion under physiological conditions. It is used to measure local calcium ion concentrations in vivo.
PM = 91; was see under AZO COMPOUNDS 1980-90
HN = 91(80); was see under AZO COMPOUNDS 1980-90
MR = 20110624
DA = 19790530
DC = 1
DX = 19910101
UI = D001150

*NEWRECORD
RECTYPE = D
MH = Arsenic
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR
MN = D01.268.513.249
EC = poisoning:Arsenic Poisoning
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T131
ST = T196
N1 = Arsenic
RN = N712M78A8G
RR = 7440-38-2 (Arsenic)
AN = As-75; As-69-81, except As-75 = ARSENIC (IM) + RADIOISOTOPES (IM)
MS = A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed)
MR = 20150622
DA = 19990101
DC = 1
UI = D001151

*NEWRECORD
RECTYPE = D
MH = Arsenicals
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK RE SD ST TU UR
PRINT ENTRY = Arsenic Compounds|T104|NON|EQV|NLM (1996)|940825|ARSENIC CPDS|abcdefv
ENTRY = Compounds, Arsenic
MN = D01.075
MN = D02.691.088
PA = Sulfhydryl Reagents
EC = poisoning:Arsenic Poisoning
EC = toxicity:Arsenic Poisoning
MH_TH = NLM (1966)
ST = T104
RN = 0
AN = inorganic or organic arsenic cpds
MS = Inorganic or organic compounds that contain arsenic.
PM = ARSENIC COMPOUNDS was heading 1994-95
HN = ARSENIC COMPOUNDS was heading 1994-95
MR = 20110624
DA = 19990101
DC = 1
UI = D001152

*NEWRECORD
RECTYPE = D
MH = Arsphenamine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Arsenobenzol|T109|T121|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = Salvarsan|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Sodium Arsenobenzol|T109|T121|NON|NRW|UNK (19XX)|811023|abbcdef
ENTRY = Arsenobenzol, Sodium
MN = D02.691.088.050
PA = Antitreponemal Agents
MH_TH = NLM (1968)
ST = T109
ST = T121
N1 = Phenol, 4,4'-(1,2-diarsenediyl)bis(2-amino)-, dihydrochloride
RN = 139-93-5
OL = use ARSPHENAMINE to search ARSPHENAMINES 1966-67
PM = 68; was ARSPHENAMINES 1963-67
HN = 68; was ARSPHENAMINES 1963-67
MR = 20110624
DA = 19990101
DC = 1
DX = 19680101
UI = D001153

*NEWRECORD
RECTYPE = D
MH = Art
AQ = HI
ENTRY = Arts
MN = K01.093
FX = Anatomy, Artistic
FX = Medical Illustration
FX = Medicine in Art
MH_TH = NLM (1966)
ST = T090
AN = works of art, the field of fine arts, artistic production; art as therapy = ART THERAPY
MR = 19960610
DA = 19990101
DC = 1
UI = D001154

*NEWRECORD
RECTYPE = D
MH = Art Therapy
DE = ART THER
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Therapy, Art|T061|NON|EQV|UNK (19XX)|860101|THER ART|abcdefv
ENTRY = Art Therapies
ENTRY = Therapies, Art
MN = E02.190.888.124
MN = E02.831.100
MN = F04.754.070
MH_TH = NLM (1974)
ST = T061
AN = a psychother technique; DF: ART THER
MS = The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.
PM = 74
HN = 74
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
DX = 19740101
UI = D001155

*NEWRECORD
RECTYPE = D
MH = Artemia
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Brine Shrimp|T204|NON|EQV|UNK (19XX)|780320|abcdef
PRINT ENTRY = Shrimp, Brine|T204|NON|EQV|NLM (2003)|011017|abcdef
ENTRY = Artemias
ENTRY = Brine Shrimps
ENTRY = Shrimps, Brine
MN = B01.050.500.131.365.060.050
MH_TH = NLM (1979)
ST = T204
AN = note X ref BRINE SHRIMP: several other shrimp terms are available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE
PI = Crustacea (1966-1978)
PI = Shrimp (1972-1978)
MS = A genus of CRUSTACEA of the order ANOSTRACA, found in briny pools and lakes and often cultured for fish food. It has 168 chromosomes and differs from most crustaceans in that its blood contains hemoglobin.
PM = 79
HN = 79
MR = 20090706
DA = 19780320
DC = 1
DX = 19790101
UI = D001156

*NEWRECORD
RECTYPE = D
MH = Arterial Occlusive Diseases
DE = ARTERIAL OCCLUSIVE DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Arterial Obstructive Diseases|T047|NON|EQV|UNK (19XX)|830503|ARTERIAL OBSTRUCTIVE DIS|abcdefv
ENTRY = Arterial Obstructive Disease
ENTRY = Arterial Occlusive Disease
ENTRY = Disease, Arterial Obstructive
ENTRY = Disease, Arterial Occlusive
ENTRY = Diseases, Arterial Obstructive
ENTRY = Diseases, Arterial Occlusive
ENTRY = Obstructive Disease, Arterial
ENTRY = Obstructive Diseases, Arterial
ENTRY = Occlusive Disease, Arterial
ENTRY = Occlusive Diseases, Arterial
MN = C14.907.137
MH_TH = NLM (1973)
ST = T047
AN = general; prefer specifics; coordinate IM with specific artery (IM) if pertinent
PI = Vascular Diseases (1966-1972)
MS = Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
PM = 73
HN = 73
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19730101
UI = D001157

*NEWRECORD
RECTYPE = D
MH = Arteries
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RE RI SE SU TR UL US VI
ENTRY = Artery
MN = A07.231.114
FX = Angiography
FX = Endarterectomy
EC = radiography:Angiography
MH_TH = NLM (1966)
ST = T023
AN = general or unspecified or as a coordinate to indicate a specific artery (e.g. pancreatic artery = PANCREAS / blood supply + ARTERIES); / surg: consider also ENDARTERECTOMY; inflammation = ARTERITIS; arterial blood = BLOOD + ARTERIES or specific artery
MS = The vessels carrying blood away from the heart.
MR = 20150605
DA = 19990101
DC = 1
UI = D001158

*NEWRECORD
RECTYPE = D
MH = Arterio-Arterial Fistula
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Arterio Arterial Fistula
ENTRY = Arterio-Arterial Fistulas
ENTRY = Fistula, Arterio-Arterial
ENTRY = Fistulas, Arterio-Arterial
MN = C14.240.850.984.500
MN = C14.907.933.110
MN = C16.131.240.850.500
MN = C23.300.575.950.150
MH_TH = NLM (1987)
ST = T190
AN = coordinate IM with specific arteries (IM) or precoordinate artery/disease term (IM); if congenital use /abnorm on the arteries and /congen on the artery/disease term and fistula
PI = specific arteries (1966-1986)
MS = Abnormal communication between two ARTERIES that may result from injury or occur as a congenital abnormality.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20130708
DA = 19860418
DC = 1
DX = 19870101
UI = D001159

*NEWRECORD
RECTYPE = D
MH = Arterioles
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteriole
MN = A07.231.114.060
MN = A07.231.461.080
MH_TH = NLM (1978)
ST = T023
AN = IM GEN only; NIM as coord with specific organ /blood supply (IM)
PI = Arteries (1966-1977)
PI = specific artery
MS = The smallest divisions of the arteries located between the muscular arteries and the capillaries.
PM = 91; was see under ARTERIES 1978-90
HN = 91(78); was see under ARTERIES 1978-90
MR = 20080708
DA = 19770301
DC = 1
DX = 19910101
UI = D001160

*NEWRECORD
RECTYPE = D
MH = Arteriosclerosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Arterioscleroses
MN = C14.907.137.126
FX = Atherectomy
FX = Diet, Atherogenic
FX = Embolism, Cholesterol
MH_TH = NLM (1963)
ST = T046
AN = general; prefer specifics; do not confuse with ARTERIOLOSCLEROSIS
MS = Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
PM = 1964
HN = 1964
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D001161

*NEWRECORD
RECTYPE = D
MH = Arteriosclerosis Obliterans
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Obliterans, Arteriosclerosis
MN = C14.907.137.126.114
MH_TH = NLM (1966)
ST = T047
MS = Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D001162

*NEWRECORD
RECTYPE = D
MH = Arteriovenous Anastomosis
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Arteriovenous Anastomoses|T023|NON|EQV|NLM (2004)|030414|abcdef
ENTRY = Anastomose, Arteriovenous
ENTRY = Anastomoses, Arteriovenous
ENTRY = Anastomosis, Arteriovenous
ENTRY = Arteriovenous Anastomose
MN = A07.231.461.085
MH_TH = NLM (1964)
ST = T023
AN = note category: do not confuse with ARTERIOVENOUS FISTULA; Manual 23.19.6.2
MS = A vessel that directly interconnects an artery and a vein, and that acts as a shunt to bypass the capillary bed. Not to be confused with surgical anastomosis, nor with arteriovenous fistula.
PM = 66
HN = 66(64)
MR = 20130709
DA = 19990101
DC = 1
DX = 19660101
UI = D001163

*NEWRECORD
RECTYPE = D
MH = Arteriovenous Fistula
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aneurysm, Arteriovenous|T190|NON|NRW|UNK (19XX)|770428|abcdef
PRINT ENTRY = Arteriovenous Aneurysm|T190|NON|NRW|NLM (1991)|900309|abcdef
ENTRY = Arteriovenous Fistulas|T046|T190|NON|EQV|NLM (2008)|060831|abbcdef
ENTRY = Fistula, Arteriovenous
ENTRY = Fistulas, Arteriovenous
MN = C14.240.850.750.147
MN = C14.240.850.984.750
MN = C14.907.150.125
MN = C14.907.933.555
MN = C16.131.240.850.750.125
MN = C23.300.575.950.250
FX = Arteriovenous Malformations
MH_TH = NLM (1967)
ST = T046
ST = T190
AN = do not confuse with ARTERIOVENOUS ANASTOMOSIS, an anatomical term; coordinate IM with specific artery /abnorm + specific vein /abnorm (IM) or precoordinate vessel/disease headings (IM); Manual 23.19.6+; congenital cerebral arteriovenous fistula = INTRACRANIAL ARTERIOVENOUS MALFORMATIONS (IM) + ARTERIOVENOUS FISTULA (IM); surgically created arteriovenous fistula = ARTERIOVENOUS SHUNT, SURGICAL
MS = An abnormal direct communication between an artery and a vein without passing through the CAPILLARIES. An A-V fistula usually leads to the formation of a dilated sac-like connection, arteriovenous aneurysm. The locations and size of the shunts determine the degree of effects on the cardiovascular functions such as BLOOD PRESSURE and HEART RATE.
OL = use ARTERIOVENOUS FISTULA to search FISTULA, ARTERIOVENOUS 1966
PM = 67; was FISTULA, ARTERIOVENOUS 1963-66
HN = 67; was FISTULA, ARTERIOVENOUS 1963-66
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
DX = 19670101
UI = D001164

*NEWRECORD
RECTYPE = D
MH = Arteriovenous Malformations
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Arteriovenous Malformation
ENTRY = Malformation, Arteriovenous
ENTRY = Malformations, Arteriovenous
MN = C14.240.850.750
MN = C14.907.150
MN = C16.131.240.850.750
FX = Angiomatosis
FX = Arteriovenous Fistula
FX = Hemangioma
MH_TH = NLM (1969)
ST = T019
AN = general or unspecified; coordinate IM with specific artery /abnorm (IM) + specific vein /abnorm (IM) or use specific available precoordinated arterial or venous abnormalities (IM)
PI = Arteriovenous Fistula/congenital (1966-1968)
MS = Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.
PM = 73
HN = 73(69)
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19730101
UI = D001165

*NEWRECORD
RECTYPE = D
MH = Arteriovenous Shunt, Surgical
DE = ARTERIOVENOUS SHUNT SURG
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Shunt, Surgical Arteriovenous|T061|NON|EQV|UNK (19XX)|860101|SHUNT SURG ARTERIOVENOUS|abcdefv
ENTRY = Surgical Arteriovenous Shunt|T061|NON|EQV|UNK (19XX)|860101|SURG ARTERIOVENOUS SHUNT|abcdefv
ENTRY = Arteriovenous Shunts, Surgical
ENTRY = Shunts, Surgical Arteriovenous
ENTRY = Surgical Arteriovenous Shunts
MN = E04.035.087
MN = E04.100.814.868.249
MH_TH = NLM (1970)
ST = T061
AN = do not use /util except by MeSH definition; Manual 23.19.6.2
PI = Arteries/surgery (1966-1969)
PI = Arteriovenous Fistula (1966-1969)
MS = Surgical shunt allowing direct passage of blood from an artery to a vein. (From Dorland, 28th ed)
PM = 70
HN = 70
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19700101
UI = D001166

*NEWRECORD
RECTYPE = D
MH = Arteritis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Arterial Inflammation|T047|NON|EQV|NLM (2008)|061017|abcdef
ENTRY = Arteritides
ENTRY = Inflammation, Arterial
MN = C14.907.940.090
MH_TH = NLM (1966)
ST = T047
AN = general, unspecified; coordinate IM with specific artery (IM)
MS = INFLAMMATION of any ARTERIES.
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001167

*NEWRECORD
RECTYPE = D
MH = Arthritis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Polyarthritis|T047|NON|REL|NLM (1993)|911107|abcdef
ENTRY = Arthritides
ENTRY = Polyarthritides
MN = C05.550.114
FX = Arthritis, Gouty
FX = Arthritis, Psoriatic
MH_TH = NLM (1966)
ST = T047
AN = inflamm: do not confuse with ARTHRALGIA which is non-inflamm; note X ref POLYARTHRITIS but polyarthrite chronique volutive (PCE) = ARTHRITIS, RHEUMATOID; septic arthritis = ARTHRITIS, INFECTIOUS; tends to be chronic so do not coord with CHRONIC DISEASE; degenerative arthritis = OSTEOARTHRITIS; ARTHRITIS, PSORIATIC is also available
PM = ARTHRITIS, ADJUVANT was ADJUVANT ARTHRITIS see under ARTHRITIS, RHEUMATOID 1975-76
CATSH = CAT LIST
MR = 20010813
DA = 19990101
DC = 1
UI = D001168

*NEWRECORD
RECTYPE = D
MH = Arthritis, Experimental
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Adjuvant Arthritis|T050|NON|NRW|UNK (19XX)|760505|abcdef
PRINT ENTRY = Arthritis, Adjuvant-Induced|T050|NON|NRW|NLM (2002)|010103|abcdef
PRINT ENTRY = Arthritis, Collagen-Induced|T050|NON|NRW|NLM (2002)|010103|abcdef
ENTRY = Arthritis, Adjuvant|T050|NON|NRW|NLM (1977)|990101|abcdef
ENTRY = Collagen Arthritis|T050|NON|NRW|NLM (2002)|010103|abcdef
ENTRY = Arthritides, Collagen
ENTRY = Arthritis, Collagen
ENTRY = Collagen Arthritides
ENTRY = Collagen-Induced Arthritides
ENTRY = Collagen-Induced Arthritis
MN = C05.550.114.015
MN = E05.598.500.249
MH_TH = NLM (2002)
ST = T050
AN = coord with specific type of arthritis if pertinent
PI = Arthritis (1966-1974)
PI = Arthritis, Rheumatoid (1966-1974)
MS = ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN.
PM = 1991; see ARTHRITIS 1977-90; see ARTHRITIS, RHEUMATOID 1975-76
HN = 1991(77); use ARTHRITIS 1977-90; use ARTHRITIS, RHEUMATOID 1975-76
CATSH = CAT LIST
MR = 20040707
DA = 19760505
DC = 1
DX = 19910101
UI = D001169

*NEWRECORD
RECTYPE = D
MH = Arthritis, Infectious
DE = ARTHRITIS INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Arthritis, Bacterial|T033|T047|NON|NRW|UNK (19XX)|880602|ARTHRITIS BACT|abbcdefv
PRINT ENTRY = Arthritis, Septic|T033|T047|NON|NRW|UNK (19XX)|880602|abbcdef
PRINT ENTRY = Arthritis, Viral|T047|NON|NRW|UNK (19XX)|880602|abcdef
ENTRY = Arthritides, Bacterial|T033|T047|NON|NRW|NLM (1992)|901102|ARTHRITIDES BACT|abbcdefv
ENTRY = Arthritis, Suppurative|T047|NON|REL|NLM (2016)|150609|abcdef
ENTRY = Bacterial Arthritides|T033|T047|NON|NRW|NLM (1992)|901102|BACT ARTHRITIDES|abbcdefv
ENTRY = Bacterial Arthritis|T033|T047|NON|NRW|NLM (1992)|901020|BACT ARTHRITIS|abbcdefv
ENTRY = Infectious Arthritis|T047|NON|EQV|NLM (1992)|910617|INFECT ARTHRITIS|abcdefv
ENTRY = Suppurative Arthritis|T047|NON|REL|NLM (2006)|050325|abcdef
ENTRY = Septic Arthritis
ENTRY = Viral Arthritis
MN = C01.539.100
MN = C05.550.114.099
MH_TH = NLM (1965)
ST = T047
AN = coordinate IM with specific infection (IM) + site (IM)
MS = Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
DX = 19650101
UI = D001170

*NEWRECORD
RECTYPE = D
MH = Arthritis, Juvenile
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Arthritis, Juvenile Chronic|T047|NON|EQV|NLM (1992)|901102|abcdef
PRINT ENTRY = Arthritis, Juvenile Idiopathic|T047|NON|EQV|NLM (2006)|041117|abcdef
PRINT ENTRY = Arthritis, Juvenile Rheumatoid|T047|NON|EQV|GHR (2014)|NLM (1966)|990101|abcdeef
PRINT ENTRY = Still's Disease, Juvenile-Onset|T047|EPO|REL|NLM (1992)|901221|STILLS DIS JUVENILE ONSET|abcdefv
ENTRY = Enthesitis-Related Arthritis, Juvenile|T047|NON|EQV|NLM (2014)|130422|abcdef
ENTRY = Juvenile Chronic Arthritis|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Juvenile Idiopathic Arthritis|T047|NON|EQV|GHR (2014)|NLM (2006)|041117|abcdeef
ENTRY = Juvenile Rheumatoid Arthritis|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Juvenile-Onset Still Disease|T047|EPO|REL|NLM (1992)|901221|JUVENILE ONSET STILL DIS|abcdefv
ENTRY = Juvenile-Onset Stills Disease|T047|EPO|REL|NLM (1992)|901221|JUVENILE ONSET STILLS DIS|abcdefv
ENTRY = Oligoarthritis, Juvenile|T047|NON|EQV|NLM (2014)|130422|abcdef
ENTRY = Polyarthritis, Juvenile, Rheumatoid Factor Negative|T047|NON|EQV|NLM (2014)|130422|abcdef
ENTRY = Polyarthritis, Juvenile, Rheumatoid Factor Positive|T047|NON|EQV|NLM (2014)|130422|abcdef
ENTRY = Psoriatic Arthritis, Juvenile|T047|NON|EQV|NLM (2014)|130422|abcdef
ENTRY = Still Disease, Juvenile-Onset|T047|EPO|REL|NLM (1992)|901221|STILL DISEASE JUVENILE ONSET|abcdefv
ENTRY = Systemic Arthritis, Juvenile|T047|NON|EQV|NLM (2014)|130422|abcdef
ENTRY = Arthritis, Juvenile Enthesitis-Related
ENTRY = Arthritis, Juvenile Psoriatic
ENTRY = Arthritis, Juvenile Systemic
ENTRY = Chronic Arthritis, Juvenile
ENTRY = Enthesitis Related Arthritis, Juvenile
ENTRY = Idiopathic Arthritis, Juvenile
ENTRY = Juvenile Arthritis
ENTRY = Juvenile Enthesitis-Related Arthritis
ENTRY = Juvenile Oligoarthritis
ENTRY = Juvenile Onset Still Disease
ENTRY = Juvenile Onset Stills Disease
ENTRY = Juvenile Psoriatic Arthritis
ENTRY = Juvenile Systemic Arthritis
ENTRY = Juvenile-Onset Still's Disease
ENTRY = Rheumatoid Arthritis, Juvenile
ENTRY = Still Disease, Juvenile Onset
ENTRY = Still's Disease, Juvenile Onset
ENTRY = Stills Disease, Juvenile-Onset
MN = C05.550.114.122
MN = C05.799.056
MN = C17.300.775.049
MN = C20.111.198
MH_TH = NLM (2014)
ST = T047
AN = note entry term STILL'S DISEASE, JUVENILE-ONSET: STILL'S DISEASE, ADULT-ONSET is also available
MS = Arthritis of children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001171

*NEWRECORD
RECTYPE = D
MH = Arthritis, Rheumatoid
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Rheumatoid Arthritis|T047|NON|EQV|NLM (2000)|OMIM (2013)|991109|abcdeef
MN = C05.550.114.154
MN = C05.799.114
MN = C17.300.775.099
MN = C20.111.199
MH_TH = NLM (1966)
ST = T047
AN = in children = ARTHRITIS, JUVENILE RHEUMATOID; includes PCE: polyarthrite chronique volutive; tends to be chronic so do not coord with CHRONIC DISEASE
MS = A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D001172

*NEWRECORD
RECTYPE = D
MH = Arthrobacter
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.510.024.049.475.050
MN = B03.510.460.400.400.049.074
MH_TH = NLM (1966)
ST = T007
AN = in soil
MS = A genus of asporogenous bacteria isolated from soil that displays a distinctive rod-coccus growth cycle.
MR = 20090706
DA = 19990101
DC = 1
UI = D001173

*NEWRECORD
RECTYPE = D
MH = Arthrodesis
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Arthrodeses
MN = E04.555.100
MH_TH = NLM (1966)
ST = T061
AN = a method of joint surg; do not use /util except by MeSH definition; vertebral or spinal arthrodesis = SPINAL FUSION
MS = The surgical fixation of a joint by a procedure designed to accomplish fusion of the joint surfaces by promoting the proliferation of bone cells. (Dorland, 28th ed)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001174

*NEWRECORD
RECTYPE = D
MH = Arthrography
DE = ARTHROGR
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Arthrographies
MN = E01.370.350.700.070
MH_TH = NLM (1986)
ST = T060
AN = do not use /util except by MeSH definition; DF: ARTHROGR
PI = Radiography (1966-1985)
PI = specific joint/RA (1967-1985)
MS = Roentgenography of a joint, usually after injection of either positive or negative contrast medium.
PM = 86
HN = 86
CATSH = CAT LIST
MR = 19970620
DA = 19850607
DC = 1
DX = 19860101
UI = D001175

*NEWRECORD
RECTYPE = D
MH = Arthrogryposis
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Amyoplasia Congenita|T019|NON|EQV|ORD (2010)|UNK (19XX)|750101|AMYOPLASIA CONGEN|abcdeefv
PRINT ENTRY = Arthromyodysplasia, Congenital|T019|NON|EQV|UNK (19XX)|740329|ARTHROMYODYSPLASIA CONGEN|abcdefv
PRINT ENTRY = Guerin-Stern Syndrome|T019|EPO|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Myodystrophia Fetalis Deformans|T019|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Arthrogryposis Multiplex Congenita|T019|NON|EQV|ORD (2010)|121212|abcdef
ENTRY = Arthrogryposis Multiplex Congenita (AMC)|T019|ABX|EQV|ORD (2010)|121212|abcdef
ENTRY = Congenital Arthromyodysplasia|T019|NON|EQV|UNK (19XX)|740329|CONGEN ARTHROMYODYSPLASIA|abcdefv
ENTRY = Congenital Multiple Arthrogryposis|T019|NON|EQV|ORD (2010)|121212|abcdef
ENTRY = Fibrous Ankylosis of Multiple Joints|T019|NON|EQV|ORD (2010)|121212|abcdef
ENTRY = Gurin-Stern Syndrome|T019|EPO|EQV|ORD (2010)|121212|abcdef
ENTRY = Otto Syndrome|T019|EPO|EQV|ORD (2010)|121212|abcdef
ENTRY = Rocher-Sheldon Syndrome|T019|EPO|EQV|ORD (2010)|121212|abcdef
ENTRY = Rossi Syndrome|T019|EPO|EQV|ORD (2010)|121212|abcdef
ENTRY = Arthrogryposes
ENTRY = Arthrogryposes, Congenital Multiple
ENTRY = Arthrogryposis Multiplex Congenitas
ENTRY = Arthrogryposis Multiplex Congenitas (AMC)
ENTRY = Arthrogryposis, Congenital Multiple
ENTRY = Arthromyodysplasias, Congenital
ENTRY = Congenita, Arthrogryposis Multiplex
ENTRY = Congenita, Arthrogryposis Multiplex (AMC)
ENTRY = Congenital Arthromyodysplasias
ENTRY = Congenital Multiple Arthrogryposes
ENTRY = Congenitas, Arthrogryposis Multiplex
ENTRY = Congenitas, Arthrogryposis Multiplex (AMC)
ENTRY = Guerin Stern Syndrome
ENTRY = Gurin Stern Syndrome
ENTRY = Multiple Arthrogryposes, Congenital
ENTRY = Multiple Arthrogryposis, Congenital
ENTRY = Multiplex Congenita, Arthrogryposis
ENTRY = Multiplex Congenita, Arthrogryposis (AMC)
ENTRY = Multiplex Congenitas, Arthrogryposis
ENTRY = Multiplex Congenitas, Arthrogryposis (AMC)
ENTRY = Rocher Sheldon Syndrome
ENTRY = Syndrome, Guerin-Stern
ENTRY = Syndrome, Gurin-Stern
ENTRY = Syndrome, Otto
ENTRY = Syndrome, Rocher-Sheldon
ENTRY = Syndrome, Rossi
MN = C05.550.150
MN = C05.651.102
MN = C05.660.077
MN = C16.131.621.077
MH_TH = NLM (1963)
ST = T019
AN = "persistent flexure or contracture of a joint"; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
MS = Persistent flexure or contracture of a joint.
PM = 65
HN = 65(63)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D001176

*NEWRECORD
RECTYPE = D
MH = Arthropathy, Neurogenic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Charcot's Joint|T047|EPO|EQV|UNK (19XX)|740329|abcdef
ENTRY = Arthropathies, Neurogenic
ENTRY = Charcot Joint
ENTRY = Charcots Joint
ENTRY = Joint, Charcot's
ENTRY = Neurogenic Arthropathies
ENTRY = Neurogenic Arthropathy
MN = C05.550.186
MH_TH = NLM (1966)
ST = T047
MS = Chronic progressive degeneration of the stress-bearing portion of a joint, with bizarre hypertrophic changes at the periphery. It is probably a complication of a variety of neurologic disorders, particularly TABES DORSALIS, involving loss of sensation, which leads to relaxation of supporting structures and chronic instability of the joint. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 19940524
DA = 19990101
DC = 1
UI = D001177

*NEWRECORD
RECTYPE = D
MH = Arthroplasty
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Arthroplasties
MN = E04.555.110
MN = E04.680.101
MH_TH = NLM (1966)
ST = T061
AN = surg reconstruct of a joint; total or partial joint replacement = ARTHROPLASTY, REPLACEMENT or its specifics; joint revision (see REOPERATION) = ARTHROPLASTY (IM) + REOPERATION (NIM); do not use /util except by MeSH definition
MS = Surgical reconstruction of a joint to relieve pain or restore motion.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001178

*NEWRECORD
RECTYPE = D
MH = Arthropod Vectors
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Arthropod Vector
ENTRY = Vector, Arthropod
ENTRY = Vectors, Arthropod
MN = N06.850.310.350.100
MH_TH = NLM (1964)
ST = T204
AN = coord IM with specific arthropod (IM); specify both infecting organism & vector if pertinent; ARACHNID VECTORS and INSECT VECTORS are also avail
MS = Arthropods, other than insects and arachnids, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
PM = 64
HN = 64
MR = 20080708
DA = 19990101
DC = 1
DX = 19640101
UI = D001179

*NEWRECORD
RECTYPE = D
MH = Arthropod Venoms
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC EN GE HI IM IP ME PD PK PO RE SE TO TU UR
ENTRY = Arthropod Venom|T123|T131|NON|EQV|NLM (1999)|980217|abbcdef
ENTRY = Venom, Arthropod
ENTRY = Venoms, Arthropod
MN = D20.888.065
MN = D23.946.833.065
MH_TH = NLM (1978)
ST = T123
ST = T131
RN = 0
AN = /antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific arachnid or insect (IM or NIM) but note available specifics: ANT VENOMS; BEE VENOMS; SCORPION VENOMS; SPIDER VENOMS & WASP VENOMS & their indentions
PI = Arthropods (1966-1977)
PI = Venoms (1966-1977)
MS = Venoms from animals of the phylum Arthropoda. Those most investigated are from scorpions and spiders of the class Arachnidae and from ant, bee, and wasp families of the Insecta order Hymenoptera. The venoms contain protein toxins, enzymes, and other bioactive substances and may be lethal to man.
PM = 78
HN = 78
MR = 20050630
DA = 19770422
DC = 1
DX = 19780101
UI = D001180

*NEWRECORD
RECTYPE = D
MH = Arthropods
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Arthropoda|T204|NON|EQV|NLM (2012)|110315|abcdef
ENTRY = Arthropod
MN = B01.050.500.131
MH_TH = NLM (1966)
ST = T204
MS = Members of the phylum Arthropoda, composed of organisms having a hard, jointed exoskeleton and paired jointed legs. It includes the class INSECTS and the subclass ARACHNIDA, many species of which are important medically as parasites or as vectors of organisms capable of causing disease in man.
MR = 20110624
DA = 19990101
DC = 1
UI = D001181

*NEWRECORD
RECTYPE = D
MH = Arthroscopy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Arthroscopic Surgical Procedures|T060|T061|NON|NRW|NLM (2000)|991103|ARTHROSCOPIC SURG PROCEDURES|abbcdefv
PRINT ENTRY = Surgical Procedures, Arthroscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES ARTHROSCOPIC|abbcdefv
ENTRY = Arthroscopic Surgery|T060|T061|NON|NRW|NLM (2000)|991103|ARTHROSCOPIC SURG|abbcdefv
ENTRY = Surgery, Arthroscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG ARTHROSCOPIC|abbcdefv
ENTRY = Arthroscopic Surgeries
ENTRY = Arthroscopic Surgical Procedure
ENTRY = Arthroscopies
ENTRY = Procedure, Arthroscopic Surgical
ENTRY = Procedures, Arthroscopic Surgical
ENTRY = Surgeries, Arthroscopic
ENTRY = Surgical Procedure, Arthroscopic
MN = E01.370.388.250.070
MN = E04.502.250.070
MN = E04.555.113
FX = Arthroscopes
MH_TH = NLM (1982)
ST = T060
ST = T061
AN = / instrum permitted but consider also ARTHROSCOPES
PI = Endoscopy (1966-1981)
PI = Joint Diseases (1966-1981)
PI = Knee Injuries (1966-1981)
PI = Knee Joint (1966-1981)
PI = other joint heading
MS = Endoscopic examination, therapy and surgery of the joint.
PM = 82
HN = 82
CATSH = CAT LIST
MR = 20100625
DA = 19810415
DC = 1
DX = 19820101
UI = D001182

*NEWRECORD
RECTYPE = D
MH = Arthus Reaction
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Arthus Phenomenon|T047|EPO|EQV|NLM (1993)|920107|abcdef
ENTRY = Phenomenon, Arthus
ENTRY = Reaction, Arthus
MN = C20.543.520.100
MH_TH = NLM (1964)
ST = T047
AN = note category; an inflamm skin reaction to antibody excess
MS = A dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage, and vascular necrosis.
OL = use ARTHUS REACTION to search ARTHUS PHENOMENON 1966-92
PM = 93; was ARTHUS PHENOMENON 1966-92
HN = 93; was ARTHUS PHENOMENON 1966-92 (Prov 63-65)
CATSH = CAT LIST
MR = 19930602
DA = 19990101
DC = 1
DX = 19660101
UI = D001183

*NEWRECORD
RECTYPE = D
MH = Articulation Disorders
DE = ARTICULATION DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Phonological Impairments|T048|T184|NON|EQV|NLM (2000)|991103|abbcdef
PRINT ENTRY = Speech Articulation Disorders|T048|T184|NON|EQV|NLM (2000)|991103|SPEECH ARTICULATION DIS|abbcdefv
ENTRY = Articulation Disorders, Developmental|T048|NON|NRW|NLM (2000)|991103|ARTICULATION DIS DEVELOPMENTAL|abcdefv
ENTRY = Developmental Articulation Disorders|T048|NON|NRW|NLM (2000)|991103|DEVELOPMENTAL ARTICULATION DIS|abcdefv
ENTRY = Disarticulation Disorders|T048|T184|NON|EQV|NLM (2000)|991103|DYSARTICULATION DIS|abbcdefv
ENTRY = Misarticulation|T048|T184|NON|EQV|UNK (19XX)|780522|abbcdef
ENTRY = Phonology Impairment|T048|T184|NON|EQV|NLM (2000)|991103|abbcdef
ENTRY = Unintelligible Articulation|T048|NON|REL|NLM (2000)|991103|abcdef
ENTRY = Articulation Disorder
ENTRY = Articulation Disorder, Developmental
ENTRY = Articulation Disorder, Speech
ENTRY = Articulation Disorders, Speech
ENTRY = Articulation, Unintelligible
ENTRY = Articulations, Unintelligible
ENTRY = Developmental Articulation Disorder
ENTRY = Disarticulation Disorder
ENTRY = Disorder, Disarticulation
ENTRY = Disorders, Disarticulation
ENTRY = Impairment, Phonological
ENTRY = Impairment, Phonology
ENTRY = Impairments, Phonological
ENTRY = Impairments, Phonology
ENTRY = Phonological Impairment
ENTRY = Phonology Impairments
ENTRY = Speech Articulation Disorder
ENTRY = Unintelligible Articulations
MN = C10.597.606.150.500.800.150
MN = C23.888.592.604.150.500.800.150
MH_TH = NLM (1979)
ST = T048
ST = T184
AN = note categories: "articulation" refers to speech, not to joints
MS = Disorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes.
PM = 1979
HN = 1979
CATSH = CAT LIST
MR = 20050729
DA = 19780522
DC = 1
DX = 19790101
UI = D001184

*NEWRECORD
RECTYPE = D
MH = Artificial Intelligence
AQ = CL EC ES HI LJ SD SN ST TD UT
PRINT ENTRY = AI (Artificial Intelligence)|T057|T066|EQV|NLM (1997)|960620|abbdef
PRINT ENTRY = Computer Reasoning|T057|T066|NON|EQV|UNK (19XX)|860618|abbcdef
PRINT ENTRY = Computer Vision Systems|T073|NON|NRW|UNK (19XX)|860618|abcdef
PRINT ENTRY = Knowledge Acquisition (Computer)|T066|NON|NRW|UNK (19XX)|860618|KNOWLEDGE ACQUISITION|abcdefv
PRINT ENTRY = Knowledge Representation (Computer)|T066|NON|NRW|UNK (19XX)|860618|KNOWLEDGE REPRESENTATION|abcdefv
PRINT ENTRY = Machine Intelligence|T057|T066|NON|EQV|NLM (1997)|960620|abbcdef
ENTRY = Computational Intelligence|T057|T066|NON|EQV|NLM (2013)|111017|abbcdef
ENTRY = Acquisition, Knowledge (Computer)
ENTRY = Computer Vision System
ENTRY = Intelligence, Artificial
ENTRY = Intelligence, Computational
ENTRY = Intelligence, Machine
ENTRY = Knowledge Representations (Computer)
ENTRY = Reasoning, Computer
ENTRY = Representation, Knowledge (Computer)
ENTRY = System, Computer Vision
ENTRY = Systems, Computer Vision
ENTRY = Vision System, Computer
ENTRY = Vision Systems, Computer
MN = G17.035.250
MN = L01.224.050.375
FX = Heuristics
MH_TH = NLM (1986)
ST = T057
ST = T066
PI = Computers (1966-1985)
MS = Theory and development of COMPUTER SYSTEMS which perform tasks that normally require human intelligence. Such tasks may include speech recognition, LEARNING; VISUAL PERCEPTION; MATHEMATICAL COMPUTING; reasoning, PROBLEM SOLVING, DECISION-MAKING, and translation of language.
PM = 86
HN = 86
MR = 20150626
DA = 19850606
DC = 1
DX = 19860101
UI = D001185

*NEWRECORD
RECTYPE = D
MH = Artificial Limbs
AQ = AE CL CT EC ES HI MI PS PX SD SN ST TD UT VE VI
PRINT ENTRY = Arm Prosthesis|T074|NON|NRW|NLM (1998)|970211|abcdef
PRINT ENTRY = Arm, Artificial|T074|NON|NRW|NLM (1998)|970211|abcdef
PRINT ENTRY = Artificial Arm|T074|NON|NRW|NLM (1998)|970210|abcdef
PRINT ENTRY = Artificial Leg|T074|NON|NRW|NLM (1998)|970210|abcdef
PRINT ENTRY = Extremities, Artificial|T074|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Leg Prosthesis|T074|NON|NRW|NLM (1998)|970211|abcdef
PRINT ENTRY = Leg, Artificial|T074|NON|NRW|NLM (1998)|970211|abcdef
PRINT ENTRY = Limb Prosthesis|T074|NON|EQV|NLM (1998)|970211|abcdef
PRINT ENTRY = Limbs, Artificial|T074|NON|EQV|NLM (1998)|970211|abcdef
ENTRY = Arm Prostheses
ENTRY = Arms, Artificial
ENTRY = Artificial Arms
ENTRY = Artificial Extremities
ENTRY = Artificial Extremity
ENTRY = Artificial Legs
ENTRY = Artificial Limb
ENTRY = Extremity, Artificial
ENTRY = Leg Prostheses
ENTRY = Legs, Artificial
ENTRY = Limb Prostheses
ENTRY = Limb, Artificial
ENTRY = Prostheses, Arm
ENTRY = Prostheses, Leg
ENTRY = Prostheses, Limb
ENTRY = Prosthesis, Arm
ENTRY = Prosthesis, Leg
ENTRY = Prosthesis, Limb
MN = E07.695.050
MN = E07.858.082.050
MN = E07.858.442.050
MH_TH = NLM (1966)
ST = T074
AN = coord ARM or LEG (NIM) if pertinent
MS = Prosthetic replacements for arms, legs, and parts thereof.
CATSH = CAT LIST
MR = 20040719
DA = 19990101
DC = 1
UI = D001186

*NEWRECORD
RECTYPE = D
MH = Artificial Organs
AQ = AE CL CT EC ES HI MI PS PX SD SN ST TD UT VE VI
ENTRY = Artificial Organ
ENTRY = Organ, Artificial
ENTRY = Organs, Artificial
MN = E07.858.082
MH_TH = BIOETHICS (1989)
ST = T074
AN = usually to replace function, as HEART, ARTIFICIAL or KIDNEY, ARTIFICIAL: do not confuse with PROSTHESES AND IMPLANTS which is usually cosmetic; not for injections, like silicones, to replace substance; coord IM with specific organ (IM) with no qualif but note available precoords
MS = Devices intended to replace non-functioning organs. They may be temporary or permanent. Since they are intended always to function as the natural organs they are replacing, they should be differentiated from PROSTHESES AND IMPLANTS and specific types of prostheses which, though also replacements for body parts, are frequently cosmetic (EYE, ARTIFICIAL) as well as functional (ARTIFICIAL LIMBS).
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001187

*NEWRECORD
RECTYPE = D
MH = Artiodactyla
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Artiodactylas
MN = B01.050.150.900.649.077
MH_TH = NLM (1966)
ST = T015
AN = GEN or unspecified; prefer specifics; includes giraffe, hippopotamus, peccary; IM; qualif permitted
MR = 20090706
DA = 19990101
DC = 1
UI = D001188

*NEWRECORD
RECTYPE = D
MH = Aryl Hydrocarbon Hydroxylases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Microsomal Monooxygenases|T116|T126|NON|EQV|NLM (2003)|020313|abbcdef
ENTRY = Xenobiotic Monooxygenases|T116|T126|NON|NRW|NLM (2003)|020313|abbcdef
ENTRY = Hydroxylases, Aryl Hydrocarbon
ENTRY = Monooxygenases, Microsomal
ENTRY = Monooxygenases, Xenobiotic
MN = D08.244.453.040
MN = D08.811.682.690.708.170.040
MN = D12.776.422.220.453.040
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 1.14.14.1
RR = EC 1.14.14.1
PI = Hydroxylases (1971-1974)
PI = Polycyclic Hydrocarbons (1974)
MS = A large group of cytochrome P-450 (heme-thiolate) monooxygenases that complex with NAD(P)H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides.
PM = 75
HN = 75
MR = 20040707
DA = 19741111
DC = 1
DX = 19750901
UI = D001189

*NEWRECORD
RECTYPE = D
MH = Arylsulfonates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aryl Sulfonates|T109|NON|EQV|NLM (1994)|920903|abcdef
ENTRY = Sulfonates, Aryl
MN = D02.886.645.600.080.050
MH_TH = NLM (1974)
ST = T109
RN = 0
MS = Organic sulfonic acid esters or salts which contain an aromatic hydrocarbon radical.
OL = use ARYLSULFONATES to search ARYL SULFONATES 1974-93
PM = 94; was ARYL SULFONATES 1974-93
HN = 94; was ARYL SULFONATES 1974-93
MR = 19930604
DA = 19990101
DC = 1
DX = 19740101
UI = D001190

*NEWRECORD
RECTYPE = D
MH = Arylamine N-Acetyltransferase
DS = ARYLAMINE ACETYLTRANSFERASE N
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Arylamine Acetylases|T116|T126|NON|EQV|UNK (19XX)|790523|abbcdef
PRINT ENTRY = Arylamine Acetyltransferases|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef
ENTRY = Acetyl-CoA Arylamine N-Acetyltransferase|T116|T126|EQV|UNK (19XX)|810130|abbdef
ENTRY = Arylamine Acetylase|T116|T126|NON|EQV|NLM (2005)|031120|abbcdef
ENTRY = Acetyl CoA Arylamine N Acetyltransferase
ENTRY = Acetylase, Arylamine
ENTRY = Acetylases, Arylamine
ENTRY = Acetyltransferases, Arylamine
ENTRY = Arylamine N Acetyltransferase
ENTRY = Arylamine N-Acetyltransferase, Acetyl-CoA
ENTRY = N-Acetyltransferase, Acetyl-CoA Arylamine
ENTRY = N-Acetyltransferase, Arylamine
MN = D08.811.913.050.134.138
MH_TH = NLM (1980)
ST = T116
ST = T126
N1 = Acetyl-CoA:arylamine N-acetyltransferase
RN = EC 2.3.1.5
RR = 9027-33-2 (CAS RN)
AN = do not confuse with ARYLALKYLAMINE N-ACETYLTRANSFERASE
PI = Acetyltransferases (1973-1979)
PI = Acyltransferases (1966-1972)
PI = Serotonin (1966-1974) /analogs & derivatives (1975-1979)
MS = An enzyme that catalyzes the transfer of acetyl groups from ACETYL-COA to arylamines. It can also catalyze acetyl transfer between arylamines without COENZYME A and has a wide specificity for aromatic amines, including SEROTONIN. However, arylamine N-acetyltransferase should not be confused with the enzyme ARYLALKYLAMINE N-ACETYLTRANSFERASE which is also referred to as SEROTONIN ACETYLTRANSFERASE.
PM = 98(80); see ARYLAMINE ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1980-90
HN = 98(80)
MR = 20120703
DA = 19790523
DC = 1
DX = 19910101
UI = D001191

*NEWRECORD
RECTYPE = D
MH = Arylsulfatases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Arylsulfate Sulfohydrolases|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Arylsulphatases|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Pseudo Arylsulfatase A|T116|T126|NON|NRW|UNK (19XX)|840920|abbcdef
MN = D08.811.277.352.827.070
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Aryl-sulfate sulfohydrolase
RN = EC 3.1.6.1
PI = Phenols (1973-1974)
PI = Sulfatases (1973-1974)
MS = Enzymes that catalyze the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A, B, and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.1.
PM = 91; was see under SULFATASES 1975-90
HN = 91(75); was see under SULFATASES 1975-90
MR = 20050729
DA = 19741119
DC = 1
DX = 19910101
UI = D001192

*NEWRECORD
RECTYPE = D
MH = Arytenoid Cartilage
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arytenoid Cartilages
ENTRY = Cartilage, Arytenoid
ENTRY = Cartilages, Arytenoid
MN = A02.165.257.625.083
MN = A02.165.407.500.083
MN = A04.329.591.085
MH_TH = NLM (1980)
ST = T023
PI = Laryngeal Cartilages (1966-1979)
MS = One of a pair of small pyramidal cartilages that articulate with the lamina of the CRICOID CARTILAGE. The corresponding VOCAL LIGAMENT and several muscles are attached to it.
PM = 91; was see under LARYNGEAL CARTILAGES 1980-90
HN = 91(80); was see under LARYNGEAL CARTILAGES 1980-90
MR = 20080708
DA = 19781221
DC = 1
DX = 19910101
UI = D001193

*NEWRECORD
RECTYPE = D
MH = Asbestos
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.578.725.050
MN = D01.837.725.700.760.070
PA = Carcinogens
MH_TH = NLM (1969)
ST = T131
ST = T197
N1 = Asbestos
RN = 1332-21-4
AN = a silicate used in insulation & fireproofing; carcinogenic; GEN or unspecified; prefer specifics; /adv eff: consider also ASBESTOSIS; disease coord with ASBESTOS /adv eff is dis /etiol, not dis /chem ind; for emphasis on asbestos fibers, MINERAL FIBERS is available: see note there
PI = Minerals (1966-1968)
MS = Asbestos. Fibrous incombustible mineral composed of magnesium and calcium silicates with or without other elements. It is relatively inert chemically and used in thermal insulation and fireproofing. Inhalation of dust causes asbestosis and later lung and gastrointestinal neoplasms.
PM = 70
HN = 70(69)
MR = 19950531
DA = 19990101
DC = 1
DX = 19700101
UI = D001194

*NEWRECORD
RECTYPE = D
MH = Asbestosis
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Idiopathic Interstitial Pneumonitis - from Asbestos Exposure|T047|NON|NRW|NLM (2011)|ORD (2010)|100119|abcdeef
PRINT ENTRY = Pulmonary Fibrosis - from Asbestos Exposure|T047|NON|NRW|NLM (2011)|ORD (2010)|100119|abcdeef
ENTRY = Asbestoses
MN = C08.381.483.581.125
MN = C08.381.520.702.125
MN = C24.800.127
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T037
ST = T047
AN = do not coordinate with OCCUPATIONAL DISEASES; for emphasis on presence of asbestos fibers, MINERAL FIBERS is available: see note there
MS = A form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001195

*NEWRECORD
RECTYPE = D
MH = Ascariasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Ascariases
MN = C03.335.508.700.100.070
MH_TH = NLM (1966)
ST = T047
AN = nematode infect caused by ASCARIS; do not confuse with ACARIASIS, mite infestation or ASCARIDIASIS, infection with ASCARIDIA; coord IM with species (IM)
MS = Infection by nematodes of the genus ASCARIS. Ingestion of infective eggs causes diarrhea and pneumonitis. Its distribution is more prevalent in areas of poor sanitation and where human feces are used for fertilizer.
CATSH = CAT LIST
MR = 20040713
DA = 19990101
DC = 1
UI = D001196

*NEWRECORD
RECTYPE = D
MH = Ascaridia
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Ascaridia galli|T204|NON|NRW|NLM (1993)|911107|abcdef
ENTRY = Ascaridia gallus
ENTRY = Ascaridias
ENTRY = galli, Ascaridia
ENTRY = gallus, Ascaridia
MN = B01.050.500.500.294.700.100.090
MH_TH = NLM (1972)
ST = T204
AN = do not confuse with the order ASCARIDIDA; infection = ASCARIDIASIS (do not confuse with ASCARIASIS or ACARIASIS); coordinate with specific helminth term (ANTIGENS, HELMINTH; etc) if pertinent
PI = Nematoda (1966-1971)
MS = A genus of nematode worms in the superfamily Heterakoidea. A. galli and A. lineata are important intestinal parasites of domestic fowl.
PM = 72
HN = 72
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D001197

*NEWRECORD
RECTYPE = D
MH = Ascaridiasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Ascaridiases
MN = C03.335.508.700.100.080
MH_TH = NLM (1975)
ST = T047
AN = nematode infect caused by ASCARIDIA; do not confuse with ASCARIASIS (caused by ASCARIS) or ACARIASIS (caused by ACARI or ACARUS) or with ASCARIDIDA INFECTIONS
MS = Infection with nematodes of the genus ASCARIDIA. This condition usually occurs in fowl, often manifesting diarrhea.
OL = search ASCARIASIS 1968-74
PM = 91; was see under NEMATODE INFECTIONS 1979-90; was see under ASCARIASIS 1968-78
HN = 91(75); was see under NEMATODE INFECTIONS 1979-90; was see under ASCARIASIS 1968-78
CATSH = CAT LIST
MR = 19930604
DA = 19990101
DC = 1
DX = 19910101
UI = D001198

*NEWRECORD
RECTYPE = D
MH = Ascaridoidea
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Ascaroidea|T204|NON|EQV|NLM (1990)|890331|abcdef
PRINT ENTRY = Baylisascaris|T204|NON|NRW|NLM (2007)|050804|abcdef
PRINT ENTRY = Parascaris|T204|NON|NRW|NLM (2007)|050804|abcdef
ENTRY = Ascaridoideas
ENTRY = Ascaroideas
ENTRY = Baylisascari
ENTRY = Parascari
MN = B01.050.500.500.294.700.100.100
MH_TH = NLM (1975)
ST = T204
AN = do not confuse with the genera ASCARIDIA and ASCARIS; infection: coordinate IM with ASCARIDIDA INFECTIONS (IM); coordinate with specific helminth term (ANTIGENS, HELMINTH; etc) if pertinent
PI = Nematoda (1966-1974)
MS = A superfamily of polymyarian nematode worms. An important characteristic of this group is the presence of three prominent lips around the mouth of the organism.
OL = use ASCARIDOIDEA to search ASCAROIDEA 1975-85
PM = 86; was ASCAROIDEA 1975-85
HN = 86; was ASCAROIDEA 1975-85
MR = 20090706
DA = 19990101
DC = 1
DX = 19750101
UI = D001199

*NEWRECORD
RECTYPE = D
MH = Ascaris
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
ENTRY = Ascari
MN = B01.050.500.500.294.700.100.100.108
MH_TH = NLM (1966)
ST = T204
AN = a genus of nematodes; do not confuse with ASCARIDIA, another genus, both belonging to the superfamily of ASCARIDOIDEA; do not confuse with ACARI (mites & ticks) or ACARUS (mites); infection = ASCARIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
MS = A genus of nematodes of the superfamily ASCARIDOIDEA whose species usually inhabit the intestine.
MR = 20090706
DA = 19990101
DC = 1
UI = D001200

*NEWRECORD
RECTYPE = D
MH = Ascites
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
MN = C23.550.081
MH_TH = NLM (1966)
ST = T033
ST = T046
AN = do not index here for routine liver cirrhosis or Ehrlich ascites tumor; text must discuss ascites especially; chylous ascites: index CHYLOPERITONEUM
MS = Accumulation or retention of free fluid within the peritoneal cavity.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D001201

*NEWRECORD
RECTYPE = D
MH = Ascitic Fluid
AQ = CH CY DE EN IM ME MI PA PH PS RA RE RI SE US VI
PRINT ENTRY = Peritoneal Effusion|T031|NON|EQV|UNK (19XX)|830422|abcdef
PRINT ENTRY = Peritoneal Fluid|T031|NON|EQV|NLM (1990)|890331|abcdef
ENTRY = Ascitic Fluids
ENTRY = Effusion, Peritoneal
ENTRY = Effusions, Peritoneal
ENTRY = Fluid, Ascitic
ENTRY = Fluid, Peritoneal
ENTRY = Fluids, Ascitic
ENTRY = Fluids, Peritoneal
ENTRY = Peritoneal Effusions
ENTRY = Peritoneal Fluids
MN = A12.207.119
FX = Peritoneal Lavage
MH_TH = NLM (1968)
ST = T031
PI = Ascites (1966-1967)
MS = The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY.
OL = use ASCITIC FLUID to search PERITONEAL FLUID 1968-89
PM = 68
HN = 68; was in Cat A 1968-83; PERITONEAL EFFUSION was PERITONEAL FLUID see under ASCITIC FLUID 1968-83
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
DX = 19680101
UI = D001202

*NEWRECORD
RECTYPE = D
MH = Ascomycota
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Ascomycetes|T004|NON|EQV|NLM (1999)|970924|abcdef
PRINT ENTRY = Cochliobolus|T004|NON|NRW|UNK (19XX)|850208|abcdef
PRINT ENTRY = Sclerotinia|T004|NON|NRW|UNK (19XX)|850208|abcdef
ENTRY = Ascomycete
ENTRY = Ascomycotas
ENTRY = Sclerotinias
MN = B01.300.107
MH_TH = NLM (1966)
ST = T004
AN = GEN or unspecified; prefer specifics; infection coord IM with MYCOSES (IM) or specific mycosis (IM)
MS = A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell (ascus) containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum.
PM = 99; see ASCOMYCETES 1963-98; for COCHLIOBOLUS & SCLEROTINA see ASCOMYCETES 1975-85
HN = 99(75)
MR = 20090706
DA = 19990101
DC = 1
UI = D001203

*NEWRECORD
RECTYPE = D
MH = Ascorbate Oxidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Ascorbase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Ascorbino Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = L-Ascorbate Oxidase|T116|T126|NON|EQV|NLM (2008)|070327|abbcdef
ENTRY = Dehydrogenase, Ascorbino
ENTRY = L Ascorbate Oxidase
ENTRY = Oxidase, Ascorbate
ENTRY = Oxidase, L-Ascorbate
MN = D08.811.682.180
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = L-Ascorbate:oxygen oxidoreductase
RN = EC 1.10.3.3
PI = Ascorbic Acid (1973-1974)
PI = Oxidoreductases (1973-1974)
MS = An enzyme that converts ascorbic acid to dehydroascorbic acid. EC 1.10.3.3.
PM = 91; was see under OXIDOREDUCTASES 1975-90
HN = 91(75); was see under OXIDOREDUCTASES 1975-90
MR = 20070709
DA = 19741119
DC = 1
DX = 19910101
UI = D001204

*NEWRECORD
RECTYPE = D
MH = Ascorbic Acid
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Vitamin C|T118|T121|T127|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbbcdeef
ENTRY = Ascorbic Acid, Monosodium Salt|T109|T121|T127|NRW|NLM (1999)|990913|abbbdef
ENTRY = Ferrous Ascorbate|T109|T121|NON|NRW|UNK (19XX)|821124|abbcdef
ENTRY = Hybrin|T109|T121|T127|TRD|NRW|UNK (19XX)|801120|abbbcdef
ENTRY = L-Ascorbic Acid|T118|T121|T127|NON|EQV|FDA SRS (2014)|UNK (19XX)|811023|abbbcdeef
ENTRY = Magnesium Ascorbate|T109|T121|T127|NON|NRW|NLM (2014)|130305|abbbcdef
ENTRY = Magnesium Ascorbicum|T109|T121|T127|NON|NRW|UNK (19XX)|820902|abbbcdef
ENTRY = Magnesium di-L-Ascorbate|T109|T121|T127|NON|NRW|NLM (2014)|130305|abbbcdef
ENTRY = Magnorbin|T109|T121|TRD|NRW|UNK (19XX)|820902|abbcdef
ENTRY = Sodium Ascorbate|T109|T121|T127|NON|NRW|FDA SRS (2014)|INN (19XX)|USP (19XX)|810807|abbbcdeeef
ENTRY = Acid, Ascorbic
ENTRY = Acid, L-Ascorbic
ENTRY = Ascorbate, Ferrous
ENTRY = Ascorbate, Magnesium
ENTRY = Ascorbate, Sodium
ENTRY = L Ascorbic Acid
ENTRY = Magnesium di L Ascorbate
ENTRY = di-L-Ascorbate, Magnesium
MN = D02.241.081.844.107
MN = D02.241.511.902.107
MN = D09.811.100
PA = Antioxidants
PA = Vitamins
EC = deficiency:Ascorbic Acid Deficiency
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = POPLINE (1978)
MH_TH = USP (19XX)
ST = T118
ST = T121
ST = T127
N1 = L-Ascorbic acid
RN = PQ6CK8PD0R
RR = 0N1G678593
RR = 134-03-2 (monosodium salt)
RR = 50-81-7 (Ascorbic Acid)
RR = S033EH8359
AN = /defic = ASCORBIC ACID DEFICIENCY or SCURVY
MS = A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.
PM = /therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965
HN = /therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965
MR = 20130708
DA = 19990101
DC = 1
UI = D001205

*NEWRECORD
RECTYPE = D
MH = Ascorbic Acid Deficiency
DE = ASCORBIC ACID DEFIC
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Vitamin C Deficiency|T047|NON|EQV|NLM (1994)|921110|abcdef
ENTRY = Deficiency, Ascorbic Acid|T047|NON|EQV|UNK (19XX)|860101|DEFIC ASCORBIC ACID|abcdefv
ENTRY = Deficiency, Vitamin C|T047|NON|EQV|UNK (19XX)|881108|DEFIC VITAMIN C|abcdefv
ENTRY = Ascorbic Acid Deficiencies
ENTRY = Deficiencies, Ascorbic Acid
ENTRY = Deficiencies, Vitamin C
ENTRY = Vitamin C Deficiencies
MN = C18.654.521.500.133.115
FX = Scurvy
MH_TH = NLM (1966)
ST = T047
AN = note X ref; DF: ASCORBIC ACID DEFIC
MS = A condition due to a dietary deficiency of ascorbic acid (vitamin C), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic alcoholism. (Cecil Textbook of Medicine, 19th ed, p1177)
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D001206

*NEWRECORD
RECTYPE = D
MH = Asepsis
AQ = HI IS MT ST
MN = N06.850.780.200.450.150.160
MH_TH = NLM (1975)
ST = T061
AN = differentiate from ANTISEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion
MS = The prevention of access by infecting organisms to the locus of potential infection.
OL = search ANTISEPSIS 1966-74
PM = 91; was see under ANTISEPSIS 1975-90
HN = 91(75); was see under ANTISEPSIS 1975-90
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D001207

*NEWRECORD
RECTYPE = D
MH = Asia
AQ = EH EP
ENTRY = Southern Asia|T083|NAM|NRW|POPLINE (1983)|861231|abcdef
MN = Z01.252
MH_TH = POPLINE (1978)
ST = T083
AN = several geog subdivisions & all Asiatic countries are available as headings
MS = The largest of the continents. It was known to the Romans more specifically as what we know today as Asia Minor. The name comes from at least two possible sources: from the Assyrian asu (to rise) or from the Sanskrit usa (dawn), both with reference to its being the land of the rising sun, i.e., eastern as opposed to Europe, to the west. (From Webster's New Geographical Dictionary, 1988, p82 & Room, Brewer's Dictionary of Names, 1992, p34)
MR = 19960610
DA = 19990101
DC = 4
UI = D001208

*NEWRECORD
RECTYPE = D
MH = Asia, Central
AQ = EH EP
MN = Z01.252.100
MH_TH = NLM (1982)
ST = T083
AN = a geog area; prefer specific countries
MS = The geographical area of Asia comprising KAZAKHSTAN; KYRGYZSTAN; TAJIKISTAN; TURKMENISTAN; and UZBEKISTAN. The desert region of Kara Kum (Qara Qum) is largely in Turkmenistan and the desert region of Kyzyl Kum (Kizil Kum or Qizil Qum), is in Uzbekistan and Kazakhstan. (From Webster's New Geographical Dictionary, 1988, p233, 590, 636)
HN = 82
MR = 20010725
DA = 19810227
DC = 4
DX = 19820101
UI = D001209

*NEWRECORD
RECTYPE = D
MH = Asia, Southeastern
AQ = EH EP
PRINT ENTRY = Southeast Asia|T083|NAM|EQV|NLM (1992)|910611|abcdef
ENTRY = Southeastern Asia|T083|NAM|EQV|POPLINE (1983)|861231|abcdef
MN = Z01.252.145
MH_TH = NLM (1966)
ST = T083
AN = a geog area; prefer specific countries
MS = The geographical area of Asia comprising BORNEO; BRUNEI; CAMBODIA; INDONESIA; LAOS; MALAYSIA; the MEKONG VALLEY; MYANMAR (formerly Burma), the PHILIPPINES; SINGAPORE; THAILAND; and VIETNAM.
MR = 20010725
DA = 19990101
DC = 4
UI = D001210

*NEWRECORD
RECTYPE = D
MH = Asia, Western
AQ = EH EP
ENTRY = Western Asia|T083|NAM|EQV|POPLINE (1983)|861231|abcdef
MN = Z01.252.245
MH_TH = NLM (1966)
ST = T083
AN = a geog area; prefer specific countries; MIDDLE EAST is also available
MS = The geographical designation for the countries of the MIDDLE EAST and the countries BANGLADESH; BHUTAN; INDIA; NEPAL; PAKISTAN; and SRI LANKA. (From Random House Unabridged Dictionary, 2d ed, 1993 & Webster's New Geographical Dictionary, 1988)
MR = 20010725
DA = 19990101
DC = 4
UI = D001211

*NEWRECORD
RECTYPE = D
MH = Asialoglycoproteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Desialylated Glycoproteins|T116|T123|NON|EQV|UNK (19XX)|840530|abbcdef
ENTRY = Glycoproteins, Desialylated
MN = D12.776.395.140
FX = Asialoglycoprotein Receptor
MH_TH = NLM (1985)
ST = T116
ST = T123
RN = 0
PI = Glycoproteins (1966-1984)
MS = Endogenous glycoproteins from which SIALIC ACID has been removed by the action of sialidases. They bind tightly to the ASIALOGLYCOPROTEIN RECEPTOR which is located on hepatocyte plasma membranes. After internalization by adsorptive ENDOCYTOSIS they are delivered to LYSOSOMES for degradation. Therefore receptor-mediated clearance of asialoglycoproteins is an important aspect of the turnover of plasma glycoproteins. They are elevated in serum of patients with HEPATIC CIRRHOSIS or HEPATITIS.
PM = 85
HN = 85
MR = 20050713
DA = 19840530
DC = 1
DX = 19850101
UI = D001212

*NEWRECORD
RECTYPE = D
MH = Asian Americans
AQ = CL ED EH GE HI LJ PX SN
PRINT ENTRY = Chinese Americans|T098|NON|NRW|UNK (19XX)|800512|abcdef
PRINT ENTRY = Japanese Americans|T098|NON|NRW|UNK (19XX)|800512|abcdef
PRINT ENTRY = Korean Americans|T098|NON|NRW|NLM (2005)|040406|abcdef
ENTRY = American, Asian
ENTRY = American, Chinese
ENTRY = American, Japanese
ENTRY = American, Korean
ENTRY = Americans, Asian
ENTRY = Americans, Chinese
ENTRY = Americans, Japanese
ENTRY = Americans, Korean
ENTRY = Asian American
ENTRY = Chinese American
ENTRY = Japanese American
ENTRY = Korean American
MN = M01.686.508.200.100
MN = M01.686.754.225
MH_TH = BIOETHICS (1998)
MH_TH = NLM (1981)
ST = T098
AN = Asian includes Far East, Southeast Asia, & the Indian subcontinent; despite X refs specify CHINA /ethnol, JAPAN /ethnol, KOREA/ethnol, or other Asiatic country with /ethnol (all NIM) when pertinent
PI = Ethnic Groups (1968-1974)
PI = United States (1966-1980)
PI = specific Asia heading (1966-1974) /ethnology (1975-1980)
PI = specific state (1966-1980)
MS = Persons living in the United States having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent.
PM = 81
HN = 81
MR = 20090730
DA = 19800512
DC = 1
DX = 19810101
UI = D001213

*NEWRECORD
RECTYPE = D
MH = Asparaginase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Asparaginase II|T116|T121|T126|NON|EQV|UNK (19XX)|810608|abbbcdef
ENTRY = Asparaginase medac|T116|T121|T126|TRD|NRW|DE|020806|abbbcdef
ENTRY = Asparagine Deaminase|T116|T121|T126|NON|EQV|UNK (19XX)|801120|abbbcdef
ENTRY = Bayer Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = Bellon Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = Christiaens Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = Colaspase|T116|T121|T126|NON|EQV|BAN (19XX)|800818|abbbcdef
ENTRY = Crasnitin|T116|T121|T126|TRD|NRW|NL|020806|abbbcdef
ENTRY = Elspar|T116|T121|T126|TRD|NRW|US|861119|abbbcdef
ENTRY = Erwinase|T116|T121|T126|TRD|NRW|DE|NLM (1996)|UK|950522|abbbcdeeef
ENTRY = Ispen Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = Kidrolase|T116|T121|T126|TRD|NRW|CA|FR|020806|abbbcdeef
ENTRY = Leunase|T116|T121|T126|TRD|NRW|AU|MX|020806|abbbcdeef
ENTRY = Merck Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = Paronal|T116|T121|T126|TRD|NRW|NL|020806|abbbcdef
ENTRY = Rhne-Poulenc Rorer Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = Sanfer Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = Speywood Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = medac Brand of Asparaginase|T116|T121|T126|NON|NRW|NLM (2004)|020806|abbbcdef
ENTRY = Asparaginase Bayer Brand
ENTRY = Asparaginase Bellon Brand
ENTRY = Asparaginase Christiaens Brand
ENTRY = Asparaginase Ispen Brand
ENTRY = Asparaginase Merck Brand
ENTRY = Asparaginase Sanfer Brand
ENTRY = Asparaginase Speywood Brand
ENTRY = Asparaginase medac Brand
ENTRY = Deaminase, Asparagine
ENTRY = Rhne Poulenc Rorer Brand of Asparaginase
ENTRY = medac, Asparaginase
MN = D08.811.277.087.116
PA = Antineoplastic Agents
MH_TH = USAN (1970)
ST = T116
ST = T121
ST = T126
N1 = L-Asparagine amidohydrolase
RN = EC 3.5.1.1
PI = Amidohydrolases (1966-1967)
MS = A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1.
PM = 68
HN = 68
MR = 20130709
DA = 19990101
DC = 1
DX = 19680101
UI = D001215

*NEWRECORD
RECTYPE = D
MH = Asparagine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = L-Asparagine|T116|T123|NON|EQV|NLM (2000)|991104|abbcdef
MN = D12.125.068.060
MN = D12.125.095.165
MN = D12.125.154.049
MH_TH = NLM (1966)
ST = T116
ST = T123
N1 = Asparagine
RN = 7006-34-0
RR = 70-47-3 (L-isomer)
AN = /biosyn /physiol permitted
MS = A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)
MR = 20010725
DA = 19990101
DC = 1
UI = D001216

*NEWRECORD
RECTYPE = D
MH = Aspartate-Ammonia Ligase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Asparagine Synthase|T116|T126|NON|EQV|NLM (1995)|940302|abbcdef
ENTRY = Asparagine Synthetase|T116|T126|NON|EQV|NLM (1995)|940302|abbcdef
ENTRY = Asparagine Synthetase B|T116|T126|NON|NRW|NLM (1997)|950713|abbcdef
ENTRY = Aspartate Ammonia Ligase
ENTRY = Ligase, Aspartate-Ammonia
ENTRY = Synthase, Asparagine
ENTRY = Synthetase B, Asparagine
ENTRY = Synthetase, Asparagine
MN = D08.811.464.259.200.200
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = L-Aspartate:ammonia ligase (AMP-forming)
RN = EC 6.3.1.1
RR = 9023-69-2 (CAS RN)
PI = Ammonia (1973-1974)
PI = Aspartic Acid (1973-1974)
PI = Ligases (1973-1974)
MS = An enzyme that catalyzes the formation of asparagine from ammonia and aspartic acid, in the presence of ATP. EC 6.3.1.1.
OL = use ASPARTATE-AMMONIA LIGASE to search ASPARAGINE SYNTHETASE 1975-94
PM = 95: was ASPARAGINE SYNTHETASE 1975-94 (see under LIGASES 1975-90)
HN = 95; was ASPARAGINE SYNTHETASE 1975-94 (see under LIGASES 1975-90)
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001217

*NEWRECORD
RECTYPE = D
MH = Aspartame
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Aspartylphenylalanine Methyl Ester|T116|NON|EQV|UNK (19XX)|820505|abcdef
ENTRY = Canderel|T116|T121|TRD|NRW|US|020806|abbcdef
ENTRY = Dittiques et Sant Brand of Aspartame|T116|T121|NON|NRW|NLM (2004)|020806|abbcdef
ENTRY = Fuca Brand of Aspartame|T116|T121|NON|NRW|NLM (2004)|020806|abbcdef
ENTRY = Goldswite|T116|T121|TRD|NRW|FR|020806|abbcdef
ENTRY = Hermes Brand of Aspartame|T116|T121|NON|NRW|NLM (2004)|020806|abbcdef
ENTRY = Hermesetas Gold|T116|T121|TRD|NRW|DE|020806|abbcdef
ENTRY = Methyl Aspartylphenylalanine|T116|NON|EQV|UNK (19XX)|820505|abcdef
ENTRY = Milisucre|T116|T121|TRD|NRW|FR|020806|abbcdef
ENTRY = Muro Brand of Aspartame|T116|T121|NON|NRW|NLM (2004)|020806|abbcdef
ENTRY = Nozucar|T116|T121|TRD|NRW|ES|020806|abbcdef
ENTRY = NutraSweet|T116|TRD|NRW|NLM (1993)|911113|abcdef
ENTRY = Prodes Brand of Aspartame|T116|T121|NON|NRW|NLM (2004)|020806|abbcdef
ENTRY = SC-18862|T116|LAB|NRW|UNK (19XX)|800731|abcdef
ENTRY = Tri-Sweet|T116|T168|TRD|NRW|NLM (1993)|911113|abbcdef
ENTRY = Aspartame Fuca Brand
ENTRY = Aspartame Hermes Brand
ENTRY = Aspartame Muro Brand
ENTRY = Aspartame Prodes Brand
ENTRY = Aspartylphenylalanine, Methyl
ENTRY = Gold, Hermesetas
ENTRY = Methyl Ester, Aspartylphenylalanine
ENTRY = SC 18862
ENTRY = SC18862
ENTRY = Tri Sweet
ENTRY = TriSweet
MN = D12.644.456.345.190
PA = Sweetening Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1971)
ST = T116
N1 = L-Phenylalanine, N-L-alpha-aspartyl-, 1-methyl ester
RN = Z0H242BBR1
RR = 22839-47-0 (Aspartame)
AN = D25-26 qualif
PI = Aspartic Acid (1974)
PI = Dipeptides (1974-1975)
PI = Phenylalanine (1974)
MS = Flavoring agent sweeter than sugar, metabolized as PHENYLALANINE and ASPARTIC ACID.
PM = 91; was see under DIPEPTIDES 1975-90
HN = 91(75); was see under DIPEPTIDES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001218

*NEWRECORD
RECTYPE = D
MH = Aspartate Aminotransferases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aspartate Aminotransferase|T116|T126|NON|EQV|NLM (1998)|960906|abbcdef
PRINT ENTRY = Aspartate Transaminase|T116|T126|NON|EQV|NLM (1966)|990101|abbcdef
PRINT ENTRY = Glutamic-Oxaloacetic Transaminase|T116|T126|NON|EQV|UNK (19XX)|740329|GLUTAMIC OXALOACETIC TRANS 000|abbcdefs
PRINT ENTRY = SGOT|T116|T126|ABB|REL|UNK (19XX)|740329|abbcdef
ENTRY = Aspartate Apoaminotransferase|T116|T126|NON|EQV|UNK (19XX)|821124|abbcdef
ENTRY = Glutamate-Aspartate Transaminase|T116|T126|NON|EQV|UNK (19XX)|830916|abbcdef
ENTRY = L-Aspartate-2-Oxoglutarate Aminotransferase|T116|T126|NON|EQV|UNK (19XX)|830330|abbcdef
ENTRY = Serum Glutamic-Oxaloacetic Transaminase|T116|T126|NON|REL|NLM (2002)|001002|abbcdef
ENTRY = Aminotransferase, Aspartate
ENTRY = Aminotransferase, L-Aspartate-2-Oxoglutarate
ENTRY = Aminotransferases, Aspartate
ENTRY = Apoaminotransferase, Aspartate
ENTRY = Glutamate Aspartate Transaminase
ENTRY = Glutamic Oxaloacetic Transaminase
ENTRY = Glutamic-Oxaloacetic Transaminase, Serum
ENTRY = L Aspartate 2 Oxoglutarate Aminotransferase
ENTRY = Serum Glutamic Oxaloacetic Transaminase
ENTRY = Transaminase, Aspartate
ENTRY = Transaminase, Glutamate-Aspartate
ENTRY = Transaminase, Glutamic-Oxaloacetic
ENTRY = Transaminase, Serum Glutamic-Oxaloacetic
MN = D08.811.913.477.700.225
MH_TH = NLM (2002)
ST = T116
ST = T126
N1 = L-Aspartate:2-oxoglutarate aminotransaminase
RN = EC 2.6.1.1
AN = note specifics
MS = Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.
PM = 2002; see ASPARTATE TRANSAMINASE 1998-2002, see ASPARTATE AMINOTRANSFERASE 1963-1997
HN = 2002(1963)
MR = 20150708
DA = 19990101
DC = 1
UI = D001219

*NEWRECORD
RECTYPE = D
MH = Aspartate Ammonia-Lyase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aspartase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Fumaric Aminase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Aminase, Fumaric
ENTRY = Ammonia-Lyase, Aspartate
ENTRY = Aspartate Ammonia Lyase
MN = D08.811.520.232.400.200
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = L-Aspartate ammonia-lyase
RN = EC 4.3.1.1
RR = 9027-30-9 (CAS RN)
PI = Ammonia-Lyases (1973-1974)
PI = Aspartic Acid (1973-1974)
MS = An enzyme that catalyzes the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms. EC 4.3.1.1.
PM = 91; was see under AMMONIA-LYASES 1975-90
HN = 91(75); was see under AMMONIA-LYASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001220

*NEWRECORD
RECTYPE = D
MH = Aspartate Carbamoyltransferase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aspartate Transcarbamylase|T116|T126|NON|EQV|UNK (19XX)|760317|abbcdef
ENTRY = Co(II)-Aspartate Transcarbamoylase|T116|T126|NRW|UNK (19XX)|830916|abbdef
ENTRY = Ni(II)-Aspartate Transcarbamoylase|T116|T126|NRW|UNK (19XX)|830916|abbdef
ENTRY = Carbamoyltransferase, Aspartate
ENTRY = Transcarbamylase, Aspartate
MN = D08.811.641.500
MN = D08.811.913.555.275.200
MH_TH = NLM (1964)
ST = T116
ST = T126
N1 = Carbamoyl-phosphate:L-aspartate carbamoyltransferase
RN = EC 2.1.3.2
RR = 9012-49-1 (CAS RN)
MS = An enzyme that catalyzes the conversion of carbamoyl phosphate and L-aspartate to yield orthophosphate and N-carbamoyl-L-aspartate. (From Enzyme Nomenclature, 1992) EC 2.1.3.2.
PM = 73
HN = 73
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D001221

*NEWRECORD
RECTYPE = D
MH = Aspartate Kinase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aspartokinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Aspartate Kinase I|T116|T126|NON|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Aspartate Kinase II|T116|T126|NON|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Aspartate Kinase III|T116|T126|NON|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Aspartyl Kinase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Kinase I, Aspartate
ENTRY = Kinase II, Aspartate
ENTRY = Kinase III, Aspartate
ENTRY = Kinase, Aspartate
ENTRY = Kinase, Aspartyl
MN = D08.811.913.696.630.050
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = ATP:L-aspartate 4-phosphotransferase
RN = EC 2.7.2.4
RR = 9012-50-4 (CAS RN)
PI = Aspartic Acid (1974)
PI = Phosphotransferases, ATP (1974)
MS = An enzyme that catalyzes the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine. EC 2.7.2.4.
PM = 91; was see under PHOSPHOTRANSFERASES, ATP 1975-90
HN = 91(75); was see under PHOSPHOTRANSFERASES, ATP 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001222

*NEWRECORD
RECTYPE = D
MH = Aspartate-Semialdehyde Dehydrogenase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Semiaspartate Aldehyde Dehydrogenase|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Aldehyde Dehydrogenase, Semiaspartate
ENTRY = Aspartate Semialdehyde Dehydrogenase
ENTRY = Dehydrogenase, Aspartate-Semialdehyde
ENTRY = Dehydrogenase, Semiaspartate Aldehyde
MN = D08.811.682.657.163.374
MH_TH = NLM (1965)
ST = T116
ST = T126
N1 = L-Aspartate-4-semialdehyde:NADP+ oxidoreductase (phosphorylating)
RN = EC 1.2.1.11
MS = An enzyme that catalyzes the conversion of L-aspartate 4-semialdehyde, orthophosphate, and NADP+ to yield L-4-aspartyl phosphate and NADPH. EC 1.2.1.11.
PM = 65
HN = 65
MR = 20050630
DA = 19990101
DC = 1
DX = 19650101
UI = D001223

*NEWRECORD
RECTYPE = D
MH = Aspartic Acid
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = (+-)-Aspartic Acid|T116|NON|BRD|NLM (2009)|071218|abcdef
ENTRY = (R,S)-Aspartic Acid|T116|NON|BRD|NLM (2009)|071218|abcdef
ENTRY = Ammonium Aspartate|T116|T123|NON|NRW|NLM (2009)|071012|abbcdef
ENTRY = Aspartate|T116|T123|NON|NRW|FDA SRS (2014)|UNK (19XX)|840521|abbcdeef
ENTRY = Aspartate Magnesium Hydrochloride|T116|T123|NON|NRW|FDA SRS (2014)|NLM (1989)|890208|abbcdeef
ENTRY = Aspartic Acid, Ammonium Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Calcium Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Dipotassium Salt|T116|T123|NON|NRW|FDA SRS (2014)|NLM (1999)|990913|abbcdeef
ENTRY = Aspartic Acid, Disodium Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Hydrobromide|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Hydrochloride|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Magnesium (2:1) Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Magnesium-Potassium (2:1:2) Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Monopotassium Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Monosodium Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Potassium Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Aspartic Acid, Sodium Salt|T116|T123|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcium Aspartate|T116|T123|NON|NRW|FDA SRS (2014)|NLM (2009)|071012|abbcdeef
ENTRY = Dipotassium Aspartate|T116|T123|NON|NRW|FDA SRS (2014)|NLM (2009)|071012|abbcdeef
ENTRY = Disodium Aspartate|T116|T123|NON|NRW|FDA SRS (2014)|NLM (2009)|071012|abbcdeef
ENTRY = L-Aspartate|T116|T123|NON|NRW|UNK (19XX)|870114|abbcdef
ENTRY = L-Aspartic Acid|T116|T123|NON|EQV|FDA SRS (2014)|NLM (2000)|991105|abbcdeef
ENTRY = Magnesiocard|T116|T121|TRD|NRW|NLM (1992)|910311|abbcdef
ENTRY = Magnesium Aspartate|T116|T123|NON|NRW|FDA SRS (2014)|UNK (19XX)|810728|abbcdeef
ENTRY = Mg-5-Longoral|T116|T121|TRD|NRW|NLM (1992)|910311|abbcdef
ENTRY = Monopotassium Aspartate|T116|T123|NON|NRW|NLM (2009)|071012|abbcdef
ENTRY = Monosodium Aspartate|T116|T123|NON|NRW|NLM (2009)|071012|abbcdef
ENTRY = Potassium Aspartate|T116|T123|NON|NRW|FDA SRS (2014)|UNK (19XX)|810728|abbcdeef
ENTRY = Sodium Aspartate|T116|T123|NON|NRW|FDA SRS (2014)|UNK (19XX)|811218|abbcdeef
ENTRY = Aspartate, Ammonium
ENTRY = Aspartate, Calcium
ENTRY = Aspartate, Dipotassium
ENTRY = Aspartate, Disodium
ENTRY = Aspartate, Magnesium
ENTRY = Aspartate, Monopotassium
ENTRY = Aspartate, Monosodium
ENTRY = Aspartate, Potassium
ENTRY = Aspartate, Sodium
ENTRY = Hydrobromide Aspartic Acid
ENTRY = Hydrochloride Aspartic Acid
ENTRY = Hydrochloride, Aspartate Magnesium
ENTRY = L Aspartate
ENTRY = L Aspartic Acid
ENTRY = Mg 5 Longoral
ENTRY = Mg5Longoral
MN = D12.125.067.500
MN = D12.125.119.170
MN = D12.125.427.040
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1979)
MH_TH = USP (19XX)
ST = T116
ST = T123
N1 = L-Aspartic Acid
RN = 30KYC7MIAI
RR = 10139-86-3
RR = 1115-63-5
RR = 14007-45-5 (Potassium Aspartate)
RR = 17090-93-6 (Sodium Aspartate)
RR = 17585-59-0
RR = 2001-89-0 (Dipotassium Aspartate)
RR = 2068-80-6 (Magnesium Aspartate)
RR = 21059-46-1 (Calcium Aspartate)
RR = 30697-27-9
RR = 32259-99-7
RR = 3792-50-5
RR = 48MC6MXP9X
RR = 5598-53-8 (Disodium Aspartate)
RR = 56-84-8 (Aspartic Acid)
RR = 5LK942W2PC
RR = 617-45-8
RR = 72231-13-1 (Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate)
RR = 74X989P9A6
RR = OC4598NZEQ
RR = R17X820ROL
RR = SV5R735TZQ
RR = T9680JD4IY
AN = D-ASPARTIC ACID is also available
MS = One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
OL = use ASPARTIC ACID (NM) to search ISOASPARTIC ACID 1990-92
PM = 93; ISOASPARTIC ACID was indexed under ASPARTIC ACID 1990-92
HN = 93; ISOASPARTIC ACID was (NM) 1990-92
MR = 20130708
DA = 19990101
DC = 1
UI = D001224

*NEWRECORD
RECTYPE = D
MH = Aspartokinase Homoserine Dehydrogenase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Aspartokinase I Homoserine Dehydrogenase I|T116|T126|NON|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Aspartokinase II Homoserine Dehydrogenase II|T116|T126|NON|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Bifunctional Aspartokinase-Homoserine Dehydrogenase|T116|T126|NON|EQV|NLM (2014)|130122|abbcdef
ENTRY = Bifunctional Aspartokinase-Homoserine Dehydrogenase 1|T116|T126|NON|NRW|NLM (2014)|130122|abbcdef
ENTRY = Bifunctional Aspartokinase-Homoserine Dehydrogenase 2|T116|T126|NON|NRW|NLM (2014)|130122|abbcdef
ENTRY = Aspartokinase-Homoserine Dehydrogenase, Bifunctional
ENTRY = Bifunctional Aspartokinase Homoserine Dehydrogenase
ENTRY = Bifunctional Aspartokinase Homoserine Dehydrogenase 1
ENTRY = Bifunctional Aspartokinase Homoserine Dehydrogenase 2
ENTRY = Dehydrogenase, Aspartokinase Homoserine
ENTRY = Dehydrogenase, Bifunctional Aspartokinase-Homoserine
ENTRY = Homoserine Dehydrogenase, Aspartokinase
MN = D08.811.641.750
MN = D08.811.682.047.820.300.060
MN = D08.811.913.696.630.050.050
MH_TH = NLM (1976)
ST = T116
ST = T126
RN = EC 2.7.2.4
RR = EC 1.1.1.3
PI = Alcohol Oxidoreductases (1973-1975)
PI = Aspartic Acid (1973-1975)
PI = Homoserine (1973-1975)
PI = Multienzyme Complexes (1973-1975)
PI = Phosphotransferases, ATP (1974-1975)
MS = A bifunctional protein consisting of aspartokinase, and homoserine dehydrogenase activities. It is found primarily in BACTERIA and in PLANTS.
PM = 91; was see under MULTIENZYME COMPLEXES 1976-90
HN = 91(76); was see under MULTIENZYME COMPLEXES 1976-90
MR = 20130708
DA = 19750723
DC = 1
DX = 19910101
UI = D001225

*NEWRECORD
RECTYPE = D
MH = Aspartate-tRNA Ligase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aspartyl T RNA Synthetase|T116|T126|EQV|NLM (1998)|961105|abbdef
ENTRY = Asp-tRNA Ligase|T116|T126|NON|EQV|NLM (2001)|000316|abbcdef
ENTRY = Aspartyl-tRNA Synthetase|T116|T126|NON|EQV|NLM (2001)|000316|abbcdef
ENTRY = Asp tRNA Ligase
ENTRY = Aspartate tRNA Ligase
ENTRY = Aspartyl tRNA Synthetase
ENTRY = Ligase, Asp-tRNA
ENTRY = Ligase, Aspartate-tRNA
ENTRY = Synthetase, Aspartyl-tRNA
MN = D08.811.464.263.200.150
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = L-Aspartate:tRNA-(Asp) ligase (AMP-forming)
RN = EC 6.1.1.12
PI = Amino Acyl T RNA Synthetases (1973-1974)
PI = Aspartic Acid (1973-1974)
MS = An enzyme that activates aspartic acid with its specific transfer RNA. EC 6.1.1.12.
PM = 98; see ASPARTYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90
HN = 98(75)
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001226

*NEWRECORD
RECTYPE = D
MH = Aspartylglucosylaminase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Aspartylglucosaminidase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Aspartylglucosylamine Deaspartylase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Aspartylglycosamine Amidohydrolase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Aspartylglucosamine Amidohydrolase|T116|T126|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = Glycosylasparaginase|T116|T126|NON|EQV|UNK (19XX)|880808|abbcdef
ENTRY = Amidohydrolase, Aspartylglucosamine
ENTRY = Amidohydrolase, Aspartylglycosamine
ENTRY = Deaspartylase, Aspartylglucosylamine
MN = D08.811.277.087.125
EC = deficiency:Aspartylglucosaminuria
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = N(4)-(beta-N-Acetyl-D-glucosaminyl)-L-asparagine amidohydrolase
RN = EC 3.5.1.26
PI = Amidohydrolases (1970-1974)
PI = Aspartic Acid (1970-1974)
PI = Glucosamine (1970-1974)
MS = An enzyme that catalyzes the conversion of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine and water to N-acetyl-beta-D-glucosaminylamine and L-aspartate. It acts only on asparagine-oligosaccharides containing one amino acid, i.e. the ASPARAGINE has free alpha-amino and alpha-carboxyl groups. (From Enzyme Nomenclature, 1992)
PM = 91; was see under AMIDOHYDROLASES 1975-90
HN = 91(75); was see under AMIDOHYDROLASES 1975-90
MR = 20080708
DA = 19741119
DC = 1
DX = 19910101
UI = D001227

*NEWRECORD
RECTYPE = D
MH = Aspergillosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Aspergilloses
MN = C01.539.800.200.383.249
MN = C01.703.295.328.249
MN = C17.800.838.208.416.249
MH_TH = NLM (1966)
ST = T047
AN = specify species (IM) if pertinent; coordinate IM with precoordinated organ/disease term (IM); note PULMONARY ASPERGILLOSIS and specifics and NEUROASPERGILLOSIS are also available
MS = Infections with fungi of the genus ASPERGILLUS.
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001228

*NEWRECORD
RECTYPE = D
MH = Aspergillosis, Allergic Bronchopulmonary
DE = ABPA
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Allergic Bronchopulmonary Aspergillosis|T047|NON|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|780519|ALLERGIC BRONCHOPULM ASPERG|abcdeeefv
ENTRY = Allergic Bronchopulmonary Aspergilloses|T047|NON|EQV|NLM (1992)|900925|abcdef
ENTRY = Aspergilloses, Allergic Bronchopulmonary|T047|NON|EQV|NLM (1992)|900925|ASPERG ALLERGIC BRONCHOPULM|abcdefv
ENTRY = Aspergillosis, Bronchopulmonary Allergic|T047|NON|EQV|NLM (1992)|901108|ASPERG BRONCHOPULM ALLERGIC|abcdefv
ENTRY = Bronchopulmonary Aspergilloses, Allergic|T047|NON|EQV|NLM (1992)|900925|abcdef
ENTRY = Bronchopulmonary Aspergillosis, Allergic|T047|NON|EQV|NLM (1992)|900925|BRONCHOPULM ASPERG ALLERGIC|abcdefv
ENTRY = Allergic Aspergilloses, Bronchopulmonary
ENTRY = Allergic Aspergillosis, Bronchopulmonary
ENTRY = Aspergilloses, Bronchopulmonary Allergic
ENTRY = Bronchopulmonary Allergic Aspergilloses
ENTRY = Bronchopulmonary Allergic Aspergillosis
MN = C01.539.800.200.383.249.074
MN = C01.703.295.328.249.074
MN = C01.703.534.090
MN = C08.381.472.850.500
MN = C08.674.060
MN = C08.730.435.090
MN = C17.800.838.208.416.249.074
MN = C20.543.480.680.085
MH_TH = NLM (1979)
MH_TH = ORD (2010)
ST = T047
AN = do not coordinate with BRONCHIAL DISEASES; DF: ABPA or ALLERGIC BRONCHOPULM ASPERG
PI = Aspergillosis (1966-1978)
PI = Lung Diseases, Fungal (1966-1978)
PI = Respiratory Hypersensitivity (1966-1978)
MS = Hypersensitivity reaction (ALLERGIC REACTION) to fungus ASPERGILLUS in an individual with long-standing BRONCHIAL ASTHMA. It is characterized by pulmonary infiltrates, EOSINOPHILIA, elevated serum IMMUNOGLOBULIN E, and skin reactivity to Aspergillus antigen.
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20150622
DA = 19780519
DC = 1
DX = 19790101
UI = D001229

*NEWRECORD
RECTYPE = D
MH = Aspergillus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B01.300.381.081
MH_TH = NLM (1966)
ST = T004
AN = GEN or unspecified; prefer specific genera; infection = ASPERGILLOSIS
MS = A genus of mitosporic fungi containing about 100 species and eleven different teleomorphs in the family Trichocomaceae.
MR = 20090706
DA = 19990101
DC = 1
UI = D001230

*NEWRECORD
RECTYPE = D
MH = Aspergillus flavus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = flavus, Aspergillus
MN = B01.300.381.081.170
FX = Aflatoxins
MH_TH = NLM (1972)
ST = T004
AN = infection: coord IM with ASPERGILLOSIS (IM)
PI = Aspergillus (1966-1971)
MS = A species of imperfect fungi which grows on peanuts and other plants and produces the carcinogenic substance aflatoxin. It is also used in the production of the antibiotic flavicin.
PM = 74
HN = 74(72)
MR = 20090706
DA = 19990101
DC = 1
DX = 19740101
UI = D001231

*NEWRECORD
RECTYPE = D
MH = Aspergillus fumigatus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = fumigatus, Aspergillus
MN = B01.300.381.081.295
MH_TH = NLM (1972)
ST = T004
AN = infection: coord IM with ASPERGILLOSIS (IM)
PI = Aspergillus (1966-1971)
MS = A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals.
PM = 74
HN = 74(72)
MR = 20090706
DA = 19990101
DC = 1
DX = 19740101
UI = D001232

*NEWRECORD
RECTYPE = D
MH = Aspergillus nidulans
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Aspergillus nidulan
ENTRY = nidulan, Aspergillus
ENTRY = nidulans, Aspergillus
MN = B01.300.381.081.420
MH_TH = NLM (1972)
ST = T004
AN = infection: coord IM with ASPERGILLOSIS (IM)
PI = Aspergillus (1966-1971)
MS = A species of imperfect fungi from which the antibiotic nidulin is obtained. Its teleomorph is Emericella nidulans.
PM = 74
HN = 74(72)
MR = 20090706
DA = 19990101
DC = 1
DX = 19740101
UI = D001233

*NEWRECORD
RECTYPE = D
MH = Aspergillus niger
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Aspergillus nigers
ENTRY = niger, Aspergillus
ENTRY = nigers, Aspergillus
MN = B01.300.381.081.450
MH_TH = NLM (1975)
ST = T004
AN = infection: coord IM with ASPERGILLOSIS (IM)
PI = Aspergillus (1966-1974)
MS = An imperfect fungus causing smut or black mold of several fruits, vegetables, etc.
PM = 78; see ASPERGILLUS 1975-77
HN = 78(75)
MR = 20090706
DA = 19741212
DC = 1
DX = 19780101
UI = D001234

*NEWRECORD
RECTYPE = D
MH = Aspergillus ochraceus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = ochraceus, Aspergillus
MN = B01.300.381.081.480
MH_TH = NLM (1986)
ST = T004
PI = Aspergillus (1966-1985)
MS = An imperfect fungus that produces ochratoxins and contaminates EDIBLE GRAIN and coffee beans.
PM = 91; was see under ASPERGILLUS 1986-90
HN = 91(86); was see under ASPERGILLUS 1986-90
MR = 20150713
DA = 19850211
DC = 1
DX = 19910101
UI = D001235

*NEWRECORD
RECTYPE = D
MH = Aspergillus oryzae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = oryzae, Aspergillus
MN = B01.300.381.081.500
MH_TH = NLM (1975)
ST = T004
MS = An imperfect fungus present on most agricultural seeds and often responsible for the spoilage of seeds in bulk storage. It is also used in the production of fermented food or drink, especially in Japan.
PM = 91; see ASPERGILLUS 1975-90
HN = 91(75)
MR = 20090706
DA = 19741212
DC = 1
DX = 19910101
UI = D001236

*NEWRECORD
RECTYPE = D
MH = Asphyxia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Suffocation|T033|T046|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Asphyxias
ENTRY = Suffocations
MN = C23.550.260.095
MN = C26.103
EC = congenital:Asphyxia Neonatorum
MH_TH = NLM (1966)
ST = T033
ST = T046
AN = in newborn inf = ASPHYXIA NEONATORUM + tag INFANT, NEWBORN; choking: use AIRWAY OBSTRUCTION
MS = A pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001237

*NEWRECORD
RECTYPE = D
MH = Asphyxia Neonatorum
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
MN = C16.614.092
MH_TH = NLM (1966)
ST = T047
AN = do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; tag INFANT, NEWBORN
MS = Respiratory failure in the newborn. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D001238

*NEWRECORD
RECTYPE = D
MH = Inhalation
AQ = DE ES GE IM PH RE
PRINT ENTRY = Inhaling|T042|NON|EQV|NLM (1990)|890520|abcdef
ENTRY = Inspiration, Respiratory|T042|NON|EQV|NLM (2004)|030311|abcdef
ENTRY = Respiratory Inspiration
MN = G09.772.770.755.700.390
MH_TH = NLM (2004)
ST = T042
MS = The act of BREATHING in.
PM = 2004; see ASPIRATION 1991-2003; was see under RESPIRATION 1966-1990
HN = 2004(1966); was see under RESPIRATION 1966-1990
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19910101
UI = D001239

*NEWRECORD
RECTYPE = D
MH = Aspirations (Psychology)
DE = ASPIRATIONS PSYCHOL
ENTRY = Aspiration (Psychology)|T041|NON|EQV|NLM (1992)|901016|ASPIRATION PSYCHOL|abcdefv
ENTRY = Aspirations|T041|NON|EQV|POPLINE (1986)|790326|abcdef
MN = F01.658.100
MN = F02.784.629.155
MH_TH = NLM (1975)
ST = T041
AN = no qualif; DF: ASPIRATIONS
PI = Motivation (1966-1974)
MS = Strong desires to accomplish something. This usually pertains to greater values or high ideals.
PM = 75
HN = 75
CATSH = CAT LIST
MR = 19930604
DA = 19741111
DC = 1
DX = 19750901
UI = D001240

*NEWRECORD
RECTYPE = D
MH = Aspirin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetylsalicylic Acid|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef
ENTRY = 2-(Acetyloxy)benzoic Acid|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1995)|931206|abbcdeef
ENTRY = Acetysal|T109|T121|TRD|NRW|UNK (19XX)|800813|abbcdef
ENTRY = Acylpyrin|T109|T121|TRD|NRW|UNK (19XX)|800821|abbcdef
ENTRY = Aloxiprimum|T109|T121|TRD|REL|UNK (19XX)|850528|abbcdef
ENTRY = Colfarit|T109|T121|TRD|NRW|UNK (19XX)|840919|abbcdef
ENTRY = Dispril|T109|T121|TRD|NRW|UNK (19XX)|861118|abbcdef
ENTRY = Easprin|T109|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Ecotrin|T109|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Endosprin|T109|T121|TRD|NRW|UNK (19XX)|850528|abbcdef
ENTRY = Magnecyl|T109|T121|TRD|NRW|UNK (19XX)|800801|abbcdef
ENTRY = Micristin|T109|T121|TRD|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Polopirin|T109|T121|TRD|REL|UNK (19XX)|850103|abbcdef
ENTRY = Polopiryna|T109|T121|TRD|NRW|UNK (19XX)|810728|abbcdef
ENTRY = Solprin|T109|T121|TRD|NRW|UNK (19XX)|850103|abbcdef
ENTRY = Solupsan|T109|T121|TRD|REL|UNK (19XX)|840918|abbcdef
ENTRY = Zorprin|T109|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Acid, Acetylsalicylic
MN = D02.455.426.559.389.657.410.595.176
PA = Anti-Inflammatory Agents, Non-Steroidal
PA = Antipyretics
PA = Cyclooxygenase Inhibitors
PA = Fibrinolytic Agents
PA = Platelet Aggregation Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = JAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzoic acid, 2-(acetyloxy)-
RN = R16CO5Y76E
RR = 50-78-2 (Aspirin)
MS = The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
PM = 65; was ACETYLSALICYLIC ACID 1963-64
HN = 65; was ACETYLSALICYLIC ACID 1963-64
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D001241

*NEWRECORD
RECTYPE = D
MH = Assertiveness
ENTRY = Assertivenesses
MN = F01.752.049
MH_TH = NLM (1980)
ST = T055
AN = no qualif; assertiveness training: coord IM with BEHAVIOR THERAPY (IM)
PI = Aggression (1966-1979)
MS = Strongly insistent, self-assured, and demanding behavior.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 19970620
DA = 19790411
DC = 1
DX = 19800101
UI = D001242

*NEWRECORD
RECTYPE = D
MH = Assisted Circulation
DE = ASSISTED CIRC
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Circulation, Assisted|T061|NON|EQV|NLM (1994)|921001|CIRC ASSISTED|abcdefv
MN = E04.050
FX = Heart-Assist Devices
MH_TH = NLM (1967)
ST = T061
AN = do not use /util except by MeSH definition; do not confuse with EXTRACORPOREAL CIRCULATION or its specifics; DF: ASSISTED CIRC
PI = Heart-Lung Machine (1966)
MS = Pumping that aids the natural activity of the heart. (Dorland, 27th ed)
PM = 67
HN = 67
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
DX = 19670101
UI = D001243

*NEWRECORD
RECTYPE = D
MH = Association
DE = ASSOC
ENTRY = Associations
MN = F02.463.425.069
MN = F04.754.720.346
FX = Word Association Tests
MH_TH = NLM (1965)
ST = T041
AN = a psychol or learning context; no qualif; DF: ASSOC
MS = A functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established.
PM = 66
HN = 66(65)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19660101
UI = D001244

*NEWRECORD
RECTYPE = D
MH = Association Learning
DE = ASSOC LEARNING
AQ = CL DE ES PH RE
ENTRY = Association Learnings
ENTRY = Learning, Association
ENTRY = Learnings, Association
MN = F02.463.425.069.296
MH_TH = NLM (1975)
ST = T041
AN = a form of learning; DF: ASSOC LEARNING
MS = The principle that items experienced together enter into a connection, so that one tends to reinstate the other.
OL = search LEARNING 1966-74
PM = 91; was see under LEARNING 1975-90
HN = 91(75); was see under LEARNING 1975-90
CATSH = CAT LIST
MR = 19940512
DA = 19990101
DC = 1
DX = 19910101
UI = D001245

*NEWRECORD
RECTYPE = D
MH = Astatine
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.268.271.110
MN = D01.268.380.075
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T121
ST = T196
N1 = Astatine
RN = XI595HAL7H
RR = 7440-68-8 (Astatine)
AN = naturally radioactive; IM
MS = Astatine. A radioactive halogen with the atomic symbol At, atomic number 85, and atomic weight 210. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism.
MR = 20130708
DA = 19990101
DC = 1
UI = D001246

*NEWRECORD
RECTYPE = D
MH = Asthenia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Asthenias
MN = C23.888.089
FX = Fatigue
FX = Muscle Weakness
FX = Neurasthenia
MH_TH = NLM (1966)
ST = T047
AN = NEUROCIRCULATORY ASTHENIA is also available
MS = Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D001247

*NEWRECORD
RECTYPE = D
MH = Asthenopia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Eye Fatigue|T047|NON|EQV|NLM (1998)|960729|abcdef
PRINT ENTRY = Eyestrain|T047|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Fatigue, Visual|T047|NON|EQV|NLM (1995)|940214|abcdef
PRINT ENTRY = Visual Fatigue|T047|NON|EQV|NLM (1995)|930913|abcdef
ENTRY = Fatigue, Eye
MN = C11.093
MH_TH = NLM (1966)
ST = T047
AN = ocular fatigue
MS = Term generally used to describe complaints related to refractive error, ocular muscle imbalance, including pain or aching around the eyes, burning and itchiness of the eyelids, ocular fatigue, and headaches.
OL = use ASTHENOPIA to search EYESTRAIN 1966-67
PM = EYESTRAIN was heading 1963-67
HN = EYESTRAIN was heading 1963-67
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001248

*NEWRECORD
RECTYPE = D
MH = Asthma
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Asthma, Bronchial|T047|NON|EQV|UNK (19XX)|840210|abcdef
PRINT ENTRY = Bronchial Asthma|T047|NON|EQV|UNK (19XX)|840210|abcdef
ENTRY = Asthmas
MN = C08.127.108
MN = C08.381.495.108
MN = C08.674.095
MN = C20.543.480.680.095
FX = Anti-Asthmatic Agents
MH_TH = NLM (1966)
ST = T047
AN = note specifics; ASTHMA, CARDIAC see DYSPNEA, PAROXYSMAL is also available; in historical literature consider indexing "phthisic" here; "phthisis" probably goes under TUBERCULOSIS, PULMONARY
MS = A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001249

*NEWRECORD
RECTYPE = D
MH = Asthma, Exercise-Induced
DE = ASTHMA EXERCISE IND
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bronchospasm, Exercise-Induced|T047|NON|NRW|UNK (19XX)|790305|BRONCHOSPASM EXERCISE IND|abcdefv
PRINT ENTRY = Exercise-Induced Asthma|T047|NON|EQV|UNK (19XX)|780512|EXERCISE IND ASTHMA|abcdefv
PRINT ENTRY = Exercise-Induced Bronchospasm|T047|NON|NRW|UNK (19XX)|780512|EXERCISE IND BRONCHOSPASM|abcdefv
ENTRY = Asthma, Exercise Induced
ENTRY = Asthmas, Exercise-Induced
ENTRY = Bronchospasm, Exercise Induced
ENTRY = Bronchospasms, Exercise-Induced
ENTRY = Exercise Induced Asthma
ENTRY = Exercise Induced Bronchospasm
ENTRY = Exercise-Induced Asthmas
ENTRY = Exercise-Induced Bronchospasms
MN = C08.127.108.110
MN = C08.674.095.110
MN = C20.543.480.680.095.110
FX = Vocal Cord Dysfunction
MH_TH = NLM (1979)
ST = T047
PI = Asthma (1966-1978)
PI = Bronchial Spasm (1966-1978)
PI = Exertion (1966-1978)
MS = Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it).
PM = 91; was see under ASTHMA 1979-90
HN = 91(79); was see under ASTHMA 1979-90
CATSH = CAT LIST
MR = 20130708
DA = 19780512
DC = 1
DX = 19910101
UI = D001250

*NEWRECORD
RECTYPE = D
MH = Astigmatism
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
MN = C11.744.212
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
ST = T047
AN = refractive error
MS = Unequal curvature of the refractive surfaces of the eye. Thus a point source of light cannot be brought to a point focus on the retina but is spread over a more or less diffuse area. This results from the radius of curvature in one plane being longer or shorter than the radius at right angles to it. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D001251

*NEWRECORD
RECTYPE = D
MH = Astringents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Astringent Effect|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Astringent Effects|T039|NON|REL|NLM (2012)|110329|abcdef
ENTRY = Effect, Astringent
ENTRY = Effects, Astringent
MN = D27.505.696.207
MN = D27.505.954.444.100
MH_TH = NLM (1966)
ST = T121
RN = 0
MS = Agents, usually topical, that cause the contraction of tissues for the control of bleeding or secretions.
OL = use ASTRINGENTS to search ANTIPERSPIRANTS 1985-94
PM = ANTIPERSPIRANTS was see ASTRINGENTS 1985-94
HN = ANTIPERSPIRANTS was see ASTRINGENTS 1985-94
MR = 20110624
DA = 19990101
DC = 1
UI = D001252

*NEWRECORD
RECTYPE = D
MH = Astrocytes
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Astroglia|T025|NON|EQV|NLM (1994)|920827|abcdef
ENTRY = Astrocyte
ENTRY = Astroglias
MN = A08.637.200
MN = A11.650.200
FX = Blood-Brain Barrier
MH_TH = NLM (1975)
ST = T025
PI = Neuroglia (1966-1974)
MS = A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury.
OL = search NEUROGLIA 1966-74
PM = 79; was see under NEUROGLIA 1963-78
HN = 79(75); was see under NEUROGLIA 1963-78
MR = 20010725
DA = 19990101
DC = 1
DX = 19790101
UI = D001253

*NEWRECORD
RECTYPE = D
MH = Astrocytoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Astrocytoma, Subependymal Giant Cell|T191|NON|NRW|NLM (1994)|930326|abcdef
PRINT ENTRY = Glioma, Astrocytic|T191|NON|EQV|NLM (2000)|991108|abcdef
PRINT ENTRY = Oligoastrocytoma, Mixed|T191|NON|REL|NLM (2000)|991108|abcdef
ENTRY = Anaplastic Astrocytoma|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Astrocytoma, Grade I|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Astrocytoma, Grade II|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Astrocytoma, Grade III|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Astrocytoma, Protoplasmic|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Astroglioma|T191|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Cerebral Astrocytoma|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Childhood Cerebral Astrocytoma|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Fibrillary Astrocytoma|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Gemistocytic Astrocytoma|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Intracranial Astrocytoma|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Juvenile Pilocytic Astrocytoma|T191|NON|NRW|NLM (2000)|ORD (2010)|991108|abcdeef
ENTRY = Pilocytic Astrocytoma|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Subependymal Giant Cell Astrocytoma|T191|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Anaplastic Astrocytomas
ENTRY = Astrocytic Glioma
ENTRY = Astrocytic Gliomas
ENTRY = Astrocytoma, Anaplastic
ENTRY = Astrocytoma, Cerebral
ENTRY = Astrocytoma, Childhood Cerebral
ENTRY = Astrocytoma, Fibrillary
ENTRY = Astrocytoma, Gemistocytic
ENTRY = Astrocytoma, Intracranial
ENTRY = Astrocytoma, Juvenile Pilocytic
ENTRY = Astrocytoma, Pilocytic
ENTRY = Astrocytomas
ENTRY = Astrocytomas, Anaplastic
ENTRY = Astrocytomas, Cerebral
ENTRY = Astrocytomas, Childhood Cerebral
ENTRY = Astrocytomas, Fibrillary
ENTRY = Astrocytomas, Gemistocytic
ENTRY = Astrocytomas, Grade I
ENTRY = Astrocytomas, Grade II
ENTRY = Astrocytomas, Grade III
ENTRY = Astrocytomas, Intracranial
ENTRY = Astrocytomas, Juvenile Pilocytic
ENTRY = Astrocytomas, Pilocytic
ENTRY = Astrocytomas, Protoplasmic
ENTRY = Astrogliomas
ENTRY = Cerebral Astrocytoma, Childhood
ENTRY = Cerebral Astrocytomas
ENTRY = Cerebral Astrocytomas, Childhood
ENTRY = Childhood Cerebral Astrocytomas
ENTRY = Fibrillary Astrocytomas
ENTRY = Gemistocytic Astrocytomas
ENTRY = Gliomas, Astrocytic
ENTRY = Grade I Astrocytoma
ENTRY = Grade I Astrocytomas
ENTRY = Grade II Astrocytoma
ENTRY = Grade II Astrocytomas
ENTRY = Grade III Astrocytoma
ENTRY = Grade III Astrocytomas
ENTRY = Intracranial Astrocytomas
ENTRY = Juvenile Pilocytic Astrocytomas
ENTRY = Mixed Oligoastrocytoma
ENTRY = Mixed Oligoastrocytomas
ENTRY = Oligoastrocytomas, Mixed
ENTRY = Pilocytic Astrocytoma, Juvenile
ENTRY = Pilocytic Astrocytomas
ENTRY = Pilocytic Astrocytomas, Juvenile
ENTRY = Protoplasmic Astrocytoma
ENTRY = Protoplasmic Astrocytomas
MN = C04.557.465.625.600.380.080
MN = C04.557.470.670.380.080
MN = C04.557.580.625.600.380.080
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
ST = T191
AN = coord IM with precoord CNS/neopl term (IM) + site (IM); Grades I-III go here, with pathol; for ASTROCYTOMA, GRADE IV see GLIOBLASTOMA; for SUBEPENDYMAL ASTROCYTOMA see GLIOMA, SUBEPENDYMAL; for MIXED OLIGODENDROGLIOMA-ASTROCYTOMA see OLIGODENDROGLIOMA
MS = Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)
PM = 1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL see GLIOMA 1994-1999
HN = 1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL use GLIOMA 1994-1999
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D001254

*NEWRECORD
RECTYPE = D
MH = Astrology
DE = ASTROL
AQ = HI PX
MN = K01.672.296
MH_TH = NLM (1966)
ST = T170
AN = a form of occultism; DF: ASTROL
MR = 20010725
DA = 19990101
DC = 1
UI = D001255

*NEWRECORD
RECTYPE = D
MH = Astronomy
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = H01.671.065
MH_TH = NLM (1966)
ST = T090
AN = the discipline (education, history, etc) only; use ASTRONOMICAL PHENOMENA or specifics treed under it for properties and processes of matter in outer space (stars, planets, comets etc)
MS = The science concerned with celestial bodies and the observation and interpretation of the radiation received in the vicinity of the earth from the component parts of the universe (McGraw Hill Dictionary of Scientific and Technical Terms, 5th ed)
MR = 20130709
DA = 19990101
DC = 1
UI = D001256

*NEWRECORD
RECTYPE = D
MH = Mamastrovirus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Human astrovirus|T005|NON|NRW|NLM (2007)|050829|abcdef
ENTRY = Human astroviruses
ENTRY = Mamastroviruses
ENTRY = astrovirus, Human
ENTRY = astroviruses, Human
MN = B04.820.069.500
MH_TH = NLM (2007)
ST = T005
AN = infection: coordinate IM with ASTROVIRIDAE INFECTIONS (IM)
PI = Diarrhea, Infantile (1975-1978)
PI = Vertebrate Viruses (1975-1978)
PI = Vertebrate Viruses, Unclassified (1975-1978)
MS = A genus of small, circular RNA viruses in the family ASTROVIRIDAE. They cause GASTROENTERITIS and are found in the stools of several vertebrates including humans. Transmission is by the fecal-oral route and there are at least eight human serotypes. The type species is Human astrovirus.
PM = 2007; see ASTROVIRUS 1997-2006, see ASTROVIRUSES 1991-1996, see VERTEBRATE VIRUSES, UNCLASSIFIED 1979-1990
HN = 2007 (1979)
MR = 20150623
DA = 19780320
DC = 1
DX = 19910101
UI = D001257

*NEWRECORD
RECTYPE = D
MH = Ataxia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Coordination Impairment|T184|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Dyssynergia|T184|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Incoordination|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Ataxia, Appendicular|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Ataxia, Limb|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Ataxia, Motor|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Ataxia, Sensory|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Ataxia, Truncal|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Ataxy|T184|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Dyscoordination|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Lack of Coordination|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Tremor, Rubral|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Appendicular Ataxia
ENTRY = Appendicular Ataxias
ENTRY = Ataxias
ENTRY = Ataxias, Appendicular
ENTRY = Ataxias, Limb
ENTRY = Ataxias, Motor
ENTRY = Ataxias, Sensory
ENTRY = Ataxias, Truncal
ENTRY = Coordination Impairments
ENTRY = Coordination Lack
ENTRY = Impairment, Coordination
ENTRY = Impairments, Coordination
ENTRY = Incoordinations
ENTRY = Limb Ataxia
ENTRY = Limb Ataxias
ENTRY = Motor Ataxia
ENTRY = Motor Ataxias
ENTRY = Rubral Tremor
ENTRY = Rubral Tremors
ENTRY = Sensory Ataxia
ENTRY = Sensory Ataxias
ENTRY = Tremors, Rubral
ENTRY = Truncal Ataxia
ENTRY = Truncal Ataxias
MN = C10.597.350.090
MN = C23.888.592.350.090
MH_TH = NLM (1966)
ST = T184
AN = note specifics; coord other ataxias with organ/diseases term; enzootic = SWAYBACK; familial: consider also SPINOCEREBELLAR DEGENERATIONS
MS = Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
CATSH = CAT LIST
MR = 20021114
DA = 19990101
DC = 1
UI = D001259

*NEWRECORD
RECTYPE = D
MH = Ataxia Telangiectasia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Louis-Bar Syndrome|T047|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|740329|abcdeeeef
ENTRY = Ataxia Telangiectasia Syndrome|T047|NON|EQV|GHR (2014)|NLM (2000)|991104|abcdeef
ENTRY = Ataxia-Telangiectasia|T047|NON|EQV|GHR (2014)|NLM (1997)|OMIM (2013)|ORD (2010)|950719|abcdeeeef
ENTRY = Telangiectasia, Cerebello-Oculocutaneous|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Louis Bar Syndrome
ENTRY = Syndrome, Ataxia Telangiectasia
ENTRY = Syndrome, Louis-Bar
MN = C10.228.140.252.190.530.060
MN = C10.562.100
MN = C10.597.350.090.500.530.060
MN = C14.907.823.213
MN = C16.320.080
MN = C18.452.284.060
MN = C20.673.290
MH_TH = NLM (1968)
ST = T047
PI = Ataxia (1966-1967)
MS = An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23).
PM = 1968
HN = 1968
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19680101
UI = D001260

*NEWRECORD
RECTYPE = D
MH = Pulmonary Atelectasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Atelectasis, Congestive|T047|NON|NRW|UNK (19XX)|760518|abcdef
PRINT ENTRY = Lung Collapse|T047|NON|EQV|NLM (2009)|080110|abcdef
ENTRY = Atelectasis|T047|NON|EQV|NLM (1963)|990101|abcdef
ENTRY = Compression Atelectasis|T047|NON|NRW|NLM (2009)|080110|abcdef
ENTRY = Compression Pulmonary Atelectasis|T047|NON|NRW|NLM (2009)|080110|abcdef
ENTRY = Congestive Atelectasis|T047|NON|NRW|NLM (2009)|080110|abcdef
ENTRY = Congestive Pulmonary Atelectasis|T047|NON|NRW|NLM (2009)|080110|abcdef
ENTRY = Contraction Pulmonary Atelectasis|T047|NON|NRW|NLM (2009)|080110|abcdef
ENTRY = Postoperative Pulmonary Atelectasis|T047|NON|NRW|NLM (2009)|080110|abcdef
ENTRY = Resorption Atelectasis|T047|NON|NRW|NLM (2009)|080110|abcdef
ENTRY = Resorption Pulmonary Atelectasis|T047|NON|NRW|NLM (2009)|080110|abcdef
ENTRY = Atelectases
ENTRY = Atelectases, Compression
ENTRY = Atelectases, Compression Pulmonary
ENTRY = Atelectases, Congestive
ENTRY = Atelectases, Congestive Pulmonary
ENTRY = Atelectases, Contraction Pulmonary
ENTRY = Atelectases, Postoperative Pulmonary
ENTRY = Atelectases, Pulmonary
ENTRY = Atelectases, Resorption
ENTRY = Atelectases, Resorption Pulmonary
ENTRY = Atelectasis, Compression
ENTRY = Atelectasis, Compression Pulmonary
ENTRY = Atelectasis, Congestive Pulmonary
ENTRY = Atelectasis, Contraction Pulmonary
ENTRY = Atelectasis, Postoperative Pulmonary
ENTRY = Atelectasis, Pulmonary
ENTRY = Atelectasis, Resorption
ENTRY = Atelectasis, Resorption Pulmonary
ENTRY = Collapse, Lung
ENTRY = Compression Atelectases
ENTRY = Compression Pulmonary Atelectases
ENTRY = Congestive Atelectases
ENTRY = Congestive Pulmonary Atelectases
ENTRY = Contraction Pulmonary Atelectases
ENTRY = Postoperative Pulmonary Atelectases
ENTRY = Pulmonary Atelectases
ENTRY = Pulmonary Atelectases, Compression
ENTRY = Pulmonary Atelectases, Congestive
ENTRY = Pulmonary Atelectases, Contraction
ENTRY = Pulmonary Atelectases, Postoperative
ENTRY = Pulmonary Atelectases, Resorption
ENTRY = Pulmonary Atelectasis, Compression
ENTRY = Pulmonary Atelectasis, Congestive
ENTRY = Pulmonary Atelectasis, Contraction
ENTRY = Pulmonary Atelectasis, Postoperative
ENTRY = Pulmonary Atelectasis, Resorption
ENTRY = Resorption Atelectases
ENTRY = Resorption Pulmonary Atelectases
MN = C08.381.730
MH_TH = NLM (2009)
ST = T047
MS = Absence of air in the entire or part of a lung, such as an incompletely inflated neonate lung or a collapsed adult lung. Pulmonary atelectasis can be caused by airway obstruction, lung compression, fibrotic contraction, or other factors.
PM = 2009; see ATELECTASIS 1963-2008; for ATELECTASIS, CONGESTIVE see RESPIRATORY DISTRESS SYNDROME, ADULT 1976-2008
HN = 2009 (1963); for ATELECTASIS, CONGESTIVE use RESPIRATORY DISTRESS SYNDROME, ADULT 1976-2008
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D001261

*NEWRECORD
RECTYPE = D
MH = Atenolol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = ICI-66082|T109|T121|LAB|NRW|UNK (19XX)|770325|abbcdef
ENTRY = Tenormin|T109|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Tenormine|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = ICI 66082
ENTRY = ICI66082
MN = D02.033.100.624.698.070
MN = D02.033.755.624.698.070
MN = D02.092.063.624.698.070
PA = Adrenergic beta-1 Receptor Antagonists
PA = Anti-Arrhythmia Agents
PA = Antihypertensive Agents
PA = Sympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1976)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-
RN = 50VV3VW0TI
RR = 29122-68-7 (Atenolol)
PI = Acetamides (1974)
PI = Phenyl Ethers (1974)
PI = Propanolamines (1974)
MS = A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
PM = 84; was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77
HN = 84(78); was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77
MR = 20130708
DA = 19741119
DC = 1
DX = 19840101
UI = D001262

*NEWRECORD
RECTYPE = D
MH = Athetosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Athetoid Movements|T184|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Hammond Disease|T184|NON|EQV|NLM (2000)|991103|HAMMOND DIS|abcdefv
ENTRY = Hammond's Disease|T184|NON|EQV|NLM (2000)|991103|HAMMONDS DIS|abcdefv
ENTRY = Athetoid Movement
ENTRY = Athetoses
ENTRY = Disease, Hammond
ENTRY = Disease, Hammond's
ENTRY = Diseases, Hammond
ENTRY = Diseases, Hammond's
ENTRY = Hammond Diseases
ENTRY = Hammond's Diseases
ENTRY = Hammonds Disease
ENTRY = Movement, Athetoid
ENTRY = Movements, Athetoid
MN = C10.597.350.110
MN = C23.888.592.350.110
MH_TH = NLM (1966)
ST = T184
AN = choreoathetosis = CHOREA (IM) + ATHETOSIS (IM)
MS = A dyskinesia characterized by an inability to maintain the fingers, toes, tongue, or other body parts in a stable position, resulting in continuous slow, sinusoidal, and flowing involuntary movements. This condition is frequently accompanied by CHOREA, where it is referred to as choreoathetosis. Athetosis may occur as a manifestation of BASAL GANGLIA DISEASES or DRUG TOXICITY. (From Adams et al., Principles of Neurology, 6th ed, p76)
CATSH = CAT LIST
MR = 20050713
DA = 19990101
DC = 1
UI = D001264

*NEWRECORD
RECTYPE = D
MH = Athletic Injuries
DE = ATHLETIC INJ
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Sports Injuries|T037|NON|EQV|NLM (1998)|961216|SPORTS INJ|abcdefv
ENTRY = Injuries, Athletic|T037|NON|EQV|UNK (19XX)|860101|INJ ATHLETIC|abcdefv
ENTRY = Injuries, Sports|T037|NON|EQV|NLM (1998)|961216|INJ SPORTS|abcdefv
ENTRY = Athletic Injury
ENTRY = Injury, Athletic
ENTRY = Injury, Sports
ENTRY = Sports Injury
MN = C26.115
MH_TH = NLM (1968)
ST = T037
AN = GEN only: prefer specific sport /inj; when GEN, coord IM with specific inj (IM); Manual 30.15.1: relation to SPORTS MEDICINE; consider also TENNIS ELBOW but see note there
PI = Sport Medicine (1966-1967)
PI = Sports (1966-1967)
MS = Injuries incurred during participation in competitive or non-competitive sports.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19680101
UI = D001265

*NEWRECORD
RECTYPE = D
MH = Atlantic Islands
AQ = EH EP
ENTRY = Saint Helena|T083|NAM|NRW|POPLINE (1993)|950110|abcdef
ENTRY = Sao Tome and Principe|T083|NAM|NRW|POPLINE (1983)|861231|abcdef
ENTRY = St. Helena|T083|NAM|NRW|NLM (1987)|861231|abcdef
MN = Z01.639.040
MH_TH = NLM (1966)
ST = T083
AN = in addition to indentions here & under CARIBBEAN REGION, see MeSH definition for other specific islands; in titles & translations use accents on island names as in author's text
MS = Widely scattered islands in the Atlantic Ocean as far north as the AZORES and as far south as the South Sandwich Islands, with the greatest concentration found in the CARIBBEAN REGION. They include Annobon Island, Ascension, Canary Islands, Falkland Islands, Fernando Po (also called Isla de Bioko and Bioko), Gough Island, Madeira, Sao Tome and Principe, Saint Helena, and Tristan da Cunha.
MR = 20120703
DA = 19990101
DC = 4
UI = D001266

*NEWRECORD
RECTYPE = D
MH = Atlantic Ocean
AQ = EH EP
MN = Z01.756.092
MH_TH = NLM (1987)
ST = T083
AN = no qualif
HN = 87
MR = 20090706
DA = 19860402
DC = 4
DX = 19870101
UI = D001267

*NEWRECORD
RECTYPE = D
MH = Atlanto-Axial Joint
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Atlanto Axial Joint|T030|NON|EQV|UNK (19XX)|820426|abcdef
ENTRY = Atlantoaxial Joint|T030|NON|EQV|UNK (19XX)|820426|abcdef
ENTRY = Atlanto Axial Joints
ENTRY = Atlanto-Axial Joints
ENTRY = Atlantoaxial Joints
ENTRY = Joint, Atlanto Axial
ENTRY = Joint, Atlanto-Axial
ENTRY = Joint, Atlantoaxial
ENTRY = Joints, Atlanto Axial
ENTRY = Joints, Atlanto-Axial
ENTRY = Joints, Atlantoaxial
MN = A02.835.583.097
MH_TH = NLM (1983)
ST = T030
PI = Atlas (1966-1982)
PI = Axis (1966-1982)
MS = The joint involving the CERVICAL ATLAS and axis bones.
PM = 83
HN = 83
MR = 20080709
DA = 19820426
DC = 1
DX = 19830101
UI = D001268

*NEWRECORD
RECTYPE = D
MH = Atlanto-Occipital Joint
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
PRINT ENTRY = Atloido-Occipital Joint|T030|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Atlanto Occipital Joint
ENTRY = Atlanto-Occipital Joints
ENTRY = Atloido Occipital Joint
ENTRY = Atloido-Occipital Joints
ENTRY = Joint, Atlanto-Occipital
ENTRY = Joint, Atloido-Occipital
ENTRY = Joints, Atlanto-Occipital
ENTRY = Joints, Atloido-Occipital
MN = A02.835.583.101
MH_TH = NLM (1966)
ST = T030
MS = The point of articulation between the OCCIPITAL BONE and the CERVICAL ATLAS.
MR = 20150616
DA = 19990101
DC = 1
UI = D001269

*NEWRECORD
RECTYPE = D
MH = Cervical Atlas
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
PRINT ENTRY = Atlas, Cervical|T023|NON|EQV|NLM (2009)|070725|abcdef
MN = A02.835.232.834.151.500
MH_TH = NLM (2009)
ST = T023
MS = The first cervical vertebra.
PM = 2009; see ATLAS 1963-2008
HN = 2009 (1963)
MR = 20120703
DA = 19990101
DC = 1
UI = D001270

*NEWRECORD
RECTYPE = D
MH = Atlases as Topic
AQ = HI
ENTRY = Atlases as Topics
MN = L01.178.682.192.836.147
MH_TH = NLM (2008)
ST = T073
ST = T170
AN = anatomical atlases go under ATLASES AS TOPIC (IM) + ANATOMY, ARTISTIC (IM)
MS = Collections of illustrative plates, charts, etc., usually with explanatory captions.
PM = 2008; see ATLASES 1963-2007
HN = 2008(1963)
MR = 20090706
DA = 19990101
DC = 1
UI = D001271

*NEWRECORD
RECTYPE = D
MH = Atmosphere
AQ = AN CH
ENTRY = Atmospheres
MN = G16.500.275.063
MN = N06.230.300.100
MH_TH = NLM (1972)
ST = T070
AN = /anal /chem permitted
PI = Air (1966-1971)
PI = Extraterrestrial Environment (1966-1971)
MS = The gaseous envelope surrounding a planet or similar body. (From Random House Unabridged Dictionary, 2d ed)
PM = 74
HN = 74(72)
MR = 20080708
DA = 19990101
DC = 1
DX = 19740101
UI = D001272

*NEWRECORD
RECTYPE = D
MH = Atmosphere Exposure Chambers
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
ENTRY = Atmosphere Exposure Chamber
ENTRY = Chamber, Atmosphere Exposure
ENTRY = Chambers, Atmosphere Exposure
ENTRY = Exposure Chamber, Atmosphere
ENTRY = Exposure Chambers, Atmosphere
MN = E07.079
MH_TH = NLM (1973)
ST = T074
MS = Experimental devices used in inhalation studies in which a person or animal is either partially or completely immersed in a chemically controlled atmosphere.
PM = 73
HN = 73
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
DX = 19730101
UI = D001273

*NEWRECORD
RECTYPE = D
MH = Atmospheric Pressure
ENTRY = Atmospheric Pressures
ENTRY = Pressure, Atmospheric
ENTRY = Pressures, Atmospheric
MN = G16.500.750.274
MN = N06.230.300.100.185
FX = Altitude
FX = Anoxia
FX = Barotrauma
FX = Decompression Sickness
FX = Hyperbaric Oxygenation
MH_TH = NLM (1966)
ST = T070
AN = no qualif
MS = The pressure at any point in an atmosphere due solely to the weight of the atmospheric gases above the point concerned.
MR = 20080708
DA = 19990101
DC = 1
UI = D001274

*NEWRECORD
RECTYPE = D
MH = ATP Citrate (pro-S)-Lyase
DS = ATP CITRATE LYASE PRO S
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = ATP Citrate Lyase|T116|T126|EQV|NLM (1998)|961118|abbdef
PRINT ENTRY = ATP Citrate Synthase|T116|T126|ABX|EQV|NLM (2006)|050428|abbcdef
PRINT ENTRY = Citrate Cleavage Enzyme|T116|T126|NON|EQV|UNK (19XX)|760324|abbcdef
ENTRY = ATP Citrate (pro-3S)-Lyase|T116|T126|EQV|UNK (19XX)|821206|abbdef
ENTRY = ATP-Dependent Citrate Lyase|T116|T126|EQV|UNK (19XX)|801120|abbdef
ENTRY = ATP Dependent Citrate Lyase
ENTRY = Citrate Lyase, ATP
ENTRY = Citrate Lyase, ATP-Dependent
ENTRY = Citrate Synthase, ATP
ENTRY = Cleavage Enzyme, Citrate
ENTRY = Lyase, ATP Citrate
ENTRY = Lyase, ATP-Dependent Citrate
ENTRY = Synthase, ATP Citrate
MN = D08.811.913.050.331
MH_TH = NLM (1973)
ST = T116
ST = T126
N1 = ATP:citrate oxaloacetate-lyase ((pro-S)-CH2COO(-)--acetyl-CoA) (ATP-dephosphorylating)
RN = EC 2.3.3.8
RR = 9027-95-6 (CAS RN)
PI = Lyases (1966-1972)
MS = An enzyme that, in the presence of ATP and COENZYME A, catalyzes the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and ORTHOPHOSPHATE. This reaction represents an important step in fatty acid biosynthesis. This enzyme was formerly listed as EC 4.1.3.8.
PM = 98; see ATP CITRATE LYASE 1977-97; see KETOACID-LYASES 1973-76
HN = 98(73)
MR = 20050630
DA = 19990101
DC = 1
DX = 19770101
UI = D001275

*NEWRECORD
RECTYPE = D
MH = ATP Phosphoribosyltransferase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Phosphoribosyl-ATP Pyrophosphorylase|T116|T126|EQV|UNK (19XX)|750711|abbdef
ENTRY = Phosphoribosyl ATP Pyrophosphorylase
ENTRY = Phosphoribosyltransferase, ATP
ENTRY = Pyrophosphorylase, Phosphoribosyl-ATP
MN = D08.811.913.400.725.200
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = 1-(5-Phospho-D-ribosyl)-ATP:pyrophosphate phospho-alpha-D- ribosyltransferase
RN = EC 2.4.2.17
RR = 9031-46-3 (CAS RN)
PI = Adenosine Triphosphate (1972-1975)
PI = Pentosephosphates (1971-1975)
PI = Pentosyltransferases (1971-1975)
PI = Pyrophosphoric Acids (1971-1975)
MS = An enzyme that catalyzes the first step of the pathway for histidine biosynthesis in Salmonella typhimurium. ATP reacts reversibly with 5-phosphoribosyl-1-pyrophosphate to yield N-1-(5'-phosphoribosyl)-ATP and pyrophosphate. EC 2.4.2.17.
PM = 91; was see under PENTOSYLTRANSFERASES 1976-90
HN = 91(76); was see under PENTOSYLTRANSFERASES 1976-90
MR = 20030709
DA = 19750723
DC = 1
DX = 19910101
UI = D001276

*NEWRECORD
RECTYPE = D
MH = GTP Pyrophosphokinase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = ATP-Guanosine Phosphate Pyrophosphotransferase|T116|T126|EQV|NLM (1992)|910114|abbdef
PRINT ENTRY = Stringent Factor|T116|T126|NON|EQV|UNK (19XX)|790523|abbcdef
ENTRY = ATP Guanosine Phosphate Pyrophosphotransferase
ENTRY = Factor, Stringent
ENTRY = Pyrophosphokinase, GTP
ENTRY = Pyrophosphotransferase, ATP-Guanosine Phosphate
MN = D08.811.913.696.175.300
MH_TH = NLM (1980)
ST = T116
ST = T126
N1 = ATP:GTP 3'-pyrophosphotransferase
RN = EC 2.7.6.5
RR = 63690-89-1 (CAS RN)
PI = Adenosine Triphosphate (1966-1979)
PI = Bacterial Proteins (1966-1979)
PI = Guanine Nucleotides (1966-1979)
PI = Phosphotransferases (1966-1973)
PI = Phosphotransferases, ATP (1974-1979)
PI = Pyrophosphates (1966-1979)
PI = Ribosomal Proteins (1975-1979)
MS = An enzyme that catalyzes reversibly the transfer of a pyrophosphate group from ATP to the 3'-OH group of GDP or GTP with the formation of guanosine 3'-diphosphate 5'-diphosphate or guanosine 3'-diphosphate 5'-triphosphate and AMP. The enzyme, also called stringent factor, is located in the relA gene in stringent strains of bacteria. The above synthesis is induced by mRNA and uncharged tRNA which is bound to the aminoacyl-t-RNA binding site of the ribosome by a codon-specific association. EC 2.7.6.5.
OL = use GTP PYROPHOSPHOKINASE to search ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91
PM = 92; was ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91 (see under PHOSPHOTRANSFERASES, ATP 1980-90)
HN = 92; was ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91 (see under PHOSPHOTRANSFERASES, ATP 1980-90)
MR = 20030709
DA = 19790523
DC = 1
DX = 19910101
UI = D001277

*NEWRECORD
RECTYPE = D
MH = Atractyloside
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Atractylic Acid|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Atractylate|T109|T131|NON|EQV|UNK (19XX)|850528|abbcdef
ENTRY = Acid, Atractylic
MN = D02.455.849.291.162
MN = D09.408.105
PA = Enzyme Inhibitors
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = 19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-((2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-beta-D-glucopyranosyl)oxy)-, (2beta,4alpha,15alpha)-
RN = 17754-44-8
PI = Glycosides (1968-1975)
PI = Phenanthrenes (1973-1974)
MS = A glycoside of a kaurene type diterpene that is found in some plants including Atractylis gummifera (ATRACTYLIS); COFFEE; XANTHIUM, and CALLILEPIS. Toxicity is due to inhibition of ADENINE NUCLEOTIDE TRANSLOCASE.
PM = 91; was see under GLYCOSIDES 1975-90
HN = 91(75); was see under GLYCOSIDES 1975-90
MR = 20040707
DA = 19741119
DC = 1
DX = 19910101
UI = D001278

*NEWRECORD
RECTYPE = D
MH = Atracurium
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Atracurium Besylate|T109|T121|NON|NRW|BAN (19XX)|USAN (1983)|860602|abbcdeef
PRINT ENTRY = Atracurium Dibesylate|T109|T121|NON|NRW|UNK (19XX)|860602|abbcdef
ENTRY = 33 A 74|T109|T121|LAB|NRW|UNK (19XX)|860602|abbcdef
ENTRY = Atracurium Besilate|T109|T121|NON|NRW|INN (19XX)|940811|abbcdef
ENTRY = BW-33A|T109|T121|LAB|NRW|UNK (19XX)|860602|abbcdef
ENTRY = Glaxo Wellcome Brand of Atracurium Besilate|T109|T121|NON|NRW|NLM (2004)|021021|abbcdef
ENTRY = Pisa Brand of Atracurium Besilate|T109|T121|NON|NRW|NLM (2004)|021021|abbcdef
ENTRY = Relatrac|T109|T121|TRD|NRW|MX|021021|abbcdef
ENTRY = Tracrium|T109|T121|TRD|NRW|AU|CA|DE|ES|FR|MX|NL|UK|UNK (19XX)|US|860602|abbcdeeeeeeeeeef
ENTRY = Wellcome Brand of Atracurium Besilate|T109|T121|NON|NRW|NLM (2004)|021021|abbcdef
ENTRY = A 74, 33
ENTRY = BW 33A
ENTRY = BW33A
ENTRY = Besilate, Atracurium
MN = D03.438.531.085.061
PA = Neuromuscular Nondepolarizing Agents
PA = Nicotinic Antagonists
MH_TH = NLM (19XX)
ST = T109
ST = T121
N1 = Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl))-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-
RN = 64228-79-1
RR = 64228-81-5 (besylate)
PI = Isoquinolines (1966-1986)
MS = A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
PM = 87
HN = 87
MR = 20060705
DA = 19860714
DC = 1
DX = 19870101
UI = D001279

*NEWRECORD
RECTYPE = D
MH = Atrazine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Gesamprim|T109|T121|TRD|NRW|NLM (1998)|961121|abbcdef
MN = D03.383.931.247
PA = Herbicides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T131
N1 = 1,3,5-Triazine-2,4-diamine, 6-chloro-N-ethyl-N'-(1-methylethyl)-
RN = QJA9M5H4IM
RR = 1912-24-9 (Atrazine)
PI = Herbicides (1966-1971)
PI = Triazines (1966-1971)
MS = A selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. (From The Merck Index, 11th ed)
PM = 74
HN = 74(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D001280

*NEWRECORD
RECTYPE = D
MH = Atrial Fibrillation
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Auricular Fibrillation|T033|T046|NON|EQV|GHR (2014)|UNK (19XX)|830503|abbcdeef
ENTRY = Familial Atrial Fibrillation|T033|T046|NON|EQV|GHR (2014)|NLM (2014)|130418|abbcdeef
ENTRY = Atrial Fibrillations
ENTRY = Auricular Fibrillations
ENTRY = Fibrillation, Atrial
ENTRY = Fibrillation, Auricular
ENTRY = Fibrillations, Atrial
ENTRY = Fibrillations, Auricular
MN = C14.280.067.198
MN = C23.550.073.198
MH_TH = NLM (1966)
ST = T033
ST = T046
AN = do not confuse with ATRIAL FLUTTER
MS = Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
OL = use ATRIAL FIBRILLATION to search AURICULAR FIBRILLATION 1966-83
PM = 84; was AURICULAR FIBRILLATION 1963-83
HN = 84; was AURICULAR FIBRILLATION 1963-83
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001281

*NEWRECORD
RECTYPE = D
MH = Atrial Flutter
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Auricular Flutter|T033|T046|NON|EQV|UNK (19XX)|830503|abbcdef
ENTRY = Atrial Flutters
ENTRY = Auricular Flutters
ENTRY = Flutter, Atrial
ENTRY = Flutter, Auricular
ENTRY = Flutters, Atrial
ENTRY = Flutters, Auricular
MN = C14.280.067.248
MN = C23.550.073.248
MH_TH = NLM (1966)
ST = T033
ST = T046
AN = do not confuse with ATRIAL FIBRILLATION
MS = Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).
OL = use ATRIAL FLUTTER to search AURICULAR FLUTTER 1966-83
PM = 84; was AURICULAR FLUTTER 1963-83
HN = 84; was AURICULAR FLUTTER 1963-83
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D001282

*NEWRECORD
RECTYPE = D
MH = Atrioventricular Node
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = AV Node|T023|NON|EQV|NLM (1991)|891228|abcdef
ENTRY = A-V Node|T023|NON|EQV|NLM (1991)|891228|abcdef
ENTRY = Atrio-Ventricular Node|T023|NON|EQV|NLM (1991)|900208|abcdef
ENTRY = A V Node
ENTRY = A-V Nodes
ENTRY = AV Nodes
ENTRY = Atrio Ventricular Node
ENTRY = Atrio-Ventricular Nodes
ENTRY = Atrioventricular Nodes
ENTRY = Node, A-V
ENTRY = Node, AV
ENTRY = Node, Atrio-Ventricular
ENTRY = Node, Atrioventricular
ENTRY = Nodes, A-V
ENTRY = Nodes, AV
ENTRY = Nodes, Atrio-Ventricular
ENTRY = Nodes, Atrioventricular
MN = A07.541.409.147
MH_TH = NLM (1975)
ST = T023
MS = A small nodular mass of specialized muscle fibers located in the interatrial septum near the opening of the coronary sinus. It gives rise to the atrioventricular bundle of the conduction system of the heart.
OL = search HEART CONDUCTION SYSTEM 1966-74
PM = 91; was see under HEART CONDUCTION SYSTEM 1975-90
HN = 91(75); was see under HEART CONDUCTION SYSTEM 1975-90
MR = 19920325
DA = 19990101
DC = 1
DX = 19910101
UI = D001283

*NEWRECORD
RECTYPE = D
MH = Atrophy
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Atrophies
MN = C23.300.070
MH_TH = NLM (1966)
ST = T046
AN = NIM; coord with organ/pathol (IM)
MS = Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
UI = D001284

*NEWRECORD
RECTYPE = D
MH = Atropine
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = AtroPen|T109|T121|TRD|NRW|US|021021|abbcdef
ENTRY = Atropin Augenl|T109|T121|TRD|NRW|DE|021021|abbcdef
ENTRY = Atropine Sulfate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|USP (19XX)|810807|abbcdeeef
ENTRY = Atropine Sulfate Anhydrous|T109|T121|NON|NRW|NLM (2014)|130410|abbcdef
ENTRY = Atropinol|T109|T121|TRD|NRW|DE|021021|abbcdef
ENTRY = Chauvin Brand of Atropine|T109|T121|NON|NRW|NLM (2004)|021021|abbcdef
ENTRY = Survival Technology Brand of Atropine|T109|T121|NON|NRW|NLM (2004)|021021|abbcdef
ENTRY = Winzer Brand of Atropine|T109|T121|NON|NRW|NLM (2004)|021021|abbcdef
ENTRY = Anhydrous, Atropine Sulfate
ENTRY = Atropine Chauvin Brand
ENTRY = Atropine Winzer Brand
ENTRY = Augenl, Atropin
ENTRY = Sulfate Anhydrous, Atropine
ENTRY = Sulfate, Atropine
MN = D02.145.074.722.229.199
MN = D03.132.760.180.572.199
MN = D03.132.889.180.648.199
MN = D03.605.869.229.199
MN = D04.075.080.875.099.722.229.199
PA = Adjuvants, Anesthesia
PA = Anti-Arrhythmia Agents
PA = Bronchodilator Agents
PA = Muscarinic Antagonists
PA = Mydriatics
PA = Parasympatholytics
EC = analogs & derivatives:Atropine Derivatives
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzeneacetic acid, alpha-(hydroxymethyl)- 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester endo-(+-)-
RN = 7C0697DR9I
RR = 03J5ZE7KA5
RR = 51-55-8 (Atropine)
RR = KAE4PSB0Z3
MS = An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.
PM = 1975
HN = 1975
MR = 20130708
DA = 19990101
DC = 1
UI = D001285

*NEWRECORD
RECTYPE = D
MH = Atropine Derivatives
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Atropines|T109|NON|EQV|NLM (2014)|130607|abcdef
MN = D02.145.074.722.229
MN = D03.132.760.180.572
MN = D03.132.889.180.648
MN = D03.605.869.229
MN = D04.075.080.875.099.722.229
MH_TH = NLM (1975)
ST = T109
RN = 0
PI = Atropine (1966-1974)
PI = Tropanes (1966-1974)
MS = Analogs and derivatives of atropine.
OL = search TROPANES 1969-74
PM = 78; was see under ATROPINE 1975-77, was see under TROPANES 1969-74; N-ISOPROPYLATROPINE was see under ATROPINE 1975-77
HN = 78(75); was see under ATROPINE 1975-77, was see under TROPANES 1969-74
MR = 20130708
DA = 19990101
DC = 1
DX = 19780101
UI = D001286

*NEWRECORD
RECTYPE = D
MH = Attachment Sites, Microbiological
AQ = DE ES GE IM PH RE
PRINT ENTRY = Attachment Sites (Microbiology)|T114|T123|NON|EQV|NLM (1980)|990101|ATTACHMENT SITES|ATTACHMENT SITES MICROBIOL|abbcdefsv
PRINT ENTRY = Bacterial Attachment Sites|T114|NON|NRW|NLM (1992)|901109|BACT ATTACHMENT SITES|abcdefv
PRINT ENTRY = Phage Attachment Sites|T114|NON|NRW|NLM (1992)|901109|abcdef
ENTRY = Att Attachment Sites|T114|T123|NON|EQV|NLM (2006)|050412|abbcdef
ENTRY = AttB Attachment Sites|T114|NON|NRW|NLM (2006)|050412|abcdef
ENTRY = AttP Attachment Sites|T114|NON|NRW|NLM (2006)|050412|abcdef
ENTRY = Attachment Site (Microbiology)|T114|T123|NON|EQV|NLM (1994)|920825|ATTACHMENT SITE MICROBIOL|abbcdefv
ENTRY = Attachment Site, Bacterial|T114|NON|NRW|NLM (1994)|920825|ATTACHMENT SITE BACT|abcdefv
ENTRY = Attachment Sites, Bacterial|T114|NON|NRW|NLM (1994)|920825|ATTACHMENT SITES BACT|abcdefv
ENTRY = Bacterial Attachment Site|T114|NON|NRW|NLM (1994)|920825|BACT ATTACHMENT SITE|abcdefv
ENTRY = Microbiologic Attachment Site|T114|T123|NON|EQV|NLM (1994)|930202|MICROBIOL ATTACHMENT SITE|abbcdefv
ENTRY = Microbiologic Attachment Sites|T114|T123|NON|EQV|UNK (19XX)|790523|MICROBIOL ATTACHMENT SITES|abbcdefv
ENTRY = Att Attachment Site
ENTRY = AttB Attachment Site
ENTRY = AttP Attachment Site
ENTRY = Attachment Site, Att
ENTRY = Attachment Site, AttB
ENTRY = Attachment Site, AttP
ENTRY = Attachment Site, Microbiologic
ENTRY = Attachment Site, Microbiological
ENTRY = Attachment Site, Phage
ENTRY = Attachment Sites, Att
ENTRY = Attachment Sites, AttB
ENTRY = Attachment Sites, AttP
ENTRY = Attachment Sites, Microbiologic
ENTRY = Attachment Sites, Phage
ENTRY = Microbiological Attachment Site
ENTRY = Microbiological Attachment Sites
ENTRY = Phage Attachment Site
MN = G05.360.340.024.079
FX = Lysogeny
FX = Virus Integration
MH_TH = NLM (1991)
ST = T114
ST = T123
AN = do not confuse with VIRUS ATTACHMENT or RECEPTORS, VIRUS
PI = Coliphages (1966-1979)
PI = DNA, Viral (1966-1979)
PI = Lysogeny (1968-1979)
PI = Recombination, Genetic (1968-1979)
MS = Specific loci on both the bacterial DNA (attB) and the phage DNA (attP) which delineate the sites where recombination takes place between them, as the phage DNA becomes integrated (inserted) into the BACTERIAL DNA during LYSOGENY.
PM = 2006; see ATTACHMENT SITES (MICROBIOLOGY) 1991-2006, see LYSOGENY 1980-1990
HN = 2006 (1980)
CATSH = CAT LIST
MR = 20080708
DA = 19790523
DC = 1
DX = 19910101
UI = D001287

*NEWRECORD
RECTYPE = D
MH = Attention
AQ = CL DE ES PH RE
PRINT ENTRY = Concentration|T041|NON|NRW|UNK (19XX)|770422|abcdef
ENTRY = Attentions
ENTRY = Concentrations
MN = F02.830.104.214
MH_TH = NLM (1966)
ST = T041
MS = Focusing on certain aspects of current experience to the exclusion of others. It is the act of heeding or taking notice or concentrating.
CATSH = CAT LIST
MR = 19920325
DA = 19990101
DC = 1
UI = D001288

*NEWRECORD
RECTYPE = D
MH = Attention Deficit Disorder with Hyperactivity
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Attention Deficit Disorder|T048|NON|REL|NLM (1997)|951121|ATTENTION DEFICIT DIS|abcdefv
PRINT ENTRY = Attention Deficit Hyperactivity Disorder|T048|NON|EQV|NLM (1992)|910124|ADHD|abcdefv
PRINT ENTRY = Brain Dysfunction, Minimal|T048|NON|BRD|UNK (19XX)|740330|abcdef
PRINT ENTRY = Hyperkinetic Syndrome|T048|NON|EQV|UNK (19XX)|830614|abcdef
PRINT ENTRY = Minimal Brain Dysfunction|T048|NON|BRD|UNK (19XX)|800521|abcdef
ENTRY = ADDH|T048|ACR|EQV|NLM (2016)|150206|abcdef
ENTRY = Attention Deficit Disorders with Hyperactivity|T048|NON|EQV|UNK (19XX)|830614|ATTENTION DEFICIT DIS WITH HYPERACTIVITY|abcdefv
ENTRY = Attention Deficit Hyperactivity Disorders|T048|NON|EQV|NLM (1992)|910124|ATTENTION DEFICIT HYPERACTIVITY DIS|abcdefv
ENTRY = Attention Deficit-Hyperactivity Disorder|T048|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Attention Deficit Disorders
ENTRY = Attention Deficit-Hyperactivity Disorders
ENTRY = Deficit Disorder, Attention
ENTRY = Deficit Disorders, Attention
ENTRY = Deficit-Hyperactivity Disorder, Attention
ENTRY = Deficit-Hyperactivity Disorders, Attention
ENTRY = Disorder, Attention Deficit
ENTRY = Disorder, Attention Deficit-Hyperactivity
ENTRY = Disorders, Attention Deficit
ENTRY = Disorders, Attention Deficit-Hyperactivity
ENTRY = Dysfunction, Minimal Brain
ENTRY = Syndromes, Hyperkinetic
MN = F03.625.094.150
MH_TH = NLM (1969)
ST = T048
AN = not confined to children; do not confuse with HYPERKINESIS; may appear in the literature as ADDH or ADHD
PI = Brain Damage, Chronic (1966-1968)
MS = A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late   adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
OL = use ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY to search HYPERKINETIC SYNDROME 1981-83 & MINIMAL BRAIN DYSFUNCTION 1969-80 (as Prov 1969-72)
PM = 84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1973-80
HN = 84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1969-80 (Prov 1969-72)
CATSH = CAT LIST
MR = 20150707
DA = 19990101
DC = 1
DX = 19730101
UI = D001289

*NEWRECORD
RECTYPE = D
MH = Attitude
AQ = EH
ENTRY = Attitudes|T041|NON|EQV|BIOETHICS (1989)|770317|abcdef
MN = F01.100
FX = Intention
FX = Public Opinion
FX = Set (Psychology)
MH_TH = POPLINE (1978)
ST = T041
MS = An enduring, learned predisposition to behave in a consistent way toward a given class of objects, or a persistent mental and/or neural state of readiness to react to a certain class of objects, not as they are but as they are conceived to be.
PM = 65; was see under BEHAVIOR 1963-64
HN = 65(64); was see under BEHAVIOR 1963-64
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19650101
UI = D001290

*NEWRECORD
RECTYPE = D
MH = Attitude of Health Personnel
AQ = EH
ENTRY = Staff Attitude|T041|NON|BRD|POPLINE (1978)|781218|abcdef
ENTRY = Attitude, Staff
ENTRY = Attitudes, Staff
ENTRY = Health Personnel Attitude
ENTRY = Health Personnel Attitudes
ENTRY = Staff Attitudes
MN = F01.100.050
MN = N05.300.100
MH_TH = NLM (1968)
ST = T041
PI = Attitude (1966-1967)
MS = Attitudes of personnel toward their patients, other professionals, toward the medical care system, etc.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19680101
UI = D001291

*NEWRECORD
RECTYPE = D
MH = Attitude to Computers
AQ = EH
ENTRY = Attitude to Computer
ENTRY = Computer, Attitude to
ENTRY = Computers, Attitude to
ENTRY = to Computer, Attitude
ENTRY = to Computers, Attitude
MN = F01.100.100
MH_TH = NLM (1987)
ST = T041
AN = /ethnol permitted
MS = The attitude and behavior associated with an individual using the computer.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 19970620
DA = 19860618
DC = 1
DX = 19870101
UI = D001292

*NEWRECORD
RECTYPE = D
MH = Attitude to Death
AQ = EH
ENTRY = Attitudes to Death|T041|NON|EQV|BIOETHICS (1989)|770317|abcdef
ENTRY = Death, Attitude to
ENTRY = Death, Attitudes to
MN = F01.100.125
MN = N05.300.125
MH_TH = NLM (1974)
ST = T041
MS = Conceptual response of the person to the various aspects of death, which are based on individual psychosocial and cultural experience.
PM = 74
HN = 74
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
DX = 19740101
UI = D001293

*NEWRECORD
RECTYPE = D
MH = Attitude to Health
AQ = EH
ENTRY = Health Attitude|T054|NON|EQV|UNK (19XX)|881119|abcdef
ENTRY = Attitude, Health
ENTRY = Attitudes, Health
ENTRY = Health Attitudes
ENTRY = Health, Attitude to
MN = F01.100.150
MN = N05.300.150
FX = Patient Dropouts
FX = Sick Role
MH_TH = NLM (1968)
ST = T054
AN = includes attitude to disease
PI = Attitude (1966-1967)
MS = Public attitudes toward health, disease, and the medical care system.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19680101
UI = D001294

*NEWRECORD
RECTYPE = D
MH = Atypical Bacterial Forms
DE = ATYPICAL BACT FORMS
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Bacterial Forms, Atypical|T007|NON|EQV|NLM (1992)|901102|BACT FORMS ATYPICAL|abcdefv
MN = B03.110
MN = B05.110
MH_TH = NLM (1975)
ST = T007
AN = DF: ATYPICAL BACT FORMS
PI = Bacteria (1966-1974)
MS = Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics.
PM = 75
HN = 75
MR = 20090706
DA = 19990101
DC = 1
DX = 19750101
UI = D001295

*NEWRECORD
RECTYPE = D
MH = Audiovisual Aids
AQ = CL EC ES HI LJ SD SN ST TD UT
PRINT ENTRY = Visual Aids|T073|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Audio-Visual Aids|T073|NON|EQV|NLM (1996)|950103|abcdef
ENTRY = Aid, Audio-Visual
ENTRY = Aid, Audiovisual
ENTRY = Aid, Visual
ENTRY = Aids, Audio-Visual
ENTRY = Aids, Audiovisual
ENTRY = Aids, Visual
ENTRY = Audio Visual Aids
ENTRY = Audio-Visual Aid
ENTRY = Audiovisual Aid
ENTRY = Visual Aid
MN = J01.897.280.500
MN = L01.178.820.090
MH_TH = BIOETHICS (1976)
MH_TH = POPLINE (1978)
ST = T073
AN = TEACHING MATERIALS is also available
MS = Auditory and visual instructional materials.
PM = 96; was AUDIO-VISUAL AIDS 1963-95
HN = 96; was AUDIO-VISUAL AIDS 1963-95
MR = 20040707
DA = 19990101
DC = 1
UI = D001296

*NEWRECORD
RECTYPE = D
MH = Audioanalgesia
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Audioanalgesias
MN = E03.091.214
MH_TH = NLM (1965)
ST = T061
MS = Method of pain control in which auditory stimulation including music, white noise, and environmental sounds are used.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
DX = 19650101
UI = D001297

*NEWRECORD
RECTYPE = D
MH = Audiology
DE = AUDIOL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = H02.010.150
FX = Otolaryngology
MH_TH = NLM (1978)
ST = T091
AN = SPEC: SPEC qualif; do not confuse with HEARING (physiol process) or HEARING TESTS or AUDIOMETRY (a specific type of hearing test); AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available; DF: AUDIOL
PI = Hearing (1966-1977)
MS = The study of hearing and hearing impairment.
OL = search HEARING 1966-74
PM = 78; was see under HEARING 1963-74
HN = 78; was see under HEARING 1963-74
MR = 20120703
DA = 19770512
DC = 1
DX = 19780101
UI = D001298

*NEWRECORD
RECTYPE = D
MH = Audiometry
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Audiometries
MN = E01.370.382.375.060
FX = Acoustic Impedance Tests
MH_TH = NLM (1966)
ST = T060
AN = a specific type of hearing test: do not use as a general term for "the measurement of hearing" ( = HEARING TESTS)
MS = The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D001299

*NEWRECORD
RECTYPE = D
MH = Audiometry, Evoked Response
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Audiometry, Electroencephalic Response|T060|NON|EQV|UNK (19XX)|790221|abcdef
PRINT ENTRY = Electrocochleography|T060|NON|NRW|UNK (19XX)|991012|abcdef
PRINT ENTRY = Evoked Response Audiometry|T060|NON|EQV|UNK (19XX)|790221|abcdef
ENTRY = Audiometries, Electroencephalic Response
ENTRY = Audiometries, Evoked Response
ENTRY = Electrocochleographies
ENTRY = Electroencephalic Response Audiometries
ENTRY = Electroencephalic Response Audiometry
ENTRY = Evoked Response Audiometries
ENTRY = Response Audiometries, Electroencephalic
ENTRY = Response Audiometries, Evoked
ENTRY = Response Audiometry, Electroencephalic
ENTRY = Response Audiometry, Evoked
MN = E01.370.382.375.060.050
MH_TH = NLM (1980)
ST = T060
AN = do not use /util except by MeSH definition; also called "electric response audiometry"
PI = Audiometry (1966-1979)
PI = Evoked Potentials (1967-1979)
MS = A form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry.
PM = 86; was see under AUDIOMETRY 1980-85
HN = 86(80); was see under AUDIOMETRY 1980-85
CATSH = CAT LIST
MR = 19970620
DA = 19790221
DC = 1
DX = 19860101
UI = D001300

*NEWRECORD
RECTYPE = D
MH = Audiometry, Pure-Tone
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Audiometry, Bekesy|T060|EPO|NRW|UNK (19XX)|781214|abcdef
ENTRY = Audiometry, Pure Tone
ENTRY = Bekesy Audiometry
ENTRY = Pure-Tone Audiometry
MN = E01.370.382.375.060.055
MH_TH = NLM (1980)
ST = T060
AN = do not use /util except by MeSH definition; note X ref: spell in titles & translations with accents: Bksy
PI = Audiometry (1966-1979)
MS = Measurement of hearing based on the use of pure tones of various frequencies and intensities as auditory stimuli.
PM = 91; was see under AUDIOMETRY 1980-90
HN = 91(80); was see under AUDIOMETRY 1980-90
CATSH = CAT LIST
MR = 20010813
DA = 19781214
DC = 1
DX = 19910101
UI = D001301

*NEWRECORD
RECTYPE = D
MH = Audiometry, Speech
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Audiometries, Speech
ENTRY = Speech Audiometries
ENTRY = Speech Audiometry
MN = E01.370.382.375.060.060
MH_TH = NLM (1980)
ST = T060
PI = Audiometry (1966-1979)
PI = Speech (1966-1979)
MS = Measurement of the ability to hear speech under various conditions of intensity and noise interference using sound-field as well as earphones and bone oscillators.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 19970620
DA = 19781214
DC = 1
DX = 19800101
UI = D001302

*NEWRECORD
RECTYPE = D
MH = Auditory Cortex
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Auditory Area|T023|NON|EQV|NLM (2015)|140331|abcdef
ENTRY = Heschl's Convolutions|T023|EPO|NRW|NLM (2015)|140331|abcdef
ENTRY = Heschl's Gyri|T023|EPO|NRW|NLM (2015)|140331|abcdef
ENTRY = Primary Auditory Cortex|T023|NON|NRW|NLM (2015)|140331|abcdef
ENTRY = Temporal Auditory Area|T023|NON|EQV|NLM (2015)|140331|abcdef
ENTRY = Transverse Temporal Gyri|T023|NON|NRW|NLM (2015)|140331|abcdef
ENTRY = Area, Auditory
ENTRY = Area, Temporal Auditory
ENTRY = Areas, Auditory
ENTRY = Areas, Temporal Auditory
ENTRY = Auditory Area, Temporal
ENTRY = Auditory Areas
ENTRY = Auditory Areas, Temporal
ENTRY = Auditory Cortex, Primary
ENTRY = Auditory Cortices, Primary
ENTRY = Convolutions, Heschl's
ENTRY = Cortex, Auditory
ENTRY = Cortex, Primary Auditory
ENTRY = Cortices, Primary Auditory
ENTRY = Gyri, Heschl's
ENTRY = Gyri, Transverse Temporal
ENTRY = Gyrus, Transverse Temporal
ENTRY = Heschl Convolutions
ENTRY = Heschl Gyri
ENTRY = Heschls Convolutions
ENTRY = Heschls Gyri
ENTRY = Primary Auditory Cortices
ENTRY = Temporal Auditory Areas
ENTRY = Temporal Gyri, Transverse
ENTRY = Temporal Gyrus, Transverse
ENTRY = Transverse Temporal Gyrus
MN = A08.186.211.730.885.287.500.814.249
MN = A08.186.211.730.885.287.500.863.297
FX = Auditory Diseases, Central
MH_TH = NLM (1968)
ST = T023
AN = diseases: coordinate with AUDITORY DISEASES, CENTRAL
PI = Cerebral Cortex (1966-1967)
PI = Hearing (1966-1967)
MS = The region of the cerebral cortex that receives the auditory radiation from the MEDIAL GENICULATE BODY.
PM = 70
HN = 70(68)
MR = 20140613
DA = 19990101
DC = 1
DX = 19700101
UI = D001303

*NEWRECORD
RECTYPE = D
MH = Auditory Diseases, Central
DE = AUDITORY DIS CENTRAL
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Auditory Cortex Disorder|T047|NON|NRW|NLM (2000)|991103|AUDITORY CORTEX DIS|abcdefv
PRINT ENTRY = Central Auditory Diseases|T047|NON|EQV|NLM (2000)|991103|CENTRAL AUDITORY DIS|abcdefv
ENTRY = Auditory Dysfunction, Central|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Auditory Pathway Disorders, Central|T047|NON|EQV|NLM (2000)|991103|AUDITORY PATHWAY DIS CENTRAL|abcdefv
ENTRY = Central Auditory Pathway Disorders|T047|NON|EQV|NLM (2000)|991103|CENTRAL AUDITORY PATHWAY DIS|abcdefv
ENTRY = Auditory Cortex Disorders
ENTRY = Auditory Disease, Central
ENTRY = Central Auditory Disease
ENTRY = Central Auditory Dysfunction
ENTRY = Cortex Disorder, Auditory
ENTRY = Cortex Disorders, Auditory
ENTRY = Dysfunction, Central Auditory
ENTRY = Dysfunctions, Central Auditory
MN = C09.218.807.186
MN = C10.228.140.068
MH_TH = NLM (1980)
ST = T047
MS = Disorders of hearing or auditory perception due to pathological processes of the AUDITORY PATHWAYS in the CENTRAL NERVOUS SYSTEM. These include CENTRAL HEARING LOSS and AUDITORY PERCEPTUAL DISORDERS.
PM = 1980
HN = 1980
CATSH = CAT LIST
MR = 20070709
DA = 19781222
DC = 1
DX = 19800101
UI = D001304

*NEWRECORD
RECTYPE = D
MH = Auditory Fatigue
AQ = CL DE ES PH RE
PRINT ENTRY = Fatigue, Auditory|T041|NON|EQV|NLM (1995)|940214|abcdef
PRINT ENTRY = Temporary Threshold Shift, Auditory|T041|NON|REL|UNK (19XX)|781214|abcdef
ENTRY = Auditory Fatigues
ENTRY = Fatigues, Auditory
MN = F02.463.593.071.173.095
MH_TH = NLM (1980)
ST = T041
PI = Auditory Threshold (1968-1979)
PI = Fatigue (1966-1979)
PI = Hearing (1966-1967)
MS = Loss of sensitivity to sounds as a result of auditory stimulation, manifesting as a temporary shift in auditory threshold. The temporary threshold shift, TTS, is expressed in decibels.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 19940512
DA = 19781214
DC = 1
DX = 19800101
UI = D001305

*NEWRECORD
RECTYPE = D
MH = Auditory Pathways
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Auditory Pathway
ENTRY = Pathway, Auditory
ENTRY = Pathways, Auditory
MN = A08.612.220.110
FX = Auditory Diseases, Central
MH_TH = NLM (1971)
ST = T023
AN = diseases: coordinate with AUDITORY DISEASES, CENTRAL
PI = Auditory Cortex (1968-1970)
PI = Central Nervous System (1966-1970)
MS = NEURAL PATHWAYS and connections within the CENTRAL NERVOUS SYSTEM, beginning at the hair cells of the ORGAN OF CORTI, continuing along the eighth cranial nerve, and terminating at the AUDITORY CORTEX.
PM = 72
HN = 72(71)
MR = 20150616
DA = 19990101
DC = 1
DX = 19720101
UI = D001306

*NEWRECORD
RECTYPE = D
MH = Auditory Perception
AQ = DE GE IM PH RE
ENTRY = Auditory Perceptions
ENTRY = Perception, Auditory
ENTRY = Perceptions, Auditory
MN = F02.463.593.071
FX = Auditory Perceptual Disorders
MH_TH = NLM (1967)
ST = T041
AN = differentiate from HEARING: auditory perception takes place in the brain, hearing takes place in the ear
PI = Hearing (1966)
PI = Perception (1966)
MS = The process whereby auditory stimuli are selected, organized, and interpreted by the organism.
PM = 68
HN = 68(67)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D001307

*NEWRECORD
RECTYPE = D
MH = Auditory Perceptual Disorders
DE = AUDITORY PERCEPTUAL DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Acoustic Perceptual Disorder|T048|NON|EQV|NLM (2000)|991103|ACOUSTIC PERCEPTUAL DIS|abcdefv
PRINT ENTRY = Perceptual Disorders, Auditory|T048|NON|EQV|NLM (2000)|991103|PERCEPTUAL DIS AUDITORY|abcdefv
ENTRY = Auditory Comprehension Disorder|T048|NON|EQV|NLM (2000)|991103|AUDITORY COMPREHENSION DIS|abcdefv
ENTRY = Auditory Inattention|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Auditory Processing Disorder|T048|NON|EQV|NLM (2000)|991103|AUDITORY PROCESSING DIS|abcdefv
ENTRY = Psychoacoustical Disorders|T048|NON|EQV|NLM (2000)|991103|PSYCHOACOUSTICAL DIS|abcdefv
ENTRY = Acoustic Perceptual Disorders
ENTRY = Auditory Comprehension Disorders
ENTRY = Auditory Inattentions
ENTRY = Auditory Perceptual Disorder
ENTRY = Auditory Processing Disorders
ENTRY = Comprehension Disorder, Auditory
ENTRY = Comprehension Disorders, Auditory
ENTRY = Disorder, Acoustic Perceptual
ENTRY = Disorder, Auditory Comprehension
ENTRY = Disorder, Auditory Processing
ENTRY = Disorder, Psychoacoustical
ENTRY = Disorders, Acoustic Perceptual
ENTRY = Disorders, Auditory Comprehension
ENTRY = Disorders, Auditory Processing
ENTRY = Disorders, Psychoacoustical
ENTRY = Inattention, Auditory
ENTRY = Inattentions, Auditory
ENTRY = Perceptual Disorder, Acoustic
ENTRY = Perceptual Disorder, Auditory
ENTRY = Perceptual Disorders, Acoustic
ENTRY = Processing Disorder, Auditory
ENTRY = Processing Disorders, Auditory
ENTRY = Psychoacoustical Disorder
MN = C09.218.807.186.094
MN = C10.228.140.068.094
MN = C10.597.606.762.200
MN = C23.888.592.604.764.200
MN = F01.700.750.200
MN = F03.615.250.100
FX = Auditory Perception
MH_TH = NLM (1980)
MH_TH = ORD (2010)
ST = T048
PI = Auditory Perception (1967-1979)
PI = Hearing (1966)
PI = Perception (1966-1968)
PI = Perceptual Disorders (1969-1979)
MS = Acquired or developmental cognitive disorders of AUDITORY PERCEPTION characterized by a reduced ability to perceive information contained in auditory stimuli despite intact auditory pathways. Affected individuals have difficulty with speech perception, sound localization, and comprehending the meaning of inflections of speech.
PM = 91; was see under PERCEPTUAL DISORDERS 1980-90
HN = 91(80); was see under PERCEPTUAL DISORDERS 1980-90
CATSH = CAT LIST
MR = 20150630
DA = 19781214
DC = 1
DX = 19910101
UI = D001308

*NEWRECORD
RECTYPE = D
MH = Auditory Threshold
AQ = CL DE ES PH RE
ENTRY = Auditory Thresholds
ENTRY = Threshold, Auditory
ENTRY = Thresholds, Auditory
MN = F02.463.593.071.173
MN = F02.463.593.710.190
FX = Audiometry
MH_TH = NLM (1968)
ST = T081
PI = Hearing (1966-1967)
MS = The audibility limit of discriminating sound intensity and pitch.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 19920325
DA = 19990101
DC = 1
DX = 19680101
UI = D001309

*NEWRECORD
RECTYPE = D
MH = Auranofin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Crisinor|T109|T121|TRD|NRW|ES|021028|abbcdef
ENTRY = Recordati Brand of Auranofin|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Ridaura|T109|T121|TRD|NRW|AU|CA|DE|ES|IE|NL|UK|UNK (19XX)|US|860616|abbcdeeeeeeeeef
ENTRY = Ridauran|T109|T121|TRD|NRW|FR|021028|abbcdef
ENTRY = Robapharm Brand of Auranofin|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Rubio Brand of Auranofin|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = SK&F D 39162|T109|T121|LAB|NRW|UNK (19XX)|860616|abbcdef
ENTRY = SK&F-39162|T109|T121|LAB|NRW|UNK (19XX)|860616|abbcdef
ENTRY = SmithKline Beecham Brand of Auranofin|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Yamanouchi Brand of Auranofin|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = Auranofin Recordati Brand
ENTRY = Auranofin Robapharm Brand
ENTRY = Auranofin Rubio Brand
ENTRY = Auranofin Yamanouchi Brand
ENTRY = SK&F 39162
ENTRY = SK&F39162
MN = D02.691.675.249.150
PA = Antirheumatic Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1976)
ST = T109
ST = T121
N1 = Gold, (1-thio-beta-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-
RN = 3H04W2810V
RR = 34031-32-8 (Auranofin)
PI = Gold (1966-1974)
PI = Gold Thioglucose/analogs & derivatives (1975-1986)
MS = An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.
PM = 87
HN = 87
MR = 20130708
DA = 19860616
DC = 1
DX = 19870101
UI = D001310

*NEWRECORD
RECTYPE = D
MH = Aurintricarboxylic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aurintricarboxylate|T109|T121|T130|NON|NRW|UNK (19XX)|741111|abbbcdef
ENTRY = Aluminon|T109|T121|T130|NON|NRW|UNK (19XX)|810427|abbbcdef
ENTRY = Ammonium Aurintricarboxylate|T109|T121|T130|NON|NRW|UNK (19XX)|800918|abbbcdef
ENTRY = Aurin Tricarboxylic Acid|T109|T121|T130|NON|EQV|NLM (1992)|910311|abbbcdef
ENTRY = Aurintricarboxylic Acid, Calcium (1:3) Salt|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Aurintricarboxylic Acid, Calcium (2:3) Salt|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Aurintricarboxylic Acid, Triammonium Salt|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Aurintricarboxylic Acid, Trisodium Salt|T109|T121|T130|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Acid, Aurin Tricarboxylic
ENTRY = Acid, Aurintricarboxylic
MN = D02.241.223.268.070
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T130
N1 = Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy-
RN = 4431-00-9
RR = 13186-45-3 (tri-Na salt)
RR = 569-58-4 (tri-NH4 salt)
RR = 63451-31-0 (Ca (2:3) salt)
RR = 93480-02-5 (Ca (1:3) salt)
PI = Benzoates (1972-1974)
PI = Cyclohexanecarboxylic Acids (1969-1974)
PI = Phenols (1972-1974)
MS = A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.
PM = 91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90
HN = 91(75); was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90
MR = 20000621
DA = 19741119
DC = 1
DX = 19910101
UI = D001312

*NEWRECORD
RECTYPE = D
MH = Aurovertins
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aurovertin|T109|T123|T130|NON|EQV|UNK (19XX)|790223|abbbcdef
MN = D03.383.663.075
PA = Indicators and Reagents
PA = Uncoupling Agents
MH_TH = NLM (1975)
ST = T109
ST = T123
ST = T130
RN = 0
AN = uncoupling agents; D25-26 qualif
PI = Antibiotics (1968-1974)
MS = Very toxic and complex pyrone derivatives from the fungus Calcarisporium arbuscula. They bind to and inhibit mitochondrial ATPase, thereby uncoupling oxidative phosphorylation. They are used as biochemical tools.
OL = use AUROVERTINS to search AUROVERTIN 1975-79
PM = 91; was see under PYRANS 1980-90; was AUROVERTIN see under ANTIBIOTICS 1975-79
HN = 91(80); was see under PYRANS 1980-90; was AUROVERTIN see under ANTIBIOTICS 1975-79
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D001313

*NEWRECORD
RECTYPE = D
MH = Auscultation
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Auscultations
MN = E01.370.600.060
FX = Heart Auscultation
FX = Stethoscopes
MH_TH = NLM (1966)
ST = T060
AN = /instrum: STETHOSCOPES is also available
MS = Act of listening for sounds within the body.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001314

*NEWRECORD
RECTYPE = D
MH = Australia
AQ = EH EP
ENTRY = Canton and Enderbury Islands|T083|NAM|NRW|POPLINE (1978)|930108|abcdef
ENTRY = Christmas Island|T083|NAM|NRW|UNK (19XX)|781226|abcdef
ENTRY = Christmas Island (Australia)|T083|NAM|NRW|POPLINE (1983)|861231|abcdef
MN = Z01.639.100
MN = Z01.678.100.373
MH_TH = NLM (1978)
ST = T083
AN = each of the states is available; do not confuse with AUSTRALASIA
MS = The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra.
MR = 20150623
DA = 19990101
DC = 4
UI = D001315

*NEWRECORD
RECTYPE = D
MH = Austria
AQ = EH EP
MN = Z01.542.088
MH_TH = POPLINE (1978)
ST = T083
MR = 19911102
DA = 19990101
DC = 4
UI = D001317

*NEWRECORD
RECTYPE = D
MH = Authoritarianism
ENTRY = Authoritarianisms
MN = F01.752.098
MH_TH = BIOETHICS (1993)
ST = T041
ST = T055
AN = no qualif
MS = The personality pattern or syndrome consisting of behavioral and attitudinal characteristics reflecting a preoccupation with the factors of power and authority in interpersonal relationships.
CATSH = CAT LIST
MR = 19950523
DA = 19990101
DC = 1
UI = D001318

*NEWRECORD
RECTYPE = D
MH = Authorship
AQ = HI ST
ENTRY = Authorships
MN = L01.143.506.423.906.215
FX = Plagiarism
MH_TH = BIOETHICS (1999)
MH_TH = NLM (1966)
ST = T057
AN = do not confuse with WRITING or PUBLISHING
MS = The profession of writing. Also the identity of the writer as the creator of a literary production.
MR = 20100625
DA = 19990101
DC = 1
UI = D001319

*NEWRECORD
RECTYPE = D
MH = Autistic Disorder
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Autism, Infantile|T048|NON|EQV|NLM (1971)|980323|abcdef
PRINT ENTRY = Kanner's Syndrome|T048|EPO|EQV|UNK (19XX)|740329|abcdef
ENTRY = Autism|T048|NON|EQV|NLM (1999)|980520|abcdef
ENTRY = Autism, Early Infantile|T048|NON|EQV|UNK (19XX)|800521|abcdef
ENTRY = Disorder, Autistic
ENTRY = Disorders, Autistic
ENTRY = Early Infantile Autism
ENTRY = Infantile Autism
ENTRY = Infantile Autism, Early
ENTRY = Kanner Syndrome
ENTRY = Kanners Syndrome
MN = F03.625.164.125
MH_TH = NLM (1971)
ST = T048
PI = Autism (1966-1970)
PI = Schizophrenia, Childhood (1966-1970)
MS = A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
OL = use AUTISM, INFANTILE to search AUTISM, EARLY INFANTILE 1971-80; use SCHIZOPHRENIA, CHILDHOOD 1968-70
PM = 1999; see AUTISM INFANTILE 1981-1998; see AUTISM, EARLY INFANTILE 1971-1980; see SCHIZOPHRENIA, CHILDHOOD 1968-1970; AUTISM was heading 1966-1998
HN = 1981(1966)
CATSH = CAT LIST
MR = 20151208
DA = 19990101
DC = 1
DX = 19710101
UI = D001321

*NEWRECORD
RECTYPE = D
MH = Autoanalysis
DE = AUTOANAL
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Autoanalyses
MN = E05.059
MH_TH = NLM (1967)
ST = T059
AN = NIM
PI = Automation (1966)
PI = Chemistry, Analytical (1966)
PI = Computers (1966)
MS = Method of analyzing chemicals using automation.
PM = 67
HN = 67
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19670101
UI = D001322

*NEWRECORD
RECTYPE = D
MH = Autoantibodies
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
MN = D12.776.124.486.485.114.323
MN = D12.776.124.790.651.114.323
MN = D12.776.377.715.548.114.323
PA = Immunologic Factors
FX = Autoimmune Diseases
FX = Autoimmunity
MH_TH = POPLINE (1984)
ST = T129
RN = 0
AN = do not confuse with ANTIBODIES, ANTI-IDIOTYPIC
MS = Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
MR = 20050630
DA = 19990101
DC = 1
UI = D001323

*NEWRECORD
RECTYPE = D
MH = Autoantigens
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Autologous Antigens|T129|NON|EQV|NLM (2001)|000516|abcdef
PRINT ENTRY = Self-Antigens|T129|NON|EQV|NLM (2001)|000516|abcdef
ENTRY = Antigens, Autologous
ENTRY = Self Antigens
MN = D23.050.422
MH_TH = NLM (1973)
ST = T129
RN = 0
PI = Antigens (1966-1972)
MS = Endogenous tissue constituents that have the ability to interact with AUTOANTIBODIES and cause an immune response.
PM = 87; was see under ANTIGENS 1973-86
HN = 87(73); was see under ANTIGENS 1973-86
MR = 20050630
DA = 19990101
DC = 1
DX = 19870101
UI = D001324

*NEWRECORD
RECTYPE = D
MH = Autobiography as Topic
MN = K01.517.211.215
MH_TH = NLM (2011)
ST = T170
AN = use only for autobiography as a subject; for autobiographies of persons use the Publication Type AUTOBIOGRAPHY
MS = The life of a person written by himself or herself. (Harrod's Librarians' Glossary, 7th ed)
PM = 2011; see AUTOBIOGRAPHY 1963-2010
HN = 2011 (1963)
MR = 20120703
DA = 19990101
DC = 1
UI = D001325

*NEWRECORD
RECTYPE = D
MH = Autogenic Training
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Progressive Muscle Relaxation|T061|NON|EQV|NLM (2016)|150521|abcdef
ENTRY = Progressive Relaxation|T061|NON|EQV|NLM (2016)|150120|abcdef
ENTRY = Muscle Relaxation, Progressive
ENTRY = Relaxation, Progressive
ENTRY = Relaxation, Progressive Muscle
ENTRY = Training, Autogenic
MN = E02.190.525.217.100
MN = F04.754.424.386
MH_TH = NLM (1963)
ST = T061
AN = a psychother technique
MS = Technique based on muscle relaxation during self-hypnotic exercises. It is used in conjunction with psychotherapy.
PM = 66
HN = 66(63)
CATSH = CAT LIST
MR = 20150522
DA = 19990101
DC = 1
DX = 19660101
UI = D001326

*NEWRECORD
RECTYPE = D
MH = Autoimmune Diseases
DE = AUTOIMMUNE DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Autoimmune Disease|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Disease, Autoimmune
ENTRY = Diseases, Autoimmune
MN = C20.111
FX = Autoantibodies
FX = Autoimmunity
MH_TH = NLM (1966)
ST = T047
AN = AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM is available
MS = Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D001327

*NEWRECORD
RECTYPE = D
MH = Autolysis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Autolyses
MN = C23.550.260.224.617.236
MH_TH = NLM (1968)
ST = T033
ST = T046
AN = restrict to humans and higher animals; BACTERIOLYSIS is also available
PI = Postmortem Changes (1966-1967)
MS = The spontaneous disintegration of tissues or cells by the action of their own autogenous enzymes.
PM = 72
HN = 72(68)
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
DX = 19720101
UI = D001329

*NEWRECORD
RECTYPE = D
MH = Automatic Data Processing
AQ = CL EC ES HI IS LJ MA MT OG SD SN ST TD UT
PRINT ENTRY = Bar Codes|T170|NON|REL|UNK (19XX)|860618|abcdef
PRINT ENTRY = Computer Data Processing|T066|NON|EQV|UNK (19XX)|840412|abcdef
PRINT ENTRY = Data Processing, Automatic|T066|NON|EQV|UNK (19XX)|771212|abcdef
PRINT ENTRY = Electronic Data Processing|T066|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Information Processing, Automatic|T066|NON|BRD|UNK (19XX)|771212|abcdef
PRINT ENTRY = Optical Readers|T073|NON|REL|UNK (19XX)|860618|abcdef
ENTRY = Information Processing|T066|NON|BRD|POPLINE (1978)|781218|abcdef
ENTRY = Automatic Information Processing
ENTRY = Bar Code
ENTRY = Code, Bar
ENTRY = Codes, Bar
ENTRY = Data Processing, Computer
ENTRY = Data Processing, Electronic
ENTRY = Optical Reader
ENTRY = Processing, Automatic Data
ENTRY = Processing, Automatic Information
ENTRY = Processing, Computer Data
ENTRY = Processing, Electronic Data
ENTRY = Processing, Information
ENTRY = Reader, Optical
ENTRY = Readers, Optical
MN = L01.224.085
MH_TH = NLM (1966)
ST = T066
AN = general or unspecified only; prefer specific informatics & computer terms
MS = Data processing largely performed by automatic means.
MR = 20150701
DA = 19990101
DC = 1
UI = D001330

*NEWRECORD
RECTYPE = D
MH = Automation
AQ = CL EC ES HI IS LJ MA MT SN ST
ENTRY = Automations
MN = J01.897.104
MH_TH = NLM (1966)
ST = T066
AN = for automation as a concept in technol: not for "automated" equipment or "automated" processes & techniques ( = specific technique without AUTOMATION unless especially discussed)
MS = Controlled operation of an apparatus, process, or system by mechanical or electronic devices that take the place of human organs of observation, effort, and decision. (From Webster's Collegiate Dictionary, 1993)
MR = 20040713
DA = 19990101
DC = 1
UI = D001331

*NEWRECORD
RECTYPE = D
MH = Automatism
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
MN = F02.463.425.179.149
MH_TH = NLM (1966)
ST = T055
MS = Automatic, mechanical, and apparently undirected behavior which is outside of conscious control.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001332

*NEWRECORD
RECTYPE = D
MH = Automobile Driver Examination
DE = AUTO DRIVER EXAM
AQ = HI LJ PX SN
ENTRY = Driver Examination, Automobile|T064|NON|EQV|NLM (1995)|930920|DRIVER EXAM AUTO|abcdefv
ENTRY = Examination, Automobile Driver|T064|NON|EQV|NLM (1995)|930920|EXAM AUTO DRIVER|abcdefv
ENTRY = Automobile Driver Examinations
ENTRY = Driver Examinations, Automobile
ENTRY = Examinations, Automobile Driver
MN = I03.125.299
MH_TH = NLM (1966)
ST = T064
AN = DF: AUTO DRIVER EXAM
MS = Government required written and driving test given to individuals prior to obtaining an operator's license.
MR = 19940512
DA = 19990101
DC = 1
UI = D001333

*NEWRECORD
RECTYPE = D
MH = Automobile Driving
AQ = ED LJ PX SN ST
ENTRY = Automobile Drivings
ENTRY = Driving, Automobile
ENTRY = Drivings, Automobile
MN = I03.125
FX = Accidents, Traffic
FX = Motor Vehicles
MH_TH = NLM (1964)
ST = T056
MS = The effect of environmental or physiological factors on the driver and driving ability. Included are driving fatigue, and the effect of drugs, disease, and physical disabilities on driving.
PM = 67
HN = 67(64)
MR = 19970620
DA = 19990101
DC = 1
DX = 19670101
UI = D001334

*NEWRECORD
RECTYPE = D
MH = Vehicle Emissions
AQ = AN LJ PC PO TO
PRINT ENTRY = Automobile Exhaust|T131|NON|NRW|NLM (1996)|950316|abcdef
PRINT ENTRY = Diesel Exhaust|T131|NON|NRW|NLM (1996)|950316|abcdef
PRINT ENTRY = Engine Exhaust|T131|NON|NRW|NLM (1996)|950316|abcdef
ENTRY = Vehicular Emissions|T131|NON|EQV|NLM (1996)|950316|abcdef
ENTRY = Emission, Vehicle
ENTRY = Emission, Vehicular
ENTRY = Emissions, Vehicle
ENTRY = Emissions, Vehicular
ENTRY = Exhaust, Automobile
ENTRY = Exhaust, Diesel
ENTRY = Exhaust, Engine
ENTRY = Vehicle Emission
ENTRY = Vehicular Emission
MN = D20.832
PA = Air Pollutants
MH_TH = NLM (1966)
ST = T131
RN = 0
MS = Gases, fumes, vapors, and odors escaping from the cylinders of a gasoline or diesel internal-combustion engine. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed & Random House Unabridged Dictionary, 2d ed)
PM = 96; was AUTOMOBILE EXHAUST 1963-95
HN = 96; was AUTOMOBILE EXHAUST 1963-95; was in Cat G only 1968-74, was in Cat G & J 1963-67
MR = 20060705
DA = 19990101
DC = 1
UI = D001335

*NEWRECORD
RECTYPE = D
MH = Automobiles
AQ = CL EC ES HI LJ SN ST
ENTRY = Automobile
MN = J01.937.500.100
FX = Air Bags
FX = Seat Belts
MH_TH = NLM (1966)
ST = T073
MS = A usually four-wheeled automotive vehicle designed for passenger transportation and commonly propelled by an internal-combustion engine using a volatile fuel. (Webster, 1973)
MR = 19950531
DA = 19990101
DC = 1
UI = D001336

*NEWRECORD
RECTYPE = D
MH = Autonomic Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Autonomic Drugs|T121|NON|EQV|UNK (19XX)|810513|abcdef
ENTRY = Autonomic Effect|T039|NON|REL|NLM (2012)|110330|abcdef
ENTRY = Autonomic Effects|T039|NON|REL|NLM (2012)|110330|abcdef
ENTRY = Agents, Autonomic
ENTRY = Drugs, Autonomic
ENTRY = Effect, Autonomic
ENTRY = Effects, Autonomic
MN = D27.505.696.663.050
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = general or unspecified; prefer specifics; note entry term AUTONOMIC EFFECT: use only for the autonomic effect of a chemical substance
MS = Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc.
OL = use AUTONOMIC AGENTS to search AUTONOMIC DRUGS 1966-81
PM = 82; was AUTONOMIC DRUGS 1963-81
HN = 82; was AUTONOMIC DRUGS 1963-81
MR = 20110624
DA = 19990101
DC = 1
UI = D001337

*NEWRECORD
RECTYPE = D
MH = Autonomic Fibers, Postganglionic
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Autonomic Fiber, Postganglionic
ENTRY = Fiber, Postganglionic Autonomic
ENTRY = Fibers, Postganglionic Autonomic
ENTRY = Postganglionic Autonomic Fiber
ENTRY = Postganglionic Autonomic Fibers
MN = A08.675.542.100
MN = A08.800.050.050.050
MN = A08.800.800.060.050
MN = A11.671.501.100
MH_TH = NLM (1971)
ST = T023
AN = do not confuse with AUTONOMIC FIBERS, PREGANGLIONIC
PI = Ganglia, Autonomic (1966-1970)
MS = Nerve fibers which project from cell bodies of AUTONOMIC GANGLIA to SYNAPSES on target organs.
PM = 71
HN = 71
MR = 19930618
DA = 19990101
DC = 1
DX = 19710101
UI = D001338

*NEWRECORD
RECTYPE = D
MH = Autonomic Fibers, Preganglionic
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Autonomic Fiber, Preganglionic
ENTRY = Fiber, Preganglionic Autonomic
ENTRY = Fibers, Preganglionic Autonomic
ENTRY = Preganglionic Autonomic Fiber
ENTRY = Preganglionic Autonomic Fibers
MN = A08.675.542.234.060
MN = A08.800.050.050.060
MN = A08.800.800.060.060
MN = A11.671.501.234.060
MH_TH = NLM (1971)
ST = T023
AN = do not confuse with AUTONOMIC FIBERS, POSTGANGLIONIC
PI = Ganglia, Autonomic (1966-1970)
MS = NERVE FIBERS which project from the central nervous system to AUTONOMIC GANGLIA. In the sympathetic division most preganglionic fibers originate with neurons in the intermediolateral column of the SPINAL CORD, exit via ventral roots from upper thoracic through lower lumbar segments, and project to the paravertebral ganglia; there they either terminate in SYNAPSES or continue through the SPLANCHNIC NERVES to the prevertebral ganglia. In the parasympathetic division the fibers originate in neurons of the BRAIN STEM and sacral spinal cord. In both divisions the principal transmitter is ACETYLCHOLINE but peptide cotransmitters may also be released.
PM = 71
HN = 71
MR = 20150622
DA = 19990101
DC = 1
DX = 19710101
UI = D001339

*NEWRECORD
RECTYPE = D
MH = Autonomic Nerve Block
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Sympathetic Nerve Block|T061|NON|REL|UNK (19XX)|810227|abcdef
ENTRY = Autonomic Nerve Blocks
ENTRY = Block, Autonomic Nerve
ENTRY = Block, Sympathetic Nerve
ENTRY = Blocks, Autonomic Nerve
ENTRY = Blocks, Sympathetic Nerve
ENTRY = Nerve Block, Autonomic
ENTRY = Nerve Block, Sympathetic
ENTRY = Nerve Blocks, Autonomic
ENTRY = Nerve Blocks, Sympathetic
ENTRY = Sympathetic Nerve Blocks
MN = E03.155.086.711.299
MN = E04.525.210.550.500
MH_TH = NLM (1966)
ST = T061
AN = NERVE BLOCK is also available; coordinate with substance used to induce the block with no qualifiers if particularly discussed
MS = Interruption of sympathetic pathways, by local injection of an anesthetic agent, at any of four levels: peripheral nerve block, sympathetic ganglion block, extradural block, and subarachnoid block.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001340

*NEWRECORD
RECTYPE = D
MH = Autonomic Nervous System
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Vegetative Nervous System|T022|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Visceral Nervous System|T022|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Autonomic Nervous Systems
ENTRY = Nervous System, Autonomic
ENTRY = Nervous System, Vegetative
ENTRY = Nervous System, Visceral
ENTRY = Nervous Systems, Autonomic
ENTRY = Nervous Systems, Vegetative
ENTRY = Nervous Systems, Visceral
ENTRY = System, Autonomic Nervous
ENTRY = System, Vegetative Nervous
ENTRY = System, Visceral Nervous
ENTRY = Systems, Autonomic Nervous
ENTRY = Systems, Vegetative Nervous
ENTRY = Systems, Visceral Nervous
ENTRY = Vegetative Nervous Systems
ENTRY = Visceral Nervous Systems
MN = A08.800.050
FX = Autonomic Denervation
FX = Visceral Afferents
MH_TH = NLM (1966)
ST = T022
AN = dysfunction = AUTONOMIC NERVOUS SYSTEM DISEASES but consider also DYSAUTONOMIA, FAMILIAL
MS = The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.
MR = 19930621
DA = 19990101
DC = 1
UI = D001341

*NEWRECORD
RECTYPE = D
MH = Autonomic Nervous System Diseases
DE = AUTONOMIC NERVOUS SYSTEM DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Central Autonomic Nervous System Diseases|T047|NON|EQV|NLM (2000)|991108|CENTRAL AUTONOMIC NERVOUS SYSTEM DIS|abcdefv
PRINT ENTRY = Disorders of the Autonomic Nervous System|T047|NON|EQV|NLM (2000)|991108|DIS AUTONOMIC NERVOUS SYSTEM|abcdefv
PRINT ENTRY = Nervous System Diseases, Autonomic|T047|NON|EQV|NLM (2000)|991108|NERVOUS SYSTEM DIS AUTONOMIC|abcdefv
PRINT ENTRY = Nervous System Diseases, Parasympathetic|T047|NON|NRW|NLM (2000)|991108|NERVOUS SYSTEM DIS PARASYMPATHETIC|abcdefv
PRINT ENTRY = Nervous System Diseases, Sympathetic|T047|NON|NRW|NLM (2000)|991108|NERVOUS SYSTEM DIS SYMPATHETIC|abcdefv
PRINT ENTRY = Parasympathetic Nervous System Diseases|T047|NON|NRW|NLM (2000)|991108|PARASYMPATHETIC NERVOUS SYSTEM DIS|abcdefv
PRINT ENTRY = Peripheral Autonomic Nervous System Diseases|T047|NON|NRW|NLM (2000)|991108|PERIPHERAL AUTONOMIC NERVOUS SYSTEM DIS|abcdefv
PRINT ENTRY = Sympathetic Nervous System Diseases|T047|NON|NRW|NLM (2000)|991108|SYMPATHETIC NERVOUS SYSTEM DIS|abcdefv
ENTRY = ANS (Autonomic Nervous System) Diseases|T047|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = ANS Diseases|T047|NON|EQV|UNK (19XX)|810316|ANS DIS|abcdefv
ENTRY = Autonomic Central Nervous System Diseases|T047|NON|EQV|NLM (2000)|991108|AUTONOMIC CNS DIS|abcdefv
ENTRY = Autonomic Diseases|T047|NON|EQV|NLM (1994)|921222|AUTONOMIC DIS|abcdefv
ENTRY = Autonomic Nervous System Disorders|T047|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Autonomic Peripheral Nervous System Diseases|T047|NON|NRW|NLM (2000)|991108|AUTONOMIC PERIPHERAL NERVOUS SYSTEM DIS|abcdefv
ENTRY = Segmental Autonomic Dysfunction|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = ANS Disease
ENTRY = Autonomic Disease
ENTRY = Autonomic Dysfunction, Segmental
ENTRY = Autonomic Dysfunctions, Segmental
ENTRY = Segmental Autonomic Dysfunctions
MN = C10.177
MH_TH = NLM (1981)
ST = T047
PI = Autonomic Nervous System (1966-1980)
PI = Nervous System Diseases (1966-1980)
MS = Diseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.
PM = 1981
HN = 1981; was AUTONOMIC SYSTEM DISEASES (NON MESH) before 1981
CATSH = CAT LIST
MR = 20121129
DA = 19990101
DC = 1
DX = 19810101
UI = D001342

*NEWRECORD
RECTYPE = D
MH = Autophagy
AQ = DE ES GE IM PH RE
PRINT ENTRY = Autophagocytosis|T043|NON|EQV|NLM (1979)|990101|abcdef
ENTRY = Autophagic Cell Death|T043|NON|NRW|NLM (2006)|050303|abcdef
ENTRY = Autophagic Programmed Cell Death|T043|NON|NRW|NLM (2006)|041025|abcdef
ENTRY = Autophagy, Cellular|T043|NON|EQV|NLM (2006)|050303|abcdef
ENTRY = Programmed Cell Death, Type II|T043|NON|NRW|NLM (2006)|041025|abcdef
ENTRY = Autophagic Cell Deaths
ENTRY = Autophagies
ENTRY = Autophagies, Cellular
ENTRY = Cell Death, Autophagic
ENTRY = Cell Deaths, Autophagic
ENTRY = Cellular Autophagies
ENTRY = Cellular Autophagy
ENTRY = Death, Autophagic Cell
ENTRY = Deaths, Autophagic Cell
MN = G04.299.139.399
MN = G04.299.482.350.091
MH_TH = NLM (2006)
ST = T043
AN = programmed cell death unspecified probably = APOPTOSIS, but check text
PI = Autolysis (1968-1978)
PI = Lysosomes (1966-1978)
PI = Phagocytosis (1966-1978)
MS = The segregation and degradation of damaged or unwanted cytoplasmic constituents by autophagic vacuoles (cytolysosomes) composed of LYSOSOMES containing cellular components in the process of digestion; it plays an important role in BIOLOGICAL METAMORPHOSIS of amphibians, in the removal of bone by osteoclasts, and in the degradation of normal cell components in nutritional deficiency states.
PM = 2006; see AUTOPHAGOCYTOSIS 1991-2005, PHAGOCYTOSIS 1979-1990
HN = 2006(1979)
CATSH = CAT LIST
MR = 20080708
DA = 19780320
DC = 1
DX = 19910101
UI = D001343

*NEWRECORD
RECTYPE = D
MH = Autopsy
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Autopsies|T060|NON|EQV|BIOETHICS (1989)|770317|abcdef
ENTRY = Post-Mortem Examination|T060|NON|EQV|NLM (2012)|110218|abcdef
ENTRY = Postmortem Examination|T060|NON|EQV|NLM (2012)|110218|abcdef
ENTRY = Examination, Post-Mortem
ENTRY = Examination, Postmortem
ENTRY = Examinations, Post-Mortem
ENTRY = Examinations, Postmortem
ENTRY = Post Mortem Examination
ENTRY = Post-Mortem Examinations
ENTRY = Postmortem Examinations
MN = E01.370.060
MN = E05.070
MN = I01.198.780.937.120
MH_TH = NLM (1994)
ST = T060
AN = no qualifiers when NIM; not a routine coordinate for postmortem pathology ( = /pathol): discussion must be on autopsy as a procedure
MS = Postmortem examination of the body.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001344

*NEWRECORD
RECTYPE = D
MH = Autoradiography
DE = AUTORADIOGR
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Radioautography|T059|NON|EQV|UNK (19XX)|740329|RADIOAUTOGR|abcdefv
MN = E01.370.225.750.132
MN = E05.200.750.132
MN = E05.799.256
MH_TH = NLM (1973)
ST = T059
AN = NIM, usually no qualif; DF: AUTORADIOGR
MS = The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed)
OL = use AUTORADIOGRAPHY to search RADIOAUTOGRAPHY 1966-72
PM = 73; was RADIOAUTOGRAPHY 1963-72
HN = 73; was RADIOAUTOGRAPHY 1963-72
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
DX = 19730101
UI = D001345

*NEWRECORD
RECTYPE = D
MH = Autosuggestion
ENTRY = Autosuggestions
MN = E02.190.525.217.771.100
MN = F04.754.424.771.299
MH_TH = NLM (1975)
ST = T041
AN = no qualif
MS = Suggestion coming from the subject himself.
OL = search SUGGESTION 1966-74
PM = 91; was see under SUGGESTION 1975-90
HN = 91(75); was see under SUGGESTION 1975-90
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
DX = 19910101
UI = D001346

*NEWRECORD
RECTYPE = D
MH = Aversive Therapy
DE = AVERSIVE THER
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Aversion Therapy|T061|NON|EQV|IOM (1990)|890417|AVERSION THER|abcdefv
ENTRY = Therapy, Aversion|T061|NON|EQV|NLM (1990)|890417|THER AVERSION|abcdefv
ENTRY = Therapy, Aversive|T061|NON|EQV|UNK (19XX)|860101|THER AVERSIVE|abcdefv
ENTRY = Aversion Therapies
ENTRY = Aversive Therapies
ENTRY = Therapies, Aversion
ENTRY = Therapies, Aversive
MN = F04.754.137.174
MH_TH = NLM (1970)
ST = T061
AN = a psychother technique; DF: AVERSIVE THER
PI = Behavior Therapy (1966-1969)
MS = A treatment that suppresses undesirable behavior by simultaneously exposing the subject to unpleasant consequences.
PM = 70
HN = 70
CATSH = CAT LIST
MR = 19950531
DA = 19990101
DC = 1
DX = 19700101
UI = D001348

*NEWRECORD
RECTYPE = D
MH = Encephalomyelitis Virus, Avian
DE = ENCEPH VIRUS AVIAN
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Avian Encephalomyelitis Virus|T005|NON|EQV|NLM (1994)|921119|AVIAN ENCEPH VIRUS|abcdefv
PRINT ENTRY = Epidemic Tremor Virus|T005|NON|EQV|UNK (19XX)|741111|abcdef
ENTRY = Avian Encephalomyelitis Viruses|T005|NON|EQV|NLM (1995)|931207|AVIAN ENCEPH VIRUSES|abcdefv
ENTRY = Avian encephalomyelitis-like virus|T005|NON|EQV|NLM (2002)|010427|AVIAN ENCEPH LIKE VIRUS|abcdefv
ENTRY = Encephalomyelitis Viruses, Avian|T005|NON|EQV|NLM (1995)|931207|ENCEPH VIRUSES AVIAN|abcdefv
ENTRY = Encephalomyelitis-like Virus, Avian|T005|NON|EQV|NLM (2002)|010427|ENCEPH LIKE VIRUS AVIAN|abcdefv
ENTRY = Virus, Avian Encephalomyelitis|T005|NON|EQV|NLM (1995)|931207|VIRUS AVIAN ENCEPH|abcdefv
ENTRY = Viruses, Avian Encephalomyelitis|T005|NON|EQV|NLM (1995)|931207|VIRUSES AVIAN ENCEPH|abcdefv
ENTRY = Epidemic Tremor Viruses
ENTRY = Tremor Virus, Epidemic
ENTRY = Tremor Viruses, Epidemic
MN = B04.820.565.400.250
MH_TH = NLM (1975)
ST = T005
AN = infection: coord IM with PICORNAVIRIDAE INFECTIONS (IM)
MS = A tentative species in the genus HEPATOVIRUS infecting primarily young chicks, but also found in turkeys, pheasants, and guinea fowl. It causes a fatal neuronal degeneration and is transmitted by mechanical contact.
OL = use ENCEPHALOMYELITIS VIRUS, AVIAN to search AVIAN ENCEPHALOMYELITIS VIRUS 1975-93
PM = 94; was AVIAN ENCEPHALOMYELITIS VIRUS 1975-93 (see under ENTEROVIRUSES 1975-90)
HN = 94; was AVIAN ENCEPHALOMYELITIS VIRUS 1975-93 (see under ENTEROVIRUSES 1975-90)
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D001350

*NEWRECORD
RECTYPE = D
MH = Infectious bronchitis virus
DE = INFECT BRONCHITIS VIRUS
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Avian Infectious Bronchitis Virus|T005|NON|EQV|NLM (1994)|921117|AVIAN INFECT BRONCHITIS VIRUS|abcdefv
ENTRY = Infectious Bronchitis Virus, Avian|T005|NON|EQV|NLM (1975)|990101|INFECT BRONCHITIS VIRUS AVIAN|abcdefv
ENTRY = Infectious bronchitis viruses
ENTRY = bronchitis virus, Infectious
ENTRY = bronchitis viruses, Infectious
MN = B04.820.504.540.150.500
MH_TH = NLM (2002)
ST = T005
AN = infection: coord IM with CORONAVIRUS INFECTIONS (IM); DF: INFECT BRONCHITIS VIRUS
MS = A species of CORONAVIRUS causing infections in chickens and possibly pheasants. Chicks up to four weeks old are the most severely affected.
PM = 2002; see INFECTIOUS BRONCHITIS VIRUS, AVIAN 1994-2001, see AVIAN INFECTIOUS BRONCHITIS VIRUS 1991-1993, see CORONAVIRIDAE 1981-1990, see CORONAVIRUSES 1975-1980
HN = 2002 (1975)
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D001351

*NEWRECORD
RECTYPE = D
MH = Herpesvirus 1, Gallid
DS = HERPESVIRUS GALLID 01
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Avian Infectious Laryngotracheitis Virus|T005|NON|EQV|NLM (1994)|930302|AVIAN INFECT LARYNGOTRACHEITIS VIRUS|abcdefv
ENTRY = Gallid Herpesvirus 1|T005|NON|EQV|NLM (1994)|150623|GALLID HERPESVIRUS 01|abcdefs
ENTRY = Herpesvirus 1 (alpha), Gallid|T005|NON|EQV|NLM (1994)|930302|HERPESVIRUS 1 ALPHA GALLID|abcdefv
ENTRY = Infectious Laryngotracheitis Virus, Avian|T005|NON|EQV|NLM (1994)|930325|INFECT LARYNGOTRACHEITIS VIRUS AVIAN|abcdefv
MN = B04.280.382.100.374.450
MH_TH = NLM (1975)
ST = T005
AN = do not confuse with HERPESVIRUS 2, GALLID; infection: coord IM with HERPESVIRIDAE INFECTIONS (IM)
MS = The type species of the genus ILTOVIRUS found on every continent and affecting mainly chickens and occasionally pheasants.
OL = use HERPESVIRUS 1, GALLID to search AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93
PM = 94; was AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)
HN = 94; was AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80)
MR = 20150624
DA = 19741212
DC = 1
DX = 19910101
UI = D001352

*NEWRECORD
RECTYPE = D
MH = Avian Leukosis
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
PRINT ENTRY = Leukosis, Avian|T050|T191|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Avian Leukoses
ENTRY = Leukoses, Avian
MN = C02.782.815.096
MN = C02.928.120
MN = C04.557.337.372.216
MN = C04.619.531.216
MN = C22.131.094
MH_TH = NLM (1966)
ST = T050
ST = T191
AN = don't forget also BIRDS (NIM) or specific bird (IM) & check tag ANIMALS
MS = A group of transmissible viral diseases of chickens and turkeys. Liver tumors are found in most forms, but tumors can be found elsewhere.
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001353

*NEWRECORD
RECTYPE = D
MH = Avian Leukosis Virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Leukosis Virus, Avian|T005|NON|EQV|NLM (1966)|990101|abcdef
PRINT ENTRY = Lymphomatosis Virus, Avian|T005|NON|NRW|UNK (19XX)|770428|abcdef
PRINT ENTRY = Rous-Associated Virus|T005|EPO|REL|UNK (19XX)|750101|abcdef
ENTRY = Avian Leukosis Viruses
ENTRY = Avian Lymphomatosis Virus
ENTRY = Avian Lymphomatosis Viruses
ENTRY = Leukosis Viruses, Avian
ENTRY = Lymphomatosis Viruses, Avian
ENTRY = Rous Associated Virus
ENTRY = Virus, Avian Leukosis
ENTRY = Virus, Avian Lymphomatosis
ENTRY = Virus, Rous-Associated
ENTRY = Viruses, Avian Leukosis
ENTRY = Viruses, Avian Lymphomatosis
MN = B04.613.807.070.100
MN = B04.820.650.070.100
MH_TH = NLM (2016)
ST = T005
AN = infection = AVIAN LEUKOSIS + BIRDS or POULTRY (NIM) or specific bird or fowl (IM)
MS = The type species of ALPHARETROVIRUS producing latent or manifest lymphoid leukosis in fowl.
PM = 2007; see LEUKOSIS VIRUS, AVIAN 1994-2006, see AVIAN LEUKOSIS VIRUSES 1975-1993, see AVIAN LEUKOSIS VIRUS 1963-1974; for LEUKEMIA VIRUS, AVIAN see AVIAN LEUKOSIS VIRUSES 1978-1993; for LEUKEMIA VIRUS, AVIAN & LYMPHOMATOSIS VIRUS, AVIAN see AVIAN LEUKOSIS VIRUSES 1975-1977, see AVIAN LEUKOSIS VIRUS 1963-1974
HN = 2007, 1963-1974
MR = 20150623
DA = 19990101
DC = 1
UI = D001354

*NEWRECORD
RECTYPE = D
MH = Alpharetrovirus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Avian Erythroblastosis Virus|T005|NON|NRW|NLM (1994)|921208|abcdef
PRINT ENTRY = Retroviruses Type C, Avian|T005|NON|EQV|NLM (1966)|990101|abcdef
PRINT ENTRY = Type C Avian Retroviruses|T005|NON|EQV|NLM (1997)|960326|abcdef
ENTRY = Avian Leukosis-Sarcoma Viruses|T005|NON|EQV|NLM (1994)|921208|abcdef
ENTRY = Erythroblastosis Virus, Avian|T005|NON|NRW|NLM (1975)|990101|abcdef
ENTRY = Retroviruses, ALV-Related|T005|EQV|NLM (1997)|951011|abdef
ENTRY = ALV-Related Retrovirus
ENTRY = ALV-Related Retroviruses
ENTRY = Alpharetroviruses
ENTRY = Avian Erythroblastosis Viruses
ENTRY = Avian Leukosis Sarcoma Viruses
ENTRY = Avian Leukosis-Sarcoma Virus
ENTRY = Erythroblastosis Viruses, Avian
ENTRY = Leukosis-Sarcoma Virus, Avian
ENTRY = Leukosis-Sarcoma Viruses, Avian
ENTRY = Retrovirus, ALV-Related
ENTRY = Retroviruses, ALV Related
ENTRY = Virus, Avian Erythroblastosis
ENTRY = Virus, Avian Leukosis-Sarcoma
ENTRY = Viruses, Avian Erythroblastosis
ENTRY = Viruses, Avian Leukosis-Sarcoma
MN = B04.613.807.070
MN = B04.820.650.070
MH_TH = NLM (2002)
ST = T005
AN = infection: coordinate IM with AVIAN LEUKOSIS (IM) or SARCOMA, AVIAN (IM), but if not so specified coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) if pertinent; index also BIRDS or POULTRY (NIM) or specific bird or fowl (IM)
MS = A genus of the family RETROVIRIDAE with type C morphology, that causes malignant and other diseases in wild birds and domestic fowl.
PM = 2002; see RETROVIRUSES TYPE C, AVIAN 1997-2001, see RETROVIRUSES, ALV-RELATED 1994-1996, see AVIAN LEUKOSIS-SARCOMA VIRUSES 1966-1993; for RETROVIRUSES TYPE C, AVIAN see RETROVIRUSES TYPE C, AVIAN 1997-2001, see RETROVIRUSES, ALV-RELATED 1994-1996; for AVIAN ERYTHROBLASTOSIS VIRUS see ERYTHROBLASTOSIS VIRUS, AVIAN 1991-2006, see AVIAN LEUKOSIS VIRUSES 1975-1990, see AVIAN LEUKOSIS VIRUS 1963-1974
HN = 2002 (1966)
MR = 20150622
DA = 19990101
DC = 1
DX = 19660101
UI = D001355

*NEWRECORD
RECTYPE = D
MH = Reticuloendotheliosis virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = T Virus|T005|NON|NRW|UNK (19XX)|741111|abcdef
ENTRY = T Viruses
ENTRY = Virus, T
MN = B04.613.807.375.700.700
MN = B04.820.650.375.700.700
MH_TH = NLM (2002)
ST = T005
AN = do not confuse X ref T VIRUS with T-PHAGES; infection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)
MS = A species in the group RETICULOENDOTHELIOSIS VIRUSES, AVIAN of the genus GAMMARETROVIRUS that causes a chronic neoplastic and a more acute immunosuppressive disease in fowl.
PM = 2002; see RETICULOENDOTHELIOSIS VIRUS, AVIAN 1994-2001, see AVIAN RETICULOENDOTHELIOSIS VIRUS 1991-1993, see RETROVIRIDAE 1981-1990, see LEUKOVIRUSES 1978-1980, see LEUKEMOGENIC VIRUSES 1975-1977
HN = 2002 (1975)
MR = 20150623
DA = 19741119
DC = 1
DX = 19910101
UI = D001356

*NEWRECORD
RECTYPE = D
MH = Sarcoma, Avian
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SC SE SU TH UL UR US VI
PRINT ENTRY = Avian Sarcoma|T050|T191|NON|EQV|NLM (1994)|930624|abbcdef
PRINT ENTRY = Rous Sarcoma|T050|T191|EPO|REL|UNK (19XX)|991012|abbcdef
PRINT ENTRY = Sarcoma, Rous|T050|T191|EPO|REL|UNK (19XX)|740330|abbcdef
ENTRY = Avian Sarcomas
ENTRY = Sarcomas, Avian
MN = C02.782.815.800
MN = C02.928.800
MN = C04.557.450.795.830.800
MN = C04.619.857.800
MN = C22.131.800
MH_TH = NLM (1966)
ST = T050
ST = T191
AN = caused by a retrovirus; /blood supply /chem /second /secret /ultrastruct permitted; don't forget also BIRDS or POULTRY (NIM) or specific bird or fowl (IM); check tag ANIMALS
MS = Connective tissue tumors, affecting primarily fowl, that are usually caused by avian sarcoma viruses.
OL = use SARCOMA, AVIAN to search AVIAN SARCOMA 1983-93 & ROUS SARCOMA 1966-82
PM = 94; was AVIAN SARCOMA 1983-93; was ROUS SARCOMA 1963-82
HN = 94; was AVIAN SARCOMA 1983-93; was ROUS SARCOMA 1963-82
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
UI = D001357

*NEWRECORD
RECTYPE = D
MH = Avian Sarcoma Viruses
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Avian Sarcoma Virus B77|T005|NON|NRW|NLM (1994)|921209|AVIAN SARCOMA VIRUS B 77|abcdefs
PRINT ENTRY = Chicken Sarcoma Virus B77|T005|NON|NRW|NLM (1994)|921208|CHICKEN SARCOMA VIRUS B 77|abcdefs
PRINT ENTRY = Chicken Tumor 1 Virus|T005|NON|NRW|UNK (19XX)|750101|CHICKEN TUMOR VIRUS 01|abcdefs
PRINT ENTRY = Fujinami sarcoma virus|T005|NON|NRW|NLM (2007)|050908|abcdef
PRINT ENTRY = Sarcoma Viruses, Avian|T005|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Avian Sarcoma Virus
ENTRY = Fujinami sarcoma viruses
ENTRY = Sarcoma Virus, Avian
ENTRY = Virus, Avian Sarcoma
ENTRY = Viruses, Avian Sarcoma
ENTRY = sarcoma virus, Fujinami
ENTRY = sarcoma viruses, Fujinami
ENTRY = virus, Fujinami sarcoma
ENTRY = viruses, Fujinami sarcoma
MN = B04.613.807.070.120
MN = B04.820.650.070.120
MH_TH = NLM (1994)
ST = T005
AN = infection: coordinate IM with SARCOMA, AVIAN (IM) + BIRDS or POULTRY (NIM) or specific bird or fowl (IM)
MS = Group of alpharetroviruses (ALPHARETROVIRUS) producing sarcomata and other tumors in chickens and other fowl and also in pigeons, ducks, and RATS.
PM = 2007; see SARCOMA VIRUSES, AVIAN 1994-2006, see AVIAN SARCOMA VIRUSES 1983-1993, see ROUS SARCOMA VIRUS 1963-1982; for CHICKEN SARCOMA VIRUS B77 see CHICKEN SARCOMA VIRUS B77 1991-1993, see AVIAN SARCOMA VIRUSES 1983-1990, see ROUS SARCOMA VIRUS 1975-1982
HN = 2007 (1963); for CHICKEN SARCOMA VIRUS B77 see CHICKEN SARCOMA VIRUS B77 1991-1993, see AVIAN SARCOMA VIRUSES 1983-1990, see ROUS SARCOMA VIRUS 1975-1982
MR = 20150622
DA = 19990101
DC = 1
UI = D001358

*NEWRECORD
RECTYPE = D
MH = Aviation
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Parachuting|T056|T057|NON|NRW|UNK (19XX)|820429|abbcdef
ENTRY = Air Traffic Control|T052|NON|NRW|NLM (2008)|070126|abcdef
ENTRY = Control, Air Traffic
ENTRY = Traffic Control, Air
MN = J01.937.285
FX = Aircraft
MH_TH = NLM (1966)
ST = T090
AN = for medical, physiological, psychological aspect of flying index AEROSPACE MEDICINE: Manual 28.7
MS = Design, development, manufacture, and operation of heavier-than-air AIRCRAFT.
OL = use AVIATION to search PARACHUTING 1966-82
PM = PARACHUTING was heading 1963-82
HN = PARACHUTING was heading 1963-82
MR = 20070709
DA = 19990101
DC = 1
UI = D001359

*NEWRECORD
RECTYPE = D
MH = Avidin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
MN = D12.776.034.614.300
MN = D12.776.256.317.663.300
MN = D12.776.290.663.100
MN = D12.776.395.175
FX = Biotin
MH_TH = NLM (1973)
ST = T116
ST = T123
N1 = Avidins
RN = 1405-69-2
MS = A specific protein in egg albumin that interacts with BIOTIN to render it unavailable to mammals, thereby producing biotin deficiency.
OL = search OVALBUMIN 1969-72
PM = 87; was see under OVALBUMIN 1969-86
HN = 87(73); was see under OVALBUMIN 1969-86
MR = 20010725
DA = 19990101
DC = 1
DX = 19870101
UI = D001360

*NEWRECORD
RECTYPE = D
MH = Avitaminosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Vitamin Deficiency|T047|NON|REL|UNK (19XX)|740329|VITAMIN DEFIC|abcdefv
ENTRY = Deficiency, Vitamin|T047|NON|REL|UNK (19XX)|740329|DEFIC VITAMIN|abcdefv
ENTRY = Avitaminoses
ENTRY = Deficiencies, Vitamin
ENTRY = Vitamin Deficiencies
MN = C18.654.521.500.133
MH_TH = NLM (1966)
ST = T047
AN = includes hypovitaminosis; GEN: prefer specifics: avitaminosis A = VITAMIN A DEFICIENCY, etc.
MS = A condition due to a deficiency of one or more essential vitamins. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D001361

*NEWRECORD
RECTYPE = D
MH = Avoidance Learning
AQ = CL DE ES PH RE
ENTRY = Avoidance Behavior|T053|NON|REL|NLM (2016)|OBSSR (2016)|141001|abcdeef
ENTRY = Avoidance Behaviors
ENTRY = Behavior, Avoidance
ENTRY = Behaviors, Avoidance
ENTRY = Learning, Avoidance
MN = F02.463.425.097
MN = F02.463.785.373.173
FX = Escape Reaction
MH_TH = NLM (1966)
ST = T041
MS = A response to a cue that is instrumental in avoiding a noxious experience.
CATSH = CAT LIST
MR = 20150707
DA = 19990101
DC = 1
UI = D001362

*NEWRECORD
RECTYPE = D
MH = Awards and Prizes
DE = AWARDS PRIZES
ENTRY = Awards|T073|NON|NRW|UNK (19XX)|790329|abcdef
ENTRY = Prizes|T073|NON|NRW|NLM (1991)|900816|abcdef
ENTRY = Award
ENTRY = Prize
ENTRY = Prizes and Awards
MN = K01.150
MH_TH = NLM (1966)
ST = T073
AN = IM; no qualif; awards & prizes in field of medicine: do not coord with MEDICINE but coord with specific med specialty or other field (IM); DF: AWARDS
MR = 19991103
DA = 19990101
DC = 1
UI = D001363

*NEWRECORD
RECTYPE = D
MH = Awareness
AQ = CL DE ES PH RE
ENTRY = Situation Awareness|T041|NON|EQV|NLM (2016)|150109|abcdef
ENTRY = Situational Awareness|T041|NON|EQV|NLM (2016)|141118|abcdef
ENTRY = Awareness, Situation
ENTRY = Awareness, Situational
ENTRY = Awarenesses
ENTRY = Awarenesses, Situation
ENTRY = Awarenesses, Situational
ENTRY = Situation Awarenesses
ENTRY = Situational Awarenesses
MN = F02.463.188.150
MH_TH = NLM (1975)
ST = T041
AN = awareness of health matters = HEALTH KNOWLEDGE, ATTITUDES, PRACTICE
MS = The act of "taking account" of an object or state of affairs. It does not imply assessment of, nor attention to the qualities or nature of the object.
PM = 91; was see under COGNITION 1975-90
HN = 91(75); was see under COGNITION 1975-90
CATSH = CAT LIST
MR = 20150708
DA = 19990101
DC = 1
DX = 19910101
UI = D001364

*NEWRECORD
RECTYPE = D
MH = Axilla
AQ = AB AH BS EM GD IN IR MI PA PH PP PS RA RE RI SU US VI
ENTRY = Armpit|T029|NON|BRD|NLM (2016)|150203|abcdef
ENTRY = Underarm|T029|NON|BRD|NLM (2016)|150205|abcdef
MN = A01.378.800.090
MH_TH = NLM (1966)
ST = T029
AN = "axillary lymph nodes" = LYMPH NODES (IM) + AXILLA (NIM, no qualifiers)
MS = Area of the human body underneath the SHOULDER JOINT, also known as the armpit or underarm.
MR = 20150616
DA = 19990101
DC = 1
UI = D001365

*NEWRECORD
RECTYPE = D
MH = Axillary Artery
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, Axillary
ENTRY = Artery, Axillary
ENTRY = Axillary Arteries
MN = A07.231.114.085
MH_TH = NLM (1966)
ST = T023
MS = The continuation of the subclavian artery; it distributes over the upper limb, axilla, chest and shoulder.
MR = 19920526
DA = 19990101
DC = 1
UI = D001366

*NEWRECORD
RECTYPE = D
MH = Axillary Vein
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Axillary Veins
ENTRY = Vein, Axillary
ENTRY = Veins, Axillary
MN = A07.231.908.077
MH_TH = NLM (1966)
ST = T023
MS = The venous trunk of the upper limb; a continuation of the basilar and brachial veins running from the lower border of the teres major muscle to the outer border of the first rib where it becomes the subclavian vein.
MR = 19920526
DA = 19990101
DC = 1
UI = D001367

*NEWRECORD
RECTYPE = D
MH = Axis, Cervical Vertebra
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
PRINT ENTRY = Epistropheus|T023|T032|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Axi, Cervical Vertebra
ENTRY = Cervical Vertebra Axi
ENTRY = Cervical Vertebra Axis
ENTRY = Vertebra Axi, Cervical
ENTRY = Vertebra Axis, Cervical
MN = A02.835.232.834.151.383
MH_TH = NLM (2016)
ST = T023
ST = T032
MS = The second cervical vertebra.
MR = 20150302
DA = 19990101
DC = 1
UI = D001368

*NEWRECORD
RECTYPE = D
MH = Axons
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Axon
MN = A08.675.542.145
MN = A11.284.180.075
MN = A11.671.137
MN = A11.671.501.145
FX = Axotomy
MH_TH = NLM (1966)
ST = T026
AN = NERVE FIBERS is available; giant squid axon: coord IM with SQUID (NIM)
MS = Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body.
MR = 20000621
DA = 19990101
DC = 1
UI = D001369

*NEWRECORD
RECTYPE = D
MH = Axonal Transport
AQ = DE ES GE IM PH RE
PRINT ENTRY = Axoplasmic Flow|T043|NON|REL|NLM (1996)|941007|abcdef
PRINT ENTRY = Axoplasmic Transport|T043|NON|EQV|NLM (1996)|941007|abcdef
ENTRY = Axoplasmic Streaming|T043|NON|REL|NLM (2004)|030508|abcdef
ENTRY = Axonal Transports
ENTRY = Axoplasmic Flows
ENTRY = Axoplasmic Transports
ENTRY = Streaming, Axoplasmic
ENTRY = Transport, Axonal
ENTRY = Transport, Axoplasmic
ENTRY = Transports, Axonal
ENTRY = Transports, Axoplasmic
MN = G03.495.166.355.040
MN = G04.299.418.040
MN = G11.561.600.085
MH_TH = NLM (1969)
ST = T043
PI = Axons (1966-1968)
PI = Cytoplasmic Streaming (1967-1968)
MS = The directed transport of ORGANELLES and molecules along nerve cell AXONS. Transport can be anterograde (from the cell body) or retrograde (toward the cell body). (Alberts et al., Molecular Biology of the Cell, 3d ed, pG3)
PM = 96; was AXOPLASMIC FLOW 1972-95
HN = 96; was AXOPLASMIC FLOW 1972-95 (Prov 1969-71)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19720101
UI = D001370

*NEWRECORD
RECTYPE = D
MH = trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride
DS = TRANSBISCHLOROBENZAMINOMETHYLCYCLOHEXANE DIHYDROCHLORIDE 01 04 02
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = AY-9944|T109|T121|LAB|NRW|NLM (1975)|990101|abbcdef
ENTRY = AY 9944
ENTRY = AY9944
MN = D02.455.426.392.368.367.900
PA = Anticholesteremic Agents
MH_TH = NLM (2005)
ST = T109
ST = T121
N1 = 1,4-Cyclohexanedimethanamine, N,N'-bis((2-chlorophenyl)methyl)-, dihydrochloride, trans-
RN = 366-93-8
PI = Benzyl Compounds (1972-1974)
PI = Cyclohexanes (1968-1974)
PI = Methylamines (1972-1974)
MS = An anticholesteremic agent that inhibits sterol biosynthesis in animals.
PM = 2005; see AY-9944 1991-2004; see CYCLOHEXANES 1975-1990
HN = 2005(1975)
MR = 20040707
DA = 19741111
DC = 1
DX = 19910101
UI = D001371

*NEWRECORD
RECTYPE = D
MH = Aza Compounds
DE = AZA CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compounds, Aza
MN = D02.145
MH_TH = NLM (1972)
ST = T109
RN = 0
AN = do not confuse with AZO COMPOUNDS
PI = specific parent compound (1972-1973)
PM = 74
HN = 74(72)
MR = 20140613
DA = 19990101
DC = 1
DX = 19740101
UI = D001372

*NEWRECORD
RECTYPE = D
MH = Azacosterol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 20,25-Diazacholesterol|T110|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770329|DIAZACHOLESTEROL 20 25|abbcdeefs
ENTRY = Diazacholesterol Dihydrochloride|T110|T121|NON|NRW|NLM (1999)|980406|abbcdef
ENTRY = SC 12937|T110|T121|LAB|NRW|UNK (19XX)|800326|abbcdef
ENTRY = 12937, SC
ENTRY = 20,25 Diazacholesterol
ENTRY = Dihydrochloride, Diazacholesterol
MN = D04.808.247.222.284.070
MN = D04.808.247.808.197.070
MN = D10.570.938.208.070
PA = Anticholesteremic Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1978)
ST = T110
ST = T121
N1 = Androst-5-en-3-ol, 17-((3-(dimethylamino)propyl)methylamino)-, (3beta,17beta)-
RN = EPT876J73A
RR = 313-05-3 (Azacosterol)
PI = Aza Compounds (1972-1977)
PI = Cholesterol (1966-1977)
MS = Diaza derivative of cholesterol which acts as a hypocholesteremic agent by blocking delta-24-reductase, which causes the accumulation of desmosterol.
PM = 91; was see under CHOLESTEROL 1978-90
HN = 91(78); was see under CHOLESTEROL 1978-90
MR = 20150622
DA = 19770415
DC = 1
DX = 19910101
UI = D001373

*NEWRECORD
RECTYPE = D
MH = Azacitidine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Azacytidine|T114|T121|NON|EQV|NLM (1996)|941123|abbcdef
ENTRY = 5-Azacytidine|T114|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|811102|abbcdeef
ENTRY = NSC-102816|T114|T121|LAB|NRW|NLM (1996)|941019|abbcdef
ENTRY = Pharmion Brand of Azacitidine|T114|T121|NON|NRW|NLM (2006)|041004|abbcdef
ENTRY = Vidaza|T114|T121|TRD|NRW|US|041004|abbcdef
ENTRY = 5 Azacytidine
ENTRY = NSC 102816
ENTRY = NSC102816
MN = D02.145.150
MN = D03.383.742.680.245.217
MN = D13.570.685.245.217
MN = D13.570.800.286.300
PA = Antimetabolites, Antineoplastic
PA = Enzyme Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1978)
ST = T114
ST = T121
N1 = 1,3,5-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-
RN = M801H13NRU
RR = 320-67-2 (Azacitidine)
PI = Nucleosides (1966-1971)
PI = Triazines (1966-1971)
MS = A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.
PM = 96; was AZACYTIDINE 1974-95
HN = 96; was AZACYTIDINE 1972-95 (Prov 1972-73)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D001374

*NEWRECORD
RECTYPE = D
MH = Azaguanine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Guanazolo|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|780517|abbcdeef
ENTRY = 8-Azaguanine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|821129|abbcdeef
ENTRY = 8 Azaguanine
MN = D02.145.250
MN = D03.438.759.758.399.454.300
PA = Antimetabolites, Antineoplastic
MH_TH = NLM (1966)
ST = T109
ST = T121
N1 = 7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,4-dihydro-
RN = Q150359I72
RR = 134-58-7 (Azaguanine)
MS = One of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids.
MR = 20130708
DA = 19990101
DC = 1
UI = D001375

*NEWRECORD
RECTYPE = D
MH = Azaperone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Janssen Brand of Azaperone|T109|T121|NON|NRW|NLM (2004)|021028|abbcdef
ENTRY = R-1929|T109|T121|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Stresnil|T109|T121|TRD|NRW|DE|FR|UNK (19XX)|800319|abbcdeeef
ENTRY = Azaperone Janssen Brand
ENTRY = R1929
MN = D02.522.352.110
PA = Antipsychotic Agents
PA = Dopamine Antagonists
PA = Hypnotics and Sedatives
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1967)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 1-Butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-
RN = 19BV78AK7W
RR = 1649-18-9 (Azaperone)
PI = Butyrophenones (1971-1974)
PI = Piperazines (1971-1974)
PI = Pyridines (1971-1974)
MS = A butyrophenone used in the treatment of PSYCHOSES.
PM = 91; was see under BUTYROPHENONES 1975-90
HN = 91(75); was see under BUTYROPHENONES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001376

*NEWRECORD
RECTYPE = D
MH = Azaserine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Azeserine|T116|T195|NON|EQV|UNK (19XX)|760422|abbcdef
ENTRY = LL-D05139a|T116|T195|LAB|NRW|UNK (19XX)|880719|abbcdef
ENTRY = O-Diazoacetyl-L-serine|T116|T195|NON|EQV|NLM (1992)|901022|abbcdef
ENTRY = O Diazoacetyl L serine
MN = D12.125.154.800.500
PA = Antibiotics, Antineoplastic
PA = Antifungal Agents
PA = Antimetabolites, Antineoplastic
PA = Immunosuppressive Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1968)
ST = T116
ST = T195
N1 = L-Serine, diazoacetate (ester)
RN = 87299V3Q9W
RR = 115-02-6 (Azaserine)
AN = /biosyn permitted
MS = Antibiotic substance produced by various Streptomyces species. It is an inhibitor of enzymatic activities that involve glutamine and is used as an antineoplastic and immunosuppressive agent.
MR = 20150622
DA = 19990101
DC = 1
UI = D001377

*NEWRECORD
RECTYPE = D
MH = Azasteroids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.925.100
MH_TH = NLM (1975)
ST = T110
RN = 0
PI = Steroids (1968-1974)
MS = Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with nitrogen atoms.
PM = 91; was see under STEROIDS, HETEROCYCLIC 1975-90
HN = 91(75); was see under STEROIDS, HETEROCYCLIC 1975-90
MR = 19930603
DA = 19741114
DC = 1
DX = 19910101
UI = D001378

*NEWRECORD
RECTYPE = D
MH = Azathioprine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Azathioprine Sodium|T109|T121|T131|NON|NRW|NLM (2014)|USP (19XX)|130305|abbbcdeef
ENTRY = Azathioprine Sodium Salt|T109|T121|T131|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Azathioprine Sulfate|T109|T121|T131|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Azothioprine|T109|T121|T131|NON|EQV|UNK (19XX)|800917|abbbcdef
ENTRY = Immuran|T109|T121|T131|TRD|NRW|NLM (1990)|890607|abbbcdef
ENTRY = Imuran|T109|T121|T131|TRD|NRW|UNK (19XX)|810210|abbbcdef
ENTRY = Imurel|T109|T121|T131|TRD|NRW|UNK (19XX)|820203|abbbcdef
ENTRY = Sodium, Azathioprine
MN = D02.886.759.111
MN = D03.438.759.534.090
MN = D13.570.900.111
PA = Antimetabolites
PA = Antimetabolites, Antineoplastic
PA = Antirheumatic Agents
PA = Immunosuppressive Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1962)
MH_TH = USP (19XX)
ST = T109
ST = T121
ST = T131
N1 = 1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-
RN = MRK240IY2L
RR = 446-86-6 (Azathioprine)
RR = 55372-48-0 (sulfate)
RR = AM94R510MS
MS = An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
PM = 66
HN = 66(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D001379

*NEWRECORD
RECTYPE = D
MH = Azauridine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione|T114|T121|NON|EQV|NLM (1996)|950517|abbcdef
ENTRY = 6-Azauridine|T114|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|781218|abbcdeef
ENTRY = 6 Azauridine
MN = D02.145.451
MN = D03.383.742.680.852.176
MN = D13.570.685.852.176
MN = D13.570.800.892.176
PA = Antimetabolites, Antineoplastic
PA = Dermatologic Agents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T114
ST = T121
N1 = 1,2,4-Triazine-3,5(2H,4H)-dione, 2-beta-D-ribofuranosyl-
RN = 7BVB29RCPR
RR = 39455-15-7 (other number)
RR = 54-25-1 (Azauridine)
PI = Antimetabolites (1966-1971)
PI = Uridine (1966-1971)
MS = A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
PM = 73
HN = 73(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D001380

*NEWRECORD
RECTYPE = D
MH = Azepines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hexamethyleneimines|T109|NON|EQV|UNK (19XX)|770520|abcdef
MN = D03.383.066
FX = Benzazepines
FX = Dibenzazepines
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Seven membered heterocyclic rings containing a NITROGEN atom.
MR = 20040707
DA = 19990101
DC = 1
UI = D001381

*NEWRECORD
RECTYPE = D
MH = Azerbaijan
AQ = EH EP
PRINT ENTRY = Azerbaijan S.S.R.|T083|NAM|EQV|NLM (1993)|920422|abcdef
ENTRY = Azerbaijan SSR|T083|NAM|EQV|NLM (1993)|920422|abcdef
MN = Z01.542.900.120
MN = Z01.586.200.120
MN = Z01.586.950.120
MH_TH = POPLINE (1993)
ST = T083
AN = use this spelling in translations
OL = use AZERBAIJAN to search AZERBAIJAN S.S.R. 1982-92
HN = 93; was AZERBAIJAN S.S.R. 1982-92; was heading 1963-81
MR = 19940317
DA = 19990101
DC = 4
UI = D001382

*NEWRECORD
RECTYPE = D
MH = Azetidinecarboxylic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Azetidine-2-carboxylic Acid|T116|NON|EQV|UNK (19XX)|800917|abcdef
ENTRY = Acid, Azetidine-2-carboxylic
ENTRY = Acid, Azetidinecarboxylic
ENTRY = Azetidine 2 carboxylic Acid
MN = D02.241.081.583.100
MN = D02.491.485.100
MN = D03.383.082.301.100
MN = D12.125.072.401.200
MH_TH = NLM (1975)
ST = T116
N1 = 2-Azetidinecarboxylic acid
RN = 2517-04-6
PI = Azetines (1974-1975)
PI = Imino Acids (1974)
MS = A proline analog that acts as a stoichiometric replacement of proline. It causes the production of abnormal proteins with impaired biological activity.
PM = 91; was see under AZETINES 1975-90
HN = 91(75); was see under AZETINES 1975-90
MR = 20130709
DA = 19741119
DC = 1
DX = 19910101
UI = D001383

*NEWRECORD
RECTYPE = D
MH = Azetidines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.383.082.301
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = do not confuse with AZETINES
OL = search AZETINES 1974
PM = 91; was see under AZETINES 1975-90
HN = 91(75); was see under AZETINES 1975-90
MR = 19920507
DA = 19990101
DC = 1
DX = 19910101
UI = D001384

*NEWRECORD
RECTYPE = D
MH = Azetines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.383.082
MH_TH = NLM (1974)
ST = T109
RN = 0
AN = do not confuse with AZETIDINES
PM = 74
HN = 74
MR = 19920507
DA = 19990101
DC = 1
DX = 19740101
UI = D001385

*NEWRECORD
RECTYPE = D
MH = Azides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.625.100
MN = D02.159
MH_TH = NLM (1966)
ST = T104
RN = 0
MS = Organic or inorganic compounds that contain the -N3 group.
MR = 19980610
DA = 19990101
DC = 1
UI = D001386

*NEWRECORD
RECTYPE = D
MH = Azinphosmethyl
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK RE SD ST TO TU UR
ENTRY = Azinphos-Methyl|T115|T131|NON|EQV|FDA SRS (2014)|NLM (1996)|941020|abbcdeef
ENTRY = Guthion|T115|T131|TRD|NRW|UNK (19XX)|800801|abbcdef
ENTRY = Azinphos Methyl
MN = D02.705.400.625.060
MN = D02.705.539.345.060
MN = D02.886.300.692.060
PA = Acaricides
PA = Cholinesterase Inhibitors
PA = Insecticides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T115
ST = T131
N1 = Phosphorodithioic acid, O,O-dimethyl S-((4-oxo-1,2,3-benzotriazin-3(4H)-yl)methyl) ester
RN = 265842EWUV
RR = 86-50-0 (Azinphosmethyl)
AN = for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
PI = Insecticides (1966-1971)
MS = An organothiophosphorus cholinesterase inhibitor. It has been used as an acaricide and as an insecticide.
PM = 91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90
HN = 91(72); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001387

*NEWRECORD
RECTYPE = D
MH = Aziridines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Ethyleneimines|T109|NON|EQV|UNK (19XX)|760317|abcdef
ENTRY = Azacyclopropanes, Saturated|T109|NON|EQV|NLM (2005)|031230|abcdef
ENTRY = Dimethyleneimines|T109|NON|EQV|NLM (1988)|881129|abcdef
ENTRY = Saturated Azacyclopropanes
MN = D03.383.097.217
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = AZACYCLOPROPANES, UNSATURATED see AZIRINES is available
MS = Saturated azacyclopropane compounds. They include compounds with substitutions on CARBON or NITROGEN atoms.
OL = search AZIRINES 1966-74
PM = 90;66-67; was see under AZIRINES 1975-89; was heading 1966-67
HN = 90(75)66-67; was see under AZIRINES 1975-89; was heading 1966-67
MR = 20040707
DA = 19990101
DC = 1
DX = 19900101
UI = D001388

*NEWRECORD
RECTYPE = D
MH = Azirines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Azacyclopropanes, Unsaturated|T109|NON|EQV|NLM (2005)|031230|abcdef
ENTRY = Unsaturated Azacyclopropanes
MN = D03.383.097
MH_TH = NLM (1968)
ST = T109
RN = 0
AN = AZACYCLOPROPANES, SATURATED see AZIRIDINES is available
MS = Unsaturated azacyclopropane compounds that are three-membered heterocycles of a nitrogen and two carbon atoms.
PM = 68; AZIRIDINES was heading 1966-67
HN = 68
MR = 20040707
DA = 19990101
DC = 1
DX = 19680101
UI = D001389

*NEWRECORD
RECTYPE = D
MH = Azlocillin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Azlin|T109|T195|TRD|NRW|UNK (19XX)|840524|abbcdef
ENTRY = Azlocillin Sodium|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2014)|130130|abbcdeef
ENTRY = Bay-e 6905|T109|T195|LAB|NRW|UNK (19XX)|840524|abbcdef
ENTRY = Bayer Brand of Azlocillin|T109|T195|NON|NRW|NLM (2004)|030115|abbcdef
ENTRY = Securopen|T109|T195|TRD|NRW|DE|IE|UK|UNK (19XX)|840524|abbcdeeeef
ENTRY = Sodium Azlocillin|T109|T121|NON|NRW|NLM (2014)|130130|abbcdef
ENTRY = Azlocillin Bayer Brand
ENTRY = Azlocillin, Sodium
ENTRY = Bay e 6905
ENTRY = Baye 6905
ENTRY = Sodium, Azlocillin
MN = D02.065.589.099.750.750.050.075
MN = D02.886.108.750.750.050.075
MN = D03.438.260.825.750.050.075
MN = D03.605.084.737.750.050.075
MN = D04.075.080.875.099.221.750.750.050.075
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (2014)
MH_TH = USAN (1976)
ST = T109
ST = T195
N1 = 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta(S*)))-
RN = HUM6H389W0
RR = 37091-66-0 (Azlocillin)
RR = DWV1EFW947
PI = Penicillins (1966-1984)
MS = A semisynthetic ampicillin-derived acylureido penicillin.
PM = 85
HN = 85
MR = 20130708
DA = 19840524
DC = 1
DX = 19850101
UI = D001390

*NEWRECORD
RECTYPE = D
MH = Azo Compounds
DE = AZO CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Azo Dyes|T109|NON|NRW|NLM (2015)|131030|abcdef
ENTRY = Compounds, Azo
ENTRY = Dyes, Azo
MN = D02.172
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = do not confuse with AZA COMPOUNDS
MR = 20140606
DA = 19990101
DC = 1
UI = D001391

*NEWRECORD
RECTYPE = D
MH = Azocines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.383.113
MH_TH = NLM (1964)
ST = T109
RN = 0
PM = 66
HN = 66(64)
MR = 19920507
DA = 19990101
DC = 1
DX = 19660101
UI = D001392

*NEWRECORD
RECTYPE = D
MH = Azoles
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.383.129
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Five membered rings containing a NITROGEN atom.
MR = 20050630
DA = 19990101
DC = 1
UI = D001393

*NEWRECORD
RECTYPE = D
MH = Azores
AQ = EH EP
MN = Z01.639.040.218
MH_TH = NLM (1966)
ST = T083
AN = a group of 9 Atlantic islands off the coast of Portugal
MS = A group of nine islands and several islets belonging to Portugal in the north Atlantic Ocean off the coast of Portugal. The islands are named after the acores, the Portuguese for goshawks, living there in abundance. (Webster's New Geographical Dictionary, 1988, p102 & Room, Brewer's Dictionary of Names, 1992, p42)
MR = 20120703
DA = 19990101
DC = 4
UI = D001394

*NEWRECORD
RECTYPE = D
MH = Azotobacter
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.400.425.625.050
MN = B03.660.250.580.022
MH_TH = NLM (1966)
ST = T007
AN = in soil & water
MS = A genus of gram-negative, aerobic bacteria found in soil and water. Its organisms occur singly, in pairs or irregular clumps, and sometimes in chains of varying lengths.
MR = 20090706
DA = 19990101
DC = 1
UI = D001395

*NEWRECORD
RECTYPE = D
MH = Azoxymethane
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.172.080
PA = Carcinogens
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = Diazene, dimethyl-, 1-oxide
RN = MO0N1J0SEN
RR = 25843-45-2 (Azoxymethane)
AN = a carcinogen
PI = Azo Compounds (1973-1975)
PI = Nitrogen Oxides (1973-1974)
MS = A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas.
PM = 91; was see under AZO COMPOUNDS 1975-90
HN = 91(75); was see under AZO COMPOUNDS 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D001397

*NEWRECORD
RECTYPE = D
MH = Aztreonam
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Az-threonam|T109|T195|NON|EQV|UNK (19XX)|850614|abbcdef
ENTRY = Azactam|T109|T195|TRD|NRW|AU|DE|ES|FR|IE|NL|UK|UNK (19XX)|US|850614|abbcdeeeeeeeeef
ENTRY = Azthreonam|T109|T195|NON|EQV|NLM (1990)|891115|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Aztreonam|T109|T195|NON|NRW|NLM (2004)|030115|abbcdef
ENTRY = Esteve Brand of Aztreonam|T109|T195|NON|NRW|NLM (2004)|030115|abbcdef
ENTRY = SQ-26,776|T109|T195|LAB|NRW|UNK (19XX)|850614|abbcdef
ENTRY = Sanofi Winthrop Brand of Aztreonam|T109|T195|NON|NRW|NLM (2004)|030115|abbcdef
ENTRY = Squibb Brand of Aztreonam|T109|T195|NON|NRW|NLM (2004)|030115|abbcdef
ENTRY = Urobactam|T109|T195|TRD|NRW|ES|030115|abbcdef
ENTRY = Az threonam
ENTRY = Aztreonam Esteve Brand
ENTRY = Aztreonam Squibb Brand
ENTRY = Bristol Myers Squibb Brand of Aztreonam
ENTRY = SQ 26,776
ENTRY = SQ26,776
MN = D02.065.589.099.500.044
MN = D02.886.108.500.044
MN = D03.383.411.350.044
MN = D04.075.080.875.099.221.500.044
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1983)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = Propanoic acid, 2-(((1-(2-amino-4-thiazolyl)-2-((2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino)-2-oxoethylidene)amino)oxy)-2-methyl-, (2S-(2alpha,3beta(Z)))-
RN = G2B4VE5GH8
RR = 78110-38-0 (Aztreonam)
AN = do not use /biosyn unless by living matter
PI = Antibiotics (1966-1982)
PI = Antibiotics, Lactam (1983-1985)
MS = A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
PM = 86
HN = 86
MR = 20130708
DA = 19850614
DC = 1
DX = 19860101
UI = D001398

*NEWRECORD
RECTYPE = D
MH = Azure Stains
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Giemsa Stain|T109|T130|EPO|NRW|UNK (19XX)|750630|abbcdef
ENTRY = Giemsa-11|T109|T130|EPO|NRW|UNK (19XX)|850528|abbcdef
ENTRY = Giemsa 11
ENTRY = Stain, Giemsa
ENTRY = Stains, Azure
MN = D02.886.369.080
MN = D03.494.741.080
PA = Coloring Agents
MH_TH = NLM (1976)
ST = T109
ST = T130
RN = 0
PI = Dimethylamines (1974-1975)
PI = Imines (1974-1975)
PI = Phenothiazines (1969-1975)
PI = Staining (1966-1975)
MS = PHENOTHIAZINES with an amino group at the 3-position that are green crystals or powder. They are used as biological stains.
PM = 91; was see under PHENOTHIAZINES 1976-90
HN = 91(76); was see under PHENOTHIAZINES 1976-90
MR = 20050630
DA = 19750718
DC = 1
DX = 19910101
UI = D001399

*NEWRECORD
RECTYPE = D
MH = Azurin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
MN = D12.776.097.100
MN = D12.776.556.080
MH_TH = NLM (1975)
ST = T116
ST = T123
N1 = Azurin (Pseudomonas fluorescens protein)
RN = 12284-43-4
AN = a bact protein; /drug eff /ultrastruct permitted
PI = Bacterial Proteins (1970-1974)
PI = Copper (1970-1974)
PI = Metalloproteins (1973-1974)
MS = A bacterial protein from Pseudomonas, Bordetella, or Alcaligenes which operates as an electron transfer unit associated with the cytochrome chain. The protein has a molecular weight of approximately 16,000, contains a single copper atom, is intensively blue, and has a fluorescence emission band centered at 308nm.
PM = 91; was see under BACTERIAL PROTEINS 1975-90
HN = 91(75); was see under BACTERIAL PROTEINS 1975-90
MR = 19920507
DA = 19741119
DC = 1
DX = 19910101
UI = D001400

*NEWRECORD
RECTYPE = D
MH = Azygos Vein
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Azygos Veins
ENTRY = Vein, Azygos
ENTRY = Veins, Azygos
MN = A07.231.908.106
MH_TH = NLM (1966)
ST = T023
MS = A vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava.
MR = 19920325
DA = 19990101
DC = 1
UI = D001401

*NEWRECORD
RECTYPE = D
MH = B-Lymphocytes
DS = LYMPHOCYTES B
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = B-Cells|T025|NON|EQV|NLM (1990)|890224|abcdef
PRINT ENTRY = Bursa-Dependent Lymphocytes|T025|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = B Cells
ENTRY = B Lymphocytes
ENTRY = B-Cell
ENTRY = B-Lymphocyte
ENTRY = Bursa Dependent Lymphocytes
ENTRY = Bursa-Dependent Lymphocyte
ENTRY = Lymphocyte, Bursa-Dependent
ENTRY = Lymphocytes, Bursa-Dependent
MN = A11.063.438
MN = A11.118.637.555.567.562
MN = A15.145.229.637.555.567.562
MN = A15.382.032.438
MN = A15.382.490.555.567.562
FX = Germinal Center
FX = Lymphocyte Cooperation
MH_TH = NLM (1973)
ST = T025
AN = involved in antibody formation; do not confuse X ref B-CELLS with pancreatic B cells or beta cells (index under ISLANDS OF LANGERHANS); A 11 qualif; subpopulations = B-LYMPHOCYTE SUBSETS
PI = Lymphocytes (1966-1972)
MS = Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.
PM = 90; was B LYMPHOCYTES 1973-89
HN = 90; was B LYMPHOCYTES 1973-89
MR = 20030709
DA = 19990101
DC = 1
DX = 19730101
UI = D001402

*NEWRECORD
RECTYPE = D
MH = Babesia
AQ = CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Piroplasma|T204|NON|EQV|UNK (19XX)|750212|abcdef
ENTRY = Babesias
ENTRY = Piroplasmas
MN = B01.043.075.600.580.070
MH_TH = NLM (1974)
ST = T204
AN = infection = BABESIOSIS; coordinate with specific terms (ANTIGENS, PROTOZOAN, etc) if pertinent
MS = A genus of tick-borne protozoan parasites that infests the red blood cells of mammals, including humans. There are many recognized species, and the distribution is world-wide.
PM = 74
HN = 74
MR = 20090706
DA = 19990101
DC = 1
DX = 19740101
UI = D001403

*NEWRECORD
RECTYPE = D
MH = Babesiosis
AQ = BL CF CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VI
PRINT ENTRY = Babesiasis|T047|NON|EQV|UNK (19XX)|810609|abcdef
PRINT ENTRY = Piroplasmosis|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Babesia Parasite Infection|T047|NON|EQV|NLM (2011)|ORD (2010)|100113|abcdeef
ENTRY = Human Babesiosis|T047|NON|NRW|NLM (2011)|100113|abcdef
ENTRY = Babesia Parasite Infections
ENTRY = Babesiases
ENTRY = Babesioses
ENTRY = Babesioses, Human
ENTRY = Babesiosis, Human
ENTRY = Human Babesioses
ENTRY = Infection, Babesia Parasite
ENTRY = Infections, Babesia Parasite
ENTRY = Piroplasmoses
MN = C03.701.688.122
MN = C03.752.625.122
MN = C03.752.875.175
MN = C22.674.710.122
MH_TH = NLM (1968)
MH_TH = ORD (2010)
ST = T047
PI = Protozoan Infections (1966-1967)
MS = A group of tick-borne diseases of mammals including ZOONOSES in humans. They are caused by protozoa of the genus BABESIA, which parasitize erythrocytes, producing hemolysis. In the U.S., the organism's natural host is mice and transmission is by the deer tick IXODES SCAPULARIS.
OL = use BABESIOSIS to search BABESIASIS 1968-81
PM = 82; was BABESIASIS 1968-81
HN = 82; was BABESIASIS 1968-81
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
DX = 19680101
UI = D001404

*NEWRECORD
RECTYPE = D
MH = Reflex, Babinski
AQ = DE GE IM PH RE
PRINT ENTRY = Babinski Reflex|T033|EPO|EQV|NLM (1990)|890322|abcdef
PRINT ENTRY = Extensor Plantar Response|T033|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Paradoxical Extensor Reflex, Great Toe|T033|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Babinski Reflexes|T033|EPO|EQV|NLM (1990)|890322|abcdef
ENTRY = Babinski Sign|T033|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Babinski Sign Absent|T033|NON|REL|NLM (2000)|991103|abcdef
ENTRY = Babinski Sign Negative|T033|NON|REL|NLM (2000)|991103|abcdef
ENTRY = Babinski Sign Positive|T033|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Babinski's Reflex|T033|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Babinski's Sign|T033|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Extensor Plantar Reflex|T033|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Great Toe Paradoxical Extensor Reflex|T033|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Reflexes, Babinski|T033|EPO|EQV|NLM (1990)|890322|abcdef
ENTRY = Reflex, Babinski's
MN = E01.370.376.550.650.680
MN = E01.370.600.550.650.680
MN = G11.561.600.765.618
FX = Reflex, Abnormal
MH_TH = NLM (1975)
ST = T033
MS = A reflex found in normal infants consisting of dorsiflexion of the HALLUX and abduction of the other TOES in response to cutaneous stimulation of the plantar surface of the FOOT. In adults, it is used as a diagnostic criterion, and if present is a NEUROLOGIC MANIFESTATION of dysfunction in the CENTRAL NERVOUS SYSTEM.
PM = 1991; see REFLEX 1990, see REFLEX, ABNORMAL 1975-1989
HN = 1991(1975)
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
DX = 19910101
UI = D001405

*NEWRECORD
RECTYPE = D
MH = Bacillaceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.300.390.400.158
MN = B03.353.500.100
MN = B03.510.100.100
MN = B03.510.415.400.158
MN = B03.510.460.410.158
MH_TH = NLM (1975)
ST = T007
AN = pathogenic & non-pathogenic
PI = Bacteria (1966-1974)
MS = A family of bacteria which produce endospores. They are mostly saprophytes from soil, but a few are insect or animal parasites or pathogens.
PM = 75
HN = 75
MR = 20150415
DA = 19990101
DC = 1
DX = 19750101
UI = D001406

*NEWRECORD
RECTYPE = D
MH = Bacillus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.300.390.400.158.218
MN = B03.353.500.100.218
MN = B03.510.100.100.218
MN = B03.510.415.400.158.218
MN = B03.510.460.410.158.218
MH_TH = NLM (1966)
ST = T007
AN = specific genus: do not confuse with "bacillus" as "bacterium"; Bacillus mesentericus goes here
MS = A genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic.
MR = 20150415
DA = 19990101
DC = 1
UI = D001407

*NEWRECORD
RECTYPE = D
MH = Bacillus anthracis
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.300.390.400.158.218.151
MN = B03.353.500.100.218.151
MN = B03.510.100.100.218.151
MN = B03.510.415.400.158.218.151
MN = B03.510.460.410.158.218.151
MH_TH = NLM (1966)
ST = T007
AN = infection = ANTHRAX
MS = A species of bacteria that causes ANTHRAX in humans and animals.
MR = 20150415
DA = 19990101
DC = 1
UI = D001408

*NEWRECORD
RECTYPE = D
MH = Bacillus cereus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.300.390.400.158.218.252
MN = B03.353.500.100.218.252
MN = B03.510.100.100.218.252
MN = B03.510.415.400.158.218.252
MN = B03.510.460.410.158.218.252
MH_TH = NLM (1966)
ST = T007
AN = in soil, dust, plants
MS = A species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning.
MR = 20150415
DA = 19990101
DC = 1
UI = D001409

*NEWRECORD
RECTYPE = D
MH = Bacillus megaterium
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Bacillus megatherium|T007|NON|EQV|UNK (19XX)|781218|abcdef
MN = B03.300.390.400.158.218.500
MN = B03.353.500.100.218.500
MN = B03.510.100.100.218.500
MN = B03.510.415.400.158.218.500
MN = B03.510.460.410.158.218.500
MH_TH = NLM (1966)
ST = T007
AN = same as B. megatherium; in soil, water, dust, decomposing material
MS = A species of bacteria whose spores vary from round to elongate. It is a common soil saprophyte.
MR = 20150415
DA = 19990101
DC = 1
UI = D001410

*NEWRECORD
RECTYPE = D
MH = Geobacillus stearothermophilus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Bacillus stearothermophilus|T007|NON|EQV|NLM (1975)|990101|abcdef
MN = B03.300.390.400.158.400.400
MN = B03.353.500.100.400.400
MN = B03.510.100.100.400.400
MN = B03.510.415.400.158.400.400
MN = B03.510.460.410.158.400.400
MH_TH = NLM (2010)
ST = T007
PI = Bacillus (1966-1974)
MS = A species of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family BACILLACEAE, found in soil, hot springs, Arctic waters, ocean sediments, and spoiled food products.
PM = 2010; see BACILLUS STEAROTHERMOPHILUS 1975-2009
HN = 2010 (1975)
MR = 20150415
DA = 19741119
DC = 1
DX = 19750901
UI = D001411

*NEWRECORD
RECTYPE = D
MH = Bacillus subtilis
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Natto Bacteria|T007|NON|NRW|NLM (2004)|030507|abcdef
ENTRY = Bacillus subtilis (natto)|T007|NON|NRW|NLM (2004)|030507|abcdef
ENTRY = Bacillus subtilis var. natto|T007|NON|NRW|NLM (2004)|030507|abcdef
MN = B03.300.390.400.158.218.725
MN = B03.353.500.100.218.725
MN = B03.510.100.100.218.725
MN = B03.510.415.400.158.218.725
MN = B03.510.460.410.158.218.725
MH_TH = NLM (1966)
ST = T007
MS = A species of gram-positive bacteria that is a common soil and water saprophyte.
MR = 20150415
DA = 19990101
DC = 1
UI = D001412

*NEWRECORD
RECTYPE = D
MH = Bacillus thuringiensis
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Bacilan|T007|TRD|NRW|UNK (19XX)|861203|abcdef
ENTRY = Dipel|T007|TRD|NRW|UNK (19XX)|820330|abcdef
ENTRY = Thuricide|T007|TRD|NRW|UNK (19XX)|800821|abcdef
MN = B03.300.390.400.158.218.800
MN = B03.353.500.100.218.800
MN = B03.510.100.100.218.800
MN = B03.510.415.400.158.218.800
MN = B03.510.460.410.158.218.800
MH_TH = NLM (1975)
ST = T007
AN = pathogenic for insects
PI = Bacillus (1966-1974)
MS = A species of gram-positive bacteria which may be pathogenic for certain insects. It is used for the biological control of the Gypsy moth.
PM = 75
HN = 75
MR = 20150415
DA = 19741119
DC = 1
DX = 19750901
UI = D001413

*NEWRECORD
RECTYPE = D
MH = Bacitracin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = A.L. Labs Brand of Bacitracin Zinc Salt|T116|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Ak-Tracin|T116|T195|TRD|NRW|CA|US|031006|abbcdeef
ENTRY = Akorn Brand of Bacitracin|T116|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Altracin|T116|T195|TRD|NRW|US|031006|abbcdef
ENTRY = Baci-IM|T116|T195|TRD|NRW|US|031006|abbcdef
ENTRY = Baci-Rx|T116|T195|TRD|NRW|US|031006|abbcdef
ENTRY = Baciguent|T116|TRD|NRW|CA|US|031006|abcdeef
ENTRY = Bacitin|T116|T195|TRD|NRW|CA|FR|031006|abbcdeef
ENTRY = Bacitracin Zinc|T116|T195|NON|NRW|BAN (19XX)|USP (19XX)|941129|abbcdeef
ENTRY = Bacitracin Zinc Complex|T116|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Bacitracine Martinet|T116|T195|TRD|NRW|FR|031006|abbcdef
ENTRY = Ciba Vision Brand of Bacitracin|T116|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Dioptic Brand of Bacitracin|T116|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Lee Brand of Bacitracin|T116|NON|NRW|NLM (2005)|031006|abcdef
ENTRY = McNeil Brand of Bacitracin|T116|NON|NRW|NLM (2005)|031006|abcdef
ENTRY = Ocu-Tracin|T116|T195|TRD|NRW|US|031006|abbcdef
ENTRY = Ocumed Brand of Bacitracin|T116|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Pharma Tek Brand of Bacitracin|T116|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Pharmascience Brand of Bacitracin|T116|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Reed & Carnrick Brand of Bacitracin|T116|T195|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Topitracin|T116|T195|TRD|NRW|US|031006|abbcdef
ENTRY = Zeba-Rx|T116|T195|TRD|NRW|US|031006|abbcdef
ENTRY = Zinc Bacitracin|T116|T195|NON|NRW|UNK (19XX)|801205|abbcdef
ENTRY = Ak Tracin
ENTRY = Baci IM
ENTRY = Baci Rx
ENTRY = Bacitracin Akorn Brand
ENTRY = Bacitracin Dioptic Brand
ENTRY = Bacitracin Lee Brand
ENTRY = Bacitracin McNeil Brand
ENTRY = Bacitracin Pharmascience Brand
ENTRY = Bacitracin, Zinc
ENTRY = Martinet, Bacitracine
ENTRY = Ocu Tracin
ENTRY = OcuTracin
ENTRY = Zeba Rx
ENTRY = Zinc, Bacitracin
MN = D04.345.566.075
MN = D12.644.641.075
PA = Anti-Bacterial Agents
PA = Anti-Infective Agents, Local
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T116
ST = T195
N1 = Bacitracin
RN = 1405-87-4
RR = 1405-89-6 (zinc complex)
MS = A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140)
MR = 20050630
DA = 19990101
DC = 1
UI = D001414

*NEWRECORD
RECTYPE = D
MH = Back
AQ = AB AH BS EM GD IR MI PA PH PP PS RA RE RI SU US VI
MN = A01.923.176
EC = injuries:Back Injuries
MH_TH = NLM (1966)
ST = T029
MS = The rear surface of an upright primate from the shoulders to the hip, or the dorsal surface of tetrapods.
MR = 20150616
DA = 19990101
DC = 1
UI = D001415

*NEWRECORD
RECTYPE = D
MH = Back Pain
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Backache|T184|NON|EQV|NLM (1993)|911009|abcdef
ENTRY = Back Ache|T184|NON|EQV|NLM (1993)|911009|abcdef
ENTRY = Back Pain with Radiation|T184|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Back Pain without Radiation|T184|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Vertebrogenic Pain Syndrome|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Ache, Back
ENTRY = Aches, Back
ENTRY = Back Aches
ENTRY = Back Pains
ENTRY = Backaches
ENTRY = Pain Syndrome, Vertebrogenic
ENTRY = Pain Syndromes, Vertebrogenic
ENTRY = Pain, Back
ENTRY = Pains, Back
ENTRY = Syndrome, Vertebrogenic Pain
ENTRY = Syndromes, Vertebrogenic Pain
ENTRY = Vertebrogenic Pain Syndromes
MN = C10.597.617.140
MN = C23.888.592.612.107
FX = Low Back Pain
MH_TH = NLM (1966)
ST = T184
AN = GEN or unspecified; "lombo-sciatique" in French texts is indexed under LOW BACK PAIN (IM) + SCIATICA (IM); for lower back pain or pain in the lumbar region, LOW BACK PAIN is available
MS = Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.
OL = use BACK PAIN to search BACKACHE 1966-92
PM = 93; was BACKACHE 1963-92
HN = 93; was BACKACHE 1963-92
CATSH = CAT LIST
MR = 20150702
DA = 19990101
DC = 1
UI = D001416

*NEWRECORD
RECTYPE = D
MH = Background Radiation
DE = BACKGROUND RAD
AQ = AE
PRINT ENTRY = Natural Radiation|T070|NON|EQV|UNK (19XX)|840224|NATURAL RAD|abcdefv
ENTRY = Radiation, Background|T070|NON|EQV|UNK (19XX)|840224|RAD BACKGROUND|abcdefv
ENTRY = Radiation, Natural|T070|NON|EQV|UNK (19XX)|840224|RAD NATURAL|abcdefv
ENTRY = Background Radiations
ENTRY = Natural Radiations
ENTRY = Radiations, Background
ENTRY = Radiations, Natural
MN = G01.750.750.115
MH_TH = NLM (1971)
ST = T070
PI = Radiation (1966-1970)
PI = Radioactivity (1966-1970)
MS = Radiation from sources other than the source of interest. It is due to cosmic rays and natural radioactivity in the environment.
PM = 91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975
HN = 91(71); was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975
MR = 20110624
DA = 19990101
DC = 1
DX = 19910101
UI = D001417

*NEWRECORD
RECTYPE = D
MH = Baclofen
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Baclophen|T116|T121|NON|EQV|UNK (19XX)|790223|abbcdef
PRINT ENTRY = Chlorophenyl GABA|T116|T121|EQV|UNK (19XX)|790223|abbdef
ENTRY = ASTA Medica Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Alphapharm Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Apo-Baclofen|T116|T121|TRD|NRW|CA|031006|abbcdef
ENTRY = Apotex Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Ashbourne Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Athena Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Atrofen|T116|T121|TRD|NRW|US|031006|abbcdef
ENTRY = Ba-34,647|T116|T121|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Ba-34647|T116|T121|LAB|NRW|NLM (1992)|901022|abbcdef
ENTRY = Baclofen AWD|T116|T121|TRD|NRW|DE|031006|abbcdef
ENTRY = Baclofne-Irex|T116|T121|TRD|NRW|FR|031006|abbcdef
ENTRY = Baclospas|T116|T121|TRD|NRW|UK|031006|abbcdef
ENTRY = CIBA-34,647-BA|T116|T121|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Ciba-Geigy Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Clofen|T116|T121|TRD|NRW|AU|031006|abbcdef
ENTRY = Gen-Baclofen|T116|T121|TRD|NRW|CA|031006|abbcdef
ENTRY = Genpharm|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Irex Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Isis Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Lebic|T116|T121|TRD|NRW|DE|031006|abbcdef
ENTRY = Lioresal|T116|T121|TRD|NRW|AU|CA|DE|ES|IE|NL|UK|UNK (19XX)|US|800730|abbcdeeeeeeeeef
ENTRY = Liorsal|T116|T121|TRD|NRW|FR|031006|abbcdef
ENTRY = Medtronic Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Novartis Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Nu-Baclo|T116|T121|TRD|NRW|CA|031006|abbcdef
ENTRY = Nu-Pharm Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = PCP-GABA|T116|T121|ABB|EQV|NLM (1992)|901022|abbcdef
ENTRY = PMS-Baclofen|T116|T121|TRD|NRW|CA|031006|abbcdef
ENTRY = Pharmascience Brand of Baclofen|T116|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid|T116|T121|NON|EQV|NLM (1995)|930902|abbcdef
ENTRY = beta-(p-Chlorophenyl)-gamma-aminobutyric Acid|T116|T121|NON|EQV|NLM (1992)|901022|abbcdef
ENTRY = AWD, Baclofen
ENTRY = Apo Baclofen
ENTRY = ApoBaclofen
ENTRY = Ba34,647
ENTRY = Ba34647
ENTRY = Baclofen Alphapharm Brand
ENTRY = Baclofen Apotex Brand
ENTRY = Baclofen Ashbourne Brand
ENTRY = Baclofen Athena Brand
ENTRY = Baclofen Ciba-Geigy Brand
ENTRY = Baclofen Irex Brand
ENTRY = Baclofen Isis Brand
ENTRY = Baclofen Medtronic Brand
ENTRY = Baclofen Novartis Brand
ENTRY = Baclofen Nu-Pharm Brand
ENTRY = Baclofen Pharmascience Brand
ENTRY = Baclofne Irex
ENTRY = BaclofneIrex
ENTRY = CIBA34,647BA
ENTRY = Ciba Geigy Brand of Baclofen
ENTRY = GABA, Chlorophenyl
ENTRY = Gen Baclofen
ENTRY = GenBaclofen
ENTRY = Nu Baclo
ENTRY = Nu Pharm Brand of Baclofen
ENTRY = NuBaclo
ENTRY = PMS Baclofen
ENTRY = PMSBaclofen
MN = D02.241.081.114.500.350.100
PA = GABA-B Receptor Agonists
PA = Muscle Relaxants, Central
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1977)
MH_TH = USP (19XX)
ST = T116
ST = T121
N1 = Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-
RN = H789N3FKE8
RR = 1134-47-0 (Baclofen)
PI = Aminobutyric Acids (1972-1974)
PI = Chlorobenzenes (1974)
MS = A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.
PM = 80; was see under AMINOBUTYRIC ACIDS 1975-79
HN = 80(75); was see under AMINOBUTYRIC ACIDS 1975-79
MR = 20130708
DA = 19741111
DC = 1
DX = 19800101
UI = D001418

*NEWRECORD
RECTYPE = D
MH = Bacteria
DE = BACT
AQ = CH CL CY DE EN GD GE IM IP ME PY RE UL VI
PRINT ENTRY = Eubacteria|T007|NON|EQV|NLM (2004)|021122|abcdef
MN = B03
RH = B3 - ORGANISMS-BACTERIA
FX = Fimbriae, Bacterial
FX = Pili, Sex
EC = physiology:Bacterial Physiological Phenomena
MH_TH = NLM (1966)
ST = T007
AN = general; prefer specifics; relation to bacterial disease: Manual 22.12-22.16; presence of bacteria in organs vs infection: Manual 22.11; note many precoordinated bacterial - terms (BACTERIAL PROTEINS; ANTIBODIES, BACTERIAL; etc); "coliform bacteria" = COLIFORM BACILLI see ENTEROBACTERIACEAE; presence of bacteria in blood = BACTEREMIA: see note there; DF: BACT
MS = One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
PM = 1963
HN = 1963
MR = 20090706
DA = 19990101
DC = 1
UI = D001419

*NEWRECORD
RECTYPE = D
MH = Bacteria, Aerobic
DE = BACT AEROBIC
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Aerobic Bacteria|T007|NON|EQV|UNK (19XX)|830603|AEROBIC BACT|abcdefv
MN = B03.120
MH_TH = NLM (1984)
ST = T007
AN = GEN: avoid; prefer specifics; do not use as a routine coord for an aerobic bact; infection: coord IM with BACTERIAL INFECTIONS (IM); DF: BACT AEROBIC
PI = Aerobiosis (1971-1983)
PI = Bacteria (1966-1983)
PM = 84
HN = 84
MR = 20090706
DA = 19830603
DC = 1
DX = 19840101
UI = D001420

*NEWRECORD
RECTYPE = D
MH = Bacteria, Anaerobic
DE = BACT ANAEROBIC
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Anaerobic Bacteria|T007|NON|EQV|UNK (19XX)|830603|ANAEROBIC BACT|abcdefv
MN = B03.130
MH_TH = NLM (1984)
ST = T007
AN = GEN: avoid; prefer specifics; do not use as a routine coord for an anaerobic bact; facultatively anaerobic bact: index only here & not also under BACTERIA, AEROBIC; infection: coord IM with BACTERIAL INFECTIONS (IM); DF: BACT ANAEROBIC
PI = Anaerobiosis (1971-1983)
PI = Bacteria (1966-1983)
PM = 84
HN = 84
MR = 20090706
DA = 19830603
DC = 1
DX = 19840101
UI = D001421

*NEWRECORD
RECTYPE = D
MH = Bacterial Adhesion
DE = BACT ADHESION
AQ = DE ES GE IM PH RE
PRINT ENTRY = Adhesion, Bacterial|T040|NON|EQV|UNK (19XX)|860619|ADHESION BACT|abcdefv
ENTRY = Adhesions, Bacterial|T040|NON|EQV|NLM (1992)|901020|ADHESIONS BACT|abcdefv
ENTRY = Bacterial Adhesions|T040|NON|EQV|NLM (1992)|901020|BACT ADHESIONS|abcdefv
MN = G06.099.112.100
MN = G06.590.110.100
FX = Adhesins, Bacterial
MH_TH = NLM (1987)
ST = T040
AN = do not confuse with X ref BACTERIAL ADHESINS see ADHESINS, BACTERIAL, bact antigens; DF: BACT ADHESION
PI = Adhesiveness (1969-1986)
PI = Bacteria (1966-1986)
PI = Pili, Bacterial (1980-1986)
MS = Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D001422

*NEWRECORD
RECTYPE = D
MH = Bacterial Infections and Mycoses
DE = BACT INFECT MYCOSES
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
MN = C01
RH = C1 - DISEASES-BACTERIAL AND FUNGAL
MH_TH = NLM (1974)
ST = T047
AN = used for searching; INDEXER: Do not use; CATALOGER: Do not use
MS = Infections caused by bacteria and fungi, general, specified, or unspecified.
PM = 98
HN = 98; use explode 1975-98
CATSH = CAT LIST
MR = 20150605
DA = 19990101
DC = 1
DX = 19980101
UI = D001423

*NEWRECORD
RECTYPE = D
MH = Bacterial Infections
DE = BACT INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Bacterial Infection|T047|NON|EQV|NLM (1992)|901020|abcdef
ENTRY = Infection, Bacterial|T047|NON|EQV|NLM (1992)|901020|abcdef
ENTRY = Infections, Bacterial|T047|NON|EQV|NLM (1992)|901020|INFECT BACT|abcdefv
MN = C01.252
MH_TH = NLM (1972)
ST = T047
AN = GEN: prefer specifics; many texts saying "sepsis" mean BACTERIAL INFECTIONS: check text; TN 209: differentiation from presence of bacteria in organs; DF: BACT INFECT
PI = Infection (1966-1971)
MS = Infections by bacteria, general or unspecified.
OL = pre-explosion = BACTERIAL INFECTIONS (PX)
PM = 72
HN = 72
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19720101
UI = D001424

*NEWRECORD
RECTYPE = D
MH = Bacterial Outer Membrane Proteins
DE = BACT OUTER MEMBRANE PROTEINS
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = OMP Proteins|T116|T123|EQV|UNK (19XX)|840530|abbdef
PRINT ENTRY = Outer Membrane Proteins, Bacterial|T116|T123|NON|EQV|UNK (19XX)|840530|OUTER MEMBRANE PROTEINS BACT|abbcdefv
ENTRY = Outer Membrane Lipoproteins, Bacterial|T116|T123|NON|NRW|UNK (19XX)|840530|OUTER MEMBRANE LIPOPROTEINS BACT|abbcdefv
MN = D12.776.097.120
MN = D12.776.543.100
MH_TH = NLM (1985)
ST = T116
ST = T123
RN = 0
AN = coord IM with specific protein (IM) + specific gram-negative bacterium (IM)
PI = Bacterial Proteins (1966-1984)
PI = Membrane Proteins (1977-1984)
MS = Proteins isolated from the outer membrane of Gram-negative bacteria.
PM = 85
HN = 85
MR = 20050630
DA = 19840530
DC = 1
DX = 19850101
UI = D001425

*NEWRECORD
RECTYPE = D
MH = Bacterial Proteins
DE = BACT PROTEINS
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Bacterial Gene Products|T116|T123|NON|EQV|NLM (1990)|881201|BACT GENE PRODUCTS|abbcdefv
PRINT ENTRY = Bacterial Gene Proteins|T116|T123|NON|EQV|NLM (1990)|881201|BACT GENE PROTEINS|abbcdefv
PRINT ENTRY = Gene Products, Bacterial|T116|T123|NON|EQV|NLM (1991)|900126|GENE PRODUCTS BACT|abbcdefv
ENTRY = Bacterial Gene Product|T116|T123|NON|EQV|NLM (1992)|901102|BACT GENE PRODUCT|abbcdefv
ENTRY = Bacterial Gene Protein|T116|T123|NON|EQV|NLM (1992)|901102|BACT GENE PROTEIN|abbcdefv
ENTRY = Bacterial Protein|T116|T123|NON|EQV|NLM (1992)|901102|BACT PROTEIN|abbcdefv
ENTRY = Gene Product, Bacterial|T116|T123|NON|EQV|NLM (1992)|901102|GENE PRODUCT BACT|abbcdefv
ENTRY = Gene Protein, Bacterial|T116|T123|NON|EQV|NLM (1992)|901102|GENE PROTEIN BACT|abbcdefv
ENTRY = Gene Proteins, Bacterial|T116|T123|NON|EQV|NLM (1994)|921026|GENE PROTEINS BACT|abbcdefv
ENTRY = Protein, Bacterial|T116|T123|NON|EQV|NLM (1992)|901102|PROTEIN BACT|abbcdefv
ENTRY = Proteins, Bacterial|T116|T123|NON|EQV|NLM (1992)|901102|PROTEINS BACT|abbcdefv
MN = D12.776.097
MH_TH = NLM (1966)
ST = T116
ST = T123
RN = 0
AN = /drug eff /ultrastruct permitted; /physiol permitted for function within the bacterium; coord IM with specific protein (IM) + specific bacterium (IM); BACTERIAL OUTER MEMBRANE PROTEINS is also available; DF: BACT PROTEINS
MS = Proteins found in any species of bacterium.
OL = use BACTERIAL PROTEINS (NM) to search GENE PROTEINS, BACTERIAL 1981-93
PM = GENE PROTEINS, BACTERIAL was indexed under BACTERIAL PROTEINS 1981-93
HN = GENE PROTEINS, BACTERIAL was (NM) 1981-93
MR = 20050630
DA = 19990101
DC = 1
UI = D001426

*NEWRECORD
RECTYPE = D
MH = Bacterial Toxins
DE = BACT TOXINS
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Toxins, Bacterial|T123|T131|NON|EQV|NLM (1992)|901105|TOXINS BACT|abbcdefv
MN = D23.946.123
MH_TH = NLM (1977)
ST = T123
ST = T131
RN = 0
AN = general or unspecified: prefer specifics; coordinate IM with specific bacterium (IM); / antag permitted but consider also ANTITOXINS
PI = Bacteria (1966-1976)
PI = Toxins (1966-1976)
MS = Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.
PM = 77
HN = 77; was NON MESH before 1977
MR = 20150624
DA = 19990101
DC = 1
DX = 19770101
UI = D001427

*NEWRECORD
RECTYPE = D
MH = Bacterial Vaccines
DE = BACT VACCINES
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME MI PD PK PO RE SD SE ST TO TU UR VI
ENTRY = Bacterial Vaccine|T121|T129|NON|EQV|NLM (1992)|901103|BACT VACCINE|abbcdefv
ENTRY = Bacterin|T121|T129|NON|EQV|UNK (19XX)|820603|abbcdef
ENTRY = Vaccine, Bacterial|T121|T129|NON|EQV|NLM (1992)|901103|VACCINE BACT|abbcdefv
ENTRY = Vaccines, Bacterial|T121|T129|NON|EQV|NLM (1992)|901103|VACCINES BACT|abbcdefv
MN = D20.215.894.135
MH_TH = NLM (1965)
ST = T121
ST = T129
RN = 0
AN = for specifics not indented here coord IM with specific bacterium /immunol (IM); DF: BACT VACCINES
MS = Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
PM = 65
HN = 65
MR = 20050630
DA = 19990101
DC = 1
DX = 19650101
UI = D001428

*NEWRECORD
RECTYPE = D
MH = Bacteriochlorophylls
AQ = AD AE AG AI AN BI CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU
ENTRY = Bacteriochlorophyll|T109|T123|NON|EQV|NLM (1991)|891012|abbcdef
MN = D03.383.129.578.840.374.100
MN = D03.383.129.578.840.500.640.220.100
MN = D03.549.909.374.100
MN = D03.549.909.500.640.220.100
MN = D04.345.783.374.100
MN = D04.345.783.500.640.220.100
MN = D12.776.752.249
MN = D23.767.727.640.220.100
MH_TH = NLM (1975)
ST = T109
ST = T123
RN = 0
PI = Chlorophyll (1974)
MS = Pyrrole containing pigments found in photosynthetic bacteria.
PM = 91; was see under CHLOROPHYLL 1975-90
HN = 91(75); was see under CHLOROPHYLL 1975-90
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D001429

*NEWRECORD
RECTYPE = D
MH = Bacteriocins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Lantibiotics|T116|T123|NON|NRW|NLM (2006)|050103|abbcdef
MN = D12.776.097.151
MN = D12.776.543.695.110
PA = Anti-Bacterial Agents
MH_TH = NLM (1965)
ST = T116
ST = T123
RN = 0
MS = Substances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species. They are protein or lipopolysaccharide-protein complexes used in taxonomy studies of bacteria.
HN = 68(65)
MR = 20070709
DA = 19990101
DC = 1
DX = 19680101
UI = D001430

*NEWRECORD
RECTYPE = D
MH = Bacteriological Techniques
DE = BACTERIOL TECHNIQUES
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Bacteriologic Technic|T059|NON|EQV|NLM (1994)|920825|BACTERIOL TECHNIC|abcdefv
ENTRY = Bacteriologic Technics|T059|NON|EQV|UNK (19XX)|780628|BACTERIOL TECHNICS|abcdefv
ENTRY = Bacteriologic Techniques|T059|NON|EQV|NLM (1991)|900110|abcdef
ENTRY = Bacteriological Technique|T059|NON|EQV|NLM (1994)|920825|BACTERIOL TECHNIQUE|abcdefv
ENTRY = Technic, Bacteriological|T059|NON|EQV|NLM (1994)|930202|TECHNIC BACTERIOL|abcdefv
ENTRY = Technics, Bacteriological|T059|NON|EQV|NLM (1994)|920825|TECHNICS BACTERIOL|abcdefv
ENTRY = Technique, Bacteriological|T059|NON|EQV|NLM (1994)|920825|TECHNIQUE BACTERIOL|abcdefv
ENTRY = Techniques, Bacteriological|T059|NON|EQV|NLM (1994)|920825|TECHNIQUES BACTERIOL|abcdefv
ENTRY = Bacteriologic Technique
ENTRY = Bacteriological Technic
ENTRY = Bacteriological Technics
ENTRY = Technic, Bacteriologic
ENTRY = Technics, Bacteriologic
ENTRY = Technique, Bacteriologic
ENTRY = Techniques, Bacteriologic
MN = E01.370.225.875.150
MN = E05.200.875.150
FX = Culture Media
MH_TH = NLM (1966)
ST = T059
MS = Techniques used in studying bacteria.
OL = use BACTERIOLOGICAL TECHNIQUES to search BACTERIOLOGICAL TECHNICS 1966-90
PM = 91; was BACTERIOLOGICAL TECHNICS 1963-90
HN = 91; was BACTERIOLOGICAL TECHNICS 1963-90
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D001431

*NEWRECORD
RECTYPE = D
MH = Bacteriology
DE = BACTERIOL
AQ = CL EC ED ES HI IS LJ MA OG SN ST TD
MN = H01.158.273.540.177
FX = Infectious Disease Medicine
EC = methods:Bacteriological Techniques
MH_TH = NLM (1966)
ST = T091
AN = the discipline (education, history, etc) only; use BACTERIAL PHYSIOLOGICAL PHENOMENA or specifics treed under it for biological processes and properties of bacteria
MS = The study of the structure, growth, function, genetics, and reproduction of bacteria, and BACTERIAL INFECTIONS.
MR = 20090706
DA = 19990101
DC = 1
UI = D001432

*NEWRECORD
RECTYPE = D
MH = Bacteriolysis
AQ = DE ES GE IM PH RE
ENTRY = Bacteriolyses
MN = G06.099.112.120
MN = G06.590.110.120
FX = Lysostaphin
MH_TH = NLM (1966)
ST = T070
AN = coord with specific bacterium
MS = Rupture of bacterial cells due to mechanical force, chemical action, or the lytic growth of BACTERIOPHAGES.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D001433

*NEWRECORD
RECTYPE = D
MH = Bacteriophage Typing
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Phage Typing|T059|NON|EQV|UNK (19XX)|880603|abcdef
PRINT ENTRY = Typing, Bacteriophage|T059|NON|EQV|UNK (19XX)|880603|abcdef
ENTRY = Typing, Phage
MN = E01.370.225.875.150.125.150
MN = E05.200.875.150.125.150
MH_TH = NLM (1966)
ST = T059
AN = policy: Manual 22.24.4
MS = A technique of bacterial typing which differentiates between bacteria or strains of bacteria by their susceptibility to one or more bacteriophages.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001434

*NEWRECORD
RECTYPE = D
MH = Bacteriophages
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Phages|T005|NON|EQV|NLM (1993)|911009|abcdef
ENTRY = Bacteriophage
ENTRY = Phage
MN = B04.123
FX = Genetic Vectors
FX = Lysogeny
MH_TH = NLM (1966)
ST = T005
AN = = "bacterial virus"; GEN or unspecified: prefer specific available phages; for other phages, coord IM with specific bacterium /virol (NIM; IM only when identity of bacterium is particularly significant); policy: Manual 22.24.3
MS = Viruses whose hosts are bacterial cells.
OL = use BACTERIOPHAGES to search BACTERIOPHAGE 1966-74
PM = 75; was BACTERIOPHAGE 1963-74
HN = 75; was BACTERIOPHAGE 1963-74
MR = 20030709
DA = 19990101
DC = 1
UI = D001435

*NEWRECORD
RECTYPE = D
MH = Bacteriorhodopsins
AQ = AD AE AG AI AN BI CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL
ENTRY = Bacteriorhodopsin|T116|T126|NON|EQV|NLM (1976)|990101|abbcdef
MN = D12.776.090.200
MN = D12.776.157.530.450.250.875.249
MN = D12.776.543.585.450.250.875.249
MN = D12.776.752.812.249
FX = Purple Membrane
MH_TH = NLM (2002)
ST = T116
ST = T126
N1 = Bacteriorhodopsins
RN = 53026-44-1
AN = do not confuse with BACTERIAL RHODOPSINS see RHODOPSINS, MICROBIAL
PI = Bacterial Proteins (1974-1975)
PI = Retinal Pigments (1974-1975)
MS = Rhodopsins found in the PURPLE MEMBRANE of halophilic archaea such as HALOBACTERIUM HALOBIUM. Bacteriorhodopsins function as an energy transducers, converting light energy into electrochemical energy via PROTON PUMPS.
PM = 2002; see BACTERIORHODOPSIN 1977-2001, see CAROTENOIDS 1976-1986
HN = 2002(1976)
MR = 20050630
DA = 19750718
DC = 1
DX = 19870101
UI = D001436

*NEWRECORD
RECTYPE = D
MH = Bacteriuria
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Bacteriurias
MN = C01.539.895.219
MN = C12.777.892.219
MN = C13.351.968.892.219
MH_TH = NLM (1964)
ST = T047
AN = differentiate from URINE/microbiol; coordinate IM with specific bacterium (IM) and specific bacterial infection (IM)
MS = The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection.
PM = 66
HN = 66(64)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19660101
UI = D001437

*NEWRECORD
RECTYPE = D
MH = Bacteroidaceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.140.094
MN = B03.440.425.410.194
MH_TH = NLM (1975)
ST = T007
PI = Bacteria (1966-1974)
MS = A family of gram-negative bacteria found primarily in the intestinal tracts and mucous membranes of warm-blooded animals. Its organisms are sometimes pathogenic.
PM = 75
HN = 75
MR = 20090706
DA = 19990101
DC = 1
DX = 19750101
UI = D001438

*NEWRECORD
RECTYPE = D
MH = Bacteroides
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.140.094.152
MN = B03.440.425.410.194.152
MH_TH = NLM (1966)
ST = T007
AN = infection = BACTEROIDES INFECTIONS; BACTEROIDES CORRODENS see EIKENELLA CORRODENS and BACTEROIDES NODOSUS see DICHELOBACTER NODOSUS are also available
MS = A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic.
MR = 20090706
DA = 19990101
DC = 1
UI = D001439

*NEWRECORD
RECTYPE = D
MH = Bacteroides fragilis
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.140.094.152.400
MN = B03.440.425.410.194.152.400
MH_TH = NLM (1976)
ST = T007
AN = infection: coord IM with BACTEROIDES INFECTIONS (IM)
PI = Bacteroides (1966-1975)
MS = Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
PM = 76
HN = 76
MR = 20090706
DA = 19750725
DC = 1
DX = 19760101
UI = D001441

*NEWRECORD
RECTYPE = D
MH = Bacteroides Infections
DE = BACTEROIDES INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Infections, Bacteroides|T047|NON|EQV|NLM (1992)|910228|INFECT BACTEROIDES|abcdefv
ENTRY = Bacteroides Infection
ENTRY = Infection, Bacteroides
MN = C01.252.400.110.109
MH_TH = NLM (1968)
ST = T047
AN = gram-neg bact infect
PI = Bacteroides (1966-1967)
MS = Infections with bacteria of the genus BACTEROIDES.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 19930602
DA = 19990101
DC = 1
DX = 19680101
UI = D001442

*NEWRECORD
RECTYPE = D
MH = Prevotella melaninogenica
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Bacteroides melaninogenicus|T007|NON|EQV|NLM (1995)|931222|abcdef
MN = B03.140.094.640.500
MN = B03.440.425.410.194.640.500
MH_TH = NLM (1976)
ST = T007
AN = infection: coord IM with BACTEROIDACEAE INFECTIONS (IM)
PI = Bacteroides (1966-1975)
MS = A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium has been isolated from the mouth, urine, feces, and infections of the mouth, soft tissue, respiratory tract, urogenital tract, and intestinal tract. It is pathogenic, but usually in association with other kinds of organisms.
OL = use PREVOTELLA MELANINOGENICA to search BACTEROIDES MELANINOGENICUS 1976-94
PM = 95; was BACTEROIDES MELANINOGENICUS 1976-94 (see under BACTEROIDES 1976-90)
HN = 95; was BACTEROIDES MELANINOGENICUS 1976-94 (see under BACTEROIDES 1976-90)
MR = 20090706
DA = 19750725
DC = 1
DX = 19910101
UI = D001443

*NEWRECORD
RECTYPE = D
MH = Bahamas
AQ = EH EP
MN = Z01.107.084.900.100
MN = Z01.639.880.100
MH_TH = POPLINE (1978)
ST = T083
AN = a chain of islands in the West Indies
MS = A chain of islands, cays, and reefs in the West Indies, lying southeast of Florida and north of Cuba. It is an independent state, called also the Commonwealth of the Bahamas or the Bahama Islands. The name likely represents the local name Guanahani, itself of uncertain origin. (From Webster's New Geographical Dictionary, 1988, p106 & Room, Brewer's Dictionary of Names, 1992, p45)
MR = 20120703
DA = 19990101
DC = 4
UI = D001444

*NEWRECORD
RECTYPE = D
MH = Bahrain
AQ = EH EP
MN = Z01.252.245.500.175
MH_TH = POPLINE (1978)
ST = T083
AN = a state in the Persian Gulf
MS = An independent state, an archipelago in the western Persian Gulf, northwest of Qatar. It comprises low-lying islands of Bahrain (the largest), Muharraq, Sitra, and several islets. It has extensive oil fields. The name comes from the Arabic al-bahrayn, "the two seas", with reference to its lying in the middle of a bay with its "two seas" east and west of it. (From Webster's New Geographical Dictionary, 1988, p107 & Room, Brewer's Dictionary of Names, 1992, p45)
HN = 75
MR = 20150527
DA = 19741111
DC = 4
DX = 19750101
UI = D001445

*NEWRECORD
RECTYPE = D
MH = Balanitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Balanitides
MN = C12.294.494.136
MH_TH = NLM (1966)
ST = T047
MS = Inflammation of the head of the PENIS, glans penis.
PM = 1966
HN = 1966
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D001446

*NEWRECORD
RECTYPE = D
MH = Balantidiasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Balantidiases
MN = C03.432.146
MN = C03.752.200.146
MN = C06.405.469.452.146
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
MS = Infection by parasites of the genus BALANTIDIUM. The presence of Balantidium in the LARGE INTESTINE leads to DIARRHEA; DYSENTERY; and occasionally ULCER.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001447

*NEWRECORD
RECTYPE = D
MH = Balantidium
AQ = CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI
ENTRY = Balantidiums
MN = B01.043.185.375.650.650.153
MH_TH = NLM (1966)
ST = T204
AN = infection = BALANTIDIASIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
MS = A genus of protozoa parasitic in the digestive tract of vertebrate or invertebrate hosts. Asexual multiplication is accomplished by transverse binary fission. Its organisms are ovoidal in shape and have a ciliated covering over the entire body.
MR = 20090706
DA = 19990101
DC = 1
UI = D001448

*NEWRECORD
RECTYPE = D
MH = Balkan Nephropathy
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Endemic Nephropathy, Balkan|T047|EPO|EQV|UNK (19XX)|810223|abcdef
PRINT ENTRY = Nephropathy, Balkan|T047|EPO|EQV|UNK (19XX)|810223|abcdef
ENTRY = Balkan Endemic Nephropathy|T047|EPO|EQV|NLM (2007)|OMIM (2013)|ORD (2010)|051027|abcdeeef
ENTRY = Danubian Endemic Familial Nephropathy|T047|EPO|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101213|abcdeeef
ENTRY = Nephropathy, Balkan Endemic
MN = C12.777.419.570.643.150
MN = C13.351.968.419.570.643.150
MH_TH = NLM (1982)
ST = T047
AN = do not specify geography unless particularly discussed
PI = Kidney Diseases (1966-1981)
PI = Nephritis (1966-1975)
PI = Nephritis, Interstitial (1969-1981)
PI = Pyelonephritis (1966-1969)
MS = A form of chronic interstitial nephritis that is endemic to limited areas of BULGARIA, the former YUGOSLAVIA, and ROMANIA. It is characterized by a progressive shrinking of the KIDNEYS that is often associated with uroepithelial tumors.
PM = 1991; see NEPHRITIS, INTERSTITIAL 1982-90; for Danubian Endemic Familial Nephropathy see Hemorrhagic Fever with Renal Syndrome 2012
HN = 1991(1982); use NEPHRITIS, INTERSTITIAL 1982-90; for Danubian Endemic Familial Nephropathy use Hemorrhagic Fever with Renal Syndrome 2012
CATSH = CAT LIST
MR = 20150630
DA = 19810223
DC = 1
DX = 19910101
UI = D001449

*NEWRECORD
RECTYPE = D
MH = Ballistocardiography
DE = BALLISTOCARDIOGR
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
ENTRY = Ballistocardiographies
MN = E01.370.370.380.100
MH_TH = NLM (1966)
ST = T060
AN = /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: BALLISTOCARDIOGR
MS = Technique of graphic representation of the movements of the body imparted by the ballistic forces (recoil and impact) associated with cardiac contraction and ejection of blood and with the deceleration of blood flow through the large blood vessels. These movements, quantitatively very minute, are translated by a pickup device (transducer) into an electrical potential which is suitably amplified and recorded on a conventional electrocardiograph or other recording machine.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001450

*NEWRECORD
RECTYPE = D
MH = Balneology
DE = BALNEOL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Balneotherapy|T061|NON|NRW|UNK (19XX)|850228|BALNEOTHER|abcdefv
MN = E02.056
FX = Health Resorts
FX = Mineral Waters
MH_TH = NLM (1966)
ST = T061
AN = differentiate from HYDROTHERAPY where emphasis is on plain water (not natural mineral water; see note there); coordinate with MINERAL WATERS as appropriate
MS = Therapy by various hot or warm baths in natural mineral waters, spas, or "cures". It includes not only bathing in, but also drinking the waters, but it does not include whirlpool baths (HYDROTHERAPY).
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
UI = D001452

*NEWRECORD
RECTYPE = D
MH = Balsams
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
MN = D05.750.078.840.219
MN = D20.215.721.500.219
MH_TH = NLM (1966)
ST = T167
RN = 0
AN = D25-26 qualif
MS = Resinous substances which most commonly originate from trees. In addition to resins, they contain oils, cinnamic acid and BENZOIC ACID.
MR = 20070709
DA = 19990101
DC = 1
UI = D001453

*NEWRECORD
RECTYPE = D
MH = Baltic States
AQ = EH EP
MN = Z01.542.248.136
MN = Z01.586.950.140
MH_TH = NLM (1975)
ST = T083
AN = = ESTONIA; LATVIA & LITHUANIA collectively
MS = The collective name for the republics of ESTONIA; LATVIA; and LITHUANIA on the eastern shore of the Baltic Sea. (Webster's New Geographical Dictionary, 1988, p111)
HN = 75
MR = 20010725
DA = 19990101
DC = 4
DX = 19750101
UI = D001454

*NEWRECORD
RECTYPE = D
MH = Bambermycins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Flavophospholipols|T118|T195|NON|EQV|UNK (19XX)|780316|abbcdef
PRINT ENTRY = Moenomycins|T118|T195|NON|EQV|UNK (19XX)|780316|abbcdef
ENTRY = Bambermycin|T118|T195|NON|EQV|BAN (19XX)|INN (19XX)|940725|abbcdeef
ENTRY = Flavomycin|T118|T195|TRD|NRW|NLM (1990)|890124|abbcdef
ENTRY = Flavomycins|T118|T195|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Flavophospholipol|T118|T195|NON|EQV|NLM (1990)|890124|abbcdef
ENTRY = Menomycin|T118|T195|NON|EQV|NLM (1990)|890124|abbcdef
MN = D09.698.718.220
PA = Anti-Bacterial Agents
MH_TH = USAN (1972)
ST = T118
ST = T195
N1 = Bambermycin
RN = 11015-37-5
PI = Antibiotics (1966-1978)
PI = Glycolipids (1966-1978)
MS = Antibiotic complex obtained from Streptomyces bambergiensis containing mainly Moenomycins A and C. They are used as feed additives and growth promoters for poultry, swine, and cattle.
PM = 91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1979-90
HN = 91(79); was see under ANTIBIOTICS, AMINOGLYCOSIDE 1979-90
MR = 20040707
DA = 19780316
DC = 1
DX = 19910101
UI = D001455

*NEWRECORD
RECTYPE = D
MH = Anion Exchange Protein 1, Erythrocyte
DS = ANION EXCHANGE PROTEIN ERYTHROCYTE 001
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Anion Transport Protein, Erythrocyte|T116|T123|NON|EQV|NLM (1993)|920403|abbcdef
PRINT ENTRY = Band 3 Protein|T116|T123|NON|EQV|NLM (1984)|990101|BAND PROTEIN 03|abbcdefs
PRINT ENTRY = Erythrocyte Anion Transport Protein|T116|T123|NON|EQV|NLM (1993)|920403|abbcdef
PRINT ENTRY = Erythrocyte Membrane Band 3 Protein|T116|T123|NON|EQV|UNK (19XX)|830531|ERYTHROCYTE MEMBRANE BAND PROTEIN 03|abbcdefs
ENTRY = AE1 Anion Exchanger|T116|T123|ABX|EQV|NLM (2002)|abbcde
ENTRY = AE1 Chloride-Bicarbonate Exchanger|T116|T123|ABX|EQV|NLM (2002)|abbcde
ENTRY = AE1 Cl- HCO3- Exchanger|T116|T123|ABX|EQV|NLM (2002)|abbcde
ENTRY = AE1 Gene Product|T116|T123|ABX|EQV|NLM (2002)|abbcde
ENTRY = Anion Exchanger 1|T116|T123|NON|EQV|NLM (2014)|130403|abbcdef
ENTRY = Antigens, CD233|T116|T123|ABX|EQV|NLM (2014)|130403|abbcdef
ENTRY = Band 3 Anion Transport Protein|T116|T123|NON|EQV|NLM (2014)|130403|abbcdef
ENTRY = Band III Protein|T116|T123|NON|EQV|UNK (19XX)|830531|abbcdef
ENTRY = CD233 Antigen|T116|T123|ACX|EQV|NLM (2014)|130403|abbcdef
ENTRY = CD233 Antigens|T116|T123|ACX|EQV|NLM (2014)|130403|abbcdef
ENTRY = Capnophorin|T116|T123|NON|EQV|UNK (19XX)|861007|abbcdef
ENTRY = EPB3 Protein|T116|T123|ABX|EQV|NLM (2014)|130403|abbcdef
ENTRY = Erythrocyte Anion Exchanger|T116|T123|NON|EQV|NLM (1993)|920403|abbcdef
ENTRY = Erythrocyte Membrane Anion Transport Protein|T116|T123|NON|EQV|NLM (1993)|920408|abbcdef
ENTRY = Erythrocyte Membrane Protein Band 3, Diego Blood Group|T116|T123|NON|EQV|NLM (2014)|130404|abbcdef
ENTRY = Protein Band 3|T116|T123|NON|EQV|UNK (19XX)|830531|abbcdef
ENTRY = SLC4A1 Protein|T116|T123|ABX|EQV|NLM (2014)|130403|abbcdef
ENTRY = Solute Carrier Family 4 Member 1|T116|T123|NON|EQV|NLM (2014)|130403|abbcdef
ENTRY = Solute Carrier Family 4, Anion Exchanger, Member 1|T116|T123|NON|EQV|NLM (2014)|130404|abbcdef
ENTRY = AE1 Chloride Bicarbonate Exchanger
ENTRY = AE1 Cl HCO3 Exchanger
ENTRY = Anion Exchanger, Erythrocyte
ENTRY = Antigen, CD233
ENTRY = Chloride-Bicarbonate Exchanger, AE1
ENTRY = Exchanger 1, Anion
ENTRY = Protein, Band 3
ENTRY = Protein, Band III
ENTRY = Protein, EPB3
ENTRY = Protein, SLC4A1
MN = D12.776.124.078
MN = D12.776.157.530.450.162.193.500
MN = D12.776.157.530.450.437.249.500
MN = D12.776.543.550.190.276.500
MN = D12.776.543.550.779.249.500
MN = D12.776.543.585.450.162.193.500
MN = D12.776.543.585.450.437.249.500
FX = Spherocytosis, Hereditary
MH_TH = NLM (2002)
ST = T116
ST = T123
RN = 0
PI = Blood Proteins (1966-1983)
PI = Membrane Proteins (1977-1983)
MS = A major integral transmembrane protein of the ERYTHROCYTE MEMBRANE. It is the anion exchanger responsible for electroneutral transporting in CHLORIDE IONS in exchange of BICARBONATE IONS allowing CO2 uptake and transport from tissues to lungs by the red blood cells. Genetic mutations that result in a loss of the protein function have been associated with type 4 HEREDITARY SPHEROCYTOSIS.
PM = 2002; see BAND 3 PROTEIN 1984-2000; AE1 ANION EXCHANGER, AE1 CHLORIDE-BICARBONATE EXCHANGER, AE1 Cl- HCO3- EXCHANGER & AE1 GENE PRODUCT were indexed under ANTIPORTERS 1998-2001
HN = 2002(1984); for AE1 ANION EXCHANGER, AE1 CHLORIDE-BICARBONATE EXCHANGER, AE1 Cl- HCO3- EXCHANGER & AE1 GENE PRODUCT use CHLORIDE-BICARBONATE ANTIPORTERS (NM) 1998-2001
MR = 20130708
DA = 19830531
DC = 1
DX = 19840101
UI = D001457

*NEWRECORD
RECTYPE = D
MH = Bandages
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Dressings|T074|NON|REL|UNK (19XX)|740329|abcdef
ENTRY = Bandage
ENTRY = Dressing
MN = E07.101
MH_TH = NLM (1966)
ST = T074
AN = spray-on bandages = OCCLUSIVE DRESSINGS
MS = Material used for wrapping or binding any part of the body.
OL = Use CLOTHING to search ELASTIC STOCKINGS & STOCKINGS, COMPRESSION 1982-89
PM = ELASTIC STOCKINGS & STOCKINGS, COMPRESSION were see CLOTHING 1982-89
HN = ELASTIC STOCKINGS & STOCKINGS, COMPRESSION were see CLOTHING 1982-89
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D001458

*NEWRECORD
RECTYPE = D
MH = Bangladesh
AQ = EH EP
MN = Z01.252.245.131
MH_TH = POPLINE (1978)
ST = T083
HN = 73
MR = 19911102
DA = 19990101
DC = 4
UI = D001459

*NEWRECORD
RECTYPE = D
MH = Barbados
AQ = EH EP
MN = Z01.107.084.900.140
MN = Z01.639.880.140
MH_TH = POPLINE (1978)
ST = T083
AN = an island in the Lesser Antilles in the West Indies
MS = An island in the Lesser Antilles in the West Indies. It is chiefly of coral formation with no good harbors and only small streams. It was probably discovered by the Portuguese in the sixteenth century. The name was given by 16th-century Spanish explorers from barbados, the plural for "bearded", with reference to the beard-like leaves or trails of moss on the trees that grew there in abundance. (From Webster's New Geographical Dictionary, 1988, p116 & Room, Brewer's Dictionary of Names, 1992, p49)
HN = 75
MR = 20120703
DA = 19741111
DC = 4
DX = 19750101
UI = D001460

*NEWRECORD
RECTYPE = D
MH = Barbering
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Barberings
MN = J01.576.082
FX = Barber Surgeons
MH_TH = NLM (1966)
ST = T057
AN = SPEC: SPEC qualif
MS = The occupation concerned with the cutting and dressing of the hair of customers and, of men, the shaving and trimming of the beard and mustache. (From Random House Unabridged Dictionary, 2d ed)
MR = 19950531
DA = 19990101
DC = 1
UI = D001461

*NEWRECORD
RECTYPE = D
MH = Barbital
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Barbitone|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|750630|abbcdeef
PRINT ENTRY = Diethylmalonylurea|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef
PRINT ENTRY = Ethylbarbital|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef
ENTRY = Diemal|T109|T121|TRD|NRW|UNK (19XX)|750630|abbcdef
ENTRY = Dormileno|T109|T121|TRD|NRW|ES|031006|abbcdef
ENTRY = Faes Brand of Barbital|T109|T121|NON|NRW|NLM (2005)|031006|abbcdef
ENTRY = Medinal|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Veronal|T109|T121|TRD|NRW|UNK (19XX)|820903|abbcdef
ENTRY = Barbital Faes Brand
MN = D03.383.742.698.253.150
PA = GABA Modulators
PA = Hypnotics and Sedatives
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-
RN = 5WZ53ENE2P
RR = 57-44-3 (Barbital)
PI = Barbiturates (1968-1975)
MS = A long-acting barbiturate that depresses most metabolic processes at high doses. It is used as a hypnotic and sedative and may induce dependence. Barbital is also used in veterinary practice for central nervous system depression.
PM = 91; was see under BARBITURATES 1976-90
HN = 91(76); was see under BARBITURATES 1976-90
MR = 20130708
DA = 19750721
DC = 1
DX = 19910101
UI = D001462

*NEWRECORD
RECTYPE = D
MH = Barbiturates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.383.742.698.253
FX = Anesthetics, Intravenous
FX = Anticonvulsants
FX = Hypnotics and Sedatives
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = GEN or unspecified; prefer specifics
MS = A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
PM = /adverse effects /poisoning /toxicity were BARBITURATE TOXICOLOGY 1963-65
HN = /adv eff-pois-tox was BARBITURATE TOXICOLOGY 1963-65
MR = 20030709
DA = 19990101
DC = 1
UI = D001463

*NEWRECORD
RECTYPE = D
MH = Barium
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.552.050
MN = D01.268.556.062
MN = D01.552.539.124
MN = D01.552.544.062
FX = Barium Radioisotopes
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Barium
RN = 24GP945V5T
RR = 7440-39-3 (Barium)
AN = Ba-138; Ba-130, 132, 134-137 = BARIUM (IM) + ISOTOPES (NIM); Ba-126-129, 131, 133, 139-143 = BARIUM RADIOISOTOPES (IM); barium enema = BARIUM SULFATE  + ENEMA
MS = An element of the alkaline earth group of metals. It has an atomic symbol Ba, atomic number 56, and atomic weight 138. All of its acid-soluble salts are poisonous.
MR = 20150605
DA = 19990101
DC = 1
UI = D001464

*NEWRECORD
RECTYPE = D
MH = Barium Radioisotopes
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Radioisotopes, Barium
MN = D01.496.749.075
MH_TH = NLM (1988)
ST = T196
RN = 0
AN = Ba-126-129, 131, 133, 139-143; for routine use as tracer, use no qualifiers
PI = Barium (1968-1987)
PI = Radioisotopes (1966-1987)
MS = Unstable isotopes of barium that decay or disintegrate emitting radiation. Ba atoms with atomic weights 126-129, 131, 133, and 139-143 are radioactive barium isotopes.
PM = 88
HN = 88
MR = 20150605
DA = 19870331
DC = 1
DX = 19880101
UI = D001465

*NEWRECORD
RECTYPE = D
MH = Barium Sulfate
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Barite|T197|NON|NRW|UNK (19XX)|861001|abcdef
ENTRY = Baritop|T130|T197|TRD|NRW|NLM (1992)|901022|abbcdef
ENTRY = Barium Sulfate (2:1)|T130|T197|NRW|NLM (1999)|990913|abbdef
ENTRY = E-Z-CAT|T130|T197|TRD|NRW|UNK (19XX)|841002|abbcdef
ENTRY = Micropaque Oral|T130|T197|TRD|NRW|UNK (19XX)|870810|abbcdef
ENTRY = E Z CAT
ENTRY = EZCAT
ENTRY = Sulfate, Barium
MN = D01.103.075
MN = D01.875.800.800.850.075
PA = Contrast Media
MH_TH = FDA SRS (2014)
MH_TH = USP (19XX)
ST = T130
ST = T197
N1 = Sulfuric acid, barium salt (1:1)
RN = 25BB7EKE2E
RR = 25105-31-1 (barium salt (2:1))
RR = 7727-43-7 (Barium Sulfate)
AN = for enema, use BARIUM SULFATE not BARIUM
MS = A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.
MR = 20150605
DA = 19990101
DC = 1
UI = D001466

*NEWRECORD
RECTYPE = D
MH = Hordeum
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Barley|T002|T168|NON|REL|NLM (1975)|990101|abbcdef
ENTRY = Hordeum vulgare|T002|NON|NRW|NLM (2003)|011010|abcdef
MN = B01.650.940.800.575.100.822.481
MH_TH = UNK (19XX)
ST = T002
AN = malted barley = HORDEUM + SEEDLINGS
MS = A plant genus of the family POACEAE. The EDIBLE GRAIN, barley, is widely used as food.
PM = 2003; see BARLEY 1991-2002, CEREALS 1985-1990, GRAIN 1963-1984
HN = 2003; use BARLEY 1991-2002, CEREALS 1985-1990, GRAIN 1963-1984
MR = 20150901
DA = 19990101
DC = 1
DX = 19910101
UI = D001467

*NEWRECORD
RECTYPE = D
MH = Thoracica
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Balanus|T204|NON|NRW|NLM (2003)|011017|abcdef
PRINT ENTRY = Barnacles|T204|NON|EQV|NLM (1972)|990101|abcdef
PRINT ENTRY = Pedunculata|T204|NON|NRW|NLM (2003)|011017|abcdef
PRINT ENTRY = Sessilia|T204|NON|NRW|NLM (2003)|011017|abcdef
ENTRY = Barnacle
ENTRY = Pedunculatas
ENTRY = Sessilias
ENTRY = Thoracicas
MN = B01.050.500.131.365.880
MH_TH = NLM (2003)
ST = T204
PI = Crustacea (1966-1971)
MS = A superorder of marine CRUSTACEA, free swimming in the larval state, but permanently fixed as adults. There are some 800 described species, grouped in several genera, and comprising of two major orders of barnacles: stalked (Pedunculata) and sessile (Sessilia).
PM = 2003; see BARNACLES 1972-2002
HN = 2003 (1972)
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D001468

*NEWRECORD
RECTYPE = D
MH = Barotrauma
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Barotraumas
MN = C26.120
FX = Decompression Sickness
FX = High Pressure Neurological Syndrome
MH_TH = NLM (1979)
ST = T037
AN = inj caused by pressure changes: not restricted to ear; IM; coord with organ injured by pressure with /inj; also available is BLAST INJURIES
PI = Decompression Sickness (1966-1978)
PI = Pressure (1966-1978)
MS = Injury following pressure changes; includes injury to the eustachian tube, ear drum, lung and stomach.
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20100625
DA = 19780522
DC = 1
DX = 19790101
UI = D001469

*NEWRECORD
RECTYPE = D
MH = Barrett Esophagus
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Barrett Syndrome|T047|EPO|EQV|NLM (1999)|980305|abcdef
PRINT ENTRY = Esophagus, Barrett|T047|EPO|EQV|UNK (19XX)|800404|abcdef
ENTRY = Barrett Epithelium|T047|EPO|NRW|NLM (2004)|030507|abcdef
ENTRY = Barrett Metaplasia|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Barrett's Esophagus|T047|EPO|EQV|NLM (1999)|980305|abcdef
ENTRY = Barrett's Syndrome|T047|EPO|EQV|NLM (1999)|980401|abcdef
ENTRY = Barretts Esophagus
ENTRY = Barretts Syndrome
ENTRY = Epithelium, Barrett
ENTRY = Esophagus, Barrett's
ENTRY = Syndrome, Barrett
ENTRY = Syndrome, Barrett's
MN = C06.198.102
MN = C06.405.117.102
MH_TH = NLM (1981)
MH_TH = OMIM (2013)
ST = T047
AN = note category; do not coord with INFANT, NEWBORN, DISEASES
PI = Esophageal Stenosis (1966-1980)
PI = Esophagitis, Peptic (1966-1980)
MS = A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.
PM = 89; was see under ESOPHAGEAL DISEASES 1981-88
HN = 89(81); was see under ESOPHAGEAL DISEASES 1981-88
CATSH = CAT LIST
MR = 20130708
DA = 19800404
DC = 1
DX = 19890101
UI = D001471

*NEWRECORD
RECTYPE = D
MH = Bartholin's Glands
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Bartholin Glands
ENTRY = Bartholins Glands
ENTRY = Glands, Bartholin's
MN = A05.360.319.887.220
MN = A10.336.095
MH_TH = NLM (1966)
ST = T023
MS = Mucus-secreting glands situated on the posterior and lateral aspect of the vestibule of the vagina.
MR = 19991103
DA = 19990101
DC = 1
UI = D001472

*NEWRECORD
RECTYPE = D
MH = Bartonella
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Rochalimaea|T007|NON|EQV|NLM (1996)|950315|abcdef
MN = B03.440.090.100
MN = B03.660.050.030.040
MH_TH = NLM (1966)
ST = T007
AN = infection = BARTONELLA INFECTIONS
MS = A genus of gram-negative bacteria characteristically appearing in chains of several segmenting organisms. It occurs in man and arthropod vectors and is found only in the Andes region of South America. This genus is the etiologic agent of human bartonellosis. The genus Rochalimaea, once considered a separate genus, has recently been combined with the genus Bartonella as a result of high levels of relatedness in 16S rRNA sequence data and DNA hybridization data.
PM = ROCHALIMAEA was heading 1995
HN = ROCHALIMAEA was heading 1995
MR = 20090706
DA = 19990101
DC = 1
UI = D001473

*NEWRECORD
RECTYPE = D
MH = Bartonella Infections
DE = BARTONELLA INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Bartonellosis|T047|NON|EQV|NLM (1992)|ORD (2010)|910227|abcdeef
PRINT ENTRY = Carrion's Disease|T047|EPO|EQV|UNK (19XX)|740329|CARRIONS DIS|abcdefv
PRINT ENTRY = Oroya Fever|T047|EPO|REL|UNK (19XX)|740329|abcdef
PRINT ENTRY = Rochalimaea Infections|T047|NON|EQV|NLM (1996)|950315|ROCHALIMAEA INFECT|abcdefv
PRINT ENTRY = Verruga Peruana|T047|NON|REL|UNK (19XX)|740329|abcdef
ENTRY = Carrion Disease|T047|EPO|EQV|UNK (19XX)|840615|CARRION DIS|abcdefv
ENTRY = Cat Scratch Fever|T047|NON|REL|NLM (2010)|ORD (2010)|090512|abcdeef
ENTRY = Infections, Bartonella|T047|NON|EQV|NLM (1992)|910228|INFECT BARTONELLA|abcdefv
ENTRY = Infections, Rochalimaea|T047|NON|EQV|NLM (1996)|950315|INFECT ROCHALIMAEA|abcdefv
ENTRY = Bartonella Infection
ENTRY = Bartonelloses
ENTRY = Carrions Disease
ENTRY = Cat Scratch Fevers
ENTRY = Disease, Carrion
ENTRY = Disease, Carrion's
ENTRY = Fever, Cat Scratch
ENTRY = Fever, Oroya
ENTRY = Fevers, Cat Scratch
ENTRY = Infection, Bartonella
ENTRY = Infection, Rochalimaea
ENTRY = Rochalimaea Infection
ENTRY = Scratch Fever, Cat
ENTRY = Scratch Fevers, Cat
MN = C01.252.400.126.100
MH_TH = NLM (1966)
ST = T047
AN = gram-neg bact infect
MS = Infections by the genus BARTONELLA. Bartonella bacilliformis can cause acute febrile anemia, designated Oroya fever, and a benign skin eruption, called verruga peruana. BARTONELLA QUINTANA causes TRENCH FEVER, while BARTONELLA HENSELAE is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY) and is also one of the causes of CAT-SCRATCH DISEASE in immunocompetent patients.
PM = ROCHALIMAEA INFECTIONS was heading 1995
HN = ROCHALIMAEA INFECTIONS was heading 1995
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001474

*NEWRECORD
RECTYPE = D
MH = Bartonellaceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.090
MN = B03.660.050.030
MH_TH = NLM (1975)
ST = T007
PI = Bacteria (1966-1974)
MS = A family of small gram-negative bacteria whose organisms are parasites of erythrocytes in man and other vertebrates and the etiologic agents of several diseases.
PM = 75
HN = 75
MR = 20090706
DA = 19990101
DC = 1
DX = 19750101
UI = D001475

*NEWRECORD
RECTYPE = D
MH = Bartonellaceae Infections
DE = BARTONELLACEAE INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Infections, Bartonellaceae|T047|NON|EQV|NLM (1992)|910228|INFECT BARTONELLACEAE|abcdefv
ENTRY = Bartonellaceae Infection
ENTRY = Infection, Bartonellaceae
MN = C01.252.400.126
MH_TH = NLM (1977)
ST = T047
AN = gram-neg bact infect
PI = Bartonella Infections (1966-1976)
PI = Rickettsial Infections (1966-1976)
MS = Infections with bacteria of the family BARTONELLACEAE.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 20030709
DA = 19760427
DC = 1
DX = 19770101
UI = D001476

*NEWRECORD
RECTYPE = D
MH = Bartter Syndrome
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Aldosteronism with Hyperplasia of the Adrenal Cortex|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Bartter Disease|T047|EPO|EQV|GHR (2014)|UNK (19XX)|810316|BARTTER DIS|abcdeefv
ENTRY = Bartter's Disease|T047|EPO|EQV|NLM (1975)|990101|BARTTERS DIS|abcdefv
ENTRY = Bartter's Syndrome|T047|EPO|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090609|abcdeeef
ENTRY = Juxtaglomerular Hyperplasia with Secondary Aldosteronism|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Bartters Disease
ENTRY = Bartters Syndrome
ENTRY = Syndrome, Bartter
ENTRY = Syndrome, Bartter's
MN = C12.777.419.815.279
MN = C13.351.968.419.815.279
MN = C19.053.800.604.249
FX = Sodium-Potassium-Chloride Symporters
MH_TH = GHR (2014)
MH_TH = NLM (2005)
ST = T047
MS = A group of disorders caused by defective salt reabsorption in the ascending LOOP OF HENLE. It is characterized by severe salt-wasting, HYPOKALEMIA; HYPERCALCIURIA; metabolic ALKALOSIS, and hyper-reninemic HYPERALDOSTERONISM without HYPERTENSION. There are several subtypes including ones due to mutations in the renal specific SODIUM-POTASSIUM-CHLORIDE SYMPORTERS.
PM = 2005; see BARTTER'S DISEASE 1991-2004, see HYPERALDOSTERONISM 1975-1990
HN = 2005 (1975)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001477

*NEWRECORD
RECTYPE = D
MH = Basal Cell Nevus Syndrome
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Gorlin Syndrome|T191|EPO|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|790425|abcdeeeef
PRINT ENTRY = Nevoid Basal Cell Carcinoma Syndrome|T191|NON|EQV|GHR (2014)|OMIM (2013)|ORD (2010)|UNK (19XX)|790425|abcdeeeef
PRINT ENTRY = Nevus Syndrome, Basal Cell|T191|NON|EQV|UNK (19XX)|860418|abcdef
ENTRY = Fifth Phacomatosis|T191|NON|EQV|NLM (2012)|ORD (2010)|090224|abcdeef
ENTRY = Gorlin-Goltz Syndrome|T191|EPO|EQV|GHR (2014)|NLM (2012)|OMIM (2013)|ORD (2010)|090224|abcdeeeef
ENTRY = Multiple Basal Cell Nevi, Odontogenic Keratocysts, and Skeletal Anomalies|T191|NON|EQV|NLM (2012)|OMIM (2013)|ORD (2010)|101214|abcdeeef
ENTRY = NBCCS|T191|NON|EQV|GHR (2014)|NLM (2014)|130501|abcdeef
ENTRY = Fifth Phacomatoses
ENTRY = Gorlin Goltz Syndrome
ENTRY = Syndrome, Gorlin
ENTRY = Syndrome, Gorlin-Goltz
MN = C04.182.089.530.690.150
MN = C04.557.470.200.165.150
MN = C04.557.470.565.165.150
MN = C04.700.175
MN = C05.116.099.105
MN = C05.500.470.690.150
MN = C07.320.450.670.130
MN = C16.131.077.130
MN = C16.320.700.175
MH_TH = GHR (2014)
MH_TH = NLM (1980)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T191
AN = coordinate IM with precoordinated organ/neoplasm (IM or NIM) only if pertinent; do not confuse entry term GORLIN-GOLTZ SYNDROME with GOLTZ- GORLIN SYNDROME see FOCAL DERMAL HYPOPLASIA
PI = Bone Cyst (1966-1979)
PI = Carcinoma, Basal Cell (1966-1979)
PI = Jaw Diseases (1967-1979)
PI = Jaw Neoplasms (1967-1979)
PI = Skin Neoplasms (1967-1979)
PI = Syndrome (1972-1979)
PI = specific jaw disease (1967-1979)
PI = specific jaw neoplasm (1967-1979)
MS = Hereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant.
PM = 91; was see under CARCINOMA, BASAL CELL 1980-90
HN = 91(80); was see under CARCINOMA, BASAL CELL 1980-90
CATSH = CAT LIST
MR = 20130708
DA = 19790425
DC = 1
DX = 19910101
UI = D001478

*NEWRECORD
RECTYPE = D
MH = Basal Ganglia
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Basal Nuclei|T023|NON|EQV|UNK (19XX)|740330|abcdef
PRINT ENTRY = Claustrum|T023|NON|NRW|UNK (19XX)|780522|abcdef
PRINT ENTRY = Ganglia, Basal|T023|NON|EQV|NLM (1991)|891213|abcdef
ENTRY = Ganglion, Basal|T023|NON|EQV|NLM (1991)|900108|abcdef
ENTRY = Nuclei, Basal
MN = A08.186.211.730.885.287.249
MH_TH = NLM (1966)
ST = T023
AN = disease = BASAL GANGLIA DISEASES
MS = Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres.
OL = use BASAL GANGLIA to search GANGLIA, BASAL 1966-81
PM = 82; was GANGLIA, BASAL 1963-81
HN = 82; was GANGLIA, BASAL 1963-81; CLAUSTRUM was see under GANGLIA, BASAL 1963-78
MR = 20150605
DA = 19990101
DC = 1
UI = D001479

*NEWRECORD
RECTYPE = D
MH = Basal Ganglia Diseases
DE = BASAL GANGLIA DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Extrapyramidal Disorders|T047|NON|BRD|UNK (19XX)|780517|EXTRAPYRAMIDAL DIS|abcdefv
ENTRY = Basal Ganglia Disorders|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Lenticulostriate Disorders|T047|NON|NRW|NLM (2000)|991103|LENTICULOSTRIATE DIS|abcdefv
ENTRY = Basal Ganglia Disease
ENTRY = Basal Ganglia Disorder
ENTRY = Extrapyramidal Disorder
ENTRY = Lenticulostriate Disorder
MN = C10.228.140.079
MH_TH = NLM (1972)
ST = T047
AN = GEN: prefer specifics; coord IM with specific site (IM)
PI = Movement Disorders (1966-1971)
PI = specific anatomic site (1966-1971)
MS = Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
PM = 79; was EXTRAPYRAMIDAL DISORDERS 1974-78
HN = 79; was EXTRAPYRAMIDAL DISORDERS 1972-78 (Prov 1972-73)
CATSH = CAT LIST
MR = 20050712
DA = 19990101
DC = 1
DX = 19740101
UI = D001480

*NEWRECORD
RECTYPE = D
MH = Basal Metabolism
DE = BASAL METAB
AQ = DE ES GE IM PH RE
PRINT ENTRY = Metabolism, Basal|T040|T060|T201|NON|EQV|NLM (1992)|910512|METAB BASAL|abbbcdefv
ENTRY = Basal Metabolic Rate|T040|T060|T201|NON|EQV|UNK (19XX)|881119|BASAL METAB RATE|abbbcdefv
ENTRY = Metabolic Rate, Basal|T040|T060|T201|NON|EQV|NLM (1992)|910512|METAB RATE BASAL|abbbcdefv
ENTRY = Basal Metabolic Rates
ENTRY = Metabolic Rates, Basal
ENTRY = Rate, Basal Metabolic
ENTRY = Rates, Basal Metabolic
MN = E01.370.374.750.100
MN = G03.495.335.154
FX = Calorimetry
FX = Secondary Metabolism
MH_TH = NLM (1966)
ST = T040
ST = T060
ST = T201
AN = resting state only; energy expenditure, energy cost = ENERGY METABOLISM
MS = Heat production, or its measurement, of an organism at the lowest level of cell chemistry in an inactive, awake, fasting state. It may be determined directly by means of a calorimeter or indirectly by calculating the heat production from an analysis of the end products of oxidation within the organism or from the amount of oxygen utilized.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001481

*NEWRECORD
RECTYPE = D
MH = Base Composition
AQ = DE GE IM PH RE
PRINT ENTRY = Base Ratio|T081|NON|NRW|UNK (19XX)|790524|abcdef
PRINT ENTRY = G+C Composition|T081|NON|NRW|NLM (2003)|010928|G C COMPOSITION|abcdefs
PRINT ENTRY = Guanine + Cytosine Composition|T081|NON|NRW|NLM (2003)|010928|GUANINE CYTOSINE COMPOSITION|abcdefs
ENTRY = G+C Content|T081|NON|NRW|NLM (2003)|010928|abcdef
ENTRY = GC Composition|T081|NON|NRW|NLM (2003)|011116|abcdef
ENTRY = GC Content|T081|NON|NRW|NLM (2003)|011116|abcdef
ENTRY = Guanine + Cytosine Content|T081|NON|NRW|NLM (2003)|010928|abcdef
ENTRY = Base Compositions
ENTRY = Base Ratios
ENTRY = Composition, Base
ENTRY = Composition, G+C
ENTRY = Composition, GC
ENTRY = Compositions, Base
ENTRY = Compositions, G+C
ENTRY = Compositions, GC
ENTRY = Content, G+C
ENTRY = Content, GC
ENTRY = Contents, G+C
ENTRY = Contents, GC
ENTRY = G+C Compositions
ENTRY = G+C Contents
ENTRY = GC Compositions
ENTRY = GC Contents
ENTRY = Ratio, Base
ENTRY = Ratios, Base
MN = G02.111.080
FX = AT Rich Sequence
FX = Base Pairing
FX = GC Rich Sequence
FX = Isochores
MH_TH = NLM (1980)
ST = T081
AN = IM general only; NIM with specific nucleic acid (IM); do not confuse with BASE SEQUENCE: sequ = order in which arranged, comp = what components & how many
MS = The relative amounts of the PURINES and PYRIMIDINES in a nucleic acid.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20080708
DA = 19790524
DC = 1
DX = 19800101
UI = D001482

*NEWRECORD
RECTYPE = D
MH = Base Sequence
DE = BASE SEQ
AQ = DE GE PH RE
PRINT ENTRY = DNA Sequence|T086|T114|NRW|BIOETHICS (1997)|NLM (1993)|920326|DNA SEQ|abbdeefv
PRINT ENTRY = Nucleotide Sequence|T086|T114|NON|EQV|UNK (19XX)|870509|NUCLEOTIDE SEQ|abbcdefv
PRINT ENTRY = RNA Sequence|T086|T114|NRW|NLM (1993)|920326|RNA SEQ|abbdefv
ENTRY = DNA Sequences|T086|T114|NON|NRW|BIOETHICS (1997)|970619|abbcdef
ENTRY = Base Sequences
ENTRY = Nucleotide Sequences
ENTRY = RNA Sequences
ENTRY = Sequence, Base
ENTRY = Sequence, DNA
ENTRY = Sequence, Nucleotide
ENTRY = Sequence, RNA
ENTRY = Sequences, Base
ENTRY = Sequences, DNA
ENTRY = Sequences, Nucleotide
ENTRY = Sequences, RNA
MN = G02.111.570.080
MN = G05.360.080
MN = L01.453.245.667.080
MH_TH = NLM (1971)
ST = T086
ST = T114
AN = IM general only; coord with specific nucleic acid; do not confuse with BASE COMPOSITION: comp = what components & how many, sequ = order in which arranged; for base sequencing, use SEQUENCE ANALYSIS, DNA or SEQUENCE ANALYSIS, RNA; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: BASE SEQ
PI = Nucleotides/analysis (1966-1970)
PI = Polynucleotides (1966-1970)
PI = specific nucleic acid (1966-1970)
MS = The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
PM = 78; was see under BIOCHEMISTRY 1975-77
HN = 78(71); was see under BIOCHEMISTRY 1975-77
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19780101
UI = D001483

*NEWRECORD
RECTYPE = D
MH = Baseball
AQ = CL EC ED ES HI IN LJ PH PX SN ST TD
PRINT ENTRY = Softball|T056|NON|NRW|NLM (1990)|890324|abcdef
ENTRY = Baseballs|T073|NON|REL|NLM (1997)|960415|abcdef
ENTRY = Softballs|T073|NON|REL|NLM (1997)|960415|abcdef
MN = I03.450.642.845.110
MH_TH = NLM (1977)
ST = T056
AN = /inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
PI = Sports (1966-1976)
MS = A competitive nine-member team sport including softball.
PM = 90; was see under SPORTS 1977-89
HN = 90(77); was see under SPORTS 1977-89
MR = 19960610
DA = 19760519
DC = 1
DX = 19900101
UI = D001484

*NEWRECORD
RECTYPE = D
MH = Basement Membrane
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Basal Lamina|T024|NON|NRW|UNK (19XX)|880412|abcdef
PRINT ENTRY = Basement Lamina|T024|NON|NRW|UNK (19XX)|880412|abcdef
ENTRY = Basal Laminas
ENTRY = Basement Laminas
ENTRY = Basement Membranes
ENTRY = Lamina, Basal
ENTRY = Lamina, Basement
ENTRY = Laminas, Basal
ENTRY = Laminas, Basement
ENTRY = Membrane, Basement
ENTRY = Membranes, Basement
MN = A10.272.220
MN = A10.615.179
MH_TH = NLM (1965)
ST = T024
AN = do not confuse X ref BASAL LAMINA with "lamina basalis", the basal plate of the embryonic neural tube
MS = A darkly stained mat-like EXTRACELLULAR MATRIX (ECM) that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane (BM) can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers.
PM = 67
HN = 67(65)
MR = 20050630
DA = 19990101
DC = 1
DX = 19670101
UI = D001485

*NEWRECORD
RECTYPE = D
MH = Bashkiria
AQ = EH EP
PRINT ENTRY = Bashkir Republic|T083|NON|EQV|NLM (1999)|980306|abcdef
PRINT ENTRY = Bashkortostan|T083|NON|EQV|NLM (1999)|980306|abcdef
MN = Z01.542.248.775.150
MN = Z01.586.200.775.150
MN = Z01.586.950.775.150
MH_TH = NLM (1975)
ST = T083
MS = A political subdivision of eastern RUSSIA located within Europe. It consists of a plateau and mountainous area of the Southern Urals. (From Webster's New Geographical Dictionary, 1997)
HN = 75
MR = 19980610
DA = 19990101
DC = 4
DX = 19750101
UI = D001486

*NEWRECORD
RECTYPE = D
MH = Basidiomycota
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Basidiomycetes|T004|NON|EQV|NLM (1999)|971119|abcdef
ENTRY = Basidiomycete
ENTRY = Basidiomycotas
MN = B01.300.179
MH_TH = NLM (1966)
ST = T004
AN = GEN or unspecified; prefer specifics
MS = A phylum of fungi that produce their sexual spores (basidiospores) on the outside of the basidium. It includes forms commonly known as mushrooms, boletes, puffballs, earthstars, stinkhorns, bird's-nest fungi, jelly fungi, bracket or shelf fungi, and rust and smut fungi.
PM = 99; see BASIDIOMYCETES 1963-98
HN = 99
MR = 20090706
DA = 19990101
DC = 1
UI = D001487

*NEWRECORD
RECTYPE = D
MH = Basilar Artery
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, Basilar
ENTRY = Artery, Basilar
ENTRY = Basilar Arteries
MN = A07.231.114.106
MH_TH = NLM (1966)
ST = T023
MS = The artery formed by the union of the right and left vertebral arteries; it runs from the lower to the upper border of the pons, where it bifurcates into the two posterior cerebral arteries.
MR = 19920526
DA = 19990101
DC = 1
UI = D001488

*NEWRECORD
RECTYPE = D
MH = Basilar Membrane
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Basilar Membranes
ENTRY = Membrane, Basilar
ENTRY = Membranes, Basilar
MN = A09.246.631.246.125
MN = A10.615.179.124
MH_TH = NLM (1975)
ST = T023
MS = A basement membrane in the cochlea that supports the hair cells of the ORGAN OF CORTI, consisting keratin-like fibrils. It stretches from the SPIRAL LAMINA to the basilar crest. The movement of fluid in the cochlea, induced by sound, causes displacement of the basilar membrane and subsequent stimulation of the attached hair cells which transform the mechanical signal into neural activity.
OL = use LABYRINTH to search BASILAR MEMBRANE 1966-74
PM = 91; was see under COCHLEA 1990; was see under LABYRINTH 1960-89
HN = 91(75); was see under COCHLEA 1990; was see under LABYRINTH 1960-89
MR = 20070711
DA = 19990101
DC = 1
DX = 19910101
UI = D001489

*NEWRECORD
RECTYPE = D
MH = Basketball
AQ = CL EC ED ES HI IN LJ PH PX SN ST TD
ENTRY = Basketballs|T073|NON|REL|NLM (1997)|960415|abcdef
MN = I03.450.642.845.117
MH_TH = NLM (1987)
ST = T056
AN = /inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
PI = Athletic Injuries (1968-1986)
PI = Sports (1966-1986)
MS = A competitive team sport played on a rectangular court having a raised basket at each end.
PM = 90; was see under SPORTS 1987-89
HN = 90(87); was see under SPORTS 1987-89
MR = 19960610
DA = 19860325
DC = 1
DX = 19900101
UI = D001490

*NEWRECORD
RECTYPE = D
MH = Basophils
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Basophil
MN = A11.118.637.415.120
MN = A11.627.340.120
MN = A15.145.229.637.415.120
MN = A15.382.490.315.120
MH_TH = NLM (1966)
ST = T025
AN = restrict to leukocytes: not for "basophilic" when referring only to staining ( = STAINING)
MS = Granular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes.
MR = 20030709
DA = 19990101
DC = 1
UI = D001491

*NEWRECORD
RECTYPE = D
MH = Bass
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Dicentrarchus|T013|NON|NRW|UNK (19XX)|860415|abcdef
PRINT ENTRY = Micropterus|T013|NON|NRW|UNK (19XX)|860415|abcdef
PRINT ENTRY = Morone|T013|NON|NRW|UNK (19XX)|860415|abcdef
PRINT ENTRY = Moronidae|T013|NON|NRW|NLM (2006)|050114|abcdef
PRINT ENTRY = Serranidae|T013|NON|NRW|NLM (2006)|050114|abcdef
ENTRY = Morone americana|T013|NON|NRW|NLM (2006)|041215|abcdef
ENTRY = Sea Bass|T013|NON|NRW|NLM (2006)|050114|abcdef
ENTRY = Sea Basses|T013|NON|NRW|NLM (2006)|050114|abcdef
ENTRY = Temperate Basses|T013|NON|NRW|NLM (2006)|050114|abcdef
ENTRY = White Perch|T013|NON|NRW|NLM (2006)|041215|abcdef
ENTRY = Bass, Sea
ENTRY = Basses, Sea
ENTRY = Basses, Temperate
ENTRY = Perch, White
MN = B01.050.150.900.493.602.105
MH_TH = NLM (1987)
ST = T013
PI = Fishes (1966-1986)
MS = Common name for FISHES belonging to the order Perciformes and occurring in three different families.
PM = 91; was see under PERCIFORMES 1987-90
HN = 91(87); was see under PERCIFORMES 1987-90
MR = 20090706
DA = 19860415
DC = 1
DX = 19910101
UI = D001492

*NEWRECORD
RECTYPE = D
MH = Bathing Beaches
AQ = CL EC HI LJ SN ST
ENTRY = Beaches, Bathing
MN = N06.850.860.410.110
MH_TH = NLM (1966)
ST = T083
MS = Beaches, both natural and man-made, used for bathing and other activities.
MR = 20080708
DA = 19990101
DC = 1
UI = D001493

*NEWRECORD
RECTYPE = D
MH = Baths
AQ = AE CL CT EC ES HI IS LJ MO MT NU PX SN ST TD UT VE
ENTRY = Bath
MN = E02.056.110
MH_TH = NLM (1966)
ST = T056
ST = T061
AN = for personal hygiene or med treatment; at home or in hosp, often not plain water (see note on HYDROTHERAPY), usually with additives; do not confuse with BALNEOLOGY (see note there); general only or unspecified; prefer specifics; note MUD BATHS see MUD THERAPY & SAND BATHS see AMMOTHERAPY; bathing in seawater is probably CLIMATOTHERAPY
MS = The immersion or washing of the body or any of its parts in water or other medium for cleansing or medical treatment. It includes bathing for personal hygiene as well as for medical purposes with the addition of therapeutic agents, such as alkalines, antiseptics, oil, etc.
CATSH = CAT LIST
MR = 20150626
DA = 19990101
DC = 1
UI = D001494

*NEWRECORD
RECTYPE = D
MH = Batrachotoxins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Batrachotoxin B|T109|T131|NON|EQV|UNK (19XX)|820902|abbcdef
ENTRY = B, Batrachotoxin
MN = D20.888.033.112
MN = D23.946.833.033.112
MH_TH = NLM (1974)
ST = T109
ST = T131
RN = 0
AN = from frogs; /antag permitted but consider also ANTITOXINS
MS = Batrachotoxin is the 20-alpha-bromobenzoate of batrachotoxin A; they are toxins from the venom of a small Colombian frog, Phyllobates aurotaenia, cause release of acetylcholine, destruction of synaptic vesicles and depolarization of nerve and muscle fibers.
PM = 74
HN = 74
MR = 20050630
DA = 19990101
DC = 1
DX = 19740101
UI = D001496

*NEWRECORD
RECTYPE = D
MH = Battered Child Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Nonaccidental Trauma in Children|T037|T047|NON|EQV|NLM (2015)|131122|abbcdef
ENTRY = Battered Child Syndromes
ENTRY = Child Syndrome, Battered
ENTRY = Child Syndromes, Battered
ENTRY = Syndrome, Battered Child
ENTRY = Syndromes, Battered Child
MN = C26.130
MN = F03.950.750.124
FX = Adult Survivors of Child Abuse
FX = Child Abuse
MH_TH = NLM (1975)
ST = T037
ST = T047
MS = A clinical condition resulting from repeated physical and psychological injuries inflicted on a child by the parents or caregivers.
OL = search CHILD ABUSE 1966-74
PM = 91; was see under CHILD ABUSE 1975-90
HN = 91(75); was see under CHILD ABUSE 1975-90
MR = 20150630
DA = 19990101
DC = 1
DX = 19910101
UI = D001497

*NEWRECORD
RECTYPE = D
MH = 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
DS = PYRIDINECARBOXYLIC ACID 03 1 4 DIHYDRO 2 6 DIMETHYL 5 NITRO 4 2 TRIFLUOROMETHYL PHENYL METHYL ESTER
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = BK-8644|T109|T121|LAB|NRW|UNK (19XX)|881011|abbcdef
ENTRY = Bay R5417|T109|T121|LAB|NRW|NLM (1998)|961122|abbcdef
ENTRY = Bay-K-8644|T109|T121|LAB|NRW|NLM (1987)|990101|abbcdef
ENTRY = Bay-K-8644, (+)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bay-K-8644, (+-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bay-K-8644, (-)-Isomer|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bay-K8644|T109|T121|LAB|NRW|UNK (19XX)|860602|abbcdef
ENTRY = Bay-R-5417|T109|T121|LAB|NRW|NLM (1992)|910312|abbcdef
ENTRY = BK 8644
ENTRY = BK8644
ENTRY = Bay K 8644
ENTRY = Bay K8644
ENTRY = Bay R 5417
ENTRY = BayK8644
ENTRY = BayR5417
ENTRY = R5417, Bay
MN = D03.383.725.203.600
MN = D03.383.725.547.900
PA = Calcium Channel Agonists
MH_TH = NLM (2005)
ST = T109
ST = T121
N1 = 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester
RN = 71145-03-4
RR = 97217-82-8 ((+-)-isomer)
RR = 98625-26-4 ((-)-isomer)
RR = 98791-67-4 ((+)-isomer)
AN = a calcium channel agonist
PI = Nifedipine/analogs & derivatives (1975-1986)
PI = Pyridines (1966-1974)
MS = A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.
PM = 87
HN = 87
MR = 20060705
DA = 19860602
DC = 1
DX = 19870101
UI = D001498

*NEWRECORD
RECTYPE = D
MH = Bayes Theorem
PRINT ENTRY = Bayesian Analysis|T081|EPO|REL|UNK (19XX)|860620|BAYESIAN ANAL|abcdefv
PRINT ENTRY = Bayesian Forecast|T081|EPO|REL|UNK (19XX)|860620|abcdef
PRINT ENTRY = Bayesian Method|T081|EPO|REL|UNK (19XX)|860620|abcdef
PRINT ENTRY = Bayesian Prediction|T081|EPO|REL|UNK (19XX)|860620|abcdef
ENTRY = Analysis, Bayesian|T081|EPO|REL|UNK (19XX)|860620|ANAL BAYESIAN|abcdefv
ENTRY = Bayesian Approach|T081|NON|REL|NLM (2016)|141118|abcdef
ENTRY = Approach, Bayesian
ENTRY = Approachs, Bayesian
ENTRY = Bayesian Approachs
ENTRY = Forecast, Bayesian
ENTRY = Method, Bayesian
ENTRY = Prediction, Bayesian
ENTRY = Theorem, Bayes
MN = E05.318.740.600.200
MN = N05.715.360.750.625.150
MN = N06.850.520.830.600.200
MH_TH = NLM (1975)
ST = T081
AN = IM general only
PI = Probability (1966-1974)
MS = A theorem in probability theory named for Thomas Bayes (1702-1761). In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihood of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result.
OL = search PROBABILITY 1968-74
PM = 91; was see under PROBABILITY 1975-90
HN = 91(75); was see under PROBABILITY 1975-90
CATSH = CAT LIST
MR = 20150709
DA = 19990101
DC = 1
DX = 19910101
UI = D001499

*NEWRECORD
RECTYPE = D
MH = BCG Vaccine
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Bacillus Calmette Guerin Vaccine|T121|T129|EPO|EQV|UNK (19XX)|780201|abbcdef
PRINT ENTRY = Calmette Guerin Bacillus Vaccine|T121|T129|EPO|EQV|UNK (19XX)|780201|abbcdef
ENTRY = Calmette's Vaccine|T121|T129|EPO|EQV|NLM (1990)|890404|abbcdef
ENTRY = Calmette Vaccine
ENTRY = Calmettes Vaccine
ENTRY = Vaccine, BCG
ENTRY = Vaccine, Calmette's
MN = D20.215.894.135.825.100
PA = Adjuvants, Immunologic
MH_TH = NLM (1975)
ST = T121
ST = T129
RN = 0
AN = BCG vaccination in prev of tuberc = BCG VACCINE (IM) + TUBERCULOSIS /prev (IM); BCG ther of various diseases = BCG VACCINE /ther use (IM) + dis /drug ther (IM)
MS = An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
PM = 1979; see TUBERCULOSIS VACCINES 1974-1978
HN = 1979 (1974)
MR = 20050630
DA = 19990101
DC = 1
DX = 19790101
UI = D001500

*NEWRECORD
RECTYPE = D
MH = Bdellovibrio
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.400.425.180
MN = B03.660.125.050
MH_TH = NLM (1977)
ST = T007
PI = Bacteria (1966-1976)
MS = A genus of bacteria capable of developing within other bacteria.
PM = 77
HN = 77
MR = 20090706
DA = 19760416
DC = 1
DX = 19770101
UI = D001501

*NEWRECORD
RECTYPE = D
MH = Beak
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Bill, Avian|T023|NON|NRW|NLM (1996)|940728|abcdef
ENTRY = Avian Bill
ENTRY = Avian Bills
ENTRY = Beaks
ENTRY = Bills, Avian
MN = A13.114
MH_TH = NLM (1968)
ST = T023
AN = not restricted to birds
PI = Birds (1966-1967)
MS = In some animals, the jaws together with their horny covering. The beak usually refers to the bill of birds in which the whole varies greatly in form according of the food and habits of the bird. While the beak refers most commonly to birds, the anatomical counterpart is found also in the turtle, squid, and octopus. (From Webster, 3d ed & Storer, et al., General Zoology, 6th ed, p491, 755)
PM = 68
HN = 68
MR = 19950313
DA = 19990101
DC = 1
DX = 19680101
UI = D001502

*NEWRECORD
RECTYPE = D
MH = Ursidae
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Ailuropoda|T015|NON|NRW|NLM (1998)|961031|abcdef
PRINT ENTRY = Bears|T015|NON|EQV|NLM (1975)|990101|abcdef
PRINT ENTRY = Black Bears|T015|NON|NRW|NLM (1998)|961025|abcdef
PRINT ENTRY = Giant Pandas|T015|NON|NRW|NLM (1998)|970127|abcdef
PRINT ENTRY = Grizzly Bears|T015|NON|NRW|NLM (1998)|961025|abcdef
PRINT ENTRY = Pandas, Giant|T015|NON|NRW|NLM (1998)|961031|abcdef
PRINT ENTRY = Pandas, Greater|T015|NON|NRW|NLM (1998)|961031|abcdef
PRINT ENTRY = Polar Bears|T015|NON|NRW|NLM (1998)|961025|abcdef
PRINT ENTRY = Spectacled Bear|T015|NON|NRW|NLM (1998)|970127|abcdef
PRINT ENTRY = Tremarctos|T015|NON|NRW|NLM (1998)|970127|abcdef
PRINT ENTRY = Ursus|T015|NON|NRW|NLM (1998)|961025|abcdef
ENTRY = Bear
ENTRY = Bear, Black
ENTRY = Bear, Grizzly
ENTRY = Bear, Polar
ENTRY = Bear, Spectacled
ENTRY = Bears, Black
ENTRY = Bears, Grizzly
ENTRY = Bears, Polar
ENTRY = Bears, Spectacled
ENTRY = Black Bear
ENTRY = Giant Panda
ENTRY = Greater Panda
ENTRY = Greater Pandas
ENTRY = Grizzly Bear
ENTRY = Panda, Giant
ENTRY = Panda, Greater
ENTRY = Polar Bear
ENTRY = Spectacled Bears
MN = B01.050.150.900.649.147.890
MH_TH = NLM (1998)
ST = T015
AN = note X refs PANDAS, GIANT and PANDAS, GREATER: PANDAS, LESSER see PROCYONIDAE is also available
MS = The family of carnivorous or omnivorous bears, having massive bodies, coarse heavy fur, relatively short limbs, and almost rudimentary tails.
PM = 2005; see BEARS 1991-2004, see CARNIVORA 1975-1990; for PANDAS, GREATER see CARNIVORA 1997
HN = 2005 (1975); for PANDAS, GREATER use CARNIVORA 1997
MR = 20090706
DA = 19741212
DC = 1
DX = 19910101
UI = D001503

*NEWRECORD
RECTYPE = D
MH = Beauty
MN = F02.463.785.477.304
MN = K01.752.210.304
MH_TH = NLM (1975)
ST = T080
AN = no qualif
MS = Characteristics or attributes of persons or things which elicit pleasurable feelings.
OL = search ESTHETICS 1966-74
PM = 91,63-66; was see under ESTHETICS 1967-90; was heading 1963-66
HN = 91(75)63; was see under ESTHETICS 1967-90; was heading 1963-66
CATSH = CAT LIST
MR = 19900501
DA = 19990101
DC = 1
DX = 19910101
UI = D001504

*NEWRECORD
RECTYPE = D
MH = Beauty Culture
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Beauty Cultures
ENTRY = Culture, Beauty
ENTRY = Cultures, Beauty
MN = J01.576.112
MH_TH = NLM (1966)
ST = T057
AN = SPEC: SPEC qualif
MR = 19890614
DA = 19990101
DC = 1
UI = D001505

*NEWRECORD
RECTYPE = D
MH = Beckwith-Wiedemann Syndrome
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Wiedemann-Beckwith Syndrome|T019|T047|EPO|EQV|NLM (1991)|OMIM (2013)|ORD (2010)|900521|abbcdeeef
PRINT ENTRY = Wiedemann-Beckwith Syndrome (WBS)|T019|T047|ABX|EQV|GHR (2014)|NLM (2010)|ORD (2010)|090225|abbcdeeef
ENTRY = EMG Syndrome|T019|T047|ABX|EQV|GHR (2014)|OMIM (2013)|120202|abbcdeef
ENTRY = Exomphalos-Macroglossia-Gigantism Syndrome|T019|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abbcdeef
ENTRY = Beckwith Wiedemann Syndrome
ENTRY = EMG Syndromes
ENTRY = Syndrome, Beckwith-Wiedemann
ENTRY = Syndrome, EMG
ENTRY = Syndrome, Wiedemann-Beckwith
ENTRY = Syndrome, Wiedemann-Beckwith (WBS)
ENTRY = Syndromes, EMG
ENTRY = Syndromes, Wiedemann-Beckwith (WBS)
ENTRY = Wiedemann Beckwith Syndrome
ENTRY = Wiedemann Beckwith Syndrome (WBS)
ENTRY = Wiedemann-Beckwith Syndromes (WBS)
MN = C16.131.077.133
MN = C16.131.260.080
MN = C16.320.180.080
FX = Gigantism
FX = Silver-Russell Syndrome
MH_TH = GHR (2014)
MH_TH = NLM (1983)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T019
ST = T047
PI = Abnormalities, Multiple (1968-1982)
PI = Gigantism (1966-1982)
PI = Hernia, Umbilical (1966-1982)
PI = Macroglossia (1975-1982)
PI = Tongue/abnormalities (1966-1974)
MS = A syndrome of multiple defects characterized primarily by umbilical hernia (HERNIA, UMBILICAL); MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.
PM = 1983
HN = 1983
CATSH = CAT LIST
MR = 20130708
DA = 19820426
DC = 1
DX = 19830101
UI = D001506

*NEWRECORD
RECTYPE = D
MH = Beclomethasone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Beclomethasone Dipropionate|T110|T121|NON|NRW|FDA SRS (2014)|JAN (19XX)|USAN (1973)|USP (19XX)|760517|abbcdeeeef
ENTRY = 3M Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = A & H Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = AeroBec Forte|T110|T121|TRD|NRW|UK|041005|abbcdef
ENTRY = Aerobec|T110|T121|TRD|NRW|DE|IE|NL|UK|041005|abbcdeeeef
ENTRY = Aldecin|T110|T121|TRD|NRW|AU|NL|041005|abbcdeef
ENTRY = Aldo Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Allen & Hanburys Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Apo-Beclomethasone|T110|T121|TRD|NRW|CA|041005|abbcdef
ENTRY = Apotex Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Asche Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041007|abbcdef
ENTRY = Ascocortonyl|T110|T121|TRD|NRW|FR|041005|abbcdef
ENTRY = Asmabec Clickhaler|T110|T121|TRD|NRW|ES|IE|UK|041005|abbcdeeef
ENTRY = Azupharma Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Beclamet|T110|T121|TRD|NRW|UNK (19XX)|830330|abbcdef
ENTRY = Beclazone|T110|T121|TRD|NRW|UK|041005|abbcdef
ENTRY = Beclazone Easy Breathe|T110|T121|TRD|NRW|IE|UK|041005|abbcdeef
ENTRY = Beclo AZU|T110|T121|TRD|NRW|DE|041005|abbcdef
ENTRY = Beclo Asma|T110|T121|TRD|NRW|ES|041005|abbcdef
ENTRY = Beclocort|T110|T121|TRD|NRW|NLM (1998)|961112|abbcdef
ENTRY = Becloforte|T110|T121|TRD|NRW|AU|ES|NL|UK|041005|abbcdeeeef
ENTRY = Beclomet|T110|T121|TRD|NRW|DE|041006|abbcdef
ENTRY = Beclometasone|T110|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1998)|961114|abbcdeeef
ENTRY = Beclorhinol|T110|T121|TRD|NRW|DE|041007|abbcdef
ENTRY = Becloturmant|T110|T121|TRD|NRW|DE|041007|abbcdef
ENTRY = Beclovent|T110|T121|TRD|NRW|US|041006|abbcdef
ENTRY = Becodisk|T110|T121|TRD|NRW|NLM (2009)|080529|abbcdef
ENTRY = Becodisks|T110|T121|TRD|NRW|IE|UK|041006|abbcdeef
ENTRY = Beconase|T110|T121|TRD|NRW|AU|DE|ES|FR|IE|MX|NL|UK|US|041005|abbcdeeeeeeeeef
ENTRY = Beconase AQ|T110|T121|TRD|NRW|US|041006|abbcdef
ENTRY = Becotide|T110|T121|TRD|NRW|AU|ES|FR|MX|NL|UK|800801|abbcdeeeeeef
ENTRY = Bemedrex Easyhaler|T110|T121|TRD|NRW|FR|041006|abbcdef
ENTRY = Bronchocort|T110|T121|TRD|NRW|DE|041007|abbcdef
ENTRY = Celltech Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Ecobec|T110|T121|TRD|NRW|FR|041005|abbcdef
ENTRY = Filair|T110|T121|TRD|NRW|UK|041005|abbcdef
ENTRY = Filair Forte|T110|T121|TRD|NRW|UK|041005|abbcdef
ENTRY = Fujisawa Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041007|abbcdef
ENTRY = Glaxo Wellcome Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = GlaxoSmithKline Brand 1 of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = GlaxoSmithKline Brand 2 of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041006|abbcdef
ENTRY = GlaxoSmithKline Brand 3 of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041006|abbcdef
ENTRY = Ivax Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Junik|T110|T121|TRD|NRW|DE|041007|abbcdef
ENTRY = Medeva Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Nasobec Aqueous|T110|T121|TRD|NRW|IE|UK|041005|abbcdeef
ENTRY = Norton Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Orion Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041006|abbcdef
ENTRY = Prolair|T110|T121|TRD|NRW|FR|041005|abbcdef
ENTRY = Propaderm|T110|T121|TRD|NRW|CA|UK|041006|abbcdeef
ENTRY = Qvar|T110|T121|TRD|NRW|AU|CA|FR|IE|NL|UK|US|041005|abbcdeeeeeeef
ENTRY = Respocort|T110|T121|TRD|NRW|AU|041005|abbcdef
ENTRY = Sanasthmax|T110|T121|TRD|NRW|DE|050614|abbcdef
ENTRY = Sanasthmyl|T110|T121|TRD|NRW|DE|041006|abbcdef
ENTRY = Schering Brand 1 of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041006|abbcdef
ENTRY = Schering Brand 2 of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041006|abbcdef
ENTRY = Schering-Plough Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Shire Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041006|abbcdef
ENTRY = United Drug Brand of Beclomethasone Dipropionate|T110|T121|NON|NRW|NLM (2006)|041005|abbcdef
ENTRY = Vancenase|T110|T121|TRD|NRW|US|041006|abbcdef
ENTRY = Vanceril|T110|T121|TRD|NRW|US|041006|abbcdef
ENTRY = Ventolair|T110|T121|TRD|NRW|DE|041006|abbcdef
ENTRY = Viarin|T110|T121|TRD|NRW|NL|041005|abbcdef
ENTRY = Dipropionate, Beclomethasone
MN = D04.808.745.432.769.125
MN = D04.808.883.154
PA = Anti-Asthmatic Agents
PA = Anti-Inflammatory Agents
PA = Glucocorticoids
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T110
ST = T121
N1 = Pregna-1,4-diene-3,20-dione, 9-chloro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-
RN = KGZ1SLC28Z
RR = 4419-39-0 (Beclomethasone)
RR = 5534-09-8 (diproprionate)
RR = 5B307S63B2
PI = Pregnanetriol (1966-1972)
MS = An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.
PM = 1977; BECODISK was indexed under HYDROCORTICOSTEROIDS 1997-2008
HN = 1977(1973)
MR = 20130708
DA = 19990101
DC = 1
DX = 19770101
UI = D001507

*NEWRECORD
RECTYPE = D
MH = Bed Conversion
AQ = EC ES HI LJ SN ST TD UT
PRINT ENTRY = Beds, Swing|T058|NON|REL|UNK (19XX)|810226|abcdef
PRINT ENTRY = Swing Beds|T058|NON|REL|UNK (19XX)|810226|abcdef
ENTRY = Bed Conversions
ENTRY = Bed, Swing
ENTRY = Conversion, Bed
ENTRY = Conversions, Bed
ENTRY = Swing Bed
MN = N03.349.650.250.080
MH_TH = NLM (1982)
ST = T058
AN = from one type of care service to another
PI = Bed Occupancy (1978-1981)
PI = Hospital Planning (1968-1981)
MS = The reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds.
PM = 91; was see under HEALTH FACILITY PLANNING 1982-90
HN = 91(82); was see under HEALTH FACILITY PLANNING 1982-90
MR = 19930916
DA = 19810226
DC = 1
DX = 19910101
UI = D001508

*NEWRECORD
RECTYPE = D
MH = Bed Occupancy
AQ = CL EC ES HI LJ MT SN ST TD UT
ENTRY = Bed Occupancies
ENTRY = Occupancies, Bed
ENTRY = Occupancy, Bed
MN = N02.278.050
FX = Hospital Bed Capacity
MH_TH = NLM (1978)
ST = T081
AN = coord IM with specific hosp or department (IM) + geog if pertinent
MS = A measure of inpatient health facility use based upon the average number or proportion of beds occupied for a given period of time.
PM = 78
HN = 78
MR = 19970620
DA = 19770505
DC = 1
DX = 19780101
UI = D001509

*NEWRECORD
RECTYPE = D
MH = Bed Rest
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Bedrest|T061|NON|EQV|UNK (19XX)|760512|abcdef
ENTRY = Bed Rests
ENTRY = Bedrests
ENTRY = Rest, Bed
ENTRY = Rests, Bed
MN = E02.075
MH_TH = NLM (1977)
ST = T061
AN = do not confuse with IMMOBILIZATION: TN 166
PI = Immobilization (1966-1976)
PI = Rest (1966-1976)
MS = Confinement of an individual to bed for therapeutic or experimental reasons.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 19920325
DA = 19760519
DC = 1
DX = 19770101
UI = D001510

*NEWRECORD
RECTYPE = D
MH = Bedbugs
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Cimex|T204|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Bed Bugs|T204|NON|EQV|UNK (19XX)|880711|abcdef
ENTRY = Bed Bug
ENTRY = Bedbug
ENTRY = Bug, Bed
ENTRY = Bugs, Bed
ENTRY = Cimices
MN = B01.050.500.131.617.412.420.150.100
MH_TH = NLM (1966)
ST = T204
AN = do not use /drug eff for insecticides: TN 111
MS = Bugs of the family CIMICIDAE, genus Cimex. They are flattened, oval, reddish insects which inhabit houses, wallpaper, furniture, and beds. C. lectularius, of temperate regions, is the common bedbug that attacks humans and is frequently a serious pest in houses, hotels, barracks, and other living quarters. Experiments have shown that bedbugs can transmit a variety of diseases, but they are not normal vectors under natural conditions. (From Dorland, 27th ed; Borror, et al., An Introduction to the Study of Insects, 4th ed, p272)
MR = 20090706
DA = 19990101
DC = 1
UI = D001511

*NEWRECORD
RECTYPE = D
MH = Bedding and Linens
DE = BEDDING LINENS
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Linens|T073|NON|NRW|UNK (19XX)|741105|abcdef
ENTRY = Bedding|T073|NON|NRW|NLM (1991)|900222|abcdef
ENTRY = Beddings
ENTRY = Linen
ENTRY = Linens and Bedding
MN = E07.325.137
MN = J01.494.221
MH_TH = NLM (1963)
ST = T073
AN = includes all bedclothes & towels, washcloths, gowns, pajamas; DF: BEDDING
MS = Articles of cloth, usually cotton or rayon and other synthetic or cotton-blend fabrics, used in households, hospitals, physicians' examining rooms, nursing homes, etc., for sheets, pillow cases, toweling, gowns, drapes, and the like.
PM = 68
HN = 68(63)
CATSH = CAT LIST
MR = 19930604
DA = 19990101
DC = 1
DX = 19680101
UI = D001512

*NEWRECORD
RECTYPE = D
MH = Beds
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Mattresses|T073|NON|REL|UNK (19XX)|840620|abcdef
ENTRY = Bed
MN = E07.325.220
MH_TH = NLM (1966)
ST = T073
MS = Equipment on which one may lie and sleep, especially as used to care for the hospital patient.
CATSH = CAT LIST
MR = 19930603
DA = 19990101
DC = 1
UI = D001513

*NEWRECORD
RECTYPE = D
MH = Bee Venoms
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC EN GE HI IM IP ME PD PK PO RE SE TO TU UR
PRINT ENTRY = Apis Venoms|T123|T131|NON|EQV|UNK (19XX)|770418|abbcdef
ENTRY = Apitoxin|T123|T131|NON|NRW|NLM (1990)|891109|abbcdef
ENTRY = Bee Venom|T123|T131|NON|EQV|NLM (1999)|980217|abbcdef
ENTRY = Venom, Bee
ENTRY = Venoms, Apis
ENTRY = Venoms, Bee
MN = D20.888.065.115
MN = D23.946.833.065.115
MH_TH = NLM (1978)
ST = T123
ST = T131
RN = 0
AN = /antag permitted but consider also ANTIVENINS; /enzymol permitted
PI = Bees (1966-1977)
PI = Venoms (1966-1977)
MS = Venoms obtained from Apis mellifera (honey bee) and related species. They contain various enzymes, polypeptide toxins, and other substances, some of which are allergenic or immunogenic or both. These venoms were formerly used in rheumatism to stimulate the pituitary-adrenal system.
PM = 78
HN = 78
MR = 20050630
DA = 19770422
DC = 1
DX = 19780101
UI = D001514

*NEWRECORD
RECTYPE = D
MH = Beer
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Beers
MN = G07.203.100.100.200
MN = J02.200.100.200
MH_TH = NLM (1966)
ST = T168
MS = An alcoholic beverage usually made from malted cereal grain (as barley), flavored with hops, and brewed by slow fermentation.
MR = 20141014
DA = 19990101
DC = 1
UI = D001515

*NEWRECORD
RECTYPE = D
MH = Bees
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Apidae|T204|NON|NRW|NLM (1999)|971217|abcdef
PRINT ENTRY = Apis|T204|NON|NRW|NLM (1999)|971217|abcdef
ENTRY = Api
ENTRY = Bee
MN = B01.050.500.131.617.479.387
FX = Honey
FX = Propolis
MH_TH = NLM (1966)
ST = T204
AN = does not include WASPS; for stings, coordinate IM with INSECT BITES AND STINGS (IM)
MS = Insect members of the superfamily Apoidea, found almost everywhere, particularly on flowers. About 3500 species occur in North America. They differ from most WASPS in that their young are fed honey and pollen rather than animal food.
MR = 20090706
DA = 19990101
DC = 1
UI = D001516

*NEWRECORD
RECTYPE = D
MH = Beetles
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Coleoptera|T204|NON|EQV|NLM (1975)|990101|abcdef
ENTRY = Beetle
ENTRY = Coleopteras
MN = B01.050.500.131.617.069
MH_TH = NLM (1966)
ST = T204
AN = for killing beetles with insecticides, see note at INSECTICIDES
MS = INSECTS of the order Coleoptera, containing over 350,000 species in 150 families. They possess hard bodies and their mouthparts are adapted for chewing.
PM = 1963; for COLEPTERA see COLEPTERA 1975-2004
HN = 1963
MR = 20090706
DA = 19990101
DC = 1
UI = D001517

*NEWRECORD
RECTYPE = D
MH = Behavior
AQ = CL DE ES PH RE
ENTRY = Acceptance Process|T055|NON|NRW|POPLINE (1986)|861231|abcdef
ENTRY = Acceptance Processes|T055|NON|NRW|UNK (19XX)|881119|abcdef
ENTRY = Behaviors
ENTRY = Process, Acceptance
ENTRY = Processes, Acceptance
MN = F01.145
FX = Genetics, Behavioral
MH_TH = POPLINE (1978)
ST = T055
AN = human only; GEN; prefer specifics
MS = The observable response of a man or animal to a situation.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D001519

*NEWRECORD
RECTYPE = D
MH = Behavior and Behavior Mechanisms
AQ = CL DE ES PH RE
MN = F01
RH = F1 - BEHAVIOR AND BEHAVIOR MECHANISMS
MH_TH = NLM (1974)
ST = T054
AN = used for searching; INDEXER: Do not use; CATALOGER: Do not use
PI = Behavior (1966-1997)
PI = Defense Mechanisms (1966-1997)
MS = The observable response made to a situation and the unconscious processes underlying it.
OL = pre-explosion = BEHAVIOR A#D BEHAVIOR MECHANISMS (PX)
PM = 98
HN = 98; use pre-explosion
CATSH = CAT LIST
MR = 20150605
DA = 19990101
DC = 1
DX = 19980101
UI = D001520

*NEWRECORD
RECTYPE = D
MH = Behavior Therapy
DE = BEHAVIOR THER
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Behavior Modification|T061|NON|EQV|UNK (19XX)|780426|abcdef
PRINT ENTRY = Conditioning Therapy|T061|NON|EQV|UNK (19XX)|740329|CONDITIONING THER|abcdefv
ENTRY = Therapy, Behavior|T061|NON|EQV|UNK (19XX)|740329|THER BEHAVIOR|abcdefv
ENTRY = Therapy, Conditioning|T061|NON|EQV|UNK (19XX)|740329|THER CONDITIONING|abcdefv
ENTRY = Behavior Modifications
ENTRY = Behavior Therapies
ENTRY = Conditioning Therapies
ENTRY = Modification, Behavior
ENTRY = Modifications, Behavior
ENTRY = Therapies, Behavior
ENTRY = Therapies, Conditioning
MN = F04.754.137
FX = Behavior Control
MH_TH = NLM (1964)
ST = T061
AN = a psychother technique; assertiveness training: coord IM with ASSERTIVENESS (IM); DF: BEHAVIOR THER
MS = The application of modern theories of learning and conditioning in the treatment of behavior disorders.
OL = use BEHAVIOR THERAPY to search BEHAVIOR MODIFICATION 1974-78
PM = 66
HN = 66(64); BEHAVIOR MODIFICATION was see under BEHAVIOR THERAPY 1974-78
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19660101
UI = D001521

*NEWRECORD
RECTYPE = D
MH = Behavior, Animal
AQ = CL DE ES PH RE
ENTRY = Animal Behavior
ENTRY = Animal Behaviors
ENTRY = Behaviors, Animal
MN = F01.145.113
MH_TH = NLM (1964)
ST = T053
MS = The observable response an animal makes to any situation.
PM = 64
HN = 64
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19640101
UI = D001522

*NEWRECORD
RECTYPE = D
MH = Mental Disorders
DE = MENTAL DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Behavior Disorders|T048|NON|NRW|BIOETHICS (1974)|970523|BEHAVIOR DIS|abcdefv
ENTRY = Diagnosis, Psychiatric|T048|NON|REL|NLM (1998)|970523|DIAG PSYCHIATRIC|abcdefv
ENTRY = Mental Disorders, Severe|T048|NON|BRD|NLM (2016)|150528|abcdef
ENTRY = Psychiatric Diagnosis|T048|NON|REL|BIOETHICS (1974)|970523|PSYCHIATRIC DIAG|abcdefv
ENTRY = Disorder, Mental
ENTRY = Disorder, Severe Mental
ENTRY = Disorders, Behavior
ENTRY = Disorders, Mental
ENTRY = Disorders, Severe Mental
ENTRY = Mental Disorder
ENTRY = Mental Disorder, Severe
ENTRY = Severe Mental Disorder
ENTRY = Severe Mental Disorders
MN = F03
RH = F3 - MENTAL DISORDERS
FX = Mentally Ill Persons
MH_TH = NLM (1998)
ST = T048
MS = Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
OL = pre-explosion = MENTAL DISORDERS (PX)
HN = use pre-explosion 1974-97
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
DX = 19980101
UI = D001523

*NEWRECORD
RECTYPE = D
MH = Behavioral Medicine
DE = BEHAVIORAL MED
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Health Psychology|T091|NON|NRW|NLM (1997)|960327|HEALTH PSYCHOL|abcdefv
PRINT ENTRY = Psychology, Health|T091|NON|NRW|NLM (1997)|960327|PSYCHOL HEALTH|abcdefv
ENTRY = Medicine, Behavioral|T091|NON|EQV|NLM (1991)|891129|MED BEHAVIORAL|abcdefv
ENTRY = Health Psychologies
ENTRY = Psychologies, Health
MN = F04.096.080
MN = H02.403.090
MH_TH = NLM (1983)
ST = T091
AN = SPEC: SPEC qualif; DF: BEHAVIORAL MED
MS = The interdisciplinary field concerned with the development and integration of behavioral and biomedical science, knowledge, and techniques relevant to health and illness and the application of this knowledge and these techniques to prevention, diagnosis, treatment, and rehabilitation.
PM = 83
HN = 83
CATSH = CAT LIST
MR = 20080708
DA = 19820428
DC = 1
DX = 19830101
UI = D001524

*NEWRECORD
RECTYPE = D
MH = Behavioral Sciences
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Proxemics|T055|NON|NRW|NLM (1997)|960416|abcdef
ENTRY = Behavioral Science
ENTRY = Proxemic
ENTRY = Science, Behavioral
ENTRY = Sciences, Behavioral
MN = F04.096
MH_TH = NLM (1969)
ST = T090
AN = use for the specialty only
PI = Behavior (1966-1969)
PI = specific discipline
MS = Disciplines concerned with the study of human and animal behavior.
PM = 1969; PROXEMICS was heading 1975-96 (see under SPATIAL BEHAVIOR 1975-90 and 1997-2014)
HN = 1969;  PROXEMICS was heading 1975-96 (see under SPATIAL BEHAVIOR 1975-90 and 1997-2014)
CATSH = CAT LIST
MR = 20140616
DA = 19990101
DC = 1
DX = 19690101
UI = D001525

*NEWRECORD
RECTYPE = D
MH = Behavioral Symptoms
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Behavioral Symptom
ENTRY = Symptom, Behavioral
ENTRY = Symptoms, Behavioral
MN = F01.145.126
MH_TH = NLM (1966)
ST = T184
AN = GEN or unspecified; prefer specifics; do not confuse with BEHAVIOR: read MeSH definitions
MS = Observable manifestations of impaired psychological functioning.
PM = 98
HN = 98; use explode 1970-97
CATSH = CAT LIST
MR = 20040719
DA = 19990101
DC = 1
DX = 19980101
UI = D001526

*NEWRECORD
RECTYPE = D
MH = Behaviorism
AQ = HI
ENTRY = Behaviorisms
MN = F02.739.138
MH_TH = NLM (1966)
ST = T078
AN = a school of psychology: do not confuse with BEHAVIOR
MS = A psychologic theory, developed by John Broadus Watson, concerned with studying and measuring behaviors that are observable.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001527

*NEWRECORD
RECTYPE = D
MH = Behcet Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Behcet Disease|T047|EPO|EQV|GHR (2014)|NLM (2003)|OMIM (2013)|ORD (2010)|010831|BEHCET DIS|abcdeeeefv
PRINT ENTRY = Behcet's Syndrome|T047|EPO|EQV|GHR (2014)|NLM (1966)|990101|abcdeef
PRINT ENTRY = Triple-Symptom Complex|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Adamantiades-Behcet Disease|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Behcet Triple Symptom Complex|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Behet Disease|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Old Silk Route Disease|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Triple Symptom Complex|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Adamantiades Behcet Disease
ENTRY = Adamantiades-Behcet Diseases
ENTRY = Behcets Syndrome
ENTRY = Behet Diseases
ENTRY = Complex, Triple Symptom
ENTRY = Complices, Triple Symptom
ENTRY = Disease, Adamantiades-Behcet
ENTRY = Disease, Behet
ENTRY = Diseases, Adamantiades-Behcet
ENTRY = Diseases, Behet
ENTRY = Symptom Complex, Triple
ENTRY = Symptom Complices, Triple
ENTRY = Triple Symptom Complices
MN = C07.465.075
MN = C11.941.879.780.880.200
MN = C14.907.940.100
MN = C16.320.382.250
MN = C17.800.827.368.250
MN = C17.800.862.150
MH_TH = GHR (2014)
MH_TH = NLM (2003)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
AN = in translations spell Behet's, not Behcet's
MS = Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
PM = 2003; see BEHCET'S SYNDROME 1963-2002
HN = 2003 (1963)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001528

*NEWRECORD
RECTYPE = D
MH = Belgium
AQ = EH EP
MN = Z01.542.115
MH_TH = POPLINE (1978)
ST = T083
MR = 19911102
DA = 19990101
DC = 4
UI = D001530

*NEWRECORD
RECTYPE = D
MH = Belize
AQ = EH EP
PRINT ENTRY = British Honduras|T083|NAM|EQV|UNK (19XX)|770427|abcdef
MN = Z01.107.169.133
MH_TH = POPLINE (1981)
ST = T083
OL = use BELIZE to search BRITISH HONDURAS 1966-77
HN = 78; was BRITISH HONDURAS 1966-77
MR = 19911112
DA = 19990101
DC = 4
UI = D001531

*NEWRECORD
RECTYPE = D
MH = Atropa belladonna
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Belladonna|T002|NON|EQV|NLM (1986)|990101|abcdef
ENTRY = Atropa belladonnas
ENTRY = Belladonnas
ENTRY = belladonna, Atropa
ENTRY = belladonnas, Atropa
MN = B01.650.940.800.575.100.905.049.222
FX = Belladonna Alkaloids
MH_TH = UNK (19XX)
ST = T002
AN = BLACK NIGHTSHADE see SOLANUM NIGRUM is also available
MS = A plant species of the genus ATROPA, family SOLANACEAE that contains ATROPINE; SCOPOLAMINE; BELLADONNA ALKALOIDS and other SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for SOLANUM.
PM = 2003; see BELLADONA 1991-2003, see PLANTS, TOXIC 1986-1990, see BELLADONA 1963-1985
HN = 2003(1963)
MR = 20150622
DA = 19990101
DC = 1
DX = 19910101
UI = D001532

*NEWRECORD
RECTYPE = D
MH = Belladonna Alkaloids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alkaloids, Belladonna
MN = D03.132.760.180
MN = D03.132.889.180
MH_TH = NLM (1975)
ST = T109
ST = T123
RN = 0
PI = Belladonna (1968-1974)
PI = Tropanes (1968-1974)
MS = Alkaloids obtained from various plants, especially the deadly nightshade (Atropa belladonna), variety acuminata; atropine, hyoscyamine and scopolamine are classical, specific antimuscarinic agents with many pharmacologic actions; used mainly as antispasmodics.
OL = search TROPANES 1969-74
PM = 76; was see under BELLADONNA 1975-76, was see under TROPANES 1969-74
HN = 76(75); was see under BELLADONNA 1975-76, was see under TROPANES 1969-74
MR = 19920508
DA = 19990101
DC = 1
DX = 19760101
UI = D001533

*NEWRECORD
RECTYPE = D
MH = Bemegride
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Ethylmethylglutarimide|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Methetharimide|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef
ENTRY = Megimide|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
MN = D03.383.725.791.100
PA = Central Nervous System Stimulants
PA = Convulsants
PA = Respiratory System Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 2,6-Piperidinedione, 4-ethyl-4-methyl-
RN = 57DQA39DO2
RR = 64-65-3 (Bemegride)
MS = A CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.
PM = ETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963
HN = ETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963
MR = 20130708
DA = 19990101
DC = 1
UI = D001534

*NEWRECORD
RECTYPE = D
MH = Benactyzine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amizil|T109|T121|TRD|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Amizyl|T109|T121|TRD|NRW|UNK (19XX)|870812|abbcdef
ENTRY = Lucidil|T109|T121|TRD|NRW|UK|040112|abbcdef
ENTRY = Smith & Nephew Brand of Benactyzine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040112|abbcdef
MN = D02.241.223.601.238.306.140
MN = D02.241.511.085.140
PA = Antidepressive Agents
PA = Muscarinic Antagonists
PA = Parasympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 2-(diethylamino)ethyl ester
RN = 595EG71R3F
RR = 302-40-9 (Benactyzine)
MS = A centrally acting muscarinic antagonist. Benactyzine has been used in the treatment of depression and is used in research to investigate the role of cholinergic systems on behavior.
MR = 20130708
DA = 19990101
DC = 1
UI = D001535

*NEWRECORD
RECTYPE = D
MH = Bence Jones Protein
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Bence Jones Protein Den|T116|T129|EPO|NRW|UNK (19XX)|821123|abbcdef
ENTRY = Bence Jones Protein SUT|T116|T129|EPO|NRW|UNK (19XX)|831209|abbcdef
ENTRY = Jones Protein, Bence
ENTRY = Protein, Bence Jones
MN = D12.776.124.486.485.900.120
MN = D12.776.124.790.651.900.120
MN = D12.776.377.715.548.900.120
PA = Immunologic Factors
MH_TH = NLM (1966)
ST = T116
ST = T129
RN = 9006-99-9
MS = An abnormal protein with unusual thermosolubility characteristics that is found in the urine of patients with MULTIPLE MYELOMA.
MR = 20050630
DA = 19990101
DC = 1
UI = D001536

*NEWRECORD
RECTYPE = D
MH = Bencyclane
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Andreu Brand of Bencyclane acefyllinate and fumarate|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Bencyclane Fumarate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|800917|abbcdeef
ENTRY = Desoblit|T109|T121|TRD|NRW|ES|040120|abbcdef
ENTRY = Dilangio compositu|T109|T121|TRD|NRW|ES|040120|abbcdef
ENTRY = Elmuquimica Brand of Bencyclane Fumarate|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Fludilat|T109|T121|TRD|NRW|DE|940819|abbcdef
ENTRY = Fluxema|T109|T121|TRD|NRW|ES|040120|abbcdef
ENTRY = Halidor|T109|T121|TRD|NRW|UNK (19XX)|800801|abbcdef
ENTRY = Rovi Brand of Bencyclane Fumarate|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Thiemann Brand of Bencyclane Fumarate|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Fumarate, Bencyclane
ENTRY = compositu, Dilangio
MN = D02.455.426.392.368.284.100
PA = Calcium Channel Blockers
PA = Vasodilator Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)cycloheptyl)oxy)-
RN = 6I97Z6S135
RR = 2179-37-5 (Bencyclane)
RR = OZN2MG334O
PI = Benzyl Compounds (1972-1974)
PI = Cycloheptanes (1971-1974)
PI = Dimethylamines (1974)
MS = A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.
PM = 91; was see under CYCLOHEPTANES 1975-90
HN = 91(75); was see under CYCLOHEPTANES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001537

*NEWRECORD
RECTYPE = D
MH = Bender-Gestalt Test
AQ = HI SN ST
ENTRY = Bender Visual Motor Gestalt Test|T060|T170|EPO|EQV|NLM (1992)|901016|abbcdef
ENTRY = Bender Gestalt Test
ENTRY = Test, Bender-Gestalt
MN = F04.711.513.180
MN = F04.711.647.138
MH_TH = NLM (1966)
ST = T060
ST = T170
MS = A psychological test consisting of nine geometric designs on cards. The subject is asked to redraw them from memory after each one is presented individually.
CATSH = CAT LIST
MR = 19920526
DA = 19990101
DC = 1
UI = D001538

*NEWRECORD
RECTYPE = D
MH = Bendroflumethiazide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Bendrofluazide|T109|T121|NON|EQV|BAN (19XX)|FDA SRS (2014)|770425|abbcdeef
ENTRY = Apothecon Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Aprinox|T109|T121|TRD|NRW|AU|UK|040120|abbcdeef
ENTRY = Benzide|T109|T121|TRD|NRW|AU|040120|abbcdef
ENTRY = Benzide-M|T109|T121|TRD|NRW|AU|040120|abbcdef
ENTRY = Berk Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Berkozide|T109|T121|TRD|NRW|UK|040120|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Centyl|T109|T121|TRD|NRW|IE|UK|040120|abbcdeef
ENTRY = DDSA Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Esberizid|T109|T121|TRD|NRW|DE|040120|abbcdef
ENTRY = Goldshield Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Knoll Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Leo Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Naturetin|T109|T121|TRD|NRW|CA|UNK (19XX)|US|861119|abbcdeeef
ENTRY = Naturine|T109|T121|TRD|NRW|FR|040120|abbcdef
ENTRY = Neo-NaClex|T109|T121|TRD|NRW|UK|040120|abbcdef
ENTRY = Pluryl|T109|T121|TRD|NRW|NL|040120|abbcdef
ENTRY = Protea Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Schaper & Brmmer Brand of Bendroflumethiazide|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Urizid|T109|T121|TRD|NRW|UK|040120|abbcdef
ENTRY = Bendroflumethiazide Apothecon Brand
ENTRY = Bendroflumethiazide Berk Brand
ENTRY = Bendroflumethiazide DDSA Brand
ENTRY = Bendroflumethiazide Goldshield Brand
ENTRY = Bendroflumethiazide Knoll Brand
ENTRY = Bendroflumethiazide Leo Brand
ENTRY = Bendroflumethiazide Protea Brand
ENTRY = Benzide M
ENTRY = BenzideM
ENTRY = Bristol Myers Squibb Brand of Bendroflumethiazide
ENTRY = Neo NaClex
ENTRY = NeoNaClex
MN = D02.886.590.700.135.138
MN = D02.886.655.500.138
MN = D03.438.174.138
PA = Antihypertensive Agents
PA = Diuretics
PA = Sodium Chloride Symporter Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide
RN = 5Q52X6ICJI
RR = 73-48-3 (Bendroflumethiazide)
MS = A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
MR = 20130708
DA = 19990101
DC = 1
UI = D001539

*NEWRECORD
RECTYPE = D
MH = Benin
AQ = EH EP
PRINT ENTRY = Dahomey|T083|NAM|EQV|UNK (19XX)|781219|abcdef
ENTRY = Republic of Benin|T083|NAM|EQV|NLM (2009)|080326|abcdef
MN = Z01.058.290.190.200
MH_TH = NLM (1980)
ST = T083
MS = A republic in western Africa, south of NIGER and between TOGO and NIGERIA. Its capital is Porto-Novo. It was formerly called Dahomey. In the 17th century it was a kingdom in the southern area of Africa. Coastal footholds were established by the French who deposed the ruler by 1892. It was made a French colony in 1894 and gained independence in 1960. Benin comes from the name of the indigenous inhabitants, the Bini, now more closely linked with southern Nigeria (Benin City, a town there). Bini may be related to the Arabic bani, sons. (From Webster's New Geographical Dictionary, 1988, p136, 310 & Room, Brewer's Dictionary of Names, 1992, p60)
MR = 20080708
DA = 19990101
DC = 4
UI = D001541

*NEWRECORD
RECTYPE = D
MH = Benomyl
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Benlate|T109|T131|TRD|NRW|UNK (19XX)|861008|abbcdef
ENTRY = Fundasol|T109|T131|TRD|REL|UNK (19XX)|810130|abbcdef
ENTRY = Fundazol|T109|T131|TRD|REL|UNK (19XX)|820120|abbcdef
MN = D02.241.081.251.125
MN = D03.438.103.140
PA = Anthelmintics
PA = Fungicides, Industrial
PA = Tubulin Modulators
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = Carbamic acid, (1-((butylamino)carbonyl)-1H-benzimidazol-2-yl)-, methyl ester
RN = TLW21058F5
RR = 17804-35-2 (Benomyl)
PI = Benzimidazoles (1972-1974)
PI = Carbamates (1972-1974)
MS = A systemic agricultural fungicide used for control of certain fungal diseases of stone fruit.
PM = 91; was see under CARBAMATES 1975-90
HN = 91(75); was see under CARBAMATES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D001542

*NEWRECORD
RECTYPE = D
MH = Benperidol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anquil|T109|T121|TRD|NRW|UK|040120|abbcdef
ENTRY = Bayer Brand of Benperidol|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Benperidol-neuraxpharm|T109|T121|TRD|NRW|DE|040120|abbcdef
ENTRY = Frenactil|T109|T121|TRD|NRW|NL|040120|abbcdef
ENTRY = Glianimon|T109|T121|TRD|NRW|DE|040120|abbcdef
ENTRY = Janssen Brand of Benperidol|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = neuraxpharm Brand of Benperidol|T109|T121|NON|NRW|NLM (2005)|040120|abbcdef
ENTRY = Benperidol Bayer Brand
ENTRY = Benperidol Janssen Brand
ENTRY = Benperidol neuraxpharm
ENTRY = Benperidol neuraxpharm Brand
ENTRY = Benperidolneuraxpharm
MN = D02.522.352.155
PA = Antipsychotic Agents
PA = Dopamine Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1963)
ST = T109
ST = T121
N1 = 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl)-1,3-dihydro-
RN = 97O6X78C53
RR = 2062-84-2 (Benperidol)
MS = A butyrophenone with general properties similar to those of HALOPERIDOL. It has been used in the treatment of aberrant sexual behavior. (From Martindale, The Extra Pharmacopoeia, 30th ed, p567)
PM = 66
HN = 66
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D001544

*NEWRECORD
RECTYPE = D
MH = Benserazide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Serazide|T109|T121|NON|EQV|UNK (19XX)|780208|abbcdef
PRINT ENTRY = Seryltrihydroxybenzylhydrazine|T109|T121|NON|EQV|UNK (19XX)|780208|abbcdef
ENTRY = DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide|T109|T121|NON|EQV|NLM (1995)|940325|abbcdef
ENTRY = Ro 4-4602|T109|T121|LAB|NRW|UNK (19XX)|760630|abbcdef
ENTRY = Seryltrihydroxy Benzylhydrazine|T109|T121|NON|EQV|UNK (19XX)|780208|abbcdef
ENTRY = Benzylhydrazine, Seryltrihydroxy
ENTRY = Ro 4 4602
ENTRY = Ro 44602
MN = D02.442.175
PA = Antiparkinson Agents
PA = Dopamine Agents
PA = Enzyme Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1976)
ST = T109
ST = T121
N1 = DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide
RN = 762OS3ZEJU
RR = 322-35-0 (Benserazide)
PI = Benzene (1966-1967)
PI = Benzene Derivatives (1968-1971)
PI = Benzyl Compounds (1972)
PI = Hydrazines (1966-1972)
PI = Serine (1966-1972)
MS = An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
OL = use BENSERAZIDE to search SERYLTRIHYDROXY BENZYLHYDRAZINE 1973-78 (as Prov 73-74)
PM = 91; was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1975-78
HN = 91(79); was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1973-78 (Prov 1973-74)
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001545

*NEWRECORD
RECTYPE = D
MH = Bentonite
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Montmorillonite|T197|NON|BRD|FDA SRS (2014)|NLM (1994)|930106|abcdeef
ENTRY = Montmorrillonite|T197|NON|BRD|NLM (1994)|930106|abcdef
MN = D01.056.050.075.100
MN = D01.578.725.025.100
MN = D01.650.550.050.075.100
MN = D01.837.725.700.760.050.100
PA = Antidotes
MH_TH = JAN (19XX)
MH_TH = NLM (1973)
ST = T121
ST = T197
RN = 1302-78-9
RR = A585MN1H2L
PI = Aluminum Silicates (1966-1972)
MS = A colloidal, hydrated aluminum silicate that swells 12 times its dry size when added to water.
OL = use ALUMINUM SILICATES to search BENTONITE 1966-72
PM = 73; was see ALUMINUM SILICATES 1963-72; MONTMORILLONITE was MONTMORRILLONITE 1977-93
HN = 73; was see ALUMINUM SILICATES 1963-72; MONTMORILLONITE was MONTMORRILLONITE 1977-93
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D001546

*NEWRECORD
RECTYPE = D
MH = Benzaldehydes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.047.222
MH_TH = NLM (1972)
ST = T109
RN = 0
PI = Aldehydes (1966-1971)
PM = 74
HN = 74(72)
MR = 19920508
DA = 19990101
DC = 1
DX = 19740101
UI = D001547

*NEWRECORD
RECTYPE = D
MH = Benzalkonium Compounds
DE = BENZALKONIUM CPDS
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Benzalkonium|T109|T121|NON|NRW|UNK (19XX)|830404|abbcdef
PRINT ENTRY = Benzalkonium Chloride|T109|T121|NON|NRW|BAN (19XX)|INN (19XX)|JAN (19XX)|NLM (1996)|941130|abbcdeeeef
ENTRY = Alkyldimethylbenzylammonium Chloride|T109|T121|NON|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Asepsol|T109|T121|TRD|NRW|UNK (19XX)|840305|abbcdef
ENTRY = BTC-2125|T109|T121|LAB|NRW|UNK (19XX)|840305|abbcdef
ENTRY = Drapolene|T109|T121|TRD|NRW|UNK (19XX)|810130|abbcdef
ENTRY = Germex|T109|T121|TRD|NRW|UNK (19XX)|830330|abbcdef
ENTRY = Osvan|T109|T121|TRD|NRW|NLM (1998)|961115|abbcdef
ENTRY = Zephiran|T109|T121|TRD|NRW|UNK (19XX)|820203|abbcdef
ENTRY = BTC 2125
ENTRY = BTC2125
ENTRY = Chloride, Alkyldimethylbenzylammonium
ENTRY = Chloride, Benzalkonium
ENTRY = Compounds, Benzalkonium
MN = D02.092.877.096.040
MN = D02.675.276.080
PA = Anti-Infective Agents, Local
PA = Detergents
PA = Preservatives, Pharmaceutical
MH_TH = NLM (1964)
ST = T109
ST = T121
RN = 0
RR = 8001-54-5 (benzalkonium chloride)
AN = D25-26 qualif
MS = A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.
OL = use BENZALKONIUM COMPOUNDS to search BENZALKONIUM 1981-83 & BENZALKONIUM CHLORIDE 1966-80 (as Prov 1966-67)
PM = 84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1968-80, was BENZALKONIUM CHLORIDE see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963
HN = 84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1964-80 (Prov 1964-67) see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963
MR = 20130709
DA = 19990101
DC = 1
DX = 19680101
UI = D001548

*NEWRECORD
RECTYPE = D
MH = Benzamides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.065.277
MN = D02.241.223.100.100
MN = D02.455.426.559.389.127.085
MH_TH = NLM (1973)
ST = T109
RN = 0
PI = Amides (1966-1972)
PI = Benzoates (1966-1972)
MS = BENZOIC ACID amides.
OL = use BENZAMIDES to search TRIMETHOBENZAMIDE 1966-84
PM = 73; TRIMETHOBENZAMIDE was heading 1963-84
HN = 73; TRIMETHOBENZAMIDE was heading 1963-84
MR = 20120703
DA = 19990101
DC = 1
DX = 19730101
UI = D001549

*NEWRECORD
RECTYPE = D
MH = Benzamidines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.078.100
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = peptidase inhib
PI = Amidines (1972-1974)
PI = Benzene Derivatives (1972-1974)
MS = Amidines substituted with a benzene group. Benzamidine and its derivatives are known as peptidase inhibitors.
PM = 91; was see under AMIDINES 1975-90
HN = 91(75); was see under AMIDINES 1975-90
MR = 19920508
DA = 19741119
DC = 1
DX = 19910101
UI = D001550

*NEWRECORD
RECTYPE = D
MH = Benz(a)Anthracenes
DS = BENZANTHRACENES A
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Benz(b)Phenanthrenes|T109|T131|NON|EQV|NLM (2005)|040105|abbcdef
ENTRY = Naphthanthracenes|T109|T131|NON|EQV|NLM (2005)|040105|abbcdef
MN = D02.455.426.559.847.149
MN = D04.615.149
MH_TH = NLM (2005)
ST = T109
ST = T131
RN = 0
MS = Four fused benzyl rings with three linear and one angular, that can be viewed as a benzyl-phenanthrenes. Compare with NAPHTHACENES which are four linear rings.
PM = 2005; see BENZANTHRACENES 1963-2005
HN = 2005(1963)
MR = 20060705
DA = 19990101
DC = 1
UI = D001551

*NEWRECORD
RECTYPE = D
MH = Benzazepines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.438.079
FX = Azepines
FX = Dibenzazepines
MH_TH = NLM (1968)
ST = T109
RN = 0
MS = Compounds with BENZENE fused to AZEPINES.
PM = 68
HN = 68
MR = 20040707
DA = 19990101
DC = 1
DX = 19680101
UI = D001552

*NEWRECORD
RECTYPE = D
MH = Benzbromarone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acifugan|T109|T121|TRD|NRW|UNK (19XX)|840920|abbcdef
ENTRY = Aliud Brand of Benzbromarone|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = Benzbromaron|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
ENTRY = Benzbromaron AL|T109|T121|TRD|NRW|DE|040121|abbcdef
ENTRY = Benzbromaron-ratiopharm|T109|T121|TRD|NRW|DE|040121|abbcdef
ENTRY = Besuric|T109|T121|TRD|NRW|MX|040121|abbcdef
ENTRY = Desuric|T109|T121|TRD|NRW|NL|UNK (19XX)|810427|abbcdeef
ENTRY = Heumann Brand of Benzbromarone|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = Narcaricin|T109|T121|TRD|NRW|DE|040121|abbcdef
ENTRY = Sanfer Brand of Benzbromarone|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = Sanofi Winthrop Brand of Benzbromarone|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = Urinorm|T109|T121|TRD|NRW|ES|040121|abbcdef
ENTRY = ratiopharm Brand of Benzbromarone|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = AL, Benzbromaron
ENTRY = Benzbromaron ratiopharm
ENTRY = Benzbromarone Aliud Brand
ENTRY = Benzbromarone Heumann Brand
ENTRY = Benzbromarone Sanfer Brand
ENTRY = Benzbromarone ratiopharm Brand
ENTRY = Benzbromaronratiopharm
MN = D03.438.127.110
PA = Uricosuric Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1976)
ST = T109
ST = T121
N1 = Methanone, (3,5-dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)-
RN = 4POG0RL69O
RR = 3562-84-3 (Benzbromarone)
PI = Benzoates (1971-1974)
PI = Benzofurans (1971-1974)
PI = Bromine (1973-1974)
MS = Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
PM = 91; was see under BENZOFURANS 1975-90
HN = 91(75); was see under BENZOFURANS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001553

*NEWRECORD
RECTYPE = D
MH = Benzene
AQ = AD AE AI AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Benzol|T109|T131|NON|EQV|UNK (19XX)|790507|abbcdef
ENTRY = Benzole|T109|T131|NON|EQV|UNK (19XX)|790507|abbcdef
ENTRY = Cyclohexatriene|T109|T131|NON|EQV|NLM (1996)|950330|abbcdef
MN = D02.455.426.559.389.023
EC = analogs & derivatives:Benzene Derivatives
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T131
N1 = Benzene
RN = J64922108F
RR = 71-43-2 (Benzene)
AN = do not confuse with benzil or benzal
MS = Toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide.
MR = 20130708
DA = 19990101
DC = 1
UI = D001554

*NEWRECORD
RECTYPE = D
MH = Benzene Derivatives
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Derivatives, Benzene
MN = D02.455.426.559.389
MH_TH = NLM (1968)
ST = T109
RN = 0
PI = Benzene (1966-1967)
PM = 68
HN = 68
MR = 19920508
DA = 19990101
DC = 1
DX = 19680101
UI = D001555

*NEWRECORD
RECTYPE = D
MH = Lindane
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Benzene Hexachloride|T109|T131|NON|EQV|NLM (1996)|941129|abbcdef
PRINT ENTRY = Hexachlorocyclohexane|T109|T131|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = gamma-Benzene Hexachloride|T109|T131|NON|EQV|UNK (19XX)|760517|abbcdef
ENTRY = BHC Insecticide|T109|T131|TRD|NRW|UNK (19XX)|810427|abbcdef
ENTRY = Chinoin Brand of Lindane|T109|T121|T131|NON|NRW|NLM (2005)|040407|abbbcdef
ENTRY = Delitex|T109|T121|T131|TRD|NRW|DE|040407|abbbcdef
ENTRY = Gamma-666|T109|T131|TRD|NRW|NLM (2006)|041130|abbcdef
ENTRY = Gammexane|T109|T131|TRD|NRW|UNK (19XX)|830330|abbcdef
ENTRY = Hexachlorane|T109|T131|NON|EQV|UNK (19XX)|810918|abbcdef
ENTRY = Infectopharm Brand of Lindane|T109|T121|T131|NON|NRW|NLM (2005)|040407|abbbcdef
ENTRY = Jacutin|T109|T131|TRD|NRW|UNK (19XX)|800801|abbcdef
ENTRY = Kwell|T109|T121|TRD|NRW|UNK (19XX)|861007|abbcdef
ENTRY = PMS-Lindane|T109|T121|T131|TRD|NRW|CA|040407|abbbcdef
ENTRY = Pharmascience Brand of Lindane|T109|T121|T131|NON|NRW|NLM (2005)|040407|abbbcdef
ENTRY = Scabecid|T109|T121|T131|TRD|NRW|FR|040407|abbbcdef
ENTRY = Scabene|T109|T121|T131|TRD|NRW|US|040407|abbbcdef
ENTRY = Scabisan|T109|T121|T131|TRD|NRW|MX|040407|abbbcdef
ENTRY = Stiefel Brand of Lindane|T109|T121|T131|NON|NRW|NLM (2005)|040407|abbbcdef
ENTRY = Tetocid|T109|T131|TRD|NRW|UNK (19XX)|810519|abbcdef
ENTRY = gamma-Hexachlorocyclohexane|T109|T131|NON|EQV|UNK (19XX)|840919|abbcdef
ENTRY = Gamma 666
ENTRY = Gamma666
ENTRY = Hexachloride, Benzene
ENTRY = Hexachloride, gamma-Benzene
ENTRY = Insecticide, BHC
ENTRY = PMS Lindane
ENTRY = PMSLindane
ENTRY = gamma Benzene Hexachloride
ENTRY = gamma Hexachlorocyclohexane
MN = D02.455.526.439.600
PA = Insecticides
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1980)
MH_TH = USP (19XX)
ST = T109
ST = T131
N1 = Cyclohexane, 1,2,3,4,5,6-hexachloro-, (1alpha,2alpha,3beta,4alpha,5alpha,6beta)-
RN = 59NEE7PCAB
RR = 58-89-9 (Lindane)
AN = do not confuse X ref BENZENE HEXACHLORIDE with HEXACHLOROBENZENE
MS = An organochlorine insecticide that has been used as a pediculicide and a scabicide. It has been shown to cause cancer.
PM = 96; was BENZENE HEXACHLORIDE 1963-95; LINDANE was see BENZENE HEXACHLORIDE 1963-95
HN = 96; was BENZENE HEXACHLORIDE 1963-95; LINDANE was see BENZENE HEXACHLORIDE 1963-95
MR = 20130708
DA = 19990101
DC = 1
UI = D001556

*NEWRECORD
RECTYPE = D
MH = Benzenesulfonates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.426.559.389.097
MN = D02.886.645.600.080.050.100
MH_TH = NLM (1974)
ST = T109
RN = 0
MS = Organic salts and esters of benzenesulfonic acid.
PM = 74
HN = 74
MR = 19930604
DA = 19990101
DC = 1
DX = 19740101
UI = D001557

*NEWRECORD
RECTYPE = D
MH = Benzethonium
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Bencetonium Chloride|T109|T121|T131|NON|NRW|NLM (1991)|900116|abbbcdef
ENTRY = Benzethonium Chloride|T109|T121|T131|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|JAN (19XX)|USP (19XX)|800411|abbbcdeeeeef
ENTRY = Care-Tech Brand of Benzethonium Chloride|T109|T121|T131|NON|NRW|NLM (2005)|040123|abbbcdef
ENTRY = Formula Magic|T109|T121|T131|TRD|NRW|US|040123|abbbcdef
ENTRY = Hyamine 1622|T109|T121|T131|TRD|NRW|NLM (1991)|900116|abbbcdef
ENTRY = Orchid Fresh II|T109|T121|T131|TRD|NRW|US|040123|abbbcdef
ENTRY = Phemeride|T109|T121|T131|TRD|NRW|NLM (1991)|900116|abbbcdef
ENTRY = Phemerol|T109|T121|T131|TRD|NRW|NLM (1991)|900116|abbbcdef
ENTRY = Phemethryn|T109|T121|T131|TRD|NRW|NLM (1991)|900116|abbbcdef
ENTRY = Puri-Clens|T109|T121|T131|TRD|NRW|US|040123|abbbcdef
ENTRY = Quatrachlor|T109|T121|T131|TRD|NRW|NLM (1991)|900116|abbbcdef
ENTRY = Solamin|T109|T121|T131|TRD|NRW|NLM (1991)|900116|abbbcdef
ENTRY = Sween Brand of Benzethonium Chloride|T109|T121|T131|NON|NRW|NLM (2005)|040123|abbbcdef
ENTRY = Care Tech Brand of Benzethonium Chloride
ENTRY = Chloride, Bencetonium
ENTRY = Chloride, Benzethonium
ENTRY = Magic, Formula
ENTRY = Puri Clens
ENTRY = PuriClens
MN = D02.092.877.096.082
MN = D02.675.276.090
PA = Anti-Infective Agents, Local
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T131
N1 = Benzenemethanaminium, N,N-dimethyl-N-(2-(2-(4-(1,1,3,3-tetramethylbutyl)phenoxy)ethoxy)ethyl)-, chloride
RN = 1VU15B70BP
RR = 121-54-0 (Benzethonium)
RR = PH41D05744
AN = D25-26 qualif
PI = Ammonium Compounds (1969-1974)
PI = Benzyl Compounds (1971-1974)
PI = Phenyl Ethers (1974)
MS = Bactericidal cationic quaternary ammonium surfactant used as a topical anti-infective agent. It is an ingredient in medicaments, deodorants, mouthwashes, etc., and is used to disinfect apparatus, etc., in the food processing and pharmaceutical industries, in surgery, and also as a preservative. The compound is toxic orally as a result of neuromuscular blockade.
OL = use BENZETHONIUM to search BENZETHONIUM COMPOUNDS 1975-80
PM = 91; was see under AMMONIUM COMPOUNDS 1981-90; was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80
HN = 91(81); was see under AMMONIUM COMPOUNDS 1981-90; was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001558

*NEWRECORD
RECTYPE = D
MH = Benzhydryl Compounds
DE = BENZHYDRYL CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Diphenylmethyl Compounds|T109|NON|EQV|UNK (19XX)|770401|DIPHENYLMETHYL CPDS|abcdefv
ENTRY = Compounds, Benzhydryl
ENTRY = Compounds, Diphenylmethyl
MN = D02.455.426.559.389.115
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = DF: BENZHYDRYL CPDS
PI = Benzene Derivatives (1968-1974)
PI = Benzyl Compounds (1972-1974)
MS = Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.
PM = 75
HN = 75
MR = 19920508
DA = 19741111
DC = 1
DX = 19750901
UI = D001559

*NEWRECORD
RECTYPE = D
MH = Benzidines
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Bianilines|T109|T131|NON|EQV|UNK (19XX)|760421|abbcdef
PRINT ENTRY = Biphenyldiamines|T109|T131|NON|EQV|UNK (19XX)|760421|abbcdef
MN = D02.455.426.559.389.185.100
FX = Carcinogens
MH_TH = NLM (1975)
ST = T109
ST = T131
RN = 0
MS = Very toxic industrial chemicals. They are absorbed through the skin, causing lethal blood, bladder, liver, and kidney damage and are potent, broad-spectrum carcinogens in most species.
OL = use BENZIDINES to search BENZIDINE 1975-77; use BIPHENYL COMPOUNDS 1966-74
PM = 77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74; 3,3'-DIAMINOBENZIDINE & DIANISIDINE were see under AMINOBIPHENYL COMPOUNDS 1975-76
HN = 77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74
MR = 20000622
DA = 19990101
DC = 1
DX = 19770101
UI = D001560

*NEWRECORD
RECTYPE = D
MH = Benzilates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.241.223.601.238.306
MN = D02.241.511.085
MH_TH = NLM (1966)
ST = T109
RN = 0
MR = 19920508
DA = 19990101
DC = 1
UI = D001561

*NEWRECORD
RECTYPE = D
MH = Benzimidazoles
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.438.103
FX = Imidazoles
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Compounds with a BENZENE fused to IMIDAZOLES.
MR = 20040707
DA = 19990101
DC = 1
UI = D001562

*NEWRECORD
RECTYPE = D
MH = Benzo(a)pyrene
DS = BENZOPYRENE A
AQ = AA AD AE AI AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = 3,4-Benzopyrene|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|840411|BENZOPYRENE AA 0304|abbcdeefs
ENTRY = 3,4-Benzpyrene|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|840411|abbcdeef
ENTRY = 3,4 Benzopyrene
ENTRY = 3,4 Benzpyrene
MN = D02.455.426.559.847.799.306.300
MN = D04.615.799.306.300
FX = Bay-Region, Polycyclic Aromatic Hydrocarbon
MH_TH = FDA SRS (2014)
MH_TH = NLM (1985)
ST = T109
ST = T131
N1 = Benzo(a)pyrene
RN = 3417WMA06D
RR = 50-32-8 (Benzo(a)pyrene)
AN = a mutagen & carcinogen; D25-26 qualif
PI = Benzopyrenes (1966-1984)
MS = A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke.
PM = 85
HN = 85
MR = 20130708
DA = 19840411
DC = 1
DX = 19850101
UI = D001564

*NEWRECORD
RECTYPE = D
MH = Benzoates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Benzoate|T109|NON|NRW|NLM (1999)|980202|abcdef
ENTRY = Benzoic Acids|T109|NON|REL|NLM (1999)|990101|abcdef
ENTRY = Acids, Benzoic
MN = D02.241.223.100
MN = D02.455.426.559.389.127
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure.
PM = 1963; see BENZOIC ACIDS 1999-2012; BENZOATE was indexed under BENZOATES 1980-1998
HN = 1963
MR = 20120703
DA = 19990101
DC = 1
UI = D001565

*NEWRECORD
RECTYPE = D
MH = Benzocaine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Ethyl Aminobenzoate|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = 4-Aminobenzoic Acid Ethyl Ester|T109|T121|NON|EQV|NLM (1992)|910312|abbcdef
ENTRY = Americaine|T109|T121|TRD|NRW|NLM (1992)|910312|abbcdef
ENTRY = Anaesthesin|T109|T121|TRD|NRW|UNK (19XX)|811026|abbcdef
ENTRY = Anesthesin|T109|T121|TRD|NRW|UNK (19XX)|800825|abbcdef
ENTRY = Bensokain|T109|T121|NON|EQV|NLM (1999)|UNK (19XX)|980121|abbcdeef
ENTRY = Benzocaine Acetate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Benzocaine Formate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Benzocaine Hydrobromide|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Benzocaine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1999)|990913|abbcdeef
ENTRY = Benzocaine Methanesulfonate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ethoform|T109|T121|TRD|NRW|NLM (1999)|UNK (19XX)|980121|abbcdeef
ENTRY = Acetate, Benzocaine
ENTRY = Formate, Benzocaine
ENTRY = Hydrobromide, Benzocaine
ENTRY = Hydrochloride, Benzocaine
ENTRY = Methanesulfonate, Benzocaine
MN = D02.241.223.100.050.500.687
MN = D02.455.426.559.389.127.020.937.687
PA = Anesthetics, Local
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzoic acid, 4-amino-, ethyl ester
RN = U3RSY48JW5
RR = 115008-66-7 (HBr)
RR = 129781-06-2 (methanesulfonate)
RR = 23239-88-5 (HCl)
RR = 37673-45-3 (formate)
RR = 37673-46-4 (acetate)
RR = 94-09-7
RR = OG625Z9LEO
MS = A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.
PM = 65; was ETHYL AMINOBENZOATE 1963-64
HN = 65; was ETHYL AMINOBENZOATE 1963-64
MR = 20150709
DA = 19990101
DC = 1
DX = 19650101
UI = D001566

*NEWRECORD
RECTYPE = D
MH = Benzocycloheptenes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.426.559.847.181
MN = D04.615.181
MH_TH = NLM (1968)
ST = T109
RN = 0
PM = 68
HN = 68
MR = 20060705
DA = 19990101
DC = 1
DX = 19680101
UI = D001567

*NEWRECORD
RECTYPE = D
MH = Benzodiazepines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Benzodiazepine|T109|NON|NRW|FDA SRS (2014)|NLM (2008)|abcdee
ENTRY = Benzodiazepine Compounds|T109|T121|NON|EQV|NLM (2005)|040514|BENZODIAZEPINE CPDS|abbcdefv
MN = D03.438.079.080
MH_TH = NLM (1975)
ST = T109
ST = T121
RN = 12794-10-4
RR = M0Q7802G2B
AN = do not confuse with BENZODIAZEPINONES
PI = Benzazepines (1968-1974)
MS = A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.
PM = 75
HN = 75
MR = 20130708
DA = 19741111
DC = 1
DX = 19750901
UI = D001569

*NEWRECORD
RECTYPE = D
MH = Benzodiazepinones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.438.079.080.070
MH_TH = NLM (1974)
ST = T109
RN = 0
AN = do not confuse with BENZODIAZEPINES
PM = 74
HN = 74
MR = 19920508
DA = 19990101
DC = 1
DX = 19740101
UI = D001570

*NEWRECORD
RECTYPE = D
MH = Benzoflavones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Benzoflavone Compounds|T109|T121|NON|EQV|NLM (2015)|140213|abbcdef
ENTRY = Compounds, Benzoflavone
MN = D03.383.663.283.266.450.175
MN = D03.438.150.266.450.175
PA = Enzyme Inhibitors
MH_TH = NLM (1979)
ST = T109
ST = T121
RN = 0
PI = Flavones (1966-1978)
MS = Organic compounds containing a BENZENE ring attached to a flavone group. Some of these are potent arylhydrocarbon hydroxylase inhibitors. They may also inhibit the binding of NUCLEIC ACIDS to BENZOPYRENES and related compounds. The designation includes all isomers; the 7,8-isomer is most frequently encountered.
PM = 91; was see under FLAVONES 1979-90
HN = 91(79); was see under FLAVONES 1979-90
MR = 20150622
DA = 19771209
DC = 1
DX = 19910101
UI = D001571

*NEWRECORD
RECTYPE = D
MH = Benzofurans
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Coumarones|T109|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Diphenylbenzofuran|T109|NON|NRW|UNK (19XX)|781219|abcdef
MN = D03.438.127
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Compounds that contain a BENZENE ring fused to a furan ring.
PM = 66
HN = 66
MR = 20090706
DA = 19990101
DC = 1
DX = 19660101
UI = D001572

*NEWRECORD
RECTYPE = D
MH = Benzoin
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = 2-hydroxy-1,2-diphenylethanone|T109|T130|NON|EQV|FDA SRS (2014)|NLM (2003)|020625|abbcdeef
ENTRY = 2 hydroxy 1,2 diphenylethanone
MN = D02.522.120.100
MH_TH = FDA SRS (2014)
MH_TH = NLM (1963)
ST = T109
ST = T130
N1 = Ethanone, 2-hydroxy-1,2-diphenyl-
RN = L7J6A1NE81
RR = 119-53-9 (Benzoin)
AN = D25-26 qualif; benzoin gum (NM) is also available
MS = A white crystalline compound prepared by condensation of benzaldehyde in potassium cyanide and used in organic syntheses. This should not be confused with benzoin gum from STYRAX.
MR = 20130708
DA = 19990101
DC = 1
UI = D001573

*NEWRECORD
RECTYPE = D
MH = Benzolamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = CL-11366|T109|T121|LAB|NRW|UNK (19XX)|750630|abbcdef
ENTRY = CL 11366
ENTRY = CL11366
MN = D02.065.884.120
MN = D02.886.590.700.120
MN = D02.886.675.867.120
MN = D03.383.129.708.867.120
PA = Carbonic Anhydrase Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = NLM (1976)
ST = T109
ST = T121
N1 = 1,3,4-Thiadiazole-2-sulfonamide, 5-((phenylsulfonyl)amino)-
RN = FC5AAH89R5
RR = 3368-13-6 (Benzolamide)
PI = Sulfonamides (1970-1975)
PI = Thiadiazoles (1972-1975)
MS = Selective renal carbonic anhydrase inhibitor. It may also be of use in certain cases of respiratory failure.
PM = 91; was see under THIADIAZOLES 1976-90
HN = 91(76); was see under THIADIAZOLES 1976-90
MR = 20130708
DA = 19750723
DC = 1
DX = 19910101
UI = D001574

*NEWRECORD
RECTYPE = D
MH = Benzomorphans
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Benzomorphan|T109|T121|NON|NRW|UNK (19XX)|840416|abbcdef
MN = D03.132.577.249.106
MN = D04.615.723.795.106
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = analgesics
MS = Morphine derivatives of the methanobenzazocine family that act as potent analgesics.
OL = use BENZOMORPHANS to search BENZOMORPHAN 1975-84; use MORPHINANS 1973-74 & BRIDGED COMPOUNDS 1966-72
PM = 91; was see under MORPHINANS 1985-90; was BENZOMORPHAN see under MORPHINANS 1973-84 & see under BRIDGED COMPOUNDS 1966-72
HN = 91(85); was see under MORPHINANS 1985-90; was BENZOMORPHAN see under MORPHINANS 1973-84 & see under BRIDGED COMPOUNDS 1966-72
MR = 20060705
DA = 19990101
DC = 1
DX = 19910101
UI = D001575

*NEWRECORD
RECTYPE = D
MH = Benzophenoneidum
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Auramine|T109|T121|T130|TRD|NRW|UNK (19XX)|801104|abbbcdef
ENTRY = Auramine O|T109|T121|T130|TRD|NRW|UNK (19XX)|741111|abbbcdef
ENTRY = O, Auramine
MN = D02.092.146.215
PA = Anti-Infective Agents
PA = Coloring Agents
PA = Disinfectants
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T130
N1 = Benzenamine, 4,4'-carbonimidoylbis(N,N-dimethyl)-, monohydrochloride
RN = 2465-27-2
AN = D25-26 qualif
PI = Aniline Compounds (1969-1974)
PI = Dimethylamines (1974)
PI = Imines (1972-1974)
MS = An aniline dye used as a disinfectant and an antiseptic agent. It is weakly fluorescing and binds specifically to certain proteins.
PM = 91; was see under ANILINE COMPOUNDS 1975-90; PYOCTANIUM AUREUM was see BENZOPHENONEIUM 1975-95
HN = 91(75); was see under ANILINE COMPOUNDS 1975-90; PYOCTANIUM AUREUM was see BENZOPHENONEIDUM 1975-95
MR = 20050706
DA = 19741119
DC = 1
DX = 19910101
UI = D001576

*NEWRECORD
RECTYPE = D
MH = Benzophenones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.426.559.389.115.124
MN = D02.522.223
MH_TH = NLM (1968)
ST = T109
RN = 0
PI = Ketones (1966-1967)
PM = 68
HN = 68
MR = 20100625
DA = 19990101
DC = 1
DX = 19680101
UI = D001577

*NEWRECORD
RECTYPE = D
MH = Benzopyrans
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chromenes|T109|NON|EQV|NLM (2003)|020108|abcdef
MN = D03.383.663.283
MN = D03.438.150
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = do not confuse with BENZOPYRENES
MS = Compounds with a core of fused benzo-pyran rings.
PM = 66
HN = 66
MR = 20150622
DA = 19990101
DC = 1
DX = 19660101
UI = D001578

*NEWRECORD
RECTYPE = D
MH = Benzopyrene Hydroxylase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Benzopyrene-3-Monooxygenase|T116|T126|NON|EQV|UNK (19XX)|741111|BENZOPYRENE MONOOXYGENASE 003|abbcdefs
ENTRY = Benzo(a)pyrene Hydroxylase|T116|T126|NON|EQV|UNK (19XX)|811202|abbcdef
ENTRY = Benzo(a)pyrene Monooxygenase|T116|T126|NON|EQV|UNK (19XX)|861128|abbcdef
ENTRY = Benzopyrene 3 Monooxygenase
ENTRY = Hydroxylase, Benzopyrene
MN = D08.244.453.040.110
MN = D08.811.682.690.708.170.040.110
MN = D12.776.422.220.453.040.110
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 1.14.14.-
AN = a cytochrome
PI = Benzopyrenes (1968-1974)
PI = Hydroxylases (1968-1974)
MS = A drug-metabolizing, cytochrome P-448 (P-450) enzyme which catalyzes the hydroxylation of benzopyrene to 3-hydroxybenzopyrene in the presence of reduced flavoprotein and molecular oxygen. Also acts on certain anthracene derivatives. An aspect of EC 1.14.14.1.
PM = 91; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76
HN = 91(75); was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76
MR = 20040707
DA = 19741111
DC = 1
DX = 19910101
UI = D001579

*NEWRECORD
RECTYPE = D
MH = Benzopyrenes
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Benzpyrene|T109|T131|NON|NRW|UNK (19XX)|800917|abbcdef
MN = D02.455.426.559.847.799.306
MN = D04.615.799.306
MH_TH = NLM (1966)
ST = T109
ST = T131
RN = 0
AN = do not confuse with BENZOPYRANS
MS = A class of chemicals that contain an anthracene ring with a naphthalene ring attached to it.
MR = 20060705
DA = 19990101
DC = 1
UI = D001580

*NEWRECORD
RECTYPE = D
MH = Benzothiadiazines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.886.590.700.135
MN = D02.886.655.500
MN = D03.438.174
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Heterocyclic compounds of a ring with SULFUR and two NITROGEN atoms fused to a BENZENE ring. Members inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.
MR = 20050630
DA = 19990101
DC = 1
UI = D001581

*NEWRECORD
RECTYPE = D
MH = Benzothiepins
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.886.092
MN = D03.438.197
MH_TH = NLM (1968)
ST = T109
RN = 0
PM = 68
HN = 68
MR = 20050630
DA = 19990101
DC = 1
DX = 19680101
UI = D001582

*NEWRECORD
RECTYPE = D
MH = Benzoxazoles
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.438.221
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = includes benzoxazolines, benzoxazolidines
PM = 66
HN = 66
MR = 19920508
DA = 19990101
DC = 1
DX = 19660101
UI = D001583

*NEWRECORD
RECTYPE = D
MH = Benzoxepins
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.438.245
MH_TH = NLM (1968)
ST = T109
RN = 0
PM = 68
HN = 68
MR = 19920508
DA = 19990101
DC = 1
DX = 19680101
UI = D001584

*NEWRECORD
RECTYPE = D
MH = Benzoyl Peroxide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Benzoyl Superoxide|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef
ENTRY = Dibenzoyl Peroxide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|861202|abbcdeef
ENTRY = Diphenylglyoxal Superoxide|T109|T121|NON|EQV|UNK (19XX)|820302|abbcdef
ENTRY = PanOxyl|T109|T121|TRD|NRW|UNK (19XX)|861202|abbcdef
ENTRY = Peroxide, Benzoyl
ENTRY = Peroxide, Dibenzoyl
ENTRY = Superoxide, Benzoyl
ENTRY = Superoxide, Diphenylglyoxal
MN = D02.241.223.100.133
MN = D02.455.426.559.389.127.133
PA = Dermatologic Agents
MH_TH = FDA SRS (2014)
MH_TH = USAN (1972)
MH_TH = USP (19XX)
ST = T109
ST = T121
RN = W9WZN9A0GM
RR = 94-36-0 (Benzoyl Peroxide)
PI = Benzoates (1972-1975)
PI = Peroxides (1972-1975)
MS = A peroxide derivative that has been used topically for BURNS and as a dermatologic agent in the treatment of ACNE and POISON IVY DERMATITIS. It is used also as a bleach in the food industry.
PM = 91; was see under PEROXIDES 1976-90
HN = 91(76); was see under PEROXIDES 1976-90
MR = 20130708
DA = 19750721
DC = 1
DX = 19910101
UI = D001585

*NEWRECORD
RECTYPE = D
MH = Benzoylarginine Nitroanilide
DE = BAPA
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = BAPNA|T116|T130|ABB|EQV|NLM (1994)|921026|abbcdef
PRINT ENTRY = N-alpha-Benzoyl-DL-arginine-4-nitroanilide|T116|T130|NON|NRW|NLM (1994)|921026|ALPHA BENZOYLARGININENITROANILIDE N DL 04|abbcdefs
ENTRY = Benzoylarginine Nitroanilide Monohydrochloride|T116|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Benzoylarginine Nitroanilide, (R)-Isomer|T116|T130|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Benzoylarginine Nitroanilide, (S)-Isomer|T116|T130|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Benzoylarginine Nitroanilide, Monosodium Salt, Monohydrochloride|T116|T130|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = N-Benzoylarginine-4-nitroanilide|T116|T130|NON|EQV|UNK (19XX)|840925|abbcdef
ENTRY = N-Benzoylarginyl-4-nitroanilide|T116|T130|NON|EQV|NLM (1994)|921026|abbcdef
ENTRY = Monohydrochloride, Benzoylarginine Nitroanilide
ENTRY = N Benzoylarginine 4 nitroanilide
ENTRY = N Benzoylarginyl 4 nitroanilide
ENTRY = N alpha Benzoyl DL arginine 4 nitroanilide
ENTRY = Nitroanilide, Benzoylarginine
MN = D02.065.199.200
MN = D12.125.068.050.100
MN = D12.125.095.104.100
PA = Chromogenic Compounds
MH_TH = NLM (1975)
ST = T116
ST = T130
N1 = Benzamide, N-(4-((aminoiminomethyl)amino)-1-(((4-nitrophenyl)amino)carbonyl)butyl)-, (+-)-
RN = 911-76-2
RR = 26056-64-4 ((R)-isomer)
RR = 6208-93-1 ((S)-isomer)
RR = 70066-65-8 (mono-Na salt, mono-HCl)
RR = 7723-66-2 (cpd w/o isomeric designation)
RR = 911-77-3 (mono-HCl)
AN = DF: BAPA
PI = Anilides (1971-1974)
PI = Arginine (1971-1974)
PI = Benzamides (1974)
PI = Nitro Compounds (1971-1974)
MS = A chromogenic substrate that permits direct measurement of peptide hydrolase activity, e.g., papain and trypsin, by colorimetry. The substrate liberates p-nitroaniline as a chromogenic product.
OL = use BENZOYLARGININE NITROANILIDE (NM) to search N-BENZOYLARGINYL-4-NITROANILIDE 1988-93
PM = 91; was see under ARGININE 1975-90; N-BENZOYLARGINYL-4-NITROANILIDE was indexed under BENZOYLARGININE NITROANILIDE 1993 & ARGININE/*analogs & derivatives 1988-92
HN = 91(75); was see under ARGININE 1975-90; N-BENZOYLARGINYL-4-NITROANILIDE was (NM) 1988-93
MR = 20010725
DA = 19741119
DC = 1
DX = 19910101
UI = D001586

*NEWRECORD
RECTYPE = D
MH = Benzoylarginine-2-Naphthylamide
DE = BANA
DS = BENZOYLARGININE NAPHTHYLAMIDE 02
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Benzoylarginine beta-Naphthylamide|T116|T130|NON|EQV|UNK (19XX)|760517|abbcdef
ENTRY = Benzoylarginine 2 Naphthylamide|T116|T130|NON|EQV|UNK (19XX)|780126|abbcdef
ENTRY = 2 Naphthylamide, Benzoylarginine
ENTRY = Benzoylarginine beta Naphthylamide
ENTRY = Naphthylamide, Benzoylarginine 2
ENTRY = beta-Naphthylamide, Benzoylarginine
MN = D02.065.300
MN = D12.125.068.050.095
MN = D12.125.095.104.095
MH_TH = NLM (1976)
ST = T116
ST = T130
N1 = Benzamide, N-(4-((aminoiminomethyl)amino)-1-((2-naphthalenylamino)carbonyl)butyl)-, (+-)-
RN = 305-09-9
AN = DF: BANA
PI = Arginine (1973-1974) /analogs & derivatives (1975)
PI = Benzamides (1974-1975)
PI = Naphthalenes (1973-1975)
MS = An enzyme substrate which permits the measurement of peptide hydrolase activity, e.g. trypsin and thrombin. The enzymes liberate 2-naphthylamine, which is measured by colorimetric procedures.
OL = use BENZOYLARGININE-2-NAPHTHYLAMIDE to search BENZOYLARGININE BETA NAPHTHYLAMIDE 1976
PM = 91; was see under ARGININE 1977-90; was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976
HN = 91(77); was see under ARGININE 1977-90; was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976
MR = 20010725
DA = 19750723
DC = 1
DX = 19910101
UI = D001587

*NEWRECORD
RECTYPE = D
MH = Benzoylcholine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.092.877.883.333.100
MN = D02.241.223.100.141
MN = D02.455.426.559.389.127.141
MN = D02.675.276.232.100
MH_TH = NLM (1976)
ST = T109
N1 = Ethanaminium, 2-(benzoyloxy)-N,N,N-trimethyl-
RN = 2208-04-0
PI = Benzoates (1972-1975)
PI = Choline (1968-1974) /AA (1975)
MS = The benzoic acid ester of choline.
PM = 91; was see under CHOLINE 1976-90
HN = 91(76); was see under CHOLINE 1976-90
MR = 20120703
DA = 19750721
DC = 1
DX = 19910101
UI = D001588

*NEWRECORD
RECTYPE = D
MH = Benzphetamine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Benzfetamine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|941129|abbcdeef
ENTRY = Didrex|T109|T121|TRD|NRW|UNK (19XX)|US|861119|abbcdeef
ENTRY = Pfizer Brand of Benzfetamine Hydrochloride|T109|T121|NON|NRW|NLM (2011)|100511|abbcdef
MN = D02.092.471.683.152.619.307
PA = Adrenergic Agents
PA = Adrenergic Uptake Inhibitors
PA = Central Nervous System Stimulants
PA = Dopamine Agents
PA = Dopamine Uptake Inhibitors
PA = Sympathomimetics
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T121
N1 = Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-, (S)-
RN = 0M3S43XK27
RR = 156-08-1 (Benzphetamine)
MS = A sympathomimetic agent with properties similar to DEXTROAMPHETAMINE. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)
PM = 91; was see under PHENETHYLAMINES 1966-90
HN = 91(66); was see under PHENETHYLAMINES 1966-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001589

*NEWRECORD
RECTYPE = D
MH = Benztropine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Apo-Benztropine|T109|T121|TRD|NRW|CA|040121|abbcdef
ENTRY = Apotex Brand of Benzatropine Mesilate|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = Astra Brand of Benzatropine Mesilate|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = Bensylate|T109|T121|TRD|NRW|CA|040121|abbcdef
ENTRY = Benzatropine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|941129|abbcdeef
ENTRY = Benzatropine Mesylate|T109|T121|NON|NRW|NLM (2006)|abbcde
ENTRY = Benzatropine Methanesulfonate|T109|T121|NON|NRW|NLM (2006)|abbcde
ENTRY = Benzatropine Methanesulfonate, Hydrobromide|T109|T121|NON|NRW|NLM (2006)|990818|abbcdef
ENTRY = Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer|T109|T121|NON|NRW|NLM (2006)|990818|abbcdef
ENTRY = Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer|T109|T121|NON|NRW|NLM (2006)|990818|abbcdef
ENTRY = Benztropine Mesylate|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2006)|USP (19XX)|abbcdeee
ENTRY = Cogentin|T109|T121|TRD|NRW|NLM (2006)|abbcde
ENTRY = Cogentinol|T109|T121|TRD|NRW|DE|040121|abbcdef
ENTRY = ICN Brand of Benzatropine Mesilate|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = N-Methylbenztropine|T109|T121|NON|REL|NLM (2006)|abbcde
ENTRY = PMS-Benztropine|T109|T121|TRD|NRW|CA|040121|abbcdef
ENTRY = Pharmascience Brand of Benzatropine Mesilate|T109|T121|NON|NRW|NLM (2005)|040121|abbcdef
ENTRY = Apo Benztropine
ENTRY = ApoBenztropine
ENTRY = Hydrobromide Benzatropine Methanesulfonate
ENTRY = Mesylate, Benzatropine
ENTRY = Mesylate, Benztropine
ENTRY = Methanesulfonate, Benzatropine
ENTRY = Methanesulfonate, Hydrobromide Benzatropine
ENTRY = N Methylbenztropine
ENTRY = PMS Benztropine
ENTRY = PMSBenztropine
MN = D02.145.074.722.270
MN = D03.132.889.244
MN = D03.605.869.270
MN = D04.075.080.875.099.722.270
PA = Antiparkinson Agents
PA = Dopamine Uptake Inhibitors
PA = Muscarinic Antagonists
PA = Parasympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T121
N1 = 8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-
RN = 1NHL2J4X8K
RR = 132-17-2 (Benzatropine Methanesulfonate)
RR = 25471-65-2 (HCl(endo)-isomer)
RR = 6148-20-5 (HBr(endo)-isomer)
RR = 80677-48-1 (HBr)
RR = 86-13-5 (Benztropine)
RR = WMJ8TL7510
PI = Tropanes (1972-1990)
MS = A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.
PM = 1991; see TROPANES 1972-1990; BENZATROPINE METHANESULFONATE was indexed under BENZOTROPINE 1977-2005
HN = 1991(1972); use TROPANES 1972-1990
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001590

*NEWRECORD
RECTYPE = D
MH = Benzydamine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Benzindamine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
ENTRY = 3M Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Benzidamine|T109|T121|NON|EQV|UNK (19XX)|820519|abbcdef
ENTRY = Benzydamine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1965)|941129|abbcdeef
ENTRY = Benzydamine Monohydrochloride|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = CSC Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Chefaro Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Difflam|T109|T121|TRD|NRW|AU|IE|041208|abbcdeef
ENTRY = Eipico Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Farma Lepori Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Grossmann Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Innotech Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Lonol|T109|T121|TRD|NRW|MX|041208|abbcdef
ENTRY = Novo-Benzydamine|T109|T121|TRD|NRW|CA|041208|abbcdef
ENTRY = Novopharm Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Opalgyne|T109|T121|TRD|NRW|FR|041208|abbcdef
ENTRY = PMS-Benzydamine|T109|T121|TRD|NRW|CA|041208|abbcdef
ENTRY = Pharmascience Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Promeco Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Ratiopharm Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Rosalgin|T109|T121|TRD|NRW|ES|041208|abbcdef
ENTRY = Sun Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Sun-Benz|T109|T121|TRD|NRW|CA|041208|abbcdef
ENTRY = Tantum|T109|T121|TRD|NRW|CA|DE|ES|NL|041208|abbcdeeeef
ENTRY = Tantum Topico|T109|T121|TRD|NRW|ES|041208|abbcdef
ENTRY = United Drug Brand of Benzydamine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Vantal Brand of Benzydamine Hydrochloride|T109|T121|TRD|NRW|MX|041208|abbcdef
ENTRY = ratio-Benzydamine|T109|T121|TRD|NRW|CA|041208|abbcdef
ENTRY = Hydrochloride, Benzydamine
ENTRY = Monohydrochloride, Benzydamine
ENTRY = Novo Benzydamine
ENTRY = PMS Benzydamine
ENTRY = Sun Benz
ENTRY = ratio Benzydamine
MN = D03.383.129.539.487.130
MN = D03.438.449.130
PA = Anti-Inflammatory Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-
RN = 4O21U048EF
RR = 132-69-4 (mono-HCl)
RR = 642-72-8 (Benzydamine)
RR = K2GI407R4Q
PI = Benzyl Compounds (1971-1974)
PI = Dimethylamines (1973-1974)
PI = Indazoles (1973-1974)
PI = Pyrazoles (1968-1973)
MS = A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat.
PM = 91; was see under PYRAZOLES 1975-90
HN = 91(75); was see under PYRAZOLES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001591

*NEWRECORD
RECTYPE = D
MH = Benzyl Alcohols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Phenylcarbinols|T109|NON|EQV|UNK (19XX)|741111|abcdef
PRINT ENTRY = Phenylmethanols|T109|NON|EQV|UNK (19XX)|741111|abcdef
ENTRY = Alcohols, Benzyl
MN = D02.033.160
MN = D02.455.426.559.389.140.200
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = BENZYL ALCOHOL also available
PI = Alcohols (1972-1974)
PI = Benzyl Compounds (1972-1974)
MS = Alcohols derived from the aryl radical (C6H5CH2-) and defined by C6H5CHOH. The concept includes derivatives with any substituents on the benzene ring.
PM = 91; was see under BENZYL COMPOUNDS 1975-90
HN = 91(75); was see under BENZYL COMPOUNDS 1975-90
MR = 19970620
DA = 19741119
DC = 1
DX = 19910101
UI = D001592

*NEWRECORD
RECTYPE = D
MH = Benzyl Compounds
DE = BENZYL CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compounds, Benzyl
MN = D02.455.426.559.389.140
MH_TH = NLM (1971)
ST = T109
RN = 0
AN = do not confuse with benzil; DF: BENZYL CPDS
PI = Benzene Derivatives (1968-1970)
PM = 72
HN = 72(71)
MR = 19920508
DA = 19990101
DC = 1
DX = 19720101
UI = D001593

*NEWRECORD
RECTYPE = D
MH = Benzyl Viologen
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Viologen, Benzyl
MN = D03.383.725.762.925.100
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = 4,4'-Bipyridinium, 1,1'-bis(phenylmethyl)-
RN = 13096-46-3
AN = an indicator
PI = Benzyl Compounds (1972-1974)
PI = Pyridinium Compounds (1970-1974)
MS = 1,1'-Bis(phenylmethyl)4,4'-bipyridinium dichloride. Oxidation-reduction indicator.
PM = 91; was see under PYRIDINIUM COMPOUNDS 1975-90
HN = 91(75); was see under PYRIDINIUM COMPOUNDS 1975-90
MR = 19920508
DA = 19741119
DC = 1
DX = 19910101
UI = D001594

*NEWRECORD
RECTYPE = D
MH = Benzylamine Oxidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Clorgyline-Resistant Amine Oxidase|T116|T126|NON|NRW|UNK (19XX)|820330|abbcdef
ENTRY = Amine Oxidase, Clorgyline-Resistant
ENTRY = Clorgyline Resistant Amine Oxidase
ENTRY = Oxidase, Benzylamine
ENTRY = Oxidase, Clorgyline-Resistant Amine
MN = D08.811.682.664.750.100
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 1.4.3.-
PI = Benzyl Compounds (1973-1974)
PI = Monoamine Oxidase (1973-1974)
MS = An aspect of monoamine oxidase, EC 1.4.3.4. Catalyzes the oxidation of benzylamine to form benzaldehyde, ammonia and hydrogen peroxide.
PM = 91; was see under MONOAMINE OXIDASE 1975-90
HN = 91(75); was see under MONOAMINE OXIDASE 1975-90
MR = 20050630
DA = 19741119
DC = 1
DX = 19910101
UI = D001595

*NEWRECORD
RECTYPE = D
MH = Benzylamines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Phenylmethylamine|T109|T130|NON|REL|UNK (19XX)|750701|abbcdef
PRINT ENTRY = alpha-Aminotoluene|T109|T130|NON|NRW|UNK (19XX)|760517|abbcdef
ENTRY = alpha Aminotoluene
MN = D02.092.200
MN = D02.455.426.559.389.140.210
MH_TH = NLM (1976)
ST = T109
RN = 0
PI = Amines (1969-1975)
PI = Benzyl Compounds (1974-1975)
MS = Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group.
PM = 87; was see under AMINES 1976-86
HN = 87(76); was see under AMINES 1976-86
MR = 19920508
DA = 19750723
DC = 1
DX = 19870101
UI = D001596

*NEWRECORD
RECTYPE = D
MH = Benzylidene Compounds
DE = BENZYLIDENE CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compounds, Benzylidene
MN = D02.455.426.559.389.150
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = = benzals; DF: BENZYLIDENE CPDS
PI = Benzene Derivatives (1968-1974)
MS = Compounds containing the PhCH= radical.
PM = 75
HN = 75
MR = 19920508
DA = 19741119
DC = 1
DX = 19750901
UI = D001597

*NEWRECORD
RECTYPE = D
MH = Bephenium Compounds
DE = BEPHENIUM CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Bephenium Derivatives|T109|NON|EQV|NLM (1996)|940901|abcdef
ENTRY = Compounds, Bephenium
ENTRY = Derivatives, Bephenium
MN = D02.092.877.096.166
MN = D02.675.276.102
PA = Antinematodal Agents
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = DF: BEPHENIUM CPDS
MS = Analogs or derivatives of bephenium (N,N-dimethyl-N-(2-phenoxyethyl)benzenemethanaminium).
MR = 20050630
DA = 19990101
DC = 1
UI = D001598

*NEWRECORD
RECTYPE = D
MH = Berberine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Umbellatine|T109|T121|NON|EQV|NLM (2001)|000510|abbcdef
MN = D03.132.098.057.100
MN = D03.549.168.100
MH_TH = FDA SRS (2014)
MH_TH = NLM (1976)
ST = T109
ST = T121
N1 = Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-
RN = 0I8Y3P32UF
RR = 2086-83-1 (Berberine)
PI = Berbines (1972-1975)
PI = Dioxolanes (1975)
PI = Dioxoles (1972-1974)
MS = An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal.
PM = 91; was see under BERBINES 1976-90
HN = 91(76); was see under BERBINES 1976-90
MR = 20130708
DA = 19750725
DC = 1
DX = 19910101
UI = D001599

*NEWRECORD
RECTYPE = D
MH = Berberine Alkaloids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Berbines|T109|NON|EQV|NLM (1969)|990101|abcdef
ENTRY = Alkaloids, Berberine
MN = D03.132.098.057
MN = D03.549.168
MH_TH = NLM (2001)
ST = T109
RN = 0
PI = Alkaloids (1966-1968)
MS = A group of related plant alkaloids that contain the BERBERINE heterocyclic ring structure.
PM = 2001; see BERBINES 1969-2000
HN = 2001(1969)
MR = 20060705
DA = 19990101
DC = 1
DX = 19690101
UI = D001600

*NEWRECORD
RECTYPE = D
MH = Bereavement
ENTRY = Bereavements
MN = F01.470.142
FX = Grief
MH_TH = NLM (1988)
ST = T041
AN = human & animal; no qualif
PI = Grief (1968-1987)
MS = Refers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 19910620
DA = 19870314
DC = 1
DX = 19880101
UI = D001601

*NEWRECORD
RECTYPE = D
MH = Beriberi
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
MN = C18.654.521.500.133.699.827.223
MH_TH = NLM (1966)
ST = T047
AN = caused by THIAMINE DEFICIENCY
MS = A disease caused by a deficiency of thiamine (vitamin B1) and characterized by polyneuritis, cardiac pathology, and edema. The epidemic form is found primarily in areas in which white (polished) rice is the staple food, as in Japan, China, the Philippines, India, and other countries of southeast Asia. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D001602

*NEWRECORD
RECTYPE = D
MH = Berkelium
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.268.271.100.100
MN = D01.268.556.075
MN = D01.552.020.150
MN = D01.552.544.075
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Berkelium
RN = 2YQA718KUU
RR = 7440-40-6 (Berkelium)
AN = man-made radioactive element; IM
MS = Berkelium. A man-made radioactive actinide with atomic symbol Bk, atomic number 97, and atomic weight 247. Its valence can be +3 or +4. Twelve isotopes have been produced with mass numbers 240-251.
MR = 20150622
DA = 19990101
DC = 1
UI = D001603

*NEWRECORD
RECTYPE = D
MH = Berlin
AQ = EH EP
MN = Z01.433.128
MN = Z01.542.315.182
MH_TH = NLM (1966)
ST = T083
AN = includes East or West Berlin; for historical or modern Berlin
MR = 19890713
DA = 19990101
DC = 4
UI = D001604

*NEWRECORD
RECTYPE = D
MH = Bermuda
AQ = EH EP
MN = Z01.639.040.390
MH_TH = POPLINE (1978)
ST = T083
AN = a British colony in the North Atlantic
MS = A British colony in the western North Atlantic Ocean about 640 miles east southeast of Cape Hatteras, North Carolina. It comprises a group of about 300 islands of which only about 20 are inhabited. It is called also the Bermuda Islands or the Bermudas. It was named for the Spanish explorer Juan Bermudez who visited the islands in 1515. (From Webster's New Geographical Dictionary, 1988, p140 & Room, Brewer's Dictionary of Names, 1992, p61)
MR = 20120703
DA = 19990101
DC = 4
UI = D001605

*NEWRECORD
RECTYPE = D
MH = Bernard-Soulier Syndrome
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Giant Platelet Syndrome|T047|NON|EQV|ORD (2010)|UNK (19XX)|850311|abcdeef
ENTRY = Deficiency of Platelet Glycoprotein 1b|T047|NON|REL|NLM (2010)|ORD (2010)|090617|abcdeef
ENTRY = Glycoprotein Ib, Platelet, Deficiency Of|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Platelet Glycoprotein 1b, Deficiency of|T047|NON|REL|NLM (2010)|ORD (2010)|090617|abcdeef
ENTRY = Platelet Glycoprotein Ib Deficiency|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Von Willebrand Factor Receptor Deficiency|T047|EPO|REL|NLM (2010)|OMIM (2013)|090617|abcdeef
ENTRY = Bernard Soulier Syndrome
ENTRY = Platelet Syndromes, Giant
ENTRY = Syndrome, Bernard-Soulier
ENTRY = Syndrome, Giant Platelet
ENTRY = Syndromes, Giant Platelet
MN = C15.378.100.100.080
MN = C15.378.140.120
MN = C15.378.463.080
MN = C16.320.099.080
MH_TH = NLM (1986)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
PI = Blood Platelet Disorders (1967-1985)
MS = A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.
PM = 1991; see BLOOD PLATELET DISORDERS 1986-1990
HN = 1991(1986)
CATSH = CAT LIST
MR = 20120703
DA = 19850311
DC = 1
DX = 19910101
UI = D001606

*NEWRECORD
RECTYPE = D
MH = Berylliosis
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Beryllium Disease|T047|NON|BRD|UNK (19XX)|780519|BERYLLIUM DIS|abcdefv
ENTRY = Beryllioses
MN = C08.381.483.581.225
MN = C08.381.520.702.225
MN = C24.800.225
MH_TH = NLM (1979)
ST = T037
ST = T047
AN = do not coordinate with OCCUPATIONAL DISEASES
PI = Lung Diseases (1966-1978)
PI = Occupational Diseases (1966-1978)
PI = Pneumoconiosis (1966-1978)
MS = A form of pneumoconiosis caused by inhaled rare metal BERYLLIUM or its soluble salts which are used in a wide variety of industry including alloys, ceramics, radiographic equipment, and vacuum tubes. Berylliosis is characterized by an acute inflammatory reaction in the upper airway leading to BRONCHIOLITIS; PULMONARY EDEMA; and pneumonia.
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20100625
DA = 19780519
DC = 1
DX = 19790101
UI = D001607

*NEWRECORD
RECTYPE = D
MH = Beryllium
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR
MN = D01.268.552.075
MN = D01.268.557.080
MN = D01.552.547.080
EC = poisoning:Berylliosis
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T131
ST = T196
N1 = Beryllium
RN = OW5102UV6N
RR = 7440-41-7 (Beryllium)
AN = Be-9; Be-6-8, 10, 11 = BERYLLIUM (IM) + RADIOISOTOPES (IM); /adv eff /tox permitted but /pois = BERYLLIOSIS
MS = Beryllium. An element with the atomic symbol Be, atomic number 4, and atomic weight 9.01218. Short exposure to this element can lead to a type of poisoning known as BERYLLIOSIS.
MR = 20130708
DA = 19990101
DC = 1
UI = D001608

*NEWRECORD
RECTYPE = D
MH = Beta-Globulins
AQ = AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Beta(1)CA Globulin|T116|T123|NRW|UNK (19XX)|820331|abbdef
ENTRY = Beta-Globulin|T116|T123|NON|EQV|UNK (19XX)|760905|abbcdef
ENTRY = Beta Globulin
ENTRY = Beta Globulins
MN = D12.776.124.790.223
MN = D12.776.377.715.182
MH_TH = NLM (1963)
ST = T116
ST = T123
RN = 0
AN = GEN or unspecified; prefer specifics; do not confuse with beta 2 A-globulin or beta 2 M-globulin ( = BETA 2-MICROGLOBULIN)
MS = Serum proteins with an electrophoretic mobility that falls between ALPHA-GLOBULINS and GAMMA-GLOBULINS.
OL = use BETA-GLOBULINS to search BETA GLOBULIN 1966-74
PM = 75; was BETA GLOBULIN 1965-74
HN = 75; was BETA GLOBULIN 1963-74 (Prov 1963-64)
MR = 20050701
DA = 19990101
DC = 1
DX = 19650101
UI = D001609

*NEWRECORD
RECTYPE = D
MH = Beta Particles
AQ = AE CL HI TU
PRINT ENTRY = Beta Rays|T070|NON|REL|NLM (1985)|990101|abcdef
ENTRY = Beta Radiation|T070|NON|REL|NLM (1995)|940630|BETA RAD|abcdefv
ENTRY = Radiation, Beta|T070|NON|REL|NLM (1995)|940630|RAD BETA|abcdefv
ENTRY = Beta Particle
ENTRY = Beta Radiations
ENTRY = Beta Ray
ENTRY = Particle, Beta
ENTRY = Particles, Beta
ENTRY = Radiations, Beta
ENTRY = Ray, Beta
ENTRY = Rays, Beta
MN = G01.750.750.125
MH_TH = UNK (19XX)
ST = T070
PI = Electrons (1966-1984)
PI = Elementary Particles (1970-1984)
PI = Radiation (1966-1984)
MS = High energy POSITRONS or ELECTRONS ejected from a disintegrating atomic nucleus.
PM = 2010; BETA RAYS 1985-2009
HN = 2010 (1985)
MR = 20110624
DA = 19840224
DC = 1
DX = 19850101
UI = D001610

*NEWRECORD
RECTYPE = D
MH = Beta Rhythm
AQ = DE GE IM PH RE
ENTRY = Beta Rhythms
ENTRY = Rhythm, Beta
ENTRY = Rhythms, Beta
MN = E01.370.376.300.150.750
MN = E01.370.405.245.287.750
MN = G07.265.087.750
MN = G11.561.127.750
MH_TH = NLM (1975)
ST = T042
MS = Brain waves with frequency between 15-30 Hz seen on EEG during wakefulness and mental activity.
PM = 91; was see under ELECTROENCEPHALOGRAPHY 1975-90
HN = 91(75); was see under ELECTROENCEPHALOGRAPHY 1975-90
CATSH = CAT LIST
MR = 20140616
DA = 19741212
DC = 1
DX = 19910101
UI = D001611

*NEWRECORD
RECTYPE = D
MH = beta 2-Microglobulin
DS = BETA MICROGLOBULIN 2
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Thymotaxin|T116|T129|NON|EQV|NLM (1991)|900302|abbcdef
ENTRY = 2-Microglobulin, beta
ENTRY = beta 2 Microglobulin
MN = D12.776.124.790.223.100
MN = D12.776.377.715.182.100
MH_TH = NLM (1975)
ST = T116
ST = T129
RN = 0
AN = /biosyn /physiol /blood permitted
PI = Beta Globulins (1973-1974)
MS = An 11-kDa protein associated with the outer membrane of many cells including lymphocytes. It is the small subunit of the MHC class I molecule. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinemia, renal failure, or kidney transplants.
OL = use BETA 2-MICROGLOBULIN tosearch BETA 2 MICROGLOBULIN 1984-90
PM = 91; was BETA 2 MICROGLOBULIN 1984-90; was see under BETA GLOBULINS 1975-83
HN = 91(75); was BETA 2 MICROGLOBULIN 1984-90; was see under BETA GLOBULINS 1975-83
MR = 20040707
DA = 19741119
DC = 1
DX = 19840101
UI = D001613

*NEWRECORD
RECTYPE = D
MH = beta-Amylase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = beta Amylase
MN = D08.811.277.450.066.100
MH_TH = NLM (1978)
ST = T116
ST = T126
N1 = 1,4-alpha-D-Glucan maltohydrolase
RN = EC 3.2.1.2
PI = Amylases (1966-1977)
MS = An enzyme that catalyzes the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. EC 3.2.1.2.
PM = 91; was see under AMYLASES 1978-90
HN = 91(78); was see under AMYLASES 1978-90
MR = 20030709
DA = 19770415
DC = 1
DX = 19910101
UI = D001614

*NEWRECORD
RECTYPE = D
MH = beta-Endorphin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Endorphin, beta|T116|T124|NON|EQV|UNK (19XX)|870504|abbcdef
ENTRY = beta-Endorphin (1-31)|T116|T124|NON|EQV|NLM (2007)|abbcde
ENTRY = beta Endorphin
MN = D06.472.699.327.935.239
MN = D06.472.699.631.525.600.239
MN = D12.644.400.400.935.239
MN = D12.644.400.575.241.080
MN = D12.644.548.365.935.239
MN = D12.644.548.691.525.690.239
MN = D12.776.641.650.405.935.239
MN = D12.776.641.650.575.241.080
PA = Neurotransmitter Agents
MH_TH = NLM (1988)
ST = T116
ST = T124
RN = 60617-12-1
PI = Endorphins (1978-1987)
PI = Peptides (1966-1977)
MS = A 31-amino acid peptide that is the C-terminal fragment of BETA-LIPOTROPIN. It acts on OPIOID RECEPTORS and is an analgesic. Its first four amino acids at the N-terminal are identical to the tetrapeptide sequence of METHIONINE ENKEPHALIN and LEUCINE ENKEPHALIN.
PM = 1988; BETA-ENDORPHIN (1-31) was indexed under BETA-ENDORPHIN & PEPTIDE FRAGMENTS 1985-2006
HN = 1988 (1985)
MR = 20150622
DA = 19870504
DC = 1
DX = 19880101
UI = D001615

*NEWRECORD
RECTYPE = D
MH = beta-Galactosidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Lactases|T116|T126|NON|EQV|UNK (19XX)|770331|abbcdef
ENTRY = Dairyaid|T116|T121|T126|TRD|NRW|CA|041207|abbbcdef
ENTRY = Lactaid|T116|T121|T126|TRD|NRW|AU|CA|UNK (19XX)|861103|abbbcdeeef
ENTRY = Lactogest|T116|T121|T126|TRD|NRW|US|041207|abbbcdef
ENTRY = Lactrase|T116|T121|T126|TRD|NRW|CA|041207|abbbcdef
ENTRY = McNeil Brand of beta-Galactosidase|T116|T121|T126|NON|NRW|NLM (2006)|041207|abbbcdef
ENTRY = Rivex Brand of beta-Galactosidase|T116|T121|T126|NON|NRW|NLM (2006)|041207|abbbcdef
ENTRY = Sunrise Brand of beta-Galactosidase|T116|T121|T126|NON|NRW|NLM (2006)|041207|abbbcdef
ENTRY = Tanta Brand of beta-Galactosidase|T116|T121|T126|NON|NRW|NLM (2006)|041207|abbbcdef
ENTRY = Thompson Brand of beta-Galactosidase|T116|T121|T126|NON|NRW|NLM (2006)|041207|abbbcdef
ENTRY = beta-D-Galactosidase|T116|T126|NON|EQV|UNK (19XX)|811113|abbcdef
ENTRY = beta-Galactosidase A1|T116|T126|NON|NRW|UNK (19XX)|800731|abbcdef
ENTRY = beta-Galactosidase A2|T116|T126|NON|NRW|UNK (19XX)|800731|abbcdef
ENTRY = beta-Galactosidase A3|T116|T126|NON|NRW|UNK (19XX)|800731|abbcdef
ENTRY = beta-Galactosidases|T116|T126|NON|EQV|NLM (1992)|910116|abbcdef
ENTRY = lac Z Protein|T116|T126|NON|EQV|NLM (1992)|910315|abbcdef
ENTRY = Protein, lac Z
ENTRY = Rivex Brand of beta Galactosidase
ENTRY = Sunrise Brand of beta Galactosidase
ENTRY = Tanta Brand of beta Galactosidase
ENTRY = Thompson Brand of beta Galactosidase
ENTRY = beta D Galactosidase
ENTRY = beta Galactosidase
ENTRY = beta Galactosidase A1
ENTRY = beta Galactosidase A2
ENTRY = beta Galactosidase A3
ENTRY = beta Galactosidases
MN = D08.811.277.450.410.100
FX = Gangliosidosis, GM1
MH_TH = NLM (1978)
ST = T116
ST = T126
N1 = beta-D-Galactoside galactohydrolase
RN = EC 3.2.1.23
AN = /defic: consider also LACTOSE INTOLERANCE and GANGLIOSIDOSIS, GM1
PI = Galactosidases (1966-1977)
MS = A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1.
OL = use BETA-GALACTOSIDASE to search BETA-GALACTOSIDASES 1978-91
PM = 92; was BETA-GALACTOSIDASES 1978-91 (see under GALACTOSIDASES 1978-90)
HN = 92; was BETA-GALACTOSIDASES 1978-91 (see under GALACTOSIDASES 1978-90)
MR = 20060707
DA = 19770415
DC = 1
DX = 19910101
UI = D001616

*NEWRECORD
RECTYPE = D
MH = beta-Glucosidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Cellobiases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef
ENTRY = Amygdalase|T116|T126|NON|EQV|UNK (19XX)|880719|abbcdef
ENTRY = Cellobiase|T116|T126|NON|EQV|NLM (2004)|030211|abbcdef
ENTRY = Emulsion beta-D-Glucosidase|T116|T126|NON|NRW|UNK (19XX)|820330|abbcdef
ENTRY = Gentiobiase|T116|T126|NON|EQV|NLM (1992)|910207|abbcdef
ENTRY = Emulsion beta D Glucosidase
ENTRY = beta Glucosidase
ENTRY = beta-D-Glucosidase, Emulsion
MN = D08.811.277.450.420.200.100
MH_TH = NLM (1978)
ST = T116
ST = T126
N1 = beta-D-Glucoside glucohydrolase
RN = EC 3.2.1.21
PI = Glucosidases (1966-1977)
MS = An exocellulase with specificity for a variety of beta-D-glycoside substrates. It catalyzes the hydrolysis of terminal non-reducing residues in beta-D-glucosides with release of GLUCOSE.
OL = use BETA-GLUCOSIDASE to search BETA-GLUCOSIDASES 1978-91
PM = 92; was BETA-GLUCOSIDASES 1978-91 (see under GLUCOSIDASES 1978-90)
HN = 92; was BETA-GLUCOSIDASES 1978-91 (see under GLUCOSIDASES 1978-90)
MR = 20030709
DA = 19770415
DC = 1
DX = 19910101
UI = D001617

*NEWRECORD
RECTYPE = D
MH = beta-Lactamases
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = beta-Lactamase|T116|T126|NON|EQV|UNK (1990)|870504|abbcdef
ENTRY = beta Lactamase
ENTRY = beta Lactamases
MN = D08.811.277.087.180
EC = antagonists & inhibitors:beta-Lactamase Inhibitors
MH_TH = NLM (1979)
ST = T116
ST = T126
N1 = beta-Lactamhydrolase
RN = EC 3.5.2.6
PI = Amidohydrolases (1966-1978)
PI = Cephalosporinase (1975-1978)
PI = Penicillinase (1966-1978)
MS = Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
PM = 79
HN = 79
MR = 20140610
DA = 19780516
DC = 1
DX = 19790101
UI = D001618

*NEWRECORD
RECTYPE = D
MH = beta-N-Acetylhexosaminidases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = beta-N-Acetylhexosaminidase|T116|T126|NON|EQV|NLM (1987)|990101|BETA ACETYLHEXOSAMINIDASE N|abbcdefs
ENTRY = N-Acetyl-beta-D-hexosaminidase|T116|T126|NON|EQV|UNK (19XX)|860602|abbcdef
ENTRY = beta-Hexosaminidase|T116|T126|NON|EQV|UNK (19XX)|860602|abbcdef
ENTRY = beta-N-Acetyl-D-hexosaminidase|T116|T126|NON|EQV|UNK (19XX)|860602|abbcdef
ENTRY = beta-N-Acetyl-hexosaminidase|T116|T126|NON|EQV|NLM (2005)|040406|abbcdef
ENTRY = N Acetyl beta D hexosaminidase
ENTRY = beta Hexosaminidase
ENTRY = beta N Acetyl D hexosaminidase
ENTRY = beta N Acetyl hexosaminidase
ENTRY = beta N Acetylhexosaminidase
ENTRY = beta N Acetylhexosaminidases
MN = D08.811.277.450.483.180
FX = Sandhoff Disease
FX = Tay-Sachs Disease
MH_TH = NLM (2008)
ST = T116
ST = T126
N1 = beta-N-Acetyl-D-hexosaminide N-acetylhexosaminohydrolase
RN = EC 3.2.1.52
AN = do not confuse with ACETYLGLUCOSAMINIDASE; /defic: consider also TAY SACHS DISEASE and SANDHOFF DISEASE
PI = Glycoside Hydrolases (1966-1970)
PI = Hexosaminidases (1971-1986)
MS = A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease.
PM = 2008; see BETA-N-ACETYL-D-HEXOSAMINIDASE 1988-2007
HN = 2008(1988)
MR = 20070709
DA = 19860602
DC = 1
DX = 19870101
UI = D001619

*NEWRECORD
RECTYPE = D
MH = beta-Thromboglobulin
DE = BETA TG
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = beta-2 Thromboglobulin|T116|NON|NRW|UNK (19XX)|870814|abcdef
ENTRY = Thromboglobulin, beta-2
ENTRY = beta 2 Thromboglobulin
ENTRY = beta Thromboglobulin
MN = D12.644.276.374.200.070
MN = D12.776.124.125.050
MN = D12.776.124.790.223.160
MN = D12.776.377.715.182.160
MN = D12.776.467.374.200.070
MN = D23.119.050
MN = D23.125.300.070
MN = D23.469.200.070
MN = D23.529.374.200.070
MH_TH = NLM (1980)
ST = T116
ST = T123
RN = 0
AN = /biosyn /physiol permitted; DF: BETA TG
PI = Beta Globulins (1966-1979)
MS = A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders.
PM = 87; was see under BETA GLOBULINS 1980-86
HN = 87(80); was see under BETA GLOBULINS 1980-86
MR = 20060705
DA = 19790523
DC = 1
DX = 19870101
UI = D001620

*NEWRECORD
RECTYPE = D
MH = Betahistine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aequamen|T109|T121|TRD|NRW|DE|831209|abbcdef
ENTRY = Aliud Brand of Betahistine Mesylate|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Altana Pharma Brand of Betahistine Mesylate|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Betahistin AL|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Betahistin Stada|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Betahistin-ratiopharm|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Betahistine Biphar|T109|T121|TRD|NRW|FR|041209|abbcdef
ENTRY = Betahistine Dihydrobromide|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Betahistine Dihydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1999)|990913|abbcdeef
ENTRY = Betahistine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1962)|USP (19XX)|941129|abbcdeeef
ENTRY = Betahistine Mesylate|T109|T121|NON|NRW|JAN (19XX)|NLM (1999)|990913|abbcdeef
ENTRY = Betahistine Methanesulfonate|T109|T121|NON|NRW|NLM (1995)|940429|abbcdef
ENTRY = Betahistine Methanesulphonate|T109|T121|NON|NRW|UNK (19XX)|810608|abbcdef
ENTRY = Betaserc|T109|T121|TRD|NRW|DE|FR|NL|041209|abbcdeeef
ENTRY = Betavert|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Bouchara Brand of Betahistine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = By-Vertin|T109|T121|TRD|NRW|IE|041209|abbcdef
ENTRY = Byk Gulden Brand of Betahistine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Dexo Brand of Betahistine Mesylate|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Ergha Brand of Betahistine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Eurim Brand of Betahistine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Extovyl|T109|T121|TRD|NRW|FR|041209|abbcdef
ENTRY = Fides Ecopharma Brand of Betahistine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Fidium|T109|T121|TRD|NRW|ES|041209|abbcdef
ENTRY = Gerard Brand of Betahistine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Hennig Brand of Betahistine Mesylate|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Lectil|T109|T121|TRD|NRW|FR|041209|abbcdef
ENTRY = Medopharm Brand of Betahistine Mesylate|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Melopat|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Mersilon|T109|T121|TRD|NRW|NLM (1993)|920331|abbcdef
ENTRY = PT-9|T109|T121|LAB|NRW|NLM (1993)|920331|abbcdef
ENTRY = Ribrain|T109|T121|TRD|NRW|UNK (19XX)|831014|abbcdef
ENTRY = Serc|T109|T121|TRD|NRW|AU|CA|ES|FR|IE|MX|NLM (1993)|UK|US|920331|abbcdeeeeeeeeef
ENTRY = Solvay Brand of Betahistine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Stadapharm Brand of Betahistine Mesylate|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Unimed Brand of Betahistine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Vasomotal|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Vertigon|T109|T121|TRD|NRW|IE|041209|abbcdef
ENTRY = ratiopharm Brand of Betahistine Mesylate|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Betahistin ratiopharm
ENTRY = By Vertin
ENTRY = Dihydrobromide, Betahistine
ENTRY = Dihydrochloride, Betahistine
ENTRY = Hydrochloride, Betahistine
ENTRY = Mesylate, Betahistine
ENTRY = Methanesulfonate, Betahistine
ENTRY = Methanesulphonate, Betahistine
ENTRY = PT 9
ENTRY = PT9
MN = D03.383.725.086
PA = Histamine Agonists
PA = Vasodilator Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 2-Pyridineethanamine, N-methyl-
RN = X32KK4201D
RR = 49K58SMZ7U
RR = 54856-23-4 (mesylate)
RR = 5579-84-0 (di-HCl)
RR = 5638-76-6 (Betahistine)
RR = 64335-09-7 (di-HBr)
MS = A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
PM = 91; was see under PYRIDINES 1967-90
HN = 91(67); was see under PYRIDINES 1967-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001621

*NEWRECORD
RECTYPE = D
MH = Betaine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Lycine|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Oxyneurine|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Acidin-Pepsin|T116|T121|T126|TRD|NRW|UNK (19XX)|860929|abbbcdef
ENTRY = Beaufour Brand of Betaine Citrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Betaine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USP (19XX)|941129|abbcdeef
ENTRY = Boizot Brand of Betaine Aspartate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Byk Brand of Betaine Phosphate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = C.B.B.|T109|T121|TRD|NRW|FR|040202|abbcdef
ENTRY = Citrate de Btane Beaufour|T109|T121|TRD|NRW|FR|040202|abbcdef
ENTRY = Citrate de Btane UPSA|T109|T121|TRD|NRW|FR|040202|abbcdef
ENTRY = Cystadane|T109|T121|TRD|NRW|AU|US|040202|abbcdeef
ENTRY = Fournier Brand of Betaine Ascorbate and Hydrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Glycine Betaine|T109|T121|NON|EQV|UNK (19XX)|801204|abbcdef
ENTRY = Hepastyl|T109|T121|TRD|NRW|ES|040202|abbcdef
ENTRY = Logeais Brand of Betaine Cyclobutyrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Novobetaine|T109|T121|TRD|NRW|FR|040202|abbcdef
ENTRY = Orphan Brand of Betaine|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Scorbo-btane|T109|T121|TRD|NRW|FR|040202|abbcdef
ENTRY = Stea-16|T109|T121|TRD|NRW|FR|040202|abbcdef
ENTRY = UPSA Brand of Betaine Citrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Acidin Pepsin
ENTRY = AcidinPepsin
ENTRY = Betaine Orphan Brand
ENTRY = Betaine, Glycine
ENTRY = Hydrochloride, Betaine
ENTRY = Scorbo btane
ENTRY = Scorbobtane
ENTRY = Stea16
MN = D02.092.877.883.077
MN = D02.675.276.125
PA = Gastrointestinal Agents
PA = Lipotropic Agents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1964)
ST = T109
ST = T121
N1 = Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt
RN = 3SCV180C9W
RR = 107-43-7 (Betaine)
RR = 590-46-5 (HCl)
RR = JK8U8K4D6K
MS = A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341)
PM = 68
HN = 68(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19680101
UI = D001622

*NEWRECORD
RECTYPE = D
MH = Betamethasone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Betadexamethasone|T110|T121|NON|EQV|UNK (19XX)|750101|abbcdef
PRINT ENTRY = Flubenisolone|T110|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef
ENTRY = Celeston|T110|T121|TRD|NRW|UNK (19XX)|840918|abbcdef
ENTRY = Celestona|T110|T121|TRD|NRW|UNK (19XX)|840918|abbcdef
ENTRY = Celestone|T110|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Cellestoderm|T110|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
MN = D04.808.745.432.769.199
MN = D04.808.908.093
PA = Anti-Asthmatic Agents
PA = Anti-Inflammatory Agents
PA = Glucocorticoids
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1962)
MH_TH = USP (19XX)
ST = T110
ST = T121
N1 = Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-
RN = 9842X06Q6M
RR = 378-44-9 (Betamethasone)
MS = A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
PM = 64
HN = 64(63)
MR = 20130708
DA = 19990101
DC = 1
DX = 19640101
UI = D001623

*NEWRECORD
RECTYPE = D
MH = Betamethasone Valerate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Betamethasone 17-Valerate|T110|T121|NON|EQV|NLM (19XX)|990101|BETAMETHASONE VALERATE 17|abbcdefs
PRINT ENTRY = Flubenisolonvalerate|T110|T121|NON|EQV|UNK (19XX)|750630|abbcdef
ENTRY = Betnovate|T110|T121|TRD|NRW|UNK (19XX)|830223|abbcdef
ENTRY = 17-Valerate, Betamethasone
ENTRY = Betamethasone 17 Valerate
ENTRY = Valerate, Betamethasone
MN = D04.808.745.432.769.199.150
MN = D04.808.908.093.150
PA = Anti-Inflammatory Agents
PA = Glucocorticoids
MH_TH = FDA SRS (2014)
MH_TH = NLM (2014)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T110
ST = T121
N1 = Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-
RN = 9IFA5XM7R2
RR = 2152-44-5 (Betamethasone Valerate)
PI = Betamethasone (1974) /AA (1975)
PI = Valerates (1974-1975)
MS = The 17-valerate derivative of BETAMETHASONE. It has substantial topical anti-inflammatory activity and relatively low systemic anti-inflammatory activity.
PM = 91; was see under BETAMETHASONE 1976-90
HN = 91(76); was see under BETAMETHASONE 1976-90
MR = 20130708
DA = 19750721
DC = 1
DX = 19910101
UI = D001624

*NEWRECORD
RECTYPE = D
MH = Betazole
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Ametazole|T109|T121|NON|EQV|BAN (19XX)|741111|abbcdef
ENTRY = Betazole Dihydrochloride|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Betazole Monohydrochloride|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Histalog|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Lilly 96791|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = 96791, Lilly
ENTRY = Dihydrochloride, Betazole
ENTRY = Monohydrochloride, Betazole
MN = D03.383.129.539.100
PA = Gastrointestinal Agents
PA = Histamine Agonists
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 1H-Pyrazole-3-ethanamine
RN = 1C065P542O
RR = 105-20-4 (Betazole)
RR = 1121-45-5 (mono-HCl)
RR = 138-92-1 (di-HCl)
PI = Ethylamines (1972-1974)
PI = Pyrazoles (1968-1974)
MS = A histamine H2 agonist used clinically to test gastric secretory function.
PM = 91; was see under PYRAZOLES 1975-90
HN = 91(75); was see under PYRAZOLES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001625

*NEWRECORD
RECTYPE = D
MH = Bethanechol Compounds
DE = BETHANECHOL CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Urecholine|T109|T121|TRD|NRW|UNK (19XX)|760422|abbcdef
ENTRY = Compounds, Bethanechol
MN = D02.092.877.883.088
MN = D02.675.276.148
MH_TH = NLM (1964)
ST = T109
ST = T121
RN = 0
AN = ammonium cpds; BETHANECHOL is available; DF: BETHANECHOL CPDS
OL = use BETHANECHOL COMPOUNDS to search BETHANECHOL 1966-67 (as Prov 1966-67) & URECHOLINE CHLORIDE 1968-76
PM = 68
HN = 68; was BETHANECHOL 1964-67 (Prov); URECHOLINE was URECHOLINE CHLORIDE see under BETHANECHOL COMPOUNDS 1968-76
MR = 20050630
DA = 19990101
DC = 1
DX = 19680101
UI = D001626

*NEWRECORD
RECTYPE = D
MH = Bethanidine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Batel|T109|T121|TRD|NRW|ES|040202|abbcdef
ENTRY = Betanidine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|941129|abbcdeef
ENTRY = Bethanidine Sulfate|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1962)|941129|abbcdeef
ENTRY = Bethanidine, Sulfate (2:1)|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Wellcome Brand of Betanidine Sulfate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Sulfate, Bethanidine
MN = D02.078.370.120
PA = Adrenergic Agents
PA = Antihypertensive Agents
PA = Sympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T121
N1 = Guanidine, N,N'-dimethyl-N''-(phenylmethyl)-
RN = W8S3YM7AUU
RR = 114-85-2 (sulfate (2:1))
RR = 55-73-2 (Bethanidine)
RR = J4THI5N7O2
PI = Benzyl Compounds (1972-1974)
PI = Guanidines (1968-1974)
MS = A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.
PM = 91; was see under GUANIDINES 1975-90
HN = 91(75); was see under GUANIDINES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001627

*NEWRECORD
RECTYPE = D
MH = Beverages
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Beverage
MN = G07.203.100
MN = J02.200
MH_TH = NLM (1966)
ST = T168
AN = fruit or vegetable juices: coordinate IM specific fruit (IM) or specific vegetable (IM); ALCOHOLIC BEVERAGES & specifics & CARBONATED BEVERAGES are also available
MS = Liquids that are suitable for drinking. (From Merriam Webster Collegiate Dictionary, 10th ed)
MR = 20150521
DA = 19990101
DC = 1
UI = D001628

*NEWRECORD
RECTYPE = D
MH = Bezafibrate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Azufibrat|T109|T121|TRD|NRW|DE|040204|abbcdef
ENTRY = Azupharma Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040204|abbcdef
ENTRY = BM-15.075|T109|T121|LAB|NRW|UNK (19XX)|830317|abbcdef
ENTRY = Bayer Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040209|abbcdef
ENTRY = Befibrat|T109|T121|TRD|NRW|DE|040204|abbcdef
ENTRY = Berlin-Chemie Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040209|abbcdef
ENTRY = Betapharm Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040204|abbcdef
ENTRY = Beza-Lande|T109|T121|TRD|NRW|DE|040204|abbcdef
ENTRY = Beza-Puren|T109|T121|TRD|NRW|DE|040204|abbcdef
ENTRY = Bezabeta|T109|T121|TRD|NRW|DE|040204|abbcdef
ENTRY = Bezacur|T109|T121|TRD|NRW|DE|040204|abbcdef
ENTRY = Bezafibrat PB|T109|T121|TRD|NRW|DE|040209|abbcdef
ENTRY = Bezafisal|T109|T121|TRD|NRW|MX|040202|abbcdef
ENTRY = Bezalip|T109|T121|TRD|NRW|CA|DE|MX|NL|UK|UNK (19XX)|830317|abbcdeeeeeef
ENTRY = Bezamerck|T109|T121|TRD|NRW|DE|040202|abbcdef
ENTRY = Boehringer Mannheim Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Bfizal|T109|T121|TRD|NRW|FR|040202|abbcdef
ENTRY = Cedur|T109|T121|TRD|NRW|DE|UNK (19XX)|830317|abbcdeef
ENTRY = Cryopharma Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Difaterol|T109|T121|TRD|NRW|ES|040202|abbcdef
ENTRY = Elfar Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Eulitop|T109|T121|TRD|NRW|DE|ES|040202|abbcdeef
ENTRY = Hennig Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040204|abbcdef
ENTRY = Hexal Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040204|abbcdef
ENTRY = Isis Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040204|abbcdef
ENTRY = Lakeside Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Lipox|T109|T121|TRD|NRW|DE|040202|abbcdef
ENTRY = Merckle Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040209|abbcdef
ENTRY = Reducterol|T109|T121|TRD|NRW|ES|040202|abbcdef
ENTRY = Regadrin B|T109|T121|TRD|NRW|DE|040209|abbcdef
ENTRY = Roche Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Sklerofibrat|T109|T121|TRD|NRW|DE|040209|abbcdef
ENTRY = Solibay|T109|T121|TRD|NRW|MX|040209|abbcdef
ENTRY = Synthelabo Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040204|abbcdef
ENTRY = TAD Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040202|abbcdef
ENTRY = Teva Brand of Bezafibrate|T109|T121|NON|NRW|NLM (2005)|040209|abbcdef
ENTRY = durabezur|T109|T121|TRD|NRW|DE|040202|abbcdef
ENTRY = BM 15.075
ENTRY = BM15.075
ENTRY = Berlin Chemie Brand of Bezafibrate
ENTRY = Beza Lande
ENTRY = Beza Puren
ENTRY = BezaLande
ENTRY = BezaPuren
ENTRY = Bezafibrate Azupharma Brand
ENTRY = Bezafibrate Bayer Brand
ENTRY = Bezafibrate Berlin-Chemie Brand
ENTRY = Bezafibrate Betapharm Brand
ENTRY = Bezafibrate Cryopharma Brand
ENTRY = Bezafibrate Elfar Brand
ENTRY = Bezafibrate Hennig Brand
ENTRY = Bezafibrate Hexal Brand
ENTRY = Bezafibrate Isis Brand
ENTRY = Bezafibrate Lakeside Brand
ENTRY = Bezafibrate Merckle Brand
ENTRY = Bezafibrate Roche Brand
ENTRY = Bezafibrate Synthelabo Brand
ENTRY = Bezafibrate TAD Brand
ENTRY = Bezafibrate Teva Brand
ENTRY = PB, Bezafibrat
MN = D02.065.277.067
MN = D02.241.081.114.968.500.249
MN = D02.241.223.100.100.120
MN = D02.241.223.100.200.249
MN = D02.355.726.305.249
MN = D02.455.426.559.389.127.085.101
MN = D02.455.426.559.389.127.250.249
MN = D02.455.426.559.389.657.654.305.249
PA = Hypolipidemic Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1978)
ST = T109
ST = T121
N1 = Propanoic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-
RN = Y9449Q51XH
RR = 41859-67-0 (Bezafibrate)
PI = Benzamides (1977-1978)
PI = Clofibrate/analogs & derivatives (1978-1983)
PI = Phenylbutyrates (1977-1978)
MS = An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS.
PM = 84
HN = 84
MR = 20130708
DA = 19830317
DC = 1
DX = 19840101
UI = D001629

*NEWRECORD
RECTYPE = D
MH = Bezoars
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Hair Balls|T167|NON|NRW|UNK (19XX)|790412|abcdef
PRINT ENTRY = Trichobezoars|T167|NON|NRW|UNK (19XX)|790412|abcdef
ENTRY = Ball, Hair
ENTRY = Balls, Hair
ENTRY = Bezoar
ENTRY = Hair Ball
ENTRY = Trichobezoar
MN = C26.392.183
MH_TH = NLM (1966)
ST = T167
AN = concretions from ingested foreign matter; coord IM with organ (IM), not organ/dis: Manual 21.39
MS = Concretions of swallowed hair, fruit or vegetable fibers, or similar substances found in the alimentary canal.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001630

*NEWRECORD
RECTYPE = D
MH = Bhutan
AQ = EH EP
MN = Z01.252.245.162
MH_TH = POPLINE (1978)
ST = T083
AN = a kingdom in the eastern Himalayas
MS = A kingdom in the eastern Himalayas on the northeast border of India, bounded on the north by Tibet, on the east by Assam, on the south by Assam and West Bengal, and on the west by Sikkim and Tibet. From 1720 to 1970 it was under Chinese or Indian domination. In 1971 it became a member of the United Nations. The name comes from the Sanskrit bhota, the name for Tibet, + anta, end, with reference to its location at the southern extremity of Tibet. (From Webster's New Geographical Dictionary, 1988, p144 & Room, Brewer's Dictionary of Names, 1992, p64)
MR = 19950217
DA = 19990101
DC = 4
UI = D001631

*NEWRECORD
RECTYPE = D
MH = Bibenzyls
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.426.559.389.140.308
MN = D02.455.426.559.389.150.700.075
MH_TH = NLM (1968)
ST = T109
RN = 0
MS = Compounds with 1,2-diphenylethane. They are structurally like reduced STILBENES.
PM = 68
HN = 68
MR = 20040707
DA = 19990101
DC = 1
DX = 19680101
UI = D001632

*NEWRECORD
RECTYPE = D
MH = Bible
ENTRY = Scriptural Interpretation|T170|NON|REL|UNK (19XX)|770317|abcdef
ENTRY = Bibles
ENTRY = Interpretation, Scriptural
ENTRY = Interpretations, Scriptural
ENTRY = Scriptural Interpretations
MN = K01.517.172
MH_TH = NLM (1966)
ST = T073
ST = T170
AN = Old and New Testament only: does not include Koran (index under ISLAM + specific aspect discussed in article); includes Talmud; CATALOGER: Use NAF entry
MS = The book composed of writings generally accepted by Christians as inspired by God and of divine authority. (Webster, 3d ed)
MR = 20150605
DA = 19990101
DC = 1
UI = D001633

*NEWRECORD
RECTYPE = D
MH = Bibliography as Topic
ENTRY = Bibliography as Topics
MN = L01.178.682.099
MN = L01.453.183
FX = Documentation
MH_TH = NLM (2008)
ST = T170
AN = do not confuse with Publication Type BIBLIOGRAPHY; for bibliography on specific subject, index under subject (IM) + the Publication Type BIBLIOGRAPHY; differentiate from LITERATURE; medical bibliography: see note on BIBLIOGRAPHY OF MEDICINE; lists of books: consider also BOOK SELECTION
MS = Discussion of lists of works, documents or other publications, usually with some relationship between them, e.g., by a given author, on a given subject, or published in a given place, and differing from a catalog in that its contents are restricted to holdings of a single collection, library, or group of libraries. (from The ALA Glossary of Library and Information Science, 1983)
PM = 2008; see BIBLIOGRAPHY 1963-2007
HN = 2008(1963)
MR = 20130709
DA = 19990101
DC = 1
UI = D001634

*NEWRECORD
RECTYPE = D
MH = Bibliography of Medicine
DE = BIBLIOG MED
ENTRY = Bibliographies, Medical|T170|NON|EQV|NLM (1991)|891129|BIBLIOGR MED|abcdefv
ENTRY = Bibliography, Medical|T170|NON|EQV|NLM (1991)|891129|abcdef
ENTRY = Medical Bibliographies|T170|NON|EQV|NLM (1991)|891129|MED BIBLIOGR|abcdefv
ENTRY = Medical Bibliography|T170|NON|EQV|NLM (1991)|891129|MED BIBLIOG|abcdefv
ENTRY = Medicine, Bibliographies|T170|NON|EQV|NLM (1991)|891129|abcdef
ENTRY = Medicine, Bibliography|T170|NON|EQV|NLM (1991)|891129|abcdef
ENTRY = Medicine Bibliographies
ENTRY = Medicine Bibliography
MN = L01.178.682.099.308
MN = L01.453.183.224
MH_TH = NLM (1966)
ST = T170
AN = IM for bibliog of med as a subject; do not use for specific medical subjects: use BIBLIOGRAPHY AS TOPIC instead but see note there; no qualif; Manual 33.9; DF: BIBLIOG MED or BIBLIOGR MED
MS = A list of works, documents, and other publications on medical subjects and topics of interest to the field of medicine.
MR = 20070710
DA = 19990101
DC = 1
UI = D001635

*NEWRECORD
RECTYPE = D
MH = Bibliography, Descriptive
DE = BIBLIOG DESCRIPTIVE
ENTRY = Bibliographies, Descriptive|T170|NON|EQV|NLM (1995)|931124|BIBLIOGR DESCRIPTIVE|abcdefv
ENTRY = Descriptive Bibliographies|T170|NON|EQV|NLM (1995)|931124|DESCRIPTIVE BIBLIOGR|abcdefv
ENTRY = Descriptive Bibliography|T170|NON|EQV|NLM (1995)|931124|DESCRIPTIVE BIBLIOG|abcdefv
MN = L01.453.183.190
MH_TH = NLM (1966)
ST = T170
AN = INDEXER: Do not use
MS = The area of bibliography which makes known precisely the material conditions of books, i.e., the full name of the author, the exact title of the work, the date and place of publication, the publisher's and printer's names, the format, the pagination, typographical particulars, illustrations, and the price, and for old books, other characteristics such as the kind of paper, binding, etc. It is also called analytical bibliography and physical bibliography. (Harrod's Librarians' Glossary, 7th ed)
PM = INSCRIPTIONS was heading 1963-65
HN = INSCRIPTIONS was heading 1963-65
MR = 20150622
DA = 19990101
DC = 1
UI = D001636

*NEWRECORD
RECTYPE = D
MH = Bibliography, National
DE = BIBLIOG NATIONAL
ENTRY = Bibliographies, National|T170|NON|EQV|NLM (1995)|931124|BIBLIOGR NATIONAL|abcdefv
ENTRY = National Bibliographies|T170|NON|EQV|NLM (1995)|931124|NATIONAL BIBLIOGR|abcdefv
ENTRY = National Bibliography|T170|NON|EQV|NLM (1995)|931124|NATIONAL BIBLIOG|abcdefv
MN = L01.178.682.099.183
MH_TH = NLM (1966)
ST = T170
AN = INDEXER: Do not use
MS = A bibliography which lists all the books and other publications published, or distributed in significant quantity, in a particular country. Sometimes the term is used with respect to the new publications published within a specific period, and sometimes with respect to all those published within a lengthy period of many years. It is also used to indicate a bibliography of publications about a country (whether written by its nationals or not) and those written in the language of the country as well as those published in it. (Harrod's Librarians' Glossary, 7th ed)
MR = 20150622
DA = 19990101
DC = 1
UI = D001637

*NEWRECORD
RECTYPE = D
MH = Bibliotherapy
DE = BIBLIOTHER
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Bibliotherapies
MN = E02.831.169
MN = F04.754.168
MH_TH = NLM (1966)
ST = T061
AN = a psychother technique; DF: BIBLIOTHER
MS = A form of supportive psychotherapy in which the patient is given carefully selected material to read.
CATSH = CAT LIST
MR = 19950531
DA = 19990101
DC = 1
UI = D001638

*NEWRECORD
RECTYPE = D
MH = Bicarbonates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Bicarbonate Ions|T196|NON|NRW|NLM (1994)|930106|abcdef
PRINT ENTRY = Hydrogen Carbonates|T197|NON|EQV|NLM (1994)|930106|abcdef
ENTRY = Bicarbonate Ion|T197|NON|NRW|FDA SRS (2014)|NLM (1994)|930106|abcdeef
ENTRY = Carbonic Acid Ions|T196|NON|NRW|NLM (1994)|930106|abcdef
ENTRY = Hydrogen Carbonate|T197|NRW|FDA SRS (2014)|NLM (1999)|990913|abdeef
ENTRY = Carbonate, Hydrogen
ENTRY = Carbonates, Hydrogen
ENTRY = Ions, Bicarbonate
ENTRY = Ions, Carbonic Acid
MN = D01.200.275.150.100
MN = D01.248.497.158.165.100
PA = Buffers
MH_TH = NLM (1966)
ST = T197
RN = 0
RR = 71-52-3 (hydrogen carbonate)
RR = HN1ZRA3Q20
MS = Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.
OL = use BICARBONATES (NM) to search BICARBONATE ION 1981-93
PM = BICARBONATE ION was indexed under BICARBONATES 1981-93
HN = BICARBONATE ION was (NM) 1981-93
MR = 20130708
DA = 19990101
DC = 1
UI = D001639

*NEWRECORD
RECTYPE = D
MH = Bicuculline
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one|T109|T121|NON|EQV|NLM (1995)|940329|abbcdef
MN = D03.132.098.077
MN = D03.438.531.085.077
PA = Convulsants
PA = GABA-A Receptor Antagonists
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Furo(3,4-e)-1,3-benzodioxol-8(6H)-one, 6-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R-(R*,S*))-
RN = Y37615DVKC
RR = 485-49-4 (Bicuculline)
PI = Alkaloids (1972-1974)
PI = Dioxoles (1972-1974)
PI = Isoquinolines (1971-1974)
MS = An isoquinoline alkaloid obtained from Dicentra cucullaria and other plants. It is a competitive antagonist for GABA-A receptors.
PM = 80; was see under ISOQUINOLINES 1975-79
HN = 80(75); was see under ISOQUINOLINES 1975-79
MR = 20130708
DA = 19741111
DC = 1
DX = 19800101
UI = D001640

*NEWRECORD
RECTYPE = D
MH = Bicuspid
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Premolar|T023|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Bicuspids
ENTRY = Premolars
MN = A14.549.167.860.150
MH_TH = NLM (1965)
ST = T023
AN = between the canine & molar teeth; NIM when merely locational
MS = One of the eight permanent teeth, two on either side in each jaw, between the canines (CUSPID) and the molars (MOLAR), serving for grinding and crushing food. The upper have two cusps (bicuspid) but the lower have one to three. (Jablonski, Dictionary of Dentistry, 1992, p822)
PM = 65
HN = 65
MR = 20030709
DA = 19990101
DC = 1
DX = 19650101
UI = D001641

*NEWRECORD
RECTYPE = D
MH = Bicycling
AQ = CL EC ED ES HI IN LJ PH PX SN ST TD
MN = I03.450.642.845.140
MH_TH = NLM (1983)
ST = T056
AN = for transport or recreation: not for test of phys exertion ( = probably BICYCLE ERGOMETRY TEST see EXERCISE TEST); /inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
PI = Exercise Test (1966-1982)
PI = Exertion (1966-1982)
MS = The use of a bicycle for transportation or recreation. It does not include the use of a bicycle in studying the body's response to physical exertion (BICYCLE ERGOMETRY TEST see EXERCISE TEST).
PM = 90; was see under SPORTS 1983-89
HN = 90(83); was see under SPORTS 1983-89
MR = 19970620
DA = 19820428
DC = 1
DX = 19900101
UI = D001642

*NEWRECORD
RECTYPE = D
MH = Bicyclo Compounds
DE = BICYCLO CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compounds, Bicyclo
MN = D02.455.426.100.080
MN = D04.075.080
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = DF: BICYCLO CPDS
OL = search BRIDGED COMPOUNDS 1966-74
PM = 91; was see under BRIDGED COMPOUNDS 1975-90
HN = 91(75); was see under BRIDGED COMPOUNDS 1975-90
MR = 19950608
DA = 19990101
DC = 1
DX = 19910101
UI = D001643

*NEWRECORD
RECTYPE = D
MH = Bifidobacterium
DE = BIFIDOBACT
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.510.024.100
MN = B03.510.460.400.400.049.100
MH_TH = NLM (1984)
ST = T007
AN = infection: coord IM with BIFIDOBACTERIALES INFECTIONS (IM); DF: BIFIDOBACT
PI = Actinomycetaceae (1975-1983)
PI = Actinomycetales (1967-1974)
MS = A rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium that is a genus of the family Bifidobacteriaceae, order Bifidobacteriales, class ACTINOBACTERIA. It inhabits the intestines and feces of humans as well as the human vagina.
PM = 84
HN = 84
MR = 20090706
DA = 19830310
DC = 1
DX = 19840101
UI = D001644

*NEWRECORD
RECTYPE = D
MH = Biguanides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.078.370.141
MH_TH = NLM (1965)
ST = T109
RN = 0
PM = 66
HN = 66(65)
MR = 19920508
DA = 19990101
DC = 1
DX = 19660101
UI = D001645

*NEWRECORD
RECTYPE = D
MH = Bile
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
PRINT ENTRY = Biliary Sludge|T031|NON|NRW|NLM (1996)|950109|abcdef
PRINT ENTRY = Sludge, Biliary|T031|NON|NRW|NLM (1996)|950109|abcdef
MN = A12.200.087
MH_TH = NLM (1966)
ST = T031
AN = stasis = CHOLESTASIS; drugs stimulating or increasing flow of bile = CHOLAGOGUES AND CHOLERETICS
MS = An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum.
MR = 20130709
DA = 19990101
DC = 1
UI = D001646

*NEWRECORD
RECTYPE = D
MH = Bile Acids and Salts
DE = BILE ACIDS SALTS
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Bile Salts|T110|T123|NON|NRW|UNK (19XX)|770312|abbcdef
ENTRY = Bile Acids|T110|T123|NON|NRW|UNK (19XX)|790329|abbcdef
ENTRY = Acids, Bile
ENTRY = Salts, Bile
MN = D04.808.105
PA = Gastrointestinal Agents
MH_TH = NLM (1966)
ST = T110
ST = T123
RN = 0
MS = Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.
MR = 20060705
DA = 19990101
DC = 1
UI = D001647

*NEWRECORD
RECTYPE = D
MH = Bile Canaliculi
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Bile Canaliculus
ENTRY = Canaliculi, Bile
ENTRY = Canaliculus, Bile
MN = A03.159.183.158.125
MN = A03.620.150.125
MH_TH = NLM (1981)
ST = T023
AN = also called "bile capillaries"
PI = Bile Ducts, Intrahepatic (1966-1980)
MS = Minute intercellular channels that occur between liver cells and carry bile towards interlobar bile ducts. Also called bile capillaries.
OL = search BILE DUCTS, INTRAHEPATIC 1980
PM = 91; was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980
HN = 91(81); was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980
MR = 19900413
DA = 19800409
DC = 1
DX = 19910101
UI = D001648

*NEWRECORD
RECTYPE = D
MH = Bile Duct Diseases
DE = BILE DUCT DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bile Duct Disease
ENTRY = Disease, Bile Duct
ENTRY = Diseases, Bile Duct
ENTRY = Duct Disease, Bile
ENTRY = Duct Diseases, Bile
MN = C06.130.120
MH_TH = NLM (1980)
ST = T047
AN = inflamm dis = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS + BILE DUCT DISEASES
PI = Bile Ducts (1966-1979)
PI = Biliary Tract Diseases (1966-1979)
PI = Cholestasis (1966-1979)
PI = specific bile duct
MS = Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20030709
DA = 19790529
DC = 1
DX = 19800101
UI = D001649

*NEWRECORD
RECTYPE = D
MH = Bile Duct Neoplasms
DE = BILE DUCT NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Bile Duct Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Cancer of Bile Duct|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer of the Bile Duct|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Neoplasms, Bile Duct|T191|NON|EQV|NLM (2000)|991103|NEOPL BILE DUCT|abcdefv
ENTRY = Bile Duct Cancers
ENTRY = Bile Duct Neoplasm
ENTRY = Cancer, Bile Duct
ENTRY = Cancers, Bile Duct
ENTRY = Neoplasm, Bile Duct
MN = C04.588.274.120.250
MN = C06.130.120.120
MN = C06.130.320.120
MN = C06.301.120.250
MH_TH = NLM (1966)
ST = T191
AN = coord IM with specific bile duct (IM) + histol type of neopl (IM)
MS = Tumors or cancer of the BILE DUCTS.
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D001650

*NEWRECORD
RECTYPE = D
MH = Cholestasis, Extrahepatic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bile Duct Obstruction, Extrahepatic|T047|NON|EQV|NLM (1980)|990101|abcdef
PRINT ENTRY = Biliary Stasis, Extrahepatic|T047|NON|EQV|UNK (19XX)|790619|abcdef
PRINT ENTRY = Extrahepatic Cholestasis|T047|NON|EQV|NLM (2004)|021115|abcdef
ENTRY = Extrahepatic Biliary Stasis
MN = C06.130.120.135.150
FX = Jaundice, Obstructive
MH_TH = UNK (19XX)
ST = T047
AN = coord IM with specific bile duct (IM) or specific precoord bile duct dis (IM)
PI = Bile Ducts (1966-1979)
PI = Biliary Tract Diseases (1966-1979)
PI = Cholestasis (1966-1979)
PI = specific extrahepatic bile duct (1966-1979)
MS = Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20030709
DA = 19790529
DC = 1
DX = 19800101
UI = D001651

*NEWRECORD
RECTYPE = D
MH = Bile Ducts
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RE RI SE SU TR UL US VI
ENTRY = Bile Duct
ENTRY = Duct, Bile
ENTRY = Ducts, Bile
MN = A03.159.183
FX = Cholangiography
FX = Cholangiopancreatography, Endoscopic Retrograde
FX = Portoenterostomy, Hepatic
EC = radiography:Cholangiography
MH_TH = NLM (1966)
ST = T023
AN = /abnorm: BILIARY ATRESIA is also available; inflammation = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS (IM) + BILE DUCT DISEASES (IM)
MS = The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.
MR = 20030709
DA = 19990101
DC = 1
UI = D001652

*NEWRECORD
RECTYPE = D
MH = Bile Ducts, Intrahepatic
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Bile Duct, Intrahepatic
ENTRY = Duct, Intrahepatic Bile
ENTRY = Ducts, Intrahepatic Bile
ENTRY = Intrahepatic Bile Duct
ENTRY = Intrahepatic Bile Ducts
MN = A03.159.183.158
MN = A03.620.150
MH_TH = NLM (1966)
ST = T023
AN = do not confuse with BILE DUCTS, EXTRAHEPATIC; do not confuse with HEPATIC DUCT, COMMON, the external junction of right & left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES (IM); neopl: coord IM with BILE DUCT NEOPLASMS (IM); inflammation: coord IM with CHOLANGITIS (IM); BILE DUCT OBSTRUCTION, INTRAHEPATIC see CHOLESTASIS, INTRAHEPATIC is also available
MS = Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.
MR = 19980610
DA = 19990101
DC = 1
UI = D001653

*NEWRECORD
RECTYPE = D
MH = Bile Pigments
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Bile Pigment|T123|NON|EQV|NLM (1991)|891012|abcdef
ENTRY = Bilin|T109|T123|NON|NRW|UNK (19XX)|840919|abbcdef
ENTRY = Pigment, Bile
ENTRY = Pigments, Bile
MN = D03.383.129.578.840.249
MN = D03.549.909.249
MN = D04.345.783.249
MN = D23.767.193
MH_TH = NLM (1966)
ST = T123
RN = 0
MS = Linear TETRAPYRROLES that give a characteristic color to BILE including: BILIRUBIN; BILIVERDIN; and bilicyanin.
MR = 20050630
DA = 19990101
DC = 1
UI = D001654

*NEWRECORD
RECTYPE = D
MH = Bile Reflux
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Reflux, Bile
MN = C06.130.140
MN = C06.405.748.240.140
MH_TH = NLM (1981)
ST = T047
PI = Bile (1966-1980)
PI = Gastritis (1966-1980)
MS = Retrograde bile flow. Reflux of bile can be from the duodenum to the stomach (DUODENOGASTRIC REFLUX); to the esophagus (GASTROESOPHAGEAL REFLUX); or to the PANCREAS.
PM = 91; was see under BILIARY TRACT DISEASES 1981-90
HN = 91(81); was see under BILIARY TRACT DISEASES 1981-90
CATSH = CAT LIST
MR = 20030709
DA = 19800404
DC = 1
DX = 19910101
UI = D001655

*NEWRECORD
RECTYPE = D
MH = Biliary Atresia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Atresia, Biliary|T019|T047|NON|EQV|NLM (1995)|940105|abbcdef
ENTRY = Biliary Atresia, Extrahepatic|T019|T047|NON|EQV|NLM (2011)|OMIM (2013)|ORD (2010)|100401|abbcdeeef
ENTRY = Familial Extrahepatic Biliary Atresia|T019|T047|NON|NRW|NLM (2011)|ORD (2010)|100401|abbcdeef
ENTRY = Idiopathic Extrahepatic Biliary Atresia|T019|T047|NON|NRW|NLM (2011)|ORD (2010)|100401|abbcdeef
ENTRY = Atresia, Extrahepatic Biliary
ENTRY = Atresias, Extrahepatic Biliary
ENTRY = Biliary Atresias, Extrahepatic
ENTRY = Extrahepatic Biliary Atresia
ENTRY = Extrahepatic Biliary Atresias
MN = C06.130.120.123
MN = C06.198.125
MN = C16.131.314.125
MH_TH = NLM (1987)
ST = T019
ST = T047
AN = do not coord with INFANT, NEWBORN, DISEASES
PI = Bile Ducts/abnormalities (1966-1986)
MS = Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20120703
DA = 19860403
DC = 1
DX = 19870101
UI = D001656

*NEWRECORD
RECTYPE = D
MH = Biliary Dyskinesia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Gallbladder Dyskinesia|T047|NON|NRW|NLM (2005)|031021|abcdef
ENTRY = Biliary Dyskinesias
ENTRY = Dyskinesia, Biliary
ENTRY = Dyskinesia, Gallbladder
ENTRY = Dyskinesias, Biliary
ENTRY = Dyskinesias, Gallbladder
ENTRY = Gallbladder Dyskinesias
MN = C06.130.120.250.098
MH_TH = NLM (1966)
ST = T047
MS = A motility disorder characterized by biliary COLIC, absence of GALLSTONES, and an abnormal GALLBLADDER ejection fraction. It is caused by gallbladder dyskinesia and/or SPHINCTER OF ODDI DYSFUNCTION.
CATSH = CAT LIST
MR = 20050801
DA = 19990101
DC = 1
UI = D001657

*NEWRECORD
RECTYPE = D
MH = Biliary Fistula
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Biliary Fistulas
ENTRY = Fistula, Biliary
ENTRY = Fistulas, Biliary
MN = C06.267.150
MN = C23.300.575.185.150
MH_TH = NLM (1966)
ST = T046
ST = T190
AN = coord IM with specific precoord biliary tract/dis heading (IM); fistula policy: Manual 23.19+
MS = Abnormal passage in any organ of the biliary tract or between biliary organs and other organs.
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D001658

*NEWRECORD
RECTYPE = D
MH = Biliary Tract
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE UL US VI
ENTRY = Biliary System|T023|NON|EQV|NLM (2004)|020926|abcdef
ENTRY = Biliary Tree|T023|NON|EQV|NLM (2004)|020926|abcdef
ENTRY = System, Biliary
ENTRY = Tract, Biliary
ENTRY = Tree, Biliary
MN = A03.159
FX = Cholagogues and Choleretics
FX = Cholangiography
FX = Cholecystography
EC = surgery:Biliary Tract Surgical Procedures
MH_TH = NLM (1966)
ST = T023
AN = /abnorm: BILIARY ATRESIA is also available; /radiogr permitted but CHOLECYSTOGRAPHY for gallbladder x-ray & CHOLANGIOGRAPHY for bile duct x-ray are available; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS; empyema = EMPYEMA, GALLBLADDER see CHOLECYSTITIS or EMPYEMA (IM) + BILIARY TRACT DISEASES (IM) if not of gallbladder; inflammation = CHOLECYSTITIS or CHOLANGITIS
MS = The BILE DUCTS and the GALLBLADDER.
MR = 20030709
DA = 19990101
DC = 1
UI = D001659

*NEWRECORD
RECTYPE = D
MH = Biliary Tract Diseases
DE = BILIARY TRACT DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Biliary Tract Disease
ENTRY = Disease, Biliary Tract
ENTRY = Diseases, Biliary Tract
ENTRY = Tract Disease, Biliary
ENTRY = Tract Diseases, Biliary
MN = C06.130
FX = Cholangiography
MH_TH = NLM (1966)
ST = T047
AN = GEN: prefer specifics; biliary empyema = EMPYEMA (IM) + BILIARY TRACT DISEASES (IM) or if of gallbladder, EMPYEMA, GALLBLADDER see CHOLECYSTITIS; inflamm dis = CHOLECYSTITIS or CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS
MS = Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
DX = 19660101
UI = D001660

*NEWRECORD
RECTYPE = D
MH = Biliary Tract Neoplasms
DE = BILIARY TRACT NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Biliary Tract Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Cancer of Biliary Tract|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer of the Biliary Tract|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Neoplasms, Biliary Tract|T191|NON|EQV|NLM (2000)|991103|NEOPL BILIARY TRACT|abcdefv
ENTRY = Biliary Tract Cancers
ENTRY = Biliary Tract Neoplasm
ENTRY = Cancer, Biliary Tract
ENTRY = Cancers, Biliary Tract
ENTRY = Neoplasm, Biliary Tract
MN = C04.588.274.120
MN = C06.130.320
MN = C06.301.120
MH_TH = NLM (1980)
ST = T191
AN = GEN: prefer specifics; coord IM with histol type of neopl (IM)
PI = Bile Duct Neoplasms (1966-1979)
PI = Gallbladder Neoplasms (1966-1979)
MS = Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20030709
DA = 19790529
DC = 1
DX = 19800101
UI = D001661

*NEWRECORD
RECTYPE = D
MH = Biliary Tract Surgical Procedures
DE = BILIARY TRACT SURG PROCEDURES
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Biliary Surgical Procedures|T061|NON|EQV|NLM (1998)|970210|BILIARY SURG PROCEDURES|abcdefv
ENTRY = Biliary Surgical Procedure|T061|NON|EQV|NLM (1998)|970210|BILIARY SURG PROCEDURE|abcdefv
ENTRY = Biliary Tract Surgical Procedure|T061|NON|EQV|NLM (1998)|970210|BILIARY TRACT SURG PROCEDURE|abcdefv
ENTRY = Surgical Procedure, Biliary|T061|NON|EQV|NLM (1998)|970210|SURG PROCEDURE BILIARY|abcdefv
ENTRY = Surgical Procedure, Biliary Tract|T061|NON|EQV|NLM (1998)|970210|SURG PROCEDURE BILIARY TRACT|abcdefv
ENTRY = Surgical Procedures, Biliary|T061|NON|EQV|NLM (1998)|970210|SURG PROCEDURES BILIARY|abcdefv
ENTRY = Surgical Procedures, Biliary Tract|T061|NON|EQV|NLM (1998)|970210|SURG PROCEDURES BILIARY TRACT|abcdefv
MN = E04.210.120
MH_TH = NLM (1988)
ST = T061
AN = GEN only: prefer specific organ with /surg or specific biliary surg technique; do not use /util except by MeSH definition.
PI = Biliary Tract Diseases/surgery (1966-1987)
PI = Biliary Tract/surgery (1966-1987)
MS = Any surgical procedure performed on the biliary tract.
PM = 98; see BILIARY TRACT SURGERY 1988-97
HN = 98(88)
CATSH = CAT LIST
MR = 19970620
DA = 19870323
DC = 1
DX = 19880101
UI = D001662

*NEWRECORD
RECTYPE = D
MH = Bilirubin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Bilirubin IX alpha|T109|T123|NON|EQV|UNK (19XX)|840919|abbcdef
ENTRY = Bilirubin, (15E)-Isomer|T109|T123|NRW|NLM (1999)|990913|abbdef
ENTRY = Bilirubin, (4E)-Isomer|T109|T123|NRW|NLM (1999)|990913|abbdef
ENTRY = Bilirubin, (4E,15E)-Isomer|T109|T123|NRW|NLM (1999)|990913|abbdef
ENTRY = Bilirubin, Calcium Salt|T109|T123|NRW|NLM (1999)|990913|abbdef
ENTRY = Bilirubin, Disodium Salt|T109|T123|NRW|NLM (1999)|990913|abbdef
ENTRY = Bilirubin, Monosodium Salt|T109|T123|NRW|NLM (1999)|990913|abbdef
ENTRY = Calcium Bilirubinate|T109|T123|NON|NRW|UNK (19XX)|821124|abbcdef
ENTRY = Hematoidin|T109|T121|TRD|REL|UNK (19XX)|820204|abbcdef
ENTRY = delta-Bilirubin|T109|T123|NON|REL|UNK (19XX)|881119|abbcdef
ENTRY = Bilirubinate, Calcium
ENTRY = Calcium Salt Bilirubin
ENTRY = Disodium Salt Bilirubin
ENTRY = Monosodium Salt Bilirubin
ENTRY = Salt Bilirubin, Calcium
ENTRY = delta Bilirubin
MN = D03.383.129.578.840.249.184
MN = D03.549.909.249.184
MN = D04.345.783.249.184
MN = D23.767.193.184
PA = Antioxidants
FX = Hyperbilirubinemia
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T123
N1 = 21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-
RN = RFM9X3LJ49
RR = 18422-02-1 (Ca salt)
RR = 635-65-4 (Bilirubin)
RR = 69853-42-5 ((15E)-isomer)
RR = 69853-43-6 ((4E)-isomer)
RR = 69853-44-7 ((4E,15E)-isomer)
RR = 7240-17-7 (mono-Na salt)
RR = 93891-87-3 (di-Na salt)
AN = BILIRUBIN ENCEPHALOPATHY see KERNICTERUS is available
MS = A bile pigment that is a degradation product of HEME.
MR = 20130708
DA = 19990101
DC = 1
UI = D001663

*NEWRECORD
RECTYPE = D
MH = Biliverdine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Dehydrobilirubin|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|750630|abbcdeef
PRINT ENTRY = Ooecyan|T109|T123|NON|EQV|UNK (19XX)|750630|abbcdef
PRINT ENTRY = Uteroverdine|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|750630|abbcdeef
ENTRY = Biliverdin|T109|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|750630|abbcdeef
ENTRY = Biliverdin IX|T109|T123|NON|NRW|UNK (19XX)|820902|abbcdef
ENTRY = Biliverdin IX alpha|T109|T123|NON|NRW|UNK (19XX)|801120|abbcdef
ENTRY = IX alpha, Biliverdin
ENTRY = IX, Biliverdin
ENTRY = alpha, Biliverdin IX
MN = D03.383.129.578.840.249.184.200
MN = D03.549.909.249.184.200
MN = D04.345.783.249.184.200
MN = D23.767.193.184.200
MH_TH = NLM (1976)
ST = T109
ST = T123
N1 = 21H-Biline-8,12-dipropanoic acid, 3,18-diethenyl-1,19,22,24-tetrahydro-2,7,13,17-tetramethyl-1,19-dioxo-
RN = O9MIA842K9
RR = 114-25-0 (Biliverdine)
AN = a bile pigment in amphibia & birds but not in normal human bile; /biosyn /physiol permitted
PI = Bilirubin (1969-1975)
MS = 1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of AMPHIBIANS and of birds, but not in normal human bile or serum.
PM = 91; was see under BILIRUBIN 1976-90
HN = 91(76); was see under BILIRUBIN 1976-90
MR = 20130708
DA = 19750718
DC = 1
DX = 19910101
UI = D001664

*NEWRECORD
RECTYPE = D
MH = Binding Sites
AQ = DE GE IM PH RE
PRINT ENTRY = Combining Site|T120|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Binding Site|T120|NON|EQV|NLM (2008)|070604|abcdef
ENTRY = Combining Sites
ENTRY = Site, Binding
ENTRY = Site, Combining
ENTRY = Sites, Binding
ENTRY = Sites, Combining
MN = G02.111.570.120
FX = Protein Binding
FX = Receptors, Cell Surface
MH_TH = NLM (1968)
ST = T120
AN = usually NIM; do not use as substitute for chemistry or metabolic mechanism of binding; do not coordinate with receptors terms unless specifically discussed
PI = Antigen-Antibody Reactions (1966-1967)
PI = Enzymes (1966-1967)
MS = The parts of a macromolecule that directly participate in its specific combination with another molecule.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D001665

*NEWRECORD
RECTYPE = D
MH = Binding Sites, Antibody
AQ = DE GE IM PH RE
PRINT ENTRY = Antibody Binding Sites|T129|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Paratopes|T129|NON|EQV|NLM (1993)|910916|abcdef
ENTRY = Antibody Binding Site
ENTRY = Binding Site, Antibody
ENTRY = Paratope
MN = G02.111.570.060.425.079
MN = G02.111.570.120.408
MN = G12.125
MN = G12.425.143.232
FX = Antibody Affinity
MH_TH = NLM (1973)
ST = T129
PI = Antibodies (1966-1972)
PI = Antigens (1966-1972)
PI = Binding Sites (1968-1972)
MS = Local surface sites on antibodies which react with antigen determinant sites on antigens (EPITOPES.) They are formed from parts of the variable regions of FAB FRAGMENTS.
PM = 73
HN = 73; was in Cat D only 1973-76
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
DX = 19730101
UI = D001666

*NEWRECORD
RECTYPE = D
MH = Binding, Competitive
AQ = DE GE IM PH RE
PRINT ENTRY = Competitive Binding|T044|NON|EQV|UNK (19XX)|740329|abcdef
MN = E05.196.080
MN = G02.111.087.090
MN = G02.111.570.120.309
MN = G02.149.115.090
MH_TH = NLM (1973)
ST = T044
PI = Binding Sites (1968-1972)
MS = The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements.
PM = 73
HN = 73
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19730101
UI = D001667

*NEWRECORD
RECTYPE = D
MH = Biobibliography as Topic
ENTRY = Biobibliography as Topics
MN = L01.178.682.099.434
MN = L01.453.183.392
MH_TH = NLM (2008)
ST = T073
ST = T170
AN = for biobibliography of a biographee coordinate NIM with the Publication Type BIBLIOGRAPHY; do not confuse with the Publication Type BIOBIBLIOGRAPHY
MS = A biography which includes a list of the writings of the subject person.
PM = 2008; see BIOBIBLIOGRAPHY 1963-2007
HN = 2008(1963)
MR = 20130709
DA = 19990101
DC = 1
UI = D001668

*NEWRECORD
RECTYPE = D
MH = Biochemical Phenomena
DE = BIOCHEM PHENOMENA
AQ = DE ES RE
ENTRY = Biochemical Concepts|T070|NON|EQV|NLM (2009)|080627|abcdef
ENTRY = Biochemical Phenomenon|T070|NON|EQV|NLM (2009)|080627|abcdef
ENTRY = Phenomena, Biochemical|T070|NON|EQV|NLM (1998)|960912|PHENOMENA BIOCHEM|abcdefv
ENTRY = Biochemical Concept
ENTRY = Concept, Biochemical
ENTRY = Concepts, Biochemical
ENTRY = Phenomenon, Biochemical
MN = G02.111
MH_TH = NLM (1966)
ST = T070
AN = general or unspecified; prefer specifics
PI = Biochemistry (1966-1997)
MS = The chemical processes, enzymatic activities, and pathways of living things and related temporal, dimensional, qualitative, and quantitative concepts.
PM = 98
HN = 98; use explode 1970-97
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19980101
UI = D001669

*NEWRECORD
RECTYPE = D
MH = Biochemistry
DE = BIOCHEM
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = H01.158.201
MN = H01.181.122
MH_TH = NLM (1966)
ST = T090
AN = the discipline (education, history, etc) only; use BIOCHEMICAL PHENOMENA or specifics treed under it for chemical processes and reactions of biological systems
MS = The study of the composition, chemical structures, and chemical reactions of living things.
MR = 20090706
DA = 19990101
DC = 1
UI = D001671

*NEWRECORD
RECTYPE = D
MH = Biocompatible Materials
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Biomaterials|T122|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Hemocompatible Materials|T122|NON|NRW|NLM (2006)|040914|abcdef
ENTRY = Materials, Biocompatible
ENTRY = Materials, Hemocompatible
MN = D25.130
MN = D27.720.102.130
MN = J01.637.051.130
FX = Biomimetic Materials
FX = Materials Testing
MH_TH = NLM (1972)
ST = T122
RN = 0
PI = Prosthesis (1966-1971)
MS = Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.
PM = 73
HN = 73(72)
MR = 20060705
DA = 19990101
DC = 1
DX = 19730101
UI = D001672

*NEWRECORD
RECTYPE = D
MH = Biodegradation, Environmental
AQ = DE RE
PRINT ENTRY = Bioremediation|T069|NON|NRW|NLM (2001)|991208|abcdef
PRINT ENTRY = Phytoremediation|T069|NON|NRW|NLM (2007)|051006|abcdef
ENTRY = Natural Attenuation, Pollution|T069|NON|NRW|NLM (2007)|051006|abcdef
ENTRY = Environmental Biodegradation
ENTRY = Pollution Natural Attenuation
MN = N06.230.080.600.500
MN = N06.850.460.375.500
MH_TH = NLM (2007)
ST = T069
AN = NIM when specific substance is IM; do not confuse with BIOTRANSFORMATION: see note there; for PHYTOREMEDIATION coordinate with PLANTS
PI = Biophysics (1966-1968)
PI = Sanitary Engineering (1966-1968)
PI = appropriate material
MS = Elimination of ENVIRONMENTAL POLLUTANTS; PESTICIDES and other waste using living organisms, usually involving intervention of environmental or sanitation engineers.
PM = 2007; see BIODEGRADATION 1978-2006; see SANITARY ENGINEERING 1975-1977;
HN = 2007(1969)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19780101
UI = D001673

*NEWRECORD
RECTYPE = D
MH = Bioelectric Energy Sources
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Power Sources, Bioelectric|T073|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Biobatteries|T073|NON|NRW|NLM (2010)|090224|abcdef
ENTRY = Biofuel Cells|T073|NON|NRW|NLM (2010)|090224|abcdef
ENTRY = Microbial Fuel Cells|T073|NON|NRW|NLM (2010)|090224|abcdef
ENTRY = Biobattery
ENTRY = Bioelectric Energy Source
ENTRY = Bioelectric Power Source
ENTRY = Bioelectric Power Sources
ENTRY = Biofuel Cell
ENTRY = Cell, Biofuel
ENTRY = Cell, Microbial Fuel
ENTRY = Cells, Biofuel
ENTRY = Cells, Microbial Fuel
ENTRY = Energy Source, Bioelectric
ENTRY = Energy Sources, Bioelectric
ENTRY = Fuel Cell, Microbial
ENTRY = Fuel Cells, Microbial
ENTRY = Microbial Fuel Cell
ENTRY = Power Source, Bioelectric
ENTRY = Source, Bioelectric Energy
ENTRY = Source, Bioelectric Power
ENTRY = Sources, Bioelectric Energy
ENTRY = Sources, Bioelectric Power
MN = E07.305.124.150
MH_TH = NLM (1974)
ST = T073
AN = includes ionic concentration cells, biogalvanic cells, etc; do not confuse entry term BIOFUEL CELLS with BIOFUELS
MS = Electric power supply devices which convert biological energy, such as chemical energy of metabolism or mechanical energy of periodic movements, into electrical energy.
PM = 74
HN = 74
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19740101
UI = D001674

*NEWRECORD
RECTYPE = D
MH = Bioethics
AQ = ED HI TD
ENTRY = Biomedical Ethics|T078|T091|NON|NRW|NLM (2003)|020129|abbcdef
ENTRY = Health Care Ethics|T078|T091|NON|NRW|NLM (2003)|020129|abbcdef
ENTRY = Ethics, Biomedical
ENTRY = Ethics, Health Care
MN = K01.752.566.479.045
MN = N05.350.200
FX = Ethicists
FX = Ethics, Medical
MH_TH = BIOETHICS (1989)
ST = T078
ST = T091
AN = SPEC only; for issues in bioethics use BIOETHICAL ISSUES or its specifics; ETHICISTS is also available
PI = Ethics, Medical (1966-1977)
MS = A branch of applied ethics that studies the value implications of practices and developments in life sciences, medicine, and health care.
PM = 78
HN = 78
MR = 20150622
DA = 19770422
DC = 1
DX = 19780101
UI = D001675

*NEWRECORD
RECTYPE = D
MH = Biofeedback, Psychology
AQ = CL DE ES IS MT PH RE
PRINT ENTRY = Biofeedback (Psychology)|T061|NON|EQV|NLM (1977)|990101|BIOFEEDBACK PSYCHOL|abcdefv
PRINT ENTRY = Bogus Physiological Feedback|T041|T061|NON|NRW|NLM (2010)|081110|abbcdef
PRINT ENTRY = False Physiological Feedback|T041|T061|NON|NRW|NLM (2010)|081110|abbcdef
PRINT ENTRY = Feedback, Psychophysiologic|T061|NON|EQV|UNK (19XX)|760414|FEEDBACK PSYCHOPHYSIOL|abcdefv
ENTRY = Biofeedback|T061|NON|EQV|UNK (19XX)|790326|abcdef
ENTRY = Feedback, Psychophysiological|T061|NON|EQV|NLM (1992)|910611|abcdef
ENTRY = Myofeedback|T041|T061|NON|NRW|NLM (2012)|101007|abbcdef
ENTRY = Psychophysiologic Feedback|T061|NON|EQV|UNK (19XX)|760414|PSYCHOPHYSIOL FEEDBACK|abcdefv
ENTRY = Biofeedbacks
ENTRY = Biofeedbacks (Psychology)
ENTRY = Biofeedbacks, Psychology
ENTRY = Bogus Physiological Feedbacks
ENTRY = False Physiological Feedbacks
ENTRY = Feedback, Bogus Physiological
ENTRY = Feedback, False Physiological
ENTRY = Feedbacks, Bogus Physiological
ENTRY = Feedbacks, False Physiological
ENTRY = Myofeedbacks
ENTRY = Physiological Feedback, Bogus
ENTRY = Physiological Feedback, False
ENTRY = Physiological Feedbacks, Bogus
ENTRY = Physiological Feedbacks, False
ENTRY = Psychology Biofeedback
ENTRY = Psychology Biofeedbacks
MN = E02.190.525.123
MN = F02.830.131
MN = F04.754.137.301
MN = F04.754.308.500
MN = L01.143.283.425.624.500
FX = Feedback
MH_TH = NLM (2010)
ST = T061
AN = FEEDBACK, PSYCHOLOGICAL is also available
PI = Feedback (1966-1976)
MS = The therapy technique of providing the status of one's own AUTONOMIC NERVOUS SYSTEM function (e.g., skin temperature, heartbeats, brain waves) as visual or auditory feedback in order to self-control related conditions (e.g., hypertension, migraine headaches).
PM = 77
HN = 77
CATSH = CAT LIST
MR = 20110624
DA = 19760416
DC = 1
DX = 19770101
UI = D001676

*NEWRECORD
RECTYPE = D
MH = Organelle Biogenesis
ENTRY = Mitochondrial Biogenesis|T043|NON|NRW|NLM (2013)|120406|abcdef
ENTRY = Biogeneses, Organelle
ENTRY = Biogenesis, Mitochondrial
ENTRY = Biogenesis, Organelle
ENTRY = Organelle Biogeneses
MN = G04.618
MN = G16.100.400
FX = Origin of Life
MH_TH = NLM (2016)
ST = T070
AN = distinguish from biogenesis in the context of ORIGIN OF LIFE
MS = The natural growth and development within living CELLS.
PM = 2016; see BIOGENESIS 1979-2015, for BIOGENESIS, MITOCHONDRIAL see MITOCHONDRIAL TURNOVER 2013-2105
HN = 2016(1979); for BIOGENESIS, MITOCHONDRIAL use MITOCHONDRIAL TURNOVER 2013-2015
CATSH = CAT LIST
MR = 20150710
DA = 19990101
DC = 1
UI = D001678

*NEWRECORD
RECTYPE = D
MH = Biogenic Amines
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
PRINT ENTRY = Amines, Biogenic|T109|T121|T124|T125|NON|EQV|UNK (19XX)|880531|abbbbcdef
ENTRY = Biogenic Amine|T109|T121|T124|T125|NON|EQV|NLM (1994)|930414|abbbbcdef
ENTRY = Amine, Biogenic
MN = D02.092.211
FX = Receptors, Biogenic Amine
MH_TH = NLM (1971)
ST = T109
ST = T121
ST = T124
ST = T125
RN = 0
AN = GEN or unspecified: prefer specific biogenic amine group term or specific biogenic amine indented under each
PI = Amines (1966-1970)
MS = A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology.
PM = 73
HN = 73(71)
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D001679

*NEWRECORD
RECTYPE = D
MH = Biography as Topic
ENTRY = Biography as Topics
ENTRY = Topic, Biography as
ENTRY = Topics, Biography as
ENTRY = as Topic, Biography
ENTRY = as Topics, Biography
MN = K01.517.211
FX = Autobiography as Topic
MH_TH = NLM (2008)
ST = T170
AN = use only for biography as a subject; memoirs as a subject go under AUTOBIOGRAPHY AS TOPIC. For biographies of persons use the Publication Type BIOGRAPHY
MS = A written account of a person's life and the branch of literature concerned with the lives of people. (Harrod's Librarians' Glossary, 7th ed)
PM = 2008; see BIOGRAPHY 1963-2007
HN = 2008(1963)
MR = 20100625
DA = 19990101
DC = 1
UI = D001680

*NEWRECORD
RECTYPE = D
MH = Biological Assay
DE = BIOL ASSAY
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Bioassay|T059|NON|EQV|UNK (19XX)|860623|abcdef
ENTRY = Assay, Biological|T059|NON|EQV|NLM (1990)|890831|ASSAY BIOL|abcdefv
ENTRY = Assays, Biological|T059|NON|EQV|UNK (19XX)|880411|ASSAYS BIOL|abcdefv
ENTRY = Biologic Assay|T059|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Biologic Assays|T059|NON|EQV|UNK (19XX)|880411|BIOL ASSAYS|abcdefv
ENTRY = Assay, Biologic
ENTRY = Assays, Biologic
ENTRY = Bioassays
ENTRY = Biological Assays
MN = E05.091
MH_TH = NLM (1966)
ST = T059
AN = assays using living-matter intermediate; check text: not all "bioassays" are MeSH term BIOLOGICAL ASSAY; Manual 22.27; DF: BIOL ASSAY
MS = A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc.
CATSH = CAT LIST
MR = 19920325
DA = 19990101
DC = 1
UI = D001681

*NEWRECORD
RECTYPE = D
MH = Biological Availability
DE = BIOL AVAILABILITY
PRINT ENTRY = Availability Equivalency|T081|NON|NRW|UNK (19XX)|860408|abcdef
PRINT ENTRY = Bioavailability|T081|NON|EQV|UNK (19XX)|770421|abcdef
PRINT ENTRY = Physiologic Availability|T081|NON|EQV|UNK (19XX)|790530|PHYSIOL AVAILABILITY|abcdefv
ENTRY = Availability, Biologic|T081|NON|EQV|NLM (1990)|890831|abcdef
ENTRY = Availability, Biological|T081|NON|EQV|NLM (1990)|890831|AVAILABILITY BIOL|abcdefv
ENTRY = Availability, Physiologic|T081|NON|EQV|UNK (19XX)|790530|AVAILABILITY PHYSIOL|abcdefv
ENTRY = Biologic Availability|T081|NON|EQV|UNK (19XX)|780201|abcdef
ENTRY = Availabilities, Biologic
ENTRY = Availabilities, Biological
ENTRY = Availabilities, Physiologic
ENTRY = Availability Equivalencies
ENTRY = Bioavailabilities
ENTRY = Biologic Availabilities
ENTRY = Biological Availabilities
ENTRY = Equivalencies, Availability
ENTRY = Equivalency, Availability
ENTRY = Physiologic Availabilities
MN = G03.787.151
MN = G07.690.725.129
MH_TH = NLM (1975)
ST = T081
AN = NIM with specific drug /pharmacokin (IM); no qualif; DF: BIOL AVAILABILITY
PI = Biopharmaceutics (1966-1974)
PI = Drug Compounding (1966-1969)
PI = Drugs (1966-1969)
PI = Pharmacology (1966-1969)
MS = The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.
OL = use BIOLOGICAL AVAILABILITY to search AVAILABILITY EQUIVALENCY 1980-86, BIOLOGIC AVAILABILITY & PHYSIOLOGIC AVAILABILITY 1975-79, & BIOPHARMACEUTICS 1970-74
PM = 79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; AVAILABILITY EQUIVALENCY & PHYSIOLOGIC AVAILABILITY were see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOLOGICAL AVAILABILITY 1980-86
HN = 79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19790101
UI = D001682

*NEWRECORD
RECTYPE = D
MH = Biological Clocks
DE = BIOL CLOCKS
AQ = DE GE IM PH RE
PRINT ENTRY = Biological Oscillators|T040|NON|NRW|UNK (19XX)|850619|BIOL OSCILLATORS|abcdefv
PRINT ENTRY = Oscillators, Endogenous|T040|NON|NRW|UNK (19XX)|850619|abcdef
PRINT ENTRY = Pacemakers, Biological|T040|NON|NRW|UNK (19XX)|850619|PACEMAKERS BIOL|abcdefv
ENTRY = Biologic Clock|T040|NON|EQV|NLM (1990)|890831|BIOL CLOCK|abcdefv
ENTRY = Biologic Oscillator|T040|NON|NRW|NLM (1992)|910512|BIOL OSCILLATOR|abcdefv
ENTRY = Biological Pacemakers|T040|NON|NRW|NLM (1990)|890831|BIOL PACEMAKERS|abcdefv
ENTRY = Clock, Biologic|T040|NON|EQV|NLM (1992)|910512|CLOCK BIOL|abcdefv
ENTRY = Clocks, Biological|T040|NON|EQV|NLM (1992)|910512|CLOCKS BIOL|abcdefv
ENTRY = Oscillator, Biologic|T040|NON|NRW|NLM (1992)|910512|OSCILLATOR BIOL|abcdefv
ENTRY = Oscillators, Biological|T040|NON|NRW|NLM (1992)|910512|OSCILLATORS BIOL|abcdefv
ENTRY = Pacemaker, Biologic|T040|NON|NRW|NLM (1990)|890831|PACEMAKER BIOL|abcdefv
ENTRY = Pacemakers, Biologic|T040|NON|NRW|NLM (1990)|890831|abcdef
ENTRY = Biologic Clocks
ENTRY = Biologic Oscillators
ENTRY = Biologic Pacemaker
ENTRY = Biologic Pacemakers
ENTRY = Biological Clock
ENTRY = Biological Oscillator
ENTRY = Biological Pacemaker
ENTRY = Clock, Biological
ENTRY = Clocks, Biologic
ENTRY = Endogenous Oscillator
ENTRY = Endogenous Oscillators
ENTRY = Oscillator, Biological
ENTRY = Oscillator, Endogenous
ENTRY = Oscillators, Biologic
ENTRY = Pacemaker, Biological
MN = G07.180.562.094
FX = Circadian Rhythm
FX = Sleep Disorders, Circadian Rhythm
MH_TH = NLM (1964)
ST = T040
MS = The physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioral phenomena.
PM = 67
HN = 67(64)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19670101
UI = D001683

*NEWRECORD
RECTYPE = D
MH = Biological Dressings
DE = BIOL DRESSINGS
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Allograft Dressings|T074|NON|NRW|UNK (19XX)|810223|abcdef
PRINT ENTRY = Amniotic Membrane Dressings|T074|NON|NRW|UNK (19XX)|800515|abcdef
PRINT ENTRY = Dressings, Biological|T074|NON|EQV|UNK (19XX)|800515|DRESSINGS BIOL|abcdefv
PRINT ENTRY = Heterograft Dressings|T074|NON|NRW|UNK (19XX)|800515|abcdef
PRINT ENTRY = Homograft Dressings|T074|NON|NRW|UNK (19XX)|810223|abcdef
PRINT ENTRY = Pig Skin Dressings|T074|NON|NRW|UNK (19XX)|800515|abcdef
PRINT ENTRY = Porcine Xenograft Dressings|T074|NON|NRW|UNK (19XX)|800515|abcdef
PRINT ENTRY = Xenograft Dressings|T074|NON|NRW|UNK (19XX)|800515|abcdef
ENTRY = Biologic Dressing|T074|NON|EQV|NLM (1990)|890831|BIOL DRESSING|abcdefv
ENTRY = Dressing, Biological|T074|NON|EQV|NLM (1990)|890831|DRESSING BIOL|abcdefv
ENTRY = Allograft Dressing
ENTRY = Amniotic Membrane Dressing
ENTRY = Biologic Dressings
ENTRY = Biological Dressing
ENTRY = Dressing, Allograft
ENTRY = Dressing, Amniotic Membrane
ENTRY = Dressing, Biologic
ENTRY = Dressing, Heterograft
ENTRY = Dressing, Homograft
ENTRY = Dressing, Pig Skin
ENTRY = Dressing, Porcine Xenograft
ENTRY = Dressing, Xenograft
ENTRY = Dressings, Allograft
ENTRY = Dressings, Amniotic Membrane
ENTRY = Dressings, Biologic
ENTRY = Dressings, Heterograft
ENTRY = Dressings, Homograft
ENTRY = Dressings, Pig Skin
ENTRY = Dressings, Porcine Xenograft
ENTRY = Dressings, Xenograft
ENTRY = Heterograft Dressing
ENTRY = Homograft Dressing
ENTRY = Pig Skin Dressing
ENTRY = Porcine Xenograft Dressing
ENTRY = Xenograft Dressing
ENTRY = Xenograft Dressing, Porcine
ENTRY = Xenograft Dressings, Porcine
MN = E07.101.150
MH_TH = NLM (1978)
ST = T074
AN = "human or animal tissue used as temporary wound covering"; do not specify source unless especially discussed & do not coord with TRANSPLANTATION, HETEROLOGOUS; note X refs below; DF: BIOL DRESSINGS
PI = Bandages (1966-1977)
PI = Skin/transplantation (1966-1977)
MS = Human or animal tissue used as temporary wound coverings.
PM = 91; was see under BANDAGES 1978-90
HN = 91(78); was see under BANDAGES 1978-90
CATSH = CAT LIST
MR = 19920325
DA = 19770301
DC = 1
DX = 19910101
UI = D001684

*NEWRECORD
RECTYPE = D
MH = Biological Factors
DE = BIOL FACTORS
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Biological Agents|T123|NON|EQV|NLM (2012)|110504|abcdef
ENTRY = Biologic Agents|T123|NON|EQV|NLM (2014)|130613|abcdef
ENTRY = Biologic Factors|T123|NON|EQV|UNK (19XX)|880607|abcdef
ENTRY = Biological Factor|T123|NON|EQV|NLM (1992)|900927|BIOL FACTOR|abcdefv
ENTRY = Factor, Biologic|T123|NON|EQV|NLM (1992)|900927|abcdef
ENTRY = Factor, Biological|T123|NON|EQV|NLM (1992)|900927|FACTOR BIOL|abcdefv
ENTRY = Factors, Biological|T123|NON|EQV|NLM (1990)|890831|FACTORS BIOL|abcdefv
ENTRY = Agents, Biologic
ENTRY = Agents, Biological
ENTRY = Biologic Factor
ENTRY = Factors, Biologic
MN = D23
RH = D23 - BIOLOGICAL FACTORS
FX = Biological Products
MH_TH = NLM (1974)
ST = T123
RN = 0
AN = differentiate from BIOLOGICAL PRODUCTS
MS = Endogenously-synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS.
PM = 1989; was Non-MeSH before 1989; BIOLOGICAL AGENTS was a heading 2012-2013, now BIOLOGICAL PRODUCTS
HN = 1989; was Non-MeSH before 1989; BIOLOGICAL AGENTS was a heading 2012-2013, now BIOLOGICAL PRODUCTS
MR = 20130708
DA = 19990101
DC = 1
DX = 19890101
UI = D001685

*NEWRECORD
RECTYPE = D
MH = Biological Phenomena
DE = BIOL PHENOMENA
AQ = DE ES RE
ENTRY = Biologic Phenomena|T070|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Biological Phenomenon|T070|NON|EQV|NLM (2009)|080625|abcdef
ENTRY = Phenomena, Biological|T070|NON|EQV|NLM (1998)|970224|PHENOMENA BIOL|abcdefv
ENTRY = Phenomena, Biologic
ENTRY = Phenomenon, Biological
MN = G16
RH = G16 - BIOLOGICAL PHENOMENA
MH_TH = NLM (1974)
ST = T070
AN = general or unspecified; prefer specifics
MS = Biological processes, properties, and characteristics of the whole organism in human, animal, microorganisms, and plants, and of the biosphere.
PM = 98
HN = 98; use explode 1970-97
CATSH = CAT LIST
MR = 20081016
DA = 19990101
DC = 1
DX = 19980101
UI = D001686

*NEWRECORD
RECTYPE = D
MH = Biological Products
DE = BIOL PRODUCTS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Biologics|T123|NON|EQV|UNK (19XX)|770421|abcdef
PRINT ENTRY = Natural Products|T123|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Biologic Products|T123|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Products, Biological|T123|NON|EQV|NLM (1990)|890831|PRODUCTS BIOL|abcdefv
ENTRY = Products, Biologic
ENTRY = Products, Natural
MN = D20.215
FX = Biological Factors
MH_TH = NLM (1966)
ST = T123
RN = 0
AN = differentiate from BIOLOGICAL FACTORS; / ther use: consider the context of the article and the intent of the author and coordinate with disease / ther or / drug ther
MS = Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.
PM = 2014(1966); for NATURAL PRODUCTS also see BIOLOGICAL FACTORS 2000-2005
HN = 2014(1966); for NATURAL PRODUCTS also use BIOLOGICAL FACTORS 2000-2005
MR = 20150623
DA = 19990101
DC = 1
UI = D001688

*NEWRECORD
RECTYPE = D
MH = Biological Psychiatry
DE = BIOL PSYCHIATRY
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Psychiatry, Biological|T091|NON|EQV|UNK (19XX)|830610|PSYCHIATRY BIOL|abcdefv
ENTRY = Biologic Psychiatry|T091|NON|EQV|UNK (19XX)|830610|abcdef
ENTRY = Psychiatry, Biologic
MN = F04.096.544.090
MN = H02.403.690.100
MH_TH = NLM (1984)
ST = T091
AN = SPEC only: SPEC qualif; DF: BIOL PSYCHIATRY
PI = Psychiatry (1966-1983)
MS = An interdisciplinary science concerned with studies of the biological bases of behavior - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness.
PM = 84
HN = 84
CATSH = CAT LIST
MR = 20090706
DA = 19830610
DC = 1
DX = 19840101
UI = D001689

*NEWRECORD
RECTYPE = D
MH = Biological Science Disciplines
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Biological Sciences|T090|NON|EQV|NLM (1974)|990101|BIOL SCIENCES|abcdefv
PRINT ENTRY = Life Sciences|T090|NON|EQV|NLM (1991)|900417|abcdef
ENTRY = Biologic Sciences|T090|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Biological Science|T090|NON|EQV|NLM (1991)|900417|BIOL SCIENCE|abcdefv
ENTRY = Science, Biological|T090|NON|EQV|NLM (1991)|900417|SCIENCE BIOL|abcdefv
ENTRY = Sciences, Biological|T090|NON|EQV|NLM (1991)|900417|SCIENCES BIOL|abcdefv
ENTRY = Biologic Science
ENTRY = Biological Science Discipline
ENTRY = Discipline, Biological Science
ENTRY = Disciplines, Biological Science
ENTRY = Life Science
ENTRY = Science Discipline, Biological
ENTRY = Science Disciplines, Biological
ENTRY = Science, Biologic
ENTRY = Science, Life
ENTRY = Sciences, Biologic
ENTRY = Sciences, Life
MN = H01.158
MH_TH = NLM (2009)
ST = T090
AN = SPEC; SPEC qualif; do not confuse with BIOLOGY; DF: BIOL SCIENCES
PI = Biology (1975-1990)
MS = All of the divisions of the natural sciences dealing with the various aspects of the phenomena of life and vital processes. The concept includes anatomy and physiology, biochemistry and biophysics, and the biology of animals, plants, and microorganisms. It should be differentiated from BIOLOGY, one of its subdivisions, concerned specifically with the origin and life processes of living organisms.
PM = 2009; see BIOLOGICAL SCIENCES 1991-2008; for BIOLOGICAL SCIENCES see BIOLOGY 1990
HN = 2009 (1991); use BIOLOGY 1975-1990
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D001690

*NEWRECORD
RECTYPE = D
MH = Biological Therapy
DE = BIOL THER
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Biologic Therapy|T061|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Biotherapy|T061|NON|EQV|NLM (2013)|111017|abcdef
ENTRY = Therapy, Biological|T061|NON|EQV|NLM (1998)|970211|THER BIOL|abcdefv
ENTRY = Biologic Therapies
ENTRY = Biological Therapies
ENTRY = Biotherapies
ENTRY = Therapies, Biologic
ENTRY = Therapies, Biological
ENTRY = Therapy, Biologic
MN = E02.095
MH_TH = NLM (1966)
ST = T061
AN = general or unspecified; prefer specifics
MS = Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.
PM = 98
HN = 98; use explode 1976-97
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19980101
UI = D001691

*NEWRECORD
RECTYPE = D
MH = Biological Transport
DE = BIOL TRANSPORT
AQ = DE ES GE IM PH RE
PRINT ENTRY = Transport, Biological|T043|NON|EQV|UNK (19XX)|740329|TRANSPORT BIOL|abcdefv
ENTRY = Biologic Transport|T043|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Transport, Biologic
MN = G03.495.166
FX = Cell Membrane Permeability
FX = Diffusion
FX = Maternal-Fetal Exchange
FX = Membrane Transport Proteins
FX = Mucociliary Clearance
FX = Proton-Motive Force
MH_TH = NLM (1964)
ST = T043
AN = almost never IM; coord NIM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM); DF: BIOL TRANSPORT
MS = The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
PM = 66
HN = 66(64)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19660101
UI = D001692

*NEWRECORD
RECTYPE = D
MH = Biological Transport, Active
DE = BIOL TRANSPORT ACTIVE
AQ = DE ES GE IM PH RE
PRINT ENTRY = Active Transport|T039|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Uphill Transport|T039|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Active Biological Transport|T039|NON|EQV|NLM (1990)|890831|ACTIVE BIOL TRANSPORT|abcdefv
ENTRY = Biologic Transport, Active|T039|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Transport, Active Biological|T039|NON|EQV|NLM (1994)|920828|TRANSPORT ACTIVE BIOL|abcdefv
ENTRY = Active Biologic Transport
ENTRY = Transport, Active
ENTRY = Transport, Active Biologic
ENTRY = Transport, Uphill
MN = G03.495.166.310
FX = Ion Pumps
MH_TH = NLM (1966)
ST = T039
AN = almost never IM; coord with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM); DF: BIOL TRANSPORT ACTIVE
MS = The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19660101
UI = D001693

*NEWRECORD
RECTYPE = D
MH = Biological Warfare
DE = BIOL WARFARE
AQ = CL EC EH ES HI LJ MT PC PX SN TD
PRINT ENTRY = Bacterial Warfare|T052|NON|NRW|UNK (19XX)|780508|BACT WARFARE|abcdefv
ENTRY = Biologic Warfare|T052|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Warfare, Bacterial|T052|NON|NRW|NLM (1992)|901103|WARFARE BACT|abcdefv
ENTRY = Warfare, Biological|T052|NON|EQV|NLM (1990)|890831|WARFARE BIOL|abcdefv
ENTRY = Warfare, Biologic
MN = I01.880.735.950.500.226
FX = Violence
MH_TH = BIOETHICS (1989)
ST = T052
AN = DF: BIOL WARFARE
MS = Warfare involving the use of living organisms or their products as disease etiologic agents against people, animals, or plants.
OL = use BIOLOGICAL WARFARE to search BACTERIAL WARFARE 1966-78
HN = BACTERIAL WARFARE was see under BIOLOGICAL WARFARE 1963-78
MR = 20150629
DA = 19990101
DC = 1
UI = D001694

*NEWRECORD
RECTYPE = D
MH = Biology
DE = BIOL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = H01.158.273
MH_TH = BIOETHICS (1989)
MH_TH = POPLINE (1978)
ST = T091
AN = the discipline (education, history, etc) only; use BIOLOGICAL PHENOMENA or specifics treed under it for biological characteristics and processes of organisms and of the biosphere; note broader heading BIOLOGICAL SCIENCE DISCIPLINES is also available; DF:BIOL
MS = One of the BIOLOGICAL SCIENCE DISCIPLINES concerned with the origin, structure, development, growth, function, genetics, and reproduction of animals, plants, and microorganisms.
MR = 20081126
DA = 19990101
DC = 1
UI = D001695

*NEWRECORD
RECTYPE = D
MH = Biomechanical Phenomena
AQ = DE GE IM PH RE
PRINT ENTRY = Kinematics|T070|NON|NRW|NLM (1999)|980226|abcdef
ENTRY = Mechanobiological Phenomena|T070|NON|REL|NLM (2014)|120914|abcdef
ENTRY = Phenomena, Biomechanical
ENTRY = Phenomena, Mechanobiological
MN = G01.154.090
MN = G01.374.089
MH_TH = NLM (2014)
ST = T070
AN = usually NIM
PI = Biophysics (1966-1967)
MS = The properties, processes, and behavior of biological systems under the action of mechanical forces.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19680101
UI = D001696

*NEWRECORD
RECTYPE = D
MH = Biomedical and Dental Materials
AQ = AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
MN = D25
MN = D27.720.102
MN = J01.637.051
RH = D25 - BIOMEDICAL AND DENTAL MATERIALS
MH_TH = NLM (1974)
ST = T122
RN = 0
AN = GEN; prefer specifics; used for mapping supplementary chemicals
MS = Substances used in biomedicine or dentistry predominantly for their physical, as opposed to chemical, properties.
PM = 98
HN = 98; use explode 1974-97
MR = 20060705
DA = 19990101
DC = 1
DX = 19980101
UI = D001697

*NEWRECORD
RECTYPE = D
MH = Biomedical Engineering
DE = BIOMED ENGINEERING
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Clinical Engineering|T091|NON|NRW|UNK (19XX)|820427|CLIN ENGINEERING|abcdefv
PRINT ENTRY = Engineering, Clinical|T091|NON|NRW|NLM (1994)|920817|ENGINEERING CLIN|abcdefv
ENTRY = Engineering, Biomedical|T091|NON|EQV|NLM (1994)|920817|ENGINEERING BIOMED|abcdefv
MN = H02.070
MN = J01.293.140
FX = Biomedical Technology
FX = Electronics, Medical
FX = Medical Informatics Applications
MH_TH = NLM (1968)
ST = T091
AN = SPEC: SPEC qualif; DF: BIOMED ENGINEERING
MS = Application of principles and practices of engineering science to biomedical research and health care.
PM = 68
HN = 68
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D001698

*NEWRECORD
RECTYPE = D
MH = Biometry
AQ = HI IS MT
MN = E05.318.740.225
MN = N06.850.505.200
MH_TH = NLM (1966)
ST = T062
PI = Scattered(1974-2008)
MS = The use of statistical and mathematical methods to analyze biological observations and phenomena.
MR = 20090706
DA = 19990101
DC = 1
UI = D001699

*NEWRECORD
RECTYPE = D
MH = Biomphalaria
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Australorbis|T204|NON|EQV|UNK (19XX)|780302|abcdef
ENTRY = Australorbis glabratus|T204|NON|NRW|UNK (19XX)|780302|abcdef
ENTRY = Australorbi
ENTRY = Biomphalarias
ENTRY = glabratus, Australorbis
MN = B01.050.500.644.400.750.185
MH_TH = NLM (1972)
ST = T204
AN = freshwater snail; /microbiol /parasitol /virol permitted
PI = Snails (1966-1971)
MS = A genus of planorbid freshwater snails, species of which are intermediate hosts of Schistosoma mansoni.
OL = use BIOMPHALARIA to search AUSTRALORBIS GLABRATUS 1972-78
PM = 72
HN = 72; AUSTRALORBIS GLABRATUS was see under BIOMPHALARIA 1972-78
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D001700

*NEWRECORD
RECTYPE = D
MH = Bionics
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Bionic
MN = H01.158.344.310
MN = H01.671.100.202
MN = H01.671.293.159
FX = Cybernetics
MH_TH = NLM (1966)
ST = T090
AN = use for the discipline (education, history, etc) only
MS = The study of systems, particularly electronic systems, which function after the manner of, in a manner characteristic of, or resembling living systems. Also, the science of applying biological techniques and principles to the design of electronic systems.
PM = 70
HN = 70(66)
MR = 20090706
DA = 19990101
DC = 1
DX = 19700101
UI = D001701

*NEWRECORD
RECTYPE = D
MH = Biopharmaceutics
DE = BIOPHARM
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = H01.158.703.003
MN = H02.628.049
FX = Drug Compounding
MH_TH = NLM (1970)
ST = T091
AN = general or specialty
PI = Chemistry, Pharmaceutical (1966-1969)
PI = Drug Compounding (1966-1969)
PI = Drugs (1966-1969)
PI = Pharmacology (1966-1969)
MS = The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action.
PM = 70
HN = 70
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19700101
UI = D001702

*NEWRECORD
RECTYPE = D
MH = Biophysics
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Mechanobiology|T091|NON|NRW|NLM (2014)|130122|abcdef
MN = H01.158.344
MN = H01.671.100
MH_TH = NLM (1966)
ST = T091
AN = the discipline (education, history, etc) only; use BIOPHYSICAL PHENOMENA or specifics treed under it for biophysical characteristics and processes of biological systems
MS = The study of PHYSICAL PHENOMENA and PHYSICAL PROCESSES as applied to living things.
MR = 20130708
DA = 19990101
DC = 1
UI = D001703

*NEWRECORD
RECTYPE = D
MH = Biopolymers
AQ = AD AE AG AI AN BI BL CF CH CL CT DF EC GE HI IM IP ME PD PH PK PO RE SE TO TU UR
ENTRY = Biopolymer
MN = D05.750.078
MN = D25.720.099
MN = J01.637.051.720.099
FX = DNA
FX = Polysaccharides
FX = RNA
MH_TH = NLM (1975)
ST = T109
ST = T123
RN = 0
AN = IM GEN only
PI = Macromolecular Substances (1975-2004)
MS = Polymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES.
PM = 1991; see MACROMOLECULAR SYSTEMS 1975-1990
HN = 1991(1975); use MACROMOLECULAR SUBSTANCES 1975-1990
MR = 20060705
DA = 19990101
DC = 1
DX = 19910101
UI = D001704

*NEWRECORD
RECTYPE = D
MH = Bioprosthesis
AQ = AE CL CT EC ES HI MI PS PX SD SN ST TD UT VE VI
PRINT ENTRY = Glutaraldehyde-Stabilized Grafts|T074|NON|NRW|UNK (19XX)|780503|abcdef
PRINT ENTRY = Heterograft Bioprosthesis|T074|NON|NRW|UNK (19XX)|800515|abcdef
PRINT ENTRY = Porcine Xenograft Bioprosthesis|T074|NON|NRW|UNK (19XX)|800515|abcdef
PRINT ENTRY = Xenograft Bioprosthesis|T074|NON|NRW|UNK (19XX)|800515|abcdef
ENTRY = Bioprostheses
ENTRY = Bioprostheses, Heterograft
ENTRY = Bioprostheses, Porcine Xenograft
ENTRY = Bioprostheses, Xenograft
ENTRY = Bioprosthesis, Heterograft
ENTRY = Bioprosthesis, Porcine Xenograft
ENTRY = Bioprosthesis, Xenograft
ENTRY = Glutaraldehyde Stabilized Grafts
ENTRY = Glutaraldehyde-Stabilized Graft
ENTRY = Graft, Glutaraldehyde-Stabilized
ENTRY = Grafts, Glutaraldehyde-Stabilized
ENTRY = Heterograft Bioprostheses
ENTRY = Porcine Xenograft Bioprostheses
ENTRY = Xenograft Bioprostheses
ENTRY = Xenograft Bioprostheses, Porcine
ENTRY = Xenograft Bioprosthesis, Porcine
MN = E07.695.100
FX = Transplants
MH_TH = NLM (1979)
ST = T074
AN = coordinate IM with specific prosthetic term (IM) as BI0PROSTHESIS + HEART VALVE PROSTHESIS; do not specify source of biological material unless especially discussed & do not coordinate with TRANSPLANTATION, HETEROLOGOUS
PI = Heart Valve Prosthesis (1966-1978)
MS = Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers.
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20130708
DA = 19780503
DC = 1
DX = 19790101
UI = D001705

*NEWRECORD
RECTYPE = D
MH = Biopsy
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Biopsies
MN = E01.370.225.500.384.100
MN = E01.370.225.998.054
MN = E01.370.388.100
MN = E04.074
MN = E05.200.500.384.100
MN = E05.200.998.054
MN = E05.242.384.100
MH_TH = NLM (1966)
ST = T060
AN = IM GEN only; NIM with specific organ /pathol (IM) + dis /pathol (IM); coord with specific technique if appropriate
MS = Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
CATSH = CAT LIST
MR = 20150601
DA = 19990101
DC = 1
UI = D001706

*NEWRECORD
RECTYPE = D
MH = Biopsy, Needle
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Aspiration Biopsy|T060|NON|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Puncture Biopsy|T060|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Aspiration Biopsies
ENTRY = Biopsies, Aspiration
ENTRY = Biopsies, Needle
ENTRY = Biopsies, Puncture
ENTRY = Biopsy, Aspiration
ENTRY = Biopsy, Puncture
ENTRY = Needle Biopsies
ENTRY = Needle Biopsy
ENTRY = Puncture Biopsies
MN = E01.370.225.500.384.100.119
MN = E01.370.225.998.054.119
MN = E01.370.388.100.100
MN = E04.074.119
MN = E04.665.100
MN = E05.200.500.384.100.119
MN = E05.200.998.054.119
MN = E05.242.384.100.119
MH_TH = NLM (1973)
ST = T060
AN = usually NIM with specific organ /pathol (IM) + disease /pathol (IM)
PI = Biopsy (1966-1972)
MS = Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.
PM = 73
HN = 73
CATSH = CAT LIST
MR = 20150601
DA = 19990101
DC = 1
DX = 19730101
UI = D001707

*NEWRECORD
RECTYPE = D
MH = Biopterin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = 2-Amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone|T109|T123|NON|EQV|NLM (1998)|961114|abbcdef
ENTRY = Dictyopterin|T109|T123|NON|REL|NLM (1992)|901214|abbcdef
ENTRY = Orinapterin|T109|T123|NON|REL|NLM (1998)|961114|abbcdef
MN = D03.438.733.631.202
MN = D08.211.090
MH_TH = NLM (1975)
ST = T109
ST = T123
N1 = 4(1H)-Pteridinone, 2-amino-6-(1,2-dihydroxypropyl)-, (S-(R*,S*))-
RN = 22150-76-1
AN = /defic /physiol permitted
PI = Propanediols (1972-1974)
PI = Pteridines (1970-1974)
MS = A natural product that has been considered as a growth factor for some insects.
PM = 87; was see under PTERIDINES 1975-86
HN = 87(75); was see under PTERIDINES 1975-86
MR = 20040707
DA = 19741119
DC = 1
DX = 19870101
UI = D001708

*NEWRECORD
RECTYPE = D
MH = Biotechnology
DE = BIOTECHNOL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Biotechnologies
MN = H01.158.550
MN = J01.897.120
FX = Genetic Engineering
FX = Recombinant Proteins
MH_TH = NLM (1987)
ST = T091
AN = SPEC: SPEC qualif; DF: BIOTECHNOL
MS = Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.
PM = 87
HN = 87
MR = 20090710
DA = 19860327
DC = 1
DX = 19870101
UI = D001709

*NEWRECORD
RECTYPE = D
MH = Biotin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Vitamin H|T109|T127|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Biocur Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Biodermatin|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = Biokur|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = Biotin Gelfert|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = Biotin Hermes|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = Biotin-ratiopharm|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = Biotine Roche|T109|T127|TRD|NRW|FR|040211|abbcdef
ENTRY = Deacura|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = Dermapharm Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Gabunat|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = Hermes Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Medea Brand of Biotin Sodium Salt|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Medebiotin|T109|T127|TRD|NRW|ES|040211|abbcdef
ENTRY = Medopharm Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Roche Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Rombellin|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = Simons Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Strathmann Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Ziethen Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = e+b Pharma Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = medobiotin|T109|T127|TRD|NRW|DE|040211|abbcdef
ENTRY = ratiopharm Brand of Biotin|T109|T127|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Biotin Biocur Brand
ENTRY = Biotin Dermapharm Brand
ENTRY = Biotin Hermes Brand
ENTRY = Biotin Medopharm Brand
ENTRY = Biotin Roche Brand
ENTRY = Biotin Simons Brand
ENTRY = Biotin Strathmann Brand
ENTRY = Biotin Ziethen Brand
ENTRY = Biotin ratiopharm
ENTRY = Biotin ratiopharm Brand
ENTRY = Biotinratiopharm
ENTRY = Gelfert, Biotin
ENTRY = H, Vitamin
ENTRY = Hermes, Biotin
ENTRY = Roche, Biotine
MN = D03.383.129.308.080
MN = D08.211.096
PA = Vitamin B Complex
FX = Avidin
FX = Biotinidase Deficiency
FX = Holocarboxylase Synthetase Deficiency
FX = Multiple Carboxylase Deficiency
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1966)
MH_TH = USP (19XX)
ST = T109
ST = T127
N1 = 1H-Thieno(3,4-d)imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS-(3aalpha,4beta,6aalpha))-
RN = 6SO6U10H04
RR = 58-85-5 (Biotin)
AN = /ther use: coordinate disease with /drug ther, not /diet ther; deficiency: coordinate BIOTIN /defic (IM) with VITAMIN B DEFICIENCY (IM)
MS = A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.
MR = 20130708
DA = 19990101
DC = 1
UI = D001710

*NEWRECORD
RECTYPE = D
MH = Biotransformation
AQ = DE GE IM PH RE
MN = G03.495.244
MN = G03.787.225
MN = G07.690.725.225
MH_TH = NLM (1966)
ST = T040
AN = restrict to chemical changes of exogenous substances; IM general only; coordinate NIM with specific drug /pharmacokin (IM) or /metab; do not confuse with BIODEGRADATION, ENVIRONMENTAL
MS = The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
PM = 70
HN = 70(66)
CATSH = CAT LIST
MR = 20140606
DA = 19990101
DC = 1
DX = 19700101
UI = D001711

*NEWRECORD
RECTYPE = D
MH = Biperiden
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Akineton|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Biperiden Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1999)|990913|abbcdeef
ENTRY = Biperiden, 1R-(1 alpha,2 alpha(R*),4 alpha)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Biperiden, 1S-(1 alpha,2 alpha(R*),4 alpha)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Biperidene|T109|T121|NON|EQV|UNK (19XX)|880423|abbcdef
ENTRY = alpha-Bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|T109|T121|NON|EQV|NLM (1995)|940322|abbcdef
ENTRY = Hydrochloride, Biperiden
MN = D02.455.426.100.080.100
MN = D03.383.621.110
MN = D04.075.080.875.099.332
PA = Antiparkinson Agents
PA = Muscarinic Antagonists
PA = Parasympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 1-Piperidinepropanol, alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-
RN = 0FRP6G56LD
RR = 106347-58-4 (1R-(1 alpha,2 alpha(R*),4 alpha)-isomer)
RR = 119542-35-7 (1S-(1 alpha,2 alpha(R*),4 alpha)-isomer)
RR = 1235-82-1 (HCl)
RR = 514-65-8 (Biperiden)
RR = K35N76CUHF
MS = A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
PM = 91; was see under PIPERIDINES 1966-90
HN = 91(66); was see under PIPERIDINES 1966-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001712

*NEWRECORD
RECTYPE = D
MH = Biphenyl Compounds
DE = BIPHENYL CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compounds, Biphenyl
MN = D02.455.426.559.389.185
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = DF: BIPHENYL CPDS
MR = 19920508
DA = 19990101
DC = 1
UI = D001713

*NEWRECORD
RECTYPE = D
MH = Bipolar Disorder
DE = BIPOLAR DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Affective Psychosis, Bipolar|T048|NON|EQV|UNK (19XX)|800521|abcdef
PRINT ENTRY = Depression, Bipolar|T048|NON|REL|UNK (19XX)|760415|abcdef
PRINT ENTRY = Manic Disorder|T048|NON|REL|NLM (1998)|970527|MANIC DIS|abcdefv
PRINT ENTRY = Manic-Depressive Psychosis|T048|NON|EQV|OMIM (2013)|UNK (19XX)|800521|abcdeef
PRINT ENTRY = Psychosis, Manic-Depressive|T048|NON|EQV|UNK (19XX)|800521|abcdef
ENTRY = Mania|T048|NON|REL|NLM (1981)|970618|abcdef
ENTRY = Manic State|T048|NON|REL|NLM (1981)|970618|abcdef
ENTRY = Psychoses, Manic-Depressive|T048|NON|EQV|UNK (19XX)|800521|abcdef
ENTRY = Bipolar Affective Psychosis
ENTRY = Bipolar Depression
ENTRY = Bipolar Disorders
ENTRY = Disorder, Bipolar
ENTRY = Disorder, Manic
ENTRY = Manias
ENTRY = Manic Depressive Psychosis
ENTRY = Manic Disorders
ENTRY = Manic States
ENTRY = Manic-Depressive Psychoses
ENTRY = Psychoses, Bipolar Affective
ENTRY = Psychoses, Manic Depressive
ENTRY = Psychosis, Bipolar Affective
ENTRY = Psychosis, Manic Depressive
ENTRY = State, Manic
ENTRY = States, Manic
MN = F03.084.500
MH_TH = NLM (1966)
ST = T048
MS = A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
PM = 81; see PSYCHOSES, MANIC-DEPRESSIVE 1963-80; see MANIC DISORDER 1984-97; for MANIC DISORDER see AFFECTIVE DISORDERS, PSYCHOTIC 1981-83
HN = 81(63)
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
UI = D001714

*NEWRECORD
RECTYPE = D
MH = Bird Diseases
DE = BIRD DIS
AQ = BL CF CI CL CN DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Avian Diseases|T047|NON|EQV|NLM (1991)|900104|AVIAN DIS|abcdefv
ENTRY = Avian Disease
ENTRY = Bird Disease
ENTRY = Disease, Avian
ENTRY = Disease, Bird
ENTRY = Diseases, Avian
ENTRY = Diseases, Bird
MN = C22.131
MH_TH = NLM (1966)
ST = T047
AN = IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific bird dis (IM); coord IM with specific bird (IM); for abnormalities or injuries, index under BIRDS /abnorm or BIRDS /inj; don't forget also BIRDS (NIM) if no specific bird is indexed; also check tag ANIMALS; differentiate from POULTRY DISEASES on basis of distinction between BIRDS & POULTRY shown under BIRDS; DF: BIRD DIS
MS = Diseases of birds not considered poultry, therefore usually found in zoos, parks, and the wild. The concept is differentiated from POULTRY DISEASES which is for birds raised as a source of meat or eggs for human consumption, and usually found in barnyards, hatcheries, etc.
CATSH = CAT LIST
MR = 20040713
DA = 19990101
DC = 1
UI = D001715

*NEWRECORD
RECTYPE = D
MH = Bird Fancier's Lung
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Avian Hypersensitivity Pneumonitis|T047|NON|EQV|NLM (1993)|920123|abcdef
PRINT ENTRY = Budgerigar Fancier's Lung|T047|NON|NRW|UNK (19XX)|760505|abcdef
PRINT ENTRY = Hypersensitivity Pneumonitis, Avian|T047|NON|EQV|NLM (1993)|920123|abcdef
PRINT ENTRY = Pigeon Breeder's Lung|T047|NON|NRW|UNK (19XX)|760505|abcdef
PRINT ENTRY = Pneumonitis, Hypersensitivity, Avian|T047|NON|EQV|NLM (1993)|920123|abcdef
ENTRY = Pneumonitis, Avian Hypersensitivity|T047|NON|EQV|NLM (1993)|920504|abcdef
ENTRY = Avian Hypersensitivity Pneumonitides
ENTRY = Bird Fancier Lung
ENTRY = Bird Fancier's Lungs
ENTRY = Bird Fanciers Lung
ENTRY = Budgerigar Fancier Lung
ENTRY = Budgerigar Fancier's Lungs
ENTRY = Budgerigar Fanciers Lung
ENTRY = Hypersensitivity Pneumonitides, Avian
ENTRY = Lung, Bird Fancier's
ENTRY = Lung, Budgerigar Fancier's
ENTRY = Lung, Pigeon Breeder's
ENTRY = Lungs, Bird Fancier's
ENTRY = Lungs, Budgerigar Fancier's
ENTRY = Lungs, Pigeon Breeder's
ENTRY = Pigeon Breeder Lung
ENTRY = Pigeon Breeder's Lungs
ENTRY = Pigeon Breeders Lung
ENTRY = Pneumonitides, Avian Hypersensitivity
MN = C08.381.483.125.125
MN = C08.674.055.125
MN = C20.543.480.680.075.125
MN = C24.125
MH_TH = NLM (1977)
ST = T047
PI = Farmer's Lung (1966-1976)
PI = Respiratory Hypersensitivity (1966-1976)
MS = A form of alveolitis or pneumonitis due to an acquired hypersensitivity to inhaled avian antigens, usually proteins in the dust of bird feathers and droppings.
PM = 91; was see under ALVEOLITIS, EXTRINSIC ALLERGIC 1977-90
HN = 91(77); was see under ALVEOLITIS, EXTRINSIC ALLERGIC 1977-90
CATSH = CAT LIST
MR = 20100625
DA = 19760505
DC = 1
DX = 19910101
UI = D001716

*NEWRECORD
RECTYPE = D
MH = Birds
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Aves|T012|NON|EQV|NLM (2005)|030930|abcdef
ENTRY = Bird
MN = B01.050.150.900.248
FX = Avian Proteins
MH_TH = NLM (1966)
ST = T012
AN = General or unspecified; prefer specifics; differentiate from POULTRY: Manual 22.29
MS = Warm-blooded VERTEBRATES possessing FEATHERS and belonging to the class Aves.
MR = 20090706
DA = 19990101
DC = 1
UI = D001717

*NEWRECORD
RECTYPE = D
MH = Birefringence
PRINT ENTRY = Birefraction|T070|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Double Refraction|T070|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Birefractions
ENTRY = Birefringences
ENTRY = Double Refractions
ENTRY = Refraction, Double
ENTRY = Refractions, Double
MN = G01.590.080
MH_TH = NLM (1964)
ST = T070
AN = a principle of optics; NIM; no qualif
MS = The property of nonisotropic media, such as crystals, whereby a single incident beam of light traverses the medium as two beams, each plane-polarized, the planes being at right angles to each other. (Cline et al., Dictionary of Visual Science, 4th ed)
PM = 68
HN = 68(64)
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D001718

*NEWRECORD
RECTYPE = D
MH = Birth Certificates
AQ = HI LJ
ENTRY = Birth Records|T073|NON|BRD|POPLINE (1986)|861231|abcdef
ENTRY = Birth Certificate
ENTRY = Birth Record
ENTRY = Certificate, Birth
ENTRY = Certificates, Birth
ENTRY = Record, Birth
ENTRY = Records, Birth
MN = E05.318.308.940.250
MN = L01.280.900.250
MN = N04.452.859.132
MN = N05.715.360.300.715.175
MN = N06.850.520.308.940.250
MH_TH = NLM (1966)
ST = T073
AN = IM
MS = Official certifications by a physician recording the individual's birth date, place of birth, parentage and other required identifying data which are filed with the local registrar of vital statistics.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D001719

*NEWRECORD
RECTYPE = D
MH = Birth Injuries
DE = BIRTH INJ
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Injuries, Birth|T037|NON|EQV|UNK (19XX)|860101|INJ BIRTH|abcdefv
ENTRY = Birth Injury
ENTRY = Injury, Birth
MN = C16.614.131
MN = C26.141
MH_TH = NLM (1973)
ST = T037
AN = do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; DF: BIRTH INJ
MS = Mechanical or anoxic trauma incurred by the infant during labor or delivery.
OL = use BIRTH INJURIES to search BIRTH INJURY 1966-72
PM = 73; was BIRTH INJURY 1963-72
HN = 73; was BIRTH INJURY 1963-72
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19730101
UI = D001720

*NEWRECORD
RECTYPE = D
MH = Birth Intervals
AQ = EH PX SN
PRINT ENTRY = Birth Spacing|T079|NON|EQV|NLM (1980)|781219|abcdef
ENTRY = First Birth Intervals|T079|NON|NRW|NLM (1980)|790123|abcdef
ENTRY = Pregnancy Intervals|T079|NON|BRD|NLM (1980)|790123|PREGN INTERVALS|abcdefv
ENTRY = Birth Interval
ENTRY = Birth Spacings
ENTRY = First Birth Interval
ENTRY = Pregnancy Interval
MN = I01.240.361.150
MN = N01.224.361.150
MH_TH = NLM (1980)
ST = T079
AN = human only; may be used in physiol or family planning context
PI = Family Characteristics (1968-1979)
PI = Family Planning (1968-1979)
MS = The lengths of intervals between births to women in the population.
OL = use BIRTH INTERVALS to search CHILD SPACING 1979-92
PM = 80; CHILD SPACING was see BIRTH INTERVALS 1979-92
HN = 80; CHILD SPACING was see BIRTH INTERVALS 1979-92
MR = 20030709
DA = 19781219
DC = 1
DX = 19800101
UI = D001721

*NEWRECORD
RECTYPE = D
MH = Birth Order
AQ = PX
ENTRY = First Birth|T079|NON|NRW|POPLINE (1983)|861231|abcdef
ENTRY = Birth Orders
ENTRY = Birth, First
ENTRY = Births, First
ENTRY = First Births
MN = F01.829.263.132
MN = I01.240.361.160
MN = N01.224.361.160
MN = N06.850.505.400.400.160
MH_TH = POPLINE (1978)
ST = T081
AN = IM
MS = The sequence in which children are born into the family.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D001722

*NEWRECORD
RECTYPE = D
MH = Birth Rate
AQ = EH TD
ENTRY = Age-Specific Birth Rate|T081|NON|NRW|NLM (1980)|781226|abcdef
ENTRY = Age-Specific Fertility Rate|T081|NON|NRW|NLM (1980)|781216|abcdef
ENTRY = Fertility Rate|T081|NON|NRW|NLM (1980)|781219|abcdef
ENTRY = Age Specific Birth Rate
ENTRY = Age Specific Fertility Rate
ENTRY = Age-Specific Birth Rates
ENTRY = Age-Specific Fertility Rates
ENTRY = Birth Rate, Age-Specific
ENTRY = Birth Rates
ENTRY = Birth Rates, Age-Specific
ENTRY = Fertility Rate, Age-Specific
ENTRY = Fertility Rates
ENTRY = Fertility Rates, Age-Specific
ENTRY = Rate, Age-Specific Birth
ENTRY = Rate, Age-Specific Fertility
ENTRY = Rate, Birth
ENTRY = Rate, Fertility
ENTRY = Rates, Age-Specific Birth
ENTRY = Rates, Age-Specific Fertility
ENTRY = Rates, Birth
ENTRY = Rates, Fertility
MN = E05.318.308.985.775.500
MN = L01.280.975.775.500
MN = N01.224.935.849.500
MN = N06.850.505.400.975.775.500
MN = N06.850.520.308.985.775.500
MH_TH = NLM (1967)
ST = T081
AN = specify geography if pertinent
PI = Population (1966)
PI = Vital Statistics (1966)
MS = The number of births in a given population per year or other unit of time.
PM = 1967: see POPULATION & VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE & AGE-SPECIFIC FERTILITY RATE see MATERNAL AGE 1980
HN = 1967: use POPULATION & VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE & AGE-SPECIFIC FERTILITY RATE use MATERNAL AGE 1980
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19670101
UI = D001723

*NEWRECORD
RECTYPE = D
MH = Birth Weight
AQ = DE GE IM PH RE
ENTRY = Birth Weights
ENTRY = Weight, Birth
ENTRY = Weights, Birth
MN = C23.888.144.186
MN = E01.370.600.115.100.160.120.186
MN = E05.041.124.160.750.149
MN = G07.100.100.160.120.186
MN = G07.700.320.249.314.120.186
FX = Infant, Low Birth Weight
FX = Infant, Very Low Birth Weight
MH_TH = NLM (1963)
ST = T032
AN = IM
MS = The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001724

*NEWRECORD
RECTYPE = D
MH = Bis(Chloromethyl) Ether
DS = BISCHLOROMETHYL ETHER
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Chloromethyl Ether|T109|T131|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Dichloromethyl Ether|T109|T131|NON|EQV|UNK (19XX)|771213|abbcdef
ENTRY = Bis(Chloromethyl)Ether|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|780321|abbcdeef
ENTRY = Ether, Chloromethyl
ENTRY = Ether, Dichloromethyl
MN = D02.355.601.250
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = Methane, oxybis(chloro)-
RN = 77382IHE37
RR = 542-88-1 (Bis(Chloromethyl) Ether)
PI = Ethers (1966-1973)
PI = Methyl Chloride (1966-1974)
PI = Methyl Ethers (1974)
MS = A substance that is an irritant to the eyes and respiratory tract and may be carcinogenic.
OL = use BIS(CHLOROMETHYL) ETHER to search DICHLOROMETHYL ETHER 1975-78
PM = 91; was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78
HN = 91(79); was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001725

*NEWRECORD
RECTYPE = D
MH = Bisacodyl
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Agaroletten|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Apo-Bisacodyl|T109|T121|TRD|NRW|CA|041209|abbcdef
ENTRY = Aventis Brand of Bisacodyl|T109|T121|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Bekunis Bisacodyl|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Bicol|T109|T121|TRD|NRW|US|041209|abbcdef
ENTRY = Bisac-Evac|T109|T121|TRD|NRW|US|041209|abbcdef
ENTRY = Bisacodyl Tannex|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1963)|800917|abbcdeef
ENTRY = Bisacodyl Uniserts|T109|T121|TRD|NRW|US|041209|abbcdef
ENTRY = Bisalax|T109|T121|TRD|NRW|AU|041209|abbcdef
ENTRY = Bisco-Lax|T109|T121|TRD|NRW|US|041209|abbcdef
ENTRY = Bisco-Zitron|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Dulco-Lax|T109|T121|TRD|NRW|IE|041209|abbcdef
ENTRY = Dulco-lax perles|T109|T121|TRD|NRW|UK|041209|abbcdef
ENTRY = Dulcolax|T109|T121|TRD|NRW|CA|FR|NL|UK|UNK (19XX)|US|800917|abbcdeeeeeef
ENTRY = Durolax|T109|T121|TRD|NRW|AU|041209|abbcdef
ENTRY = Fleet Bisacodyl|T109|T121|TRD|NRW|AU|US|041210|abbcdeef
ENTRY = Florisan N|T109|T121|TRD|NRW|DE|041209|abbcdef
ENTRY = Laxagetten|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Laxanin|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Laxans-ratiopharm|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Laxbene|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Laxysat Brger|T109|T121|TRD|NRW|DE|041214|abbcdef
ENTRY = Lnolax|T109|T121|TRD|NRW|DE|041214|abbcdef
ENTRY = Rytmil|T109|T121|TRD|NRW|US|041214|abbcdef
ENTRY = Ulcolax|T109|T121|TRD|NRW|US|041214|abbcdef
ENTRY = ratio-Bisacodyl|T109|T121|TRD|NRW|CA|041210|abbcdef
ENTRY = Apo Bisacodyl
ENTRY = Bisac Evac
ENTRY = Bisacodyl, Bekunis
ENTRY = Bisacodyl, Fleet
ENTRY = Bisco Lax
ENTRY = Bisco Zitron
ENTRY = Dulco Lax
ENTRY = Dulco lax perles
ENTRY = Dulcolax perles
ENTRY = Laxans ratiopharm
ENTRY = Tannex, Bisacodyl
ENTRY = Uniserts, Bisacodyl
ENTRY = ratio Bisacodyl
MN = D02.455.426.559.389.657.239.132
PA = Cathartics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester)
RN = 10X0709Y6I
RR = 1336-29-4 (Bisacodyl Tannex)
RR = 603-50-9
RR = T0I8L1B7J6
PI = Cathartics (1966-1971)
PI = Cresols (1966-1971)
MS = A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)
PM = 91; was see under CRESOLS 1972-90
HN = 91(72); was see under CRESOLS 1972-90
MR = 20141014
DA = 19990101
DC = 1
DX = 19910101
UI = D001726

*NEWRECORD
RECTYPE = D
MH = Bisexuality
AQ = CL DE EH ES HI PH PX RE SN
ENTRY = Bisexuals|T098|NON|REL|NLM (1996)|950322|abcdef
ENTRY = Bisexual
MN = F01.145.802.975.200
MN = G08.686.867.200
MH_TH = NLM (1988)
ST = T054
AN = note category: do not confuse with HERMAPHRODITISM see DISORDERS OF SEX DEVELOPMENT
PI = Homosexuality (1966-1987)
PI = Sex Behavior (1966-1987)
MS = The sexual attraction or relationship between members of both the same and the opposite SEX.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20130709
DA = 19870430
DC = 1
DX = 19880101
UI = D001727

*NEWRECORD
RECTYPE = D
MH = Dicumarol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Bishydroxycoumarin|T109|T121|NON|EQV|NLM (1996)|941129|abbcdef
ENTRY = Dicoumarin|T109|T121|TRD|NRW|UNK (19XX)|740329|abbcdef
ENTRY = Dicoumarol|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|820120|abbcdeef
MN = D03.383.663.283.446.520.203
MN = D03.438.150.446.520.203
PA = Anticoagulants
PA = Enzyme Inhibitors
PA = Uncoupling Agents
MH_TH = FDA SRS (2014)
MH_TH = USAN (1977)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-
RN = 7QID3E7BG7
RR = 66-76-2 (Dicumarol)
MS = An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.
PM = 96; was BISHYDROXYCOUMARIN 1963-95; DICUMAROL was see BISHYDROXYCOUMARIN 1963-95
HN = 96; was BISHYDROXYCOUMARIN 1963-95; DICUMAROL was see BISHYDROXYCOUMARIN 1963-95
MR = 20150622
DA = 19990101
DC = 1
UI = D001728

*NEWRECORD
RECTYPE = D
MH = Bismuth
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.556.100
MN = D01.552.544.100
PA = Antacids
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Bismuth
RN = U015TT5I8H
RR = 7440-69-9 (Bismuth)
AN = Bi-209; Bi-199-208, 210-215 = BISMUTH (IM) + RADIOISOTOPES (IM)
MS = A metallic element that has the atomic symbol Bi, atomic number 83 and atomic weight 208.98.
OL = use BISMUTH to search BISMUTH-ARSENIC COMPOUNDS 1963-91
PM = BISMUTH-ARSENIC COMPOUNDS was heading 1963-91
HN = BISMUTH-ARSENIC COMPOUNDS was heading 1963-91
MR = 20130708
DA = 19990101
DC = 1
UI = D001729

*NEWRECORD
RECTYPE = D
MH = Bisphosphoglycerate Mutase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Diphosphoglyceromutase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Bisphosphoglycerate Synthase|T116|T126|NON|EQV|UNK (19XX)|870722|abbcdef
ENTRY = Bisphosphoglyceromutase|T116|T126|NON|EQV|NLM (1993)|920402|abbcdef
ENTRY = Diphosphoglycerate Mutase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Mutase, Bisphosphoglycerate
ENTRY = Mutase, Diphosphoglycerate
ENTRY = Synthase, Bisphosphoglycerate
MN = D08.811.399.520.750.250
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = 3-Phospho-D-glycerate 1,2-phosphomutase
RN = EC 5.4.2.4
PI = Diphosphoglyceric Acids (1973-1974)
PI = Phosphotransferases (1973-1974)
MS = An enzyme that catalyzes the transfer of phosphate from C-3 of 1,3-diphosphoglycerate to C-2 of 3-phosphoglycerate, forming 2,3-diphosphoglycerate. EC 5.4.2.4.
OL = use BISPHOSPHOGLYCERATE MUTASE to search BISPHOSPHOGLYCEROMUTASE 1975-92
PM = 93; was BISPHOSPHOGLYCEROMUTASE 1975-92 (see under PHOSPHOTRANSFERASES 1975-90)
HN = 93; was BISPHOSPHOGLYCEROMUTASE 1975-92 (see under PHOSPHOTRANSFERASES)
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001731

*NEWRECORD
RECTYPE = D
MH = Bite Force
PRINT ENTRY = Masticatory Force|T169|NON|EQV|UNK (19XX)|830615|abcdef
PRINT ENTRY = Occlusal Force|T169|NON|EQV|UNK (19XX)|830615|abcdef
ENTRY = Bite Forces
ENTRY = Force, Bite
ENTRY = Force, Masticatory
ENTRY = Force, Occlusal
ENTRY = Forces, Bite
ENTRY = Forces, Masticatory
ENTRY = Forces, Occlusal
ENTRY = Masticatory Forces
ENTRY = Occlusal Forces
MN = E06.276.125
MH_TH = NLM (1984)
ST = T169
AN = note category; no qualif
PI = Dental Occlusion (1966-1983)
PI = Dental Stress Analysis (1968-1983)
PI = Mastication (1966-1983)
PI = Masticatory Muscles (1966-1983)
MS = The force applied by the masticatory muscles in dental occlusion.
PM = 91; was see under DENTAL OCCLUSION 1984-90
HN = 91(84); was see under DENTAL OCCLUSION 1984-90
CATSH = CAT LIST
MR = 19900413
DA = 19830615
DC = 1
DX = 19910101
UI = D001732

*NEWRECORD
RECTYPE = D
MH = Bites and Stings
DE = BITES STINGS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Stings|T037|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Bites|T037|NON|NRW|UNK (19XX)|790329|abcdef
ENTRY = Stings and Bites|T037|NON|EQV|UNK (19XX)|790329|STINGS BITES|abcdefv
ENTRY = Bite
ENTRY = Sting
MN = C25.723.127
MN = C26.176
MH_TH = NLM (1966)
ST = T037
AN = coordinate IM with biter (IM) but note specifics are available
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001733

*NEWRECORD
RECTYPE = D
MH = Bites, Human
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bite, Human
ENTRY = Human Bite
ENTRY = Human Bites
MN = C26.176.071
MH_TH = NLM (1972)
ST = T037
AN = the human is biting, not being bitten; don't forget to check tag HUMANS
PI = Bites and Stings (1966-1971)
MS = Bites inflicted by humans.
PM = 91; was see under BITES AND STINGS 1972-90
HN = 91(72); was see under BITES AND STINGS 1972-90
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19910101
UI = D001734

*NEWRECORD
RECTYPE = D
MH = Bithionol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Bitin|T109|T121|TRD|NRW|UNK (19XX)|831020|abbcdef
MN = D02.455.426.559.389.657.120
PA = Anti-Infective Agents, Local
PA = Antiplatyhelmintic Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Phenol, 2,2'-thiobis(4,6-dichloro)-
RN = AMT77LS62O
RR = 97-18-7 (Bithionol)
PI = Chlorobenzenes (1974)
PI = Phenols (1971-1974)
PI = Sulfides (1971-1974)
MS = Halogenated anti-infective agent that is used against trematode and cestode infestations.
PM = 91; was see under PHENOLS 1975-90
HN = 91(75); was see under PHENOLS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001735

*NEWRECORD
RECTYPE = D
MH = Biureas
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.948.117
MH_TH = NLM (1968)
ST = T109
RN = 0
PI = Hydrazines (1966-1967)
PM = 68
HN = 68
MR = 19920508
DA = 19990101
DC = 1
DX = 19680101
UI = D001736

*NEWRECORD
RECTYPE = D
MH = Biuret
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Allophanamide|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Carbamylurea|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
MN = D02.948.130
PA = Indicators and Reagents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = Imidodicarbonic diamide
RN = 89LJ369D1H
RR = 108-19-0 (Biuret)
AN = D25-26 qualif
PI = Amides (1974)
PI = Urea (1968-1974)
MS = Used as feed supplement for sheep and cattle since it is a good non-protein nitrogen source. In strongly alkaline solution biuret gives a violet color with copper sulfate.
PM = 91; was see under UREA 1975-90
HN = 91(75); was see under UREA 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001737

*NEWRECORD
RECTYPE = D
MH = Biuret Reaction
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Biuret Reactions
ENTRY = Reaction, Biuret
ENTRY = Reactions, Biuret
MN = E05.196.085
MH_TH = NLM (1975)
ST = T059
AN = do not confuse with BIURET: biuret reaction or method no longer uses BIURET as signif reagent
MS = A reaction characterized by a violet color upon the addition of copper sulfate to all compounds with two amide or peptide bonds linked directly or through an intermediate carbon atom. Used in the detection and estimation of proteins and peptides having more than two amino acids.
PM = 91; was see under CHEMISTRY, ANALYTICAL 1975-90
HN = 91(75); was see under CHEMISTRY, ANALYTICAL 1975-90
CATSH = CAT LIST
MR = 20020702
DA = 19741212
DC = 1
DX = 19910101
UI = D001738

*NEWRECORD
RECTYPE = D
MH = BK Virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = BK polyomavirus|T005|EPO|EQV|NLM (2002)|010307|abcdef
PRINT ENTRY = Human Polyomavirus BK|T005|EPO|EQV|NLM (2002)|010307|abcdef
PRINT ENTRY = Polyomavirus, BK|T005|EPO|EQV|NLM (2002)|010307|abcdef
ENTRY = Polyomavirus hominis 1|T005|NON|EQV|NLM (1975)|990101|abcdef
ENTRY = Polyomavirus BK, Human
MN = B04.280.210.620.615.100
MN = B04.613.204.670.615.100
MH_TH = NLM (1994)
ST = T005
AN = infection: coord IM with POLYOMAVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)
MS = A species of POLYOMAVIRUS apparently infecting over 90% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances.
OL = use POLYOMAVIRUS HOMINIS 1 to search BK VIRUS 1975-93
PM = 2002; see POLYOMAVIRUS HOMINIS 1 1994-2001, see BK VIRUS 1991-1993, see POLYOMAVIRUSES 1978-1990, see POLYOMA VIRUS 1975-1977
HN = 2002, 1975-1993
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D001739

*NEWRECORD
RECTYPE = D
MH = Black Widow Spider
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Latrodectus mactans|T204|NON|EQV|UNK (19XX)|741205|abcdef
ENTRY = Black Widow Spiders
ENTRY = Latrodectus mactan
ENTRY = Spider, Black Widow
ENTRY = Spiders, Black Widow
ENTRY = Widow Spider, Black
ENTRY = Widow Spiders, Black
ENTRY = mactan, Latrodectus
ENTRY = mactans, Latrodectus
MN = B01.050.500.131.166.803.200
MH_TH = NLM (1975)
ST = T204
AN = /microbiol /parasitol /virol permitted; bite: coord IM with SPIDER BITES (IM)
MS = A venomous New World spider with an hourglass-shaped red mark on the abdomen.
PM = 91; was see under SPIDERS 1975-90
HN = 91(75); was see under SPIDERS 1975-90
MR = 20130710
DA = 19741212
DC = 1
DX = 19910101
UI = D001740

*NEWRECORD
RECTYPE = D
MH = African Americans
AQ = CL ED EH GE HI LJ PX SN
ENTRY = Americans, African
MN = M01.686.508.100.100
MN = M01.686.754.100
MH_TH = NLM (1992)
ST = T098
MS = Persons living in the United States having origins in any of the black groups of Africa.
PM = 2004(1963); see BLACKS 1976-2003; see NEGROES 1963-75
HN = 76; was NEGROES 1963-75
MR = 20030714
DA = 19750725
DC = 1
DX = 19760101
UI = D001741

*NEWRECORD
RECTYPE = D
MH = Blackwater Fever
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Malaria, Hemolytic|T047|NON|EQV|NLM (1992)|910205|abcdef
ENTRY = Black Water Fever|T047|NON|EQV|NLM (1992)|910205|abcdef
ENTRY = Black Water Fevers
ENTRY = Blackwater Fevers
ENTRY = Fever, Black Water
ENTRY = Fever, Blackwater
ENTRY = Fevers, Black Water
ENTRY = Fevers, Blackwater
ENTRY = Hemolytic Malaria
ENTRY = Hemolytic Malarias
ENTRY = Malarias, Hemolytic
MN = C03.752.530.650.228
MH_TH = NLM (1975)
ST = T047
AN = do not confuse with BLACK FEVER see LEISHMANIASIS, VISCERAL or AMAZON BLACK FEVER see HEPATITIS D
MS = A complication of MALARIA, FALCIPARUM characterized by the passage of dark red to black urine.
PM = 1991; see MALARIA 1975-1990
HN = 1991(1975)
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
DX = 19910101
UI = D001742

*NEWRECORD
RECTYPE = D
MH = Urinary Bladder
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Bladder|T023|NON|EQV|NLM (1963)|990101|abcdef
ENTRY = Bladder, Urinary
MN = A05.810.890
FX = Administration, Intravesical
FX = Cystectomy
FX = Cystoscopy
FX = Cystostomy
FX = Urinary Catheterization
MH_TH = NLM (2007)
ST = T023
AN = inflammation = CYSTITIS
CX = consider also terms at CYST- and VESIC-
MS = A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.
PM = 2007; see BLADDER 1963-2006
HN = 2007 (1963)
MR = 20060705
DA = 19990101
DC = 1
UI = D001743

*NEWRECORD
RECTYPE = D
MH = Urinary Bladder Calculi
AQ = BL CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UL UR US VE VI
PRINT ENTRY = Urinary Bladder Stones|T031|T046|NON|EQV|NLM (2007)|051221|abbcdef
PRINT ENTRY = Vesical Calculi|T031|T046|NON|EQV|UNK (19XX)|880607|abbcdef
ENTRY = Bladder Calculi|T031|T046|NON|EQV|NLM (1966)|990101|abbcdef
ENTRY = Bladder Stones|T031|T046|NON|EQV|UNK (19XX)|880607|abbcdef
ENTRY = Calculi of Urinary Bladder|T031|T046|NON|EQV|NLM (2007)|051003|abbcdef
ENTRY = Cystoliths|T031|T046|NON|EQV|UNK (19XX)|880607|abbcdef
ENTRY = Bladder Calculi, Urinary
ENTRY = Bladder Calculus
ENTRY = Bladder Calculus, Urinary
ENTRY = Bladder Stone
ENTRY = Bladder Stone, Urinary
ENTRY = Bladder Stones, Urinary
ENTRY = Calculi, Bladder
ENTRY = Calculi, Urinary Bladder
ENTRY = Calculi, Vesical
ENTRY = Calculus, Bladder
ENTRY = Calculus, Urinary Bladder
ENTRY = Calculus, Vesical
ENTRY = Cystolith
ENTRY = Stone, Bladder
ENTRY = Stone, Urinary Bladder
ENTRY = Stones, Bladder
ENTRY = Stones, Urinary Bladder
ENTRY = Urinary Bladder Calculus
ENTRY = Urinary Bladder Stone
ENTRY = Vesical Calculus
MN = C12.777.829.720
MN = C12.777.967.500.925
MN = C13.351.968.829.521
MN = C13.351.968.967.500.925
MN = C23.300.175.850.875
MH_TH = NLM (2007)
ST = T031
ST = T046
AN = chemical composition of calculi: use /chem; /ultrastruct permitted
MS = Stones in the URINARY BLADDER; also known as vesical calculi, bladder stones, or cystoliths.
PM = 2007; see BLADDER CALCULI 1966-2006
HN = 2007 (1966)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D001744

*NEWRECORD
RECTYPE = D
MH = Urinary Bladder Diseases
DE = URINARY BLADDER DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bladder Diseases|T047|NON|EQV|NLM (1963)|990101|BLADDER DIS|abcdefv
ENTRY = Bladder Disease
ENTRY = Urinary Bladder Disease
MN = C12.777.829
MN = C13.351.968.829
MH_TH = NLM (2007)
ST = T047
AN = general: prefer specifics; inflammatory disease = CYSTITIS
MS = Pathological processes of the URINARY BLADDER.
PM = 2007; see BLADDER DISEASES 1963-2006
HN = 2007 (1963)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D001745

*NEWRECORD
RECTYPE = D
MH = Bladder Exstrophy
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bladder Extrophy|T019|NON|EQV|NLM (1991)|900316|abcdef
ENTRY = Exstrophy Of Bladder|T019|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Exstrophy of the Bladder|T019|NON|EQV|NLM (2011)|ORD (2010)|100407|abcdeef
ENTRY = Urinary Bladder Exstrophy|T019|NON|EQV|NLM (2011)|ORD (2010)|100407|abcdeef
ENTRY = Bladder Exstrophies
ENTRY = Bladder Extrophies
ENTRY = Exstrophies, Bladder
ENTRY = Exstrophies, Urinary Bladder
ENTRY = Exstrophy, Bladder
ENTRY = Exstrophy, Urinary Bladder
ENTRY = Extrophies, Bladder
ENTRY = Extrophy, Bladder
ENTRY = Urinary Bladder Exstrophies
MN = C12.706.132
MN = C12.777.829.132
MN = C13.351.875.132
MN = C13.351.968.829.132
MN = C16.131.939.132
MH_TH = NLM (1963)
ST = T019
MS = A birth defect in which the URINARY BLADDER is malformed and exposed, inside out, and protruded through the ABDOMINAL WALL. It is caused by closure defects involving the top front surface of the bladder, as well as the lower abdominal wall; SKIN; MUSCLES; and the pubic bone.
PM = 65
HN = 65(63)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19650101
UI = D001746

*NEWRECORD
RECTYPE = D
MH = Urinary Bladder Fistula
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Vesical Fistula|T046|T190|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Fistula, Urinary Bladder
ENTRY = Fistula, Vesical
ENTRY = Fistulas, Urinary Bladder
ENTRY = Fistulas, Vesical
ENTRY = Urinary Bladder Fistulas
ENTRY = Vesical Fistulas
MN = C12.706.881.312
MN = C12.777.829.733
MN = C13.351.875.881.312
MN = C13.351.968.829.548
MN = C23.300.575.825.250
MH_TH = NLM (2007)
ST = T046
ST = T190
AN = fistula policy: Manual 23.19+; VESICOVAGINAL FISTULA is available
MS = An abnormal passage in the URINARY BLADDER or between the bladder and any surrounding organ.
PM = 2007; see BLADDER FISTULA 1966-2006
HN = 2007; use BLADDER FISTULA 1966-2006
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D001747

*NEWRECORD
RECTYPE = D
MH = Urinary Bladder Neck Obstruction
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bladder Neck Obstruction|T047|T190|NON|EQV|NLM (1966)|990101|abbcdef
ENTRY = Bladder Outlet Obstruction|T047|T190|NON|EQV|NLM (2007)|051003|abbcdef
MN = C12.777.767.700.962
MN = C12.777.829.760
MN = C13.351.968.767.700.850
MN = C13.351.968.829.601
MH_TH = NLM (2007)
ST = T047
ST = T190
MS = Blocked urine flow through the bladder neck, the narrow internal urethral opening at the base of the URINARY BLADDER. Narrowing or strictures of the URETHRA can be congenital or acquired. It is often observed in males with enlarged PROSTATE glands.
PM = 2007; see BLADDER NECK OBSTRUCTION 1966-2006
HN = 2007 (1966)
CATSH = CAT LIST
MR = 20090710
DA = 19990101
DC = 1
UI = D001748

*NEWRECORD
RECTYPE = D
MH = Urinary Bladder Neoplasms
DE = URINARY BLADDER NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Bladder Cancer|T191|NON|NRW|GHR (2014)|NLM (2000)|OMIM (2013)|991103|abcdeeef
PRINT ENTRY = Bladder Neoplasms|T191|NON|EQV|NLM (1966)|ORD (2010)|990101|BLADDER NEOPL|abcdeefv
PRINT ENTRY = Cancer of Bladder|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Bladder Tumors|T191|NON|EQV|NLM (2001)|000111|abcdef
ENTRY = Cancer of the Bladder|T191|NON|NRW|GHR (2014)|NLM (2000)|991103|abcdeef
ENTRY = Malignant Tumor of Urinary Bladder|T191|NON|NRW|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Neoplasms, Bladder|T191|NON|EQV|NLM (1995)|930903|NEOPL BLADDER|abcdefv
ENTRY = Urinary Bladder Cancer|T191|NON|NRW|GHR (2014)|NLM (2007)|050928|abcdeef
ENTRY = Bladder Cancers
ENTRY = Bladder Neoplasm
ENTRY = Bladder Tumor
ENTRY = Cancer, Bladder
ENTRY = Cancer, Urinary Bladder
ENTRY = Neoplasm, Bladder
ENTRY = Neoplasm, Urinary Bladder
ENTRY = Tumor, Bladder
ENTRY = Tumors, Bladder
ENTRY = Urinary Bladder Neoplasm
MN = C04.588.945.947.960
MN = C12.758.820.968
MN = C12.777.829.813
MN = C13.351.937.820.945
MN = C13.351.968.829.707
MH_TH = NLM (2007)
ST = T191
AN = coordinate IM with histological type of neoplasm (IM)
MS = Tumors or cancer of the URINARY BLADDER.
PM = 2007; see BLADDER NEOPLASMS 1963-2006
HN = 2007 (1963)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001749

*NEWRECORD
RECTYPE = D
MH = Urinary Bladder, Neurogenic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bladder Disorder, Neurogenic|T047|NON|EQV|NLM (2000)|991105|BLADDER DIS NEUROGENIC|abcdefv
PRINT ENTRY = Neurogenic Bladder|T047|NON|EQV|NLM (2000)|991105|abcdef
ENTRY = Bladder Neurogenesis|T047|NON|REL|NLM (2000)|991105|abcdef
ENTRY = Bladder, Neurogenic|T047|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Neurogenic Bladder Disorder|T047|NON|EQV|NLM (2000)|991105|NEUROGENIC BLADDER DIS|abcdefv
ENTRY = Neurogenic Bladder, Atonic|T047|NON|NRW|NLM (2000)|991105|abcdef
ENTRY = Neurogenic Bladder, Spastic|T047|NON|NRW|NLM (2000)|991105|abcdef
ENTRY = Neurogenic Bladder, Uninhibited|T048|NON|NRW|NLM (2000)|991105|abcdef
ENTRY = Neurogenic Dysfunction of the Urinary Bladder|T047|NON|EQV|NLM (2000)|991105|abcdef
ENTRY = Neurogenic Urinary Bladder Disorder|T047|NON|EQV|NLM (2000)|991105|NEUROGENIC URINARY BLADDER DIS|abcdefv
ENTRY = Neurogenic Urinary Bladder, Atonic|T047|NON|NRW|NLM (2007)|060224|abcdef
ENTRY = Neurogenic Urinary Bladder, Spastic|T047|NON|NRW|NLM (2007)|060224|abcdef
ENTRY = Neurogenic Urinary Bladder, Uninhibited|T048|NON|NRW|NLM (2007)|060224|abcdef
ENTRY = Neuropathic Bladder|T047|NON|EQV|NLM (2000)|991105|abcdef
ENTRY = Urinary Bladder Disorder, Neurogenic|T047|NON|EQV|NLM (2000)|991105|URINARY BLADDER DIS NEUROGENIC|abcdefv
ENTRY = Urinary Bladder Neurogenesis|T047|NON|REL|NLM (2007)|060224|abcdef
ENTRY = Urinary Bladder Neurogenic Dysfunction|T047|NON|EQV|NLM (2000)|991105|abcdef
ENTRY = Atonic Neurogenic Bladder
ENTRY = Neurogenesis, Bladder
ENTRY = Neurogenesis, Urinary Bladder
ENTRY = Neurogenic Bladder Disorders
ENTRY = Neurogenic Urinary Bladder
ENTRY = Spastic Neurogenic Bladder
ENTRY = Uninhibited Neurogenic Bladder
MN = C10.597.900
MN = C12.777.829.839
MN = C13.351.968.829.760
MN = C23.888.592.900
MH_TH = NLM (2007)
ST = T047
MS = Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
PM = 2007; see BLADDER, NEUROGENIC 1966-2006
HN = 2007 (1966)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D001750

*NEWRECORD
RECTYPE = D
MH = Blade Implantation
AQ = AE CL CT EC ES HI IS MA MI MO MT NU PS PX SN ST TD UT VE VI
ENTRY = Blade Implantations
ENTRY = Implantation, Blade
ENTRY = Implantations, Blade
MN = E04.545.550.280.280.150
MN = E04.650.230.500.150
MN = E06.645.550.280.280.150
MN = E06.780.314.310.340
MH_TH = NLM (1979)
ST = T061
AN = an endosseous dent implant; do not use /util except by MeSH definition
PI = Dental Implantation (1966-1976)
PI = Dental Implantation, Endosseous (1977-1978)
MS = Insertion of an endosseous implant with a narrow wedge-shaped infrastructure extending through the oral mucosa into the mouth and bearing openings or vents through which tissue grows to obtain retention.
OL = search DENTAL IMPLANTATION 1974
PM = 91; was see under DENTAL IMPLANTATION, ENDOSSEOUS 1979-80; ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974
HN = 91(79); was see under DENTAL IMPLANTATION, ENDOSSEOUS 1979-90; ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974
CATSH = CAT LIST
MR = 20150622
DA = 19780123
DC = 1
DX = 19910101
UI = D001751

*NEWRECORD
RECTYPE = D
MH = Blast Crisis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Blast Phase|T047|NON|EQV|UNK (19XX)|860326|abcdef
ENTRY = Blast Crises
ENTRY = Blast Phases
ENTRY = Crises, Blast
ENTRY = Crisis, Blast
ENTRY = Phase, Blast
ENTRY = Phases, Blast
MN = C04.557.337.539.250.100
MN = C04.697.098.500.110
MN = C15.378.190.636.370.100
MN = C23.550.727.098.500.110
FX = Lymphocyte Activation
MH_TH = NLM (1987)
ST = T047
AN = coordinate IM with specific neoplasm term /pathol (IM); note category; do not confuse with BLAST TRANSFORMATION see LYMPHOCYTE ACTIVATION; blast transformation in chronic myelogenous leukemia goes here not at LYMPHOCYTE ACTIVATION
MS = An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20130708
DA = 19860326
DC = 1
DX = 19870101
UI = D001752

*NEWRECORD
RECTYPE = D
MH = Blast Injuries
DE = BLAST INJ
AQ = BL CF CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Injuries, Blast|T037|NON|EQV|UNK (19XX)|860101|INJ BLAST|abcdefv
ENTRY = Blast Injury
ENTRY = Injury, Blast
MN = C26.120.126
MH_TH = NLM (1973)
ST = T037
AN = various body inj from waves of high-pressure velocity; /compl permitted but do not confuse with /pathol
MS = Injuries resulting when a person is struck by particles impelled with violent force from an explosion. Blast causes pulmonary concussion and hemorrhage, laceration of other thoracic and abdominal viscera, ruptured ear drums, and minor effects in the central nervous system. (From Dorland, 27th ed)
OL = use BLAST INJURIES to search BLAST INJURY 1966-72
PM = 73; was BLAST INJURY 1963-72
HN = 73; was BLAST INJURY 1963-72
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19730101
UI = D001753

*NEWRECORD
RECTYPE = D
MH = Blastocladiella
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Blastocladiellas
MN = B01.300.230.150
MH_TH = NLM (1975)
ST = T004
MS = A genus of aquatic fungi of the family Blastocladiaceae, order Blastocladiales, used in the study of zoospore formation.
PM = 91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1963-85
HN = 91; use CHYTRIDIOMYCOTA 1986-90, use FUNGI 1963-85
MR = 20090706
DA = 19990101
DC = 1
DX = 19910101
UI = D001754

*NEWRECORD
RECTYPE = D
MH = Blastocyst
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE UL US VI
PRINT ENTRY = Embryo, Preimplantation|T018|NON|EQV|UNK (19XX)|790418|abcdef
ENTRY = Blastocysts
ENTRY = Embryos, Preimplantation
ENTRY = Preimplantation Embryo
ENTRY = Preimplantation Embryos
MN = A16.254.500
EC = transplantation:Embryo Transfer
MH_TH = NLM (1974)
ST = T018
AN = Mammalian only; non-mammalian, use BLASTULA; /transpl: coordinate BLASTOCYST (NIM with no qualifiers) + EMBRYO TRANSFER (IM); do not confuse with BLASTOCYTES see BLASTOMERES
MS = A post-MORULA preimplantation mammalian embryo that develops from a 32-cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. The inner cell mass gives rise to the embryonic disc and eventual embryo proper.
PM = 74
HN = 74
MR = 20070709
DA = 19990101
DC = 1
DX = 19740101
UI = D001755

*NEWRECORD
RECTYPE = D
MH = Blastoderm
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Blastoderms
MN = A16.331.024
MH_TH = NLM (1975)
ST = T018
PI = Blastocyst (1975-1979)
PI = Germ Layers (1966-1974)
MS = A layer of cells lining the fluid-filled cavity (blastocele) of a BLASTULA, usually developed from a fertilized insect, reptilian, or avian egg.
OL = search GERM LAYERS 1968-74
PM = 80; was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74
HN = 80(75); was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74
MR = 20070709
DA = 19990101
DC = 1
DX = 19800101
UI = D001756

*NEWRECORD
RECTYPE = D
MH = Blastomeres
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Blastocytes|T018|NON|BRD|UNK (19XX)|790417|abcdef
ENTRY = Blastocyte
ENTRY = Blastomere
MN = A11.872.700.250.130
MN = A16.094
MH_TH = NLM (1980)
ST = T018
AN = do not confuse entry term BLASTOCYTES with BLASTOCYST
PI = Blastocyst (1974-1979)
PI = Cell Division (1966-1979)
PI = Zygote (1975-1979)
MS = Undifferentiated cells resulting from cleavage of a fertilized egg (ZYGOTE). Inside the intact ZONA PELLUCIDA, each cleavage yields two blastomeres of about half size of the parent cell. Up to the 8-cell stage, all of the blastomeres are totipotent. The 16-cell MORULA contains outer cells and inner cells.
PM = 80
HN = 80
MR = 20150707
DA = 19790417
DC = 1
DX = 19800101
UI = D001757

*NEWRECORD
RECTYPE = D
MH = Blastomyces
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Blastomyces dermatitidis|T004|NON|NRW|NLM (1999)|980417|abcdef
ENTRY = Blastomyce
ENTRY = Blastomyces dermatitidi
ENTRY = dermatitidi, Blastomyces
ENTRY = dermatitidis, Blastomyces
MN = B01.300.381.125
FX = Onygenales
MH_TH = NLM (1966)
ST = T004
AN = infection = BLASTOMYCOSIS; BLASTOMYCES BRASILIENSIS see PARACOCCIDIOIDES is available
MS = A genus of onygenacetous mitosporic fungi whose perfect state is Ajellomyces (see ONYGENALES). The species Blastomyces dermatitidis (perfect state Ajellomyces dermatitidis) causes blastomycosis.
MR = 20090706
DA = 19990101
DC = 1
UI = D001758

*NEWRECORD
RECTYPE = D
MH = Blastomycosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Blastomycosis, North American|T047|EPO|NRW|ORD (2010)|UNK (19XX)|760515|abcdeef
ENTRY = Gilchrist Disease|T047|EPO|NRW|NLM (2010)|090623|abcdef
ENTRY = Gilchrist's Disease|T047|EPO|NRW|NLM (2010)|ORD (2010)|090623|abcdeef
ENTRY = Blastomycoses
ENTRY = Gilchrists Disease
ENTRY = North American Blastomycosis
MN = C01.539.800.200.055
MN = C01.703.295.055
MN = C01.703.534.395
MN = C08.381.472.350
MN = C08.730.435.395
MN = C17.800.838.208.055
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = fungus dis; do not confuse X ref BLASTOMYCOSIS, NORTH AMERICAN with BLASTOMYCOSIS, SOUTH AMERICAN see PARACOCCIDIOIDOMYCOSIS
MS = A fungal infection that may appear in two forms: 1, a primary lesion characterized by the formation of a small cutaneous nodule and small nodules along the lymphatics that may heal within several months; and 2, chronic granulomatous lesions characterized by thick crusts, warty growths, and unusual vascularity and infection in the middle or upper lobes of the lung.
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001759

*NEWRECORD
RECTYPE = D
MH = Bleeding Time
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Aspirin Tolerance Test|T059|NON|NRW|NLM (1998)|970318|abcdef
PRINT ENTRY = Bleeding Time, Template|T059|NON|NRW|NLM (1998)|970318|abcdef
PRINT ENTRY = Duke Method|T059|EPO|NRW|NLM (1998)|970318|abcdef
PRINT ENTRY = Ivy Method|T059|EPO|NRW|NLM (1998)|970318|abcdef
PRINT ENTRY = Template Bleeding Time|T059|NON|NRW|NLM (1998)|970318|abcdef
ENTRY = Aspirin Tolerance Tests
ENTRY = Bleeding Times
ENTRY = Bleeding Times, Template
ENTRY = Method, Duke
ENTRY = Method, Ivy
ENTRY = Template Bleeding Times
ENTRY = Test, Aspirin Tolerance
ENTRY = Tests, Aspirin Tolerance
ENTRY = Time, Bleeding
ENTRY = Time, Template Bleeding
ENTRY = Times, Bleeding
ENTRY = Times, Template Bleeding
ENTRY = Tolerance Test, Aspirin
ENTRY = Tolerance Tests, Aspirin
MN = E01.370.225.625.625.100
MN = E05.200.625.625.100
MN = G09.188.087
FX = Platelet Activation
MH_TH = NLM (1980)
ST = T034
AN = usually NIM
PI = Blood Coagulation (1966-1979)
PI = Blood Coagulation Tests (1966-1979)
PI = Blood Platelet Disorders (1966-1979)
PI = Blood Platelets (1966-1979)
PI = Thrombocytopenia (1966-1979)
PI = Thrombocytosis (1966-1979)
MS = Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function.
PM = 91; was see under PLATELET FUNCTION TESTS 1980-90
HN = 91(80); was see under PLATELET FUNCTION TESTS 1980-90
CATSH = CAT LIST
MR = 20110624
DA = 19790307
DC = 1
DX = 19910101
UI = D001760

*NEWRECORD
RECTYPE = D
MH = Bleomycin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Almirall Brand of Bleomycin Sulfate|T116|T195|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = BLEO-cell|T116|T195|TRD|NRW|DE|040211|abbcdef
ENTRY = Bellon Brand of Bleomycin Sulfate|T116|T195|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Blanoxan|T116|T195|TRD|NRW|MX|040211|abbcdef
ENTRY = Blenoxane|T116|T195|TRD|NRW|AU|CA|UNK (19XX)|US|840818|abbcdeeeef
ENTRY = Bleolem|T116|T195|TRD|NRW|MX|040211|abbcdef
ENTRY = Bleomicina|T116|T195|TRD|NRW|ES|040211|abbcdef
ENTRY = Bleomycin A(2)|T116|T195|NON|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Bleomycin A2|T116|T195|NON|NRW|FDA SRS (2014)|UNK (19XX)|810108|abbcdeef
ENTRY = Bleomycin B(2)|T116|T195|NON|NRW|UNK (19XX)|811202|abbcdef
ENTRY = Bleomycin B2|T116|T195|NON|NRW|FDA SRS (2014)|UNK (19XX)|811202|abbcdeef
ENTRY = Bleomycin Sulfate|T116|T195|NON|NRW|USAN (1971)|USP (19XX)|850103|abbcdeef
ENTRY = Bleomycins|T116|T195|NON|EQV|NLM (1996)|950319|abbcdef
ENTRY = Bleomycinum Mack|T116|T195|TRD|NRW|DE|040211|abbcdef
ENTRY = Blomycine Bellon|T116|T195|TRD|NRW|FR|040211|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Bleomycin Sulfate|T116|T195|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Bull Brand of Bleomycin Sulfate|T116|T195|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Lemery Brand of Bleomycin Sulfate|T116|T195|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Lundbeck Brand of Bleomycin Sulfate|T116|T195|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = Mack Brand of Bleomycin Sulfate|T116|T195|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = cell pharm Brand of Bleomycin Sulfate|T116|T195|NON|NRW|NLM (2005)|040211|abbcdef
ENTRY = BLEO cell
ENTRY = BLEOcell
ENTRY = Bellon, Blomycine
ENTRY = Bristol Myers Squibb Brand of Bleomycin Sulfate
ENTRY = Mack, Bleomycinum
ENTRY = Sulfate, Bleomycin
MN = D09.400.420.110
MN = D12.644.233.110
PA = Antibiotics, Antineoplastic
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = UK
ST = T116
ST = T195
RN = 11056-06-7
RR = 13M89UEA7W
RR = 9041-93-4 (sulfate (salt))
RR = M62KK37O40
AN = a glycopeptide antineoplastic antibiotic
PI = Antibiotics, Antineoplastic (1967-1970)
MS = A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.
PM = 96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1974-80
HN = 96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1972-80 (Prov 1972-73)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D001761

*NEWRECORD
RECTYPE = D
MH = Blepharitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Blepharitides
MN = C11.338.133
MH_TH = NLM (1965)
ST = T047
MS = Inflammation of the eyelids.
PM = 91; was see under EYELID DISEASES 1965-90
HN = 91(65); was see under EYELID DISEASES 1965-90
CATSH = CAT LIST
MR = 20150605
DA = 19990101
DC = 1
DX = 19910101
UI = D001762

*NEWRECORD
RECTYPE = D
MH = Blepharoptosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Ptosis, Eyelid|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Blepharoptoses
ENTRY = Eyelid Ptoses
ENTRY = Eyelid Ptosis
ENTRY = Ptoses, Eyelid
MN = C11.338.204
FX = Blepharoplasty
MH_TH = NLM (1965)
ST = T047
AN = drooping eyelid
MS = Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.
PM = 67
HN = 67(65)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19670101
UI = D001763

*NEWRECORD
RECTYPE = D
MH = Blepharospasm
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Blepharospasms
MN = C11.338.250
MH_TH = NLM (1975)
ST = T047
AN = spasm of eyelid musc
MS = Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.
PM = 91; was see under EYELID DISEASES 1975-90
HN = 91(75); was see under EYELID DISEASES 1975-90
CATSH = CAT LIST
MR = 19930525
DA = 19741111
DC = 1
DX = 19910101
UI = D001764

*NEWRECORD
RECTYPE = D
MH = Blind Loop Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bacterial Overgrowth Syndrome|T047|NON|EQV|NLM (2004)|030430|abcdef
ENTRY = Stagnant Loop Syndrome|T047|NON|EQV|NLM (2004)|030430|abcdef
ENTRY = Loop Syndrome, Stagnant
ENTRY = Loop Syndromes, Stagnant
ENTRY = Stagnant Loop Syndromes
ENTRY = Syndrome, Bacterial Overgrowth
ENTRY = Syndrome, Blind Loop
ENTRY = Syndrome, Stagnant Loop
ENTRY = Syndromes, Stagnant Loop
MN = C06.405.469.637.145
MN = C18.452.603.145
MH_TH = NLM (1969)
ST = T047
PI = Malabsorption Syndromes (1966-1968)
MS = A malabsorption syndrome that is associated with a blind loop in the upper SMALL INTESTINE that is characterized by the lack of peristaltic movement, stasis of INTESTINAL CONTENTS, and the overgrowth of BACTERIA. Such bacterial overgrowth interferes with BILE SALTS action, FATTY ACIDS processing, MICROVILLI integrity, and the ABSORPTION of nutrients such as VITAMIN B12 and FOLIC ACID.
PM = 73
HN = 73(69)
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
DX = 19730101
UI = D001765

*NEWRECORD
RECTYPE = D
MH = Blindness
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Amaurosis|T047|NON|REL|UNK (19XX)|740329|abcdef
PRINT ENTRY = Blindness, Legal|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
PRINT ENTRY = Blindness, Monocular|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Blindness, Acquired|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Blindness, Complete|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Blindness, Hysterical|T048|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Blindness, Transient|T047|T184|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Acquired Blindness
ENTRY = Amauroses
ENTRY = Complete Blindness
ENTRY = Hysterical Blindness
ENTRY = Legal Blindness
ENTRY = Monocular Blindness
ENTRY = Transient Blindness
MN = C10.597.751.941.162
MN = C11.966.075
MN = C23.888.592.763.941.162
FX = Sensory Aids
FX = Vision, Low
MH_TH = NLM (1966)
ST = T047
ST = T184
AN = for Braille coord IM with SENSORY AIDS (IM) + READING (IM)
MS = The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D001766

*NEWRECORD
RECTYPE = D
MH = Blinking
AQ = DE ES GE IM PH RE
PRINT ENTRY = Orbicularis Oculi Reflex|T042|NON|REL|UNK (19XX)|820428|abcdef
PRINT ENTRY = Reflex, Blink|T042|NON|REL|UNK (19XX)|800404|abcdef
PRINT ENTRY = Reflex, Corneal|T042|NON|NRW|UNK (19XX)|800404|abcdef
PRINT ENTRY = Reflex, Orbicularis Oculi|T042|NON|REL|UNK (19XX)|820428|abcdef
PRINT ENTRY = Winking|T042|NON|NRW|NLM (1998)|960724|abcdef
ENTRY = Blink Reflexes|T042|NON|REL|NLM (1990)|890710|abcdef
ENTRY = Corneal Reflexes|T042|NON|NRW|NLM (1990)|890710|abcdef
ENTRY = Orbicularis Oculi Reflexes|T042|NON|REL|NLM (1990)|890710|abcdef
ENTRY = Blink Reflex
ENTRY = Reflexes, Blink
ENTRY = Reflexes, Orbicularis Oculi
MN = G11.561.600.765.127
MN = G14.640.182
MH_TH = NLM (1981)
ST = T042
PI = Eyelids (1966-1980)
PI = Reflex (1966-1980)
MS = Brief closing of the eyelids by involuntary normal periodic closing, as a protective measure, or by voluntary action.
PM = 81
HN = 81
CATSH = CAT LIST
MR = 20080708
DA = 19800404
DC = 1
DX = 19810101
UI = D001767

*NEWRECORD
RECTYPE = D
MH = Blister
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bulla|T020|T184|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Vesication|T020|T184|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Bleb|T020|T184|NON|EQV|NLM (2001)|000324|abbcdef
ENTRY = Bullae|T020|T184|NON|EQV|NLM (1991)|891221|abbcdef
ENTRY = Bullous Lesion|T020|T184|NON|EQV|NLM (2001)|000208|abbcdef
ENTRY = Blebs
ENTRY = Blisters
ENTRY = Bullous Lesions
ENTRY = Lesion, Bullous
ENTRY = Lesions, Bullous
ENTRY = Vesications
MN = C17.800.865.187
MN = C23.300.122
MH_TH = NLM (1966)
ST = T020
ST = T184
AN = FEVER BLISTER see HERPES LABIALIS is also available
MS = Visible accumulations of fluid within or beneath the epidermis.
CATSH = CAT LIST
MR = 20000622
DA = 19990101
DC = 1
UI = D001768

*NEWRECORD
RECTYPE = D
MH = Blood
AQ = DE IM ME MI PS RA RE RI US VI
MN = A12.207.152
MN = A15.145
FX = Hematopoiesis
FX = Occult Blood
EC = analysis:Blood Chemical Analysis
EC = chemistry:Blood Chemical Analysis
EC = cytology:Blood Cells
EC = enzymology:Enzymes:blood
EC = physiology:Blood Physiological Phenomena
MH_TH = NLM (1966)
ST = T024
ST = T031
AN = general only as a substance: prefer / blood with higher animals, substances & diseases: Manual 19.7+, 19.8.10; not for hemodynamics: Manual 23.28, 23.29; reinfusion = BLOOD TRANSFUSION, AUTOLOGOUS; venous blood: coordinate BLOOD + VEINS or specific vein but do not index here for routine blood samples; arterial blood: coordinate BLOOD + ARTERIES or specific artery but only if the arterial aspect is significant; "blood picture" = probably BLOOD CELLS or BLOOD CELL COUNT; "blood clot": physiol clot or clotting = BLOOD COAGULATION, pathologic clot or clotting = THROMBOSIS or EMBOLISM
CX = consider also terms at HEM-
MS = The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
MR = 20080710
DA = 19990101
DC = 1
UI = D001769

*NEWRECORD
RECTYPE = D
MH = Blood Bactericidal Activity
AQ = DE GE IM PH RE
ENTRY = Activities, Blood Bactericidal
ENTRY = Activity, Blood Bactericidal
ENTRY = Bactericidal Activities, Blood
ENTRY = Bactericidal Activity, Blood
ENTRY = Blood Bactericidal Activities
MN = G09.188.100
MN = G12.450.564.204
FX = Antimicrobial Cationic Peptides
FX = Serum Bactericidal Antibody Assay
FX = Serum Bactericidal Test
MH_TH = NLM (1965)
ST = T042
AN = restrict to bactericidal: fungicidal = probably fungus (IM) + BLOOD PHYSIOLOGICAL PHENOMENA (IM); do not confuse with SERUM BACTERICIDAL TEST (bactericidal activity in serum after antimicrobial therapy) or SERUM BACTERICIDAL ANTIBODY ASSAY (measurement of IMMUNOGLOBULINS in blood that initiate lysis of bacteria)
MS = The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST.
PM = 70
HN = 70(65)
CATSH = CAT LIST
MR = 20150626
DA = 19990101
DC = 1
DX = 19700101
UI = D001770

*NEWRECORD
RECTYPE = D
MH = Blood Banks
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Bank, Blood
ENTRY = Banks, Blood
ENTRY = Blood Bank
MN = N02.278.065.200
MH_TH = BIOETHICS (1998)
MH_TH = NLM (1966)
ST = T093
MS = Centers for collecting, characterizing and storing human blood.
MR = 20040713
DA = 19990101
DC = 1
UI = D001771

*NEWRECORD
RECTYPE = D
MH = Blood Cell Count
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Blood Cell Number|T034|T081|NON|EQV|UNK (19XX)|790524|abbcdef
PRINT ENTRY = Blood Count, Complete|T059|NON|REL|NLM (1993)|911024|abcdef
ENTRY = Blood Cell Counts
ENTRY = Blood Cell Numbers
ENTRY = Blood Counts, Complete
ENTRY = Complete Blood Count
ENTRY = Complete Blood Counts
ENTRY = Count, Blood Cell
ENTRY = Count, Complete Blood
ENTRY = Counts, Blood Cell
ENTRY = Counts, Complete Blood
ENTRY = Number, Blood Cell
ENTRY = Numbers, Blood Cell
MN = E01.370.225.500.195.107
MN = E01.370.225.625.107
MN = E05.200.500.195.107
MN = E05.200.625.107
MN = E05.242.195.107
MN = G04.170.107
MN = G09.188.105
MH_TH = NLM (1966)
ST = T034
ST = T081
AN = GEN; prefer specifics; "blood picture" probably goes here or under specifics; usually NIM; coord with disease /blood, not /physiopathol
MS = The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES.
CATSH = CAT LIST
MR = 20150601
DA = 19990101
DC = 1
UI = D001772

*NEWRECORD
RECTYPE = D
MH = Blood Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Blood Corpuscles|T025|NON|EQV|NLM (2008)|070205|abcdef
ENTRY = Blood Cell
ENTRY = Blood Corpuscle
ENTRY = Cell, Blood
ENTRY = Cells, Blood
ENTRY = Corpuscle, Blood
ENTRY = Corpuscles, Blood
MN = A11.118
MN = A15.145.229
MH_TH = NLM (1966)
ST = T025
AN = general; prefer specifics; "blood picture" probably goes here or under BLOOD CELL COUNT
MS = The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM.
MR = 20070709
DA = 19990101
DC = 1
UI = D001773

*NEWRECORD
RECTYPE = D
MH = Blood Chemical Analysis
DE = BLOOD CHEM ANAL
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Analysis, Blood Chemical|T059|NON|EQV|UNK (19XX)|860101|ANAL BLOOD CHEM|abcdefv
ENTRY = Chemical Analysis, Blood|T059|NON|EQV|UNK (19XX)|860101|CHEM ANAL BLOOD|abcdefv
ENTRY = Analyses, Blood Chemical
ENTRY = Blood Chemical Analyses
ENTRY = Chemical Analyses, Blood
MN = E01.370.225.124.100
MN = E05.200.124.100
MH_TH = NLM (1966)
ST = T059
AN = general only: prefer specific substance with / blood; emphasis is on technique: not for "blood chemistry"
MS = An examination of chemicals in the blood.
CATSH = CAT LIST
MR = 20150616
DA = 19990101
DC = 1
UI = D001774

*NEWRECORD
RECTYPE = D
MH = Blood Circulation
DE = BLOOD CIRC
AQ = DE ES GE IM PH RE
ENTRY = Circulation, Blood|T039|NON|EQV|NLM (1994)|920922|CIRC BLOOD|abcdefv
MN = G09.330.190.163
FX = Cardiovascular System
FX = Hemodynamics
FX = Hyperemia
FX = Ischemia
FX = Plethysmography
FX = Pulsatile Flow
MH_TH = NLM (1966)
ST = T039
AN = general or unspecified, systemic; note specific indentions in tree; Manual 21.4.2-21.6; with diseases, coord IM with disease /physiopathol, not /blood (IM); circulatory failure or circulatory collapse = SHOCK; DF: BLOOD CIRC
MS = The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM.
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
UI = D001775

*NEWRECORD
RECTYPE = D
MH = Blood Circulation Time
DE = BLOOD CIRC TIME
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
ENTRY = Circulation Time, Blood|T060|NON|EQV|NLM (1994)|921001|CIRC TIME BLOOD|abcdefv
ENTRY = Time, Blood Circulation|T060|NON|EQV|NLM (1994)|921001|TIME BLOOD CIRC|abcdefv
ENTRY = Blood Circulation Times
ENTRY = Circulation Times, Blood
ENTRY = Times, Blood Circulation
MN = E01.370.370.120
MH_TH = NLM (1966)
ST = T060
AN = NIM; /drug eff /rad eff permitted; coord with disease /physiopathol, not /blood; DF: BLOOD CIRC TIME
MS = Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001776

*NEWRECORD
RECTYPE = D
MH = Blood Coagulation
DE = BLOOD COAG
AQ = DE ES GE IM PH RE
PRINT ENTRY = Blood Clotting|T042|NON|EQV|NLM (1996)|950330|abcdef
ENTRY = Coagulation, Blood|T042|NON|EQV|NLM (1992)|900925|COAG BLOOD|abcdefv
ENTRY = Blood Clottings
ENTRY = Clotting, Blood
MN = G09.188.124.560.150
FX = Anticoagulants
FX = Blood Coagulation Tests
FX = Coagulants
FX = Hemostatics
FX = Partial Thromboplastin Time
FX = Prothrombin Time
FX = Thrombin Time
FX = Whole Blood Coagulation Time
MH_TH = NLM (1966)
ST = T042
AN = coord BLOOD COAGULATION in diseases with disease /blood, not /physiopathol; "blood clot" if physiol goes here, if pathol, goes under THROMBOSIS or EMBOLISM; DF: BLOOD COAG
MS = The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D001777

*NEWRECORD
RECTYPE = D
MH = Blood Coagulation Disorders
DE = BLOOD COAG DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Coagulation Disorders, Blood|T047|NON|EQV|NLM (1992)|900917|COAG DIS BLOOD|abcdefv
ENTRY = Disorders, Blood Coagulation|T047|NON|EQV|NLM (1992)|900925|DIS BLOOD COAG|abcdefv
ENTRY = Blood Coagulation Disorder
ENTRY = Coagulation Disorder, Blood
ENTRY = Disorder, Blood Coagulation
MN = C15.378.100
MH_TH = NLM (1966)
ST = T047
AN = GEN: prefer specifics; consider also COAGULATION PROTEIN DISORDERS and indentions; see also THROMBOSIS; EMBOLISM and specifics in C14; /genet: consider also BLOOD COAGULATION DISORDERS, INHERITED; DF: BLOOD COAG DIS
MS = Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
CATSH = CAT LIST
MR = 20040719
DA = 19990101
DC = 1
UI = D001778

*NEWRECORD
RECTYPE = D
MH = Blood Coagulation Factors
DE = BLOOD COAG FACTORS
AQ = AD AE AG AI AN BI CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Coagulation Factors|T116|T123|NON|EQV|UNK (19XX)|860620|COAG FACTORS|abbcdefv
ENTRY = Blood Coagulation Factor|T116|T123|NON|EQV|NLM (1992)|900917|BLOOD COAG FACTOR|abbcdefv
ENTRY = Coagulation Factor|T116|T123|NON|EQV|NLM (1998)|961202|COAG FACTOR|abbcdefv
ENTRY = Coagulation Factor, Blood|T116|T123|NON|EQV|NLM (1992)|900925|COAG FACTOR BLOOD|abbcdefv
ENTRY = Coagulation Factors, Blood|T116|T123|NON|EQV|NLM (1992)|900925|COAG FACTORS BLOOD|abbcdefv
ENTRY = Factor, Coagulation|T116|T123|NON|EQV|NLM (1992)|900925|FACTOR COAG|abbcdefv
ENTRY = Factors, Coagulation|T116|T123|NON|EQV|NLM (1992)|900925|FACTORS COAG|abbcdefv
ENTRY = Factor, Blood Coagulation
ENTRY = Factors, Blood Coagulation
MN = D12.776.124.125
MN = D23.119
FX = Coagulants
EC = deficiency:Coagulation Protein Disorders
MH_TH = NLM (1966)
ST = T116
ST = T123
RN = 0
AN = GEN or unspecified; prefer specifics; DF: BLOOD COAG FACTORS
MS = Endogenous substances, usually proteins, that are involved in the blood coagulation process.
MR = 20050630
DA = 19990101
DC = 1
UI = D001779

*NEWRECORD
RECTYPE = D
MH = Blood Coagulation Tests
DE = BLOOD COAG TESTS
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Coagulation Tests, Blood|T059|NON|EQV|NLM (1992)|900917|COAG TESTS BLOOD|abcdefv
ENTRY = Tests, Blood Coagulation|T059|NON|EQV|NLM (1992)|900917|TESTS BLOOD COAG|abcdefv
ENTRY = Blood Coagulation Test
ENTRY = Coagulation Test, Blood
ENTRY = Test, Blood Coagulation
MN = E01.370.225.625.115
MN = E05.200.625.115
FX = Blood Coagulation
MH_TH = NLM (1966)
ST = T059
AN = GEN: prefer specifics; NIM; coord with disease /blood, not /physiopathol; DF: BLOOD COAG TESTS
MS = Laboratory tests for evaluating the individual's clotting mechanism.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001780

*NEWRECORD
RECTYPE = D
MH = Blood Component Removal
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Apheresis|T061|NON|EQV|UNK (19XX)|850617|abcdef
PRINT ENTRY = Pheresis|T061|NON|EQV|UNK (19XX)|850617|abcdef
ENTRY = Aphereses
ENTRY = Blood Component Removals
ENTRY = Component Removal, Blood
ENTRY = Component Removals, Blood
ENTRY = Phereses
ENTRY = Removal, Blood Component
ENTRY = Removals, Blood Component
MN = E02.120
FX = Hematopoietic Stem Cell Mobilization
MH_TH = NLM (1981)
ST = T061
AN = GEN or unspecified only; prefer specifics LEUKAPHERESIS; PLASMAPHERESIS; PLATELETPHERESIS; do not use /util except by MeSH definition; erythrocytapheresis, erythrapheresis: coord with ERYTHROCYTE TRANSFUSION
MS = Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.
PM = 86; PLATELETPHERESIS was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978
HN = 86; was NON MESH before 1986
CATSH = CAT LIST
MR = 20050630
DA = 19800512
DC = 1
DX = 19860101
UI = D001781

*NEWRECORD
RECTYPE = D
MH = Blood Donors
AQ = CL ED ES HI LJ PX SD SN
ENTRY = Blood Donation|T058|NON|REL|BIOETHICS (1989)|770317|abcdef
ENTRY = Blood Donations
ENTRY = Blood Donor
ENTRY = Donation, Blood
ENTRY = Donations, Blood
ENTRY = Donor, Blood
ENTRY = Donors, Blood
MN = M01.898.313
MH_TH = POPLINE (1994)
ST = T098
AN = IM
MR = 20050630
DA = 19990101
DC = 1
UI = D001782

*NEWRECORD
RECTYPE = D
MH = Blood Flow Velocity
AQ = DE ES GE IM PH RE VE
ENTRY = Blood Flow Velocities
ENTRY = Flow Velocities, Blood
ENTRY = Flow Velocity, Blood
ENTRY = Velocities, Blood Flow
ENTRY = Velocity, Blood Flow
MN = E01.370.370.130
MN = G09.330.380.630.080
MH_TH = NLM (1966)
ST = T034
ST = T169
AN = usually NIM; coordinate with disease / physiopathol, not / blood; do not confuse with PULSE WAVE VELOCITY see PULSE WAVE ANASLYSIS
MS = A value equal to the total volume flow divided by the cross-sectional area of the vascular bed.
HN = was in Cat E only 1963-85
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D001783

*NEWRECORD
RECTYPE = D
MH = Blood Gas Analysis
DE = BLOOD GAS ANAL
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Analysis, Blood Gas|T059|NON|EQV|UNK (19XX)|860101|ANAL BLOOD GAS|abcdefv
ENTRY = Analyses, Blood Gas
ENTRY = Blood Gas Analyses
ENTRY = Gas Analyses, Blood
ENTRY = Gas Analysis, Blood
MN = E01.370.225.124.100.100
MN = E01.370.386.700.100
MN = E05.200.124.100.100
MH_TH = NLM (1966)
ST = T059
AN = for determ of oxygen & carbon dioxide in the blood; NIM; coord with disease /blood, not /physiopathol
MS = Measurement of oxygen and carbon dioxide in the blood.
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001784

*NEWRECORD
RECTYPE = D
MH = Blood Gas Monitoring, Transcutaneous
DE = TCPO2
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Carbon Dioxide Partial Pressure Determination, Transcutaneous|T060|NON|NRW|UNK (19XX)|860620|abcdef
PRINT ENTRY = Cutaneous Oximetry|T060|NON|NRW|UNK (19XX)|860620|abcdef
PRINT ENTRY = Oximetry, Transcutaneous|T060|NON|NRW|UNK (19XX)|860620|abcdef
PRINT ENTRY = Oxygen Partial Pressure Determination, Transcutaneous|T060|NON|NRW|UNK (19XX)|860620|abcdef
PRINT ENTRY = Transcutaneous Blood Gas Monitoring|T060|NON|EQV|UNK (19XX)|860620|abcdef
PRINT ENTRY = Transcutaneous Capnometry|T060|NON|NRW|UNK (19XX)|860620|abcdef
PRINT ENTRY = Transcutaneous Oximetry|T060|NON|NRW|UNK (19XX)|860620|abcdef
ENTRY = PtcO2|T034|ABB|REL|UNK (19XX)|860718|abcdef
ENTRY = TcPCO2|T034|ABB|NRW|UNK (19XX)|860718|abcdef
ENTRY = Capnometries, Transcutaneous
ENTRY = Capnometry, Transcutaneous
ENTRY = Cutaneous Oximetries
ENTRY = Oximetries, Cutaneous
ENTRY = Oximetries, Transcutaneous
ENTRY = Oximetry, Cutaneous
ENTRY = Transcutaneous Capnometries
ENTRY = Transcutaneous Oximetries
MN = E01.370.225.124.100.100.600.100
MN = E01.370.370.380.600.100
MN = E01.370.386.700.100.600.100
MN = E05.200.124.100.100.600.100
MH_TH = NLM (1987)
ST = T060
AN = NIM; coord with disease /blood, not /physiopathol; when IM, do not coord with OXYGEN /blood or CARBON DIOXIDE /blood; DF: TCPO2
PI = Carbon Dioxide/blood (1966-1986)
PI = Monitoring, Physiological (1966-1986)
PI = Oxygen/blood (1966-1986)
PI = Partial Pressure (1966-1986)
MS = The noninvasive measurement or determination of the partial pressure (tension) of oxygen and/or carbon dioxide locally in the capillaries of a tissue by the application to the skin of a special set of electrodes. These electrodes contain photoelectric sensors capable of picking up the specific wavelengths of radiation emitted by oxygenated versus reduced hemoglobin.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20150622
DA = 19860620
DC = 1
DX = 19870101
UI = D001785

*NEWRECORD
RECTYPE = D
MH = Blood Glucose
AQ = AN BI CH DE GE IM IP ME PH RE
PRINT ENTRY = Blood Sugar|T118|NON|EQV|UNK (19XX)|790523|abcdef
PRINT ENTRY = Glucose, Blood|T118|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Sugar, Blood
MN = D09.546.359.448.500
FX = Glucose Clamp Technique
FX = Glucose Tolerance Test
FX = Glycemic Index
FX = Hemoglobin A, Glycosylated
FX = Hyperglycemia
FX = Hypoglycemia
MH_TH = NLM (1966)
ST = T118
RN = 0
MS = Glucose in blood.
OL = use BLOOD GLUCOSE to search BLOOD SUGAR 1966-79
PM = 80; was BLOOD SUGAR 1963-79
HN = 80; was BLOOD SUGAR 1963-79
MR = 20040707
DA = 19990101
DC = 1
UI = D001786

*NEWRECORD
RECTYPE = D
MH = Blood Group Incompatibility
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Blood Group Incompatibilities
ENTRY = Group Incompatibilities, Blood
ENTRY = Group Incompatibility, Blood
ENTRY = Incompatibilities, Blood Group
ENTRY = Incompatibility, Blood Group
MN = G09.188.114
MN = G12.186
MH_TH = NLM (1966)
ST = T047
AN = coordinate IM with specific blood group (IM)
MS = An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984).
CATSH = CAT LIST
MR = 20140623
DA = 19990101
DC = 1
UI = D001787

*NEWRECORD
RECTYPE = D
MH = Blood Grouping and Crossmatching
DE = BLOOD GROUPING CROSSMATCHING
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Blood Typing|T059|NON|NRW|UNK (19XX)|790427|abcdef
PRINT ENTRY = Crossmatching, Blood|T059|NON|NRW|UNK (19XX)|790427|abcdef
ENTRY = Blood Grouping|T059|NON|NRW|UNK (19XX)|790427|abcdef
ENTRY = Blood Crossmatching
ENTRY = Grouping, Blood
ENTRY = Typing, Blood
MN = E01.370.225.625.120
MN = E01.370.225.812.385.120
MN = E05.200.625.120
MN = E05.200.812.385.120
MN = E05.478.594.385.120
MH_TH = NLM (1980)
ST = T059
AN = DF: BLOOD GROUPING or short X ref
PI = Blood Group Incompatibility (1966-1979)
PI = Blood Groups (1966-1979)
PI = Blood Transfusion (1966-1979)
PI = Paternity (1966-1979)
PI = specific blood-group system (1966-1979)
MS = Testing erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. Crossmatching is performed prior to transfusion.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20110624
DA = 19790427
DC = 1
DX = 19800101
UI = D001788

*NEWRECORD
RECTYPE = D
MH = Blood Group Antigens
AQ = AD AE AN BI BL CF CH CL CT EC GE HI IM IP ME PD PH PO TO TU UL UR
PRINT ENTRY = Blood Groups|T170|NON|REL|NLM (1966)|990101|abcdef
ENTRY = Antigens, Blood Group
ENTRY = Groups, Blood
MN = D23.050.301.290
MN = D23.050.705.230
FX = Coombs Test
FX = Isoantibodies
MH_TH = NLM (2004)
ST = T129
RN = 0
AN = human or animal; blood group of animal: coord animal /blood (not /immunol) (IM) + BLOOD GROUP ANTIGENS (IM); blood group in a disease: coord BLOOD GROUP ANTIGENS or specific blood group (IM) + disease /blood (IM), not /immunol nor /genet
MS = Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties.
CATSH = CAT LIST
MR = 20120705
DA = 19990101
DC = 1
UI = D001789

*NEWRECORD
RECTYPE = D
MH = Blood Physiological Phenomena
AQ = DE GE IM RE
PRINT ENTRY = Blood Physiology|T042|NON|EQV|NLM (1966)|990101|BLOOD PHYSIOL|abcdefv
ENTRY = Blood Physiological Concepts|T042|NON|EQV|NLM (2009)|080702|abcdef
ENTRY = Blood Physiological Phenomenon|T042|NON|EQV|NLM (2009)|080702|abcdef
ENTRY = Physiology, Blood|T042|NON|EQV|NLM (1999)|980401|PHYSIOL BLOOD|abcdefv
ENTRY = Blood Physiological Concept
ENTRY = Blood Physiological Phenomenas
ENTRY = Concept, Blood Physiological
ENTRY = Concepts, Blood Physiological
ENTRY = Phenomena, Blood Physiological
ENTRY = Phenomenon, Blood Physiological
ENTRY = Physiological Concept, Blood
ENTRY = Physiological Concepts, Blood
ENTRY = Physiological Phenomenon, Blood
MN = G09.188
MH_TH = NLM (2009)
ST = T042
AN = general or unspecified; prefer specifics; DF: BLOOD PHYSIOL
PI = Blood/physiology (1966-1997)
MS = Physiological processes and properties of the BLOOD.
PM = 2009; see BLOOD PHYSIOLOGY 1998-2008
HN = 2009 (1998)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19980101
UI = D001790

*NEWRECORD
RECTYPE = D
MH = Blood Platelet Disorders
DE = BLOOD PLATELET DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Thrombocytopathy|T047|NON|EQV|UNK (19XX)|850325|abcdef
ENTRY = Blood Platelet Disorder
ENTRY = Disorder, Blood Platelet
ENTRY = Disorders, Blood Platelet
ENTRY = Platelet Disorder, Blood
ENTRY = Platelet Disorders, Blood
ENTRY = Thrombocytopathies
MN = C15.378.140
MH_TH = NLM (1964)
ST = T047
AN = do not use as coord for platelet factor defic: use COAGULATION PROTEIN DISORDERS
MS = Disorders caused by abnormalities in platelet count or function.
OL = use BLOOD PLATELET DISORDERS to search THROMBOCYTOPATHY 1966-85
PM = 67; THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66
HN = 67(64); THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66
CATSH = CAT LIST
MR = 19980610
DA = 19990101
DC = 1
DX = 19670101
UI = D001791

*NEWRECORD
RECTYPE = D
MH = Blood Platelets
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE UL US VI
PRINT ENTRY = Platelets|T023|T025|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Thrombocytes|T023|T025|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Blood Platelet
ENTRY = Platelet
ENTRY = Platelet, Blood
ENTRY = Platelets, Blood
ENTRY = Thrombocyte
MN = A11.118.188
MN = A15.145.229.188
FX = Platelet Activation
FX = Platelet Adhesiveness
FX = Platelet Aggregation
FX = Platelet Aggregation Inhibitors
FX = Platelet Count
FX = Platelet Function Tests
FX = Platelet Transfusion
FX = Plateletpheresis
FX = Thrombocytopenia
FX = Thrombocytosis
EC = transplantation:Platelet Transfusion
MH_TH = NLM (1966)
ST = T023
ST = T025
AN = A 11 qualif; decrease in no. of platelets = THROMBOCYTOPENIA, increase = THROMBOCYTOSIS; platelet factors & defic: TN 228
CX = consider also terms at PLATELET and THROMBOCYT-
MS = Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.
MR = 19950222
DA = 19990101
DC = 1
UI = D001792

*NEWRECORD
RECTYPE = D
MH = Blood Preservation
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Blood Preservations
ENTRY = Preservation, Blood
ENTRY = Preservations, Blood
MN = E02.792.833.230
MN = E05.760.833.230
MH_TH = NLM (1966)
ST = T061
AN = preserv of whole blood or specific cellular elements; coord IM with specific cell (IM); cryopreservation of blood: coord IM with CRYOPRESERVATION (IM)
MS = The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001793

*NEWRECORD
RECTYPE = D
MH = Blood Pressure
AQ = DE GE IM PH RE
PRINT ENTRY = Systolic Pressure|T040|NON|NRW|NLM (2002)|000714|abcdef
ENTRY = Diastolic Pressure|T040|NON|NRW|NLM (2002)|000714|abcdef
ENTRY = Pulse Pressure|T040|NON|NRW|NLM (2002)|000714|abcdef
ENTRY = Pressure, Blood
ENTRY = Pressure, Diastolic
ENTRY = Pressure, Pulse
ENTRY = Pressure, Systolic
ENTRY = Pressures, Systolic
MN = E01.370.600.875.249
MN = G09.330.380.076
FX = Hypertension
FX = Hypotension
MH_TH = NLM (1999)
ST = T033
ST = T040
AN = general; note specifics;  pressure within a specific vessel: coordinate vessel / physiol (IM) + BLOOD PRESSURE (NIM); do not add SYSTOLE; DIASTOLE; or PULSE unless particularly discussed; with diseases coordinate IM with disease / physiopathol (IM), not / blood (IM); differentiate from HYPERTENSION & HYPOTENSION
MS = PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001794

*NEWRECORD
RECTYPE = D
MH = Blood Pressure Determination
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Blood Pressure Determinations
ENTRY = Determination, Blood Pressure
ENTRY = Determinations, Blood Pressure
MN = E01.370.370.140
MN = E01.370.600.100
MH_TH = NLM (1966)
ST = T060
AN = NIM; see note on BLOOD PRESSURE
MS = Techniques for measuring blood pressure.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001795

*NEWRECORD
RECTYPE = D
MH = Blood Protein Disorders
DE = BLOOD PROTEIN DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Blood Protein Disorder
ENTRY = Disorder, Blood Protein
ENTRY = Disorders, Blood Protein
ENTRY = Protein Disorder, Blood
ENTRY = Protein Disorders, Blood
MN = C15.378.147
MH_TH = NLM (1966)
ST = T047
AN = GEN: avoid: prefer specifics
CATSH = CAT LIST
MR = 19910823
DA = 19990101
DC = 1
UI = D001796

*NEWRECORD
RECTYPE = D
MH = Blood Protein Electrophoresis
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Blood Protein Electrophoreses
ENTRY = Electrophoreses, Blood Protein
ENTRY = Electrophoresis, Blood Protein
ENTRY = Protein Electrophoreses, Blood
ENTRY = Protein Electrophoresis, Blood
MN = E01.370.225.124.100.110
MN = E05.196.401.076
MN = E05.200.124.100.110
MN = E05.301.300.049
FX = Immunoelectrophoresis
MH_TH = NLM (1966)
ST = T059
AN = electrophoresis of hemoglobin goes here + HEMOGLOBINS /analysis
MS = Electrophoresis applied to BLOOD PROTEINS.
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D001797

*NEWRECORD
RECTYPE = D
MH = Blood Proteins
AQ = AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Plasma Proteins|T116|T123|NON|REL|POPLINE (1984)|740329|abbcdef
PRINT ENTRY = Serum Proteins|T116|T123|NON|REL|POPLINE (1978)|740329|abbcdef
ENTRY = Proteins, Blood
ENTRY = Proteins, Plasma
ENTRY = Proteins, Serum
MN = D12.776.124
FX = Protein Binding
FX = Serpins
MH_TH = POPLINE (1984)
ST = T116
ST = T123
RN = 0
AN = GEN: avoid: prefer specifics; electrophoresis = BLOOD PROTEIN ELECTROPHORESIS
MS = Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.
OL = pre-explosion = BLOOD PROTEINS (PX)
MR = 20090710
DA = 19990101
DC = 1
UI = D001798

*NEWRECORD
RECTYPE = D
MH = Blood Sedimentation
AQ = DE RE
PRINT ENTRY = Erythrocyte Sedimentation|T059|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Erythrocyte Sedimentation Rate|T034|NON|REL|POPLINE (1978)|781219|abcdef
ENTRY = Erythrocyte Sedimentation Rates
ENTRY = Rate, Erythrocyte Sedimentation
ENTRY = Rates, Erythrocyte Sedimentation
ENTRY = Sedimentation Rate, Erythrocyte
ENTRY = Sedimentation Rates, Erythrocyte
ENTRY = Sedimentation, Blood
ENTRY = Sedimentation, Erythrocyte
MN = E01.370.225.625.125
MN = E05.200.625.125
MH_TH = NLM (1966)
ST = T059
AN = NIM; /drug eff /rad eff permitted; coord with disease /blood, not /physiopathol
MS = Measurement of rate of settling of erythrocytes in anticoagulated blood.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001799

*NEWRECORD
RECTYPE = D
MH = Blood Specimen Collection
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Blood Specimen Collections
ENTRY = Collection, Blood Specimen
ENTRY = Collections, Blood Specimen
ENTRY = Specimen Collection, Blood
ENTRY = Specimen Collections, Blood
MN = E01.370.225.998.110
MN = E04.665.150
MN = E05.200.998.110
MH_TH = BIOETHICS (1991)
ST = T060
AN = includes "handling"
MS = The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001800

*NEWRECORD
RECTYPE = D
MH = Blood Stains
ENTRY = Blood Stain
ENTRY = Stain, Blood
ENTRY = Stains, Blood
MN = I01.198.780.937.206
MH_TH = NLM (1966)
ST = T031
AN = no qualif
MS = Antigenic characteristics and DNA fingerprint patterns identified from blood stains. Their primary value is in criminal cases.
MR = 20030709
DA = 19990101
DC = 1
UI = D001801

*NEWRECORD
RECTYPE = D
MH = Blood Substitutes
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Artificial Blood|T121|NON|EQV|NLM (1998)|961126|abcdef
PRINT ENTRY = Artificial Erythrocytes|T121|NON|NRW|NLM (1998)|961126|abcdef
PRINT ENTRY = Artificial Hemoglobin|T121|NON|NRW|NLM (1998)|961126|abcdef
PRINT ENTRY = Blood, Artificial|T121|NON|EQV|UNK (19XX)|800402|abcdef
PRINT ENTRY = Erythrocyte Substitutes|T121|NON|NRW|UNK (19XX)|800402|abcdef
PRINT ENTRY = Hemoglobin Substitutes|T121|NON|NRW|UNK (19XX)|800402|abcdef
PRINT ENTRY = Red Cell Substitutes|T121|NON|NRW|UNK (19XX)|800402|abcdef
ENTRY = Artificial Bloods
ENTRY = Artificial Erythrocyte
ENTRY = Artificial Hemoglobins
ENTRY = Blood Substitute
ENTRY = Bloods, Artificial
ENTRY = Cell Substitute, Red
ENTRY = Cell Substitutes, Red
ENTRY = Erythrocyte Substitute
ENTRY = Erythrocyte, Artificial
ENTRY = Erythrocytes, Artificial
ENTRY = Hemoglobin Substitute
ENTRY = Hemoglobin, Artificial
ENTRY = Hemoglobins, Artificial
ENTRY = Red Cell Substitute
ENTRY = Substitute, Blood
ENTRY = Substitute, Erythrocyte
ENTRY = Substitute, Hemoglobin
ENTRY = Substitute, Red Cell
ENTRY = Substitutes, Blood
ENTRY = Substitutes, Erythrocyte
ENTRY = Substitutes, Hemoglobin
ENTRY = Substitutes, Red Cell
MN = D27.505.954.502.140
MN = J01.637.087.249
FX = Artificial Cells
FX = Bloodless Medical and Surgical Procedures
MH_TH = NLM (1981)
ST = T121
RN = 0
AN = PLASMA SUBSTITUTES is also available
PI = Erythrocytes (1968-1980)
PI = Hemoglobins (1968-1980)
PI = Plasma Substitutes (1968-1980)
MS = Substances that are used in place of blood, for example, as an alternative to BLOOD TRANSFUSIONS after blood loss to restore BLOOD VOLUME and oxygen-carrying capacity to the blood circulation, or to perfuse isolated organs.
OL = search PLASMA SUBSTITUTES 1966-80
PM = 81; was see PLASMA SUBSTITUTES 1963-80
HN = 81; was see PLASMA SUBSTITUTES 1963-80
MR = 20100625
DA = 19800402
DC = 1
DX = 19810101
UI = D001802

*NEWRECORD
RECTYPE = D
MH = Blood Transfusion
AQ = AE CL CT EC ES HI IS LJ MO MT NU PX SN ST TD UT VE
ENTRY = Blood Transfusions|T061|NON|EQV|BIOETHICS (1974)|770317|abcdef
ENTRY = Transfusion, Blood
ENTRY = Transfusions, Blood
MN = E02.095.135
FX = Blood Group Incompatibility
FX = Blood Grouping and Crossmatching
MH_TH = POPLINE (1994)
ST = T061
AN = TN 186: differentiate among various "transfusion" concepts; do not use /util except by MeSH definition; for whole blood or unspecified transfusion: note that BLOOD COMPONENT TRANSFUSION & BLOOD COMPONENT REMOVAL & its specifics are available
MS = The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 19950525
DA = 19990101
DC = 1
UI = D001803

*NEWRECORD
RECTYPE = D
MH = Blood Transfusion, Autologous
DE = BLOOD TRANSFUSION AUTOL
AQ = AE CL CT EC ES HI IS LJ MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Autotransfusion|T061|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Autologous Blood Transfusion|T061|NON|EQV|NLM (1994)|920825|AUTOL BLOOD TRANSFUSION|abcdefv
ENTRY = Autologous Blood Transfusions|T061|NON|EQV|NLM (1994)|920825|AUTOL BLOOD TRANSFUSIONS|abcdefv
ENTRY = Blood Transfusions, Autologous|T061|NON|EQV|NLM (1994)|920825|BLOOD TRANSFUSIONS AUTOL|abcdefv
ENTRY = Transfusion, Autologous Blood|T061|NON|EQV|NLM (1994)|920825|TRANSFUSION AUTOL BLOOD|abcdefv
ENTRY = Transfusions, Autologous Blood|T061|NON|EQV|NLM (1994)|920825|TRANSFUSIONS AUTOL BLOOD|abcdefv
ENTRY = Autotransfusions
MN = E02.095.135.164
FX = Operative Blood Salvage
MH_TH = NLM (1971)
ST = T061
AN = do not use /util except by MeSH definition; DF: BLOOD TRANSFUSION AUTOL
PI = Blood Transfusion (1966-1970)
MS = Reinfusion of blood or blood products derived from the patient's own circulation. (Dorland, 27th ed)
PM = 71
HN = 71
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19710101
UI = D001804

*NEWRECORD
RECTYPE = D
MH = Blood Transfusion, Intrauterine
AQ = AE CL CT EC ES HI IS LJ MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Fetal Transfusion|T061|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Intrauterine Transfusion|T061|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Blood Transfusions, Intrauterine
ENTRY = Fetal Transfusions
ENTRY = Intrauterine Blood Transfusion
ENTRY = Intrauterine Blood Transfusions
ENTRY = Intrauterine Transfusions
ENTRY = Transfusion, Fetal
ENTRY = Transfusion, Intrauterine
ENTRY = Transfusion, Intrauterine Blood
ENTRY = Transfusions, Fetal
ENTRY = Transfusions, Intrauterine
ENTRY = Transfusions, Intrauterine Blood
MN = E02.095.135.264
MN = E02.467.500
MH_TH = NLM (1965)
ST = T061
AN = coordinate with specific type of transfusion if pertinent
MS = In utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis (ERYTHROBLASTOSIS, FETAL).
PM = 68
HN = 68(65)
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
DX = 19680101
UI = D001805

*NEWRECORD
RECTYPE = D
MH = Blood Urea Nitrogen
PRINT ENTRY = BUN|T059|ABB|EQV|UNK (19XX)|740329|abcdef
ENTRY = Nitrogen, Blood Urea
ENTRY = Urea Nitrogen, Blood
MN = E01.370.225.124.100.115
MN = E01.370.390.400.100
MN = E05.200.124.100.115
MH_TH = NLM (1964)
ST = T059
AN = note category; no qualif; often correct for foreign "azotemia"; DF: note short X ref
MS = The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
PM = 67
HN = 67(64)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
DX = 19670101
UI = D001806

*NEWRECORD
RECTYPE = D
MH = Blood Vessel Prosthesis
AQ = AE CL CT EC ES HI MI PS PX SD SN ST TD UT VE VI
PRINT ENTRY = Vascular Prosthesis|T074|NON|EQV|UNK (19XX)|860325|abcdef
ENTRY = Blood Vessel Prostheses|T074|NON|EQV|NLM (2011)|091102|abcdef
ENTRY = Tissue-Engineered Vascular Graft|T074|NON|NRW|NLM (2011)|091030|abcdef
ENTRY = Graft, Tissue-Engineered Vascular
ENTRY = Grafts, Tissue-Engineered Vascular
ENTRY = Prostheses, Blood Vessel
ENTRY = Prostheses, Vascular
ENTRY = Prosthesis, Blood Vessel
ENTRY = Prosthesis, Vascular
ENTRY = Tissue Engineered Vascular Graft
ENTRY = Tissue-Engineered Vascular Grafts
ENTRY = Vascular Graft, Tissue-Engineered
ENTRY = Vascular Grafts, Tissue-Engineered
ENTRY = Vascular Prostheses
ENTRY = Vessel Prostheses, Blood
ENTRY = Vessel Prosthesis, Blood
MN = E07.695.110
FX = Blood Vessel Prosthesis Implantation
MH_TH = NLM (1966)
ST = T074
MS = Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001807

*NEWRECORD
RECTYPE = D
MH = Blood Vessels
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RE SE TR UL US VI
ENTRY = Blood Vessel
ENTRY = Vessel, Blood
ENTRY = Vessels, Blood
MN = A07.231
FX = Angiography
FX = Vascular Resistance
FX = Vascular Surgical Procedures
FX = Vasomotor System
EC = radiography:Angiography
EC = radionuclide imaging:Radionuclide Angiography
EC = surgery:Vascular Surgical Procedures
MH_TH = NLM (1966)
ST = T023
AN = general only: prefer specifics; prefer /blood supply with anatomical terms: Manual 21.4+; permeability = VASCULAR PERMEABILITY see CAPILLARY PERMEABILITY; inflammation = VASCULITIS or its specifics
CX = consider also terms at ANGI-, VASA-, VASC-, and VASO-
MS = Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins).
PM = /transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65
HN = /transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65
MR = 20130709
DA = 19990101
DC = 1
UI = D001808

*NEWRECORD
RECTYPE = D
MH = Blood Viscosity
AQ = DE ES GE IM PH RE
ENTRY = Blood Viscosities
ENTRY = Viscosities, Blood
ENTRY = Viscosity, Blood
MN = G09.188.370.124
MN = G09.330.380.630.110
FX = Hemorheology
MH_TH = NLM (1966)
ST = T039
AN = coordinate IM with disease /blood (IM), not /physiopathol
MS = The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA.
CATSH = CAT LIST
MR = 20150625
DA = 19990101
DC = 1
UI = D001809

*NEWRECORD
RECTYPE = D
MH = Blood Volume
AQ = DE ES GE IM PH RE VE
ENTRY = Blood Volumes
ENTRY = Volume, Blood
ENTRY = Volumes, Blood
MN = G09.188.130
MN = G09.330.380.092
FX = Fluid Shifts
FX = Hypovolemia
MH_TH = NLM (1966)
ST = T032
AN = PLASMA VOLUME; ERYTHROCYTE VOLUME; & ERYTHROCYTE VOLUME, PACKED are also available; coordinate IM with disease /physiopathol (IM), not /blood
MS = Volume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME.
CATSH = CAT LIST
MR = 20150625
DA = 19990101
DC = 1
UI = D001810

*NEWRECORD
RECTYPE = D
MH = Blood Volume Determination
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
ENTRY = Blood Volume Determinations
ENTRY = Determination, Blood Volume
ENTRY = Determinations, Blood Volume
ENTRY = Volume Determination, Blood
ENTRY = Volume Determinations, Blood
MN = E01.370.370.150
MH_TH = NLM (1966)
ST = T059
ST = T060
AN = NIM; coord with disease /physiopathol, not /blood
MS = Method for determining the circulating blood volume by introducing a known quantity of foreign substance into the blood and determining its concentration some minutes later when thorough mixing has occurred. From these two values the blood volume can be calculated by dividing the quantity of injected material by its concentration in the blood at the time of uniform mixing. Generally expressed as cubic centimeters or liters per kilogram of body weight.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001811

*NEWRECORD
RECTYPE = D
MH = Blood-Brain Barrier
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Brain-Blood Barrier|T042|NON|EQV|NLM (2004)|030317|abcdef
PRINT ENTRY = Hemato-Encephalic Barrier|T042|NON|EQV|UNK (19XX)|740329|HEMATOENCEPHALIC BARRIER|abcdefs
ENTRY = Barrier, Blood-Brain
ENTRY = Barrier, Brain-Blood
ENTRY = Barrier, Hemato-Encephalic
ENTRY = Barriers, Blood-Brain
ENTRY = Barriers, Brain-Blood
ENTRY = Barriers, Hemato-Encephalic
ENTRY = Blood Brain Barrier
ENTRY = Blood-Brain Barriers
ENTRY = Brain Blood Barrier
ENTRY = Brain-Blood Barriers
ENTRY = Hemato Encephalic Barrier
ENTRY = Hemato-Encephalic Barriers
MN = A07.035
MN = A08.186.211.035
FX = Capillary Permeability
MH_TH = NLM (1966)
ST = T042
AN = coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)
MS = Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.
PM = 66; was HEMATO-ENCEPHALIC BARRIER 1963-65
HN = 66; was HEMATO-ENCEPHALIC BARRIER 1963-65
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
DX = 19660101
UI = D001812

*NEWRECORD
RECTYPE = D
MH = Blood-Retinal Barrier
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Retinal-Blood Barrier|T042|NON|EQV|NLM (2004)|030317|abcdef
ENTRY = Barrier, Blood-Retinal
ENTRY = Barrier, Retinal-Blood
ENTRY = Barriers, Blood-Retinal
ENTRY = Barriers, Retinal-Blood
ENTRY = Blood Retinal Barrier
ENTRY = Blood-Retinal Barriers
ENTRY = Retinal Blood Barrier
ENTRY = Retinal-Blood Barriers
MN = A07.040
MN = A09.371.729.055
FX = Capillary Permeability
MH_TH = NLM (1987)
ST = T042
AN = coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)
PI = Retina (1966-1986)
PI = Retinal Vessels (1966-1986)
MS = A specialized transport barrier, in the EYE, formed by the retinal pigment EPITHELIUM, and the ENDOTHELIUM of the BLOOD VESSELS of the RETINA. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20030709
DA = 19860407
DC = 1
DX = 19870101
UI = D001813

*NEWRECORD
RECTYPE = D
MH = Blood-Testis Barrier
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Testis-Blood Barrier|T042|NON|EQV|NLM (2004)|030317|abcdef
ENTRY = Barrier, Blood-Testis
ENTRY = Barrier, Testis-Blood
ENTRY = Barriers, Blood-Testis
ENTRY = Barriers, Testis-Blood
ENTRY = Blood Testis Barrier
ENTRY = Blood-Testis Barriers
ENTRY = Testis Blood Barrier
ENTRY = Testis-Blood Barriers
MN = A05.360.444.849.700.349
MN = A07.045
FX = Capillary Permeability
MH_TH = NLM (1975)
ST = T042
AN = coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)
PI = Testis (1966-1974)
MS = A specialized barrier, in the TESTIS, between the interstitial BLOOD compartment and the adluminal compartment of the SEMINIFEROUS TUBULES. The barrier is formed by layers of cells from the VASCULAR ENDOTHELIUM of the capillary BLOOD VESSELS, to the SEMINIFEROUS EPITHELIUM of the seminiferous tubules. TIGHT JUNCTIONS form between adjacent SERTOLI CELLS, as well as between the ENDOTHELIAL CELLS.
PM = 76; was see under TESTIS 1975
HN = 76(75); was see under TESTIS 1975
CATSH = CAT LIST
MR = 20030709
DA = 19741111
DC = 1
DX = 19760101
UI = D001814

*NEWRECORD
RECTYPE = D
MH = Bloodletting
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
MN = E02.800.558.500
FX = Phlebotomy
MH_TH = NLM (1966)
ST = T058
AN = restrict to hist articles or hist contexts: modern counterpart is PHLEBOTOMY
MS = Puncture of a vein to draw blood for therapeutic purposes. Bloodletting therapy has been used in Talmudic and Indian medicine since the medieval time, and was still practiced widely in the 18th and 19th centuries. Its modern counterpart is PHLEBOTOMY.
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
UI = D001815

*NEWRECORD
RECTYPE = D
MH = Bloom Syndrome
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bloom-Torre-Machacek Syndrome|T019|T047|EPO|EQV|GHR (2014)|ORD (2010)|UNK (19XX)|810223|abbcdeeef
ENTRY = Bloom's Syndrome|T019|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abbcdeef
ENTRY = Congenital Telangiectatic Erythema|T019|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abbcdeef
ENTRY = Bloom Torre Machacek Syndrome
ENTRY = Syndrome, Bloom
ENTRY = Syndrome, Bloom-Torre-Machacek
MN = C16.131.077.137
MN = C18.452.284.100
MH_TH = GHR (2014)
MH_TH = NLM (1982)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T019
ST = T047
PI = Abnormalities, Multiple (1968-1981)
PI = Dwarfism (1966-1981)
PI = Facial Dermatoses (1966-1981)
PI = Telangiectasis (1966-1981)
MS = An autosomal recessive disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing cancer. The Bloom syndrome gene (BLM) encodes a RecQ-like DNA helicase.
PM = 82
HN = 82
CATSH = CAT LIST
MR = 20130708
DA = 19810223
DC = 1
DX = 19820101
UI = D001816

*NEWRECORD
RECTYPE = D
MH = Bluetongue
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Blue Tongue|T047|NON|EQV|NLM (1994)|930503|abcdef
ENTRY = Tongue, Blue
MN = C02.081.125
MN = C02.782.791.315
MN = C22.836.120
MH_TH = NLM (1968)
ST = T047
AN = caused by a reovirus; usually animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES
PI = Sheep Diseases (1966-1967)
PI = Virus Diseases/veterinary (1966-1967)
MS = A reovirus infection, chiefly of sheep, characterized by a swollen blue tongue, catarrhal inflammation of upper respiratory and gastrointestinal tracts, and often by inflammation of sensitive laminae of the feet and coronet.
OL = use BLUETONGUE to search BLUE TONGUE 1968-93 (as Prov 1968-73)
PM = 94; was BLUE TONGUE 1974-93
HN = 94; was BLUE TONGUE 1968-93 (Prov 1968-73)
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
DX = 19740101
UI = D001819

*NEWRECORD
RECTYPE = D
MH = Bluetongue virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Ovine Catarrhal Fever Virus|T005|NON|EQV|UNK (19XX)|741205|abcdef
ENTRY = Blue Tongue Virus|T005|NON|EQV|NLM (1994)|930310|abcdef
ENTRY = Blue Tongue Viruses
ENTRY = Bluetongue Viruses
MN = B04.820.630.550.100
MH_TH = NLM (1975)
ST = T005
AN = infection = BLUETONGUE: see note there
MS = The type species of ORBIVIRUS causing a serious disease in sheep, especially lambs. It may also infect wild ruminants and other domestic animals.
OL = use BLUETONGUE VIRUS to search BLUE TONGUE VIRUS 1975-93
PM = 94; was BLUE TONGUE VIRUS 1975-93 (see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80)
HN = 94; was BLUE TONGUE VIRUS 1975-93 (see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80)
MR = 20150622
DA = 19741212
DC = 1
DX = 19910101
UI = D001820

*NEWRECORD
RECTYPE = D
MH = Blushing
AQ = CL DE ES PH PX RE
ENTRY = Blushings
MN = F01.145.209.530.136
MN = F02.830.158
MH_TH = NLM (1966)
ST = T055
ST = T184
AN = note category: do not confuse with FLUSHING
MS = Involuntary reddening, especially of the face, associated with feelings of embarrassment, confusion or shame.
CATSH = CAT LIST
MR = 20090730
DA = 19990101
DC = 1
UI = D001821

*NEWRECORD
RECTYPE = D
MH = Body Burden
ENTRY = Body Burdens
ENTRY = Burden, Body
ENTRY = Burdens, Body
MN = E05.799.638.231
MN = N06.850.460.200
FX = Drug Residues
FX = Pesticide Residues
MH_TH = NLM (1971)
ST = T081
AN = NIM; not restricted to radioactive substances: applicable to chemical, metal or radioactive substances; no qualif
PI = Radiation Monitoring (1966-1970)
MS = The total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal.
PM = 73; only radioactive substances 1973-77
HN = 73(71); only radioactive substances 1971-77
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19730101
UI = D001822

*NEWRECORD
RECTYPE = D
MH = Body Composition
AQ = DE GE IM PH RE
ENTRY = Body Compositions
ENTRY = Composition, Body
ENTRY = Compositions, Body
MN = G02.111.097
MN = G03.180
MN = G07.100.049
FX = Anthropometry
MH_TH = NLM (1966)
ST = T032
MS = The relative amounts of various components in the body, such as percentage of body fat.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001823

*NEWRECORD
RECTYPE = D
MH = Body Constitution
AQ = DE EH GE IM PH RE
ENTRY = Body Constitutions
ENTRY = Constitution, Body
ENTRY = Constitutions, Body
MN = E01.370.600.115
MN = G07.100
MH_TH = NLM (1966)
ST = T032
ST = T081
MS = The physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms.
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
UI = D001824

*NEWRECORD
RECTYPE = D
MH = Body Fluid Compartments
AQ = CH DE EN GE IM ME MI PH PS RA RE RI US VI
ENTRY = Body Fluid Compartment
ENTRY = Compartment, Body Fluid
ENTRY = Compartments, Body Fluid
ENTRY = Fluid Compartment, Body
ENTRY = Fluid Compartments, Body
MN = A10.082
MN = A12.207.180
MH_TH = NLM (1978)
ST = T030
PI = Body Fluids (1966-1977)
PI = Body Water (1974-1977)
MS = The two types of spaces between which water and other body fluids are distributed: extracellular and intracellular.
PM = 91; was see under BODY FLUIDS 1978-90
HN = 91(78); was see under BODY FLUIDS 1978-90
CATSH = CAT LIST
MR = 20090706
DA = 19770301
DC = 1
DX = 19910101
UI = D001825

*NEWRECORD
RECTYPE = D
MH = Body Fluids
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
ENTRY = Body Fluid
ENTRY = Fluid, Body
ENTRY = Fluids, Body
MN = A12.207
FX = Dehydration
FX = Fluid Shifts
FX = Radioisotope Dilution Technique
MH_TH = NLM (1966)
ST = T031
MS = Liquid components of living organisms.
MR = 20070709
DA = 19990101
DC = 1
UI = D001826

*NEWRECORD
RECTYPE = D
MH = Body Height
AQ = DE EH GE IM PH RE
ENTRY = Body Heights
ENTRY = Height, Body
ENTRY = Heights, Body
MN = E01.370.600.115.100.160.100
MN = E05.041.124.160.500
MN = G07.100.100.160.100
MN = G07.700.320.249.314.100
MH_TH = NLM (1963)
ST = T032
ST = T081
AN = human only; for height or length of animals use animal /anat (IM) + BIOMETRY (NIM)
MS = The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001827

*NEWRECORD
RECTYPE = D
MH = Body Image
AQ = PX
ENTRY = Body Representation|T080|NON|BRD|NLM (2013)|110908|abcdef
ENTRY = Body Schema|T080|NON|REL|NLM (2013)|110908|abcdef
ENTRY = Body Images
ENTRY = Body Representations
ENTRY = Body Schemas
ENTRY = Image, Body
ENTRY = Images, Body
ENTRY = Representation, Body
ENTRY = Representations, Body
ENTRY = Schema, Body
ENTRY = Schemas, Body
MN = F01.752.747.792.110
MN = F02.463.593.112
MH_TH = NLM (1966)
ST = T080
MS = Individuals' concept of their own bodies.
CATSH = CAT LIST
MR = 20150522
DA = 19990101
DC = 1
UI = D001828

*NEWRECORD
RECTYPE = D
MH = Body Regions
AQ = AB AH BS EM GD IN IR MI PA PH PP PS RA RE RI SU US VI
ENTRY = Body Region
ENTRY = Region, Body
ENTRY = Regions, Body
MN = A01
RH = A1 - ANATOMY-BODY REGIONS
MH_TH = NLM (1966)
ST = T029
AN = INDEXER: Do not use
PI = specific region (1966-1997)
MS = Anatomical areas of the body.
PM = 98
HN = 98; use explode 1971-97
MR = 20150605
DA = 19990101
DC = 1
DX = 19980101
UI = D001829

*NEWRECORD
RECTYPE = D
MH = Body Surface Area
AQ = VE
ENTRY = Area, Body Surface
ENTRY = Areas, Body Surface
ENTRY = Body Surface Areas
ENTRY = Surface Area, Body
ENTRY = Surface Areas, Body
MN = E01.370.600.115.100.231
MN = E05.041.124.231
MN = G07.100.100.231
MH_TH = NLM (1967)
ST = T032
ST = T081
PI = Anthropometry (1966)
MS = The two dimensional measure of the outer layer of the body.
PM = 70
HN = 70(67)
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19700101
UI = D001830

*NEWRECORD
RECTYPE = D
MH = Body Temperature
AQ = DE GE IM PH RE
PRINT ENTRY = Organ Temperature|T032|NON|NRW|UNK (19XX)|850617|abcdef
ENTRY = Body Temperatures
ENTRY = Organ Temperatures
ENTRY = Temperature, Body
ENTRY = Temperature, Organ
ENTRY = Temperatures, Body
ENTRY = Temperatures, Organ
MN = E01.370.600.875.374
MN = G07.110
FX = Fever
FX = Thermography
FX = Thermometers
MH_TH = POPLINE (1978)
ST = T032
MS = The measure of the level of heat of a human or animal.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001831

*NEWRECORD
RECTYPE = D
MH = Body Temperature Changes
ENTRY = Body Temperature Change
ENTRY = Change, Body Temperature
ENTRY = Changes, Body Temperature
ENTRY = Temperature Change, Body
ENTRY = Temperature Changes, Body
MN = C23.888.119
MH_TH = NLM (1974)
ST = T040
ST = T184
AN = INDEXER: Do not use
PI = Body Temperature (1966-1997)
MS = Significant alterations in temperature of the human body, above or below 98.6 degrees F. or 37 degrees C. when taken orally.
PM = 98
HN = 98; use explode 1975-97
CATSH = CAT LIST
MR = 20150605
DA = 19990101
DC = 1
DX = 19980101
UI = D001832

*NEWRECORD
RECTYPE = D
MH = Body Temperature Regulation
DE = BODY TEMPERATURE REG
AQ = DE ES GE IM PH RE
PRINT ENTRY = Heat Loss|T040|NON|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Thermoregulation|T040|NON|EQV|UNK (19XX)|740329|THERMOREG|abcdefv
ENTRY = Regulation, Body Temperature|T040|NON|EQV|NLM (1992)|901015|REG BODY TEMPERATURE|abcdefv
ENTRY = Temperature Regulation, Body|T040|NON|EQV|NLM (1992)|901015|TEMPERATURE REG BODY|abcdefv
ENTRY = Body Temperature Regulations
ENTRY = Heat Losses
ENTRY = Loss, Heat
ENTRY = Losses, Heat
ENTRY = Regulations, Body Temperature
ENTRY = Temperature Regulations, Body
ENTRY = Thermoregulations
MN = G07.110.232
MN = G07.700.345.421
MN = G16.100.057.500.535
MH_TH = NLM (1966)
ST = T040
MS = The processes of heating and cooling that an organism uses to control its temperature.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001833

*NEWRECORD
RECTYPE = D
MH = Body Water
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
ENTRY = Water, Body
MN = A12.207.200
MH_TH = NLM (1972)
ST = T031
AN = do not confuse with EXTRACELLULAR FLUID
PI = Body Fluids (1966-1971)
PI = Water (1966-1971)
MS = Fluids composed mainly of water found within the body.
PM = 74
HN = 74(72)
MR = 20150630
DA = 19990101
DC = 1
DX = 19740101
UI = D001834

*NEWRECORD
RECTYPE = D
MH = Body Weight
AQ = DE EH GE IM PH RE
ENTRY = Body Weights
ENTRY = Weight, Body
ENTRY = Weights, Body
MN = C23.888.144
MN = E01.370.600.115.100.160.120
MN = E05.041.124.160.750
MN = G07.100.100.160.120
MN = G07.700.320.249.314.120
FX = Obesity
MH_TH = NLM (1963)
ST = T032
ST = T081
MS = The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001835

*NEWRECORD
RECTYPE = D
MH = Body Weight Changes
ENTRY = Body Weight Change
ENTRY = Change, Body Weight
ENTRY = Changes, Body Weight
ENTRY = Weight Change, Body
ENTRY = Weight Changes, Body
MN = C23.888.144.243
MN = G07.700.320.249.314.120.200
MH_TH = NLM (1974)
ST = T040
ST = T184
AN = INDEXER: Do not use
PI = Body Weight (1966-1997)
MS = A clinical manifestation consisting of alterations in an individual's weight from his or her norm.
PM = 98
HN = 98; use explode 1975-97
CATSH = CAT LIST
MR = 20150605
DA = 19990101
DC = 1
DX = 19980101
UI = D001836

*NEWRECORD
RECTYPE = D
MH = Body Weights and Measures
DE = BODY WEIGHTS MEASURES
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Body Measures|T060|NON|NRW|NLM (1998)|960913|abcdef
ENTRY = Body Measure
ENTRY = Measure, Body
ENTRY = Measures, Body
MN = E01.370.600.115.100
MN = E05.041.124
MN = G07.100.100
FX = Anthropometry
MH_TH = NLM (1974)
ST = T081
AN = general or unspecified; prefer specifics; do not confuse with BODY WEIGHT
PI = Anthropometry (1966-1997)
MS = Measurements of the height, weight, length, area, etc., of the human and animal body or its parts.
PM = 98
HN = 98; use explode 1975-97
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19980101
UI = D001837

*NEWRECORD
RECTYPE = D
MH = Bolivia
AQ = EH EP
MN = Z01.107.757.136
MH_TH = POPLINE (1978)
ST = T083
MR = 19911102
DA = 19990101
DC = 4
UI = D001838

*NEWRECORD
RECTYPE = D
MH = Bombesin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Bombesin 14|T116|T124|T125|NON|EQV|UNK (19XX)|830629|abbbcdef
ENTRY = Bombesin Dihydrochloride|T116|T125|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Dihydrochloride, Bombesin
MN = D06.472.699.100
MN = D12.644.400.085
MN = D12.644.548.100
MN = D12.776.641.650.085
MN = D20.888.033.137
MN = D23.946.833.033.137
PA = Neurotransmitter Agents
FX = Receptors, Bombesin
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T116
ST = T124
ST = T125
N1 = 5-oxoPro-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-MetNH2
RN = PX9AZU7QPK
RR = 31362-50-2 (Bombesin)
RR = 33910-70-2 (di-HCl)
PI = Anura (1966-1974)
PI = Peptides (1966-1974)
MS = A tetradecapeptide originally obtained from the skins of toads Bombina bombina and B. variegata. It is also an endogenous neurotransmitter in many animals including mammals. Bombesin affects vascular and other smooth muscle, gastric secretion, and renal circulation and function.
PM = 86; was see under PEPTIDES 1975-85
HN = 86(75); was see under PEPTIDES 1975-85
MR = 20130708
DA = 19741111
DC = 1
DX = 19860101
UI = D001839

*NEWRECORD
RECTYPE = D
MH = Dental Bonding
DE = DENT BONDING
AQ = AE CL CT EC ES HI IS MT NU PX SN ST TD UT VE
PRINT ENTRY = Bonding, Dental|T061|NON|EQV|NLM (1991)|900409|BONDING DENT|abcdefv
PRINT ENTRY = Cure of Orthodontic Adhesives|T061|NON|NRW|NLM (2009)|071003|abcdef
ENTRY = Curing, Dental Cement|T061|NON|NRW|NLM (2009)|071003|abcdef
ENTRY = Dental Cement Curing
ENTRY = Orthodontic Adhesives Cure
MN = E06.095
MH_TH = NLM (1971)
ST = T061
AN = general; note specifics; DF: DENT BONDING
PI = Surface Properties (1966-1970)
MS = An adhesion procedure for orthodontic attachments, such as plastic DENTAL CROWNS. This process usually includes the application of an adhesive material (DENTAL CEMENTS) and letting it harden in-place by light or chemical curing.
OL = use DENTAL BONDING to search BONDING, DENTAL 1971-90 (as Prov 1971)
PM = 91; was BONDING, DENTAL 1972-90
HN = 91(71); was BONDING, DENTAL 1971-90 (Prov 1971)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19720101
UI = D001840

*NEWRECORD
RECTYPE = D
MH = Bonding, Human-Pet
PRINT ENTRY = Animal-Human Bonding|T054|NON|BRD|UNK (19XX)|820428|abcdef
PRINT ENTRY = Human-Pet Bonding|T054|NON|EQV|UNK (19XX)|820428|abcdef
PRINT ENTRY = Pet-Human Bonding|T054|NON|EQV|UNK (19XX)|820428|abcdef
ENTRY = Animal Human Bonding
ENTRY = Animal-Human Bondings
ENTRY = Bonding, Animal-Human
ENTRY = Bonding, Human Pet
ENTRY = Bonding, Pet-Human
ENTRY = Bondings, Animal-Human
ENTRY = Bondings, Human-Pet
ENTRY = Bondings, Pet-Human
ENTRY = Human Pet Bonding
ENTRY = Human-Pet Bondings
ENTRY = Pet Human Bonding
ENTRY = Pet-Human Bondings
MN = F02.739.794.624.120
FX = Pets
MH_TH = NLM (1983)
ST = T054
AN = coordinate with specific animal pet; check tags ANIMALS & HUMAN
MS = The emotional attachment of individuals to PETS.
PM = 91; was see under OBJECT ATTACHMENT 1983-90
HN = 91(83); was see under OBJECT ATTACHMENT 1983-90
CATSH = CAT LIST
MR = 20100625
DA = 19820428
DC = 1
DX = 19910101
UI = D001841

*NEWRECORD
RECTYPE = D
MH = Bone and Bones
DE = BONE BONES
AQ = AB AH BS CH CY DE EM EN IM IN IR ME MI PA PH PP PS RA RE RI SU UL US VI
PRINT ENTRY = Bone Tissue|T024|NON|NRW|NLM (2002)|000927|abcdef
ENTRY = Bone|T024|NON|NRW|NLM (2002)|000927|abcdef
ENTRY = Bones|T021|NON|NRW|UNK (19XX)|790625|abcdef
ENTRY = Bones and Bone|T024|NON|EQV|UNK (19XX)|790625|BONES BONE|abcdefv
ENTRY = Bones and Bone Tissue|T024|NON|EQV|NLM (2002)|000927|abcdef
ENTRY = Bone Tissues
ENTRY = Tissue, Bone
ENTRY = Tissues, Bone
MN = A02.835.232
MN = A10.165.265
FX = Arthrodesis
FX = Calcification, Physiologic
FX = Osteogenesis
FX = Osteotomy
EC = growth & development:Bone Development
EC = transplantation:Bone Transplantation
MH_TH = NLM (1966)
ST = T024
AN = /cytol: consider also OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; /embryol: consider also OSTEOGENESIS; /surg: consider also OSTEOTOMY or ARTHRODESIS or FRACTURE FIXATION & its specifics; osteosynthesis not one of the preceding terms goes under BONE AND BONES /surg; differentiate from SKELETON which is almost never used: restrict SKELETON to bone arrangement as a whole & not for "skeletal" which usually means "bone" ( = BONE AND BONES); "disappearing bone" = OSTEOLYSIS, ESSENTIAL; inflammation = OSTEITIS; necrosis = OSTEONECROSIS; "bone minerals" = BONE AND BONES (IM) + MINERALS (IM) or specific mineral (IM)
CX = consider also terms at OSSI- and OSTE-
MS = A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
OL = use BONE TRANSPLANTATION to search BONE AND BONES/transplantation 1966-89
PM = /transplantation was BONE TRANSPLANTATION 1963-65; was BONE AND BONES/transplantation 1966-89
HN = /transplantation was BONE TRANSPLANTATION 1963-65; was BONE AND BONES/transplantation 1966-89
MR = 20080708
DA = 19990101
DC = 1
UI = D001842

*NEWRECORD
RECTYPE = D
MH = Bone Cements
AQ = AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Bone Glues|T122|NON|EQV|NLM (1997)|950817|abcdef
PRINT ENTRY = Bone Pastes|T122|NON|EQV|NLM (1997)|950817|abcdef
ENTRY = Bone Glue|T122|NON|EQV|NLM (1997)|950817|abcdef
ENTRY = Bone Paste|T122|NON|EQV|NLM (1997)|950817|abcdef
ENTRY = Cements, Bone
ENTRY = Glue, Bone
ENTRY = Glues, Bone
ENTRY = Paste, Bone
ENTRY = Pastes, Bone
MN = D05.750.716.822.300
MN = D25.720.716.822.300
MN = D27.720.102.158
MN = J01.637.051.720.716.822.300
MH_TH = NLM (1972)
ST = T122
RN = 0
AN = IM; coord with specific material if relevant (IM); D25-26 qualif
PI = Tissue Adhesives (1966-1971)
MS = Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste.
PM = 72
HN = 72
MR = 20060705
DA = 19990101
DC = 1
DX = 19720101
UI = D001843

*NEWRECORD
RECTYPE = D
MH = Bone Conduction
AQ = DE GE IM PH RE
ENTRY = Bone Conduction Hearing|T042|NON|EQV|NLM (2007)|060202|abcdef
ENTRY = Conduction Hearing, Bone
ENTRY = Conduction, Bone
ENTRY = Hearing, Bone Conduction
MN = F02.830.816.263.500
MN = G11.561.600.810.263.398
MH_TH = NLM (1964)
ST = T042
AN = do not confuse with OSTEOCONDUCTION
MS = Transmission of sound waves through vibration of bones in the SKULL to the inner ear (COCHLEA). By using bone conduction stimulation and by bypassing any OUTER EAR or MIDDLE EAR abnormalities, hearing thresholds of the cochlea can be determined. Bone conduction hearing differs from normal hearing which is based on air conduction stimulation via the EAR CANAL and the TYMPANIC MEMBRANE.
PM = 67
HN = 67(64)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19670101
UI = D001844

*NEWRECORD
RECTYPE = D
MH = Bone Cysts
AQ = BL BS CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Ganglia, Intraosseous|T047|NON|NRW|NLM (1995)|940121|abcdef
PRINT ENTRY = Intraosseous Ganglion|T047|NON|NRW|NLM (1995)|931123|abcdef
PRINT ENTRY = Solitary Cysts|T047|NON|EQV|NLM (1994)|921202|abcdef
PRINT ENTRY = Subchondral Cysts|T047|NON|BRD|UNK (19XX)|860623|abcdef
ENTRY = Ganglia, Intra-Osseous|T047|NON|NRW|NLM (1995)|940121|abcdef
ENTRY = Ganglion, Intra-Osseous|T047|NON|NRW|NLM (1995)|940121|abcdef
ENTRY = Intra-Osseous Ganglia|T047|NON|NRW|NLM (1995)|940121|abcdef
ENTRY = Intra-Osseous Ganglion|T047|NON|NRW|NLM (1995)|940121|abcdef
ENTRY = Bone Cyst
ENTRY = Cyst, Bone
ENTRY = Cyst, Solitary
ENTRY = Cyst, Subchondral
ENTRY = Cysts, Bone
ENTRY = Cysts, Solitary
ENTRY = Cysts, Subchondral
ENTRY = Ganglia, Intra Osseous
ENTRY = Ganglias, Intra-Osseous
ENTRY = Ganglias, Intraosseous
ENTRY = Ganglion, Intra Osseous
ENTRY = Ganglion, Intraosseous
ENTRY = Ganglions, Intra-Osseous
ENTRY = Intra Osseous Ganglia
ENTRY = Intra Osseous Ganglion
ENTRY = Intra-Osseous Ganglias
ENTRY = Intra-Osseous Ganglions
ENTRY = Intraosseous Ganglia
ENTRY = Intraosseous Ganglias
ENTRY = Intraosseous Ganglions
ENTRY = Solitary Cyst
ENTRY = Subchondral Cyst
MN = C04.182.089
MN = C05.116.070
MH_TH = NLM (1966)
ST = T047
AN = coord IM with specific bone (IM)
MS = Benign unilocular lytic areas in the proximal end of a long bone with well defined and narrow endosteal margins. The cysts contain fluid and the cyst walls may contain some giant cells. Bone cysts usually occur in males between the ages 3-15 years.
OL = use BONE CYSTS to search BONE CYST 1966-79
PM = 80; was BONE CYST 1963-79
HN = 80; was BONE CYST 1963-79
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
UI = D001845

*NEWRECORD
RECTYPE = D
MH = Bone Development
AQ = DE GE IM PH RE
ENTRY = Bone Growth|T042|NON|NRW|NLM (2002)|010109|abcdef
MN = G07.700.320.500.325.377.625.100
MN = G11.427.590.560.100
MH_TH = NLM (1965)
ST = T042
AN = OSTEOGENESIS is also available
MS = The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20080708
DA = 19780621
DC = 1
DX = 19650101
UI = D001846

*NEWRECORD
RECTYPE = D
MH = Bone Diseases
DE = BONE DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bone Disease
ENTRY = Disease, Bone
ENTRY = Diseases, Bone
MN = C05.116
FX = Fractures, Bone
MH_TH = NLM (1966)
ST = T047
AN = inflammatory disease = OSTEITIS
MS = Diseases of BONES.
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D001847

*NEWRECORD
RECTYPE = D
MH = Bone Diseases, Developmental
DE = BONE DIS DEVELOPMENTAL
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bone Dysplasias|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Developmental Bone Disease|T047|NON|EQV|UNK (19XX)|740329|DEVELOPMENTAL BONE DIS|abcdefv
ENTRY = Bone Disease, Developmental
ENTRY = Bone Dysplasia
ENTRY = Developmental Bone Diseases
ENTRY = Dysplasia, Bone
ENTRY = Dysplasias, Bone
MN = C05.116.099
MH_TH = NLM (1970)
ST = T047
PI = Bone Diseases (1966-1969)
PM = 70; HYPERTELORISM was see under CRANIOFACIAL DYSOSTOSIS 1963-84
HN = 70
CATSH = CAT LIST
MR = 19910613
DA = 19990101
DC = 1
DX = 19700101
UI = D001848

*NEWRECORD
RECTYPE = D
MH = Bone Diseases, Endocrine
DE = BONE DIS ENDOCRINE
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bone Disease, Endocrine
ENTRY = Disease, Endocrine Bone
ENTRY = Diseases, Endocrine Bone
ENTRY = Endocrine Bone Disease
ENTRY = Endocrine Bone Diseases
MN = C05.116.132
MN = C19.149
MH_TH = NLM (1966)
ST = T047
AN = General or unspecified; prefer specifics; coordinate IM with specific endocrine disease (IM)
PI = Bone Diseases (1966-1997)
PI = Endocrine Diseases (1966-1997)
MS = Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands.
PM = 98
HN = 98; use explode 1971-97
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19980101
UI = D001849

*NEWRECORD
RECTYPE = D
MH = Bone Diseases, Infectious
DE = BONE DIS INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Bone Disease, Infectious
ENTRY = Disease, Infectious Bone
ENTRY = Diseases, Infectious Bone
ENTRY = Infectious Bone Disease
ENTRY = Infectious Bone Diseases
MN = C01.539.160
MN = C05.116.165
MH_TH = NLM (1966)
ST = T047
AN = GEN or unspecified; prefer specifics; coord IM with specific infection (IM); DF: BONE DIS INFECT
PI = Bone Diseases (1966-1997)
PI = Infection (1966-1997)
PI = Orthopedics (1966-1997)
MS = Bone diseases caused by pathogenic microorganisms.
PM = 98
HN = 98; use explode 1971-97
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19980101
UI = D001850

*NEWRECORD
RECTYPE = D
MH = Bone Diseases, Metabolic
DE = BONE DIS METAB
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Osteopenia|T047|NON|NRW|UNK (19XX)|860408|abcdef
ENTRY = Metabolic Bone Diseases|T047|NON|EQV|NLM (1991)|900816|METAB BONE DIS|abcdefv
ENTRY = Bone Disease, Metabolic
ENTRY = Disease, Metabolic Bone
ENTRY = Diseases, Metabolic Bone
ENTRY = Metabolic Bone Disease
ENTRY = Osteopenias
MN = C05.116.198
MH_TH = NLM (1980)
ST = T047
PI = Bone Diseases (1966-1979)
PM = 80
HN = 80; was NON MESH before 1980
CATSH = CAT LIST
MR = 19900816
DA = 19990101
DC = 1
DX = 19800101
UI = D001851

*NEWRECORD
RECTYPE = D
MH = Bone Lengthening
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Lengthening, Bone
MN = E04.555.120
FX = Tissue Expansion
MH_TH = NLM (1972)
ST = T061
AN = not restricted to long bones; coordinate IM with specific bone /surg (IM) or specific disease /surg (IM)
PI = Leg Length Inequality (1966-1971)
PI = Osteotomy (1966-1971)
PI = specific bone/surgery (1966-1971)
MS = Increase in the longest dimension of a bone to correct anatomical deficiencies, congenital, traumatic, or as a result of disease. The lengthening is not restricted to long bones. The usual surgical methods are internal fixation and distraction.
OL = search LEG LENGTHENING under LEG LENGTH INEQUALITY 1966-71 (as Prov 1966)
PM = 72; LEG LENGTHENING was heading 1967-71
HN = 72; LEG LENGTHENING was heading 1964-71 (Prov 1964-66)
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19720101
UI = D001852

*NEWRECORD
RECTYPE = D
MH = Bone Marrow
AQ = AB AH BS CH DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
PRINT ENTRY = Marrow|T023|NON|BRD|UNK (19XX)|740329|abcdef
PRINT ENTRY = Red Marrow|T023|NON|NRW|NLM (1991)|900316|abcdef
PRINT ENTRY = Yellow Marrow|T023|NON|NRW|NLM (1991)|900316|abcdef
ENTRY = Marrow, Bone
ENTRY = Marrow, Red
ENTRY = Marrow, Yellow
MN = A15.382.216
EC = cytology:Bone Marrow Cells
EC = transplantation:Bone Marrow Transplantation
MH_TH = BIOETHICS (1989)
ST = T023
AN = /cytol = BONE MARROW CELLS; /transpl = BONE MARROW TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS; inflammation = OSTEOMYELITIS; fibrosis = MYELOFIBROSIS; do not confuse words containing "myel-" for spinal cord with "myel-" for bone marrow
CX = consider also terms at MYEL-
MS = The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
OL = use BONE MARROW /CY + BONE MARROW /qualif to search BONE MARROW CELLS /same qualif 1966-77, e.g., search BONE MARROW CELLS /DE under BONE MARROW /CY + BONE MARROW /DE
PM = 65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65, was BONE MARROW/transplantation 1966-89
HN = 65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65, was BONE MARROW/transplantation 1966-89
MR = 19970620
DA = 19990101
DC = 1
UI = D001853

*NEWRECORD
RECTYPE = D
MH = Bone Marrow Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE UL US VI
ENTRY = Bone Marrow Cell
ENTRY = Cell, Bone Marrow
ENTRY = Cells, Bone Marrow
ENTRY = Marrow Cell, Bone
ENTRY = Marrow Cells, Bone
MN = A11.148
MN = A15.378.316
FX = Bone Marrow Examination
EC = transplantation:Bone Marrow Transplantation
MH_TH = NLM (1965)
ST = T025
PI = Bone Marrow Cells (1966-1977)
PI = Bone Marrow/cytology (1978-1997)
MS = Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.
PM = 98, 65-77
HN = 98; 65-77, use explode 1978-97
MR = 20090730
DA = 19990101
DC = 1
DX = 19980101
UI = D001854

*NEWRECORD
RECTYPE = D
MH = Bone Marrow Diseases
DE = BONE MARROW DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bone Marrow Disease
ENTRY = Disease, Bone Marrow
ENTRY = Diseases, Bone Marrow
ENTRY = Marrow Disease, Bone
ENTRY = Marrow Diseases, Bone
MN = C15.378.190
MH_TH = NLM (1966)
ST = T047
AN = inflamm dis = OSTEOMYELITIS
CATSH = CAT LIST
MR = 19900529
DA = 19990101
DC = 1
UI = D001855

*NEWRECORD
RECTYPE = D
MH = Bone Marrow Examination
DE = BONE MARROW EXAM
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Examination, Bone Marrow|T059|NON|EQV|NLM (1995)|930920|EXAM BONE MARROW|abcdefv
ENTRY = Bone Marrow Examinations
ENTRY = Examinations, Bone Marrow
MN = E01.370.225.625.135
MN = E05.200.625.135
MH_TH = NLM (1966)
ST = T059
AN = NIM; DF: BONE MARROW EXAM
MS = Removal of bone marrow and evaluation of its histologic picture.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001856

*NEWRECORD
RECTYPE = D
MH = Bone Matrix
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Bone Matrices
ENTRY = Matrices, Bone
ENTRY = Matrix, Bone
MN = A10.165.265.166
MH_TH = NLM (1972)
ST = T024
PI = Bone and Bones (1966-1971)
MS = Extracellular substance of bone tissue consisting of COLLAGEN fibers, ground substance, and inorganic crystalline minerals and salts.
PM = 72
HN = 72
MR = 20150616
DA = 19990101
DC = 1
DX = 19720101
UI = D001857

*NEWRECORD
RECTYPE = D
MH = Bone Nails
AQ = AE CL CT EC ES HI MI PS PX SD SN ST TD UT VE VI
PRINT ENTRY = Bone Pins|T074|NON|EQV|NLM (1991)|891227|abcdef
ENTRY = Bone Nail
ENTRY = Bone Pin
ENTRY = Nail, Bone
ENTRY = Nails, Bone
ENTRY = Pin, Bone
ENTRY = Pins, Bone
MN = E07.695.370.249
MN = E07.858.442.660.460.249
MN = E07.858.690.725.460.249
FX = Bone Screws
FX = Bone Wires
MH_TH = NLM (1971)
ST = T074
AN = note X ref BONE PINS
MS = Rods of bone, metal, or other material used for fixation of the fragments or ends of fractured bones.
PM = 74
HN = 74(71)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19740101
UI = D001858

*NEWRECORD
RECTYPE = D
MH = Bone Neoplasms
DE = BONE NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Bone Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Cancer of Bone|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer of the Bone|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Neoplasms, Bone|T191|NON|EQV|NLM (1997)|950907|NEOPL BONE|abcdefv
ENTRY = Bone Neoplasm
ENTRY = Neoplasm, Bone
MN = C04.588.149
MN = C05.116.231
MH_TH = NLM (1966)
ST = T191
AN = GEN: prefer specific precoord; do not confuse with NEOPLASMS, BONE TISSUE (neopl composed of bone tissue); coord IM with specific bone (IM) + histol type of neopl (IM)
MS = Tumors or cancer located in bone tissue or specific BONES.
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
UI = D001859

*NEWRECORD
RECTYPE = D
MH = Bone Plates
AQ = AE CL CT EC ES HI MI PS PX SD SN ST TD UT VE VI
ENTRY = Bone Plate
ENTRY = Plate, Bone
ENTRY = Plates, Bone
MN = E07.695.370.374
MN = E07.858.442.660.460.374
MN = E07.858.690.725.460.374
MH_TH = NLM (1971)
ST = T074
MS = Implantable fracture fixation devices attached to bone fragments with screws to bridge the fracture gap and shield the fracture site from stress as bone heals. (UMDNS, 1999)
PM = 74
HN = 74(71)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19740101
UI = D001860

*NEWRECORD
RECTYPE = D
MH = Bone Regeneration
AQ = DE ES GE IM PH RE
ENTRY = Osteoconduction|T042|NON|REL|NLM (2007)|060217|abcdef
ENTRY = Bone Regenerations
ENTRY = Regeneration, Bone
ENTRY = Regenerations, Bone
MN = G11.427.590.195.140
MN = G16.100.856.150.150
FX = Bone Density Conservation Agents
FX = Bony Callus
FX = Fracture Healing
MH_TH = NLM (1965)
ST = T042
AN = not for callus formation (= BONY CALLUS with required qualifiers); not for fracture healing (= FRACTURE HEALING); do not confuse OSTEOCONDUCTION with BONE CONDUCTION
MS = Renewal or repair of lost bone tissue. It excludes BONY CALLUS formed after BONE FRACTURES but not yet replaced by hard bone.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19650101
UI = D001861

*NEWRECORD
RECTYPE = D
MH = Bone Resorption
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bone Loss, Osteoclastic|T042|NON|EQV|UNK (19XX)|860408|abcdef
PRINT ENTRY = Osteoclastic Bone Loss|T042|NON|EQV|UNK (19XX)|860408|abcdef
ENTRY = Bone Losses, Osteoclastic
ENTRY = Bone Resorptions
ENTRY = Loss, Osteoclastic Bone
ENTRY = Losses, Osteoclastic Bone
ENTRY = Osteoclastic Bone Losses
ENTRY = Resorption, Bone
ENTRY = Resorptions, Bone
MN = C05.116.264
MN = G11.427.590.195.150
FX = Alveolar Bone Loss
FX = Osteoclasts
MH_TH = NLM (1964)
ST = T042
AN = use Cat C qualif
MS = Bone loss due to osteoclastic activity.
PM = 65
HN = 65(64)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19650101
UI = D001862

*NEWRECORD
RECTYPE = D
MH = Bone Screws
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
ENTRY = Bone Screw
ENTRY = Screw, Bone
ENTRY = Screws, Bone
MN = E07.695.370.437
MN = E07.858.442.660.460.437
MN = E07.858.690.725.460.437
FX = Bone Nails
FX = Bone Wires
MH_TH = NLM (1971)
ST = T074
AN = do not confuse with BONE PINS see BONE NAILS
PI = Fracture Fixation (1966-1970)
PI = Fracture Fixation, Internal (1970)
PI = Fracture Fixation, Intramedullary (1970)
MS = Specialized devices used in ORTHOPEDIC SURGERY to repair bone fractures.
PM = 74
HN = 74(71)
CATSH = CAT LIST
MR = 20150626
DA = 19990101
DC = 1
DX = 19740101
UI = D001863

*NEWRECORD
RECTYPE = D
MH = Bone Wires
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Kirschner Wires|T074|EPO|NRW|NLM (1991)|900522|abcdef
ENTRY = Bone Wire
ENTRY = Wire, Bone
ENTRY = Wires, Bone
ENTRY = Wires, Kirschner
MN = E07.695.370.468
MN = E07.858.442.660.460.468
MN = E07.858.690.725.460.468
FX = Bone Nails
FX = Bone Screws
MH_TH = NLM (1986)
ST = T074
AN = do not confuse with BONE PINS see BONE NAILS
PI = Fracture Fixation, Internal (1970-1985)
MS = Steel wires, often threaded through the skin, soft tissues, and bone, used to fix broken bones. Kirschner wires or apparatus also includes the application of traction to the healing bones through the wires.
PM = 91; was see under ORTHOPEDIC FIXATION DEVICES 1986-90
HN = 91(86); was see under ORTHOPEDIC FIXATION DEVICES 1986-90
CATSH = CAT LIST
MR = 20060705
DA = 19850607
DC = 1
DX = 19910101
UI = D001864

*NEWRECORD
RECTYPE = D
MH = Bongkrekic Acid
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Flavotoxin A|T109|T121|NON|EQV|NLM (1991)|900404|abbcdef
ENTRY = Bongkrekate|T109|T121|NON|NRW|UNK (19XX)|850528|abbcdef
MN = D02.241.081.337.075
PA = Anti-Bacterial Agents
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = 2,4,8,10,14,18,20-Docosaheptaenedioic acid, 20-(carboxymethyl)-6-methoxy-2,5,17-trimethyl-, (R-(R*,S*-(E,Z,Z,E,E,Z,E)))-
RN = 11076-19-0
PI = Antibiotics (1973-1974)
PI = Carboxylic Acids (1973-1974)
PI = Pseudomonas (1968-1974)
MS = An antibiotic produced by Pseudomonas cocovenenans. It is an inhibitor of MITOCHONDRIAL ADP, ATP TRANSLOCASES. Specifically, it blocks adenine nucleotide efflux from mitochondria by enhancing membrane binding.
PM = 91; was see under ANTIBIOTICS 1975-90
HN = 91(75); was see under ANTIBIOTICS 1975-90
MR = 20030730
DA = 19741119
DC = 1
DX = 19910101
UI = D001865

*NEWRECORD
RECTYPE = D
MH = Book Classification
DE = BOOK CLASS
AQ = CL EC ES HI MT SN ST TD UT
ENTRY = Classification, Book|T057|NON|EQV|UNK (19XX)|860101|CLASS BOOK|abcdefv
ENTRY = Book Classifications
ENTRY = Classifications, Book
MN = L01.453.245.250.150
MN = L01.453.819.250.150
MH_TH = NLM (1966)
ST = T057
MS = A general term covering bibliographical and bibliothecal classifications. It mostly refers to library CLASSIFICATION for arrangement of books and documents on the shelves. (Harrod's Librarians' Glossary, 7th ed, p85)
MR = 20020702
DA = 19990101
DC = 1
UI = D001867

*NEWRECORD
RECTYPE = D
MH = Book Collecting
AQ = CL EC ES HI LJ SD SN ST TD UT
ENTRY = Book Collectings
ENTRY = Collecting, Book
ENTRY = Collectings, Book
MN = L01.040
MH_TH = NLM (1966)
ST = T056
ST = T057
MR = 19920325
DA = 19990101
DC = 1
UI = D001868

*NEWRECORD
RECTYPE = D
MH = Book Imprints
AQ = HI
ENTRY = Book Imprint
ENTRY = Imprint, Book
ENTRY = Imprints, Book
MN = L01.178.682.192.122
MH_TH = NLM (1966)
ST = T073
MR = 19920325
DA = 19990101
DC = 1
UI = D001869

*NEWRECORD
RECTYPE = D
MH = Book Industry
DE = BOOK INDUST
AQ = CL EC ES HI IS LJ MA OG SD SN ST TD UT
ENTRY = Industry, Book|T092|NON|EQV|NLM (1996)|950315|INDUST BOOK|abcdefv
ENTRY = Book Industries
ENTRY = Industries, Book
MN = J01.576.655.374
MN = L01.737.150
FX = Publishing
MH_TH = NLM (1966)
ST = T092
AN = specify geog if pertinent; DF: BOOK INDUST
MS = The aggregate enterprise of manufacturing and technically producing books. (From Random House Unabridged Dictionary, 2d ed)
MR = 19991103
DA = 19990101
DC = 1
UI = D001870

*NEWRECORD
RECTYPE = D
MH = Book Ornamentation
AQ = HI
ENTRY = Book Ornamentations
ENTRY = Ornamentation, Book
ENTRY = Ornamentations, Book
MN = L01.178.682.192.178
MH_TH = NLM (1966)
ST = T073
ST = T170
MR = 19920325
DA = 19990101
DC = 1
UI = D001871

*NEWRECORD
RECTYPE = D
MH = Book Prices
ENTRY = Book Price
ENTRY = Price, Book
ENTRY = Prices, Book
MN = L01.737.150.340.250
MH_TH = NLM (1966)
ST = T081
AN = no qualif
MR = 19890427
DA = 19990101
DC = 1
UI = D001872

*NEWRECORD
RECTYPE = D
MH = Book Reviews as Topic
MN = L01.178.682.150
MH_TH = NLM (2008)
ST = T170
AN = do not index book reviews; use for articles on book reviews as a subject
MS = Critical analyses of books or other monographic works.
PM = 2008; see BOOK REVIEWS 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D001873

*NEWRECORD
RECTYPE = D
MH = Book Selection
ENTRY = Book Selections
ENTRY = Selection, Book
ENTRY = Selections, Book
MN = L01.453.220
MH_TH = NLM (1966)
ST = T052
AN = no qualif; lists of books probably go here but consider also BIBLIOGRAPHY AS TOPIC
MR = 20070710
DA = 19990101
DC = 1
UI = D001874

*NEWRECORD
RECTYPE = D
MH = Bookbinding
AQ = CL EC ES HI LJ MT SD SN ST TD UT
ENTRY = Bookbindings
MN = L01.737.150.317
MH_TH = NLM (1966)
ST = T057
MR = 19991103
DA = 19990101
DC = 1
UI = D001875

*NEWRECORD
RECTYPE = D
MH = Bookplates as Topic
AQ = HI
ENTRY = Book Plates as Topic|T073|T170|NON|EQV|NLM (2008)|070622|abbcdef
ENTRY = Bookplates as Topics
MN = L01.178.682.192.234
MH_TH = NLM (2008)
ST = T073
ST = T170
AN = designed labels showing ownership of a book; medical bookplates: do not coordinate with MEDICINE; coordinate IM with subject (IM) if relevant; bookplates of famous medical & non-medical figures: coordinate IM with required biographical and historical headings & check tags; do not confuse with Publication Type BOOKPLATES
MS = Labels pasted in books to mark their ownership and sometimes to indicate their location in a library. Private bookplates are often ornate or artistic: simpler and smaller ones bearing merely the owner's name are called "book labels." They are usually pasted on the front endpaper of books. (From Harrod, The Librarians' Glossary and Reference Book, 4th rev ed & Random House Unabridged Dictionary, 2d ed)
PM = 2008; see BOOKPLATES 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D001876

*NEWRECORD
RECTYPE = D
MH = Books
AQ = HI
ENTRY = Book Chapter|T170|NON|NRW|UNK (19XX)|781219|abcdef
ENTRY = Book
ENTRY = Book Chapters
ENTRY = Chapter, Book
ENTRY = Chapters, Book
MN = L01.178.682.192
FX = Bibliotherapy
EC = classification:Book Classification
MH_TH = NLM (1966)
ST = T073
ST = T170
AN = NOT for specific books ( = LITERATURE or its indentions); NOT for lists of books ( = BIBLIOGRAPHY AS TOPIC or its indentions): for books as a means of communication or as a subject ("books as carriers of germs"): Manual 33.11; relation to LITERATURE: Manual 33.11, relation to MANUSCRIPTS: Manual 33.12;TEXTBOOKS & REFERENCE BOOKS are also available
PM = 64
HN = 64
MR = 20070710
DA = 19990101
DC = 1
UI = D001877

*NEWRECORD
RECTYPE = D
MH = Books, Illustrated
AQ = HI
PRINT ENTRY = Book Illustration|T057|NON|REL|UNK (19XX)|740329|abcdef
PRINT ENTRY = Illustrated Books|T073|T170|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Book, Illustrated
ENTRY = Illustration, Book
ENTRY = Illustrations, Book
MN = J01.897.280.500.117
MN = L01.178.682.192.289
MH_TH = NLM (1966)
ST = T073
ST = T170
AN = IM; coord with subject (IM) or type of illus (IM); do not confuse X ref BOOK ILLUSTRATION with Publication Type BOOK ILLUSTRATIONS
MS = Books containing photographs, prints, drawings, portraits, plates, diagrams, facsimiles, maps, tables, or other representations or systematic arrangement of data designed to elucidate or decorate its contents. (From The ALA Glossary of Library and Information Science, 1983, p114)
MR = 20150702
DA = 19990101
DC = 1
UI = D001878

*NEWRECORD
RECTYPE = D
MH = Bookselling
AQ = CL EC ES HI LJ MT SD SN ST TD UT
ENTRY = Booksellings
MN = L01.737.150.340
MH_TH = NLM (1966)
ST = T057
AN = IM
MR = 19991108
DA = 19990101
DC = 1
UI = D001879

*NEWRECORD
RECTYPE = D
MH = Boranes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Boron Hydrides|T104|NON|EQV|NLM (1994)|930210|abcdef
ENTRY = Hydrides, Boron
MN = D01.132.105
MN = D02.203.087
MH_TH = NLM (1968)
ST = T104
RN = 0
AN = collective name for boron hydrides (do not confuse with BOROHYDRIDES); do not confuse with BORATES or BORNANES
PI = Boron (1966-1967)
MS = The collective name for the boron hydrides, which are analogous to the alkanes and silanes. Numerous boranes are known. Some have high calorific values and are used in high-energy fuels. (From Grant & Hackh's Chemical Dictionary, 5th ed)
PM = 68
HN = 68
MR = 19930604
DA = 19990101
DC = 1
DX = 19680101
UI = D001880

*NEWRECORD
RECTYPE = D
MH = Borates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.132.250.075
MN = D01.248.497.158.076
MN = D02.203.130.075
MH_TH = NLM (1966)
ST = T104
RN = 0
AN = do not confuse with BORANES
MS = Inorganic or organic salts and esters of boric acid.
MR = 19930708
DA = 19990101
DC = 1
UI = D001881

*NEWRECORD
RECTYPE = D
MH = Border Disease
DE = BORDER DIS
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Border Diseases
MN = C02.782.350.675.100
MN = C22.836.160
MH_TH = NLM (1985)
ST = T047
AN = caused by a pestivirus; border refers to the English-Welsh border where there is a high mortal among sheep from this dis; usually animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES
PI = Bovine Diarrhea Virus (1975-1984)
PI = Sheep Diseases (1966-1984)
MS = Congenital disorder of lambs caused by a virus closely related to or identical with certain strains of bovine viral diarrhea virus.
PM = 91; was see under SHEEP DISEASES 1985-90
HN = 91(85); was see under SHEEP DISEASES 1985-90
CATSH = CAT LIST
MR = 20030730
DA = 19840406
DC = 1
DX = 19910101
UI = D001882

*NEWRECORD
RECTYPE = D
MH = Borderline Personality Disorder
DE = BORDERLINE PERSONALITY DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Personality Disorder, Borderline|T048|NON|EQV|UNK (19XX)|800521|PERSONALITY DIS BORDERLINE|abcdefv
ENTRY = Disorder, Borderline Personality|T048|NON|EQV|UNK (19XX)|800521|DIS BORDERLINE PERSONALITY|abcdefv
ENTRY = Borderline Personality Disorders
ENTRY = Disorders, Borderline Personality
ENTRY = Personality Disorders, Borderline
MN = F03.675.100
MH_TH = NLM (1981)
ST = T048
AN = "borderline" is a psychiatric diag: follow text
MS = A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)
PM = 90; was see under PERSONALITY DISORDERS 1981-89
HN = 90(81); was see under PERSONALITY DISORDERS 1981-89
CATSH = CAT LIST
MR = 19970620
DA = 19800521
DC = 1
DX = 19900101
UI = D001883

*NEWRECORD
RECTYPE = D
MH = Bordetella
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.400.425.117.075
MN = B03.660.075.027.075
MH_TH = NLM (1966)
ST = T007
AN = infection = BORDETELLA INFECTIONS
MS = A genus of gram-negative, aerobic bacteria whose cells are minute coccobacilli. It consists of both parasitic and pathogenic species.
MR = 20090706
DA = 19990101
DC = 1
UI = D001884

*NEWRECORD
RECTYPE = D
MH = Bordetella Infections
DE = BORDETELLA INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Infections, Bordetella|T047|NON|EQV|NLM (1992)|910228|INFECT BORDETELLA|abcdefv
ENTRY = Bordetella Infection
ENTRY = Infection, Bordetella
MN = C01.252.400.143
MH_TH = NLM (1972)
ST = T047
AN = gram-neg bact infect
PI = Bordetella (1966-1971)
MS = Infections with bacteria of the genus BORDETELLA.
PM = 72
HN = 72
CATSH = CAT LIST
MR = 19930602
DA = 19990101
DC = 1
DX = 19720101
UI = D001885

*NEWRECORD
RECTYPE = D
MH = Bordetella pertussis
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Haemophilus pertussis|T007|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Hemophilus pertussis|T007|NON|EQV|NLM (1992)|910402|abcdef
MN = B03.440.400.425.117.075.550
MN = B03.660.075.027.075.600
FX = Pertussis Vaccine
FX = Virulence Factors, Bordetella
MH_TH = NLM (1966)
ST = T007
AN = infection = WHOOPING COUGH
MS = A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath.
MR = 20090706
DA = 19990101
DC = 1
UI = D001886

*NEWRECORD
RECTYPE = D
MH = Boredom
ENTRY = Boredoms
MN = F01.470.192
MH_TH = NLM (1969)
ST = T041
AN = no qualif
PI = Motivation (1966-1968)
MS = A psychological state resulting from any activity that lacks motivation, or from enforced continuance in an uninteresting situation.
PM = 69
HN = 69
CATSH = CAT LIST
MR = 19890427
DA = 19990101
DC = 1
DX = 19690101
UI = D001887

*NEWRECORD
RECTYPE = D
MH = Boric Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acids, Boric
MN = D01.029.260.093
MN = D01.132.250
MN = D02.203.130
MH_TH = NLM (1968)
ST = T197
RN = 0
PI = Borates (1966-1967)
MS = Inorganic and organic derivatives of boric acid either B(OH)3 or, preferably H3BO3.
PM = 68
HN = 68
MR = 19930604
DA = 19990101
DC = 1
DX = 19680101
UI = D001888

*NEWRECORD
RECTYPE = D
MH = Borinic Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acids, Borinic
MN = D01.029.260.100
MN = D01.132.275
MN = D02.203.187
MH_TH = NLM (1968)
ST = T104
RN = 0
AN = do not confuse with BORONIC ACIDS or BORIC ACIDS
PI = Boron (1966-1967)
MS = Inorganic or organic compounds that contain the general structure R2B(OH).
PM = 68
HN = 68
MR = 19930604
DA = 19990101
DC = 1
DX = 19680101
UI = D001889

*NEWRECORD
RECTYPE = D
MH = Borna Disease
DE = BORNA DIS
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
MN = C02.782.580.124
MN = C22.152
MH_TH = NLM (1970)
ST = T047
PI = Cattle Diseases (1966-1969)
PI = Encephalomyelitis (1966-1969)
PI = Horse Diseases (1966-1969)
PI = Virus Diseases (1966-1969)
MS = An encephalomyelitis of horses, sheep and cattle caused by BORNA DISEASE VIRUS.
PM = 70
HN = 70
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
DX = 19700101
UI = D001890

*NEWRECORD
RECTYPE = D
MH = Borna disease virus
DE = BORNA DIS VIRUS
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Enzootic Encephalomyelitis Virus|T005|NON|EQV|UNK (19XX)|741205|ENZOOTIC ENCEPH VIRUS|abcdefv
PRINT ENTRY = Near East Equine Encephalomyelitis Virus|T005|EPO|EQV|UNK (19XX)|741205|NEAR EAST EQUINE ENCEPH VIRUS|abcdefv
ENTRY = Encephalomyelitis Virus, Enzootic|T005|NON|EQV|NLM (1995)|940210|ENCEPH VIRUS ENZOOTIC|abcdefv
MN = B04.820.455.149.135
MH_TH = NLM (1975)
ST = T005
AN = infection = BORNA DISEASE; DF: BORNA DIS VIRUS
MS = A species in the genus Bornavirus, family BORNAVIRIDAE, causing a rare and usually fatal encephalitic disease in horses and other domestic animals and possibly deer. Its name derives from the city in Saxony where the condition was first described in 1894, but the disease occurs in Europe, N. Africa, and the Near East.
PM = 91; was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76
HN = 91(75); was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76
MR = 20150622
DA = 19741212
DC = 1
DX = 19910101
UI = D001891

*NEWRECORD
RECTYPE = D
MH = Bornanes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Camphanes|T109|NON|EQV|UNK (19XX)|740329|abcdef
MN = D02.455.849.575.781.234
MH_TH = NLM (1972)
ST = T109
RN = 0
AN = do not confuse with BORANES; includes bornenes
PI = Bridged Compounds (1966-1970)
PI = Camphor (1966-1970)
PI = Terpenes (1970-1971)
PM = 74
HN = 74(72)
MR = 20030709
DA = 19990101
DC = 1
DX = 19740101
UI = D001892

*NEWRECORD
RECTYPE = D
MH = Borneo
AQ = EH EP
MN = Z01.252.145.103
MN = Z01.639.160
MH_TH = NLM (1966)
ST = T083
AN = an island in the Malay Archipelago; 3d largest island in the world
MS = An island in the Malay Archipelago, east of Sumatra, north of Java, and west of Celebes. It is the third largest island in the world. Its name is a Portuguese alteration of BRUNEI, located on it. (From Webster's New Geographical Dictionary, 1988, p163; Room, Brewer's Dictionary of Names, 1992, p73)
MR = 20120703
DA = 19990101
DC = 4
UI = D001893

*NEWRECORD
RECTYPE = D
MH = Borohydrides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.132.105.050
MN = D02.203.087.050
MH_TH = NLM (1971)
ST = T104
RN = 0
AN = do not confuse with boron hydrides, the collective name for BORANES
PI = Boron Compounds (1968-1970)
MS = A class of inorganic or organic compounds that contain the borohydride (BH4-) anion.
PM = 73
HN = 73(71)
MR = 19930604
DA = 19990101
DC = 1
DX = 19730101
UI = D001894

*NEWRECORD
RECTYPE = D
MH = Boron
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.513.500
PA = Trace Elements
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T121
ST = T123
ST = T196
N1 = Boron
RN = N9E3X5056Q
RR = 7440-42-8 (Boron)
AN = B-11; B-10 = BORON (IM) + ISOTOPES (NIM); B-8, 9, 12, 13 = BORON (IM) + RADIOISOTOPES (IM)
MS = A trace element with the atomic symbol B, atomic number 5, and atomic weight [10.806; 10.821]. Boron-10, an isotope of boron, is used as a neutron absorber in BORON NEUTRON CAPTURE THERAPY.
MR = 20150622
DA = 19990101
DC = 1
UI = D001895

*NEWRECORD
RECTYPE = D
MH = Boron Compounds
DE = BORON CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Borides|T197|NON|NRW|NLM (1994)|930106|abcdef
ENTRY = Compounds, Boron
MN = D01.132
MN = D02.203
MH_TH = NLM (1968)
ST = T104
RN = 0
AN = GEN or unspecified; prefer specifics; DF: BORON CPDS
PI = Boron (1966-1967)
MS = Inorganic or organic compounds that contain boron as an integral part of the molecule.
PM = 68
HN = 68
MR = 19930604
DA = 19990101
DC = 1
DX = 19680101
UI = D001896

*NEWRECORD
RECTYPE = D
MH = Boronic Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acids, Boronic
MN = D01.029.260.110
MN = D01.132.285
MN = D02.203.200
MH_TH = NLM (1968)
ST = T104
RN = 0
AN = do not confuse with BORINIC ACIDS
PI = Boron (1966-1967)
MS = Inorganic or organic compounds that contain the basic structure RB(OH)2.
PM = 68
HN = 68
MR = 19930604
DA = 19990101
DC = 1
DX = 19680101
UI = D001897

*NEWRECORD
RECTYPE = D
MH = Borrelia
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.425.410.711.193
MN = B03.851.595.193
MH_TH = NLM (1966)
ST = T007
AN = B. burgdorferi or B. burgdorferi group infection = LYME DISEASE; infection by other species = probably RELAPSING FEVER, but if not, index under BORRELIA INFECTIONS
MS = A genus of gram-negative, anaerobic, helical bacteria, various species of which produce RELAPSING FEVER in humans and other animals.
MR = 20090706
DA = 19990101
DC = 1
UI = D001898

*NEWRECORD
RECTYPE = D
MH = Borrelia Infections
DE = BORRELIA INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Infections, Borrelia|T047|NON|EQV|NLM (1992)|910228|INFECT BORRELIA|abcdefv
ENTRY = Borrelia Infection
ENTRY = Infection, Borrelia
MN = C01.252.400.155
MN = C01.252.847.193
MH_TH = NLM (1966)
ST = T047
AN = B. burgdorferi or B. burgdorferi group infection = LYME DISEASE; infection by other species = probably RELAPSING FEVER, but if not, index here
MS = Infections with bacteria of the genus BORRELIA.
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D001899

*NEWRECORD
RECTYPE = D
MH = Boston
AQ = EH EP
MN = Z01.107.567.875.550.510.210
MN = Z01.433.210
MH_TH = NLM (1970)
ST = T083
PI = Massachusetts (1966-1969)
HN = 70
MR = 19970620
DA = 19990101
DC = 4
DX = 19700101
UI = D001900

*NEWRECORD
RECTYPE = D
MH = Botany
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Botanies
MN = H01.158.273.118
FX = Ethnobotany
FX = Plants
MH_TH = NLM (1966)
ST = T090
AN = use for the discipline (education, history, etc) only
MS = The study of the origin, structure, development, growth, function, genetics, and reproduction of plants.
MR = 20090706
DA = 19990101
DC = 1
UI = D001901

*NEWRECORD
RECTYPE = D
MH = Botswana
AQ = EH EP
PRINT ENTRY = Bechuanaland|T083|NAM|EQV|NLM (1994)|920820|abcdef
PRINT ENTRY = Kalahari|T083|NAM|NRW|NLM (1998)|960815|abcdef
MN = Z01.058.290.175.230
MH_TH = NLM (1978)
ST = T083
MS = A republic in southern Africa, between NAMIBIA and ZAMBIA. It was formerly called Bechuanaland. Its capital is Gaborone. The Kalahari Desert is in the west and southwest.
MR = 20080708
DA = 19990101
DC = 4
UI = D001902

*NEWRECORD
RECTYPE = D
MH = Bottle Feeding
AQ = AE CL CT EC EH HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Bottlefeeding|T054|NON|EQV|NLM (1992)|911102|abcdef
ENTRY = Bottle Feedings
ENTRY = Bottlefeedings
ENTRY = Feeding, Bottle
ENTRY = Feedings, Bottle
MN = E02.421.150
MN = F01.145.407.099
MN = G07.203.650.220.500.250
MN = G07.203.650.353.099
MH_TH = NLM (1981)
ST = T054
AN = human & animal
PI = Infant Nutrition (1966-1974)
MS = Use of nursing bottles for feeding. Applies to humans and animals.
PM = 75
HN = 75
CATSH = CAT LIST
MR = 20150708
DA = 19741119
DC = 1
DX = 19750901
UI = D001903

*NEWRECORD
RECTYPE = D
MH = Botulinum Antitoxin
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
ENTRY = Botulism Antitoxin|T121|T129|NON|EQV|NLM (2007)|060324|abbcdef
ENTRY = Trivalent Equine Botulinum Antitoxin|T121|T129|NON|NRW|UNK (19XX)|840919|abbcdef
ENTRY = Antitoxin, Botulinum
ENTRY = Antitoxin, Botulism
MN = D12.776.124.486.485.114.573.601.268
MN = D12.776.124.790.651.114.573.601.268
MN = D12.776.377.715.548.114.573.601.268
MN = D20.215.401.601.276
PA = Immunologic Factors
MH_TH = NLM (1972)
ST = T121
ST = T129
RN = 0
PI = Antitoxins (1966-1971)
MS = Antiserum given therapeutically in BOTULISM.
PM = 73
HN = 73(72)
MR = 20150622
DA = 19990101
DC = 1
DX = 19730101
UI = D001904

*NEWRECORD
RECTYPE = D
MH = Botulinum Toxins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Botulin|T121|T126|T131|NON|EQV|UNK (19XX)|770414|abbbcdef
PRINT ENTRY = Clostridium botulinum Toxins|T121|T126|T131|NON|EQV|UNK (19XX)|850617|abbbcdef
ENTRY = Botulinum Toxin|T121|T126|T131|NON|EQV|UNK (19XX)|770421|abbbcdef
ENTRY = Toxin, Botulinum
ENTRY = Toxins, Botulinum
ENTRY = Toxins, Clostridium botulinum
MN = D08.811.277.656.300.480.153
MN = D08.811.277.656.675.374.153
MN = D12.776.097.156
MN = D23.946.123.179
PA = Acetylcholine Release Inhibitors
PA = Neurotoxins
FX = Botulism
MH_TH = NLM (1969)
ST = T121
ST = T126
ST = T131
RN = EC 3.4.24.69
AN = /antag permitted but consider also BOTULINUM ANTITOXIN
PI = Clostridium Botulinum (1966-1968)
PI = Toxins (1966-1968)
MS = Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS.
OL = use BOTULINUM TOXINS to search BOTULINUM TOXIN 1969-77 (as Prov 1969-71)
PM = 78; was BOTULINUM TOXIN 1972-77
HN = 78; was BOTULINUM TOXIN 1969-77 (Prov 1969-71)
MR = 20140612
DA = 19990101
DC = 1
DX = 19720101
UI = D001905

*NEWRECORD
RECTYPE = D
MH = Botulism
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Botulism, Infantile|T037|T047|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Botulism, Toxico-Infectious|T037|T047|NON|EQV|NLM (2000)|991103|BOTULISM TOXICO INFECT|abbcdefv
ENTRY = Foodborne Botulism|T037|T047|NON|NRW|NLM (2012)|ORD (2010)|101222|abbcdeef
ENTRY = Infant Botulism|T037|T047|NON|NRW|NLM (2012)|ORD (2010)|101222|abbcdeef
ENTRY = Toxico-Infectious Botulism|T037|T047|NON|EQV|NLM (2000)|991103|TOXICO INFECT BOTULISM|abbcdefv
ENTRY = Wound Botulism|T037|T047|NON|NRW|NLM (2012)|ORD (2010)|101222|abbcdeef
ENTRY = Botulism, Foodborne
ENTRY = Botulism, Infant
ENTRY = Botulism, Toxico Infectious
ENTRY = Botulism, Wound
ENTRY = Botulisms, Foodborne
ENTRY = Botulisms, Infant
ENTRY = Botulisms, Wound
ENTRY = Foodborne Botulisms
ENTRY = Infant Botulisms
ENTRY = Infantile Botulism
ENTRY = Toxico Infectious Botulism
ENTRY = Wound Botulisms
MN = C01.252.410.222.151
MN = C10.668.758.200
MN = C10.720.150
MN = C25.723.415.151
FX = Botulinum Toxins
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T037
ST = T047
AN = coordinate IM with specific Clostridium botulinum type (IM) if pertinent
MS = A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D001906

*NEWRECORD
RECTYPE = D
MH = Boutonneuse Fever
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Mediterranean Spotted Fever|T047|EPO|EQV|NLM (1991)|900329|abcdef
ENTRY = Boutonneuse Fevers
ENTRY = Fever, Boutonneuse
ENTRY = Fever, Mediterranean Spotted
ENTRY = Fevers, Boutonneuse
ENTRY = Spotted Fever, Mediterranean
MN = C01.252.400.780.790.125
MN = C01.252.400.825.125
MH_TH = NLM (1975)
ST = T047
AN = caused by RICKETTSIA CONORII
MS = A febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with RICKETTSIA CONORII.
OL = search RICKETTSIAL INFECTIONS 1966-74
PM = 87; was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64
HN = 87(75); was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
DX = 19870101
UI = D001907

*NEWRECORD
RECTYPE = D
MH = Diarrhea Viruses, Bovine Viral
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Bovine Viral Diarrhea Viruses|T005|NON|EQV|NLM (2002)|010510|abcdef
PRINT ENTRY = Diarrhea Virus, Bovine Viral|T005|NON|EQV|NLM (1975)|990101|abcdef
ENTRY = Bovine Diarrhea Virus|T005|NON|EQV|NLM (1994)|930202|abcdef
ENTRY = Bovine Pestivirus|T005|NON|EQV|NLM (1991)|891115|abcdef
ENTRY = Bovine Diarrhea Viruses
ENTRY = Bovine Pestiviruses
ENTRY = Diarrhea Virus, Bovine
ENTRY = Diarrhea Viruses, Bovine
ENTRY = Pestiviruses, Bovine
ENTRY = Virus, Bovine Diarrhea
ENTRY = Viruses, Bovine Diarrhea
MN = B04.820.250.700.150
MH_TH = NLM (2002)
ST = T005
AN = historical only: prefer specifics; infection = BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE or HEMORRHAGIC SYNDROME, BOVINE
MS = A group of viruses in the genus PESTIVIRUS, causing diarrhea, fever, oral ulcerations, hemorrhagic syndrome, and various necrotic lesions among cattle and other domestic animals. The two species (genotypes), BVDV-1 and BVDV-2 , exhibit antigenic and pathological differences. The historical designation, BVDV, consisted of both (then unrecognized) genotypes.
PM = 2002; see DIARRHEA VIRUS, BOVINE VIRAL 1994-2001, see BOVINE DIARRHEA VIRUS 1991-1993, see PESTIVIRUSES 1981-1990, see RNA VIRUSES 1975-1980
HN = 2002 (1975)
MR = 20150622
DA = 19741212
DC = 1
DX = 19910101
UI = D001908

*NEWRECORD
RECTYPE = D
MH = Leukemia Virus, Bovine
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = BLV|T005|ABB|EQV|NLM (1995)|940309|abcdef
PRINT ENTRY = Bovine Leukemia Virus|T005|NON|EQV|NLM (1994)|921207|abcdef
PRINT ENTRY = Cattle Leukemia Virus|T005|NON|EQV|UNK (19XX)|760517|abcdef
ENTRY = Leukemia Virus, Cattle
ENTRY = Virus, Bovine Leukemia
ENTRY = Virus, Cattle Leukemia
MN = B04.613.807.200.600
MN = B04.820.650.200.600
MH_TH = NLM (1975)
ST = T005
AN = a species of the genus DELTARETROVIRUS; infection = ENZOOTIC BOVINE LEUKOSIS
MS = The type species of DELTARETROVIRUS that causes a form of bovine lymphosarcoma (ENZOOTIC BOVINE LEUKOSIS) or persistent lymphocytosis.
OL = use LEUKEMIA VIRUS, BOVINE to search BOVINE LEUKEMIA VIRUS 1977-93 & CATTLE LEUKEMIA VIRUS 1975-76
PM = 94; was BOVINE LEUKEMIA VIRUS 1977-93 (see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977); was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76
HN = 94; was BOVINE LEUKEMIA VIRUS 1977-93 (see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977); was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76
MR = 20150623
DA = 19741212
DC = 1
DX = 19910101
UI = D001909

*NEWRECORD
RECTYPE = D
MH = Herpesvirus 2, Bovine
DS = HERPESVIRUS BOVINE 02
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Allerton Virus|T005|EPO|EQV|UNK (19XX)|741205|abcdef
PRINT ENTRY = BHM Virus|T005|EQV|UNK (19XX)|741205|abdef
PRINT ENTRY = Bovine Herpes Mammillitis Virus|T005|NON|EQV|UNK (19XX)|741205|abcdef
PRINT ENTRY = Bovine Ulcerative Mammillitis Virus|T005|NON|EQV|NLM (1994)|930301|abcdef
ENTRY = Bovine Herpesvirus 2|T005|NON|EQV|UNK (19XX)|150623|BOVINE HERPESVIRUS 02|abcdefs
ENTRY = Bovine Mamillitis Virus|T005|NON|EQV|NLM (2002)|150623|abcdef
ENTRY = Herpes Mammillitis Virus, Bovine|T005|NON|EQV|NLM (1991)|900501|abcdef
ENTRY = Herpesvirus 2 (alpha), Bovine|T005|NON|EQV|NLM (1994)|930325|abcdef
ENTRY = Ulcerative Mammillitis Virus, Bovine|T005|NON|EQV|NLM (1991)|900501|abcdef
ENTRY = Bovine Mamillitis Viruses
ENTRY = Mamillitis Virus, Bovine
ENTRY = Mamillitis Viruses, Bovine
ENTRY = Virus, Bovine Mamillitis
ENTRY = Viruses, Bovine Mamillitis
MN = B04.280.382.100.750.200
MH_TH = NLM (1975)
ST = T005
AN = do not confuse with HERPESVIRUS 1, BOVINE; infection: coord IM with HERPES SIMPLEX (IM)
MS = A species of SIMPLEXVIRUS causing mammillitis in cattle in Great Britain and South Africa.
OL = use HERPESVIRUS 2, BOVINE to search BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93; search ALLERTON VIRUS INFECTIONS under LUMPY SKIN DISEASE 1970-76
PM = 94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76
HN = 94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76
MR = 20150625
DA = 19741212
DC = 1
DX = 19910101
UI = D001911

*NEWRECORD
RECTYPE = D
MH = Bovine Virus Diarrhea-Mucosal Disease
DE = BOVINE VIRUS DIARRHEA MUCOSAL DIS
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
PRINT ENTRY = Mucosal Disease, Bovine Viral Diarrhea|T047|NON|EQV|NLM (2002)|010510|MUCOSAL DIS BOVINE VIRAL DIARRHEA|abcdefv
ENTRY = Bovine Virus Diarrhea Mucosal Disease|T047|NON|EQV|UNK (19XX)|771207|abcdef
MN = C02.782.350.675.106
MN = C22.196.106
MH_TH = NLM (1972)
ST = T047
AN = DF: BVD DIS
PI = Cattle Diseases (1966-1971)
PI = Virus Diseases/veterinary (1966-1971)
MS = Acute disease of cattle caused by the bovine viral diarrhea viruses (DIARRHEA VIRUSES, BOVINE VIRAL). Often mouth ulcerations are the only sign but fever, diarrhea, drop in milk yield, and loss of appetite are also seen. Severity of clinical disease varies and is strain dependent. Outbreaks are characterized by low morbidity and high mortality.
PM = 91; was see under CATTLE DISEASES 1972-90
HN = 91(72); was see under CATTLE DISEASES 1972-90
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
DX = 19910101
UI = D001912

*NEWRECORD
RECTYPE = D
MH = Bowen's Disease
DE = BOWENS DIS
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Bowen Disease|T191|EPO|EQV|UNK (19XX)|810316|BOWEN DIS|abcdefv
ENTRY = Bowens Disease
ENTRY = Disease, Bowen
ENTRY = Disease, Bowen's
MN = C04.557.470.200.400.130
MN = C04.557.470.700.400.130
MH_TH = NLM (1975)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS (IM)
MS = A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant. Atypical squamous cells proliferate through the whole thickness of the epidermis. The lesions may occur anywhere on the skin surface or on mucosal surfaces. The cause most frequently found is trivalent arsenic compounds. Freezing, cauterization or diathermy coagulation is often effective. (From Rook et al., Textbook of Dermatology, 4th ed, pp2428-9)
OL = search CARCINOMA, SQUAMOUS CELL 1969-74
PM = 91; was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80
HN = 91(75); was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
DX = 19910101
UI = D001913

*NEWRECORD
RECTYPE = D
MH = Boxing
AQ = CL EC ED ES HI IN LJ PH PX SN ST TD
ENTRY = Boxings
MN = I03.450.642.845.210
MH_TH = NLM (1966)
ST = T056
AN = /inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
MS = A two-person sport in which the fists are skillfully used to attack and defend.
MR = 19960610
DA = 19990101
DC = 1
UI = D001914

*NEWRECORD
RECTYPE = D
MH = Braces
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
ENTRY = Brace
MN = E07.858.442.743.319
MH_TH = NLM (1966)
ST = T074
AN = do not confuse with ORTHODONTIC BRACKETS
MS = Orthopedic appliances used to support, align, or hold parts of the body in correct position. (Dorland, 28th ed)
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
UI = D001915

*NEWRECORD
RECTYPE = D
MH = Brachial Artery
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, Brachial
ENTRY = Artery, Brachial
ENTRY = Brachial Arteries
MN = A07.231.114.139
MH_TH = NLM (1966)
ST = T023
MS = The continuation of the axillary artery; it branches into the radial and ulnar arteries.
MR = 19920325
DA = 19990101
DC = 1
UI = D001916

*NEWRECORD
RECTYPE = D
MH = Brachial Plexus
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Plexus, Brachial
MN = A08.800.800.720.050
FX = Brachial Plexus Neuropathies
FX = Thoracic Outlet Syndrome
MH_TH = NLM (1966)
ST = T023
AN = dis = BRACHIAL PLEXUS NEUROPATHIES; inflammation = BRACHIAL PLEXUS NEURITIS
MS = The large network of nerve fibers which distributes the innervation of the upper extremity. The brachial plexus extends from the neck into the axilla. In humans, the nerves of the plexus usually originate from the lower cervical and the first thoracic spinal cord segments (C5-C8 and T1), but variations are not uncommon.
MR = 20010725
DA = 19990101
DC = 1
UI = D001917

*NEWRECORD
RECTYPE = D
MH = Brachytherapy
DE = BRACHYTHER
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Curietherapy|T061|NON|EQV|NLM (1992)|901013|CURIETHER|abcdefv
PRINT ENTRY = Implant Radiotherapy|T061|NON|NRW|UNK (19XX)|790307|IMPLANT RADIOTHER|abcdefv
PRINT ENTRY = Plaque Therapy, Radioisotope|T061|NON|NRW|UNK (19XX)|790307|PLAQUE THER RADIOISOTOPE|abcdefv
PRINT ENTRY = Radioisotope Brachytherapy|T061|NON|EQV|UNK (19XX)|790307|RADIOISOTOPE BRACHYTHER|abcdefv
PRINT ENTRY = Radiotherapy, Interstitial|T061|NON|NRW|UNK (19XX)|790307|RADIOTHER INTERSTITIAL|abcdefv
PRINT ENTRY = Radiotherapy, Intracavity|T061|NON|NRW|UNK (19XX)|790307|RADIOTHER INTRACAVITY|abcdefv
PRINT ENTRY = Radiotherapy, Surface|T061|NON|NRW|UNK (19XX)|790307|RADIOTHER SURFACE|abcdefv
ENTRY = Brachytherapy, Radioisotope|T061|NON|EQV|UNK (19XX)|790307|BRACHYTHER RADIOISOTOPE|abcdefv
ENTRY = Interstitial Radiotherapy|T061|NON|NRW|UNK (19XX)|790307|INTERSTITIAL RADIOTHER|abcdefv
ENTRY = Intracavity Radiotherapy|T061|NON|NRW|UNK (19XX)|790307|INTRACAVITY RADIOTHER|abcdefv
ENTRY = Radioisotope Plaque Therapy|T061|NON|NRW|UNK (19XX)|790307|RADIOISOTOPE PLAQUE THER|abcdefv
ENTRY = Radiotherapy, Implant|T061|NON|NRW|UNK (19XX)|790307|RADIOTHER IMPLANT|abcdefv
ENTRY = Surface Radiotherapy|T061|NON|NRW|UNK (19XX)|790307|SURFACE RADIOTHER|abcdefv
ENTRY = Therapy, Radioisotope Plaque
MN = E02.815.150
MH_TH = NLM (1980)
ST = T061
AN = a type of radiother
PI = Neoplasms/radiotherapy (1966-1979)
PI = Radioisotopes/administration & dosage/therapeutic use (1966-1979)
PI = Radiotherapy (1966-1979)
PI = specific neoplasm/radiotherapy (1966-1979)
PI = specific radioisotope/administration & dosage/therapeutic use (1966-1979)
MS = A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20050630
DA = 19790307
DC = 1
DX = 19800101
UI = D001918

*NEWRECORD
RECTYPE = D
MH = Bradycardia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bradyarrhythmia|T033|T046|NON|EQV|NLM (1991)|900404|abbcdef
ENTRY = Bradyarrhythmias|T033|T046|NON|EQV|NLM (2008)|060919|abbcdef
ENTRY = Bradycardias
MN = C14.280.067.319
MN = C23.550.073.300
MH_TH = NLM (1966)
ST = T033
ST = T046
MS = Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D001919

*NEWRECORD
RECTYPE = D
MH = Bradykinin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg|T116|T124|T125|NON|EQV|FDA SRS (2014)|NLM (1995)|930908|abbbcdeef
ENTRY = Bradykinin Acetate, (9-D-Arg)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin Diacetate|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin Hydrochloride|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin Triacetate|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (1-D-Arg)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (2-D-Pro)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (2-D-Pro-7-D-Pro)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (3-D-Pro)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (3-D-Pro-7-D-Pro)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (5-D-Phe)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (5-D-Phe-8-D-Phe)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (6-D-Ser)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (7-D-Pro)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (8-D-Phe)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bradykinin, (9-D-Arg)-Isomer|T116|T124|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Arg Pro Pro Gly Phe Ser Pro Phe Arg
MN = D12.644.276.812.169
MN = D12.644.400.090
MN = D12.644.456.193
MN = D12.776.467.812.169
MN = D12.776.641.650.090
MN = D23.469.050.375.110
MN = D23.529.812.169
PA = Vasodilator Agents
FX = Receptors, Bradykinin
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T116
ST = T124
ST = T125
N1 = Bradykinin
RN = S8TIM42R2W
RR = 13865-66-2 ((6-D-Ser)-isomer)
RR = 14033-58-0 ((3-D-Pro)-isomer)
RR = 14109-47-8 (enantio, (2-L-Pro-3-L-Pro-7-L-Pro)-isomer)
RR = 14109-48-9 ((2-D-Pro-3-D-Pro-7-D-Pro)-isomer)
RR = 14109-50-3 ((2-D-Pro)-isomer)
RR = 15626-83-2 ((5-D-Phe)-isomer)
RR = 16511-76-5 ((8-D-Phe)-isomer)
RR = 18942-27-3 ((7-D-Pro)-isomer)
RR = 19187-64-5 (diacetate (salt))
RR = 31021-87-1 ((5-D-Phe-8-D-Phe)-isomer)
RR = 487-75-2 ((1-D-Arg)-isomer)
RR = 487-77-4 ((9-D-Arg)-isomer)
RR = 53807-04-8 (HCl)
RR = 58-82-2 (Bradykinin)
RR = 5979-11-3 (triacetate (salt))
RR = 634-56-0 (enantio)
RR = 6846-03-3 (acetate (salt))
RR = 76094-83-2 ((3-D-Pro-7-D-Pro)-isomer)
RR = 76123-99-4 ((2-D-Pro-7-D-Pro)-isomer)
MS = A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.
MR = 20130708
DA = 19990101
DC = 1
UI = D001920

*NEWRECORD
RECTYPE = D
MH = Brain
AQ = AB AH BS CY DE EM EN GD IM ME MI PA PH PP PS RA RE RI SE SU UL VI
ENTRY = Encephalon|T023|NON|EQV|NLM (2001)|991129|abcdef
ENTRY = Brains
ENTRY = Encephalons
MN = A08.186.211
FX = Cerebral Decortication
FX = Psychosurgery
EC = chemistry:Brain Chemistry
EC = injuries:Brain Injuries
EC = transplantation:Brain Tissue Transplantation
EC = ultrasonography:Echoencephalography
MH_TH = BIOETHICS (1989)
ST = T023
AN = general; /blood supply: consider also CEREBROVASCULAR CIRCULATION; CEREBRAL ARTERIES; CEREBRAL VEINS; CRANIAL SINUSES; /cytol: do not routinely convert to NEURONS; /surg: consider specific neurosurgical procedures in Category E4; inflammation = ENCEPHALITIS & its specifics; infarct = CEREBRAL INFARCTION; malacia = ENCEPHALOMALACIA; brain-isolated, encphale isol, cerveau isol: index DECEREBRATE STATE
CX = consider also terms at CEREBR- and ENCEPHAL-
MS = The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
OL = pre-explosion = BRAIN (PX)
PM = /enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65
HN = /enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65
MR = 20130709
DA = 19990101
DC = 1
UI = D001921

*NEWRECORD
RECTYPE = D
MH = Brain Abscess
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Brain Abscess, Child|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Brain Abscess, Multiple|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Brain Abscess, Pyogenic|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Brain Abscess, Sterile|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cerebral Abscess|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Abscess, Brain
ENTRY = Abscess, Cerebral
ENTRY = Abscess, Child Brain
ENTRY = Abscess, Multiple Brain
ENTRY = Abscess, Pyogenic Brain
ENTRY = Abscesses, Cerebral
ENTRY = Abscesses, Multiple Brain
ENTRY = Brain Abscesses
ENTRY = Brain Abscesses, Multiple
ENTRY = Brain Abscesses, Pyogenic
ENTRY = Brain Abscesses, Sterile
ENTRY = Cerebral Abscesses
ENTRY = Child Brain Abscess
ENTRY = Multiple Brain Abscess
ENTRY = Multiple Brain Abscesses
ENTRY = Pyogenic Brain Abscess
ENTRY = Pyogenic Brain Abscesses
ENTRY = Sterile Brain Abscess
ENTRY = Sterile Brain Abscesses
MN = C01.395.250
MN = C01.539.830.025.160
MN = C10.228.140.116
MN = C10.228.228.090
FX = Empyema, Subdural
MH_TH = NLM (1966)
ST = T047
AN = coordinate IM with specific infection (IM) + specific CNS infection term (IM) + site/disease term (IM) if pertinent
MS = A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear (see EAR, MIDDLE); HEART (see also ENDOCARDITIS, BACTERIAL), and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. (Adams et al., Principles of Neurology, 6th ed, pp712-6)
CATSH = CAT LIST
MR = 20150702
DA = 19990101
DC = 1
UI = D001922

*NEWRECORD
RECTYPE = D
MH = Brain Chemistry
DE = BRAIN CHEM
AQ = DE GE IM PH RE
ENTRY = Chemistry, Brain|T044|NON|EQV|UNK (19XX)|860101|CHEM BRAIN|abcdefv
ENTRY = Brain Chemistries
ENTRY = Chemistries, Brain
MN = G02.111.100
MN = G03.200
MH_TH = NLM (1965)
ST = T044
AN = differentiate from BRAIN /metab; consider also /chem with specific parts of the brain but probably as NIM with BRAIN CHEMISTRY (IM) if site is merely locational & illustrative
MS = Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19650101
UI = D001923

*NEWRECORD
RECTYPE = D
MH = Brain Concussion
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerebral Concussion|T037|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Commotio Cerebri|T037|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Concussion, Intermediate|T037|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Concussion, Mild|T037|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Concussion, Severe|T037|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Brain Concussions
ENTRY = Cerebral Concussions
ENTRY = Concussion, Brain
ENTRY = Concussion, Cerebral
ENTRY = Intermediate Concussion
ENTRY = Intermediate Concussions
ENTRY = Mild Concussion
ENTRY = Mild Concussions
ENTRY = Severe Concussion
ENTRY = Severe Concussions
MN = C10.228.140.199.250
MN = C10.900.300.087.125
MN = C10.900.300.350.300
MN = C26.915.300.200.150
MN = C26.915.300.450.500
MN = C26.974.382.200
MH_TH = NLM (1963)
ST = T037
MS = A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)
PM = 65
HN = 65(63)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
DX = 19650101
UI = D001924

*NEWRECORD
RECTYPE = D
MH = Brain Damage, Chronic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Encephalopathy, Chronic|T047|NON|EQV|NLM (2000)|991108|ENCEPH CHRONIC|abcdefv
ENTRY = Chronic Encephalopathy|T047|NON|EQV|NLM (2000)|991108|CHRONIC ENCEPH|abcdefv
ENTRY = Chronic Brain Damage
MN = C10.228.140.140
MH_TH = NLM (1966)
ST = T047
AN = coord with specific condition causing damage if pertinent
MS = A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
CATSH = CAT LIST
MR = 20050721
DA = 19990101
DC = 1
UI = D001925

*NEWRECORD
RECTYPE = D
MH = Brain Death
AQ = BL CF CL DI IM LJ ME PA PP RI UR US VE
PRINT ENTRY = Brain Dead|T046|NON|EQV|NLM (2000)|991108|abcdef
PRINT ENTRY = Coma Depasse|T046|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Irreversible Coma|T046|NON|REL|NLM (2000)|991108|abcdef
ENTRY = Brain Deads
ENTRY = Coma, Irreversible
ENTRY = Death, Brain
MN = C10.228.140.151
MN = C10.597.606.358.800.200.100
MN = C23.550.260.159
MH_TH = BIOETHICS (1974)
MH_TH = NLM (1969)
ST = T046
PI = Death (1966-1968)
MS = A state of prolonged irreversible cessation of all brain activity, including lower brain stem function with the complete absence of voluntary movements, responses to stimuli, brain stem reflexes, and spontaneous respirations. Reversible conditions which mimic this clinical state (e.g., sedative overdose, hypothermia, etc.) are excluded prior to making the determination of brain death. (From Adams et al., Principles of Neurology, 6th ed, pp348-9)
PM = 1972
HN = 1972(1969)
CATSH = CAT LIST
MR = 20000622
DA = 19990101
DC = 1
DX = 19720101
UI = D001926

*NEWRECORD
RECTYPE = D
MH = Brain Diseases
DE = BRAIN DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Intracranial Central Nervous System Disorders|T047|NON|EQV|NLM (2000)|991103|INTRACRANIAL CNS DIS|abcdefv
ENTRY = Brain Disorders|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = CNS Disorders, Intracranial|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Central Nervous System Disorders, Intracranial|T047|NON|EQV|NLM (2000)|991103|CNS DIS INTRACRANIAL|abcdefv
ENTRY = Central Nervous System Intracranial Disorders|T047|NON|EQV|NLM (2000)|991103|CNS INTRACRANIAL DIS|abcdefv
ENTRY = Encephalon Diseases|T047|NON|EQV|NLM (2000)|991103|ENCEPHALON DIS|abcdefv
ENTRY = Encephalopathy|T047|NON|EQV|NLM (2016)|140922|abcdef
ENTRY = Intracranial CNS Disorders|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Brain Disease
ENTRY = Brain Disorder
ENTRY = CNS Disorder, Intracranial
ENTRY = Encephalon Disease
ENTRY = Encephalopathies
ENTRY = Intracranial CNS Disorder
MN = C10.228.140
MH_TH = NLM (1966)
ST = T047
MS = Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
CATSH = CAT LIST
MR = 20150707
DA = 19990101
DC = 1
UI = D001927

*NEWRECORD
RECTYPE = D
MH = Brain Diseases, Metabolic
DE = BRAIN DIS METAB
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Central Nervous System Metabolic Disorders|T047|NON|BRD|NLM (2000)|991104|CNS METAB DIS|abcdefv
PRINT ENTRY = Encephalopathies, Metabolic|T047|NON|EQV|NLM (2000)|991104|ENCEPH METAB|abcdefv
PRINT ENTRY = Metabolic Disorders, Brain|T047|NON|EQV|NLM (2000)|991104|METAB DIS BRAIN|abcdefv
ENTRY = Acquired Metabolic Diseases, Brain|T047|NON|NRW|NLM (2000)|991012|ACQUIRED METAB DIS BRAIN|abcdefv
ENTRY = Acquired Metabolic Diseases, Nervous System|T047|NON|BRD|NLM (2000)|991012|ACQUIRED METAB DIS NERVOUS SYSTEM|abcdefv
ENTRY = Acquired Metabolic Encephalopathies|T047|NON|NRW|NLM (2000)|991012|ACQUIRED METAB ENCEPH|abcdefv
ENTRY = Brain Diseases, Metabolic, Acquired|T047|NON|NRW|NLM (2000)|991012|BRAIN DIS METAB ACQUIRED|abcdefv
ENTRY = Brain Disorders, Metabolic|T047|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Brain Disorders, Metabolic, Acquired|T047|NON|NRW|NLM (2000)|991012|BRAIN SYNDROME METAB ACQUIRED|abcdefv
ENTRY = Brain Syndrome, Metabolic|T047|NON|EQV|NLM (2000)|991104|BRAIN SYNDROME METAB|abcdefv
ENTRY = Brain Syndrome, Metabolic, Acquired|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = CNS Metabolic Disorders|T047|NON|BRD|NLM (2000)|991104|abcdef
ENTRY = CNS Metabolic Disorders, Acquired|T047|NON|NRW|NLM (2000)|991012|CNS METAB DIS ACQUIRED|abcdefv
ENTRY = Encephalopathy, Metabolic, Acquired|T047|NON|NRW|NLM (2000)|991012|ENCEPH METAB ACQUIRED|abcdefv
ENTRY = Metabolic Brain Diseases|T047|NON|EQV|UNK (19XX)|810316|METAB BRAIN DIS|abcdefv
ENTRY = Metabolic Brain Diseases, Acquired|T047|NON|NRW|NLM (2000)|991012|METAB BRAIN DIS ACQUIRED|abcdefv
ENTRY = Metabolic Brain Syndrome|T047|NON|EQV|NLM (2000)|991104|METAB BRAIN SYNDROME|abcdefv
ENTRY = Metabolic Brain Syndrome, Acquired|T047|NON|NRW|NLM (2000)|991012|METAB BRAIN SYNDROME ACQUIRED|abcdefv
ENTRY = Metabolic Brain Syndromes|T047|NON|EQV|NLM (2000)|991104|METAB BRAIN SYNDROMES|abcdefv
ENTRY = Metabolic Brain Syndromes, Acquired|T047|NON|NRW|NLM (2000)|991012|METAB BRAIN SYNDROMES ACQUIRED|abcdefv
ENTRY = Metabolic Diseases, Acquired, Nervous System|T047|NON|BRD|NLM (2000)|991012|METAB DIS ACQUIRED NERVOUS SYSTEM|abcdefv
ENTRY = Metabolic Disorder, Central Nervous System, Acquired|T047|NON|NRW|NLM (2000)|991012|METAB DIS CNS ACQUIRED|abcdefv
ENTRY = Metabolic Disorders, CNS|T047|NON|BRD|NLM (2000)|991104|METAB DIS CNS|abcdefv
ENTRY = Metabolic Disorders, CNS, Acquired|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Metabolic Disorders, Central Nervous System|T047|NON|BRD|NLM (2000)|991104|METAB DIS CENTRAL NERVOUS SYSTEM|abcdefv
ENTRY = Metabolic Encephalopathies|T047|NON|EQV|NLM (2000)|991104|METAB ENCEPH|abcdefv
ENTRY = Nervous System Acquired Metabolic Diseases|T047|NON|BRD|NLM (2000)|991012|NERVOUS SYSTEM ACQUIRED METAB DIS|abcdefv
ENTRY = Acquired Metabolic Encephalopathy
ENTRY = Brain Disease, Metabolic
ENTRY = Brain Disorder, Metabolic
ENTRY = Brain Metabolic Disorder
ENTRY = Brain Metabolic Disorders
ENTRY = CNS Metabolic Disorder
ENTRY = Encephalopathies, Acquired Metabolic
ENTRY = Encephalopathy, Acquired Metabolic
ENTRY = Encephalopathy, Metabolic
ENTRY = Metabolic Brain Disease
ENTRY = Metabolic Brain Disorder
ENTRY = Metabolic Brain Disorders
ENTRY = Metabolic Disorder, Brain
ENTRY = Metabolic Disorder, CNS
ENTRY = Metabolic Encephalopathies, Acquired
ENTRY = Metabolic Encephalopathy
ENTRY = Metabolic Encephalopathy, Acquired
MN = C10.228.140.163
MN = C18.452.132
MH_TH = NLM (1977)
ST = T047
AN = GEN; avoid: prefer specifics; DF: BRAIN DIS METAB
PI = Brain Diseases (1966-1976)
MS = Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function.
PM = 1977
HN = 1977; was NON MESH before 1977
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19770101
UI = D001928

*NEWRECORD
RECTYPE = D
MH = Brain Edema
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Brain Swelling|T046|NON|EQV|NLM (2000)|991104|abcdef
PRINT ENTRY = Cerebral Edema|T046|NON|NRW|NLM (1993)|910923|abcdef
PRINT ENTRY = Cytotoxic Brain Edema|T046|NON|NRW|NLM (2000)|991104|abcdef
PRINT ENTRY = Intracranial Edema|T046|NON|EQV|NLM (2000)|991104|abcdef
PRINT ENTRY = Vasogenic Cerebral Edema|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cerebral Edema, Cytotoxic|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cerebral Edema, Vasogenic|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cytotoxic Cerebral Edema|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Vasogenic Brain Edema|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Brain Edema, Cytotoxic
ENTRY = Brain Edema, Vasogenic
ENTRY = Brain Swellings
ENTRY = Cerebral Edemas, Vasogenic
ENTRY = Edema, Brain
ENTRY = Edema, Cerebral
ENTRY = Edema, Cytotoxic Brain
ENTRY = Edema, Cytotoxic Cerebral
ENTRY = Edema, Intracranial
ENTRY = Edema, Vasogenic Brain
ENTRY = Edema, Vasogenic Cerebral
ENTRY = Swelling, Brain
MN = C10.228.140.187
FX = Intracranial Hypertension
MH_TH = NLM (1964)
ST = T046
MS = Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)
PM = 1965
HN = 1965(1964)
CATSH = CAT LIST
MR = 19991104
DA = 19990101
DC = 1
DX = 19650101
UI = D001929

*NEWRECORD
RECTYPE = D
MH = Brain Injuries
DE = BRAIN INJ
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Brain Contusion|T037|NON|NRW|NLM (1998)|960718|abcdef
PRINT ENTRY = Brain Injuries, Traumatic|T037|NON|NRW|NLM (2000)|991108|BRAIN INJ TRAUMATIC|abcdefv
PRINT ENTRY = Brain Lacerations|T037|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Trauma, Brain|T037|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Traumatic Brain Injury|T037|NON|NRW|NLM (2000)|991108|TRAUMATIC BRAIN INJ|abcdefv
ENTRY = Acute Brain Injuries|T037|NON|NRW|UNK (19XX)|800515|ACUTE BRAIN INJ|abcdefv
ENTRY = Brain Injuries, Acute|T037|NON|NRW|UNK (19XX)|800515|BRAIN INJ ACUTE|abcdefv
ENTRY = Brain Injuries, Diffuse|T037|NON|NRW|NLM (2000)|991108|BRAIN INJ DIFFUSE|abcdefv
ENTRY = Brain Injuries, Focal|T037|NON|NRW|NLM (2000)|991108|BRAIN INJ FOCAL|abcdefv
ENTRY = Cortical Contusion|T037|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Encephalopathy, Post-Concussive|T037|NON|NRW|NLM (2000)|991108|ENCEPH POST CONCUSSIVE|abcdefv
ENTRY = Encephalopathy, Post-Traumatic|T037|NON|NRW|NLM (2000)|991108|ENCEPH POST TRAUMATIC|abcdefv
ENTRY = Encephalopathy, Traumatic|T037|NON|NRW|NLM (2000)|991108|ENCEPH TRAUMATIC|abcdefv
ENTRY = Focal Brain Injuries|T037|NON|NRW|NLM (2000)|991108|FOCAL BRAIN INJ|abcdefv
ENTRY = Injuries, Acute Brain|T037|NON|NRW|UNK (19XX)|800515|INJ ACUTE BRAIN|abcdefv
ENTRY = Injuries, Brain|T037|NON|EQV|UNK (19XX)|800515|INJ BRAIN|abcdefv
ENTRY = Injury, Brain, Traumatic|T037|NON|NRW|NLM (2000)|991108|INJ BRAIN TRAUMATIC|abcdefv
ENTRY = Injury, Brain, Traumatic Mild|T037|NON|NRW|NLM (2014)|121015|abcdef
ENTRY = Mild Traumatic Brain Injury|T037|NON|NRW|NLM (2014)|121015|abcdef
ENTRY = Post-Concussive Encephalopathy|T037|NON|NRW|NLM (2000)|991108|POST CONCUSSIVE ENCEPH|abcdefv
ENTRY = Post-Traumatic Encephalopathy|T037|NON|NRW|NLM (2000)|991108|POST TRAUMATIC ENCEPH|abcdefv
ENTRY = TBI (Traumatic Brain Injury)|T037|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Traumatic Encephalopathy|T037|NON|NRW|NLM (2000)|991108|TRAUMATIC ENCEPH|abcdefv
ENTRY = Acute Brain Injury
ENTRY = Brain Contusions
ENTRY = Brain Injury
ENTRY = Brain Injury, Acute
ENTRY = Brain Injury, Diffuse
ENTRY = Brain Injury, Focal
ENTRY = Brain Injury, Traumatic
ENTRY = Brain Laceration
ENTRY = Brain Trauma
ENTRY = Brain Traumas
ENTRY = Contusion, Brain
ENTRY = Contusion, Cortical
ENTRY = Contusions, Brain
ENTRY = Contusions, Cortical
ENTRY = Cortical Contusions
ENTRY = Diffuse Brain Injuries
ENTRY = Diffuse Brain Injury
ENTRY = Encephalopathies, Post-Concussive
ENTRY = Encephalopathies, Post-Traumatic
ENTRY = Encephalopathies, Traumatic
ENTRY = Encephalopathy, Post Concussive
ENTRY = Encephalopathy, Post Traumatic
ENTRY = Focal Brain Injury
ENTRY = Injuries, Diffuse Brain
ENTRY = Injuries, Focal Brain
ENTRY = Injuries, Traumatic Brain
ENTRY = Injury, Acute Brain
ENTRY = Injury, Brain
ENTRY = Injury, Diffuse Brain
ENTRY = Injury, Focal Brain
ENTRY = Injury, Traumatic Brain
ENTRY = Laceration, Brain
ENTRY = Lacerations, Brain
ENTRY = Post Concussive Encephalopathy
ENTRY = Post Traumatic Encephalopathy
ENTRY = Post-Concussive Encephalopathies
ENTRY = Post-Traumatic Encephalopathies
ENTRY = TBIs (Traumatic Brain Injury)
ENTRY = Traumas, Brain
ENTRY = Traumatic Brain Injuries
ENTRY = Traumatic Encephalopathies
MN = C10.228.140.199
MN = C10.900.300.087
MN = C26.915.300.200
MH_TH = NLM (1973)
ST = T037
AN = general or unspecified; consider also /inj with specific parts of the brain; entry term BRAIN CONTUSION: do not coordinate with CONTUSIONS; do not confuse with CRANIOCEREBRAL TRAUMA
MS = Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
PM = 1981; see BRAIN INJURIES 1981-1999, see BRAIN INJURIES, ACUTE 1973-1980, see BRAIN INJURY, ACUTE 1963-1972; for BRAIN CONTUSION see BRAIN CONCUSSION 1998-1999
HN = 1981(1963); for BRAIN CONTUSION use BRAIN CONCUSSION 1998-1999
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
DX = 19730101
UI = D001930

*NEWRECORD
RECTYPE = D
MH = Brain Mapping
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Brain Electrical Activity Mapping|T060|T062|NON|NRW|IOM (1990)|890413|BEA MAPPING|abbcdefv
PRINT ENTRY = Functional Cerebral Localization|T060|T062|NON|NRW|NLM (2011)|100604|abbcdef
PRINT ENTRY = Topographic Brain Mapping|T060|T062|NON|NRW|IOM (1990)|890413|abbcdef
ENTRY = Brain Mapping, Topographic
ENTRY = Functional Cerebral Localizations
ENTRY = Mapping, Brain
ENTRY = Mapping, Topographic Brain
MN = E01.370.350.578.875.500
MN = E01.370.376.537.625.500
MN = E05.629.875.500
MH_TH = NLM (1964)
ST = T060
ST = T062
AN = coordinate with specific part of brain/ physiol
MS = Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures.
PM = 68
HN = 68(64)
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
DX = 19680101
UI = D001931

*NEWRECORD
RECTYPE = D
MH = Brain Neoplasms
DE = BRAIN NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Brain Cancer|T191|NON|NRW|NLM (2000)|991104|abcdef
PRINT ENTRY = Brain Tumors|T191|NON|EQV|NLM (2000)|991104|abcdef
PRINT ENTRY = Cancer of Brain|T191|NON|NRW|NLM (2000)|991104|abcdef
PRINT ENTRY = Malignant Primary Brain Tumors|T191|NON|NRW|NLM (2000)|991104|abcdef
PRINT ENTRY = Neoplasms, Intracranial|T191|NON|BRD|NLM (2000)|991104|NEOPL INTRACRANIAL|abcdefv
ENTRY = Benign Neoplasms, Brain|T191|NON|NRW|NLM (2000)|991104|BENIGN NEOPL BRAIN|abcdefv
ENTRY = Brain Neoplasm, Primary|T191|NON|NRW|NLM (2000)|991104|BRAIN NEOPL PRIMARY|abcdefv
ENTRY = Brain Neoplasms, Benign|T191|NON|NRW|NLM (2000)|991104|BRAIN NEOPL BENIGN|abcdefv
ENTRY = Brain Neoplasms, Malignant|T191|NON|NRW|NLM (2000)|991104|BRAIN NEOPL MALIGNANT|abcdefv
ENTRY = Brain Neoplasms, Malignant, Primary|T191|NON|NRW|NLM (2000)|991104|BRAIN NEOPL MALIGNANT PRIMARY|abcdefv
ENTRY = Brain Neoplasms, Primary Malignant|T191|NON|NRW|NLM (2000)|991104|BRAIN NEOPL PRIMARY MALIGNANT|abcdefv
ENTRY = Brain Tumor, Primary|T191|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Brain Tumor, Recurrent|T191|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cancer of the Brain|T191|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Intracranial Neoplasms|T191|NON|BRD|NLM (2000)|991104|INTRACRANIAL NEOPL|abcdefv
ENTRY = Malignant Neoplasms, Brain|T191|NON|NRW|NLM (2000)|991104|MALIGNANT NEOPL BRAIN|abcdefv
ENTRY = Malignant Primary Brain Neoplasms|T191|NON|NRW|NLM (2000)|991104|MALIGNANT PRIMARY BRAIN NEOPL|abcdefv
ENTRY = Neoplasms, Brain|T191|NON|EQV|NLM (1992)|901015|NEOPL BRAIN|abcdefv
ENTRY = Neoplasms, Brain, Benign|T191|NON|NRW|NLM (2000)|991104|NEOPL BRAIN BENIGN|abcdefv
ENTRY = Neoplasms, Brain, Malignant|T191|NON|NRW|NLM (2000)|991104|NEOPL BRAIN MALIGNANT|abcdefv
ENTRY = Neoplasms, Brain, Primary|T191|NON|NRW|NLM (2000)|991104|NEOPL BRAIN PRIMARY|abcdefv
ENTRY = Primary Brain Neoplasms|T191|NON|NRW|NLM (2000)|991104|PRIMARY BRAIN NEOPL|abcdefv
ENTRY = Primary Malignant Brain Neoplasms|T191|NON|NRW|NLM (2000)|991104|PRIMARY MALIGNANT BRAIN NEOPL|abcdefv
ENTRY = Primary Malignant Brain Tumors|T191|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Benign Brain Neoplasm
ENTRY = Benign Brain Neoplasms
ENTRY = Benign Neoplasm, Brain
ENTRY = Brain Benign Neoplasm
ENTRY = Brain Benign Neoplasms
ENTRY = Brain Cancers
ENTRY = Brain Malignant Neoplasm
ENTRY = Brain Malignant Neoplasms
ENTRY = Brain Neoplasm
ENTRY = Brain Neoplasm, Benign
ENTRY = Brain Neoplasm, Malignant
ENTRY = Brain Neoplasms, Primary
ENTRY = Brain Tumor
ENTRY = Brain Tumors, Primary
ENTRY = Brain Tumors, Recurrent
ENTRY = Cancer, Brain
ENTRY = Cancers, Brain
ENTRY = Intracranial Neoplasm
ENTRY = Malignant Brain Neoplasm
ENTRY = Malignant Brain Neoplasms
ENTRY = Malignant Neoplasm, Brain
ENTRY = Neoplasm, Brain
ENTRY = Neoplasm, Intracranial
ENTRY = Primary Brain Neoplasm
ENTRY = Primary Brain Tumor
ENTRY = Primary Brain Tumors
ENTRY = Recurrent Brain Tumor
ENTRY = Recurrent Brain Tumors
ENTRY = Tumor, Brain
ENTRY = Tumors, Brain
MN = C04.588.614.250.195
MN = C10.228.140.211
MN = C10.551.240.250
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in brain (IM) + histol type of neopl (IM)
MS = Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
UI = D001932

*NEWRECORD
RECTYPE = D
MH = Brain Stem
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Brainstem|T023|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Truncus Cerebri|T023|NON|EQV|NLM (2015)|140314|abcdef
ENTRY = Brain Stems
ENTRY = Brainstems
ENTRY = Cerebri, Truncus
ENTRY = Cerebrus, Truncus
ENTRY = Truncus Cerebrus
MN = A08.186.211.132
MH_TH = NLM (1966)
ST = T023
MS = The part of the brain that connects the CEREBRAL HEMISPHERES with the SPINAL CORD. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA.
MR = 20140613
DA = 19990101
DC = 1
UI = D001933

*NEWRECORD
RECTYPE = D
MH = Branchial Region
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
PRINT ENTRY = Branchial Arches|T018|NON|NRW|NLM (1991)|891220|abcdef
PRINT ENTRY = Branchial Clefts|T018|NON|NRW|NLM (1991)|900209|abcdef
PRINT ENTRY = Pharyngeal Arches|T018|NON|NRW|NLM (1991)|891220|abcdef
PRINT ENTRY = Visceral Arches|T018|NON|NRW|NLM (1991)|891220|abcdef
ENTRY = Branchial Arch|T018|NON|NRW|NLM (1991)|891221|abcdef
ENTRY = Branchial Grooves|T018|NON|NRW|NLM (2008)|061026|abcdef
ENTRY = Pharyngeal Arch|T018|NON|NRW|NLM (1991)|891221|abcdef
ENTRY = Pharyngeal Clefts|T018|NON|NRW|NLM (2008)|061026|abcdef
ENTRY = Pharyngeal Grooves|T018|NON|NRW|NLM (2008)|061026|abcdef
ENTRY = Visceral Arch|T018|NON|NRW|NLM (1991)|891221|abcdef
ENTRY = Arch, Branchial
ENTRY = Arch, Pharyngeal
ENTRY = Arch, Visceral
ENTRY = Arches, Branchial
ENTRY = Arches, Pharyngeal
ENTRY = Arches, Visceral
ENTRY = Archs, Pharyngeal
ENTRY = Branchial Cleft
ENTRY = Branchial Groove
ENTRY = Branchial Regions
ENTRY = Cleft, Branchial
ENTRY = Cleft, Pharyngeal
ENTRY = Clefts, Branchial
ENTRY = Clefts, Pharyngeal
ENTRY = Groove, Branchial
ENTRY = Groove, Pharyngeal
ENTRY = Grooves, Branchial
ENTRY = Grooves, Pharyngeal
ENTRY = Pharyngeal Archs
ENTRY = Pharyngeal Cleft
ENTRY = Pharyngeal Groove
ENTRY = Region, Branchial
ENTRY = Regions, Branchial
MN = A16.142
MH_TH = NLM (1966)
ST = T018
AN = branchial arch syndrome: index under BRANCHIAL REGION (IM) + SYNDROME (NIM)
MS = A region, of SOMITE development period, that contains a number of paired arches, each with a mesodermal core lined by ectoderm and endoderm on the two sides. In lower aquatic vertebrates, branchial arches develop into GILLS. In higher vertebrates, the arches forms outpouchings and develop into structures of the head and neck. Separating the arches are the branchial clefts or grooves.
MR = 20070709
DA = 19990101
DC = 1
UI = D001934

*NEWRECORD
RECTYPE = D
MH = Branchioma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Branchial Cleft Cyst|T191|NON|EQV|NLM (1995)|930915|abcdef
PRINT ENTRY = Branchial Cyst|T191|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Branchial Cysts|T191|NON|EQV|OMIM (2013)|120131|abcdef
ENTRY = Branchial Cleft Cysts
ENTRY = Branchiomas
ENTRY = Cleft Cyst, Branchial
ENTRY = Cleft Cysts, Branchial
ENTRY = Cyst, Branchial
ENTRY = Cyst, Branchial Cleft
ENTRY = Cysts, Branchial
ENTRY = Cysts, Branchial Cleft
MN = C04.182.117
MH_TH = NLM (1966)
ST = T191
AN = neoplastic; includes branchial inclusion cyst, branchial chondroma, branchial fistula; /blood supply /chem /secret /ultrastruct permitted; coord IM with HEAD AND NECK NEOPLASMS (IM)
MS = A tumor derived from branchial epithelium or branchial rests. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D001935

*NEWRECORD
RECTYPE = D
MH = Moraxella (Branhamella) catarrhalis
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Branhamella catarrhalis|T007|NON|EQV|NLM (1992)|910326|abcdef
PRINT ENTRY = Moraxella catarrhalis|T007|NON|EQV|UNK (19XX)|870507|abcdef
MN = B03.440.400.425.537.525.200
MN = B03.660.250.530.525.200
MH_TH = NLM (1988)
ST = T007
AN = infection: coord IM with MORAXELLACEAE INFECTIONS (IM)
PI = Moraxella (1983-1987)
PI = Neisseria (1975-1987)
PI = Neisseriaceae (1975-1987)
MS = Gram-negative aerobic cocci of low virulence that colonize the nasopharynx and occasionally cause MENINGITIS; BACTEREMIA; EMPYEMA; PERICARDITIS; and PNEUMONIA.
OL = use MORAXELLA (BRANHAMELLA) CATARRHALIS to search BRANHAMELLA CATARRHALIS 1988-91
PM = 92; was BRANHAMELLA CATARRHALIS 1988-91; MORAXELLA (BRANHAMELLA) CATARRHALIS was see BRANHAMELLA CATARRHALIS 1988-91
HN = 92; was BRANHAMELLA CATARRHALIS 1988-91; MORAXELLA (BRANHAMELLA) CATARRHALIS was see BRANHAMELLA CATARRHALIS 1988-91
MR = 20090706
DA = 19870507
DC = 1
DX = 19880101
UI = D001936

*NEWRECORD
RECTYPE = D
MH = Brassica
AQ = AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI
PRINT ENTRY = Broccoli|T168|NON|REL|NLM (1998)|961107|abcdef
PRINT ENTRY = Brussel Sprout|T168|NAM|REL|NLM (1998)|961107|abcdef
PRINT ENTRY = Cabbage|T168|NON|REL|UNK (19XX)|770426|abcdef
PRINT ENTRY = Cauliflower|T168|NON|REL|NLM (1998)|961107|abcdef
PRINT ENTRY = Collard Green|T168|NON|REL|NLM (1998)|961107|abcdef
PRINT ENTRY = Kale|T168|NON|REL|NLM (1998)|961107|abcdef
ENTRY = Cabbages
ENTRY = Collard Greens
MN = B01.650.940.800.575.100.157.200
MH_TH = NLM (1978)
ST = T002
PI = Plants (1966-1977)
PI = Plants, Edible (1966-1977)
MS = A plant genus of the family Cruciferae. It contains many species and cultivars used as food including cabbage, cauliflower, broccoli, Brussel sprouts, kale, collard greens, MUSTARD PLANT; (B. alba, B. junica, and B. nigra), turnips (BRASSICA NAPUS) and rapeseed (BRASSICA RAPA).
PM = 78
HN = 78
MR = 20150617
DA = 19770427
DC = 1
DX = 19780101
UI = D001937

*NEWRECORD
RECTYPE = D
MH = Brazil
AQ = EH EP
MN = Z01.107.757.176
MH_TH = POPLINE (1978)
ST = T083
MR = 19911102
DA = 19990101
DC = 4
UI = D001938

*NEWRECORD
RECTYPE = D
MH = Bread
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Breads
MN = G07.203.300.100
MN = J02.500.100
MH_TH = NLM (1966)
ST = T168
MS = Baked food product made of flour or meal that is moistened, kneaded, and sometimes fermented. A major food since prehistoric times, it has been made in various forms using a variety of ingredients and methods.
MR = 20141014
DA = 19990101
DC = 1
UI = D001939

*NEWRECORD
RECTYPE = D
MH = Breast
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RE RI SE SU TR UL VI
ENTRY = Breasts
MN = A01.236
FX = Lactation
FX = Mammaplasty
FX = Mammary Glands, Animal
FX = Mammography
FX = Mastectomy
EC = radiography:Mammography
EC = ultrasonography:Ultrasonography, Mammary
MH_TH = NLM (1966)
ST = T023
AN = human only; animal is MAMMARY GLANDS, ANIMAL; /surg: consider also MASTECTOMY & MAMMAPLASTY; inflammation = MASTITIS; tuberc of breast = MASTITIS (IM) + TUBERCULOSIS (IM), not TUBERCULOSIS, ENDOCRINE; self-examination = BREAST SELF-EXAMINATION
CX = consider also terms at MAMMA- and MAST-
MS = In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.
MR = 20030709
DA = 19990101
DC = 1
UI = D001940

*NEWRECORD
RECTYPE = D
MH = Breast Diseases
DE = BREAST DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Endocrine Breast Diseases|T047|NON|NRW|NLM (2005)|040112|ENDOCRINE BREAST DIS|abcdefv
ENTRY = Breast Disease
ENTRY = Breast Disease, Endocrine
ENTRY = Breast Diseases, Endocrine
ENTRY = Disease, Breast
ENTRY = Disease, Endocrine Breast
ENTRY = Diseases, Breast
ENTRY = Diseases, Endocrine Breast
ENTRY = Endocrine Breast Disease
MN = C17.800.090
MH_TH = NLM (1966)
ST = T047
AN = inflamm dis = MASTITIS; tuberc of breast = MASTITIS (IM) + TUBERCULOSIS (IM), not TUBERCULOSIS, ENDOCRINE
MS = Pathological processes of the BREAST.
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
UI = D001941

*NEWRECORD
RECTYPE = D
MH = Breast Feeding
AQ = AE CT EC EH ES HI IS MT PX SN TD
ENTRY = Breast Feeding, Exclusive|T055|NON|NRW|BIOETHICS (1993)|940315|abcdef
ENTRY = Breastfeeding|T040|T055|NON|EQV|NLM (1992)|910206|abbcdef
ENTRY = Breastfeeding, Exclusive|T055|NON|NRW|NLM (1995)|940315|abcdef
ENTRY = Exclusive Breast Feeding
ENTRY = Exclusive Breastfeeding
ENTRY = Feeding, Breast
MN = F01.145.407.199
MN = G07.203.650.220.500.500
MN = G07.203.650.353.199
MN = G07.203.650.593.185
MN = G07.700.620.185
FX = Bottle Feeding
FX = Milk, Human
MH_TH = NLM (1978)
ST = T040
ST = T055
AN = human only; /adv eff: refers to effect on infant or mother
MS = The nursing of an infant at the breast.
CATSH = CAT LIST
MR = 20150708
DA = 19990101
DC = 1
UI = D001942

*NEWRECORD
RECTYPE = D
MH = Breast Neoplasms
DE = BREAST NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Breast Cancer|T191|NON|NRW|BIOETHICS (1995)|GHR (2014)|NLM (1980)|OMIM (2013)|781219|abcdeeeef
PRINT ENTRY = Breast Tumors|T191|NON|EQV|NLM (2005)|040622|abcdef
PRINT ENTRY = Cancer of Breast|T191|NON|NRW|GHR (2014)|NLM (2000)|991103|abcdeef
ENTRY = Breast Carcinoma|T191|NON|NRW|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Cancer of the Breast|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Human Mammary Carcinoma|T191|NON|NRW|NLM (2004)|030211|abcdef
ENTRY = Malignant Neoplasm of Breast|T191|NON|NRW|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Malignant Tumor of Breast|T191|NON|NRW|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Mammary Cancer|T191|NON|NRW|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Mammary Carcinoma, Human|T191|NON|NRW|NLM (2004)|030211|abcdef
ENTRY = Mammary Neoplasm, Human|T191|NON|NRW|NLM (2004)|030211|abcdef
ENTRY = Mammary Neoplasms, Human|T191|NON|NRW|NLM (2004)|030211|abcdef
ENTRY = Neoplasms, Breast|T191|NON|EQV|NLM (1992)|910617|NEOPL BREAST|abcdefv
ENTRY = Tumors, Breast|T191|NON|EQV|NLM (2005)|040622|abcdef
ENTRY = Breast Neoplasm
ENTRY = Breast Tumor
ENTRY = Cancer, Breast
ENTRY = Carcinoma, Human Mammary
ENTRY = Carcinomas, Human Mammary
ENTRY = Human Mammary Carcinomas
ENTRY = Human Mammary Neoplasm
ENTRY = Human Mammary Neoplasms
ENTRY = Mammary Carcinomas, Human
ENTRY = Neoplasm, Breast
ENTRY = Neoplasm, Human Mammary
ENTRY = Neoplasms, Human Mammary
ENTRY = Tumor, Breast
MN = C04.588.180
MN = C17.800.090.500
MH_TH = NLM (1966)
ST = T191
AN = human only; BREAST NEOPLASMS, MALE is also available; for animal use MAMMARY NEOPLASMS, ANIMAL or MAMMARY NEOPLASMS, EXPERIMENTAL: Manual 24.5+, 24.6+; coordinate IM with histological type of neoplasm (IM)
MS = Tumors or cancer of the human BREAST.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001943

*NEWRECORD
RECTYPE = D
MH = Breath Tests
AQ = IS MT
PRINT ENTRY = Breathalyzer Tests|T060|TRD|NRW|UNK (19XX)|860325|abcdef
ENTRY = Breath Test
ENTRY = Breathalyzer Test
ENTRY = Test, Breath
ENTRY = Test, Breathalyzer
ENTRY = Tests, Breath
ENTRY = Tests, Breathalyzer
MN = E01.370.100
MH_TH = NLM (1974)
ST = T060
AN = NIM
MS = Any tests done on exhaled air.
PM = 74
HN = 74
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19740101
UI = D001944

*NEWRECORD
RECTYPE = D
MH = Breathing Exercises
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Respiratory Muscle Training|T061|NON|EQV|NLM (1996)|941208|abcdef
ENTRY = Exercise, Breathing
ENTRY = Muscle Training, Respiratory
ENTRY = Training, Respiratory Muscle
MN = E02.190.525.186
MN = E02.779.474.124
FX = Yoga
MH_TH = NLM (1966)
ST = T061
MS = Therapeutic exercises aimed to deepen inspiration or expiration or even to alter the rate and rhythm of respiration.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D001945

*NEWRECORD
RECTYPE = D
MH = Breech Presentation
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Fetal Presentation, Breech|T047|T082|NON|EQV|UNK (19XX)|780119|abbcdef
PRINT ENTRY = Labor Presentation, Breech|T047|T082|NON|EQV|UNK (19XX)|780119|abbcdef
PRINT ENTRY = Presentation, Breech|T047|T082|NON|EQV|UNK (19XX)|780119|abbcdef
ENTRY = Complete Breech|T047|T082|NON|NRW|NLM (2005)|040406|abbcdef
ENTRY = Frank Breech Presentation|T047|T082|NON|NRW|NLM (2005)|031215|abbcdef
ENTRY = Incomplete Breech|T047|T082|NON|NRW|NLM (2005)|040406|abbcdef
ENTRY = Breech Fetal Presentation
ENTRY = Breech Labor Presentation
ENTRY = Breech Presentation, Frank
ENTRY = Breech, Complete
ENTRY = Breech, Incomplete
ENTRY = Presentation, Breech Fetal
ENTRY = Presentation, Breech Labor
ENTRY = Presentation, Frank Breech
MN = C13.703.420.183
MN = G08.686.520.150
MN = G08.686.785.760.769.326.520.150
MH_TH = NLM (1975)
ST = T047
ST = T082
AN = check the tags FEMALE & PREGNANCY
PI = Labor Presentation (1966-1974)
MS = A malpresentation of the FETUS at near term or during OBSTETRIC LABOR with the fetal cephalic pole in the fundus of the UTERUS. There are three types of breech: the complete breech with flexed hips and knees; the incomplete breech with one or both hips partially or fully extended; the frank breech with flexed hips and extended knees.
OL = search LABOR PRESENTATION 1966-74
PM = 85; was see under LABOR PRESENTATION 1963-84
HN = 85(75); was see under LABOR PRESENTATION 1963-84
CATSH = CAT LIST
MR = 20150114
DA = 19990101
DC = 1
DX = 19850101
UI = D001946

*NEWRECORD
RECTYPE = D
MH = Breeding
AQ = EC HI LJ MT SN ST
ENTRY = Breedings
MN = E05.820.150
MN = G05.355.090
MH_TH = NLM (1966)
ST = T040
AN = animals only; PLANT BREEDING is also available
MS = The production of offspring by selective mating or HYBRIDIZATION, GENETIC in animals or plants.
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
UI = D001947

*NEWRECORD
RECTYPE = D
MH = Brenner Tumor
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Benign Brenner Tumor|T191|EPO|NRW|NLM (2006)|040913|abcdef
ENTRY = Brenner Tumor of Ovary|T191|EPO|EQV|NLM (2011)|ORD (2010)|100414|abcdeef
ENTRY = Malignant Brenner Tumor|T191|EPO|NRW|NLM (2006)|040913|abcdef
ENTRY = Ovarian Brenner Tumor|T191|EPO|EQV|NLM (2011)|ORD (2010)|100414|abcdeef
ENTRY = Proliferative Brenner Tumor|T191|EPO|NRW|NLM (2006)|040913|abcdef
ENTRY = Brenner Tumor, Benign
ENTRY = Brenner Tumor, Malignant
ENTRY = Brenner Tumor, Proliferative
ENTRY = Ovary Brenner Tumor
MN = C04.557.450.565.590.595.150
MN = C04.557.470.625.150
MN = C13.351.500.056.630.705.265
MN = C13.351.937.418.685.265
MN = C19.391.630.705.265
MH_TH = NLM (1966)
ST = T191
AN = coordinate IM with OVARIAN NEOPLASMS (IM)
MS = A smooth, solid or cystic fibroepithelial (FIBROEPITHELIAL NEOPLASMS) tumor, usually found in the OVARIES but can also be found in the adnexal region and the KIDNEYS. It consists of a fibrous stroma with nests of epithelial cells that sometimes resemble the transitional cells lining the urinary bladder. Brenner tumors generally are benign and asymptomatic. Malignant Brenner tumors have been reported.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001948

*NEWRECORD
RECTYPE = D
MH = Bretylium Compounds
DE = BRETYLIUM CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compounds, Bretylium
MN = D02.092.877.096.333
MN = D02.675.276.175
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = ammonium cpds; DF: BRETYLIUM CPDS
MR = 20050630
DA = 19990101
DC = 1
UI = D001949

*NEWRECORD
RECTYPE = D
MH = Bretylium Tosylate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Bretylate|T109|T121|TRD|NRW|IE|040325|abbcdef
ENTRY = Bretylium Tosilate|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|941129|abbcdeef
ENTRY = Bretylol|T109|T121|TRD|NRW|UNK (19XX)|US|861119|abbcdeef
ENTRY = Du Pont Brand of Bretylium Tosilate|T109|T121|NON|NRW|NLM (2005)|040325|abbcdef
ENTRY = GlaxoSmithKline Brand of Bretylium Tosilate|T109|T121|NON|NRW|NLM (2005)|040325|abbcdef
ENTRY = Ornid|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
MN = D02.092.877.096.333.150
MN = D02.675.276.175.150
PA = Adrenergic Antagonists
PA = Anti-Arrhythmia Agents
PA = Antihypertensive Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = USAN (1976)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)
RN = 78ZP3YR353
RR = 61-75-6 (Bretylium Tosylate)
PI = Aryl Sulfonates (1974-1975)
PI = Bretylium Compounds (1969-1975)
MS = An agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic.
PM = 91; was see under BRETYLIUM COMPOUNDS 1976-90
HN = 91(76); was see under BRETYLIUM COMPOUNDS 1976-90
MR = 20130708
DA = 19750723
DC = 1
DX = 19910101
UI = D001950

*NEWRECORD
RECTYPE = D
MH = Brevibacterium
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.510.024.049.100
MN = B03.510.460.400.400.049.550
MH_TH = NLM (1966)
ST = T007
AN = in soil, water, dairy prod & decaying matter
MS = A gram-positive organism found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter.
MR = 20090706
DA = 19990101
DC = 1
UI = D001951

*NEWRECORD
RECTYPE = D
MH = Bridged Compounds
DE = BRIDGED CPDS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compounds, Bridged
MN = D02.455.426.100
MN = D04.075
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = DF: BRIDGED CPDS
MS = Cyclic hydrocarbons that contain multiple rings and share one or more atoms.
MR = 19950608
DA = 19990101
DC = 1
UI = D001952

*NEWRECORD
RECTYPE = D
MH = Brinolase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Brinase|T116|T121|T126|NON|EQV|INN (19XX)|741111|abbbcdef
MN = D08.811.277.656.300.099
PA = Fibrinolytic Agents
MH_TH = USAN (1971)
ST = T116
ST = T121
ST = T126
RN = EC 3.4.99.-
PI = Aspergillus/enzymology (1972-1974)
PI = Peptide Hydrolases (1972-1974)
MS = A fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. EC 3.4.99.-.
PM = 91; was see under PEPTIDE HYDROLASES 1975-90
HN = 91(75); was see under PEPTIDE HYDROLASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D001954

*NEWRECORD
RECTYPE = D
MH = British Columbia
AQ = EH EP
MN = Z01.107.567.176.160
MH_TH = NLM (1966)
ST = T083
AN = a province of Canada on the Pacific coast
MS = A province of Canada on the Pacific coast. Its capital is Victoria. The name given in 1858 derives from the Columbia River which was named by the American captain Robert Gray for his ship Columbia which in turn was named for Columbus. (From Webster's New Geographical Dictionary, 1988, p178 & Room, Brewer's Dictionary of Names, 1992, p81-2)
MR = 19950217
DA = 19990101
DC = 4
UI = D001955

*NEWRECORD
RECTYPE = D
MH = Broad Ligament
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Broad Ligaments
ENTRY = Ligament, Broad
ENTRY = Ligaments, Broad
MN = A02.513.170
MN = A05.360.319.114.170
MH_TH = NLM (1975)
ST = T023
AN = an adnexal ligament; inflammation = PARAMETRITIS
MS = A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis.
OL = search ADNEXA UTERI 1966-74
PM = 91; was see under ADNEXA UTERI 1975-90
HN = 91(75); was see under ADNEXA UTERI 1975-90
MR = 19900212
DA = 19990101
DC = 1
DX = 19910101
UI = D001956

*NEWRECORD
RECTYPE = D
MH = Broadsides as Topic
AQ = HI
ENTRY = Broadside as Topic|T073|T170|NON|EQV|NLM (2008)|070622|abbcdef
ENTRY = Broadsides as Topics
MN = L01.178.682.236
MH_TH = NLM (2008)
ST = T073
ST = T170
AN = IM; coordinate with subject (IM); do not confuse with Publication Type BROADSIDES
MS = Published pieces of paper or other material, usually printed on one side and intended to be read unfolded and usually intended to be posted, publicly distributed, or sold. (From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed)
PM = 2008; see BROADSIDES 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D001957

*NEWRECORD
RECTYPE = D
MH = Brocresine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = NSD-1055|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = NSD 1055
ENTRY = NSD1055
MN = D02.455.426.559.389.657.239.180
PA = Enzyme Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1967)
ST = T109
ST = T121
N1 = Phenol, 5-((aminooxy)methyl)-2-bromo-
RN = 11F6O06WN0
RR = 555-65-7 (Brocresine)
PI = Cresols (1968-1974)
PI = Hydroxylamines (1971-1974)
MS = A histidine decarboxylase inhibitor.
PM = 91; was see under CRESOLS 1975-90
HN = 91(75); was see under CRESOLS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001958

*NEWRECORD
RECTYPE = D
MH = Bromates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.139.100
MN = D01.248.497.158.100
MH_TH = NLM (1971)
ST = T197
RN = 0
PI = Bromine (1966-1970)
MS = Negative ions or salts derived from bromic acid, HBrO3.
PM = 91; was see under BROMINE 1971-90
HN = 91(71); was see under BROMINE 1971-90
MR = 20000822
DA = 19990101
DC = 1
DX = 19910101
UI = D001959

*NEWRECORD
RECTYPE = D
MH = Bromazepam
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1A Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Aliud Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Anxyrex|T109|T121|TRD|NRW|FR|041210|abbcdef
ENTRY = Apo-Bromazepam|T109|T121|TRD|NRW|CA|041210|abbcdef
ENTRY = Apotex Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = BromaLich|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Bromaz 1A Pharma|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Bromazanil|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Bromazepam AL|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Bromazepam Heumann|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Bromazepam beta|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Bromazepam-neuraxpharm|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Bromazepam-ratiopharm|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = Gen-Bromazepam|T109|T121|TRD|NRW|CA|041210|abbcdef
ENTRY = Genpharm Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Heumann Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Hexal Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Irex Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Lexatin|T109|T121|TRD|NRW|ES|041210|abbcdef
ENTRY = Lexomil|T109|T121|TRD|NRW|FR|041210|abbcdef
ENTRY = Lexotan|T109|T121|TRD|NRW|AU|IE|MX|UNK (19XX)|800731|abbcdeeeef
ENTRY = Lexotanil|T109|T121|TRD|NRW|DE|NL|UNK (19XX)|800731|abbcdeeef
ENTRY = Lichtenstein Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Merck dura Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Ro 5-3350|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Roche Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = betapharm Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = bromazep von ct|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = ct-Arzneimittel Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = durazanil|T109|T121|TRD|NRW|DE|041210|abbcdef
ENTRY = neuraxpharm Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = ratiopharm Brand of Bromazepam|T109|T121|NON|NRW|NLM (2006)|041210|abbcdef
ENTRY = Apo Bromazepam
ENTRY = Bromazepam Lichtenstein Brand
ENTRY = Bromazepam Roche Brand
ENTRY = Bromazepam ratiopharm
ENTRY = Gen Bromazepam
ENTRY = Ro 53350
ENTRY = ct Arzneimittel Brand of Bromazepam
MN = D03.438.079.080.070.110
PA = Anti-Anxiety Agents
PA = GABA Modulators
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1969)
ST = T109
ST = T121
N1 = 2H-1,4-Benzodiazepin-2-one, 7-bromo-1,3-dihydro-5-(2-pyridinyl)-
RN = X015L14V0O
RR = 1812-30-2 (Bromazepam)
PI = Benzodiazepinones (1974)
PI = Pyridines (1974)
MS = One of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS.
PM = 91; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90
HN = 91(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001960

*NEWRECORD
RECTYPE = D
MH = Bromcresol Green
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Tetrabromocresolsulfonphthalein|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Bromocresol Green|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|830629|abbcdeef
ENTRY = Green, Bromcresol
ENTRY = Green, Bromocresol
MN = D02.455.426.559.389.657.239.190
MN = D02.455.426.559.389.832.140
MN = D02.886.590.887.140
PA = Indicators and Reagents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-3-methyl)-, S,S-dioxide
RN = 8YGN0Y942M
RR = 76-60-8 (Bromcresol Green)
AN = D25-26 qualif
PI = Bromine (1972-1974)
PI = Cresols (1969-1974)
PI = Tosyl Compounds (1974)
MS = An indicator and reagent. It has been used in serum albumin determinations and as a pH indicator.
PM = 91; was see under CRESOLS 1975-90
HN = 91(75); was see under CRESOLS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001961

*NEWRECORD
RECTYPE = D
MH = Bromcresol Purple
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Bromocresol Purple|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|861009|abbcdeef
ENTRY = Purple, Bromcresol
ENTRY = Purple, Bromocresol
MN = D02.455.426.559.389.657.239.195
MN = D02.455.426.559.389.832.150
MN = D02.886.590.887.150
PA = Indicators and Reagents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2-bromo-6-methyl)-, S,S-dioxide
RN = 201C22C3EC
RR = 115-40-2 (Bromcresol Purple)
AN = D25-26 qualif
PI = Bromine (1973-1974)
PI = Cresols (1969-1974)
PI = Tosyl Compounds (1973-1974)
MS = An indicator and reagent. It has been used for several purposes including the determination of serum albumin concentrations
PM = 91; was see under CRESOLS 1975-90
HN = 91(75); was see under CRESOLS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001962

*NEWRECORD
RECTYPE = D
MH = Bromelains
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Bromelins|T116|T121|T126|NON|EQV|UNK (19XX)|760317|abbbcdef
ENTRY = Ananase|T116|T121|T126|TRD|NRW|IE|US|861202|abbbcdeef
ENTRY = Aventis Brand of Bromelains|T116|T121|T126|NON|NRW|NLM (2005)|040325|abbbcdef
ENTRY = Bromelain|T116|T121|T126|NON|EQV|NLM (1989)|890208|abbbcdef
ENTRY = Bromelain-POS|T116|T121|T126|TRD|NRW|DE|040325|abbbcdef
ENTRY = Bromelin|T116|T121|T126|NON|EQV|UNK (19XX)|810728|abbbcdef
ENTRY = Dayto Anase|T116|T126|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Debrase|T121|T126|TRD|NRW|NLM (2011)|091119|abbcdef
ENTRY = Dontisanin|T116|T121|T126|TRD|NRW|DE|040325|abbbcdef
ENTRY = Extranase|T116|T121|T126|TRD|NRW|FR|US|040329|abbbcdeef
ENTRY = Mucos Brand of Bromelains|T116|NON|NRW|NLM (2005)|040329|abcdef
ENTRY = Mucozym|T116|TRD|NRW|DE|040325|abcdef
ENTRY = Nattermann Brand of Bromelains|T116|T121|T126|NON|NRW|NLM (2005)|040325|abbbcdef
ENTRY = Proteozym|T116|T121|T126|TRD|NRW|DE|040329|abbbcdef
ENTRY = Rhne-Poulenc Rorer Brand 1 of Bromelains|T116|T121|T126|NON|NRW|NLM (2005)|040325|abbbcdef
ENTRY = Rhne-Poulenc Rorer Brand 2 of Bromelains|T116|T121|T126|NON|NRW|NLM (2005)|040329|abbbcdef
ENTRY = Rhne-Poulenc Rorer Brand 3 of Bromelains|T116|T121|T126|NON|NRW|NLM (2005)|040329|abbbcdef
ENTRY = Rottapharm Brand of Bromelains|T116|T121|T126|NON|NRW|NLM (2005)|040329|abbbcdef
ENTRY = Teva Pharmaceutical's Brand of Bromelain|T121|T126|NON|NRW|NLM (2011)|091223|abbcdef
ENTRY = Traumanase|T116|T121|T126|TRD|NRW|DE|UNK (19XX)|US|810728|abbbcdeeef
ENTRY = Ursapharm Brand of Bromelains|T116|T121|T126|NON|NRW|NLM (2005)|040325|abbbcdef
ENTRY = Wiedemann Brand of Bromelains|T116|T121|T126|NON|NRW|NLM (2005)|040329|abbbcdef
ENTRY = Bromelain POS
ENTRY = BromelainPOS
ENTRY = Bromelains Aventis Brand
ENTRY = Bromelains Mucos Brand
ENTRY = Bromelains Nattermann Brand
ENTRY = Bromelains Rottapharm Brand
ENTRY = Bromelains Ursapharm Brand
ENTRY = Bromelains Wiedemann Brand
ENTRY = Rhne Poulenc Rorer Brand 1 of Bromelains
ENTRY = Rhne Poulenc Rorer Brand 2 of Bromelains
ENTRY = Rhne Poulenc Rorer Brand 3 of Bromelains
MN = D08.811.277.656.262.500.096
MN = D08.811.277.656.300.200.096
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = USAN (1962)
ST = T116
ST = T121
ST = T126
RN = 9001-00-7
RR = EC 3.4.22.32 (stem bromelain)
RR = EC 3.4.22.33 (fruit bromelain)
MS = Protein-digesting and milk-clotting enzymes found in PINEAPPLE fruit juice and stem tissue. Enzymes from the two sources are distinguished as fruit bromelain and stem bromelain. This enzyme was formerly listed as EC 3.4.22.4.
PM = 67; was see under PEPTIDE PEPTIDOHYDROLASES 1963-66
HN = 67(65); was see under ENDOPEPTIDASES 1963-66
MR = 20100625
DA = 19990101
DC = 1
DX = 19670101
UI = D001963

*NEWRECORD
RECTYPE = D
MH = Bromhexine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 3M Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040426|abbcdef
ENTRY = Aparsonin|T109|T121|TRD|NRW|DE|040329|abbcdef
ENTRY = Apex Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040426|abbcdef
ENTRY = Berlin-Chemie Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040329|abbcdef
ENTRY = Bisolvon|T109|T121|TRD|NRW|AU|DE|ES|FR|MX|NL|801104|abbcdeeeeeef
ENTRY = Boehringer Ingelheim Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040329|abbcdef
ENTRY = Boehrvet Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040329|abbcdef
ENTRY = Boots Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040426|abbcdef
ENTRY = Bromhexin|T109|T121|TRD|NRW|DE|040426|abbcdef
ENTRY = Bromhexin BC|T109|T121|TRD|NRW|DE|040329|abbcdef
ENTRY = Bromhexin Berlin-Chemie|T109|T121|TRD|NRW|DE|040329|abbcdef
ENTRY = Bromhexin-ratiopharm|T109|T121|TRD|NRW|DE|040426|abbcdef
ENTRY = Bromhexine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1969)|941020|abbcdeef
ENTRY = Bromhexine Monohydrochloride|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Brotussol|T109|T121|TRD|NRW|DE|040426|abbcdef
ENTRY = Darolan|T109|T121|TRD|NRW|NL|040426|abbcdef
ENTRY = Dur-Elix|T109|T121|TRD|NRW|AU|040426|abbcdef
ENTRY = Famel Bromhexine|T109|T121|TRD|NRW|NL|040426|abbcdef
ENTRY = Fher Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040329|abbcdef
ENTRY = Flegamin|T109|T121|TRD|NRW|UNK (19XX)|861009|abbcdef
ENTRY = Flubron|T109|T121|TRD|NRW|FR|040426|abbcdef
ENTRY = Hoechst Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040426|abbcdef
ENTRY = Hustentabs-ratiopharm|T109|T121|TRD|NRW|DE|040426|abbcdef
ENTRY = Krewel Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040426|abbcdef
ENTRY = Merckle Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040329|abbcdef
ENTRY = Mucohexine|T109|T121|TRD|NRW|AU|040426|abbcdef
ENTRY = NA-274|T109|T121|LAB|NRW|UNK (19XX)|820830|abbcdef
ENTRY = Novartis Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040329|abbcdef
ENTRY = Omniapharm Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040329|abbcdef
ENTRY = Promeco Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040329|abbcdef
ENTRY = Quentan|T109|T121|TRD|NRW|FR|040329|abbcdef
ENTRY = SB-CH Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040426|abbcdef
ENTRY = Tesacof|T109|T121|TRD|NRW|MX|040329|abbcdef
ENTRY = bromhexin von ct|T109|T121|TRD|NRW|DE|040426|abbcdef
ENTRY = ct-Arzneimittel Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040426|abbcdef
ENTRY = ratiopharm Brand of Bromhexine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040426|abbcdef
ENTRY = BC, Bromhexin
ENTRY = Berlin Chemie Brand of Bromhexine Hydrochloride
ENTRY = Bromhexin Berlin Chemie
ENTRY = Bromhexin BerlinChemie
ENTRY = Bromhexin ratiopharm
ENTRY = Bromhexine, Famel
ENTRY = Bromhexinratiopharm
ENTRY = Dur Elix
ENTRY = DurElix
ENTRY = Hustentabs ratiopharm
ENTRY = Hustentabsratiopharm
ENTRY = Hydrochloride, Bromhexine
ENTRY = Monohydrochloride, Bromhexine
ENTRY = NA 274
ENTRY = NA274
ENTRY = SB CH Brand of Bromhexine Hydrochloride
ENTRY = ct Arzneimittel Brand of Bromhexine Hydrochloride
ENTRY = ct, bromhexin von
ENTRY = von ct, bromhexin
MN = D02.092.146.271
MN = D02.092.384.175
PA = Expectorants
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-
RN = Q1J152VB1P
RR = 3572-43-8 (Bromhexine)
RR = 611-75-6 (mono-HCl)
RR = YC2ZOM3Z8V
MS = A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
PM = 74
HN = 74
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D001964

*NEWRECORD
RECTYPE = D
MH = Bromides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.139.300.050
MN = D01.248.497.158.125
PA = Anticonvulsants
MH_TH = NLM (1966)
ST = T197
RN = 0
AN = only for inorganic cpds or bromide ion
MS = Salts of hydrobromic acid, HBr, with the bromine atom in the 1- oxidation state. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
MR = 20060705
DA = 19990101
DC = 1
UI = D001965

*NEWRECORD
RECTYPE = D
MH = Bromine
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.380.112
FX = Bromine Radioisotopes
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T131
ST = T196
N1 = Bromine
RN = SBV4XY874G
RR = 7726-95-6 (Bromine)
AN = a halogen; Br-79; Br-81 = BROMINE (IM) + ISOTOPES (NIM); Br-74-78, 80, 82-90 = BROMINE RADIOISOTOPES (IM)
MS = A halogen with the atomic symbol Br, atomic number 36, and atomic weight 79.904. It is a volatile reddish-brown liquid that gives off suffocating vapors, is corrosive to the skin, and may cause severe gastroenteritis if ingested.
MR = 20130708
DA = 19990101
DC = 1
UI = D001966

*NEWRECORD
RECTYPE = D
MH = Bromine Radioisotopes
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Radioisotopes, Bromine
MN = D01.496.749.090
MH_TH = NLM (1988)
ST = T196
RN = 0
AN = Br-74-78, 80, 82-90; for routine use as tracer, use no qualifiers
PI = Bromine (1966-1987)
PI = Radioisotopes (1966-1987)
MS = Unstable isotopes of bromine that decay or disintegrate emitting radiation. Br atoms with atomic weights 74-78, 80, and 82-90 are radioactive bromine isotopes.
PM = 88
HN = 88
MR = 20150605
DA = 19870406
DC = 1
DX = 19880101
UI = D001967

*NEWRECORD
RECTYPE = D
MH = Bromisovalum
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Bromisoval|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|741111|abbcdeef
PRINT ENTRY = Bromovalcarbamide|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Bromovalerylurea|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
ENTRY = (alpha-Bromoisovaleryl)urea|T109|T121|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = Bromoisovalerylurea|T109|T121|NON|EQV|UNK (19XX)|881011|abbcdef
ENTRY = Bromvaleton|T109|T121|TRD|NRW|UNK (19XX)|741111|abbcdef
ENTRY = Bromyl|T109|T121|TRD|NRW|UNK (19XX)|741111|abbcdef
ENTRY = Sedes A|T109|T121|TRD|NRW|UNK (19XX)|850528|abbcdef
MN = D02.948.160
PA = Hypnotics and Sedatives
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Butanamide, N-(aminocarbonyl)-2-bromo-3-methyl-
RN = 469GW8R486
RR = 496-67-3 (Bromisovalum)
PI = Urea (1969-1974)
PI = Valerates (1972-1974)
MS = A sedative and mild hypnotic with potentially toxic effects.
PM = 91; was see under UREA 1975-90
HN = 91(75); was see under UREA 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001968

*NEWRECORD
RECTYPE = D
MH = Bromobenzenes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.426.559.389.220
MN = D02.455.526.368.150
MH_TH = NLM (1975)
ST = T109
RN = 0
PI = Bromine (1973-1974)
PI = Hydrocarbons, Halogenated (1969-1974)
MS = Derivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms.
PM = 75
HN = 75
MR = 19920508
DA = 19741119
DC = 1
DX = 19750901
UI = D001969

*NEWRECORD
RECTYPE = D
MH = Bromobenzoates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Bromobenzoic Acids|T109|NON|REL|NLM (2013)|120113|abcdef
ENTRY = Acids, Bromobenzoic
MN = D02.241.223.100.150
MN = D02.455.426.559.389.127.150
MH_TH = NLM (1975)
ST = T109
RN = 0
PI = Benzoates (1966-1974)
MS = Benzoic acid or benzoic acid esters substituted with one or more bromine atoms.
PM = 75
HN = 75
MR = 20120703
DA = 19741111
DC = 1
DX = 19750901
UI = D001970

*NEWRECORD
RECTYPE = D
MH = Bromocriptine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 2-Bromoergocryptine|T109|T121|NON|EQV|UNK (19XX)|800520|BROMOERGOCRYPTINE 02|abbcdefs
PRINT ENTRY = Bromocryptin|T109|T121|NON|EQV|UNK (19XX)|760429|abbcdef
ENTRY = 2-Bromo-alpha-ergocryptine|T109|T121|NON|EQV|UNK (19XX)|800815|abbcdef
ENTRY = 2-Bromo-alpha-ergokryptine|T109|T121|NON|EQV|UNK (19XX)|800815|abbcdef
ENTRY = 2-Bromoergocryptine Mesylate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|800815|abbcdeef
ENTRY = 2-Bromoergocryptine Methanesulfonate|T109|T121|NON|NRW|UNK (19XX)|800815|abbcdef
ENTRY = 2-Bromoergokryptine|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Bromocriptin|T109|T121|NON|EQV|UNK (19XX)|800815|abbcdef
ENTRY = Bromocriptine Mesylate|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1977)|USAN (19XX)|USP (1996)|USP (19XX)|811218|abbcdeeeeef
ENTRY = CB-154|T109|T121|LAB|NRW|UNK (19XX)|800815|abbcdef
ENTRY = Parlodel|T109|T121|TRD|NRW|UNK (19XX)|800815|abbcdef
ENTRY = 2 Bromo alpha ergocryptine
ENTRY = 2 Bromo alpha ergokryptine
ENTRY = 2 Bromoergocryptine
ENTRY = 2 Bromoergocryptine Mesylate
ENTRY = 2 Bromoergocryptine Methanesulfonate
ENTRY = 2 Bromoergokryptine
ENTRY = CB 154
ENTRY = CB154
ENTRY = Mesylate, 2-Bromoergocryptine
ENTRY = Mesylate, Bromocriptine
ENTRY = Methanesulfonate, 2-Bromoergocryptine
MN = D03.132.327.412.100
MN = D03.549.439.131
MN = D03.549.562.100
PA = Antiparkinson Agents
PA = Dopamine Agonists
PA = Hormone Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (19XX)
ST = T109
ST = T121
N1 = Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-
RN = 3A64E3G5ZO
RR = 22260-51-1 (mesylate (salt))
RR = 25614-03-3 (Bromocriptine)
RR = FFP983J3OD
PI = Ergot Alkaloids (1966-1974)
MS = A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.
OL = use BROMOCRIPTINE to search 2-BROMOERGOCRYPTINE 1975-80
PM = 81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76
HN = 81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76
MR = 20130708
DA = 19741111
DC = 1
DX = 19780101
UI = D001971

*NEWRECORD
RECTYPE = D
MH = Bromodeoxycytidine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5-Bromo-2'-Deoxycytidine|T114|T123|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = 5 Bromo 2' Deoxycytidine
MN = D03.383.742.680.245.500.250
MN = D13.570.230.329.100
MN = D13.570.685.245.500.250
MH_TH = NLM (1975)
ST = T114
ST = T123
N1 = Cytidine, 5-bromo-2'-deoxy-
RN = 1022-79-3
PI = Bromine (1974)
PI = Deoxycytidine (1974)
MS = 5-Bromo-2'-deoxycytidine. Can be incorporated into DNA in the presence of DNA polymerase, replacing dCTP.
PM = 91; was see under DEOXYCYTIDINE 1975-90
HN = 91(75); was see under DEOXYCYTIDINE 1975-90
MR = 20060705
DA = 19741119
DC = 1
DX = 19910101
UI = D001972

*NEWRECORD
RECTYPE = D
MH = Bromodeoxyuridine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = BUdR|T114|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef
PRINT ENTRY = BrdU|T114|T121|ABB|EQV|NLM (1990)|890308|abbcdef
PRINT ENTRY = Bromouracil Deoxyriboside|T114|T121|NON|EQV|UNK (19XX)|800523|abbcdef
PRINT ENTRY = Broxuridine|T114|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|800523|abbcdeeef
ENTRY = 5-Bromo-2'-deoxyuridine|T114|T121|NON|EQV|FDA SRS (2014)|NLM (1997)|960328|abbcdeef
ENTRY = 5-Bromodeoxyuridine|T114|T121|NON|EQV|UNK (19XX)|811026|abbcdef
ENTRY = NSC-38297|T114|T121|LAB|NRW|NLM (1990)|890405|abbcdef
ENTRY = 5 Bromo 2' deoxyuridine
ENTRY = 5 Bromodeoxyuridine
ENTRY = Deoxyriboside, Bromouracil
MN = D03.383.742.680.852.300.150
MN = D13.570.230.430.196
MN = D13.570.685.852.300.150
PA = Antimetabolites
PA = Antimetabolites, Antineoplastic
PA = Antiviral Agents
PA = Radiation-Sensitizing Agents
MH_TH = NLM (1965)
ST = T114
ST = T121
N1 = Uridine, 5-bromo-2'-deoxy-
RN = G34N38R2N1
RR = 59-14-3 (Bromodeoxyuridine)
MS = A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.
PM = 66
HN = 66(65)
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D001973

*NEWRECORD
RECTYPE = D
MH = Bromosuccinimide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Succinbromimide|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbcdeef
ENTRY = N-Bromosuccinimide|T109|T130|NON|EQV|FDA SRS (2014)|NLM (1998)|970311|abbcdeef
ENTRY = N Bromosuccinimide
MN = D02.478.770.150
MN = D03.383.773.812.852.150
FX = Succinates
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = 2,5-Pyrrolidinedione, bromo-
RN = K8G1F2UCJF
RR = 39660-53-2 (Bromosuccinimide)
PI = Bromine (1972-1974)
PI = Succinimides (1972-1974)
MS = A brominating agent that replaces hydrogen atoms in benzylic or allylic positions. It is used in the oxidation of secondary alcohols to ketones and in controlled low-energy brominations. (From Miall's Dictionary of Chemistry, 5th ed; Hawley's Condensed Chemical Dictionary, 12th ed,).
PM = 91; was see under SUCCINIMIDES 1975-90
HN = 91(75); was see under SUCCINIMIDES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001974

*NEWRECORD
RECTYPE = D
MH = Bromotrichloromethane
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Trichlorobromomethane|T109|T131|NON|EQV|UNK (19XX)|760305|abbcdef
MN = D02.455.526.368.200
MN = D02.455.526.439.224.200
MH_TH = FDA SRS (2014)
MH_TH = NLM (1976)
ST = T109
ST = T131
N1 = Methane, bromotrichloro-
RN = IKJ30QXM63
RR = 75-62-7 (Bromotrichloromethane)
PI = Bromine (1974-1975)
PI = Chloroform (1974) /AA (1975)
MS = A potent liver poison. In rats, bromotrichloromethane produces about three times the degree of liver microsomal lipid peroxidation as does carbon tetrachloride.
PM = 91; was see under CHLOROFORM 1976-90
HN = 91(76); was see under CHLOROFORM 1976-90
MR = 20130708
DA = 19750718
DC = 1
DX = 19910101
UI = D001975

*NEWRECORD
RECTYPE = D
MH = Bromouracil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5-Bromouracil|T114|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|811209|abbcdeef
ENTRY = Bromuracil|T114|T131|NON|EQV|UNK (19XX)|800521|abbcdef
ENTRY = 5 Bromouracil
MN = D03.383.742.698.875.237
PA = Antimetabolites
PA = Mutagens
MH_TH = FDA SRS (2014)
MH_TH = NLM (1971)
ST = T114
ST = T131
N1 = 2,4(1H,3H)-Pyrimidinedione, 5-bromo-
RN = 4HK400G5UO
RR = 51-20-7 (Bromouracil)
AN = an antimetabolite
PI = Uracil (1966-1970)
MS = 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
PM = 74
HN = 74(71)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D001976

*NEWRECORD
RECTYPE = D
MH = Brompheniramine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = p-Bromdylamine|T109|T121|NON|EQV|UNK (19XX)|760626|BROMDYLAMINE P|abbcdefs
PRINT ENTRY = para-Bromdylamine|T109|T121|NON|EQV|UNK (19XX)|760626|abbcdef
ENTRY = Brompheniramine Maleate|T109|T121|NON|NRW|FDA SRS (2014)|USP (19XX)|941129|abbcdeef
ENTRY = Brompheniramine Maleate (1:1)|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Chlorphed|T109|T121|TRD|NRW|US|040427|abbcdef
ENTRY = Dimetane|T109|T121|TRD|NRW|US|830330|abbcdef
ENTRY = Dimetane-Ten|T109|T121|TRD|NRW|US|040427|abbcdef
ENTRY = Dimetapp Allergy|T109|T121|TRD|NRW|US|040427|abbcdef
ENTRY = Oraminic-2|T109|T121|TRD|NRW|US|040427|abbcdef
ENTRY = Roberts Brand of Brompheniramine Maleate|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Robins Brand of Brompheniramine Maleate|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Vortech Brand of Brompheniramine Maleate|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Whitehall-Robins Brand of Brompheniramine Maleate|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Dimetane Ten
ENTRY = Maleate, Brompheniramine
ENTRY = Oraminic 2
ENTRY = p Bromdylamine
ENTRY = para Bromdylamine
MN = D03.383.725.620.129
PA = Anti-Allergic Agents
PA = Histamine H1 Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-
RN = H57G17P2FN
RR = 86-22-6 (Brompheniramine)
RR = 980-71-2 (maleate (1:1))
RR = IXA7C9ZN03
MS = Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria.
PM = 91; was see under PYRIDINES 1966-90
HN = 91(66); was see under PYRIDINES 1966-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D001977

*NEWRECORD
RECTYPE = D
MH = Bromphenol Blue
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Bromophenol Blue|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|811026|abbcdeef
ENTRY = Tetrabromophenol Blue|T109|T130|NON|EQV|UNK (19XX)|811026|abbcdef
ENTRY = Blue, Bromophenol
ENTRY = Blue, Bromphenol
ENTRY = Blue, Tetrabromophenol
MN = D02.455.426.559.389.657.150
MN = D02.455.426.559.389.832.180
MN = D02.886.590.887.180
PA = Coloring Agents
PA = Indicators and Reagents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo)-, S,S-dioxide
RN = 0R2969YC90
RR = 115-39-9 (Bromphenol Blue)
AN = D25-26 qualif
PI = Bromine (1972-1974)
PI = Phenols (1969-1974)
PI = Tosyl Compounds (1972-1974)
MS = A dye that has been used as an industrial dye, a laboratory indicator, and a biological stain.
PM = 91; was see under PHENOLS 1975-90
HN = 91(75); was see under PHENOLS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001978

*NEWRECORD
RECTYPE = D
MH = Bromthymol Blue
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Dibromothymolsulfonphthalein|T109|T130|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Bromothymol Blue|T109|T130|NON|EQV|FDA SRS (2014)|NLM (1997)|960116|abbcdeef
ENTRY = Blue, Bromothymol
ENTRY = Blue, Bromthymol
MN = D02.455.426.559.389.832.200
MN = D02.455.849.575.875.200
MN = D02.886.590.887.200
PA = Coloring Agents
PA = Indicators and Reagents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-methylethyl))-, S,S-dioxide
RN = VGU4LM0H96
RR = 76-59-5 (Bromthymol Blue)
AN = D25-26 qualif
PI = Thymol (1974)
PI = Tosyl Compounds (1974)
MS = A pH sensitive dye that has been used as an indicator in many laboratory reactions.
PM = 91; was see under THYMOL 1975-90
HN = 91(75); was see under THYMOL 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D001979

*NEWRECORD
RECTYPE = D
MH = Bronchi
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RE RI SE SU TR UL US VI
ENTRY = Primary Bronchi|T023|NON|NRW|NLM (2009)|080402|abcdef
ENTRY = Primary Bronchus|T023|NON|NRW|NLM (2009)|080402|abcdef
ENTRY = Secondary Bronchi|T023|NON|NRW|NLM (2009)|080402|abcdef
ENTRY = Secondary Bronchus|T023|NON|NRW|NLM (2009)|080402|abcdef
ENTRY = Tertiary Bronchi|T023|NON|NRW|NLM (2009)|080402|abcdef
ENTRY = Tertiary Bronchus|T023|NON|NRW|NLM (2009)|080402|abcdef
ENTRY = Bronchi, Secondary
ENTRY = Bronchi, Tertiary
ENTRY = Bronchus
ENTRY = Bronchus, Secondary
ENTRY = Bronchus, Tertiary
MN = A04.411.125
FX = Bronchoconstrictor Agents
FX = Bronchodilator Agents
FX = Bronchography
FX = Bronchoscopy
EC = radiography:Bronchography
MH_TH = NLM (1966)
ST = T023
AN = inflammation = BRONCHITIS; dilatation = BRONCHIECTASIS; bronchial tuberculosis or tuberculous bronchitis: index under TUBERCULOSIS, PULMONARY & not also under BRONCHI or BRONCHITIS unless particularly discussed
MS = The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.
MR = 20080708
DA = 19990101
DC = 1
UI = D001980

*NEWRECORD
RECTYPE = D
MH = Bronchial Arteries
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, Bronchial
ENTRY = Artery, Bronchial
ENTRY = Bronchial Artery
MN = A07.231.114.158
MH_TH = NLM (1963)
ST = T023
MS = Left bronchial arteries arise from the thoracic aorta, the right from the first aortic intercostal or the upper left bronchial artery; they supply the bronchi and the lower trachea.
PM = 66
HN = 66(63)
MR = 19920526
DA = 19990101
DC = 1
DX = 19660101
UI = D001981

*NEWRECORD
RECTYPE = D
MH = Bronchial Diseases
DE = BRONCHIAL DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bronchial Disease
ENTRY = Disease, Bronchial
ENTRY = Diseases, Bronchial
MN = C08.127
MH_TH = NLM (1966)
ST = T047
AN = inflamm dis = BRONCHITIS
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D001982

*NEWRECORD
RECTYPE = D
MH = Bronchial Fistula
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bronchial Fistulas
ENTRY = Fistula, Bronchial
ENTRY = Fistulas, Bronchial
MN = C08.127.196
MN = C08.702.196
MN = C23.300.575.687.225
MH_TH = NLM (1966)
ST = T019
ST = T020
AN = fistula policy: Manual 23.19+
MS = An abnormal passage or communication between a bronchus and another part of the body.
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
UI = D001983

*NEWRECORD
RECTYPE = D
MH = Bronchial Neoplasms
DE = BRONCHIAL NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Neoplasms, Bronchial|T191|NON|EQV|NLM (1995)|940209|NEOPL BRONCHIAL|abcdefv
ENTRY = Bronchial Neoplasm
ENTRY = Neoplasm, Bronchial
MN = C04.588.894.797.520.109
MN = C08.127.265
MN = C08.785.520.100
MH_TH = NLM (1966)
ST = T191
AN = not for bronchial carcinoma (= CARCINOMA, BRONCHIAL see CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS), nor bronchogenic carcinoma (= CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS) nor bronchiolar carcinoma (= CARCINOMA, BRONCHIOLAR + LUNG NEOPLASMS); coordinate IM with histological type of neoplasm (IM)
MS = Tumors or cancer of the BRONCHI.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D001984

*NEWRECORD
RECTYPE = D
MH = Bronchial Provocation Tests
DE = BP TESTS
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Allergen Bronchial Provocation Tests|T060|NON|EQV|UNK (19XX)|790308|abcdef
PRINT ENTRY = Allergen Challenge, Endobronchial|T060|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Antigen Bronchial Provocation Tests|T060|NON|EQV|UNK (19XX)|790308|abcdef
PRINT ENTRY = Bronchial Allergen Challenge|T060|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Bronchial Challenge Tests|T060|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Inhalation Provocation Tests|T060|NON|EQV|UNK (19XX)|790308|abcdef
PRINT ENTRY = Provocation Tests, Bronchial|T060|NON|EQV|UNK (19XX)|790308|abcdef
ENTRY = Endobronchial Challenge Tests|T060|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Allergen Challenge, Bronchial
ENTRY = Allergen Challenges, Bronchial
ENTRY = Allergen Challenges, Endobronchial
ENTRY = Bronchial Allergen Challenges
ENTRY = Bronchial Challenge Test
ENTRY = Bronchial Provocation Test
ENTRY = Challenge Test, Bronchial
ENTRY = Challenge Test, Endobronchial
ENTRY = Challenge Tests, Bronchial
ENTRY = Challenge Tests, Endobronchial
ENTRY = Challenge, Bronchial Allergen
ENTRY = Challenge, Endobronchial Allergen
ENTRY = Challenges, Bronchial Allergen
ENTRY = Challenges, Endobronchial Allergen
ENTRY = Endobronchial Allergen Challenge
ENTRY = Endobronchial Allergen Challenges
ENTRY = Endobronchial Challenge Test
ENTRY = Inhalation Provocation Test
ENTRY = Provocation Test, Bronchial
ENTRY = Provocation Test, Inhalation
ENTRY = Provocation Tests, Inhalation
ENTRY = Test, Bronchial Challenge
ENTRY = Test, Bronchial Provocation
ENTRY = Test, Endobronchial Challenge
ENTRY = Test, Inhalation Provocation
ENTRY = Tests, Bronchial Challenge
ENTRY = Tests, Bronchial Provocation
ENTRY = Tests, Endobronchial Challenge
ENTRY = Tests, Inhalation Provocation
MN = E01.370.386.700.125
MH_TH = NLM (1980)
ST = T060
AN = DF: BP TESTS
PI = Allergens (1966-1979)
PI = Asthma (1966-1979)
PI = Bronchi (1966-1979)
PI = Histamine (1966-1979)
PI = Respiratory Function Tests (1966-1979)
PI = specific respiratory function test (1966-1979)
MS = Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 19991103
DA = 19790308
DC = 1
DX = 19800101
UI = D001985

*NEWRECORD
RECTYPE = D
MH = Bronchial Spasm
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bronchospasm|T047|T184|NON|EQV|UNK (19XX)|780519|abbcdef
ENTRY = Bronchial Spasms
ENTRY = Bronchospasms
ENTRY = Spasm, Bronchial
ENTRY = Spasms, Bronchial
MN = C08.127.321
MH_TH = NLM (1963)
ST = T047
ST = T184
MS = Spasmodic contraction of the smooth muscle of the bronchi.
PM = 64
HN = 64(63)
CATSH = CAT LIST
MR = 19910613
DA = 19990101
DC = 1
DX = 19640101
UI = D001986

*NEWRECORD
RECTYPE = D
MH = Bronchiectasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bronchiectases
MN = C08.127.384
MH_TH = NLM (1966)
ST = T047
AN = bronchial dilatation
MS = Persistent abnormal dilatation of the bronchi.
CATSH = CAT LIST
MR = 19930525
DA = 19990101
DC = 1
UI = D001987

*NEWRECORD
RECTYPE = D
MH = Bronchiolitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bronchiolitides
MN = C08.127.446.135
MN = C08.381.495.146.135
MN = C08.730.099.135
MH_TH = NLM (1988)
ST = T047
AN = general or unspecified; prefer specifics
PI = Bronchiolitis, Viral (1966-1987)
PI = Bronchitis (1966-1987)
PI = Bronchopneumonia (1966-1987)
MS = Inflammation of the BRONCHIOLES.
OL = search BRONCHIOLITIS, VIRAL 1966 (as Prov)
PM = 88
HN = 88; 64-66 (Prov)
CATSH = CAT LIST
MR = 20080708
DA = 19870327
DC = 1
DX = 19880101
UI = D001988

*NEWRECORD
RECTYPE = D
MH = Bronchiolitis Obliterans
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bronchiolitis, Exudative|T047|NON|NRW|UNK (19XX)|870402|abcdef
PRINT ENTRY = Bronchiolitis, Proliferative|T047|NON|NRW|UNK (19XX)|870402|abcdef
ENTRY = Constrictive Bronchiolitis|T047|NON|NRW|NLM (2009)|070731|abcdef
ENTRY = Exudative Bronchiolitis|T047|NON|NRW|NLM (2009)|070731|abcdef
ENTRY = Proliferative Bronchiolitis|T047|NON|NRW|UNK (19XX)|870515|abcdef
ENTRY = Bronchiolitides, Constrictive
ENTRY = Bronchiolitides, Exudative
ENTRY = Bronchiolitides, Proliferative
ENTRY = Bronchiolitis, Constrictive
ENTRY = Constrictive Bronchiolitides
ENTRY = Exudative Bronchiolitides
ENTRY = Proliferative Bronchiolitides
MN = C08.127.446.135.140
MN = C08.381.495.146.135.140
MH_TH = NLM (1988)
ST = T047
AN = do not confuse with BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA see CRYPTOGENIC ORGANIZING PNEUMONIA
PI = Bronchial Diseases (1966-1987)
PI = Bronchitis (1966-1987)
PI = Bronchopneumonia (1966-1987)
MS = Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20080708
DA = 19870402
DC = 1
DX = 19880101
UI = D001989

*NEWRECORD
RECTYPE = D
MH = Bronchiolitis, Viral
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Bronchiolitides, Viral
ENTRY = Viral Bronchiolitides
ENTRY = Viral Bronchiolitis
MN = C02.109
MN = C08.127.446.135.321
MN = C08.381.495.146.135.321
MN = C08.730.099.135.321
MH_TH = NLM (1964)
ST = T047
AN = coord IM with specific virus dis (IM)
MS = An acute inflammatory disease of the lower RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.
PM = 67
HN = 67
CATSH = CAT LIST
MR = 20101129
DA = 19990101
DC = 1
DX = 19670101
UI = D001990

*NEWRECORD
RECTYPE = D
MH = Bronchitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bronchitides
MN = C08.127.446
MN = C08.381.495.146
MN = C08.730.099
MH_TH = NLM (1966)
ST = T047
AN = tuberculous bronchitis: index under TUBERCULOSIS, PULMONARY & not also under BRONCHITIS unless particularly discussed; BRONCHIOLITIS is also available
MS = Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D001991

*NEWRECORD
RECTYPE = D
MH = Bronchoalveolar Lavage Fluid
DE = BALF
AQ = CH CY IM MI PS VI
PRINT ENTRY = Alveolar Lavage Fluid|T031|NON|EQV|UNK (19XX)|870402|abcdef
PRINT ENTRY = Bronchial Lavage Fluid|T031|NON|EQV|UNK (19XX)|870402|abcdef
PRINT ENTRY = Lung Lavage Fluid|T031|NON|EQV|UNK (19XX)|870402|abcdef
ENTRY = Bronchial Alveolar Lavage Fluid|T031|NON|EQV|NLM (2009)|080221|abcdef
ENTRY = Lavage Fluid, Bronchial|T031|NON|EQV|UNK (19XX)|870515|abcdef
ENTRY = Lavage Fluid, Lung|T031|NON|EQV|UNK (19XX)|870515|abcdef
ENTRY = Pulmonary Lavage Fluid|T031|NON|EQV|NLM (2009)|080221|abcdef
ENTRY = Alveolar Lavage Fluids
ENTRY = Bronchial Lavage Fluids
ENTRY = Bronchoalveolar Lavage Fluids
ENTRY = Lavage Fluid, Alveolar
ENTRY = Lavage Fluid, Bronchoalveolar
ENTRY = Lavage Fluid, Pulmonary
ENTRY = Lavage Fluids, Alveolar
ENTRY = Lavage Fluids, Bronchial
ENTRY = Lavage Fluids, Bronchoalveolar
ENTRY = Lavage Fluids, Lung
ENTRY = Lavage Fluids, Pulmonary
ENTRY = Lung Lavage Fluids
ENTRY = Pulmonary Lavage Fluids
MN = E05.927.100.500
MH_TH = NLM (1988)
ST = T031
AN = do not confuse with BRONCHOALVEOLAR LAVAGE, the irrigation technique; DF: BALF
PI = Bronchi (1971-1987)
PI = Irrigation (1971-1987)
PI = Lung (1971-1987)
PI = Pulmonary Alveoli (1971-1987)
MS = Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20100625
DA = 19870402
DC = 1
DX = 19880101
UI = D001992

*NEWRECORD
RECTYPE = D
MH = Bronchodilator Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Bronchial-Dilating Agents|T121|NON|EQV|NLM (1995)|940510|abcdef
ENTRY = Bronchodilator Effect|T039|NON|REL|NLM (2012)|110330|abcdef
ENTRY = Bronchodilator Effects|T039|NON|REL|NLM (2012)|110330|abcdef
ENTRY = Bronchodilators|T121|NON|EQV|NLM (1995)|940311|abcdef
ENTRY = Broncholytic Agents|T121|NON|NRW|NLM (1990)|890518|abcdef
ENTRY = Broncholytic Effect|T039|NON|REL|NLM (2012)|110330|abcdef
ENTRY = Broncholytic Effects|T039|NON|REL|NLM (2012)|110330|abcdef
ENTRY = Agents, Bronchial-Dilating
ENTRY = Agents, Bronchodilator
ENTRY = Agents, Broncholytic
ENTRY = Bronchial Dilating Agents
ENTRY = Effect, Bronchodilator
ENTRY = Effect, Broncholytic
ENTRY = Effects, Bronchodilator
ENTRY = Effects, Broncholytic
MN = D27.505.696.663.050.110
MN = D27.505.954.796.050.100
MH_TH = NLM (1963)
ST = T121
RN = 0
AN = note entry term BRONCHODILATOR EFFECT: use only for the bronchodilator effect of a chemical substance
MS = Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
PM = 65
HN = 65(63)
MR = 20110624
DA = 19990101
DC = 1
DX = 19650101
UI = D001993

*NEWRECORD
RECTYPE = D
MH = Bronchogenic Cyst
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
PRINT ENTRY = Bronchial Cyst|T019|NON|EQV|UNK (19XX)|860623|abcdef
ENTRY = Bronchial Cysts
ENTRY = Bronchogenic Cysts
ENTRY = Cyst, Bronchial
ENTRY = Cyst, Bronchogenic
ENTRY = Cysts, Bronchial
ENTRY = Cysts, Bronchogenic
MN = C04.182.195
MN = C08.127.480
MN = C08.695.195
MN = C16.131.740.195
MH_TH = NLM (1987)
ST = T019
AN = non-neoplastic; /blood supply /chem /secret /ultrastruct permitted
PI = Bronchial Diseases (1966-1986)
PI = Cysts (1966-1986)
PI = Mediastinal Cyst (1966-1986)
MS = A usually spherical cyst, arising as an embryonic out-pouching of the foregut or trachea. It is generally found in the mediastinum or lung and is usually asymptomatic unless it becomes infected.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 19940512
DA = 19860623
DC = 1
DX = 19870101
UI = D001994

*NEWRECORD
RECTYPE = D
MH = Bronchography
DE = BRONCHOGR
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Bronchographies
MN = E01.370.350.700.730.100
MN = E01.370.386.100
MH_TH = NLM (1963)
ST = T060
AN = NIM; do not use /util except by MeSH definition; DF: BRONCHOGR
MS = Radiography of the bronchial tree after injection of a contrast medium.
PM = 64
HN = 64(63)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19640101
UI = D001995

*NEWRECORD
RECTYPE = D
MH = Bronchopneumonia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Bronchial Pneumonia|T047|NON|EQV|NLM (2009)|080409|abcdef
ENTRY = Bronchial Pneumonias
ENTRY = Bronchopneumonias
ENTRY = Pneumonia, Bronchial
ENTRY = Pneumonias, Bronchial
MN = C08.127.509
MN = C08.381.677.127
MN = C08.730.610.127
MH_TH = NLM (1966)
ST = T047
MS = Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches.
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D001996

*NEWRECORD
RECTYPE = D
MH = Bronchopulmonary Dysplasia
DE = BRONCHOPULM DYSPLASIA
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Dysplasia, Bronchopulmonary
MN = C08.381.520.750.500
MN = C16.614.521.125
MH_TH = NLM (1982)
ST = T047
AN = restrict to newborn infants; for lung injury caused by mechanical ventilation in other age groups, use VENTILATOR-INDUCED LUNG INJURY; DF: BRONCHOPULM DYSPLASIA
PI = Lung Diseases (1966-1981)
PI = Respiratory Tract Diseases (1966-1981)
MS = A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
PM = 82
HN = 82
CATSH = CAT LIST
MR = 20080708
DA = 19810519
DC = 1
DX = 19820101
UI = D001997

*NEWRECORD
RECTYPE = D
MH = Bronchopulmonary Sequestration
DE = BRONCHOPULM SEQUESTRATION
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Pulmonary Sequestration|T019|NON|EQV|UNK (19XX)|740329|PULM SEQUESTRATION|abcdefv
ENTRY = Bronchopulmonary Sequestrations|T019|NON|EQV|NLM (1992)|900925|BRONCHOPULM SEQUESTRATIONS|abcdefv
ENTRY = Pulmonary Sequestrations|T019|NON|EQV|NLM (1992)|900925|PULM SEQUESTRATIONS|abcdefv
ENTRY = Sequestration, Bronchopulmonary|T019|NON|EQV|NLM (1992)|900925|SEQUESTRATION BRONCHOPULM|abcdefv
ENTRY = Sequestration, Pulmonary|T019|NON|EQV|NLM (1992)|900925|SEQUESTRATION PULM|abcdefv
ENTRY = Sequestrations, Bronchopulmonary|T019|NON|EQV|NLM (1992)|900925|SEQUESTRATIONS BRONCHOPULM|abcdefv
ENTRY = Sequestrations, Pulmonary|T019|NON|EQV|NLM (1992)|900925|SEQUESTRATIONS PULM|abcdefv
MN = C08.695.214
MN = C16.131.740.214
MH_TH = NLM (1964)
ST = T019
AN = a lung abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; DF: PULM SEQUESTRATION
MS = A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung.
PM = 65
HN = 65(64)
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
DX = 19650101
UI = D001998

*NEWRECORD
RECTYPE = D
MH = Bronchoscopy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Bronchoscopic Surgical Procedures|T060|T061|NON|NRW|NLM (2000)|991103|BRONCHOSCOPIC SURG PROCEDURES|abbcdefv
PRINT ENTRY = Surgical Procedures, Bronchoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG PROCEDURES BRONCHOSCOPIC|abbcdefv
ENTRY = Bronchoscopic Surgery|T060|T061|NON|NRW|NLM (2000)|991103|BRONCHOSCOPIC SURG|abbcdefv
ENTRY = Surgery, Bronchoscopic|T060|T061|NON|NRW|NLM (2000)|991103|SURG BRONCHOSCOPIC|abbcdefv
ENTRY = Bronchoscopic Surgeries
ENTRY = Bronchoscopic Surgical Procedure
ENTRY = Bronchoscopies
ENTRY = Surgeries, Bronchoscopic
ENTRY = Surgical Procedure, Bronchoscopic
MN = E01.370.386.105
MN = E01.370.388.250.100
MN = E04.502.250.100
MN = E04.928.600.080
FX = Bronchoscopes
FX = Catheterization, Peripheral
MH_TH = NLM (1966)
ST = T060
AN = / instrum permitted but consider also BRONCHOSCOPES
MS = Endoscopic examination, therapy or surgery of the bronchi.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D001999

*NEWRECORD
RECTYPE = D
MH = Bronchospirometry
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Bronchospirometries
MN = E01.370.386.700.750.100
MH_TH = NLM (1966)
ST = T060
AN = NIM
MS = Spirometric technique in which the volume of air breathed in the right and left lung is recorded separately.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D002000

*NEWRECORD
RECTYPE = D
MH = Adipose Tissue, Brown
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Brown Fat|T024|NON|EQV|NLM (1968)|990101|abcdef
PRINT ENTRY = Hibernating Gland|T024|NON|NRW|NLM (1998)|960730|abcdef
ENTRY = Brown Adipose Tissue|T024|NON|EQV|NLM (2007)|050714|abcdef
ENTRY = Fat, Brown
ENTRY = Tissue, Brown Adipose
MN = A10.165.114.322
MH_TH = NLM (1996)
ST = T024
PI = Adipose Tissue (1966-1967)
MS = A thermogenic form of adipose tissue composed of BROWN ADIPOCYTES. It is found in newborns of many species including humans, and in hibernating mammals. Brown fat is richly vascularized, innervated, and densely packed with MITOCHONDRIA which can generate heat directly from the stored lipids.
PM = 2007; see BROWN FAT 1968-2006
HN = 2007 (1968)
MR = 20060705
DA = 19990101
DC = 1
DX = 19720101
UI = D002001

*NEWRECORD
RECTYPE = D
MH = Brucella
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.400.425.215.500
MN = B03.660.050.070.100
MH_TH = NLM (1966)
ST = T007
AN = infection = BRUCELLOSIS
MS = A genus of gram-negative, aerobic bacteria that causes BRUCELLOSIS. Its cells are nonmotile coccobacilli and are animal parasites and pathogens. The bacterium is transmissible to humans through contact with infected dairy products or tissue.
PM = 1963
HN = 1963
MR = 20090706
DA = 19990101
DC = 1
UI = D002002

*NEWRECORD
RECTYPE = D
MH = Brucella abortus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Brucella melitensis biovar abortus|T007|NON|EQV|NLM (2004)|021017|abcdef
MN = B03.440.400.425.215.500.100
MN = B03.660.050.070.100.100
MH_TH = NLM (1966)
ST = T007
AN = infection = probably BRUCELLOSIS, BOVINE but for man or other animals coord IM with BRUCELLOSIS (IM)
MS = A species of the genus BRUCELLA whose natural hosts are cattle and other bovidae. Abortion and placentitis are frequently produced in the pregnant animal. Other mammals, including humans, may be infected.
MR = 20090706
DA = 19990101
DC = 1
UI = D002003

*NEWRECORD
RECTYPE = D
MH = Brucella Vaccine
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
ENTRY = Vaccine, Brucella
MN = D20.215.894.135.134
MH_TH = NLM (1966)
ST = T121
ST = T129
RN = 0
AN = coord IM with specific Brucella /immunol (IM)
MS = A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.
MR = 20050630
DA = 19990101
DC = 1
UI = D002004

*NEWRECORD
RECTYPE = D
MH = Brucellosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Malta Fever|T047|EPO|EQV|ORD (2010)|UNK (19XX)|740329|abcdeef
PRINT ENTRY = Undulant Fever|T047|NON|EQV|ORD (2010)|UNK (19XX)|740329|abcdeef
ENTRY = Brucellosis, Pulmonary|T047|NON|NRW|NLM (2012)|110207|abcdef
ENTRY = Cyprus Fever|T047|NON|EQV|NLM (2012)|ORD (2010)|101209|abcdeef
ENTRY = Gibraltar Fever|T047|EPO|EQV|NLM (2012)|ORD (2010)|101209|abcdeef
ENTRY = Rock Fever|T047|NON|EQV|NLM (2012)|ORD (2010)|101209|abcdeef
ENTRY = Brucelloses
ENTRY = Brucelloses, Pulmonary
ENTRY = Cyprus Fevers
ENTRY = Fever, Cyprus
ENTRY = Fever, Gibraltar
ENTRY = Fever, Malta
ENTRY = Fever, Rock
ENTRY = Fever, Undulant
ENTRY = Fevers, Cyprus
ENTRY = Fevers, Rock
ENTRY = Fevers, Undulant
ENTRY = Pulmonary Brucelloses
ENTRY = Pulmonary Brucellosis
ENTRY = Rock Fevers
ENTRY = Undulant Fevers
MN = C01.252.400.167
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = for entry term BRUCELLOSIS, PULMONARY, coordinate with LUNG DISEASES or specifics
MS = Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D002006

*NEWRECORD
RECTYPE = D
MH = Brucellosis, Bovine
AQ = BL CF CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
PRINT ENTRY = Bang's Disease|T047|EPO|EQV|UNK (19XX)|740329|BANGS DIS|abcdefv
ENTRY = Bang Disease|T047|EPO|EQV|UNK (19XX)|840615|BANG DIS|abcdefv
ENTRY = Bangs Disease
ENTRY = Bovine Brucelloses
ENTRY = Bovine Brucellosis
ENTRY = Brucelloses, Bovine
ENTRY = Disease, Bang
ENTRY = Disease, Bang's
MN = C01.252.400.167.322
MN = C22.021.322
MN = C22.196.148
MH_TH = NLM (1966)
ST = T047
AN = in cattle only: if transmitted to man, use BRUCELLOSIS for the human; don't forget also CATTLE (NIM) & check tag ANIMALS
MS = A disease of cattle caused by bacteria of the genus BRUCELLA leading to abortion in late pregnancy. BRUCELLA ABORTUS is the primary infective agent.
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
UI = D002007

*NEWRECORD
RECTYPE = D
MH = Brugia
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
ENTRY = Brugias
MN = B01.050.500.500.294.700.750.700.300.088
MH_TH = NLM (1975)
ST = T204
AN = infection: check text for probable lymphatic involvement & coord IM with ELEPHANTIASIS, FILARIAL (IM); coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES
MS = A filarial worm of Southeast Asia, producing filariasis and elephantiasis in various mammals including man. It was formerly included in the genus WUCHERERIA.
OL = search FILARIOIDEA 1969-74
PM = 86; was see under FILARIOIDEA 1969-85
HN = 86(75); was see under FILARIOIDEA 1969-85
MR = 20090706
DA = 19990101
DC = 1
DX = 19860101
UI = D002009

*NEWRECORD
RECTYPE = D
MH = Brunei
AQ = EH EP
MN = Z01.252.145.130
MH_TH = POPLINE (1978)
ST = T083
AN = a sultanate on the northeast coast of Borneo
MS = An independent sultanate on the northeast coast of Borneo. Its chief products are oil and natural gas. Its name is Hindi, coming from the Sanskrit bhumi, land or region. It gave its name Brunei to Borneo. (From Webster's New Geographical Dictionary, 1988, p183 & Room, Brewer's Dictionary of Names, 1992, p82)
HN = 75
MR = 19950217
DA = 19741111
DC = 4
DX = 19750101
UI = D002010

*NEWRECORD
RECTYPE = D
MH = Brunner Glands
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Brunner Gland|T023|NON|EQV|NLM (2004)|030213|abcdef
ENTRY = Brunner's Glands|T023|EPO|EQV|NLM (1975)|990101|abcdef
ENTRY = Brunners Glands
ENTRY = Gland, Brunner
ENTRY = Glands, Brunner
ENTRY = Glands, Brunner's
MN = A03.556.124.684.124.322
MN = A03.556.875.249.322
MH_TH = NLM (2004)
ST = T023
MS = The abundant submucosal mucous glands in the DUODENUM. These glands secrete BICARBONATE IONS; GLYCOPROTEINS; and PEPSINOGEN II.
PM = 2004; see BRUNNER'S GLANDS 1991-2003, see DUODENUM 1975-1990
HN = 2004 (1991)
MR = 20030709
DA = 19990101
DC = 1
DX = 19910101
UI = D002011

*NEWRECORD
RECTYPE = D
MH = Bruxism
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Teeth Grinding Disorder|T047|NON|EQV|NLM (2001)|991202|TEETH GRINDING DIS|abcdefv
ENTRY = Disorder, Teeth Grinding
ENTRY = Disorders, Teeth Grinding
ENTRY = Grinding Disorder, Teeth
ENTRY = Grinding Disorders, Teeth
ENTRY = Teeth Grinding Disorders
MN = C07.793.099
MH_TH = NLM (1965)
ST = T047
AN = SLEEP BRUXISM is also available
MS = A disorder characterized by grinding and clenching of the teeth.
PM = 65; was see under MASTICATION 1963-64
HN = 65; was see under MASTICATION 1963-64
CATSH = CAT LIST
MR = 20000622
DA = 19990101
DC = 1
DX = 19650101
UI = D002012

*NEWRECORD
RECTYPE = D
MH = Bryozoa
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Moss Animals|T204|NON|EQV|NLM (1993)|920206|abcdef
PRINT ENTRY = Zoophytes|T204|NON|EQV|NLM (1993)|920206|abcdef
ENTRY = Animal, Moss
ENTRY = Animals, Moss
ENTRY = Bryozoas
ENTRY = Moss Animal
ENTRY = Zoophyte
MN = B01.050.500.217
MH_TH = NLM (1966)
ST = T204
AN = a phylum of tiny aquatic colonial animals; /microbiol /parasitol /virol permitted
MS = A phylum of small sessile aquatic animals living as small tufted colonies. Some appear like hydroids or corals, but their internal structure is more advanced. Most bryozoans are matlike, forming thin encrustations on rocks, shells, or kelp. (Storer & Stebbins, General Zoology, 6th ed, p443)
MR = 20090706
DA = 19990101
DC = 1
UI = D002013

*NEWRECORD
RECTYPE = D
MH = Bucrylate
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Isobutylcyanoacrylate|T109|T122|NON|EQV|UNK (19XX)|790503|abbcdef
ENTRY = Bucrilate|T109|T122|NON|EQV|FDA SRS (2014)|INN (19XX)|790503|abbcdeef
ENTRY = Isobutyl Cyanoacrylate|T109|T122|NON|EQV|UNK (19XX)|810807|abbcdef
ENTRY = Isobutyl alpha-Cyanoacrylate|T109|T122|NON|EQV|UNK (19XX)|810807|abbcdef
ENTRY = Isobutyl-2-cyanoacrylate|T109|T122|NON|EQV|UNK (19XX)|820603|abbcdef
ENTRY = Cyanoacrylate, Isobutyl
ENTRY = Isobutyl 2 cyanoacrylate
ENTRY = Isobutyl alpha Cyanoacrylate
ENTRY = alpha-Cyanoacrylate, Isobutyl
MN = D02.241.081.069.366.200
MN = D02.626.290.200
MN = D05.750.259.341.110
MN = D25.720.259.341.110
MN = D25.919.367.341.110
MN = J01.637.051.720.259.341.110
MN = J01.637.051.919.367.341.110
PA = Tissue Adhesives
MH_TH = FDA SRS (2014)
MH_TH = USAN (1969)
ST = T109
ST = T122
N1 = 2-Propenoic acid, 2-cyano-, 2-methylpropyl ester
RN = 2HJV1F859Z
RR = 1069-55-2 (Bucrylate)
AN = D25-26 qualif
MS = Cyanoacrylate tissue adhesive also used to occlude blood vessels supplying neoplastic or other diseased tissue.
OL = use BUCRYLATE to search ISOBUTYLCYANOACRYLATE 1975-79; use CYANOACRYLATES 1972-74
PM = 91; was see under CYANOACRYLATES 1980-90; was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79
HN = 91(80); was see under CYANOACRYLATES 1980-90; was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002015

*NEWRECORD
RECTYPE = D
MH = Buddhism
AQ = HI PX
ENTRY = Buddhist Ethics|T074|NON|REL|BIOETHICS (1994)|931129|abcdef
ENTRY = Buddhist Ethic
ENTRY = Ethic, Buddhist
ENTRY = Ethics, Buddhist
MN = K01.844.117
MH_TH = BIOETHICS (1993)
MH_TH = POPLINE (1978)
ST = T078
AN = IM; specify geog if pertinent
MS = The teaching ascribed to Gautama Buddha (ca. 483 B.C.) holding that suffering is inherent in life and that one can escape it into nirvana by mental and moral self-purification. (Webster, 3d ed)
MR = 19991103
DA = 19990101
DC = 1
UI = D002016

*NEWRECORD
RECTYPE = D
MH = Budgets
AQ = CL ES HI LJ MT OG SN ST TD UT
PRINT ENTRY = Budgetary Control|T057|NON|NRW|UNK (19XX)|770505|abcdef
ENTRY = Budget
ENTRY = Budgetary Controls
ENTRY = Control, Budgetary
ENTRY = Controls, Budgetary
MN = N03.219.463.060
MH_TH = NLM (1978)
ST = T073
ST = T170
MS = Detailed financial plans for carrying out specific activities for a certain period of time. They include proposed income and expenditures.
PM = 90; was see under FINANCIAL MANAGEMENT 1978-89
HN = 90(78); was see under FINANCIAL MANAGEMENT 1978-89
MR = 19980610
DA = 19770505
DC = 1
DX = 19900101
UI = D002017

*NEWRECORD
RECTYPE = D
MH = Bufanolides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Bufadienolides|T110|NON|NRW|UNK (19XX)|880719|abcdef
MN = D04.808.155.580.064
PA = Cardiotonic Agents
MH_TH = NLM (1968)
ST = T110
RN = 0
AN = includes bufenolides, bufatrienolides
MS = Cyclopentanophenanthrenes with a 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. They are found in BUFONIDAE and often possess cardiotonic properties.
PM = 68
HN = 68
MR = 20060705
DA = 19990101
DC = 1
DX = 19680101
UI = D002018

*NEWRECORD
RECTYPE = D
MH = Bufexamac
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = AHP Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Allergipuran|T109|T121|TRD|NRW|DE|040427|abbcdef
ENTRY = Bioglan Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Bufal|T109|T121|TRD|NRW|FR|040427|abbcdef
ENTRY = Bufederm|T109|T121|TRD|NRW|DE|040427|abbcdef
ENTRY = Bufexamac-ratiopharm|T109|T121|TRD|NRW|DE|040427|abbcdef
ENTRY = Dermapharm Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Droxaryl|T109|T121|TRD|NRW|NL|801120|abbcdef
ENTRY = GALENpharma Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Jomax|T109|T121|TRD|NRW|DE|040427|abbcdef
ENTRY = Malipuran|T109|T121|TRD|NRW|DE|040427|abbcdef
ENTRY = Merck dura Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Paraderm|T109|T121|TRD|NRW|AU|040427|abbcdef
ENTRY = Parfenac|T109|T121|TRD|NRW|DE|FR|NL|040427|abbcdeeef
ENTRY = Pfizer Brand of Bufexamac|T109|T121|NON|NRW|NLM (2011)|100512|abbcdef
ENTRY = Pierre Fabre Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Sanofi Synthelabo Brand of Bufexamac|T109|T121|NON|NRW|NLM (2011)|100512|abbcdef
ENTRY = Scheurich Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Whitehall Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Windol|T109|T121|TRD|NRW|DE|040427|abbcdef
ENTRY = duradermal|T109|T121|TRD|NRW|DE|040427|abbcdef
ENTRY = p-Butoxyphenylacethydroxamic Acid|T109|T121|NON|EQV|UNK (19XX)|810130|abbcdef
ENTRY = ratiopharm Brand of Bufexamac|T109|T121|NON|NRW|NLM (2005)|040427|abbcdef
ENTRY = Bufexamac AHP Brand
ENTRY = Bufexamac Bioglan Brand
ENTRY = Bufexamac Dermapharm Brand
ENTRY = Bufexamac GALENpharma Brand
ENTRY = Bufexamac Pfizer Brand
ENTRY = Bufexamac Scheurich Brand
ENTRY = Bufexamac Whitehall Brand
ENTRY = Bufexamac ratiopharm
ENTRY = Bufexamac ratiopharm Brand
ENTRY = Bufexamacratiopharm
ENTRY = p Butoxyphenylacethydroxamic Acid
MN = D02.065.064.294.088
MN = D02.092.570.394.150
MN = D02.241.511.372.150
MN = D02.455.426.559.389.048.088
PA = Anti-Inflammatory Agents, Non-Steroidal
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Benzeneacetamide, 4-butoxy-N-hydroxy-
RN = 4T3C38J78L
RR = 2438-72-4 (Bufexamac)
PI = Hydroxamic Acids (1971-1974)
PI = Phenylacetates (1971-1974)
MS = A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.
PM = 91; was see under HYDROXAMIC ACIDS 1975-90
HN = 91(75); was see under HYDROXAMIC ACIDS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002019

*NEWRECORD
RECTYPE = D
MH = Buffaloes
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Bubalus|T015|NON|NRW|NLM (1998)|961010|abcdef
PRINT ENTRY = Syncerus|T015|NON|NRW|NLM (1998)|961010|abcdef
PRINT ENTRY = Water Buffaloes|T015|NON|NRW|NLM (1991)|900319|abcdef
ENTRY = Buffalo|T015|NON|EQV|NLM (1991)|900319|abcdef
ENTRY = Water Buffalo|T015|NON|NRW|NLM (1991)|900319|abcdef
ENTRY = Buffalo, Water
MN = B01.050.150.900.649.077.380.135
MH_TH = NLM (1968)
ST = T015
AN = do not confuse with BUFFALO, AMERICAN see BISON; IM; qualif permitted
PI = Artiodactyla (1966-1967)
PI = Cattle (1966-1967)
MS = Ruminants of the family Bovidae consisting of Bubalus arnee and Syncerus caffer. This concept is differentiated from BISON, which refers to Bison bison and Bison bonasus.
PM = 68
HN = 68
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D002020

*NEWRECORD
RECTYPE = D
MH = Buffers
ENTRY = Ampholytes|T123|T130|NON|NRW|UNK (19XX)|800918|abbcdef
MN = D27.720.470.280
MH_TH = NLM (1964)
ST = T123
ST = T130
RN = 0
AN = almost never IM
MS = A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer.
PM = 67
HN = 67(64)
MR = 20030709
DA = 19990101
DC = 1
DX = 19670101
UI = D002021

*NEWRECORD
RECTYPE = D
MH = Bufo arenarum
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Toad, Argentine|T011|NON|EQV|UNK (19XX)|800402|abcdef
ENTRY = Argentine Toad
ENTRY = Argentine Toads
ENTRY = Toads, Argentine
MN = B01.050.150.900.090.180.210.080
MH_TH = NLM (1972)
ST = T011
AN = So. Amer. toad; NIM when exper animal: no qualif; when IM, qualif permitted
PI = Anura (1966-1971)
MS = A species of the true toads, Bufonidae, found in South America.
PM = 72
HN = 72
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D002022

*NEWRECORD
RECTYPE = D
MH = Bufo bufo
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Toad, Common|T011|NON|EQV|UNK (19XX)|800402|abcdef
ENTRY = Common Toad
ENTRY = Common Toads
ENTRY = Toads, Common
MN = B01.050.150.900.090.180.210.108
MH_TH = NLM (1972)
ST = T011
AN = common U.S. & European toad; NIM when exper animal: no qualif; when IM, qualif permitted
PI = Anura (1966-1971)
MS = A species of the true toads, Bufonidae, widely distributed in the United States and Europe.
PM = 72
HN = 72
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D002023

*NEWRECORD
RECTYPE = D
MH = Bufo marinus
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Rhinella marina|T011|NON|EQV|NLM (2013)|120319|abcdef
PRINT ENTRY = Toad, Giant|T011|NON|EQV|UNK (19XX)|800402|abcdef
PRINT ENTRY = Toad, Marine|T011|NON|EQV|UNK (19XX)|800402|abcdef
ENTRY = Giant Toad
ENTRY = Giant Toads
ENTRY = Marine Toad
ENTRY = Marine Toads
ENTRY = Toads, Giant
ENTRY = Toads, Marine
ENTRY = marinas, Rhinella
MN = B01.050.150.900.090.180.210.580
MH_TH = NLM (1972)
ST = T011
AN = NIM with no qualifiers when experimental animal
PI = Anura (1966-1971)
MS = A species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals.
PM = 72
HN = 72
MR = 20120927
DA = 19990101
DC = 1
DX = 19720101
UI = D002024

*NEWRECORD
RECTYPE = D
MH = Bufonidae
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Bufo|T011|NON|NRW|UNK (19XX)|800508|abcdef
PRINT ENTRY = Toads, True|T011|NON|EQV|UNK (19XX)|800508|abcdef
ENTRY = Bufos
ENTRY = Toad, True
ENTRY = True Toad
ENTRY = True Toads
MN = B01.050.150.900.090.180.210
MH_TH = NLM (1972)
ST = T011
AN = toads including genera Bufo, Ansonia, Nectophrynoides & Atelopus; NIM when exper animal: no qualif; when IM, qualif permitted
PI = Anura (1966-1971)
MS = The family of true toads belonging to the order Anura. The genera include Bufo, Ansonia, Nectophrynoides, and Atelopus.
OL = use BUFONIDAE to search BUFO 1972-80
PM = 81; was BUFO 1972-80
HN = 81; was BUFO 1972-80
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D002025

*NEWRECORD
RECTYPE = D
MH = Buformin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Butylbiguanide|T109|T121|NON|EQV|UNK (19XX)|760520|abbcdef
ENTRY = 1-Butylbiguanide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|800821|abbcdeef
ENTRY = Adebit|T109|T121|TRD|NRW|UNK (19XX)|800821|abbcdef
ENTRY = Andromaco Brand of Buformin|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Gliporal|T109|T121|TRD|NRW|MX|040428|abbcdef
ENTRY = Grossmann Brand of Buformin Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Silubin|T109|T121|TRD|NRW|UNK (19XX)|800821|abbcdef
ENTRY = Silubin Retard|T109|T121|TRD|NRW|ES|040428|abbcdef
ENTRY = 1 Butylbiguanide
ENTRY = Buformin Andromaco Brand
ENTRY = Retard, Silubin
MN = D02.078.370.141.075
PA = Hypoglycemic Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1965)
ST = T109
ST = T121
N1 = Imidodicarbonimidic diamide, N-butyl-
RN = W2115E9C7B
RR = 692-13-7 (Buformin)
PI = Biguanides (1968-1974)
PI = Butanes (1973-1974)
MS = An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
PM = 91; was see under BIGUANIDES 1975-90
HN = 91(75); was see under BIGUANIDES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D002026

*NEWRECORD
RECTYPE = D
MH = Bufotenin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Dimethylserotonin|T109|T121|T123|T131|NON|EQV|UNK (19XX)|781215|abbbbcdef
PRINT ENTRY = Mappine|T109|T121|T123|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|781215|abbbbcdeef
ENTRY = 5-Hydroxy-N,N-dimethyltryptamine|T109|T121|T123|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|810210|abbbbcdeef
ENTRY = Bufotenine|T109|T121|T123|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|781215|abbbbcdeef
ENTRY = Mappin|T109|T121|T123|T131|NON|EQV|UNK (19XX)|781215|abbbbcdef
ENTRY = N,N-Dimethyl-5-hydroxytryptamine|T109|T121|T123|T131|NON|EQV|UNK (19XX)|801120|abbbbcdef
ENTRY = 5 Hydroxy N,N dimethyltryptamine
ENTRY = N,N Dimethyl 5 hydroxytryptamine
MN = D03.438.473.914.237.150
MN = D03.438.473.914.814.150
MN = D20.888.033.163
MN = D23.946.833.033.163
PA = Hallucinogens
PA = Serotonin Antagonists
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T123
ST = T131
N1 = 1H-Indol-5-ol, 3-(2-(dimethylamino)ethyl)-
RN = 0A31347TZK
RR = 487-93-4 (Bufotenin)
AN = /biosyn permitted if by toads, mushrooms, etc.
MS = A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic.
OL = search HALLUCINOGENS 1966-74
PM = 91; was see under SEROTONIN 1975-90; was see under HALLUCINOGENS 1966-74
HN = 91(75); was see under SEROTONIN 1975-90; was see under HALLUCINOGENS 1966-74
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002027

*NEWRECORD
RECTYPE = D
MH = Building Codes
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Building Code
ENTRY = Code, Building
ENTRY = Codes, Building
MN = N02.278.200.100
MH_TH = NLM (1984)
ST = T089
AN = coord IM with type of facility (IM)
PI = Facility Design and Construction (1967-1983)
PI = Hospital Design and Construction (1966-1983)
PI = Safety (1975-1983)
MS = Standards or regulations for construction which are designed to ensure safety against electrical hazards, fires, etc.
PM = 91; was see under FACILITY DESIGN AND CONSTRUCTION 1984-90
HN = 91(84); was see under FACILITY DESIGN AND CONSTRUCTION 1984-90
MR = 19920325
DA = 19830606
DC = 1
DX = 19910101
UI = D002028

*NEWRECORD
RECTYPE = D
MH = Bulbourethral Glands
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Cowper's Glands|T023|EPO|EQV|UNK (19XX)|740329|abcdef
ENTRY = Bulbourethral Gland
ENTRY = Cowper Glands
ENTRY = Cowpers Glands
ENTRY = Gland, Bulbourethral
ENTRY = Glands, Bulbourethral
ENTRY = Glands, Cowper's
MN = A05.360.444.123
MN = A10.336.197
MH_TH = NLM (1966)
ST = T023
MS = Glands situated on each side of the prostate that secrete a fluid component of the seminal fluid into the urethra.
MR = 19991103
DA = 19990101
DC = 1
UI = D002030

*NEWRECORD
RECTYPE = D
MH = Bulgaria
AQ = EH EP
MN = Z01.542.248.180
MH_TH = POPLINE (1978)
ST = T083
AN = in translations of historical articles use spelling People's Republic, not Peoples' nor Peoples
MR = 19920507
DA = 19990101
DC = 4
UI = D002031

*NEWRECORD
RECTYPE = D
MH = Bulimia
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Binge Eating|T184|NON|EQV|NLM (2001)|991209|abcdef
ENTRY = Bulimias
ENTRY = Eating, Binge
MN = C23.888.821.645.500
FX = Bulimia Nervosa
MH_TH = NLM (1987)
ST = T184
AN = BULIMIA NERVOSA is also available
PI = Hyperphagia (1981-1986)
MS = Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as "ox hunger".
OL = search HYPERPHAGIA 1981-86
PM = 87; was see HYPERPHAGIA 1981-86
HN = 87; was see HYPERPHAGIA 1981-86
CATSH = CAT LIST
MR = 20050630
DA = 19860530
DC = 1
DX = 19870101
UI = D002032

*NEWRECORD
RECTYPE = D
MH = Bulinus
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
MN = B01.050.500.644.400.750.323
MH_TH = NLM (1972)
ST = T204
AN = freshwater snail; /microbiol /parasitol /virol permitted
PI = Snails (1966-1971)
MS = A genus of small freshwater snails of the order Pulmonata, found throughout Africa and the Middle East, where it is a vector of SCHISTOSOMA HAEMATOBIUM.
PM = 72
HN = 72
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D002033

*NEWRECORD
RECTYPE = D
MH = Bumetanide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = AstraZeneca Brand of Bumetanide|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Atlantis Brand of Bumetanide|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Bumedyl|T109|T121|TRD|NRW|MX|040428|abbcdef
ENTRY = Bumethanide|T109|T121|NON|EQV|UNK (19XX)|850103|abbcdef
ENTRY = Bumex|T109|T121|TRD|NRW|US|040428|abbcdef
ENTRY = Burinex|T109|T121|TRD|NRW|AU|CA|DE|FR|IE|NL|040428|abbcdeeeeeef
ENTRY = Drenural|T109|T121|TRD|NRW|MX|040428|abbcdef
ENTRY = Farmacusi Brand of Bumetanide|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Fordiuran|T109|T121|TRD|NRW|ES|040428|abbcdef
ENTRY = Grossmann Brand of Bumetanide|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Leo Brand of Bumetanide|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Miccil|T109|T121|TRD|NRW|MX|040428|abbcdef
ENTRY = PF-1593|T109|T121|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Roche Brand of Bumetanide|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Senosiain Brand of Bumetanide|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Bumetanide AstraZeneca Brand
ENTRY = Bumetanide Atlantis Brand
ENTRY = Bumetanide Farmacusi Brand
ENTRY = Bumetanide Grossmann Brand
ENTRY = Bumetanide Leo Brand
ENTRY = Bumetanide Roche Brand
ENTRY = Bumetanide Senosiain Brand
ENTRY = PF 1593
ENTRY = PF1593
MN = D02.065.884.150
MN = D02.241.223.100.050.300.200
MN = D02.455.426.559.389.127.020.452.500
MN = D02.886.590.700.150
PA = Diuretics
PA = Sodium Potassium Chloride Symporter Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1976)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-
RN = 0Y2S3XUQ5H
RR = 28395-03-1 (Bumetanide)
PI = Benzoates (1974)
PI = Butylamines (1974)
PI = Diuretics, Sulfamyl (1974)
PI = Phenyl Ethers (1974)
MS = A sulfamyl diuretic.
PM = 91; was see under DIURETICS, SULFAMYL 1975-90
HN = 91(75); was see under DIURETICS, SULFAMYL 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002034

*NEWRECORD
RECTYPE = D
MH = Bunaftine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Bunaphtide|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770418|abbcdeef
ENTRY = Bunaftide|T109|T121|NON|EQV|UNK (19XX)|770418|abbcdef
ENTRY = Bunaphtine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|770418|abbcdeef
MN = D02.455.426.559.847.638.120
MN = D04.615.638.120
PA = Anti-Arrhythmia Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 1-Naphthalenecarboxamide, N-butyl-N-(2-(diethylamino)ethyl)-
RN = GH09PRQ3FU
RR = 32421-46-8 (Bunaftine)
AN = an anti-arrhythmic
PI = Butylamines (1966-1977)
PI = Naphthalenes (1966-1977)
MS = N-Butyl-N-(2-(diethylamino)ethyl)-1-naphthamide. A proposed antiarrhythmic that prolongs myocardial refractory period and stabilizes cell membranes.
PM = 91; was see under NAPHTHALENES 1978-90
HN = 91(78); was see under NAPHTHALENES 1978-90
MR = 20130708
DA = 19770422
DC = 1
DX = 19910101
UI = D002035

*NEWRECORD
RECTYPE = D
MH = Bundle of His
AQ = AB AH CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Atrioventricular Bundle|T023|NON|EQV|UNK (19XX)|850311|abcdef
ENTRY = Anterior Fascicle|T023|NON|NRW|NLM (2008)|060921|abcdef
ENTRY = Kent-His Bundle|T023|EPO|EQV|NLM (2011)|100326|abcdef
ENTRY = Left Bundle Branch of His|T023|EPO|NRW|NLM (2008)|060921|abcdef
ENTRY = Posterior Fascicle|T023|NON|NRW|NLM (2008)|060921|abcdef
ENTRY = Right Bundle Branch of His|T023|EPO|NRW|NLM (2008)|060921|abcdef
ENTRY = Atrioventricular Bundles
ENTRY = Bundle, Atrioventricular
ENTRY = Bundle, Kent-His
ENTRY = Bundles, Atrioventricular
ENTRY = Fascicle, Anterior
ENTRY = Fascicle, Posterior
ENTRY = His Bundle
ENTRY = Kent His Bundle
MN = A07.541.409.273
FX = Bundle-Branch Block
MH_TH = NLM (1975)
ST = T023
MS = Small band of specialized CARDIAC MUSCLE fibers that originates in the ATRIOVENTRICULAR NODE and extends into the membranous part of the interventricular septum. The bundle of His, consisting of the left and the right bundle branches, conducts the electrical impulses to the HEART VENTRICLES in generation of MYOCARDIAL CONTRACTION.
OL = search HEART CONDUCTION SYSTEM 1966-74
PM = 91; was see under HEART CONDUCTION SYSTEM 1975-90
HN = 91(75); was see under HEART CONDUCTION SYSTEM 1975-90
MR = 20100625
DA = 19990101
DC = 1
DX = 19910101
UI = D002036

*NEWRECORD
RECTYPE = D
MH = Bundle-Branch Block
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Fascicular Block|T047|NON|NRW|UNK (19XX)|800324|abcdef
ENTRY = Anterior Fascicular Block|T046|NON|NRW|NLM (2008)|060921|abcdef
ENTRY = Bundle Branch Block|T046|NON|EQV|OMIM (2013)|120131|abcdef
ENTRY = Left Bundle-Branch Block|T046|NON|NRW|NLM (2008)|060921|abcdef
ENTRY = Posterior Fascicular Block|T046|NON|NRW|NLM (2008)|060921|abcdef
ENTRY = Right Bundle-Branch Block|T046|NON|NRW|NLM (2008)|060921|abcdef
ENTRY = Anterior Fascicular Blocks
ENTRY = Block, Anterior Fascicular
ENTRY = Block, Bundle Branch
ENTRY = Block, Bundle-Branch
ENTRY = Block, Fascicular
ENTRY = Block, Left Bundle-Branch
ENTRY = Block, Posterior Fascicular
ENTRY = Block, Right Bundle-Branch
ENTRY = Blocks, Anterior Fascicular
ENTRY = Blocks, Bundle Branch
ENTRY = Blocks, Bundle-Branch
ENTRY = Blocks, Fascicular
ENTRY = Blocks, Left Bundle-Branch
ENTRY = Blocks, Posterior Fascicular
ENTRY = Blocks, Right Bundle-Branch
ENTRY = Branch Block, Bundle
ENTRY = Branch Blocks, Bundle
ENTRY = Bundle Branch Blocks
ENTRY = Bundle-Branch Block, Left
ENTRY = Bundle-Branch Block, Right
ENTRY = Bundle-Branch Blocks
ENTRY = Bundle-Branch Blocks, Left
ENTRY = Bundle-Branch Blocks, Right
ENTRY = Fascicular Block, Anterior
ENTRY = Fascicular Block, Posterior
ENTRY = Fascicular Blocks
ENTRY = Fascicular Blocks, Anterior
ENTRY = Fascicular Blocks, Posterior
ENTRY = Left Bundle Branch Block
ENTRY = Left Bundle-Branch Blocks
ENTRY = Posterior Fascicular Blocks
ENTRY = Right Bundle Branch Block
ENTRY = Right Bundle-Branch Blocks
MN = C14.280.067.558.323
MN = C23.550.073.425.100
FX = Bundle of His
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T046
MS = A form of heart block in which the electrical stimulation of HEART VENTRICLES is interrupted at either one of the branches of BUNDLE OF HIS thus preventing the simultaneous depolarization of the two ventricles.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002037

*NEWRECORD
RECTYPE = D
MH = Bungarotoxins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = alpha-Bungarotoxin|T131|NON|NRW|UNK (19XX)|810108|abcdef
ENTRY = beta-Bungarotoxin|T131|NON|NRW|UNK (19XX)|810108|abcdef
ENTRY = kappa-Bungarotoxin|T131|NON|NRW|UNK (19XX)|831209|abcdef
ENTRY = alpha Bungarotoxin
ENTRY = beta Bungarotoxin
ENTRY = kappa Bungarotoxin
MN = D20.888.850.325.139
MN = D23.946.833.850.325.139
MH_TH = NLM (1974)
ST = T131
RN = 0
AN = from the krait, a snake; /antag permitted but consider also ANTIVENINS; alpha-bungarotoxin & beta-bungarotoxin go here
MS = Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms.
PM = 74
HN = 74(73)
MR = 20050630
DA = 19990101
DC = 1
DX = 19740101
UI = D002038

*NEWRECORD
RECTYPE = D
MH = Levobunolol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = AKBeta|T109|T121|TRD|NRW|US|040330|abbcdef
ENTRY = Akorn Brand of Levobunolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040330|abbcdef
ENTRY = Allergan Brand of Levobunolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040330|abbcdef
ENTRY = Apo-Levobunolol|T109|T121|TRD|NRW|CA|040330|abbcdef
ENTRY = Apotex Brand of Levobunolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040330|abbcdef
ENTRY = Betagan|T109|T121|TRD|NRW|AU|CA|ES|FR|MX|NL|UK|US|950525|abbcdeeeeeeeef
ENTRY = Ciba Vision Brand of Levobunolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040330|abbcdef
ENTRY = Levobunolol Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1979)|USP (19XX)|941130|abbcdeeef
ENTRY = Novo-Levobunolol|T109|T121|TRD|NRW|CA|040330|abbcdef
ENTRY = Novopharm Brand of Levobunolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040330|abbcdef
ENTRY = PMS-Levobunolol|T109|T121|TRD|NRW|CA|040330|abbcdef
ENTRY = Pharm-Allergan Brand of Levobunolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040330|abbcdef
ENTRY = Pharmascience Brand of Levobunolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040330|abbcdef
ENTRY = Ratiopharm Brand of Levobunolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040330|abbcdef
ENTRY = Ultracortenol|T109|T121|TRD|NRW|DE|040330|abbcdef
ENTRY = Vistagan|T109|T121|TRD|NRW|DE|040330|abbcdef
ENTRY = W-7000A|T109|T121|LAB|NRW|NLM (1991)|900416|abbcdef
ENTRY = ratio-Levobunolol|T109|T121|TRD|NRW|CA|040330|abbcdef
ENTRY = Apo Levobunolol
ENTRY = ApoLevobunolol
ENTRY = Novo Levobunolol
ENTRY = NovoLevobunolol
ENTRY = PMS Levobunolol
ENTRY = PMSLevobunolol
ENTRY = Pharm Allergan Brand of Levobunolol Hydrochloride
ENTRY = W 7000A
ENTRY = W7000A
ENTRY = ratio Levobunolol
MN = D02.033.100.624.698.115.500
MN = D02.033.755.624.698.115.500
MN = D02.092.063.624.698.115.500
MN = D02.455.426.559.847.638.960.446.500
MN = D04.615.638.960.446.500
PA = Adrenergic beta-Antagonists
PA = Sympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1972)
ST = T109
ST = T121
N1 = 1(2H)-Naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, (S)-
RN = G6317AOI7K
RR = 27912-14-7 (Levobunolol HCl)
RR = 47141-42-4 (Levobunolol)
RR = O90S49LDHH
PI = Amino Alcohols (1966-1971)
PI = Sympatholytics (1966-1971)
MS = The L-Isomer of bunolol.
OL = use LEVOBUNOLOL to search BUNOLOL 1972-90 (as Prov 1972)
PM = 91; was BUNOLOL 1973-90
HN = 91(72); was BUNOLOL 1972-90 (Prov 1972)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D002040

*NEWRECORD
RECTYPE = D
MH = Bunyamwera virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Batai virus|T005|EPO|NRW|NLM (2002)|010417|abcdef
PRINT ENTRY = Cache Valley virus|T005|EPO|NRW|NLM (1998)|970429|abcdef
PRINT ENTRY = Calovo virus|T005|EPO|NRW|UNK (19XX)|741211|abcdef
PRINT ENTRY = Chittoor virus|T005|EPO|NRW|UNK (19XX)|741211|abcdef
ENTRY = Bunyamwera Group Viruses|T005|EPO|BRD|NLM (1975)|990101|abcdef
MN = B04.820.087.640.147
MH_TH = UNK (19XX)
ST = T005
AN = infection: coord IM with BUNYAVIRIDAE INFECTIONS (IM)
MS = A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. A large number of serotypes or strains exist in many parts of the world. They are transmitted by mosquitoes and infect humans in some areas.
PM = 2002; see BUNYAMWERA VIRUS GROUP 1991-2001, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-80
HN = 2002 (1975)
MR = 20150622
DA = 19741212
DC = 1
DX = 19910101
UI = D002042

*NEWRECORD
RECTYPE = D
MH = Bunyaviridae
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
MN = B04.820.087
MH_TH = NLM (1981)
ST = T005
AN = from BUNYAmwera, an African place name; infection = BUNYAVIRIDAE INFECTIONS
PI = Arboviruses (1966-1980)
PI = Bunyamwera Group Viruses (1975-1980)
MS = A family of viruses, mainly arboviruses, consisting of a single strand of RNA. Virions are enveloped particles 90-120 nm diameter. The complete family contains over 300 members arranged in five genera: ORTHOBUNYAVIRUS; HANTAVIRUS; NAIROVIRUS; PHLEBOVIRUS; and TOSPOVIRUS.
PM = 81
HN = 81
MR = 20150622
DA = 19800521
DC = 1
DX = 19810101
UI = D002043

*NEWRECORD
RECTYPE = D
MH = Bunyaviridae Infections
DE = BUNYAVIRIDAE INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Bunyavirus Infections|T047|NON|NRW|NLM (1992)|910307|BUNYAVIRUS INFECT|abcdefv
ENTRY = Infections, Bunyaviridae|T047|NON|EQV|NLM (1992)|910307|INFECT BUNYAVIRIDAE|abcdefv
ENTRY = Infections, Bunyavirus|T047|NON|NRW|NLM (1992)|910307|INFECT BUNYAVIRUS|abcdefv
ENTRY = Bunyaviridae Infection
ENTRY = Bunyavirus Infection
MN = C02.782.147
MH_TH = NLM (1981)
ST = T047
AN = GEN or unspecified; prefer specifics
PI = Arbovirus Infections (1966-1980)
MS = Virus diseases caused by the BUNYAVIRIDAE.
OL = use BUNYAVIRIDAE INFECTIONS to search BUNYAVIRUS INFECTIONS 1981-91
PM = 92; was BUNYAVIRUS INFECTIONS 1981-91
HN = 92; was BUNYAVIRUS INFECTIONS 1981-91
CATSH = CAT LIST
MR = 19960610
DA = 19800513
DC = 1
DX = 19810101
UI = D002044

*NEWRECORD
RECTYPE = D
MH = Bupivacaine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|T109|T121|NON|EQV|NLM (1998)|961112|abbcdef
ENTRY = Abbott Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Astra Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = AstraZeneca Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Aventis Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Braun Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Bupivacain Janapharm|T109|T121|TRD|NRW|DE|040428|abbcdef
ENTRY = Bupivacain-RPR|T109|T121|TRD|NRW|DE|040428|abbcdef
ENTRY = Bupivacaina Braun|T109|T121|TRD|NRW|ES|040428|abbcdef
ENTRY = Bupivacaine Anhydrous|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Bupivacaine Carbonate|T109|T121|NON|NRW|UNK (19XX)|810427|abbcdef
ENTRY = Bupivacaine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|JAN (19XX)|USAN (1967)|USP (19XX)|930201|abbcdeeeef
ENTRY = Bupivacaine Monohydrochloride, Monohydrate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Buvacaina|T109|T121|TRD|NRW|MX|040428|abbcdef
ENTRY = Carbostesin|T109|T121|TRD|NRW|DE|961112|abbcdef
ENTRY = Dolanaest|T109|T121|TRD|NRW|DE|040428|abbcdef
ENTRY = Inibsa Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Jenapharm Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Marcain|T109|T121|TRD|NRW|AU|UK|040428|abbcdeef
ENTRY = Marcaine|T109|T121|TRD|NRW|CA|FR|NL|040428|abbcdeeef
ENTRY = Pisa Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Sensorcaine|T109|T121|TRD|NRW|CA|US|040428|abbcdeef
ENTRY = Strathmann Brand of Bupivacaine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = Svedocain Sin Vasoconstr|T109|T121|TRD|NRW|ES|040428|abbcdef
ENTRY = Anhydrous, Bupivacaine
ENTRY = Braun, Bupivacaina
ENTRY = Bupivacain RPR
ENTRY = Carbonate, Bupivacaine
ENTRY = Hydrochloride, Bupivacaine
ENTRY = Janapharm, Bupivacain
MN = D02.065.199.239
MN = D03.383.621.758.323
PA = Anesthetics, Local
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (19XX)
ST = T109
ST = T121
N1 = 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-
RN = Y8335394RO
RR = 14252-80-3 (mono-HCl, monohydrate)
RR = 18010-40-7 (anhydrous)
RR = 2180-92-9 (Bupivacaine)
RR = 7TQO7W3VT8
PI = Anesthetics, Local (1966-1970)
MS = A widely used local anesthetic agent.
PM = 73
HN = 73(71)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D002045

*NEWRECORD
RECTYPE = D
MH = Bupranolol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Betadrenol|T109|T121|TRD|NRW|DE|800917|abbcdef
ENTRY = Desma Brand of Bupranolol Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040428|abbcdef
ENTRY = KL-255|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = KL 255
ENTRY = KL255
MN = D02.033.100.624.698.146
MN = D02.033.755.624.698.146
MN = D02.092.063.624.698.146
PA = Adrenergic beta-Antagonists
PA = Anti-Arrhythmia Agents
PA = Antihypertensive Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 2-Propanol, 1-(2-chloro-5-methylphenoxy)-3-((1,1-dimethylethyl)amino)-, hydrochloride, (+-)-
RN = 858YGI5PIT
RR = 23284-25-5 (Bupranolol)
PI = Amino Alcohols (1966-1974)
PI = Propanolamines (1974-1978)
MS = An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
PM = 91; was see under PROPANOLAMINES 1979-90
HN = 91(79); was see under PROPANOLAMINES 1979-90
MR = 20130708
DA = 19780201
DC = 1
DX = 19910101
UI = D002046

*NEWRECORD
RECTYPE = D
MH = Buprenorphine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 6029-M|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Buprenex|T109|T121|TRD|NRW|US|861119|abbcdef
ENTRY = Buprenorphine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1976)|USP (19XX)|941129|abbcdeeef
ENTRY = Buprex|T109|T121|TRD|NRW|ES|US|040504|abbcdeef
ENTRY = Essex Brand of Buprenorphine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040504|abbcdef
ENTRY = Grnenthal Brand of Buprenorphine|T109|T121|NON|NRW|NLM (2005)|040504|abbcdef
ENTRY = Grnenthal Brand of Buprenorphine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040504|abbcdef
ENTRY = Key Brand of Buprenorphine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040504|abbcdef
ENTRY = Prefin|T109|T121|TRD|NRW|ES|040504|abbcdef
ENTRY = RX-6029-M|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Reckitt & Colman Brand 1 of Buprenorphine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040504|abbcdef
ENTRY = Reckitt & Colman Brand 2 of Buprenorphine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|050307|abbcdef
ENTRY = Reckitt Benckiser Brand of Buprenorphine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040504|abbcdef
ENTRY = Reckitt Brand of Buprenorphine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040504|abbcdef
ENTRY = Schering-Plough Brand of Buprenorphine Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040504|abbcdef
ENTRY = Subutex|T109|T121|TRD|NRW|DE|ES|FR|UK|US|040504|abbcdeeeeef
ENTRY = Temgesic|T109|T121|TRD|NRW|AU|DE|IE|MX|NL|UK|820519|abbcdeeeeeef
ENTRY = Temgsic|T109|T121|TRD|NRW|FR|040504|abbcdef
ENTRY = 6029 M
ENTRY = 6029M
ENTRY = Buprenorphine Grnenthal Brand
ENTRY = Hydrochloride, Buprenorphine
ENTRY = RX 6029 M
ENTRY = RX6029M
ENTRY = Schering Plough Brand of Buprenorphine Hydrochloride
MN = D03.132.577.249.150
MN = D03.549.686.150
MN = D03.605.497.150
MN = D04.615.723.795.150
PA = Analgesics, Opioid
PA = Narcotic Antagonists
PA = Narcotics
FX = Opiate Substitution Treatment
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))-
RN = 40D3SCR4GZ
RR = 52485-79-7 (Buprenorphine)
RR = 53152-21-9 (HCl)
RR = 56W8MW3EN1
AN = for buprenorphine maintenance treatment, coordinate with OPIATE SUBSTITUTION TREATMENT
PI = Dihydromorphinone (1966-1968)
PI = Morphinans (1969-1978)
PI = Morphine (1966-1968)
MS = A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.
PM = 87; was see under MORPHINANS 1979-86
HN = 87(79); was see under MORPHINANS 1979-86
MR = 20130708
DA = 19780317
DC = 1
DX = 19870101
UI = D002047

*NEWRECORD
RECTYPE = D
MH = Burial
AQ = EC ES HI LJ MT SN ST
ENTRY = Burials
MN = I01.076.201.450.550.150
MH_TH = NLM (1975)
ST = T052
MS = The act or ceremony of putting a corpse into the ground or a vault, or into the sea; or the inurnment of CREMAINS.
OL = search MORTUARY PRACTICE 1966-74
PM = 91; was see under MORTUARY PRACTICE 1975-90
HN = 91(75); was see under MORTUARY PRACTICE 1975-90
MR = 20081016
DA = 19990101
DC = 1
DX = 19910101
UI = D002048

*NEWRECORD
RECTYPE = D
MH = Burimamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.886.904.200
MN = D02.948.898.200
PA = Anti-Ulcer Agents
PA = Histamine H2 Antagonists
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Thiourea, N-(4-(1H-imidazol-4-yl)butyl)-N'-methyl-
RN = TN5A4OD2TV
RR = 34970-69-9 (Burimamide)
PI = Imidazoles (1972-1974)
PI = Thiourea (1972-1974)
MS = An antagonist of histamine that appears to block both H2 and H3 histamine receptors. It has been used in the treatment of ulcers.
PM = 91; was see under THIOUREA 1975-90
HN = 91(75); was see under THIOUREA 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D002049

*NEWRECORD
RECTYPE = D
MH = Burkina Faso
AQ = EH EP
PRINT ENTRY = Upper Volta|T083|NAM|EQV|UNK (19XX)|850507|abcdef
ENTRY = Burkina Fasso|T083|NAM|EQV|UNK (19XX)|850507|abcdef
MN = Z01.058.290.190.245
MH_TH = NLM (1986)
ST = T083
MS = A republic in western Africa, south and east of MALI and west of NIGER. Its capital is Ouagadougou. It was formerly called Upper Volta until 1984.
HN = 1986; was UPPER VOLTA 1963-1985
MR = 20080708
DA = 19990101
DC = 4
UI = D002050

*NEWRECORD
RECTYPE = D
MH = Burkitt Lymphoma
AQ = BL CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UL UR US VE VI
PRINT ENTRY = African Lymphoma|T191|EPO|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Burkitt Cell Leukemia|T191|EPO|EQV|NLM (2008)|061020|abcdef
PRINT ENTRY = Burkitt Tumor|T191|EPO|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Lymphoma, Burkitt|T191|EPO|EQV|UNK (19XX)|740329|abcdef
ENTRY = Burkitt Leukemia|T191|EPO|EQV|UNK (19XX)|880609|abcdef
ENTRY = Burkitt's Leukemia|T191|EPO|EQV|NLM (1998)|960930|abcdef
ENTRY = Burkitt's Lymphoma|T191|EPO|EQV|NLM (1998)|ORD (2010)|961003|abcdeef
ENTRY = Burkitt's Tumor|T191|EPO|EQV|NLM (1998)|961003|abcdef
ENTRY = Leukemia, Lymphoblastic, Burkitt-Type|T191|EPO|EQV|UNK (19XX)|880609|abcdef
ENTRY = Leukemia, Lymphocytic, L3|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Lymphocytic Leukemia, L3|T191|NON|EQV|UNK (19XX)|880609|abcdef
ENTRY = Burkitts Leukemia
ENTRY = Burkitts Lymphoma
ENTRY = Burkitts Tumor
ENTRY = Cell Leukemia, Burkitt
ENTRY = L3 Lymphocytic Leukemia
ENTRY = L3 Lymphocytic Leukemias
ENTRY = Leukemia, Burkitt
ENTRY = Leukemia, Burkitt Cell
ENTRY = Leukemia, Burkitt's
ENTRY = Leukemia, L3 Lymphocytic
ENTRY = Leukemias, L3 Lymphocytic
ENTRY = Lymphocytic Leukemias, L3
ENTRY = Lymphoma, African
ENTRY = Lymphoma, Burkitt's
ENTRY = Tumor, Burkitt
ENTRY = Tumor, Burkitt's
MN = C02.256.466.313.165
MN = C02.928.313.165
MN = C04.557.386.480.150.165
MN = C15.604.515.569.480.150.165
MN = C20.683.515.761.480.150.165
MH_TH = NLM (1968)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T191
MS = A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
PM = 1998; see BURKITT'S LYMPHOMA 1968-1997; for LEUKEMIA, B-CELL, ACUTE & BURKITT LEUKEMIA see LEUKEMIA, B-CELL, ACUTE 1989-2007; for BURKITT TUMOR see BURKITT'S TUMOR 1968-1997; for LYMPHOMA, BURKITT see LYMPHOMA, BURKITT'S 1968-1997
HN = 1998 (1968)
CATSH = CAT LIST
MR = 20150601
DA = 19990101
DC = 1
DX = 19680101
UI = D002051

*NEWRECORD
RECTYPE = D
MH = Myanmar
AQ = EH EP
PRINT ENTRY = Burma|T083|NAM|EQV|NLM (1993)|910926|abcdef
ENTRY = Myanma|T083|NAM|EQV|NLM (1993)|910926|abcdef
MN = Z01.252.145.570
MH_TH = POPLINE (1986)
ST = T083
AN = capital Rangoon became Yangon when Burma became Myanmar in 1989.
MS = A republic of southeast Asia, northwest of Thailand, long familiar as Burma. Its capital is Yangon, formerly Rangoon. Inhabited by people of Mongolian stock and probably of Tibetan origin, by the 3d century A.D. it was settled by Hindus. The modern Burmese state was founded in the 18th century but was in conflict with the British during the 19th century. Made a crown colony of Great Britain in 1937, it was granted independence in 1947. In 1989 it became Myanmar. The name comes from myanma, meaning the strong, as applied to the Burmese people themselves. (From Webster's New Geographical Dictionary, 1988, p192 & Room, Brewer's Dictionary of Names, 1992, p367)
OL = use MYANMAR to search BURMA 1968-92
HN = 93; was BURMA 1968-92
MR = 19950608
DA = 19990101
DC = 4
UI = D002052

*NEWRECORD
RECTYPE = D
MH = Burn Units
AQ = CL EC ES HI LJ MA OG SD SN ST TD UT
PRINT ENTRY = Burn Centers|T093|NON|BRD|UNK (19XX)|810226|abcdef
ENTRY = Burn Center
ENTRY = Burn Unit
ENTRY = Center, Burn
ENTRY = Centers, Burn
ENTRY = Unit, Burn
ENTRY = Units, Burn
MN = N02.278.388.493.160
MH_TH = NLM (1982)
ST = T073
ST = T093
PI = Intensive Care Units (1966-1981)
MS = Specialized hospital facilities which provide intensive care for burn patients.
PM = 91; was see under INTENSIVE CARE UNITS 1982-90
HN = 91(82); was see under INTENSIVE CARE UNITS 1982-90
MR = 19920325
DA = 19810226
DC = 1
DX = 19910101
UI = D002053

*NEWRECORD
RECTYPE = D
MH = Burning Mouth Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Burning Mouth Syndromes
ENTRY = Mouth Syndrome, Burning
ENTRY = Mouth Syndromes, Burning
ENTRY = Syndrome, Burning Mouth
ENTRY = Syndromes, Burning Mouth
MN = C07.465.114
MH_TH = NLM (1968)
MH_TH = ORD (2010)
ST = T047
AN = "painful oral symptoms assoc with a burning sensation"
PI = Mouth Diseases (1966-1967)
MS = A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.
PM = 91; was see under MOUTH DISEASES 1968-90
HN = 91(68); was see under MOUTH DISEASES 1968-90
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19910101
UI = D002054

*NEWRECORD
RECTYPE = D
MH = Burnout, Professional
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Professional Burnout
MN = C24.198
MN = F02.830.900.110
MH_TH = NLM (1983)
ST = T048
PI = Stress, Psychological (1969-1982)
MS = An excessive stress reaction to one's occupational or professional environment. It is manifested by feelings of emotional and physical exhaustion coupled with a sense of frustration and failure.
PM = 90; was see under STRESS, PSYCHOLOGICAL 1983-89
HN = 90(83); was see under STRESS, PSYCHOLOGICAL 1983-89
CATSH = CAT LIST
MR = 20150707
DA = 19820427
DC = 1
DX = 19900101
UI = D002055

*NEWRECORD
RECTYPE = D
MH = Burns
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Burn
MN = C26.200
EC = chemically induced:Burns, Chemical
MH_TH = BIOETHICS (1974)
MH_TH = POPLINE (1978)
ST = T037
AN = GEN; "thermal injury"; EYE BURNS & SUNBURN are also available; burn shock: coord IM with SHOCK, TRAUMATIC (IM)
MS = Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002056

*NEWRECORD
RECTYPE = D
MH = Burns, Chemical
DE = BURNS CHEM
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Chemical Burns|T037|NON|EQV|UNK (19XX)|860101|CHEM BURNS|abcdefv
ENTRY = Burn, Chemical
ENTRY = Chemical Burn
MN = C26.200.156
MH_TH = NLM (1966)
ST = T037
AN = chem eye burns = BURNS, CHEMICAL (IM) + EYE BURNS /chem ind (IM)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002057

*NEWRECORD
RECTYPE = D
MH = Burns, Electric
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Electric Burns|T037|NON|EQV|NLM (1992)|901017|abcdef
ENTRY = Burn, Electric
ENTRY = Electric Burn
MN = C26.200.239
MN = C26.324.323
MH_TH = NLM (1966)
ST = T037
MS = Burns produced by contact with electric current or from a sudden discharge of electricity.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002058

*NEWRECORD
RECTYPE = D
MH = Burns, Inhalation
DE = BURNS INHAL
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Inhalation Burns|T037|NON|EQV|UNK (19XX)|880502|INHAL BURNS|abcdefv
ENTRY = Burn, Inhalation
ENTRY = Inhalation Burn
MN = C26.200.322
MH_TH = NLM (1966)
ST = T037
AN = resp tract burns from heat or chemicals; SMOKE INHALATION INJURY is also available
MS = Burns of the respiratory tract caused by heat or inhaled chemicals.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002059

*NEWRECORD
RECTYPE = D
MH = Bursa of Fabricius
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Fabricius Bursa
MN = A10.549.175
MN = A13.163
MN = A15.382.520.604.114
MH_TH = NLM (1965)
ST = T023
MS = An epithelial outgrowth of the cloaca in birds similar to the thymus in mammals. It atrophies within 6 months after birth and remains as a fibrous remnant in adult birds. It is composed of lymphoid tissue and prior to involution, is the site of B-lymphocyte maturation.
PM = 66
HN = 66(65)
MR = 20030709
DA = 19990101
DC = 1
DX = 19660101
UI = D002060

*NEWRECORD
RECTYPE = D
MH = Bursa, Synovial
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Bursas, Synovial
ENTRY = Synovial Bursa
ENTRY = Synovial Bursas
MN = A02.835.583.156
MH_TH = NLM (1965)
ST = T023
AN = inflammation = BURSITIS
MS = A fluid-filled sac lined with SYNOVIAL MEMBRANE that provides a cushion between bones, tendons and/or muscles around a joint.
PM = 65
HN = 65
MR = 20150616
DA = 19990101
DC = 1
DX = 19650101
UI = D002061

*NEWRECORD
RECTYPE = D
MH = Bursitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Adhesive Capsulitis|T047|NON|NRW|NLM (1995)|931215|abcdef
PRINT ENTRY = Capsulitis, Adhesive|T047|NON|NRW|NLM (1995)|931215|abcdef
PRINT ENTRY = Frozen Shoulder|T047|NON|REL|NLM (2010)|081205|abcdef
ENTRY = Adhesive Capsulitides
ENTRY = Bursitides
ENTRY = Capsulitides, Adhesive
MN = C05.550.251
MH_TH = NLM (1966)
ST = T047
AN = coordinate IM with specific joint IM
MS = Inflammation or irritation of a bursa, the fibrous sac that acts as a cushion between moving structures of bones, muscles, tendons or skin.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D002062

*NEWRECORD
RECTYPE = D
MH = Burundi
AQ = EH EP
PRINT ENTRY = Republic of Burundi|T083|NAM|EQV|NLM (2009)|080304|abcdef
PRINT ENTRY = Urundi|T083|NAM|EQV|NLM (1998)|960816|abcdef
MN = Z01.058.290.120.180
MH_TH = NLM (1978)
ST = T083
MS = A republic in eastern Africa bounded on the north by RWANDA and on the south by TANZANIA. Its capital is Bujumbura.
MR = 20080708
DA = 19990101
DC = 4
UI = D002063

*NEWRECORD
RECTYPE = D
MH = Buserelin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aventis Brand of Buserelin Acetate|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Bigonist|T109|T121|TRD|NRW|FR|040513|abbcdef
ENTRY = Buserelin Acetate|T116|T121|NON|NRW|FDA SRS (2014)|NLM (1992)|USAN (1979)|910104|abbcdeeef
ENTRY = Galenpharma Brand of Buserelin Acetate|T109|T121|NON|NRW|NLM (2012)|110620|abbcdef
ENTRY = HOE-766|T116|T121|LAB|NRW|UNK (19XX)|830404|abbcdef
ENTRY = Hoechst Brand of Buserelin Acetate|T116|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Intervet Brand of Buserelin Acetate|T116|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Profact|T109|T121|TRD|NRW|DE|040513|abbcdef
ENTRY = Receptal|T116|T121|TRD|NRW|AU|DE|FR|850528|abbcdeeef
ENTRY = Sanofi-Aventis Brand of Buserelin Acetate|T109|T121|NON|NRW|NLM (2012)|110620|abbcdef
ENTRY = Suprecur|T109|T121|TRD|NRW|DE|IE|NL|040513|abbcdeeef
ENTRY = Suprefact|T109|T121|TRD|NRW|CA|ES|FR|IE|NL|040513|abbcdeeeeef
ENTRY = Tiloryth|T116|T121|TRD|NRW|DE|040513|abbcdef
ENTRY = Acetate, Buserelin
ENTRY = HOE 766
ENTRY = HOE766
ENTRY = Sanofi Aventis Brand of Buserelin Acetate
MN = D06.472.699.327.740.320.100
MN = D12.644.400.400.740.320.100
MN = D12.644.456.460.150
MN = D12.644.548.365.740.320.100
MN = D12.776.641.650.405.740.320.100
PA = Fertility Agents, Female
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T116
ST = T121
N1 = Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-
RN = PXW8U3YXDV
RR = 13U86G7YSP
RR = 57982-77-1 (Buserelin)
RR = 68630-75-1 (Buserelin Acetate)
PI = FSH (1966-1973)
PI = LH (Luteinizing Hormone) (1966-1973)
PI = LH-FSH Releasing Hormone/analogs & derivatives (1974-1983)
PI = Pituitary Hormone Releasing Hormones (1968-1973)
MS = A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications.
OL = use BUSERELIN to search BUSERELIN ACETATE 1984-91
PM = 92; was BUSERELIN ACETATE 1984-91; BUSERELIN was see BUSERELIN ACETATE 1984-91
HN = 92; was BUSERELIN ACETATE 1984-91; BUSERELIN was see BUSERELIN ACETATE 1984-91
MR = 20130708
DA = 19830404
DC = 1
DX = 19840101
UI = D002064

*NEWRECORD
RECTYPE = D
MH = Buspirone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Anxut|T109|T121|TRD|NRW|DE|040513|abbcdef
ENTRY = Apo-Buspirone|T109|T121|TRD|NRW|CA|040513|abbcdef
ENTRY = Apotex Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Armstrong Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Bespar|T109|T121|TRD|NRW|DE|040513|abbcdef
ENTRY = Bristol-Myers Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Busp|T109|T121|TRD|NRW|DE|040513|abbcdef
ENTRY = Buspar|T109|T121|TRD|NRW|AU|CA|ES|FR|IE|NL|US|870504|abbcdeeeeeeef
ENTRY = Buspirone Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1973)|USP (19XX)|940809|abbcdeeef
ENTRY = Eisai Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Gen-Buspirone|T109|T121|TRD|NRW|CA|040513|abbcdef
ENTRY = Genpharm Brand of Buspirone|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Hexal Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Hormosan Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Lin-Buspirone|T109|T121|TRD|NRW|CA|040513|abbcdef
ENTRY = Linson Pharma Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = MJ-9022-1|T109|T121|LAB|NRW|UNK (19XX)|870504|abbcdef
ENTRY = N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide|T109|T121|NON|EQV|NLM (1995)|931123|abbcdef
ENTRY = Neurosine|T109|T121|TRD|NRW|MX|040513|abbcdef
ENTRY = Novo-Buspirone|T109|T121|TRD|NRW|CA|040513|abbcdef
ENTRY = Novopharm Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Nu-Buspirone|T109|T121|TRD|NRW|CA|040513|abbcdef
ENTRY = Nu-Pharm Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = PMS-Buspirone|T109|T121|TRD|NRW|CA|040513|abbcdef
ENTRY = Pharmascience Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = Ratiopharm Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = UPSA Brand of Buspirone Hydrochloride|T109|T121|NON|NRW|NLM (2005)|040513|abbcdef
ENTRY = ratio-Buspirone|T109|T121|TRD|NRW|CA|040513|abbcdef
ENTRY = Apo Buspirone
ENTRY = Bristol Myers Brand of Buspirone Hydrochloride
ENTRY = Bristol Myers Squibb Brand of Buspirone Hydrochloride
ENTRY = Gen Buspirone
ENTRY = Hydrochloride, Buspirone
ENTRY = Lin Buspirone
ENTRY = MJ 9022 1
ENTRY = MJ90221
ENTRY = Novo Buspirone
ENTRY = Nu Buspirone
ENTRY = Nu Pharm Brand of Buspirone Hydrochloride
ENTRY = PMS Buspirone
ENTRY = ratio Buspirone
MN = D02.455.426.779.120
MN = D03.383.606.210
MN = D03.383.742.120
MN = D04.711.120
PA = Anti-Anxiety Agents
PA = Serotonin Receptor Agonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-
RN = TK65WKS8HL
RR = 207LT9J9OC
RR = 33386-08-2 (Buspirone Hydrochloride)
RR = 36505-84-7 (Buspirone)
PI = Pyrimidines (1972-1987)
PI = Spiro Compounds (1973-1982)
MS = An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
PM = 88
HN = 88
MR = 20140617
DA = 19870504
DC = 1
DX = 19880101
UI = D002065

*NEWRECORD
RECTYPE = D
MH = Busulfan
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Busulphan|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|761230|abbbcdeef
ENTRY = Busulfan Wellcome|T109|T121|T131|TRD|NRW|ES|040526|abbbcdef
ENTRY = Busulfex|T109|T121|T131|TRD|NRW|CA|US|040526|abbbcdeef
ENTRY = Glaxo Wellcome Brand of Busulfan|T109|T121|T131|NON|NRW|NLM (2005)|040526|abbbcdef
ENTRY = GlaxoSmithKline Brand of Busulfan|T109|T121|T131|NON|NRW|NLM (2005)|040526|abbbcdef
ENTRY = Glyzophrol|T109|T121|T131|TRD|NRW|UNK (19XX)|870114|abbbcdef
ENTRY = Myelosan|T109|T121|T131|TRD|NRW|UNK (19XX)|830629|abbbcdef
ENTRY = Mylecytan|T109|T121|T131|TRD|NRW|UNK (19XX)|810210|abbbcdef
ENTRY = Myleran|T109|T121|T131|TRD|NRW|AU|CA|DE|NL|US|810210|abbbcdeeeeef
ENTRY = Mylran|T109|T121|T131|TRD|NRW|FR|040526|abbbcdef
ENTRY = Orphan Brand of Busulfan|T109|T121|T131|NON|NRW|NLM (2005)|040526|abbbcdef
ENTRY = Wellcome Brand of Busulfan|T109|T121|T131|NON|NRW|NLM (2005)|040526|abbbcdef
ENTRY = n-Butane-1,3-di(methylsulfonate)|T109|NON|REL|NLM (1992)|910312|abcdef
ENTRY = Busulfan GlaxoSmithKline Brand
ENTRY = Busulfan Orphan Brand
ENTRY = Busulfan Wellcome Brand
ENTRY = Wellcome, Busulfan
MN = D02.033.455.125.125
MN = D02.455.326.146.100.050.500.100
MN = D02.886.645.600.055.050.510.100
PA = Alkylating Agents
PA = Antineoplastic Agents, Alkylating
PA = Immunosuppressive Agents
PA = Myeloablative Agonists
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
ST = T131
N1 = 1,4-Butanediol, dimethanesulfonate
RN = G1LN9045DK
RR = 55-98-1 (Busulfan)
MS = An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.
MR = 20130708
DA = 19990101
DC = 1
UI = D002066

*NEWRECORD
RECTYPE = D
MH = Butaclamol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = AY-23,028|T109|T121|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Butaclamol Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1973)|941129|abbcdeef
ENTRY = AY 23,028
ENTRY = AY23,028
ENTRY = Hydrochloride, Butaclamol
MN = D02.455.426.559.847.181.384.230
MN = D04.615.181.384.230
PA = Antipsychotic Agents
PA = Dopamine Antagonists
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
RN = A7A2802VNL
RR = 36504-93-5 (Butaclamol)
RR = 36504-94-6 (HCl)
RR = 8TUG8SF12T
PI = Dibenzocycloheptenes (1968-1977)
MS = A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia.
PM = 91; was see under DIBENZOCYCLOHEPTENES 1978-90
HN = 91(78); was see under DIBENZOCYCLOHEPTENES 1978-90
MR = 20130708
DA = 19770422
DC = 1
DX = 19910101
UI = D002069

*NEWRECORD
RECTYPE = D
MH = Butadienes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Butadiene Derivatives|T109|NON|EQV|NLM (2014)|130610|abcdef
ENTRY = Derivatives, Butadiene
MN = D02.455.326.271.665.146.240
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Four carbon unsaturated hydrocarbons containing two double bonds.
OL = use BUTADIENES to search BUTADIENE 1966-77
PM = 78; was BUTADIENE 1963-77
HN = 78; was BUTADIENE 1963-77
MR = 20130708
DA = 19990101
DC = 1
UI = D002070

*NEWRECORD
RECTYPE = D
MH = Butylene Glycols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Butanediols|T109|NON|EQV|UNK (19XX)|741111|abcdef
PRINT ENTRY = Dihydroxybutanes|T109|NON|EQV|UNK (19XX)|741111|abcdef
ENTRY = Glycols, Butylene
MN = D02.033.455.125
MH_TH = NLM (1975)
ST = T109
RN = 0
PI = Glycols (1969-1974)
MS = 4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom.
PM = 98; see BUTANEDIOLS 1975-97
HN = 98(75)
MR = 19970620
DA = 19741111
DC = 1
DX = 19750901
UI = D002072

*NEWRECORD
RECTYPE = D
MH = Butanes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Isobutanes|T109|NON|NRW|UNK (19XX)|770520|abcdef
MN = D02.455.326.146.216
MH_TH = NLM (1973)
ST = T109
RN = 0
AN = does not include butenes ( = ALKENES); CYCLOBUTANES is also available
PI = Alkanes (1966-1972)
PM = 73
HN = 73
MR = 19920508
DA = 19990101
DC = 1
DX = 19730101
UI = D002073

*NEWRECORD
RECTYPE = D
MH = Butanones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.522.296
MH_TH = NLM (1968)
ST = T109
RN = 0
PI = Ketones (1966-1967)
PM = 68
HN = 68
MR = 19920508
DA = 19990101
DC = 1
DX = 19680101
UI = D002074

*NEWRECORD
RECTYPE = D
MH = Butirosin Sulfate
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Butirosins|T118|T195|NON|BRD|NLM (1996)|940720|abbcdef
ENTRY = Butirosin|T118|T195|NON|BRD|INN (19XX)|741111|abbcdef
ENTRY = Butirosin A|T118|T195|NON|NRW|FDA SRS (2014)|UNK (19XX)|800826|abbcdeef
ENTRY = Butirosin B|T118|T195|NON|NRW|FDA SRS (2014)|UNK (19XX)|800826|abbcdeef
ENTRY = Butirosin Sulfate, Anhydrous|T118|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Butirosin Sulphate|T118|T195|NON|EQV|BAN (19XX)|940720|abbcdef
ENTRY = Anhydrous Butirosin Sulfate
ENTRY = Sulfate, Anhydrous Butirosin
ENTRY = Sulfate, Butirosin
ENTRY = Sulphate, Butirosin
MN = D09.408.051.120
PA = Anti-Bacterial Agents
MH_TH = USAN (1976)
ST = T118
ST = T195
RN = 51022-98-1
RR = 12772-35-9 (butirosin)
RR = 285798GUS5
RR = 57549-48-1 (anhydrous)
RR = BC4D059GIG
PI = Aminoglycosides (1974)
PI = Antibiotics (1973-1974)
MS = A water-soluble aminoglycosidic antibiotic complex isolated from fermentation filtrates of Bacillus circulans. Two components (A and B) have been separated from the complex. Both are active against many gram-positive and some gram-negative bacteria.
PM = 96; was BUTIROSINS 1975-95 (see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90)
HN = 96; was BUTIROSINS 1975-95 (see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90)
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002076

*NEWRECORD
RECTYPE = D
MH = Butorphanol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 17-(Cyclobutylmethyl)morphinan-3,14-diol|T109|T121|NON|EQV|NLM (1996)|950404|abbcdef
ENTRY = Apo-Butorphanol|T109|T121|TRD|NRW|CA|040526|abbcdef
ENTRY = Apotex Brand of Butorphanol Tartrate|T109|T121|NON|NRW|NLM (2005)|040526|abbcdef
ENTRY = BC-2627|T109|T121|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Beforal|T109|T121|TRD|NRW|NLM (1998)|961113|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Butorphanol Tartrate|T109|T121|NON|NRW|NLM (2006)|050222|abbcdef
ENTRY = Butorphanol Tartrate|T109|T121|NON|NRW|BAN (19XX)|FDA SRS (2014)|JAN (19XX)|USAN (19XX)|USP (19XX)|840920|abbcdeeeeef
ENTRY = Cephalon Brand of Butorphanol Tartrate|T109|T121|NON|NRW|NLM (2005)|040526|abbcdef
ENTRY = Dolorex|T109|T121|TRD|NRW|AU|040526|abbcdef
ENTRY = Fort Dodge Brand of Butorphanol Tartrate|T109|T121|NON|NRW|NLM (2005)|040526|abbcdef
ENTRY = Geneva Brand of Butorphanol Tartrate|T109|T121|NON|NRW|NLM (2005)|040526|abbcdef
ENTRY = Intervet Brand of Butorphanol Tartrate|T109|T121|NON|NRW|NLM (2005)|040526|abbcdef
ENTRY = Moradol|T109|T121|TRD|NRW|UNK (19XX)|881102|abbcdef
ENTRY = Stadol|T109|T121|TRD|NRW|US|861119|abbcdef
ENTRY = Stadol NS|T109|T121|TRD|NRW|CA|US|040526|abbcdeef
ENTRY = Torbugesic|T109|T121|TRD|NRW|AU|040526|abbcdef
ENTRY = BC 2627
ENTRY = BC2627
MN = D03.132.577.249.165
MN = D03.549.686.165
MN = D03.605.497.165
MN = D04.615.723.795.165
PA = Analgesics, Opioid
PA = Antitussive Agents
PA = Narcotic Antagonists
PA = Narcotics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1974)
ST = T109
ST = T121
N1 = Morphinan-3,14-diol, 17-(cyclobutylmethyl)-
RN = QV897JC36D
RR = 2L7I72RUHN
RR = 42408-82-2 (Butorphanol)
PI = Morphinans (1969-1978)
MS = A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain.
PM = 91; was see under MORPHINANS 1979-90
HN = 91(79); was see under MORPHINANS 1979-90
MR = 20130708
DA = 19780501
DC = 1
DX = 19910101
UI = D002077

*NEWRECORD
RECTYPE = D
MH = Butoxamine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Butaxamine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1996)|941031|abbcdeeef
ENTRY = Butoxamine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (1996)|USAN (1965)|941031|abbcdeeef
ENTRY = Hydrochloride, Butoxamine
MN = D02.092.471.683.221
PA = Adrenergic beta-2 Receptor Antagonists
PA = Hypoglycemic Agents
PA = Hypolipidemic Agents
PA = Sympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T121
N1 = Benzenemethanol, alpha-(1-((1,1-dimethylethyl)amino)ethyl)-2,5-dimethoxy-
RN = 0NM31M53PW
RR = 2922-20-5 (Butoxamine)
RR = 2O68ZJ8BLQ
RR = 5696-15-1 (Butoxamine Hydrochloride)
PI = Adrenergic Beta Receptor Blockaders (1969-1972)
PI = Amino Alcohols (1966-1972)
PI = Antilipemic Agents (1966-1972)
MS = A beta-2 selective adrenergic antagonist. It is used primarily in animal and tissue experiments to characterize BETA-2 ANDRENERGIC RECEPTORS.
PM = 91; was see under PROPANOLAMINES 1973-90
HN = 91(73); was see under PROPANOLAMINES 1973-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002078

*NEWRECORD
RECTYPE = D
MH = Butter
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Butters
MN = D10.212.302.199
MN = G07.203.300.350.100
MN = G07.203.300.375.200
MN = J02.500.350.100
MN = J02.500.375.200
MH_TH = NLM (1966)
ST = T119
ST = T168
N1 = Butter
RN = 8029-34-3
AN = a dairy product & dietary fat; MARGARINE is also available
MS = The fatty portion of milk, separated as a soft yellowish solid when milk or cream is churned. It is processed for cooking and table use. (Random House Unabridged Dictionary, 2d ed)
MR = 20141014
DA = 19990101
DC = 1
UI = D002079

*NEWRECORD
RECTYPE = D
MH = Butterflies
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Butterfly
MN = B01.050.500.131.617.561.200
MH_TH = NLM (1975)
ST = T204
AN = /microbiol /parasitol /virol permitted
MS = Slender-bodies diurnal insects having large, broad wings often strikingly colored and patterned.
PM = 91; was see under LEPIDOPTERA 1975-90
HN = 91(75); was see under LEPIDOPTERA 1975-90
MR = 20090706
DA = 19741212
DC = 1
DX = 19910101
UI = D002080

*NEWRECORD
RECTYPE = D
MH = Buttocks
AQ = AB AH BS EM GD IN IR MI PA PH PP PS RA RE RI SU US VI
PRINT ENTRY = Gluteal Region|T029|NON|BRD|UNK (19XX)|740329|abcdef
ENTRY = Buttock
ENTRY = Gluteal Regions
ENTRY = Region, Gluteal
ENTRY = Regions, Gluteal
MN = A01.378.610.100
MH_TH = NLM (1966)
ST = T029
AN = usually NIM as site
MS = Either of two fleshy protuberances at the lower posterior section of the trunk or HIP in humans and primate on which a person or animal sits, consisting of gluteal MUSCLES and fat.
MR = 20150616
DA = 19990101
DC = 1
UI = D002081

*NEWRECORD
RECTYPE = D
MH = Butylamines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.092.264
MH_TH = NLM (1966)
ST = T109
RN = 0
PM = 66
HN = 66
MR = 19920508
DA = 19990101
DC = 1
DX = 19660101
UI = D002082

*NEWRECORD
RECTYPE = D
MH = Butylated Hydroxyanisole
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Butylhydroxyanisole|T109|T121|NON|EQV|UNK (19XX)|781215|abbcdef
ENTRY = (1,1-Dimethylethyl)-4-methoxyphenol|T109|T121|NON|EQV|NLM (1996)|950404|abbcdef
ENTRY = AMIF-72|T109|T121|LAB|BRD|NLM (1992)|910220|abbcdef
ENTRY = BHA|T109|T121|ABB|EQV|UNK (19XX)|810728|abbcdef
ENTRY = Butyl Methoxyphenol|T109|T121|NON|EQV|UNK (19XX)|801203|abbcdef
ENTRY = Embanox|T109|T121|TRD|NRW|NLM (1992)|910220|abbcdef
ENTRY = Nipantiox 1-F|T109|T121|TRD|NRW|NLM (1992)|910220|abbcdef
ENTRY = Tenox BHA|T109|T121|TRD|NRW|NLM (1992)|910220|abbcdef
ENTRY = AMIF 72
ENTRY = AMIF72
ENTRY = Hydroxyanisole, Butylated
ENTRY = Methoxyphenol, Butyl
ENTRY = Nipantiox 1 F
ENTRY = Nipantiox 1F
MN = D02.355.601.200.324
MN = D02.355.726.158.324
MN = D02.455.426.559.389.657.654.158.324
PA = Antioxidants
PA = Carcinogens
MH_TH = BAN (19XX)
ST = T109
ST = T121
N1 = Phenol, (1,1-dimethylethyl)-4-methoxy-
RN = 25013-16-5
AN = D25-26 qualif; DF: BHA
MS = Mixture of 2- and 3-tert-butyl-4-methoxyphenols that is used as an antioxidant in foods, cosmetics, and pharmaceuticals.
OL = search ANISOLES 1973-74
PM = 87; was see under ANISOLES 1973-86
HN = 87(75); was see under ANISOLES 1973-86
MR = 20120703
DA = 19990101
DC = 1
DX = 19870101
UI = D002083

*NEWRECORD
RECTYPE = D
MH = Butylated Hydroxytoluene
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Butylhydroxytoluene|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|790227|abbcdeef
ENTRY = 2,6-Bis(1,1-dimethylethyl)-4-methylphenol|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|950404|abbcdeef
ENTRY = 2,6-Di-t-butyl-4-methylphenol|T109|T121|NON|EQV|NLM (1990)|890609|abbcdef
ENTRY = 2,6-Di-tert-butyl-p-cresol|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|810305|abbcdeef
ENTRY = 4-Methyl-2,6-ditertbutylphenol|T109|T121|NON|EQV|UNK (19XX)|800801|abbcdef
ENTRY = BHT|T109|T121|ABB|EQV|UNK (19XX)|810728|abbcdef
ENTRY = Dibunol|T109|T121|TRD|NRW|UNK (19XX)|801203|abbcdef
ENTRY = Ionol|T109|T121|TRD|NRW|UNK (19XX)|801205|abbcdef
ENTRY = Ionol (BHT)|T109|T121|TRD|NRW|NLM (2004)|030513|abbcdef
ENTRY = 2,6 Di t butyl 4 methylphenol
ENTRY = 2,6 Di tert butyl p cresol
ENTRY = 4 Methyl 2,6 ditertbutylphenol
ENTRY = Hydroxytoluene, Butylated
MN = D02.455.426.559.389.657.239.216
PA = Antioxidants
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T121
N1 = Phenol, 2,6-bis(1,1-dimethylethyl)-4-methyl-
RN = 1P9D0Z171K
RR = 128-37-0 (Butylated Hydroxytoluene)
AN = consider IONONES if C13-norisoprenoid or ionanes are discussed; DF: BHT;
PI = Cresols (1966-1974)
MS = A di-tert-butyl PHENOL with antioxidant properties.
OL = search CRESOLS 1973-74
PM = 80; was see under CRESOLS 1973-79
HN = 80(75); was see under CRESOLS 1973-79
MR = 20130708
DA = 19990101
DC = 1
DX = 19800101
UI = D002084

*NEWRECORD
RECTYPE = D
MH = Butylhydroxybutylnitrosamine
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Butylbutanolnitrosamine|T109|T131|NON|EQV|NLM (1992)|910114|abbcdef
ENTRY = N-Butyl-N-(4-hydroxybutyl)nitrosamine|T109|T131|NON|EQV|UNK (19XX)|850103|abbcdef
ENTRY = N-Nitroso-N-butyl-(4-hydroxybutyl)amine|T109|T131|NON|EQV|UNK (19XX)|830916|abbcdef
ENTRY = N-Nitrosobutyl-4-hydroxybutylamine|T109|T131|NON|EQV|NLM (1992)|910312|abbcdef
ENTRY = N Nitrosobutyl 4 hydroxybutylamine
MN = D02.654.442.100
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = 1-Butanol, 4-(butylnitrosoamino)-
RN = 3817-11-6
AN = D25-26 qualif
PI = Alcohols, Butyl (1974)
PI = Nitrosamines (1974)
MS = A substituted carcinogenic nitrosamine.
PM = 91; was see under NITROSAMINES 1975-90
HN = 91(75); was see under NITROSAMINES 1975-90
MR = 20000622
DA = 19741119
DC = 1
DX = 19910101
UI = D002085

*NEWRECORD
RECTYPE = D
MH = Butylscopolammonium Bromide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hyoscinbutylbromide|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef
PRINT ENTRY = Scopolaminebutylbromide|T109|T121|NON|EQV|UNK (19XX)|750630|abbcdef
ENTRY = Buscapine|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Buscolysin|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Buscopan|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Butylscopolamine|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1990)|890607|abbcdeef
ENTRY = Hyoscine N-Butylbromide|T109|T121|NON|EQV|UNK (19XX)|871021|abbcdef
ENTRY = N-Butylscopolammonium Bromide|T109|T121|NON|EQV|UNK (19XX)|811026|abbcdef
ENTRY = Scopolan|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Bromide, Butylscopolammonium
ENTRY = Bromide, N-Butylscopolammonium
ENTRY = Hyoscine N Butylbromide
ENTRY = N Butylscopolammonium Bromide
ENTRY = N-Butylbromide, Hyoscine
MN = D02.092.877.310
MN = D02.145.074.722.822.200
MN = D03.132.889.601.200
MN = D03.605.869.822.200
MN = D04.075.080.875.099.722.822.200
PA = Muscarinic Antagonists
PA = Parasympatholytics
MH_TH = NLM (1976)
ST = T109
ST = T121
N1 = 3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-
RN = 2Z3E1OF81V
RR = 149-64-4 (Butylscopolammonium Bromide)
PI = Bromine (1972-1974)
PI = Scopolamine (1969-1975)
PI = Scopolamine Derivatives (1975)
MS = Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract.
PM = 91; was see under SCOPOLAMINE DERIVATIVES 1978-90; was see under SCOPOLAMINE 1976-77
HN = 91(76); was see under SCOPOLAMINE DERIVATIVES 1978-90; was see under SCOPOLAMINE 1976-77
MR = 20130708
DA = 19750718
DC = 1
DX = 19910101
UI = D002086

*NEWRECORD
RECTYPE = D
MH = Butyrates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Butyrate|T119|NON|NRW|NLM (1999)|980105|abcdef
PRINT ENTRY = n-Butyrate|T119|NON|NRW|NLM (1999)|980105|BUTYRATE N|abcdefs
ENTRY = Butanoic Acids|T119|NON|REL|UNK (19XX)|741111|abcdef
ENTRY = Butyric Acids|T119|NON|REL|NLM (1975)|990101|abcdef
ENTRY = Acids, Butanoic
ENTRY = Acids, Butyric
ENTRY = n Butyrate
MN = D02.241.081.114
MN = D10.251.400.143
MH_TH = NLM (1966)
ST = T119
RN = 0
MS = Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure.
PM = 1963; for BUTYRIC ACIDS see SUTYRIC ACIDS 1999-2012, BUTYRATE and N-BUTYRATE were indexed under BUTYRIC ACIDS 1975-1998
HN = 1963
MR = 20120703
DA = 19990101
DC = 1
UI = D002087

*NEWRECORD
RECTYPE = D
MH = Butyrophenones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.522.352
FX = Antipsychotic Agents
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Compounds containing phenyl-1-butanone.
PM = 66
HN = 66
MR = 20030709
DA = 19990101
DC = 1
DX = 19660101
UI = D002090

*NEWRECORD
RECTYPE = D
MH = Butyrylcholinesterase
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Butyrylthiocholinesterase|T116|T126|NON|NRW|UNK (19XX)|810427|abbcdef
MN = D08.811.277.352.100.170.250
EC = antagonists & inhibitors:Cholinesterase Inhibitors
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 3.1.1.-
AN = /antag = CHOLINESTERASE INHIBITORS (IM) + BUTYRYLCHOLINESTERASE (NIM with no qualif)
PI = Butyrates (1973-1974)
PI = Cholinesterases (1973-1974)
MS = An aspect of cholinesterase (EC 3.1.1.8).
PM = 91; was see under CHOLINESTERASES 1975-90
HN = 91(75); was see under CHOLINESTERASES 1975-90
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D002091

*NEWRECORD
RECTYPE = D
MH = Butyrylthiocholine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (2-Mercaptoethyl)Trimethylammonium Butyrate|T109|T130|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = S-Butyrylthiocholine Iodide|T109|T130|NON|NRW|UNK (19XX)|820302|abbcdef
ENTRY = Iodide, S-Butyrylthiocholine
ENTRY = S Butyrylthiocholine Iodide
MN = D02.092.877.883.333.800.200
MN = D02.675.276.232.800.200
MN = D02.886.489.789.200
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = Ethanaminium, N,N,N-trimethyl-2-((1-oxobutyl)thio)-
RN = 4555-00-4
PI = Butyrates (1972-1974)
PI = Choline (1968-1974)
PI = Sulfhydryl Compounds (1972-1974)
MS = A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity.
PM = 91; was see under CHOLINE 1975-90
HN = 91(75); was see under CHOLINE 1975-90
MR = 20070709
DA = 19741119
DC = 1
DX = 19910101
UI = D002092

*NEWRECORD
RECTYPE = D
MH = Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide
DS = BENZENAMINIUM 4 4 3 OXO 1 5 PENTANEDIYL BIS N N DIMETHYL N 2 PROPENYL DIBROMIDE
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = BW 284 C 51|T109|T121|LAB|NRW|NLM (1975)|990101|abbcdef
ENTRY = BW-284-C-51|T109|T121|LAB|NRW|UNK (19XX)|741111|abbcdef
ENTRY = BW284C51|T109|T121|LAB|NRW|UNK (19XX)|741111|abbcdef
MN = D02.092.146.290
MH_TH = NLM (2005)
ST = T109
ST = T121
N1 = Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl)-, dibromide
RN = 402-40-4
PI = Allyl Compounds (1971-1974)
PI = Aniline Compounds (1971-1974)
PI = Ketones (1971-1974)
MS = Proposed cholinesterase inhibitor.
PM = 2005; see BW 284 C 51 1991-2004; see ANILINE COMPOUNDS 1975-1990
HN = 2005(1975)
MR = 20040707
DA = 19741119
DC = 1
DX = 19910101
UI = D002093

*NEWRECORD
RECTYPE = D
MH = Republic of Belarus
AQ = EH EP
PRINT ENTRY = Belarus|T083|NAM|REL|NLM (1993)|920513|abcdef
PRINT ENTRY = Belorussian S.S.R.|T083|NAM|REL|UNK (19XX)|810302|abcdef
PRINT ENTRY = Byelarus|T083|NAM|REL|NLM (1966)|990101|abcdef
PRINT ENTRY = Byelorussian S.S.R.|T083|NAM|REL|NLM (1993)|920422|abcdef
ENTRY = Belorussia|T083|NAM|REL|UNK (19XX)|810302|abcdef
ENTRY = Belorussian SSR|T083|NAM|REL|NLM (1993)|920422|abcdef
ENTRY = Byelorussian SSR|T083|NAM|REL|NLM (1993)|920422|abcdef
MN = Z01.542.248.700
MN = Z01.586.200.650
MN = Z01.586.950.600
MH_TH = NLM (2011)
ST = T083
AN = variant spellings (Byelorussia, Belorussia, etc.) permitted in translations of historical articles; use Belarus as spelling in translations of current articles
HN = 2011; use BYELARUS 1993-2010, use BYELORUSSIAN S.S.R. 1982-1992, use BELORUSSIA 1963-1981
MR = 20120703
DA = 19990101
DC = 4
UI = D002094

*NEWRECORD
RECTYPE = D
MH = Byssinosis
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Brown Lung|T037|T047|NON|EQV|NLM (2009)|071101|abbcdef
ENTRY = Brown Lung Disease|T037|T047|NON|EQV|NLM (2009)|071101|abbcdef
ENTRY = Brown Lung Diseases
ENTRY = Brown Lungs
ENTRY = Byssinoses
MN = C08.381.483.581.275
MN = C08.381.520.702.275
MN = C24.800.323
MH_TH = NLM (1969)
MH_TH = ORD (2010)
ST = T037
ST = T047
AN = do not coordinate with OCCUPATIONAL DISEASES
PI = Pneumoconiosis (1966-1968)
MS = A condition of BRONCHOCONSTRICTION resulting from hypersensitive reaction to inhaled dust during the initial processing of cotton, flax, or hemp in the textile industry. Symptoms include wheezing and tightness in the chest.
PM = 74
HN = 74(69)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19740101
UI = D002095

*NEWRECORD
RECTYPE = D
MH = C-Peptide
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Proinsulin C-Peptide|T116|T123|NON|EQV|NLM (2007)|060327|abbcdef
ENTRY = C-Peptide, Proinsulin|T116|T123|NON|EQV|NLM (2007)|060327|abbcdef
ENTRY = Connecting Peptide|T116|T123|NON|EQV|UNK (19XX)|760414|abbcdef
ENTRY = C Peptide
ENTRY = C Peptide, Proinsulin
ENTRY = Proinsulin C Peptide
MN = D06.472.699.587.200.500.250
MN = D12.644.548.586.200.500.250
MH_TH = NLM (1977)
ST = T116
ST = T123
RN = 0
AN = from proinsulin only: not for peptide fragments from other proteins ( = PEPTIDE FRAGMENTS)
PI = Peptides (1973-1976)
PI = Proinsulin (1975-1976)
MS = The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.
PM = 84; was see under PEPTIDES 1977-83
HN = 84(77); was see under PEPTIDES 1977-83
MR = 20110624
DA = 19760416
DC = 1
DX = 19840101
UI = D002096

*NEWRECORD
RECTYPE = D
MH = C-Reactive Protein
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = C Reactive Protein
ENTRY = Protein, C-Reactive
MN = D12.776.034.145
MN = D12.776.124.050.120
MN = D12.776.124.486.157
MH_TH = NLM (1966)
ST = T116
ST = T129
N1 = Proteins, specific or class, C-reactive
RN = 9007-41-4
AN = an acute phase protein; /drug eff /ultrastruct permitted
MS = A plasma protein that circulates in increased amounts during inflammation and after tissue damage.
MR = 19921030
DA = 19990101
DC = 1
UI = D002097

*NEWRECORD
RECTYPE = D
MH = Cacao
AQ = AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI
PRINT ENTRY = Chocolate|T168|NON|REL|UNK (19XX)|840620|abcdef
PRINT ENTRY = Cocoa|T168|NON|NRW|UNK (19XX)|840620|abcdef
PRINT ENTRY = Theobroma cacao|T002|NON|EQV|NLM (1998)|961004|abcdef
ENTRY = Cacaos
ENTRY = Chocolates
ENTRY = Cocoas
ENTRY = Theobroma cacaos
ENTRY = cacao, Theobroma
ENTRY = cacaos, Theobroma
MN = B01.650.940.800.575.100.915.144
MH_TH = NLM (1986)
ST = T002
AN = as plant & as chocolate or cocoa; coordinate IM with CANDY (IM) for chocolate candy or with BEVERAGES (IM) for chocolate drinks
MS = A tree of the family Sterculiaceae (or Byttneriaceae), usually Theobroma cacao, or its seeds, which after fermentation and roasting, yield cocoa and chocolate.
OL = use CACAO to search CHOCOLATE & COCOA 1966-84
PM = 91,63-85; was see under PLANTS, EDIBLE 1986-90; CHOCOLATE & COCOA were see under CACAO 1963-84
HN = 91(86)63; was see under PLANTS, EDIBLE 1986-90; CHOCOLATE & COCOA were see under CACAO 1963-84
MR = 20100625
DA = 19990101
DC = 1
DX = 19910101
UI = D002099

*NEWRECORD
RECTYPE = D
MH = Cachexia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
MN = C23.888.144.243.963.500.500
FX = HIV Wasting Syndrome
FX = Wasting Syndrome
MH_TH = NLM (1966)
ST = T184
AN = WASTING SYNDROME is also available: do not make diagnosis, use words of text
MS = General ill health, malnutrition, and weight loss, usually associated with chronic disease.
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
UI = D002100

*NEWRECORD
RECTYPE = D
MH = Cacodylic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cacodylate|T109|T131|NON|NRW|UNK (19XX)|801203|abbcdef
ENTRY = Dimethylarsinate|T109|T131|NON|NRW|UNK (19XX)|810519|abbcdef
ENTRY = Dimethylarsinic Acid|T109|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|820203|abbcdeef
ENTRY = Acid, Cacodylic
ENTRY = Acid, Dimethylarsinic
MN = D02.691.088.100
PA = Herbicides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = Arsinic acid, dimethyl-
RN = AJ2HL7EU8K
RR = 75-60-5 (Cacodylic Acid)
PI = Arsenicals (1969-1974)
MS = An arsenical that has been used as a dermatologic agent and as an herbicide.
PM = 91; was see under ARSENICALS 1975-90
HN = 91(75); was see under ARSENICALS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002101

*NEWRECORD
RECTYPE = D
MH = Cadaver
ENTRY = Corpse|T015|NON|EQV|NLM (2010)|090128|abcdef
ENTRY = Cadavers
ENTRY = Corpses
MN = C23.550.260.224
MH_TH = NLM (1966)
ST = T015
AN = NIM for cadaveric organs in transplantation; do not index here routinely for postmortem studies; article must be on cadavers as a corpse; AUTOPSY is available for the procedure and / pathol is available with diseases and tissues for postmortem pathology
MS = A dead body, usually a human body.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D002102

*NEWRECORD
RECTYPE = D
MH = Cadaverine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
ENTRY = 1,5-Pentanediamine|T109|T124|NON|EQV|FDA SRS (2014)|UNK (19XX)|801205|abbcdeef
ENTRY = BioDex 1|T109|T130|TRD|NRW|UNK (19XX)|830916|abbcdef
ENTRY = Pentamethylenediamine|T109|T124|NON|EQV|FDA SRS (2014)|UNK (19XX)|830916|abbcdeef
ENTRY = 1,5 Pentanediamine
MN = D02.092.211.415.261
MN = D02.092.782.258.174
MH_TH = FDA SRS (2014)
MH_TH = NLM (1973)
ST = T109
ST = T124
N1 = 1,5-Pentanediamine
RN = L90BEN6OLL
RR = 462-94-2 (Cadaverine)
PI = Amines (1966-1972)
PI = Polyamines (1971-1972)
MS = A foul-smelling diamine formed by bacterial decarboxylation of lysine.
PM = 91; was see under DIAMINES 1973-90
HN = 91(73); was see under DIAMINES 1973-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002103

*NEWRECORD
RECTYPE = D
MH = Cadmium
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK RE SD ST TO TU UR
MN = D01.268.556.137
MN = D01.268.956.061
MN = D01.552.544.137
FX = Cadmium Radioisotopes
EC = poisoning:Cadmium Poisoning
MH_TH = FDA SRS (2014)
MH_TH = POPLINE (1978)
ST = T131
ST = T196
N1 = Cadmium
RN = 00BH33GNGH
RR = 7440-43-9 (Cadmium)
AN = Cd-114; Cd-106, 108, 110-113, 116 = CADMIUM (IM) + ISOTOPES (NIM); Cd-103-105, 107, 109, 115, 117-119 = CADMIUM RADIOISOTOPES (IM)
MS = An element with atomic symbol Cd, atomic number 48, and atomic weight 114. It is a metal and ingestion will lead to CADMIUM POISONING.
OL = search CADMIUM/PO under CADMIUM POISONING 1966-76
PM = /poisoning ( = CADMIUM POISONING as of 1977) was used for indexing 1966-76
HN = /poisoning was used for indexing 1966-76
MR = 20130708
DA = 19990101
DC = 1
UI = D002104

*NEWRECORD
RECTYPE = D
MH = Cadmium Poisoning
DE = CADMIUM POIS
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Itai-Itai|T037|NON|EQV|UNK (19XX)|760427|abcdef
ENTRY = Poisoning, Cadmium|T037|NON|EQV|UNK (19XX)|760427|POIS CADMIUM|abcdefv
ENTRY = Cadmium Poisonings
ENTRY = Itai Itai
ENTRY = Poisonings, Cadmium
MN = C25.723.165
MH_TH = NLM (1977)
ST = T037
AN = occup cadmium pois: coord IM with OCCUPATIONAL DISEASES (IM) but not also ENVIRONMENTAL EXPOSURE (see note there)
MS = Poisoning occurring after exposure to cadmium compounds or fumes. It may cause gastrointestinal syndromes, anemia, or pneumonitis.
OL = use CADMIUM POISONING to search CADMIUM/poisoning 1966-76
PM = 77; was CADMIUM/poisoning 1966-76
HN = 77; was CADMIUM/poisoning 1966-76
CATSH = CAT LIST
MR = 20100625
DA = 19760427
DC = 1
DX = 19770101
UI = D002105

*NEWRECORD
RECTYPE = D
MH = Cadmium Radioisotopes
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Radioisotopes, Cadmium
MN = D01.496.749.108
MH_TH = NLM (1988)
ST = T196
RN = 0
AN = Cd-103-105, 107, 109, 115, 117-119; for routine use as tracer, use no qualifiers
PI = Cadmium (1966-1987)
PI = Radioisotopes (1966-1987)
MS = Unstable isotopes of cadmium that decay or disintegrate emitting radiation. Cd atoms with atomic weights 103-105, 107, 109, 115, and 117-119 are radioactive cadmium isotopes.
PM = 88
HN = 88
MR = 20150605
DA = 19870406
DC = 1
DX = 19880101
UI = D002106

*NEWRECORD
RECTYPE = D
MH = Caenorhabditis
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
ENTRY = Caenorhabditides
MN = B01.050.500.500.294.700.700.660.250
MH_TH = NLM (1979)
ST = T204
AN = a genus of nematodes used in exper
PI = Nematoda (1966-1978)
MS = A genus of small free-living nematodes. Two species, CAENORHABDITIS ELEGANS and C. briggsae are much used in studies of genetics, development, aging, muscle chemistry, and neuroanatomy.
PM = 79
HN = 79
MR = 20090706
DA = 19780302
DC = 1
DX = 19790101
UI = D002107

*NEWRECORD
RECTYPE = D
MH = Ceruletide
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Caerulein|T116|T121|T123|NON|EQV|NLM (1972)|990101|abbbcdef
PRINT ENTRY = Cerulein|T116|T121|T123|NON|EQV|UNK (19XX)|800703|abbbcdef
ENTRY = Ceruletid|T116|T121|T123|NON|EQV|UNK (19XX)|800703|abbbcdef
ENTRY = FI-6934|T116|T121|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Takus|T116|T121|TRD|NRW|NLM (1996)|940824|abbcdef
ENTRY = FI 6934
ENTRY = FI6934
MN = D12.644.456.241
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (2014)
MH_TH = USAN (1980)
ST = T116
ST = T121
ST = T123
N1 = Caerulein
RN = 888Y08971B
RR = 17650-98-5 (Caerulein)
AN = /biosyn /physiol permitted; do not confuse X ref CERULEIN with CERULENIN
PI = Gastrointestinal Agents (1967-1971)
PI = Peptides (1966-1971)
MS = A specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian. Caerulein is similar in action and composition to CHOLECYSTOKININ. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. It is used in paralytic ileus and as diagnostic aid in pancreatic malfunction.
PM = 2013; see CAERULEIN 1972-2013
HN = 2013(1972)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D002108

*NEWRECORD
RECTYPE = D
MH = Caffeic Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acids, Caffeic
MN = D02.241.223.200.054
MH_TH = NLM (1975)
ST = T109
ST = T123
RN = 0
PI = Catechols (1972-1974)
PI = Cinnamates (1968-1974)
MS = A class of phenolic acids related to chlorogenic acid, p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation.
PM = 91; was see under CINNAMATES 1975-90
HN = 91(75); was see under CINNAMATES 1975-90
MR = 20120703
DA = 19741119
DC = 1
DX = 19910101
UI = D002109

*NEWRECORD
RECTYPE = D
MH = Caffeine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
ENTRY = 1,3,7-Trimethylxanthine|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|801205|abbcdeef
ENTRY = Berlin-Chemie Brand of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Caffedrine|T109|T121|TRD|NRW|US|040601|abbcdef
ENTRY = Coffeinum N|T109|T121|TRD|NRW|US|040601|abbcdef
ENTRY = Coffeinum Purrum|T109|T121|TRD|NRW|DE|040601|abbcdef
ENTRY = Dexitac|T109|T121|TRD|NRW|US|040601|abbcdef
ENTRY = Durvitan|T109|T121|TRD|NRW|ES|040601|abbcdef
ENTRY = GlaxoSmithKline Brand of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Merck dura Brand of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = No Doz|T109|T121|TRD|NRW|US|861119|abbcdef
ENTRY = Passauer Brand of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Percoffedrinol N|T109|T121|TRD|NRW|DE|040601|abbcdef
ENTRY = Percutafine|T109|T121|TRD|NRW|FR|040601|abbcdef
ENTRY = Pierre Fabre Brand of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Quick-Pep|T109|T121|TRD|NRW|US|040601|abbcdef
ENTRY = Republic Drug Brand of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Seid Brand of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Thompson Brand 1 of Caffeine|T109|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Thompson Brand 2 of Caffeine|T109|T121|NON|NRW|NLM (2006)|041006|abbcdef
ENTRY = Vivarin|T109|T121|TRD|NRW|US|040601|abbcdef
MN = D03.132.960.175
MN = D03.438.759.758.824.175
PA = Central Nervous System Stimulants
PA = Phosphodiesterase Inhibitors
PA = Purinergic P1 Receptor Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-
RN = 3G6A5W338E
RR = 58-08-2 (Caffeine)
MS = A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
MR = 20130708
DA = 19990101
DC = 1
UI = D002110

*NEWRECORD
RECTYPE = D
MH = Calcaneus
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
PRINT ENTRY = Heel Bone|T023|NON|EQV|NLM (2002)|010315|abcdef
ENTRY = Bone, Heel
MN = A02.835.232.043.300.710.300
FX = Heel
MH_TH = NLM (1966)
ST = T023
AN = do not confuse with HEEL, the area
MS = The largest of the TARSAL BONES which is situated at the lower and back part of the FOOT, forming the HEEL.
MR = 20080708
DA = 19990101
DC = 1
UI = D002111

*NEWRECORD
RECTYPE = D
MH = Calcifediol
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = 25-Hydroxycholecalciferol|T110|T127|NON|EQV|UNK (19XX)|820504|HYDROXYCHOLECALCIFEROL A 25|abbcdefs
PRINT ENTRY = 25-Hydroxyvitamin D 3|T110|T127|NON|EQV|UNK (19XX)|820504|HYDROXYVITAMIN D 03 25|abbcdefs
ENTRY = 25-Hydroxycholecalciferol Monohydrate|T110|T127|NON|EQV|NLM (2014)|130617|abbcdef
ENTRY = 25-Hydroxyvitamin D3|T110|T127|NON|EQV|NLM (1990)|890404|abbcdef
ENTRY = Aventis Brand of Calcifediol|T110|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = Calcidiol|T110|T127|NON|EQV|NLM (1997)|960116|abbcdef
ENTRY = Calcifediol Anhydrous|T110|T127|NON|NRW|FDA SRS (2014)|NLM (2014)|130617|abbcdeef
ENTRY = Calcifediol, (3 alpha,5Z,7E)-Isomer|T110|T127|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcifediol, (3 beta,5E,7E)-Isomer|T110|T127|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calderol|T110|T121|TRD|NRW|US|861119|abbcdef
ENTRY = Dedrogyl|T110|T121|TRD|NRW|DE|FR|820504|abbcdeef
ENTRY = Faes Brand of Calcifediol|T110|T121|T127|NON|NRW|NLM (2005)|040601|abbbcdef
ENTRY = Hidroferol|T110|T121|T127|TRD|NRW|ES|040601|abbbcdef
ENTRY = Organon Brand of Calcifediol|T110|T121|NON|NRW|NLM (2005)|040601|abbcdef
ENTRY = 25 Hydroxycholecalciferol
ENTRY = 25 Hydroxycholecalciferol Monohydrate
ENTRY = 25 Hydroxyvitamin D 3
ENTRY = 25 Hydroxyvitamin D3
ENTRY = Anhydrous, Calcifediol
ENTRY = Calcifediol Aventis Brand
ENTRY = Calcifediol Faes Brand
ENTRY = Calcifediol Organon Brand
ENTRY = Monohydrate, 25-Hydroxycholecalciferol
MN = D04.808.247.222.159.478.250
MN = D04.808.247.808.146.478.250
MN = D04.808.812.768.196.478.250
MN = D10.570.938.146.478.250
PA = Bone Density Conservation Agents
PA = Vitamins
MH_TH = FDA SRS (2014)
MH_TH = NLM (1983)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T110
ST = T127
N1 = 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-
RN = P6YZ13C99Q
RR = 19356-17-3 (Calcifediol)
RR = 36149-00-5 ((3 beta,5E,7E)-isomer)
RR = 73809-05-9 ((3 alpha,5Z,7E)-isomer)
RR = T0WXW8F54E
AN = deficiency: coordinate CALCIFEDIOL /defic (IM) with VITAMIN D DEFICIENCY (IM)
PI = Cholecalciferols (1966-1972)
PI = Hydroxycholecalciferols (1972-1982)
MS = The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
PM = 83
HN = 83
MR = 20130708
DA = 19820504
DC = 1
DX = 19830101
UI = D002112

*NEWRECORD
RECTYPE = D
MH = Calcification, Physiologic
DE = CALCIFICATION PHYSIOL
AQ = DE GE IM PH RE
PRINT ENTRY = Bone Mineralization|T042|NON|NRW|NLM (1990)|881130|abcdef
ENTRY = Calcification, Physiological|T042|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Physiologic Calcification|T042|NON|EQV|UNK (19XX)|780626|PHYSIOL CALCIFICATION|abcdefv
ENTRY = Mineralization, Bone
ENTRY = Physiological Calcification
MN = G07.700.320.186
MN = G07.700.320.500.325.377.625.100.175
MN = G11.427.590.560.100.175
FX = Bone Development
FX = Osteogenesis
MH_TH = NLM (1965)
ST = T042
AN = TOOTH CALCIFICATION is also available; DF: CALCIFICATION PHYSIOL
MS = Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.
PM = 65; was CALCIFICATION 1963-64
HN = 65; was CALCIFICATION 1963-64
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19650101
UI = D002113

*NEWRECORD
RECTYPE = D
MH = Calcinosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Calcification, Pathologic|T047|NON|EQV|UNK (19XX)|740329|CALCIFICATION PATHOL|abcdefv
ENTRY = Calcinosis, Tumoral|T047|NON|NRW|NLM (2014)|130418|abcdef
ENTRY = Pathologic Calcification|T047|NON|EQV|UNK (19XX)|740329|PATHOL CALCIFICATION|abcdefv
ENTRY = Calcinoses
ENTRY = Calcinoses, Tumoral
ENTRY = Tumoral Calcinoses
ENTRY = Tumoral Calcinosis
MN = C18.452.174.130
FX = Chondrocalcinosis
MH_TH = NLM (1966)
ST = T047
AN = coordinate IM with organ/diseases term (IM); for calcinosis of the heart, coordinate IM with CARDIOMYOPATHIES (IM), not HEART DISEASES
MS = Pathologic deposition of calcium salts in tissues.
PM = CALCIPHYLAXIS was heading 1965-83
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D002114

*NEWRECORD
RECTYPE = D
MH = Calciphylaxis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Calciphylaxes|T047|NON|EQV|NLM (1991)|900501|abcdef
ENTRY = Idiopathic Calciphylaxis|T047|NON|EQV|NLM (2011)|ORD (2010)|100113|abcdeef
ENTRY = Calciphylaxis, Idiopathic
MN = C18.452.174.130.186
MH_TH = NLM (1965)
MH_TH = ORD (2010)
ST = T047
AN = hypersensitivity with sudden local calcification
MS = Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.
PM = 91,63-83; was see under CALCINOSIS 1984-90
HN = 91(84)63; was see under CALCINOSIS 1984-90
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19650101
UI = D002115

*NEWRECORD
RECTYPE = D
MH = Calcitonin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Thyrocalcitonin|T116|T125|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Calcitonin(1-32)|T116|T125|NON|EQV|UNK (19XX)|830217|abbcdef
ENTRY = Calcitrin|T116|T125|NON|EQV|UNK (19XX)|830629|abbcdef
ENTRY = Ciba 47175-BA|T121|LAB|NRW|UNK (19XX)|830223|abcdef
ENTRY = Eel Calcitonin|T116|T125|NON|NRW|UNK (19XX)|820902|abbcdef
ENTRY = Calcitonin, Eel
ENTRY = Ciba 47175 BA
ENTRY = Ciba 47175BA
MN = D06.472.699.150
MN = D12.644.400.095
MN = D12.644.548.150
MN = D12.776.641.650.095
PA = Bone Density Conservation Agents
FX = Receptors, Calcitonin
MH_TH = USAN (1967)
ST = T116
ST = T125
N1 = Calcitonin
RN = 9007-12-9
MS = A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.
OL = use CALCITONIN to search THYROCALCITONIN 1966-73
PM = 74,66-67; was THYROCALCITONIN 1968-73
HN = 74,66-67; was THYROCALCITONIN 1968-73 & 1964-65 (Prov 1964-65)
MR = 20060705
DA = 19990101
DC = 1
DX = 19740101
UI = D002116

*NEWRECORD
RECTYPE = D
MH = Calcitriol
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = 1 alpha,25-Dihydroxycholecalciferol|T110|T121|T125|NON|EQV|UNK (19XX)|810512|DIHYDROXYCHOLECALCIFEROL 01 ALPHA 25|abbbcdefs
PRINT ENTRY = 1 alpha,25-Dihydroxyvitamin D3|T110|T121|T125|NON|EQV|UNK (19XX)|810512|DIHYDROXYVITAMIN D3 01 ALPHA 25|abbbcdefs
PRINT ENTRY = 1,25-Dihydroxycholecalciferol|T110|T121|T125|NON|EQV|UNK (19XX)|810512|DIHYDROXYCHOLECALCIFEROL 01 25|abbbcdefs
PRINT ENTRY = 1,25-Dihydroxyvitamin D3|T110|T121|T125|NON|EQV|FDA SRS (2014)|UNK (19XX)|810512|DIHYDROXYVITAMIN D3 01 25|abbbcdeefs
ENTRY = 1 alpha, 25-dihydroxy-20-epi-Vitamin D3|T110|T125|NON|REL|NLM (1998)|961114|abbcdef
ENTRY = 1,25(OH)2-20epi-D3|T110|T125|ABB|REL|NLM (1998)|970311|abbcdef
ENTRY = 1,25-dihydroxy-20-epi-Vitamin D3|T110|T125|NON|REL|NLM (1998)|970311|abbcdef
ENTRY = 20-epi-1alpha,25-dihydroxycholecaliferol|T110|T125|NON|REL|NLM (1998)|961121|abbcdef
ENTRY = Abbott Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040603|abbbcdef
ENTRY = Alphapharm Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040610|abbbcdef
ENTRY = Bocatriol|T110|T121|T125|TRD|NRW|DE|040603|abbbcdef
ENTRY = Calcijex|T110|T121|T125|TRD|NRW|AU|ES|NL|US|040603|abbbcdeeeef
ENTRY = Calcitriol KyraMed|T110|T121|T125|TRD|NRW|DE|040610|abbbcdef
ENTRY = Calcitriol-Nefro|T110|T121|T125|TRD|NRW|DE|040610|abbbcdef
ENTRY = Cryopharma Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040610|abbbcdef
ENTRY = Decostriol|T110|T121|T125|TRD|NRW|DE|040610|abbbcdef
ENTRY = Galderma Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040610|abbbcdef
ENTRY = Gry Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040610|abbbcdef
ENTRY = Hoffmann-La Roche Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040603|abbbcdef
ENTRY = Jenapharm Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040610|abbbcdef
ENTRY = KyraMed Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040610|abbbcdef
ENTRY = Leo Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040603|abbbcdef
ENTRY = MC-1288|T110|T121|T125|LAB|NRW|NLM (1998)|961121|abbbcdef
ENTRY = MC1288|T110|T121|T125|LAB|NRW|NLM (1998)|961114|abbbcdef
ENTRY = Medice Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040610|abbbcdef
ENTRY = Osteotriol|T110|T121|T125|TRD|NRW|DE|040610|abbbcdef
ENTRY = RenaCare Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040610|abbbcdef
ENTRY = Renatriol|T110|T121|T125|TRD|NRW|DE|040610|abbbcdef
ENTRY = Rocaltrol|T110|T121|T125|TRD|NRW|AU|CA|DE|ES|FR|IE|MX|NL|US|830330|abbbcdeeeeeeeeef
ENTRY = Roche Brand of Calcitriol|T110|T121|T125|NON|NRW|NLM (2005)|040603|abbbcdef
ENTRY = Silkis|T110|T121|T125|TRD|NRW|DE|040610|abbbcdef
ENTRY = Sitriol|T110|T121|T125|TRD|NRW|AU|040610|abbbcdef
ENTRY = Soltriol|T110|T121|T125|NON|NRW|UNK (19XX)|881011|abbbcdef
ENTRY = Tirocal|T110|T121|T125|TRD|NRW|MX|040610|abbbcdef
ENTRY = 1 alpha, 25 dihydroxy 20 epi Vitamin D3
ENTRY = 1 alpha,25 Dihydroxycholecalciferol
ENTRY = 1 alpha,25 Dihydroxyvitamin D3
ENTRY = 1,25 Dihydroxycholecalciferol
ENTRY = 1,25 Dihydroxyvitamin D3
ENTRY = 1,25 dihydroxy 20 epi Vitamin D3
ENTRY = 20 epi 1alpha,25 dihydroxycholecaliferol
ENTRY = Calcitriol Abbott Brand
ENTRY = Calcitriol Alphapharm Brand
ENTRY = Calcitriol Cryopharma Brand
ENTRY = Calcitriol Galderma Brand
ENTRY = Calcitriol Gry Brand
ENTRY = Calcitriol Jenapharm Brand
ENTRY = Calcitriol KyraMed Brand
ENTRY = Calcitriol Leo Brand
ENTRY = Calcitriol Medice Brand
ENTRY = Calcitriol Nefro
ENTRY = Calcitriol RenaCare Brand
ENTRY = Calcitriol Roche Brand
ENTRY = CalcitriolNefro
ENTRY = D3, 1 alpha,25-Dihydroxyvitamin
ENTRY = D3, 1,25-Dihydroxyvitamin
ENTRY = D3, 1,25-dihydroxy-20-epi-Vitamin
ENTRY = Hoffmann La Roche Brand of Calcitriol
ENTRY = KyraMed, Calcitriol
ENTRY = MC 1288
ENTRY = alpha,25-Dihydroxyvitamin D3, 1
MN = D04.808.247.222.159.478.387.300
MN = D04.808.247.808.146.478.387.300
MN = D04.808.812.768.196.478.387.300
MN = D10.570.938.146.478.387.300
PA = Bone Density Conservation Agents
PA = Calcium Channel Agonists
PA = Vitamins
FX = Receptors, Calcitriol
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = JAN (19XX)
MH_TH = USAN (1978)
MH_TH = USP (19XX)
ST = T110
ST = T121
ST = T125
N1 = 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-
RN = FXC9231JVH
RR = 32222-06-3 (Calcitriol)
AN = deficiency: coordinate CALCITRIOL /defic (IM) with VITAMIN D DEFICIENCY (IM)
PI = Cholecalciferols (1966-1972)
PI = Dihydroxycholecalciferols (1973-1981)
PI = Hydroxycholecalciferols (1972-1973)
MS = The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.
PM = 82
HN = 82
MR = 20130708
DA = 19810512
DC = 1
DX = 19820101
UI = D002117

*NEWRECORD
RECTYPE = D
MH = Calcium
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
PRINT ENTRY = Coagulation Factor IV|T123|T196|NON|EQV|NLM (1998)|960731|COAG FACTOR IV|abbcdefv
PRINT ENTRY = Factor IV|T123|T196|NON|EQV|UNK (19XX)|750101|abbcdef
ENTRY = Blood Coagulation Factor IV|T123|T196|NON|EQV|NLM (1998)|970211|BLOOD COAG FACTOR IV|abbcdefv
ENTRY = Factor IV, Coagulation
MN = D01.268.552.100
MN = D01.552.539.288
MN = D23.119.100
FX = Calcium Isotopes
FX = Calcium Radioisotopes
FX = Hypercalcemia
FX = Hypocalcemia
MH_TH = FDA SRS (2014)
MH_TH = POPLINE (1984)
ST = T123
ST = T196
N1 = Calcium
RN = SY7Q814VUP
RR = 7440-70-2 (Calcium)
AN = Ca-40; / antag permitted but consider also CALCIUM CHANNEL BLOCKERS; / blood: note HYPOCALCEMIA and HYPERCALCEMIA are available; / defic: consider also HYPOCALCEMIA & note that CALCIUM, DIETARY is also available; CALCIUM CHANNELS and CALCIUM SIGNALING are also available; metabolic disorders = CALCIUM METABOLISM DISORDERS
MS = A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
PM = /metabolism was CALCIUM METABOLISM 1965
HN = /metabolism was CALCIUM METABOLISM 1965
MR = 20130708
DA = 19990101
DC = 1
UI = D002118

*NEWRECORD
RECTYPE = D
MH = Calcium Carbonate
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aragonite|T197|NON|BRD|UNK (19XX)|850528|abcdef
ENTRY = Calcite|T197|NON|BRD|UNK (19XX)|850528|abcdef
ENTRY = Chalk|T197|NON|REL|UNK (19XX)|810108|abcdef
ENTRY = Limestone|T197|NON|NRW|FDA SRS (2014)|UNK (19XX)|810108|abcdeef
ENTRY = Marble|T197|NON|NRW|UNK (19XX)|800801|abcdef
ENTRY = Milk of Calcium|T121|T197|NON|NRW|UNK (19XX)|830217|abbcdef
ENTRY = Vaterite|T197|NON|BRD|UNK (19XX)|800731|abcdef
ENTRY = Calcium Milk
ENTRY = Carbonate, Calcium
MN = D01.146.275
MN = D01.200.275.150.150
MN = D01.578.200
PA = Antacids
MH_TH = FDA SRS (2014)
MH_TH = NLM (1965)
MH_TH = USP (19XX)
ST = T121
ST = T197
N1 = Carbonic acid calcium salt (1:1)
RN = H0G9379FGK
RR = 471-34-1 (Calcium Carbonate)
RR = H0G9379FGK
AN = occurs in nature as chalk, limestone or marble; used in med as a buffer in hemodialysis
MS = Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.
PM = 65
HN = 65
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D002119

*NEWRECORD
RECTYPE = D
MH = Calcium Channel Agonists
DE = CALCIUM CHANNEL AG
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Calcium Channel Activators|T121|NON|EQV|UNK (19XX)|870323|abcdef
PRINT ENTRY = Calcium Channel Agonists, Exogenous|T121|NON|NRW|UNK (19XX)|870323|abcdef
ENTRY = Calcium Channel Agonist|T121|NON|EQV|NLM (1995)|940420|CALCIUM CHANNEL AGON|abcdefv
ENTRY = Exogenous Calcium Channel Agonists|T121|NON|NRW|UNK (19XX)|870515|abcdef
ENTRY = Activators, Calcium Channel
ENTRY = Agonist, Calcium Channel
ENTRY = Agonists, Calcium Channel
ENTRY = Channel Activators, Calcium
ENTRY = Channel Agonist, Calcium
ENTRY = Channel Agonists, Calcium
MN = D27.505.519.562.124
MN = D27.505.954.411.793.205
EC = antagonists & inhibitors:Calcium Channel Blockers
MH_TH = NLM (1988)
ST = T121
RN = 0
AN = vasoconstrictors; DF: CALCIUM CHANNEL AGON or CALCIUM CHANNEL AG
PI = Calcium/metab (1966-1987)
PI = Ion Channels (1979-1987)
MS = Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.
PM = 88
HN = 88
MR = 20080708
DA = 19870323
DC = 1
DX = 19880101
UI = D002120

*NEWRECORD
RECTYPE = D
MH = Calcium Channel Blockers
DE = CA CHANNEL BLOCK
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Calcium Antagonists, Exogenous|T121|NON|NRW|UNK (19XX)|820518|CA ANTAG EXOGENOUS|abcdefv
PRINT ENTRY = Calcium Blockaders, Exogenous|T121|NON|NRW|UNK (19XX)|810512|CA BLOCK EXOGENOUS|abcdefv
PRINT ENTRY = Calcium Inhibitors, Exogenous|T121|NON|NRW|UNK (19XX)|810512|CA INHIB EXOGENOUS|abcdefv
PRINT ENTRY = Channel Blockers, Calcium|T121|NON|EQV|UNK (19XX)|820518|CHANNEL BLOCK CA|abcdefv
ENTRY = Calcium Channel Antagonists|T121|NON|EQV|NLM (2015)|130828|abcdef
ENTRY = Calcium Channel Blocking Drugs|T121|NON|EQV|NLM (1996)|941024|abcdef
ENTRY = Exogenous Calcium Antagonists|T121|NON|NRW|NLM (1993)|920416|EXOGENOUS CA ANTAG|abcdefv
ENTRY = Exogenous Calcium Blockaders|T121|NON|NRW|NLM (1993)|920416|EXOGENOUS CA BLOCK|abcdefv
ENTRY = Exogenous Calcium Inhibitors|T121|NON|NRW|NLM (1993)|920416|EXOGENOUS CA INHIB|abcdefv
ENTRY = Antagonists, Calcium Channel
ENTRY = Antagonists, Exogenous Calcium
ENTRY = Blockers, Calcium Channel
MN = D27.505.519.562.249
MN = D27.505.954.411.192
FX = Anti-Arrhythmia Agents
FX = Antihypertensive Agents
FX = Vasodilator Agents
MH_TH = NLM (1982)
ST = T121
RN = 0
PI = Calcium (1966-1967) /antagonists & inhibitors (1968-1981)
PI = Ion Channels (1979-1981)
MS = A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
OL = use CALCIUM CHANNEL BLOCKERS to search CALCIUM ANTAGONISTS, EXOGENOUS 1982
PM = 83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982
HN = 83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982
MR = 20140610
DA = 19810512
DC = 1
DX = 19820101
UI = D002121

*NEWRECORD
RECTYPE = D
MH = Calcium Chloride
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Calcium Chloride Dihydrate|T121|T197|EQV|FDA SRS (2014)|JAN (19XX)|NLM (1999)|USP (19XX)|990913|abbdeeeef
ENTRY = Calcium Chloride, Anhydrous|T197|NON|NRW|FDA SRS (2014)|NLM (2001)|000330|abcdeef
ENTRY = Chloride Dihydrate, Calcium
ENTRY = Chloride, Calcium
ENTRY = Dihydrate, Calcium Chloride
MN = D01.146.300
MN = D01.210.450.150.150
MH_TH = FDA SRS (2014)
MH_TH = NLM (1965)
ST = T121
ST = T197
N1 = Calcium chloride
RN = M4I0D6VV5M
RR = 10035-04-8 (dihydrate)
RR = 10043-52-4 (Calcium Chloride)
RR = OFM21057LP
MS = A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning.
PM = 65
HN = 65
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D002122

*NEWRECORD
RECTYPE = D
MH = Calcium Dobesilate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Dobesilate Calcium|T109|T121|NON|EQV|NLM (1994)|921119|abbcdef
ENTRY = 2,5-Dihydroxybenzenesulfonate|T109|T121|NON|BRD|NLM (1994)|921119|abbcdef
ENTRY = 2,5-Dihydroxybenzenesulfonic Acid|T109|T121|NON|BRD|NLM (1994)|921119|abbcdef
ENTRY = Altana Pharma Oranienburg Brand of Calcium Dobesilate Monohydrate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Calcium Dobesilate (1:1)|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcium Dobesilate Monoammonium Salt|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcium Dobesilate Monopotassium Salt|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Dexium|T109|T121|TRD|NRW|DE|801203|abbcdef
ENTRY = Dobica|T109|T121|TRD|NRW|DE|040610|abbcdef
ENTRY = Doxium|T109|T121|TRD|NRW|ES|MX|801204|abbcdeef
ENTRY = Esteve Brand of Calcium Dobesilate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Knoll Brand of Calcium Dobesilate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Sanofi Synthelabo Brand of Calcium Dobesilate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = 2,5 Dihydroxybenzenesulfonate
ENTRY = 2,5 Dihydroxybenzenesulfonic Acid
ENTRY = Calcium, Dobesilate
ENTRY = Dobesilate, Calcium
MN = D02.455.426.559.389.097.120
MN = D02.886.645.600.080.050.100.075
PA = Hemostatics
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1)
RN = 5921X1560Q
RR = 20123-80-2 (Calcium Dobesilate)
RR = 20676-50-0 (mono-NH4+ salt)
RR = 21799-87-1 (mono-K salt)
RR = 86928-25-8 (Ca salt (1:1))
PI = Benzenesulfonates (1974)
PI = Hydroquinones (1972-1974)
MS = A drug used to reduce hemorrhage in diabetic retinopathy.
PM = 91; was see under BENZENESULFONATES 1975-90
HN = 91(75); was see under BENZENESULFONATES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002123

*NEWRECORD
RECTYPE = D
MH = Calcium Fluoride
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Fluoride, Calcium
MN = D01.146.325
MN = D01.303.350.300.150
MH_TH = FDA SRS (2014)
MH_TH = NLM (1965)
ST = T197
N1 = Calcium fluoride (CaF2)
RN = O3B55K4YKI
RR = 7789-75-5 (Calcium Fluoride)
MS = Calcium fluoride. Occurring in nature as the mineral fluorite or fluorspar. It is the primary source of fluorine and its compounds. Pure calcium fluoride is used as a catalyst in dehydration and dehydrogenation and is used to fluoridate drinking water. (From Merck Index, 11th ed)
PM = 65
HN = 65
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D002124

*NEWRECORD
RECTYPE = D
MH = Calcium Gluconate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 3M Brand of Calcium Gluconate Monohydrate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Braun Brand of Calcium Gluconate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = CBG|T109|T121|TRD|NRW|AU|040610|abbcdef
ENTRY = Calciofon|T109|T121|TRD|NRW|NLM (1990)|891116|abbcdef
ENTRY = Calcipot|T109|T121|TRD|NRW|DE|040610|abbcdef
ENTRY = Calcium Braun|T109|T121|TRD|NRW|DE|040610|abbcdef
ENTRY = Calcivitol|T109|T121|TRD|NRW|FR|040610|abbcdef
ENTRY = Calglucon|T109|T121|TRD|NRW|NLM (1990)|891116|abbcdef
ENTRY = Chaix et du Marais Brand of Calcium Gluconate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Coophavet Brand of Calcium Gluconate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Ebucin|T109|T121|TRD|NRW|NLM (1990)|891116|abbcdef
ENTRY = Flopak Plain|T109|T121|TRD|NRW|AU|040610|abbcdef
ENTRY = Fresenius Kabi Brand of Calcium Gluconate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Glucal|T109|T121|TRD|NRW|NLM (1990)|891116|abbcdef
ENTRY = Glucobiogen|T109|T121|TRD|NRW|NLM (1990)|891116|abbcdef
ENTRY = Gluconate de Calcium Lavoisier|T109|T121|TRD|NRW|FR|040610|abbcdef
ENTRY = Gluconato Calc Fresenius|T109|T121|TRD|NRW|ES|040610|abbcdef
ENTRY = Merial Brand of Calcium Gluconate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Pharmtech Brand of Calcium Gluconate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Gluconate, Calcium
MN = D02.241.081.844.322.200
MN = D02.241.511.902.322.200
MN = D09.811.308.200
MH_TH = FDA SRS (2014)
MH_TH = UNK (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = D-Gluconic acid, calcium salt (2:1)
RN = SQE6VB453K
RR = 299-28-5 (Calcium Gluconate)
PI = Calcium (1966-1978)
PI = Gluconates (1966-1978)
MS = The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states.
PM = 91; was see under GLUCONATES 1979-90
HN = 91(79); was see under GLUCONATES 1979-90
MR = 20130708
DA = 19771209
DC = 1
DX = 19910101
UI = D002125

*NEWRECORD
RECTYPE = D
MH = Calcium Hydroxide
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Hydroxide, Calcium
MN = D01.045.250.313
MN = D01.146.335
MN = D01.248.497.158.459.150
PA = Bone Cements
MH_TH = FDA SRS (2014)
MH_TH = NLM (1967)
MH_TH = USP (19XX)
ST = T121
ST = T197
N1 = Calcium hydroxide (Ca(OH)2)
RN = PF5DZW74VN
RR = 1305-62-0 (Calcium Hydroxide)
PI = Calcium (1966)
PI = Hydroxides (1966)
MS = A white powder prepared from lime that has many medical and industrial uses. It is in many dental formulations, especially for root canal filling.
PM = 67
HN = 67
MR = 20150622
DA = 19990101
DC = 1
DX = 19670101
UI = D002126

*NEWRECORD
RECTYPE = D
MH = Calcium Isotopes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Isotopes, Calcium
MN = D01.496.098
MH_TH = NLM (1966)
ST = T196
RN = 0
AN = Ca-42-44, 46, 48; NIM
MS = Stable calcium atoms that have the same atomic number as the element calcium, but differ in atomic weight. Ca-42-44, 46, and 48 are stable calcium isotopes.
MR = 20000622
DA = 19990101
DC = 1
UI = D002127

*NEWRECORD
RECTYPE = D
MH = Calcium Metabolism Disorders
DE = CALCIUM METAB DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Calcium Metabolism Disorder
ENTRY = Disorder, Calcium Metabolism
ENTRY = Disorders, Calcium Metabolism
MN = C18.452.174
MH_TH = NLM (1966)
ST = T047
AN = GEN or unspecified; prefer specifics; DF: CALCIUM METAB DIS
MS = Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.
CATSH = CAT LIST
MR = 19960610
DA = 19990101
DC = 1
UI = D002128

*NEWRECORD
RECTYPE = D
MH = Calcium Oxalate
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Calcium Oxalate (1:1)|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Calcium Oxalate Dihydrate|T109|NON|NRW|UNK (19XX)|841105|abcdef
ENTRY = Calcium Oxalate Dihydrate (1:1)|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Calcium Oxalate Monohydrate|T109|NON|NRW|FDA SRS (2014)|UNK (19XX)|841105|abcdeef
ENTRY = Calcium Oxalate Monohydrate (1:1)|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Calcium Oxalate Trihydrate|T109|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Dihydrate, Calcium Oxalate
ENTRY = Monohydrate, Calcium Oxalate
ENTRY = Oxalate, Calcium
ENTRY = Trihydrate, Calcium Oxalate
MN = D02.241.081.337.593.750.500
EC = analogs & derivatives:Oxalates
MH_TH = FDA SRS (2014)
MH_TH = NLM (1979)
ST = T109
N1 = Ethanedioic acid, calcium salt
RN = 2612HC57YE
RR = 17787-50-7 (Ca (1:1) salt, tri-H2O)
RR = 18400-37-8 (Ca (1:1) salt, di-H2O)
RR = 25454-23-3 (Calcium Oxalate)
RR = 4PP86KK527
RR = 563-72-4 (Ca (1:1) salt)
RR = 5794-28-5 (Ca (1:1) salt, mono-H2O)
AN = OXALATES is also available
PI = Calcium (1966-1978)
PI = Oxalates (1966-1978)
MS = The calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi.
PM = 79
HN = 79
MR = 20130708
DA = 19771209
DC = 1
DX = 19790101
UI = D002129

*NEWRECORD
RECTYPE = D
MH = Calcium Phosphates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Phosphates, Calcium
MN = D01.029.260.700.675.374.075
MN = D01.146.360
MN = D01.695.625.675.650.075
MH_TH = NLM (1964)
ST = T121
ST = T197
RN = 0
AN = GEN or unspecified; prefer specifics; often used as calcium supplement
MS = Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements.
PM = 65
HN = 65(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D002130

*NEWRECORD
RECTYPE = D
MH = Calcium Pyrophosphate
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Calcium Diphosphate|T197|NON|EQV|FDA SRS (2014)|UNK (19XX)|760414|abcdeef
ENTRY = Calcium Pyrophosphate (1:1)|T197|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Calcium Pyrophosphate (1:2)|T197|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Calcium Pyrophosphate (2:1)|T197|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Calcium Pyrophosphate Dihydrate|T197|NON|NRW|UNK (19XX)|820204|abcdef
ENTRY = Calcium Pyrophosphate, Monohydrate|T197|NON|NRW|NLM (1999)|990913|abcdef
ENTRY = Diphosphate, Calcium
ENTRY = Monohydrate Calcium Pyrophosphate
ENTRY = Pyrophosphate Dihydrate, Calcium
ENTRY = Pyrophosphate, Calcium
ENTRY = Pyrophosphate, Monohydrate Calcium
MN = D01.029.260.700.675.374.075.150
MN = D01.029.260.700.675.374.775.150.150
MN = D01.146.360.150
MN = D01.695.625.675.650.075.150
MN = D01.695.625.675.650.775.150.150
FX = Chondrocalcinosis
MH_TH = FDA SRS (2014)
MH_TH = NLM (1977)
ST = T197
N1 = Diphosphoric acid, calcium salt
RN = X69NU20D19
RR = 10086-45-0 (Calcium Pyrophosphate)
RR = 14866-19-4 (calcium salt (1:1))
RR = 35255-34-6 (monohydrate)
RR = 35405-51-7 (calcium salt (2:1))
RR = 7790-76-3 (calcium salt (1:2))
AN = deposition = CALCIUM PYROPHOSPHATE DIHYDRATE DEPOSITION see CHONDROCALCINOSIS
PI = Pyrophosphates (1966-1976)
MS = An inorganic pyrophosphate which affects calcium metabolism in mammals. Abnormalities in its metabolism occur in some human diseases, notably HYPOPHOSPHATASIA and pseudogout (CHONDROCALCINOSIS).
PM = 91; was see under PYROPHOSPHATES 1977-90
HN = 91(77); was see under PYROPHOSPHATES 1977-90
MR = 20130708
DA = 19760416
DC = 1
DX = 19910101
UI = D002131

*NEWRECORD
RECTYPE = D
MH = Calcium Radioisotopes
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Radioisotopes, Calcium
MN = D01.496.098.325
MN = D01.496.749.113
MH_TH = NLM (1974)
ST = T196
RN = 0
AN = Ca-37-39, 41, 45, 47, 49, 50; for routine use as tracer, use no qualifiers
MS = Unstable isotopes of calcium that decay or disintegrate emitting radiation. Ca atoms with atomic weights 39, 41, 45, 47, 49, and 50 are radioactive calcium isotopes.
OL = search CALCIUM ISOTOPES 1966-73
PM = 74
HN = 74
MR = 20150605
DA = 19990101
DC = 1
DX = 19740101
UI = D002132

*NEWRECORD
RECTYPE = D
MH = Calcium Sulfate
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Dental Gypsum|T122|T197|NON|NRW|NLM (1997)|960327|DENT GYPSUM|abbcdefv
PRINT ENTRY = Dental Stone, Artificial|T122|T197|NON|NRW|UNK (19XX)|790530|DENT STONE ARTIFICIAL|abbcdefv
PRINT ENTRY = Gypsum|T197|NON|NRW|FDA SRS (2014)|UNK (19XX)|790530|abcdeef
PRINT ENTRY = Plaster of Paris|T122|T197|EPO|NRW|FDA SRS (2014)|UNK (19XX)|790530|abbcdeef
ENTRY = Alabaster|T122|T197|NON|NRW|FDA SRS (2014)|NLM (1991)|900517|abbcdeef
ENTRY = Anhydrous Sulfate of Lime|T122|T197|NON|NRW|NLM (1991)|900517|abbcdef
ENTRY = Artificial Dental Stone|T122|T197|NON|NRW|NLM (1991)|900116|ARTIFICIAL DENT STONE|abbcdefv
ENTRY = Calcium Sulfate (1:1), Dihydrate|T122|T197|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcium Sulfate (1:1), Hemihydrate|T122|T197|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcium Sulfate (2:1)|T122|T197|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Calcium Sulfate, Anhydrous|T122|T197|NON|NRW|NLM (1994)|930106|abbcdef
ENTRY = Calcium Sulfate, Dihydrate|T122|T197|NON|NRW|UNK (19XX)|800801|abbcdef
ENTRY = Calcium Sulfate, Hemihydrate|T122|T197|NON|NRW|NLM (1994)|930106|abbcdef
ENTRY = Calcium Sulphate|T122|T197|NON|EQV|NLM (2002)|010123|abbcdef
ENTRY = Drierite|T197|TRD|NRW|NLM (1991)|900517|abcdef
ENTRY = Gypsite|T122|T197|NON|NRW|NLM (1991)|900517|abbcdef
ENTRY = Gypsum, Dental|T122|T197|NON|NRW|NLM (1997)|960408|GYPSUM DENT|abbcdefv
ENTRY = Karstenite|T197|NON|NRW|NLM (1991)|900517|abcdef
ENTRY = Stone, Artificial Dental|T122|T197|NON|NRW|NLM (1991)|900116|STONE ARTIFICIAL DENT|abbcdefv
ENTRY = Anhydrous Calcium Sulfate
ENTRY = Dihydrate Calcium Sulfate
ENTRY = Hemihydrate Calcium Sulfate
ENTRY = Lime Anhydrous Sulfate
ENTRY = Paris Plaster
ENTRY = Sulfate, Calcium
ENTRY = Sulphate, Calcium
MN = D01.146.375
MN = D01.578.215
MN = D01.875.800.800.850.125
PA = Dental Materials
MH_TH = NLM (1966)
ST = T122
ST = T197
N1 = Sulfuric acid, calcium salt (1:1)
RN = WAT0DDB505
RR = 10034-76-1 (1:1 salt, hemi-H2O)
RR = 10101-41-4 (1:1 salt, di-H2O)
RR = 23276-62-2 (2:1 salt)
RR = 3RW091J48V
RR = 4846Q921YM
RR = 7778-18-9 (Calcium Sulfate)
MS = A calcium salt that is used for a variety of purposes including: building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient. It exists in various forms and states of hydration. Plaster of Paris is a mixture of powdered and heat-treated gypsum.
OL = use CALCIUM SULFATE to search PLASTER OF PARIS 1966-79
PM = 80; PLASTER OF PARIS was heading 1963-79
HN = 80; PLASTER OF PARIS was heading 1963-79
MR = 20130708
DA = 19990101
DC = 1
UI = D002133

*NEWRECORD
RECTYPE = D
MH = Calcium-Binding Proteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Calcium Binding Proteins|T116|T192|NON|EQV|UNK (19XX)|790523|abbcdef
ENTRY = Binding Proteins, Calcium
MN = D12.776.157.125
MH_TH = NLM (1980)
ST = T116
ST = T192
RN = 0
AN = RECEPTORS, CALCIUM-SENSING is also available
PI = Calcium (1966-1979)
PI = Carrier Proteins (1971-1979)
PI = Proteins (1966-1970)
MS = Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS.
PM = 80; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT & CALCIUM-DEPENDENT REGULATOR were see under CARRIER PROTEINS 1979
HN = 80
MR = 20050630
DA = 19790523
DC = 1
DX = 19800101
UI = D002135

*NEWRECORD
RECTYPE = D
MH = Calcium, Dietary
AQ = AD AE AG AI AN BL CF CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Dietary Calcium|T197|NON|EQV|UNK (19XX)|740329|abcdef
MN = D01.146.315
PA = Bone Density Conservation Agents
EC = chemistry:Calcium:chemistry
EC = deficiency:Calcium:deficiency
MH_TH = NLM (1966)
ST = T197
RN = 0
AN = /adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther
MS = Calcium compounds used as food supplements or in food to supply the body with calcium. Dietary calcium is needed during growth for bone development and for maintenance of skeletal integrity later in life to prevent osteoporosis.
MR = 20050630
DA = 19990101
DC = 1
UI = D002136

*NEWRECORD
RECTYPE = D
MH = Calculi
AQ = BL CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UL UR US VE VI
ENTRY = Biliary or Urinary Stones|T031|T046|NON|EQV|NLM (2000)|991108|abbcdef
ENTRY = Calculus
MN = C23.300.175
FX = Lithiasis
FX = Lithotripsy
MH_TH = NLM (1966)
ST = T031
ST = T046
AN = GEN or unspecified: prefer specifics; coord IM with organ/diseases term (IM); chem composition of calculi: use /chem; /ultrastruct permitted; chemolysis of calculi: coord dis with /ther, not /drug ther
MS = An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.
OL = to search for chem composition of calculi, use CALCULI/anal 1987-1990 & CALCULI/metab 1966-86
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
UI = D002137

*NEWRECORD
RECTYPE = D
MH = Calibration
AQ = ST
ENTRY = Calibrations
MN = E05.978.155
MH_TH = NLM (1978)
ST = T081
AN = NIM; coordinate with specific scale (IM) if relevant
MS = Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output.
PM = 91; was see under WEIGHTS AND MEASURES 1978-90
HN = 91(78); was see under WEIGHTS AND MEASURES 1978-90
CATSH = CAT LIST
MR = 20150630
DA = 19770427
DC = 1
DX = 19910101
UI = D002138

*NEWRECORD
RECTYPE = D
MH = Caliciviridae
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
MN = B04.820.095
MH_TH = NLM (1979)
ST = T005
AN = infection = CALICIVIRIDAE INFECTIONS
PI = Picornaviridae (1966-1978)
MS = A family of RNA viruses infecting a broad range of animals. Most individual species are restricted to their natural hosts. They possess a characteristic six-pointed starlike shape whose surfaces have cup-shaped (chalice) indentions. Transmission is by contaminated food, water, fomites, and occasionally aerosolization of secretions. Genera include LAGOVIRUS; NORWALK-LIKE VIRUSES; SAPPORO-LIKE VIRUSES; and VESIVIRUS.
OL = use CALICIVIRIDAE to search CALICIVIRUSES 1979-81 & 1993
PM = 82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICIVIRIDAE 1993
HN = 82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICVIRIDAE 1993
MR = 20150622
DA = 19771202
DC = 1
DX = 19790101
UI = D002139

*NEWRECORD
RECTYPE = D
MH = California
AQ = EH EP
MN = Z01.107.567.875.580.200
MN = Z01.107.567.875.760.200
MH_TH = POPLINE (1978)
ST = T083
AN = LOS ANGELES is also available
MR = 19970620
DA = 19990101
DC = 4
UI = D002140

*NEWRECORD
RECTYPE = D
MH = Encephalitis Virus, California
DE = ENCEPH VIRUS CALIFORNIA
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Jamestown Canyon virus|T005|EPO|NRW|UNK (19XX)|750120|abcdef
PRINT ENTRY = Tahyna virus|T005|EPO|NRW|UNK (19XX)|741230|abcdef
ENTRY = California Encephalitis Virus|T005|EPO|EQV|UNK (19XX)|150623|CALIFORNIA ENCEPH VIRUS|abcdefv
ENTRY = California Encephalitis Viruses|T005|EPO|EQV|NLM (1992)|901128|CALIFORNIA ENCEPH VIRUSES|abcdefv
ENTRY = California Group Viruses|T005|EPO|EQV|NLM (1975)|990101|abcdef
ENTRY = California Virus|T005|EPO|EQV|NLM (1992)|901113|abcdef
ENTRY = Encephalitis Viruses, California|T005|EPO|EQV|NLM (1992)|901128|ENCEPH VIRUSES CALIFORNIA|abcdefv
MN = B04.820.087.640.300
MN = B04.820.230.100
MH_TH = UNK (19XX)
ST = T005
AN = infection = ENCEPHALITIS, CALIFORNIA
MS = A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. Serotypes are found in temperate and arctic regions and each is closely associated with a single species of vector mosquito. The vertebrate hosts are usually small mammals but several serotypes infect humans.
PM = 2002: see CALIFORNIA GROUP VIRUSES 1991-2001, see BUNYAVIRIDAE 1981-1990, see ENCEPHALITIS VIRUSES 1977-1980; for CALIFORNIA VIRUS see ARBOVIRUSES 1975-1976
HN = 2002 (1977)
MR = 20150623
DA = 19741111
DC = 1
DX = 19910101
UI = D002141

*NEWRECORD
RECTYPE = D
MH = Californium
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.268.271.100.150
MN = D01.268.556.156
MN = D01.552.020.200
MN = D01.552.544.156
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T121
ST = T196
N1 = Californium
RN = 975X05H15A
RR = 7440-71-3 (Californium)
AN = man-made radioactive element; IM
MS = Californium. A man-made radioactive actinide with atomic symbol Cf, atomic number 98, and atomic weight 251. Its valence can be +2 or +3. Californium has medical use as a radiation source for radiotherapy.
MR = 20150622
DA = 19990101
DC = 1
UI = D002142

*NEWRECORD
RECTYPE = D
MH = Callitrichinae
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Callithricidae|T015|NON|EQV|NLM (1992)|901102|abcdef
ENTRY = Callitrichidae|T015|NON|EQV|NLM (1991)|900410|abcdef
MN = B01.050.150.900.649.801.400.600.150.150
MH_TH = NLM (1975)
ST = T015
AN = index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
PI = Anthropoidea (1966-1974)
MS = A subfamily in the family CEBIDAE that consists of four genera: CALLITHRIX (marmosets), CALLIMICO (Goeldi's monkey), LEONTOPITHECUS (lion tamarins), and SAGUINUS (long-tusked tamarins). The members of this family inhabit the tropical forests of South and Central America.
PM = 2006; see CALLITRICHINAE 1992-2005, see CALLITHRICIDAE 1981-1991, see MARMOSETS 1975-1980
HN = 2006 (1975)
MR = 20090706
DA = 19741119
DC = 1
DX = 19750901
UI = D002143

*NEWRECORD
RECTYPE = D
MH = Callithrix
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Callithrix jacchus|T015|NON|NRW|UNK (19XX)|800507|abcdef
PRINT ENTRY = Cebuella|T015|NON|REL|UNK (19XX)|800507|abcdef
PRINT ENTRY = Hapale|T015|NON|EQV|UNK (19XX)|800507|abcdef
PRINT ENTRY = Marmoset, Common|T015|NON|NRW|UNK (19XX)|800507|abcdef
PRINT ENTRY = Marmoset, Short-Tusked|T015|NON|EQV|UNK (19XX)|800507|abcdef
PRINT ENTRY = Marmosets|T015|NON|EQV|NLM (1992)|901128|abcdef
ENTRY = Cebuellas
ENTRY = Common Marmoset
ENTRY = Common Marmosets
ENTRY = Marmoset
ENTRY = Marmoset, Short Tusked
ENTRY = Marmosets, Common
ENTRY = Marmosets, Short-Tusked
ENTRY = Short-Tusked Marmoset
ENTRY = Short-Tusked Marmosets
MN = B01.050.150.900.649.801.400.600.150.150.114
MH_TH = NLM (1981)
ST = T015
AN = index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
PI = Callithricidae (1975-1980)
MS = A genus of the subfamily CALLITRICHINAE occurring in forests of Brazil and Bolivia and containing seventeen species.
PM = 1992; see CALLITHRICIDAE 1981-1991; for CEBUELLA see CALLITRICHIDAE 1981-2005
HN = 1992 (1981); for CEBUELLA use CALLITRICHIDAE 1981-2005
MR = 20090706
DA = 19800507
DC = 1
DX = 19910101
UI = D002144

*NEWRECORD
RECTYPE = D
MH = Callosities
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Corns|T020|NON|REL|NLM (1993)|920331|abcdef
ENTRY = Callosity
MN = C17.800.428.200
MH_TH = NLM (1966)
ST = T020
ST = T047
AN = callous goes here: do not confuse with BONY CALLUS, post-fract bone formation
MS = Localized hyperplasia of the horny layer of the epidermis due to pressure or friction. (Dorland, 27th ed)
OL = use CALLOSITIES to search CORNS 1975-92
PM = CORNS was heading 1975-92 (see under CALLOSITIES 1975-90)
HN = CORNS was heading 1975-92 (see under CALLOSITIES 1975-90)
CATSH = CAT LIST
MR = 19991129
DA = 19990101
DC = 1
UI = D002145

*NEWRECORD
RECTYPE = D
MH = Bony Callus
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Callus|T024|NON|EQV|NLM (1973)|990101|abcdef
ENTRY = Callus, Bony
MN = A10.165.265.200
FX = Fractures, Bone
FX = Osteogenesis
MH_TH = NLM (2000)
ST = T024
AN = post-fract bone formation; do not confuse with "callous" ( = CALLOSITIES)
PI = Fractures (1966-1972)
MS = The bony deposit formed between and around the broken ends of BONE FRACTURES during normal healing.
PM = 2000; see CALLUS 1973-1999, see FRACTURES 1963-1972
HN = 2000(1973)
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D002146

*NEWRECORD
RECTYPE = D
MH = Calmodulin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Calcium-Dependent Activator Protein|T116|T123|NON|EQV|UNK (19XX)|780308|abbcdef
PRINT ENTRY = Calcium-Dependent Regulator|T116|T123|NON|EQV|UNK (19XX)|830404|CALCIUM DEPENDENT REG|abbcdefv
ENTRY = Bovine Activator Protein|T116|T123|NON|NRW|UNK (19XX)|801104|abbcdef
ENTRY = Cyclic AMP-Phosphodiesterase Activator|T116|T123|NRW|UNK (19XX)|820203|abbdef
ENTRY = Phosphodiesterase Activating Factor|T116|T123|NON|EQV|UNK (19XX)|801104|abbcdef
ENTRY = Phosphodiesterase Activator Protein|T116|T123|NON|EQV|UNK (19XX)|801104|abbcdef
ENTRY = Phosphodiesterase Protein Activator|T116|T123|NON|EQV|UNK (19XX)|801104|abbcdef
ENTRY = Regulator, Calcium-Dependent|T116|T123|NON|EQV|NLM (1992)|901015|REG CALCIUM DEPENDENT|abbcdefv
ENTRY = AMP-Phosphodiesterase Activator, Cyclic
ENTRY = Activating Factor, Phosphodiesterase
ENTRY = Activator Protein, Bovine
ENTRY = Activator Protein, Calcium-Dependent
ENTRY = Activator Protein, Phosphodiesterase
ENTRY = Activator, Cyclic AMP-Phosphodiesterase
ENTRY = Activator, Phosphodiesterase Protein
ENTRY = Calcium Dependent Activator Protein
ENTRY = Calcium Dependent Regulator
ENTRY = Cyclic AMP Phosphodiesterase Activator
ENTRY = Factor, Phosphodiesterase Activating
ENTRY = Protein Activator, Phosphodiesterase
ENTRY = Protein, Bovine Activator
ENTRY = Protein, Calcium-Dependent Activator
ENTRY = Protein, Phosphodiesterase Activator
ENTRY = Regulator, Calcium Dependent
MN = D12.644.360.381.249
MN = D12.776.157.125.412.249
MN = D12.776.476.387.249
MH_TH = NLM (1979)
ST = T116
ST = T123
RN = 0
AN = a calcium-binding protein; /biosyn /physiol permitted
PI = Calcium (1966-1978)
PI = Carrier Proteins (1971-1978)
PI = Enzyme Activation (1969-1978)
MS = A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels.
OL = use CALMODULIN to search CALCIUM-DEPENDENT REGULATOR 1979-83
PM = 84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83; was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979
HN = 84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83; was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979
MR = 20050630
DA = 19780308
DC = 1
DX = 19840101
UI = D002147

*NEWRECORD
RECTYPE = D
MH = Calmodulin-Binding Proteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Caldesmon|T116|T123|NON|NRW|UNK (19XX)|850425|abbcdef
PRINT ENTRY = Calspectin|T116|T123|NON|NRW|UNK (19XX)|850425|abbcdef
ENTRY = CaM-BP(80)|T116|T123|ABB|NRW|UNK (19XX)|850425|abbcdef
ENTRY = Caldesmon (77)|T116|T123|NON|NRW|UNK (19XX)|870810|abbcdef
ENTRY = Calmodulin Binding Proteins
ENTRY = Proteins, Calmodulin-Binding
MN = D12.776.157.142
MH_TH = NLM (1986)
ST = T116
ST = T123
RN = 0
AN = /biosyn /drug eff /physiol permitted
PI = Calcium-Binding Proteins (1980-1985)
PI = Carrier Proteins (1966-1979)
PI = Phosphoprotein Phosphatases (1982-1985)
MS = Proteins which bind calmodulin. They are found in many tissues and have a variety of functions including F-actin cross-linking properties, inhibition of cyclic nucleotide phosphodiesterase and calcium and magnesium ATPases.
PM = 86
HN = 86
MR = 20050630
DA = 19850425
DC = 1
DX = 19860101
UI = D002148

*NEWRECORD
RECTYPE = D
MH = Energy Intake
AQ = DE EH GE IM PH RE
PRINT ENTRY = Caloric Intake|T081|NON|EQV|POPLINE (1988)|950714|abcdef
MN = G07.203.650.240.340
MH_TH = NLM (1997)
ST = T081
AN = "total no. of calories taken in daily"
PI = Diet (1966-1976)
PI = Nutrition (1966-1976)
MS = Total number of calories taken in daily whether ingested or by parenteral routes.
PM = 97: was CALORIC INTAKE 1977-96 (see under DIET 1977-83)
HN = 97: was CALORIC INTAKE 1977-96 (see under DIET 1977-83)
CATSH = CAT LIST
MR = 20150629
DA = 19760416
DC = 1
DX = 19840101
UI = D002149

*NEWRECORD
RECTYPE = D
MH = Caloric Tests
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Barany Test|T060|EPO|NRW|NLM (1993)|911101|abcdef
ENTRY = Barany's Test|T060|EPO|NRW|NLM (1998)|961007|abcdef
ENTRY = Baranys Test
ENTRY = Caloric Test
ENTRY = Test, Barany
ENTRY = Test, Barany's
ENTRY = Test, Caloric
ENTRY = Tests, Caloric
MN = E01.370.382.900.150
MH_TH = NLM (1975)
ST = T060
AN = vestib funct test using heat or cold; note X ref: spell in titles & transl with accents: Brny
MS = Elicitation of a rotatory nystagmus by stimulating the semicircular canals with water or air which is above or below body temperature. In warm caloric stimulation a rotatory nystagmus is developed toward the side of the stimulated ear; in cold, away from the stimulated side. Absence of nystagmus indicates the labyrinth is not functioning.
PM = 91; see VESTIBULAR FUNCTION TESTS 1975-90; BARANY TEST was BARANY'S TEST 1993-97
HN = 91(75); BARANY TEST was BARANY'S TEST 1993-97
CATSH = CAT LIST
MR = 20010813
DA = 19741212
DC = 1
DX = 19910101
UI = D002150

*NEWRECORD
RECTYPE = D
MH = Calorimetry
AQ = CL EC HI IS MT SN ST TD UT VE
MN = E05.196.131
MH_TH = NLM (1965)
ST = T059
MS = The measurement of the quantity of heat involved in various processes, such as chemical reactions, changes of state, and formations of solutions, or in the determination of the heat capacities of substances. The fundamental unit of measurement is the joule or the calorie (4.184 joules). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 67
HN = 67(65)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
DX = 19670101
UI = D002151

*NEWRECORD
RECTYPE = D
MH = Calorimetry, Differential Scanning
DE = CALORIMETRY DIFFER SCAN
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Differential Thermal Analysis, Calorimetric|T059|NON|EQV|UNK (19XX)|760412|DIFFER THERMAL ANAL CALORIMETRIC|abcdefv
ENTRY = Calorimetric Differential Thermal Analysis|T059|NON|EQV|NLM (1992)|901029|CALORIMETRIC DIFFER THERMAL ANAL|abcdefv
ENTRY = Differential Scanning Calorimetry|T059|NON|EQV|NLM (1992)|901010|DIFFER SCAN CALORIMETRY|abcdefv
ENTRY = Scanning Calorimetry, Differential
MN = E05.196.131.310
MN = E05.196.370.310
MH_TH = NLM (1977)
ST = T059
AN = an anal chem technique; NIM; DF: CALORIMETRY DIFFER SCAN
PI = Calorimetry (1966-1976)
MS = Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample.
PM = 91; was see under CALORIMETRY 1977-90
HN = 91(77); was see under CALORIMETRY 1977-90
CATSH = CAT LIST
MR = 20020703
DA = 19760413
DC = 1
DX = 19910101
UI = D002152

*NEWRECORD
RECTYPE = D
MH = Calorimetry, Indirect
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Calorimetry, Respiration|T059|NON|EQV|UNK (19XX)|741212|abcdef
ENTRY = Calorimetries, Indirect
ENTRY = Calorimetries, Respiration
ENTRY = Indirect Calorimetries
ENTRY = Indirect Calorimetry
ENTRY = Respiration Calorimetries
ENTRY = Respiration Calorimetry
MN = E05.196.131.655
MH_TH = NLM (1975)
ST = T059
AN = an anal chem technique; NIM
MS = Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange.
PM = 91; was see under CALORIMETRY 1975-90
HN = 91(75); was see under CALORIMETRY 1975-90
CATSH = CAT LIST
MR = 20150622
DA = 19741212
DC = 1
DX = 19910101
UI = D002153

*NEWRECORD
RECTYPE = D
MH = Calpain
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Calcium-Activated Neutral Protease|T116|T126|NON|EQV|UNK (19XX)|850425|abbcdef
PRINT ENTRY = Calcium-Dependent Neutral Proteinase|T116|T126|NON|EQV|UNK (19XX)|850425|abbcdef
ENTRY = Ca2+-Activated Protease|T116|T126|NON|EQV|UNK (19XX)|850425|abbcdef
ENTRY = Calcium-Activated Neutral Proteinase|T116|T126|NON|EQV|UNK (19XX)|850425|abbcdef
ENTRY = Calcium-Activated Protease|T116|T126|NON|EQV|UNK (19XX)|850425|abbcdef
ENTRY = Calcium-Dependent Neutral Protease|T116|T126|NON|EQV|UNK (19XX)|850425|abbcdef
ENTRY = Calpain I|T116|T123|NON|NRW|UNK (19XX)|850425|abbcdef
ENTRY = Calpain II|T116|T123|NON|NRW|UNK (19XX)|850425|abbcdef
ENTRY = Desminase|T116|T126|NON|EQV|UNK (19XX)|871208|abbcdef
ENTRY = Ca2+ Activated Protease
ENTRY = Calcium Activated Neutral Protease
ENTRY = Calcium Activated Neutral Proteinase
ENTRY = Calcium Activated Protease
ENTRY = Calcium Dependent Neutral Protease
ENTRY = Calcium Dependent Neutral Proteinase
ENTRY = I, Calpain
ENTRY = II, Calpain
ENTRY = Neutral Protease, Calcium-Activated
ENTRY = Neutral Protease, Calcium-Dependent
ENTRY = Neutral Proteinase, Calcium-Activated
ENTRY = Neutral Proteinase, Calcium-Dependent
ENTRY = Protease, Ca2+-Activated
ENTRY = Protease, Calcium-Activated
ENTRY = Protease, Calcium-Activated Neutral
ENTRY = Protease, Calcium-Dependent Neutral
ENTRY = Proteinase, Calcium-Activated Neutral
ENTRY = Proteinase, Calcium-Dependent Neutral
MN = D08.811.277.656.262.500.120
MN = D08.811.277.656.300.200.120
MH_TH = NLM (1986)
ST = T116
ST = T126
RN = EC 3.4.22.-
RR = EC 3.4.22.52
RR = EC 3.4.22.53
AN = /biosyn /physiol permitted
PI = Peptide Peptidohydrolases (1966-1985)
MS = Cysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including NEUROPEPTIDES; CYTOSKELETAL PROTEINS; proteins from SMOOTH MUSCLE; CARDIAC MUSCLE; liver; platelets; and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. This enzyme was formerly listed as EC 3.4.22.4.
PM = 86
HN = 86
MR = 20090706
DA = 19850425
DC = 1
DX = 19860101
UI = D002154

*NEWRECORD
RECTYPE = D
MH = Calsequestrin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D12.776.157.125.155
MN = D12.776.210.500.220
MH_TH = NLM (1976)
ST = T116
ST = T123
RN = 0
PI = Calcium (1974-1975)
PI = Muscle Proteins (1974-1975)
MS = Acidic protein found in SARCOPLASMIC RETICULUM that binds calcium to the extent of 700-900 nmoles/mg. It plays the role of sequestering calcium transported to the interior of the intracellular vesicle.
PM = 91; was see under MUSCLE PROTEINS 1976-90
HN = 91(76); was see under MUSCLE PROTEINS 1976-90
MR = 20000622
DA = 19750723
DC = 1
DX = 19910101
UI = D002155

*NEWRECORD
RECTYPE = D
MH = Calymmatobacterium
DE = CALYMMATOBACT
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Calymmatobacterium granulomatis|T007|NON|NRW|NLM (2003)|020529|abcdef
PRINT ENTRY = Donovania|T007|NON|EQV|UNK (19XX)|760414|abcdef
MN = B03.440.450.425.180
MN = B03.660.250.150.095
MH_TH = NLM (1977)
ST = T007
AN = infection: probably GRANULOMA INGUINALE, otherwise coord IM with ENTEROBACTERIACEAE INFECTIONS (IM) + GRANULOMA or specific granuloma if pertinent
PI = Bacteria (1966-1976)
PI = Granuloma Inguinale (1966-1976)
MS = A genus of bacteria causing GRANULOMA INGUINALE and other granulomatous lesions.
PM = 77,63-65
HN = 77,63-65
MR = 20090706
DA = 19760416
DC = 1
DX = 19770101
UI = D002157

*NEWRECORD
RECTYPE = D
MH = Cambendazole
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5-Isopropoxycarbonylamino-2-(4-thiazoyl)benzimidazole|T109|T121|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = Noviben|T109|T121|TRD|NRW|UNK (19XX)|820519|abbcdef
MN = D03.438.103.190
PA = Antinematodal Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1970)
ST = T109
ST = T121
N1 = Carbamic acid, (2-(4-thiazolyl)-1H-benzimidazol-5-yl)-, 1-methylethyl ester
RN = 079X63S3DU
RR = 26097-80-3 (Cambendazole)
PI = Benzimidazoles (1971-1974)
PI = Carbamates (1972-1974)
PI = Thiazoles (1971-1974)
MS = A nematocide effective against a variety of gastrointestinal parasites in cattle, sheep, and horses.
PM = 91; was see under BENZIMIDAZOLES 1975-90
HN = 91(75); was see under BENZIMIDAZOLES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D002159

*NEWRECORD
RECTYPE = D
MH = Cambodia
AQ = EH EP
PRINT ENTRY = Kampuchea|T083|NAM|EQV|UNK (19XX)|860617|abcdef
PRINT ENTRY = Khmer Republic|T083|NAM|EQV|POPLINE (1986)|761231|abcdef
MN = Z01.252.145.182
MH_TH = POPLINE (1978)
ST = T083
MR = 19911104
DA = 19990101
DC = 4
UI = D002160

*NEWRECORD
RECTYPE = D
MH = Camelids, New World
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Alpacas|T015|NON|NRW|UNK (19XX)|741211|abcdef
PRINT ENTRY = Guanacos|T015|NON|NRW|UNK (19XX)|741211|abcdef
PRINT ENTRY = Llamas|T015|NON|NRW|UNK (19XX)|741211|abcdef
ENTRY = Alpaca
ENTRY = Camelid, New World
ENTRY = Guanaco
ENTRY = Llama
ENTRY = New World Camelid
ENTRY = New World Camelids
MN = B01.050.150.900.649.077.380.175
MH_TH = NLM (1975)
ST = T015
AN = note X refs; IM; qualif permitted
MS = Ruminant mammals of South America. They are related to camels.
PM = 91; was see under ARTIODACTYLA 1975-90
HN = 91(75); was see under ARTIODACTYLA 1975-90
MR = 20090706
DA = 19741212
DC = 1
DX = 19910101
UI = D002161

*NEWRECORD
RECTYPE = D
MH = Camels
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Dromedary|T015|NON|NRW|OBSSR (2016)|UNK (19XX)|741118|abcdeef
ENTRY = Bactrian|T015|NON|NRW|NLM (2016)|OBSSR (2016)|150210|abcdeef
ENTRY = Bactrians
ENTRY = Camel
ENTRY = Dromedaries
MN = B01.050.150.900.649.077.380.201
MH_TH = NLM (1968)
MH_TH = OBSSR (2016)
ST = T015
PI = Artiodactyla (1966-1967)
MS = Hoofed mammals with four legs, a big-lipped snout, and a humped back belonging to the family Camelidae.
PM = 68
HN = 68
MR = 20150616
DA = 19990101
DC = 1
DX = 19680101
UI = D002162

*NEWRECORD
RECTYPE = D
MH = Cameroon
AQ = EH EP
PRINT ENTRY = Republic of Cameron|T083|NAM|EQV|NLM (2009)|080303|abcdef
ENTRY = Cameroons|T083|NAM|EQV|NLM (1996)|940801|abcdef
ENTRY = United Republic of Cameroon|T083|NAM|EQV|NLM (1996)|940801|abcdef
MN = Z01.058.290.100.110
MH_TH = NLM (1978)
ST = T083
MS = A republic in central Africa lying east of CHAD and the CENTRAL AFRICAN REPUBLIC and west of NIGERIA. The capital is Yaounde.
MR = 20080708
DA = 19990101
DC = 4
UI = D002163

*NEWRECORD
RECTYPE = D
MH = Camphor
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Camphor, (+-)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Camphor, (1R)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Camphor, (1S)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
MN = D02.455.849.575.781.234.326
MN = D02.522.376
PA = Anti-Infective Agents, Local
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Bicyclo(2.2.1)heptan-2-one, 1,7,7-trimethyl-
RN = 76-22-2
RR = 21368-68-3 ((+-)-isomer)
RR = 464-48-2 ((1S)-isomer)
RR = 464-49-3 ((1R)-isomer)
MS = A bicyclic monoterpene ketone found widely in plants, especially CINNAMOMUM CAMPHORA. It is used topically as a skin antipruritic and as an anti-infective agent.
MR = 20060705
DA = 19990101
DC = 1
UI = D002164

*NEWRECORD
RECTYPE = D
MH = Camping
AQ = CL EC ES HI LJ PX SN ST TD
MN = I03.450.642.159
MH_TH = NLM (1966)
ST = T056
MS = Living outdoors as a recreational activity.
MR = 19920507
DA = 19990101
DC = 1
UI = D002165

*NEWRECORD
RECTYPE = D
MH = Camptothecin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Camptothecine|T109|T121|NON|EQV|NLM (1990)|890609|abbcdef
MN = D03.132.151
PA = Antineoplastic Agents, Phytogenic
PA = Topoisomerase I Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = NLM (1973)
ST = T109
ST = T121
N1 = 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-
RN = XT3Z54Z28A
RR = 7689-03-4 (Camptothecin)
PI = Alkaloids (1966-1972)
PI = Antineoplastic Agents (1966-1972)
MS = An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity.
PM = 73
HN = 73
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D002166

*NEWRECORD
RECTYPE = D
MH = Campylobacter
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.180
MN = B03.660.150.100
MH_TH = NLM (1976)
ST = T007
AN = infection = CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER PYLORI see HELICOBACTER PYLORI is also available
PI = Vibrio (1968-1975)
MS = A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.
PM = 76
HN = 76
MR = 20090706
DA = 19750725
DC = 1
DX = 19760101
UI = D002167

*NEWRECORD
RECTYPE = D
MH = Campylobacter fetus
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Vibrio fetus|T007|NON|EQV|UNK (19XX)|750731|abcdef
MN = B03.440.180.325
MN = B03.660.150.100.220
MH_TH = NLM (1976)
ST = T007
AN = causes abortion in cattle & sheep; infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)
PI = Vibrio (1966-1971)
MS = A species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion.
OL = use CAMPYLOBACTER FETUS to search VIBRIO FETUS 1972-83 (as Prov 1972-73)
PM = 84; was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1974-75
HN = 84(76); was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1972-75 (Prov 1972-73)
MR = 20090706
DA = 19750801
DC = 1
DX = 19840101
UI = D002168

*NEWRECORD
RECTYPE = D
MH = Campylobacter Infections
DE = CAMPYLOBACTER INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Infections, Campylobacter|T047|NON|EQV|NLM (1992)|910228|INFECT CAMPYLOBACTER|abcdefv
ENTRY = Campylobacter Infection
ENTRY = Infection, Campylobacter
MN = C01.252.400.177
MH_TH = NLM (1977)
ST = T047
AN = gram-neg bact infect
PI = Vibrio (1966-1967)
PI = Vibrio Infections (1968-1976)
MS = Infections with bacteria of the genus CAMPYLOBACTER.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 19930602
DA = 19760416
DC = 1
DX = 19770101
UI = D002169

*NEWRECORD
RECTYPE = D
MH = Canada
AQ = EH EP
MN = Z01.107.567.176
MH_TH = POPLINE (1978)
ST = T083
AN = each of the provinces & territories is available as a heading
MS = The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
MR = 19991103
DA = 19990101
DC = 4
UI = D002170

*NEWRECORD
RECTYPE = D
MH = Canaries
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Serinus|T012|NON|EQV|NLM (2004)|021119|abcdef
ENTRY = Canary
MN = B01.050.150.900.248.620.750.250.150
MH_TH = NLM (1968)
ST = T012
PI = Birds (1966-1967)
MS = Any of several Old World finches of the genus Serinus.
PM = 68
HN = 68
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D002171

*NEWRECORD
RECTYPE = D
MH = Canavanine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
MN = D12.125.311
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T116
ST = T123
N1 = L-Homoserine, O-((aminoiminomethyl)amino)-
RN = 3HZV514J4B
RR = 543-38-4 (Canavanine)
AN = an amino acid
MR = 20130708
DA = 19990101
DC = 1
UI = D002172

*NEWRECORD
RECTYPE = D
MH = Cancer Care Facilities
AQ = CL EC ES HI LJ MA OG SD SN ST TD UT
PRINT ENTRY = Hospitals, Cancer|T073|T093|NON|NRW|UNK (19XX)|840515|HOSP CANCER|abbcdefv
ENTRY = Cancer Care Facility
ENTRY = Cancer Hospital
ENTRY = Cancer Hospitals
ENTRY = Facilities, Cancer Care
ENTRY = Facility, Cancer Care
ENTRY = Hospital, Cancer
MN = N02.278.421.556.070
FX = Oncology Service, Hospital
MH_TH = NLM (1977)
ST = T073
ST = T093
MS = Institutions specializing in the care of cancer patients.
PM = 91; was see under HOSPITALS, SPECIAL Aug 1977-90
HN = 91(Aug 77); was see under HOSPITALS, SPECIAL 1977-90
MR = 19920507
DA = 19770519
DC = 1
DX = 19910101
UI = D002173

*NEWRECORD
RECTYPE = D
MH = Candicidin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Levorin|T109|T195|TRD|NRW|UNK (19XX)|810514|abbcdef
ENTRY = Candeptin|T109|T195|TRD|NRW|NLM (1990)|881229|abbcdef
ENTRY = Candicidin D|T109|T195|NON|NRW|FDA SRS (2014)|UNK (19XX)|811209|abbcdeef
ENTRY = Candimon|T109|T195|TRD|NRW|NLM (1990)|881229|abbcdef
ENTRY = Levorine|T109|T195|TRD|NRW|UNK (19XX)|810514|abbcdef
ENTRY = Vanobid|T109|T195|TRD|NRW|NLM (1990)|881229|abbcdef
MN = D02.540.576.500.968
PA = Anti-Bacterial Agents
PA = Antifungal Agents
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
MH_TH = USAN (1965)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = Candicidin
RN = 1403-17-4
RR = 5190Y348H9
PI = Antibiotics, Antifungal (1970-1974)
PI = Polyenes (1974)
MS = Mixture of antifungal heptaene macrolides from Streptomyces griseus or Actinomyces levoris used topically in candidiasis. The antibiotic complex is composed of candicidins A, B, C, and D, of which D is the major component.
OL = use CANDICIDIN to search LEVORIN 1978-89
PM = 91; was see under ANTIBIOTICS, MACROLIDE 1990; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89; LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81
HN = 91(75); was see under ANTIBIOTICS, MACROLIDE 1990; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89; LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D002174

*NEWRECORD
RECTYPE = D
MH = Candida
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Candida utilis|T004|NON|NRW|NLM (1998)|970523|abcdef
PRINT ENTRY = Monilia|T004|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Torulopsis utilis|T004|NON|NRW|NLM (1998)|970523|abcdef
ENTRY = Candida utili
ENTRY = Candidas
ENTRY = Monilias
ENTRY = Torulopsis utili
ENTRY = utili, Candida
ENTRY = utili, Torulopsis
ENTRY = utilis, Candida
ENTRY = utilis, Torulopsis
MN = B01.300.381.147
MN = B01.300.930.176
MH_TH = NLM (1966)
ST = T004
AN = infection = CANDIDIASIS or its indentions; for specific mycoses in scope note: coord CANDIDIASIS (IM) or its indentions (IM) with specific mycosis (IM)
MS = A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; vulvovaginal candidiasis (CANDIDIASIS, VULVOVAGINAL), and thrush (see CANDIDIASIS, ORAL). (From Dorland, 28th ed)
PM = TORULOPSIS was heading 1974-85
MR = 20090706
DA = 19990101
DC = 1
UI = D002175

*NEWRECORD
RECTYPE = D
MH = Candida albicans
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Candida albican
ENTRY = albican, Candida
ENTRY = albicans, Candida
MN = B01.300.381.147.326
MN = B01.300.930.176.326
MH_TH = NLM (1973)
ST = T004
AN = infection = CANDIDIASIS or its indentions & do not coord with CANDIDA ALBICANS unless particularly discussed
PI = Candida (1966-1971)
MS = A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis).
PM = 73
HN = 73(72)
MR = 20090706
DA = 19990101
DC = 1
DX = 19730101
UI = D002176

*NEWRECORD
RECTYPE = D
MH = Candidiasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Moniliasis|T047|NON|EQV|UNK (19XX)|800512|abcdef
ENTRY = Candidiases
ENTRY = Moniliases
MN = C01.703.160
MH_TH = POPLINE (1990)
ST = T047
AN = CANDIDIASIS, INVASIVE and CANDIDEMIA are also available
MS = Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
OL = use CANDIDIASIS to search MONILIASIS 1966-80
PM = 81; was MONILIASIS 1963-80
HN = 81; was MONILIASIS 1963-80
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002177

*NEWRECORD
RECTYPE = D
MH = Candidiasis, Chronic Mucocutaneous
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Candidiases, Chronic Mucocutaneous
ENTRY = Chronic Mucocutaneous Candidiases
ENTRY = Chronic Mucocutaneous Candidiasis
ENTRY = Mucocutaneous Candidiases, Chronic
ENTRY = Mucocutaneous Candidiasis, Chronic
MN = C01.539.800.200.100
MN = C01.703.160.165
MN = C01.703.295.165
MN = C17.800.838.208.165
MH_TH = NLM (1981)
ST = T047
AN = fungus dis of skin; do not bother to coord with CANDIDA or CANDIDA ALBICANS
PI = Candidiasis (1966-1980)
PI = Candidiasis, Cutaneous (1966-1980)
MS = A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.
PM = 91; was see under CANDIDIASIS 1981-90
HN = 91(81); was see under CANDIDIASIS 1981-90
CATSH = CAT LIST
MR = 19930602
DA = 19800512
DC = 1
DX = 19910101
UI = D002178

*NEWRECORD
RECTYPE = D
MH = Candidiasis, Cutaneous
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Moniliasis, Cutaneous|T047|NON|EQV|UNK (19XX)|800513|abcdef
ENTRY = Candidiases, Cutaneous
ENTRY = Cutaneous Candidiases
ENTRY = Cutaneous Candidiasis
ENTRY = Cutaneous Moniliases
ENTRY = Cutaneous Moniliasis
ENTRY = Moniliases, Cutaneous
MN = C01.539.800.200.105
MN = C01.703.160.170
MN = C01.703.295.170
MN = C17.800.838.208.170
MH_TH = NLM (1966)
ST = T047
AN = fungus dis of skin; do not bother to coord with CANDIDA or CANDIDA ALBICANS
MS = Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (Dorland, 27th ed)
OL = use CANDIDIASIS, CUTANEOUS to search MONILIASIS, CUTANEOUS 1966-80
PM = 81; was MONILIASIS, CUTANEOUS 1963-80
HN = 81; was MONILIASIS, CUTANEOUS 1963-80
CATSH = CAT LIST
MR = 19930602
DA = 19990101
DC = 1
UI = D002179

*NEWRECORD
RECTYPE = D
MH = Candidiasis, Oral
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Moniliasis, Oral|T047|NON|EQV|UNK (19XX)|800513|abcdef
PRINT ENTRY = Thrush|T047|NON|EQV|UNK (19XX)|740330|abcdef
ENTRY = Candidiases, Oral
ENTRY = Moniliases, Oral
ENTRY = Oral Candidiases
ENTRY = Oral Candidiasis
ENTRY = Oral Moniliases
ENTRY = Oral Moniliasis
MN = C01.703.160.180
MN = C07.465.130
MH_TH = NLM (1966)
ST = T047
AN = fungus dis of mouth; do not bother to coord with CANDIDA or CANDIDA ALBICANS
MS = Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)
OL = use CANDIDIASIS, ORAL to search MONILIASIS, ORAL 1966-80
PM = 81; was MONILIASIS, ORAL 1963-80
HN = 81; was MONILIASIS, ORAL 1963-80
CATSH = CAT LIST
MR = 19930602
DA = 19990101
DC = 1
UI = D002180

*NEWRECORD
RECTYPE = D
MH = Candidiasis, Vulvovaginal
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Moniliasis, Vulvovaginal|T047|NON|EQV|UNK (19XX)|800513|abcdef
PRINT ENTRY = Vaginitis, Monilial|T047|NON|NRW|NLM (1998)|960716|abcdef
ENTRY = Monilial Vaginitides
ENTRY = Monilial Vaginitis
ENTRY = Vaginitides, Monilial
ENTRY = Vulvovaginal Candidiases
ENTRY = Vulvovaginal Candidiasis
ENTRY = Vulvovaginal Moniliases
ENTRY = Vulvovaginal Moniliasis
MN = C01.703.160.190
MN = C13.351.500.894.906.820.500
MN = C13.351.500.944.902.737.500
MH_TH = NLM (1966)
ST = T047
MS = Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.
OL = use CANDIDIASIS, VULVOVAGINAL to search MONILIASIS, VULVOVAGINAL 1966-80
PM = 81; was MONILIASIS, VULVOVAGINAL 1963-80
HN = 81; was MONILIASIS, VULVOVAGINAL 1963-80
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D002181

*NEWRECORD
RECTYPE = D
MH = Candy
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
PRINT ENTRY = Confection|T168|NON|EQV|NLM (1998)|961004|abcdef
ENTRY = Candies
ENTRY = Confections
MN = G07.203.300.140
MN = J02.500.140
MH_TH = NLM (1966)
ST = T168
MS = Sweet food products combining cane or beet sugars with other carbohydrates and chocolate, milk, eggs, and various flavorings. In the United States, candy refers to both sugar- and cocoa-based confections and is differentiated from sweetened baked goods; elsewhere the terms sugar confectionary, chocolate confectionary, and flour confectionary (meaning goods such as cakes and pastries) are used.
MR = 20141014
DA = 19990101
DC = 1
UI = D002182

*NEWRECORD
RECTYPE = D
MH = Canes
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Walking Sticks|T074|NON|EQV|UNK (19XX)|741205|abcdef
ENTRY = Cane
ENTRY = Stick, Walking
ENTRY = Sticks, Walking
ENTRY = Walking Stick
MN = E07.858.442.250
MH_TH = NLM (1975)
ST = T074
MS = Sticks used as walking aids. The canes may have three or four prongs at the end of the shaft.
PM = 91; was see under ORTHOPEDIC EQUIPMENT 1975-90
HN = 91(75); was see under ORTHOPEDIC EQUIPMENT 1975-90
CATSH = CAT LIST
MR = 19920507
DA = 19741212
DC = 1
DX = 19910101
UI = D002183

*NEWRECORD
RECTYPE = D
MH = Herpesvirus 1, Canid
DS = HERPESVIRUS CANID 01
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
PRINT ENTRY = Canine Herpesvirus 1|T005|NON|EQV|NLM (1994)|930302|CANINE HERPESVIRUS 01|abcdefs
PRINT ENTRY = Canine Tracheobronchitis Virus|T005|NON|EQV|NLM (1994)|930302|abcdef
ENTRY = Canid Herpesvirus 1|T005|NON|EQV|NLM (2002)|150623|CANID HERPESVIRUS 001|abcdefs
ENTRY = Herpesvirus 1 (alpha), Canine|T005|NON|EQV|NLM (1994)|930302|HERPESVIRUS 1 ALPHA CANINE|abcdefv
ENTRY = Canine Tracheobronchitis Viruses
ENTRY = Herpesvirus 1, Canine
ENTRY = Tracheobronchitis Virus, Canine
ENTRY = Tracheobronchitis Viruses, Canine
MN = B04.280.382.100.900.420
MH_TH = NLM (1975)
ST = T005
AN = infect: coord IM with HERPESVIRIDAE INFECTIONS (IM)
MS = A species of VARICELLOVIRUS virus that causes a disease in newborn puppies.
OL = use HERPESVIRUS 1, CANID to search CANINE TRACHEOBRONCHITIS VIRUS & CANINE HERPESVIRUS 1975-93
PM = 94; was CANINE TRACHEOBRONCHITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-90); CANINE HERPESVIRUS was see CANINE TRACHEOBRONCHITIS VIRUS 1975-93
HN = 94; was CANINE TRACHEOBRONCHITIS VIRUS 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); CANINE HERPESVIRUS was see CANINE TRACHEOBRONCHITIS VIRUS 1975-93
MR = 20150624
DA = 19741212
DC = 1
DX = 19910101
UI = D002184

*NEWRECORD
RECTYPE = D
MH = Cannabidiol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.849.090.100
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T123
N1 = 1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-
RN = 19GBJ60SN5
RR = 13956-29-1 (Cannabidiol)
PI = Cannabis (1973-1974)
PI = Resorcinols (1969-1974)
PI = Terpenes (1973-1974)
MS = Compound isolated from Cannabis sativa extract.
PM = 91; was see under CANNABINOIDS 1977-90; was see under CANNABIS 1975-76
HN = 91(75); was see under CANNABINOIDS 1977-90; was see under CANNABIS 1975-76
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002185

*NEWRECORD
RECTYPE = D
MH = Cannabinoids
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
MN = D02.455.849.090
FX = Receptors, Cannabinoid
MH_TH = NLM (1977)
ST = T109
RN = 0
PI = Cannabis (1966-1976)
MS = Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.
PM = 77
HN = 77
MR = 20120703
DA = 19760519
DC = 1
DX = 19770101
UI = D002186

*NEWRECORD
RECTYPE = D
MH = Cannabinol
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
MN = D02.455.849.090.110
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1977)
ST = T109
ST = T121
N1 = 6H-Dibenzo(b,d)pyran-1-ol, 6,6,9-trimethyl-3-pentyl-
RN = 7UYP6MC9GH
RR = 521-35-7 (Cannabinol)
PI = Cannabis (1966-1976)
PI = Tetrahydrocannabinol (1975-1976)
MS = A physiologically inactive constituent of Cannabis sativa L.
PM = 91; was see under CANNABINOIDS 1977-90
HN = 91(77); was see under CANNABINOIDS 1977-90
MR = 20130708
DA = 19760521
DC = 1
DX = 19910101
UI = D002187

*NEWRECORD
RECTYPE = D
MH = Cannabis
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Bhang|T002|NON|NRW|NLM (1990)|890329|abcdef
PRINT ENTRY = Ganja|T167|NON|NRW|NLM (1990)|890329|abcdef
PRINT ENTRY = Hashish|T167|NON|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Hemp|T167|NON|NRW|NLM (1993)|910924|abcdef
PRINT ENTRY = Marijuana|T121|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Cannabis indica|T002|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cannabis sativa|T002|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Hemp Plant|T002|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Marihuana|T121|NON|NRW|UNK (19XX)|870302|abcdef
ENTRY = Bhangs
ENTRY = Cannabi
ENTRY = Cannabis indicas
ENTRY = Cannabis sativas
ENTRY = Ganjas
ENTRY = Hashishs
ENTRY = Hemp Plants
ENTRY = Hemps
ENTRY = Marihuanas
ENTRY = Marijuanas
ENTRY = Plant, Hemp
ENTRY = Plants, Hemp
ENTRY = indica, Cannabis
ENTRY = indicas, Cannabis
ENTRY = sativa, Cannabis
ENTRY = sativas, Cannabis
MN = B01.650.940.800.575.100.175.500
FX = Cannabinoids
FX = Marijuana Abuse
FX = Marijuana Smoking
MH_TH = NLM (1966)
ST = T002
AN = use in therapy = MEDICAL MARIJUANA
MS = The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.
HN = was in Cat B & D 1963-76
MR = 20140618
DA = 19990101
DC = 1
UI = D002188

*NEWRECORD
RECTYPE = D
MH = Marijuana Abuse
AQ = BL CF CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Cannabis Abuse|T047|NON|BRD|NLM (1990)|890321|abcdef
PRINT ENTRY = Cannabis Dependence|T048|NON|REL|NLM (1999)|980303|abcdef
PRINT ENTRY = Cannabis-Related Disorder|T048|NON|BRD|NLM (1998)|970515|CANNABIS RELATED DIS|abcdefv
PRINT ENTRY = Hashish Abuse|T047|NON|NRW|NLM (1990)|890322|abcdef
PRINT ENTRY = Marijuana Dependence|T048|NON|REL|NLM (1999)|980303|abcdef
ENTRY = Marihuana Abuse|T048|NON|EQV|UNK (19XX)|870302|abcdef
ENTRY = Abuse, Cannabis
ENTRY = Abuse, Hashish
ENTRY = Abuse, Marihuana
ENTRY = Abuse, Marijuana
ENTRY = Cannabis Related Disorder
ENTRY = Dependence, Cannabis
ENTRY = Dependence, Marijuana
ENTRY = Disorder, Cannabis-Related
MN = C25.775.635
MN = F03.900.635
MH_TH = NLM (1990)
ST = T048
AN = see note on CANNABIS
PI = Cannabis (1966-1980)
PI = Substance Abuse (1968-1980)
MS = The excessive use of marijuana with associated psychological symptoms and impairment in social or occupational functioning.
OL = use MARIJUANA ABUSE to search CANNABIS ABUSE 1981-89
PM = 90; was CANNABIS ABUSE 1981-89
HN = 90; was CANNABIS ABUSE 1981-89
CATSH = CAT LIST
MR = 20130708
DA = 19800521
DC = 1
DX = 19810101
UI = D002189

*NEWRECORD
RECTYPE = D
MH = Cannibalism
AQ = EH HI PX
ENTRY = Cannibalisms
MN = F01.145.113.547.200
MH_TH = NLM (1977)
ST = T054
AN = animal and human
MS = Eating other individuals of one's own species.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 20020703
DA = 19760413
DC = 1
DX = 19770101
UI = D002190

*NEWRECORD
RECTYPE = D
MH = Canrenoic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Canrenoate Potassium|T110|T121|NON|NRW|FDA SRS (2014)|NLM (2014)|USAN (1967)|990101|abbcdeeef
PRINT ENTRY = Potassium Canrenoate|T110|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|760520|abbcdeef
ENTRY = 17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic Acid|T110|T121|NON|EQV|NLM (2014)|130201|abbcdef
ENTRY = Boehringer Mannheim Brand of Canrenoate Potassium|T110|T121|NON|NRW|NLM (2006)|041103|abbcdef
ENTRY = Kalium-Can.-ratiopharm|T110|T121|TRD|NRW|DE|041103|abbcdef
ENTRY = Pfizer Brand of Canrenoate Potassium|T110|T121|NON|NRW|NLM (2011)|100511|abbcdef
ENTRY = SC-14266|T110|T121|LAB|NRW|UNK (19XX)|800326|abbcdef
ENTRY = Soldactone|T110|T121|TRD|NRW|NL|870114|abbcdef
ENTRY = Soludactone|T110|T121|TRD|NRW|FR|800326|abbcdef
ENTRY = Spiroctan|T110|T121|TRD|NRW|NL|041103|abbcdef
ENTRY = ratiopharm Brand of Canrenoate Potassium|T110|T121|NON|NRW|NLM (2006)|041103|abbcdef
ENTRY = 17 Hydroxy 3 Oxo 17alpha Pregna 4,6 Diene 21 Carboxylic Acid
ENTRY = Acid, 17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic
ENTRY = Acid, Canrenoic
ENTRY = Canrenoate, Potassium
ENTRY = SC 14266
ENTRY = SC14266
MN = D04.808.745.432.100
PA = Mineralocorticoid Receptor Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1996)
ST = T110
ST = T121
RN = 87UG89VA9K
RR = 2181-04-6 (Canrenoate Potassium)
RR = 4138-96-9 (Canrenoic Acid)
RR = M671F9NLEA
PI = Carboxylic Acids (1974)
PI = Ketosteroids (1974)
PI = Pregnadienes (1974)
MS = A synthetic pregnadiene derivative with anti-aldosterone activity.
PM = 2014; see CANRENOATE POTASSIUM 1991-2014; see PREGNADIENES 1975-1990
HN = 2014(1975)
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D002191

*NEWRECORD
RECTYPE = D
MH = Canrenone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 11614 R.P.|T110|T121|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Aldadiene|T110|T121|NON|EQV|UNK (19XX)|800319|abbcdef
ENTRY = Phanurane|T110|T121|TRD|NRW|UNK (19XX)|800319|abbcdef
ENTRY = SC-9376|T110|T121|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = R.P., 11614
ENTRY = SC 9376
ENTRY = SC9376
MN = D04.808.745.432.120
PA = Mineralocorticoid Receptor Antagonists
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1967)
ST = T110
ST = T121
N1 = Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, gamma-lactone, (17alpha)-
RN = 78O20X9J0U
RR = 976-71-6 (Canrenone)
PI = Ketosteroids (1974)
PI = Lactones (1974)
PI = Pregnadienes (1974)
MS = A synthetic pregnadiene compound with anti-aldosterone activity.
PM = 91; was see under PREGNADIENES 1975-90
HN = 91(75); was see under PREGNADIENES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D002192

*NEWRECORD
RECTYPE = D
MH = Cantharidin
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Cantharides|T204|NON|REL|UNK (19XX)|771005|abcdef
ENTRY = Cantharidine|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|771005|abbbcdeef
MN = D03.438.127.125
PA = Enzyme Inhibitors
PA = Irritants
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T121
ST = T131
N1 = 4,7-Epoxyisobenzofuran-1,3-dione, hexahydro-3a,7a-dimethyl-, (3aalpha,4beta,7beta,7aalpha)-
RN = IGL471WQ8P
RR = 56-25-7 (Cantharidin)
MS = A toxic compound, isolated from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally.
OL = use CANTHARIDIN to search CANTHARIDES 1966-78
PM = 79; was CANTHARIDES 1963-78
HN = 79; was CANTHARIDES 1963-78
MR = 20130708
DA = 19990101
DC = 1
UI = D002193

*NEWRECORD
RECTYPE = D
MH = Capgras Syndrome
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Syndrome, Capgras
MN = F03.700.300
MH_TH = NLM (1982)
ST = T048
AN = a psychosis wherein patient thinks familiar persons are doubles of themselves or imposters
PI = Psychoses (1966-1981)
MS = A psychotic disorder characterized by the patient's belief that acquaintances or closely related persons have been replaced by doubles or imposters.
PM = 91; was see under PSYCHOTIC DISORDERS 1982-90
HN = 91(82); was see under PSYCHOTIC DISORDERS 1982-90
CATSH = CAT LIST
MR = 19991103
DA = 19810226
DC = 1
DX = 19910101
UI = D002194

*NEWRECORD
RECTYPE = D
MH = Capillaria
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Capillaria hepatica|T204|NON|NRW|NLM (1993)|911106|abcdef
PRINT ENTRY = Hepaticola hepatica|T204|NON|NRW|UNK (19XX)|780303|abcdef
ENTRY = Capillaria hepaticas
ENTRY = Capillarias
ENTRY = Hepaticola hepaticas
ENTRY = hepatica, Capillaria
ENTRY = hepatica, Hepaticola
ENTRY = hepaticas, Capillaria
ENTRY = hepaticas, Hepaticola
MN = B01.050.500.500.294.100.275.780.180
MH_TH = NLM (1975)
ST = T204
AN = a genus of nematodes in liver & intestines of birds & mammals including man; infection: coord IM with ENOPLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
MS = A genus of trichuroid nematodes parasitic in the liver and intestines of many mammals and birds. Two species, C. hepatica and C. philippinensis, produce often fatal infections in man.
OL = search TRICHUROIDEA 1966-74; use CAPILLARIA to search HEPATICOLA HEPATICA 1975-78 & use TRICHUROIDEA 1966-74
PM = 91; was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66
HN = 91(75); was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66
MR = 20090706
DA = 19990101
DC = 1
DX = 19910101
UI = D002195

*NEWRECORD
RECTYPE = D
MH = Capillaries
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Capillary
MN = A07.231.461.165
FX = Capillary Action
MH_TH = NLM (1966)
ST = T023
AN = coordinate with specific organ / blood supply; not for lymphatic capillaries
MS = The minute vessels that connect the arterioles and venules.
MR = 20110624
DA = 19990101
DC = 1
UI = D002196

*NEWRECORD
RECTYPE = D
MH = Capillary Action
AQ = DE RE
PRINT ENTRY = Capillarity|T070|NON|BRD|NLM (1966)|990101|abcdef
ENTRY = Wicking|T070|NON|EQV|NLM (2012)|110103|abcdef
ENTRY = Action, Capillary
ENTRY = Capillarities
MN = G02.842.850.327
FX = Capillaries
MH_TH = NLM (2012)
ST = T070
MS = A phenomenon in which the surface of a liquid where it contacts a solid is elevated or depressed, because of the relative attraction of the molecules of the liquid for each other and for those of the solid. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 2012; see CAPILLARITY 1966-2011
HN = 2012 (1966)
MR = 20110624
DA = 19990101
DC = 1
UI = D002197

*NEWRECORD
RECTYPE = D
MH = Capillary Fragility
AQ = DE ES GE IM PH RE
ENTRY = Fragility, Capillary
MN = E01.370.370.170
MN = G09.330.160
MH_TH = NLM (1968)
ST = T042
PI = Capillaries (1966-1967)
PI = Capillary Resistance (1966-1967)
MS = The susceptibility of CAPILLARIES, under conditions of increased stress, to leakage.
PM = 70
HN = 70(68)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19700101
UI = D002198

*NEWRECORD
RECTYPE = D
MH = Capillary Permeability
AQ = DE ES GE IM PH RE
PRINT ENTRY = Microvascular Permeability|T042|NON|BRD|NLM (1993)|911031|abcdef
PRINT ENTRY = Permeability, Capillary|T042|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Permeability, Microvascular|T042|NON|BRD|NLM (1993)|911031|abcdef
PRINT ENTRY = Vascular Permeability|T042|NON|BRD|NLM (1993)|911106|abcdef
ENTRY = Capillary Permeabilities
ENTRY = Microvascular Permeabilities
ENTRY = Permeabilities, Capillary
ENTRY = Permeabilities, Microvascular
ENTRY = Permeabilities, Vascular
ENTRY = Permeability, Vascular
ENTRY = Vascular Permeabilities
MN = G03.495.166.330
MN = G09.330.165
FX = Blood-Air Barrier
FX = Blood-Aqueous Barrier
FX = Blood-Brain Barrier
FX = Blood-Nerve Barrier
FX = Blood-Retinal Barrier
FX = Blood-Testis Barrier
FX = Capillary Leak Syndrome
FX = Transendothelial and Transepithelial Migration
MH_TH = NLM (1966)
ST = T042
AN = coord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)
MS = The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002199

*NEWRECORD
RECTYPE = D
MH = Capillary Resistance
AQ = DE ES GE IM PH RE
ENTRY = Capillary Resistances
ENTRY = Resistance, Capillary
ENTRY = Resistances, Capillary
MN = G09.330.380.921.327
MH_TH = NLM (1986)
ST = T042
MS = The vascular resistance to the flow of BLOOD through the CAPILLARIES portions of the peripheral vascular bed.
PM = 91,63-85; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85
HN = 91(86)63; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19910101
UI = D002200

*NEWRECORD
RECTYPE = D
MH = Capital Expenditures
AQ = CL ES HI LJ SN ST TD
ENTRY = Capital Expenditure
ENTRY = Expenditure, Capital
ENTRY = Expenditures, Capital
MN = N03.219.151.450.200
MH_TH = NLM (1977)
ST = T058
AN = not restricted to health care; NIM
MS = Those funds disbursed for facilities and equipment, particularly those related to the delivery of health care.
PM = 91; was see under ECONOMICS Aug 1977-90
HN = 91(Aug 77); was see under ECONOMICS 1977-90
MR = 19930916
DA = 19770512
DC = 1
DX = 19910101
UI = D002201

*NEWRECORD
RECTYPE = D
MH = Capital Financing
AQ = CL EC ES HI LJ MT OG SN ST TD UT
PRINT ENTRY = Financing, Capital|T057|NON|EQV|UNK (19XX)|790529|abcdef
PRINT ENTRY = Funding, Capital|T057|NON|EQV|UNK (19XX)|790529|abcdef
ENTRY = Capital Financings
ENTRY = Capital Funding
ENTRY = Capital Fundings
MN = N03.219.463.085
MH_TH = NLM (1980)
ST = T057
PI = Financial Management (1978-1979)
MS = Institutional funding for facilities and for equipment which becomes a part of the assets of the institution.
PM = 91; was see under FINANCIAL MANAGEMENT 1980-90
HN = 91(80); was see under FINANCIAL MANAGEMENT 1980-90
MR = 19991103
DA = 19790529
DC = 1
DX = 19910101
UI = D002202

*NEWRECORD
RECTYPE = D
MH = Capital Punishment
AQ = HI LJ MT SN TD
PRINT ENTRY = Death Penalty|T089|NON|EQV|BIOETHICS (1989)|740329|abcdef
PRINT ENTRY = Electrocution, Judicial|T089|NON|NRW|NLM (1998)|960719|abcdef
ENTRY = Gas Chamber Execution|T089|NON|NRW|NLM (2012)|110405|abcdef
ENTRY = Hanging, Judicial|T089|NON|NRW|NLM (2012)|110311|abcdef
ENTRY = Lethal Injection|T089|NON|NRW|NLM (2012)|110405|abcdef
ENTRY = Capital Punishments
ENTRY = Chamber Execution, Gas
ENTRY = Death Penalties
ENTRY = Electrocutions, Judicial
ENTRY = Execution, Gas Chamber
ENTRY = Executions, Gas Chamber
ENTRY = Gas Chamber Executions
ENTRY = Hangings, Judicial
ENTRY = Injection, Lethal
ENTRY = Injections, Lethal
ENTRY = Judicial Electrocution
ENTRY = Judicial Electrocutions
ENTRY = Judicial Hanging
ENTRY = Judicial Hangings
ENTRY = Lethal Injections
ENTRY = Penalties, Death
ENTRY = Penalty, Death
ENTRY = Punishment, Capital
ENTRY = Punishments, Capital
MN = I01.880.604.160
MH_TH = BIOETHICS (1989)
ST = T089
AN = entry term ELECTROCUTION, JUDICIAL: do not index also under the electricity aspect unless particularly discussed
MS = The use of the death penalty for certain crimes.
MR = 20110624
DA = 19990101
DC = 1
UI = D002203

*NEWRECORD
RECTYPE = D
MH = Capitation Fee
AQ = CL ES HI LJ OG SN ST TD UT
PRINT ENTRY = Fee, Capitation|T081|NON|EQV|UNK (19XX)|770505|abcdef
ENTRY = Capitation Fees
ENTRY = Fees, Capitation
MN = N03.219.442.090
MH_TH = NLM (1977)
ST = T081
AN = "capitation" refers to "a fixed per capita amt without regard to no. or nature of serv provided"
MS = A method of payment for health services in which an individual or institutional provider is paid a fixed, per capita amount without regard to the actual number or nature of services provided to each patient.
PM = 91; was see under FEES AND CHARGES Aug 1977-90
HN = 91(Aug 77); was see under FEES AND CHARGES 1977-90
MR = 19970620
DA = 19770505
DC = 1
DX = 19910101
UI = D002204

*NEWRECORD
RECTYPE = D
MH = Caplan Syndrome
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Caplan's Syndrome|T047|EPO|EQV|NLM (1984)|990101|abcdef
ENTRY = Caplan Syndromes
ENTRY = Caplans Syndrome
MN = C05.550.114.154.219
MN = C05.799.114.219
MN = C08.381.483.581.300
MN = C08.381.520.702.300
MN = C17.300.775.099.219
MN = C24.800.340
MH_TH = NLM (2009)
ST = T047
AN = do not coordinate with OCCUPATIONAL DISEASES
MS = A condition characterized by the presence of RHEUMATOID ARTHRITIS associated with a specific form of pneumoconiosis, often in coal miners and asbestos workers.
PM = 2009; see CAPLAN'S SYNDROME 1991-2008, see PNEUMOCONIOSIS 1984-1990, see CAPLAN'S SYNDROME 1963-1983
HN = 2009 (1984); 1963-1983
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19910101
UI = D002205

*NEWRECORD
RECTYPE = D
MH = Capnocytophaga
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.140.190.100
MN = B03.440.450.340
MH_TH = NLM (1982)
ST = T007
AN = infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
PI = Bacteroides (1975-1981)
PI = Cytophagaceae (1975-1981)
MS = A gram-negative gliding bacterium isolated from the oral cavity. It is a pathogen often causing PERIODONTITIS.
PM = 91; was see under CYTOPHAGACEAE 1982-90
HN = 91(82); was see under CYTOPHAGACEAE 1982-90
MR = 20090706
DA = 19810520
DC = 1
DX = 19910101
UI = D002206

*NEWRECORD
RECTYPE = D
MH = Capreomycin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Capreomycin Sulfate|T116|T195|NON|NRW|USAN (1962)|USP (19XX)|990101|abbcdeef
ENTRY = Capastat|T109|T121|TRD|NRW|AU|ES|US|040610|abbcdeeef
ENTRY = Capromycin|T116|T195|NON|EQV|NLM (1994)|920924|abbcdef
ENTRY = Dista Brand of Capreomycin Disulfate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Elan Brand of Capreomycin Disulfate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
ENTRY = Lilly Brand of Capreomycin Disulfate|T109|T121|NON|NRW|NLM (2005)|040610|abbcdef
MN = D04.345.566.142
MN = D12.644.641.142
PA = Anti-Bacterial Agents
PA = Antibiotics, Antitubercular
PA = Protein Synthesis Inhibitors
MH_TH = BAN (19XX)
MH_TH = INN (19XX)
ST = T116
ST = T195
RN = 11003-38-6
RR = 1405-37-4
PI = Antitubercular Agents (1966-1971)
MS = Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus.
PM = 2009; see CAPREOMYCIN SULFATE 1996-2007, see CAPREOMYCIN 1974-1995; see CAPREOMYCIN 1978-1993
HN = 2009(1996)
MR = 20080708
DA = 19990101
DC = 1
DX = 19740101
UI = D002207

*NEWRECORD
RECTYPE = D
MH = Caproates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hexanoates|T119|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Caproic Acid Derivatives|T119|NON|REL|NLM (2014)|130610|abcdef
ENTRY = Caproic Acids|T119|NON|REL|NLM (2014)|130327|abcdef
ENTRY = Hexanoic Acid Derivatives|T119|NON|REL|NLM (2014)|130610|abcdef
ENTRY = Hexanoic Acids|T119|NON|REL|NLM (1975)|990101|abcdef
ENTRY = Acid Derivatives, Caproic
ENTRY = Acid Derivatives, Hexanoic
ENTRY = Acids, Caproic
ENTRY = Acids, Hexanoic
ENTRY = Derivatives, Caproic Acid
ENTRY = Derivatives, Hexanoic Acid
MN = D02.241.081.193
MN = D10.251.400.326
MH_TH = NLM (1966)
ST = T119
RN = 0
MS = Derivatives of caproic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a carboxy terminated six carbon aliphatic structure.
PM = 1966; for HEXANOIC ACIDS see HEXANOIC ACIDS 1991-2012
HN = 1966
MR = 20130708
DA = 19990101
DC = 1
UI = D002208

*NEWRECORD
RECTYPE = D
MH = Caprolactam
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aminocaproic Lactam|T130|T195|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Hexahydro-2H-Azepin-2-One|T130|T195|NON|EQV|UNK (19XX)|801205|abbcdef
ENTRY = Hexahydro 2H Azepin 2 One
ENTRY = Lactam, Aminocaproic
MN = D02.065.589.200
MN = D03.383.066.150
MN = D03.383.411.200
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T130
ST = T195
N1 = 2H-Azepin-2-one, hexahydro-
RN = 6879X594Z8
RR = 105-60-2 (Caprolactam)
PI = Azepines (1968-1974)
MS = Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation.
PM = 91; was see under AZEPINES 1975-90
HN = 91(75); was see under AZEPINES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002209

*NEWRECORD
RECTYPE = D
MH = Caprylates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Octanoates|T119|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Caprylic Acids|T119|NON|REL|NLM (2013)|120124|abcdef
ENTRY = Octanoic Acids|T119|NON|REL|NLM (1975)|990101|abcdef
ENTRY = Acids, Caprylic
ENTRY = Acids, Octanoic
MN = D02.241.081.222
MN = D10.251.122
MH_TH = NLM (1966)
ST = T119
RN = 0
MS = Derivatives of caprylic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a carboxy terminated eight carbon aliphatic structure.
PM = 1966; for OCTANOIC ACIDS see OCTANOIC ACIDS 1976-2013
HN = 1966
MR = 20120703
DA = 19990101
DC = 1
UI = D002210

*NEWRECORD
RECTYPE = D
MH = Capsaicin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 8-Methyl-N-Vanillyl-6-Nonenamide|T119|T121|NON|EQV|UNK (19XX)|801205|abbcdef
ENTRY = Alacan Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Antiphlogistine Rub A-535 Capsaicin|T119|T121|TRD|NRW|CA|040614|abbcdef
ENTRY = Axsain|T119|T121|TRD|NRW|IE|040614|abbcdef
ENTRY = Capsaicine|T119|T121|NON|EQV|UNK (19XX)|771005|abbcdef
ENTRY = Capsicum Farmaya|T119|T121|TRD|NRW|ES|040614|abbcdef
ENTRY = Capsidol|T119|T121|TRD|NRW|ES|040614|abbcdef
ENTRY = Capsin|T119|T121|TRD|NRW|US|040614|abbcdef
ENTRY = Capzasin|T119|T121|TRD|NRW|US|040614|abbcdef
ENTRY = Carter Horner Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Centrum Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Elan Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Flemming Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Gelcen|T119|T121|TRD|NRW|ES|040614|abbcdef
ENTRY = Katrum|T119|T121|TRD|NRW|ES|040614|abbcdef
ENTRY = Link Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Medicis Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = NGX-4010|T109|T121|LAB|NRW|NLM (2010)|090116|abbcdef
ENTRY = Smaller Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Thompson Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Vinas Brand of Capsaicin|T119|T121|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Zacin|T119|T121|TRD|NRW|IE|040614|abbcdef
ENTRY = Zostrix|T119|T121|TRD|NRW|AU|CA|040614|abbcdeef
ENTRY = 8 Methyl N Vanillyl 6 Nonenamide
ENTRY = NGX 4010
ENTRY = NGX4010
MN = D02.065.160.500
MN = D02.455.326.271.060.222
MN = D02.455.426.559.389.657.166.099
MN = D03.132.760.200
MN = D10.251.355.325.190
PA = Antipruritics
PA = Sensory System Agents
MH_TH = FDA SRS (2014)
MH_TH = UNK (19XX)
MH_TH = USP (19XX)
ST = T119
ST = T121
N1 = 6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-
RN = S07O44R1ZM
RR = 404-86-4 (Capsaicin)
PI = Alkaloids (1966-1974)
PI = Amides (1966-1974)
PI = Capsicum (1966-1974)
PI = Catechols (1966-1974)
PI = Fatty Acids, Unsaturated (1973-1974)
MS = An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.
PM = 1984; see FATTY ACIDS, UNSATURATED 1975-1983; NGX-4010 was indexed under CAPSAICIN 2009
HN = 1984(1975)
MR = 20130708
DA = 19741127
DC = 1
DX = 19840101
UI = D002211

*NEWRECORD
RECTYPE = D
MH = Capsicum
AQ = AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI
PRINT ENTRY = Bell Pepper|T002|T168|NON|REL|NLM (2003)|011001|abbcdef
PRINT ENTRY = Cayenne Pepper|T002|T168|NON|NRW|UNK (19XX)|850516|abbcdef
PRINT ENTRY = Chili Pepper|T002|T168|NON|REL|NLM (2003)|011204|abbcdef
PRINT ENTRY = Chilli Pepper|T002|T168|NON|REL|NLM (2003)|011001|abbcdef
PRINT ENTRY = Green Pepper|T002|T168|NON|REL|NLM (1998)|961107|abbcdef
PRINT ENTRY = Jalapeno Pepper|T002|T168|NON|NRW|NLM (1998)|961107|abbcdef
PRINT ENTRY = Paprika|T168|NON|NRW|NLM (1998)|961004|abcdef
PRINT ENTRY = Pimiento|T168|NON|NRW|NLM (2003)|011001|abcdef
PRINT ENTRY = Red Pepper|T002|T168|NON|REL|NLM (1998)|961107|abbcdef
ENTRY = Capsicum annuum|T002|NON|NRW|NLM (2015)|140303|abcdef
ENTRY = Cayenne|T002|T168|NON|NRW|NLM (2015)|140303|abbcdef
ENTRY = Chile Pepper|T002|T168|NON|REL|NLM (2015)|140403|abbcdef
ENTRY = Hot Pepper|T002|T168|NON|NRW|NLM (2015)|140422|abbcdef
ENTRY = Sweet Pepper|T002|T168|NON|REL|NLM (2015)|140422|abbcdef
ENTRY = Bell Peppers
ENTRY = Cayenne Peppers
ENTRY = Chile Peppers
ENTRY = Chili Peppers
ENTRY = Chilli Peppers
ENTRY = Green Peppers
ENTRY = Hot Peppers
ENTRY = Jalapeno Peppers
ENTRY = Pepper, Bell
ENTRY = Pepper, Cayenne
ENTRY = Pepper, Chile
ENTRY = Pepper, Chili
ENTRY = Pepper, Chilli
ENTRY = Pepper, Green
ENTRY = Pepper, Hot
ENTRY = Pepper, Jalapeno
ENTRY = Pepper, Red
ENTRY = Pepper, Sweet
ENTRY = Peppers, Bell
ENTRY = Peppers, Cayenne
ENTRY = Peppers, Chile
ENTRY = Peppers, Chili
ENTRY = Peppers, Chilli
ENTRY = Peppers, Green
ENTRY = Peppers, Hot
ENTRY = Peppers, Jalapeno
ENTRY = Peppers, Red
ENTRY = Peppers, Sweet
ENTRY = Red Peppers
ENTRY = Sweet Peppers
MN = B01.650.940.800.575.100.905.145
MH_TH = NLM (1986)
ST = T002
AN = BLACK PEPPER and WHITE PEPPER see PIPER NIGRUM  are also available
MS = A plant genus of the family SOLANACEAE. The hot peppers yield CAPSAICIN, which activates VANILLOID RECEPTORS. Several varieties have sweet or pungent edible fruits that are used as vegetables when fresh and spices when the pods are dried.
PM = 91,63-85; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85
HN = 91(86)63; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85
MR = 20150623
DA = 19990101
DC = 1
DX = 19910101
UI = D002212

*NEWRECORD
RECTYPE = D
MH = Capsid
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Capsids
MN = A21.249.500.250
MN = B04.950.500.250
MH_TH = NLM (1975)
ST = T017
AN = CAPSID PROTEINS is also available
PI = Viral Proteins (1968-1974)
MS = The outer protein protective shell of a virus, which protects the viral nucleic acid.
PM = 84; was see under VIRAL PROTEINS 1975-83
HN = 84(75); was see under VIRAL PROTEINS 1975-83
MR = 20090706
DA = 19741111
DC = 1
DX = 19840101
UI = D002213

*NEWRECORD
RECTYPE = D
MH = Capsules
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Microcapsules|T122|NON|NRW|UNK (19XX)|840223|abcdef
MN = D26.255.150
MH_TH = NLM (1966)
ST = T122
RN = 0
AN = IM for general only; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in capsule form, not the capsule; note X ref MICROCAPSULES: do not confuse with MICROENCAPSULATION see DRUG COMPOUNDING
MS = Hard or soft soluble containers used for the oral administration of medicine.
MR = 20030709
DA = 19990101
DC = 1
UI = D002214

*NEWRECORD
RECTYPE = D
MH = Captan
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = N-Trichloromethylthio-4-cyclohexane-1,2-dicarboximide|T109|T131|NON|EQV|UNK (19XX)|821123|abbcdef
ENTRY = Vancide 89|T109|T131|TRD|NRW|UNK (19XX)|840305|abbcdef
ENTRY = N Trichloromethylthio 4 cyclohexane 1,2 dicarboximide
MN = D03.438.513.124
PA = Fungicides, Industrial
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T131
N1 = 1H-Isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-2-((trichloromethyl)thio)-
RN = EOL5G26Q9F
RR = 133-06-2 (Captan)
PI = Antifungal Agents (1966-1971)
PI = Indoles (1966-1971)
PI = Pesticides (1966-1971)
MS = One of the phthalimide fungicides.
PM = 74
HN = 74(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D002215

*NEWRECORD
RECTYPE = D
MH = Captopril
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline|T116|T121|NON|EQV|NLM (1996)|950404|abbcdef
ENTRY = Capoten|T116|T121|TRD|NRW|UNK (19XX)|841002|abbcdef
ENTRY = Lopirin|T116|T121|TRD|NRW|UNK (19XX)|841002|abbcdef
ENTRY = SQ-14,225|T116|T121|LAB|NRW|NLM (1997)|960306|abbcdef
ENTRY = SQ-14,534|T116|T121|LAB|REL|NLM (1997)|960116|abbcdef
ENTRY = SQ-14225|T116|T121|LAB|NRW|NLM (1994)|930210|abbcdef
ENTRY = SQ-14534|T116|T121|LAB|REL|NLM (1997)|960116|abbcdef
ENTRY = SQ 14,225
ENTRY = SQ 14,534
ENTRY = SQ 14225
ENTRY = SQ 14534
ENTRY = SQ14,225
ENTRY = SQ14,534
ENTRY = SQ14225
ENTRY = SQ14534
MN = D12.125.072.401.623.270
PA = Angiotensin-Converting Enzyme Inhibitors
PA = Antihypertensive Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1978)
MH_TH = USP (19XX)
ST = T116
ST = T121
N1 = L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)-
RN = 9G64RSX1XD
RR = 62571-86-2 (Captopril)
RR = 63250-36-2 ((R)-isomer)
PI = Kininase II/antagonists & inhibitors (1973-1979)
PI = Peptide Peptidohydrolases (1966-1967) /antagonists & inhibitors (1968-1972)
PI = Proline (1966-1974) /antagonists & inhibitors (1975-1979)
MS = A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
OL = use CAPTOPRIL to search SQ 14225 1980-93
PM = 86; was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93
HN = 86(80); was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93
MR = 20130708
DA = 19790523
DC = 1
DX = 19860101
UI = D002216

*NEWRECORD
RECTYPE = D
MH = Carbachol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carbamylcholine|T109|T121|NON|BRD|UNK (19XX)|741217|abbcdef
ENTRY = Carbacholine|T109|T121|NON|EQV|UNK (19XX)|810210|abbcdef
ENTRY = Carbamann|T109|T121|TRD|NRW|DE|040614|abbcdef
ENTRY = Carbamoylcholine|T109|T121|NON|BRD|FDA SRS (2014)|UNK (19XX)|801120|abbcdeef
ENTRY = Carbastat|T109|T121|TRD|NRW|CA|US|040614|abbcdeef
ENTRY = Carbocholine|T109|T121|NON|EQV|UNK (19XX)|801203|abbcdef
ENTRY = Carboptic|T109|T121|TRD|NRW|US|040614|abbcdef
ENTRY = Doryl|T109|T121|TRD|NRW|DE|040614|abbcdef
ENTRY = Isopto Carbachol|T109|T121|TRD|NRW|AU|CA|DE|IE|NL|UK|US|040614|abbcdeeeeeeef
ENTRY = Jestryl|T109|T121|TRD|NRW|DE|961129|abbcdef
ENTRY = Miostat|T109|T121|TRD|NRW|AU|CA|NL|US|040614|abbcdeeeef
ENTRY = Carbachol, Isopto
MN = D02.092.877.883.333.115
MN = D02.675.276.232.115
PA = Analgesics, Non-Narcotic
PA = Cardiotonic Agents
PA = Cholinergic Agonists
PA = Miotics
MH_TH = BAN (19XX)
MH_TH = CA
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = US
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Ethanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-, chloride
RN = 8Y164V895Y
RR = 51-83-2
RR = 54Z8M50D6Q
MS = A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
MR = 20141014
DA = 19990101
DC = 1
UI = D002217

*NEWRECORD
RECTYPE = D
MH = Carbadox
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Fortrigo|T109|T121|T131|TRD|NRW|UNK (19XX)|801204|abbbcdef
ENTRY = Getroxel|T109|T121|T131|TRD|NRW|UNK (19XX)|880808|abbbcdef
ENTRY = Mecadox|T109|T121|T131|TRD|NRW|UNK (19XX)|801205|abbbcdef
MN = D02.241.081.251.140
MN = D03.438.857.140
PA = Anti-Infective Agents
PA = Anti-Infective Agents, Local
PA = Carcinogens
PA = Mutagens
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1968)
ST = T109
ST = T121
ST = T131
N1 = Hydrazinecarboxylic acid, (2-quinoxalinylmethylene)-, methyl ester, N,N'-dioxide
RN = M2X04R2E2Y
RR = 6804-07-5 (Carbadox)
PI = Carbamates (1969-1974)
PI = Quinoxalines (1973-1974)
MS = An antibacterial agent that has been used in veterinary practice for treating swine dysentery and enteritis and for promoting growth. However, its use has been prohibited in the UK following reports of carcinogenicity and mutagenicity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p125)
PM = 91; was see under QUINOXALINES 1975-90
HN = 91(75); was see under QUINOXALINES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002218

*NEWRECORD
RECTYPE = D
MH = Carbamates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aminoformic Acids|T109|NON|NRW|NLM (2013)|120209|abcdef
ENTRY = Carbamic Acids|T109|NON|NRW|NLM (2013)|120209|abcdef
ENTRY = Acids, Aminoformic
ENTRY = Acids, Carbamic
MN = D02.241.081.251
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = Derivatives of carbamic acid, H2NC(=O)OH. Included under this heading are N-substituted and O-substituted carbamic acids. In general carbamate esters are referred to as urethanes, and polymers that include repeating units of carbamate are referred to as POLYURETHANES. Note however that polyurethanes are derived from the polymerization of ISOCYANATES and the singular term URETHANE refers to the ethyl ester of carbamic acid.
OL = use CARBAMATES to search TYBAMATE 1966-84 (as Prov 1966-72)
PM = TYBAMATE was heading 1973-84
HN = TYBAMATE was heading 1965-84 (Prov 1965-72)
MR = 20120703
DA = 19990101
DC = 1
UI = D002219

*NEWRECORD
RECTYPE = D
MH = Carbamazepine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Amizepine|T109|T121|TRD|NRW|NLM (1990)|890607|abbcdef
ENTRY = Carbamazepine Acetate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Carbamazepine Anhydrous|T109|T121|NON|EQV|NLM (2015)|140318|abbcdef
ENTRY = Carbamazepine Dihydrate|T109|T121|NON|NRW|FDA SRS (2015)|NLM (1999)|990913|abbcdeef
ENTRY = Carbamazepine Hydrochloride|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Carbamazepine L-Tartrate (4:1)|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Carbamazepine Phosphate|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Carbamazepine Sulfate (2:1)|T109|T121|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Carbazepin|T109|T121|TRD|NRW|UNK (19XX)|801203|abbcdef
ENTRY = Epitol|T109|T121|TRD|NRW|NLM (1997)|960116|abbcdef
ENTRY = Finlepsin|T109|T121|TRD|NRW|UNK (19XX)|820203|abbcdef
ENTRY = Neurotol|T109|T121|TRD|NRW|NLM (1992)|910312|abbcdef
ENTRY = Tegretol|T109|T121|TRD|NRW|UNK (19XX)|820203|abbcdef
MN = D03.494.240.127
PA = Analgesics, Non-Narcotic
PA = Anticonvulsants
PA = Antimanic Agents
PA = Cytochrome P-450 CYP3A Inducers
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = JAN (19XX)
MH_TH = USAN (1965)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 5H-Dibenz(b,f)azepine-5-carboxamide
RN = 33CM23913M
RR = 298-46-4 (Carbamazepine)
RR = 70972-22-4 (sulfate (2:1))
RR = 70972-23-5 (phosphate)
RR = 70972-24-6 (HCl)
RR = 70972-25-7 (L-tartrate (4:1))
RR = 70972-26-8 (acetate)
RR = 78M1RMW7Q8
PI = Anticonvulsants (1966-1967)
PI = Azepines (1966-1967)
MS = An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.
PM = 72
HN = 72(68)
MR = 20140617
DA = 19990101
DC = 1
DX = 19720101
UI = D002220

*NEWRECORD
RECTYPE = D
MH = Carbamyl Phosphate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Carbamoyl Phosphate|T115|T123|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Dilithium Carbamyl Phosphate|T115|NON|NRW|UNK (19XX)|820302|abcdef
ENTRY = Carbamyl Phosphate, Dilithium
ENTRY = Phosphate, Carbamoyl
ENTRY = Phosphate, Carbamyl
ENTRY = Phosphate, Dilithium Carbamyl
MN = D02.241.081.251.145
MN = D02.705.400.100
MH_TH = NLM (1975)
ST = T115
ST = T123
N1 = Carbamic acid, monoanhydride with phosphoric acid
RN = 590-55-6
PI = Carbamates (1973-1974)
PI = Organophosphorus Compounds (1973-1974)
MS = The monoanhydride of carbamic acid with PHOSPHORIC ACID. It is an important intermediate metabolite and is synthesized enzymatically by CARBAMYL-PHOSPHATE SYNTHASE (AMMONIA) and CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING).
PM = 91; was see under CARBAMATES 1975-90
HN = 91(75); was see under CARBAMATES 1975-90
MR = 20120703
DA = 19741119
DC = 1
DX = 19910101
UI = D002221

*NEWRECORD
RECTYPE = D
MH = Carbamoyl-Phosphate Synthase (Ammonia)
DE = AMMONIA CP SYNTHASE
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carbamoyl Phosphate Synthetase I|T116|T126|NON|EQV|NLM (2000)|991108|abbcdef
ENTRY = CP Synthase I|T116|T126|NON|EQV|UNK (19XX)|810210|abbcdef
ENTRY = Carbamoyl-Phosphate Synthetase (Ammonia)|T116|T126|NON|EQV|NLM (2000)|991108|abbcdef
ENTRY = Carbamoyl-Phosphate Synthetase I|T116|T126|NON|EQV|NLM (2000)|991108|abbcdef
ENTRY = Carbamoylphosphate Synthetase I|T116|T126|NON|EQV|UNK (19XX)|840919|abbcdef
ENTRY = Carbamyl Phosphate Synthase (Ammonia)|T116|T126|NON|EQV|NLM (1998)|970114|abbcdef
ENTRY = Carbamyl-Phosphate Synthase (Ammonia)|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = I, Carbamoyl-Phosphate Synthetase
ENTRY = Synthase I, CP
ENTRY = Synthetase I, Carbamoyl-Phosphate
ENTRY = Synthetase I, Carbamoylphosphate
MN = D08.811.464.259.350
FX = Carbamoyl-Phosphate Synthase I Deficiency Disease
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Carbon dioxide:ammonia ligase (ADP-forming, carbamate-phosphorylating)
RN = EC 6.3.4.16
RR = 9026-23-7 (CAS RN)
AN = /defic: consider CARBAMOYL-PHOSPHATE SYNTHETASE I DEFICIENCY DISEASE; DF: AMMONIA CP SYNTHASE or CP SYNTHASE I
PI = Ammonia (1974)
PI = Carbamates (1974)
PI = Phosphotransferases, ATP (1974)
MS = An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. This enzyme is specific for arginine biosynthesis or the urea cycle. Absence or lack of this enzyme may cause CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE. EC 6.3.4.16.
PM = 98; see CARBAMYL PHOSPHATE SYNTHASE (AMMONIA) 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80
HN = 98(75)
MR = 20050711
DA = 19741119
DC = 1
DX = 19890101
UI = D002222

*NEWRECORD
RECTYPE = D
MH = Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)
DE = GLUTAMINE CP SYNTHASE
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carbamyl Phosphate Synthase (Glutamine)|T116|T126|NON|EQV|NLM (1998)|961105|abbcdef
ENTRY = Carbamoyl-Phosphate Synthase (Glutamine)|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Carbamoylphosphate Synthetase II|T116|T126|NON|NRW|UNK (19XX)|850528|abbcdef
ENTRY = Carbamyl Phosphate Synthase II|T116|T126|NON|NRW|UNK (19XX)|860528|abbcdef
ENTRY = Carbamyl-Phosphate Synthase (Glutamine)|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Synthetase II, Carbamoylphosphate
MN = D08.811.464.259.400.300
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Carbon dioxide:L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating)
RN = EC 6.3.5.5
RR = 37233-48-0 (CAS RN)
AN = DF: GLUTAMINE CP SYNTHASE
PI = Carbamates (1974)
PI = Glutamine (1974)
PI = Phosphotransferases, ATP (1974)
MS = An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. This enzyme is important in the de novo biosynthesis of pyrimidines. EC 6.3.5.5.
PM = 98; see CARBAMYL PHOSPHATE SYNTHASE (GLUTAMINE) 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80
HN = 98(75)
MR = 20030709
DA = 19741119
DC = 1
DX = 19890101
UI = D002223

*NEWRECORD
RECTYPE = D
MH = Carbanilides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Diphenylurea Compounds|T109|NON|EQV|UNK (19XX)|770401|DIPHENYLUREA CPDS|abcdefv
ENTRY = Compounds, Diphenylurea
MN = D02.065.199.326
MN = D02.455.426.559.389.703.202
MN = D02.948.681.202
MH_TH = NLM (1972)
ST = T109
RN = 0
PI = Urea (1970-1971)
PM = 74
HN = 74(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D002224

*NEWRECORD
RECTYPE = D
MH = Carbazilquinone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carboquinone|T109|T121|NON|EQV|UNK (19XX)|771201|abbcdef
PRINT ENTRY = Carboquone|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|790606|abbcdeef
ENTRY = Esquinon|T109|T121|TRD|NRW|UNK (19XX)|831020|abbcdef
MN = D02.806.250.180
MN = D03.383.097.217.300
PA = Antineoplastic Agents, Alkylating
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = 2,5-Cyclohexadiene-1,4-dione, 2-(2-((aminocarbonyl)oxy)-1-methoxyethyl)-3,6-bis(1-aziridinyl)-5-methyl-
RN = 1CB0HBT12C
RR = 24279-91-2 (Carbazilquinone)
PI = Azirines (1971-1974)
PI = Carbamates (1972-1974)
PI = Quinones (1972-1974)
MS = An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
PM = 91; was see under AZIRINES 1975-90
HN = 91(75); was see under AZIRINES 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002225

*NEWRECORD
RECTYPE = D
MH = Carbazoles
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.438.473.144
MN = D03.494.148
MH_TH = NLM (1969)
ST = T109
RN = 0
PI = Azoles (1966-1968)
MS = Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
OL = search AZOLES 1966-68
PM = 69; was see under AZOLES 1963-68
HN = 69; was see under AZOLES 1963-68
MR = 20070709
DA = 19990101
DC = 1
DX = 19690101
UI = D002227

*NEWRECORD
RECTYPE = D
MH = Carbenicillin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carboxybenzyl Penicillin|T109|T195|NON|EQV|UNK (19XX)|790606|abbcdef
ENTRY = Anabactyl|T109|T195|TRD|NRW|NLM (1990)|891116|abbcdef
ENTRY = CSL Brand of Carbenicillin Disodium Salt|T109|T195|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Carbapen|T109|T195|TRD|NRW|AU|040614|abbcdef
ENTRY = Carbecin|T109|T195|TRD|NRW|MX|891116|abbcdef
ENTRY = Carbenicillin Disodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1969)|USP (19XX)|941129|abbcdeeef
ENTRY = Geopen|T109|T195|TRD|NRW|UNK (19XX)|861024|abbcdef
ENTRY = Microcillin|T109|T195|TRD|NRW|NLM (1990)|891116|abbcdef
ENTRY = Pyopen|T109|T195|TRD|NRW|NLM (1990)|891116|abbcdef
ENTRY = Sanfer Brand of Carbenicillin Disodium Salt|T109|T195|NON|NRW|NLM (2005)|040614|abbcdef
ENTRY = Disodium, Carbenicillin
ENTRY = Penicillin, Carboxybenzyl
MN = D02.065.589.099.750.750.170
MN = D02.886.108.750.750.170
MN = D03.438.260.825.750.170
MN = D03.605.084.737.750.170
MN = D04.075.080.875.099.221.750.750.170
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxyphenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-
RN = G42ZU72N5G
RR = 4697-36-3 (Carbenicillin)
RR = 4800-94-6 (di-Na salt)
RR = 9TS4B3H261
PI = Penicillins (1966-1970)
MS = Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.
PM = 73
HN = 73(71)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D002228

*NEWRECORD
RECTYPE = D
MH = Carbenoxolone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carbenoxalone|T110|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = 18alpha-Carbenoxolone|T110|T121|NON|NRW|NLM (2003)|abbcde
ENTRY = 18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate|T110|T121|NON|NRW|NLM (2003)|abbcde
ENTRY = Biogastrone|T110|T121|TRD|NRW|UNK (19XX)|800917|abbcdef
ENTRY = Bioral|T110|T121|TRD|NRW|NLM (1991)|900116|abbcdef
ENTRY = Byk Brand of Carbenoxolone Disodium Salt|T110|T121|NON|NRW|NLM (2005)|040617|abbcdef
ENTRY = Carbeneoxolone|T110|T121|NON|EQV|NLM (1991)|900116|abbcdef
ENTRY = Carbenoxolone Disodium Salt|T110|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Carbenoxolone Sodium|T110|T121|NON|NRW|FDA SRS (2014)|USAN (1974)|861202|abbcdeef
ENTRY = Carbosan|T110|T121|TRD|NRW|IE|040617|abbcdef
ENTRY = Duogastrone|T110|T121|TRD|NRW|UNK (19XX)|810130|abbcdef
ENTRY = Glycyrrhetinic Acid 3-O-hemisuccinate|T110|T121|NON|NRW|NLM (2003)|abbcde
ENTRY = Pharmaxolon|T110|T121|TRD|NRW|UNK (19XX)|871021|abbcdef
ENTRY = Rowa Brand of Carbenoxolone Disodium Salt|T110|T121|NON|NRW|NLM (2005)|040617|abbcdef
ENTRY = Sanodin|T110|T121|TRD|NRW|ES|900116|abbcdef
ENTRY = 18alpha Carbenoxolone
ENTRY = 18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate
ENTRY = 3-O-hemisuccinate, Glycyrrhetinic Acid
ENTRY = 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid
ENTRY = Acid 3-O-hemisuccinate, Glycyrrhetinic
ENTRY = Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic
ENTRY = Glycyrrhetinic Acid 3 O hemisuccinate
MN = D02.455.849.919.530.444.250
PA = Anti-Ulcer Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T110
ST = T121
N1 = Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, (3beta,20beta)-
RN = MM6384NG73
RR = 5697-56-3 (Carbenoxolone)
RR = 7421-40-1 (di-Na salt)
RR = F1MP7242Z5
AN = /biosyn permitted if by plant
PI = Glycyrrhiza (1966-1974)
PI = Succinates (1974)
PI = Triterpenes (1974)
MS = An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.
PM = 1991; see GLYCYRRHETINIC ACID 1979-1990, see TRITERPENES 1975-1978; for 18ALPHA-CARBENOXOLONE was indexed under CARBENOXOLONE (NM) 1995-2002
HN = 1991(1975); for 18ALPHA-CARBENOXOLONE use CARBENOXOLONE (NM) 1995-2002
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D002229

*NEWRECORD
RECTYPE = D
MH = Carbidopa
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Methyldopahydrazine|T109|T121|NON|EQV|UNK (19XX)|790530|abbcdef
ENTRY = Carbidopa, (R)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Carbidopa, (S)-Isomer|T109|T121|NON|REL|NLM (1999)|990913|abbcdef
ENTRY = Lodosin|T109|T121|TRD|NRW|NLM (1991)|900307|abbcdef
ENTRY = Lodosyn|T109|T121|TRD|NRW|NLM (1991)|900307|abbcdef
ENTRY = MK-485|T109|T121|LAB|NRW|UNK (19XX)|770520|abbcdef
ENTRY = MK-486|T109|T121|LAB|NRW|UNK (19XX)|770520|abbcdef
ENTRY = MK 485
ENTRY = MK 486
ENTRY = MK485
ENTRY = MK486
MN = D02.092.311.200.538.200
MN = D02.442.200
PA = Antiparkinson Agents
PA = Aromatic Amino Acid Decarboxylase Inhibitors
PA = Dopamine Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1972)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)-
RN = MNX7R8C5VO
RR = 28860-95-9 ((S)-isomer)
RR = 28875-92-5 ((R)-isomer)
RR = 38821-49-7 (Carbidopa)
PI = Dopa (1972-1974)
PI = Hydrazines (1972-1974)
PI = Methyldopa (1972-1974)
MS = An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.
OL = use CARBIDOPA to search METHYLDOPAHYDRAZINE 1973-79 (as Prov 1973-74)
PM = 80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79
HN = 80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79; was METHYLDOPAHYDRAZINE 1973-74 (Prov)
MR = 20140612
DA = 19990101
DC = 1
DX = 19800101
UI = D002230

*NEWRECORD
RECTYPE = D
MH = Carbimazole
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Carbimazole Henning|T109|T121|TRD|NRW|DE|041208|abbcdef
ENTRY = Henning Berlin Brand of Carbimazole|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Herbrand Brand of Carbimazole|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Neo Tomizol|T109|T121|TRD|NRW|ES|041208|abbcdef
ENTRY = Neo-Mercazole|T109|T121|TRD|NRW|AU|IE|UK|041208|abbcdeeef
ENTRY = Neo-Thyreostat|T109|T121|TRD|NRW|DE|041208|abbcdef
ENTRY = Neomercazole|T109|T121|TRD|NRW|NLM (1998)|961112|abbcdef
ENTRY = Roche Brand of Carbimazole|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Sanofi Synthelabo Brand of Carbimazole|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Tarbis Brand of Carbimazole|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
MN = D03.383.129.308.108
PA = Antithyroid Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester
RN = 8KQ660G60G
RR = 22232-54-8 (Carbimazole)
PI = Imidazoles (1966-1967)
PI = Thyroid Antagonists (1966-1967)
MS = An imidazole antithyroid agent. Carbimazole is metabolized to METHIMAZOLE, which is responsible for the antithyroid activity.
PM = 73
HN = 73(68)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D002231

*NEWRECORD
RECTYPE = D
MH = Carbocyanines
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
MN = D02.455.326.397.300
PA = Coloring Agents
MH_TH = NLM (1976)
ST = T109
ST = T130
RN = 0
AN = D25-26 qualif
PI = Alkenes (1972-1975)
PI = Quinolines (1972-1975)
MS = Compounds that contain three methine groups. They are frequently used as cationic dyes used for differential staining of biological materials.
PM = 91; was see under QUINOLINES 1976-90
HN = 91(76); was see under QUINOLINES 1976-90
MR = 20050706
DA = 19750718
DC = 1
DX = 19910101
UI = D002232

*NEWRECORD
RECTYPE = D
MH = Carbocysteine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 3-(Carboxymethylthio)alanine|T116|T121|NON|EQV|UNK (19XX)|801203|abbcdef
ENTRY = Carbocysteine, L-Isomer|T116|T121|EQV|NLM (1999)|990913|abbdef
ENTRY = Mucodine|T116|T121|TRD|NRW|NLM (1990)|890609|abbcdef
ENTRY = Mucodyne|T116|T121|TRD|NRW|UNK (19XX)|801205|abbcdef
ENTRY = Mukodin|T116|T121|TRD|NRW|NLM (1991)|900116|abbcdef
ENTRY = Rhinathiol|T116|T121|TRD|NRW|UNK (19XX)|801205|abbcdef
ENTRY = S-(Carboxymethyl)-L-cysteine|T116|T121|NON|EQV|FDA SRS (2014)|NLM (1995)|930901|abbcdeef
ENTRY = S-Carboxymethylcysteine|T116|T121|NON|EQV|UNK (19XX)|801203|abbcdef
ENTRY = Thiodril|T116|T121|TRD|NRW|UNK (19XX)|801205|abbcdef
ENTRY = Carbocysteine, L Isomer
ENTRY = L-Isomer Carbocysteine
ENTRY = S Carboxymethylcysteine
MN = D02.886.030.230.310
MN = D12.125.119.270
MN = D12.125.166.230.310
PA = Anti-Infective Agents, Local
PA = Expectorants
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (2014)
MH_TH = USAN (1975)
ST = T116
ST = T121
N1 = Cysteine, S-(carboxymethyl)-
RN = 740J2QX53R
RR = 2387-59-9 (Carbocysteine)
PI = Amino Acids, Dicarboxylic (1974)
PI = Amino Acids, Sulfur (1974)
MS = A compound formed when iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action.
OL = use CARBOCYSTEINE to search CARBOXYMETHYLCYSTEINE 1975-79
PM = 91; was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79
HN = 91(80); was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002233

*NEWRECORD
RECTYPE = D
MH = Carbodiimides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.491.203
MH_TH = NLM (1973)
ST = T109
RN = 0
AN = do not confuse CARBODIIMIDES (a group term) with "carbodiimide" (a specific chemical)
PI = Imines (1966-1972)
PM = 73
HN = 73
MR = 19920511
DA = 19990101
DC = 1
DX = 19730101
UI = D002234

*NEWRECORD
RECTYPE = D
MH = Carbofuran
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Bayer 70143|T109|T121|T131|LAB|NRW|UNK (19XX)|800730|abbbcdef
ENTRY = Furadan|T109|T121|T131|TRD|NRW|UNK (19XX)|800730|abbbcdef
ENTRY = NIA-10242|T109|T121|T131|LAB|NRW|UNK (19XX)|800730|abbbcdef
ENTRY = 70143, Bayer
ENTRY = NIA 10242
ENTRY = NIA10242
MN = D02.241.081.251.583.166
PA = Antinematodal Agents
PA = Cholinesterase Inhibitors
PA = Insecticides
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T121
ST = T131
N1 = 7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-, methylcarbamate
RN = SKF77S6Y67
RR = 1563-66-2 (Carbofuran)
AN = TN 111 for eff on insects
PI = Carbamates (1966-1971)
PI = Insecticides (1966-1971)
MS = A cholinesterase inhibitor that is used as a systemic insecticide, an acaricide, and nematocide. (From Merck Index, 11th ed)
PM = 91; was see under INSECTICIDES, CARBAMATE 1972-90
HN = 91(72); was see under INSECTICIDES, CARBAMATE 1972-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002235

*NEWRECORD
RECTYPE = D
MH = Carbohydrate Conformation
DE = CARB CONFORMATION
AQ = DE RE
PRINT ENTRY = Carbohydrate Linkage|T078|NON|REL|UNK (19XX)|790524|abcdef
ENTRY = Carbohydrate Conformations
ENTRY = Carbohydrate Linkages
ENTRY = Conformation, Carbohydrate
ENTRY = Conformations, Carbohydrate
ENTRY = Linkage, Carbohydrate
ENTRY = Linkages, Carbohydrate
MN = G02.111.570.820.235
MH_TH = NLM (1980)
ST = T082
AN = IM general only; coord NIM with specific carbohydrate (IM); do not confuse CARBOHYDRATE LINKAGE see CARBOHYDRATE CONFORMATION with CARBOHYDRATE SEQUENCE: conform = spatial or 3-dimensional struct, sequ = order in which components are arranged
PI = Molecular Conformation (1973-1979)
MS = The characteristic 3-dimensional shape of a carbohydrate.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20150622
DA = 19790524
DC = 1
DX = 19800101
UI = D002236

*NEWRECORD
RECTYPE = D
MH = Carbohydrate Dehydrogenases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carbohydrate Oxidoreductases|T116|T126|NON|EQV|UNK (19XX)|770329|abbcdef
ENTRY = Dehydrogenases, Carbohydrate
ENTRY = Oxidoreductases, Carbohydrate
MN = D08.811.682.047.150
MH_TH = NLM (1978)
ST = T116
ST = T126
RN = EC 1.1.-
PI = Alcohol Oxidoreductases (1966-1977)
MS = Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2.; and 1.1.99.
PM = 78; FRUCTURONATE REDUCTASE, PHOSPHOGLYCERATE DEHYDROGENASE, TAGATURONATE REDUCTASE & URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE were see under ALCOHOL OXIDOREDUCTASES 1975-77
HN = 78
MR = 20060705
DA = 19770415
DC = 1
DX = 19780101
UI = D002237

*NEWRECORD
RECTYPE = D
MH = Carbohydrate Epimerases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carbohydrate Isomerases|T116|T126|NON|EQV|NLM (1998)|970411|abbcdef
ENTRY = Epimerases, Carbohydrate
ENTRY = Isomerases, Carbohydrate
MN = D08.811.399.894.500
MH_TH = NLM (1973)
ST = T116
ST = T126
RN = EC 5.1.3.-
PI = Isomerases (1966-1972)
MS = Enzymes that catalyze the epimerization of chiral centers within carbohydrates or their derivatives. EC 5.1.3.
PM = 73
HN = 73
MR = 20060705
DA = 19990101
DC = 1
DX = 19730101
UI = D002238

*NEWRECORD
RECTYPE = D
MH = Carbohydrate Metabolism, Inborn Errors
DE = CARB METAB INBORN ERR
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Carbohydrate Metabolism, Inborn Error|T047|NON|EQV|NLM (1991)|900524|CARBOHYDRATE METAB INBORN ERR|abcdefv
MN = C16.320.565.202
MN = C18.452.648.202
MH_TH = NLM (1965)
ST = T047
AN = do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific carbohydrate /metab (IM); FRUCTOSE METABOLISM, INBORN ERRORS & PYRUVATE METABOLISM, INBORN ERRORS are also available; DF: CARB METAB INBORN ERR
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19650101
UI = D002239

*NEWRECORD
RECTYPE = D
MH = Carbohydrate Sequence
DE = CARB SEQ
AQ = DE GE PH RE
ENTRY = Carbohydrate Sequences
ENTRY = Sequence, Carbohydrate
ENTRY = Sequences, Carbohydrate
MN = G02.111.570.160
MN = L01.453.245.667.160
MH_TH = NLM (1980)
ST = T088
AN = IM for general only; coord NIM with specific carbohydrate (IM); do not confuse with CARBOHYDRATE LINKAGE see CARBOHYDRATE CONFORMATION: sequ = order in which components are arranged, conform = spatial or 3-dimensional struct; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: CARB SEQ
MS = The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20080708
DA = 19790524
DC = 1
DX = 19800101
UI = D002240

*NEWRECORD
RECTYPE = D
MH = Carbohydrates
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Sugars|T118|NON|REL|UNK (19XX)|740329|abcdef
MN = D09
RH = D9 - CARBOHYDRATES
FX = Dietary Carbohydrates
EC = metabolism:Carbohydrate Metabolism
MH_TH = NLM (1994)
ST = T118
RN = 0
AN = general only; prefer specifics; glucides go here but could also be GLYCOSIDES; carbohydrates in the diet = DIETARY CARBOHYDRATES
MS = The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n.
OL = pre-explosion = CARBOHYDRATES (PX)
PM = /metabolism was CARBOHYDRATE METABOLISM 1963-65
HN = /metabolism was CARBOHYDRATE METABOLISM 1963-65
MR = 20050630
DA = 19990101
DC = 1
UI = D002241

*NEWRECORD
RECTYPE = D
MH = Carbolines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Beta-Carbolines|T109|NON|REL|UNK (19XX)|821129|abcdef
ENTRY = Pyrido(4,3-b)Indoles|T109|NON|EQV|UNK (19XX)|801205|abcdef
ENTRY = Beta Carbolines
MN = D03.383.725.150
MN = D03.438.473.155
MN = D03.494.154
MH_TH = NLM (1975)
ST = T109
N1 = Pyrido(4,3-b)Indoles
RN = 0
PI = Indoles (1969-1974)
PI = Pyridines (1969-1974)
MS = A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles.
PM = 86; was see under INDOLES 1975-85
HN = 86(75); was see under INDOLES 1975-85
MR = 20060705
DA = 19741119
DC = 1
DX = 19860101
UI = D002243

*NEWRECORD
RECTYPE = D
MH = Carbon
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
ENTRY = Vitreous Carbon|T196|NON|NRW|UNK (19XX)|810423|abcdef
ENTRY = Carbon, Vitreous
MN = D01.268.150
FX = Carbon Isotopes
FX = Carbon Radioisotopes
MH_TH = NLM (1966)
ST = T196
N1 = Carbon
RN = 7440-44-0
AN = C-12
MS = A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight [12.0096; 12.0116]. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE; and as SOOT from incompletely burned fuel.
MR = 20110701
DA = 19990101
DC = 1
UI = D002244

*NEWRECORD
RECTYPE = D
MH = Carbon Dioxide
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
PRINT ENTRY = Carbonic Anhydride|T123|T197|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Anhydride, Carbonic
ENTRY = Dioxide, Carbon
MN = D01.200.200
MN = D01.362.150
MN = D01.650.550.200
FX = Capnography
FX = Hypercapnia
FX = Hypocapnia
MH_TH = FDA SRS (2014)
MH_TH = POPLINE (1978)
MH_TH = USP (19XX)
ST = T123
ST = T197
N1 = Carbon dioxide
RN = 142M471B3J
RR = 124-38-9 (Carbon Dioxide)
AN = in respiration, /physiol permitted; /metab permitted for cell & tissue resp & non-lung tissue but do not use /metab for gas exchange in lung ( = PULMONARY GAS EXCHANGE) or blood CO2 transport ( = /blood but consider also HYPERCAPNIA & HYPOCAPNIA)
MS = A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.
MR = 20130708
DA = 19990101
DC = 1
UI = D002245

*NEWRECORD
RECTYPE = D
MH = Carbon Disulfide
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Disulfide, Carbon
MN = D01.200.210
MN = D01.875.350.850.074
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T131
ST = T197
N1 = Carbon disulfide
RN = S54S8B99E8
RR = 75-15-0 (Carbon Disulfide)
MS = A colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects.
MR = 20130708
DA = 19990101
DC = 1
UI = D002246

*NEWRECORD
RECTYPE = D
MH = Carbon Isotopes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Isotopes, Carbon
MN = D01.496.123
MH_TH = NLM (1966)
ST = T196
RN = 0
AN = C-13; NIM
MS = Stable carbon atoms that have the same atomic number as the element carbon, but differ in atomic weight. C-13 is a stable carbon isotope.
MR = 20000622
DA = 19990101
DC = 1
UI = D002247

*NEWRECORD
RECTYPE = D
MH = Carbon Monoxide
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PH PK RE SD ST TO TU UR
ENTRY = Monoxide, Carbon
MN = D01.200.250
MN = D01.362.200
MN = D01.650.550.250
PA = Antimetabolites
PA = Gasotransmitters
EC = poisoning:Carbon Monoxide Poisoning
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
MH_TH = USAN (19XX)
ST = T131
ST = T197
N1 = CO
RN = 7U1EE4V452
RR = 630-08-0 (Carbon Monoxide)
AN = a poisonous gas; /tox permitted but consider also CARBON MONOXIDE POISONING
MS = Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
MR = 20130708
DA = 19990101
DC = 1
UI = D002248

*NEWRECORD
RECTYPE = D
MH = Carbon Monoxide Poisoning
DE = CARBON MONOXIDE POIS
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Illuminating Gas Poisoning|T037|NON|NRW|UNK (19XX)|771205|ILLUMINATING GAS POIS|abcdefv
ENTRY = Poisoning, Carbon Monoxide|T037|NON|EQV|UNK (19XX)|771205|POIS CARBON MONOXIDE|abcdefv
ENTRY = Poisoning, Illuminating Gas|T037|NON|NRW|UNK (19XX)|771205|POIS ILLUMINATING GAS|abcdefv
ENTRY = Carbon Monoxide Poisonings
ENTRY = Gas Poisoning, Illuminating
ENTRY = Gas Poisonings, Illuminating
ENTRY = Illuminating Gas Poisonings
ENTRY = Monoxide Poisoning, Carbon
ENTRY = Monoxide Poisonings, Carbon
ENTRY = Poisonings, Carbon Monoxide
ENTRY = Poisonings, Illuminating Gas
MN = C25.723.455.245
MH_TH = NLM (1966)
ST = T037
MS = Toxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide.
OL = use CARBON MONOXIDE POISONING to search ILLUMINATING GAS POISONING 1969-78
HN = ILLUMINATING GAS POISONING was see under CARBON MONOXIDE POISONING 1969-78
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002249

*NEWRECORD
RECTYPE = D
MH = Carbon Radioisotopes
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Radioisotopes, Carbon
MN = D01.496.123.328
MN = D01.496.749.154
MH_TH = NLM (1974)
ST = T196
RN = 0
AN = C-10,11,14-16; for routine use as tracer, use no qualifiers
MS = Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes.
OL = search CARBON ISOTOPES 1966-73
PM = 74
HN = 74
MR = 20150605
DA = 19990101
DC = 1
DX = 19740101
UI = D002250

*NEWRECORD
RECTYPE = D
MH = Carbon Tetrachloride
DE = CCL4
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK RE SD ST TO TU UR
ENTRY = Tetrachloromethane|T109|T131|NON|EQV|UNK (19XX)|810608|abbcdef
ENTRY = Tetrachloride, Carbon
MN = D02.455.526.439.150
EC = poisoning:Carbon Tetrachloride Poisoning
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T131
N1 = Methane, tetrachloro-
RN = CL2T97X0V0
RR = 56-23-5 (Carbon Tetrachloride)
AN = /tox permitted but consider also CARBON TETRACHLORIDE POISONING; DF: CCL4
MS = A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)
MR = 20130708
DA = 19990101
DC = 1
UI = D002251

*NEWRECORD
RECTYPE = D
MH = Carbon Tetrachloride Poisoning
DE = CARBON TETRACHLORIDE POIS
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = CCl4 Poisoning|T037|EQV|UNK (19XX)|790323|CCL4 POIS|abdefv
ENTRY = Poisoning, CCl4|T037|EQV|UNK (19XX)|880802|POIS CCL4|abdefv
ENTRY = Poisoning, Carbon Tetrachloride|T037|EQV|UNK (19XX)|790323|POIS CARBON TETRACHLORIDE|abdefv
ENTRY = CCl4 Poisonings
ENTRY = Carbon Tetrachloride Poisonings
ENTRY = Poisonings, Carbon Tetrachloride
MN = C25.723.177
MH_TH = NLM (1966)
ST = T037
AN = DF: CCL4 POIS
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002252

*NEWRECORD
RECTYPE = D
MH = Carbonated Beverages
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Carbonated Drinks|T168|NON|EQV|NLM (2013)|111028|abcdef
ENTRY = Soda Pop|T168|NON|NRW|NLM (2013)|110713|abcdef
ENTRY = Soft Drinks|T168|NON|NRW|NLM (2013)|110713|abcdef
ENTRY = Beverage, Carbonated
ENTRY = Beverages, Carbonated
ENTRY = Carbonated Beverage
ENTRY = Carbonated Drink
ENTRY = Drink, Carbonated
ENTRY = Drink, Soft
ENTRY = Drinks, Carbonated
ENTRY = Drinks, Soft
ENTRY = Pop, Soda
ENTRY = Pops, Soda
ENTRY = Soda Pops
ENTRY = Soft Drink
MN = G07.203.100.300
MN = J02.200.300
MH_TH = NLM (1975)
ST = T168
MS = Drinkable liquids combined with or impregnated with carbon dioxide.
OL = search BEVERAGES 1966-74
PM = 91; was see under BEVERAGES 1975-90
HN = 91(75); was see under BEVERAGES 1975-90
MR = 20141014
DA = 19990101
DC = 1
DX = 19910101
UI = D002253

*NEWRECORD
RECTYPE = D
MH = Carbonates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.045.125
MN = D01.200.275.150
MN = D01.248.497.158.165
MH_TH = NLM (1966)
ST = T197
RN = 0
AN = GEN or unspecified; prefer specifics
MS = Salts or ions of the theoretical carbonic acid, containing the radical CO2(3-). Carbonates are readily decomposed by acids. The carbonates of the alkali metals are water-soluble; all others are insoluble. (From Grant & Hackh's Chemical Dictionary, 5th ed)
MR = 19930604
DA = 19990101
DC = 1
UI = D002254

*NEWRECORD
RECTYPE = D
MH = Carbonic Acid
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acid, Carbonic
MN = D01.029.260.150
MN = D01.200.275
MH_TH = NLM (1975)
ST = T197
N1 = Carbonic acid
RN = 463-79-6
AN = "the hypothetical acid of carbon dioxide & water"
MS = Carbonic acid (H2C03). The hypothetical acid of carbon dioxide and water. It exists only in the form of its salts (carbonates), acid salts (hydrogen carbonates), amines (carbamic acid), and acid chlorides (carbonyl chloride). (From Grant & Hackh's Chemical Dictionary, 5th ed)
OL = search CARBON DIOXIDE 1966-74
PM = 91; was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74
HN = 91(75); was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74
MR = 19930604
DA = 19990101
DC = 1
DX = 19910101
UI = D002255

*NEWRECORD
RECTYPE = D
MH = Carbonic Anhydrases
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carbonate Dehydratase|T116|T126|NON|EQV|NLM (1966)|990101|abbcdef
PRINT ENTRY = Carbonic Anhydrase|T116|T126|NON|EQV|NLM (1992)|910312|abbcdef
ENTRY = Anhydrases, Carbonic
ENTRY = Dehydratase, Carbonate
MN = D08.811.520.241.300.150
EC = antagonists & inhibitors:Carbonic Anhydrase Inhibitors
MH_TH = NLM (2002)
ST = T116
ST = T126
N1 = Carbonate hydro-lyase
RN = EC 4.2.1.1
RR = 9001-03-0 (CAS RN)
AN = note specifics
MS = A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1.
PM = 2002; see CARBONATE DEHYDRATASE 1992-2001, see CARBONIC ANHYDRASE 1963-1991
HN = 2002(1963)
MR = 20130709
DA = 19990101
DC = 1
UI = D002256

*NEWRECORD
RECTYPE = D
MH = Carbonic Anhydrase Inhibitors
DE = CARBONIC ANHYDRASE INHIB
DS = CARBONIC ANHYDRASE Z INHIBITORS
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carbonate Dehydratase Inhibitors|T121|NON|EQV|NLM (1992)|910529|CARBONATE DEHYDRATASE INHIB|abcdefv
ENTRY = Carboxyanhydrase Inhibitors|T121|NON|EQV|UNK (19XX)|820830|CARBOXYANHYDRASE INHIB|abcdefv
ENTRY = Inhibitors, Carbonate Dehydratase
ENTRY = Inhibitors, Carbonic Anhydrase
ENTRY = Inhibitors, Carboxyanhydrase
MN = D27.505.519.389.200
MH_TH = NLM (1964)
ST = T121
RN = 0
AN = DF: CARBONIC ANHYDRASE INHIB
MS = A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.
PM = 65
HN = 65(64)
MR = 20140625
DA = 19990101
DC = 1
DX = 19650101
UI = D002257

*NEWRECORD
RECTYPE = D
MH = Carbonyl Cyanide m-Chlorophenyl Hydrazone
DS = CARBONYL CYANIDE CHLOROPHENYL HYDRAZONE M
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = CCCP|T109|T130|ABB|EQV|UNK (19XX)|760513|abbcdef
PRINT ENTRY = Carbonyl Cyanide meta-Chlorophenyl Hydrazone|T109|T130|NON|EQV|UNK (19XX)|760515|CARBONYL CYANIDE CHLOROPHENYL HYDRAZONE META|abbcdefs
ENTRY = Carbonyl Cyanide m Chlorophenyl Hydrazone|T109|T130|EQV|UNK (19XX)|780126|abbdef
ENTRY = Carbonyl Cyanide meta Chlorophenyl Hydrazone
MN = D02.442.288.200
MN = D02.626.260
PA = Proton Ionophores
MH_TH = NLM (1975)
ST = T109
ST = T130
N1 = Propanedinitrile, ((3-chlorophenyl)hydrazono)-
RN = 555-60-2
PI = Chlorobenzenes (1974)
PI = Hydrazones (1972-1974)
PI = Nitriles (1970-1974)
MS = A proton ionophore. It is commonly used as an uncoupling agent and inhibitor of photosynthesis because of its effects on mitochondrial and chloroplast membranes.
PM = 91; was see under NITRILES 1975-90
HN = 91(75); was see under NITRILES 1975-90
MR = 20110624
DA = 19741111
DC = 1
DX = 19910101
UI = D002258

*NEWRECORD
RECTYPE = D
MH = Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
DS = CARBONYL CYANIDE TRIFLUOROMETHOXYPHENYLHYDRAZONE P
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carbonyl Cyanide para-Trifluoromethoxyphenylhydrazone|T109|T121|NON|EQV|UNK (19XX)|760515|CARBONYL CYANIDE TRIFLUOROMETHOXYPHENYLHYDRAZONE PARA|abbcdefs
PRINT ENTRY = FCCP|T109|T121|ABB|EQV|UNK (19XX)|741111|abbcdef
ENTRY = (4-(Trifluoromethoxy)phenyl)hydrazonopropanedinitrile|T109|T121|NON|EQV|NLM (1996)|950404|abbcdef
ENTRY = Carbonyl Cyanide p Trifluoromethoxyphenylhydrazone|T109|T121|EQV|UNK (19XX)|780126|abbdef
ENTRY = Carbonyl Cyanide para Trifluoromethoxyphenylhydrazone
ENTRY = Cyanide p-Trifluoromethoxyphenylhydrazone, Carbonyl
ENTRY = Cyanide para-Trifluoromethoxyphenylhydrazone, Carbonyl
ENTRY = p-Trifluoromethoxyphenylhydrazone, Carbonyl Cyanide
ENTRY = para-Trifluoromethoxyphenylhydrazone, Carbonyl Cyanide
MN = D02.442.288.220
MN = D02.626.270
PA = Proton Ionophores
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Propanedinitrile, ((4-(trifluoromethoxy)phenyl)hydrazono)-
RN = 370-86-5
PI = Hydrazones (1973-1974)
PI = Nitriles (1973-1974)
MS = A proton ionophore that is commonly used as an uncoupling agent in biochemical studies.
PM = 91; was see under NITRILES 1975-90
HN = 91(75); was see under NITRILES 1975-90
MR = 20110624
DA = 19741119
DC = 1
DX = 19910101
UI = D002259

*NEWRECORD
RECTYPE = D
MH = Carboprost
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 15-Methylprostaglandin F2alpha|T111|T121|NON|EQV|UNK (19XX)|790523|METHYLPROSTAGLANDIN F2ALPHA A 15|abbcdefs
ENTRY = 15(S)-15-Methyl PGF2alpha|T111|T121|EQV|UNK (19XX)|830223|abbdef
ENTRY = 15 Methylprostaglandin F2alpha
MN = D10.251.355.255.550.775.500.150
MN = D23.469.050.175.725.775.500.150
MN = D23.469.700.670.150
PA = Abortifacient Agents, Nonsteroidal
PA = Oxytocics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1976)
ST = T111
ST = T121
N1 = Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9alpha,11alpha,13E,15S)-
RN = 7B5032XT6O
RR = 35700-23-3 (Carboprost)
PI = Prostaglandins (1966-1974)
PI = Prostaglandins F (1975-1977)
PI = Prostaglandins F, Synthetic (1978-1979)
PI = Prostaglandins, Synthetic (1977)
MS = A nonsteroidal abortifacient agent that is effective in both the first and second trimesters of PREGNANCY.
OL = use CARBOPROST to search METHYLDINOPROST & 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER 1980-93
PM = 91; was see under PROSTAGLANDINS F, SYNTHETIC 1980-90; METHYLDINOPROST & 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER were see CARBOPROST 1980-93
HN = 91(80); was see under PROSTAGLANDINS F, SYNTHETIC 1980-90; METHYLDINOPROST & 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER were see CARBOPROST 1980-93
MR = 20150608
DA = 19790523
DC = 1
DX = 19910101
UI = D002260

*NEWRECORD
RECTYPE = D
MH = Carboxin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide|T109|T131|NON|EQV|FDA SRS (2014)|NLM (1996)|950404|abbcdeef
ENTRY = D-735|T109|T131|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Vitavax|T109|T131|TRD|NRW|UNK (19XX)|850103|abbcdef
ENTRY = D 735
ENTRY = D735
MN = D02.065.199.350
MN = D03.383.517.200
PA = Fungicides, Industrial
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T131
N1 = 1,4-Oxathiin-3-carboxamide, 5,6-dihydro-2-methyl-N-phenyl-
RN = 5A8K850HDE
RR = 5234-68-4 (Carboxin)
PI = Anilides (1972-1974)
PI = Oxathiins (1972-1974)
MS = A systemic agricultural fungicide and seed treatment agent.
PM = 91; was see under ANILIDES 1975-90
HN = 91(75); was see under ANILIDES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D002261

*NEWRECORD
RECTYPE = D
MH = Carboxy-Lyases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Decarboxylases|T116|T126|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Carboxy Lyases
MN = D08.811.520.224.125
MH_TH = NLM (1964)
ST = T116
ST = T126
RN = EC 4.1.1.-
MS = Enzymes that catalyze the addition of a carboxyl group to a compound (carboxylases) or the removal of a carboxyl group from a compound (decarboxylases). EC 4.1.1.
OL = use CARBOXY-LYASES & LIGASES to search CARBOXYLASES 1966-74
PM = 64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963
HN = 64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963
MR = 20060705
DA = 19990101
DC = 1
DX = 19640101
UI = D002262

*NEWRECORD
RECTYPE = D
MH = Carboxyhemoglobin
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carbomonoxyhemoglobin|T116|T123|NON|EQV|UNK (19XX)|800624|abbcdef
ENTRY = Carbonmonoxyhemoglobin|T116|T123|NON|EQV|UNK (19XX)|820603|abbcdef
ENTRY = Carbonylhemoglobin|T116|T123|NON|EQV|UNK (19XX)|820331|abbcdef
ENTRY = Carboxyhemoglobin A|T116|T123|NON|NRW|UNK (19XX)|830914|abbcdef
ENTRY = Carboxyhemoglobin C|T116|T123|NON|NRW|UNK (19XX)|830914|abbcdef
MN = D12.776.124.400.141
MN = D12.776.422.316.762.149
MH_TH = NLM (1973)
ST = T116
ST = T123
N1 = Hemoglobins, carbonyl-
RN = 9061-29-4
PM = 87; was see under HEMOGLOBINS 1975-86
HN = 87(73); was see under HEMOGLOBINS 1975-86
MR = 20080708
DA = 19990101
DC = 1
DX = 19870101
UI = D002263

*NEWRECORD
RECTYPE = D
MH = Carboxylic Acids
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Acids, Carboxylic
MN = D02.241
MH_TH = POPLINE (1984)
ST = T109
RN = 0
AN = do not confuse with CARBOCYCLIC ACIDS see ACIDS, CARBOCYCLIC
PI = Acids (1966-1970)
PI = Fatty Acids (1966-1970)
MS = Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic.
PM = 73
HN = 73(71)
MR = 20000621
DA = 19990101
DC = 1
DX = 19730101
UI = D002264

*NEWRECORD
RECTYPE = D
MH = Carboxylic Ester Hydrolases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carboxylesterases|T116|T126|NON|EQV|UNK (19XX)|750715|abbcdef
ENTRY = Ester Hydrolases, Carboxylic
ENTRY = Hydrolases, Carboxylic Ester
MN = D08.811.277.352.100
MH_TH = NLM (1976)
ST = T116
ST = T126
RN = EC 3.1.1.-
PI = Esterases (1972-1975)
MS = Enzymes which catalyze the hydrolysis of carboxylic acid esters with the formation of an alcohol and a carboxylic acid anion.
PM = 76; ALDONOLACTONASE, CHOLESTEROL ESTERASE, DEHYDROASCORBATASE, MONOACYLGLYCEROL LIPASES & NAPHTHOL AS D ESTERASE were see under ESTERASES 1975
HN = 76
MR = 20060705
DA = 19750725
DC = 1
DX = 19760101
UI = D002265

*NEWRECORD
RECTYPE = D
MH = Carboxymethylcellulose Sodium
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Carboxymethyl Cellulose|T118|T121|NON|EQV|UNK (19XX)|790606|abbcdef
PRINT ENTRY = Carboxymethylcellulose|T118|T121|NON|EQV|NLM (1975)|990101|abbcdef
ENTRY = Aquacel|T118|TRD|NRW|NLM (2011)|010702|abcdef
ENTRY = Aquaplast|T121|TRD|NRW|UNK (19XX)|800731|abcdef
ENTRY = Carmellose Sodium|T118|T121|NON|EQV|NLM (2011)|100505|abbcdef
ENTRY = Cellolax|T121|TRD|NRW|NLM (1990)|891116|abcdef
ENTRY = Cethylose|T121|TRD|NRW|NLM (1990)|891116|abcdef
ENTRY = Croscarmellose Sodium|T121|TRD|NRW|UNK (19XX)|830916|abcdef
ENTRY = Polycell|T121|TRD|NRW|NLM (1990)|891116|abcdef
ENTRY = Ruspol|T118|T121|TRD|EQV|NLM (1998)|961120|abbcdef
ENTRY = Sodium Carboxymethylcellulose|T118|T121|NON|EQV|UNK (19XX)|810918|abbcdef
ENTRY = Carboxymethylcellulose, Sodium
ENTRY = Cellulose, Carboxymethyl
ENTRY = Sodium, Carboxymethylcellulose
ENTRY = Sodium, Carmellose
ENTRY = Sodium, Croscarmellose
MN = D09.698.365.180.663.329
PA = Laxatives
MH_TH = USP (19XX)
ST = T118
ST = T121
RN = 9004-32-4
PI = Methylcellulose (1966-1974)
MS = A cellulose derivative which is a beta-(1,4)-D-glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in cosmetics and pharmaceuticals and as a stabilizer for reagents.
OL = search METHYLCELLULOSE 1966-74
PM = 91; was see under METHYLCELLULOSE 1975-90
HN = 91(75); was see under METHYLCELLULOSE 1975-90
MR = 20140617
DA = 19990101
DC = 1
DX = 19910101
UI = D002266

*NEWRECORD
RECTYPE = D
MH = Muramoylpentapeptide Carboxypeptidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carboxypeptidase Transpeptidase|T116|T126|NON|EQV|NLM (1997)|951213|abbcdef
ENTRY = Carboxypeptidase, Muramoylpentapeptide
ENTRY = Transpeptidase, Carboxypeptidase
MN = D08.811.277.656.350.245.500
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 3.4.17.8
PI = Acyltransferases (1974)
PI = Carboxypeptidases (1974)
PI = Peptidoglycan (1974)
MS = Enzyme which catalyzes the peptide cross-linking of nascent CELL WALL; PEPTIDOGLYCAN.
PM = 97; was CARBOXYPEPTIDASE TRANSPEPTIDASE 1975-96 (see under CARBOXYPEPTIDASES 1975-86); MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE was see CARBOXYPEPTIDASE TRANSPEPTIDASE 1979-96
HN = 97; was CARBOXYPEPTIDASE TRANSPEPTIDASE 1975-96 (see under CARBOXYPEPTIDASES 1975-86); MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE was see CARBOXYPEPTIDASE TRANSPEPTIDASE 1979-96
MR = 20040707
DA = 19741119
DC = 1
DX = 19870101
UI = D002267

*NEWRECORD
RECTYPE = D
MH = Carboxypeptidases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D08.811.277.656.350.245
MH_TH = NLM (1966)
ST = T116
ST = T126
RN = EC 3.4.-
AN = general or unspecified; prefer specifics
MS = Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue.
MR = 20090706
DA = 19990101
DC = 1
UI = D002268

*NEWRECORD
RECTYPE = D
MH = Carbuncle
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Carbuncles
MN = C01.252.410.868.820.270.200
MN = C01.252.825.770.270.200
MN = C01.539.800.720.770.270.200
MN = C17.800.838.765.770.270.200
FX = Furunculosis
MH_TH = NLM (1966)
ST = T020
AN = usually caused by Staph; malignant carbuncle = ANTHRAX
MS = An infection of cutaneous and subcutaneous tissue that consists of a cluster of boils. Commonly, the causative agent is STAPHYLOCOCCUS AUREUS. Carbuncles produce fever, leukocytosis, extreme pain, and prostration.
CATSH = CAT LIST
MR = 19940208
DA = 19990101
DC = 1
UI = D002270

*NEWRECORD
RECTYPE = D
MH = Carbutamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Aminophenurobutane|T109|T121|NON|EQV|UNK (19XX)|770117|abbcdef
PRINT ENTRY = Butylcarbamide|T109|T121|NON|REL|UNK (19XX)|770117|abbcdef
PRINT ENTRY = Glybutamide|T109|T121|NON|EQV|UNK (19XX)|770117|abbcdef
PRINT ENTRY = Sulfaninylbutylurea|T109|T121|NON|EQV|UNK (19XX)|770117|abbcdef
ENTRY = Bucarban|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Bukarban|T109|T121|TRD|NRW|UNK (19XX)|820603|abbcdef
ENTRY = Diabetal|T109|T121|NON|EQV|UNK (19XX)|810305|abbcdef
ENTRY = Glucidoral|T109|T121|TRD|NRW|FR|041208|abbcdef
ENTRY = Oranil|T109|T121|TRD|NRW|UNK (19XX)|811023|abbcdef
ENTRY = Oranyl|T109|T121|TRD|NRW|UNK (19XX)|811023|abbcdef
ENTRY = Servier Brand of Carbutamide|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
MN = D02.886.590.795.204
MN = D02.948.828.204
PA = Hypoglycemic Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Benzenesulfonamide, 4-amino-N-((butylamino)carbonyl)-
RN = E3K8P4869P
RR = 339-43-5 (Carbutamide)
MS = A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
MR = 20130708
DA = 19990101
DC = 1
UI = D002271

*NEWRECORD
RECTYPE = D
MH = Carcinoembryonic Antigen
DE = CEA
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Antigens, CD66e|T129|NON|EQV|NLM (2006)|050601|ANTIGENS CD 066E|abcdefs
PRINT ENTRY = CD66e Antigen|T129|ACX|EQV|NLM (2002)|001128|CD 066 E ANTIGEN|abcdefs
ENTRY = Antigen, CD66e|T129|ACX|EQV|NLM (2002)|001128|abcdef
ENTRY = Antigen, Carcinoembryonic
ENTRY = CD66e Antigens
MN = D12.776.395.550.200.210
MN = D12.776.543.550.200.210
MN = D23.050.285.329
MN = D23.050.301.350.210
MN = D23.101.140.300
MH_TH = NLM (1974)
ST = T129
RN = 0
MS = A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment.
PM = 74
HN = 74(73)
MR = 20150619
DA = 19990101
DC = 1
DX = 19740101
UI = D002272

*NEWRECORD
RECTYPE = D
MH = Carcinogens
AQ = AD AI AN CH CL CS CT EC HI IP ME PD PK RE SD ST TO
PRINT ENTRY = Oncogens|T131|NON|EQV|UNK (19XX)|750116|abcdef
PRINT ENTRY = Tumor Initiators|T131|NON|NRW|UNK (19XX)|810513|abcdef
PRINT ENTRY = Tumor Promoters|T131|NON|NRW|UNK (19XX)|810513|abcdef
ENTRY = Initiators, Tumor
ENTRY = Promoters, Tumor
MN = D27.888.569.100
FX = Anticarcinogenic Agents
FX = Cocarcinogenesis
FX = Mutagens
FX = Oncogenic Viruses
MH_TH = NLM (1966)
ST = T131
RN = 0
AN = Manual 24.5.6.2+
MS = Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.
MR = 20150402
DA = 19990101
DC = 1
UI = D002273

*NEWRECORD
RECTYPE = D
MH = Carcinogens, Environmental
DE = CARCINOGENS ENVIR
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Environmental Carcinogens|T131|NON|EQV|NLM (1996)|950327|ENVIR CARCINOGENS|abcdefv
MN = D27.888.569.100.125
MH_TH = NLM (1975)
ST = T131
RN = 0
AN = DF: CARCINOGENS ENVIR
PI = Carcinogens (1966-1974)
MS = Carcinogenic substances that are found in the environment.
PM = 75
HN = 75
MR = 20130708
DA = 19990101
DC = 1
DX = 19750901
UI = D002274

*NEWRECORD
RECTYPE = D
MH = Carcinoid Heart Disease
DE = CARCINOID HEART DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Carcinoid Heart Diseases
ENTRY = Heart Disease, Carcinoid
ENTRY = Heart Diseases, Carcinoid
MN = C04.557.465.625.650.200.500.205
MN = C04.557.470.200.025.200.500.205
MN = C04.557.580.625.650.200.500.205
MN = C14.280.104
MH_TH = NLM (1975)
ST = T047
MS = Cardiac manifestation of gastrointestinal CARCINOID TUMOR that metastasizes to the liver. Substances secreted by the tumor cells, including SEROTONIN, promote fibrous plaque formation in ENDOCARDIUM and its underlying layers. These deposits cause distortion of the TRICUSPID VALVE and the PULMONARY VALVE eventually leading to STENOSIS and valve regurgitation.
OL = search MALIGNANT CARCINOID SYNDROME 1966-74
PM = 91; was see under MALIGNANT CARCINOID SYNDROME 1964-90
HN = 91(75)(64-72); was see under MALIGNANT CARCINOID SYNDROME 1964-90 (Prov 1964-72)
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
DX = 19910101
UI = D002275

*NEWRECORD
RECTYPE = D
MH = Carcinoid Tumor
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Argentaffinoma|T191|NON|REL|UNK (19XX)|740329|abcdef
PRINT ENTRY = Carcinoid|T191|NON|EQV|NLM (1994)|930326|abcdef
PRINT ENTRY = Carcinoid, Goblet Cell|T191|NON|REL|NLM (1994)|930326|abcdef
ENTRY = Argentaffinomas
ENTRY = Carcinoid Tumors
ENTRY = Carcinoids
ENTRY = Carcinoids, Goblet Cell
ENTRY = Goblet Cell Carcinoid
ENTRY = Goblet Cell Carcinoids
ENTRY = Tumor, Carcinoid
ENTRY = Tumors, Carcinoid
MN = C04.557.465.625.650.200
MN = C04.557.470.200.025.200
MN = C04.557.580.625.650.200
MH_TH = NLM (1968)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); consider also MALIGNANT CARCINOID SYNDROME or CARCINOID HEART DISEASE
MS = A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)
OL = use CARCINOID TUMOR to search ARGENTAFFINOMA 1966-67
PM = 68; was ARGENTAFFINOMA 1963-67
HN = 68; was ARGENTAFFINOMA 1963-67
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
DX = 19680101
UI = D002276

*NEWRECORD
RECTYPE = D
MH = Carcinoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Anaplastic|T191|NON|REL|NLM (1994)|930527|abcdef
PRINT ENTRY = Carcinoma, Spindle-Cell|T191|NON|NRW|NLM (1994)|930527|abcdef
PRINT ENTRY = Carcinoma, Undifferentiated|T191|NON|REL|NLM (1994)|930527|abcdef
PRINT ENTRY = Carcinomatosis|T191|NON|NRW|NLM (1994)|930527|abcdef
PRINT ENTRY = Epithelial Neoplasms, Malignant|T191|NON|EQV|NLM (1994)|930527|EPITHELIAL NEOPL MALIGNANT|abcdefv
PRINT ENTRY = Epithelioma|T191|NON|EQV|UNK (19XX)|810515|abcdef
ENTRY = Epithelial Tumors, Malignant|T191|NON|EQV|NLM (1994)|930527|abcdef
ENTRY = Malignant Epithelial Neoplasms|T191|NON|EQV|NLM (1994)|930527|MALIGNANT EPITHELIAL NEOPL|abcdefv
ENTRY = Neoplasms, Malignant Epithelial|T191|NON|EQV|NLM (1994)|930527|NEOPL MALIGNANT EPITHELIAL|abcdefv
ENTRY = Anaplastic Carcinoma
ENTRY = Anaplastic Carcinomas
ENTRY = Carcinoma, Spindle Cell
ENTRY = Carcinomas
ENTRY = Carcinomas, Anaplastic
ENTRY = Carcinomas, Spindle-Cell
ENTRY = Carcinomas, Undifferentiated
ENTRY = Carcinomatoses
ENTRY = Epithelial Neoplasm, Malignant
ENTRY = Epithelial Tumor, Malignant
ENTRY = Epitheliomas
ENTRY = Malignant Epithelial Neoplasm
ENTRY = Malignant Epithelial Tumor
ENTRY = Malignant Epithelial Tumors
ENTRY = Neoplasm, Malignant Epithelial
ENTRY = Spindle-Cell Carcinoma
ENTRY = Spindle-Cell Carcinomas
ENTRY = Tumor, Malignant Epithelial
ENTRY = Tumors, Malignant Epithelial
ENTRY = Undifferentiated Carcinoma
ENTRY = Undifferentiated Carcinomas
MN = C04.557.470.200
MH_TH = NLM (1966)
ST = T191
AN = do not use for "cancer" routinely: use only for carcinoma as a histological type: Manual 24.2.1.3; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); X ref CARCINOMA, ANAPLASTIC: do not coord with ANAPLASIA unless anaplasia is particularly discussed
MS = A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D002277

*NEWRECORD
RECTYPE = D
MH = Carcinoma in Situ
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Intraepithelial|T191|NON|EQV|NLM (1994)|930326|abcdef
PRINT ENTRY = Carcinoma, Preinvasive|T191|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Intraepithelial Neoplasms|T191|NON|BRD|NLM (2002)|010110|INTRAEPITHELIAL NEOPL|abcdefv
ENTRY = Neoplasms, Intraepithelial|T191|NON|BRD|NLM (1994)|930330|NEOPL INTRAEPITHELIAL|abcdefv
ENTRY = Intraepithelial Carcinoma
ENTRY = Intraepithelial Neoplasm
ENTRY = Neoplasm, Intraepithelial
ENTRY = Preinvasive Carcinoma
MN = C04.557.470.200.240
MH_TH = NLM (1973)
ST = T191
AN = coord IM with precoord organ/neopl term (IM)
PI = Carcinoma (1966-1972)
MS = A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
PM = 73
HN = 73
CATSH = CAT LIST
MR = 20010725
DA = 19990101
DC = 1
DX = 19730101
UI = D002278

*NEWRECORD
RECTYPE = D
MH = Carcinoma 256, Walker
DS = CARCINOMA A 256 WALKER
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SC SE SU TH UL UR US VI
PRINT ENTRY = Carcinosarcoma 256, Walker|T050|T191|EPO|EQV|UNK (19XX)|740329|CARCINOSARCOMA A 256 WALKER|abbcdefs
ENTRY = Walker Carcinoma 256
ENTRY = Walker Carcinosarcoma 256
MN = C04.557.435.290.210
MN = C04.557.450.795.290.210
MN = C04.619.045
MH_TH = NLM (1966)
ST = T050
ST = T191
AN = exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don't forget check tag ANIMALS
MS = A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
UI = D002279

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Basal Cell
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Basal Cell, Pigmented|T191|NON|NRW|NLM (1994)|930326|abcdef
PRINT ENTRY = Epithelioma, Basal Cell|T191|NON|EQV|UNK (19XX)|810515|abcdef
PRINT ENTRY = Rodent Ulcer|T191|NON|EQV|NLM (1998)|961213|abcdef
PRINT ENTRY = Ulcer, Rodent|T191|NON|EQV|NLM (1998)|961213|abcdef
ENTRY = Basal Cell Carcinoma
ENTRY = Basal Cell Carcinomas
ENTRY = Basal Cell Epithelioma
ENTRY = Basal Cell Epitheliomas
ENTRY = Carcinomas, Basal Cell
ENTRY = Epitheliomas, Basal Cell
ENTRY = Rodent Ulcers
ENTRY = Ulcers, Rodent
MN = C04.557.470.200.165
MN = C04.557.470.565.165
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably SKIN NEOPLASMS (IM); X ref RODENT ULCER: do not coord with ULCER
MS = A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D002280

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Basosquamous
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Basosquamous Carcinoma
ENTRY = Basosquamous Carcinomas
ENTRY = Carcinomas, Basosquamous
MN = C04.557.470.200.170
MN = C04.557.470.565.170
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably SKIN NEOPLASMS (IM)
MS = A skin carcinoma that histologically exhibits both basal and squamous elements. (From Dorland, 27th ed)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D002281

*NEWRECORD
RECTYPE = D
MH = Adenocarcinoma, Bronchiolo-Alveolar
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Alveolar|T191|NON|EQV|NLM (1992)|910308|abcdef
PRINT ENTRY = Carcinoma, Bronchiolar|T191|NON|EQV|NLM (1994)|930329|abcdef
PRINT ENTRY = Carcinoma, Bronchiolo-Alveolar|T191|NON|EQV|NLM (1992)|910308|abcdef
ENTRY = Adenocarcinoma, Alveolar|T191|NON|EQV|NLM (1992)|910308|abcdef
ENTRY = Alveolar Cell Carcinoma|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Carcinoma, Bronchioloalveolar|T191|NON|EQV|NLM (1992)|910514|abcdef
ENTRY = Adenocarcinoma, Bronchiolo Alveolar
ENTRY = Adenocarcinomas, Alveolar
ENTRY = Adenocarcinomas, Bronchiolo-Alveolar
ENTRY = Alveolar Adenocarcinoma
ENTRY = Alveolar Adenocarcinomas
ENTRY = Alveolar Carcinoma
ENTRY = Alveolar Carcinomas
ENTRY = Bronchiolar Carcinoma
ENTRY = Bronchiolar Carcinomas
ENTRY = Bronchiolo-Alveolar Adenocarcinoma
ENTRY = Bronchiolo-Alveolar Adenocarcinomas
ENTRY = Bronchiolo-Alveolar Carcinoma
ENTRY = Bronchiolo-Alveolar Carcinomas
ENTRY = Bronchioloalveolar Carcinoma
ENTRY = Bronchioloalveolar Carcinomas
ENTRY = Carcinoma, Bronchiolo Alveolar
ENTRY = Carcinomas, Alveolar
ENTRY = Carcinomas, Bronchiolar
ENTRY = Carcinomas, Bronchiolo-Alveolar
ENTRY = Carcinomas, Bronchioloalveolar
MN = C04.557.470.200.025.030
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS (IM)
MS = A carcinoma thought to be derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed)
OL = use ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR to search CARCINOMA, BRONCHIOLAR 1966-93
PM = 94; was CARCINOMA, BRONCHIOLAR 1963-93
HN = 94; was CARCINOMA, BRONCHIOLAR 1963-93
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002282

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Bronchogenic
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Bronchial|T191|NON|EQV|UNK (19XX)|810515|abcdef
ENTRY = Bronchial Carcinoma
ENTRY = Bronchial Carcinomas
ENTRY = Bronchogenic Carcinoma
ENTRY = Bronchogenic Carcinomas
ENTRY = Carcinomas, Bronchial
ENTRY = Carcinomas, Bronchogenic
MN = C04.588.894.797.520.109.220
MN = C08.381.540.140
MN = C08.785.520.100.220
MH_TH = NLM (1966)
ST = T191
AN = coordinate IM with LUNG NEOPLASMS (IM), not BRONCHIAL NEOPLASMS; do not confuse entry term CARCINOMA, BRONCHIAL with BRONCHIAL NEOPLASMS
MS = Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.
CATSH = CAT LIST
MR = 20090710
DA = 19990101
DC = 1
UI = D002283

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Brown-Pearce
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SC SE SU TH UL UR US VI
PRINT ENTRY = Epithelioma, Brown-Pearce|T191|EPO|EQV|UNK (19XX)|740329|abcdef
ENTRY = Brown-Pearce Carcinoma
ENTRY = Brown-Pearce Epithelioma
ENTRY = Carcinoma, Brown Pearce
ENTRY = Epithelioma, Brown Pearce
MN = C04.619.124
MH_TH = NLM (1966)
ST = T191
AN = exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don't forget check tag ANIMALS
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
UI = D002284

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Intraductal, Noninfiltrating
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Intraductal|T191|NON|EQV|NLM (1994)|930330|abcdef
PRINT ENTRY = DCIS|T191|ABB|EQV|NLM (1999)|971014|abcdef
PRINT ENTRY = Ductal Carcinoma In Situ|T191|NON|EQV|NLM (1999)|971014|abcdef
ENTRY = Intraductal Carcinoma, Noninfiltrating|T191|NON|EQV|NLM (1994)|930330|abcdef
ENTRY = Carcinoma, Noninfiltrating Intraductal
ENTRY = Carcinomas, Intraductal
ENTRY = Carcinomas, Noninfiltrating Intraductal
ENTRY = Intraductal Carcinoma
ENTRY = Intraductal Carcinomas
ENTRY = Intraductal Carcinomas, Noninfiltrating
ENTRY = Noninfiltrating Intraductal Carcinoma
ENTRY = Noninfiltrating Intraductal Carcinomas
MN = C04.557.470.200.025.275
MN = C04.557.470.615.275
MH_TH = NLM (1966)
ST = T191
AN = intraductal refers to mammary ducts only; do not confuse entry term CARCINOMA, INTRADUCTAL with CARCINOMA, DUCTAL; CARCINOMA, DUCTAL, BREAST; or CARCINOMA, PANCREATIC DUCTAL; coordinate IM with BREAST NEOPLASMS (IM)
MS = A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.
OL = use CARCINOMA, INTRADUCTAL, NONINFILTRATING to search CARCINOMA, DUCTAL 1966-93
PM = 94; was CARCINOMA, DUCTAL 1963-93
HN = 94; was CARCINOMA, DUCTAL 1963-93
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D002285

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Ehrlich Tumor
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SC SE SU TH UL UR US VI
PRINT ENTRY = Ehrlich Ascites Tumor|T050|T191|EPO|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Ascites Tumor, Ehrlich
ENTRY = Ehrlich Tumor Carcinoma
ENTRY = Tumor, Ehrlich Ascites
MN = C04.557.470.200.200
MN = C04.619.169
MH_TH = NLM (1966)
ST = T050
ST = T191
AN = exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; note X ref: do not also index under ASCITES; don't forget check tag ANIMALS
MS = A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
UI = D002286

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Krebs 2
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SC SE SU TH UL UR US VI
ENTRY = Krebs 2 Carcinoma
MN = C04.557.470.200.255
MN = C04.619.214
MH_TH = NLM (1966)
ST = T050
ST = T191
AN = exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don't forget check tag ANIMALS
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
UI = D002287

*NEWRECORD
RECTYPE = D
MH = Adenocarcinoma, Mucinous
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Colloid|T191|NON|EQV|UNK (19XX)|800509|abcdef
PRINT ENTRY = Carcinoma, Mucinous|T191|NON|EQV|NLM (1994)|930330|abcdef
ENTRY = Adenocarcinomas, Mucinous
ENTRY = Carcinomas, Colloid
ENTRY = Carcinomas, Mucinous
ENTRY = Colloid Carcinoma
ENTRY = Colloid Carcinomas
ENTRY = Mucinous Adenocarcinoma
ENTRY = Mucinous Adenocarcinomas
ENTRY = Mucinous Carcinoma
ENTRY = Mucinous Carcinomas
MN = C04.557.470.200.025.075
MN = C04.557.470.590.075
MH_TH = NLM (1966)
ST = T191
AN = also called "mucoid" or "mucous" carcinoma; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
OL = use ADENOCARCINOMA, MUCINOUS to search CARCINOMA, MUCINOUS 1981-93 & CARCINOMA, COLLOID 1966-80
PM = 94; was CARCINOMA, MUCINOUS 1981-93; CARCINOMA, COLLOID was heading 1963-80
HN = 94; was CARCINOMA, MUCINOUS 1981-93; CARCINOMA, COLLOID was heading 1963-80
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D002288

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Non-Small-Cell Lung
DE = NSCLC
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Non-Small Cell Lung|T191|NON|EQV|NLM (1994)|930702|abcdef
PRINT ENTRY = Non-Small Cell Lung Cancer|T191|NON|EQV|NLM (2011)|ORD (2010)|100407|abcdeef
PRINT ENTRY = Non-Small-Cell Lung Carcinoma|T191|NON|EQV|UNK (19XX)|860623|NONSMALL CELL LUNG CARCINOMA|abcdefs
ENTRY = Nonsmall Cell Lung Cancer|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Carcinoma, Non Small Cell Lung
ENTRY = Carcinomas, Non-Small-Cell Lung
ENTRY = Lung Carcinoma, Non-Small-Cell
ENTRY = Lung Carcinomas, Non-Small-Cell
ENTRY = Non Small Cell Lung Carcinoma
ENTRY = Non-Small-Cell Lung Carcinomas
MN = C04.588.894.797.520.109.220.249
MN = C08.381.540.140.500
MN = C08.785.520.100.220.500
FX = Adenocarcinoma
FX = Carcinoma, Large Cell
FX = Carcinoma, Small Cell
FX = Carcinoma, Squamous Cell
MH_TH = NLM (1987)
MH_TH = ORD (2010)
ST = T191
AN = coordinate IM with LUNG NEOPLASMS (IM); CARCINOMA, LARGE CELL and SMALL CELL LUNG CARCINOMA are also available; DF: NSCLC
PI = Lung Neoplasms (1966-1986)
MS = A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
OL = use CARCINOMA, NON-SMALL-CELL LUNG to search CARCINOMA, NON-SMALL CELL LUNG 1987-93
PM = 94; was CARCINOMA, NON-SMALL CELL LUNG 1987-93
HN = 94; was CARCINOMA, NON-SMALL CELL LUNG 1987-93
CATSH = CAT LIST
MR = 20120703
DA = 19860623
DC = 1
DX = 19870101
UI = D002289

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Papillary
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Carcinomas, Papillary
ENTRY = Papillary Carcinoma
ENTRY = Papillary Carcinomas
MN = C04.557.470.200.360
MN = C04.557.470.700.360
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D002291

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Renal Cell
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Adenocarcinoma, Renal Cell|T191|NON|EQV|UNK (19XX)|840529|abcdef
PRINT ENTRY = Carcinoma, Hypernephroid|T191|NON|NRW|UNK (19XX)|840529|abcdef
PRINT ENTRY = Grawitz Tumor|T191|EPO|NRW|UNK (19XX)|840529|abcdef
PRINT ENTRY = Hypernephroma|T191|NON|NRW|OMIM (2013)|ORD (2010)|UNK (19XX)|840529|abcdeeef
ENTRY = Adenocarcinoma Of Kidney|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Adenocarcinoma, Renal|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Chromophil Renal Cell Carcinoma|T191|NON|NRW|NLM (2012)|ORD (2010)|101213|abcdeef
ENTRY = Chromophobe Renal Cell Carcinoma|T191|NON|NRW|NLM (2006)|ORD (2010)|050418|abcdeef
ENTRY = Clear Cell Renal Carcinoma|T191|NON|NRW|NLM (2006)|050511|abcdef
ENTRY = Clear Cell Renal Cell Carcinoma|T191|NON|NRW|NLM (2006)|ORD (2010)|050418|abcdeef
ENTRY = Collecting Duct Carcinoma|T191|NON|NRW|NLM (2011)|ORD (2010)|100421|abcdeef
ENTRY = Collecting Duct Carcinoma (Kidney)|T191|NON|NRW|NLM (2006)|050418|abcdef
ENTRY = Collecting Duct Carcinoma of the Kidney|T191|NON|NRW|NLM (2011)|ORD (2010)|100421|abcdeef
ENTRY = Nephroid Carcinoma|T191|NON|EQV|UNK (19XX)|840529|abcdef
ENTRY = Papillary Renal Cell Carcinoma|T191|NON|NRW|NLM (2006)|ORD (2010)|050418|abcdeef
ENTRY = Renal Cell Cancer|T191|NON|EQV|NLM (2011)|ORD (2010)|100421|abcdeef
ENTRY = Renal Cell Carcinoma|T191|NON|EQV|NLM (2006)|OMIM (2013)|050418|abcdeef
ENTRY = Renal Cell Carcinoma, Papillary|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Renal Collecting Duct Carcinoma|T191|NON|NRW|NLM (2011)|ORD (2010)|100421|abcdeef
ENTRY = Sarcomatoid Renal Cell Carcinoma|T191|NON|NRW|NLM (2009)|080201|abcdef
ENTRY = Adenocarcinomas, Renal Cell
ENTRY = Cancer, Renal Cell
ENTRY = Cancers, Renal Cell
ENTRY = Carcinoma, Collecting Duct
ENTRY = Carcinoma, Collecting Duct (Kidney)
ENTRY = Carcinoma, Nephroid
ENTRY = Carcinomas, Collecting Duct
ENTRY = Carcinomas, Collecting Duct (Kidney)
ENTRY = Carcinomas, Hypernephroid
ENTRY = Carcinomas, Nephroid
ENTRY = Carcinomas, Renal Cell
ENTRY = Collecting Duct Carcinomas
ENTRY = Collecting Duct Carcinomas (Kidney)
ENTRY = Duct Carcinoma, Collecting
ENTRY = Duct Carcinoma, Collecting (Kidney)
ENTRY = Duct Carcinomas, Collecting
ENTRY = Duct Carcinomas, Collecting (Kidney)
ENTRY = Hypernephroid Carcinoma
ENTRY = Hypernephroid Carcinomas
ENTRY = Hypernephromas
ENTRY = Nephroid Carcinomas
ENTRY = Renal Cell Adenocarcinoma
ENTRY = Renal Cell Adenocarcinomas
ENTRY = Renal Cell Cancers
ENTRY = Renal Cell Carcinomas
ENTRY = Tumor, Grawitz
MN = C04.557.470.200.025.390
MN = C04.588.945.947.535.160
MN = C12.758.820.750.160
MN = C12.777.419.473.160
MN = C13.351.937.820.535.160
MN = C13.351.968.419.473.160
MH_TH = NLM (1985)
ST = T191
AN = coordinate IM with KIDNEY NEOPLASMS (IM)
PI = Adenocarcinoma (1966-1984)
PI = Kidney Neoplasms (1966-1984)
MS = A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
PM = 85
HN = 85
CATSH = CAT LIST
MR = 20120703
DA = 19840529
DC = 1
DX = 19850101
UI = D002292

*NEWRECORD
RECTYPE = D
MH = Adenocarcinoma, Scirrhous
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Scirrhous|T191|NON|EQV|NLM (1994)|930330|abcdef
ENTRY = Adenocarcinomas, Scirrhous
ENTRY = Carcinomas, Scirrhous
ENTRY = Scirrhous Adenocarcinoma
ENTRY = Scirrhous Adenocarcinomas
ENTRY = Scirrhous Carcinoma
ENTRY = Scirrhous Carcinomas
MN = C04.557.470.200.025.095
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense connective tissue in the stroma. (From Dorland, 27th ed)
OL = use ADENOCARCINOMA, SCIRRHOUS to search CARCINOMA, SCIRRHOUS 1966-93
PM = 94; was CARCINOMA, SCIRRHOUS 1963-93
HN = 94; was CARCINOMA, SCIRRHOUS 1963-93
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D002293

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Squamous Cell
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Carcinoma, Epidermoid|T191|NON|EQV|UNK (19XX)|800509|abcdef
PRINT ENTRY = Carcinoma, Planocellular|T191|NON|EQV|NLM (1992)|910110|abcdef
PRINT ENTRY = Carcinoma, Squamous|T191|NON|EQV|NLM (1994)|930326|abcdef
ENTRY = Squamous Cell Carcinoma|T191|NON|EQV|NLM (2009)|080303|abcdef
ENTRY = Carcinomas, Epidermoid
ENTRY = Carcinomas, Planocellular
ENTRY = Carcinomas, Squamous
ENTRY = Carcinomas, Squamous Cell
ENTRY = Epidermoid Carcinoma
ENTRY = Epidermoid Carcinomas
ENTRY = Planocellular Carcinoma
ENTRY = Planocellular Carcinomas
ENTRY = Squamous Carcinoma
ENTRY = Squamous Carcinomas
ENTRY = Squamous Cell Carcinomas
MN = C04.557.470.200.400
MN = C04.557.470.700.400
MH_TH = NLM (1966)
ST = T191
AN = coordinate IM with precoordinated organ/neoplasm term (IM)
MS = A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
OL = use CARCINOMA, SQUAMOUS CELL to search CARCINOMA, EPIDERMOID 1966-80
PM = 81; was CARCINOMA, EPIDERMOID 1963-80
HN = 81; was CARCINOMA, EPIDERMOID 1963-80
CATSH = CAT LIST
MR = 20140613
DA = 19990101
DC = 1
UI = D002294

*NEWRECORD
RECTYPE = D
MH = Carcinoma, Transitional Cell
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Carcinomas, Transitional Cell
ENTRY = Cell Carcinoma, Transitional
ENTRY = Cell Carcinomas, Transitional
ENTRY = Transitional Cell Carcinoma
ENTRY = Transitional Cell Carcinomas
MN = C04.557.470.200.430
MH_TH = NLM (1966)
ST = T191
AN = coordinate IM with precoordinated organ/neoplasm term (IM)
MS = A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
CATSH = CAT LIST
MR = 20140613
DA = 19990101
DC = 1
UI = D002295

*NEWRECORD
RECTYPE = D
MH = Carcinosarcoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Carcinosarcomas
MN = C04.557.435.290
MN = C04.557.450.795.290
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D002296

*NEWRECORD
RECTYPE = D
MH = Cardanolides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.155
MH_TH = NLM (1968)
ST = T110
RN = 0
AN = do not confuse with CARDENOLIDES
MS = The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position.
PM = 68
HN = 68
MR = 19930603
DA = 19990101
DC = 1
DX = 19680101
UI = D002297

*NEWRECORD
RECTYPE = D
MH = Cardenolides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.155.580.130
MH_TH = NLM (1977)
ST = T110
RN = 0
AN = includes cardadienolides & cardatrienolides; do not confuse with CARDANOLIDES
PI = Cardanolides (1968-1976)
MS = C(23)-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS.
PM = 77
HN = 77
MR = 20150622
DA = 19760416
DC = 1
DX = 19770101
UI = D002298

*NEWRECORD
RECTYPE = D
MH = Cardia
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Cardias
MN = A03.556.875.875.163
MH_TH = NLM (1966)
ST = T023
AN = adjective form = "cardial": do not confuse with "cardiac" (heart); diseases: coord IM with STOMACH DISEASES (IM); neoplasms: coord IM with STOMACH NEOPLASMS (IM) + histol type of neopl (IM)
MS = That part of the STOMACH close to the opening from ESOPHAGUS into the stomach (cardiac orifice), the ESOPHAGOGASTRIC JUNCTION. The cardia is so named because of its closeness to the HEART. Cardia is characterized by the lack of acid-forming cells (GASTRIC PARIETAL CELLS).
MR = 20040707
DA = 19990101
DC = 1
UI = D002299

*NEWRECORD
RECTYPE = D
MH = Cardiac Care Facilities
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Cardiac Care Facility
ENTRY = Facilities, Cardiac Care
ENTRY = Facility, Cardiac Care
MN = N02.278.421.556.110
MH_TH = NLM (1977)
ST = T073
ST = T093
MS = Institutions specializing in the care of patients with heart disorders.
PM = 91; was see under HOSPITALS, SPECIAL Aug 1977-90
HN = 91(Aug 77); was see under HOSPITALS, SPECIAL 1977-90
MR = 19920507
DA = 19770519
DC = 1
DX = 19910101
UI = D002300

*NEWRECORD
RECTYPE = D
MH = Cardiac Glycosides
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Cardiotonic Steroids|T118|T121|NON|EQV|UNK (19XX)|760422|abbcdef
ENTRY = Glycosides, Cardiac
ENTRY = Steroids, Cardiotonic
MN = D04.808.155.580
MN = D09.408.180
PA = Anti-Arrhythmia Agents
PA = Cardiotonic Agents
PA = Enzyme Inhibitors
MH_TH = NLM (1966)
ST = T118
ST = T121
RN = 0
MS = Cyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose.
MR = 20060705
DA = 19990101
DC = 1
UI = D002301

*NEWRECORD
RECTYPE = D
MH = Cardiac Output
AQ = DE ES GE IM PH RE
ENTRY = Cardiac Outputs
ENTRY = Output, Cardiac
ENTRY = Outputs, Cardiac
MN = E01.370.370.380.150
MN = G09.330.380.124
MH_TH = NLM (1964)
ST = T033
AN = a physiol concept: do not confuse with the C14 diseases CARDIAC OUTPUT, HIGH or CARDIAC OUTPUT, LOW
MS = The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat).
PM = 67
HN = 67(64)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19670101
UI = D002302

*NEWRECORD
RECTYPE = D
MH = Cardiac Output, Low
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Low Cardiac Output|T033|T046|NON|EQV|UNK (19XX)|790424|abbcdef
PRINT ENTRY = Low Cardiac Output Syndrome|T046|NON|REL|NLM (1998)|960716|abcdef
ENTRY = Output, Low Cardiac
MN = C14.280.148
MN = C23.888.192
MH_TH = NLM (1980)
ST = T033
ST = T046
AN = note category: do not confuse with CARDIAC OUTPUT, a physiological concept; note entry term LOW CARDIAC OUTPUT SYNDROME: do not add SYNDROME
PI = Cardiac Output (1966-1979)
MS = A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20070709
DA = 19790424
DC = 1
DX = 19800101
UI = D002303

*NEWRECORD
RECTYPE = D
MH = Cardiac Pacing, Artificial
AQ = AE CL CT EC ES HI MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Pacing, Cardiac, Artificial|T061|T066|NON|EQV|UNK (19XX)|770418|abbcdef
ENTRY = Artificial Cardiac Pacing
ENTRY = Artificial Cardiac Pacings
ENTRY = Cardiac Pacings, Artificial
ENTRY = Pacing, Artificial Cardiac
ENTRY = Pacings, Artificial Cardiac
MN = E02.331.200
FX = Pacemaker, Artificial
EC = instrumentation:Pacemaker, Artificial
MH_TH = NLM (1978)
ST = T061
ST = T066
PI = Pacemaker, Artificial (1966-1977)
MS = Regulation of the rate of contraction of the heart muscles by an artificial pacemaker.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 20150706
DA = 19770422
DC = 1
DX = 19780101
UI = D002304

*NEWRECORD
RECTYPE = D
MH = Cardiac Tamponade
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Pericardial Tamponade|T047|NON|EQV|NLM (2008)|060926|abcdef
ENTRY = Cardiac Tamponades
ENTRY = Pericardial Tamponades
ENTRY = Tamponade, Cardiac
ENTRY = Tamponade, Pericardial
ENTRY = Tamponades, Cardiac
ENTRY = Tamponades, Pericardial
MN = C14.280.155
MH_TH = NLM (1966)
ST = T047
MS = Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D002305

*NEWRECORD
RECTYPE = D
MH = Cardiac Volume
AQ = DE ES GE IM PH RE
PRINT ENTRY = Heart Volume|T033|T040|NON|EQV|NLM (1991)|900411|abbcdef
ENTRY = Cardiac Volumes
ENTRY = Heart Volumes
ENTRY = Volume, Cardiac
ENTRY = Volume, Heart
ENTRY = Volumes, Cardiac
ENTRY = Volumes, Heart
MN = G09.330.380.249
FX = Stroke Volume
MH_TH = NLM (1968)
ST = T033
ST = T040
PI = Cardiac Output (1966-1967)
PI = Heart/physiology (1966-1967)
MS = The volume of the HEART, usually relating to the volume of BLOOD contained within it at various periods of the cardiac cycle. The amount of blood ejected from a ventricle at each beat is STROKE VOLUME.
PM = 72
HN = 72(68)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19720101
UI = D002306

*NEWRECORD
RECTYPE = D
MH = Cardiography, Impedance
DE = CARDIOGR IMPEDANCE
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
PRINT ENTRY = Impedance, Transthoracic|T060|NON|EQV|UNK (19XX)|771123|abcdef
PRINT ENTRY = Plethysmography, Impedance, Transthoracic|T060|NON|EQV|UNK (19XX)|771123|PLETHYSMOGR IMPEDANCE TRANSTHORACIC|abcdefv
ENTRY = Impedance Cardiography|T060|NON|EQV|NLM (1995)|931012|IMPEDANCE CARDIOGR|abcdefv
ENTRY = Impedance Plethysmography, Transthoracic|T060|NON|EQV|NLM (1995)|931012|IMPEDANCE PLETHYSMOGR TRANSTHORACIC|abcdefv
ENTRY = Plethysmography, Transthoracic Impedance|T060|NON|EQV|NLM (1995)|931012|PLETHYSMOGR TRANSTHORACIC IMPEDANCE|abcdefv
ENTRY = Transthoracic Impedance Plethysmography|T060|NON|EQV|NLM (1995)|931012|TRANSTHORACIC IMPEDANCE PLETHYSMOGR|abcdefv
ENTRY = Cardiographies, Impedance
ENTRY = Impedance Cardiographies
ENTRY = Impedance Plethysmographies, Transthoracic
ENTRY = Impedances, Transthoracic
ENTRY = Plethysmographies, Transthoracic Impedance
ENTRY = Transthoracic Impedance
ENTRY = Transthoracic Impedance Plethysmographies
ENTRY = Transthoracic Impedances
MN = E01.370.370.380.160
MN = E01.370.370.610.610.200
MH_TH = NLM (1979)
ST = T060
AN = NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CARDIOGR IMPEDANCE
PI = Cardiac Output (1966-1978)
PI = Plethysmography, Impedance (1966-1978)
MS = A type of impedance plethysmography in which bioelectrical impedance is measured between electrodes positioned around the neck and around the lower thorax. It is used principally to calculate stroke volume and cardiac volume, but it is also related to myocardial contractility, thoracic fluid content, and circulation to the extremities.
PM = 91; was see under PLETHYSMOGRAPHY, IMPEDANCE 1979-90
HN = 91(79); was see under PLETHYSMOGRAPHY, IMPEDANCE 1979-90
CATSH = CAT LIST
MR = 20150622
DA = 19771123
DC = 1
DX = 19910101
UI = D002307

*NEWRECORD
RECTYPE = D
MH = Cardiolipins
AQ = AD AE AN BI BL CF CH CL CT DE EC GE HI IM IP ME PD PH PO RE TO TU UL UR
PRINT ENTRY = Cardiolipin|T119|NON|EQV|NLM (1999)|980311|abcdef
PRINT ENTRY = Diphosphatidylglycerols|T119|NON|BRD|UNK (19XX)|760515|abcdef
MN = D10.570.755.375.760.400.885.185
MN = D23.050.550.480.330
FX = Antibodies, Anticardiolipin
FX = Antiphospholipid Syndrome
FX = Syphilis Serodiagnosis
MH_TH = NLM (1972)
ST = T119
RN = 0
PI = Phospholipids (1966-1971)
MS = Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS.
OL = search CARDIOLIPINS & PHOSPHATIDYLGLYCEROLS 1975-76
PM = 73; DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76
HN = 73(72); DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76
MR = 20050630
DA = 19990101
DC = 1
DX = 19730101
UI = D002308

*NEWRECORD
RECTYPE = D
MH = Cardiology
DE = CARDIOL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Angiology|T091|NON|NRW|NLM (2012)|110128|abcdef
ENTRY = Cardiovascular Disease Specialty|T091|NON|NRW|NLM (2012)|110218|abcdef
ENTRY = Vascular Medicine|T091|NON|NRW|NLM (2012)|110128|abcdef
ENTRY = Disease Specialty, Cardiovascular
ENTRY = Medicine, Vascular
ENTRY = Specialty, Cardiovascular Disease
MN = H02.403.429.163
FX = Cardiovascular Diseases
FX = Heart Diseases
FX = Vascular Diseases
MH_TH = NLM (1966)
ST = T091
AN = use for the discipline (education, history, etc) only; corresponding disease term is CARDIOVASCULAR DISEASES or specifics
MS = The study of the heart, its physiology, and its functions.
MR = 20110624
DA = 19990101
DC = 1
UI = D002309

*NEWRECORD
RECTYPE = D
MH = Cardiomyopathy, Alcoholic
AQ = BL CF CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Alcoholic Cardiomyopathy|T047|NON|EQV|UNK (19XX)|780519|abcdef
MN = C14.280.238.057
MN = C25.775.100.087.250
MH_TH = NLM (1979)
ST = T047
PI = Alcoholism (1966-1978)
PI = Heart Diseases (1966-1978)
PI = Myocardial Diseases (1966-1978)
MS = Disease of CARDIAC MUSCLE resulting from chronic excessive alcohol consumption. Myocardial damage can be caused by: (1) a toxic effect of alcohol; (2) malnutrition in alcoholics such as THIAMINE DEFICIENCY; or (3) toxic effect of additives in alcoholic beverages such as COBALT. This disease is usually manifested by DYSPNEA and palpitations with CARDIOMEGALY and congestive heart failure (HEART FAILURE).
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20130708
DA = 19780519
DC = 1
DX = 19790101
UI = D002310

*NEWRECORD
RECTYPE = D
MH = Cardiomyopathy, Dilated
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cardiomyopathy, Congestive|T047|NON|NRW|NLM (1984)|990101|abcdef
PRINT ENTRY = Congestive Cardiomyopathy|T047|NON|NRW|UNK (19XX)|830531|abcdef
PRINT ENTRY = Dilated Cardiomyopathy|T047|NON|EQV|UNK (19XX)|840424|abcdef
ENTRY = Cardiomyopathy, Dilated, 1a|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cardiomyopathy, Dilated, Autosomal Recessive|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cardiomyopathy, Dilated, CMD1A|T047|NON|NRW|NLM (2005)|030825|abcdef
ENTRY = Cardiomyopathy, Dilated, LMNA|T047|NON|NRW|NLM (2005)|030825|abcdef
ENTRY = Cardiomyopathy, Dilated, With Conduction Defect 1|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cardiomyopathy, Dilated, with Conduction Deffect1|T047|NON|NRW|NLM (2005)|030825|abcdef
ENTRY = Cardiomyopathy, Familial Idiopathic|T047|NON|NRW|NLM (2005)|OMIM (2013)|ORD (2010)|030825|abcdeeef
ENTRY = Cardiomyopathy, Idiopathic Dilated|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Dilated cardiomyopathy 1A|T047|NON|NRW|ORD (2010)|130326|abcdef
ENTRY = 1A, Dilated cardiomyopathy
ENTRY = 1As, Dilated cardiomyopathy
ENTRY = Cardiomyopathies, Congestive
ENTRY = Cardiomyopathies, Dilated
ENTRY = Cardiomyopathies, Familial Idiopathic
ENTRY = Cardiomyopathies, Idiopathic Dilated
ENTRY = Congestive Cardiomyopathies
ENTRY = Dilated Cardiomyopathies
ENTRY = Dilated Cardiomyopathies, Idiopathic
ENTRY = Dilated Cardiomyopathy, Idiopathic
ENTRY = Dilated cardiomyopathy 1As
ENTRY = Familial Idiopathic Cardiomyopathies
ENTRY = Familial Idiopathic Cardiomyopathy
ENTRY = Idiopathic Cardiomyopathies, Familial
ENTRY = Idiopathic Cardiomyopathy, Familial
ENTRY = Idiopathic Dilated Cardiomyopathies
ENTRY = Idiopathic Dilated Cardiomyopathy
ENTRY = cardiomyopathy 1A, Dilated
ENTRY = cardiomyopathy 1As, Dilated
MN = C14.280.195.160
MN = C14.280.238.070
MH_TH = UNK (19XX)
ST = T047
AN = note entry term CARDIOMYOPATHY, CONGESTIVE: do not confuse with HEART FAILURE
PI = Heart Failure, Congestive (1966-1983)
PI = Myocardial Diseases (1979-1983)
MS = A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
PM = 2005; see CARDIOMYOPATHY, CONGESTIVE 1986-2004, see HEART FAILURE, CONGESTIVE 1984-1985
HN = 2005 (1984)
CATSH = CAT LIST
MR = 20130708
DA = 19830531
DC = 1
DX = 19860101
UI = D002311

*NEWRECORD
RECTYPE = D
MH = Cardiomyopathy, Hypertrophic
DE = SUBVALV STENOSIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cardiomyopathy, Hypertrophic Obstructive|T047|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Cardiomyopathies, Hypertrophic
ENTRY = Cardiomyopathies, Hypertrophic Obstructive
ENTRY = Hypertrophic Cardiomyopathies
ENTRY = Hypertrophic Cardiomyopathy
ENTRY = Hypertrophic Obstructive Cardiomyopathies
ENTRY = Hypertrophic Obstructive Cardiomyopathy
ENTRY = Obstructive Cardiomyopathies, Hypertrophic
ENTRY = Obstructive Cardiomyopathy, Hypertrophic
MN = C14.280.238.100
MN = C14.280.484.150.070.160
MH_TH = NLM (1966)
ST = T047
AN = do not confuse with CARDIAC HYPERTROPHY see CARDIOMEGALY
MS = A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
OL = use CARDIOMYOPATHY, HYPERTROPHIC to search IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85
PM = 86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85
HN = 86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85
CATSH = CAT LIST
MR = 20140613
DA = 19990101
DC = 1
DX = 19660101
UI = D002312

*NEWRECORD
RECTYPE = D
MH = Cardiomyopathy, Restrictive
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Familial Restrictive Cardiomyopathy|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Cardiomyopathies, Restrictive
ENTRY = Restrictive Cardiomyopathies
ENTRY = Restrictive Cardiomyopathy
MN = C14.280.238.160
MH_TH = GHR (2014)
MH_TH = NLM (1986)
ST = T047
PI = Myocardial Diseases (1979-1985)
MS = A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.
PM = 86
HN = 86
CATSH = CAT LIST
MR = 20130708
DA = 19850311
DC = 1
DX = 19860101
UI = D002313

*NEWRECORD
RECTYPE = D
MH = Cardioplegic Solutions
DE = CARDIOPLEGIC SOL
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Cardioplegic Solution|T121|NON|EQV|UNK (19XX)|870504|abcdef
ENTRY = Solution, Cardioplegic
ENTRY = Solutions, Cardioplegic
MN = D26.776.708.160
MN = D27.505.954.411.207
MN = D27.505.954.578.322
MN = D27.720.752.322
MH_TH = NLM (1988)
ST = T121
RN = 0
AN = D25-26 qualif; coord IM with specific drug in solution (IM); DF: CARDIOPLEGIC SOL
PI = Heart Arrest, Induced (1966-1987)
PI = Hypertonic Solutions (1966-1987)
PI = Hypotonic Solutions (1966-1987)
PI = Isotonic Solutions (1966-1987)
MS = Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery.
PM = 88
HN = 88
MR = 20130708
DA = 19870504
DC = 1
DX = 19880101
UI = D002314

*NEWRECORD
RECTYPE = D
MH = Cardiopulmonary Bypass
DE = CARDIOPULM BYPASS
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Heart-Lung Bypass|T061|NON|EQV|UNK (19XX)|741125|abcdef
ENTRY = Bypass, Cardiopulmonary|T061|NON|EQV|NLM (1996)|950302|BYPASS CARDIOPULM|abcdefv
ENTRY = Bypass, Heart-Lung
ENTRY = Bypasses, Cardiopulmonary
ENTRY = Bypasses, Heart-Lung
ENTRY = Cardiopulmonary Bypasses
ENTRY = Heart Lung Bypass
ENTRY = Heart-Lung Bypasses
MN = E04.292.413
FX = Heart Bypass, Left
FX = Heart-Lung Machine
MH_TH = NLM (1975)
ST = T061
AN = diverts blood from right atrium: consider also HEART BYPASS, LEFT which diverts blood from left atrium; /instrum: consider also HEART-LUNG MACHINE; do not use /util except by MeSH definition; DF: CARDIOPULM BYPASS
PI = Extracorporeal Circulation (1967-1976)
MS = Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.
OL = search EXTRACORPOREAL CIRCULATION 1967-74
PM = 77; was see under EXTRACORPOREAL CIRCULATION 1967-76
HN = 77(75); was see under EXTRACORPOREAL CIRCULATION 1967-76
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19770101
UI = D002315

*NEWRECORD
RECTYPE = D
MH = Cardiotonic Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cardiac Stimulants|T121|NON|EQV|UNK (19XX)|790228|abcdef
PRINT ENTRY = Cardioprotective Agents|T121|NON|EQV|NLM (2002)|001121|abcdef
PRINT ENTRY = Inotropic Agents, Positive Cardiac|T121|NON|EQV|UNK (19XX)|790501|abcdef
PRINT ENTRY = Myocardial Stimulants|T121|NON|EQV|UNK (19XX)|790228|abcdef
ENTRY = Cardiotonic Drugs|T121|NON|EQV|NLM (1996)|941130|abcdef
ENTRY = Cardiotonics|T121|NON|EQV|UNK (19XX)|790228|abcdef
MN = D27.505.954.411.222
MN = D27.720.799.080
MH_TH = NLM (1980)
ST = T121
RN = 0
AN = do not confuse with CARDIOTOXINS
PI = Cardiac Glycosides (1966-1979)
PI = Sympathomimetics (1966-1979)
PI = specific drug or agent (1966-1979)
MS = Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
PM = 80
HN = 80
MR = 20070711
DA = 19790228
DC = 1
DX = 19800101
UI = D002316

*NEWRECORD
RECTYPE = D
MH = Cardiovascular Agents
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cardiovascular Drugs|T121|NON|EQV|NLM (1996)|941205|abcdef
ENTRY = Agents, Cardiovascular
ENTRY = Drugs, Cardiovascular
MN = D27.505.954.411
MH_TH = NLM (1979)
ST = T121
RN = 0
MS = Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.
OL = consider also CARDIOVASCULAR SYSTEM /DE
PM = 79
HN = 79; was NON MESH before 1979
MR = 20050815
DA = 19990101
DC = 1
DX = 19790101
UI = D002317

*NEWRECORD
RECTYPE = D
MH = Cardiovascular Diseases
DE = CARDIOVASC DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Cardiovascular Disease
ENTRY = Disease, Cardiovascular
ENTRY = Diseases, Cardiovascular
MN = C14
RH = C14 - DISEASES-CARDIOVASCULAR
MH_TH = NLM (1966)
ST = T047
AN = general, prefer specifics
MS = Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
CATSH = CAT LIST
MR = 20150605
DA = 19990101
DC = 1
UI = D002318

*NEWRECORD
RECTYPE = D
MH = Cardiovascular System
DE = CARDIOVASC SYSTEM
AQ = AH CH CY DE EM EN GD IM IN IR ME MI PA PP PS RA RE RI SE UL US VI
ENTRY = Cardiovascular Systems
ENTRY = System, Cardiovascular
ENTRY = Systems, Cardiovascular
MN = A07
RH = A7 - ANATOMY-CARDIOVASCULAR SYSTEM
FX = Blood Circulation
EC = abnormalities:Cardiovascular Abnormalities
EC = physiology:Cardiovascular Physiological Phenomena
EC = surgery:Cardiovascular Surgical Procedures
MH_TH = NLM (1966)
ST = T022
AN = GEN or unspecified; prefer specifics; /abnorm = CARDIOVASCULAR ABNORMALITIES but consider also specific artery or vein with /abnorm; DF: CARDIOVASC SYSTEM
MS = The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.
OL = pre-explosion = CARDIOVASCULAR SYSTEM (PX)
MR = 20080710
DA = 19990101
DC = 1
UI = D002319

*NEWRECORD
RECTYPE = D
MH = Cardiovascular Physiological Phenomena
AQ = DE GE IM RE
PRINT ENTRY = Cardiovascular Physiology|T042|NON|EQV|NLM (1966)|990101|CARDIOVASC PHYSIOL|abcdefv
ENTRY = Cardiovascular Physiological Concepts|T042|NON|EQV|NLM (2009)|080702|abcdef
ENTRY = Cardiovascular Physiological Phenomenon|T042|NON|EQV|NLM (2009)|080702|abcdef
ENTRY = Physiology, Cardiovascular|T042|NON|EQV|NLM (1998)|960916|PHYSIOL CARDIOVASC|abcdefv
ENTRY = Cardiovascular Physiological Concept
ENTRY = Cardiovascular Physiological Phenomenas
ENTRY = Concept, Cardiovascular Physiological
ENTRY = Concepts, Cardiovascular Physiological
ENTRY = Phenomena, Cardiovascular Physiological
ENTRY = Phenomenon, Cardiovascular Physiological
ENTRY = Physiological Concept, Cardiovascular
ENTRY = Physiological Concepts, Cardiovascular
ENTRY = Physiological Phenomena, Cardiovascular
ENTRY = Physiological Phenomenon, Cardiovascular
MN = G09.330
MH_TH = NLM (2009)
ST = T042
AN = general or unspecified; prefer specifics; DF: CARDIOVASC PHYSIOL
PI = Cardiovascular System/physiology (1966-1997)
MS = Processes and properties of the CARDIOVASCULAR SYSTEM as a whole or of any of its parts.
PM = 2009; see CARDIOVASCULAR PHYSIOLOGY 1998-2008
HN = 2009 (1998)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19980101
UI = D002320

*NEWRECORD
RECTYPE = D
MH = Career Choice
ENTRY = Career Choices
ENTRY = Choice, Career
ENTRY = Choices, Career
MN = F02.463.785.373.346.400
MH_TH = NLM (1975)
ST = T041
AN = no qualif
MS = Selection of a type of occupation or profession.
PM = 83; was see under CHOICE BEHAVIOR 1981-82 & DECISION MAKING 1975-80
HN = 83(75); was see under CHOICE BEHAVIOR 1981-82 & DECISION MAKING 1975-80
CATSH = CAT LIST
MR = 19890428
DA = 19741111
DC = 1
DX = 19830101
UI = D002321

*NEWRECORD
RECTYPE = D
MH = Career Mobility
PRINT ENTRY = Career Ladders|T080|NON|NRW|NLM (1991)|900409|abcdef
PRINT ENTRY = Clinical Ladders|T080|NON|NRW|NLM (1991)|900409|CLIN LADDERS|abcdefv
PRINT ENTRY = Job Ladders|T080|NON|NRW|NLM (1991)|900409|abcdef
ENTRY = Clinical Ladder|T080|NON|NRW|NLM (1994)|930526|abcdef
ENTRY = Ladder, Clinical|T080|NON|NRW|NLM (1994)|920817|LADDER CLIN|abcdefv
ENTRY = Ladders, Clinical|T080|NON|NRW|NLM (1994)|920817|LADDERS CLIN|abcdefv
ENTRY = Career Ladder
ENTRY = Career Mobilities
ENTRY = Job Ladder
ENTRY = Ladder, Career
ENTRY = Ladder, Job
ENTRY = Ladders, Career
ENTRY = Ladders, Job
ENTRY = Mobilities, Career
ENTRY = Mobility, Career
MN = N01.824.245.175
MN = N01.824.547.330
MH_TH = NLM (1972)
ST = T080
PI = Health Occupations (1966-1971)
PI = Occupations (1966-1971)
PI = specific occupation (1966-1971)
MS = The upward or downward mobility in an occupation or the change from one occupation to another.
PM = 74
HN = 74(72)
MR = 20150630
DA = 19990101
DC = 1
DX = 19740101
UI = D002322

*NEWRECORD
RECTYPE = D
MH = Carfecillin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carbenicillin Phenyl Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1973)|770418|abbcdeef
ENTRY = BRL-3475|T109|T195|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Carfecillin Sodium Salt|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Carphecillin|T109|T195|NON|EQV|UNK (19XX)|820226|abbcdef
ENTRY = Uticillin|T109|T195|TRD|NRW|UNK (19XX)|800730|abbcdef
ENTRY = BRL 3475
ENTRY = BRL3475
ENTRY = Salt, Carfecillin Sodium
ENTRY = Sodium Salt, Carfecillin
MN = D02.065.589.099.750.750.170.200
MN = D02.886.108.750.750.170.200
MN = D03.438.260.825.750.170.200
MN = D03.605.084.737.750.170.200
MN = D04.075.080.875.099.221.750.750.170.200
PA = Anti-Bacterial Agents
PA = Anti-Infective Agents, Urinary
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((1,3-dioxo-3-phenoxy-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-
RN = 9UU4XDB74X
RR = 18N5JP36GY
RR = 21649-57-0 (Na salt)
RR = 27025-49-6 (Carfecillin)
PI = Carbenicillin (1973-1977)
PI = Penicillins (1966-1972)
MS = The phenyl ester of CARBENICILLIN that, upon oral administration, is broken down in the intestinal mucosa to the active antibacterial. It is used for urinary tract infections.
PM = 91; was see under CARBENICILLIN 1978-90
HN = 91(78); was see under CARBENICILLIN 1978-90
MR = 20130708
DA = 19770422
DC = 1
DX = 19910101
UI = D002323

*NEWRECORD
RECTYPE = D
MH = Caricatures as Topic
AQ = CL ES HI PX SN TD
ENTRY = Caricature as Topic|T170|NON|EQV|NLM (2008)|070622|abcdef
ENTRY = Caricature as Topics
ENTRY = Caricatures as Topics
MN = K01.093.206
MH_TH = NLM (2008)
ST = T170
AN = IM; coordinate with subject (IM) or person with required biography and history headings & check tags; do not confuse with Publication Type CARICATURES; CARTOONS AS TOPIC is also available
MS = Portraying in a critical or facetious way a real individual or group, or a figure representing a social, political, ethnic, or racial type. The effect is usually achieved through distortion or exaggeration of characteristics. (Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed)
PM = 2008; see CARICATURES 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D002325

*NEWRECORD
RECTYPE = D
MH = Cariogenic Agents
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Agents, Cariogenic
MN = D25.187
MN = D27.720.102.187
MN = J01.637.051.187
FX = Diet, Cariogenic
MH_TH = NLM (1965)
ST = T120
RN = 0
MS = Substances that promote DENTAL CARIES.
PM = 65
HN = 65
MR = 20060705
DA = 19990101
DC = 1
DX = 19650101
UI = D002326

*NEWRECORD
RECTYPE = D
MH = Cariostatic Agents
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Cariostatic Effect|T039|NON|REL|NLM (2012)|110331|abcdef
ENTRY = Cariostatic Effects|T039|NON|REL|NLM (2012)|110331|abcdef
ENTRY = Agent, Cariostatic
ENTRY = Agents, Cariostatic
ENTRY = Cariostatic Agent
ENTRY = Effect, Cariostatic
ENTRY = Effects, Cariostatic
MN = D25.223
MN = D27.505.696.706.222
MN = D27.720.102.223
MN = D27.720.799.113
MN = J01.637.051.223
FX = Fluoridation
MH_TH = NLM (1965)
ST = T121
RN = 0
AN = note entry term CARIOSTATIC EFFECT: use only for the cariostatic effect of a chemical
MS = Substances that inhibit or arrest DENTAL CARIES formation. (Boucher's Clinical Dental Terminology, 4th ed)
PM = 65
HN = 65
MR = 20110624
DA = 19990101
DC = 1
DX = 19650101
UI = D002327

*NEWRECORD
RECTYPE = D
MH = Carisoprodol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carisoprodate|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef
PRINT ENTRY = Isobamate|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef
PRINT ENTRY = Isomeprobamate|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef
PRINT ENTRY = Isopropylmeprobamate|T109|T121|NON|EQV|UNK (19XX)|770317|abbcdef
ENTRY = Belmac Brand of Carisoprodol|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Carisoma|T109|T121|TRD|NRW|UK|US|041208|abbcdeef
ENTRY = Carter Horner Brand of Carisoprodol|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Forest Brand of Carisoprodol|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = GM Pharmaceuticals Brand of Carisoprodol|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Mio Relax|T109|T121|TRD|NRW|ES|041208|abbcdef
ENTRY = Schein Brand of Carisoprodol|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Soma|T109|T121|TRD|NRW|CA|US|041208|abbcdeef
ENTRY = Somalgit|T109|T121|TRD|NRW|US|041208|abbcdef
ENTRY = Soprodol|T109|T121|NON|NRW|US|861119|abbcdef
ENTRY = Vanadom|T109|T121|TRD|NRW|US|041208|abbcdef
ENTRY = Wallace Brand 1 of Carisoprodol|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Wallace Brand 2 of Carisoprodol|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
ENTRY = Wallace Brand 3 of Carisoprodol|T109|T121|NON|NRW|NLM (2006)|041208|abbcdef
MN = D02.241.081.251.165
PA = Muscle Relaxants, Central
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Carbamic acid, (1-methylethyl)-, 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester
RN = 21925K482H
RR = 78-44-4 (Carisoprodol)
MS = A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
MR = 20130708
DA = 19990101
DC = 1
UI = D002328

*NEWRECORD
RECTYPE = D
MH = Carmine
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Coccinellin|T109|T130|TRD|NRW|UNK (19XX)|750630|abbcdef
PRINT ENTRY = Natural Red 4|T109|T130|NON|EQV|FDA SRS (2014)|UNK (19XX)|750630|abbcdeef
ENTRY = 7-Glucopyranosyl-3,5,6,8-tetrahydroxyl-1-methyl-9,10-dioxoanthracene-2-carboxylic Acid|T109|T130|NON|EQV|NLM (2014)|130213|abbcdef
ENTRY = C.I. 75470|T109|T130|LAB|NRW|NLM (1991)|900303|abbcdef
ENTRY = Carminic Acid|T109|T130|NON|EQV|FDA SRS (2014)|NLM (2014)|130213|abbcdeef
ENTRY = Cochineal Dye|T109|T130|NON|EQV|NLM (2014)|130213|abbcdef
ENTRY = Dye, Cochineal
MN = D02.455.426.559.847.117.159.200
MN = D02.806.100.200
MN = D04.615.117.159.200
PA = Coloring Agents
PA = Food Coloring Agents
MH_TH = NLM (1976)
ST = T109
ST = T130
N1 = 2-Anthracenecarboxylic acid, 7-beta-D-glucopyranosyl-9,10-dihydro-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-
RN = CID8Z8N95N
RR = 1260-17-9 (Carmine)
RR = 476-39-1 (carminic acid)
AN = D25-26 qualif
PI = Aluminum (1972-1975)
PI = Anthraquinones (1972-1975)
PI = Calcium (1972-1975)
MS = Coloring matter from the insect Coccus cacti L. It is used in foods, pharmaceuticals, toiletries, etc., as a dye, and also has use as a microscopic stain and biological marker.
PM = 1991; CARMIC ACID was indexed under CARMINE 1977-2013, see ANTHRAQUINONES 1976-1990
HN = 1991(1976)
MR = 20130708
DA = 19750723
DC = 1
DX = 19910101
UI = D002329

*NEWRECORD
RECTYPE = D
MH = Carmustine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = BCNU|T109|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|740329|abbcdeef
ENTRY = 1,3-Bis(2-Chloroethyl)-1-Nitrosourea|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|810917|abbcdeef
ENTRY = BiCNU|T109|T121|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = FIVB|T109|T121|ABB|EQV|UNK (19XX)|811218|abbcdef
ENTRY = N,N'-Bis(2-Chloroethyl)-N-Nitrosourea|T109|T121|NON|EQV|UNK (19XX)|810427|abbcdef
ENTRY = Nitrumon|T109|T121|TRD|NRW|UNK (19XX)|801205|abbcdef
MN = D02.654.692.247
MN = D02.948.594.247
PA = Antineoplastic Agents, Alkylating
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1970)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Urea, N,N'-bis(2-chloroethyl)-N-nitroso-
RN = U68WG3173Y
RR = 154-93-8 (Carmustine)
PI = Alkylating Agents (1966-1971)
PI = Nitroso Compounds (1966-1971)
PI = Urea (1966-1971)
MS = A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
PM = 73
HN = 73(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D002330

*NEWRECORD
RECTYPE = D
MH = Carnitine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Bicarnesine|T109|TRD|NRW|UNK (19XX)|861118|abcdef
ENTRY = L-Carnitine|T109|NON|NRW|UNK (19XX)|831014|abcdef
ENTRY = Levocarnitine|T109|NON|NRW|FDA SRS (2015)|INN (19XX)|NLM (2008)|USAN (19XX)|060717|abcdeeeef
ENTRY = Vitamin BT|T109|NON|NRW|NLM (2009)|080117|abcdef
ENTRY = L Carnitine
MN = D02.092.877.883.099
MH_TH = FDA SRS (2015)
MH_TH = INN (19XX)
MH_TH = NLM (1964)
MH_TH = USAN (19XX)
ST = T116
ST = T123
N1 = 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, inner salt, (R)-
RN = S7UI8SM58A
RR = 0G389FZZ9M
RR = 541-15-1
MS = A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism.
PM = 66; was see under VITAMIN B COMPLEX 1963-65
HN = 66(64); was see under VITAMIN B COMPLEX 1963-65
MR = 20141014
DA = 19990101
DC = 1
DX = 19660101
UI = D002331

*NEWRECORD
RECTYPE = D
MH = Carnitine O-Acetyltransferase
DS = CARNITINE ACETYLTRANSFERASE O
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carnitine Acetyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef
ENTRY = Carnitine-Acetyl-CoA-Transferase|T116|T126|EQV|UNK (19XX)|830223|abbdef
ENTRY = Acetyltransferase, Carnitine
ENTRY = Carnitine Acetyl CoA Transferase
ENTRY = Carnitine O Acetyltransferase
ENTRY = O-Acetyltransferase, Carnitine
MN = D08.811.913.050.134.150
MN = D08.811.913.050.350.170
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Acetyl-CoA:carnitine O-acetyltransferase
RN = EC 2.3.1.7
RR = 9029-90-7 (CAS RN)
AN = do not confuse with CARNITINE ACYLTRANSFERASES
PI = Acetyltransferases (1973-1974)
PI = Carnitine (1973-1974)
MS = An enzyme that catalyzes the formation of O-acetylcarnitine from acetyl-CoA plus carnitine. EC 2.3.1.7.
PM = 98; see CARNITINE ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1975-90
HN = 98(75)
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D002332

*NEWRECORD
RECTYPE = D
MH = Carnitine Acyltransferases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Acylcarnitine Translocase|T116|T126|NON|EQV|NLM (1992)|901211|abbcdef
ENTRY = Carnitine Translocase|T116|T126|NON|EQV|NLM (1992)|901211|abbcdef
ENTRY = Carnitine-Acetylcarnitine Translocase|T116|T126|NON|NRW|NLM (1992)|901211|abbcdef
ENTRY = Carnitine-Acylcarnitine Translocase|T116|T126|NON|EQV|UNK (19XX)|810318|abbcdef
ENTRY = Acyltransferases, Carnitine
ENTRY = Carnitine Acetylcarnitine Translocase
ENTRY = Carnitine Acylcarnitine Translocase
ENTRY = Translocase, Acylcarnitine
ENTRY = Translocase, Carnitine
ENTRY = Translocase, Carnitine-Acetylcarnitine
ENTRY = Translocase, Carnitine-Acylcarnitine
MN = D08.811.913.050.350
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 2.3.1.-
RR = 39386-49-7 (CAS RN)
AN = do not confuse with CARNITINE ACETYLTRANSFERASE see CARNITINE O-ACETYLTRANSFERASE
PI = Acyltransferases (1972-1974)
MS = Acyltransferases in the inner mitochondrial membrane that catalyze the reversible transfer of acyl groups from acyl-CoA to L-carnitine and thereby mediate the transport of activated fatty acids through that membrane. EC 2.3.1.
PM = 91; was see under ACYLTRANSFERASES 1975-90
HN = 91(75); was see under ACYLTRANSFERASES 1975-90
MR = 20030709
DA = 19741111
DC = 1
DX = 19910101
UI = D002333

*NEWRECORD
RECTYPE = D
MH = Carnitine O-Palmitoyltransferase
DS = CARNITINE PALMITOYLTRANSFERASE O
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Carnitine Palmitoyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef
ENTRY = CPT II|T116|T126|ABB|NRW|NLM (1998)|970303|abbcdef
ENTRY = Carnitine Acyltransferase I|T116|T126|NON|EQV|UNK (19XX)|821129|abbcdef
ENTRY = Carnitine Palmitoyltransferase I|T116|T126|NON|NRW|UNK (19XX)|831014|abbcdef
ENTRY = Carnitine Palmitoyltransferase II|T116|T126|NON|NRW|NLM (1998)|970303|abbcdef
ENTRY = Palmitoylcarnitine Transferase|T116|T126|NON|EQV|UNK (19XX)|880808|abbcdef
ENTRY = Palmitylcarnitine Acyltransferase|T116|T126|NON|EQV|UNK (19XX)|810210|abbcdef
ENTRY = Acyltransferase I, Carnitine
ENTRY = Acyltransferase, Palmitylcarnitine
ENTRY = Carnitine O Palmitoyltransferase
ENTRY = II, Carnitine Palmitoyltransferase
ENTRY = O-Palmitoyltransferase, Carnitine
ENTRY = Palmitoyltransferase I, Carnitine
ENTRY = Palmitoyltransferase II, Carnitine
ENTRY = Palmitoyltransferase, Carnitine
ENTRY = Transferase, Palmitoylcarnitine
MN = D08.811.913.050.350.200
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Palmitoyl-CoA:L-carnitine O-palmitoyltransferase
RN = EC 2.3.1.21
RR = 9068-41-1 (CAS RN)
PI = Acyltransferases (1973-1974)
PI = Carnitine (1973-1974)
PI = Palmitic Acids (1973-1974)
MS = An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21.
PM = 98; see CARNITINE PALMITOYLTRANSFERASE 1991-97; see ACYLTRANSFERASES 1975-90
HN = 98(75)
MR = 20030709
DA = 19741111
DC = 1
DX = 19910101
UI = D002334

*NEWRECORD
RECTYPE = D
MH = Carnivora
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
MN = B01.050.150.900.649.147
MH_TH = NLM (1966)
ST = T015
AN = GEN or unspecified; prefer specifics
MS = An order of MAMMALS, usually flesh eaters with appropriate dentition. Suborders include the terrestrial carnivores Fissipedia, and the aquatic carnivores PINNIPEDIA.
MR = 20090706
DA = 19990101
DC = 1
UI = D002335

*NEWRECORD
RECTYPE = D
MH = Carnosine
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Carnosine Hydrochloride|T109|T124|NON|NRW|FDA SRS (2014)|NLM (2014)|130415|abbcdeef
ENTRY = Carnosine, (D-His)-Isomer|T116|T124|NRW|NLM (1999)|990913|abbdef
ENTRY = L-Carnosine|T116|T124|NON|EQV|NLM (2014)|130415|abbcdef
ENTRY = beta-Alanylhistidine|T116|T124|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = Hydrochloride, Carnosine
ENTRY = L Carnosine
ENTRY = beta Alanylhistidine
MN = D12.644.400.100
MN = D12.644.456.345.331
MN = D12.776.641.650.100
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T116
ST = T124
N1 = L-Histidine, N-beta-alanyl-
RN = 8HO6PVN24W
RR = 305-84-0 (Carnosine)
RR = 5853-00-9 ((D-His)-isomer)
RR = 5II09M0I3L
MS = A naturally occurring dipeptide neuropeptide found in muscles.
OL = search DIPEPTIDES 1967-74 & PEPTIDES 1966
PM = 91; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66
HN = 91(75); was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002336

*NEWRECORD
RECTYPE = D
MH = Carotenoids
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Carotenes|T109|T123|NON|NRW|NLM (2002)|000925|abbcdef
ENTRY = Carotene|T109|T123|NON|NRW|NLM (1966)|990101|abbcdef
MN = D02.455.326.271.665.202
MN = D02.455.426.392.368.367.379.249
MN = D02.455.849.131
MN = D23.767.261
PA = Antioxidants
MH_TH = NLM (1966)
ST = T109
ST = T123
N1 = Carotenes and Carotenoids
RN = 36-88-4
MS = The general name for a group of fat-soluble pigments found in green, yellow, and leafy vegetables, and yellow fruits. They are aliphatic hydrocarbons consisting of a polyisoprene backbone.
PM = 1966; for CAROTENE see CAROTENE 1966-2001
HN = 1966
MR = 20060705
DA = 19990101
DC = 1
UI = D002338

*NEWRECORD
RECTYPE = D
MH = Carotid Arteries
AQ = AB AH CH CY DE EM EN GD IM IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, Carotid
ENTRY = Artery, Carotid
ENTRY = Carotid Artery
MN = A07.231.114.186
EC = injuries:Carotid Artery Injuries
MH_TH = NLM (1966)
ST = T023
AN = inj = CAROTID ARTERY INJURIES or specifics
MS = Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery.
MR = 19991103
DA = 19990101
DC = 1
UI = D002339

*NEWRECORD
RECTYPE = D
MH = Carotid Artery Diseases
DE = CAROTID ARTERY DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Carotid Atherosclerosis|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Arterial Diseases, Carotid|T047|NON|EQV|NLM (2000)|991103|ARTERIAL DIS CAROTID|abcdefv
ENTRY = Arterial Diseases, Common Carotid|T047|NON|NRW|NLM (2000)|991103|ARTERIAL DIS COMMON CAROTID|abcdefv
ENTRY = Arterial Diseases, External Carotid|T047|NON|NRW|NLM (2000)|991103|ARTERIAL DIS EXTERNAL CAROTID|abcdefv
ENTRY = Arterial Diseases, Internal Carotid|T047|NON|NRW|NLM (2000)|991103|ARTERIAL DIS INTERNAL CAROTID|abcdefv
ENTRY = Atherosclerotic Disease, Carotid|T047|NON|NRW|NLM (2000)|991103|ATHEROSCLEROTIC DIS CAROTID|abcdefv
ENTRY = Carotid Artery Disorders|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Carotid Atherosclerotic Disease|T047|NON|NRW|NLM (2000)|991103|CAROTID ATHEROSCLEROTIC DIS|abcdefv
ENTRY = Common Carotid Artery Diseases|T047|NON|NRW|NLM (2000)|991103|COMMON CAROTID ARTERY DIS|abcdefv
ENTRY = External Carotid Artery Diseases|T047|NON|NRW|NLM (1999)|980310|EXTERNAL CAROTID ARTERY DIS|abcdefv
ENTRY = Internal Carotid Artery Diseases|T047|NON|NRW|NLM (1999)|980310|INTERNAL CAROTID ARTERY DIS|abcdefv
ENTRY = Arterial Disease, Carotid
ENTRY = Artery Disease, Carotid
ENTRY = Artery Diseases, Carotid
ENTRY = Artery Disorder, Carotid
ENTRY = Artery Disorders, Carotid
ENTRY = Atherosclerotic Diseases, Carotid
ENTRY = Carotid Arterial Disease
ENTRY = Carotid Arterial Diseases
ENTRY = Carotid Artery Disease
ENTRY = Carotid Artery Disorder
ENTRY = Carotid Atheroscleroses
ENTRY = Carotid Atherosclerotic Diseases
ENTRY = Disorders, Carotid Artery
MN = C10.228.140.300.200
MN = C14.907.253.123
MH_TH = NLM (1966)
ST = T047
AN = general or unspecified; coordinate IM with CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL or CAROTID ARTERY, EXTERNAL (IM) if pertinent
MS = Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D002340

*NEWRECORD
RECTYPE = D
MH = Carotid Artery Thrombosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Thrombosis, Carotid Artery|T047|NON|EQV|NLM (1999)|980218|abcdef
ENTRY = Carotid Thrombosis|T047|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Common Carotid Artery Thrombosis|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = External Carotid Artery Thrombosis|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Internal Carotid Artery Thrombosis|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Thrombosis, Carotid|T047|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Thrombosis, Common Carotid Artery|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Thrombosis, External Carotid Artery|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Thrombosis, Internal Carotid Artery|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Carotid Artery Thromboses
MN = C10.228.140.300.200.355
MN = C14.907.253.123.355
MN = C14.907.253.566.206
MN = C14.907.355.590.213.206
MH_TH = NLM (1964)
ST = T047
AN = coordinate IM with specific carotid artery (IM) if pertinent
MS = Blood clot formation in any part of the CAROTID ARTERIES. This may produce CAROTID STENOSIS or occlusion of the vessel, leading to TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.
PM = 1964
HN = 1964
CATSH = CAT LIST
MR = 20150608
DA = 19990101
DC = 1
DX = 19640101
UI = D002341

*NEWRECORD
RECTYPE = D
MH = Carotid Artery, External
AQ = AB AH CH CY DE EM EN GD IM IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, External Carotid
ENTRY = Artery, External Carotid
ENTRY = Carotid Arteries, External
ENTRY = External Carotid Arteries
ENTRY = External Carotid Artery
MN = A07.231.114.186.200.210
EC = injuries:Carotid Artery Injuries
MH_TH = NLM (1972)
ST = T023
AN = dis: coord IM with CAROTID ARTERY DISEASES (IM); inj: coord IM with CAROTID ARTERY INJURIES (IM) or specifics (IM)
PI = Carotid Arteries (1966-1971)
MS = Branch of the common carotid artery which supplies the exterior of the head, the face, and the greater part of the neck.
PM = 74
HN = 74(72)
MR = 19991103
DA = 19990101
DC = 1
DX = 19740101
UI = D002342

*NEWRECORD
RECTYPE = D
MH = Carotid Artery, Internal
AQ = AB AH CH CY DE EM EN GD IM IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, Internal Carotid
ENTRY = Artery, Internal Carotid
ENTRY = Carotid Arteries, Internal
ENTRY = Internal Carotid Arteries
ENTRY = Internal Carotid Artery
MN = A07.231.114.186.200.230
EC = injuries:Carotid Artery Injuries
MH_TH = NLM (1972)
ST = T023
AN = dis: coord IM with CAROTID ARTERY DISEASES (IM); inj: coord IM with CAROTID ARTERY INJURIES (IM) or specifics (IM)
PI = Carotid Arteries (1966-1971)
MS = Branch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose.
PM = 74
HN = 74(72)
MR = 19991103
DA = 19990101
DC = 1
DX = 19740101
UI = D002343

*NEWRECORD
RECTYPE = D
MH = Carotid Body
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Glomus Caroticum|T023|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Bodies, Carotid
ENTRY = Body, Carotid
ENTRY = Caroticum, Glomus
ENTRY = Carotid Bodies
MN = A08.675.650.915.500.600.150
MN = A08.800.950.500.600.150
MN = A11.671.650.915.500.600.150
FX = Carotid Body Tumor
MH_TH = NLM (1966)
ST = T023
AN = a nonchromaffin paraganglion
MS = A small cluster of chemoreceptive and supporting cells located near the bifurcation of the internal carotid artery. The carotid body, which is richly supplied with fenestrated capillaries, senses the pH, carbon dioxide, and oxygen concentrations in the blood and plays a crucial role in their homeostatic control.
MR = 20080708
DA = 19990101
DC = 1
UI = D002344

*NEWRECORD
RECTYPE = D
MH = Carotid Body Tumor
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Paraganglioma, Carotid Body|T191|NON|EQV|NLM (1994)|OMIM (2013)|930326|abcdeef
ENTRY = Carotid Body Tumors|T191|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Carotid Body Paraganglioma
ENTRY = Carotid Body Paragangliomas
ENTRY = Paragangliomas, Carotid Body
ENTRY = Tumor, Carotid Body
ENTRY = Tumors, Carotid Body
MN = C04.557.465.625.650.700.705.220
MN = C04.557.580.625.650.700.705.220
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; organ/neopl & histol coords not necessary
MS = Benign paraganglioma at the bifurcation of the COMMON CAROTID ARTERIES. It can encroach on the parapharyngeal space and produce dysphagia, pain, and cranial nerve palsies.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002345

*NEWRECORD
RECTYPE = D
MH = Carotid Sinus
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Sinus, Carotid
MN = A07.231.114.186.456
FX = Pressoreceptors
MH_TH = NLM (1966)
ST = T023
MS = The dilated portion of the common carotid artery at its bifurcation into external and internal carotids. It contains baroreceptors which, when stimulated, cause slowing of the heart, vasodilatation, and a fall in blood pressure.
MR = 19920507
DA = 19990101
DC = 1
UI = D002346

*NEWRECORD
RECTYPE = D
MH = Carps
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Carassius carassius|T013|NON|NRW|UNK (19XX)|860415|abcdef
PRINT ENTRY = Crucian Carp|T013|NON|NRW|NLM (2002)|000913|abcdef
PRINT ENTRY = Cyprinus|T013|NON|NRW|UNK (19XX)|860415|abcdef
PRINT ENTRY = Grass Carp|T013|NON|NRW|NLM (2002)|000913|abcdef
ENTRY = Carp|T013|NON|NRW|NLM (1975)|990101|abcdef
ENTRY = Ctenopharyngodon idellus|T013|NON|NRW|NLM (2002)|000913|abcdef
ENTRY = Cyprinus carpio|T013|NON|NRW|NLM (2002)|000808|abcdef
ENTRY = Hypophthalmichthys molitrix|T013|NON|NRW|NLM (2002)|000913|abcdef
ENTRY = Koi Carp|T013|NON|NRW|NLM (2002)|000808|abcdef
ENTRY = Silver Carp|T013|NON|NRW|NLM (2002)|000913|abcdef
ENTRY = Carp, Crucian
ENTRY = Carp, Grass
ENTRY = Carp, Koi
ENTRY = Carp, Silver
ENTRY = Carps, Crucian
ENTRY = Carps, Grass
ENTRY = Carps, Silver
ENTRY = Crucian Carps
ENTRY = Grass Carps
ENTRY = Silver Carps
MN = B01.050.150.900.493.200.244.248
MH_TH = NLM (2002)
ST = T013
MS = Common name for a number of different species of fish in the family Cyprinidae. This includes, among others, the common carp, crucian carp, grass carp, and silver carp.
PM = 2002; see CARP 1991-2001, see CYPRINIDAE 1975-90
HN = 2002 (1975)
MR = 20130709
DA = 19990101
DC = 1
DX = 19910101
UI = D002347

*NEWRECORD
RECTYPE = D
MH = Carpal Bones
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
ENTRY = Bone, Carpal
ENTRY = Bones, Carpal
ENTRY = Carpal Bone
MN = A02.835.232.087.319.150
MH_TH = NLM (1972)
ST = T023
AN = do not confuse with WRIST (the area) or WRIST JOINT; see note on CARPUS, ANIMAL; /inj permitted: not necessarily WRIST INJURIES
PI = Wrist (1966-1971)
PI = Wrist Joint (1966-1971)
MS = The eight bones of the wrist: SCAPHOID BONE; LUNATE BONE; TRIQUETRUM BONE; PISIFORM BONE; TRAPEZIUM BONE; TRAPEZOID BONE; CAPITATE BONE; and HAMATE BONE.
PM = 72
HN = 72
MR = 20080708
DA = 19990101
DC = 1
DX = 19720101
UI = D002348

*NEWRECORD
RECTYPE = D
MH = Carpal Tunnel Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Compression Neuropathy, Carpal Tunnel|T047|NON|EQV|NLM (2000)|991104|abcdef
PRINT ENTRY = Entrapment Neuropathy, Carpal Tunnel|T047|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Amyotrophy, Thenar, Of Carpal Origin|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Median Neuropathy, Carpal Tunnel|T047|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Carpal Tunnel Syndromes
ENTRY = Syndrome, Carpal Tunnel
ENTRY = Syndromes, Carpal Tunnel
MN = C10.668.829.500.500.200
MN = C10.668.829.550.200
MN = C26.844.150.206
MH_TH = NLM (1963)
MH_TH = OMIM (2013)
ST = T047
MS = Entrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma (CUMULATIVE TRAUMA DISORDERS); wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis (see ARTHRITIS, RHEUMATOID); ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. (Joynt, Clinical Neurology, 1995, Ch51, p45)
PM = 1965
HN = 1965(1963)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19650101
UI = D002349

*NEWRECORD
RECTYPE = D
MH = Carpus, Animal
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Animal Carpus
MN = A13.395.248
MH_TH = NLM (1975)
ST = T029
AN = TN 117 & table: animal extremities
MS = The region corresponding to the human WRIST in non-human ANIMALS.
OL = search FORELIMB 1968-74
PM = 91; was see under FORELIMB 1975-90
HN = 91(75); was see under FORELIMB 1975-90
MR = 20050630
DA = 19990101
DC = 1
DX = 19910101
UI = D002350

*NEWRECORD
RECTYPE = D
MH = Carrageenan
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Carrageenin|T118|T121|T123|NON|EQV|UNK (19XX)|810108|abbbcdef
ENTRY = iota-Carrageenan|T118|T121|T123|NON|NRW|UNK (19XX)|811209|abbbcdef
ENTRY = kappa-Carrageenan|T118|T121|T123|NON|NRW|UNK (19XX)|810918|abbbcdef
ENTRY = lambda-Carrageenan|T118|T121|T123|NON|NRW|UNK (19XX)|810918|abbbcdef
ENTRY = iota Carrageenan
ENTRY = kappa Carrageenan
ENTRY = lambda Carrageenan
MN = D09.698.152
FX = Chondrus
MH_TH = NLM (1964)
ST = T118
ST = T121
ST = T123
N1 = Carrageenan
RN = 9000-07-1
MS = A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES.
PM = 66
HN = 66(64)
MR = 20040707
DA = 19990101
DC = 1
DX = 19660101
UI = D002351

*NEWRECORD
RECTYPE = D
MH = Carrier Proteins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Binding Proteins|T116|T123|NON|REL|UNK (19XX)|750101|abbcdef
PRINT ENTRY = Transport Proteins|T116|T123|NON|EQV|UNK (19XX)|760515|abbcdef
ENTRY = Binding Protein|T116|T123|NON|REL|NLM (1988)|870504|abbcdef
ENTRY = Protein, Binding
ENTRY = Proteins, Binding
ENTRY = Proteins, Carrier
ENTRY = Proteins, Transport
MN = D12.776.157
MH_TH = NLM (1971)
ST = T116
ST = T123
RN = 0
AN = do not confuse BINDING PROTEINS (X ref) with PROTEIN BINDING; do not use CARRIER PROTEINS if the protein functions as a receptor: use instead the pertinent receptors term; not for antigenic carriers ( = ANTIGENS)
PI = Protein Binding (1966-1970)
PI = Proteins (1966-1970)
MS = Transport proteins that carry specific substances in the blood or across cell membranes.
PM = 73
HN = 73(71)
MR = 20050728
DA = 19990101
DC = 1
DX = 19730101
UI = D002352

*NEWRECORD
RECTYPE = D
MH = Carrier State
AQ = BL CF CL CN DH DI DT EC EH EN EP IM ME MI NU PA PC PP PS PX RA RI TH TM UR VE VI
ENTRY = Carrier States
ENTRY = State, Carrier
ENTRY = States, Carrier
MN = N06.850.160
FX = Disease Reservoirs
MH_TH = NLM (1963)
ST = T046
AN = disease carriers, not genetic carriers ( = CARRIERS, GENETIC see HETEROZYGOTE); coord with disease, not organism
MS = The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.
PM = 65
HN = 65(63)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19650101
UI = D002353

*NEWRECORD
RECTYPE = D
MH = Carteolol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Carteolol Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1967)|USP (19XX)|941114|abbcdeeef
ENTRY = Carteolol Monohydrochloride|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = OPC-1085|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Hydrochloride, Carteolol
ENTRY = Monohydrochloride, Carteolol
ENTRY = OPC 1085
ENTRY = OPC1085
MN = D02.033.100.624.698.207
MN = D02.033.755.624.698.207
MN = D02.092.063.624.698.207
MN = D03.438.810.835.188
PA = Adrenergic beta-Antagonists
PA = Anti-Arrhythmia Agents
PA = Antihypertensive Agents
PA = Sympatholytics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 2(1H)-Quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-
RN = 8NF31401XG
RR = 4797W6I0T4
RR = 51781-06-7 (Carteolol)
RR = 51781-21-6 (mono HCl)
PI = Amino Alcohols (1966-1972)
PI = Bunolol (1973-1978)
PI = Quinolines (1966-1978)
MS = A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
PM = 91; was see under PROPANOLAMINES 1979-90
HN = 91(79); was see under PROPANOLAMINES 1979-90
MR = 20130708
DA = 19780501
DC = 1
DX = 19910101
UI = D002354

*NEWRECORD
RECTYPE = D
MH = Carticaine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Articaine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|NLM (1991)|900116|abbcdeeef
ENTRY = Articain|T109|T121|NON|EQV|INN (19XX)|UNK (19XX)|861009|abbcdeef
ENTRY = Carticain|T109|T121|NON|EQV|UNK (19XX)|820519|abbcdef
ENTRY = Carticaine Hydrochloride|T109|T121|NON|NRW|NLM (2007)|051205|abbcdef
ENTRY = Hoe-045|T109|T121|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Hoe-40045|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Hoechst Brand of Carticaine Hydrochloride|T109|T121|NON|NRW|NLM (2004)|020806|abbcdef
ENTRY = Ultracaine|T109|T121|TRD|NRW|DE|NL|800731|abbcdeef
ENTRY = Hoe 045
ENTRY = Hoe 40045
ENTRY = Hoe045
ENTRY = Hoe40045
ENTRY = Hydrochloride, Carticaine
MN = D02.886.778.150
MN = D03.383.903.150
PA = Anesthetics, Local
MH_TH = BAN (19XX)
ST = T109
ST = T121
N1 = 2-Thiophenecarboxylic acid, 4-methyl-3-((1-oxo-2-(propylamino)propyl)amino)-, methyl ester
RN = D3SQ406G9X
RR = 23964-57-0 (HCl)
RR = 23964-58-1 (Carticaine)
PI = Thiophenes (1966-1978)
MS = A thiophene-containing local anesthetic pharmacologically similar to MEPIVACAINE.
PM = 91; was see under THIOPHENES 1979-90
HN = 91(79); was see under THIOPHENES 1979-90
MR = 20130708
DA = 19780317
DC = 1
DX = 19910101
UI = D002355

*NEWRECORD
RECTYPE = D
MH = Cartilage
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Cartilages
MN = A02.165
MN = A10.165.382
FX = Chondroitin
MH_TH = NLM (1966)
ST = T024
AN = general: prefer specifics; inflammation (chondritis) is likely to be OSTEOCHONDRITIS
CX = consider also terms at CHONDRO-
MS = A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.
MR = 20050630
DA = 19990101
DC = 1
UI = D002356

*NEWRECORD
RECTYPE = D
MH = Cartilage Diseases
DE = CARTILAGE DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Chondromalacia|T047|NON|NRW|NLM (2009)|070918|abcdef
ENTRY = Cartilage Disease
ENTRY = Chondromalacias
MN = C05.182
MN = C17.300.182
FX = Ellis-Van Creveld Syndrome
FX = Epiphyses, Slipped
FX = Osteochondritis
MH_TH = NLM (1968)
ST = T047
AN = general; inflammatory disease (chondritis) is likely to be OSTEOCHONDRITIS
PI = Cartilage (1966-1967)
PI = Cartilage, Articular (1966-1967)
PI = Osteochondritis (1966-1967)
MS = Pathological processes involving the chondral tissue (CARTILAGE).
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D002357

*NEWRECORD
RECTYPE = D
MH = Cartilage, Articular
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Articular Cartilage
ENTRY = Articular Cartilages
ENTRY = Cartilages, Articular
MN = A02.165.407.150
MN = A02.835.583.192
MH_TH = NLM (1965)
ST = T024
AN = inflammation (chondritis) is likely to be OSTEOCHONDRITIS
MS = A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact.
PM = 65
HN = 65
MR = 20150616
DA = 19990101
DC = 1
DX = 19650101
UI = D002358

*NEWRECORD
RECTYPE = D
MH = Cartoons as Topic
AQ = CL ES HI PX SN TD
ENTRY = Cartoon as Topic|T170|NON|EQV|NLM (2008)|070623|abcdef
ENTRY = Cartoon as Topics
ENTRY = Cartoons as Topics
MN = K01.093.206.332
MH_TH = NLM (2008)
ST = T170
AN = do not confuse with Publication Type CARTOONS; CARICATURES AS TOPIC is also available
MS = Images used to comment on such things as contemporary events, social habits, or political trends; usually executed in a broad or abbreviated manner.
PM = 2008; see CARTOONS 1991-2007, see CARICATURES 1975-1990
HN = 2008(1975)
MR = 20120703
DA = 19990101
DC = 1
DX = 19910101
UI = D002359

*NEWRECORD
RECTYPE = D
MH = Carubicin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carminomycin|T109|T121|NON|EQV|UNK (19XX)|830614|abbcdef
PRINT ENTRY = Karminomycin|T109|T121|NON|EQV|UNK (19XX)|790606|abbcdef
ENTRY = Carminomicin|T109|T121|NON|EQV|UNK (19XX)|790607|abbcdef
ENTRY = Carminomycin I|T109|T121|NON|EQV|UNK (19XX)|820519|abbcdef
ENTRY = Carminomycin II|T109|T195|NON|NRW|UNK (19XX)|820902|abbcdef
ENTRY = Carminomycin III|T109|T121|NON|NRW|UNK (19XX)|820902|abbcdef
ENTRY = Carubicin Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1978)|941114|abbcdeef
ENTRY = Demethyldaunomycin|T109|T121|NON|EQV|NLM (1990)|891109|abbcdef
ENTRY = Demethyldaunorubicin|T109|T121|NON|EQV|NLM (1990)|891109|abbcdef
ENTRY = Karminomicin|T109|T121|NON|EQV|UNK (19XX)|790607|abbcdef
ENTRY = NSC-180,024|T109|T121|LAB|NRW|UNK (19XX)|800818|abbcdef
ENTRY = NSC-180024|T109|T121|LAB|NRW|NLM (2004)|021231|abbcdef
ENTRY = Rubeomycin A|T109|T121|NON|NRW|UNK (19XX)|840920|abbcdef
ENTRY = Rubeomycin A1|T109|T121|NON|NRW|UNK (19XX)|840920|abbcdef
ENTRY = Hydrochloride, Carubicin
ENTRY = NSC 180,024
ENTRY = NSC 180024
ENTRY = NSC180,024
ENTRY = NSC180024
MN = D02.455.426.559.847.562.050.200.150
MN = D04.615.562.050.200.150
MN = D09.408.051.059.200.150
PA = Antibiotics, Antineoplastic
PA = Topoisomerase II Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Carminomycin
RN = E7437K3983
RR = 39472-31-6 (Carubicin)
RR = 4V3R166MB3
RR = 52794-97-5 (HCl)
PI = Aminoglycosides (1974)
PI = Antibiotics, Antineoplastic (1967-1974)
PI = Naphthacenes (1966-1974)
MS = A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata.
OL = use CARUBICIN to search CARMINOMYCIN 1975-83
PM = 91; was see under DAUNORUBICIN/analogs & derivatives 1984-90; was CARMINOMYCIN see under DAUNORUBICIN 1980-83 & see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79
HN = 91(84); was see under DAUNORUBICIN/analogs & derivatives 1984-90; was CARMINOMYCIN see under DAUNORUBICIN 1980-83 & see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002360

*NEWRECORD
RECTYPE = D
MH = Cascara
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Casanthranol|T109|T121|NON|NRW|USAN (1962)|800520|abbcdef
ENTRY = Cascara Sagrada|T002|NON|EQV|USP (19XX)|800520|abcdef
ENTRY = Sacred Bark|T002|NON|EQV|NLM (1991)|900303|abcdef
MN = D02.455.426.559.847.117.159.205
MN = D02.806.100.205
MN = D04.615.117.159.205
MN = D20.215.784.500.175
PA = Cathartics
MH_TH = NLM (1975)
ST = T002
RN = 8047-27-6
AN = coord with FRANGULA when appropriate; in translations use "cascara sagrada", not "sacred bark"; use in therapy: coord with PHYTOTHERAPY
MS = Dried aged bark of a buckthorn, Frangula purshiana (FRANGULA), that contains the anthraquinone EMODIN and cascarosides. It is used as a laxative (CATHARTICS).
OL = search CATHARTICS 1966-74
PM = 91; was see under CATHARTICS 1975-90
HN = 91(75); was see under CATHARTICS 1975-90
MR = 20060705
DA = 19990101
DC = 1
DX = 19910101
UI = D002362

*NEWRECORD
RECTYPE = D
MH = Case Reports
ENTRY = Case Histories|T170|NON|REL|NLM (1978)|781219|CASE HIST|abcdefv
ENTRY = Case Studies|T170|NON|REL|BIOETHICS (1974)|NLM (1992)|920505|abcdeef
ENTRY = Case Study|T170|NON|REL|NLM (1978)|781219|abcdef
MN = V03.100
MH_TH = BIOETHICS (1991)
ST = T170
AN = This heading is used as a Publication Type. permitted for veterinary case reports but not for historical articles; Case reports as a form of writing are indexed under MEDICAL RECORDS or specific records term (IM). CATALOGER: do not use for institutional case reports. Use instead the heading ORGANIZATIONAL CASE STUDIES
MS = Clinical presentations that may be followed by evaluative studies that eventually lead to a diagnosis.
HN = 2008(1966)
MR = 20150605
DA = 19990101
DC = 2
UI = D002363

*NEWRECORD
RECTYPE = D
MH = Caseins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
ENTRY = AD beta-Casein|T116|T123|NRW|UNK (19XX)|850528|abbdef
ENTRY = Acetylated, Dephosphorylated beta-Casein|T116|T123|NON|NRW|UNK (19XX)|850528|abbcdef
ENTRY = Casein|T116|T123|NON|EQV|UNK (19XX)|810512|abbcdef
ENTRY = Casein A|T116|T123|NON|NRW|UNK (19XX)|840919|abbcdef
ENTRY = K-Casein|T116|T123|NON|NRW|UNK (19XX)|881011|abbcdef
ENTRY = Sodium Caseinate|T116|T121|NON|NRW|UNK (19XX)|820203|abbcdef
ENTRY = alpha(S1)-Casein|T116|T123|NON|NRW|NLM (1991)|900116|abbcdef
ENTRY = alpha(S1)-Casein A|T116|T123|NON|NRW|NLM (1991)|900116|abbcdef
ENTRY = alpha(S1)-Casein B|T116|T123|NON|NRW|NLM (1991)|900116|abbcdef
ENTRY = alpha(S1)-Casein C|T116|T123|NON|NRW|NLM (1991)|900116|abbcdef
ENTRY = alpha(S2)-Casein|T116|T123|NON|NRW|UNK (19XX)|840919|abbcdef
ENTRY = alpha-Caseins|T116|T123|NON|NRW|UNK (19XX)|821124|abbcdef
ENTRY = beta-Casein|T116|T123|NON|NRW|UNK (19XX)|881102|abbcdef
ENTRY = beta-Caseins|T116|T123|NON|NRW|UNK (19XX)|821123|abbcdef
ENTRY = epsilon-Casein|T116|T123|NON|NRW|UNK (19XX)|821206|abbcdef
ENTRY = gamma-Caseins|T116|T123|NON|NRW|UNK (19XX)|821123|abbcdef
ENTRY = kappa-Casein|T116|T123|NON|NRW|NLM (1992)|910114|abbcdef
ENTRY = kappa-Caseins|T116|T123|NON|NRW|UNK (19XX)|811202|abbcdef
ENTRY = AD beta Casein
ENTRY = Caseinate, Sodium
ENTRY = K Casein
ENTRY = alpha Caseins
ENTRY = beta Casein
ENTRY = beta Caseins
ENTRY = beta-Casein Acetylated, Dephosphorylated
ENTRY = beta-Casein, AD
ENTRY = epsilon Casein
ENTRY = gamma Caseins
ENTRY = kappa Casein
ENTRY = kappa Caseins
MN = D12.776.256.626.207
MN = D12.776.744.150
PA = Chelating Agents
MH_TH = NLM (1966)
ST = T116
ST = T123
RN = 0
MS = A mixture of related phosphoproteins occurring in milk and cheese. The group is characterized as one of the most nutritive milk proteins, containing all of the common amino acids and rich in the essential ones.
OL = use CASEINS to search CASEIN 1966-81
PM = 82; was CASEIN 1963-81
HN = 82; was CASEIN 1963-81
MR = 20050630
DA = 19990101
DC = 1
UI = D002364

*NEWRECORD
RECTYPE = D
MH = Manihot
AQ = AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI
PRINT ENTRY = Arrowroot, Brazilian|T168|NON|REL|NLM (2003)|010926|abcdef
PRINT ENTRY = Brazilian Arrowroot|T168|NON|REL|NLM (2003)|010830|abcdef
PRINT ENTRY = Cassava|T002|NON|EQV|NLM (1986)|990101|abcdef
PRINT ENTRY = Kasaba|T002|NON|EQV|NLM (2003)|010830|abcdef
PRINT ENTRY = Manioc|T168|NON|REL|UNK (19XX)|740329|abcdef
PRINT ENTRY = Tapioca|T168|NON|REL|UNK (19XX)|850516|abcdef
ENTRY = Manihot esculenta|T002|NON|NRW|NLM (2003)|010830|abcdef
ENTRY = Arrowroots, Brazilian
ENTRY = Brazilian Arrowroots
ENTRY = Cassavas
ENTRY = Kasabas
ENTRY = Manihot esculentas
ENTRY = Manihots
ENTRY = Maniocs
ENTRY = Tapiocas
ENTRY = esculenta, Manihot
ENTRY = esculentas, Manihot
MN = B01.650.940.800.575.100.350.535
MH_TH = UNK (19XX)
ST = T002
AN = ARROWROOT see MARANTACEAE is also available
MS = A plant genus of the family EUPHORBIACEAE that is perennial with conspicuous, almost palmate leaves like those of RICINUS but more deeply parted into five to nine lobes. It is a source of a starch after removal of the cyanogenic glucosides. The common name of Arrowroot is also used with Maranta (MARANTACEAE). The common name of yuca is also used for YUCCA.
PM = 2003; see CASSAVA 1991-2002, see PLANTS, EDIBLE 1986-1990, see CASSAVA 1963-1985
HN = 2003(1963)
MR = 20150623
DA = 19990101
DC = 1
DX = 19910101
UI = D002365

*NEWRECORD
RECTYPE = D
MH = Cassia
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
PRINT ENTRY = Indian Laburnum|T002|NON|NRW|NLM (2003)|010830|abcdef
ENTRY = Cassia fistula|T002|NON|NRW|NLM (2003)|010830|abcdef
ENTRY = Cassia fistulas
ENTRY = Cassias
ENTRY = Indian Laburnums
ENTRY = Laburnum, Indian
ENTRY = Laburnums, Indian
ENTRY = fistula, Cassia
ENTRY = fistulas, Cassia
MN = B01.650.940.800.575.100.401.100
FX = Senna Extract
MH_TH = NLM (1978)
ST = T002
AN = CASSIA SENNA; CASSIA ANGUSTIFOLIA and CASSIA OCCIDENTALIS see SENNA PLANT are also available
PI = Senna (1966-1977)
MS = A plant genus of the family FABACEAE. Many species of this genus, including the medicinal C. senna and C. angustifolia, have been reclassified into the Senna genus (SENNA PLANT) and some to CHAMAECRISTA.
PM = 91; was see under PLANTS, MEDICINAL 1978-90
HN = 91(78); was see under PLANTS, MEDICINAL 1978-90
MR = 20150623
DA = 19770301
DC = 1
DX = 19910101
UI = D002366

*NEWRECORD
RECTYPE = D
MH = Castor Bean
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Bean, Castor
ENTRY = Beans, Castor
ENTRY = Castor Beans
MN = B01.650.940.800.575.100.350.650.300
FX = Castor Oil
MH_TH = NLM (1975)
ST = T002
MS = Common name for Ricinus communis, a species in the family EUPHORBIACEAE. It is the source of CASTOR OIL.
OL = search RICINUS 1966-74
PM = 91; was see under RICINUS 1975-90
HN = 91(75); was see under RICINUS 1975-90
MR = 20100625
DA = 19990101
DC = 1
DX = 19910101
UI = D002367

*NEWRECORD
RECTYPE = D
MH = Castor Oil
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
ENTRY = Oil, Castor
MN = D10.212.507.300
MN = D10.627.700.132
MN = D20.215.784.750.132
PA = Cathartics
MH_TH = USP (19XX)
ST = T119
ST = T121
N1 = Castor oil
RN = 8001-79-4
MS = Oil obtained from seeds of Ricinus communis that is used as a cathartic and as a plasticizer.
MR = 20060705
DA = 19990101
DC = 1
UI = D002368

*NEWRECORD
RECTYPE = D
MH = Castration
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Castrations
MN = E04.270.282
MN = E04.950.165
FX = Eunuchism
MH_TH = POPLINE (1978)
ST = T061
AN = GEN or unspecified: prefer OVARIECTOMY or ORCHIECTOMY; do not use /util except by MeSH definition
MS = Surgical removal or artificial destruction of gonads.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D002369

*NEWRECORD
RECTYPE = D
MH = Casts, Surgical
DE = CASTS SURG
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Fiberglass Casts|T074|NON|NRW|NLM (1991)|900517|abcdef
PRINT ENTRY = Plaster Casts|T074|NON|NRW|UNK (19XX)|740329|abcdef
PRINT ENTRY = Plastic Casts|T074|NON|NRW|NLM (1991)|900517|abcdef
ENTRY = Cast, Surgical|T074|NON|EQV|UNK (19XX)|740329|CAST SURG|abcdefv
ENTRY = Surgical Cast|T074|NON|EQV|UNK (19XX)|740329|SURG CAST|abcdefv
ENTRY = Surgical Casts|T074|NON|EQV|UNK (19XX)|740329|SURG CASTS|abcdefv
ENTRY = Cast, Fiberglass
ENTRY = Cast, Plaster
ENTRY = Cast, Plastic
ENTRY = Casts, Fiberglass
ENTRY = Casts, Plaster
ENTRY = Casts, Plastic
ENTRY = Fiberglass Cast
ENTRY = Plaster Cast
ENTRY = Plastic Cast
MN = E07.858.442.660.430.500
MN = E07.858.690.725.430.500
MH_TH = NLM (1966)
ST = T074
AN = "cast syndrome" (duodenal compression caused by wearing a body cast) = SUPERIOR MESENTERIC ARTERY SYNDROME if confirmed by text but do not index under CASTS, SURGICAL /adv eff unless particularly discussed
MS = Dressings made of fiberglass, plastic, or bandage impregnated with plaster of paris used for immobilization of various parts of the body in cases of fractures, dislocations, and infected wounds. In comparison with plaster casts, casts made of fiberglass or plastic are lightweight, radiolucent, able to withstand moisture, and less rigid.
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D002370

*NEWRECORD
RECTYPE = D
MH = Cat Diseases
DE = CAT DIS
AQ = BL CF CI CL CN DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Feline Diseases|T047|NON|EQV|NLM (1991)|900104|FELINE DIS|abcdefv
ENTRY = Cat Disease
ENTRY = Disease, Cat
ENTRY = Disease, Feline
ENTRY = Diseases, Cat
ENTRY = Diseases, Feline
ENTRY = Feline Disease
MN = C22.180
MH_TH = NLM (1966)
ST = T047
AN = IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific cat dis (IM); for abnormalities or injuries, index under CATS /abnorm or CATS /inj; does not include diseases of the so-called "big cats" (LIONS; CHEETAHS; tigers, panthers, etc.); don't forget also check tags CATS (NIM) & ANIMALS; DF: CAT DIS
MS = Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
UI = D002371

*NEWRECORD
RECTYPE = D
MH = Cat-Scratch Disease
DE = CAT SCRATCH DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Inoculation Lymphoreticulosis|T047|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Catscratch Disease|T047|NON|EQV|UNK (19XX)|771207|CATSCRATCH DIS|abcdefv
ENTRY = Inoculative Lymphoreticulosis|T047|NON|EQV|NLM (1993)|911015|abcdef
ENTRY = Cat Scratch Disease
ENTRY = Disease, Cat-Scratch
ENTRY = Disease, Catscratch
ENTRY = Inoculation Lymphoreticuloses
ENTRY = Inoculative Lymphoreticuloses
ENTRY = Lymphoreticuloses, Inoculation
ENTRY = Lymphoreticuloses, Inoculative
ENTRY = Lymphoreticulosis, Inoculation
ENTRY = Lymphoreticulosis, Inoculative
MN = C01.252.400.126.100.150
MN = C01.252.400.200
MN = C15.604.315.249
MH_TH = NLM (1966)
MH_TH = ORD (2010)
ST = T047
AN = coord IM with AFIPIA (IM) or BARTONELLA HENSELAE (IM) if appropriate
MS = A self-limiting bacterial infection of the regional lymph nodes caused by AFIPIA felis, a gram-negative bacterium recently identified by the Centers for Disease Control and Prevention and by BARTONELLA HENSELAE. It usually arises one or more weeks following a feline scratch, with raised inflammatory nodules at the site of the scratch being the primary symptom.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D002372

*NEWRECORD
RECTYPE = D
MH = Cyclic AMP Receptor Protein
DE = CYCLIC AMP RECEPT PROTEIN
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Catabolic Gene Activators|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
PRINT ENTRY = Catabolite Activator Protein|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
PRINT ENTRY = Catabolite Gene Activator Protein|T116|T123|NON|EQV|UNK (19XX)|870723|CGA PROTEIN|abbcdefv
PRINT ENTRY = Catabolite Gene Activator Proteins|T116|T123|NON|EQV|NLM (1994)|930107|abbcdef
ENTRY = Activator Protein, Catabolite|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Activator Proteins, Catabolite|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Activator, Catabolic Gene|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Activators, Catabolic Gene|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Catabolic Gene Activator|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Catabolite Activator Proteins|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Catabolite Regulator Protein|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Catabolite Regulator Proteins|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Cyclic AMP Receptor Proteins|T116|T123|EQV|NLM (1994)|930107|CYCLIC AMP RECEPT PROTEINS|abbdefv
ENTRY = Gene Activator, Catabolic|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Gene Activators, Catabolic|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Protein, Catabolite Activator|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Protein, Catabolite Regulator|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Proteins, Catabolite Activator|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Proteins, Catabolite Regulator|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Regulator Protein, Catabolite|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = Regulator Proteins, Catabolite|T116|T123|NON|EQV|UNK (19XX)|870723|abbcdef
ENTRY = cAMP Receptor Protein|T116|T123|EQV|NLM (1994)|930107|CAMP RECEPT PROTEIN|abbdefv
ENTRY = cAMP Receptor Proteins|T116|T123|EQV|NLM (1994)|930107|CAMP RECEPT PROTEINS|abbdefv
ENTRY = Protein, cAMP Receptor
ENTRY = Proteins, cAMP Receptor
ENTRY = Receptor Protein, cAMP
ENTRY = Receptor Proteins, cAMP
MN = D12.776.930.165
MH_TH = NLM (1988)
ST = T116
ST = T123
RN = 0
PI = Amino Acid Sequence (1975-1987)
PI = Bacterial Proteins (1972-1987)
PI = Base Sequence (1980-1987)
PI = Receptors, Cyclic AMP (1980-1993)
PI = Transcription Factors (1980-1987)
PI = Transcription, Genetic (1978-1987)
MS = A transcriptional regulator in prokaryotes which, when activated by binding cyclic AMP, acts at several promoters. Cyclic AMP receptor protein was originally identified as a catabolite gene activator protein. It was subsequently shown to regulate several functions unrelated to catabolism, and to be both a negative and a positive regulator of transcription. Cell surface cyclic AMP receptors are not included (CYCLIC AMP RECEPTORS), nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins, which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES.
OL = use CYCLIC AMP RECEPTOR PROTEIN to search CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; use RECEPTORS, CYCLIC AMP to search CATABOLITE GENE ACTIVATOR PROTEINS & CATABOLITE ACTIVATOR PROTEIN 1987 & CATABOLIC GENE ACTIVATORS 1977-87
PM = 94; was CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; CYCLIC AMP RECEPTOR PROTEIN was see CATABOLITE GENE ACTIVATOR PROTEIN 1990-93; CATABOLITE GENE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLITE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLIC GENE ACTIVATORS was see RECEPTORS, CYCLIC AMP 1977-87
HN = 94; was CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; CYCLIC AMP RECEPTOR PROTEIN was see CATABOLITE GENE ACTIVATOR PROTEIN 1990-93; CATABOLITE GENE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLITE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLIC GENE ACTIVATORS was see RECEPTORS, CYCLIC AMP 1977-87
MR = 19970620
DA = 19870511
DC = 1
DX = 19880101
UI = D002373

*NEWRECORD
RECTYPE = D
MH = Catalase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Catalase A|T116|T126|NON|NRW|UNK (19XX)|830223|abbcdef
ENTRY = Catalase T|T116|T126|NON|NRW|UNK (19XX)|830223|abbcdef
ENTRY = Manganese Catalase|T116|T126|NON|NRW|UNK (19XX)|831014|abbcdef
ENTRY = Mn Catalase|T116|T126|NON|NRW|UNK (19XX)|840305|abbcdef
MN = D08.811.682.732.332
PA = Antioxidants
EC = deficiency:Acatalasia
MH_TH = NLM (1966)
ST = T116
ST = T126
RN = EC 1.11.1.6
MS = An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA.
MR = 20060705
DA = 19990101
DC = 1
UI = D002374

*NEWRECORD
RECTYPE = D
MH = Catalepsy
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerea Flexibilitas|T184|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Flexibility, Waxy|T184|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Anochlesia|T048|T184|NON|EQV|NLM (2000)|991103|abbcdef
ENTRY = Anochlesias
ENTRY = Catalepsies
ENTRY = Flexibilitas, Cerea
ENTRY = Flexibilities, Waxy
ENTRY = Waxy Flexibilities
ENTRY = Waxy Flexibility
MN = C10.597.350.200
MN = C23.888.592.350.200
FX = Cataplexy
FX = Catatonia
FX = Freezing Reaction, Cataleptic
MH_TH = NLM (1966)
ST = T048
ST = T184
AN = do not confuse with CATAPLEXY
MS = A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions.
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
UI = D002375

*NEWRECORD
RECTYPE = D
MH = Cataloging
AQ = CL EC ES HI MT SN ST TD UT
MN = L01.453.245.250
MN = L01.453.819.250
MH_TH = NLM (1966)
ST = T057
MS = Activities performed in the preparation of bibliographic records for CATALOGS. It is carried out according to a set of rules and contains information enabling the user to know what is available and where items can be found.
MR = 20020703
DA = 19990101
DC = 1
UI = D002376

*NEWRECORD
RECTYPE = D
MH = Catalogs as Topic
ENTRY = Catalogs as Topics
ENTRY = Topic, Catalogs as
ENTRY = Topics, Catalogs as
ENTRY = as Topic, Catalogs
ENTRY = as Topics, Catalogs
MN = L01.178.682.290
MH_TH = NLM (2008)
ST = T170
AN = general or unspecified; prefer specifics; do not confuse with Publication Type CATALOGS
MS = Ordered compilations of item descriptions and sufficient information to afford access to them.
PM = 2008; see CATALOGS 1963-2007
HN = 2008(1963)
MR = 20070709
DA = 19990101
DC = 1
UI = D002377

*NEWRECORD
RECTYPE = D
MH = Catalogs, Booksellers'
PRINT ENTRY = Booksellers' Catalogs|T073|NON|EQV|NLM (1992)|901227|abcdef
ENTRY = Bookseller Catalogs
ENTRY = Bookseller's Catalogs
ENTRY = Booksellers Catalogs
ENTRY = Booksellers' Catalog
ENTRY = Catalog, Booksellers'
ENTRY = Catalogs, Bookseller
ENTRY = Catalogs, Bookseller's
ENTRY = Catalogs, Booksellers
MN = L01.178.682.290.183.249
MH_TH = NLM (1966)
ST = T073
AN = no qualif
MR = 19991103
DA = 19990101
DC = 1
UI = D002378

*NEWRECORD
RECTYPE = D
MH = Catalogs, Commercial
ENTRY = Catalog, Commercial
ENTRY = Commercial Catalog
ENTRY = Commercial Catalogs
MN = L01.178.682.290.183
MH_TH = NLM (1966)
ST = T073
ST = T170
AN = no qualif
MR = 19991103
DA = 19990101
DC = 1
UI = D002379

*NEWRECORD
RECTYPE = D
MH = Catalogs, Drug
PRINT ENTRY = Drug Catalogs|T073|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Catalog, Drug
ENTRY = Drug Catalog
MN = L01.178.682.290.283
MH_TH = NLM (1966)
ST = T073
AN = no qualif
MR = 19991103
DA = 19990101
DC = 1
UI = D002380

*NEWRECORD
RECTYPE = D
MH = Catalogs, Library
ENTRY = Catalog, Library
ENTRY = Library Catalog
ENTRY = Library Catalogs
MN = L01.178.682.290.383
MH_TH = NLM (1966)
ST = T073
ST = T170
AN = no qualif
MR = 19991103
DA = 19990101
DC = 1
UI = D002381

*NEWRECORD
RECTYPE = D
MH = Catalogs, Publishers'
PRINT ENTRY = Publishers' Catalogs|T073|NON|EQV|NLM (1992)|901227|abcdef
ENTRY = Catalog, Publishers'
ENTRY = Catalogs, Publisher
ENTRY = Catalogs, Publisher's
ENTRY = Catalogs, Publishers
ENTRY = Publisher Catalogs
ENTRY = Publisher's Catalogs
ENTRY = Publishers Catalogs
ENTRY = Publishers' Catalog
MN = L01.178.682.290.183.416
MH_TH = NLM (1966)
ST = T073
AN = no qualif
MR = 19991103
DA = 19990101
DC = 1
UI = D002382

*NEWRECORD
RECTYPE = D
MH = Catalogs, Union
ENTRY = Catalog, Union
ENTRY = Union Catalog
ENTRY = Union Catalogs
MN = L01.178.682.290.483
MH_TH = NLM (1966)
ST = T073
ST = T170
AN = no qualif
MR = 19991103
DA = 19990101
DC = 1
UI = D002383

*NEWRECORD
RECTYPE = D
MH = Catalysis
AQ = DE RE
ENTRY = Catalyses
MN = G02.149.170
MN = G02.149.767.500
MN = G02.842.750.500
MH_TH = NLM (1966)
ST = T070
AN = NIM; BIOCATALYSIS is also available
MS = The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction.
MR = 20150626
DA = 19990101
DC = 1
UI = D002384

*NEWRECORD
RECTYPE = D
MH = Cataplexy
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Henneberg Syndrome|T047|EPO|EQV|NLM (2000)|991108|abcdef
PRINT ENTRY = Status Cataplexicus|T047|NON|NRW|NLM (2000)|991108|abcdef
PRINT ENTRY = Tonelessness Syndrome|T047|NON|EQV|NLM (2000)|991108|abcdef
ENTRY = Cataleptic Attacks|T047|NON|EQV|NLM (2011)|ORD (2010)|100113|abcdeef
ENTRY = Attack, Cataleptic
ENTRY = Attacks, Cataleptic
ENTRY = Cataleptic Attack
ENTRY = Syndrome, Henneberg
ENTRY = Syndrome, Tonelessness
ENTRY = Syndromes, Tonelessness
ENTRY = Tonelessness Syndromes
MN = C10.886.425.800.200.750.500
MN = F03.870.400.800.200.750.500
FX = Catalepsy
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
AN = do not confuse with CATALEPSY
MS = A condition characterized by transient weakness or paralysis of somatic musculature triggered by an emotional stimulus or physical exertion. Cataplexy is frequently associated with NARCOLEPSY. During a cataplectic attack, there is a marked reduction in muscle tone similar to the normal physiologic hypotonia that accompanies rapid eye movement sleep (SLEEP, REM). (From Adams et al., Principles of Neurology, 6th ed, p396)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002385

*NEWRECORD
RECTYPE = D
MH = Cataract
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT TH UR US VE VI
PRINT ENTRY = Cataract, Membranous|T047|NON|NRW|NLM (1998)|OMIM (2013)|960822|abcdeef
PRINT ENTRY = Lens Opacities|T033|T047|NON|REL|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Pseudoaphakia|T047|NON|NRW|NLM (1998)|960822|abcdef
ENTRY = Cataracts
ENTRY = Cataracts, Membranous
ENTRY = Lens Opacity
ENTRY = Membranous Cataract
ENTRY = Membranous Cataracts
ENTRY = Opacities, Lens
ENTRY = Opacity, Lens
ENTRY = Pseudoaphakias
MN = C11.510.245
EC = surgery:Cataract Extraction
MH_TH = NLM (1966)
ST = T047
AN = lens opacity; do not confuse X ref PSEUDOAPHAKIA (a synonym for membranous cataract) with PSEUDOPHAKIA, the presence of an intraocular lens after cataract extraction
MS = Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002386

*NEWRECORD
RECTYPE = D
MH = Cataract Extraction
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Enzymatic Zonulolysis|T061|NON|REL|NLM (1997)|960412|abcdef
ENTRY = Phakectomy|T061|NON|REL|NLM (2008)|061109|abcdef
ENTRY = Cataract Extractions
ENTRY = Enzymatic Zonulolyses
ENTRY = Extraction, Cataract
ENTRY = Extractions, Cataract
ENTRY = Phakectomies
ENTRY = Zonulolyses, Enzymatic
ENTRY = Zonulolysis, Enzymatic
MN = E04.540.825.249
FX = Aphakia, Postcataract
FX = Lenses, Intraocular
FX = Pseudophakia
MH_TH = NLM (1966)
ST = T061
MS = The removal of a cataractous CRYSTALLINE LENS from the eye.
PM = ENZYMATIC ZONULOLYSIS was heading 1963-96
HN = ENZYMATIC ZONULOLYSIS was heading 1963-96
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D002387

*NEWRECORD
RECTYPE = D
MH = Catastrophic Illness
AQ = CL EC EP MO NU PX RH TH
ENTRY = Catastrophic Illnesses
ENTRY = Illness, Catastrophic
ENTRY = Illnesses, Catastrophic
MN = C23.550.291.250
FX = Insurance, Major Medical
MH_TH = NLM (1982)
ST = T047
AN = usually GEN & IM; if a specific catastrophic illiness, coord NIM with specific dis (IM)
MS = An acute or prolonged illness usually considered to be life-threatening or with the threat of serious residual disability. Treatment may be radical and is frequently costly.
PM = 82
HN = 82
CATSH = CAT LIST
MR = 19991108
DA = 19810226
DC = 1
DX = 19820101
UI = D002388

*NEWRECORD
RECTYPE = D
MH = Catatonia
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Catatonia, Malignant|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Catatonia, Organic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Lethal Catatonia|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Organic Catatonic Disorder|T047|NON|NRW|NLM (2000)|991103|ORGANIC CATATONIC DIS|abcdefv
ENTRY = Schizophreniform Catatonia|T048|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Catatonia, Lethal
ENTRY = Catatonia, Schizophreniform
ENTRY = Catatonias
ENTRY = Catatonias, Lethal
ENTRY = Catatonias, Malignant
ENTRY = Catatonias, Organic
ENTRY = Catatonias, Schizophreniform
ENTRY = Catatonic Disorder, Organic
ENTRY = Catatonic Disorders, Organic
ENTRY = Lethal Catatonias
ENTRY = Malignant Catatonia
ENTRY = Malignant Catatonias
ENTRY = Organic Catatonia
ENTRY = Organic Catatonias
ENTRY = Organic Catatonic Disorders
ENTRY = Schizophreniform Catatonias
MN = C10.597.606.115
MN = C23.888.592.604.115
MN = F01.145.126.156
MN = F01.700.165
FX = Catalepsy
MH_TH = NLM (1966)
ST = T184
MS = A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
UI = D002389

*NEWRECORD
RECTYPE = D
MH = Catchment Area (Health)
DE = CATCHMENT AREA
AQ = EC LJ SN
PRINT ENTRY = Health Service Area|T083|NON|EQV|UNK (19XX)|790601|HEALTH SERV AREA|abcdefv
ENTRY = Service Area, Health|T083|NON|EQV|NLM (1996)|950213|SERV AREA HEALTH|abcdefv
ENTRY = Area, Catchment (Health)
ENTRY = Area, Health Service
ENTRY = Areas, Catchment (Health)
ENTRY = Areas, Health Service
ENTRY = Catchment Areas (Health)
ENTRY = Health Service Areas
ENTRY = Service Areas, Health
MN = N01.224.791.200
MN = N03.349.650.095
MN = N06.850.505.400.800.200
MH_TH = NLM (1978)
ST = T083
AN = specify geog; DF: CATCHMENT AREA
MS = A geographic area defined and served by a health program or institution.
PM = 78
HN = 78
MR = 20080708
DA = 19770512
DC = 1
DX = 19780101
UI = D002391

*NEWRECORD
RECTYPE = D
MH = Catechin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Catechinic Acid|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760412|abbcdeef
PRINT ENTRY = Catechuic Acid|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|760412|abbcdeef
ENTRY = (+)-Catechin|T109|T121|NON|EQV|FDA SRS (2014)|UNK (19XX)|810918|abbcdeef
ENTRY = (+)-Cyanidanol|T109|T121|NON|EQV|UNK (19XX)|800825|abbcdef
ENTRY = (+)-Cyanidanol-3|T109|T121|NON|NRW|UNK (19XX)|810917|abbcdef
ENTRY = 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-|T109|T121|NON|REL|NLM (2001)|000524|abbcdef
ENTRY = 3,3',4',5,7-Flavanpentol|T109|T121|NON|EQV|UNK (19XX)|800319|abbcdef
ENTRY = Catergen|T109|T121|TRD|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Cianidanol|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|UNK (19XX)|820903|abbcdeeef
ENTRY = Cyanidanol-3|T109|T121|NON|NRW|UNK (19XX)|830531|abbcdef
ENTRY = Epicatechin|T109|T121|NON|REL|FDA SRS (2014)|UNK (19XX)|841002|abbcdeef
ENTRY = KB-53|T109|T121|LAB|NRW|UNK (19XX)|831014|abbcdef
ENTRY = Z 7300|T109|T121|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Zyma|T109|T121|TRD|NRW|UNK (19XX)|810519|abbcdef
ENTRY = Acid, Catechinic
ENTRY = Acid, Catechuic
ENTRY = Cyanidanol 3
ENTRY = KB 53
ENTRY = KB53
MN = D03.383.663.283.240.190
MN = D03.383.663.283.266.450.206
MN = D03.438.150.240.190
MN = D03.438.150.266.450.206
MH_TH = FDA SRS (2014)
MH_TH = NLM (1977)
ST = T109
ST = T121
N1 = 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-
RN = 8R1V1STN48
RR = 154-23-4 (Catechin)
RR = 16198-00-8
RR = 321-01-7
RR = 34PHS7TU43
RR = 490-46-0 (Epicatechin)
PI = Benzopyrans (1973-1976)
PI = Catechols (1973-1976)
MS = An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms.
PM = 87; was see under BENZOPYRANS 1977-86
HN = 87(77); was see under BENZOPYRANS 1977-86
MR = 20150622
DA = 19760413
DC = 1
DX = 19870101
UI = D002392

*NEWRECORD
RECTYPE = D
MH = Estrogens, Catechol
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Catechol Estrogens|T110|T125|NON|EQV|NLM (1994)|920811|abbcdef
ENTRY = Catecholestrogens|T110|T125|NON|EQV|NLM (1994)|930323|abbcdef
MN = D02.455.426.559.389.657.166.350
MN = D06.472.334.851.437.984
MH_TH = NLM (1982)
ST = T110
ST = T125
RN = 0
AN = /biosyn /physiol permitted
PI = Catechols (1966-1981)
PI = Estrogens (1966-1981)
PI = specific estrogen (1966-1981)
MS = 2- or 4-Hydroxyestrogens. Substances that are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an estrogenic action or interaction with the catecholaminergic system.
OL = use ESTROGENS, CATECHOL to search CATECHOL ESTROGENS 1982-93
PM = 94; was CATECHOL ESTROGENS 1982-93; ESTROGENS, CATECHOL was see CATECHOL ESTROGENS 1982-93
HN = 94; was CATECHOL ESTROGENS 1982-93; ESTROGENS, CATECHOL was see CATECHOL ESTROGENS 1982-93
MR = 20120703
DA = 19810513
DC = 1
DX = 19820101
UI = D002393

*NEWRECORD
RECTYPE = D
MH = Catechol O-Methyltransferase
DS = CATECHOL METHYLTRANSFERASE O
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Catechol Methyltransferase|T116|T126|NON|EQV|NLM (1998)|970425|abbcdef
ENTRY = Catechol-O-Methyltransferase|T116|T126|NON|EQV|UNK (19XX)|811218|abbcdef
ENTRY = Catechol O Methyltransferase
ENTRY = Methyltransferase, Catechol
ENTRY = O-Methyltransferase, Catechol
MN = D08.811.913.555.500.250
EC = antagonists & inhibitors:Catechol O-Methyltransferase Inhibitors
MH_TH = NLM (1972)
ST = T116
ST = T126
N1 = S-Adenosyl-L-methionine:catechol O-methyltransferase
RN = EC 2.1.1.6
PI = Methyltransferases (1971)
PI = Transferase (1966-1971)
MS = Enzyme that catalyzes the movement of a methyl group from S-adenosylmethionone to a catechol or a catecholamine.
PM = 98; see CATECHOL METHYLTRANSFERASE 1974-97
HN = 98(72)
MR = 20140610
DA = 19990101
DC = 1
DX = 19740101
UI = D002394

*NEWRECORD
RECTYPE = D
MH = Catecholamines
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Sympathins|T109|T124|NON|EQV|UNK (19XX)|740329|abbcdef
MN = D02.092.211.215.311
MN = D02.092.311
FX = Receptors, Catecholamine
MH_TH = POPLINE (1978)
ST = T109
ST = T124
RN = 0
AN = if only EPINEPHRINE & NOREPINEPHRINE are discussed index under each & not also here
MS = A general class of ortho-dihydroxyphenylalkylamines derived from tyrosine.
MR = 19930621
DA = 19990101
DC = 1
UI = D002395

*NEWRECORD
RECTYPE = D
MH = Catechols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Pyrocatechols|T109|NON|EQV|UNK (19XX)|760324|abcdef
PRINT ENTRY = o-Dihydroxybenzenes|T109|NON|EQV|UNK (19XX)|770520|DIHYDROXYBENZENES O|abcdefs
PRINT ENTRY = ortho-Dihydroxybenzenes|T109|NON|EQV|UNK (19XX)|770520|abcdef
ENTRY = o Dihydroxybenzenes
ENTRY = ortho Dihydroxybenzenes
MN = D02.455.426.559.389.657.166
MH_TH = NLM (1966)
ST = T109
RN = 0
MS = A group of 1,2-benzenediols that contain the general formula R-C6H5O2.
OL = use CATECHOLS to search CATECHOL 1966-74
PM = 75; was CATECHOL 1963-74
HN = 75; was CATECHOL 1963-74
MR = 20120703
DA = 19990101
DC = 1
UI = D002396

*NEWRECORD
RECTYPE = D
MH = Catfishes
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Eremophilus mutisii|T013|NON|NRW|NLM (2004)|020918|abcdef
PRINT ENTRY = Heteropneustes|T013|NON|NRW|UNK (19XX)|860415|abcdef
PRINT ENTRY = Plotosus|T013|NON|NRW|UNK (19XX)|860415|abcdef
PRINT ENTRY = Siluriformes|T013|NON|EQV|NLM (2002)|000809|abcdef
ENTRY = Arius|T013|NON|NRW|NLM (2002)|000809|abcdef
ENTRY = Catfish|T013|NON|EQV|NLM (1987)|990101|abcdef
ENTRY = Colombian Catfish|T013|EPO|NRW|NLM (2004)|020918|abcdef
ENTRY = Catfish, Colombian
MN = B01.050.150.900.493.080
MH_TH = NLM (1991)
ST = T013
AN = BULLHEAD CATFISHES and CHANNEL CATFISH see ICTALURIDAE are also available; X ref EREMOPHILUS MUTISII: EREMOPHILA PLANT and EREMOPHILA ALPESTRIS see SONGBIRDS are also available
PI = Fishes (1966-1986)
MS = Common name of the order Siluriformes. This order contains many families and over 2,000 species, including venomous species. Heteropneustes and Plotosus genera have dangerous stings and are aggressive. Most species are passive stingers.
PM = 2002; see CATFISH 1987-2001
HN = 2002 (1987)
MR = 20090706
DA = 19860415
DC = 1
DX = 19870101
UI = D002397

*NEWRECORD
RECTYPE = D
MH = Catgut
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
ENTRY = Catguts
MN = E07.858.690.820.250
MH_TH = NLM (1979)
ST = T116
ST = T122
ST = T123
PI = Sutures (1966-1978)
MS = Sterile collagen strands obtained from healthy mammals. They are used as absorbable surgical ligatures and are frequently impregnated with chromium or silver for increased strength. They tend to cause tissue reaction.
PM = 91; was see under SUTURES 1979-90
HN = 91(79); was see under SUTURES 1979-90
CATSH = CAT LIST
MR = 20060705
DA = 19780201
DC = 1
DX = 19910101
UI = D002398

*NEWRECORD
RECTYPE = D
MH = Catharsis
ENTRY = Catharses
MN = F04.754.720.107.333
MH_TH = NLM (1975)
ST = T041
AN = no qualif
MS = The release of ideas, thoughts, and repressed material from the unconscious, accompanied by an emotional response and relief. (From Dorland, 28th ed)
OL = search ABREACTION 1969-74
PM = 91; was see under ABREACTION 1975-90
HN = 91(75); was see under ABREACTION 1975-90
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19910101
UI = D002399

*NEWRECORD
RECTYPE = D
MH = Cathartics
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Purgatives|T121|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Bowel Evacuants|T121|NON|EQV|NLM (2008)|061201|abcdef
ENTRY = Bowel Preparation Solutions|T121|NON|NRW|NLM (2011)|091021|abcdef
ENTRY = Evacuants, Bowel
ENTRY = Preparation Solutions, Bowel
ENTRY = Solutions, Bowel Preparation
MN = D27.505.954.483.396
MH_TH = NLM (1966)
ST = T121
RN = 0
MS = Agents that are used to stimulate evacuation of the bowels.
MR = 20100625
DA = 19990101
DC = 1
UI = D002400

*NEWRECORD
RECTYPE = D
MH = Cathepsin B
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Cathepsin B-Like Proteinase|T116|T126|NON|REL|UNK (19XX)|860616|abbcdef
ENTRY = Cathepsin B1|T116|T126|NON|EQV|UNK (19XX)|860616|abbcdef
ENTRY = Cathepsin B Like Proteinase
ENTRY = Proteinase, Cathepsin B-Like
MN = D08.811.277.656.224.125
MN = D08.811.277.656.262.500.133
MN = D08.811.277.656.300.200.133
MH_TH = NLM (1987)
ST = T116
ST = T126
RN = EC 3.4.22.1
PI = Cathepsins (1966-1986)
MS = A lysosomal cysteine proteinase with a specificity similar to that of PAPAIN. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in DEMYELINATION; EMPHYSEMA; RHEUMATOID ARTHRITIS, and NEOPLASM INVASIVENESS.
PM = 87
HN = 87
MR = 20090706
DA = 19860616
DC = 1
DX = 19870101
UI = D002401

*NEWRECORD
RECTYPE = D
MH = Cathepsin D
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D08.811.277.656.074.500.180
MN = D08.811.277.656.224.187
MN = D08.811.277.656.300.048.180
MH_TH = NLM (1985)
ST = T116
ST = T126
RN = EC 3.4.23.5
PI = Cathepsins (1966-1984)
MS = An intracellular proteinase found in a variety of tissue. It has specificity similar to but narrower than that of pepsin A. The enzyme is involved in catabolism of cartilage and connective tissue. EC 3.4.23.5. (Formerly EC 3.4.4.23).
PM = 85
HN = 85
MR = 20090706
DA = 19840524
DC = 1
DX = 19850101
UI = D002402

*NEWRECORD
RECTYPE = D
MH = Cathepsins
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Cathepsin|T116|T126|NON|EQV|UNK (19XX)|780518|abbcdef
MN = D08.811.277.656.224
MH_TH = NLM (1963)
ST = T116
ST = T126
RN = EC 3.4.-
AN = note specifics
MS = A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissues. They function optimally within an acidic pH range. The cathepsins occur as a variety of enzyme subtypes including SERINE PROTEASES; ASPARTIC PROTEINASES; and CYSTEINE PROTEASES.
OL = use CATHEPSINS to search CATHEPSIN 1966-78
PM = 79; was CATHEPSIN 1965-78
HN = 79; was CATHEPSIN 1963-78 (Prov 1963-64)
MR = 20090706
DA = 19990101
DC = 1
DX = 19650101
UI = D002403

*NEWRECORD
RECTYPE = D
MH = Catheterization
DE = CATH
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Cannulation|T061|NON|REL|UNK (19XX)|760512|abcdef
ENTRY = Cannulations
ENTRY = Catheterizations
MN = E02.148
MN = E05.157
FX = Catheters, Indwelling
FX = Venous Cutdown
MH_TH = NLM (1966)
ST = T061
AN = general or unspecified; prefer specifics
MS = Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions.
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002404

*NEWRECORD
RECTYPE = D
MH = Catheterization, Central Venous
DE = CATH CENTRAL VENOUS
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Central Venous Catheterization|T060|T061|NON|EQV|UNK (19XX)|870509|CENTRAL VENOUS CATH|abbcdefv
PRINT ENTRY = Venous Catheterization, Central|T060|T061|NON|EQV|NLM (1991)|900515|VENOUS CATH CENTRAL|abbcdefv
ENTRY = Catheterization, Central|T060|T061|NON|EQV|NLM (1993)|911009|CATH CENTRAL|abbcdefv
ENTRY = Central Catheterization|T060|T061|NON|EQV|UNK (19XX)|870509|CENTRAL CATH|abbcdefv
ENTRY = Catheterizations, Central
ENTRY = Catheterizations, Central Venous
ENTRY = Central Catheterizations
ENTRY = Central Venous Catheterizations
ENTRY = Venous Catheterizations, Central
MN = E02.148.167
MN = E04.100.814.529.875
MN = E04.502.382.875
MN = E05.157.313
FX = Central Venous Catheters
FX = Venous Cutdown
MH_TH = NLM (1988)
ST = T060
ST = T061
PI = Catheterization (1966-1987)
PI = Catheters, Indwelling (1978-1987)
MS = Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20150622
DA = 19870509
DC = 1
DX = 19880101
UI = D002405

*NEWRECORD
RECTYPE = D
MH = Catheterization, Peripheral
DE = CATH PERIPHERAL
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Arterial Catheterization, Peripheral|T060|T061|NON|NRW|NLM (1991)|900515|ARTERIAL CATH PERIPHERAL|abbcdefv
PRINT ENTRY = Catheterization, Bronchial|T060|T061|NON|NRW|UNK (19XX)|870509|CATH BRONCHIAL|abbcdefv
PRINT ENTRY = Catheterization, Peripheral Arterial|T060|T061|NON|NRW|UNK (19XX)|870509|CATH PERIPHERAL ARTERIAL|abbcdefv
PRINT ENTRY = Catheterization, Peripheral Venous|T060|T061|NON|NRW|UNK (19XX)|870509|CATH PERIPHERAL VENOUS|abbcdefv
PRINT ENTRY = Peripheral Catheterization|T060|T061|NON|EQV|UNK (19XX)|870509|PERIPHERAL CATH|abbcdefv
PRINT ENTRY = Venous Catheterization, Peripheral|T060|T061|NON|NRW|NLM (1991)|900515|VENOUS CATH PERIPHERAL|abbcdefv
ENTRY = Bronchial Catheterization|T060|T061|NON|NRW|UNK (19XX)|870509|BRONCHIAL CATH|abbcdefv
ENTRY = PICC Line Catheterization|T060|T061|ABX|NRW|NLM (2016)|150520|abbcdef
ENTRY = PICC Line Placement|T060|T061|ABX|NRW|NLM (2016)|150520|abbcdef
ENTRY = PICC Placement|T060|T061|ABX|NRW|NLM (2016)|150520|abbcdef
ENTRY = Peripheral Arterial Catheterization|T060|T061|NON|NRW|NLM (1990)|891107|PERIPHERAL ARTERIAL CATH|abbcdefv
ENTRY = Peripheral Venous Catheterization|T060|T061|NON|NRW|UNK (19XX)|870509|PERIPHERAL VENOUS CATH|abbcdefv
ENTRY = Peripherally Inserted Central Catheter Line Insertion|T060|T061|NON|NRW|NLM (2016)|150520|abbcdef
ENTRY = Arterial Catheterizations, Peripheral
ENTRY = Bronchial Catheterizations
ENTRY = Catheterization, PICC Line
ENTRY = Catheterizations, Bronchial
ENTRY = Catheterizations, PICC Line
ENTRY = Catheterizations, Peripheral
ENTRY = Catheterizations, Peripheral Arterial
ENTRY = Catheterizations, Peripheral Venous
ENTRY = PICC Line Catheterizations
ENTRY = PICC Line Placements
ENTRY = PICC Placements
ENTRY = Peripheral Arterial Catheterizations
ENTRY = Peripheral Catheterizations
ENTRY = Peripheral Venous Catheterizations
ENTRY = Placement, PICC
ENTRY = Placement, PICC Line
ENTRY = Placements, PICC
ENTRY = Placements, PICC Line
ENTRY = Venous Catheterizations, Peripheral
MN = E02.148.224
MN = E04.100.814.529.937
MN = E04.502.382.937
MN = E05.157.375
MH_TH = NLM (1988)
ST = T060
ST = T061
PI = Bronchi (1966-1987)
PI = Bronchoscopy (1966-1987)
PI = Catheterization (1966-1987)
PI = Catheters, Indwelling (1978-1987)
PI = Heart Catheterization (1966-1987)
MS = Insertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20150622
DA = 19870509
DC = 1
DX = 19880101
UI = D002406

*NEWRECORD
RECTYPE = D
MH = Catheterization, Swan-Ganz
DE = CATH SWAN GANZ
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
PRINT ENTRY = Catheterization, Pulmonary Artery|T060|NON|NRW|NLM (1996)|950202|CATH PULM ARTERY|abcdefv
PRINT ENTRY = Swan-Ganz Catheterization|T060|EPO|EQV|UNK (19XX)|870509|SWAN GANZ CATH|abcdefv
ENTRY = Pulmonary Artery Catheterization|T060|NON|NRW|NLM (1996)|950202|PULM ARTERY CATH|abcdefv
ENTRY = Artery Catheterization, Pulmonary
ENTRY = Artery Catheterizations, Pulmonary
ENTRY = Catheterization, Swan Ganz
ENTRY = Catheterizations, Pulmonary Artery
ENTRY = Pulmonary Artery Catheterizations
ENTRY = Swan Ganz Catheterization
MN = E01.370.370.380.140.210
MN = E02.148.224.165
MN = E02.148.442.165
MN = E04.100.814.529.937.165
MN = E04.502.382.937.165
MN = E05.157.250.165
MN = E05.157.375.165
FX = Pulmonary Wedge Pressure
MH_TH = NLM (1988)
ST = T060
AN = DF: CATH SWAN GANZ
PI = Heart Catheterization (1971-1987)
MS = Placement of a balloon-tipped catheter into the pulmonary artery through the antecubital, subclavian, and sometimes the femoral vein. It is used to measure pulmonary artery pressure and pulmonary artery wedge pressure which reflects left atrial pressure and left ventricular end-diastolic pressure. The catheter is threaded into the right atrium, the balloon is inflated and the catheter follows the blood flow through the tricuspid valve into the right ventricle and out into the pulmonary artery.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20150622
DA = 19870509
DC = 1
DX = 19880101
UI = D002407

*NEWRECORD
RECTYPE = D
MH = Catheters, Indwelling
AQ = AE CL CT EC ES HI MI PS SD SN ST TD UT VE VI
PRINT ENTRY = Implantable Catheters|T074|NON|NRW|NLM (1990)|890512|abcdef
ENTRY = In-Dwelling Catheters|T074|NON|EQV|NLM (1990)|890512|abcdef
ENTRY = Catheter, In-Dwelling
ENTRY = Catheter, Indwelling
ENTRY = Catheters, In-Dwelling
ENTRY = In Dwelling Catheters
ENTRY = In-Dwelling Catheter
ENTRY = Indwelling Catheter
ENTRY = Indwelling Catheters
MN = E07.132.500
FX = Infusion Pumps, Implantable
MH_TH = NLM (1975)
ST = T074
AN = coordinate with specific site (NIM) if pertinent
PI = Catheterization (1966-1974)
PI = Heart Catheterization (1966-1974)
PI = Urinary Catheterization (1966-1974)
MS = Catheters designed to be left within an organ or passage for an extended period of time.
OL = use CATHETERS, INDWELLING to search INDWELLING CATHETER 1975-77; use URINARY CATHETERIZATION 1966-74
PM = 78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77
HN = 78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19780101
UI = D002408

*NEWRECORD
RECTYPE = D
MH = Cathexis
MN = F01.393.246.250
MH_TH = NLM (1975)
ST = T041
AN = no qualif
MS = Attachment, conscious or unconscious, of emotional feeling and significance to an idea, object or most commonly a person.
OL = search DISPLACEMENT (PSYCHOLOGY) 1974
PM = 91; was see under DISPLACEMENT (PSYCHOLOGY) 1975-90
HN = 91(75); was see under DISPLACEMENT (PSYCHOLOGY) 1975-90
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19910101
UI = D002409

*NEWRECORD
RECTYPE = D
MH = Catholicism
AQ = HI PX
ENTRY = Roman Catholic Ethics|T078|NON|REL|BIOETHICS (1974)|900802|abcdef
ENTRY = Roman Catholicism|T078|NON|EQV|BIOETHICS (1974)|770317|abcdef
ENTRY = Roman Catholics|T098|NON|REL|BIOETHICS (1994)|931129|abcdef
ENTRY = Catholic, Roman
ENTRY = Catholicism, Roman
ENTRY = Catholics, Roman
ENTRY = Ethic, Roman Catholic
ENTRY = Ethics, Roman Catholic
ENTRY = Roman Catholic
ENTRY = Roman Catholic Ethic
MN = K01.844.188.250
MH_TH = POPLINE (1978)
ST = T078
AN = IM; specify geog if pertinent
MS = The Christian faith, practice, or system of the Catholic Church, specifically the Roman Catholic, the Christian church that is characterized by a hierarchic structure of bishops and priests in which doctrinal and disciplinary authority are dependent upon apostolic succession, with the pope as head of the episcopal college. (From Webster, 3d ed; American Heritage Dictionary, 2d college ed)
MR = 19991103
DA = 19990101
DC = 1
UI = D002410

*NEWRECORD
RECTYPE = D
MH = Cation Exchange Resins
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Cation Exchangers (Resins)|T122|T130|NON|EQV|NLM (2002)|010319|abbcdef
ENTRY = Exchange Resins, Cation
ENTRY = Resins, Cation Exchange
MN = D27.720.470.420.275
MH_TH = NLM (1975)
ST = T122
ST = T130
RN = 0
MS = High molecular weight insoluble polymers which contain functional anionic groups that are capable of undergoing exchange reactions with cations.
OL = search ION EXCHANGE RESINS 1966-74
PM = 91; was see under ION EXCHANGE RESINS 1975-90
HN = 91(75); was see under ION EXCHANGE RESINS 1975-90
MR = 20030709
DA = 19990101
DC = 1
DX = 19910101
UI = D002411

*NEWRECORD
RECTYPE = D
MH = Cations
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.248.497.300
MH_TH = NLM (1978)
ST = T104
RN = 0
AN = GEN or unspecified; avoid as too general: prefer specifics; use qualif discreetly: few apply
PI = Cations, Divalent (1973-1977)
PI = Cations, Monovalent (1973-1977)
PI = Ions (1966-1977)
MS = Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis.
PM = 78
HN = 78
MR = 20040719
DA = 19770422
DC = 1
DX = 19780101
UI = D002412

*NEWRECORD
RECTYPE = D
MH = Cations, Divalent
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Divalent Cations|T104|NON|EQV|NLM (2008)|060612|abcdef
MN = D01.248.497.300.333
MH_TH = NLM (1973)
ST = T104
RN = 0
AN = general only: prefer specifics
PI = Ions (1966-1972)
PI = Metals (1966-1972)
PI = specific element(1966-1972)
MS = Positively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis.
PM = 73
HN = 73
MR = 20070709
DA = 19990101
DC = 1
DX = 19730101
UI = D002413

*NEWRECORD
RECTYPE = D
MH = Cations, Monovalent
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Monovalent Cations
MN = D01.248.497.300.459
MH_TH = NLM (1973)
ST = T104
RN = 0
AN = NIM: avoid as IM except when general only: prefer specifics; use qualif discreetly: few apply
PI = Ions (1966-1972)
PI = Metals (1966-1972)
PI = specific element ( - )
MS = Positively charged atoms, radicals or group of atoms with a valence of plus 1, which travel to the cathode or negative pole during electrolysis.
PM = 73
HN = 73
MR = 20130709
DA = 19990101
DC = 1
DX = 19730101
UI = D002414

*NEWRECORD
RECTYPE = D
MH = Cats
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Felis catus|T015|NON|EQV|NLM (1998)|961025|abcdef
PRINT ENTRY = Felis domesticus|T015|NON|EQV|NLM (2005)|030805|abcdef
ENTRY = Domestic Cats|T015|NON|EQV|NLM (2005)|030805|abcdef
ENTRY = Felis domestica|T015|NON|EQV|NLM (1998)|961025|abcdef
ENTRY = Felis sylvestris catus|T015|NON|EQV|NLM (2005)|030805|abcdef
ENTRY = Cat
ENTRY = Cat, Domestic
ENTRY = Cats, Domestic
ENTRY = Domestic Cat
MN = B01.050.150.900.649.147.354.250.125
MH_TH = NLM (1966)
ST = T015
AN = check tag: no qualifiers; restrict to domestic cat
CX = consider also terms at FELINE
MS = The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801)
MR = 20090706
DA = 19990101
DC = 1
UI = D002415

*NEWRECORD
RECTYPE = D
MH = Cattell Personality Factor Questionnaire
AQ = HI SN ST
MN = F04.711.647.513.146
MH_TH = NLM (1975)
ST = T060
ST = T170
MS = Self report questionnaire which yields 16 scores on personality traits, such as reserved vs. outgoing, humble vs. assertive, etc.
OL = search PERSONALITY INVENTORY 1968-74
PM = 91; was see under PERSONALITY INVENTORY 1975-90
HN = 91(75); was see under PERSONALITY INVENTORY 1975-90
CATSH = CAT LIST
MR = 19920507
DA = 19990101
DC = 1
DX = 19910101
UI = D002416

*NEWRECORD
RECTYPE = D
MH = Cattle
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Bos grunniens|T015|NON|NRW|NLM (2003)|011116|abcdef
PRINT ENTRY = Bos indicus|T015|NON|NRW|NLM (2003)|011116|abcdef
PRINT ENTRY = Bos taurus|T015|NON|NRW|NLM (2003)|011116|abcdef
PRINT ENTRY = Cow, Domestic|T015|NON|NRW|NLM (2003)|011116|abcdef
PRINT ENTRY = Yak|T015|NON|NRW|NLM (2003)|011116|abcdef
PRINT ENTRY = Zebu|T015|NON|NRW|NLM (2003)|011116|abcdef
ENTRY = Cows, Domestic
ENTRY = Domestic Cow
ENTRY = Domestic Cows
ENTRY = Yaks
ENTRY = Zebus
MN = B01.050.150.900.649.077.380.271
MH_TH = NLM (1966)
ST = T015
AN = not for all Bovidae: only cows, yaks & zebus
CX = consider also terms at BOVINE
MS = Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
MR = 20090706
DA = 19990101
DC = 1
UI = D002417

*NEWRECORD
RECTYPE = D
MH = Cattle Diseases
DE = CATTLE DIS
AQ = BL CF CI CL CN DH DI DT EC EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RI RT SU TH TM UR US VI
ENTRY = Bovine Diseases|T047|NON|EQV|NLM (1991)|900104|BOVINE DIS|abcdefv
ENTRY = Bovine Disease
ENTRY = Cattle Disease
ENTRY = Disease, Bovine
ENTRY = Disease, Cattle
ENTRY = Diseases, Bovine
ENTRY = Diseases, Cattle
MN = C22.196
MH_TH = NLM (1966)
ST = T047
AN = IM GEN or unspecified; coord IM with specific dis /vet (IM) or specific cattle dis (IM); for abnormalities or injuries, index under CATTLE /abnorm or CATTLE /inj; includes diseases of yaks & zebus but does not include diseases of BISON or BUFFALOES; don't forget also check tags CATTLE (NIM) & ANIMALS; DF: CATTLE DIS
MS = Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus.
CATSH = CAT LIST
MR = 20030730
DA = 19990101
DC = 1
UI = D002418

*NEWRECORD
RECTYPE = D
MH = Cauda Equina
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
PRINT ENTRY = Filum Terminale|T023|NON|NRW|UNK (19XX)|780522|abcdef
ENTRY = Equina, Cauda
ENTRY = Terminale, Filum
MN = A08.800.800.720.725.150
FX = Spinal Cord
MH_TH = NLM (1966)
ST = T023
AN = disease: coordinate IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neoplasms: coordinate IM with PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM); cauda equina syndrome: CAUDA EQUINA SYNDROME see POLYRADICULOPATHY is available
MS = The lower part of the SPINAL CORD consisting of the lumbar, sacral, and coccygeal nerve roots.
OL = use CAUDA EQUINA to search FILUM TERMINALE 1966-78
PM = FILUM TERMINALE was see under CAUDA EQUINA 1963-78
HN = FILUM TERMINALE was see under CAUDA EQUINA 1963-78
MR = 20140613
DA = 19990101
DC = 1
UI = D002420

*NEWRECORD
RECTYPE = D
MH = Caudate Nucleus
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Caudatus|T023|NON|EQV|NLM (2015)|140324|abcdef
ENTRY = Nucleus Caudatus|T023|NON|EQV|NLM (2015)|140324|abcdef
ENTRY = Caudatus, Nucleus
ENTRY = Nucleus, Caudate
MN = A08.186.211.730.885.287.249.487.550.184
MH_TH = NLM (1966)
ST = T023
MS = Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain.
MR = 20140613
DA = 19990101
DC = 1
UI = D002421

*NEWRECORD
RECTYPE = D
MH = Causalgia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Complex Regional Pain Syndrome Type II|T047|NON|EQV|NLM (2000)|991103|CRPS II|abcdefv
ENTRY = CRPS Type II|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Causalgia Syndrome|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Deafferentation Pain|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Type II Complex Regional Pain Syndrome|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Causalgia Syndromes
ENTRY = Pain, Deafferentation
ENTRY = Syndrome, Causalgia
ENTRY = Syndromes, Causalgia
MN = C10.177.195.200
MN = C10.668.829.250.200
MN = C10.668.829.600.200
MH_TH = NLM (1971)
ST = T047
AN = coord IM with specific nerve (IM)
PI = Neuralgia (1966-1970)
MS = A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359)
PM = 1991; was see under NEURALGIA 1971-1990
HN = 1991(1971); was see under NEURALGIA 1971-1990
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
DX = 19910101
UI = D002422

*NEWRECORD
RECTYPE = D
MH = Cause of Death
AQ = TD
ENTRY = Causes of Death|T078|NON|EQV|POPLINE (1978)|870519|abcdef
ENTRY = Death Cause
ENTRY = Death Causes
MN = E05.318.308.985.550.250
MN = L01.280.975.550.250
MN = N01.224.935.698.100
MN = N06.850.505.400.975.550.250
MN = N06.850.520.308.985.550.250
MH_TH = NLM (1988)
ST = T078
AN = note categories; do not use for cause of death in every clinical case; restrict to cause of death as an epidemiological consideration: "mortality by cause of death", "certification of cause of death"; probably IM in such cases; coord NIM with specific disease /mortal (IM); specify geog if pertinent
PI = Mortality (1966-1987)
MS = Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20080708
DA = 19870513
DC = 1
DX = 19880101
UI = D002423

*NEWRECORD
RECTYPE = D
MH = Caustics
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Corrosives|T131|NON|BRD|NLM (1998)|970114|abcdef
MN = D27.720.185
MN = D27.888.569.185
MH_TH = NLM (1966)
ST = T121
ST = T131
RN = 0
AN = caustic injury: index CAUSTICS /tox + BURNS, CHEMICAL + organ /inj; see also note on ESOPHAGEAL STENOSIS
MS = Strong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides of light metals. SODIUM HYDROXIDE and potassium hydroxide are the most widely used caustic agents in industry. Medically, they have been used externally to remove diseased or dead tissues and destroy warts and small tumors. The accidental ingestion of products (household and industrial) containing caustic ingredients results in thousands of injuries per year.
MR = 20050630
DA = 19990101
DC = 1
UI = D002424

*NEWRECORD
RECTYPE = D
MH = Cautery
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Cauterization|T061|NON|EQV|NLM (2014)|130417|abcdef
ENTRY = Cauterizations
MN = E02.154
MN = E04.014.170
FX = Electrocoagulation
MH_TH = NLM (1966)
ST = T061
AN = coordinate with organ or disease /surg
MS = The application of a caustic substance, a hot instrument, an electric current, or other agent to control bleeding while removing or destroying tissue.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D002425

*NEWRECORD
RECTYPE = D
MH = Cavernous Sinus
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Sinus, Cavernous
MN = A07.231.908.224.334
MH_TH = NLM (1966)
ST = T030
MS = An irregularly shaped venous space in the dura mater at either side of the sphenoid bone.
MR = 20080708
DA = 19990101
DC = 1
UI = D002426

*NEWRECORD
RECTYPE = D
MH = Cebidae
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Platyrrhina|T015|NON|EQV|UNK (19XX)|800507|abcdef
ENTRY = Platyrrhinas
MN = B01.050.150.900.649.801.400.600.150
MH_TH = NLM (1981)
ST = T015
AN = index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
MS = A family of New World monkeys in the infraorder PLATYRRHINI, consisting of nine subfamilies: ALOUATTINAE; AOTINAE; Atelinae; Callicebinae; CALLIMICONINAE; CALLITRICHINAE; CEBINAE; Pithecinae; and SAIMIRINAE. They inhabit the forests of South and Central America, comprising the largest family of South American monkeys.
PM = 81
HN = 81
MR = 20090706
DA = 19800507
DC = 1
DX = 19810101
UI = D002427

*NEWRECORD
RECTYPE = D
MH = Cebus
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Monkey, Capuchin|T015|NON|EQV|UNK (19XX)|800507|abcdef
PRINT ENTRY = Monkey, Ring-Tail|T015|NON|EQV|UNK (19XX)|800507|abcdef
ENTRY = Monkey, Ring-Tailed|T015|NON|EQV|NLM (1992)|901128|abcdef
ENTRY = Capuchin Monkey
ENTRY = Capuchin Monkeys
ENTRY = Monkey, Ring Tail
ENTRY = Monkey, Ring Tailed
ENTRY = Monkeys, Capuchin
ENTRY = Monkeys, Ring-Tail
ENTRY = Monkeys, Ring-Tailed
ENTRY = Ring-Tail Monkey
ENTRY = Ring-Tail Monkeys
ENTRY = Ring-Tailed Monkey
ENTRY = Ring-Tailed Monkeys
MN = B01.050.150.900.649.801.400.600.150.120.120
MH_TH = NLM (1981)
ST = T015
AN = New World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
PI = Anthropoidea (1966-1980)
MS = A genus of the family CEBIDAE, subfamily CEBINAE, consisting of four species which are divided into two groups, the tufted and untufted. C. apella has tufts of hair over the eyes and sides of the head. The remaining species are without tufts - C. capucinus, C. nigrivultatus, and C. albifrons. Cebus inhabits the forests of Central and South America.
PM = 91; was see under CEBIDAE 1981-90
HN = 91(81); was see under CEBIDAE 1981-90
MR = 20090706
DA = 19800507
DC = 1
DX = 19910101
UI = D002428

*NEWRECORD
RECTYPE = D
MH = Cecal Diseases
DE = CECAL DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Cecal Disease
ENTRY = Disease, Cecal
ENTRY = Diseases, Cecal
MN = C06.405.469.110
MH_TH = NLM (1966)
ST = T047
AN = general: prefer specifics; inflammation = CECITIS see TYPHLITIS
MS = Pathological developments in the CECUM.
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D002429

*NEWRECORD
RECTYPE = D
MH = Cecal Neoplasms
DE = CECAL NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Cancer of Cecum|T191|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Cecal Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer of the Cecum|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer, Cecal|T191|NON|NRW|NLM (2004)|030228|abcdef
ENTRY = Neoplasms, Cecal|T191|NON|EQV|NLM (2000)|991103|NEOPL CECAL|abcdefv
ENTRY = Cecal Neoplasm
ENTRY = Neoplasm, Cecal
MN = C04.588.274.476.411.184
MN = C06.301.371.411.184
MN = C06.405.249.411.184
MN = C06.405.469.110.417
MN = C06.405.469.491.184
MH_TH = NLM (1966)
ST = T191
AN = coord IM with histol type of neopl (IM)
MS = Tumors or cancer of the CECUM.
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D002430

*NEWRECORD
RECTYPE = D
MH = Cecostomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Tube Cecostomy|T061|NON|NRW|UNK (19XX)|870319|abcdef
ENTRY = Cecostomies
ENTRY = Cecostomies, Tube
ENTRY = Cecostomy, Tube
ENTRY = Tube Cecostomies
MN = E04.210.338.175
MN = E04.579.338.175
FX = Surgical Stomas
MH_TH = NLM (1988)
ST = T061
PI = Cecal Diseases/surgery (1966-1987)
PI = Cecum/surgery (1966-1987)
MS = Surgical construction of an opening into the CECUM with a tube through the ABDOMINAL WALL (tube cecostomy) or by skin level approach, in which the cecum is sewn to the surrounding PERITONEUM. Its primary purpose is decompression of colonic obstruction.
PM = 91; was see under ENTEROSTOMY 1988-90
HN = 91(88); was see under ENTEROSTOMY 1988-90
CATSH = CAT LIST
MR = 20070709
DA = 19870319
DC = 1
DX = 19910101
UI = D002431

*NEWRECORD
RECTYPE = D
MH = Cecum
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Cecums
MN = A03.556.124.526.209
MN = A03.556.249.249.209
FX = Cecostomy
MH_TH = NLM (1966)
ST = T023
AN = Inflammation = CECITIS see TYPHLITIS
MS = The blind sac or outpouching area of the LARGE INTESTINE that is below the entrance of the SMALL INTESTINE. It has a worm-like extension, the vermiform APPENDIX.
MR = 20060705
DA = 19990101
DC = 1
UI = D002432

*NEWRECORD
RECTYPE = D
MH = Cefaclor
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Ceclor|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Cefaclor Anhydrous|T109|T195|NON|NRW|FDA SRS (2014)|NLM (2014)|130617|abbcdeef
ENTRY = Cefaclor Monohydrate|T109|T195|NON|EQV|FDA SRS (2014)|NLM (2014)|130617|abbcdeef
ENTRY = Keclor|T109|T195|TRD|NRW|NLM (1990)|890609|abbcdef
ENTRY = Lilly 99638|T109|T195|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = S-6472|T109|T195|LAB|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Anhydrous, Cefaclor
ENTRY = Monohydrate, Cefaclor
ENTRY = S 6472
ENTRY = S6472
MN = D02.065.589.099.249.200.155
MN = D02.886.665.074.200.155
MN = D04.075.080.875.099.221.249.200.155
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1976)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-
RN = 69K7K19H4L
RR = 3Z6FS3IK0K
RR = 53994-73-3 (Cefaclor)
PI = Cephalosporins (1966-1979)
MS = Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.
PM = 91; was see under CEPHALEXIN 1980-90
HN = 91(80); was see under CEPHALEXIN 1980-90
MR = 20130708
DA = 19790301
DC = 1
DX = 19910101
UI = D002433

*NEWRECORD
RECTYPE = D
MH = Cefadroxil
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 4-Hydroxycephalexin|T109|T195|NON|EQV|NLM (1990)|891121|abbcdef
ENTRY = BL-S 578|T109|T195|LAB|NRW|UNK (19XX)|830610|abbcdef
ENTRY = BL-S578|T109|T195|LAB|NRW|UNK (19XX)|830610|abbcdef
ENTRY = Bidocef|T109|T195|TRD|NRW|UNK (19XX)|830610|abbcdef
ENTRY = Cefadroxil Anhydrous|T109|T195|NON|NRW|NLM (2014)|130617|abbcdef
ENTRY = Cefadroxil Monohydrate|T109|T195|NON|EQV|FDA SRS (2014)|NLM (2014)|130617|abbcdeef
ENTRY = Cephadroxyl|T109|T195|NON|EQV|UNK (19XX)|830610|abbcdef
ENTRY = Duricef|T109|T195|TRD|NRW|NLM (1990)|891121|abbcdef
ENTRY = S-578|T109|T195|LAB|NRW|UNK (19XX)|830610|abbcdef
ENTRY = S578|T109|T195|LAB|NRW|UNK (19XX)|830610|abbcdef
ENTRY = Ultracef|T109|T195|TRD|NRW|NLM (1990)|891121|abbcdef
ENTRY = 4 Hydroxycephalexin
ENTRY = Anhydrous, Cefadroxil
ENTRY = BL S 578
ENTRY = BL S578
ENTRY = BLS 578
ENTRY = BLS578
ENTRY = Monohydrate, Cefadroxil
ENTRY = S 578
MN = D02.065.589.099.249.200.165
MN = D02.886.665.074.200.165
MN = D04.075.080.875.099.221.249.200.165
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1974)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-
RN = 280111G160
RR = 50370-12-2 (Cefadroxil)
RR = Q525PA8JJB
PI = Cephalexin (1972-1974)
PI = Cephalexin/analogs & derivatives (1975-1983)
PI = Cephalosporins (1966-1971)
MS = Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative.
PM = 84
HN = 84
MR = 20130708
DA = 19830610
DC = 1
DX = 19840101
UI = D002434

*NEWRECORD
RECTYPE = D
MH = Cefamandole
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cephamandole|T109|T195|NON|EQV|BAN (19XX)|800731|abbcdef
ENTRY = Compound 83405|T109|T121|LAB|NRW|UNK (19XX)|800731|abbcdef
MN = D02.065.589.099.249.150
MN = D02.886.665.074.150
MN = D04.075.080.875.099.221.249.150
PA = Anti-Bacterial Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1973)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-
RN = 5CKP8C2LLI
RR = 34444-01-4 (Cefamandole)
PI = Cephalosporins (1966-1977)
MS = Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.
PM = 84; was see under CEPHALOSPORINS 1978-83
HN = 84(78); was see under CEPHALOSPORINS 1978-83
MR = 20130708
DA = 19770422
DC = 1
DX = 19840101
UI = D002435

*NEWRECORD
RECTYPE = D
MH = Cefatrizine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = BL-S 640|T109|T195|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = BL-S640|T109|T195|LAB|NRW|NLM (1990)|891121|abbcdef
ENTRY = S 640-P|T109|T195|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = S-640P|T109|T195|LAB|NRW|NLM (1990)|891121|abbcdef
ENTRY = SK&F-60771|T109|T195|LAB|NRW|UNK (19XX)|800731|abbcdef
ENTRY = SKF-60771|T109|T195|LAB|NRW|NLM (1990)|891121|abbcdef
ENTRY = BL S 640
ENTRY = BL S640
ENTRY = BLS 640
ENTRY = BLS640
ENTRY = S 640 P
ENTRY = S 640P
ENTRY = S640P
ENTRY = SK&F 60771
ENTRY = SK&F60771
ENTRY = SKF 60771
ENTRY = SKF60771
MN = D02.065.589.099.249.200.165.125
MN = D02.886.665.074.200.165.125
MN = D04.075.080.875.099.221.249.200.165.125
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1975)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1H-1,2,3-triazol-4-ylthio)methyl)-, (6R-(6alpha,7beta(R*)))-
RN = 8P4W949T8K
RR = 51627-14-6 (Cefatrizine)
PI = Cephalosporins (1966-1977)
MS = Orally active semisynthetic cephalosporin antibiotic with broad-spectrum activity.
PM = 91; was see under CEPHALOSPORINS 1978-90
HN = 91(78); was see under CEPHALOSPORINS 1978-90
MR = 20130708
DA = 19770422
DC = 1
DX = 19910101
UI = D002436

*NEWRECORD
RECTYPE = D
MH = Cefazolin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cephazolin|T109|T195|NON|EQV|BAN (19XX)|741111|abbcdef
ENTRY = Ancef|T109|T195|TRD|NRW|UNK (19XX)|800825|abbcdef
ENTRY = Cefamedin|T109|T195|TRD|NRW|NLM (1990)|891121|abbcdef
ENTRY = Cefamezine|T109|T195|TRD|NRW|UNK (19XX)|880423|abbcdef
ENTRY = Cefazolin Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1972)|USP (19XX)|940825|abbcdeeef
ENTRY = Cephamezine|T109|T195|TRD|NRW|UNK (19XX)|880423|abbcdef
ENTRY = Cephazolin Sodium|T109|T195|NON|NRW|BAN (19XX)|940825|abbcdef
ENTRY = Gramaxin|T109|T195|TRD|NRW|NLM (1990)|891121|abbcdef
ENTRY = Kefzol|T109|T195|TRD|NRW|UNK (19XX)|830328|abbcdef
ENTRY = Sodium Cephazolin|T109|T195|NON|NRW|UNK (19XX)|811113|abbcdef
ENTRY = Totacef|T109|T195|TRD|NRW|NLM (1990)|891121|abbcdef
ENTRY = Cephazolin, Sodium
ENTRY = Sodium, Cefazolin
ENTRY = Sodium, Cephazolin
MN = D02.065.589.099.249.160
MN = D02.886.665.074.160
MN = D04.075.080.875.099.221.249.160
PA = Anti-Bacterial Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-, (6R-trans)-
RN = IHS69L0Y4T
RR = 25953-19-9 (Cefazolin)
RR = 27164-46-1 (Cefazolin Sodium)
RR = P380M0454Z
PI = Cephalosporins (1970-1974)
PI = Sulfides (1973-1974)
PI = Tetrazoles (1973-1974)
PI = Thiadiazoles (1973-1974)
MS = A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
PM = 80; was see under CEPHALOSPORINS 1975-79
HN = 80(75); was see under CEPHALOSPORINS 1975-79
MR = 20130708
DA = 19741111
DC = 1
DX = 19800101
UI = D002437

*NEWRECORD
RECTYPE = D
MH = Cefoperazone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cefobid|T109|T195|TRD|NRW|ES|NLM (1992)|US|910225|abbcdeeef
ENTRY = Cefoperazon|T109|T195|NON|EQV|UNK (19XX)|830404|abbcdef
ENTRY = Cefoperazone Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1979)|USP (19XX)|940825|abbcdeeef
ENTRY = Cefoperazone Sodium Salt|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Cfobis|T109|T195|TRD|NRW|FR|041209|abbcdef
ENTRY = Farmasierra Brand of Cefoperazone Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Pfizer Brand of Cefoperazone Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = T-1551|T109|T195|LAB|NRW|UNK (19XX)|830404|abbcdef
ENTRY = T1551|T109|T195|LAB|NRW|UNK (19XX)|830404|abbcdef
ENTRY = Salt, Cefoperazone Sodium
ENTRY = Sodium Salt, Cefoperazone
ENTRY = Sodium, Cefoperazone
ENTRY = T 1551
MN = D02.065.589.099.249.150.160
MN = D02.886.665.074.150.160
MN = D04.075.080.875.099.221.249.150.160
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-
RN = 7U75I1278D
RR = 5FQG9774WD
RR = 62893-19-0 (Cefoperazone)
RR = 62893-20-3 (Na salt)
PI = Cephalosporins (1966-1983)
MS = Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It has been proposed especially against Pseudomonas infections.
PM = 84
HN = 84
MR = 20130708
DA = 19830404
DC = 1
DX = 19840101
UI = D002438

*NEWRECORD
RECTYPE = D
MH = Cefotaxime
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aventis Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Aventis Pharma Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Benaxima|T109|T195|TRD|NRW|MX|041209|abbcdef
ENTRY = Biosint|T109|T195|TRD|NRW|MX|041209|abbcdef
ENTRY = Cefotaxim|T109|T195|NON|EQV|UNK (19XX)|810513|abbcdef
ENTRY = Cefotaxime Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1979)|USP (19XX)|940825|abbcdeeef
ENTRY = Cefradil|T109|T195|TRD|NRW|MX|041209|abbcdef
ENTRY = Cephotaxim|T109|T195|NON|EQV|UNK (19XX)|831020|abbcdef
ENTRY = Claforan|T109|T195|TRD|NRW|AU|CA|ES|FR|IE|MX|NL|UK|US|821123|abbcdeeeeeeeeef
ENTRY = Fotexina|T109|T195|TRD|NRW|MX|041209|abbcdef
ENTRY = Fustery Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Galen Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = HR-756|T109|T195|LAB|NRW|NLM (1990)|891121|abbcdef
ENTRY = Hoechst Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Kendrick|T109|T195|TRD|NRW|MX|041209|abbcdef
ENTRY = Klaforan|T109|T195|TRD|NRW|UNK (19XX)|821123|abbcdef
ENTRY = Liomont Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Merck Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Pisa Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Primafen|T109|T195|TRD|NRW|ES|041209|abbcdef
ENTRY = Ru-24756|T109|T195|LAB|NRW|UNK (19XX)|840305|abbcdef
ENTRY = Taporin|T109|T195|TRD|NRW|MX|041209|abbcdef
ENTRY = Viken Brand of Cefotaxime Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = HR 756
ENTRY = HR756
ENTRY = Ru 24756
ENTRY = Ru24756
ENTRY = Sodium, Cefotaxime
MN = D02.065.589.099.249.190.190
MN = D02.886.665.074.190.190
MN = D04.075.080.875.099.221.249.190.190
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(Z)))-
RN = N2GI8B1GK7
RR = 258J72S7TZ
RR = 63527-52-6 (Cefotaxime)
RR = 64485-93-4 (mono-Na salt)
PI = Cephalosporins (1966-1981)
MS = Semisynthetic broad-spectrum cephalosporin.
PM = 82
HN = 82
MR = 20130708
DA = 19810513
DC = 1
DX = 19820101
UI = D002439

*NEWRECORD
RECTYPE = D
MH = Cefoxitin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cefoxitin Sodium|T109|T195|NON|NRW|BAN (19XX)|FDA SRS (2014)|USAN (1979)|USP (19XX)|940819|abbcdeeeef
ENTRY = MK-306|T109|T195|LAB|NRW|NLM (1990)|891121|abbcdef
ENTRY = MSD Brand of Cefoxitin Sodium|T109|T195|NON|NRW|NLM (2006)|041213|abbcdef
ENTRY = Mefoxin|T109|T195|TRD|NRW|AU|CA|NL|UK|US|810625|abbcdeeeeef
ENTRY = Mefoxitin|T109|T195|TRD|NRW|DE|ES|810427|abbcdeef
ENTRY = Merck Brand of Cefoxitin Sodium|T109|T195|NON|NRW|NLM (2006)|041213|abbcdef
ENTRY = Merck Frosst Brand of Cefoxitin Sodium|T109|T195|NON|NRW|NLM (2006)|041213|abbcdef
ENTRY = Merck Sharp & Dohme Brand of Cefoxitin Sodium|T109|T195|NON|NRW|NLM (2006)|041213|abbcdef
ENTRY = Mfoxin|T109|T195|TRD|NRW|FR|041213|abbcdef
ENTRY = MK 306
ENTRY = MK306
ENTRY = Sodium, Cefoxitin
MN = D02.065.589.099.249.250.222
MN = D02.886.665.074.250.222
MN = D04.075.080.875.099.221.249.250.222
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1973)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)-, (6R-cis)-
RN = 6OEV9DX57Y
RR = 33564-30-6 (Cefoxitin Sodium)
RR = 35607-66-0 (Cefoxitin)
RR = Q68050H03T
PI = Carbamates (1974)
PI = Cephalosporins (1974)
MS = A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
PM = 80; was see under CEPHALOSPORINS 1975-79
HN = 80(75); was see under CEPHALOSPORINS 1975-79
MR = 20130708
DA = 19741119
DC = 1
DX = 19800101
UI = D002440

*NEWRECORD
RECTYPE = D
MH = Cefsulodin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Abbott 46811|T109|T195|LAB|NRW|UNK (19XX)|840524|abbcdef
ENTRY = CGP-7174-E|T109|T195|LAB|NRW|UNK (19XX)|840524|abbcdef
ENTRY = Cefsulodin Monosodium Salt|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Cefsulodin Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1979)|940822|abbcdeef
ENTRY = Monaspor|T109|T195|TRD|NRW|UNK (19XX)|881011|abbcdef
ENTRY = Pyocefal|T109|T195|TRD|NRW|FR|041215|abbcdef
ENTRY = SCE-129|T109|T195|LAB|NRW|UNK (19XX)|840524|abbcdef
ENTRY = Takeda Brand of Cefsulodin Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = CGP 7174 E
ENTRY = CGP7174E
ENTRY = Monosodium Salt, Cefsulodin
ENTRY = SCE 129
ENTRY = SCE129
ENTRY = Salt, Cefsulodin Monosodium
ENTRY = Sodium, Cefsulodin
MN = D02.065.589.099.249.185
MN = D02.886.665.074.185
MN = D04.075.080.875.099.221.249.185
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = Pyridinium, 4-(aminocarbonyl)-1-((2-carboxy-8-oxo-7-((phenylsulfoacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, monosodium salt, (6R-(6alpha,7beta(R*)))-
RN = OV42LHE42B
RR = 2D087186PY
RR = 52152-93-9 (mono-Na salt)
RR = 62587-73-9 (Cefsulodin)
PI = Cephalosporins (1966-1984)
MS = A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.
PM = 85
HN = 85
MR = 20130708
DA = 19840524
DC = 1
DX = 19850101
UI = D002441

*NEWRECORD
RECTYPE = D
MH = Ceftazidime
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Ceftazidime Anhydrous|T109|T195|NON|NRW|FDA SRS (2014)|NLM (2014)|130617|abbcdeef
ENTRY = Ceftazidime Pentahydrate|T109|T195|NON|EQV|FDA SRS (2014)|NLM (2014)|130617|abbcdeef
ENTRY = Fortaz|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Fortum|T109|T195|TRD|NRW|NLM (1997)|960116|abbcdef
ENTRY = GR-20263|T109|T195|LAB|NRW|UNK (19XX)|840524|abbcdef
ENTRY = LY-139381|T109|T195|LAB|NRW|UNK (19XX)|840524|abbcdef
ENTRY = Tazidime|T109|T195|TRD|NRW|NLM (1990)|890607|abbcdef
ENTRY = Anhydrous, Ceftazidime
ENTRY = GR 20263
ENTRY = GR20263
ENTRY = LY 139381
ENTRY = LY139381
ENTRY = Pentahydrate, Ceftazidime
MN = D02.065.589.099.249.210.150
MN = D02.886.665.074.210.150
MN = D04.075.080.875.099.221.249.210.150
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1980)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-
RN = 9M416Z9QNR
RR = 78439-06-2 (Ceftazidime)
RR = DZR1ENT301
PI = Cephalosporins (1966-1984)
MS = Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
PM = 85
HN = 85
MR = 20130708
DA = 19840524
DC = 1
DX = 19850101
UI = D002442

*NEWRECORD
RECTYPE = D
MH = Ceftriaxone
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Benaxona|T109|T195|TRD|NRW|MX|041215|abbcdef
ENTRY = Boehringer Mannheim Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Cefatriaxone|T109|T195|NON|EQV|UNK (19XX)|850730|abbcdef
ENTRY = Cefaxona|T109|T195|TRD|NRW|MX|041215|abbcdef
ENTRY = Ceftrex|T109|T195|TRD|NRW|MX|041215|abbcdef
ENTRY = Ceftriaxon|T109|T195|NON|EQV|UNK (19XX)|850606|abbcdef
ENTRY = Ceftriaxon Curamed|T109|T195|TRD|NRW|DE|041215|abbcdef
ENTRY = Ceftriaxon Hexal|T109|T195|TRD|NRW|DE|041215|abbcdef
ENTRY = Ceftriaxona Andreu|T109|T195|TRD|NRW|ES|041215|abbcdef
ENTRY = Ceftriaxona LDP Torlan|T109|T195|TRD|NRW|ES|041215|abbcdef
ENTRY = Ceftriaxone Irex|T109|T195|TRD|NRW|FR|041215|abbcdef
ENTRY = Ceftriaxone Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1981)|USP (19XX)|941114|abbcdeeef
ENTRY = Ceftriaxone Sodium, Anhydrous|T109|T195|NON|NRW|NLM (2002)|001130|abbcdef
ENTRY = Ceftriaxone, Disodium Salt|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Ceftriaxone, Disodium Salt, Hemiheptahydrate|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Columbia Brand of Ceftriaxone|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Curamed Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Fustery Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Galen Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Hexal Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Hoffman-La Roche Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Inibsa Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Irex Brand of Ceftriaxone|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Lendacin|T109|T195|TRD|NRW|NLM (2003)|020315|abbcdef
ENTRY = Longacef|T109|T195|TRD|NRW|NLM (1992)|910114|abbcdef
ENTRY = Longaceph|T109|T195|TRD|NRW|NLM (1992)|910114|abbcdef
ENTRY = Pisa Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Ro 13-9904|T109|T195|LAB|NRW|UNK (19XX)|850606|abbcdef
ENTRY = Ro-13-9904|T109|T195|LAB|NRW|UNK (19XX)|850606|abbcdef
ENTRY = Ro13-9904|T109|T195|LAB|NRW|UNK (19XX)|850606|abbcdef
ENTRY = Rocefalin|T109|T195|TRD|NRW|ES|041215|abbcdef
ENTRY = Rocefin|T109|T195|TRD|NRW|UNK (19XX)|850606|abbcdef
ENTRY = Rocephin|T109|T195|TRD|NRW|AU|CA|DE|IE|MX|NL|UK|US|850606|abbcdeeeeeeeef
ENTRY = Rocephine|T109|T195|TRD|NRW|FR|041215|abbcdef
ENTRY = Roche Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Syntex Brand of Ceftriaxone Sodium|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Tacex|T109|T195|TRD|NRW|MX|041215|abbcdef
ENTRY = Terbac|T109|T195|TRD|NRW|MX|041215|abbcdef
ENTRY = Anhydrous Ceftriaxone Sodium
ENTRY = Hoffman La Roche Brand of Ceftriaxone Sodium
ENTRY = Ro 13 9904
ENTRY = Ro 139904
ENTRY = Ro13 9904
ENTRY = Ro139904
ENTRY = Sodium, Ceftriaxone
MN = D02.065.589.099.249.190.190.155
MN = D02.886.665.074.190.190.155
MN = D04.075.080.875.099.221.249.190.190.155
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, (6R-(6alpha,7beta(Z)))-
RN = 75J73V1629
RR = 023Z5BR09K
RR = 104376-79-6 (di-Na salt)
RR = 73384-59-5 (Ceftriaxone)
RR = 74578-69-1 (di-Na salt, anhydrous)
PI = Cefotaxime (1982-1985)
PI = Cephalosporins (1966-1981)
MS = A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
PM = 86
HN = 86
MR = 20130708
DA = 19850606
DC = 1
DX = 19860101
UI = D002443

*NEWRECORD
RECTYPE = D
MH = Cefuroxime
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cephuroxime|T109|T195|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = Ketocef|T109|T195|TRD|NRW|UNK (19XX)|830915|abbcdef
ENTRY = Zinacef|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
MN = D02.065.589.099.249.190.190.165
MN = D02.886.665.074.190.190.165
MN = D04.075.080.875.099.221.249.190.190.165
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1984)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-
RN = O1R9FJ93ED
RR = 55268-75-2 (Cefuroxime)
PI = Cephalosporins (1966-1979)
MS = Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
PM = 91; was see under CEPHALOSPORINS 1980-90
HN = 91(80); was see under CEPHALOSPORINS 1980-90
MR = 20130708
DA = 19790301
DC = 1
DX = 19910101
UI = D002444

*NEWRECORD
RECTYPE = D
MH = Celiac Artery
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, Celiac
ENTRY = Artery, Celiac
ENTRY = Celiac Arteries
MN = A07.231.114.207
MH_TH = NLM (1966)
ST = T023
MS = The arterial trunk that arises from the abdominal aorta and after a short course divides into the left gastric, common hepatic and splenic arteries.
MR = 19920507
DA = 19990101
DC = 1
UI = D002445

*NEWRECORD
RECTYPE = D
MH = Celiac Disease
DE = CELIAC DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Gluten Enteropathy|T047|NON|EQV|GHR (2014)|UNK (19XX)|810519|abcdeef
PRINT ENTRY = Sprue, Celiac|T047|NON|EQV|NLM (2004)|030501|abcdef
PRINT ENTRY = Sprue, Nontropical|T047|NON|EQV|NLM (2004)|030501|abcdef
ENTRY = Celiac Sprue|T047|NON|EQV|GHR (2014)|OMIM (2013)|111115|abcdeef
ENTRY = Gluten-Sensitive Enteropathy|T047|NON|EQV|NLM (2004)|OMIM (2013)|030501|abcdeef
ENTRY = Sprue|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Disease, Celiac
ENTRY = Enteropathies, Gluten
ENTRY = Enteropathies, Gluten-Sensitive
ENTRY = Enteropathy, Gluten
ENTRY = Enteropathy, Gluten-Sensitive
ENTRY = Gluten Enteropathies
ENTRY = Gluten Sensitive Enteropathy
ENTRY = Gluten-Sensitive Enteropathies
ENTRY = Nontropical Sprue
MN = C06.405.469.637.250
MN = C18.452.603.250
FX = Enteropathy-Associated T-Cell Lymphoma
FX = Sprue, Tropical
FX = Wheat Hypersensitivity
MH_TH = GHR (2014)
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
ST = T047
AN = do not confuse with SPRUE, TROPICAL
MS = A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D002446

*NEWRECORD
RECTYPE = D
MH = Celiac Plexus
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
PRINT ENTRY = Coeliac Plexus|T023|NON|EQV|NLM (1994)|921001|abcdef
PRINT ENTRY = Plexus Coeliacus|T023|NON|EQV|NLM (1994)|921001|abcdef
PRINT ENTRY = Solar Plexus|T023|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Coeliacus, Plexus
ENTRY = Plexus, Celiac
ENTRY = Plexus, Coeliac
ENTRY = Plexus, Solar
MN = A08.800.050.050.150
MN = A08.800.800.060.150
MH_TH = NLM (1966)
ST = T023
AN = the largest autonomic plexus; in the abdomen
MS = A complex network of nerve fibers including sympathetic and parasympathetic efferents and visceral afferents. The celiac plexus is the largest of the autonomic plexuses and is located in the abdomen surrounding the celiac and superior mesenteric arteries.
MR = 19930618
DA = 19990101
DC = 1
UI = D002447

*NEWRECORD
RECTYPE = D
MH = Cell Adhesion
AQ = DE ES GE IM PH RE
ENTRY = Adhesion, Cell
ENTRY = Adhesions, Cell
ENTRY = Cell Adhesions
MN = G04.299.117
MH_TH = NLM (1970)
ST = T043
AN = NIM; permitted with micro-organisms but BACTERIAL ADHESION is available
PI = Cytology (1966-1969)
MS = Adherence of cells to surfaces or to other cells.
PM = 72
HN = 72(70)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19720101
UI = D002448

*NEWRECORD
RECTYPE = D
MH = Cell Aggregation
AQ = DE ES GE IM PH RE
ENTRY = Aggregation, Cell
ENTRY = Aggregations, Cell
ENTRY = Cell Aggregations
MN = G04.299.283.251
MH_TH = NLM (1965)
ST = T043
AN = NIM; not for micro-organisms
MS = The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type.
PM = 68
HN = 68(65)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D002449

*NEWRECORD
RECTYPE = D
MH = Cell Communication
AQ = DE ES GE IM PH RE
PRINT ENTRY = Cell Interaction|T043|NON|EQV|NLM (1998)|960724|abcdef
PRINT ENTRY = Cell-to-Cell Interaction|T043|NON|EQV|NLM (1998)|960802|CELL CELL INTERACTION|abcdefv
ENTRY = Cell Communications
ENTRY = Cell Interactions
ENTRY = Cell to Cell Interaction
ENTRY = Cell-to-Cell Interactions
ENTRY = Communication, Cell
ENTRY = Communications, Cell
ENTRY = Interaction, Cell
ENTRY = Interaction, Cell-to-Cell
ENTRY = Interactions, Cell
ENTRY = Interactions, Cell-to-Cell
MN = G04.299.122
FX = Intercellular Junctions
FX = Second Messenger Systems
FX = Signal Transduction
MH_TH = NLM (1978)
ST = T043
AN = not for micro-organisms
PI = Intercellular Junctions (1970-1977)
MS = Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 20080708
DA = 19770516
DC = 1
DX = 19780101
UI = D002450

*NEWRECORD
RECTYPE = D
MH = Cell Compartmentation
AQ = DE ES GE IM PH RE
ENTRY = Cell Compartmentations
ENTRY = Compartmentation, Cell
ENTRY = Compartmentations, Cell
MN = G04.299.125
MH_TH = NLM (1978)
ST = T043
AN = permitted with micro-organisms
MS = A partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 20080708
DA = 19770301
DC = 1
DX = 19780101
UI = D002451

*NEWRECORD
RECTYPE = D
MH = Cell Count
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Cell Density|T081|NON|NRW|NLM (1993)|911106|abcdef
PRINT ENTRY = Cell Number|T034|NON|EQV|UNK (19XX)|790524|abcdef
ENTRY = Cell Counts
ENTRY = Cell Densities
ENTRY = Cell Numbers
ENTRY = Count, Cell
ENTRY = Counts, Cell
ENTRY = Densities, Cell
ENTRY = Density, Cell
ENTRY = Number, Cell
ENTRY = Numbers, Cell
MN = E01.370.225.500.195
MN = E05.200.500.195
MN = E05.242.195
MN = G04.170
FX = Blood Cell Count
FX = Sperm Count
MH_TH = NLM (1969)
ST = T034
AN = usually NIM; not for micro-organisms
PI = Cytology (1966-1968)
MS = The number of CELLS of a specific kind, usually measured per unit volume or area of sample.
OL = use CELL COUNT to search CELL NUMBER 1978-79
PM = 73; CELL NUMBER was heading 1978-79
HN = 73(69); CELL NUMBER was heading 1978-79
CATSH = CAT LIST
MR = 20150601
DA = 19990101
DC = 1
DX = 19730101
UI = D002452

*NEWRECORD
RECTYPE = D
MH = Cell Cycle
AQ = DE GE IM PH RE
ENTRY = Cell Division Cycle|T043|NON|EQV|NLM (2004)|030519|abcdef
ENTRY = Cell Cycles
ENTRY = Cell Division Cycles
ENTRY = Cycle, Cell
ENTRY = Cycle, Cell Division
ENTRY = Cycles, Cell
ENTRY = Cycles, Cell Division
ENTRY = Division Cycle, Cell
ENTRY = Division Cycles, Cell
MN = G04.299.134
FX = Cell Cycle Proteins
FX = Genes, cdc
MH_TH = NLM (1978)
ST = T043
AN = coordinate with specific cell /cytol; permitted with microorganisms
PI = Cell Division (1966-1977)
PI = Meiosis (1968-1977)
PI = Mitosis (1968-1977)
MS = The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 20080708
DA = 19770504
DC = 1
DX = 19780101
UI = D002453

*NEWRECORD
RECTYPE = D
MH = Cell Differentiation
DE = CELL DIFFER
AQ = DE GE IM PH RE
ENTRY = Differentiation, Cell|T043|NON|EQV|NLM (1992)|901010|DIFFER CELL|abcdefv
ENTRY = Cell Differentiations
ENTRY = Differentiations, Cell
MN = G04.299.151
FX = Antigens, Differentiation
FX = Cell Lineage
MH_TH = NLM (1964)
ST = T043
AN = not for micro-organisms; CELL DEDIFFERENTIATION and CELL TRANSDIFFERENTIATION are also available
MS = Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.
PM = 66
HN = 66(64)
CATSH = CAT LIST
MR = 20140613
DA = 19990101
DC = 1
DX = 19660101
UI = D002454

*NEWRECORD
RECTYPE = D
MH = Cell Division
AQ = DE ES GE IM PH RE
PRINT ENTRY = M Phase|T043|NRW|NLM (1991)|900220|abdef
ENTRY = Cell Division Phase|T043|NON|NRW|NLM (2005)|040316|abcdef
ENTRY = Cell Divisions|T043|NON|EQV|NLM (2005)|040419|abcdef
ENTRY = Division Phase, Cell
ENTRY = Division, Cell
ENTRY = Divisions, Cell
ENTRY = M Phases
ENTRY = Phase, Cell Division
ENTRY = Phase, M
ENTRY = Phases, M
MN = G04.299.134.220
MN = G04.299.233.750.500
MN = G05.355.105
MN = G07.700.320.249.410.750.500
FX = Cell Cycle Proteins
FX = Genes, cdc
MH_TH = NLM (1966)
ST = T043
AN = coordinate with specific cell /cytol; permitted with microorganisms; for cell division of cytoplasm only, use CYTOKINESIS; note X ref M PHASE: MITOTIC M PHASE and MEIOTIC M PHASE are also available
MS = The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.
PM = 1963; for M PHASE see MITOSIS 1991-2004
HN = 1963 for M PHASE use MITOSIS 1991-2004
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
UI = D002455

*NEWRECORD
RECTYPE = D
MH = Cell Extracts
AQ = AD AE AG AI AN CH CL CS CT EC GE HI IM IP PD PK PO RE SD SE ST TO TU UR
ENTRY = Extracts, Cell
MN = D20.777.162
MH_TH = NLM (1977)
ST = T026
RN = 0
AN = extracts of cells or cell fractions containing uncharacterized factors; do not confuse with chemical substances "extracted" from cells; not for micro-organisms
PI = Tissue Extracts (1966-1976)
MS = Preparations of cell constituents or subcellular materials, isolates, or substances.
PM = 91; was see under TISSUE EXTRACTS 1977-90
HN = 91(77); was see under TISSUE EXTRACTS 1977-90
MR = 20150331
DA = 19760413
DC = 1
DX = 19910101
UI = D002457

*NEWRECORD
RECTYPE = D
MH = Cell Fractionation
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Cell Fractionations
ENTRY = Fractionation, Cell
ENTRY = Fractionations, Cell
MN = E05.242.251
FX = Subcellular Fractions
MH_TH = NLM (1971)
ST = T059
AN = do not confuse with CELL SEPARATION; NIM, no qualif; when IM, /instrum /methods permitted; permitted with micro-organisms
PI = Cytology (1966-1970)
MS = Techniques to partition various components of the cell into SUBCELLULAR FRACTIONS.
PM = 73
HN = 73(71)
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19730101
UI = D002458

*NEWRECORD
RECTYPE = D
MH = Cell Fusion
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Cell Fusions
ENTRY = Fusion, Cell
ENTRY = Fusions, Cell
MN = E05.242.307
MN = G04.299.217
FX = Hybrid Cells
MH_TH = NLM (1971)
ST = T043
ST = T062
AN = NIM; not for micro-organisms; somatic cells only: not for sperm-ovum fusion ( = fertilization)
PI = Cytology (1966-1970)
MS = Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization.
PM = 73
HN = 73(71)
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19730101
UI = D002459

*NEWRECORD
RECTYPE = D
MH = Cell Line
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Cell Lines
ENTRY = Line, Cell
ENTRY = Lines, Cell
MN = A11.251.210
MH_TH = NLM (1969)
ST = T025
AN = almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add tissue or organ; policy: Manual 21.57, 22.26.1
PI = Tissue Culture (1966-1968)
MS = Established cell cultures that have the potential to propagate indefinitely.
PM = 72
HN = 72(69)
MR = 20030730
DA = 19990101
DC = 1
DX = 19720101
UI = D002460

*NEWRECORD
RECTYPE = D
MH = Cell Line, Transformed
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Transformed Cell Line|T025|NON|EQV|UNK (19XX)|870511|abcdef
ENTRY = Cell Lines, Transformed
ENTRY = Transformed Cell Lines
MN = A11.251.210.172
FX = Cell Transformation, Neoplastic
FX = Cell Transformation, Viral
MH_TH = NLM (1988)
ST = T025
AN = almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add tissue or organ
PI = Cell Line (1966-1987)
PI = Cell Transformation, Neoplastic (1966-1987)
PI = Cell Transformation, Viral (1978-1987)
PI = Cells, Cultured (1966-1987)
PI = Tissue Culture (1966-1976)
MS = Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals.
PM = 88
HN = 88
MR = 20030730
DA = 19870511
DC = 1
DX = 19880101
UI = D002461

*NEWRECORD
RECTYPE = D
MH = Cell Membrane
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Plasma Membrane|T026|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Cytoplasmic Membrane|T026|NON|EQV|NLM (2003)|020110|abcdef
ENTRY = Cell Membranes
ENTRY = Cytoplasmic Membranes
ENTRY = Membrane, Cell
ENTRY = Membrane, Cytoplasmic
ENTRY = Membrane, Plasma
ENTRY = Membranes, Cell
ENTRY = Membranes, Cytoplasmic
ENTRY = Membranes, Plasma
ENTRY = Plasma Membranes
MN = A11.284.149
FX = Intracellular Membranes
FX = Membrane Fluidity
FX = Membrane Fusion
FX = Membrane Glycoproteins
FX = Membrane Lipids
FX = Membrane Potentials
FX = Membrane Proteins
FX = Nuclear Envelope
FX = Osmotic Fragility
FX = Synaptic Membranes
MH_TH = NLM (1964)
ST = T026
AN = coordinate with specific cell /ultrastruct; permitted with micro-organisms
MS = The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.
PM = 65
HN = 65(64)
MR = 20050630
DA = 19990101
DC = 1
DX = 19650101
UI = D002462

*NEWRECORD
RECTYPE = D
MH = Cell Membrane Permeability
AQ = DE ES GE IM PH RE
PRINT ENTRY = Permeability, Cell Membrane|T043|NON|EQV|UNK (19XX)|740329|abcdef
MN = G03.495.166.335
MN = G04.175
FX = Ionophores
MH_TH = NLM (1965)
ST = T043
AN = coord with substance /pharmacokin (IM) or /metab (IM); for cell membrane only; intracellular membrane permeability: index INTRACELLULAR MEMBRANES + specific organelle + PERMEABILITY
MS = A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19650101
UI = D002463

*NEWRECORD
RECTYPE = D
MH = Cell Migration Inhibition
DE = CELL MIGRATION INHIB
AQ = DE GE IM PH RE
ENTRY = Chemotaxis Inhibition|T059|NON|EQV|NLM (2008)|070126|abcdef
ENTRY = Chemotaxis Inhibitions
ENTRY = Inhibition, Chemotaxis
ENTRY = Inhibitions, Chemotaxis
MN = G04.299.283.337
FX = Cell Migration Assays
FX = Leukocyte Migration-Inhibitory Factors
FX = Macrophage Migration-Inhibitory Factors
MH_TH = NLM (1971)
ST = T059
AN = coordinate with specific cell/immunol; do not confuse with LEUKOCYTE ADHERENCE INHIBITION TEST
PI = Cell Movement (1968-1970)
PI = Hypersensitivity, Delayed (1966-1970)
PI = Lymphocytes/immunology (1966-1970)
PI = Tissue Culture (1966-1970)
MS = Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms.
PM = 72
HN = 72(71)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19720101
UI = D002464

*NEWRECORD
RECTYPE = D
MH = Cell Movement
AQ = DE ES GE IM PH RE
PRINT ENTRY = Cell Migration|T043|NON|NRW|NLM (2007)|060118|abcdef
PRINT ENTRY = Locomotion, Cell|T043|NON|NRW|UNK (19XX)|850225|abcdef
PRINT ENTRY = Migration, Cell|T043|NON|NRW|UNK (19XX)|850225|abcdef
PRINT ENTRY = Motility, Cell|T043|NON|NRW|UNK (19XX)|850225|abcdef
PRINT ENTRY = Movement, Cell|T043|NON|EQV|UNK (19XX)|850225|abcdef
ENTRY = Cell Locomotion
ENTRY = Cell Motility
ENTRY = Cell Movements
ENTRY = Movements, Cell
MN = G04.299.283
MN = G07.700.560.500.180
FX = Cell Tracking
MH_TH = NLM (1968)
ST = T043
AN = not for microorganisms; do not confuse with CYTOKINESIS or CYTOPLASMIC STREAMING
PI = Cytology (1966-1967)
PI = specific cell or tissue/cytology (1966-1967)
MS = The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
PM = 70
HN = 70(68)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19700101
UI = D002465

*NEWRECORD
RECTYPE = D
MH = Cell Nucleolus
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Plasmosome|T026|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Cell Nucleoli|T026|NON|EQV|NLM (1995)|940513|abcdef
ENTRY = Nucleoli, Cell
ENTRY = Nucleolus, Cell
ENTRY = Plasmosomes
MN = A11.284.430.106.279.345.175
FX = Nucleolus Organizer Region
MH_TH = NLM (1965)
ST = T026
AN = A 11 qualif except /cytol; /genet permitted
MS = Within most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA (RNA, RIBOSOMAL) are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. (Singleton & Sainsbury, Dictionary of Microbiology & Molecular Biology, 2d ed)
PM = 67
HN = 67(65)
MR = 20030709
DA = 19990101
DC = 1
DX = 19670101
UI = D002466

*NEWRECORD
RECTYPE = D
MH = Cell Nucleus
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE UL US VI
ENTRY = Cell Nuclei|T026|NON|EQV|NLM (1995)|940513|abcdef
ENTRY = Nuclei, Cell
ENTRY = Nucleus, Cell
MN = A11.284.430.106
MN = A11.284.430.214.190.875.117
FX = Cell Compartmentation
FX = Karyometry
EC = transplantation:Nuclear Transfer Techniques
MH_TH = NLM (1966)
ST = T026
AN = A 11 qualif except /cytol; /genet permitted
MS = Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
MR = 20060705
DA = 19990101
DC = 1
UI = D002467

*NEWRECORD
RECTYPE = D
MH = Cell Physiological Phenomena
AQ = DE GE IM PH RE
PRINT ENTRY = Cell Physiology|T043|NON|EQV|NLM (1966)|990101|CELL PHYSIOL|abcdefv
ENTRY = Cell Physiological Phenomenon|T043|NON|EQV|NLM (2009)|080626|abcdef
ENTRY = Physiology, Cell|T043|NON|EQV|NLM (1999)|980401|PHYSIOL CELL|abcdefv
ENTRY = Phenomena, Cell Physiological
ENTRY = Phenomenon, Cell Physiological
MN = G04
RH = G4 - CELL PHYSIOLOGICAL PHENOMENA
MH_TH = NLM (2009)
ST = T043
AN = general or unspecified; prefer specifics; DF: CELL PHYSIOL
PI = Cells/physiology (1968-1997)
MS = Cellular processes, properties, and characteristics.
PM = 2009; see CELL PHYSIOLOGY 1998-2008
HN = 2009 (1998)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19980101
UI = D002468

*NEWRECORD
RECTYPE = D
MH = Cell Separation
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Cell Isolation|T059|NON|EQV|UNK (19XX)|750101|CELL ISOL|abcdefv
PRINT ENTRY = Cell Segregation|T059|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Isolation, Cell|T059|NON|EQV|UNK (19XX)|750101|ISOL CELL|abcdefv
ENTRY = Cell Isolations
ENTRY = Cell Segregations
ENTRY = Cell Separations
ENTRY = Isolations, Cell
ENTRY = Segregation, Cell
ENTRY = Segregations, Cell
ENTRY = Separation, Cell
ENTRY = Separations, Cell
MN = E01.370.225.500.363
MN = E05.200.500.363
MN = E05.242.363
FX = Blood Component Removal
FX = Plasmapheresis
MH_TH = NLM (1972)
ST = T059
AN = separation of 2 or more cells; do not confuse with CELL FRACTIONATION; NIM, no qualif; when IM, qualif permitted; not for micro-organisms; flow cell sorting & fluorescence- activated cell sorting: coord with FLOW CYTOMETRY
PM = 74
HN = 74(72)
CATSH = CAT LIST
MR = 20150601
DA = 19990101
DC = 1
DX = 19740101
UI = D002469

*NEWRECORD
RECTYPE = D
MH = Cell Survival
AQ = DE ES GE IM PH RE
PRINT ENTRY = Cell Viability|T043|NON|EQV|NLM (1991)|900305|abcdef
ENTRY = Cell Viabilities
ENTRY = Survival, Cell
ENTRY = Viabilities, Cell
ENTRY = Viability, Cell
MN = G04.299.316
MH_TH = NLM (1971)
ST = T043
AN = NIM; not for micro-organisms
PI = Cytology (1966-1970)
PI = specific cell (1966-1970)
MS = The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
PM = 76; was see under CYTOLOGY 1975
HN = 76(71); was see under CYTOLOGY 1975
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19760101
UI = D002470

*NEWRECORD
RECTYPE = D
MH = Cell Transformation, Neoplastic
DE = CELL TRANSFORM NEOPL
AQ = CH CI CL DE GE IM ME PA RE SE UL
PRINT ENTRY = Neoplastic Transformation, Cell|T191|NON|EQV|UNK (19XX)|740329|NEOPL TRANSFORM CELL|abcdefv
ENTRY = Neoplastic Cell Transformation|T191|NON|EQV|UNK (19XX)|740329|NEOPL CELL TRANSFORM|abcdefv
ENTRY = Transformation, Neoplastic Cell|T191|NON|EQV|NLM (1995)|930913|TRANSFORM NEOPL CELL|abcdefv
ENTRY = Tumorigenic Transformation|T191|NON|EQV|NLM (2012)|101215|abcdef
ENTRY = Cell Neoplastic Transformation
ENTRY = Cell Neoplastic Transformations
ENTRY = Cell Transformations, Neoplastic
ENTRY = Neoplastic Cell Transformations
ENTRY = Neoplastic Transformations, Cell
ENTRY = Transformation, Cell Neoplastic
ENTRY = Transformation, Tumorigenic
ENTRY = Transformations, Cell Neoplastic
ENTRY = Transformations, Neoplastic Cell
ENTRY = Transformations, Tumorigenic
ENTRY = Tumorigenic Transformations
MN = C04.697.098.500
MN = C23.550.727.098.500
FX = Antigens, Differentiation
MH_TH = NLM (1968)
ST = T191
AN = do not confuse with CELL DIFFERENTIATION, a normal process in morphogenesis
PI = Neoplasms (1966-1967)
PI = Neoplasms, Experimental (1966-1967)
MS = Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
PM = 70
HN = 70(68)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19700101
UI = D002471

*NEWRECORD
RECTYPE = D
MH = Cell Transformation, Viral
DE = CELL TRANSFORM VIRAL
AQ = DE ES GE IM PH RE
ENTRY = Transformation, Viral Cell|T045|NON|EQV|NLM (1995)|930913|TRANSFORM VIRAL CELL|abcdefv
ENTRY = Viral Cell Transformation|T045|NON|EQV|NLM (1995)|930913|VIRAL CELL TRANSFORM|abcdefv
ENTRY = Cell Transformations, Viral
ENTRY = Transformations, Viral Cell
ENTRY = Viral Cell Transformations
MN = C04.697.098.500.160
MN = C23.550.727.098.500.160
MN = G06.590.875.210
MN = G06.920.875.210
FX = Antigens, Viral, Tumor
MH_TH = NLM (1978)
ST = T045
AN = do not confuse with CYTOPATHOGENIC EFFECT, VIRAL: see scope notes; DF: CELL TRANSFORM VIRAL
PI = Cell Transformation, Neoplastic (1968-1977)
PI = Cytopathogenic Effect, Viral (1966-1967)
PI = Neoplasms, Experimental (1966-1967)
MS = An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.
PM = 78
HN = 78
CATSH = CAT LIST
MR = 20130708
DA = 19770513
DC = 1
DX = 19780101
UI = D002472

*NEWRECORD
RECTYPE = D
MH = Cell Wall
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Cell Walls
ENTRY = Wall, Cell
ENTRY = Walls, Cell
MN = A11.284.183
MH_TH = NLM (1966)
ST = T026
MS = The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents.
PM = 67
HN = 67(66)
MR = 20050630
DA = 19990101
DC = 1
DX = 19670101
UI = D002473

*NEWRECORD
RECTYPE = D
MH = Cell-Free System
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Cellfree System|T026|T075|NON|EQV|UNK (19XX)|771207|abbcdef
ENTRY = Cell Free System
ENTRY = Cell-Free Systems
ENTRY = Cellfree Systems
ENTRY = System, Cell-Free
ENTRY = System, Cellfree
ENTRY = Systems, Cell-Free
ENTRY = Systems, Cellfree
MN = A11.284.835.168
MH_TH = NLM (1967)
ST = T026
ST = T075
AN = for study of subcellular fractions; not for micro-organisms; NIM; use A 11 qualif discreetly
MS = A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p166)
PM = 91; was see under SUBCELLULAR FRACTIONS 1967-90
HN = 91(67); was see under SUBCELLULAR FRACTIONS 1967-90
MR = 20000622
DA = 19990101
DC = 1
DX = 19910101
UI = D002474

*NEWRECORD
RECTYPE = D
MH = Cellobiose
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = 4-O-beta-D-Glucopyranosyl-D-glucopyranose|T118|T123|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = 4 O beta D Glucopyranosyl D glucopyranose
MN = D09.698.365.180.180
MN = D09.698.629.305.200
MH_TH = NLM (1979)
ST = T118
ST = T123
N1 = D-Glucopyranose, 4-O-beta-D-glucopyranosyl-
RN = 16462-44-5
PI = Disaccharides (1966-1978)
MS = A disaccharide consisting of two glucose units in beta (1-4) glycosidic linkage. Obtained from the partial hydrolysis of cellulose.
PM = 91; was see under DISACCHARIDES 1979-90
HN = 91(79); was see under DISACCHARIDES 1979-90
MR = 20040707
DA = 19771209
DC = 1
DX = 19910101
UI = D002475

*NEWRECORD
RECTYPE = D
MH = Cellophane
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Cellophanes
MN = D25.720.099.500.252
MN = J01.637.051.720.099.500.252
MN = J01.637.118
MH_TH = NLM (1966)
ST = T073
ST = T122
N1 = Cellophane
RN = 9005-81-6
AN = D25-26 qualif
MS = A generic name for film produced from wood pulp by the viscose process. It is a thin, transparent sheeting of regenerated cellulose, moisture-proof and sometimes dyed, and used chiefly as food wrapping or as bags for dialysis. (Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
MR = 20060705
DA = 19990101
DC = 1
UI = D002476

*NEWRECORD
RECTYPE = D
MH = Cells
AQ = CH CL CY DE EN IM ME MI PA PS RA RE RI SE UL US VI
ENTRY = Cell
MN = A11
RH = A11 - ANATOMY-CELLS
EC = physiology:Cell Physiological Phenomena
EC = transplantation:Cell Transplantation
MH_TH = NLM (1972)
ST = T025
AN = general; prefer specific cell or specific anatomical term or organism with /cytol; cell stages = CELL CYCLE
PI = Cytology (1966-1971)
MS = The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.
OL = pre-explosion = CELLS (PX)
PM = 72; was see under CYTOLOGY 1963-71
HN = 72; was see under CYTOLOGY 1963-71
MR = 20080710
DA = 19990101
DC = 1
DX = 19720101
UI = D002477

*NEWRECORD
RECTYPE = D
MH = Cells, Cultured
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Cultured Cells|T025|NON|EQV|UNK (19XX)|870508|abcdef
ENTRY = Cell, Cultured
ENTRY = Cultured Cell
MN = A11.251
FX = Cell Culture Techniques
FX = Coculture Techniques
FX = Diffusion Chambers, Culture
MH_TH = NLM (1972)
ST = T025
AN = note category: do not confuse with CELL CULTURE TECHNIQUES (Cat E); not for bact or other micro-organisms; almost always NIM with no subheadings; check HUMANS or ANIMALS; do not routinely add tissue or organ; TUMOR CELLS, CULTURED is available
PI = Tissue Culture (1966-1971)
MS = Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
PM = 72
HN = 72
MR = 20150623
DA = 19990101
DC = 1
DX = 19720101
UI = D002478

*NEWRECORD
RECTYPE = D
MH = Inclusion Bodies
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
PRINT ENTRY = Cellular Inclusions|T026|NON|EQV|NLM (1994)|921230|abcdef
PRINT ENTRY = Cytoplasmic Inclusions|T026|NON|NRW|NLM (1994)|930222|abcdef
ENTRY = Bodies, Inclusion
ENTRY = Body, Inclusion
ENTRY = Cellular Inclusion
ENTRY = Cytoplasmic Inclusion
ENTRY = Inclusion Body
ENTRY = Inclusion, Cellular
ENTRY = Inclusion, Cytoplasmic
ENTRY = Inclusions, Cellular
ENTRY = Inclusions, Cytoplasmic
MN = A11.284.420
MH_TH = NLM (1970)
ST = T026
AN = for bacteria, coordinate IM with specific bacterium (IM); for viruses, INCLUSION BODIES, VIRAL is available
PI = Cytoplasmic Granules (1966-1969)
MS = A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or MALLORY BODIES), within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed)
OL = use INCLUSION BODIES to search CELLULAR INCLUSIONS 1972-93 (as Prov 1970-71)
PM = 94; was CELLULAR INCLUSIONS 1972-93; INCLUSION BODIES was see CELLULAR INCLUSIONS 1972-93
HN = 94; was CELLULAR INCLUSIONS 1970-93 (Prov 1970-71); INCLUSION BODIES was see CELLULAR INCLUSIONS 1972-93
MR = 20110624
DA = 19990101
DC = 1
DX = 19720101
UI = D002479

*NEWRECORD
RECTYPE = D
MH = Cellulase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Endo-1,4-beta-Glucanase|T116|T126|NON|EQV|UNK (19XX)|760523|ENDO BETA GLUCANASE 01 04|abbcdefs
ENTRY = Cellulysin|T116|T126|NON|EQV|UNK (19XX)|821124|abbcdef
ENTRY = Endoglucanase|T116|T126|NON|EQV|NLM (1990)|890609|abbcdef
ENTRY = Endoglucanase A|T116|T126|NON|NRW|UNK (19XX)|861118|abbcdef
ENTRY = Endoglucanase C|T116|T126|NON|NRW|UNK (19XX)|861201|abbcdef
ENTRY = Endoglucanase E|T116|T126|NON|NRW|NLM (1990)|890609|abbcdef
ENTRY = Endoglucanase IV|T116|T126|NON|NRW|NLM (1992)|910114|abbcdef
ENTRY = Endoglucanase Y|T116|T126|NON|NRW|UNK (19XX)|870810|abbcdef
ENTRY = beta-1,4-Glucan-4-Glucanohydrolase|T116|T126|NON|EQV|UNK (19XX)|800804|abbcdef
ENTRY = Endo 1,4 beta Glucanase
ENTRY = beta 1,4 Glucan 4 Glucanohydrolase
MN = D08.811.277.450.420.200.200
MH_TH = NLM (1973)
ST = T116
ST = T126
N1 = 1,4-(1,3;1,4)-beta-D-Glucan-4-glucanohydrolase
RN = EC 3.2.1.4
AN = CELLULASES is also available
PI = Glycoside Hydrolases (1966-1972)
MS = An endocellulase with specificity for the hydrolysis of 1,4-beta-glucosidic linkages in CELLULOSE, lichenin, and cereal beta-glucans.
PM = 77
HN = 77(73)
MR = 20030709
DA = 19990101
DC = 1
DX = 19770101
UI = D002480

*NEWRECORD
RECTYPE = D
MH = Cellulitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Phlegmon|T046|NON|NRW|UNK (19XX)|771123|abcdef
MN = C01.539.800.130
MN = C01.539.830.200
MN = C17.300.185
MN = C23.550.470.756.200
MH_TH = NLM (1966)
ST = T033
ST = T046
AN = "cellulite" in Amer or Eng lit is indexed under OBESITY (IM) + ADIPOSE TISSUE (IM), in French lit "cellulite" can be "cellulite" or CELLULITIS
MS = An acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other skin lesions.
OL = use CELLULITIS to search PHLEGMON 1966-78
PM = PHLEGMON was heading 1963-78
HN = PHLEGMON was heading 1963-78
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D002481

*NEWRECORD
RECTYPE = D
MH = Cellulose
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UL UR
ENTRY = Alphacel|T118|T122|TRD|NRW|UNK (19XX)|861007|abbcdef
ENTRY = Avicel|T118|T122|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Heweten|T118|T122|TRD|NRW|UNK (19XX)|850103|abbcdef
ENTRY = Polyanhydroglucuronic Acid|T118|T122|T123|NON|EQV|UNK (19XX)|810108|abbbcdef
ENTRY = Rayophane|T118|T122|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Sulfite Cellulose|T118|T122|NON|NRW|NLM (1992)|910312|abbcdef
ENTRY = alpha-Cellulose|T118|T122|T123|NON|EQV|UNK (19XX)|831014|abbbcdef
ENTRY = Acid, Polyanhydroglucuronic
ENTRY = alpha Cellulose
MN = D05.750.078.562.180
MN = D09.698.365.180
MN = D25.720.099.500
MN = J01.637.051.720.099.500
FX = Cellophane
FX = Paper
MH_TH = NLM (1966)
ST = T118
ST = T122
ST = T123
N1 = Cellulose
RN = 9004-34-6
MS = A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.
MR = 20060705
DA = 19990101
DC = 1
UI = D002482

*NEWRECORD
RECTYPE = D
MH = Cellulose, Oxidized
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Absorbable Cellulose|T118|T121|NON|EQV|UNK (19XX)|790606|abbcdef
PRINT ENTRY = Carboxycellulose|T118|T121|NON|EQV|UNK (19XX)|790606|abbcdef
PRINT ENTRY = Cellulosic Acid|T118|T121|NON|EQV|UNK (19XX)|790606|abbcdef
ENTRY = Oxycel|T118|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Oxycellulose|T118|T121|NON|EQV|NLM (2015)|131219|abbcdef
ENTRY = Cellulose, Absorbable
ENTRY = Oxidized Cellulose
MN = D05.750.078.562.180.200
MN = D09.698.365.180.200
PA = Hemostatics
MH_TH = USP (19XX)
ST = T118
ST = T121
RN = 0
MS = A cellulose of varied carboxyl content retaining the fibrous structure. It is commonly used as a local hemostatic and as a matrix for normal blood coagulation.
PM = 1991; see CELLULOSE 1976-1990; see HEMOSTATICS 1963-1975; OXYCELLULOSE was indexed under METHYLCELLULOSE/AA 1977-2014
HN = 1991(1975); for OXYCELLULOSE use HYPROMELLOSE DERIVATIVES 2000-2014
MR = 20140617
DA = 19990101
DC = 1
DX = 19910101
UI = D002483

*NEWRECORD
RECTYPE = D
MH = Cementation
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Cementations
MN = E05.170
MN = E06.095.170
FX = Dental Cements
MH_TH = NLM (1965)
ST = T061
MS = The joining of objects by means of a cement (e.g., in fracture fixation, such as in hip arthroplasty for joining of the acetabular component to the femoral component). In dentistry, it is used for the process of attaching parts of a tooth or restorative material to a natural tooth or for the attaching of orthodontic bands to teeth by means of an adhesive.
PM = 67
HN = 67(65)
CATSH = CAT LIST
MR = 19920507
DA = 19990101
DC = 1
DX = 19670101
UI = D002484

*NEWRECORD
RECTYPE = D
MH = Cementoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
ENTRY = Cementomas
MN = C04.557.695.210
MH_TH = NLM (1972)
ST = T191
AN = /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
PI = Odontogenic Tumors (1966-1971)
MS = An odontogenic fibroma in which cells have developed into cementoblasts and which consists largely of cementum.
OL = use ODONTOGENIC TUMORS to search CEMENTOMA 1966-71 (as Prov 1972-74)
PM = 91; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79
HN = 91(72); was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1972-79(Prov 1972-74)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
DX = 19910101
UI = D002485

*NEWRECORD
RECTYPE = D
MH = Centchroman
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Compound 67-20|T109|T121|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Compound 67 20
ENTRY = Compound 6720
MN = D03.383.663.283.240.225
MN = D03.438.150.240.225
PA = Contraceptives, Postcoital, Synthetic
PA = Estrogen Antagonists
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, trans-
RN = 31477-60-8
PI = Benzopyrans (1974)
PI = Phenyl Ethers (1974)
PI = Pyrrolidines (1974)
MS = A non-steroidal anti-fertility agent with anti-hormonal properties.
PM = 91; was see under BENZOPYRANS 1975-90
HN = 91(75); was see under BENZOPYRANS 1975-90
MR = 20150622
DA = 19741111
DC = 1
DX = 19910101
UI = D002486

*NEWRECORD
RECTYPE = D
MH = Centers for Disease Control and Prevention (U.S.)
AQ = CL EC ES HI LJ OG SN ST TD UT
PRINT ENTRY = Centers for Disease Control (U.S.)|T093|NAM|EQV|NLM (1994)|930108|CENTERS FOR DISEASE CONTROL|abcdefs
PRINT ENTRY = United States Centers for Disease Control and Prevention|T093|NAM|EQV|NLM (1994)|921230|UNITED STATES CENTERS DIS CONTROL PREV|abcdefv
ENTRY = CDC|T093|NAM|EQV|NLM (1993)|940315|abcdef
ENTRY = CDCP|T093|ACR|EQV|NLM (2008)|070223|abcdef
ENTRY = Center for Disease Control|T093|NAM|EQV|UNK (19XX)|820503|CENTER FOR DIS CONTROL|abcdefv
ENTRY = Center for Disease Control and Prevention|T093|NAM|EQV|NLM (1994)|930108|abcdef
ENTRY = Centers for Disease Control|T093|NAM|EQV|UNK (19XX)|820503|CENTERS FOR DIS CONTROL|abcdefv
ENTRY = Centers for Disease Control and Prevention|T093|NAM|EQV|NLM (1994)|930108|abcdef
ENTRY = United States Centers for Disease Control|T093|NAM|EQV|NLM (1994)|930108|abcdef
MN = I01.409.418.750.600.650.225
MN = N03.540.348.500.500.600.650.225
MH_TH = NLM (1978)
ST = T093
AN = add UNITED STATES; research support by this agency is checked as RESEARCH SUPPORT, U.S. GOV'T, P.H.S.; CATALOGER: Use NAF entry
MS = An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries.
OL = use CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.) to search CENTERS FOR DISEASE CONTROL (U.S.) & UNITED STATES CENTERS FOR DISEASE CONTROL 1983-93, CENTER FOR DISEASE CONTROL 1982 & UNITED STATES CENTER FOR DISEASE CONTROL 1978-81
PM = 94; was CENTERS FOR DISEASE CONTROL (U.S.) 1983-93, was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL (U.S.) 1983-93
HN = 94; was CENTERS FOR DISEASE CONTROL (U.S.) 1983-93, was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL (U.S.) 1983-93
MR = 20150629
DA = 19770512
DC = 1
DX = 19780101
UI = D002487

*NEWRECORD
RECTYPE = D
MH = Central African Republic
AQ = EH EP
ENTRY = Ubangi-Shari|T083|NAM|EQV|NLM (1996)|940801|abcdef
MN = Z01.058.290.100.120
MH_TH = NLM (1978)
ST = T083
MS = A republic in central Africa south of CHAD and SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. The capital is Bangui.
MR = 20130709
DA = 19990101
DC = 4
UI = D002488

*NEWRECORD
RECTYPE = D
MH = Central America
AQ = EH EP
MN = Z01.107.169
MH_TH = POPLINE (1978)
ST = T083
MR = 19911104
DA = 19990101
DC = 4
UI = D002489

*NEWRECORD
RECTYPE = D
MH = Central Nervous System
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Cerebrospinal Axis|T022|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Axi, Cerebrospinal
ENTRY = Axis, Cerebrospinal
ENTRY = Central Nervous Systems
ENTRY = Cerebrospinal Axi
ENTRY = Nervous System, Central
ENTRY = Nervous Systems, Central
ENTRY = System, Central Nervous
ENTRY = Systems, Central Nervous
MN = A08.186
MH_TH = POPLINE (1984)
ST = T022
AN = prefer BRAIN or SPINAL CORD; "CNS effects" or "central effects" of drugs in texts usually means BRAIN /drug eff, not CNS /drug eff
MS = The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.
OL = pre-explosion = CENTRAL NERVOUS SYSTEM (PX)
MR = 20140613
DA = 19990101
DC = 1
UI = D002490

*NEWRECORD
RECTYPE = D
MH = Central Nervous System Agents
DE = CNS AGENTS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Central Nervous System Drugs|T121|NON|EQV|NLM (1995)|940401|CNS DRUGS|abcdefv
MN = D27.505.954.427
MH_TH = NLM (1979)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff & BRAIN /drug eff; DF: CNS AGENTS
MS = A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252)
OL = consider also CENTRAL NERVOUS SYSTEM /DE & BRAIN /DE
PM = 79
HN = 79; was NON MESH before 1979
MR = 20050815
DA = 19990101
DC = 1
DX = 19790101
UI = D002491

*NEWRECORD
RECTYPE = D
MH = Central Nervous System Depressants
DE = CNS DEPRESS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = CNS Depressants|T121|EQV|NLM (1995)|940404|abdef
ENTRY = Depressants, CNS
MN = D27.505.696.277
MN = D27.505.954.427.210
MH_TH = NLM (1979)
ST = T121
RN = 0
AN = GEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff or BRAIN /drug eff; DF: CNS DEPRESS
MS = A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents).
OL = consider also CENTRAL NERVOUS SYSTEM /DE + DEPRESSION, CHEMICAL or BRAIN /DE + DEPRESSION, CHEMICAL
PM = 79
HN = 79; was NON MESH before 1979
MR = 20050630
DA = 19990101
DC = 1
DX = 19790101
UI = D002492

*NEWRECORD
RECTYPE = D
MH = Central Nervous System Diseases
DE = CNS DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = CNS Diseases|T047|NON|EQV|UNK (19XX)|810316|abcdef
ENTRY = Central Nervous System Disorders|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = CNS Disease
MN = C10.228
MH_TH = BIOETHICS (1989)
ST = T047
AN = GEN: prefer specifics; DF: CNS DIS
MS = Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
OL = pre-explosion = CENTRAL NERVOUS SYSTEM DISEASES (PX)
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D002493

*NEWRECORD
RECTYPE = D
MH = Central Nervous System Infections
DE = CNS INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Central Nervous System Infection|T047|NON|EQV|NLM (2000)|991104|CENTRAL NERVOUS SYSTEM INFECT|abcdefv
ENTRY = Infections, Central Nervous System|T047|NON|EQV|NLM (2000)|991104|INFECT CNS|abcdefv
MN = C01.395
MN = C10.228.228
MH_TH = NLM (1966)
ST = T047
AN = GEN or unspecified; prefer specifics; coord IM with specific site/dis term (IM) if pertinent; DF: CNS INFECT
PI = Central Nervous System Diseases (1967-1997)
PI = Infection (1967-1997)
MS = Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.
PM = 1998
HN = 1998; use explode 1971-1997
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
DX = 19980101
UI = D002494

*NEWRECORD
RECTYPE = D
MH = Central Supply, Hospital
DE = CENTRAL SUPPLY HOSP
AQ = CL EC ES HI LJ MA OG SD SN ST TD UT
PRINT ENTRY = Hospital Central Supplies|T093|NON|EQV|NLM (1997)|951003|HOSP CENTRAL SUPPLIES|abcdefv
PRINT ENTRY = Hospital Central Supply|T093|NON|EQV|UNK (19XX)|770519|HOSP CENTRAL SUPPLY|abcdefv
ENTRY = Supplies, Hospital Central|T093|NON|EQV|NLM (1997)|951003|SUPPLIES HOSP CENTRAL|abcdefv
ENTRY = Supply, Hospital Central|T093|NON|EQV|NLM (1997)|951003|SUPPLY HOSP CENTRAL|abcdefv
ENTRY = Central Supplies, Hospital
MN = N02.278.216.500.968.260
MN = N04.452.442.422.260
MH_TH = NLM (1968)
ST = T093
AN = do not confuse with CENTRALIZED HOSPITAL SERVICES
MS = Hospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment.
OL = use CENTRAL SUPPLY, HOSPITAL to search HOSPITAL CENTRAL SUPPLY 1968-77
PM = 78; was HOSPITAL CENTRAL SUPPLY 1968-77
HN = 78; was HOSPITAL CENTRAL SUPPLY 1968-77
MR = 20150622
DA = 19990101
DC = 1
DX = 19680101
UI = D002495

*NEWRECORD
RECTYPE = D
MH = Central Venous Pressure
AQ = DE ES GE IM PH RE
PRINT ENTRY = Venous Pressure, Central|T033|T040|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Central Venous Pressures
ENTRY = Pressure, Central Venous
ENTRY = Pressures, Central Venous
ENTRY = Venous Pressures, Central
MN = G09.330.380.076.732.336
MH_TH = NLM (1970)
ST = T033
ST = T040
PI = Blood Pressure (1966-1969)
PI = Veins (1966-1969)
MS = The blood pressure in the central large VEINS of the body. It is distinguished from peripheral venous pressure which occurs in an extremity.
PM = 70
HN = 70
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19700101
UI = D002496

*NEWRECORD
RECTYPE = D
MH = Centralized Hospital Services
DE = CENTRALIZED HOSP SERV
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
PRINT ENTRY = Hospital Services, Centralized|T058|NON|EQV|UNK (19XX)|770519|HOSP SERV CENTRALIZED|abcdefv
ENTRY = Centralized Services, Hospital|T058|NON|EQV|NLM (1996)|950303|CENTRALIZED SERV HOSP|abcdefv
ENTRY = Services, Centralized Hospital|T058|NON|EQV|NLM (1996)|940811|SERV CENTRALIZED HOSP|abcdefv
ENTRY = Centralized Hospital Service
ENTRY = Centralized Service, Hospital
ENTRY = Hospital Centralized Service
ENTRY = Hospital Centralized Services
ENTRY = Hospital Service, Centralized
ENTRY = Service, Centralized Hospital
ENTRY = Service, Hospital Centralized
ENTRY = Services, Hospital Centralized
MN = N02.278.216.500.750
MN = N04.452.442.110
MH_TH = NLM (1977)
ST = T058
AN = do not confuse with CENTRAL SUPPLY, HOSPITAL; DF: CENTRALIZED HOSP SERV
MS = The coordination of services in one area of a facility to improve efficiency.
PM = 91; was see under HOSPITAL ADMINISTRATION Aug 1977-90
HN = 91(Aug 77); was see under HOSPITAL ADMINISTRATION 1977-90
MR = 20150622
DA = 19770519
DC = 1
DX = 19910101
UI = D002497

*NEWRECORD
RECTYPE = D
MH = Centrifugation
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
MN = E05.181
FX = Gravity, Altered
FX = Hypergravity
FX = Ultracentrifugation
MH_TH = NLM (1966)
ST = T059
AN = as a lab technique & to simulate gravitational eff in space; NIM
MS = Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. (From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
CATSH = CAT LIST
MR = 20040713
DA = 19990101
DC = 1
UI = D002498

*NEWRECORD
RECTYPE = D
MH = Centrifugation, Density Gradient
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Centrifugations, Density Gradient
ENTRY = Density Gradient Centrifugation
ENTRY = Density Gradient Centrifugations
ENTRY = Gradient Centrifugation, Density
ENTRY = Gradient Centrifugations, Density
MN = E05.181.724.336
MN = E05.196.941.336
MH_TH = NLM (1966)
ST = T059
AN = a type of ultracentrif; NIM; index sucrose density gradient centrif here but ignore SUCROSE
MS = Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 68
HN = 68(66)
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19680101
UI = D002499

*NEWRECORD
RECTYPE = D
MH = Centrifugation, Isopycnic
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Isopycnic Centrifugation
MN = E05.181.724.336.253
MN = E05.196.941.336.253
MH_TH = NLM (1975)
ST = T059
MS = A technique used to separate particles according to their densities in a continuous density gradient. The sample is usually mixed with a solution of known gradient materials and subjected to centrifugation. Each particle sediments to the position at which the gradient density is equal to its own. The range of the density gradient is usually greater than that of the sample particles. It is used in purifying biological materials such as proteins, nucleic acids, organelles, and cell types.
OL = search CENTRIFUGATION, DENSITY GRADIENT 1968-74
PM = 91; was see under CENTRIFUGATION, DENSITY GRADIENT 1975-90
HN = 91(75); was see under CENTRIFUGATION, DENSITY GRADIENT 1975-90
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19910101
UI = D002500

*NEWRECORD
RECTYPE = D
MH = Centrifugation, Zonal
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Centrifugations, Zonal
ENTRY = Zonal Centrifugation
ENTRY = Zonal Centrifugations
MN = E05.181.724.336.336
MN = E05.196.941.336.419
MH_TH = NLM (1966)
ST = T059
AN = a type of density gradient centrif; NIM
MS = Centrifugation using a rotating chamber of large capacity in which to separate cell organelles by density-gradient centrifugation. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 68
HN = 68(66)
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19680101
UI = D002501

*NEWRECORD
RECTYPE = D
MH = Centrioles
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Centriole|T026|NON|EQV|NLM (2014)|130325|abcdef
MN = A11.284.430.214.190.750.585.160.130
MN = A11.284.430.214.190.750.820.500.500.130
MH_TH = NLM (1979)
ST = T026
AN = A 11 qualif except /cytol; /genet permitted
PI = Mitosis (1968-1978)
PI = Organoids (1966-1978)
MS = Self-replicating, short, fibrous, rod-shaped organelles. Each centriole is a short cylinder containing nine pairs of peripheral microtubules, arranged so as to form the wall of the cylinder.
PM = 85; was see under ORGANOIDS 1979-84
HN = 85(79); was see under ORGANOIDS 1979-84
MR = 20130708
DA = 19780310
DC = 1
DX = 19850101
UI = D002502

*NEWRECORD
RECTYPE = D
MH = Centromere
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Centromeres
MN = A11.284.430.106.279.345.190.160.165
MN = G05.360.160.165
FX = DNA, Satellite
MH_TH = NLM (1978)
ST = T026
PI = Chromosomes (1966-1977)
MS = The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division.
PM = 91; was see under CHROMOSOMES 1978-90
HN = 91(78); was see under CHROMOSOMES 1978-90
MR = 20080708
DA = 19770429
DC = 1
DX = 19910101
UI = D002503

*NEWRECORD
RECTYPE = D
MH = Meclofenoxate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Centrophenoxine|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1991)|900509|abbcdeef
ENTRY = Alpharma Brand of Meclofenoxate Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041028|abbcdef
ENTRY = Atsefen|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Cerutil|T109|T121|TRD|NRW|DE|810108|abbcdef
ENTRY = Cetrexin|T109|T121|TRD|NRW|UNK (19XX)|811202|abbcdef
ENTRY = Helfergin|T109|T121|TRD|NRW|DE|041028|abbcdef
ENTRY = Lundbeck Brand of Meclofenoxate Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041028|abbcdef
ENTRY = Meclofenoxate Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2003)|020515|abbcdeef
MN = D02.241.081.018.386.682.875
MN = D02.241.511.316.495
PA = Neuroprotective Agents
PA = Nootropic Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Acetic acid, (4-chlorophenoxy)-, 2-(dimethylamino)ethyl ester, hydrochloride
RN = C76QQ2I0RG
RR = 3685-84-5 (Meclofenoxate)
RR = 5BK3070BDY
MS = An ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid.
OL = use MECLOFENOXATE to search CENTROPHENOXINE 1975-90; use ACETIC ACIDS 1966-74 (as Prov 1966-67)
PM = 91; was CENTROPHENOXINE see under GLYCOLATES 1975-90 & see under ACETIC ACIDS 1968-74; MECLOFENOXATE was see CENTROPHENOXINE 1977-90
HN = 91(65); was CENTROPHENOXINE see under GLYCOLATES 1975-90 & see under ACETIC ACIDS 1965-74 (Prov 1965-67); MECLOFENOXATE was see CENTROPHENOXINE 1977-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002504

*NEWRECORD
RECTYPE = D
MH = Cephacetrile
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cefacetrile|T109|T195|NON|EQV|FDA SRS (2014)|UNK (19XX)|790606|abbcdeef
ENTRY = C-36278-Ba|T109|T195|LAB|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Celospor|T109|T195|TRD|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Cephacetrile Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1970)|USP (19XX)|940825|abbcdeeef
ENTRY = C 36278 Ba
ENTRY = C36278Ba
ENTRY = Sodium, Cephacetrile
MN = D02.065.589.099.249.190
MN = D02.886.665.074.190
MN = D04.075.080.875.099.221.249.190
PA = Anti-Bacterial Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((cyanoacetyl)amino)-8-oxo-, monosodium salt, (6R-trans)-
RN = FDM21QQ344
RR = 10206-21-0 (Cephacetrile)
RR = 23239-41-0 (mono-Na salt)
RR = 87TH1FJY1N
PI = Acetamides (1973-1974)
PI = Cephalosporins (1973-1974)
PI = Nitriles (1973-1974)
MS = A derivative of 7-aminocephalosporanic acid.
PM = 91; was see under CEPHALOSPORINS 1975-90
HN = 91(75); was see under CEPHALOSPORINS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002505

*NEWRECORD
RECTYPE = D
MH = Cephalexin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cefalexin|T109|T195|NON|EQV|INN (19XX)|800801|abbcdef
ENTRY = Cephalexin Dihydride|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin Hemihydrate|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin Hydrochloride|T109|T195|NON|NRW|FDA SRS (2014)|NLM (2014)|USAN (1987)|USP (19XX)|940825|abbcdeeeef
ENTRY = Cephalexin Monohydrate|T109|T195|NON|EQV|FDA SRS (2014)|NLM (1999)|990913|abbcdeef
ENTRY = Cephalexin Monohydrochloride|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin Monohydrochloride, Monohydrate|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin, (6R-(6alpha,7beta))-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin, Monosodium Salt|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Ceporexine|T109|T195|TRD|NRW|NLM (1992)|910225|abbcdef
ENTRY = Palitrex|T109|T195|TRD|NRW|UNK (19XX)|821129|abbcdef
ENTRY = Dihydride, Cephalexin
ENTRY = Hemihydrate, Cephalexin
ENTRY = Hydrochloride, Cephalexin
ENTRY = Monohydrate Cephalexin Monohydrochloride
ENTRY = Monohydrate, Cephalexin
ENTRY = Monohydrochloride, Cephalexin
ENTRY = Monohydrochloride, Monohydrate Cephalexin
ENTRY = Monosodium Salt Cephalexin
MN = D02.065.589.099.249.200
MN = D02.886.665.074.200
MN = D04.075.080.875.099.221.249.200
PA = Anti-Bacterial Agents
MH_TH = FDA SRS (2014)
MH_TH = USAN (1967)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-
RN = OBN7UDS42Y
RR = 105879-42-3 (mono-HCl,mono-H2O)
RR = 108260-04-4 (cpd without isomeric designation)
RR = 15686-71-2 (Cephalexin)
RR = 23325-78-2 (mono-H2O)
RR = 27726-35-8 ((6R-(6alpha,7beta))-isomer)
RR = 34632-04-7 ((6R-(6alpha,7beta(S*)))-isomer)
RR = 38932-40-0 (mono-Na salt)
RR = 56337-81-6 ((6R-(6alpha,7beta isomer)), mono-Na salt)
RR = 59695-59-9 (mono-HCl)
RR = 66905-57-5 (di-H2O)
RR = 6VJE5G3D98
RR = 79814-91-8 ((6R-(6alpha,7alpha(R*)))-isomer)
RR = 86589-33-5 (hemi-H2O)
PI = Cephalosporins (1966-1971)
MS = A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.
PM = 73
HN = 73(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D002506

*NEWRECORD
RECTYPE = D
MH = Cephaloglycin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cefaloglycin|T109|T195|NON|EQV|INN (19XX)|940825|abbcdef
ENTRY = Cephaloglycin Dihydrate|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Cephaloglycine|T109|T195|NON|EQV|UNK (19XX)|830613|abbcdef
ENTRY = Dihydrate, Cephaloglycin
MN = D02.065.589.099.249.200.180
MN = D02.886.665.074.200.180
MN = D04.075.080.875.099.221.249.200.180
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = USAN (1965)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6R-(6alpha,7beta(R*)))-
RN = NE7R11LA95
RR = 22202-75-1 (dihydrate)
RR = 3577-01-3 (Cephaloglycin)
MS = A cephalorsporin antibiotic.
PM = 73
HN = 73(72)
MR = 20130708
DA = 19990101
DC = 1
DX = 19730101
UI = D002507

*NEWRECORD
RECTYPE = D
MH = Cephalometry
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = Craniometry|T060|NON|NRW|NLM (1966)|990101|abcdef
MN = E01.370.600.024.250
MN = E05.041.250
MN = N06.850.505.200.100.300
MH_TH = NLM (1965)
ST = T060
MS = The measurement of the dimensions of the HEAD.
PM = 1965; for CRANIOMETRY see CRANIOMETRY 1966-2004
HN = 1965
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19650101
UI = D002508

*NEWRECORD
RECTYPE = D
MH = Cephaloridine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Cefaloridine|T109|T195|NON|EQV|FDA SRS (2014)|INN (19XX)|940825|abbcdeef
ENTRY = Cephalomycine|T109|T195|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = Cephaloridin|T109|T195|NON|EQV|UNK (19XX)|840305|abbcdef
ENTRY = Ceporin|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
MN = D02.065.589.099.249.210
MN = D02.886.665.074.210
MN = D04.075.080.875.099.221.249.210
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = USAN (1964)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = Pyridinium, 1-((2-carboxy-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, (6R-trans)-
RN = LVZ1VC61HB
RR = 50-59-9 (Cephaloridine)
MS = A cephalosporin antibiotic.
PM = 68
HN = 68(66)
MR = 20130708
DA = 19990101
DC = 1
DX = 19680101
UI = D002509

*NEWRECORD
RECTYPE = D
MH = Cephalosporinase
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = beta-Lactamase II|T116|T126|NON|EQV|UNK (1990)|760517|BETA LACTAMASE 02|abbcdefs
ENTRY = Cephalexin Amidase|T116|T126|NON|NRW|UNK (1990)|840917|abbcdef
ENTRY = Cephalosporin Amido-beta-Lactam Hydrolase|T116|T126|NON|EQV|UNK (1990)|800815|abbcdef
ENTRY = Cephalosporin beta-Lactamase|T116|T126|NON|EQV|UNK (1990)|800815|abbcdef
ENTRY = Amidase, Cephalexin
ENTRY = Amido-beta-Lactam Hydrolase, Cephalosporin
ENTRY = Cephalosporin Amido beta Lactam Hydrolase
ENTRY = Cephalosporin beta Lactamase
ENTRY = Hydrolase, Cephalosporin Amido-beta-Lactam
ENTRY = beta Lactamase II
ENTRY = beta-Lactamase, Cephalosporin
MN = D08.811.277.087.180.229
EC = antagonists & inhibitors:beta-Lactamase Inhibitors
MH_TH = NLM (1975)
ST = T116
ST = T126
RN = EC 3.5.2.-
OL = search AMIDOHYDROLASES 1968-74
PM = 91; was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78
HN = 91(75); was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78
MR = 20140610
DA = 19990101
DC = 1
DX = 19910101
UI = D002510

*NEWRECORD
RECTYPE = D
MH = Cephalosporins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antibiotics, Cephalosporin|T195|NON|EQV|NLM (1996)|940819|abcdef
ENTRY = Cephalosporanic Acids|T109|T195|NON|NRW|NLM (1996)|990101|abbcdef
ENTRY = Acids, Cephalosporanic
ENTRY = Cephalosporin Antibiotics
MN = D02.065.589.099.249
MN = D02.886.665.074
MN = D04.075.080.875.099.221.249
PA = Anti-Bacterial Agents
MH_TH = NLM (1965)
ST = T195
RN = 0
MS = A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
PM = 66
HN = 66(65)
MR = 20070709
DA = 19990101
DC = 1
DX = 19660101
UI = D002511

*NEWRECORD
RECTYPE = D
MH = Cephalothin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cefalotin|T109|T195|NON|EQV|FDA SRS (2014)|INN (19XX)|770317|abbcdeef
PRINT ENTRY = Sodium Cephalothin|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1965)|USP (19XX)|741125|abbcdeeef
ENTRY = Cefalotina Normon|T109|T195|TRD|NRW|ES|041209|abbcdef
ENTRY = Cefalotina Sodica Spaly|T109|T195|TRD|NRW|ES|041209|abbcdef
ENTRY = Ceftina|T109|T195|TRD|NRW|MX|041209|abbcdef
ENTRY = Cephalothin Monosodium Salt|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Galen Brand of Cephalothin Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Keflin|T109|T195|TRD|NRW|AU|MX|NL|820519|abbcdeeef
ENTRY = Lilly Brand of Cephalothin Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Normon Brand of Cephalothin Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Seffin|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Spaly Brand of Cephalothin Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Cephalothin, Sodium
ENTRY = Monosodium Salt, Cephalothin
ENTRY = Salt, Cephalothin Monosodium
MN = D02.065.589.099.249.190.210
MN = D02.886.665.074.190.210
MN = D04.075.080.875.099.221.249.190.210
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R-trans)-
RN = R72LW146E6
RR = 153-61-7 (Cephalothin)
RR = 58-71-9 (mono-Na salt)
RR = C22G6EYP8B
MS = A cephalosporin antibiotic.
PM = 66
HN = 66(63)
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D002512

*NEWRECORD
RECTYPE = D
MH = Cephamycins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Antibiotics, Cephamycin|T195|NON|EQV|NLM (1996)|940819|abcdef
ENTRY = Cephamycin Antibiotics
MN = D02.065.589.099.249.250
MN = D02.886.665.074.250
MN = D04.075.080.875.099.221.249.250
PA = Anti-Bacterial Agents
MH_TH = NLM (1975)
ST = T195
RN = 0
PI = Cephalosporins (1974)
PI = Methyl Ethers (1974)
MS = Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.
PM = 84; was see under CEPHALOSPORINS 1975-83
HN = 84(75); was see under CEPHALOSPORINS 1975-83
MR = 20070709
DA = 19741119
DC = 1
DX = 19840101
UI = D002513

*NEWRECORD
RECTYPE = D
MH = Cephapirin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Apothecon Brand of Cephapirin Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = BL-P 1322|T109|T195|LAB|NRW|UNK (19XX)|800319|abbcdef
ENTRY = Brisfirina|T109|T195|TRD|NRW|ES|041209|abbcdef
ENTRY = Bristol-Myers Brand of Cephapirin Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Cephapirin Sodium|T109|T195|NON|NRW|NLM (2006)|041209|abbcdef
ENTRY = Cefadyl|T109|T195|TRD|NRW|US|800319|abbcdef
ENTRY = Cefapirin|T109|T195|NON|EQV|BAN (19XX)|FDA SRS (2014)|INN (19XX)|820125|abbcdeeef
ENTRY = Cephapirin Monosodium Salt|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Cephapirin Sodium|T109|T195|NON|NRW|FDA SRS (2014)|USAN (1970)|USP (19XX)|940825|abbcdeeef
ENTRY = Cfaloject|T109|T195|TRD|NRW|FR|041209|abbcdef
ENTRY = Sodium Cephapirin|T109|T195|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = BL P 1322
ENTRY = BLP 1322
ENTRY = Cephapirin, Sodium
ENTRY = Monosodium Salt, Cephapirin
ENTRY = Salt, Cephapirin Monosodium
MN = D02.065.589.099.249.190.230
MN = D02.886.665.074.190.230
MN = D04.075.080.875.099.221.249.190.230
PA = Anti-Bacterial Agents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-(((4-pyridinylthio)acetyl)amino)-, (6R-trans)-
RN = 89B59H32VN
RR = 21593-23-7 (Cephapirin)
RR = 24356-60-3 (mono-Na salt)
RR = 431LFF7I7J
PI = Acetamides (1972-1974)
PI = Cephalosporins (1972-1974)
PI = Pyridines (1972-1974)
PI = Sulfides (1972-1974)
MS = Cephalosporin antibiotic, partly plasma-bound, that is effective against gram-negative and gram-positive organisms.
PM = 91; was see under CEPHALOSPORINS 1975-90
HN = 91(75); was see under CEPHALOSPORINS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002514

*NEWRECORD
RECTYPE = D
MH = Cephradine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Alpharma Brand of Cephradine|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Anspor|T109|T195|TRD|NRW|UNK (19XX)|861119|abbcdef
ENTRY = Bouchara Brand of Cephradine|T109|T121|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Bristol-Myers Squibb Brand of Cefradine|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Cefradine|T109|T195|NON|EQV|INN (19XX)|810108|abbcdef
ENTRY = Cephradine Dihydrate|T109|T195|NRW|FDA SRS (2014)|NLM (1999)|990913|abbdeef
ENTRY = Cephradine, Non-Stoichiometric Hydrate|T109|T195|NRW|NLM (1999)|990913|abbdef
ENTRY = Dexef|T109|T195|TRD|NRW|FR|041215|abbcdef
ENTRY = Dexo Brand of Cephradine|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Galen Brand of Cephradine|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Kelsef|T109|T195|TRD|NRW|FR|041215|abbcdef
ENTRY = Maxisporin|T109|T195|TRD|NRW|NL|041215|abbcdef
ENTRY = Nicef|T109|T195|TRD|NRW|UK|041215|abbcdef
ENTRY = Reig Jofre Brand of Cephradine|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = SQ-11436|T109|T195|LAB|NRW|UNK (19XX)|800826|abbcdef
ENTRY = Sefril|T109|T195|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Septa Brand of Cephradine|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Septacef|T109|T195|TRD|NRW|ES|041215|abbcdef
ENTRY = Squibb Brand of Cephradine|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Velocef|T109|T195|TRD|NRW|ES|041215|abbcdef
ENTRY = Velosef|T109|T195|TRD|NRW|IE|NL|US|861119|abbcdeeef
ENTRY = Yamanouchi Brand of Cephradine|T109|T195|NON|NRW|NLM (2006)|041215|abbcdef
ENTRY = Zeefra G|T109|T121|TRD|NRW|FR|041215|abbcdef
ENTRY = Cephradine, Non Stoichiometric Hydrate
ENTRY = Dihydrate, Cephradine
ENTRY = Non-Stoichiometric Hydrate Cephradine
ENTRY = SQ 11436
ENTRY = SQ11436
MN = D02.065.589.099.249.200.185
MN = D02.886.665.074.200.185
MN = D04.075.080.875.099.221.249.200.185
PA = Anti-Bacterial Agents
MH_TH = BAN (19XX)
MH_TH = USAN (1971)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-
RN = 38821-53-3
RR = 31828-50-9 (non-stoichiometric hydrate)
RR = 56PPJ9MMPE
RR = 58456-86-3 (dihydrate)
PI = Cephalosporins (1972-1974)
PI = Cyclohexane (1972-1974)
MS = A semi-synthetic cephalosporin antibiotic.
PM = 91; was see under CEPHALOSPORINS 1975-90
HN = 91(75); was see under CEPHALOSPORINS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002515

*NEWRECORD
RECTYPE = D
MH = Ceramics
AQ = AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
ENTRY = Ceramic
MN = J01.637.153
MH_TH = NLM (1967)
ST = T073
ST = T122
AN = not restricted to dentistry
PI = Chemical Industry (1966)
PI = Dental Materials (1966)
PI = Minerals (1966)
MS = Products made by baking or firing nonmetallic minerals (clay and similar materials). In making dental restorations or parts of restorations the material is fused porcelain. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed & Boucher's Clinical Dental Terminology, 4th ed)
PM = 73
HN = 73(67)
MR = 20150710
DA = 19990101
DC = 1
DX = 19730101
UI = D002516

*NEWRECORD
RECTYPE = D
MH = Galactosylgalactosylglucosylceramidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Ceramide Trihexosidase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef
ENTRY = Trihexosidase, Ceramide
MN = D08.811.277.450.410.150
MH_TH = UNK (19XX)
ST = T116
ST = T126
N1 = D-Galactosyl-D-galactosyl-D-glucosyl-N-acylsphingosine galactohydrolase
RN = EC 3.2.1.47
PI = Cerebrosides (1972-1974)
PI = Galactosidase (1972-1974)
MS = An enzyme that catalyzes the hydrolysis of a ceramidetrihexoside to a ceramidedihexoside plus galactose.
PM = 91; was see under GALACTOSIDASES 1975-90
HN = 91(75); was see under GALACTOSIDASES 1975-90
MR = 20080708
DA = 19741119
DC = 1
DX = 19910101
UI = D002517

*NEWRECORD
RECTYPE = D
MH = Ceramides
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
MN = D02.065.313
MN = D09.400.410.420.525.200
MN = D10.390.470.675.200
MN = D10.570.877.360.612.200
FX = Fabry Disease
MH_TH = NLM (1972)
ST = T119
ST = T123
RN = 0
AN = carbohydrate ceramides: index under CEREBROSIDES (one carbohydrate group) or NEUTRAL GLYCOSPHINGOLIPIDS (more than one carbohydrate group)
PI = Amino Alcohols (1966-1971)
PI = Fatty Acids (1966-1971)
PI = Glycols (1966-1971)
MS = Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE.
PM = 72
HN = 72
MR = 20060705
DA = 19990101
DC = 1
DX = 19720101
UI = D002518

*NEWRECORD
RECTYPE = D
MH = Ceratopogonidae
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Culicoides|T204|NON|NRW|UNK (19XX)|800519|abcdef
PRINT ENTRY = Leptoconops|T204|NON|NRW|UNK (19XX)|800519|abcdef
PRINT ENTRY = Midges, Biting|T204|NON|EQV|UNK (19XX)|800519|abcdef
ENTRY = Biting Midge
ENTRY = Biting Midges
ENTRY = Culicoide
ENTRY = Leptoconop
ENTRY = Midge, Biting
MN = B01.050.500.131.617.289.208
MH_TH = NLM (1966)
ST = T204
AN = do not confuse X ref CULICOIDES with CULEX, mosquito; do not use /drug eff for insecticides: TN 111; gall midges: index under DIPTERA
MS = A family of biting midges, in the order DIPTERA. It includes the genus Culicoides which transmits filarial parasites pathogenic to man and other primates.
OL = use CERATOPOGONIDAE to search CULICOIDES 1966-80; search MIDGES under DIPTERA 1975-80
PM = 81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80
HN = 81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80
MR = 20090706
DA = 19990101
DC = 1
UI = D002519

*NEWRECORD
RECTYPE = D
MH = Cercopithecidae
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Catarrhina|T015|NON|BRD|UNK (19XX)|800507|abcdef
PRINT ENTRY = Langurs|T015|NON|REL|UNK (19XX)|800507|abcdef
PRINT ENTRY = Miopithecus talapoin|T015|NON|NRW|UNK (19XX)|800507|abcdef
PRINT ENTRY = Monkey, Talapoin|T015|NON|NRW|UNK (19XX)|800507|abcdef
PRINT ENTRY = Monkeys, Old World|T015|NON|EQV|UNK (19XX)|800507|abcdef
PRINT ENTRY = Presbytis|T015|NON|REL|UNK (19XX)|800507|abcdef
PRINT ENTRY = Pygathrix|T015|NON|NRW|UNK (19XX)|800507|abcdef
ENTRY = Catarrhinas
ENTRY = Langur
ENTRY = Miopithecus talapoins
ENTRY = Monkey, Old World
ENTRY = Monkeys, Talapoin
ENTRY = Old World Monkey
ENTRY = Old World Monkeys
ENTRY = Presbyti
ENTRY = Pygathrices
ENTRY = Talapoin Monkey
ENTRY = Talapoin Monkeys
ENTRY = World Monkey, Old
ENTRY = World Monkeys, Old
ENTRY = talapoin, Miopithecus
ENTRY = talapoins, Miopithecus
MN = B01.050.150.900.649.801.400.112.199
MH_TH = NLM (1981)
ST = T015
AN = a family of Old World monkeys: do not confuse with CERCOPITHECINAE, a subfamily; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
MS = The family of Old World monkeys and baboons consisting of two subfamilies: CERCOPITHECINAE and COLOBINAE. They are found in Africa and part of Asia.
PM = 81
HN = 81
MR = 20090706
DA = 19800507
DC = 1
DX = 19810101
UI = D002520

*NEWRECORD
RECTYPE = D
MH = Cercopithecus
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
MN = B01.050.150.900.649.801.400.112.199.120.126
MH_TH = NLM (1975)
ST = T015
AN = Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
PI = Monkeys (1966-1974)
MS = A genus of Old World monkeys found in Africa although some species have been introduced into the West Indies. This genus is composed of at least twenty species: C. AETHIOPS, C. ascanius, C. campbelli, C. cephus, C. denti, C. diana, C. dryas, C. erythrogaster, C. erythrotis, C. hamlyni, C. lhoesti, C. mitis, C. mona, C. neglectus, C. nictitans, C. petaurista, C. pogonias, C. preussi, C. salongo, and C. wolfi.
PM = 75
HN = 75
MR = 20090706
DA = 19741111
DC = 1
DX = 19750901
UI = D002521

*NEWRECORD
RECTYPE = D
MH = Cercopithecus aethiops
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = African Green Monkey|T015|EPO|NRW|NLM (1992)|901128|abcdef
PRINT ENTRY = Cercopithecus pygerythrus|T015|NON|NRW|UNK (19XX)|800522|abcdef
PRINT ENTRY = Cercopithecus sabeus|T015|NON|NRW|UNK (19XX)|800522|abcdef
PRINT ENTRY = Cercopithecus tantalus|T015|NON|NRW|NLM (1992)|901210|abcdef
PRINT ENTRY = Green Monkey|T015|NON|NRW|NLM (1992)|901128|abcdef
PRINT ENTRY = Grivet Monkey|T015|NON|NRW|NLM (1992)|901128|abcdef
PRINT ENTRY = Monkey, African Green|T015|EPO|NRW|UNK (19XX)|800507|abcdef
PRINT ENTRY = Monkey, Green|T015|NON|NRW|UNK (19XX)|800507|abcdef
PRINT ENTRY = Monkey, Grivet|T015|NON|NRW|UNK (19XX)|800507|abcdef
PRINT ENTRY = Monkey, Vervet|T015|NON|NRW|NLM (1991)|900410|abcdef
PRINT ENTRY = Vervet Monkey|T015|NON|NRW|NLM (1992)|901128|abcdef
ENTRY = Chlorocebus aethiops|T015|NON|EQV|NLM (2016)|141203|abcdef
ENTRY = Savannah Monkey|T015|NON|BRD|NLM (2016)|141215|abcdef
ENTRY = Chlorocebus aethiop
ENTRY = Green Monkey, African
ENTRY = Green Monkeys
ENTRY = Grivet Monkeys
ENTRY = Monkey, Savannah
ENTRY = Monkeys, Green
ENTRY = Monkeys, Grivet
ENTRY = Monkeys, Savannah
ENTRY = Monkeys, Vervet
ENTRY = Savannah Monkeys
ENTRY = Vervet Monkeys
ENTRY = aethiop, Chlorocebus
ENTRY = aethiops, Cercopithecus
ENTRY = aethiops, Chlorocebus
ENTRY = pygerythrus, Cercopithecus
ENTRY = sabeus, Cercopithecus
ENTRY = tantalus, Cercopithecus
MN = B01.050.150.900.649.801.400.112.199.120.126.110
MH_TH = NLM (1981)
ST = T015
AN = index NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
MS = A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey (C. pygerythrus) is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.
OL = use CERCOPITHECUS AETHIOPS to search CERCOPITHECUS PYGERYTHRUS & CERCOPITHECUS SABEUS 1975-80
PM = 91; was see under CERCOPITHECUS 1981-90; CERCOPITHECUS PYGERYTHRUS & CERCOPITHECUS SABEUS were see under CERCOPITHECUS 1975-80
HN = 91(81); was see under CERCOPITHECUS 1981-90; CERCOPITHECUS PYGERYTHRUS & CERCOPITHECUS SABEUS were see under CERCOPITHECUS 1975-80
MR = 20150713
DA = 19800507
DC = 1
DX = 19910101
UI = D002522

*NEWRECORD
RECTYPE = D
MH = Edible Grain
AQ = AE AH CH CL CY DE EC EM EN GD GE HI IM ME MI PH PO PS RE SD ST TO UL VI
PRINT ENTRY = Cereals|T002|T168|NON|NRW|NLM (1966)|990101|abbcdef
ENTRY = Cereal Grain|T002|T168|NON|NRW|NLM (2016)|140813|abbcdef
ENTRY = Cereal
ENTRY = Cereal Grains
ENTRY = Edible Grains
ENTRY = Grain, Cereal
ENTRY = Grain, Edible
ENTRY = Grains, Cereal
ENTRY = Grains, Edible
MN = A18.024.500.750.500
MN = B01.650.510.344.250
MN = G07.203.300.300.550
MN = G07.203.300.775.500
MN = J02.500.300.550
MN = J02.500.775.500
MH_TH = NLM (2016)
ST = T002
ST = T168
MS = SEEDS used as a major nutritional source, most often the grain from the POACEAE family.
PM = 2016; see CEREALS 1966-2015; GRAIN & MALT were headings 1963-84
HN = 2016 (1966); GRAIN & MALT were headings 1963-84
MR = 20150112
DA = 19990101
DC = 1
UI = D002523

*NEWRECORD
RECTYPE = D
MH = Cerebellar Ataxia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Adiadochokinesis|T184|NON|NRW|NLM (2000)|991105|abcdef
PRINT ENTRY = Ataxia, Cerebellar|T184|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Cerebellar Dysmetria|T033|NON|NRW|NLM (2000)|991105|abcdef
PRINT ENTRY = Dysmetria|T033|NON|NRW|NLM (2000)|991105|abcdef
ENTRY = Cerebellar Hemiataxia|T184|NON|NRW|NLM (2000)|991105|abcdef
ENTRY = Cerebellar Incoordination|T184|NON|EQV|NLM (2000)|991105|abcdef
ENTRY = Hypermetria|T033|NON|NRW|NLM (2000)|991105|abcdef
ENTRY = Adiadochokineses
ENTRY = Ataxias, Cerebellar
ENTRY = Cerebellar Ataxias
ENTRY = Cerebellar Dysmetrias
ENTRY = Cerebellar Hemiataxias
ENTRY = Cerebellar Incoordinations
ENTRY = Dysmetria, Cerebellar
ENTRY = Dysmetrias
ENTRY = Dysmetrias, Cerebellar
ENTRY = Hemiataxia, Cerebellar
ENTRY = Hemiataxias, Cerebellar
ENTRY = Hypermetrias
ENTRY = Incoordination, Cerebellar
ENTRY = Incoordinations, Cerebellar
MN = C10.228.140.252.190
MN = C10.597.350.090.500
MN = C23.888.592.350.090.200
MH_TH = NLM (1968)
ST = T184
AN = DENTATE CEREBELLAR ATAXIA see MYOCLONIC CEREBELLAR DYSSYNERGIA is also available; ATAXIAS, HEREDITARY see SPINOCEREBELLAR DEGENERATION is also available
PI = Ataxia (1966-1967)
PI = Cerebellar Diseases (1966-1967)
MS = Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)
PM = 1968
HN = 1968
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
DX = 19680101
UI = D002524

*NEWRECORD
RECTYPE = D
MH = Cerebellar Cortex
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Cortex Cerebelli|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Cerebelli, Cortex
ENTRY = Cerebellus, Cortex
ENTRY = Cortex Cerebellus
ENTRY = Cortex, Cerebellar
MN = A08.186.211.132.810.428.200.212
MH_TH = NLM (1966)
ST = T023
AN = diseases: coordinate IM with CEREBELLAR DISEASES (IM)
MS = The superficial GRAY MATTER of the CEREBELLUM. It consists of two main layers, the stratum moleculare and the stratum granulosum.
MR = 20150622
DA = 19990101
DC = 1
UI = D002525

*NEWRECORD
RECTYPE = D
MH = Cerebellar Diseases
DE = CEREBELLAR DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerebellar Dysfunction|T047|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Cerebellum Diseases|T047|NON|EQV|NLM (2000)|991103|CEREBELLUM DIS|abcdefv
ENTRY = Cerebellar Disorders|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Cerebellar Syndromes|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Cerebellar Disease
ENTRY = Cerebellar Disorder
ENTRY = Cerebellar Dysfunctions
ENTRY = Cerebellar Syndrome
ENTRY = Cerebellum Disease
ENTRY = Disease, Cerebellar
ENTRY = Disease, Cerebellum
ENTRY = Disorder, Cerebellar
ENTRY = Dysfunction, Cerebellar
ENTRY = Syndrome, Cerebellar
MN = C10.228.140.252
MH_TH = NLM (1966)
ST = T047
AN = GEN: prefer specifics
MS = Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D002526

*NEWRECORD
RECTYPE = D
MH = Myoclonic Cerebellar Dyssynergia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerebellar Dyssynergia|T047|NON|EQV|NLM (1970)|990101|abcdef
PRINT ENTRY = Dentate Cerebellar Atrophy|T047|NON|EQV|NLM (2000)|991104|abcdef
PRINT ENTRY = Dyssynergia Cerebellaris Myoclonica|T047|NON|EQV|NLM (2000)|991104|abcdef
PRINT ENTRY = Ramsay Hunt Cerebellar Syndrome|T047|EPO|EQV|UNK (19XX)|760512|abcdef
ENTRY = Cerebelloparenchymal Disorder V|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Dentate Cerebellar Ataxia|T047|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Dentate Nucleus Syndrome, Ramsay Hunt|T047|EPO|EQV|NLM (2000)|991104|abcdef
ENTRY = Dyssynergia Cerebellaris Myoclonica Of Hunt|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Dyssynergia Cerebellaris Progressiva|T047|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Ramsay Hunt Dentate Syndrome|T047|EPO|EQV|NLM (1992)|901226|abcdef
ENTRY = Spinodentate Atrophy|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Ataxia, Dentate Cerebellar
ENTRY = Ataxias, Dentate Cerebellar
ENTRY = Atrophies, Dentate Cerebellar
ENTRY = Atrophy, Dentate Cerebellar
ENTRY = Cerebellar Ataxias, Dentate
ENTRY = Cerebellar Atrophy, Dentate
ENTRY = Cerebellar Dyssynergia, Myoclonic
ENTRY = Cerebellar Dyssynergias
ENTRY = Cerebellar Dyssynergias, Myoclonic
ENTRY = Dentate Cerebellar Ataxias
ENTRY = Dentate Cerebellar Atrophies
ENTRY = Dyssynergia, Cerebellar
ENTRY = Dyssynergia, Myoclonic Cerebellar
ENTRY = Dyssynergias, Cerebellar
ENTRY = Dyssynergias, Myoclonic Cerebellar
ENTRY = Myoclonic Cerebellar Dyssynergias
MN = C10.228.140.252.700.250
MN = C10.228.854.787.500
MN = C10.574.500.825.250
MN = C16.320.400.780.500
MH_TH = NLM (2000)
ST = T047
AN = do not confuse X ref RAMSAY HUNT CEREBELLAR SYNDROME with RAMSAY HUNT AURICULAR SYNDROME see HERPES ZOSTER OTICUS or RAMSAY HUNT PARALYSIS SYNDROME see PARKINSONIAN DISORDERS
PI = Cerebellar Diseases (1966-1969)
MS = A condition marked by progressive CEREBELLAR ATAXIA combined with MYOCLONUS usually presenting in the third decade of life or later. Additional clinical features may include generalized and focal SEIZURES, spasticity, and DYSKINESIAS. Autosomal recessive and autosomal dominant patterns of inheritance have been reported. Pathologically, the dentate nucleus and brachium conjunctivum of the CEREBELLUM are atrophic, with variable involvement of the spinal cord, cerebellar cortex, and basal ganglia. (From Joynt, Clinical Neurology, 1991, Ch37, pp60-1)
PM = 2000; see CEREBELLAR DYSSYNERGIA 1991-1999; see CEREBELLAR ATAXIA 1970-1990
HN = 2000(1970); use CEREBELLAR ATAXIA 1970-1990
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19910101
UI = D002527

*NEWRECORD
RECTYPE = D
MH = Cerebellar Neoplasms
DE = CEREBELLAR NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Benign Cerebellar Neoplasms|T191|NON|NRW|NLM (2000)|991103|BENIGN CEREBELLAR NEOPL|abcdefv
PRINT ENTRY = Cerebellar Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Malignant Cerebellar Neoplasms|T191|NON|NRW|NLM (2000)|991103|MALIGNANT CEREBELLAR NEOPL|abcdefv
ENTRY = Cerebellar Neoplasms, Benign|T191|NON|NRW|NLM (2000)|991103|CEREBELLAR NEOPL BENIGN|abcdefv
ENTRY = Cerebellar Neoplasms, Malignant|T191|NON|NRW|NLM (2000)|991103|CEREBELLAR NEOPL MALIGNANT|abcdefv
ENTRY = Cerebellar Neoplasms, Primary|T191|NON|NRW|NLM (2000)|991103|CEREBELLAR NEOPL PRIMARY|abcdefv
ENTRY = Cerebellar Tumors|T191|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Neoplasms, Cerebellar|T191|NON|EQV|NLM (1992)|901015|NEOPL CEREBELLAR|abcdefv
ENTRY = Neoplasms, Cerebellar, Benign|T191|NON|NRW|NLM (2000)|991103|NEOPL CEREBELLAR BENIGN|abcdefv
ENTRY = Neoplasms, Cerebellar, Malignant|T191|NON|NRW|NLM (2000)|991103|NEOPL CEREBELLAR MALIGNANT|abcdefv
ENTRY = Neoplasms, Cerebellar, Primary|T191|NON|NRW|NLM (2000)|991103|NEOPL CEREBELLAR PRIMARY|abcdefv
ENTRY = Primary Neoplasms, Cerebellum|T191|NON|NRW|NLM (2000)|991103|PRIMARY NEOPL CERBELLUM|abcdefv
ENTRY = Benign Cerebellar Neoplasm
ENTRY = Cancer, Cerebellar
ENTRY = Cerebellar Cancers
ENTRY = Cerebellar Neoplasm
ENTRY = Cerebellar Neoplasm, Benign
ENTRY = Cerebellar Neoplasm, Malignant
ENTRY = Cerebellar Neoplasm, Primary
ENTRY = Cerebellar Tumor
ENTRY = Cerebellum Primary Neoplasm
ENTRY = Cerebellum Primary Neoplasms
ENTRY = Malignant Cerebellar Neoplasm
ENTRY = Neoplasm, Benign Cerebellar
ENTRY = Neoplasm, Cerebellar
ENTRY = Neoplasm, Cerebellum Primary
ENTRY = Neoplasm, Malignant Cerebellar
ENTRY = Primary Cerebellar Neoplasm
ENTRY = Primary Cerebellar Neoplasms
ENTRY = Primary Neoplasm, Cerebellum
ENTRY = Tumor, Cerebellar
MN = C04.588.614.250.195.411.211
MN = C10.228.140.211.500.200
MN = C10.228.140.252.200
MN = C10.551.240.250.400.300
MH_TH = NLM (1966)
ST = T191
AN = coord IM with histol type of neopl (IM)
MS = Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141)
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D002528

*NEWRECORD
RECTYPE = D
MH = Cerebellar Nuclei
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Dentate Nucleus|T023|NON|NRW|NLM (1992)|900904|abcdef
PRINT ENTRY = Nucleus Dentatus|T023|NON|NRW|NLM (1992)|900904|abcdef
PRINT ENTRY = Nucleus Emboliformis|T023|NON|NRW|NLM (1998)|961010|abcdef
PRINT ENTRY = Nucleus Fastigii|T023|NON|NRW|NLM (1998)|961010|abcdef
PRINT ENTRY = Nucleus Globosus|T023|NON|NRW|NLM (1998)|961010|abcdef
ENTRY = Amiculum of the Dentate Nucleus|T023|NON|NRW|NLM (2015)|140421|abcdef
ENTRY = Anterior Interposed Nucleus|T023|NON|NRW|NLM (2015)|140310|abcdef
ENTRY = Anterior Interpositus Nucleus|T023|NON|NRW|NLM (2015)|140310|abcdef
ENTRY = Central Nuclei|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Deep Cerebellar Nuclei|T023|NON|EQV|NLM (2015)|140310|abcdef
ENTRY = Dentate Cerebellar Nucleus|T023|NON|NRW|NLM (2015)|140318|abcdef
ENTRY = Fastigial Cerebellar Nucleus|T023|NON|NRW|NLM (2015)|140310|abcdef
ENTRY = Fastigial Nucleus|T023|NON|NRW|NLM (2015)|140331|abcdef
ENTRY = Intracerebellar Nuclei|T023|NON|EQV|NLM (2015)|140310|abcdef
ENTRY = Lateral Cerebellar Nucleus|T023|NON|NRW|NLM (2015)|140318|abcdef
ENTRY = Medial Cerebellar Nucleus|T023|NON|NRW|NLM (2015)|140310|abcdef
ENTRY = Central Nucleus
ENTRY = Cerebellar Nuclei, Deep
ENTRY = Cerebellar Nucleus
ENTRY = Cerebellar Nucleus, Deep
ENTRY = Cerebellar Nucleus, Dentate
ENTRY = Cerebellar Nucleus, Fastigial
ENTRY = Cerebellar Nucleus, Lateral
ENTRY = Cerebellar Nucleus, Medial
ENTRY = Deep Cerebellar Nucleus
ENTRY = Emboliformis, Nucleus
ENTRY = Fastigii, Nucleus
ENTRY = Globosus, Nucleus
ENTRY = Interposed Nucleus, Anterior
ENTRY = Interpositus Nucleus, Anterior
ENTRY = Intracerebellar Nucleus
ENTRY = Nuclei, Central
ENTRY = Nuclei, Cerebellar
ENTRY = Nuclei, Deep Cerebellar
ENTRY = Nuclei, Intracerebellar
ENTRY = Nucleus Fastigius
ENTRY = Nucleus, Anterior Interposed
ENTRY = Nucleus, Anterior Interpositus
ENTRY = Nucleus, Central
ENTRY = Nucleus, Cerebellar
ENTRY = Nucleus, Deep Cerebellar
ENTRY = Nucleus, Dentate
ENTRY = Nucleus, Dentate Cerebellar
ENTRY = Nucleus, Fastigial
ENTRY = Nucleus, Fastigial Cerebellar
ENTRY = Nucleus, Intracerebellar
ENTRY = Nucleus, Lateral Cerebellar
ENTRY = Nucleus, Medial Cerebellar
MN = A08.186.211.132.810.428.200.337
MH_TH = NLM (1971)
ST = T023
AN = diseases: coordinate IM with CEREBELLAR DISEASES (IM)
PI = Cerebellum (1966-1970)
MS = Four clusters of neurons located deep within the WHITE MATTER of the CEREBELLUM, which are the nucleus dentatus, nucleus emboliformis, nucleus globosus, and nucleus fastigii.
PM = 71
HN = 71
MR = 20150622
DA = 19990101
DC = 1
DX = 19710101
UI = D002529

*NEWRECORD
RECTYPE = D
MH = Cerebellopontine Angle
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Cerebellopontile Angle|T030|NON|EQV|NLM (1990)|881229|abcdef
ENTRY = Angle, Cerebellopontile
ENTRY = Angle, Cerebellopontine
ENTRY = Angles, Cerebellopontile
ENTRY = Angles, Cerebellopontine
ENTRY = Cerebellopontile Angles
ENTRY = Cerebellopontine Angles
MN = A08.186.211.132.810.428.200.462
MH_TH = NLM (1966)
ST = T030
AN = diseases: coord IM with CEREBELLAR DISEASES (IM); neopl: coord (IM) with CEREBELLAR NEOPLASMS (IM) + histol type of neopl (IM)
MS = Junction between the cerebellum and the pons.
OL = use CEREBELLOPONTINE ANGLE to search CEREBELLOPONTILE ANGLE 1966-89
PM = 90; was CEREBELLOPONTILE ANGLE 1966-89
HN = 90; was CEREBELLOPONTILE ANGLE 1966-89
MR = 20150622
DA = 19990101
DC = 1
UI = D002530

*NEWRECORD
RECTYPE = D
MH = Cerebellum
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Corpus Cerebelli|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Parencephalon|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Cerebelli, Corpus
ENTRY = Cerebellums
ENTRY = Cerebellus, Corpus
ENTRY = Corpus Cerebellus
ENTRY = Parencephalons
MN = A08.186.211.132.810.428.200
MH_TH = NLM (1966)
ST = T023
AN = cerebellar artery = CEREBELLUM /blood supply (IM) + ARTERIES (NIM)
MS = The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills.
MR = 20150622
DA = 19990101
DC = 1
UI = D002531

*NEWRECORD
RECTYPE = D
MH = Intracranial Aneurysm
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aneurysm, Cerebral|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Aneurysm, Intracranial|T047|T190|NON|EQV|NLM (2008)|061005|abbcdef
PRINT ENTRY = Basilar Artery Aneurysm|T047|NON|NRW|NLM (2008)|061005|abcdef
PRINT ENTRY = Berry Aneurysm|T047|NON|NRW|UNK (19XX)|780310|abcdef
PRINT ENTRY = Brain Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Cerebral Aneurysm|T047|NON|NRW|NLM (1966)|990101|abcdef
PRINT ENTRY = Giant Intracranial Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Mycotic Aneurysm, Intracranial|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aneurysm, Anterior Cerebral Artery|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aneurysm, Anterior Communicating Artery|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aneurysm, Basilar Artery|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aneurysm, Middle Cerebral Artery|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aneurysm, Posterior Cerebral Artery|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aneurysm, Posterior Communicating Artery|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Anterior Cerebral Artery Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Anterior Communicating Artery Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Middle Cerebral Artery Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Posterior Cerebral Artery Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Posterior Communicating Artery Aneurysm|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Aneurysm, Berry
ENTRY = Aneurysm, Brain
ENTRY = Aneurysm, Giant Intracranial
ENTRY = Aneurysm, Intracranial Mycotic
ENTRY = Aneurysms, Basilar Artery
ENTRY = Aneurysms, Berry
ENTRY = Aneurysms, Brain
ENTRY = Aneurysms, Cerebral
ENTRY = Aneurysms, Giant Intracranial
ENTRY = Aneurysms, Intracranial
ENTRY = Aneurysms, Intracranial Mycotic
ENTRY = Artery Aneurysm, Basilar
ENTRY = Artery Aneurysms, Basilar
ENTRY = Basilar Artery Aneurysms
ENTRY = Berry Aneurysms
ENTRY = Brain Aneurysms
ENTRY = Cerebral Aneurysms
ENTRY = Giant Intracranial Aneurysms
ENTRY = Intracranial Aneurysm, Giant
ENTRY = Intracranial Aneurysms
ENTRY = Intracranial Aneurysms, Giant
ENTRY = Intracranial Mycotic Aneurysm
ENTRY = Intracranial Mycotic Aneurysms
ENTRY = Mycotic Aneurysms, Intracranial
MN = C10.228.140.300.510.600
MN = C14.907.055.635
MN = C14.907.253.560.300
MH_TH = UNK (19XX)
ST = T047
ST = T190
MS = Abnormal outpouching in the wall of intracranial blood vessels. Most common are the saccular (berry) aneurysms located at branch points in CIRCLE OF WILLIS at the base of the brain. Vessel rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms (>2.5 cm in diameter) may compress adjacent structures, including the OCULOMOTOR NERVE. (From Adams et al., Principles of Neurology, 6th ed, p841)
PM = 2000; see CEREBRAL ANEURYSM 1969-1999; for CEREBRAL ANEURYSM see CEREBRAL ANEURYSM 1966-1999
HN = 2000(1969)
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D002532

*NEWRECORD
RECTYPE = D
MH = Cerebral Angiography
DE = CEREBRAL ANGIOGR
AQ = AE CL CT DE EC ES HI IS MO MT NU PX RE SN ST TD UT VE
PRINT ENTRY = Angiography, Cerebral|T060|NON|EQV|NLM (1992)|910401|ANGIOGR CEREBRAL|abcdefv
ENTRY = Angiographies, Cerebral
ENTRY = Cerebral Angiographies
MN = E01.370.350.578.937.180
MN = E01.370.350.700.060.180
MN = E01.370.350.700.560.180
MN = E01.370.370.050.180
MN = E01.370.376.537.750.180
MN = E05.629.937.180
MH_TH = NLM (1966)
ST = T060
AN = GEN or unspecified only: not a substitute for CEREBRAL ARTERIES /radiogr or CEREBRAL VEINS /radiogr; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CEREBRAL ANGIOGR
MS = Radiography of the vascular system of the brain after injection of a contrast medium.
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
UI = D002533

*NEWRECORD
RECTYPE = D
MH = Hypoxia, Brain
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anoxia, Brain|T046|NON|NRW|NLM (2000)|991104|abcdef
PRINT ENTRY = Anoxic Encephalopathy|T046|NON|NRW|NLM (2000)|991104|ANOXIC ENCEPH|abcdefv
PRINT ENTRY = Brain Hypoxia|T046|NON|EQV|NLM (2000)|991104|abcdef
PRINT ENTRY = Cerebral Anoxia|T046|NON|NRW|NLM (1966)|990101|abcdef
PRINT ENTRY = Encephalopathy, Hypoxic|T046|NON|NRW|NLM (2000)|991104|ENCEPH HYPOXIC|abcdefv
PRINT ENTRY = Hypoxic Encephalopathy|T046|NON|NRW|NLM (2000)|991104|HYPOXIC ENCEPH|abcdefv
ENTRY = Anoxia, Cerebral|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Anoxic Brain Damage|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Brain Anoxia|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cerebral Hypoxia|T046|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Hypoxia, Cerebral|T046|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Hypoxic Brain Damage|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Anoxic Encephalopathies
ENTRY = Brain Damage, Anoxic
ENTRY = Brain Damage, Hypoxic
ENTRY = Damage, Anoxic Brain
ENTRY = Damage, Hypoxic Brain
ENTRY = Encephalopathies, Anoxic
ENTRY = Encephalopathies, Hypoxic
ENTRY = Encephalopathy, Anoxic
ENTRY = Hypoxic Encephalopathies
MN = C10.228.140.624
MH_TH = NLM (2000)
ST = T046
AN = do not confuse with BRAIN ISCHEMIA, a reduced blood supply
MS = A reduction in brain oxygen supply due to ANOXEMIA (a reduced amount of oxygen being carried in the blood by HEMOGLOBIN), or to a restriction of the blood supply to the brain, or both. Severe hypoxia is referred to as anoxia, and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives.
PM = 2000; see CEREBRAL ANOXIA 1963-1999
HN = 2000(1963)
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
UI = D002534

*NEWRECORD
RECTYPE = D
MH = Cerebral Aqueduct
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Aqueduct of Sylvius|T023|EPO|EQV|UNK (19XX)|740329|abcdef
ENTRY = Aqueductus Cerebri|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Mesencephalic Aqueduct|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Mesencephalic Duct|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Sylvian Aqueduct|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Aqueduct, Cerebral
ENTRY = Aqueduct, Mesencephalic
ENTRY = Aqueduct, Sylvian
ENTRY = Aqueducts, Cerebral
ENTRY = Aqueducts, Mesencephalic
ENTRY = Aqueducts, Sylvian
ENTRY = Aqueductus Cerebrus
ENTRY = Cerebral Aqueducts
ENTRY = Cerebri, Aqueductus
ENTRY = Cerebrus, Aqueductus
ENTRY = Duct, Mesencephalic
ENTRY = Ducts, Mesencephalic
ENTRY = Mesencephalic Aqueducts
ENTRY = Mesencephalic Ducts
ENTRY = Sylvian Aqueducts
ENTRY = Sylvius Aqueduct
MN = A08.186.211.132.659.413.875.187
MN = A08.186.211.276.187
MH_TH = NLM (1971)
ST = T023
AN = /radiogr: coordinate with CEREBRAL VENTRICULOGRAPHY
PI = Cerebral Ventricles (1966-1970)
MS = Narrow channel in the MESENCEPHALON that connects the third and fourth CEREBRAL VENTRICLES.
PM = 71
HN = 71
MR = 20150622
DA = 19990101
DC = 1
DX = 19710101
UI = D002535

*NEWRECORD
RECTYPE = D
MH = Cerebral Arteries
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Arteries, Cerebral
ENTRY = Artery, Cerebral
ENTRY = Cerebral Artery
MN = A07.231.114.228
FX = Cerebral Angiography
MH_TH = NLM (1966)
ST = T023
AN = general; prefer specifics; do not use for arteries of non-cerebral parts of the brain, as cerebellar artery (= CEREBELLUM/blood supply + ARTERIES); /abnorm: consider also INTRACRANIAL ARTERIOVENOUS MALFORMATIONS
MS = The arterial blood vessels supplying the CEREBRUM.
OL = use CEREBRAL ANGIOGRAPHY to search CEREBRAL ARTERIES/radiography 1975-94
PM = /radiography was CEREBRAL ANGIOGRAPHY 1975-94
HN = /radiography was CEREBRAL ANGIOGRAPHY 1975-94
MR = 20070709
DA = 19990101
DC = 1
UI = D002536

*NEWRECORD
RECTYPE = D
MH = Intracranial Arteriosclerosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerebral Arteriosclerosis|T047|NON|NRW|NLM (1966)|990101|abcdef
PRINT ENTRY = Intracranial Atherosclerosis|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Cerebral Atherosclerosis|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = Arterioscleroses, Cerebral
ENTRY = Arterioscleroses, Intracranial
ENTRY = Arteriosclerosis, Cerebral
ENTRY = Arteriosclerosis, Intracranial
ENTRY = Atheroscleroses, Cerebral
ENTRY = Atheroscleroses, Intracranial
ENTRY = Atherosclerosis, Cerebral
ENTRY = Atherosclerosis, Intracranial
ENTRY = Cerebral Arterioscleroses
ENTRY = Cerebral Atheroscleroses
ENTRY = Intracranial Arterioscleroses
ENTRY = Intracranial Atheroscleroses
MN = C10.228.140.300.510.800
MN = C14.907.137.126.372
MN = C14.907.253.560.350
MH_TH = NLM (2000)
ST = T047
MS = Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.
PM = 2000; see CEREBRAL ARTERIOSCLEROSIS 1963-1999
HN = 2000(1963)
CATSH = CAT LIST
MR = 20090730
DA = 19990101
DC = 1
UI = D002537

*NEWRECORD
RECTYPE = D
MH = Intracranial Arteriovenous Malformations
DE = INTRACRANIAL AVM
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Arteriovenous Malformations, Cerebral|T019|NON|NRW|UNK (19XX)|800512|abcdef
PRINT ENTRY = Intracranial Arteriovenous Malformations, Congenital|T019|NON|EQV|NLM (2000)|991103|INTRACRANIAL ARTERIOVENOUS MALFORMATIONS CONGEN|abcdefv
ENTRY = AVM (Arteriovenous Malformation) Intracranial|T019|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Cerebral Arteriovenous Malformations|T019|NON|NRW|NLM (1973)|OMIM (2013)|990101|abcdeef
ENTRY = Congenital Intracranial Arteriovenous Malformations|T019|NON|EQV|NLM (2000)|991103|CONGEN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS|abcdefv
ENTRY = Intracranial Arteriovenous Malformation, Ruptured|T019|T047|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Ruptured Intracranial Arteriovenous Malformation|T019|T047|NON|NRW|NLM (2000)|991103|abbcdef
ENTRY = Arteriovenous Malformation, Cerebral
ENTRY = Arteriovenous Malformation, Intracranial
ENTRY = Arteriovenous Malformations, Intracranial
ENTRY = Cerebral Arteriovenous Malformation
ENTRY = Intracranial Arteriovenous Malformation
ENTRY = Malformation, Cerebral Arteriovenous
ENTRY = Malformation, Intracranial Arteriovenous
ENTRY = Malformations, Cerebral Arteriovenous
ENTRY = Malformations, Intracranial Arteriovenous
MN = C10.228.140.300.520
MN = C10.500.190.500
MN = C14.240.850.750.295
MN = C14.240.850.875.500
MN = C14.907.150.295
MN = C14.907.253.560.400
MN = C16.131.240.850.750.295
MN = C16.131.240.850.875.500
MN = C16.131.666.190.500
MH_TH = UNK (19XX)
ST = T019
AN = coordinate IM with ARTERIOVENOUS FISTULA (IM); DF: INTRACRANIAL AVM
PI = Arteriovenous Fistula/congenital (1966-1972)
PI = Cerebrovascular Disorders (1966-1972)
MS = Congenital vascular anomalies in the brain characterized by direct communication between an artery and a vein without passing through the CAPILLARIES. The locations and size of the shunts determine the symptoms including HEADACHES; SEIZURES; STROKE; INTRACRANIAL HEMORRHAGES; mass effect; and vascular steal effect.
PM = 2000; see CEREBRAL ARTERIOVENOUS MALFORMATIONS 1973-1999; for INTRACRANIAL ARTERIOVENOUS MALFORMATIONS see CEREBRAL ARTERIOVENOUS MALFORMATIONS 1974-1999
HN = 2000(1973)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
DX = 19730101
UI = D002538

*NEWRECORD
RECTYPE = D
MH = Cerebral Arterial Diseases
DE = CEREBRAL ARTERIAL DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerebral Artery Diseases|T047|NON|EQV|NLM (1966)|990101|CEREBRAL ARTERY DIS|abcdefv
ENTRY = Arterial Diseases, Cerebral|T047|NON|EQV|NLM (2000)|991103|ARTERIAL DIS CEREBRAL|abcdefv
ENTRY = Arterial Disease, Cerebral
ENTRY = Artery Disease, Cerebral
ENTRY = Artery Diseases, Cerebral
ENTRY = Cerebral Arterial Disease
ENTRY = Cerebral Artery Disease
ENTRY = Disease, Cerebral Arterial
ENTRY = Disease, Cerebral Artery
ENTRY = Diseases, Cerebral Arterial
ENTRY = Diseases, Cerebral Artery
MN = C10.228.140.300.510.200
MN = C14.907.253.560.200
MH_TH = NLM (2000)
ST = T047
AN = coordinate IM with specific cerebral artery (IM); see note at CEREBRAL ARTERIES for scope of "cerebral arteries"
MS = Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.
PM = 2000; see CEREBRAL ARTERY DISEASES 1963-1999
HN = 2000(1963)
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D002539

*NEWRECORD
RECTYPE = D
MH = Cerebral Cortex
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Insula of Reil|T023|EPO|NRW|UNK (19XX)|780522|abcdef
ENTRY = Allocortex|T023|NON|NRW|NLM (2015)|140306|abcdef
ENTRY = Archipallium|T023|NON|NRW|NLM (2015)|140324|abcdef
ENTRY = Cortex Cerebri|T023|NON|EQV|NLM (2015)|140324|abcdef
ENTRY = Cortical Plate|T023|NON|EQV|NLM (2015)|140324|abcdef
ENTRY = Insular Cortex|T023|NON|NRW|NLM (2015)|140306|abcdef
ENTRY = Paleocortex|T023|NON|NRW|NLM (2015)|140306|abcdef
ENTRY = Periallocortex|T023|NON|NRW|NLM (2015)|140306|abcdef
ENTRY = Allocortices
ENTRY = Archipalliums
ENTRY = Cerebral Cortices
ENTRY = Cerebri, Cortex
ENTRY = Cerebrus, Cortex
ENTRY = Cortex Cerebrus
ENTRY = Cortex, Cerebral
ENTRY = Cortex, Insular
ENTRY = Cortical Plates
ENTRY = Cortices, Cerebral
ENTRY = Cortices, Insular
ENTRY = Insular Cortices
ENTRY = Paleocortices
ENTRY = Periallocortices
ENTRY = Plate, Cortical
ENTRY = Plates, Cortical
ENTRY = Reil Insula
MN = A08.186.211.730.885.287.500
FX = Cerebral Decortication
FX = Cortical Spreading Depression
FX = Electroencephalography
MH_TH = NLM (1966)
ST = T023
AN = /surg: probably CEREBRAL DECORTICATION
MS = The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulchi. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.
OL = use CEREBRAL CORTEX to search INSULA OF REIL 1968-78
PM = INSULA OF REIL was see under CEREBRAL CORTEX 1968-78
HN = INSULA OF REIL was see under CEREBRAL CORTEX 1968-78
MR = 20140613
DA = 19990101
DC = 1
UI = D002540

*NEWRECORD
RECTYPE = D
MH = Cerebral Decortication
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Decortication, Cerebral Cortex|T061|T062|NON|EQV|NLM (1990)|890215|abbcdef
ENTRY = Cerebral Cortex Decortication|T061|T062|NON|EQV|UNK (19XX)|810302|abbcdef
ENTRY = Cerebral Cortex Decortications
ENTRY = Cerebral Decortications
ENTRY = Cortex Decortication, Cerebral
ENTRY = Cortex Decortications, Cerebral
ENTRY = Decortication, Cerebral
ENTRY = Decortications, Cerebral
ENTRY = Decortications, Cerebral Cortex
MN = E04.525.160
MH_TH = NLM (1965)
ST = T061
ST = T062
AN = "partial or total removal, ablation or destruction of the cerebral cortex; may be chemical"; usually exper; coord IM or NIM with specific part of brain with probably /physiol (IM)
MS = Partial or total removal, ablation, or destruction of the cerebral cortex; may be chemical. It is not used with animals that do not possess a cortex, i.e., it is used only with mammals.
OL = use CEREBRAL DECORTICATION to search CEREBRAL CORTEX DECORTICATION 1966-81
PM = 82; was CEREBRAL CORTEX DECORTICATION 1965-81
HN = 82; was CEREBRAL CORTEX DECORTICATION 1965-81
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19650101
UI = D002541

*NEWRECORD
RECTYPE = D
MH = Intracranial Embolism and Thrombosis
DE = INTRACRANIAL EMBOLISM THROMBOSIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Brain Embolism and Thrombosis|T047|NON|NRW|NLM (2000)|991108|BRAIN EMBOLISM THROMBOSIS|abcdefv
PRINT ENTRY = Cerebral Embolism and Thrombosis|T047|NON|NRW|NLM (1966)|990101|CEREBRAL EMBOLISM THROMBOSIS|abcdefv
ENTRY = Embolism and Thrombosis, Brain|T047|NON|NRW|NLM (2000)|991108|EMBOLISM THROMBOSIS BRAIN|abcdefv
MN = C10.228.140.300.525
MN = C14.907.253.566
MN = C14.907.355.590.213
MH_TH = NLM (2000)
ST = T047
AN = used for searching; INDEXER: Do not use; CATALOGER: Do not use
MS = Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures.
PM = 2000; see CEREBRAL EMBOLISM AND THROMBOSIS 1963-1999
HN = 2000(1963)
CATSH = CAT LIST
MR = 20150605
DA = 19990101
DC = 1
UI = D002542

*NEWRECORD
RECTYPE = D
MH = Cerebral Hemorrhage
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Brain Hemorrhage, Cerebral|T046|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Cerebral Parenchymal Hemorrhage|T046|NON|EQV|NLM (2000)|991103|abcdef
PRINT ENTRY = Hemorrhage, Cerebral|T046|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Intracerebral Hemorrhage|T046|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Hemorrhage, Cerebrum|T046|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Brain Hemorrhages, Cerebral
ENTRY = Cerebral Brain Hemorrhage
ENTRY = Cerebral Brain Hemorrhages
ENTRY = Cerebral Hemorrhages
ENTRY = Cerebral Parenchymal Hemorrhages
ENTRY = Cerebrum Hemorrhage
ENTRY = Cerebrum Hemorrhages
ENTRY = Hemorrhage, Cerebral Brain
ENTRY = Hemorrhage, Cerebral Parenchymal
ENTRY = Hemorrhage, Intracerebral
ENTRY = Hemorrhages, Cerebral
ENTRY = Hemorrhages, Cerebral Brain
ENTRY = Hemorrhages, Cerebral Parenchymal
ENTRY = Hemorrhages, Cerebrum
ENTRY = Hemorrhages, Intracerebral
ENTRY = Intracerebral Hemorrhages
ENTRY = Parenchymal Hemorrhage, Cerebral
ENTRY = Parenchymal Hemorrhages, Cerebral
MN = C10.228.140.300.535.200
MN = C14.907.253.573.200
MN = C23.550.414.913.100
MH_TH = NLM (1966)
ST = T046
AN = coordinate with specific site if pertinent; BASAL GANGLIA HEMORRHAGE and PUTAMINAL HEMORRHAGE are also available
MS = Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D002543

*NEWRECORD
RECTYPE = D
MH = Cerebral Infarction
DE = CEREBRAL INFARCT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Anterior Choroidal Artery Infarction|T047|NON|NRW|NLM (2000)|991104|ANTERIOR CHOROIDAL ARTERY INFARCT|abcdefv
PRINT ENTRY = Infarction, Cerebral|T047|NON|EQV|NLM (2000)|991104|INFARCT CEREBRAL|abcdefv
PRINT ENTRY = Posterior Choroidal Artery Infarction|T047|NON|NRW|NLM (2000)|991104|POSTERIOR CHOROIDAL ARTERY INFARCT|abcdefv
PRINT ENTRY = Subcortical Infarction|T047|NON|NRW|NLM (2000)|991104|SUBCORTICAL INFARCT|abcdefv
ENTRY = Cerebral Infarction, Left Hemisphere|T047|NON|NRW|NLM (2000)|991104|CEREBRAL INFARCT LEFT HEMISPHERE|abcdefv
ENTRY = Cerebral Infarction, Right Hemisphere|T047|NON|NRW|NLM (2000)|991104|CEREBRAL INFARCT RIGHT HEMISPHERE|abcdefv
ENTRY = Cerebral, Left Hemisphere, Infarction|T047|NON|NRW|NLM (2000)|991104|CEREBRAL LEFT HEMISPHERE INFARCT|abcdefv
ENTRY = Cerebral, Right Hemisphere, Infarction|T047|NON|NRW|NLM (2000)|991104|CEREBRAL RIGHT HEMISPHERE INFARCT|abcdefv
ENTRY = Infarction, Cerebral, Left Hemisphere|T047|NON|NRW|NLM (2000)|991104|INFARCT CEREBRAL LEFT HEMISPHERE|abcdefv
ENTRY = Infarction, Cerebral, Right Hemisphere|T047|NON|NRW|NLM (2000)|991104|INFARCT CEREBRAL RIGHT HEMISPHERE|abcdefv
ENTRY = Infarction, Left Hemisphere, Cerebral|T047|NON|NRW|NLM (2000)|991104|INFARCT LEFT HEMISPHERE CEREBRAL|abcdefv
ENTRY = Infarction, Right Hemisphere, Cerebral|T047|NON|NRW|NLM (2000)|991104|INFARCT RIGHT HEMISPHERE CEREBRAL|abcdefv
ENTRY = Left Hemisphere, Cerebral Infarction|T047|NON|NRW|NLM (2000)|991104|LEFT HEMISPHERE CEREBRAL INFARCT|abcdefv
ENTRY = Left Hemisphere, Infarction, Cerebral|T047|NON|NRW|NLM (2000)|991104|LEFT HEMISPHERE INFARCT CEREBRAL|abcdefv
ENTRY = Right Hemisphere, Cerebral Infarction|T047|NON|NRW|NLM (2000)|991104|RIGHT HEMISPHERE CEREBRAL INFARCT|abcdefv
ENTRY = Right Hemisphere, Infarction, Cerebral|T047|NON|NRW|NLM (2000)|991104|RIGHT HEMISPHERE INFARCT CEREBRAL|abcdefv
ENTRY = Cerebral Infarctions
ENTRY = Infarction, Subcortical
ENTRY = Infarctions, Cerebral
ENTRY = Infarctions, Subcortical
ENTRY = Subcortical Infarctions
MN = C10.228.140.300.150.477.200
MN = C10.228.140.300.775.200.200
MN = C14.907.253.092.477.200
MN = C14.907.253.855.200.200
MH_TH = NLM (1979)
MH_TH = OMIM (2013)
ST = T047
AN = DF: CEREBRAL INFARCT
PI = Brain (1966-1978)
PI = Cerebral Embolism and Thrombosis (1966-1978)
PI = Infarction (1966-1978)
MS = The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
PM = 1979
HN = 1979
CATSH = CAT LIST
MR = 20120703
DA = 19780522
DC = 1
DX = 19790101
UI = D002544

*NEWRECORD
RECTYPE = D
MH = Brain Ischemia
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerebral Ischemia|T046|NON|NRW|NLM (1979)|990101|abcdef
PRINT ENTRY = Ischemic Encephalopathy|T047|NON|EQV|NLM (2000)|991104|ISCHEMIC ENCEPH|abcdefv
ENTRY = Encephalopathy, Ischemic|T047|NON|EQV|NLM (2000)|991104|ENCEPH ISCHEMIC|abcdefv
ENTRY = Ischemia, Cerebral|T046|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Brain Ischemias
ENTRY = Cerebral Ischemias
ENTRY = Ischemia, Brain
ENTRY = Ischemias, Cerebral
ENTRY = Ischemic Encephalopathies
MN = C10.228.140.300.150
MN = C14.907.253.092
MH_TH = NLM (2000)
ST = T047
AN = ISCHEMIC ATTACK, TRANSIENT is available
PI = Brain/blood supply (1966-1978)
PI = Cerebrovascular Disorders (1966-1978)
PI = Ischemia (1966-1978)
MS = Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
PM = 2000; see CEREBRAL ISCHEMIA 1979-1999
HN = 2000(1979)
CATSH = CAT LIST
MR = 20070709
DA = 19771208
DC = 1
DX = 19790101
UI = D002545

*NEWRECORD
RECTYPE = D
MH = Ischemic Attack, Transient
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Brain Stem Ischemia, Transient|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Cerebral Ischemia, Transient|T047|NON|NRW|NLM (1966)|990101|abcdef
PRINT ENTRY = Crescendo Transient Ischemic Attacks|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Transient Ischemic Attack|T047|NON|EQV|UNK (19XX)|850311|abcdef
ENTRY = Anterior Circulation Transient Ischemic Attack|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Brain Stem Transient Ischemic Attack|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Brain TIA|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Brainstem Ischemia, Transient|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Brainstem Transient Ischemic Attack|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Carotid Circulation Transient Ischemic Attack|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Posterior Circulation Transient Ischemic Attack|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = TIA (Transient Ischemic Attack)|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Transient Ischemic Attack, Anterior Circulation|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Transient Ischemic Attack, Brain Stem|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Transient Ischemic Attack, Brainstem|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Transient Ischemic Attack, Carotid Circulation|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Transient Ischemic Attack, Posterior Circulation|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Transient Ischemic Attack, Vertebrobasilar Circulation|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Transient Ischemic Attacks, Crescendo|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Vertebrobasilar Circulation Transient Ischemic Attack|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Attack, Transient Ischemic
ENTRY = Attacks, Transient Ischemic
ENTRY = Brainstem Ischemias, Transient
ENTRY = Cerebral Ischemias, Transient
ENTRY = Ischemia, Transient Brainstem
ENTRY = Ischemia, Transient Cerebral
ENTRY = Ischemias, Transient Brainstem
ENTRY = Ischemias, Transient Cerebral
ENTRY = Ischemic Attacks, Transient
ENTRY = TIA, Brain
ENTRY = TIAs (Transient Ischemic Attack)
ENTRY = Transient Brainstem Ischemia
ENTRY = Transient Cerebral Ischemia
ENTRY = Transient Cerebral Ischemias
ENTRY = Transient Ischemic Attacks
MN = C10.228.140.300.150.836
MN = C14.907.253.092.836
MH_TH = NLM (2000)
ST = T047
AN = coordinate with specific site in the brain if pertinent; DF: BRAIN TIA
MS = Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
PM = 2000; see CEREBRAL ISCHEMIA, TRANSIENT 1966-1999
HN = 2000(1966)
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D002546

*NEWRECORD
RECTYPE = D
MH = Cerebral Palsy
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Diplegic Infantile Cerebral Palsy|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Little Disease|T047|EPO|REL|UNK (19XX)|840615|LITTLE DIS|abcdefv
PRINT ENTRY = Monoplegic Cerebral Palsy|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Quadriplegic Infantile Cerebral Palsy|T047|NON|NRW|NLM (2000)|991103|abcdef
PRINT ENTRY = Spastic Diplegia|T047|NON|REL|NLM (1995)|931123|abcdef
ENTRY = CP (Cerebral Palsy)|T047|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Athetoid|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Atonic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Congenital|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Diplegic, Infantile|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Dyskinetic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Dystonic-Rigid|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Hypotonic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Mixed|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Monoplegic, Infantile|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Quadriplegic, Infantile|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Rolandic Type|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cerebral Palsy, Spastic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Congenital Cerebral Palsy|T047|NON|NRW|NLM (2000)|991103|CONGEN CEREBRAL PALSY|abcdefv
ENTRY = Diplegia, Spastic|T047|NON|REL|NLM (2000)|991103|abcdef
ENTRY = Infantile Cerebral Palsy, Diplegic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Infantile Cerebral Palsy, Monoplegic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Infantile Cerebral Palsy, Quadriplegic|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Little's Disease|T047|EPO|REL|UNK (19XX)|740329|LITTLES DIS|abcdefv
ENTRY = Monoplegic Infantile Cerebral Palsy|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Rolandic Type Cerebral Palsy|T047|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Athetoid Cerebral Palsy
ENTRY = Atonic Cerebral Palsy
ENTRY = Cerebral Palsies, Athetoid
ENTRY = Cerebral Palsies, Dyskinetic
ENTRY = Cerebral Palsies, Dystonic-Rigid
ENTRY = Cerebral Palsies, Monoplegic
ENTRY = Cerebral Palsy, Dystonic Rigid
ENTRY = Cerebral Palsy, Monoplegic
ENTRY = Diplegias, Spastic
ENTRY = Dyskinetic Cerebral Palsy
ENTRY = Dystonic-Rigid Cerebral Palsies
ENTRY = Dystonic-Rigid Cerebral Palsy
ENTRY = Hypotonic Cerebral Palsies
ENTRY = Hypotonic Cerebral Palsy
ENTRY = Mixed Cerebral Palsies
ENTRY = Mixed Cerebral Palsy
ENTRY = Monoplegic Cerebral Palsies
ENTRY = Spastic Cerebral Palsies
ENTRY = Spastic Cerebral Palsy
ENTRY = Spastic Diplegias
MN = C10.228.140.140.254
MH_TH = NLM (1966)
ST = T047
AN = do not index under MUSCLE SPASTICITY unless especially discussed & then only NIM
MS = A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
CATSH = CAT LIST
MR = 20030725
DA = 19990101
DC = 1
UI = D002547

*NEWRECORD
RECTYPE = D
MH = Cerebral Revascularization
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Brain Revascularization|T061|NON|EQV|UNK (19XX)|790308|abcdef
PRINT ENTRY = EC-IC Arterial Bypass|T061|NRW|UNK (19XX)|790308|abdef
PRINT ENTRY = Extracranial-Intracranial Arterial Bypass|T061|NON|NRW|UNK (19XX)|790308|abcdef
PRINT ENTRY = Microsurgical Revascularization, Cerebral|T061|NON|EQV|UNK (19XX)|790308|MICROSURG REVASCULARIZATION CEREBRAL|abcdefv
PRINT ENTRY = STA-MCA Bypass|T061|NRW|UNK (19XX)|790308|abdef
ENTRY = Cerebral Microsurgical Revascularization|T061|NON|EQV|NLM (1992)|910512|CEREBRAL MICROSURG REVASCULARIZATION|abcdefv
ENTRY = Arterial Bypass, EC-IC
ENTRY = Arterial Bypass, Extracranial-Intracranial
ENTRY = Arterial Bypasses, EC-IC
ENTRY = Arterial Bypasses, Extracranial-Intracranial
ENTRY = Bypass, EC-IC Arterial
ENTRY = Bypass, Extracranial-Intracranial Arterial
ENTRY = Bypass, STA-MCA
ENTRY = Bypasses, EC-IC Arterial
ENTRY = Bypasses, Extracranial-Intracranial Arterial
ENTRY = Bypasses, STA-MCA
ENTRY = Cerebral Microsurgical Revascularizations
ENTRY = EC IC Arterial Bypass
ENTRY = EC-IC Arterial Bypasses
ENTRY = Extracranial Intracranial Arterial Bypass
ENTRY = Extracranial-Intracranial Arterial Bypasses
ENTRY = Revascularization, Brain
ENTRY = Revascularization, Cerebral
ENTRY = Revascularization, Cerebral Microsurgical
ENTRY = STA MCA Bypass
ENTRY = STA-MCA Bypasses
MN = E04.100.814.868.625
MN = E04.494.150
MH_TH = NLM (1980)
ST = T061
AN = do not use /util except by MeSH definition
PI = Arterial Occlusive Diseases/surgery (1973-1979)
PI = Brain/blood supply(1966-1979)
PI = Cerebral Arteries/surgery (1966-1979)
PI = Cerebrovascular Circulation (1966-1979)
PI = Cerebrovascular Disorders/surgery (1966-1979)
PI = Temporal Arteries/surgery (1966-1979)
PI = specific cerebrovascular disorder/surgery (1966-1979)
MS = Microsurgical revascularization to improve intracranial circulation. It usually involves joining the extracranial circulation to the intracranial circulation but may include extracranial revascularization (e.g., subclavian-vertebral artery bypass, subclavian-external carotid artery bypass). It is performed by joining two arteries (direct anastomosis or use of graft) or by free autologous transplantation of highly vascularized tissue to the surface of the brain.
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20100625
DA = 19790308
DC = 1
DX = 19800101
UI = D002548

*NEWRECORD
RECTYPE = D
MH = Diffuse Cerebral Sclerosis of Schilder
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Alpers Syndrome|T047|EPO|REL|GHR (2014)|NLM (1993)|OMIM (2013)|ORD (2010)|911115|abcdeeeef
PRINT ENTRY = Balo Concentric Sclerosis|T047|EPO|REL|NLM (2000)|991104|abcdef
PRINT ENTRY = Cerebral Sclerosis, Diffuse|T047|NON|EQV|NLM (1966)|990101|abcdef
PRINT ENTRY = Encephalitis Periaxialis|T047|NON|EQV|NLM (1966)|990101|ENCEPH PERIAXIALIS|abcdefv
PRINT ENTRY = Myelinoclastic Diffuse Sclerosis|T047|NON|EQV|NLM (1990)|881229|abcdef
PRINT ENTRY = Poliodystrophia Cerebri|T047|NON|EQV|NLM (1993)|911216|abcdef
PRINT ENTRY = Schilder Disease|T047|EPO|EQV|OMIM (2013)|UNK (19XX)|840615|SCHILDER DIS|abcdeefv
ENTRY = Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis|T047|EPO|REL|GHR (2014)|NLM (2011)|OMIM (2013)|ORD (2010)|100415|abcdeeeef
ENTRY = Alpers Disease|T047|NON|REL|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Alpers Progressive Infantile Poliodystrophy|T047|EPO|REL|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090610|abcdeeeef
ENTRY = Alpers' Disease|T047|EPO|REL|NLM (1993)|ORD (2010)|911203|ALPERS DIS|abcdeefv
ENTRY = Alpers' Syndrome|T047|EPO|REL|NLM (1993)|911203|abcdef
ENTRY = Alpers-Huttenlocher Syndrome|T047|EPO|REL|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090610|abcdeeeef
ENTRY = Balo's Concentric Sclerosis|T047|NON|REL|NLM (1990)|881229|abcdef
ENTRY = Encephalitis Periaxialis Concentrica|T047|NON|EQV|NLM (1990)|881229|ENCEPH PERIAXIALIS CONCENTRICA|abcdefv
ENTRY = Encephalitis Periaxialis Diffusa|T047|NON|EQV|NLM (1990)|881229|ENCEPH PERIAXIALIS DIFFUSA|abcdefv
ENTRY = Neuronal Degeneration Of Childhood With Liver Disease, Progressive|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Progressive Neuronal Degeneration of Childhood with Liver Disease|T047|NON|REL|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Progressive Sclerosing Poliodystrophy|T047|NON|REL|NLM (2011)|ORD (2010)|100415|abcdeef
ENTRY = Schilder's Disease|T047|EPO|EQV|UNK (19XX)|740330|SCHILDERS DIS|abcdefv
ENTRY = Sudanophilic Cerebral Sclerosis|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Alper Disease
ENTRY = Alper Syndrome
ENTRY = Alper's Disease
ENTRY = Alper's Syndrome
ENTRY = Alpers Huttenlocher Syndrome
ENTRY = Concentric Sclerosis, Balo
ENTRY = Concentric Sclerosis, Balo's
ENTRY = Diffuse Cerebral Scleroses
ENTRY = Diffuse Cerebral Sclerosis
ENTRY = Diffuse Scleroses, Myelinoclastic
ENTRY = Diffuse Sclerosis, Myelinoclastic
ENTRY = Disease, Alpers'
ENTRY = Disease, Schilder
ENTRY = Disease, Schilder's
ENTRY = Myelinoclastic Diffuse Scleroses
ENTRY = Progressive Sclerosing Poliodystrophies
ENTRY = Schilders Disease
ENTRY = Scleroses, Balo's Concentric
ENTRY = Scleroses, Myelinoclastic Diffuse
ENTRY = Sclerosis, Diffuse Cerebral
ENTRY = Sclerosis, Myelinoclastic Diffuse
ENTRY = Syndrome, Alpers
ENTRY = Syndrome, Alpers-Huttenlocher
MN = C10.114.375.112
MN = C10.228.140.400
MN = C10.228.140.695.562.112
MN = C10.314.350.112
MN = C20.111.258.250.175
MH_TH = GHR (2014)
MH_TH = NLM (2000)
ST = T047
MS = A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers' Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73)
PM = 2000; see CEREBRAL SCLEROSIS, DIFFUSE 1963-1999; for ENCEPHALITIS PERIAXIALIS see ENCEPHALITIS PERIAXIALIS 1963-1999; for BALO'S DISEASE, ENCEPHALITIS PERIAXIALIS DIFFUSA, MYELINOCLASTIC DIFFUSE SCLEROSIS, & SCHILDER'S DISEASE see ENCEPHALITIS PERIAXIALIS 1990-1999
HN = 2000(1963)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D002549

*NEWRECORD
RECTYPE = D
MH = Cerebral Veins
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Basal Vein|T023|NON|NRW|UNK (19XX)|860418|abcdef
PRINT ENTRY = Pial Vein|T023|NON|NRW|UNK (19XX)|860418|abcdef
PRINT ENTRY = Sylvian Vein|T023|EPO|NRW|UNK (19XX)|860418|abcdef
PRINT ENTRY = Thalamostriate Vein|T023|NON|NRW|UNK (19XX)|860418|abcdef
PRINT ENTRY = Vein of Galen|T023|EPO|NRW|UNK (19XX)|860418|abcdef
ENTRY = Terminal Vein|T023|NON|NRW|NLM (2015)|140318|abcdef
ENTRY = Basal Veins
ENTRY = Cerebral Vein
ENTRY = Galen Vein
ENTRY = Pial Veins
ENTRY = Terminal Veins
ENTRY = Thalamostriate Veins
ENTRY = Vein, Basal
ENTRY = Vein, Cerebral
ENTRY = Vein, Pial
ENTRY = Vein, Sylvian
ENTRY = Vein, Terminal
ENTRY = Vein, Thalamostriate
ENTRY = Veins, Basal
ENTRY = Veins, Cerebral
ENTRY = Veins, Pial
ENTRY = Veins, Terminal
ENTRY = Veins, Thalamostriate
MN = A07.231.908.155
FX = Cerebral Angiography
MH_TH = NLM (1987)
ST = T023
MS = Veins draining the cerebrum.
PM = 87
HN = 87
MR = 20140613
DA = 19860418
DC = 1
DX = 19870101
UI = D002550

*NEWRECORD
RECTYPE = D
MH = Cerebral Ventricle Neoplasms
DE = CEREBRAL VENTRICLE NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Intraventricular Neoplasms|T191|NON|EQV|NLM (2000)|991103|INTRAVENTRICULAR NEOPL|abcdefv
PRINT ENTRY = Ventricular Neoplasms, Brain|T191|NON|EQV|NLM (2000)|991103|VENTRICULAR NEOPL BRAIN|abcdefv
PRINT ENTRY = Ventricular Tumors, Brain|T191|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Brain Ventricular Neoplasms|T191|NON|EQV|NLM (2000)|991103|BRAIN VENTRICULAR NEOPL|abcdefv
ENTRY = Cerebral Ventricle Tumors|T191|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Cerebroventricular Neoplasms|T191|NON|EQV|NLM (1992)|901015|CEREBROVENTRICULAR NEOPL|abcdefv
ENTRY = Neoplasms, Cerebral Ventricle|T191|NON|EQV|NLM (1992)|901015|NEOPL CEREBRAL VENTRICLE|abcdefv
ENTRY = Neoplasms, Cerebroventricular|T191|NON|EQV|NLM (1992)|901015|NEOPL CEREBROVENTRICULAR|abcdefv
ENTRY = Neoplasms, Intraventricular|T191|NON|EQV|NLM (2000)|991103|NEOPL INTRAVENTRICULAR|abcdefv
ENTRY = Neoplasms, Ventricular, Brain|T191|NON|EQV|NLM (2000)|991103|NEOPL VENTRICULAR BRAIN|abcdefv
ENTRY = Brain Ventricular Neoplasm
ENTRY = Brain Ventricular Tumor
ENTRY = Brain Ventricular Tumors
ENTRY = Cerebral Ventricle Neoplasm
ENTRY = Cerebral Ventricle Tumor
ENTRY = Cerebroventricular Neoplasm
ENTRY = Intraventricular Neoplasm
ENTRY = Neoplasm, Brain Ventricular
ENTRY = Neoplasm, Cerebral Ventricle
ENTRY = Neoplasm, Cerebroventricular
ENTRY = Neoplasm, Intraventricular
ENTRY = Neoplasms, Brain Ventricular
ENTRY = Tumor, Brain Ventricular
ENTRY = Tumor, Cerebral Ventricle
ENTRY = Tumors, Brain Ventricular
ENTRY = Tumors, Cerebral Ventricle
ENTRY = Ventricle Tumor, Cerebral
ENTRY = Ventricle Tumors, Cerebral
ENTRY = Ventricular Neoplasm, Brain
ENTRY = Ventricular Tumor, Brain
MN = C04.588.614.250.195.205
MN = C10.228.140.211.280
MN = C10.551.240.250.200
MH_TH = NLM (1966)
ST = T191
AN = coord IM with histol type of neopl (IM)
MS = Neoplasms located in the brain ventricles, including the two lateral, the third, and the fourth ventricle. Ventricular tumors may be primary (e.g., CHOROID PLEXUS NEOPLASMS and GLIOMA, SUBEPENDYMAL), metastasize from distant organs, or occur as extensions of locally invasive tumors from adjacent brain structures.
CATSH = CAT LIST
MR = 19991103
DA = 19990101
DC = 1
UI = D002551

*NEWRECORD
RECTYPE = D
MH = Cerebral Ventricles
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RE RI SE SU UL US VI
PRINT ENTRY = Foramen of Monro|T030|EPO|NRW|UNK (19XX)|800407|abcdef
ENTRY = Cerebral Ventricular System|T030|NON|EQV|NLM (2015)|140610|abcdef
ENTRY = Cerebral Ventricle
ENTRY = Monro Foramen
ENTRY = Ventricle, Cerebral
ENTRY = Ventricles, Cerebral
MN = A08.186.211.276
FX = Cerebral Ventriculography
FX = Injections, Intraventricular
FX = Ventriculostomy
EC = radiography:Cerebral Ventriculography
MH_TH = NLM (1966)
ST = T030
AN = inflammation = CEREBRAL VENTRICULITIS
MS = Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE).
MR = 20100625
DA = 19990101
DC = 1
UI = D002552

*NEWRECORD
RECTYPE = D
MH = Cerebroside-Sulfatase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Arylsulfatase A|T116|T126|NON|EQV|UNK (19XX)|750724|abbcdef
PRINT ENTRY = Sulfatidate Sulfatase|T116|T126|NON|EQV|UNK (19XX)|750724|abbcdef
ENTRY = Cerebroside Sulfatase
ENTRY = Sulfatase, Sulfatidate
MN = D08.811.277.352.827.070.250
FX = Leukodystrophy, Metachromatic
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = Cerebroside-3-sulfate 3-sulfohydrolase
RN = EC 3.1.6.8
AN = /defic: consider also LEUKODYSTROPHY, METACHROMATIC
PI = Arylsulfatases (1975)
PI = Sulfatases (1972-1974)
MS = An enzyme that catalyzes the hydrolysis of cerebroside 3-sulfate (sulfatide) to yield a cerebroside and inorganic sulfate. A marked deficiency of arylsulfatase A, which is considered the heat-labile component of cerebroside sulfatase, has been demonstrated in all forms of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.8.
PM = 87; was see under SULFATASES 1976-86
HN = 87(76); was see under SULFATASES 1976-86
MR = 20030709
DA = 19750725
DC = 1
DX = 19870101
UI = D002553

*NEWRECORD
RECTYPE = D
MH = Cerebrosides
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
MN = D02.065.313.250
MN = D09.400.410.420.525.200.250
MN = D10.390.470.675.200.250
MN = D10.570.877.360.612.200.250
MH_TH = NLM (1966)
ST = T118
ST = T121
RN = 0
MS = Neutral glycosphingolipids that contain a monosaccharide, normally glucose or galactose, in 1-ortho-beta-glycosidic linkage with the primary alcohol of an N-acyl sphingoid (ceramide). In plants the monosaccharide is normally glucose and the sphingoid usually phytosphingosine. In animals, the monosaccharide is usually galactose, though this may vary with the tissue and the sphingoid is usually sphingosine or dihydrosphingosine. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1st ed)
MR = 20060705
DA = 19990101
DC = 1
UI = D002554

*NEWRECORD
RECTYPE = D
MH = Cerebrospinal Fluid
DE = CSF
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
ENTRY = Cerebro Spinal Fluid|T031|NON|EQV|NLM (2015)|140422|abcdef
ENTRY = Cerebro Spinal Fluids
ENTRY = Cerebrospinal Fluids
ENTRY = Fluid, Cerebro Spinal
ENTRY = Fluid, Cerebrospinal
ENTRY = Fluids, Cerebro Spinal
ENTRY = Fluids, Cerebrospinal
ENTRY = Spinal Fluid, Cerebro
ENTRY = Spinal Fluids, Cerebro
MN = A12.207.270.210
FX = Blood-Brain Barrier
MH_TH = NLM (1966)
ST = T031
AN = IM as substance only: use the qualifier / csf with diseases & drugs; CSF production = / physiol, not / secret;  CEREBROSPINAL FLUID PRESSURE and CEREBROSPINAL FLUID PROTEINS are also  available
MS = A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.
MR = 20140613
DA = 19990101
DC = 1
UI = D002555

*NEWRECORD
RECTYPE = D
MH = Cerebrospinal Fluid Proteins
DE = CSF PROTEINS
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Proteins, Cerebrospinal Fluid|T116|T123|NON|EQV|UNK (19XX)|860101|PROTEINS CSF|abbcdefv
ENTRY = Fluid Proteins, Cerebrospinal
MN = D12.776.178
MH_TH = NLM (1966)
ST = T116
ST = T123
RN = 0
AN = IM & coord with specific protein /csf (IM)
MS = Proteins in the cerebrospinal fluid, normally albumin and globulin present in the ratio of 8 to 1. Increases in protein levels are of diagnostic value in neurological diseases. (Brain and Bannister's Clinical Neurology, 7th ed, p221)
MR = 20050630
DA = 19990101
DC = 1
UI = D002556

*NEWRECORD
RECTYPE = D
MH = Cerebrospinal Fluid Shunts
DE = CSF SHUNTS
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Cerebrospinal Fluid Shunt|T061|NON|EQV|UNK (19XX)|860101|CSF SHUNT|abcdefv
ENTRY = Shunt, Cerebrospinal Fluid|T061|NON|EQV|UNK (19XX)|860101|SHUNT CSF|abcdefv
ENTRY = Shunts, Cerebrospinal Fluid|T061|NON|EQV|UNK (19XX)|860101|SHUNTS CSF|abcdefv
MN = E04.035.188
MN = E04.525.170
MH_TH = NLM (1969)
ST = T061
AN = do not use /util except by MeSH definition; NIM destination of shunt; VENTRICULOPERITONEAL SHUNT is available
PI = Cerebral Ventricles (1966-1968)
PI = Hydrocephalus/surgery (1966-1968)
MS = Tubes inserted to create communication between a cerebral ventricle and the internal jugular vein. Their emplacement permits draining of cerebrospinal fluid for relief of hydrocephalus or other condition leading to fluid accumulation in the ventricles.
PM = 72
HN = 72(69)
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19720101
UI = D002557

*NEWRECORD
RECTYPE = D
MH = Cerebrospinal Fluid Otorrhea
DE = CSF OTORRHEA
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerebrospinal Otorrhea|T047|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = Cerebrospinal Fluid Otorrhea, Post-Traumatic|T037|NON|NRW|NLM (2000)|991108|CSF OTORRHEA POST TRAUMATIC|abcdefv
ENTRY = Cerebrospinal Fluid Otorrhea, Spontaneous|T047|NON|NRW|NLM (2000)|991108|CSF OTORRHEA SPONTANEOUS|abcdefv
ENTRY = Cerebrospinal Fluid Otorrhea, Traumatic|T037|NON|NRW|NLM (2000)|991108|CSF OTORRHEA TRAUMATIC|abcdefv
ENTRY = Otorrhea, Cerebrospinal Fluid, Post-Traumatic|T037|NON|NRW|NLM (2000)|991108|OTORRHEA CSF POST TRAUMATIC|abcdefv
ENTRY = Otorrhea, Cerebrospinal Fluid, Spontaneous|T047|NON|NRW|NLM (2000)|991108|OTORRHEA CSF SPONTANEOUS|abcdefv
ENTRY = Otorrhea, Cerebrospinal Fluid, Traumatic|T037|NON|NRW|NLM (2000)|991108|OTORRHEA CSF TRAUMATIC|abcdefv
ENTRY = Otorrhea, Post-Traumatic, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|OTORRHEA POST TRAUMATIC CSF|abcdefv
ENTRY = Otorrhea, Spontaneous, Cerebrospinal Fluid|T047|NON|NRW|NLM (2000)|991108|OTORRHEA SPONTANEOUS CSF|abcdefv
ENTRY = Otorrhea, Traumatic Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|OTORRHEA TRAUMATIC CSF|abcdefv
ENTRY = Post-Traumatic Cerebrospinal Fluid Otorrhea|T037|NON|NRW|NLM (2000)|991108|POST TRAUMATIC CSF OTORRHEA|abcdefv
ENTRY = Post-Traumatic Otorrhea, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|POST TRAUMATIC OTORRHEA CSF|abcdefv
ENTRY = Spontaneous Cerebrospinal Fluid Otorrhea|T047|NON|NRW|NLM (2000)|991108|SPONTANEOUS CSF OTORRHEA|abcdefv
ENTRY = Spontaneous Otorrhea, Cerebrospinal Fluid|T047|NON|NRW|NLM (2000)|991108|SPONTANEOUS OTORRHEA CSF|abcdefv
ENTRY = Traumatic Cerebrospinal Fluid Otorrhea|T037|NON|NRW|NLM (2000)|991108|TRAUMATIC CSF OTORRHEA|abcdefv
ENTRY = Traumatic Otorrhea, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|TRAUMATIC OTORRHEA CSF|abcdefv
ENTRY = Cerebrospinal Fluid Otorrhea, Post Traumatic
ENTRY = Cerebrospinal Fluid Otorrheas
ENTRY = Otorrhea, Cerebrospinal
ENTRY = Otorrhea, Cerebrospinal Fluid
ENTRY = Post Traumatic Cerebrospinal Fluid Otorrhea
ENTRY = Post Traumatic Otorrhea, Cerebrospinal Fluid
MN = C10.597.114.500
MN = C10.900.300.109.500
MN = C23.888.592.114.249
MN = C26.915.300.225.500
MH_TH = NLM (1988)
MH_TH = ORD (2010)
ST = T047
AN = DF: CSF OTORRHEA
MS = Discharge of cerebrospinal fluid through the external auditory meatus or through the eustachian tube into the nasopharynx. This is usually associated with CRANIOCEREBRAL TRAUMA (e.g., SKULL FRACTURE involving the TEMPORAL BONE;), NEUROSURGICAL PROCEDURES; or other conditions, but may rarely occur spontaneously. (From Am J Otol 1995 Nov;16(6):765-71)
PM = 2000; see CEREBROSPINAL OTORRHEA 1988-1999; for CEREBROSPINAL FLUID OTORRHEA see CEREBROSPINAL OTORRHEA 1988-1999
HN = 2000(1966)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D002558

*NEWRECORD
RECTYPE = D
MH = Cerebrospinal Fluid Rhinorrhea
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cerebrospinal Rhinorrhea|T047|NON|EQV|NLM (1966)|990101|abcdef
ENTRY = CSF Rhinorrhea|T047|ABX|EQV|NLM (2015)|140416|abcdef
ENTRY = Cerebrospinal Fluid Rhinorrhea, Post-Traumatic|T037|NON|NRW|NLM (2000)|991108|CSF RHINORRHEA POST TRAUMATIC|abcdefv
ENTRY = Cerebrospinal Fluid Rhinorrhea, Spontaneous|T037|NON|NRW|NLM (2000)|991108|CSF RHINORRHEA SPONTANEOUS|abcdefv
ENTRY = Cerebrospinal Fluid Rhinorrhea, Traumatic|T037|NON|NRW|NLM (2000)|991108|CSF RHINORRHEA TRAUMATIC|abcdefv
ENTRY = Post-Traumatic Cerebrospinal Fluid Rhinorrhea|T037|NON|NRW|NLM (2000)|991108|POST TRAUMATIC CSF RHINORRHEA|abcdefv
ENTRY = Post-Traumatic Rhinorrhea, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|POST TRAUMATIC RHINORRHEA CSF|abcdefv
ENTRY = Rhinorrhea, Cerebrospinal Fluid, Post-Traumatic|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA CSF POST TRAUMATIC|abcdefv
ENTRY = Rhinorrhea, Cerebrospinal Fluid, Spontaneous|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA CSF SPONTANEOUS|abcdefv
ENTRY = Rhinorrhea, Cerebrospinal Fluid, Traumatic|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA CSF TRAUMATIC|abcdefv
ENTRY = Rhinorrhea, Post-Traumatic, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA POST TRAUMATIC CSF|abcdefv
ENTRY = Rhinorrhea, Spontaneous Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA SPONTANEOUS CSF|abcdefv
ENTRY = Rhinorrhea, Traumatic Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|RHINORRHEA TRAUMATIC CSF|abcdefv
ENTRY = Spontaneous Cerebrospinal Fluid Rhinorrhea|T037|NON|NRW|NLM (2000)|991108|SPONTANEOUS CSF RHINORRHEA|abcdefv
ENTRY = Spontaneous Rhinorrhea, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|SPONTANEOUS RHINORRHEA CSF|abcdefv
ENTRY = Traumatic Cerebrospinal Fluid Rhinorrhea|T037|NON|NRW|NLM (2000)|991108|TRAUMATIC CSF RHINORRHEA|abcdefv
ENTRY = Traumatic Rhinorrhea, Cerebrospinal Fluid|T037|NON|NRW|NLM (2000)|991108|TRAUMATIC RHINORRHEA CSF|abcdefv
ENTRY = CSF Rhinorrheas
ENTRY = Cerebrospinal Fluid Rhinorrhea, Post Traumatic
ENTRY = Cerebrospinal Fluid Rhinorrheas
ENTRY = Cerebrospinal Rhinorrheas
ENTRY = Post Traumatic Cerebrospinal Fluid Rhinorrhea
ENTRY = Post Traumatic Rhinorrhea, Cerebrospinal Fluid
ENTRY = Rhinorrhea, CSF
ENTRY = Rhinorrhea, Cerebrospinal
ENTRY = Rhinorrhea, Cerebrospinal Fluid
ENTRY = Rhinorrheas, CSF
ENTRY = Rhinorrheas, Cerebrospinal
ENTRY = Rhinorrheas, Cerebrospinal Fluid
MN = C10.597.114.750
MN = C10.900.300.109.750
MN = C23.888.592.114.624
MN = C26.915.300.225.750
MH_TH = NLM (1988)
MH_TH = ORD (2010)
ST = T047
AN = DF: CSF RHINORRHEA
MS = Discharge of cerebrospinal fluid through the nose. Common etiologies include trauma, neoplasms, and prior surgery, although the condition may occur spontaneously. (Otolaryngol Head Neck Surg 1997 Apr;116(4):442-9)
PM = 2000; see CEREBROSPINAL RHINORRHEA 1966-1999; for CEREBROSPINAL FLUID RHINORRHEA see CEREBROSPINAL RHINORRHEA 1966-1999
HN = 2000(1966)
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
UI = D002559

*NEWRECORD
RECTYPE = D
MH = Cerebrovascular Circulation
DE = CEREBROVASCULAR CIRC
AQ = DE GE IM PH RE
ENTRY = Cerebral Blood Flow|T042|T081|NON|REL|NLM (2016)|150515|abbcdef
ENTRY = Cerebral Circulation|T042|NON|EQV|NLM (2016)|150515|abcdef
ENTRY = Cerebral Perfusion Pressure|T042|T081|NON|REL|NLM (2016)|150515|abbcdef
ENTRY = Circulation, Cerebrovascular|T042|NON|EQV|NLM (1994)|921001|CIRC CEREBROVASCULAR|abcdefv
ENTRY = Blood Flow, Cerebral
ENTRY = Blood Flows, Cerebral
ENTRY = Cerebral Blood Flows
ENTRY = Cerebral Circulations
ENTRY = Cerebral Perfusion Pressures
ENTRY = Circulation, Cerebral
ENTRY = Circulations, Cerebral
ENTRY = Flow, Cerebral Blood
ENTRY = Flows, Cerebral Blood
ENTRY = Perfusion Pressure, Cerebral
ENTRY = Perfusion Pressures, Cerebral
ENTRY = Pressure, Cerebral Perfusion
ENTRY = Pressures, Cerebral Perfusion
MN = G09.330.190.163.159
MH_TH = NLM (1964)
ST = T042
AN = consider also BRAIN /blood supply
MS = The circulation of blood through the BLOOD VESSELS of the BRAIN.
PM = 64
HN = 64
CATSH = CAT LIST
MR = 20150626
DA = 19990101
DC = 1
DX = 19640101
UI = D002560

*NEWRECORD
RECTYPE = D
MH = Cerebrovascular Disorders
DE = CEREBROVASCULAR DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Brain Vascular Disorders|T046|NON|EQV|NLM (2000)|991104|BRAIN VASCULAR DIS|abcdefv
PRINT ENTRY = Intracranial Vascular Disorders|T046|NON|EQV|NLM (2000)|991104|INTRACRANIAL VASCULAR DIS|abcdefv
PRINT ENTRY = Vascular Diseases, Intracranial|T046|NON|EQV|NLM (2000)|991104|VASCULAR DIS INTRACRANIAL|abcdefv
ENTRY = Cerebrovascular Diseases|T046|NON|EQV|NLM (2016)|150122|abcdef
ENTRY = Cerebrovascular Insufficiency|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cerebrovascular Occlusion|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Brain Vascular Disorder
ENTRY = Cerebrovascular Disease
ENTRY = Cerebrovascular Disorder
ENTRY = Cerebrovascular Insufficiencies
ENTRY = Cerebrovascular Occlusions
ENTRY = Disease, Cerebrovascular
ENTRY = Diseases, Cerebrovascular
ENTRY = Insufficiencies, Cerebrovascular
ENTRY = Insufficiency, Cerebrovascular
ENTRY = Intracranial Vascular Disease
ENTRY = Intracranial Vascular Diseases
ENTRY = Intracranial Vascular Disorder
ENTRY = Occlusion, Cerebrovascular
ENTRY = Occlusions, Cerebrovascular
ENTRY = Vascular Disease, Intracranial
ENTRY = Vascular Disorder, Brain
ENTRY = Vascular Disorder, Intracranial
ENTRY = Vascular Disorders, Brain
ENTRY = Vascular Disorders, Intracranial
MN = C10.228.140.300
MN = C14.907.253
MH_TH = NLM (1966)
ST = T046
AN = general or unspecified; prefer specifics
MS = A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
CATSH = CAT LIST
MR = 20150709
DA = 19990101
DC = 1
UI = D002561

*NEWRECORD
RECTYPE = D
MH = Ceremonial Behavior
PRINT ENTRY = Rituals|T054|NON|NRW|NLM (2003)|020424|abcdef
ENTRY = Behavior, Ceremonial
ENTRY = Behaviors, Ceremonial
ENTRY = Ceremonial Behaviors
MN = F01.145.813.097
MN = I01.076.201.450.170
FX = Appetitive Behavior
MH_TH = NLM (1968)
ST = T054
AN = human & animal; no qualif
PI = Anthropology (1966-1967)
PI = Behavior, Animal (1966-1967)
PI = Culture (1966-1967)
PI = Sex Behavior (1966-1967)
MS = A series of actions, sometimes symbolic actions which may be associated with a behavior pattern, and are often indispensable to its performance.
PM = 98; see CEREMONIAL 1968-97
HN = 98(68)
CATSH = CAT LIST
MR = 20030725
DA = 19990101
DC = 1
DX = 19680101
UI = D002562

*NEWRECORD
RECTYPE = D
MH = Cerium
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.558.362.249
MN = D01.552.550.399.249
FX = Cerium Isotopes
FX = Cerium Radioisotopes
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Cerium
RN = 30K4522N6T
RR = 7440-45-1 (Cerium)
AN = a rare earth metal; Ce-140
MS = An element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in industrial applications.
MR = 20150622
DA = 19990101
DC = 1
UI = D002563

*NEWRECORD
RECTYPE = D
MH = Cerium Isotopes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Isotopes, Cerium
MN = D01.496.156
MH_TH = NLM (1966)
ST = T196
RN = 0
AN = Ce-136, 138, 142; NIM
MS = Stable cerium atoms that have the same atomic number as the element cerium, but differ in atomic weight. Ce-136, 138, and 142 are stable cerium isotopes.
MR = 20000622
DA = 19990101
DC = 1
UI = D002564

*NEWRECORD
RECTYPE = D
MH = Cerium Radioisotopes
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Radioisotopes, Cerium
MN = D01.496.156.300
MN = D01.496.749.185
MH_TH = NLM (1975)
ST = T196
RN = 0
AN = Ce-132-135, 137, 139, 141-148; for routine use as tracer, use no qualifiers
PI = Cerium (1966-1974)
PI = Isotopes (1966-1974)
PI = Radioisotopes (1966-1974)
MS = Unstable isotopes of cerium that decay or disintegrate emitting radiation. Ce atoms with atomic weights 132-135, 137, 139, and 141-148 are radioactive cerium isotopes.
OL = search CERIUM ISOTOPES 1966-74
PM = 75
HN = 75
MR = 20150605
DA = 19741111
DC = 1
DX = 19750901
UI = D002565

*NEWRECORD
RECTYPE = D
MH = Ceroid
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
MN = D10.150
MN = D23.767.300
MH_TH = NLM (1975)
ST = T119
ST = T123
RN = 0
AN = a lipid pigment
PI = Pigments (1970-1974)
MS = A naturally occurring lipid pigment with histochemical characteristics similar to lipofuscin. It accumulates in various tissues in certain experimental and pathological conditions.
PM = 91; was see under PIGMENTS 1975-90
HN = 91(75); was see under PIGMENTS 1975-90
MR = 20050630
DA = 19741119
DC = 1
DX = 19910101
UI = D002566

*NEWRECORD
RECTYPE = D
MH = Certificate of Need
AQ = CL EC ES HI LJ OG SN ST TD UT
PRINT ENTRY = Need Certification, Health Care|T064|NON|BRD|UNK (19XX)|790601|abcdef
ENTRY = Need Certificate
ENTRY = Need Certificates
MN = N03.349.650.120
MH_TH = NLM (1977)
ST = T064
ST = T170
AN = regional or area needs, not personal or financial need; specify geog
MS = A certificate issued by a governmental body to an individual or organization proposing to construct or modify a health facility, or to offer a new or different service. The process of issuing the certificate is also included.
PM = 91; was see under REGIONAL HEALTH PLANNING Aug 1977-90
HN = 91(Aug 77); was see under REGIONAL HEALTH PLANNING 1977-90
MR = 19991103
DA = 19770512
DC = 1
DX = 19910101
UI = D002567

*NEWRECORD
RECTYPE = D
MH = Certification
AQ = CL EC ES HI LJ MT OG SN ST TD UT
ENTRY = Certification Level|T081|NON|REL|NLM (1992)|910429|abcdef
ENTRY = Certification Levels
ENTRY = Certifications
ENTRY = Level, Certification
ENTRY = Levels, Certification
MN = N03.706.110.120
MN = N05.700.200.190
FX = Accreditation
FX = Licensure
FX = Specialty Boards
MH_TH = NLM (1968)
ST = T064
AN = by the profession; certification by various boards can go here but consider also LICENSURE; coordinate IM with specialty or discipline (IM); specify geographic term if pertinent; ELIGIBILITY CERTIFICATION see ELIGIBILITY DETERMINATION is also available
PI = Accreditation (1966-1967)
MS = Compliance with a set of standards defined by non-governmental organizations. Certification is applied for by individuals on a voluntary basis and represents a professional status when achieved, e.g., certification for a medical specialty.
PM = 68
HN = 68
MR = 20120703
DA = 19990101
DC = 1
DX = 19680101
UI = D002568

*NEWRECORD
RECTYPE = D
MH = Cerulenin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2,3-Epoxy-4-oxo-7,10-dodecadienoylamide|T109|T121|T123|NON|EQV|UNK (19XX)|810108|abbbcdef
MN = D02.065.327
PA = Antifungal Agents
PA = Fatty Acid Synthesis Inhibitors
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T123
N1 = Oxiranecarboxamide, 3-(1-oxo-4,7-nonadienyl)-, (2R-(2alpha,3alpha(4E,7E)))-
RN = 17397-89-6
AN = do not confuse with CERULEIN see CERULETIDE
PI = Antibiotics, Antifungal (1973-1974)
PI = Ethers, Cyclic (1973-1974)
PI = Fatty Acids, Unsaturated (1974)
MS = An epoxydodecadienamide isolated from several species, including ACREMONIUM, Acrocylindrum, and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function.
PM = 91; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90
HN = 91(75); was see under ANTIBIOTICS, ANTIFUNGAL 1975-90
MR = 20130710
DA = 19741119
DC = 1
DX = 19910101
UI = D002569

*NEWRECORD
RECTYPE = D
MH = Ceruloplasmin
AQ = AA AD AE AG AI AN BI CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Caeruloplasmin|T116|T126|NON|EQV|NLM (1990)|881125|abbcdef
PRINT ENTRY = Ferroxidase|T116|T126|NON|EQV|NLM (1991)|900227|abbcdef
ENTRY = Ceruloplasmin Ferroxidase|T116|T126|NON|EQV|UNK (19XX)|880808|abbcdef
ENTRY = Ceruloplasmin Oxidase|T116|T126|NON|EQV|UNK (19XX)|810427|abbcdef
ENTRY = Ferroxidase I|T116|T126|NON|NRW|UNK (19XX)|810519|abbcdef
ENTRY = alpha(2)-Ceruloplasmin|T116|T126|NON|EQV|UNK (19XX)|840920|abbcdef
ENTRY = Ferroxidase, Ceruloplasmin
ENTRY = Oxidase, Ceruloplasmin
MN = D08.811.682.226
MN = D12.776.124.050.130
MN = D12.776.124.790.106.214
MN = D12.776.157.160
MN = D12.776.377.715.085.214
MN = D12.776.556.151
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = Fe(II):oxygen oxidoreductase
RN = EC 1.16.3.1
AN = an alpha-globulin
MR = 20030709
DA = 19990101
DC = 1
UI = D002570

*NEWRECORD
RECTYPE = D
MH = Cerumen
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
PRINT ENTRY = Ear Wax|T031|NON|EQV|NLM (2002)|000927|abcdef
ENTRY = Wax, Ear
MN = A12.200.147
MH_TH = NLM (1966)
ST = T031
MS = The yellow or brown waxy secretions produced by vestigial apocrine sweat glands in the external ear canal.
MR = 20010725
DA = 19990101
DC = 1
UI = D002571

*NEWRECORD
RECTYPE = D
MH = Cervical Plexus
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Plexus, Cervical
MN = A08.800.800.720.150
FX = Cervical Plexus Block
MH_TH = NLM (1966)
ST = T023
MS = A network of nerve fibers originating in the upper four CERVICAL SPINAL CORD segments. The cervical plexus distributes cutaneous nerves to parts of the neck, shoulders, and back of the head. It also distributes motor fibers to muscles of the cervical SPINAL COLUMN, infrahyoid muscles, and the DIAPHRAGM.
MR = 20140606
DA = 19990101
DC = 1
UI = D002572

*NEWRECORD
RECTYPE = D
MH = Cervical Rib Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cervical-Rib-Cervical-Band Syndrome|T047|NON|REL|NLM (2000)|991104|abcdef
PRINT ENTRY = Naffziger Syndrome|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Anomalous Cervical Rib Syndrome|T047|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Naffziger's Syndrome|T047|NON|NRW|NLM (2000)|991104|abcdef
ENTRY = Cervical Rib Cervical Band Syndrome
ENTRY = Cervical Rib Syndromes
ENTRY = Naffziger Syndromes
ENTRY = Naffziger's Syndromes
ENTRY = Syndrome, Cervical Rib
ENTRY = Syndrome, Cervical-Rib-Cervical-Band
ENTRY = Syndrome, Naffziger
ENTRY = Syndrome, Naffziger's
ENTRY = Syndromes, Cervical Rib
ENTRY = Syndromes, Naffziger
ENTRY = Syndromes, Naffziger's
MN = C10.668.829.550.850.200
MN = C14.907.863.200
MN = C16.131.621.174
FX = Cervical Rib
MH_TH = NLM (1975)
ST = T047
MS = A condition associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the thoracic outlet and caused by a complete or incomplete anomalous CERVICAL RIB or fascial band connecting the tip of a cervical rib with the first thoracic rib. Clinical manifestations may include pain in the neck and shoulder which radiates into the upper extremity, PARESIS or PARALYSIS of brachial plexus innervated muscles; sensory loss; PARESTHESIAS; ISCHEMIA; and EDEMA. (Adams et al., Principles of Neurology, 6th ed, p214)
OL = search THORACIC OUTLET SYNDROME 1966-74
PM = 1991; was see under THORACIC OUTLET SYNDROME 1983-90; was see under SCALENUS ANTICUS SYNDROME 1963-82
HN = 1991(1975); was see under THORACIC OUTLET SYNDROME 1983-90; was see under SCALENUS ANTICUS SYNDROME 1963-82
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19910101
UI = D002573

*NEWRECORD
RECTYPE = D
MH = Cervical Vertebrae
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SU TR UL US VI
ENTRY = Vertebrae, Cervical
MN = A02.835.232.834.151
MH_TH = NLM (1966)
ST = T023
AN = IM when discussed as bones or as a coordinate with specific spinal disease (IM); NIM when locational; inflammation = CERVICAL VERTEBRAE (IM) + SPONDYLITIS (IM)
MS = The first seven VERTEBRAE of the SPINAL COLUMN, which correspond to the VERTEBRAE of the NECK.
MR = 20150616
DA = 19990101
DC = 1
UI = D002574

*NEWRECORD
RECTYPE = D
MH = Uterine Cervicitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cervicitis|T047|NON|EQV|NLM (1963)|990101|abcdef
ENTRY = Cervicitides
ENTRY = Cervicitides, Uterine
ENTRY = Cervicitis, Uterine
ENTRY = Uterine Cervicitides
MN = C13.351.500.852.593.150
MH_TH = NLM (2006)
ST = T047
MS = Inflammation of the UTERINE CERVIX.
PM = 2006; see CERVICITIS 1963-2005
HN = 2006 (1963)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D002575

*NEWRECORD
RECTYPE = D
MH = Uterine Cervical Diseases
DE = UTERINE CERVICAL DIS
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cervix Diseases|T047|NON|EQV|NLM (1966)|990101|CERVIX DIS|abcdefv
ENTRY = Cervical Disease, Uterine
ENTRY = Cervical Diseases, Uterine
ENTRY = Cervix Disease
ENTRY = Disease, Cervix
ENTRY = Disease, Uterine Cervical
ENTRY = Diseases, Cervix
ENTRY = Diseases, Uterine Cervical
ENTRY = Uterine Cervical Disease
MN = C13.351.500.852.593
MH_TH = NLM (2006)
ST = T047
AN = inflammatory disease = UTERINE CERVICITIS
MS = Pathological processes of the UTERINE CERVIX.
PM = 2006; see CERVIX DISEASES 1966-2005
HN = 2006 (1966)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19660101
UI = D002577

*NEWRECORD
RECTYPE = D
MH = Uterine Cervical Dysplasia
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Cervix Dysplasia|T191|NON|EQV|NLM (1977)|990101|abcdef
ENTRY = Cervical Dysplasia, Uterine
ENTRY = Dysplasia, Cervix
ENTRY = Dysplasia, Uterine Cervical
MN = C04.834.818
MN = C13.351.500.852.593.074
FX = Cervical Intraepithelial Neoplasia
FX = Uterine Cervical Neoplasms
MH_TH = NLM (2006)
ST = T191
PI = Cervix Diseases (1966-1976)
PI = Cervix Neoplasms (1966-1976)
MS = Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.
PM = 2006; see CERVIX DYSPLASIA 1984-2005, see CERVIX NEOPLASMS 1977-1983
HN = 2006(1984); use CERVIX NEOPLASMS 1977-1983
CATSH = CAT LIST
MR = 20140613
DA = 19771206
DC = 1
DX = 19840101
UI = D002578

*NEWRECORD
RECTYPE = D
MH = Uterine Cervical Erosion
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cervix Erosion|T047|NON|EQV|NLM (1963)|990101|abcdef
ENTRY = Uterine Cervix Erosion|T047|NON|EQV|NLM (2006)|050426|abcdef
ENTRY = Cervical Erosion, Uterine
ENTRY = Cervix Erosion, Uterine
ENTRY = Erosion, Cervix
ENTRY = Erosion, Uterine Cervical
ENTRY = Erosion, Uterine Cervix
MN = C13.351.500.852.593.112
MH_TH = NLM (2006)
ST = T047
MS = Loss or destruction of the epithelial lining of the UTERINE CERVIX.
PM = 2006; see CERVIX EROSION 1963-2005
HN = 2006 (1963)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D002579

*NEWRECORD
RECTYPE = D
MH = Uterine Cervical Incompetence
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Cervix Incompetence|T047|NON|EQV|NLM (1973)|990101|abcdef
ENTRY = Incompetent Cervix|T047|NON|EQV|NLM (2006)|041217|abcdef
ENTRY = Cervical Incompetence, Uterine
ENTRY = Cervices, Incompetent
ENTRY = Cervix, Incompetent
ENTRY = Incompetence, Cervix
ENTRY = Incompetence, Uterine Cervical
ENTRY = Incompetent Cervices
MN = C13.351.500.852.593.120
MN = C13.703.039.089.339
MH_TH = NLM (2006)
ST = T047
AN = check the tags FEMALE & PREGNANCY
PI = Abortion, Habitual (1966-1972)
PI = Cervix Diseases (1966-1972)
MS = Incompetent UTERINE CERVIX is usually diagnosed in the second trimester of PREGNANCY. It is characterized by passive painless cervical dilation in the absence of UTERINE CONTRACTION; BLEEDING; INFECTION; and sometimes with the amniotic sac (AMNIOTIC MEMBRANE) bulging through the partially dilated cervix. Left untreated, this condition may lead to premature pregnancy loss, such as HABITUAL ABORTION.
PM = 2006; see CERVIX INCOMPETENCE 1973-2005
HN = 2006 (1973)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19730101
UI = D002581

*NEWRECORD
RECTYPE = D
MH = Cervix Mucus
AQ = CH CY DE EN IM ME MI PH PS RA RE RI SE US VI
PRINT ENTRY = Fern Test|T060|NON|REL|NLM (1998)|961010|abcdef
PRINT ENTRY = Palm-Leaf Reaction|T060|NON|REL|NLM (1998)|961010|abcdef
ENTRY = Cervical Mucus|T031|NON|EQV|POPLINE (1978)|781219|abcdef
ENTRY = Fern Tests
ENTRY = Mucus, Cervical
ENTRY = Mucus, Cervix
ENTRY = Palm Leaf Reaction
ENTRY = Palm-Leaf Reactions
ENTRY = Reaction, Palm-Leaf
ENTRY = Reactions, Palm-Leaf
ENTRY = Test, Fern
ENTRY = Tests, Fern
MN = A12.200.503.339
MH_TH = NLM (1966)
ST = T031
MS = A slightly alkaline secretion of the endocervical glands. The consistency and amount are dependent on the physiological hormone changes in the menstrual cycle. It contains the glycoprotein mucin, amino acids, sugar, enzymes, and electrolytes, with a water content up to 90%. The mucus is a useful protection against the ascent of bacteria and sperm into the uterus. (From Dictionary of Obstetrics and Gynecology, 1988)
MR = 19970620
DA = 19990101
DC = 1
UI = D002582

*NEWRECORD
RECTYPE = D
MH = Uterine Cervical Neoplasms
DE = UTERINE CERVICAL NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Cancer of Cervix|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer of the Cervix|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cancer of the Uterine Cervix|T191|NON|NRW|NLM (2006)|050331|abcdef
ENTRY = Cervical Cancer|T191|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Cervical Neoplasms|T191|NON|EQV|NLM (1992)|900906|CERVICAL NEOPL|abcdefv
ENTRY = Cervix Cancer|T191|NON|NRW|NLM (2000)|991103|abcdef
ENTRY = Cervix Neoplasms|T191|NON|EQV|NLM (1963)|990101|CERVIX NEOPL|abcdefv
ENTRY = Neoplasms, Cervical|T191|NON|EQV|NLM (1992)|910617|NEOPL CERVICAL|abcdefv
ENTRY = Neoplasms, Cervix|T191|NON|EQV|NLM (1992)|910617|NEOPL CERVIX|abcdefv
ENTRY = Uterine Cervical Cancer|T191|NON|NRW|NLM (2006)|050331|abcdef
ENTRY = Cancer, Cervix
ENTRY = Cancer, Uterine Cervical
ENTRY = Cancers, Cervix
ENTRY = Cancers, Uterine Cervical
ENTRY = Cervical Cancer, Uterine
ENTRY = Cervical Cancers, Uterine
ENTRY = Cervical Neoplasm
ENTRY = Cervical Neoplasm, Uterine
ENTRY = Cervical Neoplasms, Uterine
ENTRY = Cervix Neoplasm
ENTRY = Neoplasm, Cervical
ENTRY = Neoplasm, Cervix
ENTRY = Neoplasm, Uterine Cervical
ENTRY = Neoplasms, Uterine Cervical
ENTRY = Uterine Cervical Cancers
ENTRY = Uterine Cervical Neoplasm
MN = C04.588.945.418.948.850
MN = C13.351.500.852.593.131
MN = C13.351.500.852.762.850
MN = C13.351.937.418.875.850
FX = Cervical Intraepithelial Neoplasia
FX = Uterine Cervical Dysplasia
MH_TH = NLM (2006)
ST = T191
AN = coordinate IM with histologic type of neoplasm (IM)
MS = Tumors or cancer of the UTERINE CERVIX.
PM = 2006; see CERVIX NEOPLASMS (1963-2005)
HN = 2006 (1963)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002583

*NEWRECORD
RECTYPE = D
MH = Cervix Uteri
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Cervix|T023|NON|EQV|NLM (1980)|781219|abcdef
ENTRY = Cervixes|T023|NON|EQV|NLM (1992)|911104|abcdef
ENTRY = Uterine Cervix|T023|NON|EQV|NLM (2004)|030606|abcdef
ENTRY = Cervix, Uterine
MN = A05.360.319.679.256
FX = Colposcopy
MH_TH = NLM (1966)
ST = T023
AN = inflammation = CERVICITIS; conization = CERVIX UTERI /pathol (IM) + CONIZATION (IM)
MS = The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal.
OL = use CERVIX UTERI to search CERVIX HYPERTROPHY 1966-96
PM = CERVIX HYPERTROPHY was heading 1963-96
HN = CERVIX HYPERTROPHY was heading 1963-96
MR = 20030709
DA = 19990101
DC = 1
UI = D002584

*NEWRECORD
RECTYPE = D
MH = Cesarean Section
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Abdominal Delivery|T061|NON|EQV|NLM (2005)|031106|abcdef
PRINT ENTRY = Delivery, Abdominal|T061|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = C-Section (OB)|T061|NON|EQV|NLM (2005)|030827|abcdef
ENTRY = Caesarean Section|T061|NON|EQV|NLM (2005)|030813|abcdef
ENTRY = Postcesarean Section|T079|NON|REL|NLM (1988)|861231|abcdef
ENTRY = Abdominal Deliveries
ENTRY = C Section (OB)
ENTRY = C-Sections (OB)
ENTRY = Caesarean Sections
ENTRY = Cesarean Sections
ENTRY = Deliveries, Abdominal
MN = E04.520.252.500
FX = Vaginal Birth after Cesarean
MH_TH = BIOETHICS (1989)
MH_TH = NLM (1963)
ST = T061
AN = check the tags FEMALE & PREGNANCY; anesthesia in cesareans: coord IM with ANESTHESIA, OBSTETRICAL (IM)
MS = Extraction of the FETUS by means of abdominal HYSTEROTOMY.
CATSH = CAT LIST
MR = 20040707
DA = 19990101
DC = 1
UI = D002585

*NEWRECORD
RECTYPE = D
MH = Cesium
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.549.125
MN = D01.268.556.165
MN = D01.552.528.160
MN = D01.552.544.165
FX = Cesium Isotopes
FX = Cesium Radioisotopes
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T196
N1 = Cesium
RN = 1KSV9V4Y4I
RR = 7440-46-2 (Cesium)
AN = an alkali metal; Cs-133
MS = A member of the alkali metals. It has an atomic symbol Cs, atomic number 50, and atomic weight 132.91. Cesium has many industrial applications, including the construction of atomic clocks based on its atomic vibrational frequency.
MR = 20130708
DA = 19990101
DC = 1
UI = D002586

*NEWRECORD
RECTYPE = D
MH = Cesium Isotopes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Isotopes, Cesium
MN = D01.496.180
MH_TH = NLM (1966)
ST = T196
RN = 0
AN = Cs-133; NIM
MS = Stable cesium atoms that have the same atomic number as the element cesium, but differ in atomic weight. Cs-133 is a naturally occurring isotope.
MR = 20000622
DA = 19990101
DC = 1
UI = D002587

*NEWRECORD
RECTYPE = D
MH = Cesium Radioisotopes
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Radioisotopes, Cesium
MN = D01.496.180.300
MN = D01.496.749.190
MH_TH = NLM (1975)
ST = T196
RN = 0
AN = Cs-123,125-32,134-144; for routine use as tracer, use no qualifiers
PI = Cesium Isotopes (1966-1974)
PI = Radioisotopes (1966-1974)
MS = Unstable isotopes of cesium that decay or disintegrate emitting radiation. Cs atoms with atomic weights of 123, 125-132, and 134-145 are radioactive cesium isotopes.
OL = search CESIUM ISOTOPES 1966-74
PM = 75
HN = 75
MR = 20150605
DA = 19741111
DC = 1
DX = 19750901
UI = D002588

*NEWRECORD
RECTYPE = D
MH = Cestoda
AQ = AH CH CL CY DE EM EN GD GE IM IP ME MI PH PS PY RE UL VI
PRINT ENTRY = Raillietina|T204|NON|NRW|UNK (19XX)|850322|abcdef
PRINT ENTRY = Tapeworms|T204|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Cestodes|T204|NON|EQV|UNK (19XX)|880712|abcdef
ENTRY = Cestodas
ENTRY = Cestode
ENTRY = Raillietinas
ENTRY = Tapeworm
MN = B01.050.500.500.736.215
FX = Anticestodal Agents
MH_TH = NLM (1965)
ST = T204
AN = GEN; IM; infection = CESTODE INFECTIONS; /drug eff: consider also ANTICESTODAL AGENTS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
MS = A subclass of segmented worms comprising the tapeworms.
OL = use CESTODA to search RAILLIETINA 1966-85
PM = 65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1979-85, was indexed under CESTODA 1975-78
HN = 65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1978-85
MR = 20090706
DA = 19990101
DC = 1
DX = 19650101
UI = D002589

*NEWRECORD
RECTYPE = D
MH = Cestode Infections
DE = CESTODE INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Bertielliasis|T047|NON|REL|UNK (19XX)|850322|abcdef
PRINT ENTRY = Cenuriasis|T047|NON|NRW|UNK (19XX)|810518|abcdef
PRINT ENTRY = Coenuriasis|T047|NON|NRW|UNK (19XX)|810518|abcdef
PRINT ENTRY = Dipylidiasis|T047|NON|REL|UNK (19XX)|850322|abcdef
PRINT ENTRY = Raillietiniasis|T047|NON|REL|UNK (19XX)|850322|abcdef
PRINT ENTRY = Tapeworm Infection|T047|NON|EQV|UNK (19XX)|740329|TAPEWORM INFECT|abcdefv
ENTRY = Bertielliases
ENTRY = Cenuriases
ENTRY = Cestode Infection
ENTRY = Coenuriases
ENTRY = Dipylidiases
ENTRY = Infection, Cestode
ENTRY = Infection, Tapeworm
ENTRY = Infections, Cestode
ENTRY = Infections, Tapeworm
ENTRY = Raillietiniases
ENTRY = Tapeworm Infections
MN = C03.335.190
FX = Anticestodal Agents
MH_TH = NLM (1966)
ST = T047
AN = helminth infect; GEN only; prefer specifics; /drug ther: consider also ANTICESTODAL AGENTS
MS = Infections with true tapeworms of the helminth subclass CESTODA.
OL = use CESTODE INFECTIONS to search DIPYLIDIASIS & RAILLIETINIASIS 1968-85 & CENURIASIS 1968-81
PM = 65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS & RAILLIETINIASIS were headings 1968-85
HN = 65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS & RAILLIETINIASIS were headings 1968-85
CATSH = CAT LIST
MR = 19930604
DA = 19990101
DC = 1
UI = D002590

*NEWRECORD
RECTYPE = D
MH = Cetacea
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Cetaceas
MN = B01.050.150.900.649.189
MH_TH = NLM (1966)
ST = T015
AN = general or unspecified; prefer DOLPHINS; PORPOISES; or WHALES; or specifics
MS = An order of wholly aquatic MAMMALS occurring in all the OCEANS and adjoining seas of the world, as well as in certain river systems. They feed generally on FISHES, cephalopods, and crustaceans. Most are gregarious and most have a relatively long period of parental care and maturation. Included are DOLPHINS; PORPOISES; and WHALES. (From Walker's Mammals of the World, 5th ed, pp969-70)
MR = 20090706
DA = 19990101
DC = 1
UI = D002591

*NEWRECORD
RECTYPE = D
MH = Cetomacrogol
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Polyethylene Glycol Cetyl Ether|T109|T121|NON|EQV|UNK (19XX)|800414|abbcdef
ENTRY = Brij 52|T109|T121|TRD|NRW|UNK (19XX)|820203|abbcdef
ENTRY = Brij 56|T109|T121|TRD|NRW|UNK (19XX)|810519|abbcdef
ENTRY = Brij 58|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Brij-58|T109|T121|TRD|NRW|UNK (19XX)|800730|abbcdef
ENTRY = Cetomacrogol 1000|T109|T121|NON|NRW|BAN (19XX)|INN (19XX)|941117|abbcdeef
ENTRY = Polyethylene Glycol Monohexadecyl Ether|T109|T121|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = alpha-Hexadecyl-omega-Hydroxypoly(oxy-1,2-Ethanediyl)|T109|T121|NON|EQV|NLM (1996)|950404|abbcdef
ENTRY = n-Hexadecane Polyoxyethylene Glycol Monether|T109|T121|NON|EQV|UNK (19XX)|870812|abbcdef
ENTRY = Brij58
ENTRY = n Hexadecane Polyoxyethylene Glycol Monether
MN = D02.033.455.250.700.150
MN = D05.750.741.250
MN = D25.720.741.250
MN = J01.637.051.720.741.250
PA = Surface-Active Agents
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Poly(oxy-1,2-ethanediyl), alpha-hexadecyl-omega-hydroxy-
RN = 9004-95-9
AN = D25-26 qualif
PI = Polyethylene Glycols (1974)
MS = Non-ionic surfactant of the polyethylene glycol family. It is used as a solubilizer and emulsifying agent in foods, cosmetics, and pharmaceuticals, often as an ointment base, and also as a research tool.
PM = 91; was see under POLYETHYLENE GLYCOLS 1975-90
HN = 91(75); was see under POLYETHYLENE GLYCOLS 1975-90
MR = 20060705
DA = 19741111
DC = 1
DX = 19910101
UI = D002592

*NEWRECORD
RECTYPE = D
MH = Cetrimonium Compounds
DE = CETRIMONIUM CPDS
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Cetyltrimethylammonium Compounds|T109|T121|NON|EQV|UNK (19XX)|741111|CETYLTRIMETHYLAMMONIUM CPDS|abbcdefv
ENTRY = Cetrimides|T109|T121|NON|NRW|UNK (19XX)|800411|abbcdef
ENTRY = Compounds, Cetrimonium
ENTRY = Compounds, Cetyltrimethylammonium
MN = D02.092.877.883.111
MN = D02.675.276.190
MH_TH = NLM (1975)
ST = T109
ST = T121
RN = 0
AN = D25-26 qualif; DF: CETRIMONIUM CPDS
PI = Alkanes (1972-1974)
PI = Ammonium Compounds (1968-1974)
MS = Cetyltrimethylammonium compounds that have cationic detergent, antiseptic, and disinfectant activities. They are used in pharmaceuticals, foods, and cosmetics as preservatives; on skin, mucous membranes, etc., as antiseptics or cleansers, and also as emulsifiers. These compounds are toxic when used orally due to neuromuscular blockade.
PM = 91; was see under AMMONIUM COMPOUNDS 1975-90
HN = 91(75); was see under AMMONIUM COMPOUNDS 1975-90
MR = 20050630
DA = 19741111
DC = 1
DX = 19910101
UI = D002593

*NEWRECORD
RECTYPE = D
MH = Cetylpyridinium
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Angifonil|T109|T121|TRD|NRW|ES|041220|abbcdef
ENTRY = Aventis Pharma Brand of Cetylpyridinium Chloride|T109|T121|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Biosept|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Boots Brand of Cetylpyridinium Chloride|T109|T121|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Catamium|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Ceepryn Chloride|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Cetamium|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Cetylpyridinium Chloride|T109|T121|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|USP (19XX)|820204|abbcdeeeef
ENTRY = Cetylpyridinium Chloride Anhydrous|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2014)|130617|abbcdeef
ENTRY = Cetylpyridium|T109|T121|NON|EQV|UNK (19XX)|781218|abbcdef
ENTRY = Cetylyre|T109|T121|TRD|NRW|FR|041220|abbcdef
ENTRY = Diviser Aquilea Brand of Cetylpyridinium Chloride|T109|T121|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Dobendan|T109|T121|TRD|NRW|DE|810108|abbcdef
ENTRY = Hexadecylpyridinium|T109|T121|NON|EQV|UNK (19XX)|810918|abbcdef
ENTRY = Intra Veno Brand of Cetylpyridinium Chloride|T109|T121|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Merocets|T109|T121|TRD|NRW|IE|UK|041220|abbcdeef
ENTRY = Pristacin|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Pyrisept|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Sterogenol|T109|T121|TRD|NRW|UNK (19XX)|811023|abbcdef
ENTRY = UPSA Conseil Brand of Cetylpyridinium Chloride|T109|T121|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Anhydrous, Cetylpyridinium Chloride
ENTRY = Chloride Anhydrous, Cetylpyridinium
ENTRY = Chloride, Ceepryn
ENTRY = Chloride, Cetylpyridinium
MN = D03.383.725.762.232
PA = Anti-Infective Agents, Local
PA = Detergents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T121
N1 = Pyridinium, 1-hexadecyl-
RN = CUB7JI0JV3
RR = 6BR7T22E2S
RR = 7773-52-6 (Cetylpyridinium)
RR = D9OM4SK49P
AN = an anti-infective; = Cepacol
PI = Anti-Infective Agents, Local (1966-1971)
PI = Pyridinium Compounds (1968-1971)
PI = Surface-Active Agents (1966-1971)
MS = Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
PM = 91; was see under PYRIDINIUM COMPOUNDS 1972-90
HN = 91(72); was see under PYRIDINIUM COMPOUNDS 1972-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002594

*NEWRECORD
RECTYPE = D
MH = Cevanes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cevane Alkaloids|T109|NON|EQV|NLM (2001)|000525|abcdef
ENTRY = Alkaloids, Cevane
MN = D03.132.920.256
MN = D03.549.256
MH_TH = NLM (1969)
ST = T109
RN = 0
PI = Veratrum (1966-1968)
MS = Structurally-related alkaloids that contain the cevane carbon backbone.
PM = 69
HN = 69
MR = 20000621
DA = 19990101
DC = 1
DX = 19690101
UI = D002595

*NEWRECORD
RECTYPE = D
MH = Chad
AQ = EH EP
MN = Z01.058.290.100.130
MH_TH = NLM (1978)
ST = T083
MS = A republic in central Africa, east of NIGER, west of SUDAN and south of LIBYA. Its capital is N'Djamena.
MR = 20080708
DA = 19990101
DC = 4
UI = D002596

*NEWRECORD
RECTYPE = D
MH = Chaetomium
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
ENTRY = Chaetomiums
MN = B01.300.107.800.150
MH_TH = NLM (1975)
ST = T004
MS = A genus of ascomycetous fungi of the family Chaetomiaceae, order SORDARIALES. Many members are cellulolytic and some mycotoxic. They occur naturally on paper and cotton fabric.
PM = 91; see ASCOMYCETES 1975-90
HN = 91(75)
MR = 20090706
DA = 19741212
DC = 1
DX = 19910101
UI = D002597

*NEWRECORD
RECTYPE = D
MH = Chagas Cardiomyopathy
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Cardiomyopathy, Chagas|T047|EPO|EQV|UNK (19XX)|800402|abcdef
PRINT ENTRY = Myocarditis, Chagas|T047|NON|NRW|NLM (1998)|960710|abcdef
PRINT ENTRY = Trypanosomiasis, Cardiovascular|T047|NON|EQV|UNK (19XX)|800402|abcdef
ENTRY = Chagas' Cardiomyopathy|T047|EPO|EQV|NLM (1992)|910430|abcdef
ENTRY = Cardiomyopathy, Chagas'
ENTRY = Cardiovascular Trypanosomiasis
MN = C03.752.300.900.200.190
MN = C14.280.238.190
MH_TH = NLM (1981)
ST = T047
PI = Heart Diseases (1966-1980)
PI = Trypanosomiasis, South American (1966-1980)
PI = specific heart disease (1966-1980)
MS = A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.
PM = 81
HN = 81
CATSH = CAT LIST
MR = 20090706
DA = 19800402
DC = 1
DX = 19810101
UI = D002598

*NEWRECORD
RECTYPE = D
MH = Chalcone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Benzalacetophenone|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abcdeef
PRINT ENTRY = Benzylideneacetophenone|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abcdeef
ENTRY = 1,3-Diphenyl-2-Propen-1-One|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|810108|abcdeef
ENTRY = Chalkone|T109|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abcdeef
ENTRY = 1,3 Diphenyl 2 Propen 1 One
MN = D02.522.818.222.500
MN = D03.383.663.283.266.450.221.500
MN = D03.438.150.266.450.221.500
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
N1 = 2-Propen-1-one, 1,3-diphenyl-
RN = 5S5A2Q39HX
RR = 94-41-7 (Chalcone)
AN = do not confuse with CHALONES see GROWTH INHIBITORS
PI = Alkenes (1973-1974)
PI = Propiophenones (1969-1974)
PM = 91; was see under PROPIOPHENONES 1975-90
HN = 91(75); was see under PROPIOPHENONES 1975-90
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D002599

*NEWRECORD
RECTYPE = D
MH = Chancre
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Chancres
MN = C01.252.400.840.744.161
MN = C01.252.847.840.744.161
MH_TH = NLM (1975)
ST = T184
AN = primary lesion of syphilis: do not confuse with CHANCROID (caused by Haemophilus ducreyi)
MS = The primary sore of syphilis, a painless indurated, eroded papule, occurring at the site of entry of the infection.
OL = search SYPHILIS 1966-74
PM = 91; was see under SYPHILIS 1975-90
HN = 91(75); was see under SYPHILIS 1975-90
CATSH = CAT LIST
MR = 19911125
DA = 19990101
DC = 1
DX = 19910101
UI = D002601

*NEWRECORD
RECTYPE = D
MH = Chancroid
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Chancroids
MN = C01.252.400.700.433.257
MN = C01.252.810.201
MN = C01.539.778.281.201
MN = C12.294.668.281.201
MN = C13.351.500.711.281.201
MH_TH = POPLINE (1993)
ST = T047
AN = caused by Haemophilus ducreyi; do not confuse with CHANCRE, the primary lesion of syphilis
MS = Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
UI = D002602

*NEWRECORD
RECTYPE = D
MH = Channel Islands
AQ = EH EP
PRINT ENTRY = Alderney Island|T083|NAM|NRW|UNK (19XX)|750101|abcdef
PRINT ENTRY = Jersey Island|T083|NAM|NRW|UNK (19XX)|750101|abcdef
PRINT ENTRY = Sark|T083|NAM|NRW|NLM (1994)|920820|abcdef
MN = Z01.542.363.161
MN = Z01.639.280.161
MH_TH = POPLINE (1983)
ST = T083
AN = Channel refers to the English Channel
MS = A group of four British islands and several islets in the English Channel off the coast of France. They are known to have been occupied prehistorically. They were a part of Normandy in 933 but were united to the British crown at the time of the Norman Conquest in 1066. Guernsey and Jersey originated noted breeds of cattle. (From Webster's New Geographical Dictionary, 1988, p242)
MR = 20120703
DA = 19990101
DC = 4
UI = D002603

*NEWRECORD
RECTYPE = D
MH = Chaplaincy Service, Hospital
DE = CHAPLAINCY SERV HOSP
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
PRINT ENTRY = Hospital Chaplaincy Service|T093|NON|EQV|UNK (19XX)|770519|HOSP CHAPLAINCY SERV|abcdefv
ENTRY = Service, Chaplaincy Hospital|T093|NON|EQV|NLM (1996)|950303|SERV CHAPLAINCY HOSP|abcdefv
ENTRY = Service, Hospital Chaplaincy|T093|NON|EQV|NLM (1996)|940811|SERV HOSP CHAPLAINCY|abcdefv
ENTRY = Chaplaincy Hospital Service
ENTRY = Chaplaincy Hospital Services
ENTRY = Chaplaincy Services, Hospital
ENTRY = Hospital Chaplaincy Services
ENTRY = Hospital Service, Chaplaincy
ENTRY = Hospital Services, Chaplaincy
ENTRY = Services, Chaplaincy Hospital
ENTRY = Services, Hospital Chaplaincy
MN = N02.278.216.500.968.270
MN = N04.452.442.422.270
MH_TH = NLM (1977)
ST = T093
AN = IM; coord with specific religion (IM) if pertinent; DF: CHAPLAINCY SERV HOSP
MS = Hospital department which administers religious activities within the hospital, e.g., pastoral care, religious services.
PM = 91; was see under HOSPITAL DEPARTMENTS Aug 1977-90
HN = 91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90
MR = 20150622
DA = 19770519
DC = 1
DX = 19910101
UI = D002604

*NEWRECORD
RECTYPE = D
MH = Character
ENTRY = Characters
MN = F01.752.190
MH_TH = NLM (1966)
ST = T041
AN = no qualif
MS = In current usage, approximately equivalent to personality. The sum of the relatively fixed personality traits and habitual modes of response of an individual.
CATSH = CAT LIST
MR = 19890428
DA = 19990101
DC = 1
UI = D002605

*NEWRECORD
RECTYPE = D
MH = Charcoal
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Activated Charcoal|T121|T196|NON|NRW|NLM (1994)|USP (19XX)|930324|abbcdeef
ENTRY = Actidose|T121|T196|TRD|NRW|US|041220|abbcdef
ENTRY = Actidose-Aqua|T121|T196|TRD|NRW|UK|US|041220|abbcdeef
ENTRY = Adsorba|T121|T196|TRD|NRW|US|041220|abbcdef
ENTRY = Cambridge Laboratories Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Carbomix|T121|T196|TRD|NRW|FR|IE|UK|041220|abbcdeeef
ENTRY = Central Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Charbon|T121|T196|TRD|NRW|FR|041220|abbcdef
ENTRY = CharcoAid|T121|T196|TRD|NRW|US|041220|abbcdef
ENTRY = CharcoCaps|T121|T196|TRD|NRW|US|041220|abbcdef
ENTRY = Charcodote|T121|T196|TRD|NRW|CA|041220|abbcdef
ENTRY = Chefaro Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Cheplapharm Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Formocarbine|T121|T196|TRD|NRW|FR|041220|abbcdef
ENTRY = Gambro Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = GlaxoSmithKline Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Hevert Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Insta-Char|T121|T196|TRD|NRW|US|041220|abbcdef
ENTRY = Kerr Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Kohle-Compretten|T121|T196|TRD|NRW|DE|041221|abbcdef
ENTRY = Kohle-Hevert|T121|T196|TRD|NRW|DE|041221|abbcdef
ENTRY = Kohle-Pulvis|T121|T196|TRD|NRW|DE|041221|abbcdef
ENTRY = Kohle-Tabletten Boxo-Pharm|T121|T196|TRD|NRW|DE|041221|abbcdef
ENTRY = Khler Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Liqui-Char|T121|T196|TRD|NRW|US|041220|abbcdef
ENTRY = Little Remedies Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Merck Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Merck Selbstmedikation Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Monarch Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Norit|T121|T196|TRD|NRW|NLM (1994)|930223|abbcdef
ENTRY = Paddock Brand 1 of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Paddock Brand 2 of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Penn Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Pharmascience Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Pharmygine Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Requa Brand of Activated Charcoal|T121|T196|NON|NRW|NLM (2006)|041220|abbcdef
ENTRY = Ultracarbon|T121|T196|TRD|NRW|DE|041221|abbcdef
ENTRY = Charcoal, Activated
MN = D01.268.150.150
PA = Antidotes
MH_TH = NLM (1966)
ST = T121
ST = T196
RN = 16291-96-6
RR = 64365-11-3 (activated)
AN = D25-26 qualif only
MS = An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed)
PM = 1994; for NORIT see CARBON 1982-1993
HN = 1994; for NORIT use CARBON 1982-1993
MR = 20060705
DA = 19990101
DC = 1
UI = D002606

*NEWRECORD
RECTYPE = D
MH = Charcot-Marie-Tooth Disease
DE = CHARCOT MARIE TOOTH DIS
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Atrophy, Muscular, Peroneal|T047|NON|EQV|NLM (2000)|991108|abcdef
PRINT ENTRY = HMSN Type I|T047|NRW|UNK (19XX)|880607|abdef
PRINT ENTRY = HMSN Type II|T047|NRW|UNK (19XX)|880607|abdef
PRINT ENTRY = Hereditary Motor and Sensory-Neuropathy Type II|T047|NON|NRW|NLM (2000)|991108|HEREDITARY MOTOR SENSORY TYPE II NEUROPATHY|abcdefs
PRINT ENTRY = Hereditary Motor, and Sensory Neuropathy Type I|T047|NON|NRW|NLM (2000)|991108|HEREDITARY MOTOR SENSORY TYPE I NEUROPATHY|abcdefs
PRINT ENTRY = Muscular Atrophy, Peroneal|T047|NON|EQV|NLM (2000)|991108|abcdef
PRINT ENTRY = Peroneal Muscular Atrophy|T047|NON|EQV|GHR (2014)|NLM (2000)|OMIM (2013)|ORD (2010)|991108|abcdeeeef
PRINT ENTRY = Roussy-Levy Syndrome|T047|EPO|REL|NLM (1991)|OMIM (2013)|ORD (2010)|900112|abcdeeef
ENTRY = Charcot-Marie Disease|T047|EPO|EQV|NLM (1975)|990101|CHARCOT MARIE DIS|abcdefv
ENTRY = Charcot-Marie-Tooth Disease, Autosomal Dominant, With Focally Folded Myelin Sheaths, Type 1A|T047|NON|NRW|OMIM (2013)|130614|abcdef
ENTRY = Charcot-Marie-Tooth Disease, Autosomal Dominant, with Focally Folded Myelin Sheaths, Type 1B|T047|EPO|NRW|OMIM (2013)|130614|abcdef
ENTRY = Charcot-Marie-Tooth Disease, Demyelinating, Type 1A|T047|EPO|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101214|abcdeeef
ENTRY = Charcot-Marie-Tooth Disease, Demyelinating, Type 1B|T047|EPO|NRW|NLM (2012)|OMIM (2013)|ORD (2010)|101228|abcdeeef
ENTRY = Charcot-Marie-Tooth Disease, Slow Nerve Conduction Type, Linked To Duffy|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Charcot-Marie-Tooth Disease, Type 1A|T047|EPO|NRW|NLM (2012)|ORD (2010)|101214|abcdeef
ENTRY = Charcot-Marie-Tooth Disease, Type 1B|T047|EPO|NRW|NLM (2012)|ORD (2010)|101228|abcdeef
ENTRY = Charcot-Marie-Tooth Disease, Type I|T047|NON|NRW|NLM (2000)|991108|CHARCOT MARIE TOOTH DIS TYPE I|abcdefv
ENTRY = Charcot-Marie-Tooth Disease, Type IA|T047|EPO|NRW|NLM (2000)|130614|abcdef
ENTRY = Charcot-Marie-Tooth Disease, Type IB|T047|EPO|NRW|NLM (2000)|130614|abcdef
ENTRY = Charcot-Marie-Tooth Disease, Type II|T047|NON|NRW|NLM (2000)|991108|CHARCOT MARIE TOOTH DIS TYPE II|abcdefv
ENTRY = Charcot-Marie-Tooth Hereditary Neuropathy|T047|EPO|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Charcot-Marie-Tooth Neuropathy, Type 1A|T047|EPO|NRW|OMIM (2013)|130614|abcdef
ENTRY = Charcot-Marie-Tooth Neuropathy, Type 1B|T047|EPO|NRW|OMIM (2013)|130617|abcdef
ENTRY = Charcot-Marie-Tooth Syndrome|T047|EPO|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = HMN Distal Type I|T047|NRW|UNK (19XX)|880607|abdef
ENTRY = HMSN 1A|T047|NON|NRW|NLM (2012)|090224|abcdef
ENTRY = HMSN 1B|T047|NON|NRW|NLM (2012)|ORD (2010)|090224|abcdeef
ENTRY = HMSN I|T047|NON|NRW|NLM (2000)|OMIM (2013)|991108|abcdeef
ENTRY = HMSN IA|T047|ABB|NRW|OMIM (2013)|130614|abcdef
ENTRY = HMSN IB|T047|ABB|NRW|OMIM (2013)|130617|abcdef
ENTRY = HMSN II|T047|NON|NRW|NLM (2000)|991108|abcdef
ENTRY = HMSN1A|T047|ABB|NRW|OMIM (2013)|130614|abcdef
ENTRY = HMSN1B|T047|ABB|NRW|OMIM (2013)|130617|abcdef
ENTRY = Hereditary Areflexic Dystasia|T047|NON|REL|NLM (2010)|ORD (2010)|090514|abcdeef
ENTRY = Hereditary Motor And Sensory Neuropathy IB|T047|NON|NRW|OMIM (2013)|130614|abcdef
ENTRY = Hereditary Motor and Sensory Neuropathy 1A|T047|NON|NRW|NLM (2012)|ORD (2010)|101214|abcdeef
ENTRY = Hereditary Motor and Sensory Neuropathy 1B|T047|NON|NRW|NLM (2012)|ORD (2010)|101228|abcdeef
ENTRY = Hereditary Motor and Sensory Neuropathy IA|T047|NON|NRW|OMIM (2013)|130614|abcdef
ENTRY = Hereditary Type I Motor and Sensory Neuropathy|T047|NON|NRW|UNK (19XX)|880607|HEREDITARY TYPE I MOTOR SENSORY NEUROPATHY|abcdefv
ENTRY = Neuropathy, Type I Hereditary Motor and Sensory|T047|NON|NRW|UNK (19XX)|880607|NEUROPATHY TYPE I HEREDITARY MOTOR SENSORY|abcdefv
ENTRY = Neuropathy, Type II Hereditary Motor and Sensory|T047|NON|NRW|NLM (2000)|991108|NEUROPATHY TYPE II HEREDITARY MOTOR SENSORY|abcdefv
ENTRY = Roussy Levy Hereditary Areflexic Dystasia|T047|EPO|REL|NLM (2010)|ORD (2010)|090514|abcdeef
ENTRY = Roussy-Levy Disease|T047|EPO|REL|NLM (2010)|ORD (2010)|090514|abcdeef
ENTRY = Roussy-Levy Hereditary Areflexic Dystasia|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Areflexic Dystasia, Hereditary
ENTRY = Areflexic Dystasias, Hereditary
ENTRY = Atrophies, Peroneal Muscular
ENTRY = Atrophy, Peroneal Muscular
ENTRY = Charcot Marie Disease
ENTRY = Charcot Marie Tooth Disease
ENTRY = Charcot Marie Tooth Disease, Type 1A
ENTRY = Charcot Marie Tooth Disease, Type 1B
ENTRY = Charcot Marie Tooth Disease, Type I
ENTRY = Charcot Marie Tooth Disease, Type IA
ENTRY = Charcot Marie Tooth Disease, Type IB
ENTRY = Charcot Marie Tooth Disease, Type II
ENTRY = Charcot Marie Tooth Hereditary Neuropathy
ENTRY = Charcot Marie Tooth Neuropathy, Type 1A
ENTRY = Charcot Marie Tooth Neuropathy, Type 1B
ENTRY = Charcot Marie Tooth Syndrome
ENTRY = Dystasia, Hereditary Areflexic
ENTRY = Dystasias, Hereditary Areflexic
ENTRY = Hereditary Areflexic Dystasias
ENTRY = Hereditary Motor and Sensory Neuropathy Type II
ENTRY = Hereditary Neuropathy, Charcot-Marie-Tooth
ENTRY = Muscular Atrophies, Peroneal
ENTRY = Peroneal Muscular Atrophies
ENTRY = Roussy Levy Disease
ENTRY = Roussy Levy Syndrome
ENTRY = Syndrome, Charcot-Marie-Tooth
ENTRY = Syndrome, Roussy-Levy
MN = C10.500.300.200
MN = C10.574.500.495.200
MN = C10.668.829.800.300.200
MN = C16.131.666.300.200
MN = C16.320.400.375.200
FX = Myelin P0 Protein
MH_TH = GHR (2014)
MH_TH = ORD (2010)
MH_TH = UNK (19XX)
ST = T047
MS = A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)
PM = 2000; see CHARCOT-MARIE DISEASE 1991-1999, see MUSCULAR ATROPHY, SPINAL 1988-1990, see MUSCULAR ATROPHY 1966-1987; for CHARCOT-MARIE-TOOTH DISEASE see CHARCOT-MARIE DISEASE 1991-1999
HN = 2000(1966)
CATSH = CAT LIST
MR = 20130708
DA = 19991108
DC = 1
DX = 19910101
UI = D002607

*NEWRECORD
RECTYPE = D
MH = Charities
AQ = CL EC ED ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Charity
MN = I01.880.787.190
MN = N03.540.125
FX = Gift Giving
FX = Uncompensated Care
MH_TH = NLM (1966)
ST = T095
MS = Social welfare organizations with programs designed to assist individuals in need.
MR = 20110624
DA = 19990101
DC = 1
UI = D002608

*NEWRECORD
RECTYPE = D
MH = Chediak-Higashi Syndrome
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Chediak-Steinbrinck-Higashi Syndrome|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Oculocutaneous Albinism with Leukocyte Defect|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Chediak Higashi Syndrome
ENTRY = Syndrome, Chediak-Higashi
MN = C15.378.553.774.257
MN = C20.673.774.257
FX = Aleutian Mink Disease
MH_TH = GHR (2014)
MH_TH = NLM (1971)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
AN = "a form of phagocyte bactericidal dysfunct"
PI = Immunologic Deficiency Syndromes (1968-1970)
PI = Leukocytes (1966-1970)
MS = A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.
PM = 71
HN = 71
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19710101
UI = D002609

*NEWRECORD
RECTYPE = D
MH = Cheek
AQ = AB AH BS EM GD IN IR MI PA PH PP PS RA RE RI SU US VI
PRINT ENTRY = Bucca|T029|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Buccas
ENTRY = Cheeks
MN = A01.456.505.173
MN = A14.194
MH_TH = NLM (1966)
ST = T029
AN = for that external portion of face or that internal portion of mouth; NIM for hamster cheek pouch; buccal mucosa = MOUTH MUCOSA (IM) + CHEEK (NIM); cheek bone fracture = ZYGOMATIC FRACTURES
MS = The part of the face that is below the eye and to the side of the nose and mouth.
MR = 20150302
DA = 19990101
DC = 1
UI = D002610

*NEWRECORD
RECTYPE = D
MH = Cheese
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Cheeses
MN = G07.203.300.350.200
MN = J02.500.350.200
MH_TH = NLM (1966)
ST = T168
MS = A nutritious food consisting primarily of the curd or the semisolid substance formed when milk coagulates.
MR = 20141014
DA = 19990101
DC = 1
UI = D002611

*NEWRECORD
RECTYPE = D
MH = Acinonyx
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Cheetahs|T015|NON|EQV|NLM (1975)|990101|abcdef
ENTRY = Cheetah
MN = B01.050.150.900.649.147.354.030
MH_TH = NLM (1998)
ST = T015
MS = A genus of long-legged, swift-moving felines (FELIDAE) from Africa (and formerly Asia) about the size of a small leopard.
PM = 2005; see CHEETAHS 1991-2004, see CARNIVORA 1975-1990
HN = 2005 (1975)
MR = 20090706
DA = 19741212
DC = 1
DX = 19910101
UI = D002612

*NEWRECORD
RECTYPE = D
MH = Cheilitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Cheilitides
MN = C07.465.409.215
MH_TH = NLM (1966)
ST = T047
AN = inflamm of the lips
MS = Inflammation of the lips. It is of various etiologies and degrees of pathology.
CATSH = CAT LIST
MR = 19930526
DA = 19990101
DC = 1
UI = D002613

*NEWRECORD
RECTYPE = D
MH = Chelating Agents
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Complexons|T121|T130|NON|EQV|UNK (19XX)|740329|abbcdef
PRINT ENTRY = Metal Antagonists|T121|NON|BRD|NLM (1996)|950502|abcdef
ENTRY = Chelators|T121|T130|NON|EQV|NLM (1996)|950502|abbcdef
ENTRY = Metal Chelating Agents|T121|NON|NRW|NLM (2015)|130828|abcdef
ENTRY = Agents, Chelating
ENTRY = Agents, Metal Chelating
ENTRY = Antagonists, Metal
ENTRY = Chelating Agents, Metal
MN = D27.505.519.914.500
MN = D27.720.832.500
FX = Antidotes
FX = Iron Chelating Agents
MH_TH = NLM (1966)
ST = T121
ST = T130
RN = 0
MS = Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS.
PM = HEAVY METAL DETOXICANTS was heading 1963-65
HN = HEAVY METAL DETOXICANTS was heading 1963-65
MR = 20140610
DA = 19990101
DC = 1
UI = D002614

*NEWRECORD
RECTYPE = D
MH = Chemexfoliation
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Chemical Face Peeling|T061|NON|NRW|UNK (19XX)|760412|CHEM FACE PEELING|abcdefv
ENTRY = Face Peeling, Chemical|T061|NON|NRW|UNK (19XX)|760412|FACE PEELING CHEM|abcdefv
ENTRY = Chemexfoliations
MN = E02.218.170
MN = E04.680.275.200
MH_TH = NLM (1977)
ST = T061
PI = Face (1966-1976)
PI = Skin (1966-1976)
PI = Skin Diseases (1966-1976)
PI = Surgery, Plastic (1966-1976)
MS = Application of a cauterant to the skin for the purpose of causing a superficial destruction of the epidermis and upper layers of the dermis. After healing, the treated area has new epithelium.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 20120703
DA = 19760413
DC = 1
DX = 19770101
UI = D002615

*NEWRECORD
RECTYPE = D
MH = Chemical Engineering
DE = CHEM ENGINEERING
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Engineering, Chemical|T090|NON|EQV|UNK (19XX)|860101|ENGINEERING CHEM|abcdefv
MN = J01.293.257
MH_TH = NLM (1966)
ST = T090
AN = SPEC: SPEC qualif
PM = 66
HN = 66
MR = 20020703
DA = 19990101
DC = 1
DX = 19660101
UI = D002616

*NEWRECORD
RECTYPE = D
MH = Chemical Industry
DE = CHEM INDUST
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Industry, Chemical|T092|NON|EQV|UNK (19XX)|860101|INDUST CHEM|abcdefv
ENTRY = Chemical Industries
ENTRY = Industries, Chemical
MN = J01.576.655.437
MH_TH = NLM (1966)
ST = T092
AN = SPEC: SPEC qualif; DF: CHEM INDUST
MS = The aggregate enterprise of manufacturing and technically producing chemicals. (From Random House Unabridged Dictionary, 2d ed)
MR = 19950522
DA = 19990101
DC = 1
UI = D002617

*NEWRECORD
RECTYPE = D
MH = Chemical Warfare
DE = CHEM WARFARE
AQ = CL EC EH ES HI LJ PC PX SN TD
ENTRY = Warfare, Chemical|T052|NON|EQV|UNK (19XX)|860101|WARFARE CHEM|abcdefv
ENTRY = Chemical Warfares
ENTRY = Warfares, Chemical
MN = I01.880.735.950.500.340
FX = Decontamination
FX = Gas Poisoning
MH_TH = NLM (1966)
ST = T052
AN = DF: CHEM WARFARE
MS = Tactical warfare using incendiary mixtures, smokes, or irritant, burning, or asphyxiating gases.
MR = 20150629
DA = 19990101
DC = 1
UI = D002618

*NEWRECORD
RECTYPE = D
MH = Chemical Warfare Agents
DE = CHEM WARFARE AGENTS
AQ = AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO
ENTRY = Agents, Chemical Warfare|T131|NON|EQV|UNK (19XX)|860101|AGENTS CHEM WARFARE|abcdefv
ENTRY = Warfare Agents, Chemical|T131|NON|EQV|UNK (19XX)|860101|WARFARE AGENTS CHEM|abcdefv
ENTRY = Agent, Chemical Warfare
ENTRY = Chemical Warfare Agent
ENTRY = Warfare Agent, Chemical
MN = D27.720.777.300
MN = D27.888.569.612.150
MN = J01.637.870.900.200
FX = Tear Gases
MH_TH = NLM (1968)
ST = T131
RN = 0
PI = Chemical Warfare (1966-1967)
PI = Gases (1966-1967)
MS = Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE.
PM = 68
HN = 68
MR = 20150713
DA = 19990101
DC = 1
DX = 19680101
UI = D002619

*NEWRECORD
RECTYPE = D
MH = Pharmacological and Toxicological Phenomena and Processes
AQ = DE GE IM PH RE
ENTRY = Pharmacologic and Toxicologic Phenomena|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Pharmacological and Toxicological Concepts|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Pharmacological and Toxicological Phenomena|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Pharmacotoxicologic Phenomena|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Pharmacotoxicologic Phenomenon|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Pharmacotoxicological Phenomena|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Pharmacotoxicological Phenomenon|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Toxicopharmacological Phenomena|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Toxicopharmacological Phenomenon|T038|NON|NRW|NLM (2016)|150122|abcdef
ENTRY = Phenomena, Pharmacotoxicologic
ENTRY = Phenomena, Pharmacotoxicological
ENTRY = Phenomena, Toxicopharmacological
ENTRY = Phenomenon, Pharmacotoxicologic
ENTRY = Phenomenon, Pharmacotoxicological
ENTRY = Phenomenon, Toxicopharmacological
MN = G07.690
FX = Pharmacologic Actions
MH_TH = NLM (2016)
ST = T038
AN = used for searching; INDEXER: Do not use; CATALOGER: Do not use
MS = The properties and processes of drug, toxin, and poison metabolism, and their interactions and effects on biological systems. Toxicological phenomena also include the adverse effects of physical phenomena such as RADIATION and NOISE.
PM = 2016; see PHARMACOLOGICAL PHENOMENA 2009-2015; see CHEMICAL AND PHARMACOLOGIC PHENOMENA 1998-2008
HN = 2016 (1998)
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
DX = 19980101
UI = D002620

*NEWRECORD
RECTYPE = D
MH = Chemistry
DE = CHEM
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = H01.181
FX = Alchemy
FX = Brain Chemistry
FX = Neurochemistry
MH_TH = NLM (1966)
ST = T090
AN = the discipline (education, history, etc) only; use CHEMICAL PHENOMENA or specifics treed under it for characteristics of chemicals and their reactions; the qualifier / chemistry is available for use with specific anatomical terms, lower organisms and chemicals; DF: CHEM
MS = A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
MR = 20130709
DA = 19990101
DC = 1
UI = D002621

*NEWRECORD
RECTYPE = D
MH = Chemistry, Agricultural
DE = CHEM AGRICULTURAL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Agricultural Chemistry|T090|NON|EQV|UNK (19XX)|790329|AGRICULTURAL CHEM|abcdefv
ENTRY = Agricultural Chemistries
ENTRY = Chemistries, Agricultural
MN = H01.181.216
MH_TH = NLM (1966)
ST = T090
AN = use for the discipline (education, history, etc) only
MS = The science of the chemical composition and reactions of chemicals involved in the production, protection and use of crops and livestock. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
MR = 20090706
DA = 19990101
DC = 1
UI = D002622

*NEWRECORD
RECTYPE = D
MH = Chemistry Techniques, Analytical
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Analytical Chemistry Techniques|T059|NON|EQV|NLM (2010)|081118|abcdef
ENTRY = Analytical Chemistry Methods|T059|NON|EQV|NLM (2010)|081118|abcdef
ENTRY = Analytical Chemistry Method
ENTRY = Analytical Chemistry Technique
ENTRY = Chemistry Method, Analytical
ENTRY = Chemistry Methods, Analytical
ENTRY = Chemistry Technique, Analytical
ENTRY = Method, Analytical Chemistry
ENTRY = Methods, Analytical Chemistry
ENTRY = Technique, Analytical Chemistry
ENTRY = Techniques, Analytical Chemistry
MN = E05.196
FX = Autoanalysis
MH_TH = NLM (2010)
ST = T059
AN = general or unspecified; prefer specifics
MS = Methodologies used for the isolation, identification, detection, and quantitation of chemical substances.
PM = 2010; see CHEMISTRY, ANALYTICAL 1963-2009
HN = 2010 (1963)
CATSH = CAT LIST
MR = 20091009
DA = 19990101
DC = 1
UI = D002623

*NEWRECORD
RECTYPE = D
MH = Chemistry, Clinical
DE = CHEM CLIN
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Clinical Chemistry|T091|NON|EQV|NLM (1998)|970410|CLIN CHEM|abcdefv
MN = H01.181.341
FX = Clinical Chemistry Tests
MH_TH = NLM (1966)
ST = T091
AN = SPEC: TN 37; SPEC qualif; do not use as NIM coord; DF: CLIN CHEM
MS = The specialty of ANALYTIC CHEMISTRY applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy.
PM = 67
HN = 67(66)
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
DX = 19670101
UI = D002624

*NEWRECORD
RECTYPE = D
MH = Chemistry, Organic
DE = CHEM ORG
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Organic Chemistry|T090|NON|EQV|UNK (19XX)|860101|ORG CHEM|abcdefv
MN = H01.181.404
MH_TH = NLM (1966)
ST = T090
AN = the discipline (education, history, etc) only; use ORGANIC CHEMISTRY PHENOMENA or specifics treed under it for properties and reaction processes of organic compounds; DF: CHEM ORG
MS = The study of the structure, preparation, properties, and reactions of carbon compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
PM = 66
HN = 66
MR = 20081130
DA = 19990101
DC = 1
DX = 19660101
UI = D002625

*NEWRECORD
RECTYPE = D
MH = Chemistry, Pharmaceutical
DE = CHEM PHARM
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Drug Formulation|T058|T062|NON|REL|NLM (1998)|960815|abbcdef
PRINT ENTRY = Medicinal Chemistry|T091|NON|EQV|NLM (2007)|051201|abcdef
ENTRY = Chemistry, Pharmaceutic|T091|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Pharmaceutic Chemistry|T091|NON|EQV|UNK (19XX)|780626|abcdef
ENTRY = Pharmaceutical Chemistry|T091|NON|EQV|UNK (19XX)|780626|PHARM CHEM|abcdefv
ENTRY = Chemistry, Medicinal
ENTRY = Drug Formulations
ENTRY = Formulation, Drug
ENTRY = Formulations, Drug
MN = H01.158.703.007
MN = H01.181.466
FX = Biopharmaceutics
FX = Drug Compounding
MH_TH = NLM (1966)
ST = T091
AN = use for the specialty and as an NIM coordinate; Manual 29.7; do not confuse the entry term DRUG FORMULATION with DRUG COMPOUNDING; DF: CHEM PHARM
MS = Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.
MR = 20060705
DA = 19990101
DC = 1
UI = D002626

*NEWRECORD
RECTYPE = D
MH = Chemistry, Physical
DE = CHEM PHYSICAL
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Physical Chemistry|T090|NON|EQV|UNK (19XX)|860101|PHYSICAL CHEM|abcdefv
ENTRY = Chemistries, Physical
ENTRY = Physical Chemistries
MN = H01.181.529
MH_TH = NLM (1965)
ST = T090
AN = the discipline (education, history, etc) only; use PHYSICOCHEMICAL PHENOMENA or specifics treed under it for physical phenomena related to the structure and interactive processes of chemicals
MS = The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes.
PM = 65
HN = 65
MR = 20090710
DA = 19990101
DC = 1
DX = 19650101
UI = D002627

*NEWRECORD
RECTYPE = D
MH = Chemoreceptor Cells
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Chemoreceptive Cells|T025|NON|EQV|NLM (2009)|080507|abcdef
ENTRY = Cell, Chemoreceptive
ENTRY = Cell, Chemoreceptor
ENTRY = Cells, Chemoreceptive
ENTRY = Cells, Chemoreceptor
ENTRY = Chemoreceptive Cell
ENTRY = Chemoreceptor Cell
MN = A08.675.650.915.500
MN = A08.800.950.500
MN = A11.671.650.915.500
MH_TH = NLM (2009)
ST = T025
AN = note category: do not confuse with chemoreceptor proteins
PI = Sensory Receptor Cells (1966-1967)
MS = Cells specialized to detect chemical substances and relay that information centrally in the nervous system. Chemoreceptor cells may monitor external stimuli, as in TASTE and OLFACTION, or internal stimuli, such as the concentrations of OXYGEN and CARBON DIOXIDE in the blood.
PM = 2009; see CHEMORECEPTORS 1968-2008, see RECEPTORS, NEURAL 1963-1967
HN = 2009 (1968)
MR = 20130709
DA = 19990101
DC = 1
DX = 19680101
UI = D002628

*NEWRECORD
RECTYPE = D
MH = Chemosterilants
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D27.720.031.700.141
MN = D27.888.723.141
MH_TH = POPLINE (1978)
ST = T131
RN = 0
MS = Compounds that cause reproductive sterility in organisms. They are sometimes used to control pest populations by sterilizing males within the population.
PM = 72
HN = 72(66)
MR = 20150622
DA = 19990101
DC = 1
DX = 19720101
UI = D002629

*NEWRECORD
RECTYPE = D
MH = Chemotactic Factors
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Chemotaxins|T123|T129|NON|EQV|UNK (19XX)|790430|abbcdef
PRINT ENTRY = Cytotaxinogens|T123|NON|NRW|UNK (19XX)|790430|abcdef
PRINT ENTRY = Cytotaxins|T123|NON|NRW|UNK (19XX)|790430|abcdef
ENTRY = Chemoattractants|T123|T129|NON|EQV|UNK (19XX)|850103|abbcdef
ENTRY = Chemotactic Factors, Macrophage|T129|NON|NRW|NLM (1980)|990101|abcdef
ENTRY = Macrophage Chemotactic Factors|T129|NON|NRW|UNK (19XX)|790430|abcdef
MN = D23.125
FX = Pheromones
MH_TH = NLM (1980)
ST = T123
ST = T129
RN = 0
AN = /biosyn /physiol permitted
PI = Chemotaxis (1966-1979)
PI = Chemotaxis, Leukocyte (1977-1979)
MS = Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult.
PM = 1980; see CHEMOTACTIC FACTORS 1984-1990; for CHEMOTACTIC FACTORS, MACROPHAGE see CHEMOTACTIC FACTORS, MACROPHAGE 1980-2007
HN = 1980
MR = 20090730
DA = 19790430
DC = 1
DX = 19800101
UI = D002630

*NEWRECORD
RECTYPE = D
MH = Chemotactic Factors, Eosinophil
DE = ECF A
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Eosinophil Chemotactic Factors|T129|NON|EQV|UNK (19XX)|790430|abcdef
PRINT ENTRY = Eosinophil Chemotaxins|T129|NON|EQV|UNK (19XX)|790430|abcdef
ENTRY = Chemotaxins, Eosinophil
ENTRY = Factors, Eosinophil Chemotactic
MN = D23.125.320
MH_TH = NLM (1980)
ST = T129
RN = 0
AN = chemotactic substances attracting eosinophils, not liberated by eosinophils; /biosyn /physiol permitted; DF: ECF A
PI = Chemotaxis (1966-1979)
PI = Chemotaxis, Leukocyte (1977-1979)
PI = Eosinophils (1966-1979)
MS = Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ECF-A, released mainly by mast cells.
PM = 91; was see under CHEMOTACTIC FACTORS 1980-90
HN = 91(80); was see under CHEMOTACTIC FACTORS 1980-90
MR = 20050630
DA = 19790430
DC = 1
DX = 19910101
UI = D002631

*NEWRECORD
RECTYPE = D
MH = Chemotaxis
AQ = DE ES GE IM PH RE
MN = G04.299.283.424
FX = Chemoreceptor Cells
FX = Chemotactic Factors
MH_TH = NLM (1965)
ST = T043
MS = The movement of cells or organisms toward or away from a substance in response to its concentration gradient.
PM = 70
HN = 70(65)
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19700101
UI = D002633

*NEWRECORD
RECTYPE = D
MH = Chemotaxis, Leukocyte
AQ = DE ES GE IM PH RE
PRINT ENTRY = Leukotaxis|T043|NON|EQV|UNK (19XX)|800402|abcdef
ENTRY = Leukocyte Chemotaxis
MN = G04.299.283.424.233
MH_TH = NLM (1977)
ST = T043
AN = coordinate IM with specific type of leukocyte (IM)
PI = Chemotaxis (1966-1976)
MS = The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 20150701
DA = 19760519
DC = 1
DX = 19770101
UI = D002634

*NEWRECORD
RECTYPE = D
MH = Chenodeoxycholic Acid
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Chenic Acid|T110|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|761223|abbbcdeef
PRINT ENTRY = Chenodeoxycholate|T110|T121|T123|NON|NRW|FDA SRS (2014)|770208|abbbcdef
PRINT ENTRY = Chenodiol|T110|T121|T123|NON|EQV|FDA SRS (2014)|USAN (1978)|800520|abbbcdeef
PRINT ENTRY = Gallodesoxycholic Acid|T110|T121|T123|NON|EQV|FDA SRS (2014)|UNK (19XX)|770208|abbbcdeef
ENTRY = Antigen Brand of Chenodeoxycholic Acid|T110|T121|T123|NON|NRW|NLM (2006)|041221|abbbcdef
ENTRY = Chenique Acid|T110|T121|T123|NON|EQV|UNK (19XX)|810108|abbbcdef
ENTRY = Chenix|T110|T121|T123|TRD|NRW|US|861120|abbbcdef
ENTRY = Chenofalk|T110|T121|T123|TRD|NRW|DE|IE|NL|NLM (1998)|961115|abbbcdeeeef
ENTRY = Chenophalk|T110|T121|T123|TRD|NRW|NLM (1998)|961115|abbbcdef
ENTRY = Estedi Brand of Chenodeoxycholic Acid|T110|T121|T123|NON|NRW|NLM (2006)|041221|abbbcdef
ENTRY = Falk Brand of Chenodeoxycholic Acid|T110|T121|T123|NON|NRW|NLM (2006)|041221|abbbcdef
ENTRY = Henohol|T110|T121|T123|NON|EQV|UNK (19XX)|820603|abbbcdef
ENTRY = Quenobilan|T110|T121|T123|TRD|NRW|ES|041221|abbbcdef
ENTRY = Quenocol|T110|T121|T123|TRD|NRW|ES|041221|abbbcdef
ENTRY = Sodium Chenodeoxycholate|T110|T121|T123|NON|NRW|UNK (19XX)|811202|abbbcdef
ENTRY = Solvay Brand of Chenodeoxycholic Acid|T110|T121|T123|NON|NRW|NLM (2006)|041221|abbbcdef
ENTRY = Tramedico Brand of Chenodeoxycholic Acid|T110|T121|T123|NON|NRW|NLM (2006)|041221|abbbcdef
ENTRY = Zambon Brand of Chenodeoxycholic Acid|T110|T121|T123|NON|NRW|NLM (2006)|041221|abbbcdef
ENTRY = Acid, Chenic
ENTRY = Acid, Chenique
ENTRY = Acid, Chenodeoxycholic
ENTRY = Acid, Gallodesoxycholic
ENTRY = Chenodeoxycholate, Sodium
MN = D04.808.105.225.272.150
MN = D04.808.221.430.342.300
PA = Cathartics
PA = Gastrointestinal Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T110
ST = T121
ST = T123
N1 = Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7alpha)-
RN = 0GEI24LG0J
RR = 474-25-9 (Chenodeoxycholic Acid)
PI = Bile Acids and Salts (1966-1972)
MS = A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.
PM = 74
HN = 74(73)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D002635

*NEWRECORD
RECTYPE = D
MH = Cherubism
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Familial Benign Giant-Cell Tumor of the Jaw|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Familial Fibrous Dysplasia of Jaw|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
ENTRY = Familial Multilocular Cystic Disease of the Jaws|T047|NON|EQV|GHR (2014)|NLM (2014)|130418|abcdeef
MN = C05.116.099.708.375.199
MN = C05.500.174
MN = C07.320.173
MN = C16.131.621.207.540.170
MN = C16.320.170
MH_TH = GHR (2014)
MH_TH = NLM (1965)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
MS = A fibro-osseous hereditary disease of the jaws. The swollen jaws and raised eyes give a cherubic appearance; multiple radiolucencies are evident upon radiographic examination.
PM = 65
HN = 65
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D002636

*NEWRECORD
RECTYPE = D
MH = Chest Pain
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Chest Pains
ENTRY = Pain, Chest
ENTRY = Pains, Chest
MN = C10.597.617.192
MN = C23.888.592.612.233
FX = Angina Pectoris
MH_TH = NLM (1987)
ST = T184
AN = cardiac = probably ANGINA PECTORIS
PI = Pain (1966-1986)
PI = Thorax (1966-1986)
MS = Pressure, burning, or numbness in the chest.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 20150626
DA = 19860326
DC = 1
DX = 19870101
UI = D002637

*NEWRECORD
RECTYPE = D
MH = Chewing Gum
AQ = AE AN CL EC HI MI PO PS RE SD SN ST TO UT VI
ENTRY = Chewing Gums
ENTRY = Gum, Chewing
ENTRY = Gums, Chewing
MN = D05.750.078.739.249
MN = D09.698.700.249
MN = D20.215.721.249.249
MN = G07.203.300.140.200
MN = J02.500.140.200
MH_TH = NLM (1966)
ST = T167
RN = 0
AN = as a confection or as vehicle for admin of med substances
MS = A preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication.
MR = 20141014
DA = 19990101
DC = 1
UI = D002638

*NEWRECORD
RECTYPE = D
MH = Cheyne-Stokes Respiration
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Cheyne Stokes Respiration
ENTRY = Respiration, Cheyne-Stokes
MN = C08.618.182
MN = C23.888.852.227
MH_TH = NLM (1966)
ST = T046
ST = T184
MS = An abnormal pattern of breathing characterized by alternating periods of apnea and deep, rapid breathing. The cycle begins with slow, shallow breaths that gradually increase in depth and rate and is then followed by a period of apnea. The period of apnea can last 5 to 30 seconds, then the cycle repeats every 45 seconds to 3 minutes.
OL = use RESPIRATION to search CHEYNE-STOKES RESPIRATION 1966-76
PM = 91; was see under RESPIRATION DISORDERS 1977-90; was see under RESPIRATION 1966-76
HN = 91(66); was see under RESPIRATION DISORDERS 1977-90; was see under RESPIRATION 1966-76
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
DX = 19910101
UI = D002639

*NEWRECORD
RECTYPE = D
MH = Chiari-Frommel Syndrome
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Frommel's Disease|T047|EPO|EQV|UNK (19XX)|740329|FROMMELS DIS|abcdefv
ENTRY = Frommel Disease|T047|EPO|EQV|NLM (1992)|900906|FROMMEL DIS|abcdefv
ENTRY = Chiari Frommel Syndrome
ENTRY = Disease, Frommel
ENTRY = Disease, Frommel's
ENTRY = Syndrome, Chiari-Frommel
MN = C13.703.844.506.389.500
MN = C17.800.090.937.439.500
MH_TH = NLM (1964)
ST = T047
MS = A POSTPARTUM condition consists of persistent lactation (GALACTORRHEA) and AMENORRHEA in patients not BREAST FEEDING.
PM = 65
HN = 65(64)
CATSH = CAT LIST
MR = 20050630
DA = 19990101
DC = 1
DX = 19650101
UI = D002640

*NEWRECORD
RECTYPE = D
MH = Chicago
AQ = EH EP
MN = Z01.107.567.875.350.350.200
MN = Z01.107.567.875.510.350.200
MN = Z01.433.305
MH_TH = NLM (1966)
ST = T083
MR = 19970620
DA = 19990101
DC = 4
UI = D002641

*NEWRECORD
RECTYPE = D
MH = Chick Embryo
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Embryo, Chick|T018|NON|EQV|UNK (19XX)|771205|abcdef
ENTRY = Chick Embryos
ENTRY = Embryos, Chick
MN = A13.350.150
MN = A16.331.200
MH_TH = NLM (1964)
ST = T018
AN = check tag: NIM no qualifiers; chick embryo heart = CHICK EMBRYO + HEART /embryol (not FETAL HEART); transfer of chick embryo = CHICK EMBRYO /transpl not EMBRYO TRANSFER
MS = The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching.
PM = 64
HN = 64
MR = 20070709
DA = 19990101
DC = 1
DX = 19640101
UI = D002642

*NEWRECORD
RECTYPE = D
MH = Chickenpox
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Varicella|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Chicken Pox|T047|NON|EQV|UNK (19XX)|880712|abcdef
MN = C02.256.466.175
MH_TH = NLM (1966)
ST = T047
AN = caused by a herpesvirus
MS = A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed)
CATSH = CAT LIST
MR = 19930526
DA = 19990101
DC = 1
UI = D002644

*NEWRECORD
RECTYPE = D
MH = Chickens
AQ = AB AH BL CF CL GD GE IM IN ME MI PH PS SU UR VI
PRINT ENTRY = Gallus gallus|T012|NON|EQV|NLM (2004)|021118|abcdef
ENTRY = Gallus domesticus|T012|NON|EQV|NLM (2004)|021118|abcdef
ENTRY = Gallus gallus domesticus|T012|NON|EQV|NLM (2004)|021118|abcdef
ENTRY = Chicken
MN = B01.050.150.900.248.350.150
MN = B01.050.150.900.248.617.192
EC = embryology:Chick Embryo
MH_TH = NLM (1968)
ST = T012
AN = diseases: coord IM with POULTRY DISEASES (IM); canned chicken: coord IM with FOOD PRESERVATION
PI = Poultry (1966-1967)
MS = Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA.
PM = 68
HN = 68
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D002645

*NEWRECORD
RECTYPE = D
MH = Chikungunya virus
AQ = CH CL DE EN GD GE IM IP ME PH PY RE UL
MN = B04.820.850.054.198
MH_TH = NLM (1964)
ST = T005
AN = infection = CHIKUNGUNYA FEVER
MS = A species of ALPHAVIRUS causing an acute dengue-like fever.
PM = 66
HN = 66(64)
MR = 20150622
DA = 19990101
DC = 1
DX = 19660101
UI = D002646

*NEWRECORD
RECTYPE = D
MH = Chilblains
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Idiopathic Perniosis|T037|NON|EQV|NLM (2012)|ORD (2010)|101214|abcdeef
ENTRY = Pernio|T037|NON|EQV|NLM (2015)|140212|abcdef
ENTRY = Perniosis|T037|NON|EQV|NLM (2012)|ORD (2010)|090224|abcdeef
ENTRY = Chilblain
ENTRY = Idiopathic Pernioses
ENTRY = Pernios
ENTRY = Pernioses
ENTRY = Pernioses, Idiopathic
ENTRY = Perniosis, Idiopathic
MN = C26.212.500.217
MN = C26.417.217
MH_TH = NLM (1975)
MH_TH = ORD (2010)
ST = T037
MS = Recurrent localized itching, swelling and painful erythema on the fingers, toes or ears, produced by exposure to cold.
OL = search FROSTBITE 1966-74
PM = 91; was see under FROSTBITE 1975-90
HN = 91(75); was see under FROSTBITE 1975-90
CATSH = CAT LIST
MR = 20141202
DA = 19990101
DC = 1
DX = 19910101
UI = D002647

*NEWRECORD
RECTYPE = D
MH = Child
ENTRY = Children|T100|NON|EQV|BIOETHICS (1989)|770317|abcdef
MN = M01.060.406
FX = Minors
FX = Only Child
EC = psychology:Psychology, Child
MH_TH = NLM (1978)
ST = T100
AN = almost always check tag: NIM no qualifiers; see Manual Chapter 9
MS = A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.
MR = 20150623
DA = 19990101
DC = 1
UI = D002648

*NEWRECORD
RECTYPE = D
MH = Child Abuse
AQ = CL DI EC EH ES HI LJ MO PC PX RH SN TD TH
PRINT ENTRY = Child Neglect|T054|T055|NON|REL|BIOETHICS (1989)|770317|abbcdef
ENTRY = Child Maltreatment|T054|T055|NON|EQV|NLM (2013)|120221|abbcdef
ENTRY = Child Mistreatment|T054|T055|NON|EQV|NLM (2013)|120426|abbcdef
ENTRY = Abuse, Child
ENTRY = Maltreatment, Child
ENTRY = Mistreatment, Child
ENTRY = Neglect, Child
MN = I01.198.240.856.350.250
MN = I01.880.735.900.350.250
FX = Shaken Baby Syndrome
MH_TH = NLM (1965)
ST = T054
ST = T055
AN = check the tag CHILD or specific
MS = Abuse of children in a family, institutional, or other setting. (APA, Thesaurus of Psychological Index Terms, 1994)
PM = 65
HN = 65(64)
CATSH = CAT LIST
MR = 20150630
DA = 19990101
DC = 1
DX = 19650101
UI = D002649

*NEWRECORD
RECTYPE = D
MH = Child Abuse, Sexual
AQ = CL DI EC EH ES HI LJ MO PC PX RH SN TD TH
PRINT ENTRY = Child Molestation, Sexual|T054|T055|NON|EQV|UNK (19XX)|860325|abbcdef
PRINT ENTRY = Molestation, Sexual, Child|T054|T055|NON|EQV|UNK (19XX)|860325|abbcdef
PRINT ENTRY = Sexual Abuse of Child|T054|T055|NON|EQV|NLM (1998)|970313|abbcdef
PRINT ENTRY = Sexual Abuse, Child|T054|T055|NON|EQV|UNK (19XX)|860327|abbcdef
ENTRY = Abuse, Child Sexual
ENTRY = Child Sexual Abuse
ENTRY = Molestation, Sexual Child
ENTRY = Sexual Child Abuse
ENTRY = Sexual Child Molestation
MN = I01.198.240.748.300
MN = I01.198.240.856.350.250.255
MN = I01.880.735.900.350.250.255
MH_TH = NLM (1987)
ST = T054
ST = T055
AN = check also tag CHILD or specific; for adult survivors of child sexual abuse, check both tags CHILD or specific + relevant adult age
PI = Child Abuse (1966-1986)
PI = Sex Offenses (1968-1986)
MS = Sexual maltreatment of the child or minor.
PM = 87
HN = 87
CATSH = CAT LIST
MR = 19970620
DA = 19860325
DC = 1
DX = 19870101
UI = D002650

*NEWRECORD
RECTYPE = D
MH = Child Advocacy
AQ = CL EC ED ES HI IN LJ PX SN ST TD
ENTRY = Advocacies, Child
ENTRY = Advocacy, Child
ENTRY = Child Advocacies
MN = I01.880.604.473.300
MN = I01.880.787.293.350
MN = N03.706.437.300
MH_TH = NLM (1975)
ST = T090
AN = rights of children; check also tag CHILD or specific
PI = Child Welfare (1966-1974)
MS = Promotion and protection of the rights of children; frequently through a legal process.
PM = 75
HN = 75
MR = 19890428
DA = 19741119
DC = 1
DX = 19750901
UI = D002651

*NEWRECORD
RECTYPE = D
MH = Child Behavior
AQ = CL DE EH ES PH PX RE
PRINT ENTRY = Behavior, Child|T055|NON|EQV|NLM (1994)|921120|abcdef
MN = F01.145.179
MH_TH = NLM (1968)
ST = T055
AN = check also tag CHILD or specific; INFANT BEHAVIOR is also available
PI = Behavior (1966-1967)
PI = Child Psychology (1966-1967)
MS = Any observable response or action of a child from 24 months through 12 years of age. For neonates or children younger than 24 months, INFANT BEHAVIOR is available.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19680101
UI = D002652

*NEWRECORD
RECTYPE = D
MH = Child Behavior Disorders
DE = CHILD BEHAVIOR DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Behavior Disorders, Child
ENTRY = Disorders, Child Behavior
MN = F03.625.141
MH_TH = NLM (1966)
ST = T048
AN = check the tag CHILD or specific
MS = Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.
CATSH = CAT LIST
MR = 20150707
DA = 19990101
DC = 1
UI = D002653

*NEWRECORD
RECTYPE = D
MH = Child Care
AQ = CL EC ES HI LJ MA MT OG PX SD SN ST TD UT
PRINT ENTRY = Puericulture|T056|T057|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Child Day Care|T056|T057|NON|EQV|NLM (2016)|150527|abbcdef
ENTRY = Day Care, Child|T056|T057|NON|EQV|NLM (2016)|150527|abbcdef
ENTRY = Care, Child
MN = I01.880.787.293.360
MN = N02.421.088
FX = Child Day Care Centers
FX = Child Rearing
FX = Infant Care
MH_TH = POPLINE (1978)
ST = T056
ST = T057
AN = check also tag CHILD or specific
MS = Care of CHILDREN in the home or in an institution.
MR = 20150630
DA = 19990101
DC = 1
UI = D002654

*NEWRECORD
RECTYPE = D
MH = Child Custody
AQ = CL EC ED ES HI LJ MA MT OG SD SN ST TD UT
PRINT ENTRY = Custody, Child|T078|NON|EQV|UNK (19XX)|870227|abcdef
ENTRY = Child Support|T081|NON|REL|POPLINE (1987)|900830|abcdef
ENTRY = Support, Child
MN = I01.880.787.293.370
FX = Child Advocacy
MH_TH = POPLINE (1987)
ST = T078
AN = check also tag CHILD or specific
PI = Child Welfare (1966-1987)
MS = The formally authorized guardianship or care of a CHILD.
PM = 91; was see under CHILD WELFARE 1988-90
HN = 91(88); was see under CHILD WELFARE 1988-90
MR = 20150630
DA = 19870227
DC = 1
DX = 19910101
UI = D002655

*NEWRECORD
RECTYPE = D
MH = Child Day Care Centers
AQ = CL EC ED ES HI LJ MA MT OG SD SN ST TD UT
PRINT ENTRY = Day Care Centers for Children|T073|T092|NON|EQV|NLM (1995)|931122|abbcdef
ENTRY = Child Daycare Centers|T073|T092|NON|EQV|NLM (1995)|931122|abbcdef
ENTRY = Daycare Centers for Children|T073|T092|NON|EQV|NLM (1995)|931122|abbcdef
ENTRY = Child Daycare Center
MN = N02.421.143.098
FX = Child Care
FX = Nurseries
MH_TH = NLM (1973)
ST = T073
ST = T092
AN = check also tag CHILD or specific
PI = Child Care (1966-1972)
PI = Child Welfare (1966-1972)
MS = Facilities which provide care for pre-school and school-age children.
PM = 73
HN = 73
MR = 20150630
DA = 19990101
DC = 1
DX = 19730101
UI = D002656

*NEWRECORD
RECTYPE = D
MH = Child Development
AQ = CL DE PH RE
PRINT ENTRY = Infant Development|T041|NON|NRW|NLM (1994)|930203|abcdef
ENTRY = Development, Child
ENTRY = Development, Infant
MN = F01.525.200
MN = G07.700.320.374.750
FX = Growth
FX = Motor Skills
FX = Personality Development
MH_TH = NLM (1968)
ST = T039
ST = T041
AN = includes infant and child but not adolescents; add the appropriate age check tag
PI = Behavior (1966-1967)
PI = Child Psychology (1966-1967)
PI = Growth (1966-1967)
MS = The continuous sequential physiological and psychological maturing of an individual from birth up to but not including ADOLESCENCE.
PM = 68
HN = 68
CATSH = CAT LIST
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D002657

*NEWRECORD
RECTYPE = D
MH = Developmental Disabilities
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Child Development Deviations|T048|NON|NRW|UNK (19XX)|800521|abcdef
PRINT ENTRY = Child Development Disorders|T048|NON|EQV|NLM (1996)|950530|CHILD DEVELOPMENT DIS|abcdefv
PRINT ENTRY = Child Development Disorders, Specific|T048|NON|NRW|UNK (19XX)|800521|CHILD DEVELOPMENT DIS SPECIFIC|abcdefv
PRINT ENTRY = Developmental Delay Disorders|T048|NON|NRW|UNK (19XX)|800521|DEVELOPMENTAL DELAY DIS|abcdefv
PRINT ENTRY = Disabilities, Developmental|T048|NON|EQV|NLM (1996)|950530|abcdef
ENTRY = Development Disorders, Child|T048|NON|EQV|NLM (1992)|910611|DEVELOPMENT DIS CHILD|abcdefv
ENTRY = Child Development Deviation
ENTRY = Child Development Disorder
ENTRY = Development Deviation, Child
ENTRY = Development Deviations, Child
ENTRY = Development Disorder, Child
ENTRY = Developmental Delay Disorder
ENTRY = Developmental Disability
ENTRY = Deviation, Child Development
ENTRY = Disability, Developmental
MN = F03.625.421
MH_TH = NLM (1968)
ST = T048
PI = Child Behavior Disorders (1966-1967)
PI = Child Psychology (1966-1967)
MS = Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
PM = 96; was CHILD DEVELOPMENT DISORDERS 1981-95; was CHILD DEVELOPMENT DEVIATIONS 1968-80
HN = 96; was CHILD DEVELOPMENT DISORDERS 1981-95; was CHILD DEVELOPMENT DEVIATIONS 1968-80
CATSH = CAT LIST
MR = 20150706
DA = 19990101
DC = 1
DX = 19680101
UI = D002658

*NEWRECORD
RECTYPE = D
MH = Child Development Disorders, Pervasive
DE = CHILD DEVELOPMENT DIS PERVASIVE
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
PRINT ENTRY = Pervasive Child Development Disorders|T048|NON|EQV|UNK (19XX)|800521|PERVASIVE CHILD DEVELOPMENT DIS|abcdefv
PRINT ENTRY = Pervasive Development Disorders|T048|NON|BRD|NLM (1998)|970314|abcdef
MN = F03.625.164
MH_TH = NLM (1981)
ST = T048
AN = "pervasive" is a psychiatric diagnosis: follow text; check the tag CHILD or specific
MS = Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
PM = 81
HN = 81
CATSH = CAT LIST
MR = 20150707
DA = 19800521
DC = 1
DX = 19810101
UI = D002659

*NEWRECORD
RECTYPE = D
MH = Child Guidance
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Child Guidances
ENTRY = Guidance, Child
ENTRY = Guidances, Child
MN = F02.784.629.272
MN = F04.408.192
MH_TH = NLM (1966)
ST = T058
ST = T091
AN = SPEC; SPEC qualif; check also tag CHILD or specific
MS = The psychiatric, sociological and psychological study and treatment of the developing child with emphasis on preventive or prophylactic measures focused on the familial, educational and socio-environmental milieu of the child.
CATSH = CAT LIST
MR = 19890428
DA = 19990101
DC = 1
UI = D002660

*NEWRECORD
RECTYPE = D
MH = Child Guidance Clinics
AQ = CL EC ES HI LJ MA MT OG SD SN ST TD UT
ENTRY = Child Guidance Clinic
ENTRY = Clinic, Child Guidance
ENTRY = Clinics, Child Guidance
ENTRY = Guidance Clinic, Child
ENTRY = Guidance Clinics, Child
MN = N02.278.035.158.300
MH_TH = NLM (1975)
ST = T073
ST = T093
AN = check also tag CHILD or specific
MS = Facilities which administer the delivery of mental health counseling services to children.
OL = search COMMUNITY MENTAL HEALTH SERVICES 1967-74
PM = 91; was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78
HN = 91(75); was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78
MR = 19991103
DA = 19990101
DC = 1
DX = 19910101
UI = D002661

*NEWRECORD
RECTYPE = D
MH = Child Health Services
DE = CHILD HEALTH SERV
AQ = CL EC ES HI LJ MA OG SD SN ST TD UT
PRINT ENTRY = Infant Health Services|T058|NON|NRW|UNK (19XX)|780508|INFANT HEALTH SERV|abcdefv
ENTRY = Child Services, Health|T058|NON|EQV|NLM (1996)|950315|CHILD SERV HEALTH|abcdefv
ENTRY = Health Services, Child|T058|NON|EQV|NLM (1996)|940815|HEALTH SERV CHILD|abcdefv
ENTRY = Health Services, Infant|T058|NON|NRW|NLM (1996)|940815|HEALTH SERV INFANT|abcdefv
ENTRY = Infant Services, Health|T058|NON|NRW|NLM (1996)|950315|INFANT SERV HEALTH|abcdefv
ENTRY = Services, Child Health|T058|NON|EQV|NLM (1996)|940815|SERV CHILD HEALTH|abcdefv
ENTRY = Services, Infant Health|T058|NON|NRW|NLM (1996)|NLM (2012)|940815|SERV INFANT HEALTH|abcdeefv
ENTRY = Child Health Service
ENTRY = Health Service, Child
ENTRY = Health Service, Infant
ENTRY = Infant Health Service
ENTRY = Service, Child Health
ENTRY = Service, Infant Health
MN = N02.421.143.130
FX = Child Health
FX = Child Welfare
MH_TH = NLM (1978)
ST = T058
AN = check also tag CHILD or specific
PI = Child Care (1966-1967)
PI = Child Welfare (1966-1967)
MS = Organized services to provide health care for children.
OL = use CHILD HEALTH SERVICES to search INFANT HEALTH SERVICES 1968-78 & WELL CHILD CONFERENCE 1968-92
PM = 68; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92
HN = 68; INFANT HEALTH SERVICES was see under CHILD HEALTH SERVICES 1968-78; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92
MR = 20150626
DA = 19990101
DC = 1
DX = 19680101
UI = D002662

*NEWRECORD
RECTYPE = D
MH = Child Language
ENTRY = Child Languages
ENTRY = Language, Child
ENTRY = Languages, Child
MN = F01.525.200.310.250
MH_TH = NLM (1975)
ST = T055
AN = no qualif; check also tag CHILD or specific
MS = The language and sounds expressed by a child at a particular maturational stage in development.
OL = search LANGUAGE DEVELOPMENT 1968-74
PM = 91; was see under LANGUAGE DEVELOPMENT 1975-90
HN = 91(75); was see under LANGUAGE DEVELOPMENT 1975-90
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
DX = 19910101
UI = D002663

*NEWRECORD
RECTYPE = D
MH = Child Nutritional Physiological Phenomena
AQ = DE EH GE IM PH RE
PRINT ENTRY = Child Nutrition Physiology|T040|NON|EQV|NLM (2007)|051123|abcdef
PRINT ENTRY = Child Nutritional Physiology Phenomena|T040|NON|EQV|NLM (2009)|080701|abcdef
PRINT ENTRY = Nutrition Physiology, Child|T040|NON|EQV|NLM (2007)|051123|abcdef
ENTRY = Child Nutritional Physiology|T040|NON|EQV|NLM (2007)|051123|abcdef
ENTRY = Child Nutritional Physiology Phenomenon|T040|NON|EQV|NLM (2009)|080701|abcdef
ENTRY = Nutritional Physiology, Child
ENTRY = Physiology, Child Nutrition
ENTRY = Physiology, Child Nutritional
MN = G07.203.650.220
FX = Adolescent Nutritional Physiological Phenomena
FX = Infant Nutritional Physiological Phenomena
MH_TH = NLM (2010)
ST = T040
AN = check also tag CHILD or specific
PI = Nutrition (1966)
MS = Nutritional physiology of children aged 2-12 years.
PM = 2010; see CHILD NUTRITIONAL PHYSIOLOGY PHENOMENA 2009, see CHILD NUTRITION PHYSIOLOGY 2007-2008, see CHILD NUTRITION 1967-2006
HN = 2010 (1967)
CATSH = CAT LIST
MR = 20150629
DA = 19990101
DC = 1
DX = 19670101
UI = D002664

*NEWRECORD
RECTYPE = D
MH = Child Psychiatry
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
ENTRY = Psychiatry, Child
MN = F04.096.544.193
MN = H02.403.690.130
MH_TH = NLM (1966)
ST = T091
AN = SPEC: SPEC qualif; not for mental disord in children ( = MENTAL DISORDERS (IM) + CHILD or other child check tag (NIM) ): Manual 27.9
MS = The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in children.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D002665

*NEWRECORD
RECTYPE = D
MH = Psychology, Child
DE = PSYCHOL CHILD
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
PRINT ENTRY = Child Psychology|T091|NON|EQV|NLM (1966)|990101|CHILD PSYCHOL|abcdefv
PRINT ENTRY = Infant Psychology|T091|NON|NRW|UNK (19XX)|790531|INFANT PSYCHOL|abcdefv
PRINT ENTRY = Pediatric Psychology|T091|NON|EQV|UNK (19XX)|870325|PEDIATRIC PSYCHOL|abcdefv
ENTRY = Psychology, Infant|T091|NON|NRW|UNK (19XX)|790531|PSYCHOL INFANT|abcdefv
ENTRY = Psychology, Pediatric|T091|NON|EQV|UNK (19XX)|880718|PSYCHOL PEDIATRIC|abcdefv
MN = F04.096.628.193
FX = Child Development
FX = Psychology, Developmental
MH_TH = UNK (19XX)
ST = T091
AN = use for the specialty and also for articles on the way a normal child thinks & acts
MS = Branch of psychology involving the study of normal and abnormal behavior of children.
PM = 1966; see CHILD PSYCHOLOGY 1966-2014
HN = 1966; use CHILD PSYCHOLOGY 1966-2014
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
UI = D002666

*NEWRECORD
RECTYPE = D
MH = Child Reactive Disorders
DE = CHILD REACTIVE DIS
AQ = BL CF CI CL CO DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI SU TH UR US VI
ENTRY = Child Reactive Disorder
ENTRY = Reactive Disorder, Child
MN = F01.145.126.159
MH_TH = NLM (1975)
ST = T048
ST = T055
AN = child reaction to separation from parents: index under ANXIETY, SEPARATION; check also tag CHILD or specific
MS = Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.
OL = search CHILD BEHAVIOR DISORDERS 1968-74
PM = 84; was see under CHILD BEHAVIOR DISORDERS 1968-83
HN = 84(75); was see under CHILD BEHAVIOR DISORDERS 1968-83
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19840101
UI = D002667

*NEWRECORD
RECTYPE = D
MH = Child Rearing
AQ = EH HI PX TD
ENTRY = Child Rearings
ENTRY = Rearing, Child
ENTRY = Rearings, Child
MN = F01.318
FX = Parenting
MH_TH = POPLINE (1978)
ST = T054
AN = check also tag CHILD or specific; differentiate from PARENTING which emphasizes the role & responsibility of the parent while CHILD REARING emphasizes the upbringing: read MeSH definitions but if in doubt use term of author
MS = The training or bringing-up of children by parents or parent-substitutes. It is used also for child rearing practices in different societies, at different economic levels, in different ethnic groups, etc. It differs from PARENTING in that in child rearing the emphasis is on the act of training or bringing up the child and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent.
PM = 68
HN = 68(64)
CATSH = CAT LIST
MR = 19920507
DA = 19990101
DC = 1
DX = 19680101
UI = D002668

*NEWRECORD
RECTYPE = D
MH = Child Welfare
AQ = CL EC EH ES HI LJ PX SN TD
ENTRY = Adolescent Welfare|T058|NON|REL|NLM (2016)|150121|abcdef
ENTRY = Adolescent Well Being|T058|NON|REL|NLM (2016)|150121|abcdef
ENTRY = Adolescent Well-Being|T058|NON|REL|NLM (2016)|150121|abcdef
ENTRY = Child Well Being|T058|NON|EQV|NLM (2016)|OBSSR (2016)|140925|abcdeef
ENTRY = Child Well-Being|T058|NON|EQV|NLM (2016)|OBSSR (2016)|141021|abcdeef
ENTRY = Welfare, Adolescent
ENTRY = Welfare, Child
ENTRY = Well Being, Adolescent
ENTRY = Well Being, Child
ENTRY = Well-Being, Adolescent
ENTRY = Well-Being, Child
MN = I01.880.787.293
FX = Adolescent Health
FX = Child Health
FX = Foster Home Care
MH_TH = NLM (1966)
ST = T058
AN = check the tag CHILD or specific
MS = Organized efforts by communities or organizations to improve the health and well-being of the child.
MR = 20150707
DA = 19990101
DC = 1
UI = D002669

*NEWRECORD
RECTYPE = D
MH = Child, Abandoned
AQ = CL ED HI LJ PX SN
ENTRY = Adolescent, Abandoned|T099|NON|REL|NLM (2003)|020627|abcdef
ENTRY = Children, Abandoned|T099|NON|EQV|NLM (1995)|940202|abcdef
ENTRY = Abandoned Adolescent
ENTRY = Abandoned Adolescents
ENTRY = Abandoned Child
ENTRY = Abandoned Children
ENTRY = Adolescents, Abandoned
MN = M01.097
MH_TH = NLM (1969)
ST = T099
AN = check also tag CHILD or specific
PI = Child (1966-1968)
MS = A child or adolescent who is deserted by parents or parent substitutes without regard for its future care.
PM = 72
HN = 72(69)
MR = 20020702
DA = 19990101
DC = 1
DX = 19720101
UI = D002670

*NEWRECORD
RECTYPE = D
MH = Child, Exceptional
AQ = CL ED GE HI LJ PX SN
PRINT ENTRY = Exceptional Child|T098|NON|EQV|NLM (2000)|991104|abcdef
ENTRY = Children, Exceptional|T098|NON|EQV|NLM (1995)|940202|abcdef
ENTRY = Exceptional Children
MN = F02.784.629.228
MN = M01.102
FX = Early Intervention (Education)
FX = Mainstreaming (Education)
MH_TH = NLM (1975)
ST = T098
AN = consider also CHILD, GIFTED & MENTALLY DISABLED PERSONS; check also tag CHILD or specific
MS = A child whose needs, abilities, or other characteristics vary so much from the average in mental, physical, or social areas that a greater than usual level of services is needed to facilitate the child's maximum potential development.
OL = search CHILD, GIFTED & MENTAL RETARDATION 1968-74 & MENTAL RETARDATION 1966-67
PM = 75; was see under CHILD, GIFTED & MENTAL RETARDATION 1969-74; was see under MENTAL RETARDATION (but EXCEPTIONAL CHILD was see under CHILD, GIFTED) 1968; was see under MENTAL RETARDATION 1967; was see under MENTAL DEFICIENCY 1966
HN = 75; was see under CHILD, GIFTED & MENTAL RETARDATION 1969-74; was see under MENTAL RETARDATION (but EXCEPTIONAL CHILD was see under CHILD, GIFTED) 1968; was see under MENTAL RETARDATION 1967; was see under MENTAL DEFICIENCY 1966
CATSH = CAT LIST
MR = 20050719
DA = 19990101
DC = 1
DX = 19750101
UI = D002671

*NEWRECORD
RECTYPE = D
MH = Child, Gifted
AQ = CL ED GE HI LJ PX SN
PRINT ENTRY = Gifted Child|T098|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Adolescent, Gifted|T098|NON|REL|NLM (2003)|020627|abcdef
ENTRY = Children, Gifted|T098|NON|EQV|NLM (1992)|900917|abcdef
ENTRY = Adolescents, Gifted
ENTRY = Gifted Adolescent
ENTRY = Gifted Adolescents
ENTRY = Gifted Children
MN = F02.784.629.228.350
MN = M01.102.350
MH_TH = NLM (1966)
ST = T098
AN = check also tag CHILD or specific
MS = A child or adolescent who, when compared to others of the same age or experience, exhibits capability of high performance in intellectual, creative, or artistic areas, possesses an unusual capacity for leadership or excels in specific academic fields. (From PL 100-297, Sec. 4103, Definitions)
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20020702
DA = 19990101
DC = 1
DX = 19660101
UI = D002672

*NEWRECORD
RECTYPE = D
MH = Child, Hospitalized
AQ = CL ED HI LJ PX SN
PRINT ENTRY = Hospitalized Child|T100|T101|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Children, Hospitalized|T100|T101|NON|EQV|NLM (1992)|900917|abbcdef
ENTRY = Hospitalized Children
MN = M01.643.259
MH_TH = NLM (1965)
ST = T100
ST = T101
AN = not for dis in child in hosp for diag or ther: use only for hospitalized child as a psychol, sociol or social entity; check also tag CHILD or specific
MS = Child hospitalized for short term care.
PM = 67
HN = 67(65)
MR = 20020703
DA = 19990101
DC = 1
DX = 19670101
UI = D002673

*NEWRECORD
RECTYPE = D
MH = Child, Institutionalized
AQ = CL ED HI LJ PX SN
PRINT ENTRY = Institutionalized Child|T101|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Children, Institutionalized|T101|NON|EQV|NLM (1992)|900917|abcdef
ENTRY = Institutionalized Children
MN = M01.643.364
MH_TH = NLM (1965)
ST = T101
AN = check also tag CHILD or specific
MS = A child who is receiving long-term in-patient services or who resides in an institutional setting.
PM = 67
HN = 67(65)
MR = 20020703
DA = 19990101
DC = 1
DX = 19670101
UI = D002674

*NEWRECORD
RECTYPE = D
MH = Child, Preschool
AQ = CL ED HI LJ SN
ENTRY = Children, Preschool|T100|NON|EQV|NLM (1995)|940202|abcdef
ENTRY = Preschool Child
ENTRY = Preschool Children
MN = M01.060.406.448
MH_TH = NLM (1966)
ST = T100
AN = almost always check tag: NIM no qualifiers; see Manual Chapter 9
MS = A child between the ages of 2 and 5.
PM = 66
HN = 66
MR = 20150623
DA = 19990101
DC = 1
DX = 19660101
UI = D002675

*NEWRECORD
RECTYPE = D
MH = Child, Unwanted
AQ = CL ED HI LJ PX SN
ENTRY = Unwanted Births|T098|NON|REL|POPLINE (1981)|861231|abcdef
ENTRY = Unwanted Children|T099|NON|EQV|BIOETHICS (1975)|770420|abcdef
ENTRY = Birth, Unwanted
ENTRY = Births, Unwanted
ENTRY = Children, Unwanted
ENTRY = Unwanted Birth
ENTRY = Unwanted Child
MN = M01.111
MH_TH = NLM (1978)
ST = T099
AN = check also tag CHILD or specific
PI = Parent-Child Relations (1966-1977)
PI = Pregnancy, Unwanted (1973-1977)
MS = The child who is not wanted by one or both parents.
PM = 78
HN = 78
MR = 20020702
DA = 19770422
DC = 1
DX = 19780101
UI = D002676

*NEWRECORD
RECTYPE = D
MH = Chile
AQ = EH EP
MN = Z01.107.757.235
MH_TH = POPLINE (1978)
ST = T083
MR = 19911104
DA = 19990101
DC = 4
UI = D002677

*NEWRECORD
RECTYPE = D
MH = Chimera
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS SU UR VI
ENTRY = Hybrids|T001|NON|BRD|BIOETHICS (1989)|900827|abcdef
ENTRY = Chimeras
ENTRY = Hybrid
MN = B05.200
FX = Freemartinism
FX = Mosaicism
MH_TH = NLM (1975)
ST = T001
PI = Genetics (1966)
PI = Mosaicism (1966-1977)
MS = An individual that contains cell populations derived from different zygotes.
OL = search MOSAICISM 1967-74
PM = 78; was see under MOSAICISM 1967-77
HN = 78(75); was see under MOSAICISM 1967-77
CATSH = CAT LIST
MR = 20150622
DA = 19990101
DC = 1
DX = 19780101
UI = D002678

*NEWRECORD
RECTYPE = D
MH = Pan troglodytes
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Chimpanzee|T015|NON|EQV|UNK (19XX)|800512|abcdef
ENTRY = Chimpanzee troglodytes|T015|NON|EQV|NLM (1998)|970321|abcdef
ENTRY = Chimpanzee troglodyte
ENTRY = Chimpanzees
ENTRY = Pan troglodyte
ENTRY = troglodyte, Chimpanzee
ENTRY = troglodyte, Pan
ENTRY = troglodytes, Chimpanzee
ENTRY = troglodytes, Pan
MN = B01.050.150.900.649.801.400.112.400.620
MH_TH = NLM (1972)
ST = T015
AN = diseases: coordinate IM with APE DISEASES (IM) + specific disease/vet (IM)
PI = Pongidae (1966-1971)
MS = The common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies.
PM = 1998; see CHIMPANZEE TROGLODYTES 1981-1997 & CHIMPANZEES 1972-1980
HN = 1998 (1972)
MR = 20090706
DA = 19990101
DC = 1
DX = 19720101
UI = D002679

*NEWRECORD
RECTYPE = D
MH = Chin
AQ = AB AH BS EM GD IN IR MI PA PH PP PS RA RE RI SU US VI
ENTRY = Mentum|T029|NON|EQV|NLM (1991)|900410|abcdef
MN = A01.456.505.259
MN = A02.835.232.781.324.502.632.130
MN = A14.521.632.300
MH_TH = NLM (1966)
ST = T029
AN = bone or site; usually NIM as site: submental (beneath the chin) refers to skin, fat & other tissue below the chin as in "submental lipectomy for double chin"; /growth: consider also MAXILLOFACIAL DEVELOPMENT
MS = The anatomical frontal portion of the mandible, also known as the mentum, that contains the line of fusion of the two separate halves of the mandible (symphysis menti). This line of fusion divides inferiorly to enclose a triangular area called the mental protuberance. On each side, inferior to the second premolar tooth, is the mental foramen for the passage of blood vessels and a nerve.
MR = 19910530
DA = 19990101
DC = 1
UI = D002680

*NEWRECORD
RECTYPE = D
MH = China
AQ = EH EP
PRINT ENTRY = Inner Mongolia|T083|NAM|NRW|UNK (19XX)|750101|abcdef
PRINT ENTRY = Manchuria|T083|NAM|NRW|UNK (19XX)|750101|abcdef
PRINT ENTRY = People's Republic of China|T083|NON|EQV|NLM (2009)|080324|abcdef
PRINT ENTRY = Sinkiang|T083|NAM|NRW|UNK (19XX)|750101|abcdef
ENTRY = Mainland China|T083|NAM|EQV|NLM (1976)|750101|abcdef
MN = Z01.252.474.164
MH_TH = NLM (1981)
ST = T083
AN = mainland China: do not confuse with TAIWAN, the Republic of China; in translations use spelling: People's Republic of China, not Peoples' nor Peoples
MS = A country spanning from central Asia to the Pacific Ocean.
MR = 20080708
DA = 19990101
DC = 4
UI = D002681

*NEWRECORD
RECTYPE = D
MH = Chinchilla
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
ENTRY = Chinchillas
MN = B01.050.150.900.649.865.328
MH_TH = NLM (1968)
ST = T015
PI = Rodentia (1966-1967)
MS = A genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research.
OL = use CHINCHILLA to search CHINCHILLAS 1968-81
PM = 82; was CHINCHILLAS 1968-81
HN = 82; was CHINCHILLAS 1968-81
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D002682

*NEWRECORD
RECTYPE = D
MH = Chironomidae
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
PRINT ENTRY = Chironomus|T204|NON|REL|UNK (19XX)|800519|abcdef
PRINT ENTRY = Midges, Nonbiting|T204|NON|EQV|UNK (19XX)|800519|abcdef
ENTRY = Midge, Nonbiting
ENTRY = Nonbiting Midge
ENTRY = Nonbiting Midges
MN = B01.050.500.131.617.289.260
MH_TH = NLM (1981)
ST = T204
AN = do not use /drug eff for insecticides: TN 111; gall midges: index under DIPTERA
PI = Diptera (1975-1980)
MS = A family of nonbiting midges, in the order DIPTERA. Salivary glands of the genus Chironomus are used in studies of cellular genetics and biochemistry.
PM = 91; see DIPTERA 1981-90
HN = 91(81)
MR = 20090706
DA = 19800519
DC = 1
DX = 19910101
UI = D002683

*NEWRECORD
RECTYPE = D
MH = Chiropractic
AQ = CL EC ED ES HI IS LJ MA MT OG SN ST TD
MN = H02.110
FX = Manipulation, Chiropractic
FX = Manipulation, Orthopedic
MH_TH = NLM (1966)
ST = T091
AN = the discipline only (education, history, etc); use MANIPULATION, CHIROPRACTIC for chiropractic procedures
MS = An occupational discipline founded by D.D. Palmer in the 1890's based on the relationship of the spine to health and disease.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002684

*NEWRECORD
RECTYPE = D
MH = Chiroptera
AQ = AB AH BL CF CL EM GD GE IM IN ME MI PH PS PX SU UR VI
PRINT ENTRY = Bats|T015|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Flying Foxes|T015|NON|NRW|NLM (2001)|000602|abcdef
PRINT ENTRY = Horseshoe Bats|T015|NON|NRW|NLM (2007)|051025|abcdef
PRINT ENTRY = Pteropodidae|T015|NON|NRW|NLM (2001)|000602|abcdef
PRINT ENTRY = Pteropus|T015|NON|NRW|NLM (2001)|000321|abcdef
PRINT ENTRY = Rhinolophus|T015|NON|NRW|NLM (2007)|051025|abcdef
PRINT ENTRY = Rousettus|T015|NON|NRW|NLM (2001)|000321|abcdef
ENTRY = Bat, Horseshoe
ENTRY = Bats, Horseshoe
ENTRY = Foxes, Flying
ENTRY = Horseshoe Bat
MN = B01.050.150.900.649.225
MH_TH = NLM (1966)
ST = T015
MS = Order of mammals whose members are adapted for flight. It includes bats, flying foxes, and fruit bats.
MR = 20090706
DA = 19990101
DC = 1
UI = D002685

*NEWRECORD
RECTYPE = D
MH = Chitin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D05.750.078.139
MN = D09.698.211
MH_TH = NLM (1967)
ST = T118
ST = T123
N1 = Chitin
RN = 1398-61-4
PI = Polysaccharides (1966)
MS = A linear polysaccharide of beta-1->4 linked units of ACETYLGLUCOSAMINE. It is the second most abundant biopolymer on earth, found especially in INSECTS and FUNGI. When deacetylated it is called CHITOSAN.
PM = 72
HN = 72(67)
MR = 20040707
DA = 19990101
DC = 1
DX = 19720101
UI = D002686

*NEWRECORD
RECTYPE = D
MH = Chitin Synthase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Chitin-UDP Acetylglucosaminyltransferase|T116|T126|EQV|UNK (19XX)|741111|abbdef
ENTRY = Chitin Synthase 1|T116|T126|NON|NRW|NLM (1991)|900116|abbcdef
ENTRY = Chitin Synthetase 2|T116|T126|NON|NRW|UNK (19XX)|870810|abbcdef
ENTRY = trans-N-Acetylglucosaminosylase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Acetylglucosaminyltransferase, Chitin-UDP
ENTRY = Chitin UDP Acetylglucosaminyltransferase
ENTRY = trans N Acetylglucosaminosylase
MN = D08.811.913.400.450.460.200
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = UDP-N-acetyl-D-glucosamine:chitin 4-beta-N-acetylglucosaminyltransferase
RN = EC 2.4.1.16
RR = 9030-18-6 (CAS RN)
PI = Chitin (1974)
PI = Glucosamine (1974)
PI = Hexosyltransferases (1974)
PI = Uridine Diphosphate Sugars (1974)
MS = An enzyme that converts UDP glucosamine into chitin and UDP. EC 2.4.1.16.
PM = 91; was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78
HN = 91(75); was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D002687

*NEWRECORD
RECTYPE = D
MH = Chitinase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Endochitinase|T116|T126|NON|NRW|UNK (19XX)|820519|abbcdef
MN = D08.811.277.450.207
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = Poly(1,4-(N-acetyl-beta-D-glucosaminide)) glycanohydrolase
RN = EC 3.2.1.14
MR = 20030709
DA = 19990101
DC = 1
UI = D002688

*NEWRECORD
RECTYPE = D
MH = Chlamydia
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.190.190.190
MH_TH = NLM (1966)
ST = T007
AN = GEN or unspecified; prefer specific species; infection = CHLAMYDIA INFECTIONS
MS = A genus of the family CHLAMYDIACEAE whose species cause a variety of diseases in vertebrates including humans, mice, and swine. Chlamydia species are gram-negative and produce glycogen. The type species is CHLAMYDIA TRACHOMATIS.
MR = 20090706
DA = 19990101
DC = 1
UI = D002689

*NEWRECORD
RECTYPE = D
MH = Chlamydia Infections
DE = CHLAMYDIA INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Infections, Chlamydia|T047|NON|EQV|NLM (1992)|910228|INFECT CHLAMYDIA|abcdefv
ENTRY = Chlamydia Infection
ENTRY = Infection, Chlamydia
MN = C01.252.400.210.210
MN = C01.252.810.301
MN = C01.539.778.281.301
MN = C12.294.668.281.301
MN = C13.351.500.711.281.301
MH_TH = POPLINE (1986)
ST = T047
AN = do not confuse with CHLAMYDIACEAE INFECTIONS; Chlamydophila psittaci infection = PSITTACOSIS; Chlamydia trachomatis infection: see note at CHLAMYDIA TRACHOMATIS
PI = Conjunctivitis (1966)
PI = Trachoma (1966)
MS = Infections with bacteria of the genus CHLAMYDIA.
PM = 1967; for CHLAMYDIAL PNEUMONIA see PSITTACOSIS 2011
HN = 1967; for CHLAMYDIAL PNEUMONIA use PSITTACOSIS 2011
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
DX = 19670101
UI = D002690

*NEWRECORD
RECTYPE = D
MH = Chlamydophila psittaci
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Chlamydia psittaci|T007|NON|EQV|NLM (1975)|990101|abcdef
MN = B03.440.190.190.230.500
MH_TH = NLM (2001)
ST = T007
AN = infection = PSITTACOSIS
PI = Chlamydia (1966-1974)
MS = A genus of CHLAMYDOPHILA infecting primarily birds. It contains eight known serovars, some of which infect more than one type of host, including humans.
PM = 2001; see CHLAMYDIA PSITTACI 1976-2000, see MIYAGAWANELLA 1963-75
HN = 2001(1963)
MR = 20130709
DA = 19750725
DC = 1
DX = 19760101
UI = D002691

*NEWRECORD
RECTYPE = D
MH = Chlamydia trachomatis
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.190.190.190.750
MH_TH = NLM (1976)
ST = T007
AN = infection: coord IM with CHLAMYDIA INFECTIONS (IM) or index TRACHOMA; LYMPHOGRANULOMA VENEREUM; or CONJUNCTIVITIS, INCLUSION if specified in text
PI = Chlamydia (1966-1975)
MS = Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
OL = use CHLAMYDIA TRACHOMATIS to search TRACHOMA VIRUS 1976-91; use CHLAMYDIA 1966-74
PM = 76; TRACHOMA VIRUS was see CHLAMYDIA TRACHOMATIS 1976-91, was see CHLAMYDIA 1963-74
HN = 76; TRACHOMA VIRUS was see CHLAMYDIA TRACHOMATIS 1976-91, was see CHLAMYDIA 1963-74
MR = 20090706
DA = 19750725
DC = 1
DX = 19760101
UI = D002692

*NEWRECORD
RECTYPE = D
MH = Chlamydiaceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.190.190
MH_TH = NLM (1964)
ST = T007
AN = infection = CHLAMYDIACEAE INFECTIONS
MS = A family of gram-negative, coccoid microorganisms, in the order CHLAMYDIALES, pathogenic for vertebrates. Genera include CHLAMYDIA and CHLAMYDOPHILA.
OL = use CHLAMYDIACEAE to search BASOPHILIC VIRUSES 1975-91
PM = 76; was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91
HN = 76(64); was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91
MR = 20090706
DA = 19990101
DC = 1
DX = 19760101
UI = D002693

*NEWRECORD
RECTYPE = D
MH = Chlamydiaceae Infections
DE = CHLAMYDIACEAE INFECT
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Chlamydiaceae Infection
ENTRY = Infection, Chlamydiaceae
ENTRY = Infections, Chlamydiaceae
MN = C01.252.400.210
MH_TH = NLM (1977)
ST = T047
AN = rickettsial infect
PI = Chlamydia Infections (1967-1976)
PI = Rickettsial Infections (1966-1976)
MS = Infections with bacteria of the family CHLAMYDIACEAE.
PM = 77
HN = 77
CATSH = CAT LIST
MR = 19970620
DA = 19760427
DC = 1
DX = 19770101
UI = D002694

*NEWRECORD
RECTYPE = D
MH = Chlamydiales
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Criblamydiaceae|T007|NON|NRW|NLM (2012)|110420|abcdef
PRINT ENTRY = Parachlamydiaceae|T007|NON|NRW|NLM (2001)|000606|abcdef
PRINT ENTRY = Rhabdochlamydia|T007|NON|NRW|NLM (2012)|110420|abcdef
PRINT ENTRY = Simkaniaceae|T007|NON|NRW|NLM (2001)|000606|abcdef
PRINT ENTRY = Waddliaceae|T007|NON|NRW|NLM (2001)|000606|abcdef
ENTRY = Microorganism Z|T007|NON|NRW|NLM (2001)|000623|abcdef
MN = B03.440.190
MH_TH = NLM (1976)
ST = T007
PI = Bacteria (1966-1974)
PI = Micotatobiotes (1975)
MS = An order of obligately intracellular, gram-negative bacteria that have the chlamydia-like developmental cycle of replication. This is a two-stage cycle that includes a metabolically inactive infectious form, and a vegetative form that replicates by binary fission. Members of Chlamydiales are disseminated by aerosol or by contact. There are at least six recognized families: CHLAMYDIACEAE, Criblamydiaceae, Parachlamydiaceae, Rhabdochlamydia, Simkaniaceae, and Waddliaceae.
PM = 1976
HN = 1976
MR = 20110624
DA = 19750725
DC = 1
DX = 19760101
UI = D002695

*NEWRECORD
RECTYPE = D
MH = Chlamydomonas
AQ = AE AH CH CL CY DE EM EN GD GE IM ME MI PH PO PS RE TO UL VI
ENTRY = Chlamydomona
MN = B01.650.940.150.925.344
MH_TH = NLM (1972)
ST = T002
PI = Algae, Green (1970-1971)
MS = A genus GREEN ALGAE in the order VOLVOCIDA. It consists of solitary biflagellated organisms common in fresh water and damp soil.
PM = 74
HN = 74(72)
MR = 20150622
DA = 19990101
DC = 1
DX = 19740101
UI = D002696

*NEWRECORD
RECTYPE = D
MH = Chloral Hydrate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Noctec|T109|T121|TRD|NRW|UNK (19XX)|840213|abbcdef
ENTRY = Hydrate, Chloral
MN = D02.033.455.250.130
PA = Hypnotics and Sedatives
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 1,1-Ethanediol, 2,2,2-trichloro-
RN = 418M5916WG
RR = 302-17-0 (Chloral Hydrate)
MS = A hypnotic and sedative used in the treatment of INSOMNIA.
MR = 20130708
DA = 19990101
DC = 1
UI = D002697

*NEWRECORD
RECTYPE = D
MH = Chloralose
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Anhydroglucochloral|T118|T121|NON|EQV|UNK (19XX)|770322|abbcdef
PRINT ENTRY = Glucochloral|T118|T121|NON|EQV|UNK (19XX)|770312|abbcdef
ENTRY = Glucochloralose|T118|T121|NON|EQV|UNK (19XX)|821124|abbcdef
ENTRY = alpha-Chloralose|T118|T121|NON|EQV|UNK (19XX)|810427|abbcdef
ENTRY = beta-Chloralose|T118|T121|NON|REL|UNK (19XX)|861007|abbcdef
ENTRY = alpha Chloralose
ENTRY = beta Chloralose
MN = D02.033.455.250.130.150
MN = D09.408.348.150
PA = Anesthetics, Intravenous
PA = Hypnotics and Sedatives
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T118
ST = T121
N1 = alpha-D-Glucofuranose, 1,2-O-(2,2,2-trichloroethylidene)-, (R)-
RN = 238BZ29MUE
RR = 15879-93-3 (Chloralose)
MS = A derivative of CHLORAL HYDRATE that was used as a sedative but has been replaced by safer and more effective drugs. Its most common use is as a general anesthetic in animal experiments.
MR = 20130708
DA = 19990101
DC = 1
UI = D002698

*NEWRECORD
RECTYPE = D
MH = Chlorambucil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid|T109|T121|T131|NON|EQV|NLM (1996)|950404|abbbcdef
ENTRY = Amboclorin|T109|T121|TRD|NRW|NLM (1992)|911104|abbcdef
ENTRY = CB-1348|T109|T121|T131|LAB|NRW|NLM (1992)|911104|abbbcdef
ENTRY = Chloraminophene|T109|T121|T131|NON|EQV|UNK (19XX)|810108|abbbcdef
ENTRY = Chlorbutin|T109|T121|T131|NON|EQV|UNK (19XX)|820226|abbbcdef
ENTRY = Glaxo Wellcome Brand of Chlorambucil|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = GlaxoSmithKline Brand of Chlorambucil|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Leukeran|T109|T121|TRD|NRW|AU|CA|DE|ES|MX|NL|UK|US|810318|abbcdeeeeeeeef
ENTRY = Lympholysin|T109|T121|TRD|NRW|NLM (1992)|911104|abbcdef
ENTRY = N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid|T109|T121|T131|NON|EQV|UNK (19XX)|810305|abbbcdef
ENTRY = NSC-3088|T109|T121|T131|LAB|NRW|NLM (1992)|911104|abbbcdef
ENTRY = Wellcome Brand of Chlorambucil|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = CB 1348
ENTRY = CB1348
ENTRY = NSC 3088
ENTRY = NSC3088
MN = D02.455.526.728.650.156
PA = Antineoplastic Agents, Alkylating
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
ST = T131
N1 = Benzenebutanoic acid, 4-(bis(2-chloroethyl)amino)-
RN = 18D0SL7309
RR = 305-03-3 (Chlorambucil)
MS = A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
MR = 20130708
DA = 19990101
DC = 1
UI = D002699

*NEWRECORD
RECTYPE = D
MH = Chloramines
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chloroamines|T109|NON|EQV|UNK (19XX)|831209|abcdef
MN = D02.065.884.344
MN = D02.886.590.700.344
MH_TH = NLM (1966)
ST = T109
RN = 0
MR = 20000622
DA = 19990101
DC = 1
UI = D002700

*NEWRECORD
RECTYPE = D
MH = Chloramphenicol
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Cloranfenicol|T109|T195|NON|EQV|UNK (19XX)|770330|abbcdef
PRINT ENTRY = Kloramfenikol|T109|T195|NON|EQV|UNK (19XX)|770330|abbcdef
PRINT ENTRY = Levomycetin|T109|T121|TRD|NRW|UNK (19XX)|820421|abbcdef
ENTRY = Chlornitromycin|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Chlorocid|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Chloromycetin|T109|T121|TRD|NRW|UNK (19XX)|830915|abbcdef
ENTRY = Detreomycin|T109|T121|TRD|NRW|UNK (19XX)|810305|abbcdef
ENTRY = Ophthochlor|T109|T121|TRD|NRW|UNK (19XX)|861120|abbcdef
ENTRY = Syntomycin|T109|T121|TRD|NRW|UNK (19XX)|871215|abbcdef
MN = D02.033.455.706.300
MN = D02.455.426.559.389.565.175
MN = D02.640.529.175
PA = Anti-Bacterial Agents
PA = Protein Synthesis Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T195
N1 = Acetamide, 2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl)-, (R-(R*,R*))-
RN = 66974FR9Q1
RR = 56-75-7 (Chloramphenicol)
AN = an antibiotic
MS = An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
MR = 20130708
DA = 19990101
DC = 1
UI = D002701

*NEWRECORD
RECTYPE = D
MH = Chloramphenicol Resistance
AQ = DE EH GE IM PH RE
ENTRY = Chloramphenicol Resistances
MN = G06.099.225.750
MN = G06.225.347.750
MN = G07.690.773.984.269.347.750
MH_TH = NLM (1988)
ST = T032
PI = Chloramphenicol (1966-1987)
PI = Drug Resistance, Microbial (1966-1987)
MS = Nonsusceptibility of bacteria to the action of CHLORAMPHENICOL, a potent inhibitor of protein synthesis in the 50S ribosomal subunit where amino acids are added to nascent bacterial polypeptides.
PM = 1988
HN = 1988
CATSH = CAT LIST
MR = 20150629
DA = 19870509
DC = 1
DX = 19880101
UI = D002702

*NEWRECORD
RECTYPE = D
MH = Chloranil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 2,3,5,6-Tetrachloro-1,4-benzoquinone|T109|T131|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = Coversan|T109|T131|TRD|NRW|NLM (1991)|900305|abbcdef
ENTRY = Reranil|T109|T131|TRD|NRW|NLM (1991)|900305|abbcdef
ENTRY = Spergon|T109|T131|TRD|NRW|NLM (1991)|900305|abbcdef
ENTRY = Tetrachloro-1,4-benzoquinone|T109|T131|NON|EQV|UNK (19XX)|880912|abbcdef
ENTRY = Vulklor|T109|T131|TRD|NRW|NLM (1991)|900305|abbcdef
ENTRY = Tetrachloro 1,4 benzoquinone
MN = D02.806.250.210
PA = Fungicides, Industrial
MH_TH = FDA SRS (2014)
MH_TH = NLM (1976)
ST = T109
ST = T131
N1 = 2,5-Cyclohexadiene-1,4-dione, 2,3,5,6-tetrachloro-
RN = 01W5X7N5XV
RR = 118-75-2 (Chloranil)
PI = Chlorine (1974-1975)
PI = Quinones (1968-1975)
MS = A quinone fungicide used for treatment of seeds and foliage.
PM = 91; was see under QUINONES 1976-90
HN = 91(76); was see under QUINONES 1976-90
MR = 20130708
DA = 19750718
DC = 1
DX = 19910101
UI = D002703

*NEWRECORD
RECTYPE = D
MH = Chlorates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.210.300
MN = D01.248.497.158.190
MH_TH = NLM (1971)
ST = T197
RN = 0
PI = Chlorine (1966-1970)
MS = Inorganic salts of chloric acid that contain the ClO3- ion.
PM = 73
HN = 73(71)
MR = 19930604
DA = 19990101
DC = 1
DX = 19730101
UI = D002704

*NEWRECORD
RECTYPE = D
MH = Chlordan
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chlordane|T109|T131|NON|EQV|UNK (19XX)|830330|abbcdef
ENTRY = gamma-Chlordane|T109|T131|NON|EQV|UNK (19XX)|830330|abbcdef
ENTRY = gamma Chlordane
MN = D02.455.526.439.180
PA = Insecticides
MH_TH = NLM (1966)
ST = T109
ST = T131
N1 = Chlordane
RN = 12789-03-6
AN = TN 111 for eff on insects
MS = A highly poisonous organochlorine insecticide. The EPA has cancelled registrations of pesticides containing this compound with the exception of its use through subsurface ground insertion for termite control and the dipping of roots or tops of non-food plants. (From Merck Index, 11th ed)
MR = 20040707
DA = 19990101
DC = 1
UI = D002706

*NEWRECORD
RECTYPE = D
MH = Chlordiazepoxide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Methaminodiazepoxide|T109|T121|NON|EQV|UNK (19XX)|761223|abbcdef
ENTRY = 7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide|T109|T121|NON|EQV|NLM (1995)|930902|abbcdef
ENTRY = Chlordiazepoxide Hydrobromide|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Chlordiazepoxide Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1963)|941115|abbcdeef
ENTRY = Chlordiazepoxide Monohydrochloride|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Chlordiazepoxide Perchlorate|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Chlozepid|T109|T121|TRD|NRW|NLM (1992)|910312|abbcdef
ENTRY = Elenium|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Librium|T109|T121|TRD|NRW|NLM (1992)|910312|abbcdef
ENTRY = 7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide
ENTRY = Hydrobromide, Chlordiazepoxide
ENTRY = Hydrochloride, Chlordiazepoxide
ENTRY = Monohydrochloride, Chlordiazepoxide
ENTRY = Perchlorate, Chlordiazepoxide
MN = D03.438.079.080.150
PA = Adjuvants, Anesthesia
PA = Anti-Anxiety Agents
PA = GABA Modulators
PA = Hypnotics and Sedatives
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide
RN = 6RZ6XEZ3CR
RR = 121531-47-3 (mono-HClO4)
RR = 14844-23-6 (HCl)
RR = 438-41-5 (mono-HCl)
RR = 56617-98-2 (HBr)
RR = 58-25-3 (Chlordiazepoxide)
RR = MFM6K1XWDK
MS = An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
MR = 20130708
DA = 19990101
DC = 1
UI = D002707

*NEWRECORD
RECTYPE = D
MH = Chlorella
AQ = CH CL CY DE EN GD GE IM IP ME MI PH PS PY RE UL VI
ENTRY = Chlorellas
MN = B01.650.940.150.469
MH_TH = NLM (1972)
ST = T002
PI = Algae, Green (1970-1971)
MS = Nonmotile unicellular green algae potentially valuable as a source of high-grade protein and B-complex vitamins.
PM = 74
HN = 74(72)
MR = 20150622
DA = 19990101
DC = 1
DX = 19740101
UI = D002708

*NEWRECORD
RECTYPE = D
MH = Chlorfenvinphos
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK RE SD ST TO TU UR
ENTRY = Birlane|T115|T121|T131|TRD|NRW|UNK (19XX)|800917|abbbcdef
ENTRY = Chlorphenvinphos|T115|T121|T131|NON|EQV|UNK (19XX)|831209|abbbcdef
ENTRY = Clofenvinfos|T115|T121|T131|NON|EQV|FDA SRS (2014)|INN (19XX)|941115|abbbcdeef
ENTRY = Dermaton|T115|T121|T131|TRD|NRW|UNK (19XX)|810424|abbbcdef
MN = D02.705.400.120
PA = Acaricides
PA = Cholinesterase Inhibitors
PA = Insecticides
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T115
ST = T121
ST = T131
N1 = Phosphoric acid, 2-chloro-1-(2,4-dichlorophenyl)ethenyl diethyl ester
RN = F2G9XS1W91
RR = 470-90-6 (Chlorfenvinphos)
AN = for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
PI = Insecticides (1966-1972)
PI = Insecticides, Organophosphate (1973-1979)
PI = Organophosphorus Compounds (1971-1979)
PI = Phosphoric Acids (1966-1970)
PI = Vinyl Compounds (1971-1974)
MS = An organophosphorus cholinesterase inhibitor that is used as an insecticide and an acaricide.
PM = 91; was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90
HN = 91(80); was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90
MR = 20130708
DA = 19790523
DC = 1
DX = 19910101
UI = D002709

*NEWRECORD
RECTYPE = D
MH = Chlorhexidine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chlorhexidine Acetate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|USP (19XX)|840920|abbcdeeef
ENTRY = Chlorhexidine Hydrochloride|T109|T121|NON|NRW|BAN (19XX)|FDA SRS (2014)|USAN (1963)|USP (19XX)|811023|abbcdeeeef
ENTRY = MK-412A|T109|T121|LAB|NRW|UNK (19XX)|880808|abbcdef
ENTRY = Novalsan|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Sebidin A|T109|T121|TRD|NRW|UNK (19XX)|870617|abbcdef
ENTRY = Tubulicid|T109|T121|TRD|NRW|UNK (19XX)|811102|abbcdef
ENTRY = A, Sebidin
ENTRY = Acetate, Chlorhexidine
ENTRY = Hydrochloride, Chlorhexidine
ENTRY = MK 412A
ENTRY = MK412A
MN = D02.078.370.141.100
PA = Anti-Infective Agents, Local
PA = Disinfectants
PA = Mouthwashes
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = 2,4,11,13-Tetraazatetradecanediimidamide, N,N''-bis(4-chlorophenyl)-3,12-diimino-
RN = R4KO0DY52L
RR = 3697-42-5 (Chlorhexidine Hydrochloride)
RR = 55-56-1 (Chlorhexidine)
RR = 5908ZUF22Y
RR = E64XL9U38K
PI = Biguanides (1968-1974)
PI = Chlorobenzenes (1974)
MS = A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.
PM = 80; was see under BIGUANIDES 1975-79
HN = 80(75); was see under BIGUANIDES 1975-79
MR = 20130708
DA = 19741111
DC = 1
DX = 19800101
UI = D002710

*NEWRECORD
RECTYPE = D
MH = Chloride Peroxidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Chloroperoxidase|T116|T126|NON|EQV|UNK (19XX)|750630|abbcdef
ENTRY = Peroxidase, Chloride
MN = D08.811.682.732.360
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = Chloride:hydrogen-peroxide oxidoreductase
RN = EC 1.11.1.10
PI = Chlorine (1973-1975)
PI = Peroxidases (1973-1975)
MS = An enzyme that catalyzes the chlorination of a range of organic molecules, forming stable carbon-chloride bonds. EC 1.11.1.10.
PM = 91; was see under PEROXIDASES 1976-90
HN = 91(76); was see under PEROXIDASES 1976-90
MR = 20030709
DA = 19750723
DC = 1
DX = 19910101
UI = D002711

*NEWRECORD
RECTYPE = D
MH = Chlorides
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
ENTRY = Chloride Ion Level|T034|NON|REL|POPLINE (1978)|781219|abcdef
ENTRY = Ion Level, Chloride
ENTRY = Level, Chloride Ion
MN = D01.210.450.150
MN = D01.248.497.158.215
MH_TH = NLM (1966)
ST = T197
RN = 0
AN = only for inorganic cpds or chloride ion; /physiol permitted
MS = Inorganic compounds derived from hydrochloric acid that contain the Cl- ion.
MR = 19930604
DA = 19990101
DC = 1
UI = D002712

*NEWRECORD
RECTYPE = D
MH = Chlorine
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.380.150
MN = D01.362.225
PA = Chemical Warfare Agents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T131
ST = T196
N1 = Chlorine
RN = 4R7X1O2820
RR = 7782-50-5 (Chlorine)
AN = Cl-35; Cl-37 = CHLORINE (IM) + ISOTOPES (NIM); Cl-34, 36, 38-40 = CHLORINE (IM) + RADIOISOTOPES (IM)
MS = A greenish-yellow, diatomic gas that is a member of the halogen family of elements. It has the atomic symbol Cl, atomic number 17, and atomic weight 70.906. It is a powerful irritant that can cause fatal pulmonary edema. Chlorine is used in manufacturing, as a reagent in synthetic chemistry, for water purification, and in the production of chlorinated lime, which is used in fabric bleaching.
MR = 20130708
DA = 19990101
DC = 1
UI = D002713

*NEWRECORD
RECTYPE = D
MH = Chlorisondamine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chlorisondamine Chloride|T109|T121|NON|NRW|BAN (19XX)|FDA SRS (2014)|INN (19XX)|941115|abbcdeeef
ENTRY = Chlorisondamine Dichloride|T109|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Ecolid|T109|T121|TRD|NRW|UNK (19XX)|810130|abbcdef
ENTRY = Chloride, Chlorisondamine
ENTRY = Dichloride, Chlorisondamine
MN = D02.092.877.883.222
MN = D02.675.276.200
MN = D03.438.513.249
PA = Antihypertensive Agents
PA = Ganglionic Blockers
PA = Nicotinic Antagonists
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T121
N1 = 1H-Isoindolium, 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-(2-(trimethylammonio)ethyl)-, dichloride
RN = JD3M24F66I
RR = 69-27-2 (Cl)
RR = 7701-62-4 (Chlorisondamine)
RR = 7B58W7756G
MS = A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications.
MR = 20130708
DA = 19990101
DC = 1
UI = D002714

*NEWRECORD
RECTYPE = D
MH = Chlormadinone Acetate
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chlormadinon Acetate|T110|T121|NON|EQV|NLM (1990)|890609|abbcdef
ENTRY = Chlormadinone|T110|T121|NON|BRD|BAN (19XX)|FDA SRS (2014)|INN (19XX)|941115|abbcdeeef
ENTRY = Chlormadinone Acetate, (9 beta,10 alpha)-Isomer|T110|T121|NRW|NLM (1999)|990913|abbdef
ENTRY = Neo-Eunomin|T110|T121|TRD|NRW|UNK (19XX)|850528|abbcdef
ENTRY = Acetate, Chlormadinon
ENTRY = Acetate, Chlormadinone
ENTRY = Neo Eunomin
ENTRY = NeoEunomin
MN = D04.808.745.432.144
MN = D04.808.883.294
PA = Androgen Antagonists
PA = Contraceptives, Oral, Synthetic
MH_TH = FDA SRS (2014)
MH_TH = POPLINE (1978)
MH_TH = USAN (1964)
ST = T110
ST = T121
N1 = Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-chloro-
RN = 0SY050L61N
RR = 1961-77-9 (chlormadinone)
RR = 302-22-7 (Chlormadinone Acetate)
RR = 4203-02-5 (acetate, (9 beta,10 alpha)-isomer)
RR = SDS4N642GG
MS = An orally active synthetic progestational hormone used often in combinations as an oral contraceptive.
PM = 96; was CHLORMADINONE 1966-1995
HN = 96; was CHLORMADINONE 1964-1995 (Prov 1964-65)
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D002715

*NEWRECORD
RECTYPE = D
MH = Chlormequat
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chlorinecolinchloride|T109|T131|NON|NRW|UNK (19XX)|880727|abbcdef
ENTRY = Chlormequat Chloride|T109|T131|NON|NRW|FDA SRS (2014)|NLM (2014)|130304|abbcdeef
ENTRY = Chlorocholine Chloride|T109|T131|NON|NRW|FDA SRS (2014)|UNK (19XX)|800731|abbcdeef
ENTRY = Cycocel|T109|T131|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Chloride, Chlormequat
ENTRY = Chloride, Chlorocholine
MN = D02.092.877.883.277
MN = D02.675.276.207
PA = Plant Growth Regulators
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T131
N1 = Ethanaminium, 2-chloro-N,N,N-trimethyl-
RN = 8SUZ1123XX
RR = 999-81-5 (Chlormequat)
RR = PPL2215L82
PI = Ammonium Compounds (1966-1971)
PI = Plant Growth Regulators (1966-1971)
MS = A plant growth regulator that is commonly used on ornamental plants.
PM = 91; was see under AMMONIUM COMPOUNDS 1972-90
HN = 91(72); was see under AMMONIUM COMPOUNDS 1972-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002716

*NEWRECORD
RECTYPE = D
MH = Chlormerodrin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chlormeroprin|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
ENTRY = 3-Chloromercuri-2-methoxypropylurea|T109|T121|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = Promeran|T109|T121|NON|EQV|UNK (19XX)|830629|abbcdef
ENTRY = 3 Chloromercuri 2 methoxypropylurea
MN = D02.691.750.100.229
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Mercury, (3-((aminocarbonyl)amino)-2-methoxypropyl-C1,O3)chloro-
RN = 99T5TWO621
RR = 62-37-3 (Chlormerodrin)
MS = A mercurial compound that has been used as a diuretic but is now superseded by more potent and less toxic drugs. The radiolabeled form has been used as a diagnostic and research tool.
PM = 66; was see under DIURETICS, MERCURIAL 1963-65
HN = 66(64); was see under DIURETICS, MERCURIAL 1963-65
MR = 20130708
DA = 19990101
DC = 1
DX = 19660101
UI = D002717

*NEWRECORD
RECTYPE = D
MH = Chlormethiazole
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Clomethiazole|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|800801|abbcdeef
ENTRY = Distraneurin|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
MN = D02.886.675.180
MN = D03.383.129.708.180
PA = Anticonvulsants
PA = GABA Modulators
PA = Hypnotics and Sedatives
PA = Neuroprotective Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T121
N1 = Thiazole, 5-(2-chloroethyl)-4-methyl-
RN = 0C5DBZ19HV
RR = 533-45-9 (Chlormethiazole)
PI = Hypnotics and Sedatives (1966-1967)
PI = Thiazoles (1966-1967)
MS = A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors.
PM = 68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95
HN = 68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95
MR = 20130708
DA = 19990101
DC = 1
DX = 19680101
UI = D002719

*NEWRECORD
RECTYPE = D
MH = Chlormezanone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chlormethazanone|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef
MN = D02.886.665.150
MN = D03.383.855.150
PA = Anti-Anxiety Agents
PA = Muscle Relaxants, Central
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 4H-1,3-Thiazin-4-one, 2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide
RN = GP568V9G19
RR = 80-77-3 (Chlormezanone)
AN = an anti-anxiety agent & central muscle relaxant
MS = A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm.
MR = 20130708
DA = 19990101
DC = 1
UI = D002720

*NEWRECORD
RECTYPE = D
MH = omega-Chloroacetophenone
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = 2-Chloroacetophenone|T109|T131|NON|EQV|FDA SRS (2014)|NLM (1982)|900413|CHLOROACETOPHENONE 02|abbcdeefs
PRINT ENTRY = alpha-Chloroacetophenone|T109|T131|NON|EQV|NLM (2001)|000531|abbcdef
ENTRY = 2-Chloro-1-phenylethanone|T109|T131|NON|EQV|NLM (1996)|950525|abbcdef
ENTRY = 3'-Chloroacetophenone|T109|T121|NON|REL|NLM (2001)|000531|abbcdef
ENTRY = Chloracetophenone|T109|T131|NON|BRD|UNK (19XX)|810728|abbcdef
ENTRY = Chloroacetophenone|T109|T131|NON|BRD|FDA SRS (2014)|NLM (1991)|900413|abbcdeef
ENTRY = Mace|T109|T131|TRD|NRW|UNK (19XX)|740329|abbcdef
ENTRY = 2 Chloro 1 phenylethanone
ENTRY = 2 Chloroacetophenone
ENTRY = alpha Chloroacetophenone
ENTRY = omega Chloroacetophenone
MN = D02.522.120.575
PA = Irritants
PA = Tear Gases
MH_TH = NLM (1966)
ST = T109
ST = T131
N1 = Ethanone, 2-chloro-1-phenyl-
RN = 88B5039IQG
RR = 1341-24-8
RR = 532-27-4 (omega-Chloroacetophenone)
RR = 88B5039IQG
AN = D25-26 qualif
MS = A potent eye, throat, and skin irritant. One of its uses is as a riot control agent.
OL = use OMEGA-CHLOROACETOPHENONE to search CHLOROACETOPHENONE 1966-90
PM = 91; was CHLOROACETOPHENONE 1963-90
HN = 91; was CHLOROACETOPHENONE 1963-90
MR = 20130708
DA = 19990101
DC = 1
UI = D002721

*NEWRECORD
RECTYPE = D
MH = Chlorobenzenes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.426.559.389.261
MN = D02.455.526.439.202
MH_TH = NLM (1974)
ST = T109
ST = T131
RN = 0
PM = 74
HN = 74
MR = 19920511
DA = 19990101
DC = 1
DX = 19740101
UI = D002722

*NEWRECORD
RECTYPE = D
MH = Chlorobenzoates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chlorobenzoic Acids|T109|NON|REL|NLM (2013)|120113|abcdef
ENTRY = Acids, Chlorobenzoic
MN = D02.241.223.100.200
MN = D02.455.426.559.389.127.250
MH_TH = NLM (1975)
ST = T109
RN = 0
PI = Benzoates (1966-1974)
MS = Benzoic acid or benzoic acid esters substituted with one or more chlorine atoms.
PM = 75
HN = 75
MR = 20120703
DA = 19741111
DC = 1
DX = 19750901
UI = D002723

*NEWRECORD
RECTYPE = D
MH = Chlorobutanol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetonchloroform|T119|T121|T130|NON|EQV|UNK (19XX)|770118|abbbcdef
PRINT ENTRY = Chlorbutol|T119|T121|T130|NON|EQV|UNK (19XX)|770118|abbbcdef
PRINT ENTRY = Trichlorbutanol|T119|T121|T130|NON|EQV|UNK (19XX)|770118|abbbcdef
ENTRY = Chloretone|T119|T121|T130|TRD|NRW|UNK (19XX)|810608|abbbcdef
ENTRY = Chlorobutanol, Anhydrous|T109|T121|T130|NON|NRW|NLM (2013)|120605|abbbcdef
ENTRY = Anhydrous Chlorobutanol
MN = D02.033.260.220
MN = D02.033.415.110.220
MN = D10.289.110.220
PA = Preservatives, Pharmaceutical
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1966)
ST = T119
ST = T121
ST = T130
N1 = 2-Propanol, 1,1,1-trichloro-2-methyl-
RN = HM4YQM8WRC
RR = 57-15-8 (Chlorobutanol)
MS = A colorless to white crystalline compound with a camphoraceous odor and taste. It is a widely used preservative in various pharmaceutical solutions, especially injectables. Also, it is an active ingredient in certain oral sedatives and topical anesthetics.
MR = 20130708
DA = 19990101
DC = 1
UI = D002724

*NEWRECORD
RECTYPE = D
MH = Chloroform
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Trichloromethane|T109|T130|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|801125|abbbcdeef
MN = D02.455.526.439.224
MN = D02.455.526.913.810
PA = Solvents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T130
ST = T131
N1 = Methane, trichloro-
RN = 7V31YC746X
RR = 67-66-3 (Chloroform)
MS = A commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity.
MR = 20130708
DA = 19990101
DC = 1
UI = D002725

*NEWRECORD
RECTYPE = D
MH = Chlorogenic Acid
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = 3-Caffeoylquinic Acid|T109|T123|NON|EQV|NLM (1998)|961122|abbcdef
ENTRY = 3 Caffeoylquinic Acid
ENTRY = Acid, 3-Caffeoylquinic
ENTRY = Acid, Chlorogenic
MN = D02.241.223.200.185
MN = D02.241.223.268.220
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T123
N1 = Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S-(1alpha,3beta,4alpha,5alpha))-
RN = 318ADP12RI
RR = 327-97-9 (Chlorogenic Acid)
MS = A naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. (From J Chromatogr A 1996;741(2):223-31; Biosci Biotechnol Biochem 1996;60(5):765-68).
MR = 20130708
DA = 19990101
DC = 1
UI = D002726

*NEWRECORD
RECTYPE = D
MH = Proguanil
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chlorguanid|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef
PRINT ENTRY = Chloroguanide|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1966)|990101|abbcdeef
ENTRY = Astra Brand of Chloroguanide Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041122|abbcdef
ENTRY = AstraZeneca Brand of Chloroguanide Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041122|abbcdef
ENTRY = Bigumal|T109|T121|TRD|NRW|UNK (19XX)|870327|abbcdef
ENTRY = Chloriguane|T109|T121|TRD|NRW|UNK (19XX)|770330|abbcdef
ENTRY = Chloroguanide Hydrochloride|T109|T121|NON|NRW|NLM (1996)|USP (19XX)|941017|abbcdeef
ENTRY = Paludrin|T109|T121|TRD|NRW|UNK (19XX)|870812|abbcdef
ENTRY = Paludrine|T109|T121|TRD|NRW|AU|DE|FR|IE|NL|NLM (1989)|UK|890208|abbcdeeeeeeef
ENTRY = Proguanil Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2003)|USAN (19XX)|020513|abbcdeeef
ENTRY = Zeneca Brand of Chloroguanide Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041122|abbcdef
ENTRY = Hydrochloride, Chloroguanide
ENTRY = Hydrochloride, Proguanil
MN = D02.078.370.141.710
PA = Antimalarials
PA = Antimetabolites
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)-
RN = S61K3P7B2V
RR = 500-92-5 (Proguanil)
RR = 637-32-1 (HCl)
RR = R71Y86M0WT
MS = A biguanide compound which metabolizes in the body to form cycloguanil, an anti-malaria agent.
PM = 2011; see CHLOROGUANIDE 1963-2011
HN = 2011 (1963)
MR = 20130708
DA = 19990101
DC = 1
UI = D002727

*NEWRECORD
RECTYPE = D
MH = Chlorohydrins
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chlorhydrins|T109|NON|EQV|UNK (19XX)|741111|abcdef
MN = D02.033.260
MH_TH = NLM (1975)
ST = T109
RN = 0
PI = Alcohols (1966-1974)
MS = Any of the compounds derived from a group of glycols or polyhydroxy alcohols by chlorine substitution for part of the hydroxyl groups. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
PM = 75
HN = 75
MR = 19970620
DA = 19741111
DC = 1
DX = 19750901
UI = D002728

*NEWRECORD
RECTYPE = D
MH = Chloromercuribenzoates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.241.223.100.200.311
MN = D02.241.223.100.500.261
MN = D02.455.426.559.389.127.250.311
MN = D02.455.426.559.389.127.500.261
MN = D02.691.750.740.644.261
PA = Enzyme Inhibitors
PA = Sulfhydryl Reagents
MH_TH = NLM (1964)
ST = T109
ST = T130
RN = 0
AN = P-CHLOROMERCURIBENZOIC ACID is available
PI = Benzoates (1966)
MS = Chloride and mercury-containing derivatives of benzoic acid.
PM = 66
HN = 66(64)
MR = 20120703
DA = 19990101
DC = 1
DX = 19660101
UI = D002729

*NEWRECORD
RECTYPE = D
MH = Chloromercurinitrophenols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.691.750.740.225
PA = Sulfhydryl Reagents
MH_TH = NLM (1977)
ST = T109
ST = T130
RN = 0
PI = Mercury (1968-1976)
PI = Nitrophenols (1968-1976)
PI = Organometallic Compounds (1968-1976)
MS = Mercuriphenols substituted with one or more chlorine atoms and one or more nitro groups. Some of these are sulfhydryl reagents which act as chromophoric probes in enzymes and other proteins.
PM = 91; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79
HN = 91(77); was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79
MR = 20110624
DA = 19760419
DC = 1
DX = 19910101
UI = D002730

*NEWRECORD
RECTYPE = D
MH = 4-Chloromercuribenzenesulfonate
DS = CHLOROMERCURIBENZENESULFONATE 04
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chloromercuriphenylsulfonate|T109|T121|NON|EQV|NLM (1994)|930510|abbcdef
PRINT ENTRY = PCMBS|T109|T121|ABB|EQV|FDA SRS (2014)|UNK (19XX)|771005|abbcdeef
ENTRY = Chloromercuribenzene-p-sulphonic Acid|T109|T121|BRD|UNK (19XX)|810305|abbdef
ENTRY = Chloromercuribenzenesulfonate|T109|T121|NON|EQV|NLM (1994)|930510|abbcdef
ENTRY = PCMPS|T109|T121|ABB|EQV|UNK (19XX)|820830|abbcdef
ENTRY = p-Chloromercuriphenylsulphonate|T109|T121|EQV|UNK (19XX)|810318|abbdef
ENTRY = 4 Chloromercuribenzenesulfonate
ENTRY = Acid, Chloromercuribenzene-p-sulphonic
ENTRY = Chloromercuribenzene p sulphonic Acid
ENTRY = p Chloromercuriphenylsulphonate
MN = D02.455.426.559.389.097.150
MN = D02.691.750.740.220
MN = D02.886.645.600.080.050.100.100
PA = Enzyme Inhibitors
PA = Sulfhydryl Reagents
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Mercurate(1-), chloro(4-sulfonatophenyl)-, hydrogen
RN = 5YIN07W42H
RR = 554-77-8 (4-Chloromercuribenzenesulfonate)
AN = DF: note short X ref
PI = Benzene (1966-1967)
PI = Benzenesulfonates (1974)
PI = Mercury (1966-1974)
PI = Organometallic Compounds (1968-1974)
PI = Sulfonic Acids (1966-1973)
MS = A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology.
OL = use 4-CHLOROMERCURIBENZENESULFONATE to search CHLOROMERCURIPHENYLSULFONATE & CHLOROMERCURIBENZENESULFONATE 1975-93
PM = 94; was CHLOROMERCURIPHENYLSULFONATE (see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76); CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93
HN = 94; was CHLOROMERCURIPHENYLSULFONATE (see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76); CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002731

*NEWRECORD
RECTYPE = D
MH = Chlorophenols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Hydroxychlorobenzenes|T109|NON|EQV|UNK (19XX)|760516|abcdef
MN = D02.455.426.559.389.261.190
MN = D02.455.426.559.389.657.190
MH_TH = NLM (1977)
ST = T109
RN = 0
PI = Chlorobenzenes (1974-1976)
PI = Phenols (1966-1976)
MS = Phenols substituted with one or more chlorine atoms in any position.
PM = 77; PENTACHLOROPHENOL was see under PHENOLS 1971-76
HN = 77
MR = 20120703
DA = 19760519
DC = 1
DX = 19770101
UI = D002733

*NEWRECORD
RECTYPE = D
MH = Chlorophyll
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Chlorophyll 740|T109|T123|NON|NRW|UNK (19XX)|810918|abbcdef
ENTRY = 740, Chlorophyll
MN = D03.383.129.578.840.374
MN = D03.383.129.578.840.500.640.220
MN = D03.549.909.374
MN = D03.549.909.500.640.220
MN = D04.345.783.374
MN = D04.345.783.500.640.220
MN = D23.767.727.640.220
FX = Photosynthesis
MH_TH = NLM (1966)
ST = T109
ST = T123
N1 = Chlorophylls
RN = 1406-65-1
MS = Porphyrin derivatives containing magnesium that act to convert light energy in photosynthetic organisms.
MR = 20150622
DA = 19990101
DC = 1
UI = D002734

*NEWRECORD
RECTYPE = D
MH = Chlorophyllides
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
MN = D03.383.129.578.840.374.180
MN = D03.383.129.578.840.500.640.220.180
MN = D03.549.909.374.180
MN = D03.549.909.500.640.220.180
MN = D04.345.783.374.180
MN = D04.345.783.500.640.220.180
MN = D23.767.727.640.220.180
MH_TH = NLM (1975)
ST = T109
ST = T123
RN = 0
AN = products of chlorophil hydrolysis
PI = Chlorophyll (1972-1974)
MS = Products of the hydrolysis of chlorophylls in which the phytic acid side chain has been removed and the carboxylic acids saponified.
PM = 91; was see under CHLOROPHYLL 1975-90
HN = 91(75); was see under CHLOROPHYLL 1975-90
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D002735

*NEWRECORD
RECTYPE = D
MH = Chloroplasts
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Chloroplast|T026|NON|EQV|NLM (2004)|030314|abcdef
ENTRY = Etioplasts|T026|NON|REL|NLM (2008)|070206|abcdef
ENTRY = Etioplast
MN = A11.284.430.214.190.875.700.140
FX = Photosynthesis
MH_TH = NLM (1964)
ST = T026
MS = Plant cell inclusion bodies that contain the photosynthetic pigment CHLOROPHYLL, which is associated with the membrane of THYLAKOIDS. Chloroplasts occur in cells of leaves and young stems of plants. They are also found in some forms of PHYTOPLANKTON such as HAPTOPHYTA; DINOFLAGELLATES; DIATOMS; and CRYPTOPHYTA.
PM = 66
HN = 66(64)
MR = 20110624
DA = 19990101
DC = 1
DX = 19660101
UI = D002736

*NEWRECORD
RECTYPE = D
MH = Chloroprene
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.326.271.665.146.280
MH_TH = NLM (1979)
ST = T109
ST = T131
N1 = 1,3-Butadiene, 2-chloro-
RN = 126-99-8
PI = Butadienes (1966-1978)
PI = Neoprene (1975-1978)
MS = Toxic, possibly carcinogenic, monomer of neoprene, a synthetic rubber; causes damage to skin, lungs, CNS, kidneys, liver, blood cells and fetuses. Synonym: 2-chlorobutadiene.
PM = 91; was see under BUTADIENES 1979-90
HN = 91(79); was see under BUTADIENES 1979-90
MR = 20060705
DA = 19780501
DC = 1
DX = 19910101
UI = D002737

*NEWRECORD
RECTYPE = D
MH = Chloroquine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aralen|T109|T121|TRD|NRW|UNK (19XX)|840919|abbcdef
ENTRY = Arechine|T109|T121|TRD|NRW|UNK (19XX)|830328|abbcdef
ENTRY = Arequin|T109|T121|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Chingamin|T109|T121|NON|EQV|UNK (19XX)|871208|abbcdef
ENTRY = Chlorochin|T109|T121|NON|EQV|UNK (19XX)|831209|abbcdef
ENTRY = Chloroquine Sulfate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|821206|abbcdeef
ENTRY = Chloroquine Sulphate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|820830|abbcdeef
ENTRY = Khingamin|T109|T121|NON|EQV|UNK (19XX)|871208|abbcdef
ENTRY = Nivaquine|T109|T121|TRD|NRW|UNK (19XX)|830915|abbcdef
ENTRY = Sulfate, Chloroquine
ENTRY = Sulphate, Chloroquine
MN = D03.438.810.050.180
PA = Amebicides
PA = Antimalarials
PA = Antirheumatic Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-
RN = 886U3H6UFF
RR = 54-05-7 (Chloroquine)
RR = OE48649K6N
MS = The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
MR = 20130708
DA = 19990101
DC = 1
UI = D002738

*NEWRECORD
RECTYPE = D
MH = Chloroquinolinols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D03.438.810.350.625.250
PA = Amebicides
MH_TH = NLM (1965)
ST = T109
ST = T121
RN = 0
MS = 8-Hydroxyquinolinols chlorinated on the number 5 and/or 7 carbon atom(s). They are antibacterial, antiprotozoal, and antidiarrheal, especially in amebiasis, and have also been used as antiseborrheics. The compounds are mostly used topically, but have been used also as animal feed additives. They may cause optic and other neuropathies and are most frequently administered in combination with other agents.
OL = use HYDROXYQUINOLINES to search CHLOROQUINOLINOLS 1966-74 (as Prov)
PM = 91; was see under HYDROXYQUINOLINES 1975-90
HN = 91(65); was see under HYDROXYQUINOLINES 1965-90 (Prov 1965-74)
MR = 20000622
DA = 19990101
DC = 1
DX = 19910101
UI = D002739

*NEWRECORD
RECTYPE = D
MH = Chlorothiazide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.886.590.700.135.261
MN = D02.886.655.500.261
MN = D03.438.174.261
PA = Antihypertensive Agents
PA = Diuretics
PA = Sodium Chloride Symporter Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide
RN = 77W477J15H
RR = 58-94-6 (Chlorothiazide)
MS = A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
PM = CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adverse effects /poisoning /toxicity were CHLOROTHIAZIDE TOXICOLOGY 1963-65
HN = CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adv eff-pois-tox was CHLOROTHIAZIDE TOXICOLOGY 1963-65
MR = 20130708
DA = 19990101
DC = 1
UI = D002740

*NEWRECORD
RECTYPE = D
MH = Chlorotrianisene
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.455.426.559.389.150.700.100
PA = Antineoplastic Agents, Hormonal
PA = Estrogens, Non-Steroidal
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = POPLINE (1978)
MH_TH = USAN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy)-
RN = 6V5034L121
RR = 569-57-3 (Chlorotrianisene)
MS = A powerful synthetic, non-steroidal estrogen.
OL = use CHLOROTRIANISENE to search TRIANISOESTROL 1978-93
PM = 65; TRIANISOESTROL was see CHLOROTRIANISENE 1978-93
HN = 65(64); TRIANISOESTROL was see CHLOROTRIANISENE 1978-93
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D002741

*NEWRECORD
RECTYPE = D
MH = Chlorphenamidine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chlordimeform|T109|T121|T131|NON|EQV|FDA SRS (2014)|UNK (19XX)|741111|abbbcdeef
MN = D02.078.200
PA = Insecticides
PA = Monoamine Oxidase Inhibitors
PA = Uncoupling Agents
MH_TH = NLM (1975)
ST = T109
ST = T121
ST = T131
N1 = Methanimidamide, N'-(4-chloro-2-methylphenyl)-N,N-dimethyl-
RN = GXA8FP6Y9C
RR = 6164-98-3 (Chlorphenamidine)
AN = TN 111 for eff on insects, etc.
PI = Amidines (1971-1974)
PI = Toluene (1972-1974)
MS = An acaricide used against many organophosphate and carbamate resistant pests. It acts as an uncoupling agent and monoamine oxidase inhibitor.
PM = 91; was see under AMIDINES 1975-90
HN = 91(75); was see under AMIDINES 1975-90
MR = 20130708
DA = 19741111
DC = 1
DX = 19910101
UI = D002742

*NEWRECORD
RECTYPE = D
MH = Chlorphenesin
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D02.033.455.706.345
PA = Muscle Relaxants, Central
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1964)
ST = T109
ST = T121
N1 = 1,2-Propanediol, 3-(4-chlorophenoxy)-
RN = I670DAL4SZ
RR = 104-29-0 (Chlorphenesin)
MS = A centrally acting muscle relaxant. Its mode of action is unknown. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1203)
PM = 74
HN = 74(64)
MR = 20130708
DA = 19990101
DC = 1
DX = 19740101
UI = D002743

*NEWRECORD
RECTYPE = D
MH = Chlorpheniramine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chlorphenamine|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|760430|abbcdeef
PRINT ENTRY = Chlorprophenpyridamine|T109|T121|NON|EQV|UNK (19XX)|740329|abbcdef
ENTRY = Aller-Chlor|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Antihistaminico Llorens|T109|T121|TRD|NRW|ES|041221|abbcdef
ENTRY = Bayer Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Chlo-Amine|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Chlor-100|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Chlor-Trimeton|T109|T121|TRD|NRW|NLM (1995)|US|940530|abbcdeef
ENTRY = Chlor-Tripolon|T109|T121|TRD|NRW|CA|041221|abbcdef
ENTRY = Chlorpheniramine Maleate|T109|T121|NON|NRW|FDA SRS (2014)|USP (19XX)|840920|abbcdeef
ENTRY = Chlorpheniramine Tannate|T116|T121|NON|NRW|FDA SRS (2014)|NLM (2003)|020513|abbcdeef
ENTRY = Chlorpro|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Chlorspan 12|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Chlortab-4|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Cloro-Trimeton|T109|T121|TRD|NRW|MX|041221|abbcdef
ENTRY = Efidac 24|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Halsey Drug Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Hogil Brand 1 of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Hogil Brand 2 of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Intra Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Kloromin|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Llorens Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Piriton|T109|T121|TRD|NRW|IE|UK|861113|abbcdeef
ENTRY = Rugby Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Schein Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Schering Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Schering-Plough Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Stafford-Miller Brand of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Teldrin|T109|T121|TRD|NRW|US|041221|abbcdef
ENTRY = Vortech Brand 1 of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Vortech Brand 2 of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Vortech Brand 3 of Chlorpheniramine Maleate|T109|T121|NON|NRW|NLM (2006)|041221|abbcdef
ENTRY = Maleate, Chlorpheniramine
ENTRY = Tannate, Chlorpheniramine
MN = D03.383.725.620.150
PA = Anti-Allergic Agents
PA = Antipruritics
PA = Histamine H1 Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
ST = T109
ST = T121
N1 = 2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-
RN = 3U6IO1965U
RR = 132-22-9 (Chlorpheniramine)
RR = 72JT935YTT
RR = V1Q0O9OJ9Z
AN = a histamine H1 antag & antipruritic
MS = A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.
PM = 65
HN = 65(63)
MR = 20130708
DA = 19990101
DC = 1
DX = 19650101
UI = D002744

*NEWRECORD
RECTYPE = D
MH = Chlorphentermine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Avipron|T109|T121|TRD|NRW|UNK (19XX)|800917|abbcdef
ENTRY = Chlorphentermine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1963)|940511|abbcdeef
ENTRY = Desopimon|T109|T121|TRD|NRW|UNK (19XX)|811218|abbcdef
ENTRY = Pre-Sate|T109|T121|TRD|NRW|US|041222|abbcdef
ENTRY = Warner Chilcott Brand of Chlorphentermine Hydrochloride|T109|T121|NON|NRW|NLM (2006)|041222|abbcdef
ENTRY = Hydrochloride, Chlorphentermine
MN = D02.092.471.683.152.766.262
PA = Sympathomimetics
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = Benzeneethanamine, 4-chloro-alpha,alpha-dimethyl-
RN = NHW07912O7
RR = 151-06-4 (Chlorphentermine Hydrochloride)
RR = 461-78-9 (Chlorphentermine)
RR = RL11HOJ7DM
MS = A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1223)
PM = 91; see PHENTERMINE 1966-90
HN = 91(66)
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002745

*NEWRECORD
RECTYPE = D
MH = Chlorpromazine
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aminazine|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Chlorazine|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Chlordelazine|T109|T121|TRD|NRW|UNK (19XX)|810108|abbcdef
ENTRY = Chlorpromazine Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|NLM (2001)|000606|abbcdeef
ENTRY = Contomin|T109|T121|TRD|NRW|UNK (19XX)|840919|abbcdef
ENTRY = Fenactil|T109|T121|TRD|NRW|UNK (19XX)|850528|abbcdef
ENTRY = Largactil|T109|T121|TRD|NRW|UNK (19XX)|800731|abbcdef
ENTRY = Propaphenin|T109|T121|TRD|NRW|UNK (19XX)|821123|abbcdef
ENTRY = Thorazine|T109|T121|TRD|NRW|UNK (19XX)|810828|abbcdef
ENTRY = Hydrochloride, Chlorpromazine
MN = D02.886.369.198
MN = D03.494.741.198
PA = Antiemetics
PA = Antipsychotic Agents
PA = Dopamine Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-
RN = U42B7VYA4P
RR = 50-53-3 (Chlorpromazine)
RR = 69-09-0 (Chlorpromazine Hydrochloride)
RR = 9WP59609J6
MS = The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
PM = /adverse effects /poisoning /toxicity were CHLORPROMAZINE TOXICOLOGY 1963-65
HN = /adv eff-pois-tox was CHLORPROMAZINE TOXICOLOGY 1963-65
MR = 20130708
DA = 19990101
DC = 1
UI = D002746

*NEWRECORD
RECTYPE = D
MH = Chlorpropamide
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Clorpropamid|T109|T121|NON|EQV|UNK (19XX)|761230|abbcdef
ENTRY = Apo-Chlorpropamide|T109|T121|TRD|NRW|CA|041222|abbcdef
ENTRY = Apotex Brand of Chlorpropamide|T109|T121|NON|NRW|NLM (2006)|041222|abbcdef
ENTRY = Byk Gulden Brand of Chlorpropamide|T109|T121|NON|NRW|NLM (2006)|041222|abbcdef
ENTRY = Diabinese|T109|T121|TRD|NRW|ES|MX|UK|US|830915|abbcdeeeef
ENTRY = Farmasierra Brand of Chlorpropamide|T109|T121|NON|NRW|NLM (2006)|041222|abbcdef
ENTRY = Glucamide|T109|T121|TRD|NRW|UNK (19XX)|861120|abbcdef
ENTRY = Insogen|T109|T121|TRD|NRW|MX|041222|abbcdef
ENTRY = Meldian|T109|T121|TRD|NRW|UNK (19XX)|831020|abbcdef
ENTRY = Pfizer Brand of Chlorpropamide|T109|T121|NON|NRW|NLM (2006)|041222|abbcdef
MN = D02.886.590.795.283
MN = D02.948.828.283
PA = Hypoglycemic Agents
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-
RN = WTM2C3IL2X
RR = 94-20-2 (Chlorpropamide)
MS = A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
MR = 20130708
DA = 19990101
DC = 1
UI = D002747

*NEWRECORD
RECTYPE = D
MH = Chlorpropham
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = CIPC|T109|T131|ABB|EQV|UNK (19XX)|811023|abbcdef
ENTRY = Isopropyl N-(3-Chlorophenol)carbamate|T109|T131|NON|EQV|UNK (19XX)|811023|abbcdef
MN = D02.241.081.251.583.177
PA = Herbicides
PA = Plant Growth Regulators
MH_TH = FDA SRS (2014)
MH_TH = NLM (1972)
ST = T109
ST = T131
N1 = Carbamic acid, (3-chlorophenyl)-, 1-methylethyl ester
RN = 0HBU04R8B0
RR = 101-21-3 (Chlorpropham)
PI = Carbamates (1966-1971)
PI = Herbicides (1966-1971)
MS = A carbamate that is used as an herbicide and as a plant growth regulator.
PM = 91; was see under HERBICIDES, CARBAMATE 1972-90
HN = 91(72); was see under HERBICIDES, CARBAMATE 1972-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002748

*NEWRECORD
RECTYPE = D
MH = Chlorprothixene
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chlorprotixen|T109|T121|NON|EQV|UNK (19XX)|830914|abbcdef
ENTRY = Taractan|T109|T121|TRD|NRW|UNK (19XX)|861120|abbcdef
MN = D02.886.952.250
MN = D03.494.953.704.250
PA = Antipsychotic Agents
PA = Dopamine Antagonists
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = USAN (1962)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 1-Propanamine, 3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethyl-, (Z)-
RN = 9S7OD60EWP
RR = 113-59-7 (Chlorprothixene)
MS = A thioxanthine with effects similar to the phenothiazine antipsychotics.
MR = 20130708
DA = 19990101
DC = 1
UI = D002749

*NEWRECORD
RECTYPE = D
MH = Chlorquinaldol
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chlorchinaldol|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef
ENTRY = 5,7-Dichloro-2-methyl-8-quinolinol|T109|T121|NON|EQV|FDA SRS (2014)|NLM (1996)|950404|abbcdeef
ENTRY = Afungil|T109|T121|TRD|NRW|UNK (19XX)|800825|abbcdef
ENTRY = Chlorchinaldine|T109|T121|NON|EQV|UNK (19XX)|810108|abbcdef
ENTRY = Chloroquinaldol|T109|T121|NON|EQV|UNK (19XX)|811102|abbcdef
ENTRY = Sterosan|T109|T121|TRD|NRW|UNK (19XX)|811102|abbcdef
ENTRY = 5,7 Dichloro 2 methyl 8 quinolinol
MN = D03.438.810.350.625.250.260
PA = Anti-Infective Agents
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T121
N1 = 8-Quinolinol, 5,7-dichloro-2-methyl-
RN = D6VHC87LLS
RR = 72-80-0 (Chlorquinaldol)
MS = Local anti-infective agent used for skin, gastrointestinal, and vaginal infections with fungi, protozoa, and certain bacteria. In animals, it causes central nervous system damage and is not administered parenterally. It is also used as antiseptic, fungistat, or deodorant.
PM = 91,63-82; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82
HN = 91(83)63; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82
MR = 20130708
DA = 19990101
DC = 1
DX = 19630101
UI = D002750

*NEWRECORD
RECTYPE = D
MH = Chlortetracycline
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Aureocyclin|T109|T195|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Aureomycin|T109|T195|TRD|NRW|UNK (19XX)|801120|abbcdef
ENTRY = Aureomycine|T109|T195|TRD|NRW|UNK (19XX)|800801|abbcdef
ENTRY = Biomycin|T109|T195|TRD|NRW|UNK (19XX)|800917|abbcdef
ENTRY = Chlorotetracycline|T109|T195|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = Chlortetracycline Bisulfate|T109|T195|NON|NRW|FDA SRS (2014)|USP (19XX)|940901|abbcdeef
ENTRY = Chlortetracycline Hydrochloride|T109|T195|NON|NRW|BAN (19XX)|FDA SRS (2014)|USP (19XX)|940901|abbcdeeef
ENTRY = Chlortetracycline Monohydrochloride|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Chlortetracycline Sulfate (1:1)|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Chlortetracycline Sulfate (2:1)|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Chlortetracycline, 4-Epimer|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = Chlortetracycline, Calcium Salt|T109|T195|NON|NRW|NLM (1999)|990913|abbcdef
ENTRY = 4-Epimer Chlortetracycline
ENTRY = Bisulfate, Chlortetracycline
ENTRY = Calcium Salt Chlortetracycline
ENTRY = Chlortetracycline, 4 Epimer
ENTRY = Hydrochloride, Chlortetracycline
ENTRY = Monohydrochloride, Chlortetracycline
ENTRY = Salt Chlortetracycline, Calcium
MN = D02.455.426.559.847.562.900.146
MN = D04.615.562.900.146
PA = Anti-Bacterial Agents
PA = Antiprotozoal Agents
PA = Protein Synthesis Inhibitors
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
ST = T109
ST = T195
N1 = 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
RN = WCK1KIQ23Q
RR = 14297-93-9 (4-epimer)
RR = 1D06KZ672I
RR = 27823-62-7 (sulfate (1:1))
RR = 33662-15-6 (cpd without stereochemical designation)
RR = 3671-08-7 (HCl)
RR = 57-62-5 (Chlortetracycline)
RR = 5892-31-9 (Ca salt)
RR = 7220-97-5 (sulfate (2:1))
RR = O1GX33ON8R
MS = A TETRACYCLINE with a 7-chloro substitution.
MR = 20130708
DA = 19990101
DC = 1
UI = D002751

*NEWRECORD
RECTYPE = D
MH = Chlorthalidone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Chlorphthalidolone|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef
PRINT ENTRY = Phthalamudine|T109|T121|NON|EQV|UNK (19XX)|770330|abbcdef
ENTRY = Chlortalidone|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|JAN (19XX)|NLM (1998)|961114|abbcdeeeef
ENTRY = Hygroton|T109|T121|TRD|NRW|UNK (19XX)|820331|abbcdef
ENTRY = Oxodoline|T109|T121|NON|EQV|UNK (19XX)|800731|abbcdef
ENTRY = Thalitone|T109|T121|TRD|NRW|UNK (19XX)|861120|abbcdef
MN = D02.065.884.365
MN = D02.455.426.559.389.115.124.500
MN = D02.478.600.500
MN = D02.522.223.500
MN = D02.886.590.700.365
MN = D03.438.513.750.500
PA = Antihypertensive Agents
PA = Diuretics
PA = Sodium Chloride Symporter Inhibitors
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
MH_TH = USAN (1961)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = Benzenesulfonamide, 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-
RN = Q0MQD1073Q
RR = 77-36-1 (Chlorthalidone)
MS = A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.
MR = 20130708
DA = 19990101
DC = 1
UI = D002752

*NEWRECORD
RECTYPE = D
MH = Chlorzoxazone
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = McNeil Brand of Chlorzoxazone|T109|T121|NON|NRW|NLM (2006)|041222|abbcdef
ENTRY = Ortho Brand of Chlorzoxazone|T109|T121|NON|NRW|NLM (2006)|041222|abbcdef
ENTRY = Paraflex|T109|T121|TRD|NRW|UNK (19XX)|861120|abbcdef
ENTRY = Parafon|T109|T121|TRD|NRW|US|041222|abbcdef
ENTRY = Parafon Forte DSC|T109|T121|TRD|NRW|US|041222|abbcdef
MN = D03.438.221.346
PA = Muscle Relaxants, Central
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = NLM (1966)
MH_TH = USP (19XX)
ST = T109
ST = T121
N1 = 2(3H)-Benzoxazolone, 5-chloro-
RN = H0DE420U8G
RR = 95-25-0 (Chlorzoxazone)
MS = A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
PM = 91; was see under BENZOXAZOLES 1966-90
HN = 91(66); was see under BENZOXAZOLES 1966-90
MR = 20130708
DA = 19990101
DC = 1
DX = 19910101
UI = D002753

*NEWRECORD
RECTYPE = D
MH = Choanal Atresia
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Atresia, Choanal|T019|NON|EQV|NLM (1995)|940106|abcdef
ENTRY = Atresias, Choanal
ENTRY = Choanal Atresias
MN = C08.460.171
MN = C08.695.271
MN = C09.603.171
MN = C16.131.740.271
MH_TH = NLM (1986)
ST = T019
PI = Nasal Cavity/abnormalities (1975-1985)
PI = Nose/abnormalities (1966-1974)
MS = A congenital abnormality that is characterized by a blocked CHOANAE, the opening between the nose and the NASOPHARYNX. Blockage can be unilateral or bilateral; bony or membranous.
PM = 86
HN = 86
CATSH = CAT LIST
MR = 20080708
DA = 19850606
DC = 1
DX = 19860101
UI = D002754

*NEWRECORD
RECTYPE = D
MH = Choice Behavior
AQ = CL DE ES PH RE
ENTRY = Approach Behavior|T055|NON|REL|NLM (2016)|OBSSR (2016)|141001|abcdeef
ENTRY = Approach Behaviors
ENTRY = Behavior, Approach
ENTRY = Behavior, Choice
ENTRY = Behaviors, Approach
ENTRY = Behaviors, Choice
ENTRY = Choice Behaviors
MN = F02.463.785.373.346
MH_TH = NLM (1975)
ST = T055
PI = Decision Making (1974)
MS = The act of making a selection among two or more alternatives, usually after a period of deliberation.
OL = search DECISION MAKING 1974
PM = 79; was see under DECISION MAKING 1974-78; CAREER CHOICE was see under DECISION MAKING 1975-80
HN = 79(75); was see under DECISION MAKING 1974-78
CATSH = CAT LIST
MR = 20150707
DA = 19990101
DC = 1
DX = 19790101
UI = D002755

*NEWRECORD
RECTYPE = D
MH = Cholagogues and Choleretics
DE = CHOLAGOGUES CHOLERETICS
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Choleretics|T121|NON|NRW|UNK (19XX)|740329|abcdef
ENTRY = Cholagogues|T121|NON|NRW|UNK (19XX)|790329|abcdef
ENTRY = Cholagogues, Choleretics|T121|NON|EQV|UNK (19XX)|880713|abcdef
ENTRY = Choleretics and Cholagogues|T121|NON|EQV|UNK (19XX)|880713|CHOLERETICS CHOLAGOGUES|abcdefv
ENTRY = Hydrocholeretics|T121|NON|NRW|UNK (19XX)|840216|abcdef
MN = D27.505.954.483.508
MH_TH = NLM (1966)
ST = T121
RN = 0
AN = DF: CHOLAGOGUES
MS = Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
MR = 20050630
DA = 19990101
DC = 1
UI = D002756

*NEWRECORD
RECTYPE = D
MH = Cholanes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.221
MH_TH = NLM (1968)
ST = T110
RN = 0
AN = do not confuse with CHOLENES
PM = 68
HN = 68
MR = 19920511
DA = 19990101
DC = 1
DX = 19680101
UI = D002757

*NEWRECORD
RECTYPE = D
MH = Cholangiography
DE = CHOLANGIOGR
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Cholangiographies
MN = E01.370.350.700.715.200
MN = E01.370.372.200
MH_TH = NLM (1966)
ST = T060
AN = do not use /util except by MeSH definition; DF: CHOLANGIOGR
MS = An imaging test of the BILIARY TRACT in which a contrast dye (RADIOPAQUE MEDIA) is injected into the BILE DUCT and x-ray pictures are taken.
CATSH = CAT LIST
MR = 20070709
DA = 19990101
DC = 1
UI = D002758

*NEWRECORD
RECTYPE = D
MH = Adenoma, Bile Duct
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
PRINT ENTRY = Cholangioma|T191|NON|EQV|NLM (1994)|930329|abcdef
ENTRY = Adenomas, Bile Duct
ENTRY = Bile Duct Adenoma
ENTRY = Bile Duct Adenomas
ENTRY = Cholangiomas
MN = C04.557.470.035.085
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /secret /ultrastruct permitted; coord IM with BILE DUCTS, INTRAHEPATIC (IM) + BILE DUCT NEOPLASMS (IM)
MS = A benign tumor of the intrahepatic bile ducts.
OL = use ADENOMA, BILE DUCT to search CHOLANGIOMA 1966-93
PM = 94; was CHOLANGIOMA 1963-93
HN = 94; was CHOLANGIOMA 1963-93
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D002759

*NEWRECORD
RECTYPE = D
MH = Cholangiopancreatography, Endoscopic Retrograde
DE = CHOLANGIOPANCREATOGR ENDOSCOPIC RETROGRADE
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
PRINT ENTRY = ERCP|T060|ABB|EQV|UNK (19XX)|800404|abcdef
PRINT ENTRY = Endoscopic Retrograde Cholangiopancreatography|T060|NON|EQV|UNK (19XX)|800404|ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGR|abcdefv
ENTRY = Retrograde Cholangiopancreatography, Endoscopic|T060|NON|EQV|NLM (1995)|931012|RETROGRADE CHOLANGIOPANCREATOGR ENDOSCOPIC|abcdefv
ENTRY = Cholangiopancreatographies, Endoscopic Retrograde
ENTRY = Endoscopic Retrograde Cholangiopancreatographies
ENTRY = Retrograde Cholangiopancreatographies, Endoscopic
MN = E01.370.350.700.715.200.200
MN = E01.370.372.200.200
MN = E01.370.372.250.200
MN = E01.370.388.250.250.160
MN = E04.210.240.160
MN = E04.502.250.250.160
FX = Sphincterotomy, Endoscopic
MH_TH = NLM (1981)
ST = T060
AN = /instrum is probably DUODENOSCOPES
PI = Cholangiography (1966-1980)
PI = Endoscopy (1966-1980)
PI = Pancreas (1966-1980)
MS = Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure.
PM = 81
HN = 81
CATSH = CAT LIST
MR = 19991108
DA = 19800404
DC = 1
DX = 19810101
UI = D002760

*NEWRECORD
RECTYPE = D
MH = Cholangitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Cholangitides
MN = C06.130.120.200
FX = Cholecystitis
MH_TH = NLM (1966)
ST = T047
MS = Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D002761

*NEWRECORD
RECTYPE = D
MH = Cholecalciferol
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Vitamin D 3|T110|T127|NON|EQV|UNK (19XX)|741226|VITAMIN D A 03|abbcdefs
ENTRY = (3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|T110|T127|NON|EQV|NLM (1998)|961115|abbcdef
ENTRY = Calciol|T110|T127|NON|EQV|NLM (1998)|961115|abbcdef
ENTRY = Cholecalciferols|T110|T127|NON|BRD|NLM (1994)|930702|abbcdef
ENTRY = Vitamin D3|T110|T127|NON|EQV|FDA SRS (2014)|NLM (1990)|890413|abbcdeef
MN = D04.808.247.222.159
MN = D04.808.247.808.146
MN = D04.808.812.768.196
MN = D10.570.938.146
PA = Bone Density Conservation Agents
PA = Vitamins
FX = Receptors, Calcitriol
MH_TH = BAN (19XX)
MH_TH = FDA SRS (2014)
MH_TH = INN (19XX)
MH_TH = JAN (19XX)
MH_TH = NLM (1967)
MH_TH = USP (19XX)
ST = T110
ST = T127
N1 = 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)-
RN = 1C6V77QF41
RR = 67-97-0 (Cholecalciferol)
AN = deficiency: coordinate CHOLECALCIFEROL /defic (IM) with VITAMIN D DEFICIENCY (IM)
MS = Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.
OL = use CHOLECALCIFEROL to search CHOLECALCIFEROLS 1975-93 & VITAMIN D 3 1966-74
PM = 94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66
HN = 94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66
MR = 20130708
DA = 19990101
DC = 1
DX = 19670101
UI = D002762

*NEWRECORD
RECTYPE = D
MH = Cholecystectomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Cholecystectomies
MN = E04.210.120.172
FX = Postcholecystectomy Syndrome
MH_TH = NLM (1966)
ST = T061
MS = Surgical removal of the GALLBLADDER.
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
UI = D002763

*NEWRECORD
RECTYPE = D
MH = Cholecystitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Empyema, Gallbladder|T047|NON|REL|UNK (19XX)|830503|abcdef
PRINT ENTRY = Gallbladder Inflammation|T047|NON|EQV|NLM (2004)|021220|GALLBLADDER INFLAMM|abcdefv
ENTRY = Empyema, Gall Bladder|T047|NON|REL|NLM (1992)|901231|abcdef
ENTRY = Gall Bladder Empyema
ENTRY = Gallbladder Empyema
ENTRY = Inflammation, Gallbladder
MN = C06.130.564.263
FX = Cholangitis
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
ST = T047
AN = note specifics; X ref EMPYEMA, GALLBLADDER: restrict to gallbladder; "biliary empyema": unless of gallbladder, index under EMPYEMA (IM) + BILIARY TRACT DISEASES (IM) or specific biliary precoord
MS = Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002764

*NEWRECORD
RECTYPE = D
MH = Cholecystography
DE = CHOLECYSTOGR
AQ = AE CL CT EC ES HI IS MO MT NU PX SN ST TD UT VE
ENTRY = Cholecystographies
MN = E01.370.350.700.715.210
MN = E01.370.372.210
MH_TH = NLM (1966)
ST = T060
AN = do not use /util except by MeSH definition; DF: CHOLECYSTOGR
MS = Radiography of the gallbladder after ingestion of a contrast medium.
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D002765

*NEWRECORD
RECTYPE = D
MH = Cholecystokinin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Pancreozymin|T116|T124|T125|NON|EQV|BAN (19XX)|760517|abbbcdef
ENTRY = CCK-33|T116|T124|T125|ABB|NRW|UNK (19XX)|830831|abbbcdef
ENTRY = Cholecystokinin 33|T116|T124|T125|NON|NRW|UNK (19XX)|830831|abbbcdef
ENTRY = Uropancreozymin|T116|T124|T125|NON|EQV|UNK (19XX)|820830|abbbcdef
MN = D06.472.317.152
MN = D12.644.120
PA = Cholagogues and Choleretics
FX = Gastrointestinal Agents
FX = Receptors, Cholecystokinin
MH_TH = NLM (1966)
ST = T116
ST = T124
ST = T125
RN = 9011-97-6
MS = A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.
OL = use CHOLECYSTOKININ to search PANCREOZYMIN 1966-76 (as Prov 1966)
PM = PANCREOZYMIN was heading 1967-76
HN = PANCREOZYMIN was heading 1963-76 (Prov 1963-66), was see under GASTROINTESTINAL HORMONES 1963-66
MR = 20150602
DA = 19990101
DC = 1
UI = D002766

*NEWRECORD
RECTYPE = D
MH = Cholecystostomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
ENTRY = Cholecystostomies
MN = E04.035.195
MN = E04.210.120.195
MH_TH = NLM (1988)
ST = T061
AN = do not use /util except by MeSH definition
PI = Drainage (1966-1987)
PI = Gallbladder/surgery (1966-1987)
MS = Establishment of an opening into the gallbladder either for drainage or surgical communication with another part of the digestive tract, usually the duodenum or jejunum.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 19970620
DA = 19870320
DC = 1
DX = 19880101
UI = D002767

*NEWRECORD
RECTYPE = D
MH = Choledochostomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Choledochoduodenostomy|T061|NON|NRW|UNK (19XX)|870319|abcdef
PRINT ENTRY = Choledochojejunostomy|T061|NON|NRW|UNK (19XX)|870319|abcdef
ENTRY = Choledojejunostomies|T061|NON|NRW|UNK (19XX)|870515|abcdef
ENTRY = Choledochoduodenostomies
ENTRY = Choledochojejunostomies
ENTRY = Choledochostomies
ENTRY = Choledojejunostomy
MN = E04.035.200
MN = E04.210.120.200
FX = Postcholecystectomy Syndrome
MH_TH = NLM (1988)
ST = T061
PI = Common Bile Duct Calculi/surgery (1966-1987)
PI = Common Bile Duct/surgery (1966-1987)
PI = Drainage (1966-1987)
PI = Duodenum/surgery (1966-1987)
PI = Jejunum/surgery (1966-1987)
MS = Surgical formation of an opening (stoma) into the COMMON BILE DUCT for drainage or for direct communication with a site in the small intestine, primarily the DUODENUM or JEJUNUM.
PM = 88
HN = 88
CATSH = CAT LIST
MR = 20030709
DA = 19870319
DC = 1
DX = 19880101
UI = D002768

*NEWRECORD
RECTYPE = D
MH = Cholelithiasis
AQ = BL CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UL UR US VE VI
ENTRY = Cholelithiases
MN = C06.130.409
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
ST = T047
AN = CHOLECYSTOLITHIASIS and CHOLEDOCHOLITHIASIS are also available
MS = Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
OL = to search for chem composition of biliary calculi, use CHOLELITHIASIS/anal 1987-90 & CHOLELITHIASIS/metab 1966-86
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002769

*NEWRECORD
RECTYPE = D
MH = Cholenes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.221.263
MH_TH = NLM (1975)
ST = T110
RN = 0
AN = do not confuse with CHOLANES or CHOLINE; includes choladienes, cholatrienes
PI = Cholanes (1968-1974)
MS = Unsaturated derivatives of cholane with methyl groups at C-10 and C-13 and a branched five-carbon chain at C-17. They must have at least one double bond in the ring system.
OL = search CHOLANES 1973-74
PM = 75; was see under CHOLANES 1973-74
HN = 75; was see under CHOLANES 1973-74
MR = 19930603
DA = 19990101
DC = 1
DX = 19750101
UI = D002770

*NEWRECORD
RECTYPE = D
MH = Cholera
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
ENTRY = Choleras
MN = C01.252.400.959.347
FX = Cholera Morbus
MH_TH = POPLINE (1994)
ST = T047
MS = An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.
CATSH = CAT LIST
MR = 20090706
DA = 19990101
DC = 1
UI = D002771

*NEWRECORD
RECTYPE = D
MH = Cholera Toxin
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Cholera Toxin Protomer A|T116|T126|T131|NON|NRW|UNK (19XX)|830223|abbbcdef
PRINT ENTRY = Cholera Toxin Protomer B|T116|T129|NON|NRW|NLM (2003)|020125|abbcdef
PRINT ENTRY = Choleragen|T116|T126|T131|NON|EQV|UNK (19XX)|770420|abbbcdef
PRINT ENTRY = Choleragenoid|T116|T129|NON|NRW|UNK (19XX)|770420|abbcdef
ENTRY = Cholera Enterotoxin CT|T116|T126|T131|NON|EQV|NLM (2003)|020125|abbbcdef
ENTRY = Cholera Exotoxin|T116|T126|T131|NON|EQV|UNK (19XX)|840919|abbbcdef
ENTRY = Cholera Toxin A Subunit|T116|T126|T131|NON|NRW|NLM (2003)|020125|abbbcdef
ENTRY = Cholera Toxin B Subunit|T116|T129|NON|NRW|UNK (19XX)|830916|abbcdef
ENTRY = Procholeragenoid|T116|T129|NON|NRW|UNK (19XX)|820519|abbcdef
ENTRY = CT, Cholera Enterotoxin
ENTRY = Enterotoxin CT, Cholera
ENTRY = Exotoxin, Cholera
ENTRY = Toxin, Cholera
MN = D08.811.913.400.725.115.180
MN = D23.946.123.194
MN = D23.946.330.150
PA = Adjuvants, Immunologic
PA = Poisons
MH_TH = NLM (1978)
ST = T116
ST = T126
ST = T131
RN = 9012-63-9
RR = EC 2.4.2.31
AN = /antag permitted but consider also ANTITOXINS
PI = Bacterial Proteins (1966-1977)
PI = Bacterial Toxins (1977)
PI = Enterotoxins (1966-1977)
PI = Toxins (1966-1967)
MS = An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells, and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells.
PM = 78
HN = 78
MR = 20130709
DA = 19770422
DC = 1
DX = 19780101
UI = D002772

*NEWRECORD
RECTYPE = D
MH = Cholestadienes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.247.222.222
MH_TH = NLM (1975)
ST = T110
RN = 0
AN = do not confuse with CHOLESTADIENOLS
PI = Cholestenes (1973-1974)
MS = Cholene derivatives with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. They must have two double bonds in the ring system.
OL = search CHOLESTENES 1974
PM = 75; was see under CHOLESTENES 1974
HN = 75; was see under CHOLESTENES 1974
MR = 19930603
DA = 19990101
DC = 1
DX = 19750101
UI = D002774

*NEWRECORD
RECTYPE = D
MH = Cholestadienols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.247.222.222.347
MH_TH = NLM (1974)
ST = T110
RN = 0
AN = do not confuse with CHOLESTADIENES
MS = Cholestadiene derivatives containing a hydroxy group anywhere in the molecule.
PM = 74
HN = 74
MR = 19930603
DA = 19990101
DC = 1
DX = 19740101
UI = D002775

*NEWRECORD
RECTYPE = D
MH = Cholestanes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.247
MH_TH = NLM (1968)
ST = T110
RN = 0
AN = do not confuse with CHOLESTENES
MS = Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17.
PM = 68
HN = 68
MR = 19930603
DA = 19990101
DC = 1
DX = 19680101
UI = D002776

*NEWRECORD
RECTYPE = D
MH = Cholestanols
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Bile Alcohols|T110|T123|NON|EQV|UNK (19XX)|770329|abbcdef
PRINT ENTRY = Hydroxycholestanes|T110|T123|NON|EQV|UNK (19XX)|770329|abbcdef
ENTRY = Alcohols, Bile
MN = D04.808.247.100
MH_TH = NLM (1978)
ST = T110
ST = T123
RN = 0
AN = do not confuse with CHOLESTANOL; beta-cholestanol = BETA-CHOLESTANOL see CHOLESTANOL
PI = Cholestanes (1968-1977)
PI = Sterols (1966-1977)
MS = Cholestanes substituted in any position with one or more hydroxy groups. They are found in feces and bile. In contrast to bile acids and salts, they are not reabsorbed.
PM = 78
HN = 78
MR = 19930602
DA = 19770415
DC = 1
DX = 19780101
UI = D002777

*NEWRECORD
RECTYPE = D
MH = Cholestanones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.247.125
MH_TH = NLM (1975)
ST = T110
RN = 0
AN = do not confuse with CHOLESTENONES; includes cholestanediones, cholestanetriones
PI = Cholestanes (1968-1974)
MS = CHOLESTANES substituted with any number of keto groups.
PM = 91; was see under CHOLESTANES 1975-90
HN = 91(75); was see under CHOLESTANES 1975-90
MR = 19930603
DA = 19741111
DC = 1
DX = 19910101
UI = D002778

*NEWRECORD
RECTYPE = D
MH = Cholestasis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bile Duct Obstruction|T047|NON|EQV|UNK (19XX)|790619|abcdef
PRINT ENTRY = Biliary Stasis|T047|NON|EQV|UNK (19XX)|750101|abcdef
ENTRY = Bile Duct Obstructions
ENTRY = Biliary Stases
ENTRY = Cholestases
ENTRY = Duct Obstruction, Bile
ENTRY = Duct Obstructions, Bile
ENTRY = Obstruction, Bile Duct
ENTRY = Obstructions, Bile Duct
ENTRY = Stases, Biliary
ENTRY = Stasis, Biliary
MN = C06.130.120.135
FX = Jaundice, Obstructive
MH_TH = NLM (1972)
ST = T047
MS = Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
PM = 1972
HN = 1972 (1969)
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
DX = 19720101
UI = D002779

*NEWRECORD
RECTYPE = D
MH = Cholestasis, Intrahepatic
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Bile Duct Obstruction, Intrahepatic|T047|NON|EQV|UNK (19XX)|790529|abcdef
PRINT ENTRY = Biliary Stasis, Intrahepatic|T047|NON|EQV|UNK (19XX)|790619|abcdef
PRINT ENTRY = Intrahepatic Cholestasis|T047|NON|EQV|NLM (2004)|021115|abcdef
ENTRY = Biliary Stases, Intrahepatic
ENTRY = Cholestases, Intrahepatic
ENTRY = Intrahepatic Biliary Stases
ENTRY = Intrahepatic Biliary Stasis
ENTRY = Intrahepatic Cholestases
MN = C06.130.120.135.250
MN = C06.552.150
FX = Jaundice, Obstructive
MH_TH = NLM (1980)
ST = T047
PI = Bile Ducts, Intrahepatic (1966-1979)
PI = Cholestasis (1966-1979)
PI = Liver (1966-1979)
MS = Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
PM = 80
HN = 80
CATSH = CAT LIST
MR = 20050718
DA = 19790529
DC = 1
DX = 19800101
UI = D002780

*NEWRECORD
RECTYPE = D
MH = Cholesteatoma
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Cholesteatomas
MN = C17.800.428.260
MH_TH = NLM (1966)
ST = T047
AN = coordinate IM with organ/disease (IM) but CHOLESTEATOMA, MIDDLE EAR is available
MS = A non-neoplastic mass of keratin-producing squamous EPITHELIUM, frequently occurring in the MENINGES; bones of the skull, and most commonly in the MIDDLE EAR and MASTOID region. Cholesteatoma can be congenital or acquired. Cholesteatoma is not a tumor nor is it associated with high CHOLESTEROL.
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
UI = D002781

*NEWRECORD
RECTYPE = D
MH = Cholestenes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.247.222
MH_TH = NLM (1973)
ST = T110
RN = 0
AN = do not confuse with CHOLESTANES; includes cholestatrienes
PI = Cholestanes (1968-1972)
MS = Steroids with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. Members include compounds with any degree of unsaturation; however, CHOLESTADIENES is available for derivatives containing two double bonds.
PM = 73
HN = 73
MR = 19930603
DA = 19990101
DC = 1
DX = 19730101
UI = D002782

*NEWRECORD
RECTYPE = D
MH = Cholestenones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D04.808.247.222.265
MH_TH = NLM (1975)
ST = T110
RN = 0
AN = do not confuse with CHOLESTANONES; includes cholestenediones, cholestenetriones
PI = Cholestenes (1973-1974)
MS = CHOLESTENES with one or more double bonds and substituted by any number of keto groups.
PM = 91; was see under CHOLESTENES 1975-90
HN = 91(75); was see under CHOLESTENES 1975-90
MR = 19930603
DA = 19741111
DC = 1
DX = 19910101
UI = D002783

*NEWRECORD
RECTYPE = D
MH = Cholesterol
AQ = AA AD AE AG AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Epicholesterol|T110|T121|NON|REL|UNK (19XX)|841002|abbcdef
MN = D04.808.247.222.284
MN = D04.808.247.808.197
MN = D10.570.938.208
FX = Embolism, Cholesterol
FX = Hypercholesterolemia
EC = antagonists & inhibitors:Anticholesteremic Agents
MH_TH = FDA SRS (2014)
MH_TH = POPLINE (1978)
ST = T110
ST = T123
N1 = Cholest-5-en-3-ol (3beta)-
RN = 97C5T2UQ7J
RR = 57-88-5 (Cholesterol)
AN = GEN or unspecified; prefer specifics; /biosyn /physiol permitted; /blood: consider also HYPERCHOLESTEROLEMIA & specifics; cholesterol granuloma = CHOLESTEROL + GRANULOMA, FOREIGN-BODY
MS = The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.
OL = use CHOLESTEROL to search BLOOD CHOLESTEROL 1966-67
PM = /blood was BLOOD CHOLESTEROL 1963-67
HN = /blood was BLOOD CHOLESTEROL 1963-67
MR = 20150622
DA = 19990101
DC = 1
UI = D002784

*NEWRECORD
RECTYPE = D
MH = Sterol O-Acyltransferase
DS = STEROL ACYLTRANSFERASE O
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Acyl-CoA-Cholesterol Acyltransferase|T116|T126|EQV|UNK (19XX)|840416|abbdef
PRINT ENTRY = Cholesterol Acyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef
ENTRY = Cholesterol Esterifying Enzyme|T116|T126|NON|EQV|UNK (19XX)|811023|abbcdef
ENTRY = Acyl CoA Cholesterol Acyltransferase
ENTRY = Acyltransferase, Acyl-CoA-Cholesterol
ENTRY = Acyltransferase, Cholesterol
ENTRY = Enzyme, Cholesterol Esterifying
ENTRY = Esterifying Enzyme, Cholesterol
ENTRY = O-Acyltransferase, Sterol
ENTRY = Sterol O Acyltransferase
MN = D08.811.913.050.799
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = Acyl-CoA:cholesterol O-acyltransferase
RN = EC 2.3.1.26
RR = 9027-63-8 (CAS RN)
PI = Acyltransferases (1973-1975)
PI = Cholesterol (1973-1975)
PI = Coenzyme A (1973-1975)
MS = An enzyme that catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa, and aorta of many mammalian species. EC 2.3.1.26.
PM = 98; see CHOLESTEROL ACYLTRANSFERASE 1985-97; see ACYLTRANSFERASES 1976-84
HN = 98(76)
MR = 20030709
DA = 19750725
DC = 1
DX = 19850101
UI = D002785

*NEWRECORD
RECTYPE = D
MH = Cholesterol Side-Chain Cleavage Enzyme
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = CYP11A1|T116|T126|ABB|EQV|NLM (1997)|960208|CYP 011 A 001|abbcdefs
PRINT ENTRY = Cholesterol Desmolase|T116|T126|NON|EQV|NLM (1997)|960208|abbcdef
PRINT ENTRY = Cholesterol Monooxygenase (Side-Chain-Cleaving)|T116|T126|NON|EQV|NLM (1975)|990101|CHOLESTEROL MONOOXYGENASE A SIDE CHAIN CLEAVING|abbcdefs
PRINT ENTRY = Cytochrome P-450 CYP11A1|T116|T126|EQV|NLM (1997)|960208|CYTOCHROME P 450 CYP 011 A 001|abbdefs
PRINT ENTRY = Cytochrome P-450(scc)|T116|T126|EQV|UNK (19XX)|870504|CYTOCHROME P 450 SCC|abbdefs
ENTRY = 20,22-Desmolase|T116|T126|NON|EQV|UNK (19XX)|861009|abbcdef
ENTRY = CYP 11A1|T116|T126|ABB|EQV|NLM (1997)|960208|abbcdef
ENTRY = Cytochrome P450 11A1|T116|T126|NON|EQV|NLM (1997)|960223|abbcdef
ENTRY = Cytochrome P450scc|T116|T126|EQV|UNK (19XX)|871208|abbdef
ENTRY = 20,22 Desmolase
ENTRY = Cholesterol Side Chain Cleavage Enzyme
ENTRY = Cytochrome P 450 CYP11A1
MN = D08.244.453.915.212
MN = D08.811.682.690.708.170.915.212
MN = D12.776.422.220.453.915.212
MH_TH = UNK (19XX)
ST = T116
ST = T126
N1 = Cholesterol,reduced-adrenal-ferredoxin:oxygen oxidoreductase (side-chain-cleaving)
RN = EC 1.14.15.6
PI = Cholesterol (1971-1974)
PI = Multienzyme Complexes (1973-1974)
PI = Oxidoreductases (1971-1974)
MS = A mitochondrial cytochrome P450 enzyme that catalyzes the side-chain cleavage of C27 cholesterol to C21 pregnenolone in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11A1 gene, catalyzes the breakage between C20 and C22 which is the initial and rate-limiting step in the biosynthesis of various gonadal and adrenal steroid hormones.
PM = 2003; see CHOLESTEROL MONOOXYGENASE 1997-2002, see CHOLESTEROL DESMOLASE 1988-1996, see OXIDOREDUCTASES 1975-1987
HN = 2003 (1975)
MR = 20150622
DA = 19741119
DC = 1
DX = 19880101
UI = D002786

*NEWRECORD
RECTYPE = D
MH = Sterol Esterase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Cholesterol Esterase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef
ENTRY = 15-Ketosteryl Oleate Hydrolase|T116|T126|NON|NRW|NLM (1990)|890607|abbcdef
ENTRY = Acylcholesterol Lipase|T116|T126|NON|EQV|UNK (19XX)|840305|abbcdef
ENTRY = Cholesterol Ester Hydrolase|T116|T126|NON|EQV|UNK (19XX)|830909|abbcdef
ENTRY = Cholesteryl Oleate Hydrolase|T116|T126|NON|EQV|UNK (19XX)|850103|abbcdef
ENTRY = Cholesterylester Hydrolase|T116|T126|NON|EQV|UNK (19XX)|801120|abbcdef
ENTRY = Hormone-Sensitive Lipase|T116|T126|NON|EQV|NLM (1989)|890208|abbcdef
ENTRY = Lipase A (Lysosomal Acid Cholesterol Esterase)|T116|T126|NON|NRW|NLM (2008)|070319|abbcdef
ENTRY = Lipoidal Steroid Esterase|T116|T126|NON|EQV|NLM (1989)|890208|abbcdef
ENTRY = Lysosomal Acid Cholesterol Esterase|T116|T126|NON|NRW|NLM (2008)|070319|abbcdef
ENTRY = Lysosomal Acid Lipase|T116|T126|NON|NRW|NLM (2008)|070319|abbcdef
ENTRY = Steroid Hormone Esterase|T116|T126|NON|EQV|NLM (1989)|890208|abbcdef
ENTRY = Sterol Ester Acylhydrolase|T116|T126|NON|EQV|UNK (19XX)|811023|abbcdef
ENTRY = 15 Ketosteryl Oleate Hydrolase
ENTRY = Acid Lipase, Lysosomal
ENTRY = Acylhydrolase, Sterol Ester
ENTRY = Esterase, Cholesterol
ENTRY = Esterase, Lipoidal Steroid
ENTRY = Esterase, Steroid Hormone
ENTRY = Esterase, Sterol
ENTRY = Hormone Sensitive Lipase
ENTRY = Hydrolase, 15-Ketosteryl Oleate
ENTRY = Hydrolase, Cholesterol Ester
ENTRY = Hydrolase, Cholesteryl Oleate
ENTRY = Hydrolase, Cholesterylester
ENTRY = Lipase, Acylcholesterol
ENTRY = Lipase, Hormone-Sensitive
ENTRY = Steroid Esterase, Lipoidal
MN = D08.811.277.352.100.700
FX = Cholesterol Ester Storage Disease
MH_TH = NLM (2008)
ST = T116
ST = T126
N1 = Steryl-ester acylhydrolase
RN = EC 3.1.1.13
RR = EC 3.1.1.13
PI = Cholesterol (1973-1974)
PI = Esterases (1973-1974)
MS = An enzyme that catalyzes the hydrolysis of CHOLESTEROL ESTERS and some other sterol esters, to liberate cholesterol plus a fatty acid anion.
PM = 2008; see CHLOLESTEROL ESTERASE 1991-2007, see CARBOXYLIC ESTER HYDROLASES 1976-1990, see ESTERASES 1975
HN = 2008(1975)
MR = 20070709
DA = 19741119
DC = 1
DX = 19910101
UI = D002787

*NEWRECORD
RECTYPE = D
MH = Cholesterol Esters
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PK PO RE SD SE ST TO TU UR
ENTRY = Cholesteryl Esters|T110|T123|NON|EQV|UNK (19XX)|810728|abbcdef
ENTRY = Esters, Cholesterol
ENTRY = Esters, Cholesteryl
MN = D04.808.247.222.284.200
MN = D04.808.247.808.197.200
MN = D10.570.938.208.250
MH_TH = NLM (1976)
ST = T110
ST = T123
RN = 0
PI = Cholesterol (1966-1977)
PI = Esters (1968-1977)
MS = Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.
PM = 78; was see under CHOLESTEROL 1976-77
HN = 78(76); was see under CHOLESTEROL 1976-77
MR = 20030709
DA = 19750725
DC = 1
DX = 19780101
UI = D002788

*NEWRECORD
RECTYPE = D
MH = Cholesterol Oxidase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Oxidase, Cholesterol
MN = D08.811.682.047.436.350.150
MH_TH = NLM (1978)
ST = T116
ST = T126
N1 = Cholesterol:oxygen oxidoreductase
RN = EC 1.1.3.6
PI = Cholesterol (1966-1977)
PI = Hydroxysteroid Dehydrogenases (1966-1977)
MS = An enzyme that catalyzes the oxidation of cholesterol in the presence of molecular oxygen to 4-cholesten-3-one and hydrogen peroxide. The enzyme is not specific for cholesterol, but will also oxidize other 3-hydroxysteroids. EC 1.1.3.6.
PM = 91; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90
HN = 91(78); was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90
MR = 20030709
DA = 19770415
DC = 1
DX = 19910101
UI = D002789

*NEWRECORD
RECTYPE = D
MH = Cholesterol 7-alpha-Hydroxylase
DS = CHOLESTEROL ALPHA HYDROXYLASE 07
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = CYP7|T116|T126|ABB|EQV|NLM (1997)|960310|CYP 007|abbcdefs
PRINT ENTRY = CYP7A|T116|T126|ABB|EQV|NLM (1999)|971031|CYP 007 A|abbcdefs
PRINT ENTRY = Cytochrome P-450 CYP7|T116|T126|EQV|NLM (1997)|960310|CYTOCHROME P 450 CYP 007|abbdefs
ENTRY = CYP 7|T116|T126|ABB|EQV|NLM (1997)|960310|abbcdef
ENTRY = CYP 7A|T116|T126|ABB|EQV|NLM (1999)|971224|abbcdef
ENTRY = Cholesterol 7-alpha-Monooxygenase|T116|T126|NON|EQV|NLM (1975)|990101|abbcdef
ENTRY = Cholesterol 7alpha-Hydroxylase|T116|T126|NON|EQV|UNK (19XX)|811218|abbcdef
ENTRY = Cholesterol-7-Hydroxylase|T116|T126|NON|EQV|NLM (1997)|960221|abbcdef
ENTRY = Cytochrome P450 7|T116|T126|NON|EQV|NLM (1997)|960310|abbcdef
ENTRY = Cholesterol 7 Hydroxylase
ENTRY = Cholesterol 7 alpha Hydroxylase
ENTRY = Cholesterol 7 alpha Monooxygenase
ENTRY = Cholesterol 7alpha Hydroxylase
ENTRY = Cytochrome P 450 CYP7
MN = D08.244.453.915.200
MN = D08.811.682.690.708.170.915.200
MN = D12.776.422.220.453.915.200
MH_TH = NLM (1997)
ST = T116
ST = T126
N1 = Cholesterol,NADPH:oxygen oxidoreductase (7 alpha-hydroxylating)
RN = EC 1.14.13.17
RR = 9037-53-0 (CAS RN)
PI = Cholesterol (1974)
PI = Steroid Hydroxylases (1974)
MS = A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS.
PM = 2003; see CHOLESTEROL 7 ALPHA-MONOOXYGENASE 1997-2002, see CHOLESTEROL-7-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1975-1990
HN = 2003 (1975)
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D002790

*NEWRECORD
RECTYPE = D
MH = Cholesterol, Dietary
AQ = AA AD AE AG AI AN BL CF CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Dietary Cholesterol|T110|NON|EQV|UNK (19XX)|740329|abcdef
MN = D04.808.247.808.197.225
MN = D10.212.302.347
MN = D10.570.938.208.222
FX = Hypercholesterolemia
FX = Hyperlipoproteinemia Type II
EC = chemistry:Cholesterol:chemistry
MH_TH = NLM (1973)
ST = T110
RN = 0
AN = /adv eff: coord with disease /etiol, not /chem ind
PI = Cholesterol (1966-1972)
PI = Dietary Fats (1966-1972)
MS = Cholesterol present in food, especially in animal products.
PM = 73
HN = 73
MR = 20150622
DA = 19990101
DC = 1
DX = 19730101
UI = D002791

*NEWRECORD
RECTYPE = D
MH = Cholestyramine Resin
AQ = AA AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Cholestyramine|T109|T121|NON|EQV|BAN (19XX)|990101|abbcdef
PRINT ENTRY = Colestyramine|T109|T121|NON|EQV|INN (19XX)|761223|abbcdef
ENTRY = Colestyramin|T109|T121|NON|EQV|NLM (1991)|900307|abbcdef
ENTRY = Cuemid|T109|T121|TRD|NRW|NLM (1991)|900307|abbcdef
ENTRY = MK-135|T109|T121|LAB|NRW|UNK (19XX)|740329|abbcdef
ENTRY = Quantalan|T109|T121|TRD|NRW|NLM (1991)|900307|abbcdef
ENTRY = Questran|T109|T121|TRD|NRW|NLM (1991)|900307|abbcdef
ENTRY = Cholestyramine Resins
ENTRY = Cholestyramines
ENTRY = Colestyramines
ENTRY = Colestyramins
ENTRY = Cuemids
ENTRY = MK 135
ENTRY = MK135
ENTRY = Quantalans
ENTRY = Questrans
ENTRY = Resin, Cholestyramine
ENTRY = Resins, Cholestyramine
MN = D05.750.716.579.159
MN = D25.720.716.579.159
MN = J01.637.051.720.716.579.159
PA = Anion Exchange Resins
PA = Anticholesteremic Agents
MH_TH = NLM (1991)
MH_TH = USP (19XX)
ST = T109
ST = T121
RN = 11041-12-6
MS = A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion.
PM = 2010; see CHOLESTYRAMINE RESIN 1966-2009;
HN = 2010 (1964)
MR = 20090706
DA = 19990101
DC = 1
DX = 19660101
UI = D002792

*NEWRECORD
RECTYPE = D
MH = Cholic Acids
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Cholalic Acids|T110|T121|T123|NON|EQV|UNK (19XX)|770209|abbbcdef
ENTRY = Acids, Cholalic
ENTRY = Acids, Cholic
MN = D04.808.105.225
MN = D04.808.221.430
PA = Gastrointestinal Agents
MH_TH = NLM (1973)
ST = T110
ST = T121
ST = T123
RN = 0
AN = cholic acid glycine conjugate = GLYCOCHOLIC ACID; cholic acid taurine conjugate = TAUROCHOLIC ACID; CHOLIC ACID is also available
PI = Bile Acids and Salts (1966-1972)
MS = The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics.
OL = use CHOLIC ACIDS to search CHOLIC ACID 1973-74 (as Prov 1973); use BILE ACIDS AND SALTS 1966-72
PM = 75; was CHOLIC ACID 1974, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73
HN = 75; was CHOLIC ACID 1973-74 (Prov 1973), was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73
MR = 19991103
DA = 19990101
DC = 1
DX = 19740101
UI = D002793

*NEWRECORD
RECTYPE = D
MH = Choline
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
PRINT ENTRY = Bursine|T109|T123|NON|NRW|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef
PRINT ENTRY = Fagine|T109|T123|NON|NRW|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef
PRINT ENTRY = Vidine|T109|T123|NON|NRW|FDA SRS (2014)|UNK (19XX)|761230|abbcdeef
ENTRY = 2-Hydroxy-N,N,N-trimethylethanaminium|T109|T123|NON|EQV|FDA SRS (2014)|NLM (1996)|950404|abbcdeef
ENTRY = Choline Bitartrate|T109|T121|NON|NRW|FDA SRS (2014)|UNK (19XX)|840919|abbcdeef
ENTRY = Choline Chloride|T109|T121|NON|NRW|FDA SRS (2014)|INN (19XX)|810604|abbcdeef
ENTRY = Choline Citrate|T109|T121|NON|NRW|UNK (19XX)|840919|abbcdef
ENTRY = Choline Hydroxide|T109|T123|NON|NRW|NLM (2014)|130304|abbcdef
ENTRY = Choline O-Sulfate|T109|T121|NON|NRW|UNK (19XX)|840919|abbcdef
ENTRY = Bitartrate, Choline
ENTRY = Chloride, Choline
ENTRY = Choline O Sulfate
ENTRY = Citrate, Choline
ENTRY = Hydroxide, Choline
ENTRY = O-Sulfate, Choline
MN = D02.033.100.291.211
MN = D02.092.063.291.211
MN = D02.092.877.883.333
MN = D02.675.276.232
PA = Lipotropic Agents
PA = Nootropic Agents
EC = deficiency:Choline Deficiency
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T109
ST = T123
N1 = Ethanaminium, 2-hydroxy-N,N,N-trimethyl-
RN = N91BDP6H0X
RR = 45I14D8O27
RR = 62-49-7 (Choline)
RR = 67-48-1 (Cl)
RR = 6K2W7T9V6Y
RR = 7THJ3EG9SY
AN = /biosyn /physiol permitted
MS = A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism.
MR = 20130708
DA = 19990101
DC = 1
UI = D002794

*NEWRECORD
RECTYPE = D
MH = Choline O-Acetyltransferase
DS = CHOLINE ACETYLTRANSFERASE O
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Choline Acetylase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Choline Acetyltransferase|T116|T126|NON|EQV|NLM (1998)|961203|abbcdef
ENTRY = Acetylase, Choline
ENTRY = Acetyltransferase, Choline
ENTRY = Choline O Acetyltransferase
ENTRY = O-Acetyltransferase, Choline
MN = D08.811.913.050.134.180
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Acetyl-CoA:choline O-acetyltransferase
RN = EC 2.3.1.6
RR = 9012-78-6 (CAS RN)
PI = Acetyltransferases (1973-1974)
PI = Choline (1966-1974)
PI = Transferases (1966-1972)
MS = An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6.
PM = 98; see CHOLINE ACETYLTRANSFERASE 1978-97; see ACETYLTRANSFERASES 1975-77
HN = 98(75)
MR = 20030709
DA = 19741119
DC = 1
DX = 19780101
UI = D002795

*NEWRECORD
RECTYPE = D
MH = Choline Deficiency
DE = CHOLINE DEFIC
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Deficiency, Choline|T047|NON|EQV|UNK (19XX)|860101|DEFIC CHOLINE|abcdefv
ENTRY = Choline Deficiencies
ENTRY = Deficiencies, Choline
MN = C18.654.521.500.133.699.160
MH_TH = NLM (1964)
ST = T047
AN = a vitamin B defic in animals; DF: CHOLINE DEFIC
MS = A condition produced by a deficiency of CHOLINE in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline (included in the B vitamin complex) and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
PM = 67
HN = 67(64)
CATSH = CAT LIST
MR = 20030709
DA = 19990101
DC = 1
DX = 19670101
UI = D002796

*NEWRECORD
RECTYPE = D
MH = Choline Kinase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = ATP Choline Transphosphatase|T116|T126|EQV|UNK (19XX)|750630|abbdef
ENTRY = Choline Phosphokinase|T116|T126|NON|EQV|NLM (1998)|970303|abbcdef
ENTRY = Choline Transphosphatase, ATP
ENTRY = Kinase, Choline
ENTRY = Phosphokinase, Choline
ENTRY = Transphosphatase, ATP Choline
MN = D08.811.913.696.620.155
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = ATP:choline phosphotransferase
RN = EC 2.7.1.32
RR = 9026-67-9 (CAS RN)
PI = Choline (1974-1975)
PI = Phosphotransferases, ATP (1974-1975)
MS = An enzyme that is active in the first step of choline phosphoglyceride (lecithin) biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of ATP. Ethanolamine and its methyl and ethyl derivatives can also act as acceptors. EC 2.7.1.32.
PM = 91; was see under PHOSPHOTRANSFERASES, ATP 1976-90
HN = 91(76); was see under PHOSPHOTRANSFERASES, ATP 1976-90
MR = 20030709
DA = 19750718
DC = 1
DX = 19910101
UI = D002797

*NEWRECORD
RECTYPE = D
MH = Diacylglycerol Cholinephosphotransferase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Cholinephosphotransferase|T116|T126|NON|EQV|NLM (1994)|921015|abbcdef
PRINT ENTRY = Phosphorylcholine-Glyceride Transferase|T116|T126|NON|EQV|UNK (19XX)|750206|abbcdef
ENTRY = 1-alkyl-2-Acetylglycerol Cholinephosphotransferase|T116|T126|NON|EQV|NLM (2000)|991103|abbcdef
ENTRY = CDP-Choline 1,2-Diglyceride Choline Phosphotransferase|T116|T126|EQV|UNK (19XX)|800818|abbdef
ENTRY = CDP-Choline Cholinephosphotransferase|T116|T126|EQV|NLM (1998)|970303|abbdef
ENTRY = CDP-Diacylglycerol Synthase|T116|T126|EQV|UNK (19XX)|870810|abbdef
ENTRY = Diacylglycerol-CDP Choline Phosphotransferase|T116|T126|EQV|UNK (19XX)|821206|abbdef
ENTRY = PAF Phosphocholinetransferase|T116|T126|NON|EQV|NLM (2000)|991103|abbcdef
ENTRY = Phosphocholinetransferase|T116|T126|NON|EQV|UNK (19XX)|800818|abbcdef
ENTRY = Phosphorylcholineglyceride Transferase|T116|T126|NON|EQV|UNK (19XX)|800818|abbcdef
ENTRY = CDP Choline 1,2 Diglyceride Choline Phosphotransferase
ENTRY = CDP Choline Cholinephosphotransferase
ENTRY = CDP Diacylglycerol Synthase
ENTRY = Choline Phosphotransferase, Diacylglycerol-CDP
ENTRY = Cholinephosphotransferase, 1-alkyl-2-Acetylglycerol
ENTRY = Cholinephosphotransferase, CDP-Choline
ENTRY = Cholinephosphotransferase, Diacylglycerol
ENTRY = Diacylglycerol CDP Choline Phosphotransferase
ENTRY = Phosphocholinetransferase, PAF
ENTRY = Phosphorylcholine Glyceride Transferase
ENTRY = Phosphotransferase, Diacylglycerol-CDP Choline
ENTRY = Synthase, CDP-Diacylglycerol
ENTRY = Transferase, Phosphorylcholine-Glyceride
ENTRY = Transferase, Phosphorylcholineglyceride
MN = D08.811.913.696.900.200
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = CDPcholine:1,2-diacylglycerol cholinephosphotransferase
RN = EC 2.7.8.2
RR = 9026-13-5 (CAS RN)
PI = Choline (1973-1974)
PI = Cytosine Nucleotides (1973-1974)
PI = Glycerides (1973-1974)
PI = Phosphotransferases (1973-1974)
MS = An enzyme that catalyzes the synthesis of phosphatidylcholines from CDPcholine and 1,2-diacylglycerols. EC 2.7.8.2.
PM = 1994; see CHOLINEPHOSPHOTRANSFERASE 1975-93; 1-ALKYL-2-ACETYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE was indexed under DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE 1994-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE see PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993
HN = 1994(1975); use CHOLINEPHOSPHOTRANSFERASE 1975-93; for 1-ALKYL-2-ACETOGLYCEROL CHOLINEPHOSPHOTRANSFERASE use DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE (NM) 1987-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE use PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993
MR = 20030709
DA = 19741119
DC = 1
DX = 19910101
UI = D002798

*NEWRECORD
RECTYPE = D
MH = Cholinergic Fibers
AQ = CH CL DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Cholinergic Fiber
ENTRY = Fiber, Cholinergic
ENTRY = Fibers, Cholinergic
MN = A08.675.542.234
MN = A11.671.501.234
FX = Cholinergic Neurons
MH_TH = NLM (1977)
ST = T026
AN = CHOLINERGIC NEURONS is also available
PI = Parasympathetic Nervous System (1966-1976)
MS = Nerve fibers liberating acetylcholine at the synapse after an impulse.
PM = 77
HN = 77
MR = 20110624
DA = 19760427
DC = 1
DX = 19770101
UI = D002799

*NEWRECORD
RECTYPE = D
MH = Cholinesterase Inhibitors
DE = CHOLINESTERASE INHIB
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Acetylcholinesterase Inhibitors|T121|NON|NRW|UNK (19XX)|830504|ACETYLCHOLINESTERASE INHIB|abcdefv
PRINT ENTRY = Anticholinesterase Agents|T121|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Anti-Cholinesterases|T121|NON|EQV|NLM (1995)|940204|abcdef
ENTRY = Anticholinesterase Drugs|T121|NON|EQV|NLM (1996)|950518|abcdef
ENTRY = Anticholinesterases|T121|NON|EQV|NLM (1995)|940204|abcdef
ENTRY = Cholinesterase Inhibitors, Irreversible|T121|NON|NRW|UNK (19XX)|830504|CHOLINESTERASE INHIB IRREVERSIBLE|abcdefv
ENTRY = Cholinesterase Inhibitors, Reversible|T121|NON|NRW|UNK (19XX)|830504|CHOLINESTERASE INHIB REVERSIBLE|abcdefv
ENTRY = Agents, Anticholinesterase
ENTRY = Anti Cholinesterases
ENTRY = Drugs, Anticholinesterase
ENTRY = Inhibitors, Acetylcholinesterase
ENTRY = Inhibitors, Cholinesterase
ENTRY = Inhibitors, Irreversible Cholinesterase
ENTRY = Inhibitors, Reversible Cholinesterase
ENTRY = Irreversible Cholinesterase Inhibitors
ENTRY = Reversible Cholinesterase Inhibitors
MN = D27.505.519.389.275
MN = D27.505.519.625.120.300
MN = D27.505.696.577.120.300
FX = Insecticides
MH_TH = NLM (1965)
ST = T121
RN = 0
AN = DF: CHOLINESTERASE INHIB
MS = Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
OL = use CHOLINESTERASE INHIBITORS to search CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE 1971-83 (as Prov 1971-74)
PM = 65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted 1965)
HN = 65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83, were Prov 1971-74; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted 1965)
MR = 20050630
DA = 19990101
DC = 1
DX = 19650101
UI = D002800

*NEWRECORD
RECTYPE = D
MH = Cholinesterase Reactivators
AQ = AD AE AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Insecticides, Organophosphate, Antagonists|T121|NON|NRW|UNK (19XX)|820505|INSECTICIDES ORGANOPHOSPHATE ANTAG|abcdefv
PRINT ENTRY = Insecticides, Organothiophosphate, Antagonists|T121|NON|NRW|UNK (19XX)|820505|INSECTICIDES ORGANOTHIOPHOSPHATE ANTAG|abcdefv
PRINT ENTRY = Organophosphate Insecticide Antagonists|T121|NON|NRW|NLM (1995)|940425|ORGANOPHOSPHATE INSECTICIDE ANTAG|abcdefv
PRINT ENTRY = Organothiophosphate Insecticide Antagonists|T121|NON|NRW|NLM (1995)|940425|ORGANOTHIOPHOSPHATE INSECTICIDE ANTAG|abcdefv
ENTRY = Antagonists, Organophosphate Insecticide
ENTRY = Antagonists, Organothiophosphate Insecticide
ENTRY = Insecticide Antagonists, Organophosphate
ENTRY = Insecticide Antagonists, Organothiophosphate
ENTRY = Reactivators, Cholinesterase
MN = D27.505.519.405.347
MN = D27.505.519.625.120.400
MN = D27.505.696.577.120.400
MH_TH = NLM (1971)
ST = T121
RN = 0
AN = note X refs
PI = Acetylcholinesterase (1966-1970)
PI = Cholinesterases (1966-1970)
PI = Oximes (1966-1970)
PI = Pralidoxime Compounds (1966-1970)
PI = Pyridines (1966-1970)
PI = Pyridinium Compounds (1968-1970)
MS = Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.
PM = 72
HN = 72(71)
MR = 20050630
DA = 19990101
DC = 1
DX = 19720101
UI = D002801

*NEWRECORD
RECTYPE = D
MH = Cholinesterases
AQ = AD AE AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Acylcholineacylhydrolase|T116|T126|NON|EQV|UNK (19XX)|810519|abbcdef
ENTRY = Cholase|T116|T126|NON|NRW|UNK (19XX)|811209|abbcdef
ENTRY = Cholinesterase|T116|T126|NON|EQV|UNK (19XX)|760905|abbcdef
MN = D08.811.277.352.100.170
EC = antagonists & inhibitors:Cholinesterase Inhibitors
MH_TH = NLM (1966)
ST = T116
ST = T126
N1 = Acylcholine acylhydrolase
RN = EC 3.1.1.8
AN = reactivation: index under CHOLINESTERASE REACTIVATORS
OL = use CHOLINESTERASES to search CHOLINESTERASE 1966-74
PM = 75; was CHOLINESTERASE 1963-74
HN = 75; was CHOLINESTERASE 1963-74
MR = 20030709
DA = 19990101
DC = 1
UI = D002802

*NEWRECORD
RECTYPE = D
MH = Chondro-4-Sulfatase
DS = CHONDROSULFATASE 04
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Chondro 4 Sulfatase
MN = D08.811.277.352.827.180.175.275
MH_TH = NLM (1976)
ST = T116
ST = T126
N1 = 4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine-4-sulfate 4-sulfohydrolase
RN = EC 3.1.6.9
PI = Chondroitin (1974-1975)
PI = Sulfatases (1974-1975)
MS = An enzyme from the sulfuric ester hydrolase class that breaks down one of the products of the chondroitin lyase II reaction. EC 3.1.6.9.
PM = 91; was see under SULFATASES 1976-90
HN = 91(76); was see under SULFATASES 1976-90
MR = 20030709
DA = 19750725
DC = 1
DX = 19910101
UI = D002803

*NEWRECORD
RECTYPE = D
MH = Chondroblastoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Chondroblastomas
MN = C04.557.450.565.250
MH_TH = NLM (1966)
ST = T191
AN = benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS or precoord organ/neopl term (IM)
MS = A usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1846)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D002804

*NEWRECORD
RECTYPE = D
MH = Chondrocalcinosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Calcium Pyrophosphate Dihydrate Deposition|T047|NON|NRW|NLM (1995)|930917|abcdef
PRINT ENTRY = Pseudogout|T047|NON|REL|UNK (19XX)|740329|abcdef
ENTRY = Chondrocalcinoses
MN = C05.550.114.264
MH_TH = NLM (1972)
ST = T047
AN = a form of arthritis; note X ref: do not index under CALCIUM PYROPHOSPHATE unless particularly discussed
PI = Calcinosis (1966-1971)
PI = Joint Diseases (1966-1971)
MS = Presence of calcium salts, especially calcium pyrophosphate, in the cartilaginous structures of one or more joints. When accompanied by attacks of goutlike symptoms, it is called pseudogout. (Dorland, 27th ed)
PM = 72
HN = 72
CATSH = CAT LIST
MR = 19940125
DA = 19990101
DC = 1
DX = 19720101
UI = D002805

*NEWRECORD
RECTYPE = D
MH = Chondrodysplasia Punctata
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Chondrodystrophia Calcificans Congenita|T047|NON|EQV|UNK (19XX)|840406|CHONDRODYSTROPHIA CALCIFICANS CONGEN|abcdefv
PRINT ENTRY = Conradi-Hunermann Syndrome|T047|EPO|REL|OMIM (2013)|ORD (2010)|UNK (19XX)|840406|abcdeeef
PRINT ENTRY = Dysplasia Epiphysialis Punctata|T047|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Epiphyses, Stippled|T047|NON|EQV|UNK (19XX)|740329|abcdef
PRINT ENTRY = Stippled Epiphyses|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Chondrodysplasia Punctata 2, X-Linked|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = Conradi Hunermann Happle Syndrome|T047|EPO|REL|NLM (2010)|ORD (2010)|090518|abcdeef
ENTRY = Conradi-Hunermann-Happle Syndrome|T047|NON|REL|OMIM (2013)|111115|abcdef
ENTRY = Conradi-Hnermann Syndrome|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = Conradi-Hnermann-Happle Syndrome|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = Happle Syndrome|T047|EPO|REL|GHR (2014)|NLM (2010)|OMIM (2013)|ORD (2010)|090518|abcdeeeef
ENTRY = Hunermann-Conradi Syndrome|T047|EPO|REL|NLM (1992)|900906|abcdef
ENTRY = X-Linked Chondrodysplasia Punctata 2|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = X-Linked Dominant Chondrodysplasia Punctata|T047|NON|REL|GHR (2014)|130418|abcdef
ENTRY = Chondrodysplasia Punctata 2, X Linked
ENTRY = Conradi Hunermann Syndrome
ENTRY = Conradi Hnermann Happle Syndrome
ENTRY = Conradi Hnermann Syndrome
ENTRY = Conradi-Hunermann-Happle Syndromes
ENTRY = Conradi-Hnermann Syndromes
ENTRY = Conradi-Hnermann-Happle Syndromes
ENTRY = Hunermann Conradi Syndrome
ENTRY = Syndrome, Conradi-Hunermann
ENTRY = Syndrome, Conradi-Hunermann-Happle
ENTRY = Syndrome, Conradi-Hnermann
ENTRY = Syndrome, Conradi-Hnermann-Happle
ENTRY = Syndrome, Happle
ENTRY = Syndrome, Hunermann-Conradi
ENTRY = Syndromes, Conradi-Hunermann-Happle
ENTRY = Syndromes, Conradi-Hnermann
ENTRY = Syndromes, Conradi-Hnermann-Happle
ENTRY = X Linked Chondrodysplasia Punctata 2
ENTRY = X Linked Dominant Chondrodysplasia Punctata
MN = C05.116.099.708.195
MH_TH = NLM (1964)
MH_TH = ORD (2010)
ST = T047
AN = spell entry term name Hunermann with an umlaut in titles & translations; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC is also available
MS = A heterogeneous group of bone dysplasias, the common character of which is stippling of the epiphyses in infancy. The group includes a severe autosomal recessive form (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC), an autosomal dominant form (Conradi-Hunermann syndrome), and a milder X-linked form. Metabolic defects associated with impaired peroxisomes are present only in the rhizomelic form.
PM = 1985; see CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1967-1984
HN = 1985(1964)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
DX = 19670101
UI = D002806

*NEWRECORD
RECTYPE = D
MH = Chondroitin
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
MN = D09.698.373.200
MH_TH = NLM (1966)
ST = T118
ST = T123
N1 = Chondroitin
RN = 9007-27-6
AN = /biosyn /physiol permitted; CHONDROITIN SULFATE B see DERMATAN SULFATE is available
MS = A mucopolysaccharide constituent of chondrin. (Grant & Hackh's Chemical Dictionary, 5th ed)
MR = 20040707
DA = 19990101
DC = 1
UI = D002807

*NEWRECORD
RECTYPE = D
MH = Chondroitin Lyases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Chondroitin AC Lyase|T116|T126|NON|NRW|UNK (19XX)|750731|abbcdef
PRINT ENTRY = Chondroitin B Lyase|T116|T126|NON|NRW|UNK (19XX)|750731|abbcdef
PRINT ENTRY = Chondroitin Eliminase|T116|T126|NON|NRW|UNK (19XX)|750731|abbcdef
PRINT ENTRY = Chondroitin Sulfate Lyase|T116|T126|NON|NRW|UNK (19XX)|750731|abbcdef
ENTRY = Chondroitinase-AC II|T116|T126|NON|NRW|UNK (19XX)|821123|abbcdef
ENTRY = Chondroitinase AC II
ENTRY = Eliminase, Chondroitin
ENTRY = Lyase, Chondroitin AC
ENTRY = Lyase, Chondroitin B
ENTRY = Lyase, Chondroitin Sulfate
ENTRY = Lyases, Chondroitin
ENTRY = Sulfate Lyase, Chondroitin
MN = D08.811.520.241.700.350.500
MH_TH = NLM (1976)
ST = T116
ST = T126
RN = EC 4.2.2.-
AN = do not confuse with CHONDROITIN ABC LYASE
PI = Chondroitin (1970-1975)
PI = Lyases (1970-1974)
PI = Polysaccharide-Lyases (1975)
MS = Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C.
PM = 91; was see under CHONDROITINASES 1976-90
HN = 91(76); was see under CHONDROITINASES 1976-90
MR = 20030709
DA = 19750801
DC = 1
DX = 19910101
UI = D002808

*NEWRECORD
RECTYPE = D
MH = Chondroitin Sulfates
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Chondroitin 4-Sulfate|T118|T121|T123|NON|NRW|NLM (1992)|910312|CHONDROITIN SULFATE 04|abbbcdefs
PRINT ENTRY = Chondroitin 6-Sulfate|T118|T121|T123|NON|NRW|NLM (1992)|910312|CHONDROITIN SULFATE 06|abbbcdefs
PRINT ENTRY = Chondroitin Sulfate A|T118|T121|T123|NON|NRW|UNK (19XX)|750630|abbbcdef
PRINT ENTRY = Chondroitin Sulfate C|T118|T121|T123|NON|NRW|UNK (19XX)|750630|abbbcdef
ENTRY = Blutal|T118|T121|TRD|NRW|NLM (1992)|910312|abbcdef
ENTRY = Chondroitin 4-Sulfate, Aluminum Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin 4-Sulfate, Potassium Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin 6-Sulfate, Potassium Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin 6-Sulfate, Sodium Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin Sulfate|T118|T121|T123|NON|EQV|NLM (1992)|910312|abbbcdef
ENTRY = Chondroitin Sulfate 4-Sulfate, Sodium Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin Sulfate, Calcium Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin Sulfate, Iron (+3) Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin Sulfate, Iron Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin Sulfate, Potassium Salt|T109|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin Sulfate, Sodium Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chondroitin Sulfate, Zinc Salt|T118|T121|T123|NON|NRW|NLM (1999)|990913|abbbcdef
ENTRY = Chonsurid|T118|T121|TRD|NRW|NLM (1992)|910312|abbcdef
ENTRY = Sodium Chondroitin Sulfate|T118|T121|T123|NON|NRW|NLM (1992)|910312|abbbcdef
ENTRY = Translagen|T118|T121|TRD|NRW|NLM (2001)|abbcde
ENTRY = Chondroitin 4 Sulfate
ENTRY = Chondroitin 4 Sulfate, Aluminum Salt
ENTRY = Chondroitin 4 Sulfate, Potassium Salt
ENTRY = Chondroitin 6 Sulfate
ENTRY = Chondroitin 6 Sulfate, Potassium Salt
ENTRY = Chondroitin 6 Sulfate, Sodium Salt
ENTRY = Chondroitin Sulfate 4 Sulfate, Sodium Salt
ENTRY = Chondroitin Sulfate, Sodium
ENTRY = Sulfate, Chondroitin
ENTRY = Sulfate, Sodium Chondroitin
ENTRY = Sulfates, Chondroitin
MN = D09.698.373.200.300
MH_TH = NLM (1976)
ST = T118
ST = T121
ST = T123
N1 = Chondroitin, hydrogen sulfate
RN = 9007-28-7
RR = 106440-56-6 (unspecified sulfate, K salt)
RR = 123896-38-8 (unspecified sulfate, Zn salt)
RR = 12678-07-8 (6-sulfate, Na salt)
RR = 24967-93-9 (4-sulfate)
RR = 25322-46-7 (6-sulfate)
RR = 39455-18-0 (4-sulfate, Na salt)
RR = 54391-57-0 (unspecified sulfate, Fe salt)
RR = 62996-11-6 (4-sulfate, K salt)
RR = 66173-57-7 (4-sulfate, Al salt)
RR = 66173-60-2 (6-sulfate, K salt)
RR = 86016-46-8 (unspecified sulfate, Ca salt)
RR = 9082-07-9 (unspecified sulfate, Na salt)
RR = 9088-44-2 (unspecified sulfate, Fe(3+) salt)
PI = Chondroitin (1971-1975)
PI = Sulfuric Acids (1971-1975)
MS = Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate.
PM = 1991; see CHONDROITIN 1976-90; TRANSLAGEN was indexed under CHONDROITIN SULFATES, COLLAGEN & HEPARIN 1991-2000
HN = 1991(1976); for TRANSLAGEN use CHONDROITIN SULFATE (NM) 1991-2000
MR = 20040707
DA = 19750723
DC = 1
DX = 19910101
UI = D002809

*NEWRECORD
RECTYPE = D
MH = Chondroitinases and Chondroitin Lyases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Chondroitin-4-Sulfate Depolymerase|T116|T126|NON|NRW|UNK (19XX)|810608|abbcdef
ENTRY = Chondroitinases|T116|T126|NON|NRW|NLM (1998)|961213|abbcdef
ENTRY = Chondroitin 4 Sulfate Depolymerase
ENTRY = Depolymerase, Chondroitin-4-Sulfate
MN = D08.811.277.352.827.180
MN = D08.811.520.241.700.350
MH_TH = NLM (1976)
ST = T116
ST = T126
RN = EC 4.2.2.-
AN = CHONDROITIN LYASES is available; DF: CHONDROITINASES
PI = Chondroitin (1970-1975)
PI = Lyases (1970-1974)
PI = Polysaccharide-Lyases (1975)
PI = Sulfatases (1970-1975)
MS = Enzymes which catalyze the elimination of glucuronate residues from chondroitin A,B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. EC 4.2.2.-.
PM = 98; see CHONDROITINASES 1976-97
HN = 98(76)
MR = 20030709
DA = 19750725
DC = 1
DX = 19760101
UI = D002810

*NEWRECORD
RECTYPE = D
MH = Chondroitinsulfatases
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
ENTRY = Chondroitin Sulfohydrolase|T116|T126|NON|EQV|UNK (19XX)|810608|abbcdef
ENTRY = Chondroitinsulfatase|T116|T126|NON|EQV|NLM (1997)|951128|abbcdef
ENTRY = Sulfohydrolase, Chondroitin
MN = D08.811.277.352.827.180.175
MH_TH = NLM (1976)
ST = T116
ST = T126
RN = EC 3.1.6.-
PI = Chondroitin (1970-1975)
PI = Sulfatases (1970-1975)
MS = A group of enzymes that catalyze the hydrolysis of various sulfate bonds of chondroitin sulfate. EC 3.1.6.-.
PM = 97; was CHONDROITINSULFATASE 1976-96 (see under CHONDROITINASES 1976-90)
HN = 97; was CHONDROITINSULFATASE 1976-96 (see under CHONDROITINASES 1976-90)
MR = 20030709
DA = 19750801
DC = 1
DX = 19910101
UI = D002811

*NEWRECORD
RECTYPE = D
MH = Chondroma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SE SU TH UL UR US VE VI
PRINT ENTRY = Enchondroma|T191|NON|REL|NLM (1990)|890321|abcdef
ENTRY = Chondromas
ENTRY = Enchondromas
MN = C04.557.450.565.265
MH_TH = NLM (1966)
ST = T191
AN = solitary; multiple = CHONDROMATOSIS; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); do not confuse X ref ENCHONDROMA with ENCHONDROMATOSIS
MS = A benign neoplasm derived from mesodermal cells that form cartilage. It may remain within the substance of a cartilage or bone (true chondroma or enchondroma) or may develop on the surface of a cartilage (ecchondroma or ecchondrosis). (Dorland, 27th ed; Stedman, 25th ed)
CATSH = CAT LIST
MR = 19950608
DA = 19990101
DC = 1
UI = D002812

*NEWRECORD
RECTYPE = D
MH = Chondrosarcoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Chondrosarcomas
MN = C04.557.450.565.280
MN = C04.557.450.795.300
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS (IM) or specific precoord bone/neopl term (IM) or specific bone (IM) + BONE NEOPLASMS (IM)
MS = A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002813

*NEWRECORD
RECTYPE = D
MH = Chorda Tympani Nerve
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Chorda Tympani Nerves
ENTRY = Nerve, Chorda Tympani
ENTRY = Nerves, Chorda Tympani
ENTRY = Tympani Nerve, Chorda
ENTRY = Tympani Nerves, Chorda
MN = A08.800.800.120.250.120
MH_TH = NLM (1963)
ST = T023
AN = a branch of the facial (7th cranial) nerve; dis: coord IM with FACIAL NERVE DISEASES (IM); neopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
MS = A branch of the facial (7th cranial) nerve which passes through the middle ear and continues through the petrotympanic fissure. The chorda tympani nerve carries taste sensation from the anterior two-thirds of the tongue and conveys parasympathetic efferents to the salivary glands.
PM = 65
HN = 65(63)
MR = 19980610
DA = 19990101
DC = 1
DX = 19650101
UI = D002814

*NEWRECORD
RECTYPE = D
MH = Chordae Tendineae
AQ = AB AH CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Tendineae, Chordae
MN = A07.541.510.240
MH_TH = NLM (1966)
ST = T023
AN = for disease, coord IM with HEART VALVE DISEASES (IM); PAPILLARY MUSCLES is also available but read MeSH definition; false tendons: index PURKINJE FIBERS but see note there
MS = The tendinous cords that connect each cusp of the two atrioventricular HEART VALVES to appropriate PAPILLARY MUSCLES in the HEART VENTRICLES, preventing the valves from reversing themselves when the ventricles contract.
MR = 20050630
DA = 19990101
DC = 1
UI = D002815

*NEWRECORD
RECTYPE = D
MH = Chordata, Nonvertebrate
AQ = AH CH CL CY DE EM EN GD GE IM ME MI PH PS PY RE UL VI
ENTRY = Invertebrate Chordate|T008|NON|EQV|NLM (2014)|130104|abcdef
ENTRY = Chordatas, Nonvertebrate
ENTRY = Chordate, Invertebrate
ENTRY = Chordates, Invertebrate
ENTRY = Invertebrate Chordates
ENTRY = Nonvertebrate Chordata
ENTRY = Nonvertebrate Chordatas
MN = B01.050.150.200
MN = B01.050.500.272
MH_TH = NLM (1966)
ST = T008
MS = A portion of the animal phylum Chordata comprised of the subphyla CEPHALOCHORDATA; UROCHORDATA, and HYPEROTRETI, but not including the Vertebrata (VERTEBRATES). It includes nonvertebrate animals having a NOTOCHORD during some developmental stage.
PM = 2000; see CHORDATA 1966-1999
HN = 2000(1966)
MR = 20130708
DA = 19990101
DC = 1
UI = D002816

*NEWRECORD
RECTYPE = D
MH = Chordoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Chordomas
MN = C04.557.465.220
MH_TH = GHR (2014)
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed)
CATSH = CAT LIST
MR = 20130708
DA = 19990101
DC = 1
UI = D002817

*NEWRECORD
RECTYPE = D
MH = Cordotomy
AQ = AE CL CT EC ED ES HI IS LJ MO MT NU PX RH SN ST TD UT VE
PRINT ENTRY = Chordotomy|T061|NON|EQV|UNK (19XX)|880519|abcdef
ENTRY = Chordotomies
ENTRY = Cordotomies
MN = E04.525.210.210
MH_TH = NLM (1963)
ST = T061
AN = do not use /util except by MeSH definition
MS = Any operation on the spinal cord. (Stedman, 26th ed)
OL = use CORDOTOMY to search CHORDOTOMY 1966-88
PM = 89; was CHORDOTOMY 1966-88
HN = 89; was CHORDOTOMY 1966-88
CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
DX = 19660101
UI = D002818

*NEWRECORD
RECTYPE = D
MH = Chorea
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Choreatic Disorders|T184|NON|EQV|NLM (2000)|991012|CHOREATIC DIS|abcdefv
PRINT ENTRY = Choreiform Movement|T184|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Chorea Disorders|T184|NON|EQV|NLM (2000)|991012|CHOREA DIS|abcdefv
ENTRY = Chorea Syndromes|T184|NON|EQV|NLM (2000)|991012|abcdef
ENTRY = Chorea, Benign Hereditary|T047|NON|NRW|NLM (2000)|OMIM (2013)|991012|abcdeef
ENTRY = Chorea, Chronic Progressive|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Chorea, Rheumatic|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Chorea, Senile|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Chorea, Sydenham|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Choreatic Syndromes|T184|NON|EQV|NLM (2000)|991012|abcdef
ENTRY = Choreic Movement|T184|NON|EQV|NLM (2000)|991103|abcdef
ENTRY = Dyskinesias, Paroxysmal|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Hereditary Chorea|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Hereditary Progressive Chorea Without Dementia|T047|NON|NRW|OMIM (2013)|111115|abcdef
ENTRY = Paroxysmal Dyskinesias|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Rheumatic Chorea|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = Senile Chorea|T047|NON|NRW|NLM (2000)|991012|abcdef
ENTRY = St. Vitus's Dance|T047|NON|NRW|NLM (2000)|ORD (2010)|991012|abcdeef
ENTRY = Sydenham Chorea|T047|NON|NRW|NLM (2000)|ORD (2010)|991012|abcdeef
ENTRY = Sydenham's Chorea|T047|EPO|NRW|NLM (2010)|ORD (2010)|090514|abcdeef
ENTRY = Benign Hereditary Chorea
ENTRY = Benign Hereditary Choreas
ENTRY = Chorea Disorder
ENTRY = Chorea Syndrome
ENTRY = Chorea, Hereditary
ENTRY = Chorea, Sydenham's
ENTRY = Choreas
ENTRY = Choreas, Benign Hereditary
ENTRY = Choreas, Chronic Progressive
ENTRY = Choreas, Hereditary
ENTRY = Choreas, Rheumatic
ENTRY = Choreas, Senile
ENTRY = Choreas, Sydenham
ENTRY = Choreatic Disorder
ENTRY = Choreatic Syndrome
ENTRY = Choreic Movements
ENTRY = Choreiform Movements
ENTRY = Chronic Progressive Chorea
ENTRY = Chronic Progressive Choreas
ENTRY = Disorder, Chorea
ENTRY = Disorder, Choreatic
ENTRY = Disorders, Chorea
ENTRY = Disorders, Choreatic
ENTRY = Dyskinesia, Paroxysmal
ENTRY = Hereditary Chorea, Benign
ENTRY = Hereditary Choreas
ENTRY = Hereditary Choreas, Benign
ENTRY = Movement, Choreic
ENTRY = Movement, Choreiform
ENTRY = Movements, Choreic
ENTRY = Movements, Choreiform
ENTRY = Paroxysmal Dyskinesia
ENTRY = Progressive Chorea, Chronic
ENTRY = Progressive Choreas, Chronic
ENTRY = Rheumatic Choreas
ENTRY = Senile Choreas
ENTRY = St. Vitus Dance
ENTRY = St. Vitus's Dances
ENTRY = St. Vituss Dance
ENTRY = Sydenham Choreas
ENTRY = Sydenhams Chorea
ENTRY = Syndrome, Chorea
ENTRY = Syndrome, Choreatic
ENTRY = Syndromes, Chorea
ENTRY = Syndromes, Choreatic
MN = C10.228.662.262.249
MN = C10.597.350.250
MN = C23.888.592.350.250
MH_TH = NLM (1963)
ST = T184
AN = choreoathetosis = CHOREA (IM) + ATHETOSIS (IM); MORVAN'S CHOREA see MYOKYMIA and CHOREATIC DISORDERS are also available
MS = Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.
PM = 1963; for CHOREATIC DISORDERS; CHOREA, BENIGN HERIDITARY; CHOREA, CHRONIC PROGRESSIVE; CHOREA, RHEUMATIC; CHOREA, SENILE; DYSKINESIAS, PAROXYSMAL; & HEREDITARY CHOREA use CHOREATIC DISORDERS 2000-2007
HN = 1963; for CHOREATIC DISORDERS; CHOREA, BENIGN HERIDITARY; CHOREA, CHRONIC PROGRESSIVE; CHOREA, RHEUMATIC; CHOREA, SENILE; DYSKINESIAS, PAROXYSMAL; & HEREDITARY CHOREA use CHOREATIC DISORDERS 2000-2007
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002819

*NEWRECORD
RECTYPE = D
MH = Hydatidiform Mole, Invasive
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Chorioadenoma|T191|NON|EQV|NLM (1994)|930329|abcdef
PRINT ENTRY = Invasive Mole|T191|NON|EQV|NLM (1994)|930329|abcdef
ENTRY = Chorioadenomas
ENTRY = Hydatidiform Moles, Invasive
ENTRY = Invasive Hydatidiform Mole
ENTRY = Invasive Hydatidiform Moles
ENTRY = Invasive Moles
ENTRY = Mole, Invasive
ENTRY = Mole, Invasive Hydatidiform
ENTRY = Moles, Invasive
ENTRY = Moles, Invasive Hydatidiform
MN = C04.557.465.955.416.812.500
MN = C04.850.908.416.750.500
MN = C13.703.720.949.416.875.500
MH_TH = NLM (1966)
ST = T191
AN = coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE & PREGNANCY
MS = A uterine tumor derived from persistent gestational TROPHOBLASTS, most likely after a molar pregnancy (HYDATIDIFORM MOLE). Invasive hyadatiform mole develops in about 15% of patients after evacuation of a complete mole and less frequently after other types of gestation. It may perforate the MYOMETRIUM and erode uterine vessels causing hemorrhage.
OL = use HYDATIDIFORM MOLE, INVASIVE to search CHORIOADENOMA 1966-93
PM = 94; was CHORIOADENOMA 1963-93
HN = 94; was CHORIOADENOMA 1963-93
CATSH = CAT LIST
MR = 20040728
DA = 19990101
DC = 1
UI = D002820

*NEWRECORD
RECTYPE = D
MH = Chorioamnionitis
AQ = BL CF CI CL DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Amnionitis|T047|NON|NRW|UNK (19XX)|840620|abcdef
PRINT ENTRY = Funisitis|T047|NON|NRW|NLM (2006)|050225|abcdef
ENTRY = Amnionitides
ENTRY = Chorioamnionitides
ENTRY = Funisitides
MN = C13.703.277.030
MN = C13.703.420.339.260
MN = C13.703.590.268
MN = C16.300.030
MH_TH = NLM (1985)
ST = T047
PI = Amnion (1966-1984)
PI = Chorion (1975-1984)
PI = Fetal Membranes, Premature Rupture (1975-1984)
PI = Pregnancy Complications, Infectious (1966-1984)
MS = INFLAMMATION of the placental membranes (CHORION; AMNION) and connected tissues such as fetal BLOOD VESSELS and UMBILICAL CORD. It is often associated with intrauterine ascending infections during PREGNANCY.
PM = 85
HN = 85
CATSH = CAT LIST
MR = 20050630
DA = 19840501
DC = 1
DX = 19850101
UI = D002821

*NEWRECORD
RECTYPE = D
MH = Choriocarcinoma
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Choriocarcinomas
MN = C04.557.465.955.207
MN = C04.557.470.200.025.455
MN = C04.850.908.208
MN = C13.703.720.949.208
FX = Choriocarcinoma, Non-gestational
MH_TH = NLM (1966)
ST = T191
AN = coordinate IM with UTERINE NEOPLASMS (IM) + FEMALE + PREGNANCY
MS = A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).
CATSH = CAT LIST
MR = 20150623
DA = 19990101
DC = 1
UI = D002822

*NEWRECORD
RECTYPE = D
MH = Chorion
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Chorions
MN = A10.615.284.473
MN = A16.254.750.473
FX = Chorioallantoic Membrane
MH_TH = NLM (1975)
ST = T018
PI = Fetal Membranes (1966-1974)
MS = The outermost extra-embryonic membrane surrounding the developing embryo. In REPTILES and BIRDS, it adheres to the shell and allows exchange of gases between the egg and its environment. In MAMMALS, the chorion evolves into the fetal contribution of the PLACENTA.
OL = search FETAL MEMBRANES 1966-74
PM = 78; was see under FETAL MEMBRANES 1963-77
HN = 78(75); was see under FETAL MEMBRANES 1963-77
MR = 20070711
DA = 19990101
DC = 1
DX = 19780101
UI = D002823

*NEWRECORD
RECTYPE = D
MH = Chorionic Villi
AQ = AB AH BS CH DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
PRINT ENTRY = Placental Villi|T018|NON|EQV|UNK (19XX)|741111|abcdef
ENTRY = Chorionic Villus
ENTRY = Placental Villus
ENTRY = Villi, Chorionic
ENTRY = Villi, Placental
ENTRY = Villus, Chorionic
ENTRY = Villus, Placental
MN = A10.615.284.473.200
MN = A16.254.750.473.200
MN = A16.710.189
MH_TH = NLM (1975)
ST = T018
PI = Fetal Membranes (1966-1974)
PI = Placenta (1966-1974)
MS = The threadlike, vascular projections of the chorion. Chorionic villi may be free or embedded within the DECIDUA forming the site for exchange of substances between fetal and maternal blood (PLACENTA).
PM = 85; was see under PLACENTA 1975-84
HN = 85(75); was see under PLACENTA 1975-84
MR = 20070709
DA = 19741111
DC = 1
DX = 19850101
UI = D002824

*NEWRECORD
RECTYPE = D
MH = Chorioretinitis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Chorioretinitides
MN = C11.768.773.348
MN = C11.941.160.478.400
MN = C11.941.879.780.900.300.318
MH_TH = NLM (1966)
ST = T047
AN = inflamm of choroid & retina
MS = Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.
CATSH = CAT LIST
MR = 19930526
DA = 19990101
DC = 1
UI = D002825

*NEWRECORD
RECTYPE = D
MH = Chorismate Mutase
AQ = AD AE AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Chorismate Pyruvatemutase|T116|T126|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Mutase, Chorismate
ENTRY = Pyruvatemutase, Chorismate
MN = D08.811.399.520.250
MH_TH = NLM (1975)
ST = T116
ST = T126
N1 = Chorismate pyruvatemutase
RN = EC 5.4.99.5
RR = 9068-30-8 (CAS RN)
PI = Cyclohexanecarboxylic Acids (1969-1974)
PI = Isomerases (1969-1974)
PI = Vinyl Compounds (1972-1974)
MS = An isomerase that catalyzes the conversion of chorismic acid to prephenic acid. EC 5.4.99.5.
PM = 91; was see under ISOMERASES 1975-90
HN = 91(75); was see under ISOMERASES 1975-90
MR = 20030709
DA = 19741111
DC = 1
DX = 19910101
UI = D002826

*NEWRECORD
RECTYPE = D
MH = Chorismic Acid
AQ = AA AD AE AG AI AN BI BL CF CH CL CS CT DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UR
ENTRY = Acid, Chorismic
MN = D02.241.223.268.250
MN = D02.455.426.392.368.367.379.374
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T123
N1 = 1,5-Cyclohexadiene-1-carboxylic acid, 3-((1-carboxyethenyl)oxy)-4-hydroxy-, (3R-trans)-
RN = GI1BLY82Y1
RR = 617-12-9 (Chorismic Acid)
PI = Cyclohexanecarboxylic Acids (1969-1974)
PI = Vinyl Compounds (1972-1974)
MS = A cyclohexadiene carboxylic acid derived from SHIKIMIC ACID and a precursor for the biosynthesis of UBIQUINONE and the AROMATIC AMINO ACIDS.
PM = 91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90
HN = 91(75); was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90
MR = 20130708
DA = 19741119
DC = 1
DX = 19910101
UI = D002827

*NEWRECORD
RECTYPE = D
MH = Choristoma
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Aberrant Tissue|T046|NON|EQV|UNK (19XX)|850311|abcdef
PRINT ENTRY = Ectopic Tissue|T046|NON|EQV|UNK (19XX)|850311|abcdef
PRINT ENTRY = Heterotopic Tissue|T046|NON|EQV|UNK (19XX)|750116|abcdef
ENTRY = Aberrant Tissues
ENTRY = Choristomas
ENTRY = Ectopic Tissues
ENTRY = Heterotopic Tissues
ENTRY = Tissue, Aberrant
ENTRY = Tissue, Ectopic
ENTRY = Tissue, Heterotopic
ENTRY = Tissues, Aberrant
ENTRY = Tissues, Ectopic
ENTRY = Tissues, Heterotopic
MN = C23.300.250
MH_TH = NLM (1966)
ST = T046
AN = coord aberrant or heterotopic tissue of an organ under the organ without qualif, e.g., heterotopic pancreatic tissue in the duodenum = CHORISTOMA (IM) + DUODENAL DISEASES (IM) + PANCREAS (no qualif) (IM)
MS = A mass of histologically normal tissue present in an abnormal location.
CATSH = CAT LIST
MR = 19991108
DA = 19990101
DC = 1
UI = D002828

*NEWRECORD
RECTYPE = D
MH = Choroid
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU TR UL US VI
ENTRY = Choroids
MN = A09.371.894.223
MH_TH = NLM (1966)
ST = T023
AN = in the eye: do not confuse with CHOROID PLEXUS (in the brain); inflammation = CHOROIDITIS or CHORIORETINITIS; /blood supply consider also CILIARY ARTERIES
MS = The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.
MR = 19991103
DA = 19990101
DC = 1
UI = D002829

*NEWRECORD
RECTYPE = D
MH = Choroid Neoplasms
DE = CHOROID NEOPL
AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
ENTRY = Choroidal Neoplasms|T191|NON|EQV|NLM (1990)|890525|CHOROIDAL NEOPL|abcdefv
ENTRY = Choroid Neoplasm
ENTRY = Choroidal Neoplasm
ENTRY = Neoplasm, Choroid
ENTRY = Neoplasm, Choroidal
ENTRY = Neoplasms, Choroid
ENTRY = Neoplasms, Choroidal
MN = C04.588.364.978.223
MN = C11.319.494.198
MN = C11.941.160.238
MN = C11.941.855.198
MH_TH = NLM (1966)
ST = T191
AN = of the eye: do not confuse with neopl of CHOROID PLEXUS ( = CHOROID PLEXUS NEOPLASMS); /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
MS = Tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas (nevi).
CATSH = CAT LIST
MR = 20000622
DA = 19990101
DC = 1
UI = D002830

*NEWRECORD
RECTYPE = D
MH = Choroid Plexus
AQ = AB AH BS CH CY DE EM EN GD IM IN ME MI PA PH PP PS RA RE RI SE SU UL US VI
ENTRY = Chorioid Plexus|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Plexus Choroideus|T023|NON|EQV|NLM (2015)|140318|abcdef
ENTRY = Choroideus, Plexus
ENTRY = Plexus, Chorioid
ENTRY = Plexus, Choroid
MN = A08.186.211.276.298
MH_TH = NLM (1966)
ST = T023
AN = in the brain: do not confuse with CHOROID (in the eye); diseases: coordinate IM with BRAIN DISEASES (IM); neoplasms = CHOROID PLEXUS NEOPLASMS;  / radiogr: coordinate with CEREBRAL VENTRICULOGRAPHY
MS = A villous structure of tangled masses of BLOOD VESSELS contained within the third, lateral, and fourth ventricles of the BRAIN. It regulates part of the production and composition of CEREBROSPINAL FLUID.
MR = 20140613
DA = 19990101
DC = 1
UI = D002831

*NEWRECORD
RECTYPE = D
MH = Choroid Hemorrhage
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Hemorrhage, Choroid|T033|T046|NON|EQV|NLM (1990)|890315|abbcdef
ENTRY = Choroidal Hemorrhage|T033|T046|NON|EQV|NLM (1990)|890417|abbcdef
ENTRY = Choroidal Hemorrhages
ENTRY = Hemorrhage, Choroidal
MN = C11.290.195
MN = C11.941.160.177
MN = C23.550.414.756.300
MH_TH = NLM (1987)
ST = T033
ST = T046
AN = of the eye, not of the choroid plexus
PI = Choroid (1966-1986)
PI = Hemorrhage (1966-1986)
MS = Hemorrhage from the vessels of the choroid.
OL = use CHOROID HEMORRHAGE to search CHOROIDAL HEMORRHAGE 1987-89
PM = 91; was see under EYE HEMORRHAGE 1987-90; was CHOROIDAL HEMORRHAGE 1987-89
HN = 91(87); was see under EYE HEMORRHAGE 1987-90; was CHOROIDAL HEMORRHAGE 1987-89
CATSH = CAT LIST
MR = 19991103
DA = 19860408
DC = 1
DX = 19910101
UI = D002832

*NEWRECORD
RECTYPE = D
MH = Choroiditis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
ENTRY = Choroiditides
MN = C11.941.160.478
MN = C11.941.879.780.900.300
FX = Chorioretinitis
MH_TH = NLM (1964)
ST = T047
ST = T184
AN = of the eye, not of the choroid plexus; consider also CHORIORETINITIS
MS = Inflammation of the choroid.
PM = 66
HN = 66(64)
CATSH = CAT LIST
MR = 19910620
DA = 19990101
DC = 1
DX = 19660101
UI = D002833

*NEWRECORD
RECTYPE = D
MH = Christian Science
AQ = HI PX
ENTRY = Christian Scientists|T098|NON|REL|BIOETHICS (1994)|931129|abcdef
ENTRY = Christian Scientist
ENTRY = Science, Christian
ENTRY = Scientist, Christian
ENTRY = Scientists, Christian
MN = K01.844.188.431
MH_TH = BIOETHICS (1984)
ST = T078
AN = specify geographic location if pertinent
MS = A religion founded by Mary Baker Eddy in 1866 that was organized under the official name of the Church of Christ, Scientist. It includes the practice of spiritual healing.
MR = 20100625
DA = 19990101
DC = 1
UI = D002834

*NEWRECORD
RECTYPE = D
MH = Christianity
AQ = HI PX
PRINT ENTRY = Stigmata|T067|NON|REL|NLM (1997)|951128|abcdef
ENTRY = Christian Ethics|T078|NON|REL|BIOETHICS (1974)|900802|abcdef
ENTRY = Christian Ethic
ENTRY = Ethic, Christian
ENTRY = Ethics, Christian
MN = K01.844.188
MH_TH = POPLINE (1983)
ST = T078
AN = specify geog if pertinent
MS = The religion stemming from the life, teachings, and death of Jesus Christ: the religion that believes in God as the Father Almighty who works redemptively through the Holy Spirit for men's salvation and that affirms Jesus Christ as Lord and Savior who proclaimed to man the gospel of salvation. (From Webster, 3d ed)
HN = 1963
MR = 20020703
DA = 19990101
DC = 1
UI = D002835

*NEWRECORD
RECTYPE = D
MH = Hemophilia B
AQ = BL CF CI CL CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH UR US VE VI
PRINT ENTRY = Christmas Disease|T047|EPO|EQV|NLM (1999)|OMIM (2013)|ORD (2010)|971222|CHRISTMAS DIS|abcdeeefv
PRINT ENTRY = Factor IX Deficiency|T047|NON|EQV|OMIM (2013)|ORD (2010)|UNK (19XX)|740701|FACTOR VIIII DEFICIENCY|FACTOR IX DEFIC|abcdeeefsv
ENTRY = Deficiency, Factor IX|T047|NON|EQV|NLM (1992)|910617|DEFIC FACTOR IX|abcdefv
ENTRY = F9 Deficiency|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Haemophilia B|T047|NON|EQV|NLM (2003)|011212|abcdef
ENTRY = Hemophilia B Leyden|T047|EPO|EQV|NLM (2013)|OMIM (2013)|120619|abcdeef
ENTRY = Hemophilia B(M)|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = Plasma Thromboplastin Component Deficiency|T047|NON|EQV|OMIM (2013)|111115|abcdef
ENTRY = B, Hemophilia
ENTRY = Bs, Hemophilia
ENTRY = Deficiencies, F9
ENTRY = Deficiencies, Factor IX
ENTRY = Deficiency, F9
ENTRY = Disease, Christmas
ENTRY = F9 Deficiencies
ENTRY = Factor IX Deficiencies
ENTRY = Haemophilia Bs
ENTRY = Hemophilia Bs
ENTRY = Hemophilia Bs (M)
MN = C15.378.100.100.510
MN = C15.378.100.141.510
MN = C15.378.463.510
MN = C16.320.099.510
MN = C16.320.322.235
FX = Hemophilia A
MH_TH = NLM (1966)
MH_TH = OMIM (2013)
MH_TH = ORD (2010)
ST = T047
MS = A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008)
PM = 1999; see CHRISTMAS DISEASE 1966-1998; for HEMOPHILIA B see CHRISTMAS DISEASE 1974-1998; for Hemophilia B Leyden see FACTOR IX 1990-2012
HN = 1999(1966)
CATSH = CAT LIST
MR = 20120703
DA = 19990101
DC = 1
UI = D002836

*NEWRECORD
RECTYPE = D
MH = Chromaffin Granules
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Chromaffin Granule
ENTRY = Granule, Chromaffin
ENTRY = Granules, Chromaffin
MN = A06.224.161.500
MN = A11.284.430.214.190.500.207
MN = A11.284.430.214.190.875.190.190.207
MH_TH = NLM (1978)
ST = T026
PI = Chromaffin System (1966-1977)
PI = Cytoplasmic Granules (1966-1977)
MS = Organelles in CHROMAFFIN CELLS located in the adrenal glands and various other organs. These granules are the site of the synthesis, storage, metabolism, and secretion of EPINEPHRINE and NOREPINEPHRINE.
PM = 91; was see under CHROMAFFIN SYSTEM 1978-90
HN = 91(78); was see under CHROMAFFIN SYSTEM 1978-90
MR = 20060705
DA = 19770427
DC = 1
DX = 19910101
UI = D002837

*NEWRECORD
RECTYPE = D
MH = Chromaffin System
AQ = AB AH BS CH CY DE EM EN GD IM IN IR ME MI PA PH PP PS RA RE RI SE SU UL US VI
PRINT ENTRY = Argentaffin System|T022|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Argentaffin Systems
ENTRY = Chromaffin Systems
ENTRY = System, Argentaffin
ENTRY = System, Chromaffin
ENTRY = Systems, Argentaffin
ENTRY = Systems, Chromaffin
MN = A06.224
MH_TH = NLM (1966)
ST = T022
AN = /cytol: consider also specific CHROMAFFIN SYSTEM cell indentions
MS = The cells of the body which stain with chromium salts. They occur along the sympathetic nerves, in the adrenal gland, and in various other organs.
MR = 19960614
DA = 19990101
DC = 1
UI = D002838

*NEWRECORD
RECTYPE = D
MH = Chromans
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Dihydrobenzopyrans|T109|NON|EQV|UNK (19XX)|741111|abcdef
MN = D03.383.663.283.240
MN = D03.438.150.240
MH_TH = NLM (1975)
ST = T109
RN = 0
AN = do not confuse with CHROMONES
PI = Benzopyrans (1968-1974)
MS = Benzopyrans saturated in the 2 and 3 positions.
PM = 91; was see under BENZOPYRANS 1975-90
HN = 91(75); was see under BENZOPYRANS 1975-90
MR = 20150622
DA = 19741111
DC = 1
DX = 19910101
UI = D002839

*NEWRECORD
RECTYPE = D
MH = Chromates
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
MN = D01.220.150
MN = D01.248.497.158.235
MH_TH = NLM (1966)
ST = T197
RN = 0
MS = Salts of chromic acid containing the CrO(2-)4 radical.
MR = 19930604
DA = 19990101
DC = 1
UI = D002840

*NEWRECORD
RECTYPE = D
MH = Chromatiaceae
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
PRINT ENTRY = Bacteria, Purple Sulfur|T007|NON|EQV|NLM (2004)|021021|abcdef
PRINT ENTRY = Purple Sulfur Bacteria|T007|NON|EQV|NLM (2004)|021021|PURPLE SULFUR BACT|abcdefv
MN = B03.660.250.110
MH_TH = NLM (1975)
ST = T007
PI = Bacteria (1966-1974)
MS = A family of phototrophic purple sulfur bacteria that deposit globules of elemental sulfur inside their cells. They are found in diverse aquatic environments.
PM = 1976; see THIORHODACEAE 1975
HN = 1976
MR = 20090706
DA = 19750725
DC = 1
DX = 19760101
UI = D002841

*NEWRECORD
RECTYPE = D
MH = Chromatids
AQ = CH CL DE EN GE IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Chromatid
MN = A11.284.430.106.279.345.190.160.175
MN = G05.360.160.175
FX = Sister Chromatid Exchange
MH_TH = NLM (1968)
ST = T026
AN = A 11 qualif except /cytol; /genet permitted
PI = Chromosomes (1966-1967)
MS = Either of the two longitudinally adjacent threads formed when a eukaryotic chromosome replicates prior to mitosis. The chromatids are held together at the centromere. Sister chromatids are derived from the same chromosome. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
PM = 68
HN = 68
MR = 20080708
DA = 19990101
DC = 1
DX = 19680101
UI = D002842

*NEWRECORD
RECTYPE = D
MH = Chromatin
AQ = CH CL DE EN GE IM IP ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Chromatins
MN = A11.284.430.106.279.345.190.160.180
MN = D12.776.664.224
MN = G05.360.160.180
MH_TH = NLM (1972)
ST = T026
ST = T045
ST = T116
RN = 0
PI = Chromosomes (1966-1971)
PI = Sex Chromatin (1966-1971)
MS = The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell.
PM = 72
HN = 72
MR = 20080708
DA = 19990101
DC = 1
DX = 19720101
UI = D002843

*NEWRECORD
RECTYPE = D
MH = Chromatium
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.425.410.290
MN = B03.660.250.110.150
MH_TH = NLM (1966)
ST = T007
AN = in water
MS = A genus of gram-negative, ovoid to rod-shaped bacteria that is phototrophic. All species use ammonia as a nitrogen source. Some strains are found only in sulfide-containing freshwater habitats exposed to light while others may occur in marine, estuarine, and freshwater environments.
MR = 20090706
DA = 19990101
DC = 1
UI = D002844

*NEWRECORD
RECTYPE = D
MH = Chromatography
DE = CHROMATOGR
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Chromatographies
MN = E05.196.181
MH_TH = NLM (1966)
ST = T059
AN = GEN: prefer specifics; NIM; on Sephadex G = GEL FILTRATION see CHROMATOGRAPHY, GEL; on DEAE Sephadex = CHROMATOGRAPHY, ION EXCHANGE; DF: CHROMATOGR
MS = Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts.
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20130709
DA = 19990101
DC = 1
UI = D002845

*NEWRECORD
RECTYPE = D
MH = Chromatography, Affinity
DE = CHROMATOGR AFFINITY
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Chromatography, Bioaffinity|T059|NON|EQV|NLM (2007)|060307|abcdef
ENTRY = Affinity Chromatography|T059|NON|EQV|NLM (1995)|931012|AFFINITY CHROMATOGR|abcdefv
ENTRY = Bioaffinity Chromatography|T059|NON|EQV|NLM (2007)|060307|abcdef
MN = E05.196.181.400.170
MH_TH = NLM (1972)
ST = T059
AN = DF: CHROMATOGR AFFINITY
PI = Chromatography (1966-1971)
PI = appropriate substances used for binding
MS = A chromatographic technique that utilizes the ability of biological molecules to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 74
HN = 74(72)
CATSH = CAT LIST
MR = 20060705
DA = 19990101
DC = 1
DX = 19740101
UI = D002846

*NEWRECORD
RECTYPE = D
MH = Chromatography, Agarose
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Chromatography, Sepharose|T059|T062|NON|EQV|NLM (1993)|910924|CHROMATOGR SEPHAROSE|abbcdefv
ENTRY = Agarose Chromatography|T059|T062|NON|EQV|NLM (1995)|931012|AGAROSE CHROMATOGR|abbcdefv
ENTRY = Sepharose Chromatography|T059|T062|NON|EQV|NLM (1995)|931012|SEPHAROSE CHROMATOGR|abbcdefv
ENTRY = Agarose Chromatographies
ENTRY = Chromatographies, Agarose
ENTRY = Chromatographies, Sepharose
ENTRY = Sepharose Chromatographies
MN = E05.196.181.400.250.200
MH_TH = NLM (1975)
ST = T059
ST = T062
AN = a type of gel chromatogr; NIM; DF: CHROMATOGR AGAROSE
MS = A method of gel filtration chromatography using agarose, the non-ionic component of agar, for the separation of compounds with molecular weights up to several million.
PM = 91; was see under CHROMATOGRAPHY, GEL 1975-90
HN = 91(75); was see under CHROMATOGRAPHY, GEL 1975-90
CATSH = CAT LIST
MR = 20020702
DA = 19741111
DC = 1
DX = 19910101
UI = D002847

*NEWRECORD
RECTYPE = D
MH = Chromatography, DEAE-Cellulose
DE = CHROMATOGR DEAE CELLULOSE
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = DEAE-Cellulose Chromatography|T059|EQV|UNK (19XX)|740329|DEAE CELLULOSE CHROMATOGR|abdefv
ENTRY = Chromatography, DEAE Cellulose
ENTRY = DEAE Cellulose Chromatography
MN = E05.196.181.400.383.349
MH_TH = NLM (1970)
ST = T059
AN = a type of ion exchange chromatogr: do not confuse with chromatogr on DEAE Sephadex ( = CHROMATOGRAPHY, ION EXCHANGE); NIM; DF: CHROMATOGR DEAE CELLULOSE
PI = Chromatography (1966-1969)
MS = A type of ion exchange chromatography using diethylaminoethyl cellulose (DEAE-CELLULOSE) as a positively charged resin. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 70
HN = 70
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19700101
UI = D002848

*NEWRECORD
RECTYPE = D
MH = Chromatography, Gas
DE = CHROMATOGR GAS
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Chromatography, Gas-Liquid|T059|NON|REL|UNK (19XX)|781219|CHROMATOGR GAS LIQUID|abcdefv
ENTRY = Gas Chromatography|T059|NON|EQV|NLM (1995)|931012|GAS CHROMATOGR|abcdefv
ENTRY = Chromatographies, Gas
ENTRY = Chromatographies, Gas-Liquid
ENTRY = Chromatography, Gas Liquid
ENTRY = Gas Chromatographies
ENTRY = Gas-Liquid Chromatographies
ENTRY = Gas-Liquid Chromatography
MN = E05.196.181.349
MH_TH = NLM (1966)
ST = T059
AN = an anal chem technique; NIM; DF: CHROMATOGR GAS
MS = Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix.
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19660101
UI = D002849

*NEWRECORD
RECTYPE = D
MH = Chromatography, Gel
DE = CHROMATOGR GEL
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Chromatography, Exclusion|T059|NON|EQV|UNK (19XX)|760512|CHROMATOGR EXCLUSION|abcdefv
PRINT ENTRY = Chromatography, Gel Permeation|T059|NON|EQV|UNK (19XX)|750722|CHROMATOGR GEL PERMEATION|abcdefv
PRINT ENTRY = Chromatography, Molecular Sieve|T059|NON|NRW|UNK (19XX)|760422|CHROMATOGR MOL SIEVE|abcdefv
PRINT ENTRY = Gel Filtration|T059|NON|EQV|UNK (19XX)|750722|abcdef
PRINT ENTRY = Gel Filtration Chromatography|T059|NON|EQV|NLM (2003)|011219|GEL FILTRATION CHROMATOGR|abcdefv
ENTRY = Chromatography, Size Exclusion|T059|NON|NRW|NLM (2003)|010914|CHROMATOGR MOLECULAR SIEVE|abcdefv
ENTRY = Exclusion Chromatography|T059|NON|EQV|NLM (1995)|931012|EXCLUSION CHROMATOGR|abcdefv
ENTRY = Gel Chromatography|T059|NON|EQV|NLM (1995)|931012|GEL CHROMATOGR|abcdefv
ENTRY = Gel Permeation Chromatography|T059|NON|EQV|NLM (1995)|931012|GEL PERMEATION CHROMATOGR|abcdefv
ENTRY = Molecular Sieve Chromatography|T059|NON|NRW|NLM (1995)|931012|MOL SIEVE CHROMATOGR|abcdefv
ENTRY = Chromatography, Gel Filtration
ENTRY = Exclusion Chromatography, Size
ENTRY = Filtration Chromatography, Gel
ENTRY = Filtration, Gel
ENTRY = Sieve Chromatography, Molecular
ENTRY = Size Exclusion Chromatography
MN = E05.196.181.400.250
MH_TH = NLM (1976)
ST = T059
AN = DF: CHROMATOGR GEL
MS = Chromatography on non-ionic gels without regard to the mechanism of solute discrimination.
OL = use CHROMATOGRAPHY, GEL to search GEL FILTRATION 1966-75 & CHROMATOGRAPHY, EXCLUSION 1973-75
PM = 76; was GEL FILTRATION 1966-75; CHROMATOGRAPHY, GEL was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75
HN = 76; was GEL FILTRATION 1966-75; CHROMATOGRAPHY, GEL was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75
CATSH = CAT LIST
MR = 20020703
DA = 19750725
DC = 1
DX = 19760101
UI = D002850

*NEWRECORD
RECTYPE = D
MH = Chromatography, High Pressure Liquid
DE = CHROMATOGR HIGH PRESSURE LIQUID
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Chromatography, High Performance Liquid|T059|NON|EQV|UNK (19XX)|800519|CHROMATOGR HIGH PERFORMANCE LIQUID|abcdefv
PRINT ENTRY = Chromatography, High Speed Liquid|T059|NON|EQV|UNK (19XX)|800519|HSLC|abcdefv
PRINT ENTRY = Chromatography, Liquid, High Pressure|T059|NON|EQV|UNK (19XX)|800519|CHROMATOGR LIQUID HIGH PRESSURE|abcdefv
PRINT ENTRY = HPLC|T059|ABB|EQV|UNK (19XX)|880607|abcdef
MN = E05.196.181.400.300
MH_TH = NLM (1976)
ST = T059
AN = an anal chem technique; NIM; DF: note short X ref
PI = Chromatography (1966-1975)
MS = Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.
OL = use CHROMATOGRAPHY, HIGH PRESSURE LIQUID to search CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80
PM = 81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80
HN = 81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80
CATSH = CAT LIST
MR = 20020703
DA = 19750725
DC = 1
DX = 19760101
UI = D002851

*NEWRECORD
RECTYPE = D
MH = Chromatography, Ion Exchange
DE = CHROMATOGR ION EXCHANGE
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Chromatography, Ion-Exchange|T059|NON|EQV|UNK (19XX)|771221|abcdef
ENTRY = Ion-Exchange Chromatography|T059|NON|EQV|NLM (1995)|931012|ION EXCHANGE CHROMATOGR|abcdefv
ENTRY = Chromatographies, Ion Exchange
ENTRY = Chromatographies, Ion-Exchange
ENTRY = Ion Exchange Chromatographies
ENTRY = Ion Exchange Chromatography
ENTRY = Ion-Exchange Chromatographies
MN = E05.196.181.400.383
MH_TH = NLM (1966)
ST = T059
AN = an anal chem technique; NIM; DF: CHROMATOGR ION EXCHANGE
MS = Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins.
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19660101
UI = D002852

*NEWRECORD
RECTYPE = D
MH = Chromatography, Liquid
DE = CHROMATOGR LIQUID
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Liquid Chromatography|T059|NON|EQV|NLM (1995)|931012|LIQUID CHROMATOGR|abcdefv
MN = E05.196.181.400
MH_TH = NLM (1976)
ST = T059
AN = an anal chem technique; NIM; DF: CHROMATOGR LIQUID
PI = Chromatography (1966-1975)
MS = Chromatographic techniques in which the mobile phase is a liquid.
PM = 76
HN = 76
CATSH = CAT LIST
MR = 20020703
DA = 19750725
DC = 1
DX = 19760101
UI = D002853

*NEWRECORD
RECTYPE = D
MH = Chromatography, Paper
DE = CHROMATOGR PAPER
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Paper Chromatography|T059|NON|EQV|NLM (1995)|931012|PAPER CHROMATOGR|abcdefv
ENTRY = Chromatographies, Paper
ENTRY = Paper Chromatographies
MN = E05.196.181.400.454
MH_TH = NLM (1966)
ST = T059
AN = DF: CHROMATOGR PAPER
MS = An analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper (stationary phase) by their varied degree of solubility/mobility in the eluting solvent (mobile phase).
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19660101
UI = D002854

*NEWRECORD
RECTYPE = D
MH = Chromatography, Thin Layer
DE = CHROMATOGR THIN LAYER
AQ = CL EC ES HI IS MT SN ST TD UT VE
ENTRY = Chromatography, Thin-Layer|T059|NON|EQV|UNK (19XX)|771221|abcdef
ENTRY = Thin Layer Chromatography|T059|NON|EQV|NLM (1995)|931012|THIN LAYER CHROMATOGR|abcdefv
ENTRY = Chromatographies, Thin Layer
ENTRY = Chromatographies, Thin-Layer
ENTRY = Thin Layer Chromatographies
ENTRY = Thin-Layer Chromatographies
ENTRY = Thin-Layer Chromatography
MN = E05.196.181.400.537
MH_TH = NLM (1966)
ST = T059
AN = a type of liquid chromatogr; NIM; DF: CHROMATOGR THIN LAYER
MS = Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
PM = 66
HN = 66
CATSH = CAT LIST
MR = 20020703
DA = 19990101
DC = 1
DX = 19660101
UI = D002855

*NEWRECORD
RECTYPE = D
MH = Chromatophores
AQ = CH CL CY DE EN IM ME MI PA PH PS RA RE RI SE TR UL US VI
ENTRY = Chromatophore
MN = A11.436.265
FX = Pigmentation
MH_TH = NLM (1966)
ST = T025
AN = do not confuse with chromophores (chemical groups imparting color to a cpd); BACTERIAL CHROMATOPHORES is available
MS = The large pigment cells of fish, amphibia, reptiles and many invertebrates which actively disperse and aggregate their pigment granules. These cells include MELANOPHORES, erythrophores, xanthophores, leucophores and iridiophores. (In algae, chromatophores refer to CHLOROPLASTS. In phototrophic bacteria chromatophores refer to membranous organelles (BACTERIAL CHROMATOPHORES).)
MR = 20030709
DA = 19990101
DC = 1
UI = D002856

*NEWRECORD
RECTYPE = D
MH = Chromium
AQ = AD AE AG AN BL CF CH CL CT DF EC HI IM IP ME PD PH PK PO RE SD ST TO TU UR
MN = D01.268.556.175
MN = D01.268.956.124
MN = D01.552.544.175
PA = Trace Elements
FX = Chromium Isotopes
FX = Chromium Radioisotopes
MH_TH = FDA SRS (2014)
MH_TH = NLM (1966)
ST = T123
ST = T131
ST = T196
N1 = Chromium
RN = 0R0008Q3JB
RR = 7440-47-3 (Chromium)
AN = Cr-52
MS = A trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens (NTP85-002,1985), chromium and some of its compounds have been listed as known carcinogens.
MR = 20130708
DA = 19990101
DC = 1
UI = D002857

*NEWRECORD
RECTYPE = D
MH = Chromium Alloys
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Chromium-Cobalt Alloys|T122|T197|NON|NRW|UNK (19XX)|810513|abbcdef
PRINT ENTRY = Chromium-Nickel Alloys|T122|T197|NON|NRW|UNK (19XX)|810513|abbcdef
PRINT ENTRY = Cobalt-Chromium Alloys|T122|T197|NON|NRW|UNK (19XX)|771201|abbcdef
PRINT ENTRY = Nickel-Chromium Alloys|T122|T197|NON|NRW|UNK (19XX)|810513|abbcdef
ENTRY = Alloys, Chromium
ENTRY = Alloys, Chromium-Cobalt
ENTRY = Alloys, Chromium-Nickel
ENTRY = Alloys, Cobalt-Chromium
ENTRY = Alloys, Nickel-Chromium
ENTRY = Chromium Cobalt Alloys
ENTRY = Chromium Nickel Alloys
ENTRY = Cobalt Chromium Alloys
ENTRY = Nickel Chromium Alloys
MN = D01.220.175
MN = D01.552.033.182
MN = D25.058.224
MN = D25.339.208.224
MN = J01.637.051.058.224
MN = J01.637.051.339.208.224
FX = Dental Materials
MH_TH = NLM (1965)
ST = T122
ST = T197
RN = 0
AN = used in dent technol & orthopedics; D25-26 qualif
MS = Specific alloys not less than 85% chromium and nickel or cobalt, with traces of either nickel or cobalt, molybdenum, and other substances. They are used in partial dentures, orthopedic implants, etc.
OL = use CHROMIUM ALLOYS to search CHROMIUM-COBALT ALLOYS 1966-81 thru 1966
PM = 82; was CHROMIUM-COBALT ALLOYS 1965-81
HN = 82; was CHROMIUM-COBALT ALLOYS 1965-81
MR = 20060705
DA = 19990101
DC = 1
DX = 19650101
UI = D002858

*NEWRECORD
RECTYPE = D
MH = Chromium Isotopes
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Isotopes, Chromium
MN = D01.496.212
MH_TH = NLM (1966)
ST = T196
RN = 0
AN = Cr-50, 53, 54; NIM
MS = Stable chromium atoms that have the same atomic number as the element chromium, but differ in atomic weight. Cr-50, 53, and 54 are stable chromium isotopes.
MR = 20000622
DA = 19990101
DC = 1
UI = D002859

*NEWRECORD
RECTYPE = D
MH = Chromium Radioisotopes
AQ = AD AE AG AN BL CF CH CL CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Radioisotopes, Chromium
MN = D01.496.212.349
MN = D01.496.749.213
MH_TH = NLM (1974)
ST = T196
RN = 0
AN = Cr-46-49,51,55,56; for routine use as tracer, use no qualifiers
MS = Unstable isotopes of chromium that decay or disintegrate emitting radiation. Cr atoms with atomic weights of 46-49, 51, 55, and 56 are radioactive chromium isotopes.
OL = search CHROMIUM ISOTOPES 1966-73
PM = 74
HN = 74
MR = 20150605
DA = 19990101
DC = 1
DX = 19740101
UI = D002860

*NEWRECORD
RECTYPE = D
MH = Chromobacterium
AQ = CH CL CY DE EN GD GE IM IP ME PH PY RE UL VI
MN = B03.440.450.360
MN = B03.660.075.525.100
MH_TH = NLM (1966)
ST = T007
AN = in soil & water
MS = A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria occurring in soil and water. Its organisms are generally nonpathogenic, but some species do cause infections of mammals, including humans.
MR = 20090706
DA = 19990101
DC = 1
UI = D002861

*NEWRECORD
RECTYPE = D
MH = Chromoblastomycosis
AQ = BL CF CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SU TH TM UR US VE VI
PRINT ENTRY = Chromomycosis|T047|NON|EQV|UNK (19XX)|760515|abcdef
PRINT ENTRY = Dermatitis Verrucosa|T047|NON|EQV|UNK (19XX)|740329|abcdef
ENTRY = Chromoblastomycoses
ENTRY = Chromomycoses
MN = C01.539.800.200.110
MN = C01.703.295.182
MN = C17.800.838.208.241
MH_TH = NLM (1966)
ST = T047
AN = fungus dis of skin; coord IM with causative agent (IM)
MS = Scaly papule or warty growth, caused by five fungi, that spreads as a result of satellite lesions affecting the foot or leg. The extremity may become swollen and, at its distal portion, covered with various nodular, tumorous, verrucous lesions that resemble cauliflower. In rare instances, the disease may begin on the hand or wrist and involve the entire upper extremity. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p362)
CATSH = CAT LIST
MR = 19930602
DA = 19990101
DC = 1
UI = D002862

*NEWRECORD
RECTYPE = D
MH = Chromogenic Compounds
DE = CHROMOGENIC CPDS
AQ = AD AE AN CH CL CS CT EC HI IP ME PD PK PO RE SD ST TO TU
PRINT ENTRY = Chromogenic Substrates|T130|NON|NRW|UNK (19XX)|800402|abcdef
ENTRY = Compounds, Chromogenic
ENTRY = Substrates, Chromogenic
MN = D27.720.233.174
MN = D27.720.470.410.200
MH_TH = NLM (1981)
ST = T130
RN = 0
AN = "colorless ... precursors that may be transformed ... into colored cpds; used in biochem assays & ... as indicators"; D25-26 qualif; DF: CHROMOGENIC CPDS
MS = Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens).
PM = 81
HN = 81
MR = 20150622
DA = 19800402
DC = 1
DX = 19810101
UI = D002863

*NEWRECORD
RECTYPE = D
MH = Chromogranins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Secretogranins|T116|T124|NON|EQV|NLM (2007)|abbcde
ENTRY = Granins|T116|T124|NON|EQV|NLM (2007)|050607|abbcdef
MN = D12.776.641.199
MN = D12.776.811.185
MH_TH = NLM (1973)
ST = T116
ST = T124
RN = 0
PI = Chromaffin System (1966-1972)
PI = Nerve Tissue Proteins (1966-1972)
MS = A group of acidic proteins that are major components of SECRETORY GRANULES in the endocrine and neuroendocrine cells. They play important roles in the aggregation, packaging, sorting, and processing of secretory protein prior to secretion. They are cleaved to release biologically active peptides. There are various types of granins, usually classified by their sources.
PM = 1991; see NERVE TISSUE PROTEINS 1973-1990; SECRETOGRANINS was indexed under CHROMOGRANINS 1985-2006
HN = 1991(1973)
MR = 20060705
DA = 19990101
DC = 1
DX = 19910101
UI = D002864

*NEWRECORD
RECTYPE = D
MH = Chromomycins
AQ = AD AE AG AI AN BI BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
ENTRY = Chromomycin|T109|T121|T130|NON|NRW|UNK (19XX)|800523|abbbcdef
MN = D09.408.210
PA = Antibiotics, Antineoplastic
PA = Nucleic Acid Synthesis Inhibitors
MH_TH = NLM (1972)
ST = T109
ST = T121
ST = T130
RN = 0
AN = antineoplastic antibiotics
PI = Antibiotics, Antineoplastic (1967-1971)
MS = A complex of several closely related glycosidic antibiotics from Streptomyces griseus. The major component, CHROMOMYCIN A3, is used as a fluorescent stain of DNA where it attaches and inhibits RNA synthesis. It is also used as an antineoplastic agent, especially for solid tumors.
PM = 73
HN = 73(72)
MR = 20040707
DA = 19990101
DC = 1
DX = 19730101
UI = D002865

*NEWRECORD
RECTYPE = D
MH = Chromonar
AQ = AA AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = Carbochromen|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
PRINT ENTRY = Carbocromen|T109|T121|NON|EQV|FDA SRS (2014)|INN (19XX)|741111|abbcdeef
ENTRY = Carbochromene|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Carbocromene|T109|T121|NON|EQV|UNK (19XX)|741111|abbcdef
ENTRY = Cardiocap|T109|T121|TRD|NRW|UNK (19XX)|801203|abbcdef
ENTRY = Chromonar Hydrochloride|T109|T121|NON|NRW|FDA SRS (2014)|USAN (1965)|941118|abbcdeef
ENTRY = Intensain|T109|T121|TRD|NRW|UNK (19XX)|801205|abbcdef
ENTRY = Intercordin|T109|T121|TRD|NRW|UNK (19XX)|821206|abbcdef
ENTRY = Hydrochloride, Chromonar
MN = D03.383.663.283.446.280
MN = D03.438.150.446.280
PA = Vasodilator Agents
MH_TH = FDA SRS (2014)
MH_TH = NLM (1975)
ST = T109
ST = T121
N1 = Acetic acid, ((3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy)-, ethyl ester
RN = R0C9NIE5JJ
RR = 52C937V399
RR = 655-35-6 (HCl)
RR = 804-10-4 (Chromonar)
PI = Coumarins (1970-1974)
PI = Diethylamines (1974)
PI = Glycolates (1970-1974)
MS = A coronary vasodilator agent.
PM = 91; was see under COUMARINS 1975-90
HN = 91(75); was see under COUMARINS 1975-90
MR = 20150622
DA = 19741119
DC = 1
DX = 19910101
UI = D002866

*NEWRECORD
RECTYPE = D
MH = Chromones
AQ = AD AE AG AI AN BL CF CH CL CS CT EC HI IM IP ME PD PK PO RE SD ST TO TU UR
PRINT ENTRY = 1,4-Benzopyrones|T109|NON|EQV|UNK (19XX)|760520|BENZOPYRONES 01 04|abcdefs
ENTRY = 1,4 Benzopyrones
MN = D03.383.663.283.266
MN = D03.438.150.266
MH_TH = NLM (1966)
ST = T109
RN = 0
AN = do not confuse with CHROMANS
MR = 20150622
DA = 19990101
DC = 1
UI = D002867

*NEWRECORD
RECTYPE = D
MH = Chromosomal Proteins, Non-Histone
DS = CHROMOSOMAL PROTEINS NONHISTONE
AQ = AD AE AG AI AN BI BL CF CH CL CS CT DE DF EC GE HI IM IP ME PD PH PK PO RE SD SE ST TO TU UL UR
PRINT ENTRY = Non-Histone Chromosomal Proteins|T116|T123|NON|EQV|UNK (19XX)|770912|NONHISTONE CHROMOSOMAL PROTEINS|abbcdefs
ENTRY = Chromosomal Proteins, Non Histone|T116|T123|NON|EQV|UNK (19XX)|780203|abbcdef
ENTRY = Chromosomal Proteins, Nonhistone|T116|T123|NON|EQV|UNK (19XX)|771207|abbcdef
ENTRY = Non-Histone Chromosomal Phosphoproteins|T116|T123|NON|NRW|UNK (19XX)|850103|abbcdef
ENTRY = Chromosomal Phosphoproteins, Non-Histone
ENTRY = Non Histone Chromosomal Phosphoproteins
ENTRY = Non Histone Chromosomal Proteins
ENTRY = Nonhistone Chromosomal Proteins
ENTRY = Proteins, Non-Histone Chromosomal
MN = D12.776.660.235
MN = D12.776.664.235
MH_TH = NLM (1977)
ST = T116
ST = T123
RN = 0
PI = Chromosomes (1966-1976)
PI = Nucleoproteins (1966-1976)
MS = Nucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens.
PM = 77
HN = 77
MR = 20050630
DA = 19760416
DC = 1
DX = 19770101
UI = D002868

*NEWRECORD
RECTYPE = D
MH = Chromosome Aberrations
AQ = CI CL DE EM RE SN VE
PRINT ENTRY = Autosome Abnormalities|T019|NON|NRW|UNK (19XX)|800522|AUTOSOME ABNORM|abcdefv
PRINT ENTRY = Cytogenetic Aberrations|T049|NON|EQV|NLM (2003)|020520|abcdef
ENTRY = Abnormalities, Autosome|T019|NON|NRW|UNK (19XX)|800522|ABNORM AUTOSOME|abcdefv
ENTRY = Abnormalities, Chromosomal|T049|NON|EQV|NLM (1994)|ORD (2010)|930204|ABNORM CHROMOSOMAL|abcdeefv
ENTRY = Abnormalities, Chromosome|T049|NON|EQV|UNK (19XX)|800522|ABNORM CHROMOSOME|abcdefv
ENTRY = Chromosomal Aberrations|T049|NON|EQV|NLM (2002)|010102|abcdef
ENTRY = Chromosome Abnormalities|T049|NON|EQV|BIOETHICS (1974)|POPLINE (1978)|990101|CHROMOSOME ABNORM|abcdeefv
ENTRY = Cytogenetic Abnormalities|T049|NON|EQV|NLM (2003)|020520|abcdef
ENTRY = Aberration, Chromosomal
ENTRY = Aberration, Chromosome
ENTRY = Aberration, Cytogenetic
ENTRY = Aberrations, Chromosomal
ENTRY = Aberrations, Chromosome
ENTRY = Aberrations, Cytogenetic
ENTRY = Abnormalities, Cytogenetic
ENTRY = Abnormality, Autosome
ENTRY = Abnormality, Chromosomal
ENTRY = Abnormality, Chromosome
ENTRY = Abnormality, Cytogenetic
ENTRY = Autosome Abnormality
ENTRY = Chromosomal Aberration
ENTRY = Chromosomal Abnormalities
ENTRY = Chromosomal Abnormality
ENTRY = Chromosome Aberration
ENTRY = Chromosome Abnormality
ENTRY = Cytogenetic Aberration
ENTRY = Cytogenetic Abnormality
MN = C23.550.210
MN = G05.365.590.175
FX = Chromosome Disorders
FX = Cytogenetic Analysis
MH_TH = NLM (1968)
MH_TH = ORD (2010)
ST = T049
AN = coordinate IM with specific numbered chromosome or sex chromosome (IM) but not with CHROMOSOMES, HUMAN
PI = Chromosome Abnormalities (1966-1967)
MS = Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS.
PM = 1968; for CHROMOSOME ABNORMALITIES see CHROMOSOME ABNORMALITIES 1963-2001; for AUTOSOME ABNORMALITIES see CHROMOSOME ABNORMALITIES 1963-2001
HN = 1968; for CHROMOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001; for AUTOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001
CATSH = CAT LIST
MR = 20110624
DA = 19990101
DC = 1
DX = 19680101
UI = D002869

*NEWRECORD
RECTYPE = D
MH = Chromosome Banding
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Banding, Chromosome|T059|T063|NON|EQV|UNK (19XX)|780313|abbcdef
ENTRY = Bandings, Chromosome
ENTRY = Chromosome Bandings
MN = E01.370.225.500.385.130
MN = E01.370.225.500.620.670.130
MN = E01.370.225.750.600.670.130
MN = E05.200.500.385.130
MN = E05.200.500.620.670.130
MN = E05.200.750.600.670.130
MN = E05.242.385.130
MN = E05.393.285.130
MH_TH = NLM (1979)
ST = T059
ST = T063
PI = Chromosome Aberrations (1968-1978)
PI = Chromosomes (1966-1978)
PI = Staining (1966-1978)
PI = specific chromosome (1966-1978)
PI = specific dye (1966-1978)
MS = Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping.
PM = 79
HN = 79
CATSH = CAT LIST
MR = 20150601
DA = 19780313
DC = 1
DX = 19790101
UI = D002871

*NEWRECORD
RECTYPE = D
MH = Chromosome Deletion
PRINT ENTRY = Monosomy, Partial|T049|NON|REL|UNK (19XX)|840405|abcdef
PRINT ENTRY = Partial Monosomy|T049|NON|REL|UNK (19XX)|840405|abcdef
ENTRY = Deletion, Chromosome
ENTRY = Deletions, Chromosome
ENTRY = Monosomies, Partial
ENTRY = Partial Monosomies
MN = C23.550.210.050.500.500
MN = G05.355.600.800.180
MN = G05.365.590.029.530.175
MN = G05.365.590.175.050.500.500
MN = G05.365.590.762.180
MN = G05.700.131.500.500
FX = Gene Deletion
MH_TH = NLM (1975)
ST = T049
AN = coordinate IM with specific numbered chromosome or sex chromosome (IM) but not with CHROMOSOMES, HUMAN
PI = Chromosome Aberrations (1968-1974)
PI = Chromosome Abnormalities (1966-1967)
MS = Actual loss of portion of a chromosome.
PM = 78; was see under CHROMOSOME ABERRATIONS 1975-77
HN = 78(75); was see under CHROMOSOME ABERRATIONS 1975-77
CATSH = CAT LIST
MR = 20100625
DA = 19741111
DC = 1
DX = 19780101
UI = D002872

*NEWRECORD
RECTYPE = D
MH = Chromosome Fragility
AQ = DE ES GE IM PH RE
ENTRY = Chromosomal Fragility|T049|NON|EQV|NLM (2004)|021213|abcdef
ENTRY = Fragility, Chromosomal
ENTRY = Fragility, Chromosome
MN = C23.550.210.110.180
MN = C23.550.362.180.180
MN = G05.365.590.175.165.180
MN = G05.370.180.180
FX = Chromosome Breakage
FX = Chromosome Fragile Sites
FX = Fragile X Syndrome
FX = Trinucleotide Repeat Expansion
MH_TH = NLM (1982)
ST = T049
PI = Chromosome Aberrations (1968-1981)
PI = Chromosomes (1966-1967)
MS = Susceptibility of chromosomes to breakage leading to translocation; CHROMOSOME INVERSION; SEQUENCE DELETION; or other CHROMOSOME BREAKAGE related aberrations.
PM = 82
HN = 82
CATSH = CAT LIST
MR = 20080708
DA = 19810223
DC = 1
DX = 19820101
UI = D002873

*NEWRECORD
RECTYPE = D
MH = Chromosome Mapping
AQ = CL EC ES HI IS MT SN ST TD UT VE
PRINT ENTRY = Gene Mapping|T059|T063|NON|EQV|NLM (1990)|890214|abbcdef
PRINT ENTRY = Linkage Mapping|T059|T063|NON|EQV|NLM (1990)|890511|abbcdef
ENTRY = Genome Mapping|T062|NON|BRD|BIOETHICS (1989)|900802|abcdef
ENTRY = Chromosome Mappings
ENTRY = Gene Mappings
ENTRY = Genome Mappings
ENTRY = Linkage Mappings
ENTRY = Mapping, Chromosome
ENTRY = Mapping, Gene
ENTRY = Mapping, Genome
ENTRY = Mapping, Linkage
ENTRY = Mappings, Chromosome
ENTRY = Mappings, Gene
ENTRY = Mappings, Genome
ENTRY = Mappings, Linkage
MN = E05.393.183
FX = Cytogenetic Analysis
FX = Gene Order
FX = Polymorphism, Restriction Fragment Length
FX = Synteny
MH_TH = NLM (1965)
ST = T059
ST = T063
MS = Any method used for determining the location of and relative distances between genes on a chromosome.
PM = 1967; for GENOME MAPPING see HUMAN GENOME PROJECT 1990-2001
HN = 1967(1965); for GENOME MAPPING use HUMAN GENOME PROJECT 1990-2001
CATSH = CAT LIST
MR = 20100625
DA = 19990101
DC = 1
DX = 19670101
UI = D002874

*NEWRECORD
RECTYPE = D
MH = Chromosomes
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
ENTRY = Chromosome
MN = A11.284.187
MN = A11.284.430.106.279.345.190
MN = G05.360.162
FX = Karyotyping
EC = abnormalities:Chromosome Aberrations
MH_TH = NLM (1966)
ST = T026
AN = GEN or unspecified; prefer specifics
MS = In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
MR = 20080708
DA = 19990101
DC = 1
UI = D002875

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Bacterial
DE = CHROMOSOMES BACT
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
ENTRY = Bacterial Chromosome|T026|NON|EQV|NLM (1992)|901103|BACT CHROMOSOME|abcdefv
ENTRY = Bacterial Chromosomes|T026|NON|EQV|NLM (1992)|901103|BACT CHROMOSOMES|abcdefv
ENTRY = Chromosome, Bacterial|T026|NON|EQV|NLM (1992)|901103|CHROMOSOME BACT|abcdefv
MN = A11.284.187.190
MN = A20.812
MN = G05.360.162.190
MH_TH = NLM (1968)
ST = T026
AN = A 11 qualif except /cytol; /genet permitted; coord IM with specific bact /genet (IM); DF: CHROMOSOMES BACT
PI = Chromosomes (1966-1967)
MS = Structures within the nucleus of bacterial cells consisting of or containing DNA, which carry genetic information essential to the cell.
PM = 68
HN = 68
MR = 20090706
DA = 19990101
DC = 1
DX = 19680101
UI = D002876

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
ENTRY = Chromosome, Human
ENTRY = Human Chromosome
ENTRY = Human Chromosomes
MN = A11.284.187.520.300
MN = G05.360.162.520.300
MH_TH = NLM (1978)
ST = T026
AN = GEN only: prefer specifics; do not coord with pre-coord chromosome terms, such as CHROMOSOME ABERRATIONS; CHROMOSOMAL PROTEINS, NON-HISTONE; etc.: check tag HUMANS will serve for these
PI = Chromosomes (1966-1977)
MS = Very long DNA molecules and associated proteins, HISTONES, and non-histone chromosomal proteins (CHROMOSOMAL PROTEINS, NON-HISTONE). Normally 46 chromosomes, including two sex chromosomes are found in the nucleus of human cells. They carry the hereditary information of the individual.
PM = 78
HN = 78
MR = 20130709
DA = 19770427
DC = 1
DX = 19780101
UI = D002877

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 1
DS = CHROMOSOMES HUMAN PAIR 01
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 1|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 01|abcdefs
MN = A11.284.187.520.300.235.240
MN = G05.360.162.520.300.235.240
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 1-3 (1968-1986)
MS = A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002878

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 10
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 10|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.325.350
MN = G05.360.162.520.300.325.350
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 6-12 (1968-1986)
MS = A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002879

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 11
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 11|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.325.355
MN = G05.360.162.520.300.325.355
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 6-12 (1968-1986)
MS = A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002880

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 12
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 12|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.325.360
MN = G05.360.162.520.300.325.360
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 6-12 (1968-1986)
MS = A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002881

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 13
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 13|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.370.375
MN = G05.360.162.520.300.370.375
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 13-15 (1968-1986)
MS = A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002882

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 14
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 14|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.370.380
MN = G05.360.162.520.300.370.380
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 13-15 (1968-1986)
MS = A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002883

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 15
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 15|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.370.385
MN = G05.360.162.520.300.370.385
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 13-15 (1968-1986)
MS = A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002884

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 16
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 16|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.415.420
MN = G05.360.162.520.300.415.420
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 16-18 (1968-1986)
MS = A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002885

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 17
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 17|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.415.425
MN = G05.360.162.520.300.415.425
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 16-18 (1968-1986)
MS = A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002886

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 18
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 18|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.415.430
MN = G05.360.162.520.300.415.430
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 16-18 (1968-1986)
MS = A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002887

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 19
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 19|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.460.465
MN = G05.360.162.520.300.460.465
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 19-20 (1968-1986)
MS = A specific pair of GROUP F CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002888

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 2
DS = CHROMOSOMES HUMAN PAIR 02
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 2|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 02|abcdefs
MN = A11.284.187.520.300.235.245
MN = G05.360.162.520.300.235.245
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 1-3 (1968-1986)
MS = A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002889

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 20
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 20|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.460.470
MN = G05.360.162.520.300.460.470
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 19-20 (1968-1986)
MS = A specific pair of GROUP F CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002890

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 21
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 21|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.505.510
MN = G05.360.162.520.300.505.510
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 21-22 (1968-1986)
MS = A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002891

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 22
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 22|T026|NON|EQV|UNK (19XX)|860619|abcdef
MN = A11.284.187.520.300.505.515
MN = G05.360.162.520.300.505.515
FX = Philadelphia Chromosome
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 21-22 (1968-1986)
MS = A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002892

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 3
DS = CHROMOSOMES HUMAN PAIR 03
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 3|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 03|abcdefs
MN = A11.284.187.520.300.235.250
MN = G05.360.162.520.300.235.250
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 1-3 (1968-1986)
MS = A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002893

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 4
DS = CHROMOSOMES HUMAN PAIR 04
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 4|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 04|abcdefs
MN = A11.284.187.520.300.280.285
MN = G05.360.162.520.300.280.285
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 4-5 (1968-1986)
MS = A specific pair of GROUP B CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002894

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 5
DS = CHROMOSOMES HUMAN PAIR 05
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 5|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 05|abcdefs
MN = A11.284.187.520.300.280.290
MN = G05.360.162.520.300.280.290
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 4-5 (1968-1986)
MS = One of the two pairs of human chromosomes in the group B class (CHROMOSOMES, HUMAN, 4-5).
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002895

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 6
DS = CHROMOSOMES HUMAN PAIR 06
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 6|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 06|abcdefs
MN = A11.284.187.520.300.325.330
MN = G05.360.162.520.300.325.330
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 6-12 (1968-1986)
MS = A specific pair GROUP C CHROMSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002896

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 7
DS = CHROMOSOMES HUMAN PAIR 07
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 7|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 07|abcdefs
MN = A11.284.187.520.300.325.335
MN = G05.360.162.520.300.325.335
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 6-12 (1968-1986)
MS = A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002897

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 8
DS = CHROMOSOMES HUMAN PAIR 08
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 8|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 08|abcdefs
MN = A11.284.187.520.300.325.340
MN = G05.360.162.520.300.325.340
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 6-12 (1968-1986)
MS = A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002898

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, Pair 9
DS = CHROMOSOMES HUMAN PAIR 09
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosome 9|T026|NON|EQV|UNK (19XX)|860619|CHROMOSOME 09|abcdefs
MN = A11.284.187.520.300.325.345
MN = G05.360.162.520.300.325.345
MH_TH = NLM (1987)
ST = T026
PI = Chromosomes, Human, 6-12 (1968-1986)
MS = A specific pair of GROUP C CHROMSOMES of the human chromosome classification.
PM = 87
HN = 87
MR = 20080708
DA = 19860619
DC = 1
DX = 19870101
UI = D002899

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, 1-3
DS = CHROMOSOMES HUMAN 01 03
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosomes A|T026|NON|EQV|UNK (19XX)|760512|abcdef
ENTRY = Group A Chromosomes|T026|NON|EQV|NLM (2002)|010104|abcdef
ENTRY = Chromosome, Group A
ENTRY = Chromosomes, Group A
ENTRY = Group A Chromosome
MN = A11.284.187.520.300.235
MN = G05.360.162.520.300.235
MH_TH = NLM (1968)
ST = T026
PI = Chromosomes (1966-1967)
MS = The large, metacentric human chromosomes, called group A in the human chromosome classification. This group consists of chromosome pairs 1, 2, and 3.
PM = 68
HN = 68
MR = 20130709
DA = 19990101
DC = 1
DX = 19680101
UI = D002900

*NEWRECORD
RECTYPE = D
MH = Chromosomes, Human, 13-15
AQ = CH CL DE EN GE IM ME MI PH PS RA RE RI SE UL US VI
PRINT ENTRY = Chromosomes D|T026|NON|EQV|UNK (19XX)|760512|abcdef
PRINT ENTRY = Group D Chromosomes|T026|NON|EQV|